PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bhamidipati, CM; Mehta, GS; Moehle, CW; Meher, AK; Su, G; Vigneshwar, NG; Barbery, C; Sharma, AK; Kron, IL; Laubach, VE; Owens, GK; Upchurch, GR; Ailawadi, G				Bhamidipati, Castigliano M.; Mehta, Gaurav S.; Moehle, Christopher W.; Meher, Akshaya K.; Su, Gang; Vigneshwar, Navin G.; Barbery, Carlos; Sharma, Ashish K.; Kron, Irving L.; Laubach, Victor E.; Owens, Gary K.; Upchurch, Gilbert R., Jr.; Ailawadi, Gorav			Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms	FASEB JOURNAL			English	Article						immune modulation; CD4(+); T lymphocytes; GPCR signaling; physiological regulation; inflammation	TNF-ALPHA; CGS 21680; T-CELLS; AGONIST; ACTIVATION; ISCHEMIA; PATHOGENESIS; MONOCYTE; MICE; RECRUITMENT	Activation of the adenosine 2A receptor (A(2A)R) reduces inflammation in models of acute injury but contribution in development of chronic abdominal aortic aneurysms (AAAs) is unknown. Elastase perfusion to induce AAA formation in A(2A)R-knockout (A(2A)RKO) and C57BL6/J wild-type (WT) mice resulted in nearly 100% larger aneurysms in A2ARKO compared toWT at d 14 (P<0.05), with evidence of greater elastin fragmentation, more immune cell infiltration, and increased matrix metallatoproteinase (MMP) 9 expression (P<0.05). Separately, exogenous A(2A)R antagonism in elastase-perfused WT mice also resulted in larger aneurysms (P<0.05), while A(2A)R agonism limited aortic dilatation (P<0.05). Activated Thy-1.2(+) T lymphocytes from WT mice treated in vitro with A(2A)R antagonist increased cytokine production, and treatment with A(2A)R agonist decreased cytokine production (P<0.05 for all). Primary activated CD4(+) T lymphocytes from A(2A)RKO mice exhibited greater chemotaxis (P<0.05). A(2A)R antagonist increased chemotaxis of activated CD4(+) cells from WT mice in vitro, and A(2A)R agonist reduced this effect (P<0.05). A(2A)R activation attenuates AAA formation partly by inhibiting immune cell recruitment and reducing elastin fragmentation. These findings support augmenting A(2A)R signaling as a putative target for limiting aneurysm formation.	[Bhamidipati, Castigliano M.; Mehta, Gaurav S.; Moehle, Christopher W.; Meher, Akshaya K.; Vigneshwar, Navin G.; Barbery, Carlos; Sharma, Ashish K.; Kron, Irving L.; Laubach, Victor E.] Univ Virginia, Sch Med, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA; [Su, Gang; Upchurch, Gilbert R., Jr.] Univ Virginia, Sch Med, Div Vasc & Endovasc Surg, Dept Surg, Charlottesville, VA 22908 USA; [Owens, Gary K.; Upchurch, Gilbert R., Jr.] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Owens, Gary K.; Upchurch, Gilbert R., Jr.; Ailawadi, Gorav] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Ailawadi, Gorav] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ailawadi, G (corresponding author), Univ Virginia Hlth Syst, Dept Surg, Dept Biomed Engn, POB 800679, Charlottesville, VA 22908 USA.	gorav@virginia.edu	Laubach, Victor E./E-8818-2015; Meher, Akshaya/ABC-9797-2021	Laubach, Victor E./0000-0001-9673-5383; Meher, Akshaya/0000-0002-2802-9599; /0000-0003-2180-9178	U.S. National Institutes of Health (NIH) [K08HL098560, T32HL007849]; Thoracic Surgery Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098560, T32HL007849, T32HL007284, R01HL087867, R01HL057353] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thoracic Surgery Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) grants to G.A. (K08HL098560) and I.L.K. (T32HL007849). The Research and Education Grant from the Thoracic Surgery Foundation also supported G.A. The authors thank M. Bevard for her technical expertise and advice for histology. The authors also appreciate the administrative contributions of A. J. Herring and C. S. Dodson. The authors are grateful to Dr. M. Angulo (University of Virginia) and Dr. C. A. Whatling (AstraZeneca, Molndal, Sweden) for critical review and editorial commentary. In addition, the authors thank Dr. M. Angulo (University of Virginia) for her technical expertise in the timely resubmission of revisions. The authors also acknowledge the initial work of Dr. Hong Pei (Joel Linden Laboratory, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA) in the area of A<INF>2A</INF>R and aortic aneurysms. The authors declare no competing financial interests. This work was presented at the Annual Scientific Sessions of the American Heart Association 2010 (Chicago, IL, USA).	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Anvari F, 2010, J THORAC CARDIOV SUR, V140, P871, DOI 10.1016/j.jtcvs.2010.06.051; Applied Research Ethics National Association/Office of Laboratory Animal Welfare, 2002, I AN CAR US COMM GUI; BRUNS RF, 1990, ANN NY ACAD SCI, V603, P211; Cassada DC, 2002, ANN THORAC SURG, V74, P846, DOI 10.1016/S0003-4975(02)03793-1; Chehata VJ, 2011, CELL IMMUNOL, V267, P39, DOI 10.1016/j.cellimm.2010.11.002; Curci JA, 2004, J CLIN INVEST, V114, P168, DOI 10.1172/JCI200422309; Duftner C, 2005, ARTERIOSCL THROM VAS, V25, P1347, DOI 10.1161/01.ATV.0000167520.41436.c0; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Emaminia A, 2011, ANN THORAC SURG, V92, P1840, DOI 10.1016/j.athoracsur.2011.06.062; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Gazoni LM, 2010, J THORAC CARDIOV SUR, V140, P440, DOI 10.1016/j.jtcvs.2010.03.002; Genovese T, 2009, SHOCK, V32, P578, DOI 10.1097/SHK.0b013e3181a20792; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Hannawa KK, 2005, CIRCULATION, V112, P241, DOI 10.1161/CIRCULATIONAHA.105.535625; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; Heron MP, 2009, NATL VITAL STAT REPO, V57, P14; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; LaPar DJ, 2011, J THORAC CARDIOV SUR, V142, P887, DOI 10.1016/j.jtcvs.2011.06.015; Lappas CM, 2005, EXPERT OPIN INV DRUG, V14, P797, DOI 10.1517/13543784.14.7.797; Laubach VE, 2011, EXPERT OPIN THER TAR, V15, P103, DOI 10.1517/14728222.2011.541441; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Linden J, 2011, ADV PHARMACOL, V61, P95, DOI 10.1016/B978-0-12-385526-8.00004-7; Mazzon E, 2011, J RHEUMATOL, V38, P2119, DOI 10.3899/jrheum.110111; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Riksen NP, 2007, PHARMACOGENET GENOM, V17, P551, DOI 10.1097/FPC.0b013e32803fb78f; Riksen NP, 2007, EUR HEART J, V28, P1085, DOI 10.1093/eurheartj/ehm032; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; Sharma AK, 2010, J THORAC CARDIOV SUR, V139, P474, DOI 10.1016/j.jtcvs.2009.08.033; Shryock JC, 1997, AM J CARDIOL, V79, P2, DOI 10.1016/S0002-9149(97)00256-7; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; VALENTE AJ, 1992, CIRCULATION, V86, P20; Wagner DR, 1999, AM J PHYSIOL-HEART C, V276, pH2141, DOI 10.1152/ajpheart.1999.276.6.H2141; Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Yin MD, 2010, ARTERIOSCL THROM VAS, V30, P1825, DOI 10.1161/ATVBAHA.109.200303; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646	45	8	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2122	2131		10.1096/fj.12-214197	http://dx.doi.org/10.1096/fj.12-214197			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23413358	Green Published			2022-12-25	WOS:000319667600004
J	Ehrentraut, H; Clambey, ET; McNamee, EN; Brodsky, KS; Ehrentraut, SF; Poth, JM; Riegel, AK; Westrich, JA; Colgan, SP; Eltzschig, HK				Ehrentraut, Heidi; Clambey, Eric T.; McNamee, Eoin N.; Brodsky, Kelley S.; Ehrentraut, Stefan F.; Poth, Jens M.; Riegel, Ann K.; Westrich, Joseph A.; Colgan, Sean P.; Eltzschig, Holger K.			CD73(+) regulatory T cells contribute to adenosine-mediated resolution of acute lung injury	FASEB JOURNAL			English	Article						ectonucleotidase; lipopolysaccharide; hypoxia; Adora2b; inflammation	ACUTE KIDNEY INJURY; TOLL-LIKE RECEPTORS; ECTO-5'-NUCLEOTIDASE CD73; EXTRACELLULAR ADENOSINE; NUCLEOTIDE PHOSPHOHYDROLYSIS; DEAMINASE DEFICIENCY; DEPENDENT INDUCTION; HYPOXIA; INFLAMMATION; PROTECTION	Acute lung injury (ALI) is characterized by alveolar injury and uncontrolled inflammation. Since most cases of ALI resolve spontaneously, understanding the endogenous mechanisms that promote ALI resolution is important to developing effective therapies. Previous studies have implicated extracellular adenosine signaling in tissue adaptation and wound healing. Therefore, we hypothesized a functional contribution for the endogenous production of adenosine during ALI resolution. As a model, we administered intratracheal LPS and observed peak lung injury at 3 d, with resolution by d 14. Treatment with pegylated adenosine-deaminase to enhance extracellular adenosine breakdown revealed impaired ALI resolution. Similarly, genetic deletion of cd73, the pacemaker for extracellular adenosine generation, was associated with increased mortality (0% wild-type and 40% in cd73(-/-) mice; P<0.05) and failure to resolve ALI adequately. Studies of inflammatory cell trafficking into the lungs during ALI resolution revealed that regulatory T cells (Tregs) express the highest levels of CD73. While Treg numbers in cd73(-/-) mice were similar to controls, cd73-deficient Tregs had attenuated immunosuppressive functions. Moreover, adoptive transfer of cd73-deficient Tregs into Rag(-/-) mice emulated the observed phenotype in cd73(-/-) mice, while transfer of wild-type Tregs was associated with normal ALI resolution. Together, these studies implicate CD73-dependent adenosine generation in Tregs in promoting ALI resolution.-Ehrentraut, H., Clambey, E. T., McNamee, E. N., Brodsky, K. S., Ehrentraut, S. F., Poth, J. M., Riegel, A. K., Westrich, J. A., Colgan, S. P., Eltzschig, H. K. CD73(+) regulatory T cells contribute to adenosine-mediated resolution of acute lung injury.	[Ehrentraut, Heidi; Clambey, Eric T.; McNamee, Eoin N.; Brodsky, Kelley S.; Poth, Jens M.; Riegel, Ann K.; Westrich, Joseph A.; Eltzschig, Holger K.] Univ Colorado, Sch Med, Mucosal Inflammat Program, Dept Anesthesiol, Aurora, CO 80045 USA; [Ehrentraut, Stefan F.; Colgan, Sean P.] Univ Colorado, Sch Med, Mucosal Inflammat Program, Dept Med, Aurora, CO 80045 USA; [Ehrentraut, Heidi; Ehrentraut, Stefan F.; Poth, Jens M.] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Bonn	Eltzschig, HK (corresponding author), Univ Colorado, Sch Med, Mucosal Inflammat Program, Dept Anesthesiol, 12700 E 19th Ave,Mailstop B112,Res Complex 2,Rm 7, Aurora, CO 80045 USA.	holger.eltzschig@ucdenver.edu		McNamee, Eoin/0000-0002-3331-3148; Westrich, Joseph/0000-0003-2406-6891; Poth, Jens/0000-0003-2534-5382; Ehrentraut, Stefan/0000-0001-5747-6737	U.S. National Institutes of Health [R01-HL-092188, R01-DK-083385, R01-HL-098294, HL-560569, DK-095491]; Crohn's and Colitis Foundation of America (CCFA); German Academic Exchange Service [Deutscher Akademischer Austausch Dienst (DAAD)] [D/10/52531]; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)] [EH401/1-1, ES 371/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385, R37DK050189, R01DK095491] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); German Academic Exchange Service [Deutscher Akademischer Austausch Dienst (DAAD)](Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge Kristann Magee and Sheema Rabbaig for technical assistance. The cd73<SUP>-/-</SUP> mice were kindly provided by Linda Thompson (OK Medical Research Foundation, Okalahoma City, OK, USA). In addition, the authors acknowledge Yang Xia and Michael R. Blackburn (University of Texas Medical School, Houston, TX, USA) and Edwin F de Zoeten and Colm B Collins (University of Colorado School of Medicine, Aurora, CO, USA) for help with addressing questions that came up in the review process of this study. The present research work was supported by U.S. National Institutes of Health grants R01-HL-092188, R01-DK-083385, and R01-HL-098294 (to H.K.E.) and HL-560569 and DK-095491 (to S.P.C.); Crohn's and Colitis Foundation of America (CCFA) grants (to H.K.E.); German Academic Exchange Service [Deutscher Akademischer Austausch Dienst (DAAD)] grant D/10/52531 (to J.M.P.); and German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)] grants EH401/1-1 (to H.E.) and ES 371/1-1 (to S.F.E.).	Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Collins CB, 2013, MUCOSAL IMMUNOL, V6, P960, DOI 10.1038/mi.2012.134; CRONSTEIN BN, 1990, J CLIN INVEST, V85, P1150, DOI 10.1172/JCI114547; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Day YJ, 2006, J IMMUNOL, V176, P3108, DOI 10.4049/jimmunol.176.5.3108; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Ehrentraut H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032416; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2012, J IMMUNOL, V189, P4566, DOI 10.4049/jimmunol.1201651; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Hart ML, 2008, GASTROENTEROLOGY, V135, P1739, DOI 10.1053/j.gastro.2008.07.064; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Karmouty-Quintana H, 2012, FASEB J, V26, P2546, DOI 10.1096/fj.11-200907; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Li L, 2012, J CLIN INVEST, V122, P3931, DOI 10.1172/JCI63170; MACATANGAY BJ, 2012, 19 INT AIDS C; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907	59	84	88	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2207	2219		10.1096/fj.12-225201	http://dx.doi.org/10.1096/fj.12-225201			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23413361	Green Accepted, Green Published			2022-12-25	WOS:000319667600012
J	Tan, JHY; Ludeman, JP; Wedderburn, J; Canals, M; Hall, P; Butler, SJ; Taleski, D; Christopoulos, A; Hickey, MJ; Payne, RJ; Stone, MJ				Tan, Joshua H. Y.; Ludeman, Justin P.; Wedderburn, Jamie; Canals, Meritxell; Hall, Pam; Butler, Stephen J.; Taleski, Deni; Christopoulos, Arthur; Hickey, Michael J.; Payne, Richard J.; Stone, Martin J.			Tyrosine Sulfation of Chemokine Receptor CCR2 Enhances Interactions with Both Monomeric and Dimeric Forms of the Chemokine Monocyte Chemoattractant Protein-1 (MCP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTACTIC PROTEIN-1; CXCR4 SULFOTYROSINE; AMINO-TERMINUS; HIV-1 ENTRY; IN-VIVO; BINDING; RECOGNITION; INTERLEUKIN-8; RESIDUES; ATHEROSCLEROSIS	Chemokine receptors are commonly post-translationally sulfated on tyrosine residues in their N-terminal regions, the initial site of binding to chemokine ligands. We have investigated the effect of tyrosine sulfation of the chemokine receptor CCR2 on its interactions with the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2). Inhibition of CCR2 sulfation, by growth of expressing cells in the presence of sodium chlorate, significantly reduced the potency for MCP-1 activation of CCR2. MCP-1 exists in equilibrium between monomeric and dimeric forms. The obligate monomeric mutant MCP-1(P8A) was similar to wild type MCP-1 in its ability to induce leukocyte recruitment in vivo, whereas the obligate dimeric mutant MCP-1(T10C)was less effective at inducing leukocyte recruitment in vivo. In two-dimensional NMR experiments, sulfated peptides derived from the N-terminal region of CCR2 bound to both the monomeric and dimeric forms of wild type MCP-1 and shifted the equilibrium to favor the monomeric form. Similarly, MCP-1(P8A) bound more tightly than MCP-1(T10C) to the CCR2-derived sulfopeptides. NMR chemical shift mapping using the MCP-1 mutants showed that the sulfated N-terminal region of CCR2 binds to the same region (N-loop and beta 3-strand) of both monomeric and dimeric MCP-1 but that binding to the dimeric form also influences the environment of chemokine N-terminal residues, which are involved in dimer formation. We conclude that interaction with the sulfated N terminus of CCR2 destabilizes the dimerization interface of inactive dimeric MCP-1, thus inducing dissociation to the active monomeric state.	[Tan, Joshua H. Y.; Ludeman, Justin P.; Wedderburn, Jamie; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Canals, Meritxell; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Hall, Pam; Hickey, Michael J.] Monash Univ, Dept Med, Monash Med Ctr, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia; [Butler, Stephen J.; Taleski, Deni; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Monash University; Monash University; Monash University; University of Sydney	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Bldg 76,Wellington Rd, Clayton, Vic 3800, Australia.	martin.stone@monash.edu	Payne, Richard/AAH-3666-2021; Christopoulos, Arthur/B-6207-2013; Butler, Stephen/K-7050-2013; Hickey, Michael/A-5429-2012; Stone, Martin/C-2492-2012	Christopoulos, Arthur/0000-0003-4442-3294; Butler, Stephen/0000-0001-8109-3330; Payne, Richard/0000-0002-3618-9226; Hickey, Michael/0000-0003-2354-357X; Stone, Martin/0000-0002-6468-4427; Canals, Meritxell/0000-0002-7942-5006	Australian Research Council [DP0881570, LE0989504, DP1094884]; Australian National Health and Medical Research Council [519461]; Monash MNHS International Honours Scholarship; Australia Postgraduate Award	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash MNHS International Honours Scholarship; Australia Postgraduate Award	This work was supported by Australian Research Council Grants DP0881570 and LE0989504 (to M. J. S.) and DP1094884 (to R. J. P. and M. J. S.) and by Australian National Health and Medical Research Council Grant 519461 (to A. C.).; Supported by a Monash MNHS International Honours Scholarship.; Supported by an Australia Postgraduate Award.	Apostolopoulos J, 2008, J LEUKOCYTE BIOL, V83, P902, DOI 10.1189/jlb.0607353; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; CLUBB RT, 1994, FEBS LETT, V338, P93, DOI 10.1016/0014-5793(94)80123-1; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Fernando H, 2004, J BIOL CHEM, V279, P36175, DOI 10.1074/jbc.C400283200; Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gutierrez J, 2004, J BIOL CHEM, V279, P14726, DOI 10.1074/jbc.M309689200; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Preobrazhensky AA, 2000, J IMMUNOL, V165, P5295, DOI 10.4049/jimmunol.165.9.5295; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; ROBINSON EA, 1989, P NATL ACAD SCI USA, V86, P1850, DOI 10.1073/pnas.86.6.1850; Schmidt PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037779; Seibert C, 2008, BIOCHEMISTRY-US, V47, P11251, DOI 10.1021/bi800965m; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Taleski D, 2011, CHEM-ASIAN J, V6, P1316, DOI 10.1002/asia.201100232; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Ye JP, 2000, J BIOL CHEM, V275, P27250; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	41	67	71	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10024	10034		10.1074/jbc.M112.447359	http://dx.doi.org/10.1074/jbc.M112.447359			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408426	Green Published, hybrid			2022-12-25	WOS:000317114000041
J	Celik, H; Blouzard, JC; Voigt, B; Becher, D; Trotter, V; Fierobe, HP; Tardif, C; Pages, S; de Philip, P				Celik, Hamza; Blouzard, Jean-Charles; Voigt, Birgit; Becher, Doerte; Trotter, Valentine; Fierobe, Henri-Pierre; Tardif, Chantal; Pages, Sandrine; de Philip, Pascale			A Two-Component System (XydS/R) Controls the Expression of Genes Encoding CBM6-Containing Proteins in Response to Straw in Clostridium cellulolyticum	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; ESCHERICHIA-COLI; CELLULOSOME; BINDING; DOMAIN; METABOLISM; REGULATOR; MECHANISM; ENZYMES; CLUSTER	The composition of the cellulosomes (multi enzymatic complexes involved in the degradation of plant cell wall polysaccharides) produced by Clostridium cellulolyticum differs according to the growth substrate. In particular, the expression of a cluster of 14 hemicellulase-encoding genes (called xyl-doc) seems to be induced by the presence of straw and not of cellulose. Genes encoding a putative two-component regulation system (XydS/R) were found upstream of xyl-doc. First evidence for the involvement of the response regulator, XydR, part of this two-component system, in the expression of xyl-doc genes was given by the analysis of the cellulosomes produced by a regulator overproducing strain when grown on cellulose. Nano-LC MS/MS analysis allowed the detection of the products of all xyl-doc genes and of the product of the gene at locus Ccel_1656 predicted to bear a carbohydrate binding domain targeting hemicellulose. RT-PCR experiments further demonstrated that the regulation occurs at the transcriptional level and that all xyl-doc genes are transcriptionally linked. mRNA quantification in a regulator knock-out strain and in its complemented derivative confirmed the involvement of the regulator in the expression of xyl-doc genes and of the gene at locus Ccel_1656 in response to straw. Electrophoretic mobility shift assays using the purified regulator further demonstrated that the regulator binds to DNA regions located upstream of the first gene of the xyl-doc gene cluster and upstream of the gene at locus Ccel_1656.	[Celik, Hamza; Blouzard, Jean-Charles; Trotter, Valentine; Fierobe, Henri-Pierre; Tardif, Chantal; Pages, Sandrine; de Philip, Pascale] Aix Marseille Univ, CNRS, UMR7283, Marseille, France; [Voigt, Birgit; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Ernst Moritz Arndt Universitat Greifswald	de Philip, P (corresponding author), Aix Marseille Univ, CNRS, UMR7283, Marseille, France.	dephilip@imm.cnrs.fr	Becher, Doerte/B-4454-2015; FIEROBE, Henri-Pierre/P-4372-2019; Trotter, Valentine/A-9374-2018	Becher, Doerte/0000-0002-9630-5735; Trotter, Valentine/0000-0002-1784-9487; de philip, pascale/0000-0002-9586-7680	European Community's Seventh Framework Program [237942 (CLOSTNET)]; Centre National de la Recherche Scientifique; Aix-Marseille Universite	European Community's Seventh Framework Program; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite	This research was supported by funding from the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement no. 237942 (CLOSTNET), the Centre National de la Recherche Scientifique and Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Chow V, 2007, J BACTERIOL, V189, P8863, DOI 10.1128/JB.01141-07; DARE S, 1994, NUCLEIC ACIDS RES, V22, P1555; Dominguez-Cuevas P, 2010, J BACTERIOL, V192, P2682, DOI 10.1128/JB.00165-10; DYBVIG K, 1988, PLASMID, V20, P33, DOI 10.1016/0147-619X(88)90005-4; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; GALINIER A, 1994, J BIOL CHEM, V269, P23784; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; GIALLO J, 1985, APPL ENVIRON MICROB, V49, P1216, DOI 10.1128/AEM.49.5.1216-1221.1985; GIALLO J, 1983, APPL ENVIRON MICROB, V45, P843, DOI 10.1128/AEM.45.3.843-849.1983; GRIMSLEY JK, 1994, J BIOL CHEM, V269, P16977; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; HERTIG C, 1989, J BACTERIOL, V171, P1736, DOI 10.1128/jb.171.3.1736-1738.1989; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ibarra JA, 2003, J BACTERIOL, V185, P2835, DOI 10.1128/JB.185.9.2835-2847.2003; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI [10.1186/1754-6834-5-71, 10.1186/1754-6834-5-2]; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lundgren DH, 2009, CURRENT PROTOCOLS BI, V28; Maamar H, 2004, MOL MICROBIOL, V51, P589, DOI 10.1046/j.1365-2958.2003.03859.x; Maamar H, 2006, J BACTERIOL, V188, P2614, DOI 10.1128/JB.188.7.2614-2624.2006; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MENON KP, 1990, P NATL ACAD SCI USA, V87, P3708, DOI 10.1073/pnas.87.10.3708; Michel L, 2005, MOL MICROBIOL, V58, P495, DOI 10.1111/j.1365-2958.2005.04837.x; Mohand-Oussaid O, 1999, J BACTERIOL, V181, P4035, DOI 10.1128/JB.181.13.4035-4040.1999; Pages S, 1999, J BACTERIOL, V181, P1801; Perret S, 2004, J BACTERIOL, V186, P6544, DOI 10.1128/JB.186.19.6544-6552.2004; PETITDEMANGE E, 1984, INT J SYST BACTERIOL, V34, P155, DOI 10.1099/00207713-34-2-155; Ruiz R, 2003, J BACTERIOL, V185, P3036, DOI 10.1128/JB.185.10.3036-3041.2003; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Schuller A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103132; SLOAN J, 1992, PLASMID, V27, P207, DOI 10.1016/0147-619X(92)90023-4; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tamaru Y, 2011, MICROB BIOTECHNOL, V4, P64, DOI 10.1111/j.1751-7915.2010.00210.x; Tardif C, 2001, J IND MICROBIOL BIOT, V27, P271, DOI 10.1038/sj.jim.7000081; Wickstrum JR, 2007, J BACTERIOL, V189, P4984, DOI 10.1128/JB.00530-07; Yoder-Himes DR, 2006, J BACTERIOL, V188, P5167, DOI 10.1128/JB.00318-06	47	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56063	10.1371/journal.pone.0056063	http://dx.doi.org/10.1371/journal.pone.0056063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418511	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300103
J	Colibazzi, T; Wexler, BE; Bansal, R; Hao, XJ; Liu, J; Sanchez-Pena, J; Corcoran, C; Lieberman, JA; Peterson, BS				Colibazzi, Tiziano; Wexler, Bruce E.; Bansal, Ravi; Hao, Xuejun; Liu, Jun; Sanchez-Pena, Juan; Corcoran, Cheryl; Lieberman, Jeffrey A.; Peterson, Bradley S.			Anatomical Abnormalities in Gray and White Matter of the Cortical Surface in Persons with Schizophrenia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; VOLUME ABNORMALITIES; CEREBRAL-CORTEX; BRAIN; THICKNESS; ONSET; INTEGRITY; DEFICITS; AREA; GYRIFICATION	Background: Although schizophrenia has been associated with abnormalities in brain anatomy, imaging studies have not fully determined the nature and relative contributions of gray matter (GM) and white matter (WM) disturbances underlying these findings. We sought to determine the pattern and distribution of these GM and WM abnormalities. Furthermore, we aimed to clarify the contribution of abnormalities in cortical thickness and cortical surface area to the reduced GM volumes reported in schizophrenia. Methods: We recruited 76 persons with schizophrenia and 57 healthy controls from the community and obtained measures of cortical and WM surface areas, of local volumes along the brain and WM surfaces, and of cortical thickness. Results: We detected reduced local volumes in patients along corresponding locations of the brain and WM surfaces in addition to bilateral greater thickness of perisylvian cortices and thinner cortex in the superior frontal and cingulate gyri. Total cortical and WM surface areas were reduced. Patients with worse performance on the serial-position task, a measure of working memory, had a higher burden of WM abnormalities. Conclusions: Reduced local volumes along the surface of the brain mirrored the locations of abnormalities along the surface of the underlying WM, rather than of abnormalities of cortical thickness. Moreover, anatomical features of white matter, but not cortical thickness, correlated with measures of working memory. We propose that reductions in WM and smaller total cortical surface area could be central anatomical abnormalities in schizophrenia, driving, at least partially, the reduced regional GM volumes often observed in this illness.	[Colibazzi, Tiziano; Bansal, Ravi; Hao, Xuejun; Liu, Jun; Sanchez-Pena, Juan; Peterson, Bradley S.] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Div Child & Adolescent Psychiat, New York, NY 10032 USA; [Wexler, Bruce E.] Yale Univ, Sch Med, New Haven, CT USA; [Corcoran, Cheryl; Lieberman, Jeffrey A.] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Yale University; Columbia University; New York State Psychiatry Institute	Colibazzi, T (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Div Child & Adolescent Psychiat, New York, NY 10032 USA.	tc2237@columbia.edu	Corcoran, Cheryl M/M-1397-2016; Lieberman, Jeffrey/AAY-8239-2020	Corcoran, Cheryl M/0000-0002-8902-4353; 	NIMH [MH56642, MH01296, MH068318, MH16434, MH36197, MHK02-74677, 5T32MH15144, K23 MH85063-2]; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107558, T32MH015144, R01MH036197, K23MH085063, R01MH056642, K23MH066279, R21MH086125, R01MH068318] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by NIMH grants MH56642, MH01296, MH068318, MH16434, MH36197, MHK02-74677, 5T32MH15144, and K23 MH85063-2, and by funding from the National Alliance for Research on Schizophrenia and Depression (NARSAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018652; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; Bansal R, 2005, NEUROIMAGE, V24, P150, DOI 10.1016/j.neuroimage.2004.08.054; Bansal R, 2007, IEEE T MED IMAGING, V26, P46, DOI 10.1109/TMI.2006.884187; Boksa P, 2012, J PSYCHIATR NEUROSCI, V37, P75, DOI 10.1503/jpn.120007; Burns J, 2003, BRIT J PSYCHIAT, V182, P439, DOI 10.1192/bjp.182.5.439; Carettri F, 2012, SCHIZOPHRENIA BULL, V38, P1170, DOI 10.1093/schbul/sbs053; Catani M, 2011, BIOL PSYCHIAT, V70, P1143, DOI 10.1016/j.biopsych.2011.06.013; Corradi-Dell'Acqua C, 2012, HUM BRAIN MAPP, V33, P740, DOI 10.1002/hbm.21246; Delis DC., 2000, CALIFORNIA VERBAL LE; Di X, 2009, PROG NEURO-PSYCHOPH, V33, P1390, DOI 10.1016/j.pnpbp.2009.08.020; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Gabor F, 2011, INT J DEV NEUROSCI, V29, P305, DOI 10.1016/j.ijdevneu.2011.02.013; Gogtay N, 2008, P NATL ACAD SCI USA, V105, P15979, DOI 10.1073/pnas.0806485105; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Haijma S.V., 2012, SCHIZOPHR B; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Landing BH, 2002, PEDIATR PATHOL MOL M, V21, P321, DOI 10.1080/02770930290056541; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Makris N, 2010, PSYCHIAT RES-NEUROIM, V183, P21, DOI 10.1016/j.pscychresns.2010.04.016; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McGuire PK, 1996, PSYCHOL MED, V26, P663, DOI 10.1017/S0033291700037673; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; Nesvag R, 2009, PROG NEURO-PSYCHOPH, V33, P482, DOI 10.1016/j.pnpbp.2009.01.013; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Palaniyappan L, 2012, NEUROIMAGE, V60, P693, DOI 10.1016/j.neuroimage.2011.12.058; Palaniyappan L, 2011, SCHIZOPHR RES, V129, P163, DOI 10.1016/j.schres.2011.03.020; Palaniyappan L, 2011, BIOL PSYCHIAT, V69, P974, DOI 10.1016/j.biopsych.2010.12.012; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Perez-Iglesias R, 2010, AM J PSYCHIAT, V167, P451, DOI 10.1176/appi.ajp.2009.09050716; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Phillips OR, 2011, BIOL PSYCHIAT, V70, P680, DOI 10.1016/j.biopsych.2011.03.039; Pol HEH, 2004, BIOL PSYCHIAT, V55, P126, DOI 10.1016/S0006-3223(03)00728-5; Prasad KM, 2010, SCHIZOPHR RES, V116, P143, DOI 10.1016/j.schres.2009.11.003; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; ROSENFELD A, 1968, PATTERN RECOGN, V1, P33, DOI 10.1016/0031-3203(68)90013-7; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smieskova R, 2010, NEUROSCI BIOBEHAV R, V34, P1207, DOI 10.1016/j.neubiorev.2010.01.016; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sun D, 2009, MOL PSYCHIATR, V14, P976, DOI 10.1038/mp.2008.34; Sun D, 2009, SCHIZOPHR RES, V108, P85, DOI 10.1016/j.schres.2008.11.026; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; Wexler BE, 2009, AM J PSYCHIAT, V166, P189, DOI 10.1176/appi.ajp.2008.08020258; Whitford TJ, 2007, AM J PSYCHIAT, V164, P1082, DOI 10.1176/appi.ajp.164.7.1082; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Yamasue H, 2004, PSYCHIAT RES-NEUROIM, V131, P195, DOI 10.1016/j.pscychresns.2004.05.004; Ziermans TB, 2012, SCHIZOPHRENIA BULL, V38, P519, DOI 10.1093/schbul/sbq113; Zuliani R, 2011, PSYCHIAT RES-NEUROIM, V191, P133, DOI 10.1016/j.pscychresns.2010.11.001	61	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55783	10.1371/journal.pone.0055783	http://dx.doi.org/10.1371/journal.pone.0055783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418459	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300050
J	Cun, YP; Dai, N; Xiong, CJ; Li, MX; Sui, JD; Qian, CY; Li, Z; Wang, D				Cun, Yanping; Dai, Nan; Xiong, Chengjie; Li, Mengxia; Sui, Jiangdong; Qian, Chengyuan; Li, Zheng; Wang, Dong			Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model	PLOS ONE			English	Article							BASE EXCISION-REPAIR; PROGNOSTIC-SIGNIFICANCE; APURINIC ENDONUCLEASE; RADIATION-THERAPY; HEPATOMA-CELLS; DNA-DAMAGE; P53; CANCER; EXPRESSION; APE1/REF-1	Resistance to radiotherapy is a key limitation for the treatment of human hepatocellular carcinoma (HCC). To overcome this problem, we investigated the correlation between radioresistance and the human apurinic/apyrimidinic endonuclease (APE1), a bifunctional protein, which plays an important role in DNA repair and redox regulation activity of transcription factors. In the present study, we examined the radiosensitivity profiles of three human HCC cell lines, HepG2, Hep3B, and MHCC97L, using the adenoviral vector Ad5/F35-mediated APE1 siRNA (Ad5/F35-siAPE1). The p53 mutant cell lines MHCC97L showed radioresistance, compared with HepG2 and Hep3B cells. APE1 was strongly expressed in MHCC97L cells and was induced by irradiation in a dose-dependent manner, and Ad5/F35-siAPE1 effectively inhibited irradiation-induced APE1 and p53 expression. Moreover, silencing of APE1 significantly potentiated the growth inhibition and apoptosis induction by irradiation in all tested human HCC cell lines. In addition, Ad5/F35-siAPE1 significantly enhanced inhibition of tumor growth and potentiated cell apoptosis by irradiation both in HepG2 and MHCC97L xenografts. In conclusion, down regulation of APE1 could enhance sensitivity of human HCC cells to radiotherapy in vitro and in vivo.	[Cun, Yanping; Dai, Nan; Li, Mengxia; Sui, Jiangdong; Qian, Chengyuan; Li, Zheng; Wang, Dong] Third Mil Med Univ, Ctr Canc, Daping Hosp, Chongqing, Peoples R China; [Cun, Yanping; Dai, Nan; Li, Mengxia; Sui, Jiangdong; Qian, Chengyuan; Li, Zheng; Wang, Dong] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Xiong, Chengjie] Third Mil Med Univ, Dept Orthoped, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Wang, D (corresponding author), Third Mil Med Univ, Ctr Canc, Daping Hosp, Chongqing, Peoples R China.	dongwang64@hotmail.com	Sui, Jiang-Dong/AAU-6005-2021; Li, Mengxia/AAM-4289-2020	Li, Mengxia/0000-0003-4443-740X	National Natural Science Foundation of China [30872975]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant support was provided by the National Natural Science Foundation of China (No. 30872975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzile JP, 2006, CURR GENE THER, V6, P111, DOI 10.2174/156652306775515538; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; CHEN DS, 1994, ANN NY ACAD SCI, V726, P306, DOI 10.1111/j.1749-6632.1994.tb52834.x; Concin N, 2000, CANCER LETT, V150, P191, DOI 10.1016/S0304-3835(99)00393-6; Di Bisceglie AM, 2004, GASTROENTEROLOGY, V127, pS104, DOI 10.1053/j.gastro.2004.09.022; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; Ding J, 2006, TRENDS PHARMACOL SCI, V27, P338, DOI 10.1016/j.tips.2006.04.007; DUMENCO L, 1995, HEPATOLOGY, V22, P1279, DOI 10.1016/0270-9139(95)90640-1; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; FORRESTER K, 1995, ONCOGENE, V10, P2103; Hanson S, 2005, ONCOGENE, V24, P1641, DOI 10.1038/sj.onc.1208351; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Herring CJ, 1998, BRIT J CANCER, V78, P1128, DOI 10.1038/bjc.1998.641; Jakobs TF, 2008, RADIOLOGE, V48, P839, DOI 10.1007/s00117-008-1730-x; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jia JB, 2011, INVEST NEW DRUG, V29, P861, DOI 10.1007/s10637-010-9435-1; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lai PBS, 2007, APOPTOSIS, V12, P387, DOI 10.1007/s10495-006-0571-1; Madhusudan S, 2005, CANCER TREAT REV, V31, P603, DOI 10.1016/j.ctrv.2005.09.006; McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456; Ng LT, 2006, AM J CHINESE MED, V34, P125, DOI 10.1142/S0192415X06003692; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; Robertson KA, 2001, CANCER RES, V61, P2220; Rodemann HP, 2009, RADIOTHER ONCOL, V92, P293, DOI 10.1016/j.radonc.2009.08.023; Schindl M, 2001, INT J ONCOL, V19, P799; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh PK, 2011, EVID-BASED COMPL ALT, V2011; Tanner B, 2004, GYNECOL ONCOL, V92, P568, DOI 10.1016/j.ygyno.2003.10.037; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Toya R, 2007, RADIOTHER ONCOL, V84, P266, DOI 10.1016/j.radonc.2007.07.005; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang D, 2004, MOL CANCER THER, V3, P679; Wang D, 2007, CANCER SCI, V98, P1993, DOI 10.1111/j.1349-7006.2007.00616.x; Xiang DB, 2008, CANCER GENE THER, V15, P625, DOI 10.1038/cgt.2008.30; Yang W, 2010, INT J RADIAT BIOL, V86, P445, DOI 10.3109/09553001003668006; Yang ZZ, 2007, CLIN LYMPHOMA MYELOM, V7, P296, DOI 10.3816/CLM.2007.n.006; Yoo DG, 2008, LUNG CANCER, V60, P277, DOI 10.1016/j.lungcan.2007.10.015; You KR, 2002, J BIOL CHEM, V277, P3870, DOI 10.1074/jbc.M109284200; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zurer I, 2004, CARCINOGENESIS, V25, P11, DOI 10.1093/carcin/bgg186	45	33	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55313	10.1371/journal.pone.0055313	http://dx.doi.org/10.1371/journal.pone.0055313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418439	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300029
J	Fan, YP; Korolev, N; Lyubartsev, AP; Nordenskiold, L				Fan, Yanping; Korolev, Nikolay; Lyubartsev, Alexander P.; Nordenskiold, Lars			An Advanced Coarse-Grained Nucleosome Core Particle Model for Computer Simulations of Nucleosome-Nucleosome Interactions under Varying Ionic Conditions	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MONTE-CARLO-SIMULATION; H4 TAIL ACETYLATIONS; X-RAY-DIFFRACTION; CHROMATIN FIBER; HISTONE TAILS; K+ IONS; POLYELECTROLYTE PROPERTIES; COMPETITIVE-BINDING; PHASE-DIAGRAM	In the eukaryotic cell nucleus, DNA exists as chromatin, a compact but dynamic complex with histone proteins. The first level of DNA organization is the linear array of nucleosome core particles (NCPs). The NCP is a well-defined complex of 147 bp DNA with an octamer of histones. Interactions between NCPs are of paramount importance for higher levels of chromatin compaction. The polyelectrolyte nature of the NCP implies that nucleosome-nucleosome interactions must exhibit a great influence from both the ionic environment as well as the positively charged and highly flexible N-terminal histone tails, protruding out from the NCP. The large size of the system precludes a modelling analysis of chromatin at an all-atom level and calls for coarse-grained approximations. Here, a model of the NCP that include the globular histone core and the flexible histone tails described by one particle per each amino acid and taking into account their net charge is proposed. DNA wrapped around the histone core was approximated at the level of two base pairs represented by one bead (bases and sugar) plus four beads of charged phosphate groups. Computer simulations, using a Langevin thermostat, in a dielectric continuum with explicit monovalent (K+), divalent (Mg2+) or trivalent (Co(NH3)(6)(3+)) cations were performed for systems with one or ten NCPs. Increase of the counterion charge results in a switch from repulsive NCP-NCP interaction in the presence of K+, to partial aggregation with Mg2+ and to strong mutual attraction of all 10 NCPs in the presence of CoHex(3+). The new model reproduced experimental results and the structure of the NCP-NCP contacts is in agreement with available data. Cation screening, ion-ion correlations and tail bridging contribute to the NCP-NCP attraction and the new NCP model accounts for these interactions.	[Fan, Yanping; Korolev, Nikolay; Nordenskiold, Lars] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore; [Lyubartsev, Alexander P.] Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, Div Phys Chem, S-10691 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stockholm University	Korolev, N (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore.	Korolev@ntu.edu.sg; alexander.lyubartsev@mmk.su.se	NORDENSKIÖLD, LARS/ABD-4725-2020; Lyubartsev, Alexander/E-5489-2011; Korolev, Nikolay/H-2335-2011	NORDENSKIÖLD, LARS/0000-0002-3681-209X; Lyubartsev, Alexander/0000-0002-9390-5719; 	Singapore Agency for Science Technology and Research (A*STAR) through the Biomedical Research Council [10/1/22/19/666]; Singapore Ministry of Education Academic Research Fund (AcRF) through a Tier 1 [M52080112 RG46/10]; Swedish Research Council [621-2010-5005]	Singapore Agency for Science Technology and Research (A*STAR) through the Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education Academic Research Fund (AcRF) through a Tier 1(Ministry of Education, Singapore); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work has been supported by the Singapore Agency for Science Technology and Research (A*STAR) through the Biomedical Research Council (LN) (http://www.a-star.edu.sg) grant no. 10/1/22/19/666, by the Singapore Ministry of Education Academic Research Fund (AcRF) through a Tier 1, grant no. M52080112 RG46/10 (LN), and by the Swedish Research Council (http://www.vr.se) grant. no 621-2010-5005 (to APL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Arya G, 2006, P NATL ACAD SCI USA, V103, P16236, DOI 10.1073/pnas.0604817103; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; Arya G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2428305; Bertin A, 2004, BIOCHEMISTRY-US, V43, P4773, DOI 10.1021/bi036210g; Bertin A, 2007, EUR BIOPHYS J BIOPHY, V36, P1083, DOI 10.1007/s00249-007-0212-9; Bertin A, 2007, BIOPHYS J, V93, P3652, DOI 10.1529/biophysj.107.108365; Bertin A, 2007, BIOPHYS J, V92, P2633, DOI 10.1529/biophysj.106.093815; Bishop TC, 2005, J BIOMOL STRUCT DYN, V22, P673, DOI 10.1080/07391102.2005.10507034; Biswas M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002279; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Cao QQ, 2011, SOFT MATTER, V7, P506, DOI 10.1039/c0sm00512f; Cheatham TE, 1997, J AM CHEM SOC, V119, P4805, DOI 10.1021/ja963641w; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Daban JR, 2011, MICRON, V42, P733, DOI 10.1016/j.micron.2011.05.002; Dans PD, 2010, J CHEM THEORY COMPUT, V6, P1711, DOI 10.1021/ct900653p; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Frutos M, 2001, BIOPHYS J, V81, P1127, DOI 10.1016/S0006-3495(01)75769-4; DeMille RC, 2011, J PHYS CHEM B, V115, P132, DOI 10.1021/jp107028n; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Dobrovolskaia IV, 2012, BIOPHYS J, V103, P989, DOI 10.1016/j.bpj.2012.07.043; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Ettig R, 2011, BIOPHYS J, V101, P1999, DOI 10.1016/j.bpj.2011.07.057; FINCH JT, 1981, J MOL BIOL, V145, P757, DOI 10.1016/0022-2836(81)90313-2; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Kepper N, 2008, BIOPHYS J, V95, P3692, DOI 10.1529/biophysj.107.121079; Kepper N, 2011, BIOPOLYMERS, V95, P435, DOI 10.1002/bip.21598; Koehl P, 2006, CURR OPIN STRUC BIOL, V16, P142, DOI 10.1016/j.sbi.2006.03.001; Korolev N, 2001, J MOL BIOL, V308, P907, DOI 10.1006/jmbi.2001.4642; Korolev N, 2001, BIOPOLYMERS, V58, P268, DOI 10.1002/1097-0282(200103)58:3<268::AID-BIP1004>3.0.CO;2-8; Korolev N, 1999, J PHYS CHEM B, V103, P9008, DOI 10.1021/jp9913517; Korolev N, 1999, BIOPHYS J, V77, P2736, DOI 10.1016/S0006-3495(99)77107-9; Korolev N, 2006, BIOPHYS J, V90, P4305, DOI 10.1529/biophysj.105.080226; Korolev N, 2007, BIOPOLYMERS, V86, P409, DOI 10.1002/bip.20749; Korolev N, 2012, SOFT MATTER, V8, P9322, DOI 10.1039/c2sm25662b; Korolev N, 2012, CURR OPIN STRUC BIOL, V22, P151, DOI 10.1016/j.sbi.2012.01.006; Korolev N, 2012, BIOCHEM BIOPH RES CO, V418, P205, DOI 10.1016/j.bbrc.2011.12.112; Korolev N, 2010, BIOPHYS J, V99, P1896, DOI 10.1016/j.bpj.2010.07.017; Korolev N, 2010, ADV COLLOID INTERFAC, V158, P32, DOI 10.1016/j.cis.2009.08.002; Korolev N, 2009, NUCLEIC ACIDS RES, V37, P7137, DOI 10.1093/nar/gkp683; Kruithof M, 2009, NAT STRUCT MOL BIOL, V16, P534, DOI 10.1038/nsmb.1590; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Langowski J, 2006, COMPUTATIONAL STUDIE, P605; Langowski J, 2007, SEMIN CELL DEV BIOL, V18, P659, DOI 10.1016/j.semcdb.2007.08.011; Lavelle C, 2010, INT J MOL SCI, V11, P1557, DOI 10.3390/ijms11041557; Lee JY, 2011, J BIOL CHEM, V286, P11099, DOI 10.1074/jbc.M110.192047; Leforestier A, 1997, BIOPHYS J, V73, P1771, DOI 10.1016/S0006-3495(97)78207-9; Leforestier A., 2001, BIOPHYS J, V81, P2114; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Limbach HJ, 2006, COMPUT PHYS COMMUN, V174, P704, DOI 10.1016/j.cpc.2005.10.005; Liu Y, 2011, J MOL BIOL, V414, P749, DOI 10.1016/j.jmb.2011.10.031; Livolant F, 2006, PHILOS T R SOC A, V364, P2615, DOI 10.1098/rsta.2006.1843; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Lyubartsev AP, 1997, PHYS REV E, V55, P5689, DOI 10.1103/PhysRevE.55.5689; Lyubartsev AP, 1998, J BIOMOL STRUCT DYN, V16, P579, DOI 10.1080/07391102.1998.10508271; Lyubartsev AP, 1997, J PHYS CHEM B, V101, P4335, DOI 10.1021/jp963982w; Makde RD, 2010, NATURE IN PRESS; Mangenot S, 2002, BIOPHYS J, V82, P345, DOI 10.1016/S0006-3495(02)75399-X; Mangenot S, 2002, EUR PHYS J E, V7, P221, DOI 10.1140/epje/i200101151; Mangenot S, 2003, BIOPHYS J, V84, P2570, DOI 10.1016/S0006-3495(03)75062-0; Mangenot S, 2003, J MOL BIOL, V333, P907, DOI 10.1016/j.jmb.2003.09.015; Materese CK, 2009, J AM CHEM SOC, V131, P15005, DOI 10.1021/ja905376q; MONTORO JCG, 1995, J CHEM PHYS, V103, P8273, DOI 10.1063/1.470191; Montoro JCG, 1998, J CHEM PHYS, V109, P6200, DOI 10.1063/1.477249; Muhlbacher F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031919; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nordenskiold L, 2008, DNA INTERACTIONS POL, P209; PRATT LR, 1994, BIOPHYS CHEM, V51, P147, DOI 10.1016/0301-4622(94)00057-3; Raspaud E, 1999, BIOPHYS J, V77, P1547, DOI 10.1016/S0006-3495(99)77002-5; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Roccatano D, 2007, BIOPOLYMERS, V85, P407, DOI 10.1002/bip.20690; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Ruscio JZ, 2006, BIOPHYS J, V91, P4121, DOI 10.1529/biophysj.106.082099; Savelyev A, 2010, P NATL ACAD SCI USA, V107, P20340, DOI 10.1073/pnas.1001163107; Savelyev A, 2009, BIOPHYS J, V96, P4044, DOI 10.1016/j.bpj.2009.02.067; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Scheffer MP, 2012, J STRUCT BIOL, V178, P207, DOI 10.1016/j.jsb.2011.11.020; Stehr R, 2008, BIOPHYS J, V95, P3677, DOI 10.1529/biophysj.107.120543; Stehr R, 2010, BIOPHYS J, V98, P1028, DOI 10.1016/j.bpj.2009.11.040; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Voltz K, 2008, J COMPUT CHEM, V29, P1429, DOI 10.1002/jcc.20902; Voltz K, 2012, BIOPHYS J, V102, P849, DOI 10.1016/j.bpj.2011.11.4028; Wedemann G, 2002, BIOPHYS J, V82, P2847, DOI 10.1016/S0006-3495(02)75627-0; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang DR, 2011, PHYS CHEM CHEM PHYS, V13, P2911, DOI 10.1039/c0cp01487g; Yang Y, 2009, BIOPHYS J, V96, P2082, DOI 10.1016/j.bpj.2008.10.073; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	99	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54228	10.1371/journal.pone.0054228	http://dx.doi.org/10.1371/journal.pone.0054228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418426	Green Published, gold			2022-12-25	WOS:000315970300016
J	Kano, Y; Soda, K; Konishi, F				Kano, Yoshihiko; Soda, Kuniyasu; Konishi, Fumio			Suppression of LFA-1 Expression by Spermine Is Associated with Enhanced Methylation of ITGAL, the LFA-1 Promoter Area	PLOS ONE			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; AGE-RELATED-CHANGES; DNA METHYLATION; S-ADENOSYLMETHIONINE; HISTONE ACETYLATION; CYTOKINE PRODUCTION; T-CELLS; DEMETHYLATION; POLYAMINE; DECARBOXYLASE	Spermine and spermidine, natural polyamines, suppress lymphocyte function-associated antigen 1 (LFA-1) expression and its associated cellular functions through mechanisms that remain unknown. Inhibition of ornithine decarboxylase, which is required for polyamine synthesis, in Jurkat cells by 3 mM D,L-alpha-difluoromethylornithine hydrochloride (DFMO) significantly decreased spermine and spermidine concentrations and was associated with decreased DNA methyltransferase (Dnmt) activity, enhanced demethylation of the LFA-1 gene (ITGAL) promoter area, and increased CD11a expression. Supplementation with extracellular spermine (500 mu M) of cells pretreated with DFMO significantly increased polyamine concentrations, increased Dnmt activity, enhanced methylation of the ITGAL promoter, and decreased CD11a expression. It has been shown that changes in intracellular polyamine concentrations affect activities of -adenosyl-L-methioninede-caroboxylase, and, as a result, affect concentrations of the methyl group donor, S-adenosylmethionine (SAM), and of the competitive Dnmt inhibitor, decarboxylated SAM. Additional treatments designed to increase the amount of SAM and decrease the amount of decarboxylated SAM-such as treatment with methylglyoxal bis-guanylhydrazone (an inhibitor of S-adenosyl- L-methionine-decaroboxylase) and SAM supplementation-successfully decreased CD11a expression. Western blot analyses revealed that neither DFMO nor spermine supplementation affected the amount of active Ras-proximate-1, a member of the Ras superfamily of small GTPases and a key protein for regulation of CD11a expression. The results of this study suggest that polyamine-induced suppression of LFA-1 expression occurs via enhanced methylation of ITGAL.	[Kano, Yoshihiko; Soda, Kuniyasu; Konishi, Fumio] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan; [Soda, Kuniyasu] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Res Inst, Saitama, Japan	Jichi Medical University; Jichi Medical University	Soda, K (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan.	soda@jichi.ac.jp						Bachrach U, 2001, NEWS PHYSIOL SCI, V16, P106, DOI 10.1152/physiologyonline.2001.16.3.106; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Engwerda CR, 1996, J IMMUNOL, V156, P3621; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; GARCEA R, 1989, CARCINOGENESIS, V10, P1183, DOI 10.1093/carcin/10.7.1183; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Heby O, 1988, Adv Exp Med Biol, V250, P291; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Kouzmenko A, 2010, EPIGENOMICS-UK, V2, P765, DOI 10.2217/EPI.10.58; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; MAMONT PS, 1981, BIOCHEM J, V196, P411, DOI 10.1042/bj1960411; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Neubert R, 1998, LIFE SCI, V62, P1099, DOI 10.1016/S0024-3205(98)00033-2; O'Mahony L, 1998, CLIN EXP IMMUNOL, V113, P213; Pan ZX, 2012, J GENET GENOMICS, V39, P111, DOI 10.1016/j.jgg.2012.02.004; Pegg AE, 2011, BIOCHEM J, V433, P139, DOI 10.1042/BJ20101228; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; POWERS DC, 1992, CELL IMMUNOL, V141, P444, DOI 10.1016/0008-8749(92)90162-I; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; Sadeghi HM, 1999, EXP GERONTOL, V34, P959, DOI 10.1016/S0531-5565(99)00065-0; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; SHANTZ LM, 1992, BIOCHEM J, V288, P511, DOI 10.1042/bj2880511; Soda K, 2005, J IMMUNOL, V175, P237, DOI 10.4049/jimmunol.175.1.237; Tsuji T, 2001, ONCOGENE, V20, P24, DOI 10.1038/sj.onc.1204051; WACHOLTZ MC, 1989, J EXP MED, V170, P431, DOI 10.1084/jem.170.2.431; Werther WA, 1996, J IMMUNOL, V157, P4986; Whitcup SM, 1999, CLIN IMMUNOL, V93, P107, DOI 10.1006/clim.1999.4775; Winquist RJ, 2001, EUR J PHARMACOL, V429, P297, DOI 10.1016/S0014-2999(01)01328-0; Yamamoto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012554; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759; Zhang ZY, 2002, MECH AGEING DEV, V123, P1257, DOI 10.1016/S0047-6374(02)00014-3	45	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56056	10.1371/journal.pone.0056056	http://dx.doi.org/10.1371/journal.pone.0056056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418509	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300101
J	Wei, HS; Li, BA; Zhang, RW; Hao, XH; Huang, YB; Qiao, Y; Hou, J; Li, X; Li, XW				Wei, Hongshan; Li, Boan; Zhang, Renwen; Hao, Xiaohua; Huang, Yubo; Qiao, Yong; Hou, Jun; Li, Xin; Li, Xingwang			Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; CHRONIC HEPATITIS-C; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; EXPRESSION; DISEASE; BIOMARKERS; PREVALENCE; GUIDELINES; MANAGEMENT	This study was designed to investigate the role of serum GP73 for diagnosing significant fibrosis in patients with chronic hepatitis B virus (HBV) infections. Two populations were enrollment. All subjects were patients with chronic HBV infections. First population included 761 patients, who received liver stiffness measurement; the second population included 633 patients, who undertaken liver biopsy, in which 472 patients with nearly normal ALT. All patients received serum GP73 test. The effect of GP73 recombinant protein to HepG2 cells and LX2 cells were observed in vitro. Results showed that serum GP73 concentration is correlated with liver stiffness (r = 0.601). The area under ROC curve is 0.76. The sensitivity and specificity of GP73 for significant fibrosis (>= F2) diagnosis were 62.81%, 80.05% respectively (cut off: 76.6 ng/ml). Serum GP73 concentration was significantly correlated with the grading of fibrosis (r = 0.32, and 0.35, in 633 and 472 patients, respectively.) GP73 had a striking performance for diagnosing S2 in patients with chronic HBV infections. In 472 patients with nearly normal ALT, the sensitivity and specificity of GP73 for S2 diagnosis were 62.5% and 80.0% respectively, where the cut-off was set at 82 ng/ml. GP73 recombinant protein may prompt LX2 cells proliferation at the concentration 10-100 ng/ml. The present results indicated that GP73 may be a marker for diagnosing significant fibrosis in patients with chronic HBV infections, and may be a new contributor to fibrogensis.	[Wei, Hongshan; Zhang, Renwen; Hao, Xiaohua; Huang, Yubo; Qiao, Yong; Li, Xin; Li, Xingwang] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Li, Boan; Hou, Jun] 302 Mil Hosp, Ctr Lab Test, Beijing, Peoples R China	Capital Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wei, HS (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China.	drwei@ccmu.edu.cn		Wei, Hongshan/0000-0001-8893-653X	National Natural Science Foundation of China [30872243, 81071411]; Fund of Capital Clinical Investigation [111107058811068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Capital Clinical Investigation	Supported by grant from the National Natural Science Foundation of China (No. 30872243; No. 81071411) to Prof. HW; and grant from the Fund of Capital Clinical Investigation (No. 111107058811068) to Prof. BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2011, J GASTROEN HEPATOL, V26, P1536, DOI 10.1111/j.1440-1746.2011.06774.x; Alberti A, 2011, DIGEST LIVER DIS, V43, pS57, DOI 10.1016/S1590-8658(10)60693-7; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Cao Q, 2007, J HEPATOL, V46, P124, DOI 10.1016/j.jhep.2006.07.027; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Fung J, 2008, AM J GASTROENTEROL, V103, P1421, DOI 10.1111/j.1572-0241.2007.01751.x; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; Guha IN, 2011, HEPATOLOGY, V54, P1454, DOI 10.1002/hep.24515; Hoefs JC, 2011, GASTROENTEROLOGY, V141, P900, DOI 10.1053/j.gastro.2011.06.007; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Liu XY, 2011, CLIN CHEM LAB MED, V49, P1311, DOI 10.1515/CCLM.2011.640; Maitra A, 2004, AM J GASTROENTEROL, V99, P1096, DOI 10.1111/j.1572-0241.2004.40410.x; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; Munteanu M, 2008, CLIN BIOCHEM, V41, P1113, DOI 10.1016/j.clinbiochem.2008.04.020; Naveau S, 2009, HEPATOLOGY, V49, P97, DOI 10.1002/hep.22576; Poynard Thierry, 2011, Gastroenterol Hepatol (N Y), V7, P445; Riener MO, 2009, HEPATOLOGY, V49, P1602, DOI 10.1002/hep.22843; Sebagh M, 2012, J HEPATOL, V56, P840, DOI 10.1016/j.jhep.2011.11.016; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Sun YL, 2011, J GASTROEN HEPATOL, V26, P1207, DOI 10.1111/j.1440-1746.2011.06733.x; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tian LY, 2011, INT J CANCER, V129, P1923, DOI 10.1002/ijc.25838; Tong MJ, 2008, HEPATOLOGY, V48, P1070, DOI 10.1002/hep.22476; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Wright LM, 2009, J HEPATOL, V51, P557, DOI 10.1016/j.jhep.2009.05.029; Wright LM, 2009, INT J CLIN EXP PATHO, V2, P34; Zoulim F, 2008, J HEPATOL, V48, pS2, DOI 10.1016/j.jhep.2008.01.011	31	33	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53862	10.1371/journal.pone.0053862	http://dx.doi.org/10.1371/journal.pone.0053862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418424	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300014
J	Sandebring, A; Welander, H; Winblad, B; Graff, C; Tjernberg, LO				Sandebring, Anna; Welander, Hedvig; Winblad, Bengt; Graff, Caroline; Tjernberg, Lars O.			The Pathogenic A beta 43 Is Enriched in Familial and Sporadic Alzheimer Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; A-BETA; INTRAMEMBRANE CLEAVAGE; TRANSMEMBRANE DOMAIN; SENILE PLAQUES; GAMMA; MUTATION; BRAIN; APP	The amyloid-cascade hypothesis posits that the role of amyloid beta-peptide (A beta) in Alzheimer disease (AD) involves polymerization into structures that eventually are deposited as amyloid plaques. During this process, neurotoxic oligomers are formed that induce synaptic loss and neuronal death. Several different isoforms of A beta are produced, of which the 40 and 42 residue variants (A beta 40 and A beta 42) are the most common. A beta 42 has a strong tendency to form neurotoxic aggregates and is involved in AD pathogenesis. Longer A beta isoforms, like the less studied A beta 43, are gaining attention for their higher propensity to aggregate into neurotoxic oligomers. To further investigate A beta 43 in AD, we conducted a quantitative study on A beta 43 levels in human brain. We homogenized human brain tissue and prepared fractions of various solubility; tris buffered saline (TBS), sodium dodecyl sulfate (SDS) and formic acid (FA). Levels of A beta 43, as well as A beta 40 and A beta 42, were quantified using ELISA. We compared quantitative data showing A beta levels in occipital and frontal cortex from sporadic (SAD) and familial (FAD) AD cases, as well as non-demented (ND) controls. Results showed A beta 43 present in each fraction from the SAD and FAD cases, while its level was lower than the detection limit in the majority of the ND-cases. A beta 42 and A beta 43 were enriched in the less soluble fractions (SDS and FA) of SAD and FAD cases in both occipital and frontal cortex. Thus, although the total levels of A beta 43 in human brain are low compared to A beta 40 and A beta 42, we suggest that A beta 43 could initiate the formation of oligomers and amyloid plaques and thereby be crucial to AD pathogenesis.	[Sandebring, Anna; Winblad, Bengt; Graff, Caroline; Tjernberg, Lars O.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, KI ADRC, Huddinge, Sweden; [Welander, Hedvig] Uppsala Univ, Rudbeck Lab, Dept Publ Hlth Mol Geriatr, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Tjernberg, LO (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, KI ADRC, Huddinge, Sweden.	lars.tjernberg@ki.se	graff, caroline/A-2545-2009	Graff, Caroline/0000-0002-9949-2951; Matton, Anna/0000-0002-7819-0495	Knut & Alice Wallenbergs Stiftelse; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse; Riksbanken Jubileumsfonden; Swedish Brain Power Program; Karolinska Institutet Strategic Neuroscience Program; Alzheimerfonden	Knut & Alice Wallenbergs Stiftelse; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse; Riksbanken Jubileumsfonden; Swedish Brain Power Program; Karolinska Institutet Strategic Neuroscience Program; Alzheimerfonden	This work was supported by funding from Knut & Alice Wallenbergs Stiftelse, Stiftelsen for Gamla Tjanarinnor, Gun och Bertil Stohnes Stiftelse, Riksbanken Jubileumsfonden, the Swedish Brain Power Program, the Karolinska Institutet Strategic Neuroscience Program and Alzheimerfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Attems J, 2007, J NEUROL SCI, V257, P49, DOI 10.1016/j.jns.2007.01.013; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esh C, 2005, BIOCHEMISTRY-US, V44, P13807, DOI 10.1021/bi051213+; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goda R, 2012, J CHROMATOGR B, V895, P137, DOI 10.1016/j.jchromb.2012.03.032; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214; Keller L, 2010, EUR J HUM GENET, V18, P1202, DOI 10.1038/ejhg.2010.107; Kim S, 2011, J CLIN NEUROSCI, V18, P916, DOI 10.1016/j.jocn.2010.12.019; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MIELKE R, 1995, INT J NEUROSCI, V82, P1, DOI 10.3109/00207459508994285; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Van Vickle GD, 2008, MOL MED, V14, P184, DOI [10.2119/2007-00094.VanVickle, 10.2119/2007-00094.Van Vickle]; Van Vickle GD, 2007, BIOCHEMISTRY-US, V46, P10317, DOI 10.1021/bi700951u; Vandersteen A, 2012, J BIOL CHEM, V287, P36732, DOI 10.1074/jbc.M112.394635; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	45	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55847	10.1371/journal.pone.0055847	http://dx.doi.org/10.1371/journal.pone.0055847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409063	Green Submitted, gold, Green Published			2022-12-25	WOS:000315100000025
J	Noble, P; Spendlove, I; Harding, S; Parsons, T; Durrant, LG				Noble, Philip; Spendlove, Ian; Harding, Stephen; Parsons, Tina; Durrant, Lindy G.			Therapeutic Targeting of Lewis(y) and Lewis(b) with a Novel Monoclonal Antibody 692/29	PLOS ONE			English	Article							BLOOD-GROUP ANTIGENS; BR96-DOXORUBICIN CONJUGATE; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; PHASE-II; X-BLOOD; EXPRESSION; TUMORS; ADENOCARCINOMA; DETERMINANTS	Background: Several monoclonal antibodies (mAbs) recognising Lewis(y), such as BR96, have reached the clinic but have failed to show good anti-tumour responses with an acceptable level of toxicity. No Lewis(b) mAbs have been trialled in patients. In this study we compare the specificity of three mAbs; BR96 (Lewis(y)), 2-25 LE (Lewis(b)) and 692/29 that recognises a unique facet of both Lewis(y) and Lewis(b). We then assessed the in vivo therapeutic effect of 692/29 using xenograft models. Methodology/Principal Findings: Using a glycan array, each mAb was shown to display a different binding pattern with only 692/29 binding to both Lewis(y) and Lewis(b). 692/29 was able to kill tumour cells over-expressing Lewis(y/b) directly, as well as by antibody and complement mediated cytotoxicity (ADCC/CDC), but failed to kill cells expressing low levels of these haptens. In contrast, BR96, directly killed cells expressing either high or low levels of Lewis(y) perhaps explaining its toxicity in patients. 2-25 LE failed to cause any direct killing but did mediate ADCC/CDC. Both 692/29 and BR96 bound to >80% of a panel of over 400 colorectal tumours whereas 2-25 LE showed lower reactivity (52%). 692/29 demonstrated more restricted normal tissue reactivity than both BR96 and 2-25 LE. 692/29 anti-Lewis(y/b) mAb also showed good in vivo killing in xenograft models. Conclusions/Significance: MAbs targeting both Lewis(y) and Lewis(b) may have a therapeutic advantage over mAbs targeting just one hapten. 692/29 has a more restricted normal tissue distribution and a higher antigen threshold for killing which should reduce its toxicity compared to a Lewis(y) specific mAb. 692/29 has an ability to directly kill tumours whereas the anti-Lewis(b) mAb does not. This suggests that Lewis(y) but not Lewis(b) are functional glycans. 692/29 showed good anti-tumour responses in vivo and is a strong therapeutic candidate.	[Noble, Philip; Spendlove, Ian; Harding, Stephen; Parsons, Tina; Durrant, Lindy G.] Univ Nottingham, Acad Dept Clin Oncol, Nottingham NG7 2RD, England	University of Nottingham	Durrant, LG (corresponding author), Univ Nottingham, Acad Dept Clin Oncol, City Hosp Campus, Nottingham NG7 2RD, England.	lindy.durrant@nottingham.ac.uk		Harding, Stephen E./0000-0002-7798-9692; Multhoff, Gabriele/0000-0002-2616-3137; Spendlove, Ian/0000-0002-7480-3768	MRC	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the MRC for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1986, CANCER RES, V46, P2639; Ajani JA, 2000, CANCER J, V6, P78; Brodin T, 1987, GLYCOCONJUGATE J, V4, P339; BROWN A, 1984, INT J CANCER, V33, P727, DOI 10.1002/ijc.2910330604; BROWN A, 1983, BIOSCIENCE REP, V3, P163, DOI 10.1007/BF01121947; Burris HA, 2010, CLIN CANCER RES, V16, P1673, DOI 10.1158/1078-0432.CCR-09-2263; Duncan Timothy J, 2007, World J Surg Oncol, V5, P31, DOI 10.1186/1477-7819-5-31; DURRANT LG, 1993, HYBRIDOMA, V12, P647, DOI 10.1089/hyb.1993.12.647; DURRANT LG, 1989, J NATL CANCER I, V81, P688, DOI 10.1093/jnci/81.9.688; GARRIGUES J, 1993, AM J PATHOL, V142, P607; HAKOMORI S, 1985, CANCER RES, V45, P2405; Hernandez AM, 2011, J IMMUNOL; ITZKOWITZ SH, 1992, J CELL BIOCHEM, P97; KIM YS, 1986, CANCER RES, V46, P5985; KITAMURA K, 1994, P NATL ACAD SCI USA, V91, P12957, DOI 10.1073/pnas.91.26.12957; Loo D, 2007, MOL CANCER THER, V6, P856, DOI 10.1158/1535-7163.MCT-06-0581; Madjd Z, 2005, BREAST CANCER RES, V7, pR780, DOI 10.1186/bcr1305; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Masayuki W, 1995, CANCER, V75, P2827; Partyka K, 2012, PROTEOMICS; Pryde JG, 2000, J BIOL CHEM, V275, P33574, DOI 10.1074/jbc.M001008200; Ramsland PA, 2004, J MOL BIOL, V340, P809, DOI 10.1016/j.jmb.2004.05.037; SAKAMOTO J, 1986, CANCER RES, V46, P1553; SAKAMOTO J, 1989, CANCER RES, V49, P745; Saleh MN, 2000, J CLIN ONCOL, V18, P2282, DOI 10.1200/JCO.2000.18.11.2282; SCHREIBER GJ, 1992, CANCER RES, V52, P3262; Scott AM, 2007, CLIN CANCER RES, V13, P3286, DOI 10.1158/1078-0432.CCR-07-0284; Simpson JAD, 2010, GUT, V59, P926, DOI 10.1136/gut.2009.194472; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tolcher AW, 1999, J CLIN ONCOL, V17, P478, DOI 10.1200/JCO.1999.17.2.478; VANDONSELAAR M, 1987, J BIOL CHEM, V262, P10848; Watson NFS, 2006, CANCER IMMUNOL IMMUN, V55, P973, DOI 10.1007/s00262-005-0055-0; Watson Nicholas F S, 2005, World J Surg Oncol, V3, P47, DOI 10.1186/1477-7819-3-47; WATSON SA, 1993, EUR J CANCER, V29A, P1740, DOI 10.1016/0959-8049(93)90117-X; Westwood JA, 2005, P NATL ACAD SCI USA, V102, P19051, DOI 10.1073/pnas.0504312102; Zhang CG, 1998, P NATL ACAD SCI USA, V95, P6290, DOI 10.1073/pnas.95.11.6290	36	14	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e54892	10.1371/journal.pone.0054892	http://dx.doi.org/10.1371/journal.pone.0054892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408949	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300006
J	Zhu, L; Lou, AR				Zhu, Lin; Lou, Anru			Old-Growth Platycladus orientalis as a Resource for Reproductive Capacity and Genetic Diversity	PLOS ONE			English	Article							POPULATIONS; RESERVOIRS; FORESTS; STANDS	Aims: Platycladus orientalis (Cupressaceae) is an old-growth tree species which distributed in the imperial parks and ancient temples in Beijing, China. We aim to (1) examine the genetic diversity and reproductive traits of old-growth and young populations of P. orientalis to ascertain whether the older populations contain a higher genetic diversity, more private alleles and a higher reproductive output compared with younger populations; (2) determine the relationships between the age of the population and the genetic diversity and reproductive traits; and (3) determine whether the imperial parks and ancient temples played an important role in maintaining the reproductive capacity and genetic diversity of Platycladus orientalis. Methods: Samples from seven young (younger than 100 yrs.) and nine old-growth (older than 300 yrs.) artificial populations were collected. For comparison, three young and two old-growth natural populations were also sampled. Nine microsatellite loci were used to analyze genetic diversity parameters. These parameters were calculated using FSTAT version 2.9.3 and GenAlex v 6.41. Important Findings: The old-growth artificial populations of P. orientalis have significantly higher genetic diversity than younger artificial populations and similar levels to those in extant natural populations. The imperial parks and ancient temples, which have protected these old-growth trees for centuries, have played an important role in maintaining the genetic diversity and reproductive capacity of this tree species.	[Zhu, Lin; Lou, Anru] Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China	Beijing Normal University	Lou, AR (corresponding author), Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	louanru@bnu.edu.cn			National Natural Science Foundation of China [31070374]; Specialized Research Fund for the Doctoral Program of Higher Education [20120003130003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (project code: 31070374) and Specialized Research Fund for the Doctoral Program of Higher Education (20120003130003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anami VS, 2007, WITNESSES TIME MAGNI; Asili J, 2004, J NAT PROD, V67, P631, DOI 10.1021/np034033e; Chen X, 2010, SCI TECHNOLOGY ENG, V10, P5; Committee FoCE, 1999, FLORA CHINA; Dong Y, 1989, J BEIJING FORESTRY U, V11, P11; ELLSTRAND NC, 1989, P NATL ACAD SCI USA, V86, P9044, DOI 10.1073/pnas.86.22.9044; England PR, 2003, HEREDITY, V91, P475, DOI 10.1038/sj.hdy.6800308; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GREIPSSON S, 1995, ANN BOT-LONDON, V76, P493, DOI 10.1006/anbo.1995.1125; KONNERT M, 1991, SILVAE GENET, V40, P60; Li H, 2009, CHINESE J TROPICAL C, V30, P6; Li H, 2009, THESIS FORESTRY U; Li JY, 1989, J BEIJING FORESTRY U, V11, P9; Liang M, 2008, SHAANXI FOREST SCI T, V2, P4; Lu W, 2011, RES SOIL WATER CONSE, V18, P4; Lu W, 2011, ENVIRON SCI TECHNOL, V34, P5; Mosseler A, 2003, THEOR APPL GENET, V106, P931, DOI 10.1007/s00122-002-1156-1; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Nie LS, 2005, J BEIJING FORESTRY U, V27, P5; Orellana MR, 2005, CAN J BOT, V83, P183, DOI [10.1139/b04-166, 10.1139/B04-166]; Ostlund L, 2002, ENV HIST, V7, P21; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Reisch C, 2007, NORD J BOT, V25, P366, DOI 10.1111/j.0107-055X.2008.00188.x; Roberts DG, 2007, CONSERV BIOL, V21, P842, DOI 10.1111/j.1523-1739.2007.00691.x; ROHDE CLE, 1994, ENGLISH NATURE SCI, V22; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Stanton ML, 1994, ECOLOGY, V65, P8; Templeton AR, 1986, CONSERVATION BIOL SC; Troeh F.R., 1981, SOIL SCI, V132, P189, DOI [10.1097/00010694-198108000-00012, DOI 10.1097/00010694-198108000-00012]; Vaughton G, 1998, AUSTR J ECOLOGY, V23, P10; Xu Z, 1992, CHINESE J ECOL, V11, P5; Zhang J, 2009, J SANMENXIA POLYTECH, V8, P5; Zhu L, 2012, AM J BOT, V99, pE280, DOI 10.3732/ajb.1100583	34	11	12	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56489	10.1371/journal.pone.0056489	http://dx.doi.org/10.1371/journal.pone.0056489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409190	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300076
J	Gaujoux, S; Hantel, C; Launay, P; Bonnet, S; Perlemoine, K; Lefevre, L; Guillaud-Bataille, M; Beuschlein, F; Tissier, F; Bertherat, J; Rizk-Rabin, M; Ragazzon, B				Gaujoux, Sebastien; Hantel, Constanze; Launay, Pierre; Bonnet, Stephane; Perlemoine, Karine; Lefevre, Lucile; Guillaud-Bataille, Marine; Beuschlein, Felix; Tissier, Frederique; Bertherat, Jerome; Rizk-Rabin, Marthe; Ragazzon, Bruno			Silencing Mutated beta-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R	PLOS ONE			English	Article							SIGNALING PATHWAYS; TUMORS; EXPRESSION; MUTATIONS; GENE; ACTIVATION; CARCINOMA; PROTEIN; GROWTH	Context: Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine neoplasm, with limited therapeutic options. Activating beta-catenin somatic mutations are found in ACC and have been associated with a poor clinical outcome. In fact, activation of the Wnt/beta-catenin signaling pathway seems to play a major role in ACC aggressiveness, and might, thus, represent a promising therapeutic target. Objective: Similar to patient tumor specimen the H295 cell line derived from an ACC harbors a natural activating beta-catenin mutation. We herein assess the in vitro and in vivo effect of beta-catenin inactivation using a doxycyclin (dox) inducible shRNA plasmid in H295R adrenocortical cancer cells line (clone named sh beta). Results: Following dox treatment a profound reduction in beta-catenin expression was detectable in sh beta clones in comparison to control clones (Ctr). Accordingly, we observed a decrease in Wnt/beta catenin-dependent luciferase reporter activity as well as a decreased expression of AXIN2 representing an endogenous beta-catenin target gene. Concomitantly, beta-catenin silencing resulted in a decreased cell proliferation, cell cycle alterations with cell accumulation in the G1 phase and increased apoptosis in vitro. In vivo, on established tumor xenografts in athymic nude mice, 9 days of beta-catenin silencing resulted in a significant reduction of CTNNB1 and AXIN2 expression. Moreover, continous beta-catenin silencing, starting 3 days after tumor cell inoculation, was associated with a complete absence of tumor growth in the sh beta group while tumors were present in all animals of the control group. Conclusion: In summary, these experiments provide evidences that Wnt/beta-catenin pathway inhibition in ACC is a promising therapeutic target.	[Gaujoux, Sebastien; Launay, Pierre; Bonnet, Stephane; Perlemoine, Karine; Lefevre, Lucile; Guillaud-Bataille, Marine; Tissier, Frederique; Bertherat, Jerome; Rizk-Rabin, Marthe; Ragazzon, Bruno] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Gaujoux, Sebastien; Launay, Pierre; Bonnet, Stephane; Perlemoine, Karine; Lefevre, Lucile; Guillaud-Bataille, Marine; Tissier, Frederique; Bertherat, Jerome; Rizk-Rabin, Marthe; Ragazzon, Bruno] INSERM, U1016, Paris, France; [Gaujoux, Sebastien; Bonnet, Stephane] Hop Cochin, AP HP, Dept Digest & Endocrine Surg, F-75674 Paris, France; [Hantel, Constanze; Beuschlein, Felix] Univ Munich, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany; [Tissier, Frederique; Bertherat, Jerome] Natl Canc Inst, Rare Adrenal Canc Network Corticomedullosurrenale, Paris, France; [Tissier, Frederique] Hop Cochin, AP HP, Dept Pathol, F-75674 Paris, France; [Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, Ctr Rare Adrenal Dis, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Institut National du Cancer (INCA) France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Ragazzon, B (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	bruno.ragazzon@inserm.fr	Ragazzon, Bruno/E-6541-2017; Hantel, Constanze/AAJ-3192-2021; Launay, Pierre/AAH-7076-2019; Gaujoux, Sébastien/A-1981-2010; Rizk-Rabin, Marthe/A-1698-2018	Ragazzon, Bruno/0000-0001-9476-4973; Gaujoux, Sébastien/0000-0002-1072-7639; BERTHERAT, Jerome/0000-0003-2551-3008; Beuschlein, Felix/0000-0001-7826-3984; Rizk-Rabin, Marthe/0000-0003-1558-737X	Contrat d'Initiation a la Recherche Clinique [CIRC 05045]; Plan Hospitalier de Recherche Clinique [AOM06179]; Recherche Translationnelle DHOS/INCA [RTD09024]; ESF [07-RNP-067]; Association pour la Recherche sur le Cancer [SFI20111203542]; Weigand Trust Germany; Sander Stiftung [2011.003.1]; Ligue contre le cancer [RS12/75-105];  [259735]	Contrat d'Initiation a la Recherche Clinique; Plan Hospitalier de Recherche Clinique; Recherche Translationnelle DHOS/INCA(Institut National du Cancer (INCA) France); ESF(European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Weigand Trust Germany; Sander Stiftung; Ligue contre le cancer(Ligue nationale contre le cancer); 	This work was supported in part by the Contrat d'Initiation a la Recherche Clinique (grant CIRC 05045 - AP-HP), the Plan Hospitalier de Recherche Clinique (AOM06179) to the COMETE Network, the Recherche Translationnelle DHOS/INCA 2009 (RTD09024), ESF (07-RNP-067), Association pour la Recherche sur le Cancer (SFI20111203542), the Weigand Trust Germany, the Sander Stiftung (2011.003.1) and the Ligue contre le cancer (RS12/75-105). Furthermore, research leading to these results has received funding from the Seventh Framework Programme (FP7/2007-2013) under grant agreement number 259735 (ENS@T-CANCER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Bonnet S, 2011, J CLIN ENDOCR METAB, V96, pE419, DOI 10.1210/jc.2010-1885; Doghman M, 2008, J CLIN ENDOCR METAB, V93, P3222, DOI 10.1210/jc.2008-0247; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Gaujoux S, 2011, CLIN CANC RES; Gaujoux S, 2008, J CLIN ENDOCR METAB, V93, P4135, DOI 10.1210/jc.2008-0631; Groussin L, 2000, J CLIN ENDOCR METAB, V85, P345, DOI 10.1210/jc.85.1.345; Hantel C, 2010, J CLIN ENDOCR METAB, V95, P943, DOI 10.1210/jc.2009-1980; Kim A, 2009, ANN ENDOCRINOL-PARIS, V70, P156, DOI 10.1016/j.ando.2009.02.006; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Ragazzon B, 2010, CANCER RES, V70, P8276, DOI 10.1158/0008-5472.CAN-10-2014; Ragazzon B, 2009, CANCER RES, V69, P7278, DOI 10.1158/0008-5472.CAN-09-1601; Rizk-Rabin M, 2008, CANCER EPIDEM BIOMAR, V17, P2275, DOI 10.1158/1055-9965.EPI-07-2924; Tadjine M, 2008, CLIN ENDOCRINOL, V68, P264, DOI 10.1111/j.1365-2265.2007.03033.x; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865	20	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55743	10.1371/journal.pone.0055743	http://dx.doi.org/10.1371/journal.pone.0055743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409032	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200057
J	Ryu, I; Park, JH; An, S; Kwon, OS; Jang, SK				Ryu, Incheol; Park, Ji Hoon; An, Sihyeon; Kwon, Oh Sung; Jang, Sung Key			eIF4GI Facilitates the MicroRNA-Mediated Gene Silencing	PLOS ONE			English	Article							RNA-BINDING PROTEIN; TRANSLATIONAL REPRESSION; LET-7 MICRORNA; INITIATION; CAP; DEADENYLATION; INHIBITION; ARGONAUTE; PABP; MECHANISMS	MicroRNAs (miRNAs) are small noncoding RNAs that mediate post-transcriptional gene silencing by binding to complementary target mRNAs and recruiting the miRNA-containing ribonucleoprotein complexes to the mRNAs. However, the molecular basis of this silencing is unclear. Here, we show that human Ago2 associates with the cap-binding protein complex and this association is mediated by human eIF4GI, a scaffold protein required for the translation initiation. Using a cap photo-crosslinking method, we show that Ago2 closely associates with the cap structure. Taken together, these data suggest that eIF4GI participates in the miRNA-mediated post-transcriptional gene silencing by promoting the association of Ago2 with the cap-binding complex.	[Ryu, Incheol; Park, Ji Hoon; An, Sihyeon; Kwon, Oh Sung; Jang, Sung Key] Pohang Univ Sci & Technol, Dept Life Sci, POSTECH Biotech Ctr, Mol Virol Lab, Pohang, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Jang, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, POSTECH Biotech Ctr, Mol Virol Lab, Pohang, South Korea.	sungkey@postech.ac.kr	Jang, Sung K/P-1230-2017		NRF BRL [2010-0019706]	NRF BRL	This research is supported by NRF BRL [2010-0019706]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Choe J, 2011, FEBS LETT, V585, P2682, DOI 10.1016/j.febslet.2011.07.047; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Djuranovic S, 2010, NAT STRUCT MOL BIOL, V17, P144, DOI 10.1038/nsmb.1736; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frank F, 2011, EMBO REP, V12, P415, DOI 10.1038/embor.2011.48; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Fukaya T, 2011, EMBO J, V30, P4998, DOI 10.1038/emboj.2011.426; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kinch LN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-2; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Lindqvist L, 2008, RNA, V14, P960, DOI 10.1261/rna.971208; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079	43	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55725	10.1371/journal.pone.0055725	http://dx.doi.org/10.1371/journal.pone.0055725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409027	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200052
J	Walter, JD; Werther, RA; Polozova, MS; Pohlman, J; Healey, JF; Meeks, SL; Lollar, P; Spiegel, PC				Walter, Justin D.; Werther, Rachel A.; Polozova, Maria S.; Pohlman, Julie; Healey, John F.; Meeks, Shannon L.; Lollar, Pete; Spiegel, P. Clint, Jr.			Characterization and Solution Structure of the Factor VIII C2 Domain in a Ternary Complex with Classical and Non-classical Inhibitor Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; HEMOPHILIA-A PATIENTS; VONWILLEBRAND-FACTOR; MONOCLONAL-ANTIBODY; BINDING; MECHANISM; EFFICACY; SURFACE; SAFETY	The most significant complication for patients with severe cases of congenital or acquired hemophilia A is the development of inhibitor antibodies against coagulation factor VIII (fVIII). The C2 domain of fVIII is a significant antigenic target of anti-fVIII antibodies. Here, we have utilized small angle x-ray scattering (SAXS) and biochemical techniques to characterize interactions between two different classes of anti-C2 domain inhibitor antibodies and the isolated C2 domain. Multiple assays indicated that antibodies 3E6 and G99 bind independently to the fVIII C2 domain and can form a stable ternary complex. SAXS-derived numerical estimates of dimensional parameters for all studied complexes agree with the proportions of the constituent proteins. Ab initio modeling of the SAXS data results in a long kinked structure of the ternary complex, showing an angle centered at the C2 domain of similar to 130 degrees. Guided by biochemical data, rigid body modeling of subunits into the molecular envelope of the ternary complex suggests that antibody 3E6 recognizes a C2 domain epitope consisting of the Arg(2209)-Ser(2216) and Leu(2178)-Asp(2187) loops. In contrast, antibody G99 recognizes the C2 domain primarily through the Pro(2221)-Trp(2229) loop. These two epitopes are on opposing sides of the fVIII C2 domain, are consistent with the solvent accessibility in the context of the entire fVIII molecule, and provide further structural detail regarding the pathogenic immune response to fVIII.	[Walter, Justin D.; Werther, Rachel A.; Polozova, Maria S.; Pohlman, Julie; Spiegel, P. Clint, Jr.] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Healey, John F.; Meeks, Shannon L.; Lollar, Pete] Emory Univ, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Western Washington University; Emory University	Spiegel, PC (corresponding author), Western Washington Univ, Dept Chem, 516 High St, Bellingham, WA 98225 USA.	spiegep@chem.wwu.edu		Meeks, Shannon/0000-0002-3683-8644	National Institutes of Health [R15 HL103518, U54 HL112309, K08 HL102262, R01 HL082609, R01 HL040921]; National Science Foundation [CHE-1062722]; Western Washington University; Hemophilia of Georgia, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL103518, R01HL040921, K08HL102262, U54HL112309, R01HL082609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Western Washington University; Hemophilia of Georgia, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15 HL103518; Grant U54 HL112309 (to S. L. M. and to P. L.); Grant K08 HL102262 (to S. L. M.); and Grants R01 HL082609 and R01 HL040921 (to P. L.). This work was also supported by National Science Foundation Grant CHE-1062722, a project development award from Western Washington University (to P. C. S.), and Hemophilia of Georgia, Inc. (to S. L. M. and P. L.).	ANDERSSON LO, 1981, BIOCHEM J, V200, P161, DOI 10.1042/bj2000161; BRAY GL, 1994, BLOOD, V83, P2428; DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; Franchini M, 2008, BLOOD, V112, P250, DOI 10.1182/blood-2008-03-143586; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GAWRYL MS, 1982, BLOOD, V60, P1103; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GREENSPAN NS, 1989, FASEB J, V3, P2203, DOI 10.1096/fasebj.3.10.2666233; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; Hoots WK, 2001, HAEMOPHILIA, V7, P4, DOI 10.1046/j.1365-2516.2001.00099.x; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KANE WH, 1988, BLOOD, V71, P539; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kreuz W, 2002, SEMIN THROMB HEMOST, V28, P285, DOI 10.1055/s-2002-32664; LAJMANOVICH A, 1981, BIOCHIM BIOPHYS ACTA, V678, P132, DOI 10.1016/0304-4165(81)90056-8; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; Lusher JM, 2003, HAEMOPHILIA, V9, P38, DOI 10.1046/j.1365-2516.2003.00708.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Mauser-Bunschoten EP, 2001, HAEMOPHILIA, V7, P364, DOI 10.1046/j.1365-2516.2001.00513.x; Meeks SL, 2009, J THROMB HAEMOST, V7, P658, DOI 10.1111/j.1538-7836.2009.03299.x; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Nogami K, 2000, J BIOL CHEM, V275, P25774, DOI 10.1074/jbc.M002007200; Nogami K, 1999, J BIOL CHEM, V274, P31000, DOI 10.1074/jbc.274.43.31000; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; SAENKO EL, 1995, J BIOL CHEM, V270, P13826, DOI 10.1074/jbc.270.23.13826; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Scharrer I, 1999, HAEMOPHILIA, V5, P145; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; SHIMA M, 1995, BRIT J HAEMATOL, V91, P714, DOI 10.1111/j.1365-2141.1995.tb05374.x; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Spiegel PC, 2004, CHEM BIOL, V11, P1413, DOI 10.1016/j.chembiol.2004.08.006; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Spiegel PC, 2004, J BIOL CHEM, V279, P53691, DOI 10.1074/jbc.M409389200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	50	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9905	9914		10.1074/jbc.M112.424564	http://dx.doi.org/10.1074/jbc.M112.424564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417672	hybrid, Green Published			2022-12-25	WOS:000317114000030
J	Abler, B; Kumpfmuller, D; Gron, G; Walter, M; Stingl, J; Seeringer, A				Abler, Birgit; Kumpfmueller, Daniela; Groen, Georg; Walter, Martin; Stingl, Julia; Seeringer, Angela			Neural Correlates of Erotic Stimulation under Different Levels of Female Sexual Hormones	PLOS ONE			English	Article							BRAIN-ACTIVATION; ORAL-CONTRACEPTIVES; PREFRONTAL CORTEX; MENSTRUAL-CYCLE; HUMAN MALES; WOMEN; FMRI; AROUSAL; DYSFUNCTION; FREQUENCY	Previous studies have demonstrated variable influences of sexual hormonal states on female brain activation and the necessity to control for these in neuroimaging studies. However, systematic investigations of these influences, particularly those of hormonal contraceptives as compared to the physiological menstrual cycle are scarce. In the present study, we investigated the hormonal modulation of neural correlates of erotic processing in a group of females under hormonal contraceptives (C group; N = 12), and a different group of females (nC group; N = 12) not taking contraceptives during their mid-follicular and mid-luteal phases of the cycle. We used functional magnetic resonance imaging to measure hemodynamic responses as an estimate of brain activation during three different experimental conditions of visual erotic stimulation: dynamic videos, static erotic pictures, and expectation of erotic pictures. Plasma estrogen and progesterone levels were assessed in all subjects. No strong hormonally modulating effect was detected upon more direct and explicit stimulation (viewing of videos or pictures) with significant activations in cortical and subcortical brain regions previously linked to erotic stimulation consistent across hormonal levels and stimulation type. Upon less direct and less explicit stimulation (expectation), activation patterns varied between the different hormonal conditions with various, predominantly frontal brain regions showing significant within- or between-group differences. Activation in the precentral gyrus during the follicular phase in the nC group was found elevated compared to the C group and positively correlated with estrogen levels. From the results we conclude that effects of hormonal influences on brain activation during erotic stimulation are weak if stimulation is direct and explicit but that female sexual hormones may modulate more subtle aspects of sexual arousal and behaviour as involved in sexual expectation. Results may provide a basis for future imaging studies on sexual processing in females, especially in the context of less explicit erotic stimulation.	[Abler, Birgit; Kumpfmueller, Daniela; Groen, Georg] Univ Ulm, Dept Psychiat & Psychotherapy, D-89069 Ulm, Germany; [Walter, Martin] Otto Von Guericke Univ, Dept Psychiat, Magdeburg, Germany; [Stingl, Julia; Seeringer, Angela] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany	Ulm University; Otto von Guericke University; Ulm University	Abler, B (corresponding author), Univ Ulm, Dept Psychiat & Psychotherapy, D-89069 Ulm, Germany.	birgit.abler@uni-ulm.de	Stingl, Julia/H-2410-2013; Stingl, Julia C./ABA-7201-2020	Stingl, Julia/0000-0002-1566-8156; Stingl, Julia C./0000-0002-1566-8156; Gron, Georg/0000-0002-0282-3575; Walter, Martin/0000-0001-7857-4483				Abler B, 2011, NEUROPSYCHOPHARMACOL, V36, P1837, DOI 10.1038/npp.2011.66; Archer JS, 2006, MENOPAUSE, V13, P528, DOI 10.1097/01.gme.0000188737.46746.cd; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; BANCROFT J, 1983, PSYCHOSOM MED, V45, P509, DOI 10.1097/00006842-198312000-00005; BANCROFT J, 1991, ARCH SEX BEHAV, V20, P121, DOI 10.1007/BF01541939; Bianchi-Demicheli F, 2009, MED SCI MONITOR, V15, pCR545; Davis AR, 2004, ANN REV SEX RES, V15, P297; DENNERSTEIN L, 1976, MED J AUSTRALIA, V1, P796, DOI 10.5694/j.1326-5377.1976.tb141059.x; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; Gizewski ER, 2006, EXP BRAIN RES, V174, P101, DOI 10.1007/s00221-006-0429-3; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Klucken T, 2009, J SEX MED, V6, P3071, DOI 10.1111/j.1743-6109.2009.01405.x; Kuhn S, 2011, J SEX MED, V8, P2269, DOI 10.1111/j.1743-6109.2011.02322.x; Labbate LA, 2001, PSYCHOTHER PSYCHOSOM, V70, P221, DOI 10.1159/000056257; Lang P.J., 2008, A8 U FLOR; MACLUSKY N J, 1987, Steroids, V50, P459, DOI 10.1016/0039-128X(87)90032-8; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Naidich T. P., 2008, DUVERNOYS ATLAS HUMA; Pfaus JG, 2009, J SEX MED, V6, P1506, DOI 10.1111/j.1743-6109.2009.01309.x; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Pillsworth EG, 2004, J SEX RES, V41, P55, DOI 10.1080/00224490409552213; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Reinecke A, 2006, VERHALTENSTHERAPIE, V16, P166, DOI 10.1159/000094747; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Rumberg B, 2010, NEUROSCI RES, V66, P366, DOI 10.1016/j.neures.2009.12.011; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Rupp HA, 2009, ARCH SEX BEHAV, V38, P417, DOI 10.1007/s10508-008-9402-5; Rupp HA, 2009, EVOL HUM BEHAV, V30, P1, DOI 10.1016/j.evolhumbehav.2008.08.006; Schaffir J, 2006, J SEX MARITAL THER, V32, P305, DOI 10.1080/00926230600666311; Stuckey BGA, 2008, J SEX MED, V5, P2282, DOI 10.1111/j.1743-6109.2008.00992.x; Sugiura M, 2008, NEUROIMAGE, V42, P414, DOI 10.1016/j.neuroimage.2008.03.054; Talairach J., 1988, COPLANAR STEREOTAXIC; TRUSSELL J, 1980, FAM PLANN PERSPECT, V12, P246, DOI 10.2307/2134867; Wallen K, 2010, HORM BEHAV, V57, P263, DOI 10.1016/j.yhbeh.2009.12.005; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Walter M, 2008, MAGN RESON MATER PHY, V21, P103, DOI 10.1007/s10334-007-0103-1; Walter M, 2009, HUM BRAIN MAPP, V30, P312, DOI 10.1002/hbm.20506; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305; Zhu X, 2010, BEHAV BRAIN RES, V206, P279, DOI 10.1016/j.bbr.2009.09.027	52	48	49	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54447	10.1371/journal.pone.0054447	http://dx.doi.org/10.1371/journal.pone.0054447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418428	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300018
J	Gibbs, EM; Davidson, AE; Trickey-Glassman, A; Backus, C; Hong, Y; Sakowski, SA; Dowling, JJ; Feldman, EL				Gibbs, Elizabeth M.; Davidson, Ann E.; Trickey-Glassman, Arden; Backus, Carey; Hong, Yu; Sakowski, Stacey A.; Dowling, James J.; Feldman, Eva L.			Two Dynamin-2 Genes Are Required for Normal Zebrafish Development	PLOS ONE			English	Article							CENTRONUCLEAR MYOPATHY; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; GTP-BINDING; EXPRESSION; MUTATIONS; ENDOCYTOSIS	Dynamin-2 (DNM2) is a large GTPase involved in clathrin-mediated endocytosis and related trafficking pathways. Mutations in human DNM2 cause two distinct neuromuscular disorders: centronuclear myopathy and Charcot-Marie-Tooth disease. Zebrafish have been shown to be an excellent animal model for many neurologic disorders, and this system has the potential to inform our understanding of DNM2-related disease. Currently, little is known about the endogenous zebrafish orthologs to human DNM2. In this study, we characterize two zebrafish dynamin-2 genes, dnm2 and dnm2-like. Both orthologs are structurally similar to human DNM2 at the gene and protein levels. They are expressed throughout early development and in all adult tissues examined. Knockdown of dnm2 and dnm2-like gene products resulted in extensive morphological abnormalities during development, and expression of human DNM2 RNA rescued these phenotypes. Our findings suggest that dnm2 and dnm2-like are orthologs to human DNM2, and that they are required for normal zebrafish development.	[Gibbs, Elizabeth M.; Trickey-Glassman, Arden; Backus, Carey; Hong, Yu; Dowling, James J.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Gibbs, Elizabeth M.; Dowling, James J.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; [Davidson, Ann E.; Dowling, James J.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Sakowski, Stacey A.] Univ Michigan, A Alfred Taubman Med Res Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	efeldman@umich.edu		Feldman, Eva/0000-0002-9162-2694; Vanderwall, Arden/0000-0001-9687-6565	A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; Walbridge Aldinger Graduate Fellowship fund	A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; Walbridge Aldinger Graduate Fellowship fund	This work is supported by the A. Alfred Taubman Medical Research Institute and the Program for Neurology Research and Discovery. Support for EMG is provided by the Walbridge Aldinger Graduate Fellowship fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, MOL CELLS, V30, P377, DOI 10.1007/s10059-010-0128-6; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; Daniels GD, 1999, DEV COMP IMMUNOL, V23, P139, DOI 10.1016/S0145-305X(98)00051-2; DIATLOFFZITO C, 1995, GENE, V163, P301, DOI 10.1016/0378-1119(95)00275-B; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Durieux AC, 2012, TRAFFIC, V13, P869, DOI 10.1111/j.1600-0854.2012.01348.x; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Feng B, 2002, EXP CELL RES, V279, P14, DOI 10.1006/excr.2002.5579; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Long QM, 1997, DEVELOPMENT, V124, P4105; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Pugacheva EM, 2006, GENE, V375, P26, DOI 10.1016/j.gene.2006.01.036; Saint-Amant L, 2008, DEV NEUROBIOL, V68, P45, DOI 10.1002/dneu.20569; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	35	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55888	10.1371/journal.pone.0055888	http://dx.doi.org/10.1371/journal.pone.0055888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418470	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300061
J	Morrison, KM; Anand, SS; Yusuf, S; Atkinson, SA; Schulze, KM; Rao-Melacini, P; McQueen, MJ; McDonald, S; Persadie, R; Hunter, B; Bourgeois, J; Jansen, JW; Teo, KK				Morrison, Katherine M.; Anand, Sonia S.; Yusuf, Salim; Atkinson, Stephanie A.; Schulze, Karleen M.; Rao-Melacini, Purnima; McQueen, Matthew J.; McDonald, Sarah; Persadie, Richard; Hunter, Barry; Bourgeois, Jacqueline; Jansen, Jan W.; Teo, Koon K.		FAMILY Family Atherosclerosis Moni	Maternal and Pregnancy Related Predictors of Cardiometabolic Traits in Newborns	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE SYNDROME; SYSTOLIC BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; LIPOPROTEIN METABOLISM; PHYSICAL-ACTIVITY; MILK CONSUMPTION; FETAL-GROWTH; 52 COUNTRIES; FAT	Background: The influence of multiple maternal and pregnancy characteristics on offspring cardiometabolic traits at birth is not well understood and was evaluated in this study. Methods and Findings: The Family Atherosclerosis Monitoring In earLY life (FAMILY) Study prospectively evaluated 11 cardiometabolic traits in 901 babies born to 857 mothers. The influence of maternal age, health (pre-pregnancy weight, blood pressure, glycemic status, lipids), health behaviors (diet, activity, smoking) and pregnancy characteristics (gestational age at birth, gestational weight gain and placental-fetal ratio) were examined. Greater gestational age influenced multiple newborn cardiometabolic traits including cord blood lipids, glucose and insulin, body fat and blood pressure. In a subset of 442 singleton mother/infant pairs, principal component analysis grouped 11 newborn cardiometabolic traits into 5 components (anthropometry/insulin, 2 lipid components, blood pressure and glycemia), accounting for 74% of the variance of the 11 outcome variables. Determinants of these components, corrected for sex and gestational age, were examined. Baby anthropometry/insulin was independently predicted by higher maternal pre-pregnancy weight (standardized estimate 0.30) and gestational weight gain (0.30; both p<0.0001) and was inversely related to smoking during pregnancy (-0.144; p = 0.01) and maternal polyunsaturated to saturated fat intake (-0.135; p = 0.01). Component 2 (HDL-C/Apo Apolipoprotein1) was inversely associated with maternal age. Component 3 (blood pressure) was not clustered with any other newborn cardiometabolic trait and no associations with maternal pregnancy characteristics were identified. Component 4 (triglycerides) was positively associated with maternal hypertension and triglycerides, and inversely associated with maternal HDL and age. Component 5 (glycemia) was inversely associated with placental/fetal ratio (-0.141; p = 0.005). LDL-C was a bridging variable between the lipid factors and glycemia. Conclusions: Maternal health, health behaviours and placenta to fetal weight ratio are associated with newborn cardiometabolic traits over and above gestational age. Future investigations are needed to determine if these factors remain important determinants of cardiometabolic health throughout childhood.	[Morrison, Katherine M.; Atkinson, Stephanie A.] Hamilton Hlth Sci, Dept Pediat, Hamilton, ON, Canada; [Morrison, Katherine M.; Anand, Sonia S.; Yusuf, Salim; Atkinson, Stephanie A.; Schulze, Karleen M.; Rao-Melacini, Purnima; McQueen, Matthew J.; Teo, Koon K.] McMaster Univ, Hamilton, ON, Canada; [Morrison, Katherine M.; Anand, Sonia S.; Yusuf, Salim; Schulze, Karleen M.; Rao-Melacini, Purnima; McQueen, Matthew J.; Teo, Koon K.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Anand, Sonia S.; Yusuf, Salim; Teo, Koon K.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Anand, Sonia S.; McDonald, Sarah] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [McDonald, Sarah; Persadie, Richard] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [McQueen, Matthew J.; Hunter, Barry] Joseph Brant Hosp, Burlington, ON, Canada; [Bourgeois, Jacqueline; Jansen, Jan W.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University	Morrison, KM (corresponding author), Hamilton Hlth Sci, Dept Pediat, Hamilton, ON, Canada.	kmorrison@mcmaster.ca	Morrison, Katherine/AAO-8046-2021; Atkinson, Stephanie/AAS-4146-2021; McDonald, Sarah D/G-2653-2013	Morrison, Katherine/0000-0002-1737-256X; Atkinson, Stephanie/0000-0002-5680-7546; Rao, Purnima/0000-0002-7537-9057; Teo, Koon/0000-0002-3731-0956; Yusuf, Salim/0000-0003-4776-5601	Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Population Health Research Institute; Canadian Institutes of Health Research New Investigator Salary Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Population Health Research Institute; Canadian Institutes of Health Research New Investigator Salary Award(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario and the Population Health Research Institute. S.S.A. holds a Canada Research Chair in Ethnicity and Cardiovascular Disease, and the Michael DeGroote Heart and Stroke Foundation Chair in Population Health. S.D.M. is supported by a Canadian Institutes of Health Research New Investigator Salary Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 1998, CAN J CARDIOL, V14, P1349; Bakker H, 2011, EUR J EPIDEMIOL, V26, P763, DOI 10.1007/s10654-011-9621-2; Bansal N, 2005, CURR OPIN LIPIDOL, V16, P400, DOI 10.1097/01.mol.0000174154.61307.16; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Brizzi P, 1999, AM J OBSTET GYNECOL, V181, P430, DOI 10.1016/S0002-9378(99)70574-0; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Chen W, 1999, AM J EPIDEMIOL, V150, P667; DESWIET M, 1975, CLIN SCI MOL MED, V49, P557, DOI 10.1042/cs0490557; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gillman MW, 2004, J PEDIATR-US, V144, P240, DOI 10.1016/j.jpeds.2003.10.064; Goodman E, 2005, CIRCULATION, V111, P1970, DOI 10.1161/01.CIR.0000161957.34198.2B; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Hatcher L., 1994, STEP BY STEP APPROAC; Held C, 2012, EUR HEART J, V33, P452, DOI 10.1093/eurheartj/ehr432; Heppe DHM, 2011, AM J CLIN NUTR, V94, P501, DOI 10.3945/ajcn.111.013854; Huang RC, 2007, INT J OBESITY, V31, P236, DOI 10.1038/sj.ijo.0803394; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Kelemen LE, 2003, J AM DIET ASSOC, V103, P1178, DOI 10.1016/S0002-8223(03)00985-4; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; Langlois Kellie, 2009, Health Rep, V20, P11; Lawlor DA, 2004, CIRCULATION, V110, P2417, DOI 10.1161/01.CIR.0000145165.80130.B5; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; Merchant AT, 2008, AM J CLIN NUTR, V87, P168, DOI 10.1093/ajcn/87.1.168; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; NEARY RH, 1995, CLIN SCI, V88, P311, DOI 10.1042/cs0880311; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Olsen SF, 2007, AM J CLIN NUTR, V86, P1104, DOI 10.1093/ajcn/86.4.1104; Rodie VA, 2004, ATHEROSCLEROSIS, V176, P181, DOI 10.1016/j.atherosclerosis.2004.04.026; Schmelzle HR, 2002, AM J CLIN NUTR, V76, P1096, DOI 10.1093/ajcn/76.5.1096; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; TSANG R, 1974, AM J DIS CHILD, V127, P78, DOI 10.1001/archpedi.1974.02110200080011; Uusitalo U, 2002, GLOBALIZATION DIETS, P1; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55815	10.1371/journal.pone.0055815	http://dx.doi.org/10.1371/journal.pone.0055815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418462	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300053
J	Sun, DB; Zhang, H; Guo, DH; Sun, AG; Wang, HB				Sun, Dongbo; Zhang, Hong; Guo, Donghua; Sun, Anguo; Wang, Hongbin			Shotgun Proteomic Analysis of Plasma from Dairy Cattle Suffering from Footrot: Characterization of Potential Disease-Associated Factors	PLOS ONE			English	Article							FUSOBACTERIUM-NECROPHORUM INFECTIONS; PEPTIDOGLYCAN RECOGNITION PROTEIN; ACUTE-PHASE RESPONSE; LARGE GENE LISTS; KERATAN SULFATE; HEPATIC-ABSCESS; OVARIAN-CANCER; SERUM; IDENTIFICATION; BIOMARKER	The plasma proteome of healthy dairy cattle and those with footrot was investigated using a shotgun LC-MS/MS approach. In total, 648 proteins were identified in healthy plasma samples, of which 234 were non-redundant proteins and 123 were high-confidence proteins; 712 proteins were identified from footrot plasma samples, of which 272 were non-redundant proteins and 138 were high-confidence proteins. The high-confidence proteins showed significant differences between healthy and footrot plasma samples in molecular weight, isoelectric points and the Gene Ontology categories. 22 proteins were found that may differentiate between the two sets of plasma proteins, of which 16 potential differential expression (PDE) proteins from footrot plasma involved in immunoglobulins, innate immune recognition molecules, acute phase proteins, regulatory proteins, and cell adhesion and cytoskeletal proteins; 6 PDE proteins from healthy plasma involved in regulatory proteins, cytoskeletal proteins and coagulation factors. Of these PDE proteins, haptoglobin, SERPINA10 protein, afamin precursor, haptoglobin precursor, apolipoprotein D, predicted peptidoglycan recognition protein L (PGRP-L) and keratan sulfate proteoglycan (KS-PG) were suggested to be potential footrot-associated factors. The PDE proteins PGRP-L and KS-PG were highlighted as potential biomarkers of footrot in cattle. The resulting protein lists and potential differentially expressed proteins may provide valuable information to increase understanding of plasma protein profiles in cattle and to assist studies of footrot-associated factors.	[Sun, Dongbo; Zhang, Hong; Guo, Donghua] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Peoples R China; [Sun, Dongbo; Wang, Hongbin] Northeast Agr Univ, Postdoctoral Mobile Stn Vet Med, Harbin, Peoples R China; [Sun, Anguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Proteome Anal, Shanghai, Peoples R China	Heilongjiang Bayi Agricultural University; Northeast Agricultural University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Peoples R China.	dongbosun@yahoo.com.cn; hbwang@neau.edu.cn			Technological Innovation Team Building Program of University of Heilongjiang Province [2010td05]; National Natural Science Foundation of China [31101835]; China Postdoctoral Science Foundation [20110491022]; Postdoctoral Science Foundation of Heilongjiang Province [LBH-Z11230]; Doctor Start Foundation of Heilongjiang Bayi Agricultural University [B2009-4]	Technological Innovation Team Building Program of University of Heilongjiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation); Doctor Start Foundation of Heilongjiang Bayi Agricultural University	This work was supported by the Technological Innovation Team Building Program of University of Heilongjiang Province (Grant No. 2010td05), the National Natural Science Foundation of China (Grant No. 31101835), the China Postdoctoral Science Foundation (Grant No. 20110491022), the Postdoctoral Science Foundation of Heilongjiang Province (Grant No. LBH-Z11230), and the Doctor Start Foundation of Heilongjiang Bayi Agricultural University (B2009-4). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmed N, 2004, BRIT J CANCER, V91, P129, DOI 10.1038/sj.bjc.6601882; Alonso-Fauste I, 2012, J PROTEOMICS, V75, P3015, DOI 10.1016/j.jprot.2011.11.035; Angelucci S, 2006, BBA-PROTEINS PROTEOM, V1764, P1775, DOI 10.1016/j.bbapap.2006.09.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Dai J, 2005, ANAL CHEM, V77, P5793, DOI 10.1021/ac050251w; Fertin M, 2011, J PROTEOMICS, V74, P420, DOI 10.1016/j.jprot.2010.12.005; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Gilmore JM, 2010, J PROTEOMICS, V73, P2078, DOI 10.1016/j.jprot.2010.08.005; Goff JP, 1997, J DAIRY SCI, V80, P1260, DOI 10.3168/jds.S0022-0302(97)76055-7; Goo YA, 2010, J PROTEOMICS, V73, P1839, DOI 10.1016/j.jprot.2010.04.002; Guerrier L, 2008, J PROTEOMICS, V71, P368, DOI 10.1016/j.jprot.2008.06.003; Guo DH, 2010, ANAEROBE, V16, P317, DOI 10.1016/j.anaerobe.2010.03.007; Hall RE, 2004, PROSTATE, V58, P103, DOI 10.1002/pros.10343; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutjens M, 1998, P THES HOOV AR MAD W; Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r; Jackson D, 2007, CLIN CANCER RES, V13, P7370, DOI 10.1158/1078-0432.CCR-07-0747; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; KANOE M, 1990, J VET MED B, V37, P770, DOI 10.1111/j.1439-0450.1990.tb01127.x; Kuiper JI, 1998, SPINE, V23, P657, DOI 10.1097/00007632-199803150-00003; Kujala M, 2010, VET REC, V166, P240, DOI 10.1136/vr.b4770; Lai YH, 2012, J PROTEOMICS, V75, P2500, DOI 10.1016/j.jprot.2012.02.034; Li JY, 2009, J PROTEOME RES, V8, P2620, DOI 10.1021/pr8006123; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; MAKIMURA S, 1982, JPN J VET SCI, V44, P15, DOI 10.1292/jvms1939.44.15; Malard V, 2012, J PROTEOMICS, V75, P1043, DOI 10.1016/j.jprot.2011.10.025; Meng R, 2011, J PROTEOMICS, V75, P366, DOI 10.1016/j.jprot.2011.07.030; MORIMATSU M, 1991, J BIOL CHEM, V266, P11833; Nagaraja TG, 2005, ANAEROBE, V11, P239, DOI 10.1016/j.anaerobe.2005.01.007; Narayanan SK, 2003, VET MICROBIOL, V93, P335, DOI 10.1016/S0378-1135(03)00045-2; Nazifi S, 2012, WORLD J MICROB BIOT, V28, P1791, DOI 10.1007/s11274-011-0995-9; NIELSEN AH, 1987, SCAND J CLIN LAB INV, V47, P175; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ohtsuka H, 2001, J VET MED SCI, V63, P675, DOI 10.1292/jvms.63.675; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; SHINJO T, 1983, ANN INST PASTEUR MIC, VB134, P401; Sun DB, 2009, VET RES COMMUN, V33, P749, DOI 10.1007/s11259-009-9223-6; Tan ZL, 1996, VET RES COMMUN, V20, P113, DOI 10.1007/BF00385634; THONAR EJMA, 1985, ARTHRITIS RHEUM, V28, P1367, DOI 10.1002/art.1780281209; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wang ZQ, 2012, J PROTEOMICS, V75, P2375, DOI 10.1016/j.jprot.2012.02.005; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhang MZ, 2009, J PROTEOMICS, V72, P952, DOI 10.1016/j.jprot.2009.03.009; Zhou HT, 2009, VET MICROBIOL, V135, P363, DOI 10.1016/j.vetmic.2008.09.084	50	20	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55973	10.1371/journal.pone.0055973	http://dx.doi.org/10.1371/journal.pone.0055973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418487	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300079
J	Wang, X; Qian, YL; Jin, R; Wo, Y; Chen, J; Wang, C; Wang, DR				Wang, Xue; Qian, Yunliang; Jin, Rong; Wo, Yan; Chen, Jun; Wang, Chen; Wang, Danru			Effects of TRAP-1-Like Protein (TLP) Gene on Collagen Synthesis Induced by TGF-beta/Smad Signaling in Human Dermal Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VIVO; HYPERTROPHIC SCARS; FIBROTIC RESPONSE; SMAD 3; EXPRESSION; FIBROSIS; PATHOPHYSIOLOGY; FIBRONECTIN; PATHWAY	Background: Hypertrophic scars are pathologic proliferations of the dermal skin layer resulting from excessive collagen deposition during the healing process of cutaneous wounds. Current research suggests that the TGF-beta/Smad signaling pathway is closely associated with normal scar and hypertrophic scar formation. TRAP-1-like protein (TLP), a cytoplasmic protein, has been reported to efficiently regulate Smad2- and Smad3-dependent signal expression in the TGF-beta pathway. The relationship between TLP and Type I/III collagen (Col I/III) synthesis explored in the present study provides an effective target for wound healing and gene therapy of hypertrophic scarring. Objective: To investigate the effects of TLP on collagen synthesis in human dermal fibroblasts. Methods: Lentiviral vectors encoding TLP was constructed to transfect fibroblasts derived from normal human skin. The expression of Col I/III and phosphorylation of Smad2 and Smad3 in fibroblasts were examined after TLP treatment. In addition, the comparison of TLP expression in normal skin tissues and in hypertrophic scar tissues was performed, and the effect of TLP on cell viability was analyzed by MTT assay. Results: TLP expression in hypertrophic scar tissue was markedly higher than in normal skin tissue. The Real Time PCR and Western blot test results both revealed that the synthesis of Col I/III was positively correlated with the expression of TLP. TLP also facilitate Smad2 phosphorylation while, conversely, inhibiting Smad3 phosphorylation. TLP may play a cooperative role, along with the cytokine TGF-beta 1, in improving the overall cell viability of skin fibroblasts. Conclusions: TLP likely acts as a molecular modulator capable of altering the balance of Smad3- and Smad2-dependent signaling through regulation of phosphorylation, thus facilitating collagen synthesis in fibroblasts. Based on genetic variation in TLP levels in different tissues, these results suggest that TLP plays a key role in the process of TGF-beta 1/Smad3 signaling that contributes to wound healing and genesis of pathologic scars.	[Wang, Xue; Qian, Yunliang; Jin, Rong; Wo, Yan; Chen, Jun; Wang, Chen; Wang, Danru] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, DR (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China.	wangdanru1776@163.com			Shanghai Science and Technology Commission [09ZR1416900, 10PJD008]; National Natural Science Foundation of China [30400467]	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Shanghai Science and Technology Commission (09ZR1416900 and 10PJD008) and by a grant from National Natural Science Foundation of China (30400467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; AUTIO P, 1994, BRIT J DERMATOL, V131, P660, DOI 10.1111/j.1365-2133.1994.tb04978.x; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; Chin GS, 2001, PLAST RECONSTR SURG, V108, P423, DOI 10.1097/00006534-200108000-00022; Cui W, 2010, BRAZ J MED BIOL RES, V43, P36, DOI 10.1590/S0100-879X2009007500017; Dooley A, 2010, RHEUMATOLOGY, V49, P2024, DOI 10.1093/rheumatology/keq208; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huang JS, 2002, FASEB J, V16, P1269, DOI 10.1096/fj.02-0103fje; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lei B, 2011, J PHARMACOL SCI, V117, P98, DOI 10.1254/jphs.11065FP; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liu X, 2008, BIOCHEM J, V409, P289, DOI 10.1042/BJ20070545; Messller S, 2011, IMMUNOBIOLOGY, V216, P343, DOI 10.1016/j.imbio.2010.07.006; Moustakas A, 2001, J CELL SCI, V114, P4359; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Sayah DN, 1999, J SURG RES, V87, P209, DOI 10.1006/jsre.1999.5761; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098; Singer AJ, 2009, J BURN CARE RES, V30, P329, DOI 10.1097/BCR.0b013e31819a6369; Tan WQ, 2011, EXP DERMATOL, V20, P119, DOI 10.1111/j.1600-0625.2010.01186.x; Uemura M, 2005, MOL BIOL CELL, V16, P4214, DOI 10.1091/mbc.E05-02-0149; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang Z, 2007, J PLAST RECONSTR AES, V60, P1193, DOI 10.1016/j.bjps.2006.05.007; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Wurthner JU, 2001, J BIOL CHEM, V276, P19495, DOI 10.1074/jbc.M006473200; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Zhu B, 2010, NEPHROL DIAL TRANSPL, V25, P3180, DOI 10.1093/ndt/gfq239	36	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55899	10.1371/journal.pone.0055899	http://dx.doi.org/10.1371/journal.pone.0055899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418473	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300064
J	Brede, M				Brede, Markus			Short Versus Long Term Benefits and the Evolution of Cooperation in the Prisoner's Dilemma Game	PLOS ONE			English	Article							EMERGENCE; NETWORKS; STRATEGY	In this paper I investigate the evolution of cooperation in the prisoner's dilemma when individuals change their strategies subject to performance evaluation of their neighbours over variable time horizons. In the monochrome setting, in which all agents per default share the same performance evaluation rule, weighing past events strongly dramatically enhances the prevalence of cooperators. For co-evolutionary models, in which evaluation time horizons and strategies can co-evolve, I demonstrate that cooperation naturally associates with long-term evaluation of others while defection is typically paired with very short time horizons. Moreover, considering the continuous spectrum in between enhanced and discounted weights of past performance, cooperation is optimally supported when cooperators neither give enhanced weight to past nor more recent events, but simply average payoffs. Payoff averaging is also found to emerge as the dominant strategy for cooperators in co-evolutionary models, thus proposing a natural route to the evolution of cooperation in viscous populations.	Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England	University of Southampton	Brede, M (corresponding author), Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England.	Brede.Markus@gmail.com						Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Brede M, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/30003; Brede M, 2011, ARTIF LIFE, V17, P365, DOI 10.1162/artl_a_00044; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Chadefaux T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013471; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Mehta A, 2012, PHYS REV E, V85; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Tanimoto J, 2011, SOCIOBIOLOGY, V58, P315; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang Z, 2010, PHYS REV E, V82; Weibull Jorgen W., EVOLUTIONARY GAME TH; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	29	22	22	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56016	10.1371/journal.pone.0056016	http://dx.doi.org/10.1371/journal.pone.0056016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409114	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000315100000040
J	Makamure, B; Mhaka, J; Makumbirofa, S; Mutetwa, R; Mupfumi, L; Mason, P; Metcalfe, JZ				Makamure, Beauty; Mhaka, Jesca; Makumbirofa, Salome; Mutetwa, Reggie; Mupfumi, Lucy; Mason, Peter; Metcalfe, John Z.			Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; PREVALENCE; CULTURE; AFRICA; TRIAL	Introduction: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. Methods: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Lowenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. Results: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69-95%) and specificity was 93% (95% CI, 84-98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7-15 days) than MGIT (12 days; IQR 6-16 days) or LJ (28 days; IQR 21-35 days; p < 0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68-97%), 96% (95% CI, 79-100%), and 91% (95% CI, 72-99%), respectively; specificity was 89% (95% CI, 52-100%), 89% (95% CI, 52-100%), and 90% (95% CI, 56-100%), respectively. Conclusion: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods.	[Makamure, Beauty; Mhaka, Jesca; Makumbirofa, Salome; Mutetwa, Reggie; Mupfumi, Lucy; Mason, Peter] Biomed Res & Training Inst, Harare, Zimbabwe; [Mason, Peter] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Metcalfe, John Z.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Int TB Ctr, San Francisco, CA 94143 USA	Biomedical Research Training Institute; University of Zimbabwe; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Metcalfe, JZ (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Int TB Ctr, San Francisco, CA 94143 USA.	john.metcalfe@ucsf.edu		Mupfumi, Lucy/0000-0002-2290-2481; Metcalfe, John/0000-0002-2279-7036	National Institutes of Health [K23 AI094251, P30 AI27763]; Robert Wood Johnson Foundation; Trials of Excellence for Southern Africa (TESA) Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K23AI094251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Trials of Excellence for Southern Africa (TESA) Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (K23 AI094251 and P30 AI27763 to J.Z.M.), the Robert Wood Johnson Foundation (AMFDP Medical Faculty Development Award to J.Z.M.), and the Trials of Excellence for Southern Africa (TESA) Network (P. M., site principle investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman C, 2008, SAMJ S AFR MED J, V98, P15; Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Gumbo T, 2010, ANTIMICROB AGENTS CH, V54, P1484, DOI 10.1128/AAC.01474-09; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hesseling AC, 2012, INT J TUBERC LUNG D, V16, P192, DOI 10.5588/ijtld.10.0795; Institute of Medicine, 2009, ADDR THREAT DRUG RES ADDR THREAT DRUG RES; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Leung E, 2012, INT J TUBERC LUNG D, V16, P16, DOI 10.5588/ijtld.10.0065; Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1; Minion J, 2010, CLIN INFECT DIS, V50, P997, DOI 10.1086/651082; Moore DAJ, 2011, J INFECT DIS, V204, pS1110, DOI 10.1093/infdis/jir448; Reddy KP, 2010, CLIN INFECT DIS, V50, P988, DOI 10.1086/651081; Shah NS, 2011, AM J RESP CRIT CARE, V183, P1427, DOI 10.1164/rccm.201009-1449OC; Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, MULT EXT DRUG RES TU; WHO, 1998, LAB SERV TUB CONTR 2; World Health Organization, 2001, NONC CULT DRUG SUSCC; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	25	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55872	10.1371/journal.pone.0055872	http://dx.doi.org/10.1371/journal.pone.0055872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409072	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000028
J	Silva, GK; Cunha, LD; Horta, CV; Silva, ALN; Gutierrez, FRS; Silva, JS; Zamboni, DS				Silva, Grace K.; Cunha, Larissa D.; Horta, Catarina V.; Silva, Alexandre L. N.; Gutierrez, Fredy R. S.; Silva, Joao S.; Zamboni, Dario S.			A Parent-of-Origin Effect Determines the Susceptibility of a Non-Informative F1 Population to Trypanosoma cruzi Infection In Vivo	PLOS ONE			English	Article							EXPERIMENTAL CHAGAS-DISEASE; GROWTH-FACTOR-BETA; PLASMODIUM-CHABAUDI; GENETIC-CONTROL; NITRIC-OXIDE; METACYCLIC TRYPOMASTIGOTES; CONGOLENSE INFECTION; MEDIATES RESISTANCE; CANDIDATE GENES; MOUSE STRAINS	The development of Chagas disease is determined by a complex interaction between the genetic traits of both the protozoan parasite, T. cruzi, and the infected host. This process is regulated by multiple genes that control different aspects of the host-parasite interaction. While determination of the relevant genes in humans is extremely difficult, it is feasible to use inbred mouse strains to determine the genes and loci responsible for host resistance to infection. In this study, we investigated the susceptibility of several inbred mouse strains to infection with the highly virulent Y strain of T. cruzi and found a considerable difference in susceptibility between A/J and C57BL/6 mice. We explored the differences between these two mouse strains and found that the A/J strain presented higher mortality, exacerbated and uncontrolled parasitemia and distinct histopathology in the target organs, which were associated with a higher parasite burden and more extensive tissue lesions. We then employed a genetic approach to assess the pattern of inheritance of the resistance phenotype in an F1 population and detected a strong parent-of-origin effect determining the susceptibility of the F1 male mice. This effect is unlikely to result from imprinted genes because the inheritance of this susceptibility was affected by the direction of the parental crossing. Collectively, our genetic approach of using the F1 population suggests that genes contained in the murine chromosome X contribute to the natural resistance against T. cruzi infection. Future linkage studies may reveal the locus and genes participating on the host resistance process reported herein.	[Silva, Grace K.; Cunha, Larissa D.; Horta, Catarina V.; Silva, Alexandre L. N.; Zamboni, Dario S.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Cell Biol, FMRP USP, Sao Paulo, Brazil; [Silva, Grace K.; Gutierrez, Fredy R. S.; Silva, Joao S.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Biochem & Immunol, FMRP USP, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Zamboni, DS (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Cell Biol, FMRP USP, Sao Paulo, Brazil.	dszamboni@fmrp.usp.br	Gutierrez, Fredy R.S./C-3911-2009; Zamboni, Dario S/D-3024-2012; Silva, Joao/A-4484-2008; Cunha, Larissa D/I-4204-2012; Silva, Grace/E-7673-2012	Gutierrez, Fredy R.S./0000-0001-9873-8342; Zamboni, Dario S/0000-0002-7856-7512; Silva, Joao/0000-0002-3410-3927; Silva, Grace/0000-0001-6417-4243; Dias da Cunha, Larissa/0000-0002-1290-0263	Instituto Nacional de Cieancia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50959-4, 2007/53940-0]	Instituto Nacional de Cieancia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Instituto Nacional de Cieancia e Tecnologia em Vacinas (INCTV/CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2010/50959-4 and 2007/53940-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1999, INFECT IMMUN, V67, P4819, DOI 10.1128/IAI.67.9.4819-4826.1999; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; ANDRADE V, 1985, BRAZ J MED BIOL RES, V18, P499; Barretto A C, 1993, Arq Bras Cardiol, V60, P225; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Clapcott SJ, 2000, PARASITE IMMUNOL, V22, P259, DOI 10.1046/j.1365-3024.2000.00308.x; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; da Costa SCG, 2002, HISTOL HISTOPATHOL, V17, P837, DOI 10.14670/HH-17.837; ESPINOSA R, 1985, INT J CARDIOL, V8, P45, DOI 10.1016/0167-5273(85)90262-1; Fernandes AB, 2004, MICROBES INFECT, V6, P460, DOI 10.1016/j.micinf.2004.01.009; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; Goodhead I, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000880; Graefe SEB, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000057; Iraqi F, 2000, MAMM GENOME, V11, P645, DOI 10.1007/s003350010133; Krucken J, 2005, INFECT IMMUN, V73, P436, DOI 10.1128/IAI.73.1.436-443.2005; Laroque A, 2012, GENES IMMUN, V13, P155, DOI 10.1038/gene.2011.67; Leon JS, 2001, INFECT IMMUN, V69, P5643, DOI 10.1128/IAI.69.9.5643-5649.2001; Machado CR, 2006, MUTAT RES-REV MUTAT, V612, P40, DOI 10.1016/j.mrrev.2005.05.001; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Marinho CRF, 2004, INFECT IMMUN, V72, P2350, DOI 10.1128/IAI.72.4.2350-2357.2004; Min-Oo G, 2008, GENES IMMUN, V9, P383, DOI 10.1038/sj.gene.6364450; MINOPRIO P, 1991, INT IMMUNOL, V3, P427, DOI 10.1093/intimm/3.5.427; MINOPRIO P, 1993, J IMMUNOL, V151, P4200; Morel CM, 2003, NAT REV MICROBIOL, V1, P14, DOI 10.1038/nrmicro735; Noyes H, 2011, P NATL ACAD SCI USA, V108, P9304, DOI 10.1073/pnas.1013486108; O'Gorman GM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-207; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Roberts LJ, 1999, EUR J IMMUNOL, V29, P3047, DOI 10.1002/(SICI)1521-4141(199909)29:09&lt;3047::AID-IMMU3047&gt;3.0.CO;2-L; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; SILVA JS, 1995, INFECT IMMUN, V63, P4862, DOI 10.1128/IAI.63.12.4862-4867.1995; Silva JS, 2003, FRONT BIOSCI-LANDMRK, V8, pS314, DOI 10.2741/1012; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; Sima M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001173; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Taylor MC, 2011, ADV PARASIT, V75, P231, DOI 10.1016/B978-0-12-385863-4.00011-3; Teixeira Santuza M.R., 2003, Genetics and Molecular Research, V2, pUnpaginated; Villasenor-Cardoso MI, 2011, PARASITE IMMUNOL, V33, P643, DOI 10.1111/j.1365-3024.2011.01327.x; Williams-Blangero S, 2012, PHILOS T R SOC B, V367, P887, DOI 10.1098/rstb.2011.0296; World Health Organization, 2007, REP SCI WORK GROUP C; WUNDERLICH F, 1991, PARASITE IMMUNOL, V13, P357, DOI 10.1111/j.1365-3024.1991.tb00289.x; WUNDERLICH F, 1988, INFECT IMMUN, V56, P2400, DOI 10.1128/IAI.56.9.2400-2406.1988; Yadav JS, 2011, INFECT IMMUN, V79, P3204, DOI 10.1128/IAI.01389-10; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	45	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56347	10.1371/journal.pone.0056347	http://dx.doi.org/10.1371/journal.pone.0056347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409175	Green Published, gold, Green Submitted			2022-12-25	WOS:000315100000048
J	Shroff, RC; Price, KL; Kolatsi-Joannou, M; Todd, AF; Wells, D; Deanfield, J; Johnson, RJ; Rees, L; Woolf, AS; Long, DA				Shroff, Rukshana C.; Price, Karen L.; Kolatsi-Joannou, Maria; Todd, Alexandra F.; Wells, David; Deanfield, John; Johnson, Richard J.; Rees, Lesley; Woolf, Adrian S.; Long, David A.			Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ENDOTHELIAL FUNCTION; ARTERIAL STIFFNESS; YOUNG-ADULTS; URIC-ACID; EXPRESSION; RELEASE; TIE-2; CALCIFICATION; ANGIOGENESIS	Cardiovascular disease (CVD) is increasingly recognised as a complication of childhood chronic kidney disease (CKD) even in the absence of diabetes and hypertension. We hypothesized that an alteration in angiopoietin-1 and -2, growth factors which regulate endothelial and vascular function could be involved. We report that the endothelial survival factor, angiopoietin-1 is low in children with pre-dialysis CKD whereas the pro-inflammatory angiopoietin-2 is elevated in children on dialysis. In dialysis patients, angiopoietin-2 positively correlated with time on dialysis, systolic blood pressure, and carotid artery intima media thickness. Elevated angiopoietin-2 levels in dialysis versus pre-dialysis CKD patients were also associated with an anti-angiogenic (high soluble VEGFR-1 and low VEGF-A) and pro-inflammatory (high urate, E-selectin, P-selectin and VCAM-1) milieu. Ang-2 was immunodetected in arterial biopsy samples whilst the expression of VEGF-A was significantly downregulated in dialysis patients. Serum urate correlated with angiopoietin-2 levels in dialysis patients and addition of uric acid was able to induce rapid release of angiopoietin-2 from cultured endothelial cells. Thus, angiopoietin-2 is a marker for cardiovascular disease in children on chronic dialysis and may act as an anti-angiogenic and pro-inflammatory effector in this context. The possibility that the release of angiopoietin-2 from endothelia is mediated by urate should be explored further.	[Shroff, Rukshana C.; Price, Karen L.; Kolatsi-Joannou, Maria; Todd, Alexandra F.; Rees, Lesley; Long, David A.] UCL Inst Child Hlth, Nephrourol Unit, London, England; [Shroff, Rukshana C.; Price, Karen L.; Kolatsi-Joannou, Maria; Todd, Alexandra F.; Rees, Lesley; Long, David A.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Wells, David] Great Ormond St Hosp Sick Children, Dept Chem Pathol, London WC1N 3JH, England; [Deanfield, John] UCL, Natl Ctr Cardiovasc Dis Prevent & Outcomes, London, England; [Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Denver, CO 80202 USA; [Woolf, Adrian S.] Univ Manchester, Inst Human Dev, Manchester, Lancs, England; [Woolf, Adrian S.] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Colorado System; University of Colorado Denver; University of Manchester; Royal Manchester Children's Hospital	Long, DA (corresponding author), UCL Inst Child Hlth, Nephrourol Unit, London, England.	d.long@ucl.ac.uk	Price, Karen L/A-5323-2009; Long, David/I-3254-2019; Shroff, Rukshana C/C-7347-2008; Rees, Lesley/C-5027-2008; Shroff, Rukshana/AAG-5383-2019; Woolf, Adrian S./AAZ-1075-2020	Long, David/0000-0001-6580-3435; Shroff, Rukshana C/0000-0001-8501-1072; Shroff, Rukshana/0000-0001-8501-1072; Woolf, Adrian S./0000-0001-5541-1358; Deanfield, John/0000-0001-8806-6052; Price, Karen/0000-0002-8113-1461; Todd, Angelique/0000-0002-9207-4925	Great Ormond Street Hospital; UCL Institute of Child Health Biomedical Research Centre; Kids Kidney Research; Kidney Research UK Senior Non-Clinical Fellowship; Medical Research Council New Investigator Award; Manchester Biomedical Research Centre; MRC [MR/J003638/1] Funding Source: UKRI; Kidney Research UK [RP18/2011, SF1/2008] Funding Source: researchfish; Medical Research Council [MR/J003638/1] Funding Source: researchfish	Great Ormond Street Hospital; UCL Institute of Child Health Biomedical Research Centre; Kids Kidney Research(Kidney Research UK (KRUK)); Kidney Research UK Senior Non-Clinical Fellowship(Kidney Research UK (KRUK)); Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from the Great Ormond Street Hospital and UCL Institute of Child Health Biomedical Research Centre (to D. A. L., R. C. S. and L. R.) and a studentship from Kids Kidney Research (to L. R., D. A. L. and R. C. S.). D. A. L. is supported by a Kidney Research UK Senior Non-Clinical Fellowship and a Medical Research Council New Investigator Award. A. S. W. acknowledges grant support from the Manchester Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Covic A, 2006, NEPHROL DIAL TRANSPL, V21, P729, DOI 10.1093/ndt/gfi196; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Davis S, 2003, NAT STRUCT BIOL, V10, P38, DOI 10.1038/nsb880; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Dursun I, 2009, NEPHROL DIAL TRANSPL, V24, P2511, DOI 10.1093/ndt/gfp066; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Futrakul N, 2008, RENAL FAILURE, V30, P215, DOI 10.1080/08860220701813335; Goldstein SL, 2006, CLIN J AM SOC NEPHRO, V1, P979, DOI 10.2215/CJN.02291205; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Hubbard NE, 2005, CELL IMMUNOL, V234, P102, DOI 10.1016/j.cellimm.2005.06.001; Jourdan C, 2005, J HYPERTENS, V23, P1707, DOI 10.1097/01.hjh.0000178834.26353.d5; Kari JA, 1997, KIDNEY INT, V52, P468, DOI 10.1038/ki.1997.354; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Korff T, 2012, CARDIOVASC RES, V94, P510, DOI 10.1093/cvr/cvs124; Kracht D, 2011, AM J HYPERTENS, V24, P1294, DOI 10.1038/ajh.2011.147; Krausz S, 2012, ANN RHEUM DIS, V71, P1402, DOI 10.1136/annrheumdis-2011-200718; Kuo MC, 2008, J AM SOC NEPHROL, V19, P2321, DOI 10.1681/ASN.2007111200; Lee SW, 2007, INT J MOL MED, V19, P445; Li JJ, 2001, THROMB HAEMOSTASIS, V85, P204, DOI 10.1055/s-0037-1615677; Lieb W, 2010, CIRC-CARDIOVASC GENE, V3, P300, DOI 10.1161/CIRCGENETICS.109.914556; Lilien MR, 2009, NAT REV NEPHROL, V5, P229, DOI 10.1038/nrneph.2009.10; Lilien MR, 2005, PEDIATR NEPHROL, V20, P200, DOI 10.1007/s00467-004-1718-3; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Litwin M, 2005, J AM SOC NEPHROL, V16, P1494, DOI 10.1681/ASN.2004110932; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P1713, DOI 10.1093/ndt/17.10.1713; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Long DA, 2008, KIDNEY INT, V74, P300, DOI 10.1038/ki.2008.179; Long DA, 2012, NAT REV NEPHROL, V8, P244, DOI 10.1038/nrneph.2011.219; Lukasz A, 2008, CRIT CARE, V12, DOI 10.1186/cc6966; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Mitsnefes MM, 2006, PEDIATR NEPHROL, V21, P1167, DOI 10.1007/s00467-006-0180-9; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nakayama T, 2010, AM J PATHOL, V176, P2198, DOI 10.2353/ajpath.2010.090316; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Otani A, 2001, DIABETES, V50, P867, DOI 10.2337/diabetes.50.4.867; Phelps ED, 2006, AM J PHYSIOL-CELL PH, V290, pC352, DOI 10.1152/ajpcell.00050.2005; Price KL, 2006, J AM SOC NEPHROL, V17, P1791, DOI 10.1681/ASN.2006030264; Reusz GS, 2010, HYPERTENSION, V56, P217, DOI 10.1161/HYPERTENSIONAHA.110.152686; Scholz A, 2011, BLOOD, V118, P5050, DOI 10.1182/blood-2011-03-343293; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Shroff RC, 2007, J AM SOC NEPHROL, V18, P2996, DOI 10.1681/ASN.2006121397; Silverstein DM, 2011, PEDIATR NEPHROL, V26, P1123, DOI 10.1007/s00467-011-1875-0; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Yuan HT, 2000, J AM SOC NEPHROL, V11, P1055, DOI 10.1681/ASN.V1161055	53	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56273	10.1371/journal.pone.0056273	http://dx.doi.org/10.1371/journal.pone.0056273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409162	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300069
J	Barault, L; Ellsworth, RE; Harris, HR; Valente, AL; Shriver, CD; Michels, KB				Barault, Ludovic; Ellsworth, Rachel E.; Harris, Holly R.; Valente, Allyson L.; Shriver, Craig D.; Michels, Karin B.			Leukocyte DNA as Surrogate for the Evaluation of Imprinted Loci Methylation in Mammary Tissue DNA	PLOS ONE			English	Article							GROWTH-FACTOR-II; COLORECTAL-CANCER; BREAST-CANCER; IGF2 GENE; EXPRESSION; H19; HYPOMETHYLATION; STABILITY; PATTERNS; DISEASE	There is growing interest in identifying surrogate tissues to identify epimutations in cancer patients since primary target tissues are often difficult to obtain. Methylation patterns at imprinted loci are established during gametogenesis and post fertilization and their alterations have been associated with elevated risk of cancer. Methylation at several imprinted differentially methylated regions (GRB10 ICR, H19 ICR, KvDMR, SNRPN/SNURF ICR, IGF2 DMR0, and IGF2 DMR2) were analyzed in DNA from leukocytes and mammary tissue (normal, benign diseases, or malignant tumors) from 87 women with and without breast cancer (average age of cancer patients: 53; range: 31-77). Correlations between genomic variants and DNA methylation at the studied loci could not be assessed, making it impossible to exclude such effects. Methylation levels observed in leukocyte and mammary tissue DNA were close to the 50% expected for monoallellic methylation. While no correlation was observed between leukocyte and mammary tissue DNA methylation for most of the analyzed imprinted genes, Spearman's correlations were statistically significant for IGF2 DMR0 and IGF2 DMR2, although absolute methylation levels differed. Leukocyte DNA methylation levels of selected imprinted genes may therefore serve as surrogate markers of DNA methylation in cancer tissue.	[Barault, Ludovic; Harris, Holly R.; Michels, Karin B.] Harvard Univ, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Sch Med,Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Ellsworth, Rachel E.] Henry M Jackson Fdn Adv Mil Med, Clin Breast Care Project, Windber, PA USA; [Valente, Allyson L.] Windber Res Inst, Clin Breast Care Project, Windber, PA USA; [Shriver, Craig D.] Walter Reed Army Med Ctr, Clin Breast Care Project, Washington, DC 20307 USA; [Michels, Karin B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Windber Research Institute; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Barault, L (corresponding author), Harvard Univ, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Sch Med,Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA.	Ludovic.barault@ircc.it	Harris, Holly/AAK-6844-2020; Barault, Ludovic/J-2472-2016	Harris, Holly/0000-0002-2572-6727; Barault, Ludovic/0000-0001-5227-5047	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [R03CA143967]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R03CA143967] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a research grant from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services [R03CA143967 to KBM]; and the Breast Cancer Research Foundation (to KBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Cassidy SB, 1993, PRADER WILLI SYNDROM; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2002, CANCER RES, V62, P6442; da Rocha ST, 2004, CURR BIOL, V14, pR646, DOI 10.1016/j.cub.2004.08.007; Dammann RH, 2010, INT J ONCOL, V36, P171, DOI 10.3892/ijo_00000488; Dejeux Emelyne, 2009, V507, P189, DOI 10.1007/978-1-59745-522-0_15; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Ellis MJ, 1998, BREAST CANCER RES TR, V52, P175, DOI 10.1023/A:1006127621512; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Kaaks R, 2009, CANCER RES, V69, P5400, DOI 10.1158/0008-5472.CAN-08-3020; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; McCann AH, 1996, HUM MOL GENET, V5, P1123, DOI 10.1093/hmg/5.8.1123; Monk D, 2010, BRIEF FUNCT GENOMICS, V9, P329, DOI 10.1093/bfgp/elq013; Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Murrell A, 2006, THESCIENTIFICWORLDJO, V6, P1888, DOI 10.1100/tsw.2006.318; Saal HM, 1993, RUSSELL SILVER SYNDR; Scelfo RAM, 2002, ONCOGENE, V21, P2564, DOI 10.1038/sj.onc.1205336; Shetty PJ, 2011, J CANCER RES CLIN, V137, P339, DOI 10.1007/s00432-010-0890-z; Shuman C, 1993, BECKWITH WIEDEMANN S; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Uribe-Lewis S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001717; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Wu HK, 1997, BIOCHEM BIOPH RES CO, V235, P123, DOI 10.1006/bbrc.1997.6744; Yang Rong, 2009, Wei Sheng Yan Jiu, V38, P423; Yballe CM, 1996, J CLIN ENDOCR METAB, V81, P1607, DOI 10.1210/jc.81.4.1607; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Yun K, 1999, J PATHOL, V187, P518, DOI 10.1002/(SICI)1096-9896(199904)187:5<518::AID-PATH276>3.0.CO;2-3; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55896	10.1371/journal.pone.0055896	http://dx.doi.org/10.1371/journal.pone.0055896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409079	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200084
J	Gibson, SM; Ficklin, SP; Isaacson, S; Luo, F; Feltus, FA; Smith, MC				Gibson, Scott M.; Ficklin, Stephen P.; Isaacson, Sven; Luo, Feng; Feltus, Frank A.; Smith, Melissa C.			Massive-Scale Gene Co-Expression Network Construction and Robustness Testing Using Random Matrix Theory	PLOS ONE			English	Article							GENOME BROWSER; ARABIDOPSIS; EXPRESSION; ASSOCIATION; DATABASE; IDENTIFICATION; CONSERVATION; INFORMATION; ANNOTATION; SELECTION	The study of gene relationships and their effect on biological function and phenotype is a focal point in systems biology. Gene co-expression networks built using microarray expression profiles are one technique for discovering and interpreting gene relationships. A knowledge-independent thresholding technique, such as Random Matrix Theory (RMT), is useful for identifying meaningful relationships. Highly connected genes in the thresholded network are then grouped into modules that provide insight into their collective functionality. While it has been shown that co-expression networks are biologically relevant, it has not been determined to what extent any given network is functionally robust given perturbations in the input sample set. For such a test, hundreds of networks are needed and hence a tool to rapidly construct these networks. To examine functional robustness of networks with varying input, we enhanced an existing RMT implementation for improved scalability and tested functional robustness of human (Homo sapiens), rice (Oryza sativa) and budding yeast (Saccharomyces cerevisiae). We demonstrate dramatic decrease in network construction time and computational requirements and show that despite some variation in global properties between networks, functional similarity remains high. Moreover, the biological function captured by co-expression networks thresholded by RMT is highly robust.	[Gibson, Scott M.; Smith, Melissa C.] Clemson Univ, Holcombe Dept Elect & Comp Engn, Clemson, SC USA; [Ficklin, Stephen P.; Feltus, Frank A.] Clemson Univ, Clemson, SC 29634 USA; [Isaacson, Sven] Wittenberg Univ, Dept Comp Sci, Springfield, OH 45501 USA; [Feltus, Frank A.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA	Clemson University; Clemson University; Wittenberg University; Clemson University; Clemson University	Feltus, FA (corresponding author), Clemson Univ, Clemson, SC 29634 USA.	ffeltus@clemson.edu	Ficklin, Stephen/L-4324-2019	Ficklin, Stephen/0000-0001-9138-6292; Feltus, Frank/0000-0002-2123-6114; Smith, Melissa/0000-0003-0798-8536				Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atias O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-86; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bassel GW, 2011, PLANT CELL, V23, P3101, DOI 10.1105/tpc.111.088153; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bolstad BM, 2012, RMAEXPRESS; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Chok N.S, 2010, THESIS U PITTSBURGH; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; De Smet F, 2002, BIOINFORMATICS, V18, P735, DOI 10.1093/bioinformatics/18.5.735; Edwards KD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-142; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Faccioli P, 2005, PLANT MOL BIOL, V58, P739, DOI 10.1007/s11103-005-8159-7; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Galassi M., 2003, GNU SCI LIB REFERENC; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Leskovec J, 2010, J MACH LEARN RES, V11, P985; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Marino-Ramirez L, 2009, IDENTIFICATION CIS R, P1; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-76; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Ogata Y, 2009, J WOOD SCI, V55, P395, DOI 10.1007/s10086-009-1058-9; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Perkins AD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S4; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Puelma T, 2012, BIOINFORMATICS, V28, P2256, DOI 10.1093/bioinformatics/bts455; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2006, BIOINFORMATICS, V22, P2396, DOI 10.1093/bioinformatics/btl392; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tsaparas P, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-70; Tulino A. M., 2004, Foundations and Trends in Communications and Information Theory, V1, P1, DOI 10.1561/0100000001; Wang HY, 2008, BIOINFORMATICS, V24, P1367, DOI 10.1093/bioinformatics/btn134; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; WIGNER EP, 1967, SIAM REV, V9, P1, DOI 10.1137/1009001; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	61	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55871	10.1371/journal.pone.0055871	http://dx.doi.org/10.1371/journal.pone.0055871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409071	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200080
J	Hummitzsch, K; Irving-Rodgers, HF; Hatzirodos, N; Bonner, W; Sabatier, L; Reinhardt, DP; Sado, Y; Ninomiya, Y; Wilhelm, D; Rodgers, RJ				Hummitzsch, Katja; Irving-Rodgers, Helen F.; Hatzirodos, Nicholas; Bonner, Wendy; Sabatier, Laetitia; Reinhardt, Dieter P.; Sado, Yoshikazu; Ninomiya, Yoshifumi; Wilhelm, Dagmar; Rodgers, Raymond J.			A New Model of Development of the Mammalian Ovary and Follicles	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; HUMAN-FETAL OVARY; GERM-CELLS; DIFFERENTIAL EXPRESSION; SEX DETERMINATION; GENE-EXPRESSION; RETE OVARII; MOUSE OVARY; SURFACE; GROWTH	Ovarian follicular granulosa cells surround and nurture oocytes, and produce sex steroid hormones. It is believed that during development the ovarian surface epithelial cells penetrate into the ovary and develop into granulosa cells when associating with oogonia to form follicles. Using bovine fetal ovaries (n = 80) we identified a novel cell type, termed GREL for Gonadal Ridge Epithelial-Like. Using 26 markers for GREL and other cells and extracellular matrix we conducted immunohistochemistry and electron microscopy and chronologically tracked all somatic cell types during development. Before 70 days of gestation the gonadal ridge/ovarian primordium is formed by proliferation of GREL cells at the surface epithelium of the mesonephros. Primordial germ cells (PGCs) migrate into the ovarian primordium. After 70 days, stroma from the underlying mesonephros begins to penetrate the primordium, partitioning the developing ovary into irregularly-shaped ovigerous cords composed of GREL cells and PGCs/oogonia. Importantly we identified that the cords are always separated from the stroma by a basal lamina. Around 130 days of gestation the stroma expands laterally below the outermost layers of GREL cells forming a sub-epithelial basal lamina and establishing an epithelial-stromal interface. It is at this stage that a mature surface epithelium develops from the GREL cells on the surface of the ovary primordium. Expansion of the stroma continues to partition the ovigerous cords into smaller groups of cells eventually forming follicles containing an oogonium/oocyte surrounded by GREL cells, which become granulosa cells, all enclosed by a basal lamina. Thus in contrast to the prevailing theory, the ovarian surface epithelial cells do not penetrate into the ovary to form the granulosa cells of follicles, instead ovarian surface epithelial cells and granulosa cells have a common precursor, the GREL cell.	[Hummitzsch, Katja; Irving-Rodgers, Helen F.; Hatzirodos, Nicholas; Bonner, Wendy; Rodgers, Raymond J.] Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Inst, Adelaide, SA 5005, Australia; [Irving-Rodgers, Helen F.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Sabatier, Laetitia] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ, Canada; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Sado, Yoshikazu] Shigei Med Res Inst, Div Immunol, Okayama, Japan; [Ninomiya, Yoshifumi] Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 700, Japan; [Wilhelm, Dagmar] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Robinson Research Institute; University of Adelaide; Queensland University of Technology (QUT); McGill University; McGill University; Okayama University; Monash University	Rodgers, RJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Inst, Adelaide, SA 5005, Australia.	ray.rodgers@adelaide.edu.au	Reinhardt, Dieter P/A-3102-2008; Hatzirodos, Nick/K-6939-2013; Rodgers, Raymond J/C-3476-2009; Hummitzsch, Katja/K-6940-2013; Wilhelm, Dagmar/B-6915-2009	Reinhardt, Dieter P/0000-0001-6535-9872; Hatzirodos, Nick/0000-0002-1342-9741; Hummitzsch, Katja/0000-0001-5023-2668; Wilhelm, Dagmar/0000-0002-7757-4075	National Health and Medical Research Council of Australia; University of Adelaide; Clive and Vera Ramaciotti Foundation; Grants-in-Aid for Scientific Research [23390348] Funding Source: KAKEN	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; Clive and Vera Ramaciotti Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the National Health and Medical Research Council of Australia, the University of Adelaide and the Clive and Vera Ramaciotti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Auersperg N, 2000, METH MOLEC MED, V39, P169; BONILLAMUSOLES F, 1975, ARCH GYNAKOL, V218, P233, DOI 10.1007/BF00667384; Burkhart MN, 2010, ANIM REPROD SCI, V117, P43, DOI 10.1016/j.anireprosci.2009.02.010; BYSKOV AG, 1973, J ANAT, V116, P207; BYSKOV AG, 1977, J ANAT, V123, P77; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; CZERNOBILSKY B, 1985, EUR J CELL BIOL, V37, P175; DeFalco T, 2011, DEV BIOL, V352, P14, DOI 10.1016/j.ydbio.2011.01.011; Duffin K, 2009, MOL HUM REPROD, V15, P771, DOI 10.1093/molehr/gap065; Erickson AC, 2001, MATRIX BIOL, V19, P769, DOI 10.1016/S0945-053X(00)00126-8; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; FRIDMACHER V, 1992, DEVELOPMENT, V115, P503; Hatzirodos N, 2012, MATRIX BIOL, V31, P45, DOI 10.1016/j.matbio.2011.10.002; Hatzirodos N, 2011, FASEB J, V25, P2256, DOI 10.1096/fj.11-181099; Honda A, 2007, P NATL ACAD SCI USA, V104, P12389, DOI 10.1073/pnas.0703787104; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; Irving-Rodgers HF, 2009, REPRODUCTION, V137, P825, DOI 10.1530/REP-08-0485; Irving-Rodgers HF, 2009, HUM REPROD, V24, P936, DOI 10.1093/humrep/den447; Irving-Rodgers HF, 2002, REPRODUCTION, V123, P97, DOI 10.1530/rep.0.1230097; Irving-Rodgers HF, 2002, BIOL REPROD, V66, P934, DOI 10.1095/biolreprod66.4.934; Jimenez R, 2010, SEX DEV, V3, P291, DOI 10.1159/000280584; Juengel JL, 2002, MOL CELL ENDOCRINOL, V191, P1, DOI 10.1016/S0303-7207(02)00045-X; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Kerr JB, 2006, REPRODUCTION, V132, P95, DOI 10.1530/rep.1.01128; Kezele P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1990, DOI 10.2741/kezele; KONISHI I, 1986, J ANAT, V148, P121; Kovacic JC, 2008, TRENDS CARDIOVAS MED, V18, P45, DOI 10.1016/j.tcm.2007.12.002; Loffler S, 2000, ANAT EMBRYOL, V201, P207, DOI 10.1007/s004290050019; Logan KA, 2002, BIOL REPROD, V66, P906, DOI 10.1095/biolreprod66.4.906; Maheshwari A, 2008, ZYGOTE, V16, P285, DOI 10.1017/S0967199408004802; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; McNatty KP, 2000, MOL CELL ENDOCRINOL, V163, P11, DOI 10.1016/S0303-7207(99)00235-X; Mork L, 2011, BIOL REPROD; MOTTA PM, 1986, J SUBMICR CYTOL PATH, V18, P271; MOTTA PM, 1986, EUR J OBSTET GYN R B, V22, P271, DOI 10.1016/0028-2243(86)90115-2; Murayama C, 2008, MOL CELL BIOCHEM, V314, P51, DOI 10.1007/s11010-008-9764-y; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Pannetier M, 2003, CYTOGENET GENOME RES, V101, P199, DOI 10.1159/000074337; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Ramayya MS, 2010, J STEROID BIOCHEM, V119, P14, DOI 10.1016/j.jsbmb.2009.11.006; Russe I, 1983, Bibl Anat, V24, P77; Sabatier L, 2010, MATRIX BIOL, V21, P21; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sato Y, 2003, J CLIN ENDOCR METAB, V88, P3415, DOI 10.1210/jc.2002-021723; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Takamoto N, 2005, MOL ENDOCRINOL, V19, P2299, DOI 10.1210/me.2005-0019; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Urbanek M, 2005, J CLIN ENDOCR METAB, V90, P6623, DOI 10.1210/jc.2005-0622; VANDENHURK R, 1995, MOL REPROD DEV, V41, P459, DOI 10.1002/mrd.1080410408; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Wrobel KH, 2000, ANAT EMBRYOL, V202, P475, DOI 10.1007/s004290000133; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	65	84	85	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55578	10.1371/journal.pone.0055578	http://dx.doi.org/10.1371/journal.pone.0055578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409002	Green Published, gold			2022-12-25	WOS:000315157200041
J	Jonsson, S; Wiberg, R; McGrath, AM; Novikov, LN; Wiberg, M; Novikova, LN; Kingham, PJ				Jonsson, Samuel; Wiberg, Rebecca; McGrath, Aleksandra M.; Novikov, Lev N.; Wiberg, Mikael; Novikova, Liudmila N.; Kingham, Paul J.			Effect of Delayed Peripheral Nerve Repair on Nerve Regeneration, Schwann Cell Function and Target Muscle Recovery	PLOS ONE			English	Article							AXONAL REGENERATION; NEUROTROPHIC FACTOR; CONTRIBUTING FACTORS; NEURONAL SURVIVAL; SATELLITE CELLS; DISTAL STUMP; ADULT-RAT; EXPRESSION; DENERVATION; INJURY	Despite advances in surgical techniques for peripheral nerve repair, functional restitution remains incomplete. The timing of surgery is one factor influencing the extent of recovery but it is not yet clearly defined how long a delay may be tolerated before repair becomes futile. In this study, rats underwent sciatic nerve transection before immediate (0) or 1, 3, or 6 months delayed repair with a nerve graft. Regeneration of spinal motoneurons, 13 weeks after nerve repair, was assessed using retrograde labeling. Nerve tissue was also collected from the proximal and distal stumps and from the nerve graft, together with the medial gastrocnemius (MG) muscles. A dramatic decline in the number of regenerating motoneurons and myelinated axons in the distal nerve stump was observed in the 3- and 6-months delayed groups. After 3 months delay, the axonal number in the proximal stump increased 2-3 folds, accompanied by a smaller axonal area. RT-PCR of distal nerve segments revealed a decline in Schwann cells (SC) markers, most notably in the 3 and 6 month delayed repair samples. There was also a progressive increase in fibrosis and proteoglycan scar markers in the distal nerve with increased delayed repair time. The yield of SC isolated from the distal nerve segments progressively fell with increased delay in repair time but cultured SC from all groups proliferated at similar rates. MG muscle at 3- and 6-months delay repair showed a significant decline in weight (61% and 27% compared with contra-lateral side). Muscle fiber atrophy and changes to neuromuscular junctions were observed with increased delayed repair time suggestive of progressively impaired reinnervation. This study demonstrates that one of the main limiting factors for nerve regeneration after delayed repair is the distal stump. The critical time point after which the outcome of regeneration becomes too poor appears to be 3-months.	[Jonsson, Samuel; Wiberg, Rebecca; McGrath, Aleksandra M.; Novikov, Lev N.; Wiberg, Mikael; Novikova, Liudmila N.; Kingham, Paul J.] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [McGrath, Aleksandra M.; Wiberg, Mikael] Umea Univ, Dept Surg & Perioperat Sci, Sect Hand & Plast Surg, Umea, Sweden	Umea University; Umea University	Novikova, LN (corresponding author), Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden.	liudmila.novikova@anatomy.umu.se; paul.kingham@anatomy.umu.se		McGrath, Aleksandra/0000-0001-6142-6791; Kingham, Paul/0000-0003-2596-5936; Novikov, Lev/0000-0001-5520-3890	Swedish Medical Research Council; European Union; Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Union(European Commission); Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	This study was supported by the Swedish Medical Research Council, European Union, Umea University, County of Vasterbotten, Ake Wibergs Stiftelse, Magnus Bergvalls Stiftelse, Clas Groschinskys Minnesfond and the Gunvor and Josef Aner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel PJ, 2009, J ORTHOP RES, V27, P385, DOI 10.1002/jor.20773; Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055; Ashley Z, 2007, AM J PHYSIOL-CELL PH, V292, pC440, DOI 10.1152/ajpcell.00085.2006; Borisov AB, 2001, ANAT REC, V264, P203, DOI 10.1002/ar.1155; Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; Brauer CA, 2007, J BONE JOINT SURG AM, V89A, P970, DOI 10.2106/JBJS.E.00657; Chen DH, 2010, ACTA OTO-LARYNGOL, V130, P1411, DOI 10.3109/00016489.2010.496464; Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510; Davison SP, 1999, LARYNGOSCOPE, V109, P631, DOI 10.1097/00005537-199904000-00021; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Hart AM, 2002, EXP BRAIN RES, V142, P308, DOI 10.1007/s00221-001-0929-0; Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jivan S, 2006, EXP BRAIN RES, V170, P245, DOI 10.1007/s00221-005-0207-7; Jivan S, 2009, J PLAST RECONSTR AES, V62, P472, DOI 10.1016/j.bjps.2007.11.027; Keilhoff G, 2008, EXP NEUROL, V212, P189, DOI 10.1016/j.expneurol.2008.03.028; Kobayashi J, 1997, MUSCLE NERVE, V20, P858, DOI 10.1002/(SICI)1097-4598(199707)20:7<858::AID-MUS10>3.0.CO;2-O; Kou YH, 2011, ARTIF CELL BLOOD SUB, V39, P223, DOI 10.3109/10731199.2010.533127; Lad SP, 2010, NEUROSURGERY, V66, P953, DOI 10.1227/01.NEU.0000368545.83463.91; Li H, 1998, GLIA, V24, P290; Li H, 1997, GLIA, V20, P333, DOI 10.1002/(SICI)1098-1136(199708)20:4<333::AID-GLIA6>3.0.CO;2-6; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Ma JJ, 2007, J ORTHOP RES, V25, P1498, DOI 10.1002/jor.20414; Ma JJ, 2003, SCAND J PLAST RECONS, V37, P1; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; Midrio M, 2006, EUR J APPL PHYSIOL, V98, P1, DOI 10.1007/s00421-006-0256-z; MIYAMOTO Y, 1985, INT ORTHOP, V9, P271, DOI 10.1007/BF00266515; Muir D, 2010, EXP NEUROL, V223, P102, DOI 10.1016/j.expneurol.2009.05.038; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012; Reid AJ, 2011, HISTOCHEM CELL BIOL, V136, P71, DOI 10.1007/s00418-011-0829-8; Reid AJ, 2010, BRAIN RES, V1310, P1, DOI 10.1016/j.brainres.2009.11.011; Ronkko H, 2011, SCAND J SURG, V100, P223; Rosenfield J, 2001, Bull Hosp Jt Dis, V60, P155; Rueger MA, 2008, NEUROSCI LETT, V434, P253, DOI 10.1016/j.neulet.2008.01.073; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; Shen J, 2006, J ORTHOP RES, V24, P1128, DOI 10.1002/jor.20131; SIIRONEN J, 1995, ACTA NEUROPATHOL, V89, P219; Sulaiman OAR, 2002, GLIA, V37, P206, DOI 10.1002/glia.10022; Susarla SM, 2007, J ORAL MAXIL SURG, V65, P1070, DOI 10.1016/j.joms.2006.10.010; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; Welin D, 2008, EXP BRAIN RES, V186, P315, DOI 10.1007/s00221-007-1232-5; Wiberg Mikael, 2009, Lakartidningen, V106, P586; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	54	111	113	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56484	10.1371/journal.pone.0056484	http://dx.doi.org/10.1371/journal.pone.0056484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409189	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200136
J	Meyer, ZC; Schreinemakers, JMJ; Mulder, PGH; de Waal, RAL; Ermens, AAM; van der Laan, L				Meyer, Zainna C.; Schreinemakers, Jennifer M. J.; Mulder, Paul G. H.; de Waal, Ruud A. L.; Ermens, Antonius A. M.; van der Laan, Lijckle			The Role of C-Reactive Protein and the SOFA Score as Parameter for Clinical Decision Making in Surgical Patients during the Intensive Care Unit Course	PLOS ONE			English	Article							ORGAN FAILURE; COMPLICATIONS; PREDICTOR; MORTALITY; SEPSIS; DEFINITIONS	Introduction: C-reactive Protein (CRP) is used next to clinical scoring systems to recognize critically ill patients prone to develop complications on the Intensive Care Unit (ICU). The purpose of this study is to assess the predictive value of CRP as parameter for clinical deterioration and/or clinical decision making as ordering diagnostic procedures or performing (re) interventions. Also, we wanted to determine the value of CRP in early detection of surgical complications in the critically ill general surgical patient in the ICU and its interpretation in adjunct to a clinical scoring system, the Sequential Organ Failure Assessment Score. Materials and Methods: In our prospective observational study, 174 general surgical patients admitted into the Intensive Care Unit were included. We evaluated the Sequential Organ Failure Assessment Score (SOFA) and daily measured the C-reactive protein (CRP) concentrations. All events (diagnostic or therapeutic interventions) and surgical complications were registered. Then the relationship between SOFA score, CRP concentrations, events and complications were studied. Results: Each 10% increase in CRP resulted in a 3.5% increase in the odds of an event (odds ratio 1.035, 95% CI: 1.004-1.068; p = 0.028). However, an increase in CRP levels did not lead to a higher odds of complication (OR 0.983, 95% CI: 0.932-1.036; p = 0.52). When adjusting for the SOFA score the effect of CRP on the probability of a first event remained significant (OR 1.033, 95% CI: 1.001-1.065; p = 0.046), and again did not significantly affect the complication probability (OR 0.980, 95% CI: 0.929-1.035; p = 0.46). Conclusions: An increase in C-reactive protein is a poor parameter for early detection of complications in the critically ill surgical patient in the ICU by means of diagnostic procedures or therapeutic (re)-interventions.	[Meyer, Zainna C.; Schreinemakers, Jennifer M. J.; van der Laan, Lijckle] Amphia Hosp, Dept Surg, Breda, Netherlands; [Mulder, Paul G. H.] Amphia Hosp, Amphia Acad, Breda, Netherlands; [de Waal, Ruud A. L.] Amphia Hosp, Dept Intens Care Med, Breda, Netherlands; [Ermens, Antonius A. M.] Amphia Hosp, Lab Clin Chem & Hematol, Breda, Netherlands	Amphia Hospital; Amphia Hospital; Amphia Hospital; Amphia Hospital	Meyer, ZC (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	zienalove@hotmail.com		van der laan, lijckle/0000-0001-5631-594X				BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Prieto MF, 2008, MED INTENSIVA, V32, P424; Korner H, 2009, J GASTROINTEST SURG, V13, P1599, DOI 10.1007/s11605-009-0928-1; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; MacKay GJ, 2011, COLORECTAL DIS, V13, P583, DOI 10.1111/j.1463-1318.2010.02236.x; Matthiessen P, 2008, COLORECTAL DIS, V10, P75, DOI 10.1111/j.1463-1318.2007.01300.x; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; MUSTARD RA, 1987, ARCH SURG-CHICAGO, V122, P69; Nunes BK, 2011, REV ESC ENFERM USP, V45, P1480; Ortega-Deballon P, 2010, WORLD J SURG, V34, P808, DOI 10.1007/s00268-009-0367-x; Platt JJ, 2012, ANN SURG ONCOL; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Warschkow R, 2011, INT J COLORECTAL DIS, V26, P1405, DOI 10.1007/s00384-011-1262-0; Welsch T, 2007, INT J COLORECTAL DIS, V22, P1499, DOI 10.1007/s00384-007-0354-3; Woeste G, 2010, WORLD J SURG, V34, P140, DOI 10.1007/s00268-009-0304-z; Zhang Z, 2011, ANAESTH INTENS CARE, V39, P854, DOI 10.1177/0310057X1103900509	18	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55964	10.1371/journal.pone.0055964	http://dx.doi.org/10.1371/journal.pone.0055964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409097	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200093
J	Patel, SK; Zhang, Y; Pollock, JA; Janjic, JM				Patel, Sravan Kumar; Zhang, Yang; Pollock, John A.; Janjic, Jelena M.			Cyclooxgenase-2 Inhibiting Perfluoropoly (Ethylene Glycol) Ether Theranostic Nanoemulsions-In Vitro Study	PLOS ONE			English	Article							BREAST-CANCER; DRUG-DELIVERY; CREMOPHOR-EL; F-19 MRI; CELECOXIB; TUMOR; CELLS; MACROPHAGES; PHARMACOKINETICS; CHEMOPREVENTION	Cylcooxgenase-2 (COX-2) expressing macrophages, constituting a major portion of tumor mass, are involved in several pro-tumorigenic mechanisms. In addition, macrophages are actively recruited by the tumor and represent a viable target for anticancer therapy. COX-2 specific inhibitor, celecoxib, apart from its anticancer properties was shown to switch macrophage phenotype from tumor promoting to tumor suppressing. Celecoxib has low aqueous solubility, which may limit its tumor inhibiting effect. As opposed to oral administration, we propose that maximum anticancer effect may be achieved by nanoemulsion mediated intravenous delivery. Here we report multifunctional celecoxib nanoemulsions that can be imaged by both near-infrared fluorescence (NIRF) and F-19 magnetic resonance. Celecoxib loaded nanoemulsions showed a dose dependent uptake in mouse macrophages as measured by F-19 NMR and NIRF signal intensities of labeled cells. Dramatic inhibition of intracellular COX-2 enzyme was observed in activated macrophages upon nanoemulsion uptake. COX-2 enzyme inhibition was statistically equivalent between free drug and drug loaded nanoemulsion. However, nanoemulsion mediated drug delivery may be advantageous, helping to avoid systemic exposure to celecoxib and related side effects. Dual molecular imaging signatures of the presented nanoemulsions allow for future in vivo monitoring of the labeled macrophages and may help in examining the role of macrophage COX-2 inhibition in inflammation-cancer interactions. These features strongly support the future use of the presented nanoemulsions as anti-COX-2 theranostic nanomedicine with possible anticancer applications.	[Patel, Sravan Kumar; Zhang, Yang; Janjic, Jelena M.] Duquesne Univ, Grad Sch Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15219 USA; [Pollock, John A.] Duquesne Univ, Dept Biol Sci, Bayer Sch Nat & Environm Sci, Pittsburgh, PA 15219 USA	Duquesne University; Duquesne University	Janjic, JM (corresponding author), Duquesne Univ, Grad Sch Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15219 USA.	janjicj@duq.edu	Patel, Sravan Kumar/H-2713-2017	Patel, Sravan Kumar/0000-0002-1235-3458; Pollock, John/0000-0001-6602-3676; Janjic, Jelena/0000-0002-0539-8359	Pittsburgh Tissue Engineering Initiative Interface Seed Grant Fund; Duquesne University; NSF/Multi-User Instrumentation grant [0400776]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R41EB009618] Funding Source: NIH RePORTER	Pittsburgh Tissue Engineering Initiative Interface Seed Grant Fund; Duquesne University; NSF/Multi-User Instrumentation grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	JMJ, SKP, YZ and JAP research is supported by a grant from the Pittsburgh Tissue Engineering Initiative Interface Seed Grant Fund 2012. JMJ and SKP were also supported by Pennsylvania State Health Formula Research Grants Program (C.U.R.E. Award) and Faculty Development Funds from Duquesne University. JAP acknowledges support from NSF/Multi-User Instrumentation grant NSF# 0400776. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers WJ, 2011, ACS NANO, V5, P173, DOI 10.1021/nn102274q; Baboota S, 2007, ACTA CHROMATOGR, V18, P116; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Basu GD, 2005, BREAST CANCER RES, V7, pR422, DOI 10.1186/bcr1019; Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033; Celsense Inc. website. Celsense Inc, ANN 1 CLIN TRIAL AUT; Chao TC, 2005, INVEST NEW DRUG, V23, P171; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fang JY, 2009, ULTRASONICS, V49, P39, DOI 10.1016/j.ultras.2008.04.009; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; GERHARDT GE, 1978, J ORG CHEM, V43, P4505, DOI 10.1021/jo00417a026; Gianella A, 2011, ACS NANO, V5, P4422, DOI 10.1021/nn103336a; Harris RE, 2000, CANCER RES, V60, P2101; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Hitchens TK, 2011, MAGN RESON MED, V65, P1145, DOI 10.1002/mrm.22702; Hoffman H., 1984, PHARM Z, V129, P1730; Janjic JM, 2008, J AM CHEM SOC, V130, P2832, DOI 10.1021/ja077388j; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Janjic JM, 2012, US, Patent No. [8,277,610 B2, 8277610]; Jendrossek V, 2011, CANC LETT IN PRESS; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kaneda MM, 2010, BIOMATERIALS, V31, P3079, DOI 10.1016/j.biomaterials.2010.01.006; Krafft MP, 2007, J POLYM SCI POL CHEM, V45, P1185, DOI 10.1002/pola.21937; Lanza GM, 2005, CURR TOP DEV BIOL, V70, P57, DOI 10.1016/S0070-2153(05)70003-X; Lee SJ, 2011, J PHYS CHEM B, V115, P15271, DOI 10.1021/jp209543c; Lim YT, 2009, CHEM COMMUN, P6952, DOI 10.1039/b914006a; Mehibel M, 2009, MOL CANCER THER, V8, P1261, DOI 10.1158/1535-7163.MCT-08-0927; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Moss G, 2009, HDB PHARM EXCIPIENTS, P429; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; O'Hanlon CE, 2012, J FLUORINE CHEM, V137, P27, DOI 10.1016/j.jfluchem.2012.02.004; Paulson SK, 2000, DRUG METAB DISPOS, V28, P514; Paulson SK, 2001, J PHARMACOL EXP THER, V297, P638; Pogue BW, 2010, AM J ROENTGENOL, V195, P321, DOI 10.2214/AJR.10.5002; Rapoport N, 2011, J CONTROL RELEASE, V153, P4, DOI 10.1016/j.jconrel.2011.01.022; Reddy BS, 2000, CANCER RES, V60, P293; Rieger AM, 2010, DEV COMP IMMUNOL, V34, P1144, DOI 10.1016/j.dci.2010.06.006; Seedher N, 2003, AAPS PharmSciTech, V4, pE33; Shiraishi K, 2011, INT J PHARMACEUT, V421, P379, DOI 10.1016/j.ijpharm.2011.10.006; Singh KK, 2009, HDB PHARM EXCIPIENTS, P572; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Sumer B, 2008, NANOMEDICINE-UK, V3, P137, DOI 10.2217/17435889.3.2.137; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Uskokovic V, 2011, ARCH ORAL BIOL, V56, P521, DOI 10.1016/j.archoralbio.2010.11.011; Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027; Wang Y, 2011, J PEDIAT HEMATOL ONC, V33, P241, DOI 10.1097/MPH.0b013e318207cbf1; Wang YZ, 2007, INT J PHARM, V337, P63, DOI 10.1016/j.ijpharm.2006.12.033; Winter PM, 2007, EXPERT REV MED DEVIC, V4, P137, DOI 10.1586/17434440.4.2.137; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573	53	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55802	10.1371/journal.pone.0055802	http://dx.doi.org/10.1371/journal.pone.0055802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409048	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200068
J	Yan, L; Xing, ZQ; Guo, ZX; Fang, ZQ; Jiao, W; Guo, XY; Xu, ZH; Fang, ZH; Holmberg, A; Nilsson, S; Liu, ZX				Yan, Lei; Xing, Zhaoquan; Guo, Zhaoxin; Fang, Zhiqing; Jiao, Wei; Guo, Xiaoyu; Xu, Zhonghua; Fang, Zhenghui; Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu			Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy	PLOS ONE			English	Article							NEUROENDOCRINE DIFFERENTIATION; TUMOR; LNCAP; GRP78; EXPRESSION; PROTEIN; PROGRESSION; METASTASIS; CASTRATION; PATHOGENESIS	Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved in the development and progression of prostate cancer and the ultimate failure of androgen-deprivation therapy. To investigate the metabolism regulation effects on androgen-independent growth of prostate cancer, an established LNCaP-s cell model that resembles the clinical scenario of castration-resistant prostate cancer (CRPC), was used in this current study. This cell line was cultured from androgen-sensitive LNCaP parental cells, in an androgen-reduced condition, resembling clinical androgen deprivation therapy. To assess the effects of smsDX on the invasiveness of prostate cancer cells we used wound healing assay and Matrigel (TM) invasion assay. We evaluated differentially expressed proteins of the parental LNCaP cells and LNCaP-s cells after ADT by means of two-dimensional gel electrophoresis (2-DE) followed by MALDI-TOF mass spectrometric analysis. The covered area in the wound and the number of cells invading through a Matrigel chamber were significantly smaller for cells treated with smsDX than they were for control cells treated with vehicle. 56 proteins were found differentially expressed in LNCaP-s cells compared to LNCaP cells, majority of them were down-regulated after ADT treatment. 104 proteins of LNCaP cells and 86 in LNCaP-s cells, separately, were found differentially expressed after treatment with smsDX, When we explored these protein functions within the website UniProtKB/Swiss-Prot, surprisingly, most of the proteins were found to be involved in the cellular metabolism and mitochondrial function regulation. LNCaP-s as potential metastatic androgen-independent cancer cells, its metabolism and mitochondrial functions could be altered by a new somatostatin derivative smsDX, the smsDX regulatory effects on metabolism in LNCaP-s deliver more therapeutic information with the treatment of CRPC.	[Yan, Lei; Xing, Zhaoquan; Guo, Zhaoxin; Fang, Zhiqing; Jiao, Wei; Xu, Zhonghua; Liu, Zhaoxu] Shandong Univ, Dept Urol, Qilu Hosp, Jinan 250100, Peoples R China; [Guo, Xiaoyu; Liu, Zhaoxu] Shandong Univ, Aging & Hlth Ctr, Sch Nursing, Jinan 250100, Peoples R China; [Fang, Zhenghui] Shandong Univ, Dept Obstet & Gynecol, Jinan Cent Hosp, Jinan 250100, Peoples R China; [Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Karolinska Institutet	Xu, ZH (corresponding author), Shandong Univ, Dept Urol, Qilu Hosp, Jinan 250100, Peoples R China.	xuzhonghua@163.com; zhaoxvl@sdu.edu.cn			National Natural Science Foundation of China [81172435]; Shandong Natural Science Foundation [ZR2010HM026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province)	Grant Sponsor: The National Natural Science Foundation of China (No. 81172435) and Shandong Natural Science Foundation (No. ZR2010HM026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON PA, 1989, PROSTATE, V14, P71, DOI 10.1002/pros.2990140109; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; BREVINI TAL, 1993, J CLIN ENDOCR METAB, V77, P626, DOI 10.1210/jc.77.3.626; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Dai RY, 2010, FOLIA BIOL-PRAGUE, V56, P37; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FRANZEN B, 1993, ELECTROPHORESIS, V14, P1045, DOI 10.1002/elps.11501401167; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hejna M, 2002, ANN ONCOL, V13, P653, DOI 10.1093/annonc/mdf142; Huang WC, 2010, J BIOL CHEM, V285, P7947, DOI 10.1074/jbc.M109.092759; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Koutsilieris M, 1999, PROSTATE, V38, P313; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu ZX, 2007, INT J ONCOL, V30, P1173; Liu ZX, 2009, ONCOL REP, V22, P1451, DOI 10.3892/or_00000587; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Mitsogiannis IC, 2009, EXPERT OPIN PHARMACO, V10, P493, DOI [10.1517/14656560802694689 , 10.1517/14656560802694689]; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; RABILLOUD T, 1994, CELL MOL BIOL, V40, P57; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Sciarra A, 2006, INT J CLIN PRACT, V60, P462, DOI 10.1111/j.1742-1241.2006.00750.x; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Susini C, 2006, ANN ONCOL, V17, P1733, DOI 10.1093/annonc/mdl105; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Volante M, 2008, MOL CELL ENDOCRINOL, V286, P219, DOI 10.1016/j.mce.2007.12.002; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xing ZQ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-162; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043	48	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55790	10.1371/journal.pone.0055790	http://dx.doi.org/10.1371/journal.pone.0055790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409045	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200065
J	Zhang, GQ; Wei, HM; Lu, J; Wong, P; Shim, W				Zhang, Guang Qin; Wei, Heming; Lu, Jun; Wong, Philip; Shim, Winston			Identification and Characterization of Calcium Sparks in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; IN-VITRO; DIFFERENTIATION; TRANSIENTS; GRADIENTS	Introduction: Ca2+ spark constitutes the elementary units of cardiac excitation-contraction (E-C) coupling in mature cardiomyocytes. Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are known to have electrophysiological properties similar to mature adult cardiomyocytes. However, it is unclear if they share similar calcium handling property. We hypothesized that Ca2+ sparks in human induced pluripotent stem cell (hiPSCs)-derived cardiomyocytes (hiPSC-CMs) may display unique structural and functional properties than mature adult cardiomyocytes. Methods and results: Ca2+ sparks in hiPSC-CMs were recorded with Ca2+ imaging assay with confocal laser scanning microscopy. Those sparks were stochastic with a tendency of repetitive occurrence at the same site. Nevertheless, the spatial-temporal properties of Ca2+ spark were analogous to that of adult CMs. Inhibition of L-type Ca2+ channels by nifedipine caused a 61% reduction in calcium spark frequency without affecting amplitude of those sparks and magnitude of caffeine releasable sarcoplasmic reticulum (SR) Ca2+ content. In contrast, high extracellular Ca2+ and ryanodine increased the frequency, full width at half maximum (FWHM) and full duration at half maximum (FDHM) of spontaneous Ca2+ sparks. Conclusions: For the first time, spontaneous Ca2+ sparks were detected in hiPSC-CMs. The Ca2+ sparks are predominately triggered by L-type Ca2+ channels mediated Ca2+ influx, which is comparable to sparks detected in adult ventricular myocytes in which cardiac E-C coupling was governed by a Ca2+-induced Ca2+ release (CICR) mechanism. However, focal repetitive sparks originated from the same intracellular organelle could reflect an immature status of the hiPSC-CMs.	[Zhang, Guang Qin; Wei, Heming; Lu, Jun; Wong, Philip; Shim, Winston] Natl Heart Ctr Singapore, Res & Dev Unit, Singapore, Singapore; [Zhang, Guang Qin] China Pharmaceut Univ, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China; [Wei, Heming; Wong, Philip; Shim, Winston] DUKE NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore	National Heart Centre Singapore; China Pharmaceutical University; National University of Singapore	Shim, W (corresponding author), Natl Heart Ctr Singapore, Res & Dev Unit, Singapore, Singapore.	winston.shim.s.n@nhcs.com.sg			National Research Foundation of Singapore [NRF2008 NRF-CRP003 002]	National Research Foundation of Singapore(National Research Foundation, Singapore)	This work is supported by the National Research Foundation of Singapore (NRF2008 NRF-CRP003 002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2004, DIFFERENTIATION, V72, P224, DOI 10.1111/j.1432-0436.2004.07205005.x; Baharvand H, 2006, CELL BIOL INT, V30, P800, DOI 10.1016/j.cellbi.2006.06.002; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blatter LA, 2003, J PHYSIOL-LONDON, V546, P19, DOI 10.1113/jphysiol.2002.025239; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1995, CIRC RES, V76, P236, DOI 10.1161/01.RES.76.2.236; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Dolnikov K, 2006, STEM CELLS, V24, P236, DOI 10.1634/stemcells.2005-0036; Essin K, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/135249; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; Itzhaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018037; Izu LT, 2006, BIOPHYS J, V91, P95, DOI 10.1529/biophysj.105.077214; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Lee YK, 2011, STEM CELL REV REP, V7, P976, DOI 10.1007/s12015-011-9273-3; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Sauer H, 2001, AM J PHYSIOL-HEART C, V281, pH411, DOI 10.1152/ajpheart.2001.281.1.H411; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Shiels HA, 2005, AM J PHYSIOL-REG I, V288, pR1756, DOI 10.1152/ajpregu.00510.2004; Sobie EA, 2005, J PHYSIOL-LONDON, V565, P441, DOI 10.1113/jphysiol.2005.086496; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yang Z, 2002, CIRC RES, V91, P315, DOI 10.1161/01.RES.0000030180.06028.23; Zhang GQ, 2004, SCI CHINA SER C, V47, P31, DOI 10.1360/02yc0234; Zhu WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005407; Zhu XS, 2005, CELL CALCIUM, V37, P583, DOI 10.1016/j.ceca.2005.03.002	34	29	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55266	10.1371/journal.pone.0055266	http://dx.doi.org/10.1371/journal.pone.0055266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408964	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200022
J	Arruda, D; Publio, R; Roque, AC				Arruda, Denise; Publio, Rodrigo; Roque, Antonio C.			The Periglomerular Cell of the Olfactory Bulb and its Role in Controlling Mitral Cell Spiking: A Computational Model	PLOS ONE			English	Article							CALCIUM CURRENTS; GLOMERULAR LAYER; INHIBITION; MECHANISMS; SIMULATIONS; NEUROPIL	Interneurons in the olfactory bulb are key elements of odor processing but their roles have not yet being fully understood. Two types of inhibitory interneurons, periglomerular and granule cells, act at two different levels within the olfactory bulb and may have different roles in coordinating the spiking of mitral cells, which are the principal output neurons of the olfactory bulb. In this work we introduce a reduced compartmental model of the periglomerular cell and use it to investigate its role on mitral cell spiking in a model of an elementary cell triad composed of these two cell types plus a granule cell. Our simulation results show that the periglomerular cell is more effective in inhibiting the mitral cell than the granule cell. Based on our results we predict that periglomerular and granule cells have different roles in the control of mitral cell spiking. The periglomerular cell would be the only one capable of completely inhibiting the mitral cell, and the activity decrease of the mitral cell through this inhibitory action would occur in a stepwise fashion depending on parameters of the periglomerular and granule cells as well as on the relative times of arrival of external stimuli to the three cells. The major role of the granule cell would be to facilitate the inhibitory action of the periglomerular cell by enlarging the range of parameters of the periglomerular cell which correspond to complete inhibition of the mitral cell. The combined action of the two interneurons would thus provide an efficient way of controling the instantaneous value of the firing rate of the mitral cell.	[Arruda, Denise; Publio, Rodrigo; Roque, Antonio C.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, Brazil	Universidade de Sao Paulo	Arruda, D (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, Brazil.	denisearruda84@gmail.com	Roque, Antonio C./C-2316-2011	Roque, Antonio C./0000-0003-1260-4840	CNPq MSc scholarship; FAPESP post-doc grant; CNPq research grant	CNPq MSc scholarship; FAPESP post-doc grant; CNPq research grant(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DA was supported by a CNPq (www.cnpq.br) MSc scholarship. RP is supported by a FAPESP (www.fapesp.br) post-doc grant. ACR is supported by a CNPq research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Bardoni R, 1995, BRAIN RES, V703, P19, DOI 10.1016/0006-8993(95)01039-4; Bardoni R, 1996, NEUROSCI LETT, V210, P95, DOI 10.1016/0304-3940(96)12677-X; Bathellier B, 2006, J NEUROPHYSIOL, V95, P3961; BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Cleland TA, 2005, CHEM SENSES, V30, P801, DOI 10.1093/chemse/bji072; Cleland TA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00005; Cleland TA, 2010, TRENDS NEUROSCI, V33, P130, DOI 10.1016/j.tins.2009.12.004; David F, 2008, J COMPUT NEUROSCI, V25, P25, DOI 10.1007/s10827-007-0063-5; Davison AP, 2000, BRAIN RES BULL, V51, P393, DOI 10.1016/S0361-9230(99)00256-7; Davison AP, 2003, J NEUROPHYSIOL, V90, P1921, DOI 10.1152/jn.00623.2002; Davison AP, 2000, THESIS U CAMBRIDGE C; Destexhe A, 1996, J NEUROSCI, V16, P169; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Djurisic M, 2008, J NEUROSCI, V28, P4057, DOI 10.1523/JNEUROSCI.5296-07.2008; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Maher BJ, 2008, J NEUROPHYSIOL, V99, P1559, DOI 10.1152/jn.00636.2007; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; Migliore M, 2005, J COMPUT NEUROSCI, V18, P151, DOI 10.1007/s10827-005-6556-1; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Puopolo M, 2005, J NEUROPHYSIOL, V94, P3618, DOI 10.1152/jn.00225.2005; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; Rubin DB, 2006, J NEUROPHYSIOL, V96, P555, DOI 10.1152/jn.00264.2006; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Shen GYY, 1999, J NEUROPHYSIOL, V82, P3006, DOI 10.1152/jn.1999.82.6.3006; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Smith TC, 2002, NAT NEUROSCI, V5, P760, DOI 10.1038/nn882; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Wiechert MT, 2010, NAT NEUROSCI, V13; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	46	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56148	10.1371/journal.pone.0056148	http://dx.doi.org/10.1371/journal.pone.0056148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405261	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400207
J	Cebula, M; Moolla, N; Capovilla, A; Arner, ESJ				Cebula, Marcus; Moolla, Naazneen; Capovilla, Alexio; Arner, Elias S. J.			The Rare TXNRD1_v3 ("v3") Splice Variant of Human Thioredoxin Reductase 1 Protein Is Targeted to Membrane Rafts by N-Acylation and Induces Filopodia Independently of Its Redox Active Site Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY EMBRYONIC LETHALITY; LIPID RAFTS; PLASMA-MEMBRANE; CHOLERA-TOXIN; ANCHORED PROTEINS; MYRISTOYL-COA; CELLS; PALMITOYLATION; EXPRESSION; COMPLEX	The human selenoprotein thioredoxin reductase 1 (TrxR1), encoded by the TXNRD1 gene, is a key player in redox regulation. Alternative splicing generates several TrxR1 variants, one of which is v3 that carries an atypical N-terminal glutaredoxin domain. When overexpressed, v3 associates with membranes and triggers formation of filopodia. Here we found that membrane targeting of v3 is mediated by myristoylation and palmitoylation of its N-terminal MGC motif, through which v3 specifically targets membrane rafts. This was suggested by its localization in cholera toxin subunit B-stained membrane areas and also shown using lipid fractionation experiments. Utilizing site-directed mutant variants, we also found that v3-mediated generation of filopodia is independent of the Cys residues in its redox active site, but dependent upon its membrane raft targeting. These results identify v3 as an intricately regulated protein that expands TXNRD1-derived protein functions to the membrane raft compartment.	[Cebula, Marcus; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Moolla, Naazneen; Capovilla, Alexio] Univ Witwatersrand, Sch Med, Dept Mol Med & Haematol, ZA-2193 Johannesburg, South Africa	Karolinska Institutet; University of Witwatersrand	Arner, ESJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.	Elias.Arner@ki.se	Arnér, Elias/K-6737-2019; Arnér, Elias S.J./J-5832-2012	Arnér, Elias/0000-0002-4807-6114; Arnér, Elias S.J./0000-0002-4807-6114; Cebula, Marcus/0000-0002-0149-1580	Swedish Research Council (Medicine); Swedish Cancer Society; Wallenberg Foundations; Karolinska Institutet; Medical Research Council (MRC); Polio Research Foundation (PRF) of South Africa	Swedish Research Council (Medicine)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Wallenberg Foundations; Karolinska Institutet(Karolinska Institutet); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Polio Research Foundation (PRF) of South Africa	This work was supported by the Swedish Research Council (Medicine), the Swedish Cancer Society, The Wallenberg Foundations, and the Karolinska Institutet. This work was also supported in part by the Medical Research Council (MRC) and Polio Research Foundation (PRF) of South Africa (to A. C. and N. M.).	Alexander M, 2004, J VIROL, V78, P1685, DOI 10.1128/JVI.78.4.1685-1696.2004; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arstikaitis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016998; Bhatnagar RS, 1999, BBA-MOL CELL BIOL L, V1441, P162, DOI 10.1016/S1388-1981(99)00155-9; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; GRASSIE MA, 1994, BIOCHEM J, V302, P913, DOI 10.1042/bj3020913; Gri G, 2004, IMMUNOL LETT, V94, P247, DOI 10.1016/j.imlet.2004.05.012; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Hara T, 2007, ANTIOXID REDOX SIGN, V9, P1427, DOI 10.1089/ars.2007.1661; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Hintze KJ, 2003, J NUTR, V133, P2721, DOI 10.1093/jn/133.9.2721; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Kondo N, 2007, ANTIOXID REDOX SIGN, V9, P1439, DOI 10.1089/ars.2007.1665; Larive RM, 2010, BBA-BIOMEMBRANES, V1798, P389, DOI 10.1016/j.bbamem.2009.11.016; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; NADLER MJS, 1993, BIOCHEMISTRY-US, V32, P9250, DOI 10.1021/bi00086a034; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Osborne S A, 2001, BMC Genomics, V2, P10, DOI 10.1186/1471-2164-2-10; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rundlof AK, 2000, BIOCHEM J, V347, P661, DOI 10.1042/0264-6021:3470661; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Rundlof AK, 2001, J BIOL CHEM, V276, P30542, DOI 10.1074/jbc.M101452200; Rundlof AK, 2007, DIFFERENTIATION, V75, P123, DOI 10.1111/j.1432-0436.2006.00121.x; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Scorticati C, 2011, J NEUROCHEM, V119, P521, DOI 10.1111/j.1471-4159.2011.07252.x; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Su D, 2004, BIOCHEMISTRY-US, V43, P12177, DOI 10.1021/bi048478t; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Van't Hof W, 2000, METHOD ENZYMOL, V327, P317, DOI 10.1016/S0076-6879(00)27287-X; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	66	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10002	10011		10.1074/jbc.M112.445932	http://dx.doi.org/10.1074/jbc.M112.445932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413027	Green Published, hybrid			2022-12-25	WOS:000317114000039
J	Leng, ZW; Tao, KX; Xia, QH; Tan, J; Yue, ZY; Chen, JH; Xi, HL; Li, J; Zheng, H				Leng, Zhengwei; Tao, Kaixiong; Xia, Qinghua; Tan, Jun; Yue, Zhongyi; Chen, Jinhuang; Xi, Hailin; Li, Jie; Zheng, Hai			Kruppel-Like Factor 4 Acts as an Oncogene in Colon Cancer Stem Cell-Enriched Spheroid Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR KLF4; COLORECTAL-CANCER; CARCINOMA CELLS; PROLIFERATION; EXPRESSION; TUMOR; KRUPPEL-LIKE-FACTOR-4; DIFFERENTIATION; INVASION; SURVIVAL	Cancer stem cells (CSCs), a rare population in any type of cancers, including colon cancer, are tumorigenic. It has been thought that CSCs are responsible for cancer recurrence, metastasis, and drug resistance. Isolating CSCs in colon cancers is challenging, and thus the molecular mechanism regulating the self-renewing and differentiation of CSCs remains unknown. We cultured DLD-1 cells, one of types of cells derived from colon cancers, in serum-free medium to obtain spheroid cells. These cells possessed the characteristics of CSCs, with the expression of CD133, CD166, Lgr5, and ALDH1, higher capacities of chemo-resistance, migration, invasion, and tumorigenicity in vitro and in vivo than the adherent DLD-1 cells. Kruppel-like factor 4 (KLF4) is essential factor for maintaining self-renewal of adult and embryonic stem cells. It has been used to induce pluripotent stem cells (iPS) from somatic cells. Since KLF4 is expressed in colon cancer cells, we investigated its role in spheroid cells isolated from DLD-1 cells and found that KLF4 was overexpressed only in spheroid cells and reducing the expression of KLF4 by short-hairpin RNA significantly decreased the capacities of these cells to resist the chemicals, migrate, invade, and generate tumors in vitro and in vivo. The spheroid cells with reduced KLF4 expression also had decreased expression of CSCs markers and mesenchymal markers. Taken together, culturing DLD-1 cells in serum-free medium enriches CSCs and the expression of KLF4 is essential for the characteristics of CSCs in DLD-1; thus KLF4 can be a potential therapeutic target for treating colon cancer.	[Leng, Zhengwei; Tao, Kaixiong; Xia, Qinghua; Tan, Jun; Yue, Zhongyi; Chen, Jinhuang; Xi, Hailin; Zheng, Hai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China; [Li, Jie] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zheng, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China.	jixingc2000@yahoo.com.cn			State Foundation for the Natural Sciences of the People's Republic of China [81071541/H1504]	State Foundation for the Natural Sciences of the People's Republic of China	This work was supported by the State Foundation for the Natural Sciences of the People's Republic of China 81071541/H1504 (to HZ) [http://www.nsfc.gov.cn/Portal0/default152.htm]. The funder had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; An J, 2011, FASEB J, V25, P3634, DOI 10.1096/fj.11-186924; Bellizzi A, 2013, J CELL PHYSIOL, V228, P408, DOI 10.1002/jcp.24145; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Choijamts B, 2011, STEM CELLS, V29, P1485, DOI 10.1002/stem.711; Clark PA, 2012, NEOPLASIA, V14, P420, DOI 10.1596/neo.12432; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cui X, 2011, CANCER RES, V71, P3676, DOI 10.1158/0008-5472.CAN-10-2926; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Feng Y, 2012, CELL PROLIFERAT, V45, P413, DOI 10.1111/j.1365-2184.2012.00837.x; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Hart LS, 2011, CELL CYCLE, V10, P2331, DOI 10.4161/cc.10.14.16418; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; Kato J, 2011, CANCER RES, V71, P5327, DOI 10.1158/0008-5472.CAN-10-0733; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kobayashi S, 2012, STEM CELLS; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Liu WC, 2012, J HUAZHONG U SCI-MED, V32, P280, DOI 10.1007/s11596-012-0049-z; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Michishita M, 2011, RES VET SCI, V91, P254, DOI 10.1016/j.rvsc.2010.11.016; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; O'Leary DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044176; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rutella S, 2009, CLIN CANCER RES, V15, P4299, DOI 10.1158/1078-0432.CCR-08-1883; Rybak AP, 2011, BBA-MOL CELL RES, V1813, P683, DOI 10.1016/j.bbamcr.2011.01.018; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang SN, 2012, INT J CANCER, V131, P30, DOI 10.1002/ijc.26323; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wilson BJ, 2011, CURR COLORECT CANC R, V7, P128, DOI 10.1007/s11888-011-0093-2; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211; Zhang N, 2012, INT J ONCOL, V40, P2038, DOI 10.3892/ijo.2012.1395; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	61	91	100	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56082	10.1371/journal.pone.0056082	http://dx.doi.org/10.1371/journal.pone.0056082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418515	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300107
J	Mejak, SL; Bayliss, J; Hanks, SD				Mejak, Sandra L.; Bayliss, Julianne; Hanks, Shayne D.			Long Distance Bicycle Riding Causes Prostate-Specific Antigen to Increase in Men Aged 50 Years and Over	PLOS ONE			English	Article							DIGITAL RECTAL EXAMINATION; ACID-PHOSPHATASE; TRANSURETHRAL RESECTION; FLEXIBLE CYSTOSCOPY; SERUM; EJACULATION; PSA; CANCER; PERCENTAGE; BIOPSY	Objectives: To investigate whether bicycle riding alters total prostate-specific antigen (tPSA) serum concentrations in healthy older men. Methods: 129 male participants, ranging in age from 50 to 71 years (mean 55 years), rode in a recreational group bicycle ride of between 55 and 160 kilometers. Blood samples for tPSA analysis were drawn within 60 minutes before starting, and within 5 minutes after completing the ride. The pre-cycling and post-cycling tPSA values were log transformed for normality and compared using paired t-tests. Linear regression was used to assess the relationship between changes in tPSA with age and distance cycled. Results: Bicycle riding caused tPSA to increase by an average of 9.5% (95% CI = 6.1-12.9; p<0.001) or 0.23 ng/ml. The number of participants with an elevated tPSA (using the standard PSA normal range cut-off of 4.0 ng/ml) increased from two pre-cycle to six post-cycle (or from five to eight when using age-based normal ranges). Univariate linear regression analysis revealed that the change in tPSA was positively correlated with age and the distance cycled. Conclusions: Cycling causes an average 9.5% increase in tPSA, in healthy male cyclists >= 50 years old, when measured within 5 minutes post cycling. We considered the increase clinically significant as the number of participants with an elevated PSA, according to established cut-offs, increased post-ride. Based on the research published to date, the authors suggest a 24-48 hour period of abstinence from cycling and ejaculation before a PSA test, to avoid spurious results.	[Mejak, Sandra L.] Victorian Inst Sport, Dept Sports Med, Melbourne, Vic, Australia; [Bayliss, Julianne] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3181, Australia; [Hanks, Shayne D.] Performance Boost, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Mejak, SL (corresponding author), Victorian Inst Sport, Dept Sports Med, Melbourne, Vic, Australia.	sandramejak@gmail.com	Bayliss, Julianne/I-2227-2014	Bayliss, Julianne/0000-0003-3578-4952	Victorian Institue of Sport	Victorian Institue of Sport	The Victorian Institue of Sport (www.vis.org.au) funded the blood analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics report, 2009, AUSTRALIAN BUREAU OF; Banfi G, 1997, CLIN CHEM, V43, P1465; Coley CM, 1997, ANN INTERN MED, V126, P468, DOI 10.7326/0003-4819-126-6-199703150-00010; Collins GN, 1997, J UROLOGY, V157, P1744, DOI 10.1016/S0022-5347(01)64849-3; DeCastro BJ, 2009, UROLOGY, V73, P237, DOI 10.1016/j.urology.2008.09.011; DEJTER SW, 1988, UROLOGY, V32, P288, DOI 10.1016/0090-4295(88)90228-2; Dixon SC, 2001, PHARMACOL REV, V53, P73; ELSHIRBINY AMF, 1990, UROLOGY, V35, P88, DOI 10.1016/0090-4295(90)80023-G; Frymann RJ, 2006, INT UROL NEPHROL, V38, P161, DOI 10.1007/s11255-005-1661-7; Gregorakis AK, 2005, CLIN CHIM ACTA, V357, P196, DOI 10.1016/j.cccn.2005.03.027; Herrmann M, 2004, CLIN CHEM LAB MED, V42, P347, DOI 10.1515/CCLM.2004.061; Herschman JD, 1997, UROLOGY, V50, P239, DOI 10.1016/S0090-4295(97)00209-4; Kindermann W, 2011, UROLOGE, V50, P188, DOI 10.1007/s00120-010-2489-z; KIRKALI Z, 1995, EUR UROL, V27, P292; Lechevallier E, 1999, UROLOGY, V54, P857, DOI 10.1016/S0090-4295(99)00239-3; Lechevallier E, 1999, UROLOGY, V53, P731, DOI 10.1016/S0090-4295(98)00607-4; Lippi G, 2005, INT J SPORTS MED, V26, P79, DOI 10.1055/s-2004-830450; Luboldt HJ, 2003, UROLOGY, V61, P1177, DOI 10.1016/S0090-4295(03)00007-4; OESTERLING JE, 1993, UROLOGY, V42, P276, DOI 10.1016/0090-4295(93)90616-I; OESTERLING JE, 1995, J UROLOGY, V154, P1090, DOI 10.1016/S0022-5347(01)66984-2; Oremek GM, 1996, CLIN CHEM, V42, P691; Ornstein DK, 1997, J UROLOGY, V157, P195, DOI 10.1016/S0022-5347(01)65321-7; PRICE A, 1991, CLIN CHEM, V37, P859; RANA A, 1994, J UROLOGY, V151, P700, DOI 10.1016/S0022-5347(17)35053-X; Richardson TD, 1996, UROLOGY, V48, P40, DOI 10.1016/S0090-4295(96)00608-5; Rodriguez-Rubio FI, 1998, EUR UROL, V33, P255, DOI 10.1159/000019577; Safford HR, 1996, J UROLOGY, V156, P103, DOI 10.1016/S0022-5347(01)65954-8; Saka T, 2009, UROLOGY, V74, P1325, DOI 10.1016/j.urology.2009.07.1219; SIMAK R, 1993, J UROLOGY, V150, P895, DOI 10.1016/S0022-5347(17)35642-2; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Stamey TA, 1989, MONOGR UROL, V10, P49; Stenner J, 1998, UROLOGY, V51, P455, DOI 10.1016/S0090-4295(97)00635-3; Swain RA, 1997, ARCH FAM MED, V6, P500, DOI 10.1001/archfami.6.5.500; Tchetgen MB, 1996, UROLOGY, V47, P511, DOI 10.1016/S0090-4295(99)80486-5; The Cancer Council Queensland, THE CANCER COUNCIL Q; THOMSON RD, 1992, AM J CLIN PATHOL, V97, P528, DOI 10.1093/ajcp/97.4.528; WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109	37	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56030	10.1371/journal.pone.0056030	http://dx.doi.org/10.1371/journal.pone.0056030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418500	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300092
J	Morisaki, N; Ohuchi, A; Moriwaki, S				Morisaki, Naoko; Ohuchi, Atsushi; Moriwaki, Shigeru			The Role of Neprilysin in Regulating the Hair Cycle	PLOS ONE			English	Article							NEUTRAL ENDOPEPTIDASE; FOLLICLE DEVELOPMENT; ELASTIC FIBERS; GROWTH CYCLE; DERMAL PAPILLA; MOUSE HAIR; EXPRESSION; MICE; RAT; SKIN	In most mammals, each hair follicle undergoes a cyclic process of growing, regressing and resting phases (anagen, catagen, telogen, respectively) called the hair cycle. Various biological factors have been reported to regulate or to synchronize with the hair cycle. Some factors involved in the extracellular matrix, which is a major component of skin tissue, are also thought to regulate the hair cycle. We have focused on an enzyme that degrades elastin, which is associated with skin elasticity. Since our previous study identified skin fibroblast elastase as neprilysin (NEP), we examined the fluctuation of NEP enzyme activity and its expression during the synchronized hair cycle of rats. NEP activity in the skin was elevated at early anagen, and decreased during catagen to telogen. The expression of NEP mRNA and protein levels was modulated similarly. Immunostaining showed changes in NEP localization throughout the hair cycle, from the follicular epithelium during early anagen to the dermal papilla during catagen. To determine whether NEP plays an important role in regulating the hair cycle, we used a specific inhibitor of NEP (NPLT). NPLT was applied topically daily to the dorsal skin of C3H mice, which had been depilated in advance. Mice treated with NPLT had significantly suppressed hair growth. These data suggest that NEP plays an important role in regulating the hair cycle by its increased expression and activity in the follicular epithelium during early anagen.				morisaki.naoko@kao.co.jp			Kao Corporation	Kao Corporation	This work was supported by Kao Corporation (http://www.kao.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Bayer-Garner IB, 2002, AM J DERMATOPATH, V24, P484, DOI 10.1097/00000372-200212000-00005; CASEY ML, 1991, J BIOL CHEM, V266, P23041; CIPRIANI C, 1976, ARCH DERMATOL RES, V256, P319, DOI 10.1007/BF00572498; CONNELLY JC, 1993, J LEUKOCYTE BIOL, V53, P685, DOI 10.1002/jlb.53.6.685; COUCHMAN JR, 1990, J INVEST DERMATOL, V94, P65, DOI 10.1111/1523-1747.ep12873363; CROVATO F, 1975, ARCH DERMATOL FORSCH, V251, P325; DIVANO C, 1979, ARCH DERMATOL RES, V266, P135, DOI 10.1007/BF00694623; DUCROS DL, 1995, J INVEST DERMATOL, V105, P426, DOI 10.1111/1523-1747.ep12321131; Fujita S, 2007, ANTICANCER RES, V27, P3307; Graf K, 1998, BASIC RES CARDIOL, V93, P11, DOI 10.1007/s003950050056; Hamada K, 1996, EXP ANIM TOKYO, V45, P251, DOI 10.1538/expanim.45.251; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Holub BS, 2012, BRIT J DERMATOL, V167, P10, DOI 10.1111/j.1365-2133.2012.10890.x; Huang WB, 2005, JPN J CLIN ONCOL, V35, P245, DOI 10.1093/jjco/hyi076; KAWABE TT, 1994, J INVEST DERMATOL, V103, P122, DOI 10.1111/1523-1747.ep12391894; KAWABE TT, 1991, DEVELOPMENT, V111, P877; Kramer HH, 2005, EXP NEUROL, V195, P179, DOI 10.1016/j.expneurol.2005.04.015; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; MANIL L, 1981, BRIT J CANCER, V43, P210, DOI 10.1038/bjc.1981.30; MESSENGER AG, 1991, J INVEST DERMATOL, V96, pS75, DOI 10.1111/1523-1747.ep12471914; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nakagawa K, 1987, SKIN RES, V29, P793; Ogawa H, 1983, Curr Probl Dermatol, V11, P159; Oka T, 1993, Nihon Yakurigaku Zasshi, V101, P197; Olerud JE, 1999, J INVEST DERMATOL, V112, P873, DOI 10.1046/j.1523-1747.1999.00596.x; Panteleyev AA, 2000, EXP DERMATOL, V9, P146, DOI 10.1034/j.1600-0625.2000.009002146.x; Paus R, 1999, J INVEST DERM SYMP P, V4, P338, DOI 10.1038/sj.jidsp.5640241; PINKUS H, 1978, J CUTAN PATHOL, V5, P93, DOI 10.1111/j.1600-0560.1978.tb00946.x; Poblet E, 2008, BRIT J DERMATOL, V159, P646, DOI 10.1111/j.1365-2133.2008.08741.x; ROMAN N, 1967, STAIN TECHNOL, V42, P199, DOI 10.3109/10520296709115008; ROQUES BP, 1993, PHARMACOL REV, V45, P87; SAWAYA ME, 1992, J CUTAN PATHOL, V19, P309, DOI 10.1111/j.1600-0560.1992.tb01367.x; Solan NJ, 1998, INFLAMMATION, V22, P107, DOI 10.1023/A:1022304025789; Starcher B, 2005, J HISTOCHEM CYTOCHEM, V53, P431, DOI 10.1369/jhc.4A6484.2005; TAYLOR M, 1992, BRIT J DERMATOL, V126, P479, DOI 10.1111/j.1365-2133.1992.tb15120.x; Toyoda M, 2001, BRIT J DERMATOL, V144, P46, DOI 10.1046/j.1365-2133.2001.03951.x; Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2; VIJAYARAGHAVAN J, 1990, J BIOL CHEM, V265, P14150; Walther T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004590; WOLLINA U, 1995, HISTOL HISTOPATHOL, V10, P39; Yamazaki M, 1999, J INVEST DERM SYMP P, V4, P312, DOI 10.1038/sj.jidsp.5640236; YU DW, 1995, J CELL SCI, V108, P3867; YUSPA SH, 1993, J INVEST DERMATOL, V101, pS27, DOI 10.1111/1523-1747.ep12362567	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55947	10.1371/journal.pone.0055947	http://dx.doi.org/10.1371/journal.pone.0055947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418484	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300076
J	Rey-Santano, C; Mielgo, V; Gastiasoro, E; Valls-i-Soler, A; Murgia, X				Rey-Santano, Carmen; Mielgo, Victoria; Gastiasoro, Elena; Valls-i-Soler, Adolfo; Murgia, Xabier			Effect of Surfactant and Partial Liquid Ventilation Treatment on Gas Exchange and Lung Mechanics in Immature Lambs: Influence of Gestational Age	PLOS ONE			English	Article							PULMONARY MECHANICS; PRETERM LAMBS; CARDIOPULMONARY FUNCTION; EXOGENOUS SURFACTANT; PREMATURE LAMBS; BLOOD-FLOW; PERFLUOROCARBON; INFANTS; HEMODYNAMICS	Objectives: Surfactant (SF) and partial liquid ventilation (PLV) improve gas exchange and lung mechanics in neonatal RDS. However, variations in the effects of SF and PLV with degree of lung immaturity have not been thoroughly explored. Setting: Experimental Neonatal Respiratory Physiology Research Unit, Cruces University Hospital. Design: Prospective, randomized study using sealed envelopes. Subjects: 36 preterm lambs were exposed (at 125 or 133-days of gestational age) by laparotomy and intubated. Catheters were placed in the jugular vein and carotid artery. Interventions: All the lambs were assigned to one of three subgroups given: 20 mL/Kg perfluorocarbon and managed with partial liquid ventilation (PLV), surfactant (Curosurf (R), 200 mg/kg) or (3) no pulmonary treatment (Controls) for 3 h. Measurements and Main Results: Cardiovascular parameters, blood gases and pulmonary mechanics were measured. In 125-day gestation lambs, SF treatment partially improved gas exchange and lung mechanics, while PLV produced significant rapid improvements in these parameters. In 133-day lambs, treatments with SF or PLV achieved similarly good responses. Neither surfactant nor PLV significantly affected the cardiovascular parameters. Conclusion: SF therapy response was more effective in the older gestational age group whereas the effectiveness of PLV therapy was not gestational age dependent.	[Rey-Santano, Carmen; Mielgo, Victoria; Gastiasoro, Elena; Murgia, Xabier] Cruces Univ Hosp, Res Unit Expt Neonatal Resp Physiol, Baracaldo, Bizkaia, Spain; [Valls-i-Soler, Adolfo] Cruces Univ Hosp, Neonatal Intens Care Unit, Baracaldo, Bizkaia, Spain	Hospital Universitario Cruces; Hospital Universitario Cruces	Rey-Santano, C (corresponding author), Cruces Univ Hosp, Res Unit Expt Neonatal Resp Physiol, Baracaldo, Bizkaia, Spain.	macarmen.reysantano@osakidetza.net			Spanish Health Institute Carlos III [FIS 10/943, RD08/072]	Spanish Health Institute Carlos III(Instituto de Salud Carlos III)	This study was partially supported by grants from the Spanish Health Institute Carlos III: FIS 10/943 and RD08/072 (Red SAMID: Maternal, Child Health and Development Research Network, within the framework of the VI National I+D+i Research Program 2008-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALCORN DG, 1981, ANAT REC, V201, P655, DOI 10.1002/ar.1092010410; BHUTANI VK, 1988, PEDIATR PULM, V4, P150, DOI 10.1002/ppul.1950040306; BORN GVR, 1955, J PHYSIOL-LONDON, V130, P191, DOI 10.1113/jphysiol.1955.sp005403; Cochrane CG, 1996, AM J RESP CRIT CARE, V153, P404, DOI 10.1164/ajrccm.153.1.8542150; Cox C, 2003, BIOL NEONATE, V84, P232, DOI 10.1159/000072307; Davies MW, 2010, NEONATOLOGY, V97, P144, DOI 10.1159/000239768; Davies MW, 2002, CRIT CARE MED, V30, P1123, DOI 10.1097/00003246-200205000-00027; Degraeuwe PLJ, 2006, AM J RESP CRIT CARE, V174, P615, DOI 10.1164/ajrccm.174.5.615; DEGRAEUWE PLJ, 1995, INT J ARTIF ORGANS, V18, P674, DOI 10.1177/039139889501801020; Doctor A, 1998, J APPL PHYSIOL, V84, P1540, DOI 10.1152/jappl.1998.84.5.1540; Gastiasoro Cuesta E, 2006, PEDIATRICS, V117, P295; Gastiasoro Cuesta E, 2001, PEDIATR CRIT CARE ME, V2, P334; GREENSPAN JS, 1989, LANCET, V2, P1095; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; HIRSCHL RB, 1995, LANCET, V346, P1201, DOI 10.1016/S0140-6736(95)92903-7; HODSON WA, 1992, FETAL NEONATAL PHYSL, P771; Houmes RJM, 1995, INTENS CARE MED, V21, P966, DOI 10.1007/BF01700657; IKEGAMI M, 1987, PEDIATRICS, V79, P38; Ikegami M, 1996, J APPL PHYSIOL, V81, P2517, DOI 10.1152/jappl.1996.81.6.2517; Ikegami M, 1987, J APPL PHYSIOL, V67, P429; JACOBS H, 1982, PEDIATR RES, V16, P424, DOI 10.1203/00006450-198206000-00005; JOBE A, 1983, PEDIATR RES, V17, P444, DOI 10.1203/00006450-198306000-00002; Kacmarek RM, 2006, AM J RESP CRIT CARE, V173, P882, DOI 10.1164/rccm.200508-1196OC; Kusuda S, 2000, J PERINAT MED, V28, P363, DOI 10.1515/JPM.2000.046; Leach CL, 1996, NEW ENGL J MED, V335, P761, DOI 10.1056/NEJM199609123351101; LOWE CA, 1986, J APPL PHYSIOL, V60, P154, DOI 10.1152/jappl.1986.60.1.154; MAETA H, 1988, EUR J PEDIATR, V147, P162, DOI 10.1007/BF00442215; Mrozek JD, 1997, AM J RESP CRIT CARE, V156, P1058, DOI 10.1164/ajrccm.156.4.9610104; Murgia X, 2012, PEDIATR RES, V72, P393, DOI 10.1038/pr.2012.90; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537; Rey-Santano C, 2011, PEDIATR PULM, V46, P991, DOI 10.1002/ppul.21460; Rey-Santano C, 2012, PEDIATR CRIT CARE ME, V13, pE187, DOI 10.1097/PCC.0b013e318238b17f; ROBERTSON B, 1991, EUR J PEDIATR, V150, P433; Rudiger M, 2004, J CRIT CARE, V19, P42, DOI 10.1016/j.jcrc.2004.02.008; SEGERER H, 1991, PEDIATR RES, V30, P591, DOI 10.1203/00006450-199112000-00022; SHAFFER TH, 1983, PEDIATR RES, V17, P303, DOI 10.1203/00006450-198304000-00017; SHAFFER TH, 1983, PEDIATR RES, V17, P680, DOI 10.1203/00006450-198308000-00016; Shaffer TH, 2012, FETAL NEONATAL PHYSL, P1063; Soll R.F., 1994, NEW THERAPIES NEONAT, P49; Sweet D, 2007, J PERINAT MED, V35, P175, DOI 10.1515/JPM.2007.048; Valls-i-Soler A, 2001, BIOL NEONATE, V80, P29, DOI 10.1159/000047175; WILCOX DT, 1995, CRIT CARE MED, V23, P1858, DOI 10.1097/00003246-199511000-00012; WOLFSON MR, 1990, J DEV PHYSIOL, V13, P1; WOLFSON MR, 1992, J APPL PHYSIOL, V72, P1024, DOI 10.1152/jappl.1992.72.3.1024	44	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56127	10.1371/journal.pone.0056127	http://dx.doi.org/10.1371/journal.pone.0056127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418521	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300113
J	Sangster, G; King, BF; Verbelen, P; Trainor, CR				Sangster, George; King, Ben F.; Verbelen, Philippe; Trainor, Colin R.			A New Owl Species of the Genus Otus (Aves: Strigidae) from Lombok, Indonesia	PLOS ONE			English	Article							SCREECH-OWLS; STRIGIFORMES; GLAUCIDIUM; PHYLOGENY	The avifauna of Indonesia is one of the richest in the world but the taxonomic status of many species remains poorly documented. The sole species of scops owl known from Lombok has long been assigned to the widespread Moluccan Scops Owl Otus magicus on the basis of superficial similarities in morphology. Field work in 2003 has shown that the territorial song of the scops owls inhabiting the foothills of Gunung Rinjani differs dramatically from that of O. magicus and is more similar to those of Rufescent Scops Owl O. rufescens and Singapore Scops Owl O. cnephaeus. Detailed comparisons of sound recordings and museum specimens with those of other scops owls in Wallacea and the Indo-Malayan region have confirmed the distinctiveness of the Lombok population. We describe Otus jolandae as a new species, the Rinjani Scops Owl. It is locally common at elevations from 25-1350 m. and occurs within Gunung Rinjani National Park. The new species is known from seven specimens collected by Alfred Everett in 1896. Otus jolandae represents the first endemic bird species from Lombok.	[Sangster, George] Swedish Museum Nat Hist, Dept Vertebrate Zool, S-10405 Stockholm, Sweden; [Sangster, George] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [King, Ben F.] Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA	Swedish Museum of Natural History; Stockholm University; American Museum of Natural History (AMNH)	Sangster, G (corresponding author), Swedish Museum Nat Hist, Dept Vertebrate Zool, S-10405 Stockholm, Sweden.	george.sangster@nrm.se	Trainor, Colin R/E-3751-2010; Sangster, George/H-4901-2019	Trainor, Colin R/0000-0002-0194-7533; Sangster, George/0000-0002-2475-7468				Currie D, 2002, BIRD CONSERV INT, V12, P353, DOI 10.1017/S0959270902002228; Del Hoyo J, 1999, HDB BIRDS WORLD, V5; Dickinson EC., 2003, HOWARD MOORE COMPLET; Eck S, 1973, ZOOLOGISCHEN ABHANDL, V23, P155; Fuchs J, 2007, CONDOR, V109, P408, DOI 10.1650/0010-5422(2007)109[408:GSOGVI]2.0.CO;2; Fuchs J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-197; Gibbs D, 1990, WALLACEA PRIVATELY P; Hartert E., 1896, NOVITATES ZOOLOGICAE, V3, P591; Hartet E., 1896, Novitates Zoologicae, Viii, P537; HEIDRICH P, 1995, Z NATURFORSCH C, V50, P294; Heidrich P, 1996, STUTTGARTER BEITRA A, V534, P1; Hill FAR, 1998, EMU, V98, P209, DOI 10.1071/MU98029; Holyoak DT., 2001, NIGHTJARS THEIR ALLI; HOWELL SNG, 1995, WILSON BULL, V107, P7; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Johnson D H, 2009, ARDEA, V97, P395; K/nig C., 2008, OWLS GUIDE OWLS WORL; Koenig Claus, 2000, P781; Konig C., 1991, Oekologie der Voegel, V13, P15; Konig Claus, 1994, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V511, P1; Kuroda N., 1930, Tori Tokyo, V6, P65; Kusch Heinrich, 1998, Hoehle, V49, P5; Lafontaine Rene-Marie, 1998, Journal of African Zoology, V112, P163; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P204; Marshall JT, 1988, P W FDN VERT ZOOL, V3, p[331, 295]; Marshall JT., 1978, ORNITHOLOGICAL MONOG, V25, P1, DOI [DOI 10.2307/40166757, 10.2307/40166757]; Miranda HC, 2011, WILSON J ORNITHOL, V123, P441, DOI 10.1676/10-185.1; Morony JJ, 1975, REFERENCE LIST BIRDS; Myers Susan D., 2005, Forktail, V21, P147; Norman JA, 1998, EMU, V98, P197, DOI 10.1071/MU98028; RENSCH BERNHARD, 1931, MITTEIL ZOOL MUS BERLIN, V17, P451; Ridgway R., 1912, COLOR STANDARDS COLO; ROBBINS MB, 1995, WILSON BULL, V107, P1; Sangster G., 2004, Zoologische Verhandelingen (Leiden), V350, P7; Smithe F.B, 1975, NATURALISTS COLOR GU; SPSS INSTITUTE, 2008, SPSS WIND VERS 16 0; Van der Weijden W.J., 1973, Bulletin Inst fond Afr noire (Sci nat), V35, P716; VANDERWEYDEN WJ, 1973, IBIS, V115, P129; VANDERWEYDEN WJ, 1974, IBIS, V116, P369; Vorderman AG, 1895, NAT TIJDSCHR NED IND, V54, P327; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wallace AR, 1863, P ZOOL SOC LOND, V1863, P480; WEBSTER PJ, 1978, QUATERNARY RES, V10, P279, DOI 10.1016/0033-5894(78)90024-8; Weick F, 2006, OWLS STRIGIFORMES; White C.M.N., 1986, BIRDS WALLACEA, V7; Widodo Wahyu, 1999, Forktail, V15, P15	46	21	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53712	10.1371/journal.pone.0053712	http://dx.doi.org/10.1371/journal.pone.0053712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418422	gold, Green Published			2022-12-25	WOS:000315970300012
J	Yu, JP; Ren, XB; Chen, YZ; Liu, PP; Wei, XY; Li, H; Ying, GG; Chen, KX; Winkler, H; Hao, XS				Yu, Jinpu; Ren, Xiubao; Chen, Yongzi; Liu, Pengpeng; Wei, Xiyin; Li, Hui; Ying, Guoguang; Chen, Kexin; Winkler, Hans; Hao, Xishan			Dysfunctional Activation of Neurotensin/IL-8 Pathway in Hepatocellular Carcinoma Is Associated with Increased Inflammatory Response in Microenvironment, More Epithelial Mesenchymal Transition in Cancer and Worse Prognosis in Patients	PLOS ONE			English	Article							INTERLEUKIN-8 EXPRESSION; TUMOR ANGIOGENESIS; IN-VITRO; CELLS; GROWTH; SUPPRESSION; PREDICTION; TARGET; IDENTIFICATION; SOFTWARE	Aim: To investigate the role of neurotensin (NTS) in hepatocellular carcinoma (HCC) sub-grouping and the clinical and pathological significance of activation of NTS/IL-8 pathway in HCC. Methods: The genome-wide gene expression profiling were conducted in 10 pairs of cancer tissues and corresponding normal adjacent tissues samples using Affymetrix GeneChip (R) Human Genome U133 Plus 2.0 microarray to screen differentially expressing genes and enrich dysfunctional activated pathways among different HCC subgroups. The levels of NTS protein and multiple inflammation and epithelial mesenchymal transition (EMT) related proteins, including IL-8, VEGF, MMP9, CD68, E-Cadherin, beta-Catenin and Vimentin were examined in 64 cases of paraffin-embedded HCC samples using immunohistochemistry (IHC) staining method. The clinical outcome and overall survival (OS) were compared. Results: A subgroup of HCC characterized by up-regulated NTS expression was accompanied by up-regulated inflammatory responses and EMT. The direct interaction between NTS and IL-8 was identified by pathway enrichment analysis. Significantly increased IL-8 protein was confirmed in 90.91% of NTS+HCC samples and significantly positively correlated to the levels of NTS protein in cancer tissues (P = 0.036), which implied activation of NTS/IL-8 pathway in HCC. The levels of VEGF and MMP9 correlated with co-expression of NTS and IL-8. Increased infiltration of CD68(+) macrophages and more cancer cells displaying EMT features were found in NTS+ IL-8(+) samples. The co-expression of NTS and IL-8 in cancer significantly correlated with the clinical outcomes, as the mortality rate of NTS+IL-8(+) HCC patients is 2.5-fold higher than the others after the surgery (P = 0.022). Accordingly, the OS of NTS+IL-8(+) HCC patients significantly decreased who are under a higher hazard of death at an expected hazard ratio (HR) of 3.457. Conclusion: Dysfunctional activation of the NTS/IL-8 pathway was detected in HCC which is associated with increased inflammatory response in microenvironment, enhanced EMT in cancer, and worse prognosis in HCC patients.	[Yu, Jinpu; Liu, Pengpeng; Winkler, Hans; Hao, Xishan] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, TMUCIH JnJ Joint Lab, Tianjin, Peoples R China; [Yu, Jinpu; Ren, Xiubao; Liu, Pengpeng; Li, Hui] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Dept Immunol, Tianjin, Peoples R China; [Chen, Yongzi; Wei, Xiyin; Ying, Guoguang] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Canc Cell Biol Lab, Tianjin, Peoples R China; [Chen, Kexin] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Dept Epidemiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Hao, XS (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, TMUCIH JnJ Joint Lab, Tianjin, Peoples R China.	hxs_yjp@yahoo.com		YU, JINPU/0000-0002-5982-2266; chen, yongzi/0000-0003-3396-7130; Chen, Kexin/0000-0003-4248-7681	National Natural Science Foundation of China [81272360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81272360), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Andrisani OM, 2011, SEMIN CANCER BIOL, V21, P4, DOI 10.1016/j.semcancer.2010.09.002; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crivellato E, 2008, CANCER LETT, V269, P1, DOI 10.1016/j.canlet.2008.03.031; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Ding W, 2010, HEPATOLOGY, V52, P945, DOI 10.1002/hep.23748; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gohlmann H, 2009, GENE EXPRESSION STUD; Huynh H, 2008, J HEPATOL, V49, P52, DOI 10.1016/j.jhep.2008.02.022; Iizuka N, 2008, CANCER SCI, V99, P659, DOI 10.1111/j.1349-7006.2008.00751.x; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Labbozzetta M, 2006, ANN NY ACAD SCI, V1089, P268, DOI 10.1196/annals.1386.014; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Mijatovic T, 2007, CELL ONCOL, V29, P315; Myers RM, 2009, ACS CHEM BIOL, V4, P503, DOI 10.1021/cb900038e; Olszewski U, 2009, MOL ONCOL, V3, P204, DOI 10.1016/j.molonc.2009.01.006; Peng HH, 2007, EXP CELL RES, V313, P551, DOI 10.1016/j.yexcr.2006.10.030; Reubi JC, 1999, INT J CANCER, V82, P213, DOI 10.1002/(SICI)1097-0215(19990719)82:2<213::AID-IJC11>3.0.CO;2-8; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shimizu S, 2008, INT J CANCER, V123, P1816, DOI 10.1002/ijc.23710; Sivachenko AY, 2007, EXPERT OPIN THER TAR, V11, P411, DOI 10.1517/14728222.11.3.411; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thomas Sterling, 2010, Human Genomics, V4, P353; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Malenstein H, 2011, EUR J CANCER, V47, P1789, DOI 10.1016/j.ejca.2011.04.027; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Wang XF, 2006, CLIN CANCER RES, V12, P5346, DOI 10.1158/1078-0432.CCR-06-0968; Wang XF, 2010, MOL CANCER THER, V9, P2389, DOI 10.1158/1535-7163.MCT-09-1080; Wouters L, 2003, BIOMETRICS, V59, P1131, DOI 10.1111/j.0006-341X.2003.00130.x; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yao C, 2007, INT J CANCER, V121, P1949, DOI 10.1002/ijc.22930; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Zhao DZ, 2006, PEPTIDES, V27, P2434, DOI 10.1016/j.peptides.2005.12.016; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	48	44	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56069	10.1371/journal.pone.0056069	http://dx.doi.org/10.1371/journal.pone.0056069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418512	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300104
J	Yun, HJ; Im, K; Yang, JJ; Yoon, U; Lee, JM				Yun, Hyuk Jin; Im, Kiho; Yang, Jin-Ju; Yoon, Uicheul; Lee, Jong-Min			Automated Sulcal Depth Measurement on Cortical Surface Reflecting Geometrical Properties of Sulci	PLOS ONE			English	Article							CEREBRAL-CORTEX; ALZHEIMERS-DISEASE; FRACTAL DIMENSION; WILLIAMS-SYNDROME; FOLDING PATTERNS; 3-D EXTRACTION; HUMAN BRAIN; MRI DATA; VARIABILITY; THICKNESS	Sulcal depth that is one of the quantitative measures of cerebral cortex has been widely used as an important marker for brain morphological studies. Several studies have employed Euclidean (EUD) or geodesic (GED) algorithms to measure sulcal depth, which have limitations that ignore sulcal geometry in highly convoluted regions and result in under or overestimated depth. In this study, we proposed an automated measurement for sulcal depth on cortical surface reflecting geometrical properties of sulci, which named the adaptive distance transform (ADT). We first defined the volume region of cerebrospinal fluid between the 3D convex hull and the cortical surface, and constructed local coordinates for that restricted region. Dijkstra's algorithm was then used to compute the shortest paths from the convex hull to the vertices of the cortical surface based on the local coordinates, which may be the most proper approach for defining sulcal depth. We applied our algorithm to both a clinical dataset including patients with mild Alzheimer's disease (AD) and 25 normal controls and a simulated dataset whose shape was similar to a single sulcus. The mean sulcal depth in the mild AD group was significantly lower than controls (p = 0.007, normal [mean +/- SD]: 7.29 +/- 0.23 mm, AD: 7.11 +/- 0.29) and the area under the receiver operating characteristic curve was relatively high, showing the value of 0.818. Results from clinical dataset that were consistent with former studies using EUD or GED demonstrated that ADT was sensitive to cortical atrophy. The robustness against inter-individual variability of ADT was highlighted through simulation dataset. ADT showed a low and constant normalized difference between the depth of the simulated data and the calculated depth, whereas EUD and GED had high and variable differences. We suggest that ADT is more robust than EUD or GED and might be a useful alternative algorithm for measuring sulcal depth.	[Yun, Hyuk Jin; Yang, Jin-Ju; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Im, Kiho] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Newborn Med, Boston, MA USA; [Yoon, Uicheul] Catholic Univ Daegu, Coll Hlth & Med Sci, Dept Biomed Engn, Gyongsan, South Korea	Hanyang University; Harvard University; Boston Children's Hospital; Harvard Medical School; Catholic University of Daegu	Lee, JM (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.	ljm@hanyang.ac.kr		Yun, Hyuk Jin/0000-0002-9876-314X	Korea Science and Engineering Foundation (KOSEF) NLRL program grant; Korean Government (MEST) [2011-0028333]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology(MEST) [2011-0014862];  [P50AG05681];  [P01AG03991];  [R01AG021910];  [P50MH071616];  [U24RR021382];  [R01MH56584]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056584, P50MH071616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, R01AG021910, P01AG003991] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation (KOSEF) NLRL program grant(Korea Science and Engineering Foundation); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Korea Science and Engineering Foundation (KOSEF) NLRL program grant funded by the Korean Government (MEST) (2011-0028333) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology(MEST)(2011-0014862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the following grants (P50AG05681, P01AG03991, R01AG021910, P50MH071616, U24RR021382, R01MH56584) for providing OASIS dataset.	Andrews J, 2007, P NATL ACAD SCI USA, V104, P1118, DOI 10.1073/pnas.0609910104; Boucher M, 2009, MED IMAGE ANAL, V13, P203, DOI 10.1016/j.media.2008.09.001; Cachia A, 2003, IEEE T MED IMAGING, V22, P754, DOI 10.1109/TMI.2003.814781; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cykowski MD, 2008, CEREB CORTEX, V18, P1999, DOI 10.1093/cercor/bhm224; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Hasnain MK, 2006, HUM BRAIN MAPP, V27, P277, DOI 10.1002/hbm.20183; Hasnain MK, 2001, CEREB CORTEX, V11, P702, DOI 10.1093/cercor/11.8.702; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Im K, 2006, HUM BRAIN MAPP, V27, P994, DOI 10.1002/hbm.20238; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Im K, 2010, CEREB CORTEX, V20, P602, DOI 10.1093/cercor/bhp127; Kao CY, 2007, IEEE T MED IMAGING, V26, P530, DOI 10.1109/TMI.2006.886810; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Kippenhan JS, 2005, J NEUROSCI, V25, P7840, DOI 10.1523/JNEUROSCI.1722-05.2005; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Le Goualher G, 1999, IEEE T MED IMAGING, V18, P206, DOI 10.1109/42.764891; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lohmann G, 1999, CEREB CORTEX, V9, P754, DOI 10.1093/cercor/9.7.754; Lohmann G, 2008, CEREB CORTEX, V18, P1415, DOI 10.1093/cercor/bhm174; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Rakic P, 2004, SCIENCE, V303, P1983, DOI 10.1126/science.1096414; Regis J, 2005, NEUROL MED-CHIR, V45, P1, DOI 10.2176/nmc.45.1; Rettmann ME, 2006, CEREB CORTEX, V16, P1584, DOI 10.1093/cercor/bhj095; Rettmann ME, 2002, NEUROIMAGE, V15, P329, DOI 10.1006/nimg.2001.0975; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Seong JK, 2010, NEUROIMAGE, V49, P293, DOI 10.1016/j.neuroimage.2009.08.013; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; SMART IHM, 1986, J ANAT, V147, P27; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Turetsky BI, 2009, SCHIZOPHR RES, V115, P8, DOI 10.1016/j.schres.2009.09.005; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439, DOI 10.1007/BFb0046984	40	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e5597	10.1371/journal.pone.0055977	http://dx.doi.org/10.1371/journal.pone.0055977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418488	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300080
J	Atorrasagasti, C; Peixoto, E; Aquino, JB; Kippes, N; Malvicini, M; Alaniz, L; Garcia, M; Piccioni, F; Fiore, EJ; Bayo, J; Bataller, R; Guruceaga, E; Corrales, F; Podhajcer, O; Mazzolini, G				Atorrasagasti, Catalina; Peixoto, Estanislao; Aquino, Jorge B.; Kippes, Nestor; Malvicini, Mariana; Alaniz, Laura; Garcia, Mariana; Piccioni, Flavia; Fiore, Esteban J.; Bayo, Juan; Bataller, Ramon; Guruceaga, Elizabeth; Corrales, Fernando; Podhajcer, Osvaldo; Mazzolini, Guillermo			Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; DNA-REPAIR GENES; HEPATOCELLULAR-CARCINOMA; HEPATOCYTE SURVIVAL; INDUCED CIRRHOSIS; HYALURONIC-ACID; MESANGIAL CELLS; DOWN-REGULATION; NULL MICE	Introduction: Secreted Protein, Acidic and Rich in Cysteine (SPARC) is a matricellular protein involved in many biological processes and found over-expressed in cirrhotic livers. By mean of a genetic approach we herein provide evidence from different in vivo liver disease models suggesting a profibrogenic role for SPARC. Methods: Two in vivo models of liver fibrosis, based on TAA administration and bile duct ligation, were developed on SPARC wild-type (SPARC(+/+)) and knock-out (SPARC(-/-)) mice. Hepatic SPARC expression was analyzed by qPCR. Fibrosis was assessed by Sirius Red staining, and the maturation state of collagen fibers was analyzed using polarized light. Necroinflammatory activity was evaluated by applying the Knodell score and liver inflammatory infiltration was characterized by immunohistochemistry. Hepatic stellate cell activation was assessed by alpha-SMA immunohistochemistry. In addition, pro-fibrogenic genes and inflammatory cytokines were measured by qPCR and/or ELISA. Liver gene expression profile was analyzed in SPARC(-/-) and SPARC(+/+) mice using Affymetrix Mouse Gene ST 1.0 array. Results: SPARC expression was found induced in fibrotic livers of mouse and human. SPARC(-/-) mice showed a reduction in the degree of inflammation, mainly CD4+ cells, and fibrosis. Consistently, collagen deposits and mRNA expression levels were decreased in SPARC(-/-) mice when compared to SPARC+/+ mice; in addition, MMP-2 expression was increased in SPARC(-/-) mice. A reduction in the number of activated myofibroblasts was observed. Moreover, TGF-beta 1 expression levels were down-regulated in the liver as well as in the serum of TAA-treated knock-out animals. Ingenuity Pathway Analysis (IPA) analysis suggested several gene networks which might involve protective mechanisms of SPARC deficiency against liver fibrogenesis and a better established machinery to repair DNA and detoxify from external chemical stimuli. Conclusions: Overall our data suggest that SPARC plays a significant role in liver fibrogenesis. Interventions to inhibit SPARC expression are suggested as promising approaches for liver fibrosis treatment.	[Atorrasagasti, Catalina; Peixoto, Estanislao; Aquino, Jorge B.; Kippes, Nestor; Malvicini, Mariana; Alaniz, Laura; Garcia, Mariana; Piccioni, Flavia; Fiore, Esteban J.; Bayo, Juan; Mazzolini, Guillermo] Austral Univ, Sch Med, Gene Therapy Lab, Buenos Aires, DF, Argentina; [Aquino, Jorge B.; Alaniz, Laura; Garcia, Mariana; Podhajcer, Osvaldo; Mazzolini, Guillermo] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Bataller, Ramon] Univ N Carolina, Dept Med & Nutr, Chapel Hill, NC USA; [Guruceaga, Elizabeth; Corrales, Fernando] Univ Navarra, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain; [Podhajcer, Osvaldo] Fdn Inst Leloir, Gene Therapy Lab, Buenos Aires, DF, Argentina	Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of North Carolina; University of North Carolina Chapel Hill; University of Navarra; Leloir Institute	Mazzolini, G (corresponding author), Austral Univ, Sch Med, Gene Therapy Lab, Buenos Aires, DF, Argentina.	gmazzoli@cas.austral.edu.ar	Alaniz, Laura/AAM-2676-2020; Kippes, Nestor/H-5013-2019; , Ph.D/K-4540-2019; Guruceaga, Elizabeth/B-1796-2008	Alaniz, Laura/0000-0002-6070-6078; Kippes, Nestor/0000-0002-5852-1963; Bayo Fina, Juan Miguel/0000-0003-3999-0841; Guruceaga, Elizabeth/0000-0003-0547-681X; Peixoto, Estanislao/0000-0001-5226-9747; podhajcer, osvaldo/0000-0002-6512-8553; Corrales, Fernando/0000-0002-0231-5159; Bataller, Ramon/0000-0002-1119-7799; Fiore, Esteban/0000-0003-1059-1695; Aquino, Jorge B/0000-0002-3818-5181	Austral University; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2006-1882, PICT-2005-34788, PICT 2007-00736, PICTO-CRUP 2005-31179, PICT 2008-00123]; AECI; FIMA; UTE project CIMA; Ministerio de Ciencia e Innovacion [SAF2011-29312, PIB2010AR-00474]; ISCIII-RETIC [RD06/0020];  [CTE-06]	Austral University; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); AECI; FIMA; UTE project CIMA; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ISCIII-RETIC(Instituto de Salud Carlos III); 	This work was supported by grants from Austral University, Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2006-1882, PICT-2005-34788, PICT 2007-00736, PICTO-CRUP 2005-31179, PICT 2008-00123), CTE-06 and AECI 2008, FIMA and the "UTE project CIMA'', grants Plan Nacional SAF2011-29312 and PIB2010AR-00474 from Ministerio de Ciencia e Innovacion to FJC, and ISCIII-RETIC RD06/0020 to FJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2008, TOXICOL SCI, V104, P261, DOI 10.1093/toxsci/kfn093; Aleksunes LM, 2006, TOXICOL SCI, V89, P370, DOI 10.1093/toxsci/kfi332; Atorrasagasti C, 2011, AM J PHYSL GASTROINT; Atorrasagasti C, 2011, AM J PHYSIOL-GASTR L, V300, pG739, DOI 10.1152/ajpgi.00316.2010; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Benyon RC, 1999, HEPATOLOGY, V30, P977, DOI 10.1002/hep.510300431; Blazejewski S, 1997, AM J PATHOL, V151, P651; Bolstad B, 2005, BIOINFORMATICS COMPU; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Camino AM, 2008, J GENE MED, V10, P993, DOI 10.1002/jgm.1228; Draghici S., 2003, DATA ANAL TOOLS DNA; Dubrovska A, 2005, ONCOGENE, V24, P2289, DOI 10.1038/sj.onc.1208443; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1002/hep.1840210335; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; George J, 2004, INT J BIOCHEM CELL B, V36, P307, DOI 10.1016/S1357-2725(03)00253-X; Goldenberg D, 2002, MOL CARCINOGEN, V33, P113, DOI 10.1002/mc.10027.abs; Grant AJ, 2002, AM J PATHOL, V160, P1445, DOI 10.1016/S0002-9440(10)62570-9; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Haimerl F, 2009, J BIOL CHEM, V284, P495, DOI 10.1074/jbc.M803533200; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kim DJ, 2008, BIOCHEM BIOPH RES CO, V373, P521, DOI 10.1016/j.bbrc.2008.06.071; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lamireau T, 1999, J HEPATOL, V31, P248, DOI 10.1016/S0168-8278(99)80221-9; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Le Bail B, 1999, J PATHOL, V189, P46; Lim YS, 2007, HISTOCHEM CELL BIOL, V127, P149, DOI 10.1007/s00418-006-0233-y; Lu S, 2005, HUM MOL GENET, V14, P3019, DOI 10.1093/hmg/ddi333; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437; Oren R, 1996, HEPATOLOGY, V24, P419; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Piccioni F, 2012, GLYCOBIOLOGY, V22, P400, DOI 10.1093/glycob/cwr158; Qi Z, 1999, P NATL ACAD SCI USA, V96, P2345, DOI 10.1073/pnas.96.5.2345; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rempel SA, 2007, GENES IMMUN, V8, P262, DOI 10.1038/sj.gene.6364388; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Riccio A, 1999, NAT GENET, V23, P266, DOI 10.1038/15443; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Ronen A, 2001, ENVIRON MOL MUTAGEN, V37, P241, DOI 10.1002/em.1033; Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santamaria I, 1999, J BIOL CHEM, V274, P13800, DOI 10.1074/jbc.274.20.13800; Satterwhite DJ, 2000, BIOCHEM BIOPH RES CO, V276, P686, DOI 10.1006/bbrc.2000.3510; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Tang X, 2011, ACTA BIOCH BIOPH SIN, V43, P779, DOI 10.1093/abbs/gmr073; Wang JC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2973; Wang Y, 2000, GENE DEV, V14, P927; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	75	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54962	10.1371/journal.pone.0054962	http://dx.doi.org/10.1371/journal.pone.0054962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408952	Green Published, gold			2022-12-25	WOS:000315100000011
J	Li, M; Yasumura, D; Ma, AAK; Matthes, MT; Yang, HD; Nielson, G; Huang, Y; Szoka, FC; LaVail, MM; Diamond, MI				Li, Mei; Yasumura, Douglas; Ma, Aye Aye K.; Matthes, Michael T.; Yang, Haidong; Nielson, Gregory; Huang, Yong; Szoka, Francis C.; LaVail, Matthew M.; Diamond, Marc I.			Intravitreal Administration of HA-1077, a ROCK Inhibitor, Improves Retinal Function in a Mouse Model of Huntington Disease	PLOS ONE			English	Article							MUTANT HUNTINGTIN; POLYGLUTAMINE AGGREGATION; SUBARACHNOID HEMORRHAGE; FASUDIL HYDROCHLORIDE; ANTIVASOSPASTIC DRUG; STRUCTURAL-ANALYSIS; TRANSGENIC MICE; LIGHT; DEGENERATION; LIPOSOMES	Huntington disease (HD) is an inherited neurodegenerative disease that affects multiple brain regions. It is caused by an expanded polyglutamine tract in huntingtin (Htt). The development of therapies for HD and other neurodegenerative diseases has been hampered by multiple factors, including the lack of clear therapeutic targets, and the cost and complexity of testing lead compounds in vivo. The R6/2 HD mouse model is widely used for pre-clinical trials because of its progressive and robust neural dysfunction, which includes retinal degeneration. Profilin-1 is a Htt binding protein that inhibits Htt aggregation. Its binding to Htt is regulated by the rho-associated kinase (ROCK), which phosphorylates profilin at Ser-137. ROCK is thus a therapeutic target in HD. The ROCK inhibitor Y-27632 reduces Htt toxicity in fly and mouse models. Here we characterized the progressive retinopathy of R6/2 mice between 6-19 weeks of age to determine an optimal treatment window. We then tested a clinically approved ROCK inhibitor, HA-1077, administered intravitreally via liposome-mediated drug delivery. HA-1077 increased photopic and flicker ERG response amplitudes in R6/2 mice, but not in wild-type littermate controls. By targeting ROCK with a new inhibitor, and testing its effects in a novel in vivo model, these results validate the in vivo efficacy of a therapeutic candidate, and establish the feasibility of using the retina as a readout for CNS function in models of neurodegenerative disease.	[Li, Mei; Ma, Aye Aye K.; Diamond, Marc I.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Yasumura, Douglas; Matthes, Michael T.; Yang, Haidong; Nielson, Gregory; LaVail, Matthew M.] Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA; [Huang, Yong] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, UCSF Sch Pharm, San Francisco, CA 94143 USA; [Szoka, Francis C.] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA	Washington University (WUSTL); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	diamondm@neuro.wustl.edu	FRECHET, Jean M/P-1497-2016		National Institutes of Health (NIH) [NS076116, NS50284]; Muscular Dystrophy Association; Cure Huntington's Disease Initiative, Inc.; Sandler Family Supporting Foundation; Taube Family Foundation; NIH [EY001919, EY006842, EY002162]; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY006842, R01EY001919, U01EY006842, P30EY002162, R37EY001919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284, R21NS076116] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Cure Huntington's Disease Initiative, Inc.; Sandler Family Supporting Foundation; Taube Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants NS076116, NS50284 (MID); Muscular Dystrophy Association (mdausa.org) (MID, ML); Cure Huntington's Disease Initiative, Inc. (chdifoundation.org) (MID, MML); Sandler Family Supporting Foundation (MID); the Taube Family Foundation (MID); NIH grants EY001919, EY006842, EY002162 (MML); The Foundation Fighting Blindness (www.blindness.org) (MML) and an Unrestricted Award to UCSF from the Research to Prevent Blindness (MML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleymane G, 2006, HUM MOL GENET, V15, P691, DOI 10.1093/hmg/ddi483; BARZA M, 1987, INVEST OPHTH VIS SCI, V28, P893; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Bauer PO, 2009, AUTOPHAGY, V5, P747, DOI 10.4161/auto.5.5.8704; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Bayer AU, 1999, DOC OPHTHALMOL, V98, P233, DOI 10.1023/A:1002416918247; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hanada Yusei, 2005, J Stroke Cerebrovasc Dis, V14, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.10.006; Helmlinger D, 2004, J NEUROSCI, V24, P1881, DOI 10.1523/JNEUROSCI.4407-03.2004; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Ishida T, 2006, BIOL PHARM BULL, V29, P397, DOI 10.1248/bpb.29.397; Ishida T, 2002, INT J PHARMACEUT, V232, P59, DOI 10.1016/S0378-5173(01)00896-1; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LAVAIL MM, 1993, J COMP NEUROL, V333, P168, DOI 10.1002/cne.903330204; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; LaVail MM, 1997, EXP EYE RES, V65, P45, DOI 10.1006/exer.1997.0308; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masaoka H, 2001, ACT NEUR S, V77, P209; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; MICHON JJ, 1991, INVEST OPHTH VIS SCI, V32, P280; Mocko JA, 2011, INVEST OPHTH VIS SCI, V52, P4223, DOI 10.1167/iovs.10-6750; Nakashima S, 1998, NEUROL MED-CHIR, V38, P805, DOI 10.2176/nmc.38.805; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Paskowitz DM, 2004, INVEST OPHTH VIS SCI, V45, P4190, DOI 10.1167/iovs.04-0676; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TREMBLAY C, 1985, INVEST OPHTH VIS SCI, V26, P711; Yefimova MG, 2010, NEUROBIOL DIS, V40, P311, DOI 10.1016/j.nbd.2010.06.005; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491	42	36	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56026	10.1371/journal.pone.0056026	http://dx.doi.org/10.1371/journal.pone.0056026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409115	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000041
J	Groza, T; Hunter, J; Zankl, A				Groza, Tudor; Hunter, Jane; Zankl, Andreas			Mining Skeletal Phenotype Descriptions from Scientific Literature	PLOS ONE			English	Article							ONTOLOGY; PERFORMANCE; TOOL	Phenotype descriptions are important for our understanding of genetics, as they enable the computation and analysis of a varied range of issues related to the genetic and developmental bases of correlated characters. The literature contains a wealth of such phenotype descriptions, usually reported as free-text entries, similar to typical clinical summaries. In this paper, we focus on creating and making available an annotated corpus of skeletal phenotype descriptions. In addition, we present and evaluate a hybrid Machine Learning approach for mining phenotype descriptions from free text. Our hybrid approach uses an ensemble of four classifiers and experiments with several aggregation techniques. The best scoring technique achieves an F-1 score of 71.52%, which is close to the state-of-the-art in other domains, where training data exists in abundance. Finally, we discuss the influence of the features chosen for the model on the overall performance of the method.	[Groza, Tudor; Hunter, Jane] Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia; [Zankl, Andreas] Univ Queensland, UQCCR, Bone Dysplasia Res Grp, Brisbane, Qld 4072, Australia; [Zankl, Andreas] Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Herston, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital	Groza, T (corresponding author), Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia.	tudor.groza@uq.edu.au	Hunter, Jane/E-5213-2013	Hunter, Jane/0000-0002-7163-4137; Groza, Tudor/0000-0003-2267-8333; Zankl, Andreas/0000-0001-8612-1062	Australian Research Council (ARC) [DE120100508, LP100100156]	Australian Research Council (ARC)(Australian Research Council)	This research has been funded by the Australian Research Council (ARC) under the Discovery Early Career Researcher Award (DECRA) - DE120100508 and the Linkage grant SKELETOME - LP100100156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne A., 2000, TECHNICAL REPORT; Carey JC, 2012, HUM MUTAT, V33, P781, DOI 10.1002/humu.22053; Ciccarese Paolo, 2012, J Biomed Semantics, V3 Suppl 1, pS1, DOI 10.1186/2041-1480-3-S1-S1; Cunningham H., 2011, TEXT PROCESSING GATE; Gkoutos GV, 2009, IEEE ENG MED BIO, P7069, DOI 10.1109/IEMBS.2009.5333362; Groza T, 2011, LECT NOTES COMPUT SC, V7032, P81, DOI 10.1007/978-3-642-25093-4_6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hoehndorf R., 2011, NUCLEIC ACIDS RES, V39, P1; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kudu T., 2000, CONLL, P142; Lafferty J., 2001, P ICML, P282, DOI DOI 10.5555/645530.655813; Lee C., 2004, P JOINT WORKSH NAT L, P80; Li LS, 2012, J BIOMED INFORM, V45, P156, DOI 10.1016/j.jbi.2011.10.004; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; McCallum A. K., 2002, MALLET MACHINE LEARN; Paul Razan, 2012, The Semantic Web. 11th International Semantic Web Conference (ISWC 2012). Proceedings, P164, DOI 10.1007/978-3-642-35173-0_11; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Schofield PN, 2012, HUM MUTAT, V33, P826, DOI 10.1002/humu.22077; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vlachos A, 2007, P 2 BIOCREATIVE CHAL, P85; Wang W. B., 2009, P IEEE INT C BIOINSP, P1, DOI DOI 10.1109/MILCOM.2009.5380133; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Wilbur J., 2007, P 2 BIOCREATIVE CHAL, P7; Yang ZH, 2008, COMPUT BIOL CHEM, V32, P287, DOI 10.1016/j.compbiolchem.2008.03.008	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55656	10.1371/journal.pone.0055656	http://dx.doi.org/10.1371/journal.pone.0055656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409017	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300027
J	Wang, JH; Zhang, J; Xu, L; Shi, YB; Wu, XY; Guo, QH				Wang, Jianhong; Zhang, Jun; Xu, Lan; Shi, Yunbo; Wu, Xunyi; Guo, Qihao			Cognitive Impairments in Hashimoto's Encephalopathy: A Case-Control Study	PLOS ONE			English	Article							SCREENING-TEST; DISEASE; MEMORY	Background/Aims: Hashimoto's encephalopathy is considered as a treatable dementia, but it is often misdiagnosed. We investigated cognitive impairment and the MRI pathology of Hashimoto's encephalopathy patients. Methods: The study comprised eight patients with Hashimoto's encephalopathy, 16 patients with mild Alzheimer's disease and 24 healthy subjects. A neuropsychological battery included assessments of memory, language, attention, executive function and visuospatial ability. Cranial MRI was obtained from all Hashimoto's encephalopathy patients. Results: Hashimoto's encephalopathy and mild Alzheimer's disease showed cognitive impairments in episodic memory, attention, executive function and visuospatial ability, but naming ability was unaffected in Hashimoto's encephalopathy. The MRI of Hashimoto's encephalopathy showed leukoencephalopathy-like type or limbic encephalitis-like type; the lesions did not affect the temporal cortex which plays a role in naming ability. Conclusion: Except that the naming ability was retained, the impairments in cognitive functions for the Hashimoto's encephalopathy patients were similar to those of Alzheimer's disease patients. These results were consistent with the MRI findings.	[Wang, Jianhong; Xu, Lan; Shi, Yunbo; Wu, Xunyi; Guo, Qihao] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Huashan Hosp,Dept Neurol, Shanghai 200433, Peoples R China; [Zhang, Jun] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wu, XY (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Huashan Hosp,Dept Neurol, Shanghai 200433, Peoples R China.	dr.xunyiwu@hotmail.com; dr.guoqihao@126.com	wang, jian/GVS-0711-2022	zhang, jun/0000-0003-1849-9199	National Natural Science Foundation of China [81100964, 81201071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81100964, 81201071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; BRAIN L, 1966, LANCET, V2, P512; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Canelo-Aybar Carlos, 2010, J Med Case Rep, V4, P337, DOI 10.1186/1752-1947-4-337; Chang T, 2010, NEUROLOGIST, V16, P394, DOI 10.1097/NRL.0b013e3181d6b6f6; Cummings RR, 2007, GEN HOSP PSYCHIAT, V29, P267, DOI 10.1016/j.genhosppsych.2007.01.003; de Holanda NCP, 2011, J NEUROPSYCH CLIN N, V23, P384, DOI 10.1176/jnp.23.4.jnp384; Fukunaga Mami, 2006, Rinsho Shinkeigaku, V46, P568; Guo Q.H., 2005, CHINESE J NEUROMEDIC, V4, P701, DOI DOI 10.3760/CMA.J.ISSN.1671-8925.2005.07-17; [郭起浩 GUO Qi-hao], 2009, [中华神经科杂志, Chinese Journal of Neurology], V42, P314; Guo QH, 2010, NEUROSCI BULL, V26, P47, DOI 10.1007/s12264-010-0816-4; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; [郭起浩 GUO Qihao], 2008, [中华神经科杂志, Chinese Journal of Neurology], V41, P234; [郭起浩 GUO QiHao], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P622; [郭起浩 GUO Qihao], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P132; [郭起浩 GUO QiHao], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P81; Harzheim M, 2006, NEUROL INDIA, V54, P301, DOI 10.4103/0028-3886.27160; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P562; Livner A, 2009, J NEUROL SCI, V283, P235, DOI 10.1016/j.jns.2009.02.377; Lu JC, 2006, CHIN J CLIN PSYCHOL, V14, P118; Mazzu I, 2012, NEUROL SCI, V33, P653, DOI 10.1007/s10072-011-0813-z; Mijajovic M, 2010, J NEUROL SCI, V288, P194, DOI 10.1016/j.jns.2009.09.030; Mocellin R, 2007, CNS DRUGS, V21, P799, DOI 10.2165/00023210-200721100-00002; Okamoto Kensho, 2007, Rinsho Shinkeigaku, V47, P112; Peschen-Rosin R, 1999, EUR NEUROL, V41, P79, DOI 10.1159/000008007; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; Schiess N, 2008, ANN NY ACAD SCI, V1142, P254, DOI 10.1196/annals.1444.018; SHAW PJ, 1991, NEUROLOGY, V41, P228, DOI 10.1212/WNL.41.2_Part_1.228; Shindo Akihiro, 2007, Rinsho Shinkeigaku, V47, P629; Strauss E., 2006, COMPENDIUM NEUROPSYC, P617; Tamagno G, 2006, INTERN EMERG MED, V1, P15, DOI 10.1007/BF02934715; Wakai Masakazu, 2004, Rinsho Shinkeigaku, V44, P432; Wang JH, 2011, DEMENT GERIATR COGN, V31, P284, DOI 10.1159/000326908; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zhao QH, 2007, CHIN J CLIN PSYCHOL, V3, P241	36	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55758	10.1371/journal.pone.0055758	http://dx.doi.org/10.1371/journal.pone.0055758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409036	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300032
J	Tain, YL; Lee, WC; Hsu, CN; Lee, WC; Huang, LT; Lee, CT; Lin, CY				Tain, You-Lin; Lee, Wen-Chin; Hsu, Chien-Ning; Lee, Wei-Chia; Huang, Li-Tung; Lee, Chien-Te; Lin, Ching-Yuang			Asymmetric Dimethylarginine Is Associated with Developmental Programming of Adult Kidney Disease and Hypertension in Offspring of Streptozotocin-Treated Mothers	PLOS ONE			English	Article							NITRIC-OXIDE; DIABETES-MELLITUS; L-ARGININE; MATERNAL NUTRITION; BLOOD-PRESSURE; DIMETHYLAMINOHYDROLASE; ADMA; RATS; NEPHROPATHY; PATHWAY	Diabetes mellitus complicates pregnancies, leading to diseases in adult life in the offspring. Asymmetric dimethylarginine (ADMA) is increased in diabetes mellitus, kidney disease, and hypertension. We tested whether maternal diabetes causes increased ADMA in rats, resulting in kidney disease and hypertension in the adult offspring, and whether these can be prevented by maternal citrulline supplementation. Newborn female and pregnant Sprague-Dawley rats were injected with streptozotocin (STZ), which made up the nSTZ and STZ models, respectively. For the STZ model, 4 groups of male offspring were killed at age 3 months: the control, STZ, and Cit and STZ+Cit (control and STZ rats treated with 0.25% L-citrulline solution, respectively) groups. The nSTZ rats had lower nephron numbers. The renal level of ADMA was higher in the nSTZ rats than in controls. The STZ group developed kidney injury, renal hypertrophy, and elevated blood pressure at the age of 12 weeks. These conditions were found to be associated with increased ADMA levels, decreased nitric oxide (NO) production, and decreased dimethylarginine dimethylaminohydrolase (DDAH) activity in the kidney. In addition, ADMA caused a nephron deficit in cultured rat metanephroi. Maternal citrulline supplementation prevented hypertension and kidney injury, increased the renal DDAH-2 protein level, and restored the levels of ADMA and NO in the STZ+Cit group. Reduced nephron number and increased ADMA contribute to adult kidney disease and hypertension in offspring of mothers with STZ-induced diabetes. Manipulation of the ADMA-NO pathway by citrulline supplementation may be a potential approach to prevent these conditions.	[Tain, You-Lin; Huang, Li-Tung] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lee, Wen-Chin; Lee, Chien-Te] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Nephrol, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Med Univ, Coll Pharm, Grad Inst Clin Pharm, Kaohsiung, Taiwan; [Lee, Wei-Chia] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Devis Urol, Kaohsiung, Taiwan; [Lin, Ching-Yuang] China Med Univ, Coll Med, Clin Immunol Ctr, Taichung, Taiwan; [Lin, Ching-Yuang] China Med Univ Hosp, Div Pediat Nephrol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tain, YL (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	tainyl@hotmail.com	Tain, You-Lin/H-2827-2019; Hsu, Chien-Ning/GLS-4014-2022; LEE, Wen-Chin/AAQ-8466-2021	Tain, You-Lin/0000-0002-7059-6407; Hsu, Chien-Ning/0000-0001-7470-528X; LEE, Wen-Chin/0000-0001-6172-1483; Lee, Wei-Chia/0000-0003-0701-2285	National Science Council, Taiwan [NSC 98-2314-B-182A-006-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPG8B0171]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grant NSC 98-2314-B-182A-006-MY3 from National Science Council, Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7) and grant CMRPG8B0171 from Chang Gung Memorial Hospital, Taiwan (http://www.cgmh.org.tw/eng2002/about01.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; Bagby SP, 2007, J NUTR, V137, P1066, DOI 10.1093/jn/137.4.1066; Baylis C, 2006, NAT CLIN PRACT NEPHR, V2, P209, DOI 10.1038/ncpneph0143; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Cavanal MD, 2007, PEDIATR RES, V62, P145; Chen YH, 2009, EXP EYE RES, V89, P1028, DOI 10.1016/j.exer.2009.09.004; Hanai K, 2009, NEPHROL DIAL TRANSPL, V24, P1884, DOI 10.1093/ndt/gfn716; Huemer M, 2011, J PEDIATR-US, V158, P602, DOI 10.1016/j.jpeds.2010.09.058; Lee JH, 2011, DIABETES RES CLIN PR, V94, P111, DOI 10.1016/j.diabres.2011.07.005; Lee WC, 2007, BIOESSAYS, V29, P205, DOI 10.1002/bies.20541; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lu CW, 2010, ATHEROSCLEROSIS, V209, P66, DOI 10.1016/j.atherosclerosis.2009.08.035; Malecki MT, 2007, DIABETES CARE, V30, P2899, DOI 10.2337/dc07-1138; Mihout F, 2011, J PATHOL, V223, P37, DOI 10.1002/path.2769; Mittermayer F, 2002, DIABETOLOGIA, V45, P1372, DOI 10.1070/s00125-002-0916-4; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Nelson RG, 1998, AM J EPIDEMIOL, V148, P650, DOI 10.1093/aje/148.7.650; Romero MJ, 2006, CARDIOVASC DRUG REV, V24, P275, DOI 10.1111/j.1527-3466.2006.00275.x; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Tain YL, 2007, KIDNEY INT, V72, P886, DOI 10.1038/sj.ki.5002446; Tain YL, 2012, FREE RADICAL RES, V46, P68, DOI 10.3109/10715762.2011.639069; Tain YL, 2010, J PINEAL RES, V49, P390, DOI 10.1111/j.1600-079X.2010.00806.x; Tain YL, 2010, FREE RADICAL BIO MED, V49, P1088, DOI 10.1016/j.freeradbiomed.2010.06.029; Tain YL, 2010, NITRIC OXIDE-BIOL CH, V23, P34, DOI 10.1016/j.niox.2010.03.005; Tain YL, 2010, J PINEAL RES, V48, P212, DOI 10.1111/j.1600-079X.2010.00745.x; Tarnow L, 2004, DIABETES CARE, V27, P765, DOI 10.2337/diacare.27.3.765; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Tran S, 2008, J AM SOC NEPHROL, V19, P943, DOI 10.1681/ASN.2007080864; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Wichi RB, 2005, AM J PHYSIOL-REG I, V288, pR1129, DOI 10.1152/ajpregu.00366.2004; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P2613, DOI 10.2174/138161208786071326	35	60	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55420	10.1371/journal.pone.0055420	http://dx.doi.org/10.1371/journal.pone.0055420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408977	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200030
J	Zierler, KA; Jaeger, D; Pollak, NM; Eder, S; Rechberger, GN; Radner, FPW; Woelkart, G; Kolb, D; Schmidt, A; Kumari, M; Preiss-Landl, K; Pieske, B; Mayer, B; Zimmermann, R; Lass, A; Zechner, R; Haemmerle, G				Zierler, Kathrin A.; Jaeger, Doris; Pollak, Nina M.; Eder, Sandra; Rechberger, Gerald N.; Radner, Franz P. W.; Woelkart, Gerald; Kolb, Dagmar; Schmidt, Albrecht; Kumari, Manju; Preiss-Landl, Karina; Pieske, Burkert; Mayer, Bernd; Zimmermann, Robert; Lass, Achim; Zechner, Rudolf; Haemmerle, Guenter			Functional Cardiac Lipolysis in Mice Critically Depends on Comparative Gene Identification-58	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; LIPID STORAGE DISEASE; CELLULAR FAT STORES; ENERGY-METABOLISM; SKELETAL-MUSCLE; LYSOPHOSPHATIDIC ACID; INSULIN SENSITIVITY; PPAR-ALPHA; CGI-58	Efficient catabolism of cellular triacylglycerol (TG) stores requires the TG hydrolytic activity of adipose triglyceride lipase (ATGL). The presence of comparative gene identification-58 (CGI-58) strongly increased ATGL-mediated TG catabolism in cell culture experiments. Mutations in the genes coding for ATGL or CGI-58 in humans cause neutral lipid storage disease characterized by TG accumulation in multiple tissues. ATGL gene mutations cause a severe phenotype especially in cardiac muscle leading to cardiomyopathy that can be lethal. In contrast, CGI-58 gene mutations provoke severe ichthyosis and hepatosteatosis in humans and mice, whereas the role of CGI-58 in muscle energy metabolism is less understood. Here we show that mice lacking CGI-58 exclusively in muscle (CGI-58KOM) developed severe cardiac steatosis and cardiomyopathy linked to impaired TG catabolism and mitochondrial fatty acid oxidation. The marked increase in ATGL protein levels in cardiac muscle of CGI-58KOM mice was unable to compensate the lack of CGI-58. The addition of recombinant CGI-58 to cardiac lysates of CGI-58KOM mice completely reconstituted TG hydrolytic activities. In skeletal muscle, the lack of CGI-58 similarly provoked TG accumulation. The addition of recombinant CGI-58 increased TG hydrolytic activities in control and CGI-58KOM tissue lysates, elucidating the limiting role of CGI-58 in skeletal muscle TG catabolism. Finally, muscle CGI-58 deficiency affected whole body energy homeostasis, which is caused by impaired muscle TG catabolism and increased cardiac glucose uptake. In summary, this study demonstrates that functional muscle lipolysis depends on both CGI-58 and ATGL.	[Zierler, Kathrin A.; Jaeger, Doris; Pollak, Nina M.; Eder, Sandra; Rechberger, Gerald N.; Radner, Franz P. W.; Kumari, Manju; Preiss-Landl, Karina; Zimmermann, Robert; Lass, Achim; Zechner, Rudolf; Haemmerle, Guenter] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Woelkart, Gerald; Mayer, Bernd] Graz Univ, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Med Res Ctr, A-8036 Graz, Austria; [Schmidt, Albrecht; Pieske, Burkert] Med Univ Graz, Dept Cardiol, Dept Internal Med, A-8036 Graz, Austria	University of Graz; University of Graz; Medical University of Graz; Medical University of Graz	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.	guenter.haemmerle@uni-graz.at	Lass, Achim/C-3332-2008; Pollak, Nina M./L-3308-2018; Pieske, Burkert/M-8089-2016	Lass, Achim/0000-0002-8190-7151; Pollak, Nina M./0000-0001-8437-3303; Zechner, Rudolf/0000-0001-5483-1182; Radner, Franz/0000-0003-3466-0181; Schmidt, Albrecht/0000-0003-4783-4603; Pieske, Burkert/0000-0002-6466-5306; Mayer, Bernd/0000-0002-2921-3494; Woelkart, Gerald/0000-0003-2552-1999; Kumari, Meena/0000-0001-9716-1035; Zimmermann, Robert/0000-0002-7354-870X; Rechberger, Gerald N./0000-0002-0071-317X; Haemmerle, Guenter/0000-0001-9900-5896	Austrian Ministry for Science and Research; Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P20602-B05, DK-MCD W1226, SFB LIPOTOX F30-B05]; Austrian Science Fund (FWF) [Z 136, P 24005, P 20602, F 3002, W 901] Funding Source: researchfish	Austrian Ministry for Science and Research; Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Ministry for Science and Research and Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung (FWF)) Project Grants P20602-B05, DK-MCD W1226, and SFB LIPOTOX F30-B05.	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Badin PM, 2012, J LIPID RES, V53, P839, DOI 10.1194/jlr.M019182; Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Bieber L L, 1981, Methods Enzymol, V71 Pt C, P351; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Moro C, 2008, AM J PHYSIOL-ENDOC M, V294, pE203, DOI 10.1152/ajpendo.00624.2007; Nunes PM, 2012, AM J PHYSIOL-ENDOC M, V303, pE71, DOI 10.1152/ajpendo.00597.2011; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; RANDLE PJ, 1963, LANCET, V1, P785; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Song QJ, 2003, J CLIN INVEST, V111, P859, DOI 10.1172/JCI200316738; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	42	59	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9892	9904		10.1074/jbc.M112.420620	http://dx.doi.org/10.1074/jbc.M112.420620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413028	Green Published, hybrid			2022-12-25	WOS:000317114000029
J	Nguyen, HV; Giang, TT				Huy Van Nguyen; Thao Thach Giang			Gender Difference in Academic Planning Activity among Medical Students	PLOS ONE			English	Article							MASS-MEDIA; PHILIPPINES; EDUCATION	Background: In Vietnam, as doctor of medicine is socially considered a special career, both men and women who are enrolled in medical universities often study topics of medicine seriously. However, as culturally expected, women often perform better than men. Because of this, teaching leadership and management skill (LMS) to develop academic planning activity (APA) for female medical students would also be expected to be more effective than male counterparts. This research aimed to compare by gender the effect of teaching LMS on increasing APA, using propensity score matching (PSM). Methods: In a cross-sectional survey utilizing a self-reported structured questionnaire on a systematic random sample of 421 male and female medical students in Hanoi Medical University, this study adopted first regression techniques to construct a fit model, then PSM to create a matched control group in order to allow for evaluating the effect of LMS education. Results: There were several interesting gender differences. First, while for females LMS education had both direct and indirect effects on APA, it had only direct effect on males' APA. Second, after PSM to adjust for the possible confounders to balance statistically two groups - with and without LMS education, there is statistically a significant difference in APA between male and female students, making a net difference of 11% (p<.01), equivalent to 173 students. The difference in APA between exposed and matched control group in males and females was 9% and 20%, respectively. These estimates of 9.0 and 20.0 percentage point increase can be translated into the practice of APA by 142 males and 315 females, respectively, in the population. These numbers of APA among male and female students can be explained by LMS education. Conclusions: Gender appears to be a factor explaining in part academic planning activity.	[Huy Van Nguyen] Hanoi Med Univ, Dept Hlth Org & Management, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Thao Thach Giang] Vietnam Natl Hosp Pediat, Hanoi, Vietnam	Hanoi Medical University	Nguyen, HV (corresponding author), Hanoi Med Univ, Dept Hlth Org & Management, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.	nvanhuy@yahoo.com	Nguyen, Huy/AAF-9560-2019; Nguyen, Huy/GWQ-6433-2022	Nguyen, Huy/0000-0002-5896-9661; 	Department of Undergraduate Training from Hanoi Medical University	Department of Undergraduate Training from Hanoi Medical University	This work was undertaken with the support provided by the Department of Undergraduate Training from Hanoi Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth D., 2012, BOYS LITERACY ATTAIN; Dayioglu M, 2004, GENDER DIFFERENCES A; Eccles JS, 2004, GENDER ACAD PERFORMA; Fortin N. M., 2012, LEAVING BOYS GENDER; Gibb SJ, 2008, AUST J EDUC, V52, P63, DOI 10.1177/000494410805200105; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Keeves JP, 2005, MULTILEVEL MULTIVARI; Keeves JP, 2004, INTRO STAT DATA PROC; Kennedy P., 1996, GUIDE ECONOMETRICS; Kincaid DL, 2006, J HEALTH COMMUN, V11, P69, DOI 10.1080/10810730600974522; Kincaid DL, 2000, COMMUN RES, V27, P723, DOI 10.1177/009365000027006003; Kincaid DL, 2008, ADV RES METHODS EVAL; Kincaid DL, 2009, DATA ANAL USING LOGI; Kincaid DL, 2006, IMPACT AIDS COMMUNIC; Lietz P, 1993, MEDIATED GENDER DIFF; Livaditis M., 2003, ED PSYCHOL, V23, P223; Morgan PL, 2010, J SPEC EDUC, V43, P236, DOI 10.1177/0022466908323007; National Center for Education Statistics, 2007, COND ED 2007; Phinney HM, 2008, AM J PUBLIC HEALTH, V98, P650, DOI 10.2105/AJPH.2007.111534; ROSENBAUM PR, 1986, J EDUC STAT, V11, P207; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schneider Barbara, 2007, ESTIMATING CAUSAL EF; Warrington M, 2000, BRIT EDUC RES J, V26, P393, DOI 10.1080/01411920050030914; Weaver-Hightower M, 2003, REV EDUC RES, V73, P471, DOI 10.3102/00346543073004471; Zembar M. J., 2009, MIDDLE CHILDHOOD DEV, P212	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55845	10.1371/journal.pone.0055845	http://dx.doi.org/10.1371/journal.pone.0055845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418467	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300058
J	Kock, R; Schaumburg, F; Mellmann, A; Koksal, M; Jurke, A; Becker, K; Friedrich, AW				Koeck, Robin; Schaumburg, Frieder; Mellmann, Alexander; Koeksal, Mahir; Jurke, Annette; Becker, Karsten; Friedrich, Alexander W.			Livestock-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) as Causes of Human Infection and Colonization in Germany	PLOS ONE			English	Article							NASAL COLONIZATION; PREVALENCE; PIGS; ORIGIN; ST398; EMERGENCE; CARRIAGE; DENSITY; CC398; MILK	Pigs, cattle and poultry are colonized with MRSA and the zoonotic transmission of such MRSA to humans via direct animal contact, environmental contaminations or meat are a matter of concern. Livestock-associated (LA) MRSA are mostly belonging to clonal complex (CC) 398 as defined by multilocus sequence typing. However, MRSA of other clonal lineages including CC5, CC9 and CC97 have also been detected in livestock animals in Germany. Within the framework of a Dutch-German network project (EUREGIO), 14,036 MRSA isolated from clinical and screening specimens (January 2008 - June 2012) derived from human patients in hospitals as well as general or specialized practices in a German region characterized by a high density of livestock production, were subjected to S. aureus protein A (spa) sequence typing. The prevalence of putative LA-MRSA among the human MRSA isolates was determined by analyzing the detection of livestock-indicator (LI) spa types which had already been reported in German livestock. Overall, 578 spa types were detected among the MRSA isolates. LI spa types t011, t034, t108, t1451, t2011, t571, t1456, t1250, t1255, t1580, t2970, t2346, t1344, t2576, t2330 and t2510 (all of which are indicative for LA-MRSA CC398) accounted for 18.6% of all human isolates. The LI spa types t1430 (CC9), t3992 (CC97), t002 (CC5) and t007 (CC30) were found in 0.14%, 0.01%, 1.01% and 0.04% of all human MRSA isolates, respectively. LI spa types associated with CC398 represented 23% of all MRSA from screening samples and a varying proportion among isolates from clinical specimens ranging between 0% in cerebrospinal fluid, 8% in blood cultures and 14% in deep respiratory fluids. Our findings indicate that LA-MRSA are a major cause for human infection and stress the need for close surveillance. Although LA-MRSA CC398 predominates, the occurrence of putative LA-MRSA from other clonal lineages should be monitored.	[Koeck, Robin; Mellmann, Alexander] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Schaumburg, Frieder; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Koeksal, Mahir; Friedrich, Alexander W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Jurke, Annette] North Rhine Westphalian Ctr Hlth, Dept Infectiol & Hyg, Munster, Germany	University of Munster; University of Munster; University of Groningen	Kock, R (corresponding author), Univ Hosp Munster, Inst Hyg, Munster, Germany.	robin.koeck@ukmuenster.de	Köck, Robin/AAC-1552-2019; Schaumburg, Frieder/E-4464-2016; Becker, Karsten/O-2302-2018; Friedrich, Alex/ABG-9823-2020	Becker, Karsten/0000-0002-6391-1341; Mellmann, Alexander/0000-0002-0649-5185	German Ministry for Education and Research [MedVet-Staph 01KI1014A]; German Ministry of Health (MRE network Northwest); INTERREG IVa program of the European Union [EurSafety Health-net A-II-2-05 = 025]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Health (MRE network Northwest); INTERREG IVa program of the European Union	This study has been supported by grants to RK, AWF and KB from the German Ministry for Education and Research (MedVet-Staph 01KI1014A), from the German Ministry of Health (MRE network Northwest) and from the INTERREG IVa program of the European Union (EurSafety Health-net A-II-2-05 = 025). The study was done in close collaboration with the ESCMID Study Group of Epidemiological Markers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Boye K, 2011, FEMS MICROBIOL LETT, V314, P101, DOI 10.1111/j.1574-6968.2010.02151.x; Bundesinstitut fur Risikobewertung, 2012, DTSCH ANT RES LEB DA; Bundesinstitut fur Risikobewertung, 2009, MENSCH KONN SICH KON; Bundesinstitut fur Risikobewertung, 2011, ERR ZOON DEUTSCHL JA; Bundesinstitut fur Risikobewertung, 2009, ZOON LEB BFR S 2 3 N; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; European Centre for Disease Prevention and Control European Food Safety Agency European Medicines Agency, 2009, EFSAQ200900612 EUR C; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Kock R, 2010, EURO SURVEILL, V15; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Kreausukon K, 2012, J DAIRY SCI, V95, P4382, DOI 10.3168/jds.2011-5198; Landwirtschaftskammer Nordrhein-Westfalen, 2008, ZAHL LANDW NORDRH WE; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; Meemken D, 2010, ZOONOSES PUBLIC HLTH, V57, pE143, DOI 10.1111/j.1863-2378.2009.01313.x; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Richter A, 2012, EPIDEMIOL INFECT, V10, P1; Robert Koch Institut, 2011, EPIDEMIOLOGISCHES B, V26, P233; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Spohr M, 2011, ZOONOSES PUBLIC HLTH, V58, P252, DOI 10.1111/j.1863-2378.2010.01344.x; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Tenhagen BA, 2009, VET REC, V165, P589, DOI 10.1136/vr.165.20.589; van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Verkade E, 2012, INFECT CONT HOSP EP, V33, P624, DOI 10.1086/665726; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Wulf MW, 2008, EURO SURVEILL, V13	46	171	174	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55040	10.1371/journal.pone.0055040	http://dx.doi.org/10.1371/journal.pone.0055040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418434	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300024
J	Luque-Fernandez, MA; Van Cutsem, G; Goemaere, E; Hilderbrand, K; Schomaker, M; Mantangana, N; Mathee, S; Dubula, V; Ford, N; Hernan, MA; Boulle, A				Luque-Fernandez, Miguel Angel; Van Cutsem, Gilles; Goemaere, Eric; Hilderbrand, Katherine; Schomaker, Michael; Mantangana, Nompumelelo; Mathee, Shaheed; Dubula, Vuyiseka; Ford, Nathan; Hernan, Miguel A.; Boulle, Andrew			Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa	PLOS ONE			English	Article							TREATMENT PROGRAM; HIV TREATMENT; HEALTH-CARE; OUTCOMES; ZIDOVUDINE; EXPERIENCE; RATES	Background: Innovative models of care are required to cope with the ever-increasing number of patients on antiretroviral therapy in the most affected countries. This study, in Khayelitsha, South Africa, evaluates the effectiveness of a group-based model of care run predominantly by non-clinical staff in retaining patients in care and maintaining adherence. Methods and Findings: Participation in "adherence clubs'' was offered to adults who had been on ART for at least 18 months, had a current CD4 count > 200 cells/ml and were virologically suppressed. Embedded in an ongoing cohort study, we compared loss to care and virologic rebound in patients receiving the intervention with patients attending routine nurse-led care from November 2007 to February 2011. We used inverse probability weighting to estimate the intention-to-treat effect of adherence club participation, adjusted for measured baseline and time-varying confounders. The principal outcome was the combination of death or loss to follow-up. The secondary outcome was virologic rebound in patients who were virologically suppressed at study entry. Of 2829 patients on ART for > 18 months with a CD4 count above 200 cells/mu l, 502 accepted club participation. At the end of the study, 97% of club patients remained in care compared with 85% of other patients. In adjusted analyses club participation reduced loss-to-care by 57% (hazard ratio [HR] 0.43, 95% CI = 0.21-0.91) and virologic rebound in patients who were initially suppressed by 67% (HR 0.33, 95% CI = 0.16-0.67). Discussion: Patient adherence groups were found to be an effective model for improving retention and documented virologic suppression for stable patients in long term ART care. Out-of-clinic group-based models facilitated by non-clinical staff are a promising approach to assist in the long-term management of people on ART in high burden low or middle-income settings.	[Luque-Fernandez, Miguel Angel; Van Cutsem, Gilles; Goemaere, Eric; Hilderbrand, Katherine; Schomaker, Michael; Ford, Nathan; Boulle, Andrew] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Van Cutsem, Gilles; Goemaere, Eric; Hilderbrand, Katherine] Medecins Sans Frontieres, Cape Town, South Africa; [Mantangana, Nompumelelo; Mathee, Shaheed] Prov Govt Western Cape, Dept Hlth, Khayelitsha Community Hlth Ctr, Cape Town, South Africa; [Dubula, Vuyiseka] Treatment Act Campaign, Cape Town, South Africa; [Ford, Nathan] Medecins Sans Frontieres, Geneva, Switzerland; [Hernan, Miguel A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA	University of Cape Town; Doctors Without Borders; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Luque-Fernandez, MA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	miguel.luquefernandez@uct.ac.za	Van Cutsem, Gilles/ABB-1171-2021; Boulle, Andrew/C-1413-2008; FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; Schomaker, Michael/K-3840-2019; Dubula-Majola, Vuyiseka/AAV-2562-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015	Van Cutsem, Gilles/0000-0002-8972-4480; Boulle, Andrew/0000-0002-7713-8062; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Schomaker, Michael/0000-0002-8475-0591; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Hernan, Miguel/0000-0003-1619-8456; Dubula-Majola, Vuyiseka/0000-0003-0559-5974	University of Cape Town [LQFMIG001]; National Institute of Allergy and Infectious Diseases [U01AI069924-01]; NIH [R01 AI102634]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102634, U01AI069924] Funding Source: NIH RePORTER	University of Cape Town; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MALF was supported by the University of Cape Town with a postdoctoral fellowship (LQFMIG001). AB was partially supported by the National Institute of Allergy and Infectious Diseases (U01AI069924-01). MAH was partly funded by NIH grant R01 AI102634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Decroo T, 2010, J ACQ IMMUN DEF SYND; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Ford N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001060; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2002, STAT MED, V21, P1689, DOI 10.1002/sim.1144; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; [National Department of Health SA Health Do], 2008, S AFR ANT TREATM GUI; National Department of Health SA, 2010, S AFR ANT TREATM GUI; Organization WH, 2011, WORLD HLTH STAT; ROSENBERG PS, 1995, BIOMETRICS, V51, P874, DOI 10.2307/2532989; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629; Zachariah R, 2010, T ROY SOC TROP MED H, V104, P387, DOI 10.1016/j.trstmh.2010.01.004	30	150	152	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56088	10.1371/journal.pone.0056088	http://dx.doi.org/10.1371/journal.pone.0056088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418518	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000315970300110
J	Amaral, J; Lee, JW; Chou, J; Campos, MM; Rodriguez, IR				Amaral, Juan; Lee, Jung Wha; Chou, Joshua; Campos, Maria M.; Rodriguez, Ignacio R.			7-Ketocholesterol Induces Inflammation and Angiogenesis In Vivo: A Novel Rat Model	PLOS ONE			English	Article							EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; LOW-DENSITY-LIPOPROTEIN; MACULAR DEGENERATION; CELLS; OXYSTEROLS; VEGF; CHOLESTEROL; MACROPHAGES; OXIDATION; MEMBRANE	Accumulation of 7-Ketocholesterol (7KCh) in lipid deposits has been implicated in a variety of chronic diseases including atherosclerosis, Alzheimer's disease and age-related macular degeneration. 7KCh is known to be pro-inflammatory and cytotoxic to various types of cultured cells but little is known about its effects in vivo. In this study we have investigated the effects of 7KCh in vivo by implanting biodegradable wafers into the anterior chamber of the rat eye. The wafers were prepared using a mixture of two biodegradable polymers with different amounts of 7KCh. The 7KCh-containing implants induced massive angiogenesis and inflammation. By contrast, no angiogenesis and very little inflammation were observed with cholesterol-containing implants. The neovessel growth was monitored by fluorescein angiography. Neovessels were observed 4 days post implantation and peaked between 7 to 10 days. The angiography and isolectin IB4 labeling demonstrated that the neovessels originated from the limbus and grew through the cornea. Immunolabeling with anti-CD68 suggested that the 7KCh-containing implants had extensive macrophage infiltration as well as other cell types. A significant increase in VEGF was also observed in 7KCh-containing implants by fluorescent immunolabeling and by immunoblot of the aqueous humor (AH). Direct measurement of VEGF, IL-1 beta and GRO/KC demonstrated a marked elevation of these factors in the AH of the 7KCh-implants. In summary this study demonstrates two important things: 1) 7KCh is pro-angiogenic and pro-inflammatory in vivo and 2) implants containing 7KCh may be used to create a novel angiogenesis model in rats.	[Amaral, Juan; Lee, Jung Wha; Chou, Joshua; Rodriguez, Ignacio R.] NEI, Mech Retinal Dis Sect, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Campos, Maria M.] NEI, Biol Imaging Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Rodriguez, IR (corresponding author), NEI, Mech Retinal Dis Sect, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA.	rodriguezi@nei.nih.gov		Amaral, Juan/0000-0001-8755-9170	National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000307] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute intramural research program (IRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1996, J LIPID RES, V37, P320; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Busch TP, 2010, J AM OIL CHEM SOC, V87, P955, DOI 10.1007/s11746-010-1572-3; Campa C, 2011, CURR DRUG TARGETS, V12, P173, DOI 10.2174/138945011794182674; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; DOBI ET, 1989, ARCH OPHTHALMOL-CHIC, V107, P264, DOI 10.1001/archopht.1989.01070010270035; Dugas B, 2010, EUR J NUTR, V49, P435, DOI 10.1007/s00394-010-0102-2; Haghnegahdar H, 2000, J LEUKOCYTE BIOL, V67, P53, DOI 10.1002/jlb.67.1.53; Huang JD, 2012, BBA-MOL CELL BIOL L, V1821, P637, DOI 10.1016/j.bbalip.2012.01.013; Larrayoz IM, 2010, INVEST OPHTH VIS SCI, V51, P4942, DOI 10.1167/iovs.09-4854; Lee WH, 2009, Z NATURFORSCH C, V64, P307; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Ohtsuka M, 2006, J ATHEROSCLER THROMB, V13, P256, DOI 10.5551/jat.13.256; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; PYLE R, 1962, BRIT J RADIOL, V35, P554, DOI 10.1259/0007-1285-35-416-554; Rodriguez IR, 2010, J LIPID RES, V51, P2847, DOI 10.1194/jlr.R004820; Rodriguez IR, 2004, INVEST OPHTH VIS SCI, V45, P2830, DOI 10.1167/iovs.04-0075; Smith LL, 1996, LIPIDS, V31, P453, DOI 10.1007/BF02522641; Spaide RF, 1999, RETINA-J RET VIT DIS, V19, P141, DOI 10.1097/00006982-199902000-00010; Tang ZS, 2011, JOVE-J VIS EXP, DOI 10.3791/3077; van Reyk DM, 2006, REDOX REP, V11, P255, DOI 10.1179/135100006X155003	25	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56099	10.1371/journal.pone.0056099	http://dx.doi.org/10.1371/journal.pone.0056099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409131	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300058
J	Balog, A; Schmitz, OJ				Balog, Adalbert; Schmitz, Oswald J.			Predation Determines Different Selective Pressure on Pea Aphid Host Races in a Complex Agricultural Mosaic	PLOS ONE			English	Article							APPARENT COMPETITION; POPULATION DIFFERENTIATION; ECOLOGICAL SPECIALIZATION; REPRODUCTIVE ISOLATION; PHENOTYPIC PLASTICITY; SYMPATRIC SPECIATION; GENETIC-VARIATION; PLANT; BEHAVIOR; DIVERGENCE	Field assessments were conducted to examine the interplay between host plant and predation in complex agricultural mosaic on pea aphid clover and alfalfa races. In one experiment, we examined the relative fitness on clover race (CR) and alfalfa race (AR) pea aphids on broad bean, red clover and alfalfa alone. But because clover is typically grown in a more complex agricultural mosaic with alfalfa and broad bean, a second experiment was conducted to assess the fitness consequences under predation in a more complex agricultural field setting that also included potential apparent competition with AR pea aphids. In a third experiment we tested for the effect of differential host race density on the fitness of the other host race mediated by a predator effect. CR pea aphids always had fitness losses when on broad bean (had lower fitness on broad bean relative to red clover) and fitness benefits when on red clover (higher fitness on red clover relative to broad bean), whether or not in apparent competition with alfalfa race aphids on bean and alfalfa. AR suffered fitness loss on both alfalfa and bean in apparent competition with CR on clover. Therefore we can conclude that the predation rate between host races was highly asymmetrical. The complexity of the agricultural mosaic thus can influence prey selection by predators on different host plants. These may have evolutionary consequences through context dependent fitness benefits on particular host plants.	[Balog, Adalbert; Schmitz, Oswald J.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Balog, Adalbert] Sapientia Univ, Dept Hort, Fac Tech Sci, Targu Mures, Romania	Yale University; Sapientia Hungarian University of Transylvania	Balog, A (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	adalbert.balog@fulbrightmail.org	Adalbert, Balog/AAR-4097-2021; Balog, Adalbert/O-9649-2019	BALOG, Adalbert/0000-0001-7772-7783	Romanian National Authority for Scientific Research; CNCS - Unitatea Executiva pentru Finantarea Invatamantului Superior; Cercetarii, Dezvoltarii si Inovarii [PN-II-RU-TE-2011-3-0096]	Romanian National Authority for Scientific Research; CNCS - Unitatea Executiva pentru Finantarea Invatamantului Superior(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Cercetarii, Dezvoltarii si Inovarii	This work was supported by the grant of the Romanian National Authority for Scientific Research, CNCS - Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii, project number PN-II-RU-TE-2011-3-0096. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Braendle C, 2001, J INSECT BEHAV, V14, P497, DOI 10.1023/A:1011124122873; Brassil CE, 2004, THEOR POPUL BIOL, V66, P71, DOI 10.1016/j.tpb.2004.04.001; Caillaud CM, 1996, EXPERIENTIA, V52, P927, DOI 10.1007/BF01938882; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; Dixon AFG, 1999, P ROY SOC B-BIOL SCI, V266, P1549, DOI 10.1098/rspb.1999.0814; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Eubanks MD, 2000, ECOL ENTOMOL, V25, P140, DOI 10.1046/j.1365-2311.2000.00243.x; Ferrari J, 2006, ECOL RES, V21, P9, DOI 10.1007/s11284-005-0136-8; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Ferrari J, 2006, EVOLUTION, V60, P1574, DOI 10.1111/j.0014-3820.2006.tb00502.x; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Frommen JG, 2011, EVOL ECOL, V25, P641, DOI 10.1007/s10682-010-9454-6; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Hawlena D, 2011, FUNCT ECOL, V25, P279, DOI 10.1111/j.1365-2435.2010.01767.x; Kunert G, 2008, B ENTOMOL RES, V98, P57, DOI 10.1017/S0007485307005391; Kunert G, 2010, ECOL ENTOMOL, V35, P147, DOI 10.1111/j.1365-2311.2009.01146.x; Morris RJ, 2005, ANN ZOOL FENN, V42, P449; Nelson EH, 2006, ENTOMOL EXP APPL, V118, P211, DOI 10.1111/j.1570-7458.2006.00378.x; Nelson EH, 2007, OECOLOGIA, V151, P22, DOI 10.1007/s00442-006-0573-2; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Peccoud J, 2010, ECOL ENTOMOL, V35, P119, DOI 10.1111/j.1365-2311.2009.01147.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P1947, DOI 10.1890/0012-9658(2001)082[1947:TLEOAP]2.0.CO;2; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Snyder WE, 2003, ECOLOGY, V84, P91, DOI 10.1890/0012-9658(2003)084[0091:IBSAGN]2.0.CO;2; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Poecke RMP, 2003, ENTOMOL EXP APPL, V107, P229, DOI 10.1046/j.1570-7458.2003.00060.x; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x	40	7	7	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55900	10.1371/journal.pone.0055900	http://dx.doi.org/10.1371/journal.pone.0055900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409081	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200085
J	McAllister, CH; Facette, M; Holt, A; Good, AG				McAllister, Chandra H.; Facette, Michelle; Holt, Andrew; Good, Allen G.			Analysis of the Enzymatic Properties of a Broad Family of Alanine Aminotransferases	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; D-AMINO ACIDS; ARABIDOPSIS-THALIANA; CHROMATOGRAPHIC DETERMINATION; YOUNG SEEDLINGS; CDNA CLONING; ORYZA-SATIVA; RICE; EXPRESSION; PLANTS	Alanine aminotransferase (AlaAT) has been studied in a variety of organisms due to the involvement of this enzyme in mammalian processes such as non-alcoholic hepatocellular damage, and in plant processes such as C-4 photosynthesis, post-hypoxic stress response and nitrogen use efficiency. To date, very few studies have made direct comparisons of AlaAT enzymes and fewer still have made direct comparisons of this enzyme across a broad spectrum of organisms. In this study we present a direct kinetic comparison of glutamate: pyruvate aminotransferase (GPAT) activity for seven AlaATs and two glutamate: glyoxylate aminotransferases (GGAT), measuring the KM values for the enzymes analyzed. We also demonstrate that recombinant expression of AlaAT enzymes in Eschericia coli results in differences in bacterial growth inhibition, supporting previous reports of AlaAT possessing bactericidal properties, attributed to lipopolysaccharide endotoxin recognition and binding. A probable lipopolysaccharide binding region within the AlaAT enzymes, homologous to a region of a lipopolysaccharide binding protein (LBP) in humans, was also identified in this study. The AlaAT enzyme differences identified here indicate that AlaAT homologues have differentiated significantly and the roles these homologues play in vivo may also have diverged significantly. Specifically, the differing kinetics of AlaAT enzymes and how this may alter the nitrogen use efficiency in plants is discussed.	[McAllister, Chandra H.; Facette, Michelle; Holt, Andrew; Good, Allen G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	McAllister, CH (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	chandram@ualberta.ca	Facette, Michelle/K-6603-2019; Facette, Michelle/E-6114-2015	Facette, Michelle/0000-0002-6214-9359; Facette, Michelle/0000-0002-6214-9359	NSERC [NSERC RGPIN 89739]; Alberta Crop Industry Development Fund [ACIDF2009C001R]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Crop Industry Development Fund	This research was funded by an NSERC Discovery Grant - NSERC RGPIN 89739 to the Principal Investigator, AGG (http://www.nserc-crsng.gc.ca/), and a Research grant from the Alberta Crop Industry Development Fund; ACIDF2009C001R to AGG (URL http://www.acidf.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty PH, 2009, PLANT BIOTECHNOL J, V7, P562, DOI 10.1111/j.1467-7652.2009.00424.x; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; BRUCKNER H, 1994, CHROMATOGRAPHIA, V39, P419, DOI 10.1007/BF02278756; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Duff SMG, 2012, ARCH BIOCHEM BIOPHYS, V528, P90, DOI 10.1016/j.abb.2012.06.006; Duff SMG, 2011, PLANT PHYSIOL BIOCH, V49, P251, DOI 10.1016/j.plaphy.2010.12.006; GOOD AG, 1992, PLANT PHYSIOL, V99, P1520, DOI 10.1104/pp.99.4.1520; Good AG, 2007, US Patent, Patent No. [#20070162995, 20070162995]; Good AG, 2007, CAN J BOT, V85, P252, DOI 10.1139/B07-019; HATCH MD, 1977, ARCH BIOCHEM BIOPHYS, V179, P361, DOI 10.1016/0003-9861(77)90123-0; Jadaho SB, 2004, HEPATOLOGY, V39, P1297, DOI 10.1002/hep.20182; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11514, DOI 10.1021/bi901158h; Jiao Z, 2010, J AGR FOOD CHEM, V58, P1746, DOI 10.1021/jf902676y; Jing XL, 2011, DEV COMP IMMUNOL, V35, P94, DOI 10.1016/j.dci.2010.08.014; Kameya M, 2010, FEBS J, V277, P1876, DOI 10.1111/j.1742-4658.2010.07604.x; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Kikuchi H, 1999, PLANT MOL BIOL, V39, P149, DOI 10.1023/A:1006156214716; Kim SH, 2010, J BACTERIOL, V192, P5304, DOI 10.1128/JB.00738-10; Liepman AH, 2003, PLANT PHYSIOL, V131, P215, DOI 10.1104/pp.011460; Lock Y-Y, 2011, THESIS U ALBERTA; Marangoni B, 2003, ENZYME KINETICS MODE; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; MUENCH DG, 1994, PLANT MOL BIOL, V24, P417, DOI 10.1007/BF00024110; Narsai R, 2009, PLANT PHYSIOL, V151, P306, DOI 10.1104/pp.109.142026; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Ricoult C, 2006, J EXP BOT, V57, P3079, DOI 10.1093/jxb/erl069; Shrawat AK, 2008, PLANT BIOTECHNOL J, V6, P722, DOI 10.1111/j.1467-7652.2008.00351.x; Singh B, 1999, PLANT AMINO ACIDS BI; Sohocki MM, 1997, GENOMICS, V40, P247, DOI 10.1006/geno.1996.4604; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Wisniewski P, 2006, ACTA PHYSIOL PLANT, V28, P577, DOI 10.1007/s11738-006-0053-7; Wolansky MA, 2005, THESIS U ALBERTA; Wong KF, 2007, FASEB J, V21, P3231, DOI 10.1096/fj.06-7579com; Yang RZ, 2009, HEPATOLOGY, V49, P598, DOI 10.1002/hep.22657	41	21	24	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55032	10.1371/journal.pone.0055032	http://dx.doi.org/10.1371/journal.pone.0055032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408955	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200015
J	Yuan, TZ; Overstreet, CM; Moody, IS; Weiss, GA				Yuan, Tom Z.; Overstreet, Cathie M.; Moody, Issa S.; Weiss, Gregory A.			Protein Engineering with Biosynthesized Libraries from Bordetella bronchiseptica Bacteriophage	PLOS ONE			English	Article							PHAGE DISPLAY; SELECTION; DYNAMICS; RECOGNITION; GENERATION; ANTIBODIES; AFFINITY; CELLS	Phage display offers a powerful approach to engineer protein affinity. A naturally occurring analog to phage display, the Bordetella bronchiseptica bacteriophage (BP) employs a highly variable protein termed the major tropism determinant (Mtd) to recognize its dynamic host. Propagation of BP provides a self-made phage library (SMPL) with vast numbers of phage particles, each displaying a single Mtd variant. We report applying the diversity of the BP-SMPL to access a tyrosine-rich library of Mtd variants. Expression of the SMPL-engineered Mtd variant as a GST-bound fusion protein demonstrated specific binding to the target T4 lysozyme with dissociation constants in the sub-micromolar range. The results guide future experiments with SMPLs applied to protein engineering.	[Yuan, Tom Z.; Overstreet, Cathie M.; Moody, Issa S.; Weiss, Gregory A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Weiss, Gregory A.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Weiss, GA (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	gweiss@uci.edu	Weiss, Gregory/AEN-4604-2022		National Institute of General Medical Sciences of the National Institutes of Health [R01 GM078528-01]; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078528] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by the National Institute of General Medical Sciences of the National Institutes of Health (R01 GM078528-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Arter JA, 2010, NANO LETT; Arter JA, 2012, ANAL CHEM, V84, P2776, DOI 10.1021/ac203143y; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bock A, 2001, INT J MED MICROBIOL, V291, P119, DOI 10.1078/1438-4221-00109; Choi Y, 2012, J AM CHEM SOC, V134, P2032, DOI 10.1021/ja211540z; Choi YK, 2012, SCIENCE, V335, P319, DOI 10.1126/science.1214824; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Coia G, 1997, GENE, V201, P203, DOI 10.1016/S0378-1119(97)00452-6; Dai W, 2010, P NATL ACAD SCI USA, V107, P4347, DOI 10.1073/pnas.0915008107; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Guo HT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002414; HAN JC, 1994, ANAL BIOCHEM, V220, P5, DOI 10.1006/abio.1994.1290; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Liu MS, 2004, J BACTERIOL, V186, P1503, DOI 10.1128/JB.186.5.1503-1517.2004; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; Medhekar B, 2007, CURR OPIN MICROBIOL, V10, P388, DOI 10.1016/j.mib.2007.06.004; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miller JL, 2008, PLOS BIOL, V6, P1195, DOI 10.1371/journal.pbio.0060131; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Overstreet CM, 2012, PROTEIN ENG DES SEL, V25, P145, DOI 10.1093/protein/gzr068; ROBERTS BL, 1992, P NATL ACAD SCI USA, V89, P2429, DOI 10.1073/pnas.89.6.2429; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sidhu SS, 2007, CURR OPIN CHEM BIOL, V11, P347, DOI 10.1016/j.cbpa.2007.05.001; Sidhu SS, 2000, CURR OPIN BIOTECH, V11, P610, DOI 10.1016/S0958-1669(00)00152-X; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; Subramanian L, 2006, CALCIUM BINDING PROT, V1, P54	37	5	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55617	10.1371/journal.pone.0055617	http://dx.doi.org/10.1371/journal.pone.0055617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409008	gold, Green Published			2022-12-25	WOS:000315157200044
J	Belghiti, M; Estevez-Herrera, J; Gimenez-Garzo, C; Gonzalez-Usano, A; Montoliu, C; Ferrer-Montiel, A; Felipo, V; Planells-Cases, R				Belghiti, Majedeline; Estevez-Herrera, Judith; Gimenez-Garzo, Carla; Gonzalez-Usano, Alba; Montoliu, Carmina; Ferrer-Montiel, Antonio; Felipo, Vicente; Planells-Cases, Rosa			Potentiation of the Transient Receptor Potential Vanilloid 1 Channel Contributes to Pruritogenesis in a Rat Model of Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; LYSOPHOSPHATIDIC ACID; SCRATCHING BEHAVIOR; NEUROGENIC INFLAMMATION; THERMAL NOCICEPTION; MAST-CELLS; ITCH; TRPV1; PRURITUS; INVOLVEMENT	Persistent pruritus is a common disabling dermatologic symptom associated with different etiologic factors. These include primary skin conditions, as well as neuropathic, psychogenic, or systemic disorders like chronic liver disease. Defective clearance of potential pruritogenic substances that activate itch-specific neurons innervating the skin is thought to contribute to cholestatic pruritus. However, because the underlying disease-specific pruritogens and itch-specific neuronal pathways and mechanism(s) are unknown, symptomatic therapeutic intervention often leads to no or only limited success. In the current study, we aimed to first validate rats with bile duct ligation (BDL) as a model for hepatic pruritus and then to evaluate the contribution of inflammation, peripheral neuronal sensitization, and specific signaling pathways and subpopulations of itch-responsive neurons to scratching behavior and thermal hypersensitivity. Chronic BDL rats displayed enhanced scratching behavior and thermal hyperalgesia indicative of peripheral neuroinflammation. BDL-induced itch and hypersensitivity involved a minor contribution of histaminergic/serotonergic receptors, but significant activation of protein-activated receptor 2 (PAR(2)) receptors, prostaglandin PGE(2) formation, and potentiation of transient receptor potential vanilloid 1 (TRPV1) channel activity. The sensitization of dorsal root ganglion nociceptors in BDL rats was associated with increased surface expression of PAR(2) and TRPV1 proteins and an increase in the number of PAR(2)-and TRPV1-expressing peptidergic neurons together with a shift of TRPV1 receptor expression to medium sized dorsal root ganglion neurons. These results suggest that pruritus and hyperalgesia in chronic cholestatic BDL rats are associated with neuroinflammation and involve PAR(2)-induced TRPV1 sensitization. Thus, pharmacological modulation of PAR2 and/or TRPV1 may be a valuable therapeutic approach for patients with chronic liver pruritus refractory to conventional treatments.	[Belghiti, Majedeline; Estevez-Herrera, Judith; Gimenez-Garzo, Carla; Gonzalez-Usano, Alba; Felipo, Vicente; Planells-Cases, Rosa] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Montoliu, Carmina] Fdn Invest Hosp Clin Valencia, INCLIVA, Valencia 46010, Spain; [Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Spain; [Planells-Cases, Rosa] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Planells-Cases, Rosa] Max Delbruck Centrum Mol Med MDC, D-13125 Berlin, Germany	Prince Felipe Research Center; Universidad Miguel Hernandez de Elche; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Planells-Cases, R (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Roessle Str 10, D-13125 Berlin, Germany.	planells-cases@fmp-berlin.de	Ferrer-Montiel, Antonio/C-3072-2015; Montoliu, Carmina/ABB-1904-2021; Felipo, Vicente/A-9265-2014; Estevez Herrera, Judith/R-5333-2018	Ferrer-Montiel, Antonio/0000-0002-2973-6607; Felipo, Vicente/0000-0003-3145-9538; Gimenez-Garzo, Carla/0000-0002-9748-443X; Estevez Herrera, Judith/0000-0001-8130-2294	Ministry of Science and Innovation [BFU2009-08346, SAF2008-00062, SAF2007-63193]; Consolider-Ingenio Program [CSD2008-00005]; la Generalitat Valenciana [Prometeo-2010-046, AP-092/09, Prometeo-2009-027, ACOMP2010-220]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio Program(Spanish Government); la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by the Ministry of Science and Innovation Grants BFU2009-08346 (to A. F.-M.), SAF2008-00062 (to V. F.), and SAF2007-63193 (to R. P.-C.); Consolider-Ingenio 2010 Program Grant CSD2008-00005 (to A. F.-M., V. F., and R. P.-C.); and la Generalitat Valenciana Grants Prometeo-2010-046 (to A. F.-M.), AP-092/09, Prometeo-2009-027, and ACOMP2010-220 (to V. F.).	Akiyama T, 2009, J PHARMACOL EXP THER, V329, P945, DOI 10.1124/jpet.109.152256; Akiyama T, 2009, J NEUROSCI, V29, P6691, DOI 10.1523/JNEUROSCI.6103-08.2009; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Banik RK, 2001, NEUROSCI LETT, V299, P21, DOI 10.1016/S0304-3940(00)01770-5; Barak V, 2009, J AUTOIMMUN, V33, P178, DOI 10.1016/j.jaut.2009.09.010; Bergasa NV, 2000, BEST PRACT RES CL GA, V14, P643, DOI 10.1053/bega.2000.0109; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; CLEMENTS WDB, 1994, AGENTS ACTIONS, V41, pC30, DOI 10.1007/BF02007753; Costa R, 2008, BRIT J PHARMACOL, V154, P1094, DOI 10.1038/bjp.2008.172; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Glasova H, 2002, J GASTROEN HEPATOL, V17, P938, DOI 10.1046/j.1440-1746.2002.02717.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hasanein P, 2007, EUR J PHARMACOL, V554, P123, DOI 10.1016/j.ejphar.2006.10.026; Hashimoto T, 2005, PHARMACOLOGY, V75, P13, DOI 10.1159/000085784; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jover R, 2006, HEPATOLOGY, V43, P1257, DOI 10.1002/hep.21180; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Kremer AE, 2010, J HEPATOL, V52, pS1, DOI 10.1016/S0168-8278(10)00232-1; Kremer AE, 2012, HEPATOLOGY, V56, P1391, DOI 10.1002/hep.25748; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kremer AE, 2009, ACTA DERM-VENEREOL, V89, P702; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Mela M, 2003, ALIMENT PHARM THER, V17, P857, DOI 10.1046/j.1365-2036.2003.01458.x; Miura T, 2005, J PHARMACOL SCI, V97, P429, DOI 10.1254/jphs.FPJ04050X; Montoliu C, 2009, J CLIN GASTROENTEROL, V43, P272, DOI 10.1097/MCG.0b013e31815e7f58; Mori K, 2007, VIRCHOWS ARCH, V451, P47, DOI 10.1007/s00428-007-0425-4; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Nelson L, 2006, J HEPATOL, V44, P1141, DOI 10.1016/j.jhep.2005.11.043; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; PERKINS MN, 1992, BRIT J PHARMACOL, V107, P329, DOI 10.1111/j.1476-5381.1992.tb12746.x; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Seeliger S, 2003, FASEB J, V17, P1871, DOI 10.1096/fj.02-1112com; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Ui H, 2006, EUR J PHARMACOL, V530, P172, DOI 10.1016/j.ejphar.2005.11.021; van der Merwe JQ, 2009, J PHARMACOL EXP THER, V329, P747, DOI 10.1124/jpet.108.145466; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Weisshaar E, 2003, ACTA DERM-VENEREOL, P5; Weisshaar E, 1999, EXP DERMATOL, V8, P254; Yosipovitch G, 2008, CURR ALLERGY ASTHM R, V8, P306, DOI 10.1007/s11882-008-0049-z; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61	56	30	31	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9675	9685		10.1074/jbc.M113.455162	http://dx.doi.org/10.1074/jbc.M113.455162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408423	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000317114000010
J	Camolotto, SA; Racca, AC; Ridano, ME; Genti-Raimondi, S; Panzetta-Dutari, GM				Camolotto, Soledad A.; Racca, Ana C.; Ridano, Magali E.; Genti-Raimondi, Susana; Panzetta-Dutari, Graciela M.			PSG Gene Expression Is Up-Regulated by Lysine Acetylation Involving Histone and Nonhistone Proteins	PLOS ONE			English	Article							PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN; KRUPPEL-LIKE FACTOR-6; SP1 TRANSCRIPTION FACTOR; DEACETYLASE INHIBITORS; TROPHOBLAST DIFFERENTIATION; CHORIOCARCINOMA CELLS; GLYCOPROTEIN GENES; PROMOTER REGION; MATERNAL SERUM; HUMAN PLACENTA	Background: Lysine acetylation is an important post-translational modification that plays a central role in eukaryotic transcriptional activation by modifying chromatin and transcription-related factors. Human pregnancy-specific glycoproteins (PSG) are the major secreted placental proteins expressed by the syncytiotrophoblast at the end of pregnancy and represent early markers of cytotrophoblast differentiation. Low PSG levels are associated with complicated pregnancies, thus highlighting the importance of studying the mechanisms that control their expression. Despite several transcription factors having been implicated as key regulators of PSG gene family expression; the role of protein acetylation has not been explored. Methodology/Principal Findings: Here, we explored the role of acetylation on PSG gene expression in the human placental-derived JEG-3 cell line. Pharmacological inhibition of histone deacetylases (HDACs) up-regulated PSG protein and mRNA expression levels, and augmented the amount of acetylated histone H3 associated with PSG 5' regulatory regions. Moreover, PSG5 promoter activation mediated by Sp1 and KLF6, via the core promoter element motif (CPE, -147/-140), was markedly enhanced in the presence of the HDAC inhibitor trichostatin A (TSA). This effect correlated with an increase in Sp1 acetylation and KLF6 nuclear localization as revealed by immunoprecipitation and subcellular fractionation assays. The co-activators PCAF, p300, and CBP enhanced Sp1-dependent PSG5 promoter activation through their histone acetylase (HAT) function. Instead, p300 and CBP acetyltransferase domain was dispensable for sustaining co-activation of PSG5 promoter by KLF6. Conclusions/Significance: Results are consistent with a regulatory role of lysine acetylation on PSG expression through a relaxed chromatin state and an increase in the transcriptional activity of Sp1 and KLF6 following an augmented Sp1 acetylation and KLF6 nuclear localization.	[Camolotto, Soledad A.; Racca, Ana C.; Ridano, Magali E.; Genti-Raimondi, Susana; Panzetta-Dutari, Graciela M.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Panzetta-Dutari, GM (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina.	gpan@fcq.unc.edu.ar		Racca, Ana Cristina/0000-0002-5909-2451	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC); FONCYT fellowship; CONICET fellowship	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); FONCYT fellowship(FONCyT); CONICET fellowship(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET), the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), the Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, and the Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC). S.G.-R. and G.M.P.-D. are Career Investigators of CONICET. S.A.C. was a holder of FONCYT and CONICET fellowships. A.C.R. and M.E.R. thank CONICET for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P105, DOI 10.1152/physiolgenomics.2001.6.2.105; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Blanchon L, 2006, BIOCHEM BIOPH RES CO, V343, P745, DOI 10.1016/j.bbrc.2006.03.032; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; CHAMBERLIN ME, 1994, J BIOL CHEM, V269, P17152; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; Chuang HC, 2006, NUCLEIC ACIDS RES, V34, P1459, DOI 10.1093/nar/gkl048; Chuang JY, 2011, BIOCHEM BIOPH RES CO, V407, P587, DOI 10.1016/j.bbrc.2011.03.068; Dokras A, 2006, MOL HUM REPROD, V12, P611, DOI 10.1093/molehr/gal074; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Enya K, 2008, J LEUKOCYTE BIOL, V83, P190, DOI 10.1189/jlb.0106008; Gardner MO, 1997, ACTA OBSTET GYN SCAN, V76, P56; Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929; Gray SG, 2004, INT J ONCOL, V24, P773; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; GRUDZINSKAS JG, 1983, AM J OBSTET GYNECOL, V147, P10, DOI 10.1016/0002-9378(83)90075-3; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; KARG NJ, 1981, ARCH GYNECOL, V231, P69, DOI 10.1007/BF02110026; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; Knofler M, 2004, ENDOCRINOLOGY, V145, P1685, DOI 10.1210/en.2003-0954; Kodani M, 2005, ONCOL REP, V13, P477; Koritschoner NP, 1996, EUR J BIOCHEM, V236, P365, DOI 10.1111/j.1432-1033.1996.00365.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Kumar P, 2009, MOL ENDOCRINOL, V23, P784, DOI 10.1210/me.2008-0371; Kuninger D, 2006, AM J PHYSIOL-CELL PH, V291, pC699, DOI 10.1152/ajpcell.00056.2006; Lehrmann H, 2002, ADV CANCER RES, V86, P41, DOI 10.1016/S0065-230X(02)86002-X; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; Liu J, 2010, MOL CELL BIOCHEM, V335, P29, DOI 10.1007/s11010-009-0237-8; Lopez-Diaz F, 2007, PLACENTA, V28, P898, DOI 10.1016/j.placenta.2007.03.002; Masumi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/640610; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Motran CC, 2003, EUR J IMMUNOL, V33, P3007, DOI 10.1002/eji.200323993; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Nores R, 2004, PLACENTA, V25, P9, DOI 10.1016/S0143-4004(03)00213-3; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; PANZETTADUTARI GM, 1992, MOL BIOL REP, V16, P255, DOI 10.1007/BF00419665; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Piao YS, 1997, ENDOCRINOLOGY, V138, P3417, DOI 10.1210/en.138.8.3417; Racca A, 2010, PLACENTA, V31, pA14; Racca AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022438; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rena V, 2011, MOL ENDOCRINOL, V25, P1364, DOI 10.1210/me.2010-0503; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; SILVER RM, 1993, PLACENTA, V14, P583, DOI 10.1016/S0143-4004(05)80211-5; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Su XD, 2007, EXPERT REV PROTEOMIC, V4, P211, DOI 10.1586/14789450.4.2.211; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; THOMPSON J, 1990, BIOCHEM BIOPH RES CO, V167, P848, DOI 10.1016/0006-291X(90)92103-7; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wessells J, 2000, EUR J IMMUNOL, V30, P1830, DOI 10.1002/1521-4141(200007)30:7&lt;1830::AID-IMMU1830&gt;3.0.CO;2-M; Wolfe MW, 2006, METH MOLEC MED, V121, P229; WU SM, 1993, MOL CELL BIOCHEM, V122, P147, DOI 10.1007/BF01076099; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshikawa M, 2010, EUR J PHARMACOL, V642, P28, DOI 10.1016/j.ejphar.2010.05.055; Zhou CL, 2006, INT J ONCOL, V29, P269; Zhou GQ, 1997, PLACENTA, V18, P491, DOI 10.1016/0143-4004(77)90002-9	74	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55992	10.1371/journal.pone.0055992	http://dx.doi.org/10.1371/journal.pone.0055992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418492	gold, Green Published			2022-12-25	WOS:000315970300084
J	Gupta, A; Wood, R; Kaplan, R; Bekker, LG; Lawn, SD				Gupta, Ankur; Wood, Robin; Kaplan, Richard; Bekker, Linda-Gail; Lawn, Stephen D.			Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; IMMUNE RECONSTITUTION DISEASE; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; TREATMENT PROGRAM; INFECTED PATIENTS; EARLY OUTCOMES; RURAL UGANDA; ADULTS; DETERMINANTS	Background: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other patient characteristics. Methods/Findings: This observational ART cohort study was based in Cape Town, South Africa. Deaths from all causes were ascertained among patients receiving ART for up to 8 years. TB diagnoses and 4-monthly CD4 cell counts were recorded. Mortality rates were calculated and Poisson regression models were used to calculate incidence rate ratios (IRR) and identify risk factors for mortality. Of 1544 patients starting ART, 464 patients had prevalent TB at baseline and 424 developed incident TB during a median of 5.0 years follow-up. Most TB diagnoses (73.6%) were culture-confirmed. A total of 208 (13.5%) patients died during ART and mortality rates were 8.84 deaths/100 person-years during the first year of ART and decreased to 1.14 deaths/100 person-years after 5 years. In multivariate analyses adjusted for baseline and time-updated risk factors, both prevalent and incident TB were independent risk factors for mortality (IRR 1.7 [95% CI, 1.2-2.3] and 2.7 [95% CI, 1.9-3.8], respectively). Adjusted mortality risks were higher in the first 6 months of ART for those with prevalent TB at baseline (IRR 2.33; 95% CI, 1.5-3.5) and within the 6 months following diagnoses of incident TB (IRR 3.8; 95% CI, 2.6-5.7). Conclusions: Prevalent TB at baseline and incident TB during ART were strongly associated with increased mortality risk. This effect was time-dependent, suggesting that TB and mortality are likely to be causally related and that TB is not simply an epiphenomenon among highly immunocompromised patients. Strategies to rapidly diagnose, treat and prevent TB prior to and during ART urgently need to be implemented.	[Gupta, Ankur; Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Wood, Robin; Kaplan, Richard; Bekker, Linda-Gail; Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Lawn, SD (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England.	stephen.lawn@lshtm.ac.uk	Bekker, Linda-Gail/AAZ-8929-2020	BEKKER, LINDA-GAIL/0000-0002-0755-4386; Kaplan, Richard/0000-0003-1565-4704; Gupta-Wright, Ankur/0000-0002-5150-2970	Wellcome Trust, London, UK [074641]; International Epidemiologic Database to Evaluate Aids; National Institute of Allergy and Infectious Diseases (NIAID) [5U01AI069924-02]; National Institutes of Health (NIH) [5R01AI058736-02]; USAID Right to Care [CA 674 A 00 08 0000 700]; South African Centre for Epidemiological Modelling and Analysis (SACEMA); Cost-Effectiveness of Preventing AIDS Complications (CEPAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, R01AI058736] Funding Source: NIH RePORTER	Wellcome Trust, London, UK(Wellcome Trust); International Epidemiologic Database to Evaluate Aids; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID Right to Care(United States Agency for International Development (USAID)); South African Centre for Epidemiological Modelling and Analysis (SACEMA); Cost-Effectiveness of Preventing AIDS Complications (CEPAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SDL is funded by the Wellcome Trust, London, UK with grant number 074641. RW was funded in part by the International Epidemiologic Database to Evaluate Aids with a grant from the National Institute of Allergy and Infectious Diseases (NIAID: 5U01AI069924-02); Cost-Effectiveness of Preventing AIDS Complications (CEPAC) funded by the National Institutes of Health (NIH, 5R01AI058736-02); USAID Right to Care (CA 674 A 00 08 0000 700) and the South African Centre for Epidemiological Modelling and Analysis (SACEMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-39; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Del Amo J, 1999, AIDS, V13, P1151, DOI 10.1097/00002030-199907090-00002; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2011, LANCET INFECT DIS, DOI [10.1016/S1473-3099(1011)70251-70251, DOI 10.1016/S1473-3099(1011)70251-70251]; Lawn SD, 2012, AIDS IN PRESS; Lawn SD, 2012, 17 INT AIDS C MEX CI, V26, P1730; Lawn SD, 2012, AIDS, DOI [10.1097/QAD.1090b1013e3283553685, DOI 10.1097/QAD.1090B1013E3283553685]; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2011, SAMJ S AFR MED J, V101, P258, DOI 10.7196/SAMJ.4392; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Maro I, 2010, INT J TUBERC LUNG D, V14, P1447; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Omar GS, 2010, ABSTRACTS OF THE 18T; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; World Health Organisation, 2002, SCALING UP ANTIRETRO; World Health Organisation, 2007, IMPROVING THE DIAGNO; World Health Organization, 2011, WHO HTM TB 2011 16; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	47	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55824	10.1371/journal.pone.0055824	http://dx.doi.org/10.1371/journal.pone.0055824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418463	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000315970300054
J	Iskandarsyah, A; de Klerk, C; Suardi, DR; Soemitro, MP; Sadarjoen, SS; Passchier, J				Iskandarsyah, Aulia; de Klerk, Cora; Suardi, Dradjat R.; Soemitro, Monty P.; Sadarjoen, Sawitri S.; Passchier, Jan			The Distress Thermometer and Its Validity: A First Psychometric Study in Indonesian Women with Breast Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; HOSPITAL ANXIETY; PSYCHOLOGICAL DISTRESS; DEPRESSION SCALE; VALIDATION; ONCOLOGISTS; PREVALENCE; JAKARTA; CARE	Purpose: This study aims to translate the Distress Thermometer (DT) into Indonesian, test its validity in Indonesian women with breast cancer and determine norm scores of the Indonesian DT for clinically relevant distress. Methods: First, the original version of the DT was translated using a forward and backward translation procedure according to the guidelines. Next, a group of 120 breast cancer patients who were treated at the Outpatient Surgical Oncology Clinic in Hasan Sadikin Hospital in Indonesia completed a standard socio-demographic form, the DT and the Problem List, the Hospital Anxiety and Depression Scale (HADS) and the WHO Quality of Life (WHOQOL-BREF). Results: Receiver operating characteristic (ROC) curve analyses identified an area under the curve = 0.81 when compared to the HADS cutoff score of 15. A cutoff score of 5 on the DT had the best sensitivity (0.81) and specificity (0.64). Patients who scored above this cutoff reported more problems in the practical, family, emotional, spiritual/religious and physical domains (30 out of 36 problems, p-value<0.05) than patients below the cutoff score. Patients at advanced stages of cancer experienced more emotional and physical problems. Patient's distress level was negatively correlated with overall quality of life, general health and all quality of life domains. Conclusions: The DT was found to be a valid tool for screening distress in Indonesian breast cancer patients. We recommend using a cutoff score of 5 in this population.	[Iskandarsyah, Aulia; de Klerk, Cora; Passchier, Jan] Erasmus MC Univ Med Ctr, Sect Med Psychol & Psychotherapy, Dept Psychiat, Rotterdam, Netherlands; [Iskandarsyah, Aulia; Passchier, Jan] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Iskandarsyah, Aulia; Sadarjoen, Sawitri S.] Padjadjaran State Univ, Dept Clin Psychol, Bandung, Indonesia; [Suardi, Dradjat R.; Soemitro, Monty P.] Hasan Sadikin Hosp, Dept Surg Oncol, Bandung, Indonesia	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital	Iskandarsyah, A (corresponding author), Erasmus MC Univ Med Ctr, Sect Med Psychol & Psychotherapy, Dept Psychiat, Rotterdam, Netherlands.	a.iskandarsyah@erasmusmc.nl	Iskandarsyah, Aulia/GRJ-7939-2022	Iskandarsyah, Aulia/0000-0002-9526-6922	Directorate General of Higher Education of Indonesia	Directorate General of Higher Education of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	AI received a PhD scholarship from the Directorate General of Higher Education of Indonesia (http://www.dikti.go.id/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki N, 2003, CANCER-AM CANCER SOC, V97, P2605, DOI 10.1002/cncr.11358; Al-Shahri M, 2002, WESTERN J MED, V176, P60, DOI 10.1136/ewjm.176.1.60; Albar ZA, 2004, PROTOKOL PERABOI 200; [Anonymous], 2003, J NATL COMPR CANC NE, V1, P344, DOI [DOI 10.6004/JNCCN.2003.0031, 10.6004/jnccn.2003.0031]; Chen ML, 2006, SUPPORT CARE CANCER, V14, P825, DOI 10.1007/s00520-006-0019-8; Claramita M, 2011, ADV HEALTH SCI EDUC, V16, P69, DOI 10.1007/s10459-010-9242-7; Dabrowski Michele, 2007, J Natl Compr Canc Netw, V5, P104; Departemen Kesehatan RI, 2011, PROF KES IND 2010; Ferlay J, 2010, IARC CANCERBASE, V2; Gessler S, 2008, PSYCHO-ONCOLOGY, V17, P538, DOI 10.1002/pon.1273; Gil F, 2005, SUPPORT CARE CANCER, V13, P600, DOI 10.1007/s00520-005-0780-0; Graves KD, 2007, LUNG CANCER, V55, P215, DOI 10.1016/j.lungcan.2006.10.001; Hegel MT, 2006, CANCER-AM CANCER SOC, V107, P2924, DOI 10.1002/cncr.22335; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hoffman BM, 2004, PSYCHO-ONCOLOGY, V13, P792, DOI 10.1002/pon.796; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; IBBOTSON T, 1994, EUR J CANCER, V30A, P37, DOI 10.1016/S0959-8049(05)80015-2; Jacobsen PB, 2005, CANCER-AM CANCER SOC, V103, P1494, DOI 10.1002/cncr.20940; Kennard BD, 2004, J CLIN PSYCHOL MED S, V11, P31, DOI 10.1023/B:JOCS.0000016267.21912.74; Khatib J, 2004, PSYCHO-ONCOL, V13, pS42; Kusumaratna RK, 2007, UNIVERSA MED, V26, P179; LICKISS JN, 1993, J PAIN SYMPTOM MANAG, V8, P423, DOI 10.1016/0885-3924(93)90071-3; Mitchell AJ, 2007, J CLIN ONCOL, V25, P4670, DOI 10.1200/JCO.2006.10.0438; Montazeri A, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-32; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P81; National Comprehensive Cancer Network, 2010, CLIN PRACT GUID ONC; National Institute of Clinical Excellence, 2004, GUID CANC SERV IMPR; Ng CH, 2011, ASIAN PAC J CANCER P, V12, P2943; Ozalp E, 2007, PSYCHO-ONCOLOGY, V16, P304, DOI 10.1002/pon.1059; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; Patrick-Miller LJ, 2004, J CLIN ONCOL, V22, p525S; Peters M, 2006, HEADACHE, V46, P82, DOI 10.1111/j.1526-4610.2006.00298.x; Ransom S, 2006, PSYCHO-ONCOLOGY, V15, P604, DOI 10.1002/pon.993; Roth AJ, 1998, CANCER, V82, P1904, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X; Shim EJ, 2008, PSYCHO-ONCOLOGY, V17, P548, DOI 10.1002/pon.1275; Skarstein J, 2000, J PSYCHOSOM RES, V49, P27, DOI 10.1016/S0022-3999(00)00080-5; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Sollner W, 2001, BRIT J CANCER, V84, P179, DOI 10.1054/bjoc.2000.1545; Tuinman MA, 2008, CANCER-AM CANCER SOC, V113, P870, DOI 10.1002/cncr.23622; van Dooren S, 2009, PSYCHO-ONCOLOGY, V18, P1080, DOI 10.1002/pon.1451; vantSpijker A, 1997, PSYCHOSOM MED, V59, P280, DOI 10.1097/00006842-199705000-00011; von Essen L, 2002, EUR J CANCER CARE, V11, P91; Wada T, 2005, ARCH GERONTOL GERIAT, V41, P271, DOI 10.1016/j.archger.2005.03.003; Wakai K, 2000, INT J EPIDEMIOL, V29, P20, DOI 10.1093/ije/29.1.20; Walsh D, 2000, SUPPORT CARE CANCER, V8, P175, DOI 10.1007/s005200050281; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56353	10.1371/journal.pone.0056353	http://dx.doi.org/10.1371/journal.pone.0056353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418561	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300154
J	Kikuchi, M; Yoshimura, Y; Shitamichi, K; Ueno, S; Hiraishi, H; Munesue, T; Hirosawa, T; Ono, Y; Tsubokawa, T; Inoue, Y; Oi, M; Niida, Y; Remijn, GB; Takahashi, T; Suzuki, M; Higashida, H; Minabe, Y				Kikuchi, Mitsuru; Yoshimura, Yuko; Shitamichi, Kiyomi; Ueno, Sanae; Hiraishi, Hirotoshi; Munesue, Toshio; Hirosawa, Tetsu; Ono, Yasuki; Tsubokawa, Tsunehisa; Inoue, Yoshihiro; Oi, Manabu; Niida, Yo; Remijn, Gerard B.; Takahashi, Tsutomu; Suzuki, Michio; Higashida, Haruhiro; Minabe, Yoshio			Anterior Prefrontal Hemodynamic Connectivity in Conscious 3-to 7-Year-Old Children with Typical Development and Autism Spectrum Disorder	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; NEAR-INFRARED SPECTROSCOPY; JOINT ATTENTION EXPERIENCE; YOUNG-CHILDREN; SENTENCE COMPREHENSION; SOCIAL COGNITION; CORPUS-CALLOSUM; FRONTAL-LOBE; BLOOD-FLOW; CORTEX	Socio-communicative impairments are salient features of autism spectrum disorder (ASD) from a young age. The anterior prefrontal cortex (aPFC), or Brodmann area 10, is a key processing area for social function, and atypical development of this area is thought to play a role in the social deficits in ASD. It is important to understand these brain functions in developing children with ASD. However, these brain functions have not yet been well described under conscious conditions in young children with ASD. In the present study, we focused on the brain hemodynamic functional connectivity between the right and the left aPFC in children with ASD and typically developing (TD) children and investigated whether there was a correlation between this connectivity and social ability. Brain hemodynamic fluctuations were measured non-invasively by near-infrared spectroscopy (NIRS) in 3-to 7-year-old children with ASD (n = 15) and gender-and age-matched TD children (n = 15). The functional connectivity between the right and the left aPFC was assessed by measuring the coherence for low-frequency spontaneous fluctuations (0.01 - 0.10 Hz) during a narrated picture-card show. Coherence analysis demonstrated that children with ASD had a significantly higher inter-hemispheric connectivity with 0.02-Hz fluctuations, whereas a power analysis did not demonstrate significant differences between the two groups in terms of low frequency fluctuations (0.01 - 0.10 Hz). This aberrant higher connectivity in children with ASD was positively correlated with the severity of social deficit, as scored with the Autism Diagnostic Observation Schedule. This is the first study to demonstrate aberrant brain functional connectivity between the right and the left aPFC under conscious conditions in young children with ASD.	[Kikuchi, Mitsuru; Yoshimura, Yuko; Munesue, Toshio; Oi, Manabu; Niida, Yo; Higashida, Haruhiro; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Kikuchi, Mitsuru; Shitamichi, Kiyomi; Ueno, Sanae; Hiraishi, Hirotoshi; Munesue, Toshio; Hirosawa, Tetsu; Ono, Yasuki; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Munesue, Toshio; Oi, Manabu; Higashida, Haruhiro; Minabe, Yoshio] Chiba Univ, Hamamatsu Univ Sch Med, United Grad Sch Child Dev, Dept Child Dev,Osaka Univ,Kanazawa Univ, Osaka, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Munesue, Toshio; Oi, Manabu; Higashida, Haruhiro; Minabe, Yoshio] Osaka Univ, Fukui Univ, Osaka, Japan; [Remijn, Gerard B.] Kyushu Univ, Int Educ Ctr, Fukuoka 812, Japan; [Tsubokawa, Tsunehisa] Kanazawa Univ, Grad Sch Med Sci, Dept Anesthesiol, Kanazawa, Ishikawa, Japan; [Inoue, Yoshihiro] Shimadzu Co Ltd, Med Syst Div, R&D Dept, Kyoto, Japan; [Takahashi, Tsutomu; Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan	Kanazawa University; Kanazawa University; Chiba University; Hamamatsu University School of Medicine; Kanazawa University; Osaka University; Osaka University; Kyushu University; Kanazawa University; Shimadzu Corporation; University of Toyama	Kikuchi, M (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan.	mitsuru@zc4.so-net.ne.jp	Remijn, Gerard/CAF-9960-2022; higashida, haruhiro/L-3773-2015	higashida, haruhiro/0000-0002-1779-0606; Remijn, Gerard/0000-0002-8681-9951	Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation); Strategic Research Program for Brain Sciences from MEXT, Japan	Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation); Strategic Research Program for Brain Sciences from MEXT, Japan	This study was supported by the Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation) and the Strategic Research Program for Brain Sciences from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; BARONCOHEN S, 1991, PSYCHIAT CLIN N AM, V14, P33; Bashat DB, 2007, NEUROIMAGE, V37, P40, DOI 10.1016/j.neuroimage.2007.04.060; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Calarge C, 2003, AM J PSYCHIAT, V160, P1954, DOI 10.1176/appi.ajp.160.11.1954; Chevallier C, 2011, NEUROPSYCHOLOGIA, V49, P507, DOI 10.1016/j.neuropsychologia.2010.11.042; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Eigsti IM, 2003, MENT RETARD DEV D R, V9, P205, DOI 10.1002/mrdd.10081; Eyler LT, 2012, BRAIN, V135, P949, DOI 10.1093/brain/awr364; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox PT, 2012, NEUROIMAGE, V61, P407, DOI 10.1016/j.neuroimage.2011.12.051; Happe F, 1996, BRAIN, V119, P1377, DOI 10.1093/brain/119.4.1377; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hoshi Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2142325; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Kawakubo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025944; Kikuchi M, 2010, NEUROREPORT, V21, P1106, DOI 10.1097/WNR.0b013e3283406615; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Kumar A, 2010, CEREB CORTEX, V20, P2103, DOI 10.1093/cercor/bhp278; Lainhart JE, 2006, AM J MED GENET C, V142C, P33, DOI 10.1002/ajmg.c.30080; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Lord C., 1999, AUTISM DIAGNOSTIC OB; McCaffery P, 2005, PROG NEUROBIOL, V77, P38, DOI 10.1016/j.pneurobio.2005.10.005; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Mundy P, 2009, AUTISM RES, V2, P2, DOI 10.1002/aur.61; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Remijn GB, 2011, BRAIN RES, V1383, P242, DOI 10.1016/j.brainres.2011.01.090; Roca M, 2011, NEUROPSYCHOLOGIA, V49, P3525, DOI 10.1016/j.neuropsychologia.2011.09.003; Shih P, 2011, BIOL PSYCHIAT, V70, P270, DOI 10.1016/j.biopsych.2011.03.040; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Toth K, 2006, J AUTISM DEV DISORD, V36, P993, DOI 10.1007/s10803-006-0137-7; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Waiter GD, 2004, NEUROIMAGE, V22, P619, DOI 10.1016/j.neuroimage.2004.02.029; Walker L, 2012, BIOL PSYCHIAT, V72, P1043, DOI 10.1016/j.biopsych.2012.08.001; Weinstein M, 2011, HUM BRAIN MAPP, V32, P534, DOI 10.1002/hbm.21042; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Williams JHG, 2005, NEUROIMAGE, V25, P133, DOI 10.1016/j.neuroimage.2004.10.047; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Zhu BH, 2009, BEHAV BRAIN RES, V202, P32, DOI 10.1016/j.bbr.2009.03.029	65	14	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56087	10.1371/journal.pone.0056087	http://dx.doi.org/10.1371/journal.pone.0056087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418517	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300109
J	Lu, J; Carter, DA; Turnbull, L; Rosendale, D; Hedderley, D; Stephens, J; Gannabathula, S; Steinhorn, G; Schlothauer, RC; Whitchurch, CB; Harry, EJ				Lu, Jing; Carter, Dee A.; Turnbull, Lynne; Rosendale, Douglas; Hedderley, Duncan; Stephens, Jonathan; Gannabathula, Swapna; Steinhorn, Gregor; Schlothauer, Ralf C.; Whitchurch, Cynthia B.; Harry, Elizabeth J.			The Effect of New Zealand Kanuka, Manuka and Clover Honeys on Bacterial Growth Dynamics and Cellular Morphology Varies According to the Species	PLOS ONE			English	Article							LEPTOSPERMUM-SCOPARIUM HONEY; ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; METHYLGLYOXAL PRODUCTION; DIVISION; ANTIMICROBIALS; PROTEINS; BIOFILM; SITE; DNA	Treatment of chronic wounds is becoming increasingly difficult due to antibiotic resistance. Complex natural products with antimicrobial activity, such as honey, are now under the spotlight as alternative treatments to antibiotics. Several studies have shown honey to have broad-spectrum antibacterial activity at concentrations present in honey dressings, and resistance to honey has not been attainable in the laboratory. However not all honeys are the same and few studies have used honey that is well defined both in geographic and chemical terms. Here we have used a range of concentrations of clover honey and a suite of manuka and kanuka honeys from known geographical locations, and for which the floral source and concentration of methylglyoxal and hydrogen peroxide potential were defined, to determine their effect on growth and cellular morphology of four bacteria: Bacillus subtilis, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. While the general trend in effectiveness of growth inhibition was manuka>manuka-kanuka blend>kanuka>clover, the honeys had varying and diverse effects on the growth and cellular morphology of each bacterium, and each organism had a unique response profile to these honeys. P. aeruginosa showed a markedly different pattern of growth inhibition to the other three organisms when treated with sub-inhibitory concentrations of honey, being equally sensitive to all honeys, including clover, and the least sensitive to honey overall. While hydrogen peroxide potential contributed to the antibacterial activity of the manuka and kanuka honeys, it was never essential for complete growth inhibition. Cell morphology analysis also showed a varied and diverse set of responses to the honeys that included cell length changes, cell lysis, and alterations to DNA appearance. These changes are likely to reflect the different regulatory circuits of the organisms that are activated by the stress of honey treatment.	[Lu, Jing; Turnbull, Lynne; Whitchurch, Cynthia B.; Harry, Elizabeth J.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia; [Carter, Dee A.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Rosendale, Douglas; Hedderley, Duncan] New Zealand Inst Plant & Food Res Ltd, Food Ind Sci Ctr, Palmerston North, New Zealand; [Stephens, Jonathan; Steinhorn, Gregor; Schlothauer, Ralf C.] Comvita NZ Ltd, Te Puke, New Zealand; [Gannabathula, Swapna] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand	University of Technology Sydney; University of Sydney; New Zealand Institute for Plant & Food Research Ltd; University of Auckland	Harry, EJ (corresponding author), Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia.	liz.harry@uts.edu.au	Carter, Dee/C-1331-2010; Harry, Elizabeth/G-8123-2017; Harry, Liz/AAT-9396-2020; Rosendale, Doug/E-4938-2010; Turnbull, Lynne/A-2605-2012; Whitchurch, Cynthia/A-5954-2008	Carter, Dee/0000-0002-4638-0059; Rosendale, Doug/0000-0001-9561-335X; Hedderley, Duncan/0000-0001-7522-2212; Turnbull, Lynne/0000-0002-9255-9033; Harry, Elizabeth/0000-0003-0858-9473; Whitchurch, Cynthia/0000-0003-2296-3791	Australian Research Council; Comvita NZ Ltd.	Australian Research Council(Australian Research Council); Comvita NZ Ltd.	This work was supported by the following sources: 1) Australian Research Council http://www.arc.gov.au/. 2) Comvita NZ Ltd. http://www.comvita.co.nz/. The Australian Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Comvita NZ, Ltd. provided partial funding for the work described in the manuscript. Employees of Comvita played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Blair SE, 2005, INFECT DIS HEALTH, V10, P24, DOI 10.1071/HI05024; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Brudzynski K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00213; Chen C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00265; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cooper R, 2012, EXPERT REV ANTI-INFE, V10, P623, DOI [10.1586/ERI.12.46, 10.1586/eri.12.46]; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; EGYUD LG, 1966, P NATL ACAD SCI USA, V56, P203, DOI 10.1073/pnas.56.1.203; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; FRAVAL HNA, 1980, J GEN MICROBIOL, V117, P127; Gannabathula S, 2012, IMMUNOPHARM IMMUNOT, V34, P598, DOI 10.3109/08923973.2011.641974; Henriques AF, 2010, EUR J CLIN MICROBIOL, V29, P45, DOI 10.1007/s10096-009-0817-2; Irish J, 2006, MED MYCOL, V44, P289, DOI 10.1080/13693780500417037; Irish J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018229; Kwakman PHS, 2011, EUR J CLIN MICROBIOL, V30, P251, DOI 10.1007/s10096-010-1077-x; Kwakman PHS, 2012, IUBMB LIFE, V64, P48, DOI 10.1002/iub.578; Kwakman PHS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017709; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; Lee DS, 2011, AM J CLIN DERMATOL, V12, P181, DOI 10.2165/11538930-000000000-00000; Lin SM, 2011, EUR J CLIN MICROBIOL, V30, P569, DOI 10.1007/s10096-010-1121-x; Maddocks SE, 2012, MICROBIOL-SGM, V158, P781, DOI 10.1099/mic.0.053959-0; Majtan J, 2012, FITOTERAPIA, V83, P671, DOI 10.1016/j.fitote.2012.02.002; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Merckoll P, 2009, SCAND J INFECT DIS, V41, P341, DOI 10.1080/00365540902849383; Molan P., 2008, N BEEKEEP, V16, P11; MOLAN PC, 1992, BEE WORLD, V73, P59, DOI 10.1080/0005772X.1992.11099118; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Moriya S, 2010, MOL MICROBIOL, V76, P634, DOI 10.1111/j.1365-2958.2010.07102.x; Ngo DK, 2007, ANZ J SURG, V77, pA66; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Projan SJ, 2002, CURR OPIN MICROBIOL, V5, P463, DOI 10.1016/S1369-5274(02)00364-8; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Smaropoulos E, 2011, WOUNDS UK, V7, P33; Stephens JM, 2010, FOOD CHEM, V120, P78, DOI 10.1016/j.foodchem.2009.09.074; Sukdeo N, 2007, BBA-PROTEINS PROTEOM, V1774, P756, DOI 10.1016/j.bbapap.2007.04.005; Thomas M, 2011, WOUNDS UK, V2, P46; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; Weston RJ, 2000, FOOD CHEM, V71, P235, DOI 10.1016/S0308-8146(00)00162-X; Wolcott R D, 2008, J Wound Care, V17, P333; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	49	67	69	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55898	10.1371/journal.pone.0055898	http://dx.doi.org/10.1371/journal.pone.0055898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418472	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300063
J	Mehairi, AE; Khouri, AA; Naqbi, MM; Muhairi, SJ; Maskari, FA; Nagelkerke, N; Shah, SM				Mehairi, Aaesha E.; Khouri, Aysha A.; Naqbi, Muna M.; Muhairi, Shamma J.; Maskari, Fatima A.; Nagelkerke, Nico; Shah, Syed M.			Metabolic Syndrome among Emirati Adolescents: A School-Based Study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; HIGH PREVALENCE; CHILDHOOD; DEFINITION; OBESITY; CHILDREN	Objectives: Population-based data on metabolic syndrome (MetS) among children is lacking in the United Arab Emirates which has among the highest rates of diabetes in the world. In this study we determined the prevalence of MetS and its correlates in a sample of adolescents. Materials and Methods: A cross-sectional school-based study was conducted on 1,018 adolescents (48.4% girls) aged 12-18 years from Al Ain Abu Dhabi Emirates. A self-administered questionnaire was used to assess socio-demographic characteristics, physical activity and dietary habits. Blood pressure, height, weight, waist circumference, fasting glucose, HDL-cholesterol and triglycerides were measured. MetS was defined using the International Diabetes Federation (IDF) criteria. Results: The prevalence of metabolic syndrome was 13%. Boys compared to girls were more likely to have MetS (21% vs. 4%, odds ratio [OR]: 6.57, 95% CI: 4.01 to 10.75). The prevalence of MetS increased with increase in body mass index and reached 59 percent in obese boys. After multivariable adjustment boys who were overweight (adjusted OR: 2.72 [1.37 to 5.35]), or obese (AOR: 12.70 [7.31 to 22.05]), or spent two or more than two hours on screen in a day (AOR: 1.65 [1.01 to 2.69) were more likely to have MetS. Girls who were overweight (AOR: 4.23 [1.32 to 13.62]) or obese (AOR: 8.32 [2.73 to 25.32]) were more likely to have MetS. Conclusions: The prevalence of MetS is high among UAE boys. Population-based strategies are needed to address the high burden of metabolic syndrome targeted at the identified risk factors.	[Mehairi, Aaesha E.; Khouri, Aysha A.; Naqbi, Muna M.; Muhairi, Shamma J.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Family Med, Al Ain, U Arab Emirates; [Maskari, Fatima A.; Nagelkerke, Nico; Shah, Syed M.] United Arab Emirates Univ, Inst Publ Hlth, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Shah, SM (corresponding author), United Arab Emirates Univ, Inst Publ Hlth, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.	syeds@uaeu.ac.ae		Al-Maskari, Fatma/0000-0001-6598-4942	UAE University Individual Faculty [01-14-8-11/09]; Tawam Hospital - Al Ain, United Arab Emirates; Faculty of Medicine and Health Sciences, UAE University	UAE University Individual Faculty; Tawam Hospital - Al Ain, United Arab Emirates; Faculty of Medicine and Health Sciences, UAE University	The authors' research was supported by a grant from the UAE University Individual Faculty Grant (# 01-14-8-11/09), Shah et al. Parents Assisting Children and Teachers (PACT) for Obesity Prevention, Seed grant by Faculty of Medicine and Health Sciences, UAE University (Al Maskari et al). The laboratory investigations of this study were funded by Tawam Hospital - Al Ain, United Arab Emirates and help of laboratory staff at Tawam hospital is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirbasli M, 2006, METABOLISM, V55, P1002, DOI 10.1016/j.metabol.2006.03.009; Agirbasli M, 2009, METABOLISM, V58, P1256, DOI 10.1016/j.metabol.2009.03.024; Al-Daghri NM, 2010, EUR J CLIN INVEST, V40, P1063, DOI 10.1111/j.1365-2362.2010.02341.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Caprio S, 2002, J PEDIATR ENDOCR MET, V15, P487; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Eapen V, 2010, J TROP PEDIATRICS, V56, P325, DOI 10.1093/tropej/fmp128; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ella NAA, 2010, J CLIN LIPIDOL, V4, P185, DOI 10.1016/j.jacl.2010.03.007; Esmaillzadeh A, 2006, OBESITY, V14, P377, DOI 10.1038/oby.2006.50; Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Giordano P, 2011, EUROPEAN J PEDIAT, V13; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Kang HT, 2010, DIABETES RES CLIN PR, V89, P72, DOI 10.1016/j.diabres.2010.02.016; Katzmarzyk PT, 2004, PEDIATRICS, V114, P198; Khader Y, 2010, INT J PEDIAT ENDOCRI, V3, P161; Kohen-Avramoglu R, 2003, CLIN BIOCHEM, V36, P413, DOI 10.1016/S0009-9120(03)00038-9; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Mirhosseini NZ, 2009, ASIA PAC J CLIN NUTR, V18, P131; Morrison JA, 2008, J PEDIAT, V152, P210; Morrison JA, 2007, PEDIATRICS, V120, P340, DOI 10.1542/peds.2006-1699; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Nguyen THHD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-141; Park J, 2010, J KOREAN MED SCI, V25, P75, DOI 10.3346/jkms.2010.25.1.75; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Wan Nai-jun, 2007, Zhonghua Er Ke Za Zhi, V45, P417	30	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56159	10.1371/journal.pone.0056159	http://dx.doi.org/10.1371/journal.pone.0056159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418529	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300121
J	Miyamoto, T; Chen, Y; Slone, J; Amrein, H				Miyamoto, Tetsuya; Chen, Yan; Slone, Jesse; Amrein, Hubert			Identification of a Drosophila Glucose Receptor Using Ca2+ Imaging of Single Chemosensory Neurons	PLOS ONE			English	Article							MOLECULAR EVOLUTION; GUSTATORY RECEPTORS; CAFFEINE RESPONSE; BITTER TASTE; FLY BRAIN; MELANOGASTER; GENES; SUPERFAMILY; PERCEPTION; TREHALOSE	Evaluation of food compounds by chemosensory cells is essential for animals to make appropriate feeding decisions. In the fruit fly Drosophila melanogaster, structurally diverse chemicals are detected by multimeric receptors composed of members of a large family of Gustatory receptor (Gr) proteins. Putative sugar and bitter receptors are expressed in distinct subsets of Gustatory Receptor Neurons (GRN) of taste sensilla, thereby assigning distinct taste qualities to sugars and bitter tasting compounds, respectively. Here we report a Ca2+ imaging method that allows association of ligand-mediated responses to a single GRN. We find that different sweet neurons exhibit distinct response profiles when stimulated with various sugars, and likewise, different bitter neurons exhibit distinct response profiles when stimulated with a set of bitter chemicals. These observations suggest that individual neurons within a taste modality are represented by distinct repertoires of sweet and bitter taste receptors, respectively. Furthermore, we employed this novel method to identify glucose as the primary ligand for the sugar receptor Gr61a, which is not only expressed in sweet sensing neurons of classical chemosensory sensilla, but also in two supersensitive neurons of atypical taste sensilla. Thus, single cell Ca2+ imaging can be employed as a powerful tool to identify ligands for orphan Gr proteins.	[Miyamoto, Tetsuya; Chen, Yan; Slone, Jesse; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Amrein, H (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA.	amrein@tamhsc.edu	Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250; Chen, Yan/0000-0002-5321-3064; Slone, Jesse/0000-0002-2478-3295	Taste Receptor Genes and Sensory Coding [NIH-1RO1GMDC0560]; Pheromone Receptor [NIH-1RO1DC009014]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009014, R01DC005606] Funding Source: NIH RePORTER	Taste Receptor Genes and Sensory Coding; Pheromone Receptor; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding provided by Taste Receptor Genes and Sensory Coding (NIH-1RO1GMDC0560) and From Pheromone Receptor to Social Behaviors (NIH-1RO1DC009014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Meunier N, 2003, CHEM SENSES, V28, P671, DOI 10.1093/chemse/bjg059; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1801; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Tanimura Teiichi, 2009, SEB Experimental Biology Series, V63, P59; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001	33	44	48	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56304	10.1371/journal.pone.0056304	http://dx.doi.org/10.1371/journal.pone.0056304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418550	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300143
J	Silva, TM; Andersson, S; Sukumaran, SK; Marques, MP; Persson, L; Oredsson, S				Silva, Tania Magalhaes; Andersson, Sara; Sukumaran, Sunil Kumar; Marques, Maria Paula; Persson, Lo; Oredsson, Stina			Norspermidine and Novel Pd(II) and Pt(II) Polynuclear Complexes of Norspermidine as Potential Antineoplastic Agents Against Breast Cancer	PLOS ONE			English	Article							POLYAMINE ANALOGS; CELL-CYCLE; ORNITHINE DECARBOXYLASE; MOLECULAR-MECHANISMS; BIOGENIC POLYAMINES; ANTITUMOR-ACTIVITY; SPERMINE ANALOG; METAL-COMPLEXES; DNA-SYNTHESIS; PLATINUM(II)	Background: New strategies are needed for breast cancer treatment and one initial step is to test new chemotherapeutic drugs in breast cancer cell lines, to choose candidates for further studies towards clinical use. Methodology and Findings: The cytotoxic effects of a biogenic polyamine analogue - norspermidine - and its trinuclear Pd(II) and Pt(II) complexes - Pd(3)NSpd(2) and Pt(3)NSpd(2), respectively - were investigated in one immortalized normal-like and three breast cancer cell lines. The normal-like MCF-10A cells were least sensitive to the compounds, while growth inhibition and cell death was observed in the cancer cell lines. Norspermidine and its Pd(II) complex were generally shown to have stronger antiproliferative effects than the corresponding Pt(II) complex. Moreover, both norspermidine and the Pd(II) complex reduced the cellular activity of the growth-related enzyme, ornithine decarboxylase (ODC) to a lower level than the Pt(II) complex in most of the cell lines examined. Treatment with norspermidine or the Pd(II) complex reduced the number of colonies formed in a soft agar assay performed with the breast cancer cell lines, indicating that these compounds reduced the malignancy of the breast cancer cells. The effect of norspermidine or the Pd(II) complex on colony formation was much stronger than that observed for the Pt(II) complex. The results from a new mammalian genotoxicity screen together with those of a single cell gel electrophoresis assay indicated that none of the drugs were genotoxic at a 25 mu M concentration. Main Conclusions: Overall, norspermidine and its Pd(II) complex were shown to have strong antiproliferative effects. In comparison, the effects obtained with the Pd(II) complex were much stronger than that of the Pt(II) complex. The results obtained in the present study demonstrate that the trinuclear Pd(II) complex of norspermidine (Pd(3)NSpd(2)) may be regarded as a potential new metal-based drug against breast cancer, coupling a significant efficiency to a low toxicity.	[Silva, Tania Magalhaes; Marques, Maria Paula] Univ Coimbra, Res Unit Mol Phys Chem, P-3000 Coimbra, Portugal; [Silva, Tania Magalhaes; Andersson, Sara; Oredsson, Stina] Lund Univ, Dept Biol, S-22100 Lund, Sweden; [Silva, Tania Magalhaes; Persson, Lo] Lund Univ, Dept Expt Med Sci, S-22100 Lund, Sweden; [Sukumaran, Sunil Kumar] Anthem Biosci Pvt Ltd, Bangalore, Karnataka, India; [Marques, Maria Paula] Univ Coimbra, Dept Life Sci, Fac Sci & Technol, P-3000 Coimbra, Portugal	Universidade de Coimbra; Lund University; Lund University; Universidade de Coimbra	Oredsson, S (corresponding author), Lund Univ, Dept Biol, S-22100 Lund, Sweden.	stina.oredsson@biol.lu.se	Marques, Maria Paula M./M-4130-2013; Silva, Tania/I-4730-2012	Marques, Maria Paula M./0000-0002-8391-0055; Silva, Tania/0000-0003-2914-3120; Oredsson, Stina/0000-0003-2529-7106	Portuguese Foundation for Science and Technology [SFRH/BD/46364/2008, PTDC/QUI/66701/2006, Pest-OE/Qui/UIOO700/2011]; European Community fund FEDER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Community fund FEDER(European Commission)	The authors also acknowledge financial support from the Portuguese Foundation for Science and Technology - SFRH/BD/46364/2008, projects PTDC/QUI/66701/2006 (co-financed by the European Community fund FEDER) and Pest-OE/Qui/UIOO700/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; Alm K, 1999, J CELL BIOCHEM, V75, P46, DOI 10.1002/(SICI)1097-4644(19991001)75:1<46::AID-JCB5>3.3.CO;2-E; Amado AM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2787528; de Carvalho LAEB, 2011, CHEMPHYSCHEM, V12, P1334, DOI 10.1002/cphc.201001067; BEGG AC, 1985, CYTOMETRY, V6, P620, DOI 10.1002/cyto.990060618; Bergeron RJ, 1997, J MED CHEM, V40, P1475, DOI 10.1021/jm960849j; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; Casero RA, 2009, J MED CHEM, V52, P4551, DOI 10.1021/jm900187v; Cirenajwis H, 2010, ANTI-CANCER DRUG, V21, P897, DOI 10.1097/CAD.0b013e32833f2f77; Collins A, 1997, ENVIRON MOL MUTAGEN, V30, P139, DOI 10.1002/(SICI)1098-2280(1997)30:2<139::AID-EM6>3.0.CO;2-I; Davidson NE, 1999, ENDOCR-RELAT CANCER, V6, P69, DOI 10.1677/erc.0.0060069; Decatris MP, 2005, CLIN ONCOL-UK, V17, P249, DOI 10.1016/j.clon.2005.04.001; Fiuza SM, 2006, LETT DRUG DES DISCOV, V3, P149, DOI 10.2174/157018006776286989; Fiuza SM, 2011, CHEM BIOL DRUG DES, V77, P477, DOI 10.1111/j.1747-0285.2011.01081.x; FREDLUND JO, 1994, CELL PROLIFERAT, V27, P243, DOI 10.1111/j.1365-2184.1994.tb01422.x; Fredlund JO, 1997, EUR J BIOCHEM, V249, P232, DOI 10.1111/j.1432-1033.1997.00232.x; Fredlund JO, 1996, CELL PROLIFERAT, V29, P457, DOI 10.1111/j.1365-2184.1996.tb00988.x; Freiburghaus C, 2009, J DAIRY SCI, V92, P2477, DOI 10.3168/jds.2008-1851; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Goncalves RF, 2011, LETT DRUG DES DISCOV, V8, P897; Gugliucci A, 2004, CLIN CHIM ACTA, V344, P23, DOI 10.1016/j.cccn.2004.02.022; HAMANA K, 1982, J BIOCHEM-TOKYO, V91, P1321, DOI 10.1093/oxfordjournals.jbchem.a133818; Heinick A, 2010, FASEB J, V24, P206, DOI 10.1096/fj.09-135889; Holst CM, 2008, ANTI-CANCER DRUG, V19, P871, DOI 10.1097/CAD.0b013e32830f902b; Holst CM, 2006, TOXICOLOGY, V223, P71, DOI 10.1016/j.tox.2006.03.009; Holst CM, 2005, TOXICOL IN VITRO, V19, P379, DOI 10.1016/j.tiv.2004.10.005; Huang Y, 2003, CLIN CANCER RES, V9, P2769; JANNE J, 1971, J BIOL CHEM, V246, P1725; Johannsson OT, 2003, LAB INVEST, V83, P387, DOI 10.1097/01.LAB.0000060030.10652.8C; Johansson VM, 2008, DNA CELL BIOL, V27, P511, DOI 10.1089/dna.2008.0750; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kjellstrom J, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-20; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Marques MPM, 2002, BBA-MOL CELL RES, V1589, P63, DOI 10.1016/S0167-4889(01)00186-0; Miklasova N, 2012, EUR J MED CHEM, V49, P41, DOI 10.1016/j.ejmech.2011.12.001; Myhre L, 2008, ANTI-CANCER DRUG, V19, P359, DOI 10.1097/CAD.0b013e3282f7f518; Nasizadeh S, 2005, EXP CELL RES, V308, P254, DOI 10.1016/j.yexcr.2005.04.027; Palmer AJ, 2010, AMINO ACIDS, V38, P415, DOI 10.1007/s00726-009-0400-2; PEGG AE, 1988, CANCER RES, V48, P759; PRAKASH NJ, 1988, ANTICANCER RES, V8, P563; Rezler EM, 1997, J MED CHEM, V40, P3508, DOI 10.1021/jm960854n; RODRIGUEZGARAY B, 1989, PLANT PHYSIOL, V89, P525, DOI 10.1104/pp.89.2.525; Seiler N, 2005, PHARMACOL THERAPEUT, V107, P99, DOI 10.1016/j.pharmthera.2005.02.001; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Silva TM, 2012, J INORG BIOCHEM, V108, P1, DOI 10.1016/j.jinorgbio.2011.11.021; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; Soares AS, 2007, LETT DRUG DES DISCOV, V4, P460, DOI 10.2174/157018007781788516; SOULE HD, 1990, CANCER RES, V50, P6075; Takao K, 2006, INT J BIOCHEM CELL B, V38, P621, DOI 10.1016/j.biocel.2005.10.020; Teixeira LJ, 2004, J MED CHEM, V47, P2917, DOI 10.1021/jm0311238; THORNTHWAITE JT, 1980, CYTOMETRY, V1, P229, DOI 10.1002/cyto.990010309; Tummala R, 2010, ONCOL REP, V24, P15, DOI 10.3892/or_00000823; Wallace HM, 2007, AMINO ACIDS, V33, P261, DOI 10.1007/s00726-007-0534-z; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wallace HM, 2003, BIOCHEM SOC T, V31, P393, DOI 10.1042/BST0310393; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691	59	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55651	10.1371/journal.pone.0055651	http://dx.doi.org/10.1371/journal.pone.0055651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418450	Green Published, gold			2022-12-25	WOS:000315970300041
J	Bohrer, G; Zhu, KP; Jones, RL; Curtis, PS				Bohrer, Gil; Zhu, Kunpeng; Jones, Robert L.; Curtis, Peter S.			Optimizing Wind Power Generation while Minimizing Wildlife Impacts in an Urban Area	PLOS ONE			English	Article							ENERGY DEVELOPMENT; BIRD MORTALITY; GOLDEN EAGLES; RESOURCE AREA; TURBINES; FARMS; RAPTORS; OPTIMIZATION; CONSERVATION; MIGRATION	The location of a wind turbine is critical to its power output, which is strongly affected by the local wind field. Turbine operators typically seek locations with the best wind at the lowest level above ground since turbine height affects installation costs. In many urban applications, such as small-scale turbines owned by local communities or organizations, turbine placement is challenging because of limited available space and because the turbine often must be added without removing existing infrastructure, including buildings and trees. The need to minimize turbine hazard to wildlife compounds the challenge. We used an exclusion zone approach for turbine-placement optimization that incorporates spatially detailed maps of wind distribution and wildlife densities with power output predictions for the Ohio State University campus. We processed public GIS records and airborne lidar point-cloud data to develop a 3D map of all campus buildings and trees. High resolution large-eddy simulations and long-term wind climatology were combined to provide land-surface-affected 3D wind fields and the corresponding wind-power generation potential. This power prediction map was then combined with bird survey data. Our assessment predicts that exclusion of areas where bird numbers are highest will have modest effects on the availability of locations for power generation. The exclusion zone approach allows the incorporation of wildlife hazard in wind turbine siting and power output considerations in complex urban environments even when the quantitative interaction between wildlife behavior and turbine activity is unknown.	[Bohrer, Gil; Zhu, Kunpeng; Jones, Robert L.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Curtis, Peter S.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bohrer, G (corresponding author), Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA.	bohrer.17@osu.edu	Bohrer, Gil/A-9731-2008	Bohrer, Gil/0000-0002-9209-9540	OSU Institute for Energy and the Environment; NASA-ROSES-2010-Climate and Biological Response grant [NNX11AP61G]; U.S. Department of Agriculture-National Institute for Food & Agriculture (NIFA) [CSREES-OHOR-2009-04566]; NSF [DEB0911461, DEB0918869, CBET-1033451]; U.S. Geological Survey through the Ohio Water Resources Center [G11AP20099]; Ohio Supercomputer Center [PAS0409-2]; Division Of Environmental Biology [0911461] Funding Source: National Science Foundation	OSU Institute for Energy and the Environment; NASA-ROSES-2010-Climate and Biological Response grant; U.S. Department of Agriculture-National Institute for Food & Agriculture (NIFA); NSF(National Science Foundation (NSF)); U.S. Geological Survey through the Ohio Water Resources Center; Ohio Supercomputer Center; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	OSU Institute for Energy and the Environment 2009 Seed grant. NASA-ROSES-2010-Climate and Biological Response grant #NNX11AP61G. RAFLES representation of buildings was developed with funding from U.S. Department of Agriculture-National Institute for Food & Agriculture (NIFA) - Air Quality grant CSREES-OHOR-2009-04566 and additional improvements to RAFLES were funded in part by NSF grants #DEB0911461 and #DEB0918869, data analysis for the campus 3-D map and eddy flux observations at the ORWRP were funded in part by NSF grant CBET-1033451, and The U.S. Geological Survey through the Ohio Water Resources Center grant #G11AP20099. Simulations were conducted at The Ohio Supercomputer Center grant #PAS0409-2. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, RENEW SUST ENERG REV, V15, P3839, DOI 10.1016/j.rser.2011.07.004; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Aydin NY, 2010, RENEW SUST ENERG REV, V14, P364, DOI 10.1016/j.rser.2009.07.023; Baisner AJ, 2010, ENVIRON MANAGE, V46, P801, DOI 10.1007/s00267-010-9541-z; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bohrer G, 2008, J ECOL, V96, P569, DOI 10.1111/j.1365-2745.2008.01368.x; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bohrer G, 2009, BOUND-LAY METEOROL, V132, P351, DOI 10.1007/s10546-009-9404-4; Bright J, 2008, BIOL CONSERV, V141, P2342, DOI 10.1016/j.biocon.2008.06.029; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; Celik AN, 2007, P I MECH ENG A-J POW, V221, P1107, DOI 10.1243/09576509JPE452; Chinnasamy T. V., 1991, Renewable Energy, V1, P815, DOI 10.1016/0960-1481(91)90032-K; Cionco RM, 1998, ATMOS ENVIRON, V32, P7, DOI 10.1016/S1352-2310(97)00274-4; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; Dodge S, 2012, WORKSH GISCIENCE BIG, P35; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Eichhorn M, 2012, ECOL SOC, V17, DOI 10.5751/ES-04594-170201; El-Shimy M, 2010, RENEW ENERG, V35, P1870, DOI 10.1016/j.renene.2009.12.013; Everaert J, 2007, BIODIVERS CONSERV, V16, P3345, DOI 10.1007/s10531-006-9082-1; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Gao YF, 2012, RENEW ENERG, V46, P148, DOI 10.1016/j.renene.2012.03.005; Garvin JC, 2011, J APPL ECOL, V48, P199, DOI 10.1111/j.1365-2664.2010.01912.x; Heath MA, 2007, WIND ENERGY, V10, P271, DOI 10.1002/we.222; Katsaprakakis DA, 2012, RENEW SUST ENERG REV, V16, P2850, DOI 10.1016/j.rser.2012.02.041; Katzner TE, 2012, J APPL ECOL, V49, P1178, DOI 10.1111/j.1365-2664.2012.02185.x; Kikuchi R, 2008, J NAT CONSERV, V16, P44, DOI 10.1016/j.jnc.2007.11.001; Kranstauber B, 2011, ENVIRON MODELL SOFTW, V26, P834, DOI 10.1016/j.envsoft.2010.12.005; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Ledo L, 2011, RENEW ENERG, V36, P1379, DOI 10.1016/j.renene.2010.10.030; Leung DYC, 2012, RENEW SUST ENERG REV, V16, P1031, DOI 10.1016/j.rser.2011.09.024; Mandel JT, 2011, ECOL APPL, V21, P2258, DOI 10.1890/10-1651.1; Marmidis G, 2008, RENEW ENERG, V33, P1455, DOI 10.1016/j.renene.2007.09.004; Masden EA, 2012, J R SOC INTERFACE, V9, P2120, DOI 10.1098/rsif.2012.0121; Mertens S., 2002, REFOCUS, V3, P22, DOI [DOI 10.1016/S1471-0846(02)80023-3, 10.1016/S1471-0846(02)80023-3]; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; MOSETTI G, 1994, J WIND ENG IND AEROD, V51, P105, DOI 10.1016/0167-6105(94)90080-9; Noguera JC, 2010, ARDEOLA, V57, P41; Osborn RG, 2000, AM MIDL NAT, V143, P41, DOI 10.1674/0003-0031(2000)143[0041:BMAWWT]2.0.CO;2; Pennington DN, 2008, BIOL CONSERV, V141, P1235, DOI 10.1016/j.biocon.2008.02.021; Rinne J, 2007, TELLUS B, V59, P449, DOI 10.1111/j.1600-0889.2007.00261.x; Rodewald PG, 2005, CONDOR, V107, P259, DOI 10.1650/7810; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; van Haaren R, 2011, RENEW SUST ENERG REV, V15, P3332, DOI 10.1016/j.rser.2011.04.010; Yu BL, 2010, LANDSCAPE URBAN PLAN, V98, P210, DOI 10.1016/j.landurbplan.2010.08.004; Yu W, 2006, WIND ENG, V30, P15, DOI 10.1260/030952406777641450	48	5	5	0	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56036	10.1371/journal.pone.0056036	http://dx.doi.org/10.1371/journal.pone.0056036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409117	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300051
J	Filiatrault, MJ; Tombline, G; Wagner, VE; Van Alst, N; Rumbaugh, K; Sokol, P; Schwingel, J; Iglewski, BH				Filiatrault, Melanie J.; Tombline, Gregory; Wagner, Victoria E.; Van Alst, Nadine; Rumbaugh, Kendra; Sokol, Pam; Schwingel, Johanna; Iglewski, Barbara H.			Pseudomonas aeruginosa PA1006, Which Plays a Role in Molybdenum Homeostasis, Is Required for Nitrate Utilization, Biofilm Formation, and Virulence	PLOS ONE			English	Article							METABOLIC NETWORK ANALYSIS; CYSTIC-FIBROSIS PATIENTS; QUORUM-SENSING SYSTEMS; ESCHERICHIA-COLI K-12; ANTIMICROBIAL RESISTANCE; AEROBIC DENITRIFICATION; TRANSCRIPTOME ANALYSIS; ANAEROBIC RESPIRATION; BIOSYNTHESIS GENES; TWITCHING MOTILITY	Pseudomonas aeruginosa (Pae) is a clinically important opportunistic pathogen. Herein, we demonstrate that the PA1006 protein is critical for all nitrate reductase activities, growth as a biofilm in a continuous flow system, as well as virulence in mouse burn and rat lung model systems. Microarray analysis revealed that DPA1006 cells displayed extensive alterations in gene expression including nitrate-responsive, quorum sensing (including PQS production), and iron-regulated genes, as well as molybdenum cofactor and Fe-S cluster biosynthesis factors, members of the TCA cycle, and Type VI Secretion System components. Phenotype Microarray (TM) profiles of DPA1006 aerobic cultures using Biolog plates also revealed a reduced ability to utilize a number of TCA cycle intermediates as well as a failure to utilize xanthine as a sole source of nitrogen. As a whole, these data indicate that the loss of PA1006 confers extensive changes in Pae metabolism. Based upon homology of PA1006 to the E. coli YhhP protein and data from the accompanying study, loss of PA1006 persulfuration and/or molybdenum homeostasis are likely the cause of extensive metabolic alterations that impact biofilm development and virulence in the Delta PA1006 mutant.	[Filiatrault, Melanie J.; Tombline, Gregory; Wagner, Victoria E.; Van Alst, Nadine; Schwingel, Johanna; Iglewski, Barbara H.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Rumbaugh, Kendra] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA; [Sokol, Pam] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	University of Rochester; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Calgary	Iglewski, BH (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Barbara_Iglewski@URMC.Rochester.edu			NIH [5R37AI033713]; Cystic Fibrosis Foundation Therapeutics grant [IGLEWS00V0]; American Diabetes Association [1-08-RA-165]; Canadian Institutes of Health Research [MOP 42510]; NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) [F32AI056825]; Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033713, F32AI056825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics grant; American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NRSA Postdoctoral fellowship from the National Institutes of Health (NIH); Cystic Fibrosis Foundation Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant NIH 5R37AI033713 and the Cystic Fibrosis Foundation Therapeutics grant IGLEWS00V0 to B. H. I. Mouse experiments were supported by an American Diabetes Association research grant #1-08-RA-165 to K. P. R. Rat lung experiments were supported by the Canadian Institutes of Health Research MOP 42510 to P. A. S. M. J. F. performed this work as a postdoctoral fellow at the University of Rochester and was supported by a NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) (F32AI056825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank A. Brooks, K. Miller, L. Ascroft, and K. Wahowski at the Microarray Core Facility in The Functional Genomics Center at the University of Rochester for technical support and assistance, the Cystic Fibrosis Foundation Therapeutics, Inc. for subsidizing the P. aeruginosa Affymetrix GeneChip (R) Arrays, Axel Magalon (CNRS; Marseille, FR) for kindly providing alpha-NarGH antisera. We would also like to especially thank Don Woods (U. Calgary) and Virginia Clark (U. Rochester) for helpful discussions and critical reading of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chen F, 2006, BIOTECHNOL BIOENG, V93, P1069, DOI 10.1002/bit.20812; Chen F, 2003, APPL ENVIRON MICROB, V69, P6715, DOI 10.1128/AEM.69.11.6715-6722.2003; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; Diaz-Perez AL, 2007, FEMS MICROBIOL LETT, V269, P309, DOI 10.1111/j.1574-6968.2007.00654.x; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; Glessner A, 1999, J BACTERIOL, V181, P1623, DOI 10.1128/JB.181.5.1623-1629.1999; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hassett DJ, 1996, J BACTERIOL, V178, P7322, DOI 10.1128/jb.178.24.7322-7325.1996; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Irani VR, 1997, CURR MICROBIOL, V35, P9, DOI 10.1007/s002849900202; Kerschen EJ, 2001, J BACTERIOL, V183, P2125, DOI 10.1128/JB.183.6.2125-2131.2001; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MACGREGOR CH, 1974, J BIOL CHEM, V249, P5321; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Palmer KL, 2007, J BACTERIOL, V189, P4449, DOI 10.1128/JB.00162-07; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Rumbaugh KP, 1999, J HOSP INFECT, V43, P211, DOI 10.1053/jhin.1999.0252; RUSSO TA, 1993, MOL MICROBIOL, V9, P357, DOI 10.1111/j.1365-2958.1993.tb01696.x; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Sambrook J, 2001, MOL CLONING LAB MANU; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; SIAS SR, 1979, ARCH MICROBIOL, V122, P263, DOI 10.1007/BF00411289; Silo-Suh L, 2002, P NATL ACAD SCI USA, V99, P15699, DOI 10.1073/pnas.242343999; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STEWART V, 1988, J BACTERIOL, V170, P1589, DOI 10.1128/jb.170.4.1589-1597.1988; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tombline G., 2013, PLOS ONE, V8; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Alst NE, 2007, INFECT IMMUN, V75, P3780, DOI 10.1128/IAI.00201-07; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wagner VE, 2004, VACCINE, V22, pS15, DOI 10.1016/j.vaccine.2004.08.011; Wagner Victoria E., 2008, P129; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; WOODS DE, 1982, INFECT IMMUN, V36, P1223, DOI 10.1128/IAI.36.3.1223-1228.1982; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	86	27	28	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55594	10.1371/journal.pone.0055594	http://dx.doi.org/10.1371/journal.pone.0055594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409004	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300023
J	Lin, GJ; Stralberg, D; Gong, GQ; Huang, ZL; Ye, WH; Wu, LF				Lin, Guojun; Stralberg, Diana; Gong, Guiquan; Huang, Zhongliang; Ye, Wanhui; Wu, Linfang			Separating the Effects of Environment and Space on Tree Species Distribution: From Population to Community	PLOS ONE			English	Article							GROWTH TEMPERATE FOREST; BETA-DIVERSITY; ECOLOGICAL DATA; SPATIAL DISTRIBUTIONS; NEIGHBOR MATRICES; TROPICAL FOREST; SEED DISPERSAL; CHINA; NICHE; PATTERNS	Quantifying the relative contributions of environmental conditions and spatial factors to species distribution can help improve our understanding of the processes that drive diversity patterns. In this study, based on tree inventory, topography and soil data from a 20-ha stem-mapped permanent forest plot in Guangdong Province, China, we evaluated the influence of different ecological processes at different spatial scales using canonical redundancy analysis (RDA) at the community level and multiple linear regression at the species level. At the community level, the proportion of explained variation in species distribution increased with grid-cell sizes, primarily due to a monotonic increase in the explanatory power of environmental variables. At the species level, neither environmental nor spatial factors were important determinants of overstory species' distributions at small cell sizes. However, purely spatial variables explained most of the variation in the distributions of understory species at fine and intermediate cell sizes. Midstory species showed patterns that were intermediate between those of overstory and understory species. At the 20-m cell size, the influence of spatial factors was stronger for more dispersal-limited species, suggesting that much of the spatial structuring in this community can be explained by dispersal limitation. Comparing environmental factors, soil variables had higher explanatory power than did topography for species distribution. However, both topographic and edaphic variables were highly spatial structured. Our results suggested that dispersal limitation has an important influence on fine-intermediate scale (from several to tens of meters) species distribution, while environmental variability facilitates species distribution at intermediate (from ten to tens of meters) and broad (from tens to hundreds of meters) scales.	[Lin, Guojun; Gong, Guiquan; Huang, Zhongliang; Ye, Wanhui; Wu, Linfang] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Lin, Guojun; Gong, Guiquan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Stralberg, Diana] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Alberta	Huang, ZL (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	huangzlscbg@163.com	Stralberg, Diana/W-9267-2019	Stralberg, Diana/0000-0003-4900-024X	National Natural Science Foundation of China [30970544]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (30970544). URL is http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bin Y, 2010, PLANT ECOL, V209, P237, DOI 10.1007/s11258-009-9708-y; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Brady NC, 2002, NATURE PROPERTIES SO, P363; Cain ML, 1998, ECOL MONOGR, V68, P325, DOI 10.1890/0012-9615(1998)068[0325:SDATHM]2.0.CO;2; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 1998, TROPICAL FOREST CENS, P37; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Diniz JAF, 2012, OIKOS, V121, P201, DOI 10.1111/j.1600-0706.2011.19563.x; Dray S, 2007, FORWARD SELECTION PE, P46; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Freestone AL, 2006, ECOLOGY, V87, P2425, DOI 10.1890/0012-9658(2006)87[2425:DLAEHS]2.0.CO;2; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Gleason SM, 2010, OECOLOGIA, V162, P1047, DOI 10.1007/s00442-009-1527-2; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He J, 1997, ACTA ECOLOGICA SINIC, V17, P91; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jombart T, 2009, ECOGRAPHY, V32, P161, DOI 10.1111/j.1600-0587.2008.05567.x; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Partel M, 2010, ECOLOGY, V91, P2565, DOI 10.1890/09-1016.1; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Pebesma EJ, 2010, GEOSTATISTICAL MODEL; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Stevenson PR, 2011, OECOLOGIA, V166, P693, DOI 10.1007/s00442-011-1926-z; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2012, ECOGRAPHY, V35, P961, DOI 10.1111/j.1600-0587.2012.07339.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Ye Wan-Hui, 2008, Zhiwu Shengtai Xuebao, V32, P274, DOI 10.3773/j.issn.1005-264x.2008.02.005; Zhang J, 2009, FOREST ECOL MANAG, V257, P2115, DOI 10.1016/j.foreco.2009.02.016; Zhang LW, 2011, PLANT SOIL, V347, P211, DOI 10.1007/s11104-011-0839-2	55	41	44	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56171	10.1371/journal.pone.0056171	http://dx.doi.org/10.1371/journal.pone.0056171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409151	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300063
J	Morita-Ishihara, T; Miura, M; Iyoda, S; Izumiya, H; Watanabe, H; Ohnishi, M; Terajima, J				Morita-Ishihara, Tomoko; Miura, Masashi; Iyoda, Sunao; Izumiya, Hidemasa; Watanabe, Haruo; Ohnishi, Makoto; Terajima, Jun			EspO1-2 Regulates EspM2-Mediated RhoA Activity to Stabilize Formation of Focal Adhesions in Enterohemorrhagic Escherichia coli-Infected Host Cells	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; PEDESTAL FORMATION; EFFECTORS TIR; STRESS FIBERS; RECEPTOR; GTPASES; CONTRACTILITY; PATHOGENS; MIGRATION; VIRULENCE	Enterohemorrhagic Escherichia coli (EHEC) Sakai strain encodes two homologous type III effectors, EspO1-1 and EspO1-2. These EspO1s have amino acid sequence homology with Shigella OspE, which targets integrin-linked kinase to stabilize formation of focal adhesions (FAs). Like OspE, EspO1-1 was localized to FAs in EHEC-infected cells, but EspO1-2 was localized in the cytoplasm. An EHEC Delta espO1-1 Delta espO1-2 double mutant induced cell rounding and FA loss in most of infected cells, but neither the Delta espO1-1 nor Delta espO1-2 single mutant did. These results suggested that EspO1-2 functioned in the cytoplasm by a different mechanism from EspO1-1 and OspE. Since several type III effectors modulate Rho GTPase, which contributes to FA formation, we investigated whether EspO1-2 modulates the function of these type III effectors. We identified a direct interaction between EspO1-2 and EspM2, which acts as a RhoA guanine nucleotide exchange factor. Upon ectopic co-expression, EspO1-2 co-localized with EspM2 in the cytoplasm and suppressed EspM2-mediated stress fiber formation. Consistent with these findings, an Delta espO1-1 Delta espO1-2 Delta espM2 triple mutant did not induce cell rounding in epithelial cells. These results indicated that EspO1-2 interacted with EspM2 to regulate EspM2-mediated RhoA activity and stabilize FA formation during EHEC infection.	[Morita-Ishihara, Tomoko; Iyoda, Sunao; Izumiya, Hidemasa; Watanabe, Haruo; Ohnishi, Makoto; Terajima, Jun] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Miura, Masashi] Nagasaki Univ, Dept Ecoepidemiol, Inst Trop Med, Nagasaki 852, Japan	National Institute of Infectious Diseases (NIID); Nagasaki University	Morita-Ishihara, T (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan.	ishihara@nih.go.jp	IYODA, SUNAO/AAS-8036-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [B-21790433]; Ministry of Health, Labour and Welfare of Japan [H24-Shinkou-Ippan-005]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (B-21790433) and grant-in-aids from the Ministry of Health, Labour and Welfare of Japan (H24-Shinkou-Ippan-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Arbeloa A, 2010, CELL MICROBIOL, V12, P654, DOI 10.1111/j.1462-5822.2009.01423.x; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Khyrul WAKM, 2004, J BIOL CHEM, V279, P54131, DOI 10.1074/jbc.M410051200; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Matsuzawa T, 2004, EMBO J, V23, P3570, DOI 10.1038/sj.emboj.7600359; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Simovitch M, 2010, CELL MICROBIOL, V12, P489, DOI 10.1111/j.1462-5822.2009.01410.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Weiss SM, 2009, CELL HOST MICROBE, V5, P244, DOI 10.1016/j.chom.2009.02.003	40	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55960	10.1371/journal.pone.0055960	http://dx.doi.org/10.1371/journal.pone.0055960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409096	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300048
J	Demidyuk, IV; Shubin, AV; Gasanov, EV; Kurinov, AM; Demkin, VV; Vinogradova, TV; Zinovyeva, MV; Sass, AV; Zborovskaya, IB; Kostrov, SV				Demidyuk, Ilya V.; Shubin, Andrey V.; Gasanov, Eugene V.; Kurinov, Alexander M.; Demkin, Vladimir V.; Vinogradova, Tatyana V.; Zinovyeva, Marina V.; Sass, Alexander V.; Zborovskaya, Irina B.; Kostrov, Sergey V.			Alterations in Gene Expression of Proprotein Convertases in Human Lung Cancer Have a Limited Number of Scenarios	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SQUAMOUS-CELL CARCINOMA; NEURON-SPECIFIC ENOLASE; NEUROENDOCRINE DIFFERENTIATION; MATRIX METALLOPROTEINASES; PULMONARY ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; OVARIAN-CANCER; GROWTH-FACTOR; TUMOR-CELLS	Proprotein convertases (PCs) is a protein family which includes nine highly specific subtilisin-like serine endopeptidases in mammals. The system of PCs is involved in carcinogenesis and levels of PC mRNAs alter in cancer, which suggests expression status of PCs as a possible marker for cancer typing and prognosis. The goal of this work was to assess the information value of expression profiling of PC genes. Quantitative polymerase chain reaction was used for the first time to analyze mRNA levels of all PC genes as well as matrix metalloproteinase genes MMP2 and MMP14, which are substrates of PCs, in 30 matched pairs of samples of human lung cancer tumor and adjacent tissues without pathology. Significant changes in the expression of PCs have been revealed in tumor tissues: increased FURIN mRNA level (p<0.00005) and decreased mRNA levels of PCSK2 (p<0.007), PCSK5 (p<0.0002), PCSK7 (p<0.002), PCSK9 (p<0.00008), and MBTPS1 (p<0.00004) as well as a tendency to increase in the level of PCSK1 mRNA. Four distinct groups of samples have been identified by cluster analysis of the expression patterns of PC genes in tumor vs. normal tissue. Three of these groups covering 80% of samples feature a strong elevation in the expression of a single gene in cancer: FURIN, PCSK1, or PCSK6. Thus, the changes in the expression of PC genes have a limited number of scenarios, which may reflect different pathways of tumor development and cryptic features of tumors. This finding allows to consider the mRNAs of PC genes as potentially important tumor markers.	[Demidyuk, Ilya V.; Shubin, Andrey V.; Gasanov, Eugene V.; Kurinov, Alexander M.; Demkin, Vladimir V.; Kostrov, Sergey V.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Vinogradova, Tatyana V.; Zinovyeva, Marina V.; Sass, Alexander V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Zborovskaya, Irina B.] Russian Acad Med Sci, Blokhin Canc Res Ctr, Moscow, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences	Demidyuk, IV (corresponding author), Russian Acad Sci, Inst Mol Genet, Kurchatov Sq, Moscow 123182, Russia.	duk@img.ras.ru	Kostrov, Sergey/J-6612-2018; Gasanov, Eugene/U-7902-2018; Demidyuk, Ilya V/D-1245-2009; Demkin, Vladimir/A-2122-2014	Gasanov, Eugene/0000-0002-5020-9406; Demidyuk, Ilya V/0000-0001-8140-2287; Kurinov, Alexander M./0000-0002-8190-5973; Demkin, Vladimir/0000-0002-3408-6100	Russian Academy of Sciences for Molecular and Cell Biology; Russian Academy of Sciences "Fundamental Science for Medicine"; Russian Foundation for Basic Research [12-04-00961, 12-04-01438]; Federal Program "R&D in Priority Directions of the Russian Scientific-Technological Complex Development" [02.522.11.2005, 16.512.12.2002]; Federal Program "The development of pharmaceutical and medical industry in the Russian Federation" [11411.1008700.13.084]; President of Russian Federation for Scientific Schools [5638.2010.4]	Russian Academy of Sciences for Molecular and Cell Biology; Russian Academy of Sciences "Fundamental Science for Medicine"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program "R&D in Priority Directions of the Russian Scientific-Technological Complex Development"; Federal Program "The development of pharmaceutical and medical industry in the Russian Federation"; President of Russian Federation for Scientific Schools	This work was supported in part by the Program of the Russian Academy of Sciences for Molecular and Cell Biology, the Program of the Russian Academy of Sciences "Fundamental Science for Medicine", Russian Foundation for Basic Research (project nos. 12-04-00961 and 12-04-01438), the Federal Program "R&D in Priority Directions of the Russian Scientific-Technological Complex Development in 2007-2012" (state contracts 02.522.11.2005 and 16.512.12.2002), the Federal Program "The development of pharmaceutical and medical industry in the Russian Federation until 2020 and beyond" (state contract 11411.1008700.13.084), and a grant of the President of Russian Federation for Scientific Schools (no. 5638.2010.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JM, 2007, EUR J CANCER, V43, P1764, DOI 10.1016/j.ejca.2007.05.009; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; BERENDSEN HH, 1989, J CLIN ONCOL, V7, P1614, DOI 10.1200/JCO.1989.7.11.1614; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; CARLES J, 1993, LUNG CANCER, V10, P209, DOI 10.1016/0169-5002(93)90181-V; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Cox G, 2001, THORAX, V56, P561, DOI 10.1136/thorax.56.7.561; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; D'Anjou F, 2011, TRANSL ONCOL, V4, P157, DOI 10.1593/tlo.10295; de Cicco RL, 2004, CLIN CANCER RES, V10, P4480, DOI 10.1158/1078-0432.CCR-03-0670; Eren B, 2008, ANN ACAD MED SINGAP, V37, P32; Estilo CL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-11; Fu YX, 2003, MOL CANCER RES, V1, P569; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Hiroshima K, 2002, ANN THORAC SURG, V73, P1732, DOI 10.1016/S0003-4975(02)03504-X; Hoikkala S, 2006, CANCER LETT, V236, P125, DOI 10.1016/j.canlet.2005.05.012; Howe MC, 2005, HISTOPATHOLOGY, V46, P195, DOI 10.1111/j.1365-2559.2005.02047.x; Hubbard FC, 1997, CANCER RES, V57, P5226; Ionescu DN, 2007, AM J SURG PATHOL, V31, P26, DOI 10.1097/01.pas.0000213319.04919.97; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koo BH, 2009, FEBS J, V276, P6271, DOI 10.1111/j.1742-4658.2009.07335.x; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Leinonen T, 2008, HISTOL HISTOPATHOL, V23, P693, DOI 10.14670/HH-23.693; LINNOILA RI, 1988, AM J CLIN PATHOL, V90, P641, DOI 10.1093/ajcp/90.6.641; LINNOILA RI, 1994, CHEST, V106, pS367, DOI 10.1378/chest.106.6.367S; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; NAKAGAWA H, 1994, JPN J CANCER RES, V85, P934, DOI 10.1111/j.1349-7006.1994.tb02971.x; Nawrocki B, 1997, INT J CANCER, V72, P556, DOI 10.1002/(SICI)1097-0215(19970807)72:4<556::AID-IJC2>3.3.CO;2-#; Page RE, 2007, CELL ONCOL, V29, P289; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pelosi G, 2003, CANCER-AM CANCER SOC, V97, P2487, DOI 10.1002/cncr.11376; Polette M, 1996, VIRCHOWS ARCH, V428, P29; Pujol JL, 2001, LUNG CANCER, V31, P221, DOI 10.1016/S0169-5002(00)00186-0; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rounseville MP, 2000, J MOL ENDOCRINOL, V25, P121, DOI 10.1677/jme.0.0250121; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SCOPSI L, 1995, J CLIN ENDOCR METAB, V80, P294, DOI 10.1210/jc.80.1.294; Segawa Y, 2009, J CANCER RES CLIN, V135, P1055, DOI 10.1007/s00432-009-0544-1; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; Shibru D, 2008, CANCER-AM CANCER SOC, V113, P930, DOI 10.1002/cncr.23703; SKOV BG, 1991, ANN ONCOL, V2, P355, DOI 10.1093/oxfordjournals.annonc.a057955; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Sterlacci W, 2009, VIRCHOWS ARCH, V455, P125, DOI 10.1007/s00428-009-0812-0; Tadros H, 2001, J REPROD IMMUNOL, V49, P133, DOI 10.1016/S0165-0378(00)00085-1; Thomas P, 2000, J PATHOL, V190, P150; TORII S, 1993, FEBS LETT, V316, P12, DOI 10.1016/0014-5793(93)81726-G; Tzimas GN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-149; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; Yamamura T, 2002, LUNG CANCER-J IASLC, V35, P249, DOI 10.1016/S0169-5002(01)00431-7; Yuasa K, 2007, GENE, V402, P103, DOI 10.1016/j.gene.2007.07.028; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	65	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55752	10.1371/journal.pone.0055752	http://dx.doi.org/10.1371/journal.pone.0055752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409034	gold, Green Submitted, Green Published			2022-12-25	WOS:000315157200059
J	Franck, D; Gil, ES; Adam, RM; Kaplan, DL; Chung, YG; Estrada, CR; Mauney, JR				Franck, Debra; Gil, Eun Seok; Adam, Rosalyn M.; Kaplan, David L.; Chung, Yeun Goo; Estrada, Carlos R., Jr.; Mauney, Joshua R.			Evaluation of Silk Biomaterials in Combination with Extracellular Matrix Coatings for Bladder Tissue Engineering with Primary and Pluripotent Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SMALL-INTESTINAL SUBMUCOSA; SMOOTH-MUSCLE-CELLS; URINARY-BLADDER; UROTHELIAL CELLS; ACELLULAR MATRIX; RETINOIC ACID; MURINE MODEL; DIFFERENTIATION; AUGMENTATION	Silk-based biomaterials in combination with extracellular matrix (ECM) coatings were assessed as templates for cell-seeded bladder tissue engineering approaches. Two structurally diverse groups of silk scaffolds were produced by a gel spinning process and consisted of either smooth, compact multi-laminates (Group 1) or rough, porous lamellar-like sheets (Group 2). Scaffolds alone or coated with collagen types I or IV or fibronectin were assessed independently for their ability to support attachment, proliferation, and differentiation of primary cell lines including human bladder smooth muscle cells (SMC) and urothelial cells as well as pluripotent cell populations, such as murine embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells. AlamarBlue evaluations revealed that fibronectin-coated Group 2 scaffolds promoted the highest degree of primary SMC and urothelial cell attachment in comparison to uncoated Group 2 controls and all Group 1 scaffold variants. Real time RT-PCR and immunohistochemical (IHC) analyses demonstrated that both fibronectin-coated silk groups were permissive for SMC contractile differentiation as determined by significant upregulation of alpha-actin and SM22 alpha mRNA and protein expression levels following TGF beta 1 stimulation. Prominent expression of epithelial differentiation markers, cytokeratins, was observed in urothelial cells cultured on both control and fibronectin-coated groups following IHC analysis. Evaluation of silk matrices for ESC and iPS cell attachment by alamarBlue showed that fibronectin-coated Group 2 scaffolds promoted the highest levels in comparison to all other scaffold formulations. In addition, real time RT-PCR and IHC analyses showed that fibronectin-coated Group 2 scaffolds facilitated ESC and iPS cell differentiation toward both urothelial and smooth muscle lineages in response to all trans retinoic acid as assessed by induction of uroplakin and contractile gene and protein expression. These results demonstrate that silk scaffolds support primary and pluripotent cell responses pertinent to bladder tissue engineering and that scaffold morphology and fibronectin coatings influence these processes.	[Franck, Debra; Adam, Rosalyn M.; Chung, Yeun Goo; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA; [Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tufts University	Mauney, JR (corresponding author), Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA.	joshua.mauney@childrens.harvard.edu	Estrada, Carlos R/H-2199-2015	Estrada, Carlos R/0000-0003-0586-9832	United States National Institutes of Health (NIH)/NIDDK [P50 DK065298]; NIH/NIDDK [K99DK083616-01A2]; NIH/NIBIB [P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK083616, R00DK083616, P50DK065298] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support was provided by United States National Institutes of Health (NIH)/NIDDK P50 DK065298 (ADAM/FREEMAN); NIH/NIDDK K99DK083616-01A2 (MAUNEY); NIH/NIBIB P41 EB002520 (KAPLAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Atala A, 2000, WORLD J UROL, V18, P364, DOI 10.1007/s003450000152; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Baker SC, 2008, BIOMATERIALS, V29, P3357, DOI 10.1016/j.biomaterials.2008.04.033; Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301; Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Choudhary S, 2006, INT J NANOMED, V1, P41, DOI 10.2147/nano.2006.1.1.41; Chun YW, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085104; Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008; Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067; Hensle Terry W, 2007, Curr Urol Rep, V8, P157, DOI 10.1007/s11934-007-0066-9; Hipp JA, 2008, BJU INT, V102, P741, DOI 10.1111/j.1464-410X.2008.07606.x; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Hwang WS, 2005, STEM CELL REV, V1, P99, DOI 10.1385/SCR:1:2:099; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Kaimoto T, 2010, HYPERTENSION, V56, P247, DOI 10.1161/HYPERTENSIONAHA.110.149781; Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064; Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025; Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Ning JW, 2011, CYTOTECHNOLOGY, V63, P531, DOI 10.1007/s10616-011-9376-3; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Rooney GE, 2010, REGEN MED, V5, P365, DOI 10.2217/RME.10.20; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Subramaniam R, 2011, J UROLOGY, V186, P2014, DOI 10.1016/j.juro.2011.07.031; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Wilson CB, 1996, WORLD J UROL, V14, pS30; Woodman JR, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-5; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x; Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2	47	42	43	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56237	10.1371/journal.pone.0056237	http://dx.doi.org/10.1371/journal.pone.0056237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409160	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200124
J	Hennessey, JC; McGuire, JJ				Hennessey, John C.; McGuire, John J.			Attenuated Vasodilator Effectiveness of Protease-Activated Receptor 2 Agonist in Heterozygous par2 Knockout Mice	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; OXIDATIVE STRESS; MOUSE MODEL; RAT AORTA; DYSFUNCTION; DISEASES; FEMALE	Studies of homozygous PAR2 gene knockout mice have described a mix of phenotypic effects in vitro and in vivo. However, there have been few studies of PAR2 heterozygous (wild-type/knockout; PAR2-HET) mice. The phenotypes of many hemi and heterozygous transgenic mice have been described as intermediates between those of wild-type and knockout animals. In our study we aimed to determine the effects of intermediary par2 gene zygosity on vascular tissue responses to PAR2 activation. Specifically, we compared the vasodilator effectiveness of the PAR2 activating peptide 2-furoyl-LIGRLO-amide in aortas of wild-type PAR2 homozygous (PAR2-WT) and PAR2-HET mice. In myographs under isometric tension conditions, isolated aortic rings were contracted by alpha 1-adrenoeceptor agonist (phenylephrine), and thromboxane receptor agonist (U46619) and then relaxation responses by the additions of 2-furoyl-LIGRLO-amide, acetylcholine, and nitroprusside were recorded. A Schild regression analysis of the inhibition by a PAR2 antagonist (GB-83) of PAR2 agonist-induced aortic ring relaxations was used to compare receptor expression in PAR2-WT to PAR2-HET. PAR2 mRNA in aortas was measured by quantitative real-time PCR. In aortas contracted by either phenylephrine or U46619, the maximum relaxations induced by 2-furoyl- LIGRLO-amide were less in PAR2-HET than in the gender-matched PAR2-WT. GB-83 was 3- to 4-fold more potent for inhibition of 2fly in PAR2-HET than in PAR2-WT. PAR2 mRNA content of aortas from PAR2-HET was not significantly different than in PAR2-WT. Acetylcholine-and nitroprusside-induced relaxations of aortas from PAR2-HET were not significantly different than in PAR2-WT and PAR2 knockout. An interesting secondary finding was that relaxations induced by agonists of PAR2 and muscarinic receptors were larger in females than in males. We conclude that the lower PAR2-mediated responses in PAR2-HET aortas are consistent with evidence of a lower quantity of functional receptor expression, despite the apparently normal PAR2 mRNA content in PAR2-HET aortas.	[Hennessey, John C.; McGuire, John J.] Mem Univ Newfoundland, Fac Med, Cardiovasc Res Grp, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	McGuire, JJ (corresponding author), Mem Univ Newfoundland, Fac Med, Cardiovasc Res Grp, Div Biomed Sci, St John, NF, Canada.	mcguire@mun.ca		McGuire, John/0000-0003-0302-3884	Canadian Institutes of Health Research Regional Partnership Program (CIHR RPP) [ROP 88065, RNL 120409]; Research and Development Corporation of Newfoundland and Labrador (Industrial Research and Innovation Fund [RDC NL: IRIF 0708-022, Leverage RD 5404.1146.106]; Canadian Foundation of Innovation (CFI) [10027]	Canadian Institutes of Health Research Regional Partnership Program (CIHR RPP)(Canadian Institutes of Health Research (CIHR)); Research and Development Corporation of Newfoundland and Labrador (Industrial Research and Innovation Fund; Canadian Foundation of Innovation (CFI)(Canada Foundation for Innovation)	This study was funded by grants to JJM from Canadian Institutes of Health Research Regional Partnership Program (CIHR RPP, ROP 88065; RNL 120409; http://www.cihr-irsc.gc.ca/), the Research and Development Corporation of Newfoundland and Labrador (Industrial Research and Innovation Fund; RDC NL: IRIF 0708-022, Leverage R&D 5404.1146.106; http://www.rdc.org/) and supported by infrastructure from the Canadian Foundation of Innovation (CFI; New Opportunities Fund 10027; http://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 1999, BRIT J PHARMACOL, V128, P1105, DOI 10.1038/sj.bjp.0702834; Aloysius UI, 2012, VASC PHARMACOL, V57, P81, DOI 10.1016/j.vph.2011.11.009; Barry GD, 2010, J MED CHEM, V53, P7428, DOI 10.1021/jm100984y; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; Chia Elizabeth, 2011, BMC Pharmacology, V11, P10, DOI 10.1186/1471-2210-11-10; Colquhoun D, 2007, TRENDS PHARMACOL SCI, V28, P608, DOI 10.1016/j.tips.2007.09.011; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; FEUERSTEIN TJ, 1994, N-S ARCH PHARMACOL, V350, P1; Grenczer M, 2010, CAN J PHYSIOL PHARM, V88, P1074, DOI [10.1139/Y10-089, 10.1139/y10-089]; Hansen KK, 2008, N-S ARCH PHARMACOL, V377, P377, DOI 10.1007/s00210-007-0194-2; Hollenberg MD, 1996, MOL PHARMACOL, V49, P229; Huang A, 2001, AM J PHYSIOL-HEART C, V280, pH2462, DOI 10.1152/ajpheart.2001.280.6.H2462; Javeshghani D, 2009, J AM SOC HYPERTENS, V3, P295, DOI 10.1016/j.jash.2009.07.002; Kagota S, 2011, BRIT J PHARMACOL, V164, P358, DOI 10.1111/j.1476-5381.2011.01356.x; Kanda Y, 2009, ENDOCR J, V56, P997, DOI 10.1507/endocrj.K09E-028; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Loch T, 2009, CARDIOVASC RES, V82, P448, DOI 10.1093/cvr/cvp092; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McGuire JJ, 2004, CURR PHARM DESIGN, V10, P2769, DOI 10.2174/1381612043383656; McGuire JJ, 2007, PFLUG ARCH EUR J PHY, V454, P535, DOI 10.1007/s00424-007-0226-2; Penela P, 2008, EMBO J, V27, P1206, DOI 10.1038/emboj.2008.55; Roganovic J, 2011, EUR J ORAL SCI, V119, P352, DOI 10.1111/j.1600-0722.2011.00851.x; Ryckebusch L, 2010, CIRC RES, V106, P686, DOI 10.1161/CIRCRESAHA.109.205732; Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278; Taguchi K, 2012, PHARMACOL RES, V65, P56, DOI 10.1016/j.phrs.2011.08.009; TAKEYASU K, 1979, LIFE SCI, V25, P1761, DOI 10.1016/0024-3205(79)90480-6	29	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55965	10.1371/journal.pone.0055965	http://dx.doi.org/10.1371/journal.pone.0055965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409098	gold, Green Accepted, Green Published			2022-12-25	WOS:000315157200094
J	Huang, M; Lu, SY; Shi, T; Zhao, YX; Chen, YY; Li, XB; Liu, XY; Huang, ZM; Zhang, J				Huang, Min; Lu, Shaoyong; Shi, Ting; Zhao, Yaxue; Chen, Yingyi; Li, Xiaobai; Liu, Xinyi; Huang, Zhimin; Zhang, Jian			Conformational Transition Pathway in the Activation Process of Allosteric Glucokinase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; MINIMUM ENERGY PATHS; ELASTIC BAND METHOD; REGULATORY BEHAVIOR; MNEMONICAL ENZYME; DIABETES-MELLITUS; MONOMERIC ENZYMES; SLOW TRANSITION; NUCLEIC-ACIDS; SADDLE-POINTS	Glucokinase (GK) is a glycolytic enzyme that plays an important role in regulating blood glucose level, thus acting as a potentially attractive target for drug discovery in the treatment of diabetes of the young type 2 and persistent hyperinsulinemic hypoglycemia of infancy. To characterize the activation mechanism of GK from the super-open state (inactive state) to the closed state (active state), a series of conventional molecular dynamics (MD) and targeted MD (TMD) simulations were performed on this enzyme. Conventional MD simulation showed a specific conformational ensemble of GK when the enzyme is inactive. Seven TMD simulations depicted a reliably conformational transition pathway of GK from the inactive state to the active state, and the components important to the conformational change of GK were identified by analyzing the detailed structures of the TMD trajectories. In combination with the inactivation process, our findings showed that the whole conformational pathway for the activation-inactivation-activation of GK is a one-direction circulation, and the active state is less stable than the inactive state in the circulation. Additionally, glucose was demonstrated to gradually modulate its binding pose with the help of residues in the large domain and connecting region of GK during the activation process. Furthermore, the obtained energy barriers were used to explain the preexisting equilibrium and the slow binding kinetic process of the substrate by GK. The simulated results are in accordance with the recent findings from the mutagenesis experiments and kinetic analyses. Our observations reveal a complicated conformational process in the allosteric protein, resulting in new knowledge about the delicate mechanisms for allosteric biological macromolecules that will be useful in drug design for targeting allosteric proteins.	[Huang, Min; Lu, Shaoyong; Shi, Ting; Zhao, Yaxue; Chen, Yingyi; Li, Xiaobai; Liu, Xinyi; Huang, Zhimin; Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn	huang, zhimin o/R-4712-2018; Zhang, Jian/GXA-1303-2022; liu, xinyi/GWZ-8739-2022; huang, zhimin/H-7878-2013	huang, zhimin o/0000-0001-9230-6039; Zhang, Jian/0000-0002-6558-791X; 	National Basic Research Program of China (973 Program) [2011CB504001]; National Natural Science Foundation of China [21002062, 21102090]; Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program [10PJ406800]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program(Shanghai Pujiang Program)	This work was supported in part by grants from the National Basic Research Program of China (973 Program) (2011CB504001), the National Natural Science Foundation of China (21002062, 21102090), the Innovative Research Team of Shanghai Municipal Education Commission, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, and Shanghai PuJiang Program (10PJ406800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE GR, 1972, J BIOL CHEM, V247, P7088; Al-Hasani Hadi, 2003, Mol Interv, V3, P367, DOI 10.1124/mi.3.7.367; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bergonzo C, 2009, INT J QUANTUM CHEM, V109, P3781, DOI 10.1002/qua.22405; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Heredia VV, 2006, BIOCHEMISTRY-US, V45, P7553, DOI 10.1021/bi060253q; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Kong YF, 2002, P NATL ACAD SCI USA, V99, P5999, DOI 10.1073/pnas.092051099; Larion M, 2010, BIOCHEMISTRY-US, V49, P8902, DOI 10.1021/bi1008672; LIN SX, 1990, J BIOL CHEM, V265, P9670; Lindsley JE, 2006, P NATL ACAD SCI USA, V103, P10533, DOI 10.1073/pnas.0604452103; Lu SY, 2012, AMINO ACIDS, V43, P267, DOI 10.1007/s00726-011-1070-4; Lu SY, 2011, J MOL GRAPH MODEL, V30, P167, DOI 10.1016/j.jmgm.2011.07.003; Lu SY, 2011, J CHEM INF MODEL, V51, P1025, DOI 10.1021/ci100493j; Lu SY, 2011, BIOPOLYMERS, V95, P669, DOI 10.1002/bip.21629; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; MEUNIER JC, 1974, EUR J BIOCHEM, V49, P209, DOI 10.1111/j.1432-1033.1974.tb03826.x; Molnes J, 2008, FEBS J, V275, P2467, DOI 10.1111/j.1742-4658.2008.06391.x; Munro G, 2009, TRENDS PHARMACOL SCI, V30, P453, DOI 10.1016/j.tips.2009.06.004; Neet K E, 1980, Methods Enzymol, V64, P192; NEET KE, 1990, BIOCHEMISTRY-US, V29, P770, DOI 10.1021/bi00455a026; Ralph EC, 2009, BIOCHEMISTRY-US, V48, P2514, DOI 10.1021/bi900020n; RICARD J, 1974, EUR J BIOCHEM, V49, P195, DOI 10.1111/j.1432-1033.1974.tb03825.x; Rodriguez-Barrios F, 2005, J AM CHEM SOC, V127, P7570, DOI 10.1021/ja042289g; Rodriguez-Barrios F, 2004, J AM CHEM SOC, V126, P15386, DOI 10.1021/ja045409t; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Zelent B, 2008, BIOCHEM J, V413, P269, DOI 10.1042/BJ20071718; Zhang J, 2006, P NATL ACAD SCI USA, V103, P13368, DOI 10.1073/pnas.0605738103	53	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55857	10.1371/journal.pone.0055857	http://dx.doi.org/10.1371/journal.pone.0055857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409066	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200077
J	Jovanovic, V; Aziz, NA; Lim, YT; Poh, ANA; Chan, SJH; Pei, EHX; Lew, FC; Shui, GH; Jenner, AM; Li, BW; McKinney, EF; Lyons, PA; Kemeny, MD; Smith, KGC; Wenk, MR; MacAry, PA				Jovanovic, Vojislav; Aziz, Nurhuda Abdul; Lim, Yan Ting; Poh, Amanda Ng Ai; Chan, Sherlynn Jin Hui; Pei, Eliza Ho Xin; Lew, Fei Chuin; Shui, Guanghou; Jenner, Andrew M.; Li Bowen; McKinney, Eoin F.; Lyons, Paul A.; Kemeny, Michael D.; Smith, Kenneth G. C.; Wenk, Markus R.; MacAry, Paul A.			Lipid Anti-Lipid Antibody Responses Correlate with Disease Activity in Systemic Lupus Erythematosus	PLOS ONE			English	Article							APOPTOTIC CELLS; CHOLESTEROL HOMEOSTASIS; OXIDATIVE STRESS; ACTIVITY INDEX; HUMAN BRAIN; 24S-HYDROXYCHOLESTEROL; AUTOANTIBODIES; BILAG; TRANSDUCTION; CIRCULATION	Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder characterized by broad clinical manifestations including cardiovascular and renal complications with periodic disease flares and significant morbidity and mortality. One of the main contributing factors to the pathology of SLE is the accumulation and impaired clearance of immune complexes of which the principle components are host auto-antigens and antibodies. The contribution of host lipids to the formation of these autoimmune complexes remains poorly defined. The aim of the present study was to identify and analyze candidate lipid autoantigens and their corresponding anti-lipid antibody responses in a well-defined SLE patient cohort using a combination of immunological and biophysical techniques. Disease monitoring in the SLE cohort was undertaken with serial British Isles Lupus Assessment Group (BILAG) scoring. Correlations between specific lipid/anti-lipid responses were investigated as disease activity developed from active flares to quiescent during a follow up period. We report a significant negative correlation between anti-lipid antibodies for 24S-hydroxycholesterol, cardiolipin and phosphatidylserine with SLE disease activity. Taken together, these data suggest that lipid autoantigens represent a new family of biomarkers that can be employed to monitor disease activity plus the efficacy of therapeutic intervention in SLE.	[Jovanovic, Vojislav; Aziz, Nurhuda Abdul; Lim, Yan Ting; Poh, Amanda Ng Ai; Chan, Sherlynn Jin Hui; Pei, Eliza Ho Xin; Lew, Fei Chuin; Kemeny, Michael D.; MacAry, Paul A.] Natl Univ Singapore, Immunol Programme, Singapore 117548, Singapore; [Jovanovic, Vojislav; Aziz, Nurhuda Abdul; Lim, Yan Ting; Poh, Amanda Ng Ai; Chan, Sherlynn Jin Hui; Pei, Eliza Ho Xin; Lew, Fei Chuin; Kemeny, Michael D.; MacAry, Paul A.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [McKinney, Eoin F.; Lyons, Paul A.; Smith, Kenneth G. C.] Cambridge Inst Med Res, Cambridge, England; [McKinney, Eoin F.; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Dept Med, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Jenner, Andrew M.] Univ Wollongong, Illawara Hlth & Med Res Inst, Sch Biol Sci, Wollongong, NSW 2522, Australia	National University of Singapore; National University of Singapore; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National University of Singapore; University of Wollongong	MacAry, PA (corresponding author), Natl Univ Singapore, Immunol Programme, Singapore 117548, Singapore.	micpam@nus.edu.sg	jenner, andrew M/H-4791-2016; Wenk, Markus Rene/D-1441-2014; jenner, andrew/AGZ-2767-2022	jenner, andrew M/0000-0003-1767-2033; jenner, andrew/0000-0003-1767-2033; MacAry, Paul/0000-0002-1139-8996; McKinney, Eoin/0000-0003-3516-3072; Smith, Kenneth/0000-0003-3829-4326; Shui, Guanghou/0000-0002-1621-9643	Singapore National Research Foundation [NRF370062-HUJ-NUS]; Singapore National Medical Research Council [NMRC/1164/2008, 2007-04]; National Medical Research Council, "STOP-Dengue TCR"; National Medical Research Council; STOP-Dengue TCR; NCIS [C-000-999-002-001]; National Research Foundation [NRF-182-000-218-281, NRF2-182-005-172-281]; Wellcome Trust; NIHR Cambridge Biomedical Research Centre; Biomedical Research Council of Singapore [R-183-000-211-305];  [NMRC-182-003-220-275]	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore National Medical Research Council(National Medical Research Council, Singapore); National Medical Research Council, "STOP-Dengue TCR"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); STOP-Dengue TCR; NCIS; National Research Foundation; Wellcome Trust(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); 	This work was supported by a grant from the Singapore National Research Foundation NRF370062-HUJ-NUS, "Generation of monoclonal antibodies as tools for targeting inflammatory diseases" (to P.A.M. and D.M.K); a grant from the Singapore National Medical Research Council NMRC/1164/2008, "A comparative transcriptional analysis of Systemic Lupus Erythematosus in UK (Caucasian) and Singapore (Chinese) Patients" (to P.A.M. and D.M.K); National Medical Research Council, "STOP-Dengue TCR", NMRC-182-003-220-275, and NCIS C-000-999-002-001 and the National Research Foundation NRF-182-000-218-281 and NRF2-182-005-172-281 (to P.A.M). K.G.C.S was supported by the Wellcome Trust and NIHR Cambridge Biomedical Research Centre. M.R.W. was supported by Singapore National Research Foundation under CRPAward No. 2007-04 and the Biomedical Research Council of Singapore (R-183-000-211-305).	Abou-Raya A, 2004, CLIN INVEST MED, V27, P306; Alarcon GS, 1998, ARTHRITIS RHEUM-US, V41, P1173, DOI 10.1002/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO;2-A; Ames PRJ, 1999, RHEUMATOLOGY, V38, P529, DOI 10.1093/rheumatology/38.6.529; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bjorkhem I, 2011, J LIPID RES, V52, P170, DOI 10.1194/jlr.D011072; Bjorkhem I, 2002, CURR OPIN LIPIDOL, V13, P247, DOI 10.1097/00041433-200206000-00003; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bjorkhem I, 2011, NAT IMMUNOL, V12, P577, DOI 10.1038/ni0711-577a; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Descloux E, 2008, RHEUMATOLOGY, V47, P183, DOI 10.1093/rheumatology/kem335; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis L, 2009, EXPERT OPIN PHARMACO, V10, P1481, DOI 10.1517/14656560902971003; Fusaro AE, 2010, J CLIN IMMUNOL, V30, P872, DOI 10.1007/s10875-010-9453-y; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Griffiths WJ, 2010, J LIPID RES, V52, P4; Gronwall C, 2012, CLIN IMMUNOL, V142, P390, DOI 10.1016/j.clim.2012.01.002; HAY EM, 1993, Q J MED, V86, P447; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Isenberg DA, 2000, LUPUS, V9, P651, DOI 10.1191/096120300672904669; Jenks SA, 2009, AUTOIMMUN REV, V8, P209, DOI 10.1016/j.autrev.2008.07.047; Kim JH, 2010, J NEUROCHEM, V112, P34, DOI 10.1111/j.1471-4159.2009.06449.x; Kirou KA, 2006, RHEUM DIS CLIN N AM, V32, P103, DOI 10.1016/j.rdc.2005.12.001; KOSUGI I, 1992, J HEPATOL, V16, P106, DOI 10.1016/S0168-8278(05)80102-3; Kritharides L, 1996, J BIOL CHEM, V271, P27450, DOI 10.1074/jbc.271.44.27450; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Leoni V, 2002, NEUROSCI LETT, V331, P163, DOI 10.1016/S0304-3940(02)00887-X; Li W, 2009, FREE RADICAL RES, V43, P1072, DOI 10.1080/10715760903176919; Liu CC, 2005, CURR OPIN RHEUMATOL, V17, P543, DOI 10.1097/01.bor.0000174182.70159.22; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Mehrani T, 2011, J RHEUMATOL, V38, P450, DOI 10.3899/jrheum.100650; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Munoz LE, 2008, AUTOIMMUN REV, V7, P594, DOI 10.1016/j.autrev.2008.06.003; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Navarra SV, 2010, LUPUS; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Ortona E, 2010, BLOOD, V116, P2960, DOI 10.1182/blood-2010-04-279208; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Qin J, 2007, J NEUROSCI RES, V85, P977, DOI 10.1002/jnr.21206; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Shafaati M, 2011, J LIPID RES; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Smith MF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2834; Smith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016; Smith RM, 2010, NAT REV RHEUMATOL, V6, P547, DOI 10.1038/nrrheum.2010.117; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; Szodoray P, 2009, AUTOIMMUNITY, V42, P497, DOI 10.1080/08916930902882731; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tenbrock K, 2007, RHEUMATOLOGY, V46, P1525, DOI 10.1093/rheumatology/kem154; Yasunobu Y, 2001, ATHEROSCLEROSIS, V155, P445, DOI 10.1016/S0021-9150(00)00581-5; Zuliani G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-121	60	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55639	10.1371/journal.pone.0055639	http://dx.doi.org/10.1371/journal.pone.0055639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409013	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200046
J	Liu, Y; Wang, DK; Jiang, DZ; Qin, X; Xie, ZD; Wang, QK; Liu, MG; Chen, LM				Liu, Ying; Wang, Deng-Ke; Jiang, De-Zhi; Qin, Xue; Xie, Zhang-Dong; Wang, Qing K.; Liu, Mugen; Chen, Li-Ming			Cloning and Functional Characterization of Novel Variants and Tissue-Specific Expression of Alternative Amino and Carboxyl Termini of Products of Slc4a10	PLOS ONE			English	Article							DRIVEN CL-/HCO3-EXCHANGER; CHRONIC CONTINUOUS HYPOXIA; NA+-HCO3-COTRANSPORTER; SPLICE VARIANTS; CHOROID-PLEXUS; BASOLATERAL MEMBRANE; GENE-PRODUCT; NBCE1; NCBE; IDENTIFICATION	Previous studies have shown that the electroneutral Na+/HCO3- cotransporter NBCn2 (SLC4A10) is predominantly expressed in the central nervous system (CNS). The physiological and pathological significances of NBCn2 have been well recognized. However, little is known about the tissue specificity of expression of different NBCn2 variants. Moreover, little is known about the expression of NBCn2 proteins in systems other than CNS. Here, we identified a set of novel Slc4a10 variants differing from the originally described ones by containing a distinct 59 untranslated region encoding a new extreme amino-terminus (Nt). Electrophysiology measurements showed that both NBCn2 variants with alternative Nt contain typical electroneutral Na+-coupled HCO3- transport activity in Xenopus oocytes. Luciferase reporter assay showed that Slc4a10 contains two alternative promoters responsible for expression of the two types of NBCn2 with distinct extreme Nt. Western blotting showed that NBCn2 proteins with the original Nt are primarily expressed in CNS, whereas those with the novel Nt are predominantly expressed in the kidney and to a lesser extent in the small intestine. Due to alternative splicing, the known NBCn2 variants contain two types of carboxyl-termini (CT) differing in the optional inclusion of a PDZ-binding motif. cDNA cloning showed that virtually all NBCn2 variants expressed in epithelial tissues contain, but the vast majority of those from the neural tissues lack the PDZ-binding motif. We conclude that alternative transcription and splicing of Slc4a10 products are regulated in a tissue-specific manner. Our findings provide critical insights that will greatly influence the study of the physiology of NBCn2.	[Liu, Ying; Wang, Deng-Ke; Jiang, De-Zhi; Xie, Zhang-Dong; Chen, Li-Ming] Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Key Lab Mol Biophys, Minist Educ,Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Qin, Xue] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wang, Qing K.; Liu, Mugen] Huazhong Univ Sci & Technol, Dept Genet & Dev Biol, Key Lab Mol Biophys, Minist Educ,Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Case Western Reserve University; Huazhong University of Science & Technology	Chen, LM (corresponding author), Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Key Lab Mol Biophys, Minist Educ,Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	liming.chen@mail.hust.edu.cn	Chen, Li-Ming/AAU-2363-2021	Chen, Li-Ming/0000-0002-8129-9563	National Natural Science Foundation of China [30900513, 31000517, 31271208]; Fundamental Research Funds for the Central Universities of China [2011TS031, 2010MS123]; National Institutes of Health [NS18400 (WFB)]; American Heart Association [09POST2060873, 11POST7670014]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018400] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Natural Science Foundation of China grants 30900513 (YL), 31000517 and 31271208 (L-MC) as well as by grants 2011TS031 (L-MC) and 2010MS123 (YL) from the Fundamental Research Funds for the Central Universities of China as well as National Institutes of Health grant NS18400 (WFB). XQ was supported by grants 09POST2060873 and 11POST7670014 from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 2000, GENE, V251, P109, DOI 10.1016/S0378-1119(00)00204-3; Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Boedtkjer E, 2012, INT J CANC; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; Chen LM, 2008, NEUROSCIENCE, V151, P374, DOI 10.1016/j.neuroscience.2007.10.015; Chen LM, 2008, BRAIN RES, V1238, P85, DOI 10.1016/j.brainres.2008.08.033; Chen LM, 2007, AM J PHYSIOL-REG I, V293, pR2412, DOI 10.1152/ajpregu.00497.2007; Chen LM, 2011, J PHYSIOL-LONDON, V589, P877, DOI 10.1113/jphysiol.2010.198713; Choi I, 2002, FASEB J, V16, pA796; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Damkier HH, 2012, AM J PHYSIOL-CELL PH, V302, pC1452, DOI 10.1152/ajpcell.00285.2011; Damkier HH, 2010, J BIOL CHEM, V285, P26998, DOI 10.1074/jbc.M110.108712; Damkier HH, 2009, AM J PHYSIOL-CELL PH, V296, pC1291, DOI 10.1152/ajpcell.00062.2009; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Groger N, 2012, HUM MOL GENET, V21, P1025, DOI 10.1093/hmg/ddr533; Gurnett CA, 2008, ARCH NEUROL-CHICAGO, V65, P550, DOI 10.1001/archneur.65.4.550; Hilgen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046155; Horita S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/391762; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Lee SK, 2012, AM J PHYSIOL-CELL PH, V302, pC518, DOI 10.1152/ajpcell.00352.2011; Lee YS, 2006, FEBS LETT, V580, P4865, DOI 10.1016/j.febslet.2006.07.075; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Liu Y, 2010, NEUROSCIENCE, V169, P951, DOI 10.1016/j.neuroscience.2010.06.005; Liu Ying, 2012, Shengli Xuebao, V64, P729; Liu Y, 2011, GENOMICS, V98, P112, DOI 10.1016/j.ygeno.2011.04.010; Liu Y, 2011, BRAIN RES, V1390, P33, DOI 10.1016/j.brainres.2011.03.046; Marino CR, 1999, AM J PHYSIOL-GASTR L, V277, pG487, DOI 10.1152/ajpgi.1999.277.2.G487; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Parker MD, 2008, J BIOL CHEM, V283, P12777, DOI 10.1074/jbc.M707829200; Parker MD, 2008, PHYSIOL GENOMICS, V34, P265, DOI 10.1152/physiolgenomics.90259.2008; Parker MD, 2007, FASEB J, V21, pA1285; Parker MD, 2013, PHYSL REV IN PRESS; Praetorius J, 2004, AM J PHYSIOL-RENAL, V286, pF903, DOI 10.1152/ajprenal.00437.2002; Praetorius J, 2004, AM J PHYSIOL-CELL PH, V286, pC601, DOI 10.1152/ajpcell.00240.2003; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Snead CM, 2011, EUR J ORAL SCI, V119, P136, DOI 10.1111/j.1600-0722.2011.00867.x; SOLEIMANI M, 1987, J CLIN INVEST, V79, P1276, DOI 10.1172/JCI112948; Stutz AM, 2009, EUR J HUM GENET, V17, P1481, DOI 10.1038/ejhg.2009.64; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Krepischi AC, 2010, EPILEPSIA, V51, P2457, DOI 10.1111/j.1528-1167.2010.02742.x; Vorum H, 2000, AM J PHYSIOL-RENAL, V279, pF901, DOI 10.1152/ajprenal.2000.279.5.F901; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475; Yano H, 2000, CYTOGENET CELL GENET, V89, P276, DOI 10.1159/000015633; Yu HY, 2009, AM J PHYSIOL-GASTR L, V297, pG1223, DOI 10.1152/ajpgi.00157.2009	55	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55974	10.1371/journal.pone.0055974	http://dx.doi.org/10.1371/journal.pone.0055974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409100	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200095
J	Pepin, KM; Wang, J; Webb, CT; Hoeting, JA; Poss, M; Hudson, PJ; Hong, WS; Zhu, HC; Guan, Y; Riley, S				Pepin, Kim M.; Wang, Jia; Webb, Colleen T.; Hoeting, Jennifer A.; Poss, Mary; Hudson, Peter J.; Hong, Wenshan; Zhu, Huachen; Guan, Yi; Riley, Steven			Anticipating the Prevalence of Avian Influenza Subtypes H9 and H5 in Live-Bird Markets	PLOS ONE			English	Article							TRANSMISSION CHARACTERISTICS; PANDEMIC PREPAREDNESS; MATHEMATICAL-MODELS; RELATIVE-HUMIDITY; MEASLES EPIDEMICS; HUMAN INFECTIONS; A VIRUS; DYNAMICS; PERSISTENCE; SALINITY	An ability to forecast the prevalence of specific subtypes of avian influenza viruses (AIV) in live-bird markets would facilitate greatly the implementation of preventative measures designed to minimize poultry losses and human exposure. The minimum requirement for developing predictive quantitative tools is surveillance data of AIV prevalence sampled frequently over several years. Recently, a 4-year time series of monthly sampling of hemagglutinin subtypes 1-13 in ducks, chickens and quail in live-bird markets in southern China has become available. We used these data to investigate whether a simple statistical model, based solely on historical data (variables such as the number of positive samples in host X of subtype Y time t months ago), could accurately predict prevalence of H5 and H9 subtypes in chickens. We also examined the role of ducks and quail in predicting prevalence in chickens within the market setting because between-species transmission is thought to occur within markets but has not been measured. Our best statistical models performed remarkably well at predicting future prevalence (pseudo-R-2 = 0.57 for H9 and 0.49 for H5), especially considering the multi-host, multi-subtype nature of AIVs. We did not find prevalence of H5/H9 in ducks or quail to be predictors of prevalence in chickens within the Chinese markets. Our results suggest surveillance protocols that could enable more accurate and timely predictive statistical models. We also discuss which data should be collected to allow the development of mechanistic models.	[Pepin, Kim M.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Pepin, Kim M.; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Wang, Jia; Hong, Wenshan; Zhu, Huachen; Guan, Yi] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Peoples R China; [Wang, Jia; Zhu, Huachen; Guan, Yi; Riley, Steven] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Hoeting, Jennifer A.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Poss, Mary; Hudson, Peter J.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Riley, Steven] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Colorado State University; Shantou University; University of Hong Kong; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Imperial College London	Guan, Y (corresponding author), Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Peoples R China.	yguan@hkucc.hku.hk; s.riley@imperial.ac.uk	Hudson, Peter/AAB-8080-2020; Zhu, Huachen/A-8252-2017	Hudson, Peter/0000-0003-0468-3403; Zhu, Huachen/0000-0003-2711-0501; Riley, Steven/0000-0001-7904-4804; Guan, Yi/0000-0001-6057-9243	RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security; Fogarty International Center, NIH; NIH Fogarty Center [R01 TW008246-01]; Wellcome Trust [093488/Z/10/Z]; Medical Research Council (UK) [MR/J008761/1]; European Union [278433-PREDEMICS]; Medical Research Council [G0600719B, MR/K010174/1B, MR/K010174/1, MR/J008761/1] Funding Source: researchfish; MRC [MR/K010174/1, MR/J008761/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER	RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH Fogarty Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the RAPIDD program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, NIH. SR was also funded by: the NIH Fogarty Center (R01 TW008246-01), the Wellcome Trust (University Award 093488/Z/10/Z), The Medical Research Council (UK, Project Grant MR/J008761/1) and European Union Seventh Framework Programme (FP7/2007-2013, Grant Agreement no278433-PREDEMICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Gotway CA, 2003, STAT MED, V22, P1415, DOI 10.1002/sim.1523; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Jadhao SJ, 2009, ARCH VIROL, V154, P1249, DOI 10.1007/s00705-009-0429-2; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Lebarbenchon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026566; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Long JS, 1997, REGRESSION MODELS CA, P104; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; McVernon J, 2007, INFLUENZA OTHER RESP, V1, P43, DOI 10.1111/j.1750-2659.2007.00008.x; Negovetich NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019311; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pepin KM, 2013, INFLUENZA OTHER RESP, V7, P97, DOI 10.1111/j.1750-2659.2012.00354.x; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031114; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Tsukamoto K, 2007, AVIAN DIS, V51, P129, DOI 10.1637/0005-2086(2007)051[0129:IODHCO]2.0.CO;2; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; Van Kerkhove MD, 2012, B WORLD HEALTH ORGAN, V90, P306, DOI 10.2471/BLT.11.097949; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; Yang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050770; Yao ML, 2011, BERL MUNCH TIERARZTL, V124, P136, DOI 10.2376/0005-9366-124-136; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	41	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56157	10.1371/journal.pone.0056157	http://dx.doi.org/10.1371/journal.pone.0056157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409145	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200118
J	Taipale, RS; Hakkinen, K				Taipale, Ritva S.; Hakkinen, Keijo			Acute Hormonal and Force Responses to Combined Strength and Endurance Loadings in Men and Women: The "Order Effect"	PLOS ONE			English	Article							HEAVY-RESISTANCE EXERCISE; GROWTH-HORMONE; IGF-I; NEUROMUSCULAR PERFORMANCE; CONCURRENT ENDURANCE; TRAINING SEQUENCE; STEROID-HORMONES; MAXIMAL STRENGTH; SKELETAL-MUSCLE; RUNNING ECONOMY	Purpose: To examine acute responses and recovery of serum hormones and muscle force following combined strength (S) and endurance (E) loading sessions in which the order of exercises is reversed (ES vs. SE). Methods: This cross-over study design included recreationally endurance trained men and women (age 21-45 years, n = 12 men n = 10 women) who performed both loadings. Maximal bilateral isometric strength (MVC), isometric rate of force development (RFD) and serum concentrations of testosterone (T), cortisol (C), growth hormone (GH), insulin-like growth factor 1 (IGF-1), binding protein 3 (IGFBP3) and sex hormone binding globulin (SHBG) were measured during and after both loadings. Results: Both of the present combined (ES and SE) loadings led to a greater acute decrease in MVC in men than in women, while RFD was slightly affected only in men. Recovery of MVC and RFD to baseline was complete at 24 h regardless of the order of exercises. In men, neuromuscular fatigue was accompanied by increased C concentrations observed post SE. This was followed by decreased concentrations of T at 24 h and 48 h that were significantly lower than those observed following ES. GH response in men also differed significantly post loadings. In women, only a significant difference in T between ES and SE loadings was observed at post. Conclusion: These observed differences in hormonal responses despite similarities in neuromuscular fatigue in men indicate the presence of an order effect as the body was not fully recovered at 48 h following SE. These findings may be applicable in training prescription in order to optimize specific training adaptations.	[Taipale, Ritva S.; Hakkinen, Keijo] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland	University of Jyvaskyla	Taipale, RS (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	ritva.taipale@jyu.fi		Mikkonen (Taipale), Ritva/0000-0002-5668-2202	Department of Biology of Physical Activity, University of Jyvaskyla	Department of Biology of Physical Activity, University of Jyvaskyla	Funding for this project was provided by the Department of Biology of Physical Activity, University of Jyvaskyla. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1986, INT J SPORTS MED, V7, P27; Ahtiainen JP, 2003, EUR J APPL PHYSIOL, V89, P555, DOI 10.1007/s00421-003-0833-3; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Bell GJ, 2000, EUR J APPL PHYSIOL, V81, P418, DOI 10.1007/s004210050063; Cadore EL, 2012, J STRENGTH CONDITION; Chtara M, 2005, BRIT J SPORT MED, V39, P555, DOI 10.1136/bjsm.2004.015248; Chtara M, 2008, J STRENGTH COND RES, V22, P1037, DOI 10.1519/JSC.0b013e31816a4419; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Copeland JL, 2002, J GERONTOL A-BIOL, V57, pB158, DOI 10.1093/gerona/57.4.B158; Daly W, 2005, EUR J APPL PHYSIOL, V93, P375, DOI 10.1007/s00421-004-1223-1; Galliven EA, 1997, J APPL PHYSIOL, V83, P1822; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Goto K, 2005, EUR J APPL PHYSIOL, V94, P333, DOI 10.1007/s00421-004-1296-x; HAKKINEN K, 1993, INT J SPORTS MED, V14, P53, DOI 10.1055/s-2007-1021146; HAKKINEN K, 1985, EUR J APPL PHYSIOL O, V53, P287, DOI 10.1007/BF00422840; HAKKINEN K, 1993, ACTA PHYSIOL SCAND, V148, P199, DOI 10.1111/j.1748-1716.1993.tb09549.x; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341, DOI 10.1152/jappl.1998.84.4.1341; HAKKINEN K, 1986, EUR J APPL PHYSIOL O, V55, P588, DOI 10.1007/BF00423202; Hakkinen K, 1995, INT J SPORTS MED, V16, P507, DOI 10.1055/s-2007-973045; HAKKINEN K, 1993, J APPL PHYSIOL, V74, P882, DOI 10.1152/jappl.1993.74.2.882; HAKKINEN K, 1988, INT J SPORTS MED, V9, P422, DOI 10.1055/s-2007-1025044; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; Izquierdo M, 2004, J SPORT SCI, V22, P465, DOI 10.1080/02640410410001675342; Kanaley JA, 1997, J APPL PHYSIOL, V83, P1756, DOI 10.1152/jappl.1997.83.5.1756; Kanaley JA, 2001, J CLIN ENDOCR METAB, V86, P2881, DOI 10.1210/jc.86.6.2881; Kraemer WJ, 2010, CURR SPORT MED REP, V9, P242, DOI 10.1249/JSR.0b013e3181e976df; Kraemer WJ, 1999, J APPL PHYSIOL, V87, P982, DOI 10.1152/jappl.1999.87.3.982; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; KRAEMER WJ, 1995, J APPL PHYSIOL, V79, P1310, DOI 10.1152/jappl.1995.79.4.1310; KRAEMER WJ, 1990, J APPL PHYSIOL, V69, P1442, DOI 10.1152/jappl.1990.69.4.1442; Kraemer WJ, 1998, EUR J APPL PHYSIOL O, V78, P69, DOI 10.1007/s004210050389; Kraemer WJ, 2001, EUR J APPL PHYSIOL, V84, P13, DOI 10.1007/s004210000322; Linnamo V, 2005, J STRENGTH COND RES, V19, P566; Linnamo V, 1998, EUR J APPL PHYSIOL, V77, P176; Mauras N, 2005, GROWTH HORM IGF RES, V15, P19, DOI 10.1016/j.ghir.2004.12.003; McCaulley GO, 2009, EUR J APPL PHYSIOL, V105, P695, DOI 10.1007/s00421-008-0951-z; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Miikola JS, 2007, J STRENGTH COND RES, V21, P613, DOI 10.1519/R-20045.1; Mikkola J, 2011, J SPORT SCI, V29, P1359, DOI 10.1080/02640414.2011.589467; Nindl BC, 2007, BRIT J SPORT MED, V41, P346, DOI 10.1136/bjsm.2006.028951; Nindl BC, 2011, GROWTH HORM IGF RES, V21, P124, DOI 10.1016/j.ghir.2011.03.001; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Schilling BK, 2012, J STRENGTH CONDITION; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Storen O, 2008, MED SCI SPORT EXER, V40, P1087, DOI 10.1249/MSS.0b013e318168da2f; Tremblay MS, 2005, EUR J APPL PHYSIOL, V94, P505, DOI 10.1007/s00421-005-1380-x; Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003; VIITASALO J T, 1980, Electromyography and Clinical Neurophysiology, V20, P487; Viru AM, 2001, EUR J APPL PHYSIOL, V85, P578, DOI 10.1007/s004210100498; Vuorimaa T, 1999, EUR J APPL PHYSIOL O, V80, P575, DOI 10.1007/s004210050636; WELTMAN A, 1992, J APPL PHYSIOL, V72, P2188, DOI 10.1152/jappl.1992.72.6.2188	51	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55051	10.1371/journal.pone.0055051	http://dx.doi.org/10.1371/journal.pone.0055051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408956	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200016
J	Yeo, SK; Huggett, MJ; Eiler, A; Rappe, MS				Yeo, Sara K.; Huggett, Megan J.; Eiler, Alexander; Rappe, Michael S.			Coastal Bacterioplankton Community Dynamics in Response to a Natural Disturbance	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; LIVING BACTERIAL COMMUNITIES; ESTUARINE BACTERIOPLANKTON; PHYLOGENETIC ANALYSIS; MICROBIAL DIVERSITY; SALINITY GRADIENT; MARINE-BACTERIA; CLONE LIBRARIES; CHESAPEAKE BAY	In order to characterize how disturbances to microbial communities are propagated over temporal and spatial scales in aquatic environments, the dynamics of bacterial assemblages throughout a subtropical coastal embayment were investigated via SSU rRNA gene analyses over an 8-month period, which encompassed a large storm event. During non-perturbed conditions, sampling sites clustered into three groups based on their microbial community composition: an offshore oceanic group, a freshwater group, and a distinct and persistent coastal group. Significant differences in measured environmental parameters or in the bacterial community due to the storm event were found only within the coastal cluster of sampling sites, and only at 5 of 12 locations; three of these sites showed a significant response in both environmental and bacterial community characteristics. These responses were most pronounced at sites close to the shoreline. During the storm event, otherwise common bacterioplankton community members such as marine Synechococcus sp. and members of the SAR11 clade of Alphaproteobacteria decreased in relative abundance in the affected coastal zone, whereas several lineages of Gammaproteobacteria, Betaproteobacteria, and members of the Roseobacter clade of Alphaproteobacteria increased. The complex spatial patterns in both environmental conditions and microbial community structure related to freshwater runoff and wind convection during the perturbation event leads us to conclude that spatial heterogeneity was an important factor influencing both the dynamics and the resistance of the bacterioplankton communities to disturbances throughout this complex subtropical coastal system. This heterogeneity may play a role in facilitating a rapid rebound of regions harboring distinctly coastal bacterioplankton communities to their pre-disturbed taxonomic composition.	[Yeo, Sara K.; Huggett, Megan J.; Eiler, Alexander; Rappe, Michael S.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Yeo, Sara K.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System	Rappe, MS (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	rappe@hawaii.edu	Eiler, Alexander/V-9220-2017; Yeo, Sara K./A-5430-2009; Huggett, Megan/ABB-9400-2021; Huggett, Megan/G-3328-2012	Eiler, Alexander/0000-0001-9916-9567; Yeo, Sara K./0000-0002-2043-8400; Huggett, Megan/0000-0002-3401-0704	National Science Foundation [DEB-0207085]; Center for Microbial Oceanography: Research and Education (NSF Science and Technology Center) [EF-0424599]; Hawaii Sea Grant [R/EL-37]; Pacific Research Center for Marine Biomedicine [NSF OCE04-32479, NIEHS P50 ES012740]	National Science Foundation(National Science Foundation (NSF)); Center for Microbial Oceanography: Research and Education (NSF Science and Technology Center)(National Science Foundation (NSF)); Hawaii Sea Grant; Pacific Research Center for Marine Biomedicine	This research was supported by funding from National Science Foundation grant DEB-0207085, the Center for Microbial Oceanography: Research and Education (NSF Science and Technology Center Award EF-0424599), Hawaii Sea Grant Project R/EL-37, and the Pacific Research Center for Marine Biomedicine (NSF OCE04-32479, NIEHS P50 ES012740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2007, FEMS MICROBIOL ECOL, V60, P98, DOI 10.1111/j.1574-6941.2006.00276.x; ARMSTRONG FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Bernhardt H, 1967, TECHN S; BIDLE KD, 1995, APPL ENVIRON MICROB, V61, P944, DOI 10.1128/AEM.61.3.944-952.1995; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Brandon ML, 2006, THESIS U HAWAII MANO; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Clarke AR, 1993, MAR ECOL PROG SER, V92, P205; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Cox EF, 2006, MAR ECOL PROG SER, V324, P19, DOI 10.3354/meps324019; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hoover DJ, 2002, THESIS U HAWAII MANO; Kan J, 2008, AQUAT MICROB ECOL, V51, P55, DOI 10.3354/ame01177; Kan JJ, 2006, AQUAT MICROB ECOL, V42, P7, DOI 10.3354/ame042007; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Liao PC, 2007, MICROB ECOL, V54, P497, DOI 10.1007/s00248-007-9217-2; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Miller M. A., 2010, CIPRES PORTALS; MONGER BC, 1993, APPL ENVIRON MICROB, V59, P905, DOI 10.1128/AEM.59.3.905-911.1993; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Nogales B, 2007, ENVIRON MICROBIOL, V9, P1913, DOI 10.1111/j.1462-2920.2007.01308.x; Osborne CA, 2006, APPL ENVIRON MICROB, V72, P1270, DOI 10.1128/AEM.72.2.1270-1278.2006; Ostrander CE, 2008, ESTUAR COAST, V31, P192, DOI 10.1007/s12237-007-9001-z; Piccini C, 2006, APPL ENVIRON MICROB, V72, P6560, DOI 10.1128/AEM.01089-06; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Ringuet S, 2005, ESTUARIES, V28, P327, DOI 10.1007/BF02693916; Simu K, 2004, APPL ENVIRON MICROB, V70, P2445, DOI 10.1128/AEM.70.4.2445-2451.2004; SMITH SV, 1981, PAC SCI, V35, P279; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Suzuki MT, 2001, ENVIRON MICROBIOL, V3, P323, DOI 10.1046/j.1462-2920.2001.00198.x; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; US Environmental Protection Agency, 1983, METH CHEM AN WAT WAS; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; WILLEMS A, 1989, INT J SYST BACTERIOL, V39, P319, DOI 10.1099/00207713-39-3-319; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	58	60	61	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56207	10.1371/journal.pone.0056207	http://dx.doi.org/10.1371/journal.pone.0056207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409156	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200122
J	Zuena, AR; Giuli, C; Pesciolini, AV; Tramutola, A; Ajmone-Cat, MA; Cinque, C; Alema, GS; Giovine, A; Peluso, G; Minghetti, L; Nicolai, R; Calamandrei, G; Casolini, P				Zuena, Anna Rita; Giuli, Chiara; Pesciolini, Aldina Venerosi; Tramutola, Antonella; Ajmone-Cat, Maria Antonietta; Cinque, Carlo; Alema, Giovanni Sebastiano; Giovine, Angela; Peluso, Gianfranco; Minghetti, Luisa; Nicolai, Raffaella; Calamandrei, Gemma; Casolini, Paola			Transplacental Exposure to AZT Induces Adverse Neurochemical and Behavioral Effects in a Mouse Model: Protection by L-Acetylcarnitine	PLOS ONE			English	Article							ACETYL-L-CARNITINE; REVERSE-TRANSCRIPTASE INHIBITORS; PERSISTENT MITOCHONDRIAL DYSFUNCTION; METABOTROPIC GLUTAMATE RECEPTORS; ANTIRETROVIRAL TOXIC NEUROPATHY; TO-CHILD TRANSMISSION; IN-UTERO EXPOSURE; PERINATAL EXPOSURE; SYNAPTIC PLASTICITY; CD-1 MICE	Maternal-fetal HIV-1 transmission can be prevented by administration of AZT, alone or in combination with other antiretroviral drugs to pregnant HIV-1-infected women and their newborns. In spite of the benefits deriving from this life-saving prophylactic therapy, there is still considerable uncertainty on the potential long-term adverse effects of antiretroviral drugs on exposed children. Clinical and experimental studies have consistently shown the occurrence of mitochondrial dysfunction and increased oxidative stress following prenatal treatment with antiretroviral drugs, and clinical evidence suggests that the developing brain is one of the targets of the toxic action of these compounds possibly resulting in behavioral problems. We intended to verify the effects on brain and behavior of mice exposed during gestation to AZT, the backbone of antiretroviral therapy during human pregnancy. We hypothesized that glutamate, a neurotransmitter involved in excitotoxicity and behavioral plasticity, could be one of the major actors in AZT-induced neurochemical and behavioral alterations. We also assessed the antioxidant and neuroprotective effect of L-acetylcarnitine, a compound that improves mitochondrial function and is successfully used to treat antiretroviral-induced polyneuropathy in HIV-1 patients. We found that transplacental exposure to AZT given per os to pregnant mice from day 10 of pregnancy to delivery impaired in the adult offspring spatial learning and memory, enhanced corticosterone release in response to acute stress, increased brain oxidative stress also at birth and markedly reduced expression of mGluR1 and mGluR5 subtypes and GluR1 subunit of AMPA receptors in the hippocampus. Notably, administration during the entire pregnancy of L-acetylcarnitine was effective in preventing/ameliorating the neurochemical, neuroendocrine and behavioral adverse effects induced by AZT in the offspring. The present preclinical findings provide a mechanistic hypothesis for the neurobehavioral effects of AZT and strongly suggest that preventive administration of L-acetylcarnitine might be effective in reducing the neurological side-effects of antiretroviral therapy in fetus/newborn.	[Zuena, Anna Rita; Giuli, Chiara; Tramutola, Antonella; Cinque, Carlo; Alema, Giovanni Sebastiano; Giovine, Angela; Casolini, Paola] Univ Roma La Sapienza, Fac Med 1, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Pesciolini, Aldina Venerosi; Ajmone-Cat, Maria Antonietta; Calamandrei, Gemma] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Neurotoxicol & Neuroendocrinol, I-00161 Rome, Italy; [Minghetti, Luisa] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Expt Neurol, I-00161 Rome, Italy; [Nicolai, Raffaella] Corp R&D Sigma Tau SpA, Therapeut Area Life Cycle Management, Rome, Italy; [Peluso, Gianfranco] CNR, Inst Biochem Prot, I-80125 Naples, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR)	Calamandrei, G (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Neurotoxicol & Neuroendocrinol, Viale Regina Elena 299, I-00161 Rome, Italy.	gemma.calamandrei@iss.it	Tramutola, Antonella/AAA-9240-2022; Cinque, Carlo/AAD-6216-2019; Alemà, Giovanni Sebastiano/D-2672-2009; Minghetti, Luisa/I-9540-2014; CAT, MARIA ANTONIETTA AJMONE/E-7699-2018; Venerosi, Aldina/AAI-2808-2020; Calamandrei, Gemma/M-3815-2014	Tramutola, Antonella/0000-0002-9564-2086; Alemà, Giovanni Sebastiano/0000-0003-2350-6365; Minghetti, Luisa/0000-0002-7065-4689; CAT, MARIA ANTONIETTA AJMONE/0000-0002-7003-0972; Venerosi, Aldina/0000-0002-6599-0581; Calamandrei, Gemma/0000-0003-3762-3132	University of Rome [C26F09YEXM]; Sigma-Tau I.F.R. SpA (Rome) [D.S./2007/C.R./no6]; Sigma Tau-IFR S.p.A., Italy	University of Rome; Sigma-Tau I.F.R. SpA (Rome); Sigma Tau-IFR S.p.A., Italy	The study was supported by funds to P.C. from University of Rome (faculty project 2009 prot. C26F09YEXM) and partly sponsored by Sigma-Tau I.F.R. SpA (Rome) (D.S./2007/C.R./no6). Raffaella Niccolai is an employee of the SIGMA TAU and participated in manuscript preparation and data analysis as an expert of acetylcarnitine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Doctor Raffaella Nicolai is employed at Sigma-tau S.p.A. as Medical Research Senior Advisor; Raffaella Nicolai and Paola Casolini have been designated among inventors in the following European patent application: 11137170.3-2112 "Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is on treatment with azidothymidine". Part of this study has been financially supported by Sigma Tau-IFR S.p.A., Italy that has synthesized and provided L-acetylcarnitine. Sigma-tau is an Italian pharmaceutical company involved in research on carnitine system which produces and sells carnitine as drugs. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There are no other competing interests to declare.	Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; Balschun D, 1999, LEARN MEMORY, V6, P138; Bannerman DM, 2006, PSYCHOPHARMACOLOGY, V188, P552, DOI 10.1007/s00213-006-0403-6; Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006; Bergink V, 2004, EUR NEUROPSYCHOPHARM, V14, P175, DOI 10.1016/S0924-977X(03)00100-7; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; Bishop JB, 2004, ENVIRON MOL MUTAGEN, V43, P3, DOI 10.1002/em.10210; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Bortolotto ZA, 1999, CURR OPIN NEUROBIOL, V9, P299, DOI 10.1016/S0959-4388(99)80044-0; BRANN DW, 1994, FRONT NEUROENDOCRIN, V15, P3, DOI 10.1006/frne.1994.1002; Brogly SB, 2011, AIDS RES HUM RETROV, V27, P777, DOI [10.1089/aid.2010.0204, 10.1089/AID.2010.0204]; Busidan Y, 1999, PHARMACOL BIOCHEM BE, V64, P479, DOI 10.1016/S0091-3057(99)00157-4; Busidan Y, 1999, NEUROTOXICOL TERATOL, V21, P359, DOI 10.1016/S0892-0362(99)00003-3; Calamandrei G, 2002, NEUROTOXICOL TERATOL, V24, P529, DOI 10.1016/S0892-0362(02)00234-9; Calamandrei G, 2000, PHARMACOL BIOCHEM BE, V67, P511, DOI 10.1016/S0091-3057(00)00386-5; Calamandrei G, 1999, NEUROTOXICOLOGY, V20, P17; Calamandrei G, 1999, NEUROTOXICOL TERATOL, V21, P29, DOI 10.1016/S0892-0362(98)00035-X; Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191; Chappuy H, 2004, ANTIMICROB AGENTS CH, V48, P4332, DOI 10.1128/AAC.48.11.4332-4336.2004; Chase C, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e25; Cinque C, 2003, NEUROSCIENCE, V122, P277, DOI 10.1016/S0306-4522(03)00442-1; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X; DARLINGTON DN, 1989, AM J PHYSIOL, V256, pR112, DOI 10.1152/ajpregu.1989.256.1.R112; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Diamond DM, 1996, BEHAV NEUROSCI, V110, P661, DOI 10.1037/0735-7044.110.4.661; Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P201, DOI 10.1002/em.20201; Divi RL, 2010, TOXICOL SCI, V118, P191, DOI 10.1093/toxsci/kfq235; Divi RL, 2004, AIDS, V18, P1013, DOI 10.1097/00002030-200404300-00009; Esposito S, 1999, J DEV BEHAV PEDIATR, V20, P411, DOI 10.1097/00004703-199912000-00002; Famularo G, 1997, AIDS, V11, P185, DOI 10.1097/00002030-199702000-00008; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Frick KM, 2000, NEUROSCIENCE, V95, P293; Friese G, 2001, ANTIVI THER S4, V6, P44; Gerschenson M, 2000, AIDS RES HUM RETROV, V16, P635, DOI 10.1089/088922200308864; Greco A, 2004, CURR NEUROVASC RES, V1, P341, DOI 10.2174/1567202043362036; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hart AM, 2004, AIDS, V18, P1549, DOI 10.1097/01.aids.0000131354.14408.fb; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Herman JP, 2004, ANN NY ACAD SCI, V1018, P35, DOI 10.1196/annals.1296.004; Herzmann C, 2005, HIV CLIN TRIALS, V6, P344, DOI 10.1310/CH1N-YBNU-G3CU-JBXR; Jezova D, 2005, ENDOCRINE, V28, P287, DOI 10.1385/ENDO:28:3:287; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Landreau-Mascaro A, 2002, LANCET, V359, P583, DOI 10.1016/S0140-6736(02)07717-6; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Liu L, 1999, BRAIN RES, V821, P134, DOI 10.1016/S0006-8993(99)01085-9; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; MAKARA GB, 1975, NEUROENDOCRINOLOGY, V18, P213, DOI 10.1159/000122400; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mellins CA, 2005, J ADOLESCENT HEALTH, V36, P342, DOI 10.1016/j.jadohealth.2004.02.038; Mellins CA, 2003, PEDIATRICS, V111, P384, DOI 10.1542/peds.111.2.384; Melnick SM, 2005, NEUROTOXICOL TERATOL, V27, P599, DOI 10.1016/j.ntt.2005.05.010; Minghetti L, 2000, J NEUROPATH EXP NEUR, V59, P866, DOI 10.1093/jnen/59.10.866; Mofenson Lynne M, 2003, Semin Pediatr Infect Dis, V14, P295, DOI 10.1053/j.spid.2003.09.003; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Nedelska Z, 2012, P NATL ACAD SCI USA, V109, P2590, DOI 10.1073/pnas.1121588109; Newell ML, 2003, JAIDS-J ACQ IMM DEF, V32, P380, DOI 10.1097/00126334-200304010-00006; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Osio M, 2006, J PERIPHER NERV SYST, V11, P72, DOI 10.1111/j.1085-9489.2006.00066.x; Panel on Treatment of HIV- Infected Pregnant Women and Prevention of Perinatal Transmission, 2011, MMWR RECOMM REP, V51, P1; PETRUZZELLA V, 1992, ARCH GERONTOL GERIAT, V14, P131, DOI 10.1016/0167-4943(92)90048-9; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Poirier MC, 1999, J ACQ IMMUN DEF SYND, V22, P477; Poirier MC, 2003, JAIDS-J ACQ IMM DEF, V33, P175, DOI 10.1097/00126334-200306010-00010; Pugh CR, 1997, BEHAV NEUROSCI, V111, P503, DOI 10.1037/0735-7044.111.3.503; Rondinini C, 1999, PSYCHOPHARMACOLOGY, V145, P317, DOI 10.1007/s002130051064; Roozendaal B, 1997, NEUROBIOL LEARN MEM, V67, P176, DOI 10.1006/nlme.1996.3765; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Scarpini E, 1997, J Peripher Nerv Syst, V2, P250; Schroder UH, 2008, NEUROSCIENCE, V157, P385, DOI 10.1016/j.neuroscience.2008.08.063; Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Shiramizu B, 2003, JAIDS-J ACQ IMM DEF, V32, P370, DOI 10.1097/00126334-200304010-00004; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Tardieu M, 2005, AM J NEURORADIOL, V26, P695; Thorne C, 2007, DRUG SAFETY, V30, P203, DOI 10.2165/00002018-200730030-00004; Torres SM, 2007, ENVIRON MOL MUTAGEN, V48, P224, DOI 10.1002/em.20264; Torres SM, 2010, CARDIOVASC TOXICOL, V10, P37, DOI 10.1007/s12012-010-9061-3; Tortorella C, 2009, INT J MOL MED, V23, P799, DOI 10.3892/ijmm_00000195; Valcour V, 2009, HIV MED, V10, P103, DOI 10.1111/j.1468-1293.2008.00658.x; Venerosi A, 2005, NEUROTOXICOL TERATOL, V27, P169, DOI 10.1016/j.ntt.2004.09.008; Venerosi A, 2003, PHARMACOL BIOCHEM BE, V74, P671, DOI 10.1016/S0091-3057(02)01068-7; Venerosi A, 2001, TERATOLOGY, V63, P26, DOI 10.1002/1096-9926(200101)63:1<26::AID-TERA1005>3.0.CO;2-G; Venerosi A, 2000, PSYCHOPHARMACOLOGY, V150, P404, DOI 10.1007/s002130000455; Walker Dale M, 2004, Cardiovasc Toxicol, V4, P133, DOI 10.1385/CT:4:2:133; Walker VE, 2007, ENVIRON MOL MUTAGEN, V48, P159, DOI 10.1002/em.20296; Watts DH, 2006, DRUG SAFETY, V29, P467, DOI 10.2165/00002018-200629060-00002; Yamaguchi T, 2002, EUR J BIOCHEM, V269, P2782, DOI 10.1046/j.1432-1033.2002.02954.x; Yokoi N, 2012, INT REV CEL MOL BIO, V297, P1, DOI 10.1016/B978-0-12-394308-8.00001-7; Youle M, 2007, HIV MED, V8, P241, DOI 10.1111/j.1468-1293.2007.00467.x; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	96	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55753	10.1371/journal.pone.0055753	http://dx.doi.org/10.1371/journal.pone.0055753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409035	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200060
J	Hsu, NC; Huang, YF; Yokoyama, KK; Chu, PY; Chen, FM; Hou, MF				Hsu, Nicholas C.; Huang, Ya-Fang; Yokoyama, Kazunari K.; Chu, Pei-Yi; Chen, Fang-Ming; Hou, Ming-Feng			Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer	PLOS ONE			English	Article							SPORADIC BREAST; GERMLINE MUTATIONS; OVARIAN-CANCER; HEREDITARY BREAST; FAMILIAL BREAST; MESSENGER-RNA; EARLY-ONSET; GENETIC-HETEROGENEITY; TUMOR CHARACTERISTICS; HYPERMETHYLATION	BRCA1-associated breast cancers are associated with particular features such as early onset, poor histological differentiation, and hormone receptor negativity. Previous studies conducted in Taiwanese population showed that the mutation of BRCA1 gene does not play a significant role in the occurrence of breast cancer. The present study explored methylation of BRCA1 promoter and its relationship to clinical features and outcome in Taiwanese breast cancer patients. Tumor specimens from a cohort of 139 early-stage breast cancer patients were obtained during surgery before adjuvant treatment for DNA extraction. Methylation of BRCA1 promoter region was determined by methylation-specific PCR and the results were related to clinical features and outcome of patients using statistical analysis. Methylation of the BRCA1 promoter was detected in 78 (56%) of the 139 tumors. Chi-square analysis indicated that BRCA1 promoter methylation correlated significantly with triple-negative (ER-/PR-/HER2-) status of breast cancer patients (p = 0.041). The Kaplan-Meier method showed that BRCA1 promoter methylation was significantly associated with poor overall survival (p = 0.026) and disease-free survival (p = 0.001). Multivariate analysis which incorporated variables of patients' age, tumor size, grade, and lymph node metastasis revealed that BRCA1 promoter methylation was associated with overall survival (p = 0.27; hazard ratio, 16.38) and disease-free survival (p = 0.003; hazard ratio, 12.19). Our findings underscore the clinical relevance of the methylation of BRCA1 promoter in Taiwanese patients with early-stage breast cancer.	[Hsu, Nicholas C.; Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Huang, Ya-Fang; Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chu, Pei-Yi] St Martin De Porres Hosp, Dept Pathol, Chiayi, Taiwan; [Chen, Fang-Ming; Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Dept Surg, Div Gen & Gastroenterol Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Natl Sun Yat Sen Univ, Joint Res Ctr, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Chen, FM (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Gen & Gastroenterol Surg, Kaohsiung, Taiwan.	fchen@kmu.edu.tw; mifeho@kmu.edu.tw		Huang, Ya-Fang/0000-0002-7790-8071; Hou, Ming-Feng/0000-0001-6030-9702; Chu, Pei-Yi/0000-0001-7336-2465	Department of Health, Taiwan [DOH101-TD-C-111-002]	Department of Health, Taiwan	This study was supported by a grant from the Department of Health, Taiwan (DOH101-TD-C-111-002). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2007, CANCER LETT, V245, P90, DOI 10.1016/j.canlet.2005.12.031; [Anonymous], 2012, CANC REG ANN REP 200; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bal A, 2012, VIRCHOWS ARCH, V461, P305, DOI 10.1007/s00428-012-1286-z; Barekati Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-244; Baylin SB, 1998, ADV CANCER RES, V72, P141; Birgisdottir V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1522; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Chen ST, 2003, BREAST CANCER RES TR, V77, P133, DOI 10.1023/A:1021386026051; Chen WQ, 2009, BREAST CANCER RES TR, V117, P55, DOI 10.1007/s10549-008-0066-6; EASTON DF, 1993, AM J HUM GENET, V52, P678; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Fong M, 2006, BREAST CANCER RES TR, V97, P57, DOI 10.1007/s10549-005-9088-5; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Honrado E, 2006, ONCOGENE, V25, P5837, DOI 10.1038/sj.onc.1209875; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Krasteva ME, 2012, NEOPLASMA, V59, P85, DOI 10.4149/neo_2012_011; Krop I, 2003, CANCER RES, V63, P2024; Li SSL, 1999, HUM GENET, V104, P201, DOI 10.1007/s004390050936; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Lynch HT, 2008, BREAST J, V14, P3, DOI 10.1111/j.1524-4741.2007.00515.x; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Mehrotra J, 2004, CLIN CANCER RES, V10, P2052, DOI 10.1158/1078-0432.CCR-03-0514; Mirza S, 2007, LIFE SCI, V81, P280, DOI 10.1016/j.lfs.2007.05.012; Miyoshi Y, 2008, INT J CLIN ONCOL, V13, P395, DOI 10.1007/s10147-008-0831-x; NAROD SA, 1995, AM J HUM GENET, V56, P254; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Rice JC, 2000, CARCINOGENESIS, V21, P1761, DOI 10.1093/carcin/21.9.1761; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Sobol H, 1997, INT J ONCOL, V10, P349; Toh GT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002024; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Veronesi A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-70; Wei MJ, 2005, CANCER RES, V65, P10692, DOI 10.1158/0008-5472.CAN-05-1277; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259	40	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56256	10.1371/journal.pone.0056256	http://dx.doi.org/10.1371/journal.pone.0056256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405268	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400214
J	Pombo, M; Denadai, MR; Turra, A				Pombo, Maira; Denadai, Marcia Regina; Turra, Alexander			Seasonality, Dietary Overlap and the Role of Taxonomic Resolution in the Study of the Diet of Three Congeneric Fishes from a Tropical Bay	PLOS ONE			English	Article							PLANKTONIC COPEPODS; SOUTHEASTERN BRAZIL; STELLIFER-RASTRIFER; COMMUNITY STRUCTURE; DYNAMICS; BIODIVERSITY; VARIABILITY; PERCIFORMES; SCIAENIDAE; CRUSTACEA	Not only seasonality but also taxonomic resolution of prey categories has been shown to affect diet studies. We analyzed the stomach contents of three sympatric species, Stellifer rastrifer, S. brasiliensis and S. stellifer, sampled monthly from August 2003 to October 2004 in Caraguatatuba Bay, southeastern Brazil. General characteristics and similarities among their diets were evaluated by considering high taxonomic ranks of all prey groups, and also the lower taxonomic ranks of the main prey groups. Dietary similarity was relatively high among species and low between seasons, and both evaluation criteria gave the equivalent results. The rare items, however, provided information about resource partition, and the species compositions of the most important groups were apparently good indicators of food availability.	[Pombo, Maira; Turra, Alexander] Univ Sao Paulo, Inst Oceanog, Sao Paulo, Brazil; [Denadai, Marcia Regina] Ctr Univ Modulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Pombo, M (corresponding author), Univ Sao Paulo, Inst Oceanog, Sao Paulo, Brazil.	mairapombo@gmail.com	Turra, Alexander/G-1352-2012; Pombo, Maíra/J-7791-2015; Denadai, Marcia R/P-9927-2015	Turra, Alexander/0000-0003-2225-8371; Denadai, Marcia R/0000-0002-7236-9478	Project Aware Foundation; State of Sao Paulo Research Foundation (FAPESP) [05/60041-6]	Project Aware Foundation; State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was partially supported by the Project Aware Foundation and by the State of Sao Paulo Research Foundation (FAPESP), which we also thank for the grant provided to M.R.D. (Proc. No. 05/60041-6) and the scholarship awarded to M.P. Logistical support was provided by the Instituto Costa Brasilis and the University Center of the Fundacao de Ensino Octavio Bastos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Teodoro SDA, 2012, BRAZ J OCEANOGR, V60, P245; Anger K, 1995, J EXP MAR BIOL ECOL, V193, P119, DOI 10.1016/0022-0981(95)00114-X; Araujo HMP, 2008, BRAZ J BIOL, V68, P751, DOI 10.1590/S1519-69842008000400009; Barleta-Bergan A, 2002, ESTUAR COAST SHELF S, V54, P193, DOI 10.1006/ecss.2001.0842; Branco JO, 2006, REV BRAS ZOOL, V23, P381, DOI 10.1590/S0101-81752006000200011; Bundy A, 2011, J FISH BIOL, V78, P514, DOI 10.1111/j.1095-8649.2010.02868.x; Camargo Mauricio, 2004, Rev. Bras. Zool., V21, P85, DOI 10.1590/S0101-81752004000100015; Chaves PDC, 1998, BRAZ ARCH BIOL TECHN, V41, P423; Coelho J.A.P., 1985, Boletim do Instituto de Pesca (Sao Paulo), V12, P99; COSTELLO MJ, 1990, J FISH BIOL, V36, P261, DOI 10.1111/j.1095-8649.1990.tb05601.x; DALL W, 1990, ADV MAR BIOL, V27, P1; DAUER DM, 1993, MAR POLLUT BULL, V26, P249, DOI 10.1016/0025-326X(93)90063-P; Diamond SL, 2000, CAN J FISH AQUAT SCI, V57, P2010, DOI 10.1139/cjfas-57-10-2010; Dias CD, 2008, BRAZ ARCH BIOL TECHN, V51, P731; Dias CD, 2009, ZOOLOGIA-CURITIBA, V26, P705; Eskinazi-Sant'Anna EM, 2006, HYDROBIOLOGIA, V563, P253, DOI 10.1007/s10750-006-0014-6; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Garrison LP, 2000, MAR ECOL PROG SER, V202, P231, DOI 10.3354/meps202231; Gerking SD., 2014, FEEDING ECOLOGY FISH; German DP, 2006, MAR BIOL, V148, P1123, DOI 10.1007/s00227-005-0149-4; GIANNINI R, 1990, Boletim do Instituto Oceanografico, V38, P69; Hofling Jose Claudio, 1997, Bioikos, V11, P7; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jia YJ, 2008, ENVIRON BIOL FISH, V81, P457, DOI 10.1007/s10641-007-9242-5; Jones R., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V172, P292; Jones R., 1982, ICLARM C P, V9, P195; Karachle PK, 2010, ACTA ICHTHYOL PISCAT, V40, P45, DOI 10.3750/AIP2010.40.1.06; Kawakami E., 1980, Boletim do Instituto Oceanografico, V29, P205; López-Ibarra Gladis A, 2006, Rev. biol. mar. oceanogr., V41, P63; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Menezes NA, 1980, MANUAL PEIXES MARINH, VIV; Micheletti CV, 1996, ARQ BIOL TECNOL, V39, P639; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pauly D., 2000, TROPHLAB MANUAL; Pombo M, 2012, BRAZ J OCEANOGR, V60, P271, DOI 10.1590/S1679-87592012000300001; Rodrigues E.S., 1988, Boletim do Instituto de Pesca (Sao Paulo), V15, P135; Russo Mcircia Regina, 2004, Acta Scientiarum Biological Sciences, V26, P431; SASAKI K, 1989, Memoirs of the Faculty of Fisheries Hokkaido University, V36, P1; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; TavaresCromar AF, 1996, ECOL MONOGR, V66, P91, DOI 10.2307/2963482; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Wootton JT, 1998, AM NAT, V152, P803, DOI 10.1086/286210; Zhang Bo, 2005, Acta Zoologica Sinica, V51, P616	45	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56107	10.1371/journal.pone.0056107	http://dx.doi.org/10.1371/journal.pone.0056107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405256	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400202
J	Yeoman, CJ; Thomas, SM; Miller, MEB; Ulanov, AV; Torralba, M; Lucas, S; Gillis, M; Cregger, M; Gomez, A; Ho, MF; Leigh, SR; Stumpf, R; Creedon, DJ; Smith, MA; Weisbaum, JS; Nelson, KE; Wilson, BA; White, BA				Yeoman, Carl J.; Thomas, Susan M.; Miller, Margret E. Berg; Ulanov, Alexander V.; Torralba, Manolito; Lucas, Sarah; Gillis, Marcus; Cregger, Melissa; Gomez, Andres; Ho, Mengfei; Leigh, Steven R.; Stumpf, Rebecca; Creedon, Douglas J.; Smith, Michael A.; Weisbaum, Jon S.; Nelson, Karen E.; Wilson, Brenda A.; White, Bryan A.			A Multi-Omic Systems-Based Approach Reveals Metabolic Markers of Bacterial Vaginosis and Insight into the Disease	PLOS ONE			English	Article							NONSPECIFIC VAGINITIS; VAGINAL MICROBIOME; HAEMOPHILUS VAGINALIS; GARDNERELLA-VAGINALIS; BIOGENIC-AMINES; GRAM STAIN; SP-NOV.; WOMEN; ASSOCIATIONS; PREVALENCE	Background: Bacterial vaginosis (BV) is the most common vaginal disorder of reproductive-age women. Yet the cause of BV has not been established. To uncover key determinants of BV, we employed a multi-omic, systems-biology approach, including both deep 16S rRNA gene-based sequencing and metabolomics of lavage samples from 36 women. These women varied demographically, behaviorally, and in terms of health status and symptoms. Principal Findings: 16S rRNA gene-based community composition profiles reflected Nugent scores, but not Amsel criteria. In contrast, metabolomic profiles were markedly more concordant with Amsel criteria. Metabolomic profiles revealed two distinct symptomatic BV types (SBVI and SBVII) with similar characteristics that indicated disruption of epithelial integrity, but each type was correlated to the presence of different microbial taxa and metabolites, as well as to different host behaviors. The characteristic odor associated with BV was linked to increases in putrescine and cadaverine, which were both linked to Dialister spp. Additional correlations were seen with the presence of discharge, 2-methyl-2-hydroxybutanoic acid, and Mobiluncus spp., and with pain, diethylene glycol and Gardnerella spp. Conclusions: The results not only provide useful diagnostic biomarkers, but also may ultimately provide much needed insight into the determinants of BV.	[Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Yeoman, Carl J.; Thomas, Susan M.; Miller, Margret E. Berg; Cregger, Melissa; Gomez, Andres; Wilson, Brenda A.; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ulanov, Alexander V.] Univ Illinois, Ctr Biotechnol, Urbana, IL 61801 USA; [Ho, Mengfei; Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Leigh, Steven R.; Stumpf, Rebecca] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Torralba, Manolito; Lucas, Sarah; Gillis, Marcus; Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Creedon, Douglas J.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Smith, Michael A.] Christie Clin, Dept Obstet & Gynecol, Urbana, IL USA; [Weisbaum, Jon S.] Carle Clin Assoc, Dept Obstet & Gynecol, Urbana, IL USA	Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; J. Craig Venter Institute; Mayo Clinic	Wilson, BA (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	bawilson@life.illinois.edu; bwhite44@illinois.edu	Yeoman, Carl/ABA-1906-2021; Cregger, Melissa/D-7142-2018; Ho, Mengfei/Q-6844-2019	Yeoman, Carl/0000-0002-8775-7879; Cregger, Melissa/0000-0001-8329-366X; Lucas, Sarah/0000-0003-1676-5801; Berg, Margret/0000-0002-0411-1619; LEIGH, STEVEN/0000-0001-6844-7122; Ho, Mengfei/0000-0002-8315-8158	National Institutes of Health (NIH) [R56 AI085096-01]; Carle-UIUC translational research initiative (CUTR); National Science Foundation (NSF) [08-20709]; Institute for Genomic Biology; Research Board of the University of Illinois at Urbana-Champaign; Mayo Clinic-University of Illinois alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085096] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carle-UIUC translational research initiative (CUTR); National Science Foundation (NSF)(National Science Foundation (NSF)); Institute for Genomic Biology; Research Board of the University of Illinois at Urbana-Champaign; Mayo Clinic-University of Illinois alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) grant R56 AI085096-01 (www.NIH.gov; PI: B. White), a Carle-UIUC translational research initiative (CUTR) grant (PI: B. Wilson), and a National Science Foundation (NSF) Grant #08-20709 (www.nsf.gov; PI: RS), with additional support from the Institute for Genomic Biology and the Research Board of the University of Illinois at Urbana-Champaign. Parts of this work were also funded by the Mayo Clinic-University of Illinois alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Antoine FR, 2004, J FOOD PROTECT, V67, P2255, DOI 10.4315/0362-028X-67.10.2255; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Bartlett J G, 1984, Rev Infect Dis, V6 Suppl 1, pS67; Chatwani Ashwin J, 2006, Infect Dis Obstet Gynecol, V2006, P95618; DEBRUERES J, 1985, PATHOL BIOL, V33, P687; Downes J, 2003, INT J SYST EVOL MICR, V53, P1937, DOI 10.1099/ijs.0.02640-0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Hassan S, 2011, J LOW GENIT TRACT DI, V15, P128, DOI 10.1097/LGT.0b013e3181fb4270; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Izquierdo I, 2000, TETRAHEDRON-ASYMMETR, V11, P1749, DOI 10.1016/S0957-4166(00)00117-8; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Katikou P, 2006, J AGR FOOD CHEM, V54, P4277, DOI 10.1021/jf0602121; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lee J C, 2000, Curr Urol Rep, V1, P159, DOI 10.1007/s11934-000-0052-y; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Mills SC, 2011, CLIN EVID; Morotomi M, 2008, INT J SYST EVOL MICR, V58, P2716, DOI 10.1099/ijs.0.2008/000810-0; Nieto N, 2012, LIVER INT, V32, P189, DOI 10.1111/j.1478-3231.2011.02573.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Prester L, 2011, FOOD ADDIT CONTAM A, V28, P1547, DOI 10.1080/19440049.2011.600728; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rubio-Tapia A, 2009, J CLIN GASTROENTEROL, V43, P157, DOI 10.1097/MCG.0b013e3181557e67; SAUTTER RL, 1980, J CLIN MICROBIOL, V11, P479, DOI 10.1128/JCM.11.5.479-484.1980; Schweitzer L, 1999, WATER SCI TECHNOL, V40, P293, DOI 10.2166/wst.1999.0312; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SPIEGEL CA, 1980, NEW ENGL J MED, V303, P601, DOI 10.1056/NEJM198009113031102; SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983; TOTTEN PA, 1982, J CLIN MICROBIOL, V15, P141, DOI 10.1128/JCM.15.1.141-147.1982; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WHITE AA, 1956, ARCH BIOCHEM BIOPHYS, V64, P57, DOI 10.1016/0003-9861(56)90241-7; White BA, 2011, TRENDS ENDOCRIN MET, V22, P389, DOI 10.1016/j.tem.2011.06.001; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Zhang S, 2011, J FOOD SCI, V76, pC127, DOI 10.1111/j.1750-3841.2010.01916.x	43	80	84	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56111	10.1371/journal.pone.0056111	http://dx.doi.org/10.1371/journal.pone.0056111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405259	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400205
J	Costa, A; Oliveri, M; Barban, F; Bonni, S; Koch, G; Caltagirone, C; Carlesimo, GA				Costa, Alberto; Oliveri, Massimiliano; Barban, Francesco; Bonni, Sonia; Koch, Giacomo; Caltagirone, Carlo; Carlesimo, Giovanni A.			The Right Frontopolar Cortex Is Involved in Visual-Spatial Prospective Memory	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; STIMULATION; AREA-10; REGIONS	The involvement of frontopolar cortex in mediating prospective memory processes has been evidenced by various studies, mainly by means of neuroimaging techniques. Recently, one transcranial magnetic stimulation study documented that transient inhibition of left Brodmann Area (BA) 10 impaired verbal prospective memory. This result raises the issue of whether the BA 10 involvement in prospective memory functioning may be modulated by the physical characteristics of the stimuli used. The present study aimed to investigate the role of the frontopolar cortex in visual-spatial PM by means of the application of inhibitory theta-burst stimulation. Twelve volunteers were evaluated after inhibitory theta-burst stimulation over left BA 10, right BA10 and CZ (control condition). In the prospective memory procedure, sequences of four spatial positions (black squares) each were presented. During the inter-sequence delay, subjects had to reproduce the sequence in the observed order (ongoing task forward) or the reverse order (backward). At the occurrence of a target position, subjects had to press a key on the keyboard (prospective memory score). Recall and recognition of the target positions were also tested. We found that prospective memory accuracy was lower after theta-burst stimulation over right BA10 than CZ (p<0.01), whereas it was comparable in left BA10 and CZ conditions. No significant difference was found among the three conditions on recall and recognition of target positions and on ongoing task performance. Our findings provide a novel strong evidence for a specific involvement of right frontopolar cortex in visual-spatial prospective memory. In the context of previous data providing evidence for left BA 10 involvement in verbal prospective memory, our results also suggest material-specific lateralization of prospective memory processes in BA 10.	[Costa, Alberto; Oliveri, Massimiliano; Barban, Francesco; Bonni, Sonia; Koch, Giacomo; Caltagirone, Carlo; Carlesimo, Giovanni A.] Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Clin & Behav Neurol Lab, Rome, Italy; [Oliveri, Massimiliano] Univ Palermo, Dept Psychol, Palermo, Italy; [Koch, Giacomo; Caltagirone, Carlo; Carlesimo, Giovanni A.] Univ Roma Tor Vergata, Rome, Italy	IRCCS Santa Lucia; University of Palermo; University of Rome Tor Vergata	Costa, A (corresponding author), Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Clin & Behav Neurol Lab, Rome, Italy.	a.costa@hsantalucia.it	Koch, Giacomo/G-3155-2012; Oliveri, Massimiliano/HDO-5602-2022; Costa, Alberto/AAA-7038-2019	KOch, Giacomo/0000-0001-6155-9439; COSTA, Alberto/0000-0002-4784-5524				Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; Bunge SA, 2009, NEUROIMAGE, V46, P338, DOI 10.1016/j.neuroimage.2009.01.064; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Costa A, 2011, CEREB CORTEX, V21, P2696, DOI 10.1093/cercor/bhr052; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Pollmann S, 2001, NEUROIMAGE, V14, pS118, DOI 10.1006/nimg.2001.0837; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rea M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026290; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Uretzky S, 2010, J COGNITIVE NEUROSCI, V22, P2745, DOI 10.1162/jocn.2010.21419; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Wendelken C, 2012, HUM BRAIN MAPP, V33, P1952, DOI 10.1002/hbm.21336	29	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56039	10.1371/journal.pone.0056039	http://dx.doi.org/10.1371/journal.pone.0056039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418505	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300097
J	Jalmar, O; Francois-Moutal, L; Garcia-Saez, AJ; Perry, M; Granjon, T; Gonzalvez, F; Gottlieb, E; Ayala-Sanmartin, J; Klosgen, B; Schwille, P; Petit, PX				Jalmar, Olivier; Francois-Moutal, Liberty; Garcia-Saez, Ana-Jesus; Perry, Mark; Granjon, Thierry; Gonzalvez, Francois; Gottlieb, Eyal; Ayala-Sanmartin, Jesus; Klosgen, Beate; Schwille, Petra; Petit, Patrice X.			Caspase-8 Binding to Cardiolipin in Giant Unilamellar Vesicles Provides a Functional Docking Platform for Bid	PLOS ONE			English	Article							MITOCHONDRIAL CONTACT SITES; SIGNALING COMPLEX DISC; INDUCED CELL-DEATH; LIPID-BILAYERS; BCL-2 FAMILY; PHOSPHOLIPID-VESICLES; LAURDAN FLUORESCENCE; APOPTOSIS REGULATOR; TBID INTERACTION; NUCLEAR-BODIES	Caspase-8 is involved in death receptor-mediated apoptosis in type II cells, the proapoptotic programme of which is triggered by truncated Bid. Indeed, caspase-8 and Bid are the known intermediates of this signalling pathway. Cardiolipin has been shown to provide an anchor and an essential activating platform for caspase-8 at the mitochondrial membrane surface. Destabilisation of this platform alters receptor-mediated apoptosis in diseases such as Barth Syndrome, which is characterised by the presence of immature cardiolipin which does not allow caspase-8 binding. We used a simplified in vitro system that mimics contact sites and/or cardiolipin-enriched microdomains at the outer mitochondrial surface in which the platform consisting of caspase-8, Bid and cardiolipin was reconstituted in giant unilamellar vesicles. We analysed these vesicles by flow cytometry and confirm previous results that demonstrate the requirement for intact mature cardiolipin for caspase-8 activation and Bid binding and cleavage. We also used confocal microscopy to visualise the rupture of the vesicles and their revesiculation at smaller sizes due to alteration of the curvature following caspase-8 and Bid binding. Biophysical approaches, including Laurdan fluorescence and rupture/tension measurements, were used to determine the ability of these three components (cardiolipin, caspase-8 and Bid) to fulfil the minimal requirements for the formation and function of the platform at the mitochondrial membrane. Our results shed light on the active functional role of cardiolipin, bridging the gap between death receptors and mitochondria.	[Jalmar, Olivier; Gonzalvez, Francois; Petit, Patrice X.] Univ Paris 05, Ctr Rech St Peres, UMR S Toxicol Pharmacol & Signalisat Cellulaire 7, Paris, France; [Francois-Moutal, Liberty; Granjon, Thierry] CNRS, Inst Chim & Biochim Mol & Supramol, UMR 5246, ICBMS, Villeurbanne, France; [Garcia-Saez, Ana-Jesus; Schwille, Petra] Tech Univ Dresden, Biophys Grp, BIOTEC, Dresden, Germany; [Perry, Mark; Klosgen, Beate] Univ So Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Gonzalvez, Francois; Gottlieb, Eyal] Canc Res UK, Beatson Inst, Glasgow, Lanark, Scotland; [Ayala-Sanmartin, Jesus] Ecole Normale Super, CNRS, UMR 7203, Lab Biomol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Technische Universitat Dresden; University of Southern Denmark; Beatson Institute; Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Petit, PX (corresponding author), Univ Paris 05, Ctr Rech St Peres, UMR S Toxicol Pharmacol & Signalisat Cellulaire 7, Paris, France.	patrice.petit@inserm.fr	Kloesgen, Beate M./D-2709-2015; Schwille, Petra/A-4983-2010; Petit, patrice/AAF-6774-2020; Gottlieb, Eyal/G-6450-2010; Petit, Patrice X./A-3692-2009; Saez, Ana J. Garcia/U-1611-2019	Kloesgen, Beate M./0000-0002-2334-0388; Gottlieb, Eyal/0000-0002-9770-0956; Petit, Patrice X./0000-0002-5038-9101; Francois-Moutal, Liberty/0000-0003-1277-660X	Centre National de la Recherche Scientifique (CNRS); Association de Recherche sur le Cancer (ARC) [4493]; Association Francaise contre les Myopathies [13313/2008, 14219/2010]; Danish National Research Foundation; Oticon	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association de Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Danish National Research Foundation(Danmarks Grundforskningsfond); Oticon	This work was supported by the Centre National de la Recherche Scientifique (CNRS), and by the Association de Recherche sur le Cancer (ARC no4493 to PXP) and Association Francaise contre les Myopathies (grant no13313/2008 and grant no14219/2010 to PXP). BK is grateful for the generous support of the Danish National Research Foundation via the grant to MEMPHYS. MP was benefitting from an Oticon scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Apellaniz B, 2010, FEBS LETT, V584, P1591, DOI 10.1016/j.febslet.2010.03.021; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; ARDAIL D, 1990, BIOCHEM BIOPH RES CO, V173, P878, DOI 10.1016/S0006-291X(05)80868-X; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Granjon T, 2001, BIOCHEMISTRY-US, V40, P6016, DOI 10.1021/bi002293e; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jalmar O, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.81; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krieghoff E, 2007, CELL CYCLE, V6, P771, DOI 10.4161/cc.6.7.4046; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lamblet M, 2008, EUR PHYS J E, V26, P205, DOI 10.1140/epje/i2007-10317-x; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Li JH, 1998, J IMMUNOL, V161, P3943; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Marsh D, 2006, BIOPHYS J, V91, P227, DOI 10.1529/biophysj.105.079004; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P8261, DOI 10.1021/bi00421a041; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Ratanabanangkoon P, 2003, LANGMUIR, V19, P1054, DOI 10.1021/la026251y; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Shearman GC, 2007, BIOCHEM SOC T, V35, P498, DOI 10.1042/BST0350498; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhang SQ, 1998, PLANT CELL, V10, P435, DOI 10.1105/tpc.10.3.435	65	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55250	10.1371/journal.pone.0055250	http://dx.doi.org/10.1371/journal.pone.0055250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418437	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000315970300027
J	Singh, S; Bora-Singhal, N; Kroeger, J; Laklai, H; Chellappan, SP				Singh, Sandeep; Bora-Singhal, Namrata; Kroeger, Jodi; Laklai, Hanane; Chellappan, Srikumar P.			beta Arrestin-1 and Mcl-1 Modulate Self-Renewal Growth of Cancer Stem-Like Side-Population Cells in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; MELANOMA-CELLS; RESISTANCE; IDENTIFICATION; STATISTICS; ADENOCARCINOMA; PROLIFERATION; DETERMINANT; ACTIVATION; INHIBITORS	Side population (SP) cells have been reported to have properties of cancer stem-like cells (CSCs) in non-small cell lung carcinoma (NSCLC), yet their molecular features have not been fully elucidated. Here we show that, NSCLC-SP cells were enriched in G(0)/G-(1) phase of cell cycle, had higher aldehyde dehydrogenase activity as well as higher clonogenic and self-renewing ability compared to main population (MP) cells. Interestingly, SP cells were also able to trans-differentiate into angiogenic tubules in vitro and were highly tumorigenic as compared to MP cells. SP-derived tumors demonstrated the intratumoral heterogeneity comprising of both SP and MP cells, suggesting the self-renewal and differentiation ability of SP cells are manifested in vivo as well. beta Arrestin-1 (beta Arr1) is involved in the progression of various cancers including NSCLCs and we find that depletion of beta Arr1 significantly blocked the SP phenotype; whereas depletion of beta Arr2 had relatively minor effects. Ectopic expression of beta Arr1 resulted in increased SP frequency and ABCG2 expression while abrogation of beta Arr1 expression suppressed the self-renewal growth and expansion of A549 cells. Anti-apoptotic protein Mcl-1 is known to be one of the key regulators of self-renewal of tissue stem cells and is thought to contribute to survival of NSCLC cells. Our experiments show that higher levels of Mcl-1 were expressed in SP cells compared to MP cells at both transcriptional and translational levels. In addition, Obatoclax, a pharmacological inhibitor of Mcl-1, could effectively prevent the self-renewal of both EGFR-inhibitor sensitive and resistant NSCLC cells. In conclusion, our findings suggest that beta Arr1 and Mcl-1 are involved in the self-renewal and expansion of NSCLC-CSCs and are potential targets for anti-cancer therapy.	[Singh, Sandeep; Bora-Singhal, Namrata; Laklai, Hanane; Chellappan, Srikumar P.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Kroeger, Jodi] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Flow Cytomerty Core Facil, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chellappan, SP (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	Srikumar.Chellappan@moffitt.org			National Cancer Institute [CA127725]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA127725] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the grant CA127725 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Bai F, 2012, BIOORG MED CHEM LETT, V22, P1365, DOI 10.1016/j.bmcl.2011.12.067; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Campbell CJV, 2010, BLOOD, V116, P1433, DOI 10.1182/blood-2009-12-258095; Cetin Z, 2010, MED ONCOL, V27, P853, DOI 10.1007/s12032-009-9296-7; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Cianfrocca R, 2010, CAN J PHYSIOL PHARM, V88, P796, DOI 10.1139/Y10-052; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Driessens G, 2012, NATURE; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Johnson JL, 2011, CANC RES; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim J. I., 2010, MOL CANCER RES, V8, P569, DOI DOI 10.1158/1541-7786.MCR-09-0511.PUBMED:20353998; Kinkade R, 2008, CANCER RES, V68, P3810, DOI 10.1158/0008-5472.CAN-07-6672; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krajewska M, 1996, AM J PATHOL, V148, P1567; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu H, 2011, INT J HEMATOL, V93, P494, DOI 10.1007/s12185-011-0824-9; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Moreb J, 1996, CANCER GENE THER, V3, P24; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh S, 2010, MOL CANCER THER, V9, P3330, DOI 10.1158/1535-7163.MCT-10-0442; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	64	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55982	10.1371/journal.pone.0055982	http://dx.doi.org/10.1371/journal.pone.0055982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418490	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300082
J	Sun, CL; Shi, ZZ; Zhou, XB; Chen, LN; Zhao, XM				Sun, Chenglei; Shi, Zheng-Zheng; Zhou, Xiaobo; Chen, Luonan; Zhao, Xing-Ming			Prediction of S-Glutathionylation Sites Based on Protein Sequences	PLOS ONE			English	Article							PHOSPHORYLATION SITES; MOLECULAR-MECHANISMS; ACCURATE PREDICTION; IDENTIFICATION; CYSTEINES; STRESS; INDEX; TOOL	S-glutathionylation, the reversible formation of mixed disulfides between glutathione(GSH) and cysteine residues in proteins, is a specific form of post-translational modification that plays important roles in various biological processes, including signal transduction, redox homeostasis, and metabolism inside cells. Experimentally identifying S-glutathionylation sites is labor-intensive and time consuming, whereas bioinformatics methods provide an alternative way to this problem by predicting S-glutathionylation sites in silico. The bioinformatics approaches give not only candidate sites for further experimental verification but also bio-chemical insights into the mechanism of S-glutathionylation. In this paper, we firstly collect experimentally determined S-glutathionylated proteins and their corresponding modification sites from the literature, and then propose a new method for predicting S-glutathionylation sites by employing machine learning methods based on protein sequence data. Promising results are obtained by our method with an AUC (area under ROC curve) score of 0.879 in 5-fold cross-validation, which demonstrates the predictive power of our proposed method. The datasets used in this work are available at http://csb.shu.edu.cn/SGDB.	[Sun, Chenglei] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Sun, Chenglei] Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China; [Zhao, Xing-Ming] Tongji Univ, Dept Comp Sci, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Shi, Zheng-Zheng; Zhou, Xiaobo] Cornell Univ, Dept Radiol, Methodist Hosp, Res Inst,Weill Med Coll, Houston, TX USA	Shanghai University; Shanghai University; Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Zhou, XB (corresponding author), Cornell Univ, Dept Radiol, Methodist Hosp, Res Inst,Weill Med Coll, Houston, TX USA.	XZhou@tmhs.org; lnchen@sibs.ac.cn; zhaoxingming@gmail.com			National Natural Science Foundation of China [91130032, 61103075, 91029301, 61134013]; Innovation Program of Shanghai Municipal Education Commission [13ZZ072]; JSPS/CSTP through the FIRST Program; Shanghai Pujiang Program; Chief Scientist Program of SIBS from CAS [2009CSP002]; Graduate Innovation Funding of Shanghai University [SHUCX102039]; National Institutes of Health [R01 CA155069-01, R01 LM010185-02]; NATIONAL CANCER INSTITUTE [R01CA155069] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); JSPS/CSTP through the FIRST Program; Shanghai Pujiang Program(Shanghai Pujiang Program); Chief Scientist Program of SIBS from CAS; Graduate Innovation Funding of Shanghai University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. XMZ was partly supported by National Natural Science Foundation of China (91130032, 61103075) and Innovation Program of Shanghai Municipal Education Commission (13ZZ072). Dr. LC was supported by National Natural Science Foundation of China (91029301, 61134013), and JSPS/CSTP through the FIRST Program, Shanghai Pujiang Program, Chief Scientist Program of SIBS from CAS (2009CSP002). CS was supported by Graduate Innovation Funding of Shanghai University (Grant No. SHUCX102039). Drs. ZZS and XZ were partially funded by National Institutes of Health (R01 CA155069-01, and R01 LM010185-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen XW, 2009, BIOINFORMATICS, V25, P585, DOI 10.1093/bioinformatics/btp039; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Ghezzi P, 2006, PROTEOMICS, V6, P817, DOI 10.1002/pmic.200500177; Hamnell-Pamment Y, 2005, BIOCHEM BIOPH RES CO, V332, P362, DOI 10.1016/j.bbrc.2005.04.130; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-553; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marino SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000383; Martelli PL, 2004, PROTEOMICS, V4, P1665, DOI 10.1002/pmic.200300745; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Sun CL, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S12; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhao XM, 2005, NEURAL NETWORKS, V18, P1019, DOI 10.1016/j.neunet.2005.07.002	31	36	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55512	10.1371/journal.pone.0055512	http://dx.doi.org/10.1371/journal.pone.0055512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418443	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300034
J	Uroz, S; Ioannidis, P; Lengelle, J; Cebron, A; Morin, E; Buee, M; Martin, F				Uroz, Stephane; Ioannidis, Panos; Lengelle, Juliette; Cebron, Aurelie; Morin, Emmanuelle; Buee, Marc; Martin, Francis			Functional Assays and Metagenomic Analyses Reveals Differences between the Microbial Communities Inhabiting the Soil Horizons of a Norway Spruce Plantation	PLOS ONE			English	Article							PYROSEQUENCING-BASED ANALYSIS; FUNGAL COMMUNITIES; BACTERIAL COMMUNITIES; LITTER DECOMPOSITION; ENZYME-ACTIVITIES; FOREST SOILS; DIVERSITY; QUANTIFICATION; SEDIMENT; GRADIENT	In temperate ecosystems, acidic forest soils are among the most nutrient-poor terrestrial environments. In this context, the long-term differentiation of the forest soils into horizons may impact the assembly and the functions of the soil microbial communities. To gain a more comprehensive understanding of the ecology and functional potentials of these microbial communities, a suite of analyses including comparative metagenomics was applied on independent soil samples from a spruce plantation (Breuil-Chenue, France). The objectives were to assess whether the decreasing nutrient bioavailability and pH variations that naturally occurs between the organic and mineral horizons affects the soil microbial functional biodiversity. The 14 Gbp of pyrosequencing and Illumina sequences generated in this study revealed complex microbial communities dominated by bacteria. Detailed analyses showed that the organic soil horizon was significantly enriched in sequences related to Bacteria, Chordata, Arthropoda and Ascomycota. On the contrary the mineral horizon was significantly enriched in sequences related to Archaea. Our analyses also highlighted that the microbial communities inhabiting the two soil horizons differed significantly in their functional potentials according to functional assays and MG-RAST analyses, suggesting a functional specialisation of these microbial communities. Consistent with this specialisation, our shotgun metagenomic approach revealed a significant increase in the relative abundance of sequences related glycoside hydrolases in the organic horizon compared to the mineral horizon that was significantly enriched in glycoside transferases. This functional stratification according to the soil horizon was also confirmed by a significant correlation between the functional assays performed in this study and the functional metagenomic analyses. Together, our results suggest that the soil stratification and particularly the soil resource availability impact the functional diversity and to a lesser extent the taxonomic diversity of the bacterial communities.	[Uroz, Stephane; Ioannidis, Panos; Lengelle, Juliette; Morin, Emmanuelle; Buee, Marc; Martin, Francis] Univ Lorraine Interact Arbres Microorganismes, Ctr INRA Nancy, INRA, UMR INRA 1136, Champenoux, France; [Uroz, Stephane] Ctr INRA Nancy, INRA UR Biogeochim Ecosyst Forestiers 1138, Champenoux, France; [Cebron, Aurelie] Univ Lorraine, LIMOS, UMR CNRS 7137, Fac Sci, Vandoeuvre Les Nancy, France	INRAE; Universite de Lorraine; INRAE; Universite de Lorraine	Uroz, S (corresponding author), Univ Lorraine Interact Arbres Microorganismes, Ctr INRA Nancy, INRA, UMR INRA 1136, Champenoux, France.	uroz@nancy.inra.fr	morin, emmanuelle/AAA-1246-2019; Ioannidis, Panagiotis/I-4281-2014	morin, emmanuelle/0000-0002-7268-972X; Ioannidis, Panagiotis/0000-0003-0939-6745; Buee, Marc/0000-0001-8614-3886	Lorraine Region Council; INRA (Institut National de la Recherche Agronomique) Center of Nancy; French National Research Agency (ANR Metasoil) [ANR-08-GENM-025]; European project 'ECOFINDER'; Labex 'ARBRE'	Lorraine Region Council(Region Grand-Est); INRA (Institut National de la Recherche Agronomique) Center of Nancy; French National Research Agency (ANR Metasoil)(French National Research Agency (ANR)); European project 'ECOFINDER'; Labex 'ARBRE'	This work was funded by the "Lorraine Region Council", the INRA (Institut National de la Recherche Agronomique) Center of Nancy, the French National Research Agency (ANR Metasoil, Project ANR-08-GENM-025) and the European project 'ECOFINDER'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The UMR1136 INRA 'Interactions arbres microorganisms' is supported by the Labex 'ARBRE'. We thank Drs J. Ranger, P. Frey-Klett and L.C. Kelly for helpful discussions. The English language was reviewed by American Journal Experts. We would like to thank the reviewers, and especially Reviewer 1 for his assiduous implication in the improvement of our manuscript.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buee M, 2011, FUNGAL ECOL, V4, P22, DOI 10.1016/j.funeco.2010.07.003; Calvaruso C, 2007, MICROB ECOL, V54, P567, DOI 10.1007/s00248-007-9260-z; Calvaruso C, 2010, APPL ENVIRON MICROB, V76, P4780, DOI 10.1128/AEM.03040-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cebron A, 2008, J MICROBIOL METH, V73, P148, DOI 10.1016/j.mimet.2008.01.009; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Delmont TO, 2011, APPL ENVIRON MICROB, V77, P1315, DOI 10.1128/AEM.01526-10; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Kanokratana P, 2011, MICROB ECOL, V61, P518, DOI 10.1007/s00248-010-9766-7; Lepleux C, 2012, APPL ENVIRON MICROB, V78, P7114, DOI 10.1128/AEM.00996-12; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Lueders T, 2004, APPL ENVIRON MICROB, V70, P5778, DOI 10.1128/AEM.70.10.5778-5786.2004; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Mareschal L, 2010, EUR J SOIL SCI, V61, P14, DOI 10.1111/j.1365-2389.2009.01206.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pennanen T, 1999, MICROB ECOL, V38, P168, DOI 10.1007/s002489900161; Pfister CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010518; Pritsch K, 2004, J MICROBIOL METH, V58, P233, DOI 10.1016/j.mimet.2004.04.001; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sandnes A, 2005, SOIL BIOL BIOCHEM, V37, P259, DOI 10.1016/j.soilbio.2004.07.036; Schmid I, 2002, FOREST ECOL MANAG, V159, P37, DOI 10.1016/S0378-1127(01)00708-3; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Snajdr J, 2008, SOIL BIOL BIOCHEM, V40, P2068, DOI 10.1016/j.soilbio.2008.01.015; Suen G, 2011, PLOS GENETIC, V6; Thion C, 2012, INT BIODETER BIODEGR, V68, P28, DOI 10.1016/j.ibiod.2011.10.012; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Uroz S, 2012, APPL ENVIRON MICROB, V78, P3020, DOI 10.1128/AEM.06742-11; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144	59	114	116	6	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55929	10.1371/journal.pone.0055929	http://dx.doi.org/10.1371/journal.pone.0055929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418476	Green Published, gold			2022-12-25	WOS:000315970300067
J	Das, PJ; McCarthy, F; Vishnoi, M; Paria, N; Gresham, C; Li, G; Kachroo, P; Sudderth, AK; Teague, S; Love, CC; Varner, DD; Chowdhary, BP; Raudsepp, T				Das, Pranab J.; McCarthy, Fiona; Vishnoi, Monika; Paria, Nandina; Gresham, Cathy; Li, Gang; Kachroo, Priyanka; Sudderth, A. Kendrick; Teague, Sheila; Love, Charles C.; Varner, Dickson D.; Chowdhary, Bhanu P.; Raudsepp, Terje			Stallion Sperm Transcriptome Comprises Functionally Coherent Coding and Regulatory RNAs as Revealed by Microarray Analysis and RNA-seq	PLOS ONE			English	Article							MITOCHONDRIAL-TYPE RIBOSOMES; POLYMERASE-CHAIN-REACTION; HUMAN SPERMATOZOAL RNAS; SWINE SUS-SCROFA; MESSENGER-RNA; EJACULATED SPERMATOZOA; EPIGENETIC INHERITANCE; REVERSE-TRANSCRIPTASE; BOVINE SPERMATOZOA; EMBRYO DEVELOPMENT	Mature mammalian sperm contain a complex population of RNAs some of which might regulate spermatogenesis while others probably play a role in fertilization and early development. Due to this limited knowledge, the biological functions of sperm RNAs remain enigmatic. Here we report the first characterization of the global transcriptome of the sperm of fertile stallions. The findings improved understanding of the biological significance of sperm RNAs which in turn will allow the discovery of sperm-based biomarkers for stallion fertility. The stallion sperm transcriptome was interrogated by analyzing sperm and testes RNA on a 21,000-element equine whole-genome oligoarray and by RNA-seq. Microarray analysis revealed 6,761 transcripts in the sperm, of which 165 were sperm-enriched, and 155 were differentially expressed between the sperm and testes. Next, 70 million raw reads were generated by RNA-seq of which 50% could be aligned with the horse reference genome. A total of 19,257 sequence tags were mapped to all horse chromosomes and the mitochondrial genome. The highest density of mapped transcripts was in gene-rich ECA11, 12 and 13, and the lowest in gene-poor ECA9 and X; 7 gene transcripts originated from ECAY. Structural annotation aligned sperm transcripts with 4,504 known horse and/or human genes, rRNAs and 82 miRNAs, whereas 13,354 sequence tags remained anonymous. The data were aligned with selected equine gene models to identify additional exons and splice variants. Gene Ontology annotations showed that sperm transcripts were associated with molecular processes (chemoattractant-activated signal transduction, ion transport) and cellular components (membranes and vesicles) related to known sperm functions at fertilization, while some messenger and micro RNAs might be critical for early development. The findings suggest that the rich repertoire of coding and non-coding RNAs in stallion sperm is not a random remnant from spermatogenesis in testes but a selectively retained and functionally coherent collection of RNAs.	[Das, Pranab J.; Vishnoi, Monika; Paria, Nandina; Li, Gang; Kachroo, Priyanka; Chowdhary, Bhanu P.; Raudsepp, Terje] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77840 USA; [McCarthy, Fiona] Mississippi State Univ, Dept Basic Sci, Mississippi State, MS 39762 USA; [Gresham, Cathy] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Sudderth, A. Kendrick; Teague, Sheila; Love, Charles C.; Varner, Dickson D.] Texas A&M Univ, Dept Large Anim Clin Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Mississippi State University; Mississippi State University; Texas A&M University System; Texas A&M University College Station	Raudsepp, T (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77840 USA.	traudsepp@cvm.tamu.edu	Das, Pranab Jyoti/GNW-4748-2022; Vishnoi, Monika/AAP-4871-2021; li, gang/E-5640-2014	Das, Pranab Jyoti/0000-0003-3871-1628; Vishnoi, Monika/0000-0002-3934-7285; li, gang/0000-0001-7400-5486	American Quarter Horse Association; USDA [2006-04801]; CVMBS LINK Endowment for Equine Genomics	American Quarter Horse Association; USDA(United States Department of Agriculture (USDA)); CVMBS LINK Endowment for Equine Genomics	This study was supported by grants from American Quarter Horse Association, USDA grant 2006-04801 and CVMBS LINK Endowment for Equine Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki VW, 2006, FERTIL STERIL, V86, P1408, DOI 10.1016/j.fertnstert.2006.04.024; Arangasamy A, 2011, THERIOGENOLOGY, V76, P570, DOI 10.1016/j.theriogenology.2011.03.009; Avendano C, 2009, HUM REPROD, V24, P270, DOI 10.1093/humrep/den381; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bench GS, 1996, CYTOMETRY, V23, P263, DOI 10.1002/(SICI)1097-0320(19960401)23:4<263::AID-CYTO1>3.3.CO;2-9; BETLACH CJ, 1973, NATURE, V242, P114, DOI 10.1038/242114a0; Bissonnette N, 2009, REPRODUCTION, V138, P65, DOI 10.1530/REP-08-0503; Blanchard TL, 1997, VET MED-US, V92, P815; Boerke A, 2007, THERIOGENOLOGY, V68, pS147, DOI 10.1016/j.theriogenology.2007.05.058; Boyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029764; Bright LA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S8; Cao XR, 2010, DISCRETE EVENT DYN S, V20, P1, DOI 10.1007/s10626-010-0088-1; Carreau S, 2007, BIOCHEM SOC T, V35, P634, DOI 10.1042/BST0350634; Cavalcanti MCO, 2011, MOL HUM REPROD, V17, P415, DOI 10.1093/molehr/gar011; CHIANG MH, 1994, FERTIL STERIL, V61, P276; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; CHOUDHARY SK, 1995, J BIOL CHEM, V270, P8755, DOI 10.1074/jbc.270.15.8755; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Colenbrander B, 2003, REPROD DOMEST ANIM, V38, P305, DOI 10.1046/j.1439-0531.2003.00451.x; Curry E, 2009, MOL REPROD DEV, V76, DOI 10.1002/mrd.20980; Cuzin F, 2010, ESSAYS BIOCHEM, V48, P101, DOI [10.1042/BSE0480101, 10.1042/bse0480101]; Dadoune JP, 2009, MICROSC RES TECHNIQ, V72, P536, DOI 10.1002/jemt.20697; Das PJ, 2010, ANIMAL REPROD SCI, V121S, pS175; Das PJ, 2010, THERIOGENOLOGY, V74, P1099, DOI 10.1016/j.theriogenology.2010.04.023; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dun MD, 2012, HUM REPROD UPDATE; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Feugang JM, 2010, REPROD BIOMED ONLINE, V21, P312, DOI 10.1016/j.rbmo.2010.06.022; Feugang JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-176; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Florman HM, 2007, P NATL ACAD SCI USA, V104, P11123, DOI 10.1073/pnas.0703626104; Fujita K, 2003, GENES CELLS, V8, P559, DOI 10.1046/j.1365-2443.2003.00656.x; Galeraud-Denis I, 2007, ASIAN J ANDROL, V9, P587, DOI 10.1111/j.1745-7262.2007.00310.x; Garcia-Herrero S, 2011, REPROD BIOMED ONLINE, V22, P25, DOI 10.1016/j.rbmo.2010.09.013; Garrido N, 2009, FERTIL STERIL, V91, P1307, DOI 10.1016/j.fertnstert.2008.01.078; Gilbert I, 2007, REPRODUCTION, V133, P1073, DOI 10.1530/REP-06-0292; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Gur Yael, 2007, Soc Reprod Fertil Suppl, V65, P391; Gur Y, 2008, MOL CELL ENDOCRINOL, V282, P45, DOI 10.1016/j.mce.2007.11.015; Hamatani T, 2012, FERTIL STERIL, V97, P275, DOI 10.1016/j.fertnstert.2011.12.035; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Huber C, 2008, J BIOL CHEM, V283, P34002, DOI 10.1074/jbc.M803957200; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Kameshwari DB, 2010, ASIAN J ANDROL, V12, P344, DOI 10.1038/aja.2010.19; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Kempisty B, 2008, REPROD FERT DEVELOP, V20, P513, DOI 10.1071/RD07211; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Kumar A, 2003, J BIOL CHEM, V278, P11480, DOI 10.1074/jbc.M300080200; Lalancette C, 2008, BIOL REPROD, V78, P618, DOI 10.1095/biolreprod.106.059030; Lee TL, 2012, METHODS MOL BIOL, V825, P105, DOI 10.1007/978-1-61779-436-0_9; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Martins R P, 2007, Soc Reprod Fertil Suppl, V64, P1; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meunier J, 2012, GENOME RES; Miller D, 2006, Gynecol Obstet Fertil, V34, P840, DOI 10.1016/j.gyobfe.2006.07.013; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; MOORE GD, 1993, DEV BIOL, V159, P669, DOI 10.1006/dbio.1993.1273; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Nguyen MT, 2008, FERTIL STERIL; Ostermeier CG, 2005, FERTIL STERIL, V83, P1687, DOI 10.1016/j.fertnstert.2004.12.046; Ostermeier GC, 2005, J ANDROL, V26, P70; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Ostermeier GC, 2002, BIOINFORMATICS, V18, P949, DOI 10.1093/bioinformatics/18.7.949; Paillisson A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-76; Paria N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021374; PAUL IJ, 1975, MOL CELL BIOCHEM, V9, P9, DOI 10.1007/BF01731728; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; PESSOT CA, 1989, BIOCHEM BIOPH RES CO, V158, P272, DOI 10.1016/S0006-291X(89)80208-6; Pittoggi C, 2006, MOL REPROD DEV, V73, P1239, DOI 10.1002/mrd.20550; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Puri D, 2010, EPIGENETICS-US, V5, P386, DOI 10.4161/epi.5.5.12005; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Saengsoi W, 2011, ANIM REPROD SCI, V127, P114, DOI 10.1016/j.anireprosci.2011.07.004; Samplaski MK, 2010, INT J UROL, V17, P839, DOI 10.1111/j.1442-2042.2010.02619.x; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spadafora C, 2008, HUM REPROD, V23, P735, DOI 10.1093/humrep/dem425; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Srivastava J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-303; Sudderth AK, 2010, ANIMAL REPROD SCI S, V121S, pS149; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Varner DD, 2008, THERIOGENOLOGY, V70, P448, DOI 10.1016/j.theriogenology.2008.04.023; Varner DD, 2000, ANIM REPROD SCI, V60, P493, DOI 10.1016/S0378-4320(00)00115-9; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Woods J, 2000, THERIOGENOLOGY, V53, P1827, DOI 10.1016/S0093-691X(00)00318-6; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7; Yamazaki K, 2006, BIOL REPROD, V75, P462, DOI 10.1095/biolreprod.105.048058; Yang CC, 2010, ANIM REPROD SCI, V119, P76, DOI 10.1016/j.anireprosci.2009.12.002; Yang CC, 2009, ANIM REPROD SCI, V113, P143, DOI 10.1016/j.anireprosci.2008.08.012; Yao CJ, 2010, ASIAN J ANDROL, V12, P567, DOI 10.1038/aja.2010.28; Yao CJ, 2010, MOL REPROD DEV, V77, P158, DOI 10.1002/mrd.21116; Zhao C, 2009, PROTEOMICS, V9, P1385, DOI 10.1002/pmic.200800353; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	113	67	69	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56535	10.1371/journal.pone.0056535	http://dx.doi.org/10.1371/journal.pone.0056535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409192	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000057
J	Yao, K; Ge, W				Yao, Kai; Ge, Wei			Spatial Distribution and Receptor Specificity of Zebrafish Kit System - Evidence for a Kit-Mediated Bi-Directional Communication System in the Preovulatory Ovarian Follicle	PLOS ONE			English	Article							STEM-CELL FACTOR; EPIDERMAL-GROWTH-FACTOR; SRC FAMILY KINASE; C-KIT; TYROSINE KINASE; OOCYTE GROWTH; SWISS-MODEL; EXPRESSION PATTERNS; TEMPORAL EXPRESSION; LIGAND EXPRESSION	Consisting of Kit ligand and receptor Kit, the Kit system is involved in regulating many ovarian functions such as follicle activation, granulosa cell proliferation, and oocyte growth and maturation. In mammals, Kit ligand is derived from the granulosa cells and Kit receptor is expressed in the oocyte and theca cells. In the zebrafish, the Kit system contains two ligands (Kitlga and Kitlgb) and two receptors (Kita and Kitb). Interestingly, Kitlga and Kitb are localized in the somatic follicle cells, but Kitlgb and Kita are expressed in the oocyte. Using recombinant zebrafish Kitlga and Kitlgb, we demonstrated that Kitlga preferentially activated Kita whereas Kitlgb specifically activated Kitb by Western analysis for receptor phosphorylation. In support of this, Kitlgb triggered a stronger and longer MAPK phosphorylation in follicle cells than Kitlga, whereas Kitlga but not Kitlgb activated MAPK in the denuded oocytes, in agreement with the distribution of Kita and Kitb in the follicle and their specificity for Kitlga and Kitlgb. Further analysis of the interaction between Kit ligands and receptors by homology modeling showed that Kitlga-Kita and Kitlgb-Kitb both have more stable electrostatic interaction than Kitlgb-Kita or Kitlga-Kitb. A functional study of Kit involvement in final oocyte maturation showed that Kitlga and Kitlgb both suppressed the spontaneous maturation significantly; in contrast, Kitlgb but not Kitlga significantly promoted 17 alpha, 20 beta-dihydroxy-4-pregnen-3-one (DHP) -induced oocyte maturation. Our results provided strong evidence for a Kit-mediated bi-directional communication system in the zebrafish ovarian follicle, which could be part of the complex interplay between the oocyte and the follicle cells in the development of follicles.	[Ge, Wei] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, W (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	weige@cuhk.edu.hk		, Kai/0000-0002-8122-430X	Research Grants Council [CUHK464707, 464308, 464409]; Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	Research Grants Council(Hong Kong Research Grants Council); Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	The work was substantially supported by grants from the Research Grants Council (CUHK464707, 464308 and 464409) and the Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region to W. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bondzi C, 2000, CELL GROWTH DIFFER, V11, P305; Brankin Victoria, 2003, Reprod Biol Endocrinol, V1, P55, DOI 10.1186/1477-7827-1-55; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Cheng GFY, 2007, J ENDOCRINOL, V195, P373, DOI 10.1677/JOE-07-0265; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Ge W, 1997, J MOL ENDOCRINOL, V19, P47, DOI 10.1677/jme.0.0190047; Ge W, 2005, MOL CELL ENDOCRINOL, V237, P1, DOI 10.1016/j.mce.2005.03.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HORIE K, 1991, BIOL REPROD, V45, P547, DOI 10.1095/biolreprod45.4.547; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Ismail RS, 1997, DEV BIOL, V184, P333, DOI 10.1006/dbio.1997.8531; Ismail RS, 1996, MOL REPROD DEV, V43, P458, DOI 10.1002/(SICI)1098-2795(199604)43:4&lt;458::AID-MRD8&gt;3.0.CO;2-O; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668; MANOVA K, 1993, DEV BIOL, V157, P85, DOI 10.1006/dbio.1993.1114; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Mellgren EM, 2005, DEV GENES EVOL, V215, P470, DOI 10.1007/s00427-005-0001-3; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Misawa A, 2000, CANCER RES, V60, P64; MOTRO B, 1993, DEV DYNAM, V197, P69, DOI 10.1002/aja.1001970107; Nelson SN, 2010, GEN COMP ENDOCR, V168, P111, DOI 10.1016/j.ygcen.2010.04.020; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; PACKER AI, 1994, DEV BIOL, V161, P194, DOI 10.1006/dbio.1994.1020; Pang YF, 2002, BIOL REPROD, V66, P259, DOI 10.1095/biolreprod66.2.259; Pang YF, 2002, ENDOCRINOLOGY, V143, P47, DOI 10.1210/en.143.1.47; Parrott JA, 2000, MOL REPROD DEV, V55, P55, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;55::AID-MRD8&gt;3.0.CO;2-L; Parrott JA, 1997, ENDOCRINOLOGY, V138, P3819, DOI 10.1210/en.138.9.3819; Parrott JA, 1998, ENDOCRINOLOGY, V139, P2240, DOI 10.1210/en.139.5.2240; Peyton C, 2011, BIOL REPROD, V85, P42, DOI 10.1095/biolreprod.110.088765; Reynaud K, 2000, MOL REPROD DEV, V56, P483, DOI 10.1002/1098-2795(200008)56:4&lt;483::AID-MRD6&gt;3.0.CO;2-O; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Thomas FH, 2008, BIOL REPROD, V78, P167, DOI 10.1095/biolreprod.106.058529; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Tse AC, 2009, GEN COMP ENDOCRINOL; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; Wang YJ, 2003, BIOL REPROD, V69, P1998, DOI 10.1095/biolreprod.103.020826; Wang YJ, 2002, GEN COMP ENDOCR, V127, P209, DOI 10.1016/S0016-6480(02)00041-2; Yao K, 2010, BIOL REPROD, V82, P1216, DOI 10.1095/biolreprod.109.082644; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Yoshida H, 1997, DEV BIOL, V184, P122, DOI 10.1006/dbio.1997.8503; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732; Zhou R, 2011, BIOL REPROD, V85, P615, DOI 10.1095/biolreprod.111.091884	58	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56192	10.1371/journal.pone.0056192	http://dx.doi.org/10.1371/journal.pone.0056192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409152	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300064
J	Castagnino, P; Kothapalli, D; Hawthorne, EA; Liu, SL; Xu, TN; Rao, S; Yung, Y; Assoian, RK				Castagnino, Paola; Kothapalli, Devashish; Hawthorne, Elizabeth A.; Liu, Shu-Lin; Xu, Tina; Rao, Shilpa; Yung, Yuval; Assoian, Richard K.			miR-221/222 Compensates for Skp2-Mediated p27 Degradation and Is a Primary Target of Cell Cycle Regulation by Prostacyclin and cAMP	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; G1 PHASE; S-PHASE; INHIBITOR P27(KIP1); STENT RESTENOSIS; GENE-EXPRESSION; CDK INHIBITORS; D1 EXPRESSION; ACTIVATION; SKP2	p27(kip1) (p27) is a cdk-inhibitory protein with an important role in the proliferation of many cell types. SCFSkp2 is the best studied regulator of p27 levels, but Skp2-mediated p27 degradation is not essential in vivo or in vitro. The molecular pathway that compensates for loss of Skp2-mediated p27 degradation has remained elusive. Here, we combine vascular injury in the mouse with genome-wide profiling to search for regulators of p27 during cell cycling in vivo. This approach, confirmed by RT-qPCR and mechanistic analysis in primary cells, identified miR-221/222 as a compensatory regulator of p27. The expression of miR221/222 is sensitive to proteasome inhibition with MG132 suggesting a link between p27 regulation by miRs and the proteasome. We then examined the roles of miR-221/222 and Skp2 in cell cycle inhibition by prostacyclin (PGI(2)), a potent cell cycle inhibitor acting through p27. PGI(2) inhibited both Skp2 and miR221/222 expression, but epistasis, ectopic expression, and time course experiments showed that miR-221/222, rather than Skp2, was the primary target of PGI(2). PGI(2) activates Gs to increase cAMP, and increasing intracellular cAMP phenocopies the effect of PGI(2) on p27, miR-221/222, and mitogenesis. We conclude that miR-221/222 compensates for loss of Skp2-mediated p27 degradation during cell cycling, contributes to proteasome-dependent G1 phase regulation of p27, and accounts for the anti-mitogenic effect of cAMP during growth inhibition.	[Castagnino, Paola; Kothapalli, Devashish; Hawthorne, Elizabeth A.; Liu, Shu-Lin; Xu, Tina; Yung, Yuval; Assoian, Richard K.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Rao, Shilpa] Univ Penn, Perelman Sch Med, Mol Profiling Facil, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Assoian, RK (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.	assoian@mail.med.upenn.edu			National Institutes of Health (NIH) [HL083367, HL62250, HL094491]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094491, P01HL062250, R01HL083367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL083367, HL62250 and HL094491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkarain A, 2004, BREAST CANCER RES, V6, P13, DOI 10.1186/bcr722; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castagnino P, 2010, PROSTAG OTH LIPID M, V93, P20, DOI 10.1016/j.prostaglandins.2010.04.004; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; DeSalle LM, 2001, FEBS LETT, V490, P179, DOI 10.1016/S0014-5793(01)02121-4; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Ii M, 2001, CARDIOVASC RES, V52, P500, DOI 10.1016/S0008-6363(01)00411-4; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Kuiperij HB, 2005, ONCOGENE, V24, P2087, DOI 10.1038/sj.onc.1208450; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Marks AR, 2003, NEW ENGL J MED, V349, P1307, DOI 10.1056/NEJMp038141; Marx SO, 2001, CIRCULATION, V104, P852, DOI 10.1161/01.CIR.104.8.852; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Stewart SA, 2004, J BIOL CHEM, V279, P29109, DOI 10.1074/jbc.M404271200; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wu YJ, 2006, CIRC RES, V98, P1141, DOI 10.1161/01.RES.0000219905.16312.28; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286	48	18	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56140	10.1371/journal.pone.0056140	http://dx.doi.org/10.1371/journal.pone.0056140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409140	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200114
J	Dreifuss, AA; Bastos-Pereira, AL; Fabossi, IA; Livero, FAD; Stolf, AM; de Souza, CEA; Gomes, LD; Constantin, RP; Furman, AEF; Strapasson, RLB; Teixeira, S; Zampronio, AR; Muscara, MN; Stefanello, MEA; Acco, A				Dreifuss, Arturo Alejandro; Bastos-Pereira, Amanda Leite; Fabossi, Isabella Aviles; dos Reis Livero, Francislaine Aparecida; Stolf, Aline Maria; Alves de Souza, Carlos Eduardo; Gomes, Liana de Oliveira; Constantin, Rodrigo Polimeni; Ferreira Furman, Aline Emmer; Batista Strapasson, Regiane Lauriano; Teixeira, Simone; Zampronio, Aleksander Roberto; Muscara, Marcelo Nicolas; Alves Stefanello, Maria Elida; Acco, Alexandra			Uncaria tomentosa Exerts Extensive Anti-Neoplastic Effects against the Walker-256 Tumour by Modulating Oxidative Stress and Not by Alkaloid Activity	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; QUINOVIC ACID GLYCOSIDES; UNA-DE-GATO; NF-KAPPA-B; OXINDOLE ALKALOIDS; CATS CLAW; ANTIINFLAMMATORY ACTIVITY; BEARING RATS; CANCER CACHEXIA; LEUKEMIA-CELLS	This study aimed to compare the anti-neoplastic effects of an Uncaria tomentosa (UT) brute hydroethanolic (BHE) extract with those of two fractions derived from it. These fractions are choroformic (CHCl3) and n-butanolic (BuOH), rich in pentacyclic oxindole alkaloids (POA) and antioxidant substances, respectively. The cancer model was the subcutaneous inoculation of Walker-256 tumour cells in the pelvic limb of male Wistar rat. Subsequently to the inoculation, gavage with BHE extract (50 mg.kg(-1)) or its fractions (as per the yield of the fractioning process) or vehicle (Control) was performed during 14 days. Baseline values, corresponding to individuals without tumour or treatment with UT, were also included. After treatment, tumour volume and mass, plasma biochemistry, oxidative stress in liver and tumour, TNF-alpha level in liver and tumour homogenates, and survival rates were analysed. Both the BHE extract and its BuOH fraction successfully reduced tumour weight and volume, and modulated anti-oxidant systems. The hepatic TNF-alpha level indicated a greater effect from the BHE extract as compared to its BuOH fraction. Importantly, both the BHE extract and its BuOH fraction increased the survival time of the tumour-bearing animals. Inversely, the CHCl3 fraction was ineffective. These data represent an in vivo demonstration of the importance of the modulation of oxidative stress as part of the anti-neoplastic activity of UT, as well as constitute evidence of the lack of activity of isolated POAs in the primary tumour of this tumour lineage. These effects are possibly resulting from a synergic combination of substances, most of them with antioxidant properties.	[Dreifuss, Arturo Alejandro; Bastos-Pereira, Amanda Leite; Fabossi, Isabella Aviles; dos Reis Livero, Francislaine Aparecida; Stolf, Aline Maria; Alves de Souza, Carlos Eduardo; Gomes, Liana de Oliveira; Zampronio, Aleksander Roberto; Acco, Alexandra] Univ Fed Parana, Dept Pharmacol, BR-80060000 Curitiba, Parana, Brazil; [Constantin, Rodrigo Polimeni] Univ Maringa, Dept Biochem, Maringa, Parana, Brazil; [Ferreira Furman, Aline Emmer] Univ Fed Parana, Training Lab, Dept Pharm, BR-80060000 Curitiba, Parana, Brazil; [Batista Strapasson, Regiane Lauriano; Alves Stefanello, Maria Elida] Univ Fed Parana, Dept Chem, BR-80060000 Curitiba, Parana, Brazil; [Teixeira, Simone; Muscara, Marcelo Nicolas] Univ Sao Paulo, Dept Pharmacol, BR-05508 Sao Paulo, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana; Universidade de Sao Paulo	Acco, A (corresponding author), Univ Fed Parana, Dept Pharmacol, BR-80060000 Curitiba, Parana, Brazil.	aleacco@ufpr.br	Muscará, Marcelo N/F-3250-2012; Acco, Alexandra/AAF-8826-2020; Bastos-Pereira, Amanda/AAQ-1375-2020; Constantin, Rodrigo P/A-4727-2016; Acco, Alexandra/K-1265-2014; Zampronio, Aleksander R/B-3915-2013; Lívero, Francislaine/AAG-6083-2019; Teixeira, Simone/K-3991-2016	Muscará, Marcelo N/0000-0002-8342-5586; Acco, Alexandra/0000-0003-3977-687X; Bastos-Pereira, Amanda/0000-0001-9416-1208; Acco, Alexandra/0000-0003-3977-687X; Lívero, Francislaine/0000-0001-6533-0850; Teixeira, Simone/0000-0002-8515-5030; Zampronio, Aleksander/0000-0002-8354-7081	REUNI/CAPES	REUNI/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to express their gratitude to Dr. Jose Luis Aguilar, from the Cayetano Heredia Peruvian University, Lima, Peru; Dr. Armando Rivero, from the National University of San Marcos, Lima, Peru; and Peruvian Heritage, S. A. C., for their generous contribution of all botanic material employed in this work. Also, all our appreciation goes to Prof. Dr. Luiz Claudio Fernandes, Federal University of Parana, for his kindness in providing us with the Walker-256 tumour cells. Finally, many thankful regards go to Jorgete Constantin, Aparecida Pinto Munhos Hermoso and Renato Polimeni Constantin, from the University of Maringa, Parana, Brazil, for their invaluable help during some experimental procedures. The authors acknowledge REUNI/CAPES for the Master degree fellowship supported to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acco A, 2007, BASIC CLIN PHARMACOL, V101, P294, DOI 10.1111/j.1742-7843.2007.00124.x; Aebi H, 1984, CATALASE IN VITRO; Aguilar JL, 2002, J ETHNOPHARMACOL, V81, P271, DOI 10.1016/S0378-8741(02)00093-4; Dreifuss AA, 2010, J ETHNOPHARMACOL, V130, P127, DOI 10.1016/j.jep.2010.04.029; Allen-Hall L, 2010, J ETHNOPHARMACOL, V127, P685, DOI 10.1016/j.jep.2009.12.004; Aquino R, 1997, PHYTOCHEMISTRY, V45, P1035, DOI 10.1016/S0031-9422(96)00716-9; AQUINO R, 1991, J NAT PROD, V54, P453, DOI 10.1021/np50074a016; AQUINO R, 1990, J NAT PROD, V53, P559, DOI 10.1021/np50069a004; Bacher N, 2006, BRIT J HAEMATOL, V132, P615, DOI 10.1111/j.1365-2141.2005.05907.x; Bastos-Pereira AL, 2010, CANCER CHEMOTH PHARM, V65, P267, DOI 10.1007/s00280-009-1031-8; Bechtel W, 2009, ANTICANCER RES, V29, P4541; Bechtel W, 2009, ANTICANCER RES, V29, P4559; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; CERRI R, 1988, J NAT PROD, V51, P257, DOI 10.1021/np50056a010; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; Coelho I, 2012, LIPIDS, V47, P1031, DOI 10.1007/s11745-012-3715-9; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Martino L, 2006, J ETHNOPHARMACOL, V107, P91, DOI 10.1016/j.jep.2006.02.013; Jumes FMD, 2010, CAN J PHYSIOL PHARM, V88, P21, DOI 10.1139/Y09-111; Earle WR, 1934, AM J CANC, V24, P566; Folador A, 2009, NUTR CANCER, V61, P670, DOI 10.1080/01635580902825548; Ganzera M, 2001, PLANTA MED, V67, P447, DOI 10.1055/s-2001-15824; Gao RM, 1998, BIOELECTROCH BIOENER, V45, P41, DOI 10.1016/S0302-4598(98)00072-5; Prado EG, 2007, PHYTOMEDICINE, V14, P280, DOI 10.1016/j.phymed.2006.12.023; Gate L, 1999, BIOMED PHARMACOTHER, V53, P169, DOI 10.1016/S0753-3322(99)80086-9; Giboney PT, 2005, AM FAM PHYSICIAN, V71, P1105; Goncalves C, 2005, PHYTOCHEMISTRY, V66, P89, DOI 10.1016/j.phytochem.2004.10.025; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Heitzman ME, 2005, PHYTOCHEMISTRY, V66, P5, DOI 10.1016/j.phytochem.2004.10.022; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Kitajima Mariko, 2004, Chemical & Pharmaceutical Bulletin (Tokyo), V52, P1258, DOI 10.1248/cpb.52.1258; LAUS G, 1994, J CHROMATOGR A, V662, P243, DOI 10.1016/0021-9673(94)80511-3; Laus G, 1997, PHYTOCHEMISTRY, V45, P855, DOI 10.1016/S0031-9422(97)00061-7; Gurrola-Diaz CM, 2011, PHYTOMEDICINE, V18, P683, DOI 10.1016/j.phymed.2010.11.002; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miller M J, 2001, BMC Complement Altern Med, V1, P11, DOI 10.1186/1472-6882-1-11; Mizuno M, 1999, BIOCHEM MOL BIOL INT, V47, P707; Muhammad I, 2001, PHYTOCHEMISTRY, V57, P781, DOI 10.1016/S0031-9422(01)00043-7; Paniagua-Perez R, 2009, BASIC CLIN PHARMACOL, V104, P222, DOI 10.1111/j.1742-7843.2008.00366.x; Piffar PM, 2003, CANCER LETT, V201, P139, DOI 10.1016/S0304-3835(03)00472-5; Pilarski R, 2007, PHARMACOL REP, V59, P565; Pilarski R, 2010, PHYTOMEDICINE, V17, P1133, DOI 10.1016/j.phymed.2010.04.013; Portugal J, 2009, TUMORI J, V95, P409; Reinhard KH, 1999, J ALTERN COMPLEM MED, V5, P143, DOI 10.1089/acm.1999.5.143; Riva L, 2001, ANTICANCER RES, V21, P2457; RIZZI R, 1993, J ETHNOPHARMACOL, V38, P63, DOI 10.1016/0378-8741(93)90080-O; Sandoval M, 2000, FREE RADICAL BIO MED, V29, P71, DOI 10.1016/S0891-5849(00)00327-0; Sandoval-Chacon M, 1998, ALIMENT PHARM THER, V12, P1279, DOI 10.1046/j.1365-2036.1998.00424.x; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SEKI H, 1993, CHEM PHARM BULL, V41, P2077, DOI 10.1248/cpb.41.2077; Sheng YZ, 1998, ANTICANCER RES, V18, P3363; Sheng YZ, 2000, J ETHNOPHARMACOL, V69, P115, DOI 10.1016/S0378-8741(99)00070-7; Takayama H, 2005, CURR ORG CHEM, V9, P1445, DOI 10.2174/138527205774370559; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vicentino C, 2002, LIVER, V22, P342, DOI 10.1034/j.1600-0676.2002.01656.x; WAGNER H, 1985, PLANTA MED, V51, P419, DOI 10.1055/s-2007-969537; YAMAGUCHI Y, 1992, BIOCHEM BIOPH RES CO, V189, P1084, DOI 10.1016/0006-291X(92)92315-O; YASMINEH WG, 1991, CANCER RES, V51, P3990	61	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54618	10.1371/journal.pone.0054618	http://dx.doi.org/10.1371/journal.pone.0054618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408945	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200011
J	Ferguson, NS; Lamb, KE; Wang, Y; Ogilvie, D; Ellaway, A				Ferguson, Neil S.; Lamb, Karen E.; Wang, Yang; Ogilvie, David; Ellaway, Anne			Access to Recreational Physical Activities by Car and Bus: An Assessment of Socio-Spatial Inequalities in Mainland Scotland	PLOS ONE			English	Article							MEASURING ACCESSIBILITY; SOCIOECONOMIC-STATUS; ACTIVITY FACILITIES; RESOURCES; AVAILABILITY; DISPARITIES	Obesity and other chronic conditions linked with low levels of physical activity (PA) are associated with deprivation. One reason for this could be that it is more difficult for low-income groups to access recreational PA facilities such as swimming pools and sports centres than high-income groups. In this paper, we explore the distribution of access to PA facilities by car and bus across mainland Scotland by income deprivation at datazone level. GIS car and bus networks were created to determine the number of PA facilities accessible within travel times of 10, 20 and 30 minutes. Multilevel negative binomial regression models were then used to investigate the distribution of the number of accessible facilities, adjusting for datazone population size and local authority. Access to PA facilities by car was significantly (p<0.01) higher for the most affluent quintile of area-based income deprivation than for most other quintiles in small towns and all other quintiles in rural areas. Accessibility by bus was significantly lower for the most affluent quintile than for other quintiles in urban areas and small towns, but not in rural areas. Overall, we found that the most disadvantaged groups were those without access to a car and living in the most affluent areas or in rural areas.	[Ferguson, Neil S.; Wang, Yang] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland; [Lamb, Karen E.; Ellaway, Anne] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Ogilvie, David] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [Ogilvie, David] Univ Cambridge, Cambridge Inst Publ Hlth, United Kingdom Clin Res Collaborat Ctr Diet & Act, Cambridge, England	University of Strathclyde; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Cambridge; University of Cambridge	Ferguson, NS (corresponding author), Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland.	n.s.ferguson@strath.ac.uk	Lamb, Karen/P-4988-2016; Ellaway, Anne/A-3065-2009	Lamb, Karen/0000-0001-9782-8450; Ferguson, Neil/0000-0002-3166-2694; Ogilvie, David/0000-0002-0270-4672; Ellaway, Anne/0000-0002-2117-4451	National Prevention Research Initiative [G0701082]; Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research United Kingdom (UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Food Standards Agency; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; Stroke Association; Welsh Assembly Government; World Cancer Research Fund; Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; National Institute for Health Research (NIHR); Wellcome Trust; UK Clinical Research Collaboration; Diabetes UK; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/6, MC_UU_12017/8, MC_UP_A540_1022, MC_UP_1001/1, MC_EX_G0701942] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_EX_G0701942, MC_UP_1001/1, MC_UU_12015/6, MC_UU_12017/8, MC_UP_A540_1022] Funding Source: UKRI	National Prevention Research Initiative(Diabetes UK); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom (UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Food Standards Agency; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the National Prevention Research Initiative (www.npri.org.uk, G0701082), with support from the following organisations: Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research United Kingdom (UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Food Standards Agency; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; The Stroke Association; Welsh Assembly Government; and World Cancer Research Fund. AE and KL are employed by the UK Medical Research Council in the Neighbourhoods and Health Programme (wbs U.1300.00.011.). DO is employed by the Medical Research Council and is also supported by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, the Economic and Social Research Council, the Medical Research Council, the National Institute for Health Research (NIHR), and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or other funders.	[Anonymous], 2010, R LANG ENV STAT COMP; Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Belanger M, 2011, PREV MED, V52, P247, DOI 10.1016/j.ypmed.2011.02.008; Billaudeau N, 2011, HEALTH PLACE, V17, P114, DOI 10.1016/j.healthplace.2010.09.004; Bradshaw P, 2012, SCOTTISH HLTH SURVEY; Caliper Corporation, 2011, TRANSCAD TRANSP PLAN; Dargay J, 1999, TRANSPORT RES A-POL, V33, P101, DOI 10.1016/S0965-8564(98)00026-3; Department of Health, 2011, START ACT STAY ACT R; Estabrooks PA, 2003, ANN BEHAV MED, V25, P100, DOI 10.1207/S15324796ABM2502_05; Frank L, 2003, COMMUNITY DESIGN IMP; Geurs K. T., 2004, J TRANSP GEOGR, V12, P127, DOI [10.1016/j.jtrangeo.2003.10.005, DOI 10.1016/J.JTRANGEO.2003.10.005]; Geurs KT, 2003, ENVIRON PLANN B, V30, P69, DOI 10.1068/b12940; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Google, 2011, GOOGL MAPS; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Handy SL, 1997, ENVIRON PLANN A, V29, P1175, DOI 10.1068/a291175; Hillsdon M, 2007, AM J PREV MED, V32, P506, DOI 10.1016/j.amepre.2007.02.018; HM Government, 2011, NAT PUBL TRANSP DAT; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; Juff B, 2011, FURTHER REV DEMAND R; Lamb KE, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-55; Lamb KE, 2010, INTERNATIONAL JOURNA, P7; Lee D, 2010, J R STAT SOC C-APPL, V59, P905, DOI 10.1111/j.1467-9876.2010.00725.x; Lee RE, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.054098; Litman, 2012, EVALUATING ACCESSIBI; London 2012, 2012, LOND 2012; Lynch K., 1984, GOOD CITY FORM; Macintyre S, 2008, SOC SCI MED, V67, P900, DOI 10.1016/j.socscimed.2008.05.029; McCormack GR, 2006, INT J BEHAV NUTR PHY, P3; McDonald M., 1984, GEOMETRIC DELAY NONS; Moore LV, 2008, AM J PREV MED, V34, P16, DOI 10.1016/j.amepre.2007.09.021; Ogilvie D, 2011, HEALTH PLACE, V17, P1015, DOI 10.1016/j.healthplace.2011.07.003; Ordnance Survey, 2011, OS MAST MAK ALL DIFF; Panter, 2007, FORESIGHT TACKLING O; Panter J, 2008, PREV MED, V46, P303, DOI 10.1016/j.ypmed.2007.11.005; Physical Activity Task Force, 2003, LETS MAK SCOTL MOR A; PIRIE GH, 1979, ENVIRON PLANN A, V11, P299, DOI 10.1068/a110299; Powell LM, 2006, AM J PUBLIC HEALTH, V96, P1676, DOI 10.2105/AJPH.2005.065573; Scottish Executive, 2006, SCOTT IND MULT DEPR; Scottish Executive, 2001, CARS VANS NUMB AV HO; Scottish Executive, 2008, SCOTT EX URB RUR CLA; Scottish Executive, 2004, SCOTT NEIGHB STAT DA; Scottish Executive, 2001, CENS DAY POP; Scottish Government, 2009, PEOPL SPORT SCOTL RE; Scottish Government, 2012, LEG 2014 BE PART IT; Scottish Government, 2008, EQ WELL REP MIN TASK; Scottish Government, 2012, NAT PERF FRAM; Shen Q, 1998, ENVIRON PLANN B, V25, P345, DOI 10.1068/b250345; van Lenthe FJ, 2005, SOC SCI MED, V60, P763, DOI 10.1016/j.socscimed.2004.06.013	51	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55638	10.1371/journal.pone.0055638	http://dx.doi.org/10.1371/journal.pone.0055638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409012	Green Accepted, gold, Green Published			2022-12-25	WOS:000315157200045
J	Hutson, CL; Gallardo-Romero, N; Carroll, DS; Clemmons, C; Salzer, JS; Nagy, T; Hughes, CM; Olson, VA; Karem, KL; Damon, IK				Hutson, Christina L.; Gallardo-Romero, Nadia; Carroll, Darin S.; Clemmons, Cody; Salzer, Johanna S.; Nagy, Tamas; Hughes, Christine M.; Olson, Victoria A.; Karem, Kevin L.; Damon, Inger K.			Transmissibility of the Monkeypox Virus Clades via Respiratory Transmission: Investigation Using the Prairie Dog-Monkeypox Virus Challenge System	PLOS ONE			English	Article							ANIMAL-MODEL; RISK-FACTORS; CONGO BASIN; DISEASE; INFECTION; PATHOLOGY; STRAINS; AFRICAN; HUMANS	Monkeypox virus (MPXV) is endemic within Africa where it sporadically is reported to cause outbreaks of human disease. In 2003, an outbreak of human MPXV occurred in the US after the importation of infected African rodents. Since the eradication of smallpox (caused by an orthopoxvirus (OPXV) related to MPXV) and cessation of routine smallpox vaccination (with the live OPXV vaccinia), there is an increasing population of people susceptible to OPXV diseases. Previous studies have shown that the prairie dog MPXV model is a functional animal model for the study of systemic human OPXV illness. Studies with this model have demonstrated that infected animals are able to transmit the virus to naive animals through multiple routes of exposure causing subsequent infection, but were not able to prove that infected animals could transmit the virus exclusively via the respiratory route. Herein we used the model system to evaluate the hypothesis that the Congo Basin clade of MPXV is more easily transmitted, via respiratory route, than the West African clade. Using a small number of test animals, we show that transmission of viruses from each of the MPXV clade was minimal via respiratory transmission. However, transmissibility of the Congo Basin clade was slightly greater than West African MXPV clade (16.7% and 0% respectively). Based on these findings, respiratory transmission appears to be less efficient than those of previous studies assessing contact as a mechanism of transmission within the prairie dog MPXV animal model.	[Hutson, Christina L.; Gallardo-Romero, Nadia; Carroll, Darin S.; Clemmons, Cody; Salzer, Johanna S.; Hughes, Christine M.; Olson, Victoria A.; Karem, Kevin L.; Damon, Inger K.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA; [Hutson, Christina L.; Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Salzer, Johanna S.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; Emory University	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.	chutson1@cdc.gov; iad7@cdc.gov						BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028295; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P459; Jezek Z., 1988, MONOGRAPHS VIROLOGY, V17, P1, DOI 10.1159/000416456; Keckler MS, 2011, J VIROL, V85, P7683, DOI 10.1128/JVI.02174-10; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P681, DOI 10.1080/15459624.2012.725986; Nalca A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012880; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2007, EMERG INFECT DIS, V13, P1332, DOI 10.3201/eid1309.070175; Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004; Salzer JS, 2013, J WILDLIFE DIS, V49, P125, DOI 10.7589/2012-04-100; Sbrana E, 2007, AM J TROP MED HYG, V76, P155, DOI 10.4269/ajtmh.2007.76.155; Smith SK, 2011, J VIROL, V85, P9176, DOI 10.1128/JVI.02173-10; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	25	20	20	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55488	10.1371/journal.pone.0055488	http://dx.doi.org/10.1371/journal.pone.0055488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408990	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200033
J	Petelinc, T; Polak, T; Demsar, L; Jamnik, P				Petelinc, Tanja; Polak, Tomaz; Demsar, Lea; Jamnik, Polona			Fractionation of Phenolic Compounds Extracted from Propolis and Their Activity in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; CELL-CULTURE; BIOLOGICAL-PROPERTIES; MASS-SPECTROMETRY; GENERATION; OXIDATION	We have here investigated the activities of Slovenian propolis extracts in the yeast Saccharomyces cerevisiae, and identified the phenolic compounds that appear to contribute to these activities. We correlated changes in intracellular oxidation and cellular metabolic energy in these yeasts with the individual fractions of the propolis extracts obtained following solid-phase extraction. The most effective fraction was further investigated according to its phenolic compounds.	[Petelinc, Tanja; Polak, Tomaz; Demsar, Lea; Jamnik, Polona] Univ Ljubljana, Dept Food Sci & Technol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana	Jamnik, P (corresponding author), Univ Ljubljana, Dept Food Sci & Technol, Biotech Fac, Ljubljana, Slovenia.	polona.jamnik@bf.uni-lj.si			European Social Fund within the National Programme -Innovative scheme [278246]	European Social Fund within the National Programme -Innovative scheme	This work was partly supported by European Social Fund within the National Programme -Innovative scheme for funding the doctoral program (278246). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Castaldo S, 2002, FITOTERAPIA, V73, pS1, DOI 10.1016/S0367-326X(02)00185-5; Cigut T, 2011, J AGR FOOD CHEM, V59, P11449, DOI 10.1021/jf2022258; Clement MV, 2001, ANTIOXID REDOX SIGN, V3, P157, DOI 10.1089/152308601750100687; de Castro PA, 2011, EUKARYOT CELL, V10, P398, DOI 10.1128/EC.00256-10; Falcao SI, 2010, ANAL BIOANAL CHEM, V396, P887, DOI 10.1007/s00216-009-3232-8; Gardana C, 2007, J PHARMACEUT BIOMED, V45, P390, DOI 10.1016/j.jpba.2007.06.022; Halliwell B, 2000, IUBMB LIFE, V50, P251, DOI 10.1080/15216540051080930; Hvattum E, 2002, RAPID COMMUN MASS SP, V16, P655, DOI 10.1002/rcm.622; Jakubowski W, 1997, INT J BIOCHEM CELL B, V29, P1297, DOI 10.1016/S1357-2725(97)00056-3; Justesen U, 2000, J CHROMATOGR A, V902, P369, DOI 10.1016/S0021-9673(00)00861-X; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Long LH, 2001, BIOCHEM BIOPH RES CO, V286, P991, DOI 10.1006/bbrc.2001.5514; Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895; MARCUCCI MC, 1995, APIDOLOGIE, V26, P83, DOI 10.1051/apido:19950202; Medana C, 2008, PHYTOCHEM ANALYSIS, V19, P32, DOI 10.1002/pca.1010; Molyneux P., 2004, SJST, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Pellati F, 2011, J PHARMACEUT BIOMED, V55, P934, DOI 10.1016/j.jpba.2011.03.024; Sforcin JM, 2007, J ETHNOPHARMACOL, V113, P1, DOI 10.1016/j.jep.2007.05.012; Sigler K, 1999, FOLIA MICROBIOL, V44, P587, DOI 10.1007/BF02825650; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tsibranska H, 2011, J MEMBRA SCI TECHNOL, V348, P124; Wang BJ, 2004, FOOD CHEM, V86, P237, DOI 10.1016/j.foodchem.2003.09.031	24	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56104	10.1371/journal.pone.0056104	http://dx.doi.org/10.1371/journal.pone.0056104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409133	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200109
J	Shimizu, YK; Hijikata, M; Oshima, M; Shimizu, K; Alter, HJ; Purcell, RH; Yoshikura, H; Hotta, H				Shimizu, Yohko K.; Hijikata, Minako; Oshima, Masamichi; Shimizu, Kazufumi; Alter, Harvey J.; Purcell, Robert H.; Yoshikura, Hiroshi; Hotta, Hak			Isolation of Human Monoclonal Antibodies to the Envelope E2 Protein of Hepatitis C Virus and Their Characterization	PLOS ONE			English	Article							CELL-CULTURE SYSTEMS; NON-B HEPATITIS; NEUTRALIZING ANTIBODIES; NON-A; GLYCOPROTEIN; INFECTION; IDENTIFICATION; CHIMPANZEES; BINDING; ESCAPE	We isolated and characterized two human monoclonal antibodies to the envelope E2 protein of hepatitis C virus (HCV). Lymphoblastoid cell lines stably producing antibodies were obtained by immortalizing peripheral blood mononuclear cells of a patient with chronic hepatitis C using Epstein-Barr virus. Screening for antibody-positive clones was carried out by immunofluorescence with Huh7 cells expressing the E2 protein of HCV strain H (genotype 1a) isolated from the same patient. Isotype of resulting antibodies, #37 and #55, was IgG1/kappa and IgG1/lambda, respectively. Epitope mapping revealed that #37 and #55 recognize conformational epitopes spanning amino acids 429 to 652 and 508 to 607, respectively. By immunofluorescence using virus-infected Huh7.5 cells as targets both antibodies were reactive with all of the nine different HCV genotypes/subtypes tested. The antibodies showed a different pattern of immuno-staining; while #37 gave granular reactions mostly located in the periphery of the nucleus, #55 gave diffuse staining throughout the cytoplasm. Both antibodies were shown by immuno-gold electron microscopy to bind to intact viral particles. In a neutralization assay (focus-forming unit reduction using chimeric infectious HCV containing structural proteins derived from genotypes 1a, 1b, 2a, 2b, 3a, 4a, 5a, 6a, and 7a), #55 inhibited the infection of all HCV genotypes tested but genotype 7a to a lesser extent. #37 did not neutralize any of these viruses. As a broadly cross-neutralizing human antibody, #55 may be useful for passive immunotherapy of HCV infection.	[Shimizu, Yohko K.; Hotta, Hak] Kobe Univ, Div Microbiol, Ctr Infect Dis, Grad Sch Med, Kobe, Hyogo 657, Japan; [Hijikata, Minako] Natl Ctr Global Hlth & Med, Dept Resp Dis, Res Inst, Tokyo, Japan; [Oshima, Masamichi] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Shimizu, Kazufumi] Nihon Univ, Sch Med, Dept Gynecol, Tokyo, Japan; [Alter, Harvey J.] NIH, Dept Transfus Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Purcell, Robert H.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Yoshikura, Hiroshi] Minist Hlth Labor & Welf, Food Safety Div, Tokyo, Japan	Kobe University; National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Nihon University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shimizu, YK (corresponding author), Kobe Univ, Div Microbiol, Ctr Infect Dis, Grad Sch Med, Kobe, Hyogo 657, Japan.	yshimizu@nih.go.jp			Science and Technology Partnership for Sustainable Development (SATREPS) program of Japan; Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases; CLINICAL CENTER [ZIACL002078] Funding Source: NIH RePORTER	Science and Technology Partnership for Sustainable Development (SATREPS) program of Japan; Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan International Cooperation Agency (JICA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This work was supported, in part, by the Science and Technology Partnership for Sustainable Development (SATREPS) program of Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA) and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; Forns X, 2000, VIROLOGY, V274, P75, DOI 10.1006/viro.2000.0419; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Ishii K, 1998, HEPATOLOGY, V28, P1117, DOI 10.1002/hep.510280429; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Mancini N, 2009, PLOS ONS, V4, P1; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Sasayama M, 2012, J MED VIROL, V84, P229, DOI 10.1002/jmv.22257; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Shimizu YK, 2006, J VIRAL HEPATITIS, V13, P746, DOI 10.1111/j.1365-2893.2006.00745.x; SHIMIZU YK, 1993, P NATL ACAD SCI USA, V90, P6037, DOI 10.1073/pnas.90.13.6037; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; SHIMIZU YK, 1985, P NATL ACAD SCI USA, V82, P2138, DOI 10.1073/pnas.82.7.2138; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yi-Ping L, 2011, P NATL ACAD SCI USA, V108, P4991	28	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55874	10.1371/journal.pone.0055874	http://dx.doi.org/10.1371/journal.pone.0055874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409074	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200082
J	Smith, MG; Croy, I; Ogren, M; Waye, KP				Smith, Michael G.; Croy, Ilona; Ogren, Mikael; Waye, Kerstin Persson			On the Influence of Freight Trains on Humans: A Laboratory Investigation of the Impact of Nocturnal Low Frequency Vibration and Noise on Sleep and Heart Rate	PLOS ONE			English	Article							AIRCRAFT NOISE; RAILWAY NOISE; TRAFFIC NOISE; CARDIOVASCULAR-RESPONSES; ENVIRONMENTAL NOISE; ROAD; FRAGMENTATION; DISTURBANCES; PERFORMANCE; EXPOSURE	Background: A substantial increase in transportation of goods on railway may be hindered by public fear of increased vibration and noise leading to annoyance and sleep disturbance. As the majority of freight trains run during night time, the impact upon sleep is expected to be the most serious adverse effect. The impact of nocturnal vibration on sleep is an area currently lacking in knowledge. We experimentally investigated sleep disturbance with the aim to ascertain the impact of increasing vibration amplitude. Methodology/Principal Findings: The impacts of various amplitudes of horizontal vibrations on sleep disturbance and heart rate were investigated in a laboratory study. Cardiac accelerations were assessed using a combination of polysomnography and ECG recordings. Sleep was assessed subjectively using questionnaires. Twelve young, healthy subjects slept for six nights in the sleep laboratory, with one habituation night, one control night and four nights with a variation of vibration exposures whilst maintaining the same noise exposure. With increasing vibration amplitude, we found a decrease in latency and increase in amplitude of heart rate as well as a reduction in sleep quality and increase in sleep disturbance. Conclusions/Significance: We concluded that nocturnal vibration has a negative impact on sleep and that the impact increases with greater vibration amplitude. Sleep disturbance has short- and long-term health consequences. Therefore, it is necessary to	[Smith, Michael G.; Croy, Ilona; Waye, Kerstin Persson] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Ogren, Mikael] Swedish Natl Rd & Transport Res Inst, Gothenburg, Sweden	University of Gothenburg; VTI	Smith, MG (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	michael.smith@amm.gu.se	Smith, Michael G/G-8365-2012; Smith, Michael G./AAF-3764-2019; Persson Waye, Kerstin/J-7136-2012	Smith, Michael G/0000-0001-8541-9625; Smith, Michael G./0000-0001-8541-9625; Croy, Ilona/0000-0002-0361-5559; Persson Waye, Kerstin/0000-0003-3789-4557; Ogren, Mikael/0000-0002-4559-4127	Seventh Framework Programme [266248]	Seventh Framework Programme(European Commission)	The work was supported by grant 266248 from the Seventh Framework Programme (ec.europa.eu/research/fp7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasvang GM, 2008, J ACOUST SOC AM, V124, P257, DOI 10.1121/1.2932074; Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; ARNBERG PW, 1990, J ACOUST SOC AM, V88, P1486, DOI 10.1121/1.400305; Babisch Wolfgang, 2006, Noise Health, V8, P1; Basner M, 2004, Noise Health, V6, P83; Basner M., 2005, SOMNOLOGIE, V9, P84; Basner M, 2008, PHYSIOL MEAS, V29, P1089, DOI 10.1088/0967-3334/29/9/007; Basner M, 2008, SLEEP MED, V9, P382, DOI 10.1016/j.sleep.2007.07.002; Basner M, 2011, SLEEP, V34, P11, DOI 10.1093/sleep/34.1.11; Berglund B., 1999, GUIDELINES COMMUNITY; Bonnet MH, 2003, SLEEP MED REV, V7, P297, DOI 10.1053/smrv.2001.0245; Carter N, 2002, SLEEP, V25, P457; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Kluizenaar Y, 2009, J ACOUST SOC AM, V126, P626, DOI 10.1121/1.3158834; DINISI J, 1990, SLEEP, V13, P108, DOI 10.1093/sleep/13.2.108; Elmenhorst EM, 2012, SCI TOTAL ENVIRON, V424, P48, DOI 10.1016/j.scitotenv.2012.02.024; European Commission, 2001, WHIT PAP EUR TRANSP; Griefahn B, 2009, INT 2009 OTT CAN; Griefahn B, 2008, SLEEP, V31, P569, DOI 10.1093/sleep/31.4.569; Haines MM, 2002, J EPIDEMIOL COMMUN H, V56, P139, DOI 10.1136/jech.56.2.139; Haines MM, 2001, PSYCHOL MED, V31, P265, DOI 10.1017/S0033291701003282; Iber C., 2007, AASM MANUAL SCORING; International Organization for Standardization, 1997, ISO 2631 1 MECH VI 1; Ising H, 2004, Noise Health, V6, P5; Janssen S. A., 2011, BURDEN DIS ENV NOISE, P55; Kageyama T, 1997, SLEEP, V20, P963; Kjellberg A., 2000, 14 TRIENN C INT ERG, V5, P63, DOI [DOI 10.1177/154193120004402917, 10.1177/154193120004402917]; KNIPSCHILD P, 1977, INT ARCH OCC ENV HEA, V40, P197, DOI 10.1007/BF01842083; Madshus C, 1996, J SOUND VIB, V193, P195, DOI 10.1006/jsvi.1996.0259; Maeda S, 1999, IND HEALTH, V37, P404, DOI 10.2486/indhealth.37.404; Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; Ogren M, 2009, EFFECTS RAILWAY NOIS; Ogren M, 2008, 9 INT C NOIS PUBL HL; Ohrstrom E, 2004, J SOUND VIB, V271, P279, DOI 10.1016/S0022-460X(03)00753-3; Ohrstrom E, 2009, EFFECTS RAILWAY NOIS; Ohrstrom E, 1993, NOISE MAN 1993 NOISE, P393; Passchier-Vermeer W., 2003, NIGHT TIME NOISE EVE; Pennig S, 2012, J ACOUST SOC AM, V132, P3109, DOI 10.1121/1.4757732; Saremi M, 2008, INT J PSYCHOPHYSIOL, V70, P184, DOI 10.1016/j.ijpsycho.2008.08.002; Smith M, 2012, P M AC 15, P15; Standardiseringskommissionen i Sverige, 1992, SS 460 48 61 VIBR SH; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; Tassi P, 2010, ENVIRON INT, V36, P683, DOI 10.1016/j.envint.2010.05.001; Tassi P, 2010, EUR J APPL PHYSIOL, V108, P671, DOI 10.1007/s00421-009-1270-8; THIESSEN GJ, 1988, J ACOUST SOC AM, V84, P1741, DOI 10.1121/1.397189; Turunen-Rise IH, 2003, APPL ACOUST, V64, P71, DOI 10.1016/S0003-682X(02)00052-X; Waye KP, 2003, LIFE SCI, V72, P863, DOI 10.1016/S0024-3205(02)02336-6; Xia H, 2009, EARTHQ ENG ENG VIB, V8, P137, DOI 10.1007/s11803-009-8101-0	49	60	63	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55829	10.1371/journal.pone.0055829	http://dx.doi.org/10.1371/journal.pone.0055829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409055	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200072
J	Xu, Y; Ding, J; Wu, LY; Chou, KC				Xu, Yan; Ding, Jun; Wu, Ling-Yun; Chou, Kuo-Chen			iSNO-PseAAC: Predict Cysteine S-Nitrosylation Sites in Proteins by Incorporating Position Specific Amino Acid Propensity into Pseudo Amino Acid Composition	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; GENERAL-FORM; PROTEOMIC ANALYSIS; IDENTIFICATION; SIGNAL; SEQUENCES; REPRESENTATION; ATTRIBUTES	Posttranslational modifications (PTMs) of proteins are responsible for sensing and transducing signals to regulate various cellular functions and signaling events. S-nitrosylation (SNO) is one of the most important and universal PTMs. With the avalanche of protein sequences generated in the post-genomic age, it is highly desired to develop computational methods for timely identifying the exact SNO sites in proteins because this kind of information is very useful for both basic research and drug development. Here, a new predictor, called iSNO-PseAAC, was developed for identifying the SNO sites in proteins by incorporating the position-specific amino acid propensity (PSAAP) into the general form of pseudo amino acid composition (PseAAC). The predictor was implemented using the conditional random field (CRF) algorithm. As a demonstration, a benchmark dataset was constructed that contains 731 SNO sites and 810 non-SNO sites. To reduce the homology bias, none of these sites were derived from the proteins that had >= 40 pairwise sequence identity to any other. It was observed that the overall cross-validation success rate achieved by iSNO-PseAAC in identifying nitrosylated proteins on an independent dataset was over 90%, indicating that the new predictor is quite promising. Furthermore, a user-friendly web-server for iSNO-PseAAC was established at http://app.aporc.org/iSNO-PseAAC/, by which users can easily obtain the desired results without the need to follow the mathematical equations involved during the process of developing the prediction method. It is anticipated that iSNO-PseAAC may become a useful high throughput tool for identifying the SNO sites, or at the very least play a complementary role to the existing methods in this area.	[Xu, Yan; Ding, Jun] Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China; [Wu, Ling-Yun] Chinese Acad Sci, Inst Appl Math, Acad Math & Syst Sci, Beijing, Peoples R China; [Xu, Yan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	University of Science & Technology Beijing; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Xu, Y (corresponding author), Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China.	yxu@gordonlifescience.org; kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009; Wu, Ling-Yun/C-4222-2008	Wu, Ling-Yun/0000-0001-9487-0215; Xu, Yan/0000-0001-9462-580X	National Natural Science Foundation of China [11101029, 10971223, 60970091, 11131009, 11071013]; Fundamental Research Funds for the Central Universities, NCET of China [NCET-11-0574]; Knowledge Innovation Program of the Chinese Academy of Sciences [kjcx-yw-s7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, NCET of China; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work is partially supported by the National Natural Science Foundation of China (No. 11101029, No. 10971223, No. 60970091, No. 11131009, No. 11071013) and the Fundamental Research Funds for the Central Universities, NCET of China (No. NCET-11-0574), and Knowledge Innovation Program of the Chinese Academy of Sciences (No. kjcx-yw-s7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Aranda E, 2012, CURR MOL MED, V12, P50, DOI 10.2174/156652412798376099; Chang WC, 2009, J COMPUT CHEM, V30, P2526, DOI 10.1002/jcc.21258; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YJ, 2010, J PROTEOME RES, V9, P6417, DOI 10.1021/pr100680a; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; Chou KC, 2001, PROTEINS, V42, P136, DOI 10.1002/1097-0134(20010101)42:1<136::AID-PROT130>3.0.CO;2-F; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; DeCaprio D, 2007, GENOME RES, V17, P1389, DOI 10.1101/gr.6558107; Derakhshan B, 2007, NAT PROTOC, V2, P1685, DOI 10.1038/nprot.2007.210; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jahandideh S, 2012, J THEOR BIOL, V312, P65, DOI 10.1016/j.jtbi.2012.07.013; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li YX, 2011, PROTEIN PEPTIDE LETT, V18, P573, DOI 10.2174/092986611795222731; Lin WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049040; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nanni L, 2012, AMINO ACIDS, V43, P657, DOI 10.1007/s00726-011-1114-9; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Niu XH, 2012, PROTEIN PEPTIDE LETT, V19, P940, DOI 10.2174/092986612802084492; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schonhoff CM, 2006, P NATL ACAD SCI USA, V103, P2404, DOI 10.1073/pnas.0507243103; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; Tang YR, 2007, PROTEIN ENG DES SEL, V20, P405, DOI 10.1093/protein/gzm035; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu LJ, 2009, STROKE, V40, P2973, DOI 10.1161/STROKEAHA.109.551747; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	66	354	354	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55844	10.1371/journal.pone.0055844	http://dx.doi.org/10.1371/journal.pone.0055844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409062	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200076
J	Fang, XL; Finnegan, PM; Barbetti, MJ				Fang, Xiangling; Finnegan, Patrick M.; Barbetti, Martin J.			Wide Variation in Virulence and Genetic Diversity of Binucleate Rhizoctonia Isolates Associated with Root Rot of Strawberry in Western Australia	PLOS ONE			English	Article							SPP. CAUSING ROOT; ANASTOMOSIS GROUPS; FUSARIUM-OXYSPORUM; METHYL-BROMIDE; RIBOSOMAL DNA; SOLANI; PATHOGENICITY; FUNGI; DISEASES; CROWN	Strawberry (Fragariaxananassa) is one of the most important berry crops in the world. Root rot of strawberry caused by Rhizoctonia spp. is a serious threat to commercial strawberry production worldwide. However, there is no information on the genetic diversity and phylogenetic status of Rhizoctonia spp. associated with root rot of strawberry in Australia. To address this, a total of 96 Rhizoctonia spp. isolates recovered from diseased strawberry plants in Western Australia were characterized for their nuclear condition, virulence, genetic diversity and phylogenetic status. All the isolates were found to be binucleate Rhizoctonia (BNR). Sixty-five of the 96 BNR isolates were pathogenic on strawberry, but with wide variation in virulence, with 25 isolates having high virulence. Sequence analysis of the internal transcribed spacers of the ribosomal DNA separated the 65 pathogenic BNR isolates into six distinct clades. The sequence analysis also separated reference BNR isolates from strawberry or other crops across the world into clades that correspond to their respective anastomosis group (AG). Some of the pathogenic BNR isolates from this study were embedded in the clades for AG-A, AG-K and AG-I, while other isolates formed clades that were sister to the clades specific for AG-G, AG-B, AG-I and AG-C. There was no significant association between genetic diversity and virulence of these BNR isolates. This study demonstrates that pathogenic BNR isolates associated with root rot of strawberry in Western Australia have wide genetic diversity, and highlights new genetic groups not previously found to be associated with root rot of strawberry in the world (e. g., AG-B) or in Australia (e. g., AG-G). The wide variation in virulence and genetic diversity identified in this study will be of high value for strawberry breeding programs in selecting, developing and deploying new cultivars with resistance to these multi-genetic groups of BNR.	[Fang, Xiangling; Finnegan, Patrick M.; Barbetti, Martin J.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Finnegan, Patrick M.; Barbetti, Martin J.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Barbetti, MJ (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	martin.barbetti@uwa.edu.au	Finnegan, Patrick M/B-3469-2011; Fang, Xiangling/G-1075-2012; Barbetti, Martin J/B-3455-2011	Finnegan, Patrick M/0000-0001-5021-1138; Barbetti, Martin J/0000-0002-5331-0817	Australia Research Council; Department of Agriculture and Food Western Australia; China Scholarship Council; University of Western Australia	Australia Research Council(Australian Research Council); Department of Agriculture and Food Western Australia; China Scholarship Council(China Scholarship Council); University of Western Australia	This work was supported by the Australia Research Council and the Department of Agriculture and Food Western Australia. XLF gratefully acknowledges the financial assistance of the China Scholarship Council and the University of Western Australia by a jointly awarded PhD Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBETTI MJ, 1987, AUST J AGR RES, V38, P317, DOI 10.1071/AR9870317; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Botha A, 2003, AUSTRALAS PLANT PATH, V32, P195, DOI 10.1071/AP02067; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Cubeta M.A., 2000, ENCY MICROBIOLOGY, P109; Fang XL, 2011, AUSTRALAS PLANT PATH, V40, P109, DOI 10.1007/s13313-010-0019-5; Fang XL, 2012, PLANT SOIL, V358, P71, DOI 10.1007/s11104-012-1205-8; Fang XL, 2012, PHYTOPATHOL MEDITERR, V51, P69; Fang XL, 2011, SCI HORTIC-AMSTERDAM, V131, P39, DOI 10.1016/j.scienta.2011.09.025; Feng J, 2010, PLANT PATHOL, V59, P845, DOI 10.1111/j.1365-3059.2010.02313.x; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Gonzalez D, 2001, MYCOLOGIA, V93, P1138, DOI 10.2307/3761674; Gonzalez D, 2006, MOL PHYLOGENET EVOL, V40, P459, DOI 10.1016/j.ympev.2006.03.022; Gronberg H, 2003, MYCOL RES, V107, P428, DOI 10.1017/S0953756203007500; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Himelrick D, 1991, ADV STRAWBERRY PRODU, V10; HUA'AN Y, 1991, Australasian Plant Pathology, V20, P119, DOI 10.1071/APP9910119; Hyakumachi M, 2005, PHYTOPATHOLOGY, V95, P784, DOI 10.1094/PHYTO-95-0784; Johanson A, 1998, FEMS MICROBIOL LETT, V162, P289, DOI 10.1111/j.1574-6968.1998.tb13011.x; Katan J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P423; Krause MS, 2001, PHYTOPATHOLOGY, V91, P1116, DOI 10.1094/PHYTO.2001.91.11.1116; Kuramae EE, 2007, EUR J PLANT PATHOL, V119, P469, DOI 10.1007/s10658-007-9175-z; Lehtonen MJ, 2008, PLANT PATHOL, V57, P141, DOI 10.1111/j.1365-3059.2007.01694.x; Manici LM, 2007, EUR J PLANT PATHOL, V118, P31, DOI 10.1007/s10658-007-9100-5; MANTEL N, 1967, CANCER RES, V27, P209; Martin FN, 2002, PHYTOPATHOLOGY, V92, P1356, DOI 10.1094/PHYTO.2002.92.12.1356; MARTIN SB, 1988, PHYTOPATHOLOGY, V78, P379, DOI 10.1094/Phyto-78-379; Martin SN, 2000, PHYTOPATHOLOGY, V90, P345, DOI 10.1094/PHYTO.2000.90.4.345; Mathew FM, 2012, PLANT DIS, V96, P666, DOI 10.1094/PDIS-02-11-0087; Matsumoto Masaru, 2006, Journal of General Plant Pathology, V72, P318, DOI 10.1007/s10327-006-0286-8; Nei M., 2000, MOL EVOLUTION PHYLOG; Ohkura M, 2009, PLANT DIS, V93, P615, DOI 10.1094/PDIS-93-6-0615; Pannecoucque J, 2008, PLANT PATHOL, V57, P737, DOI 10.1111/j.1365-3059.2007.01823.x; Particka CA, 2005, J AM SOC HORTIC SCI, V130, P688, DOI 10.21273/JASHS.130.5.688; Porter IJ, 1999, AUSTRALAS PLANT PATH, V28, P65, DOI 10.1071/AP99009; Rinehart TA, 2007, PLANT DIS, V91, P616, DOI 10.1094/PDIS-91-5-0616; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharon M, 2008, MYCOSCIENCE, V49, P93, DOI 10.1007/s10267-007-0394-0; Sharon Michal, 2006, Mycoscience, V47, P299, DOI 10.1007/s10267-006-0320-x; Sharon M, 2007, EUR J PLANT PATHOL, V117, P247, DOI 10.1007/s10658-006-9091-7; Sneh B., 1991, IDENTIFICATION RHIZO; Strausbaugh CA, 2011, CAN J PLANT PATHOL, V33, P210, DOI 10.1080/07060661.2011.558523; Subbarao KV, 2007, PLANT DIS, V91, P964, DOI 10.1094/PDIS-91-8-0964; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toda Takeshi, 2004, Journal of General Plant Pathology, V70, P270, DOI 10.1007/s10327-004-0123-x; Watanabe K, 2011, PLANT SOIL, V347, P255, DOI 10.1007/s11104-011-0843-6; WATANABE T, 1977, T MYCOL SOC JPN, V18, P251; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wilhelm S., 1980, Plant Disease, V64, P264; YUEN GY, 1991, PLANT DIS, V75, P416, DOI 10.1094/PD-75-0416	52	38	41	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55877	10.1371/journal.pone.0055877	http://dx.doi.org/10.1371/journal.pone.0055877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405226	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400171
J	Hastie, AR; Dong, LL; Smith, A; Finklestein, J; Lam, ET; Huo, NX; Cao, H; Kwok, PY; Deal, KR; Dvorak, J; Luo, MC; Gu, Y; Xiao, M				Hastie, Alex R.; Dong, Lingli; Smith, Alexis; Finklestein, Jeff; Lam, Ernest T.; Huo, Naxin; Cao, Han; Kwok, Pui-Yan; Deal, Karin R.; Dvorak, Jan; Luo, Ming-Cheng; Gu, Yong; Xiao, Ming			Rapid Genome Mapping in Nanochannel Arrays for Highly Complete and Accurate De Novo Sequence Assembly of the Complex Aegilops tauschii Genome	PLOS ONE			English	Article							WHOLE-GENOME; PHYSICAL MAP; STRUCTURAL VARIATION; GENERATION; VALIDATION; RESOLUTION; CLONE; DNA	Next-generation sequencing (NGS) technologies have enabled high-throughput and low-cost generation of sequence data; however, de novo genome assembly remains a great challenge, particularly for large genomes. NGS short reads are often insufficient to create large contigs that span repeat sequences and to facilitate unambiguous assembly. Plant genomes are notorious for containing high quantities of repetitive elements, which combined with huge genome sizes, makes accurate assembly of these large and complex genomes intractable thus far. Using two-color genome mapping of tiling bacterial artificial chromosomes (BAC) clones on nanochannel arrays, we completed high-confidence assembly of a 2.1-Mb, highly repetitive region in the large and complex genome of Aegilops tauschii, the D-genome donor of hexaploid wheat (Triticum aestivum). Genome mapping is based on direct visualization of sequence motifs on single DNA molecules hundreds of kilobases in length. With the genome map as a scaffold, we anchored unplaced sequence contigs, validated the initial draft assembly, and resolved instances of misassembly, some involving contigs <2 kb long, to dramatically improve the assembly from 75% to 95% complete.	[Hastie, Alex R.; Smith, Alexis; Finklestein, Jeff; Lam, Ernest T.; Cao, Han; Xiao, Ming] BioNano Genom, San Diego, CA USA; [Dong, Lingli; Huo, Naxin; Gu, Yong] ARS, Genom & Gene Discovery Res Unit, USDA, Albany, CA 94710 USA; [Dong, Lingli; Huo, Naxin; Deal, Karin R.; Dvorak, Jan; Luo, Ming-Cheng; Gu, Yong] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California San Francisco	Gu, Y (corresponding author), ARS, Genom & Gene Discovery Res Unit, USDA, Albany, CA 94710 USA.	yong.gu@ars.usda.gov; ming.xiao@drexel.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Luo, Ming-Cheng/0000-0002-9744-5887	US National Institutes of Health (NIH) [R01 HG005946]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005946] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research is supported in part by US National Institutes of Health (NIH) award to P.-Y.K. and M. X. (R01 HG005946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Blakesley RW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-21; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; CASSIDY BG, 1991, THEOR APPL GENET, V81, P653, DOI 10.1007/BF00226733; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; Dvorak J, 2009, TRITICEAE GENOME STR; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Howden BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lee H, 2012, METHODS MOL BIOL, V855, P155, DOI 10.1007/978-1-61779-582-4_5; Leroy P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00005; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Lin HC, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-189; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mun JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-280; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Philippe R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-47; Riley MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027085; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; van Oeveren J, 2011, GENOME RES, V21, P618, DOI 10.1101/gr.112094.110; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Warren RL, 2006, GENOME RES, V16, P768, DOI 10.1101/gr.5090606; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	36	110	120	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55864	10.1371/journal.pone.0055864	http://dx.doi.org/10.1371/journal.pone.0055864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405223	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400168
J	Zhao, A; Tsechansky, M; Swaminathan, J; Cook, L; Ellington, AD; Marcotte, EM				Zhao, Alice; Tsechansky, Mark; Swaminathan, Jagannath; Cook, Lindsey; Ellington, Andrew D.; Marcotte, Edward M.			Transiently Transfected Purine Biosynthetic Enzymes Form Stress Bodies	PLOS ONE			English	Article							MULTIENZYME COMPLEX; ALPHA-SYNUCLEIN; CELL-GROWTH; AGGREGATION; PROTEINS	It has been hypothesized that components of enzymatic pathways might organize into intracellular assemblies to improve their catalytic efficiency or lead to coordinate regulation. Accordingly, de novo purine biosynthesis enzymes may form a purinosome in the absence of purines, and a punctate intracellular body has been identified as the purinosome. We investigated the mechanism by which human de novo purine biosynthetic enzymes might be organized into purinosomes, especially under differing cellular conditions. Irregardless of the activity of bodies formed by endogenous enzymes, we demonstrate that intracellular bodies formed by transiently transfected, fluorescently tagged human purine biosynthesis proteins are best explained as protein aggregation.	[Zhao, Alice; Tsechansky, Mark; Swaminathan, Jagannath; Cook, Lindsey; Ellington, Andrew D.; Marcotte, Edward M.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Zhao, Alice/J-8115-2016	Zhao, Alice/0000-0001-5845-8071; Fox, Lindsey/0000-0001-7558-618X; Marcotte, Edward/0000-0001-8808-180X	United States National Institutes of Health, National Science Foundation, and Welch [F1515]; Packard Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536] Funding Source: NIH RePORTER	United States National Institutes of Health, National Science Foundation, and Welch; Packard Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the United States National Institutes of Health, National Science Foundation, and Welch (F1515) and Packard Foundations to EMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Baresova V, 2012, HUM MOL GENET, V21, P1534, DOI 10.1093/hmg/ddr591; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gooljarsingh LT, 2001, P NATL ACAD SCI USA, V98, P6565, DOI 10.1073/pnas.121182998; Howard RA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-32; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Lewers JC, 2008, NEUROSCIENCE, V152, P761, DOI 10.1016/j.neuroscience.2007.10.065; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Proctor CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022038; Sagot I, 2006, MOL BIOL CELL, V17, P4645, DOI 10.1091/mbc.E06-04-0282; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Verrier F, 2011, NAT CHEM BIOL, V7, P909, DOI [10.1038/NCHEMBIO.690, 10.1038/nchembio.690]; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200	20	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56203	10.1371/journal.pone.0056203	http://dx.doi.org/10.1371/journal.pone.0056203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405267	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400213
J	Zhou, C; Tong, Y; Wawrowsky, K; Melmed, S				Zhou, C.; Tong, Y.; Wawrowsky, K.; Melmed, S.			PTTG acts as a STAT3 target gene for colorectal cancer cell growth and motility	ONCOGENE			English	Article						STAT3; PTTG; transformation	TUMOR-TRANSFORMING GENE; SIGNAL TRANSDUCER; MATRIX METALLOPROTEINASE-2; CONSTITUTIVE ACTIVATION; EXPRESSION; SECURIN; TRANSCRIPTION-3; OVEREXPRESSION; INHIBITOR; IDENTIFICATION	Pituitary tumor-transforming gene (PTTG), the index mammalian securin, is abundantly expressed in several tumors and regulates tumor growth and progression. Molecular mechanisms elucidating PTTG regulation and actions remain elusive. Here, we provide evidence that PTTG acts as a signal transducer and activator of transcription factor 3 (STAT3) target gene. Total STAT3 and Tyr705 phosphorylated STAT3 were concordantly expressed with PTTG in human colorectal tumors (n = 97 and n = 95, respectively, P<0.001). STAT3 specifically bound the human PTTG promoter and induced PTTG transcriptional activity (twofold) as assessed by chromatin immunoprecipitation and luciferase reporter assays. STAT3 transfection increased PTTG mRNA and protein abundance twofold in HCT116 human colon cancer cells, and induction was further enhanced (threefold) by constitutively active STAT3 (STAT3-C), whereas strongly abrogated by dominant-negative STAT3 (STAT3-DN). Attenuating PTTG expression by siRNA in STAT3 HCT116 stable transfectants suppressed cell growth and colony formation in vitro, and PTTG cell knockout also constrained activated STAT3-induced explanted murine tumor growth in vivo. STAT3 increased HCT116 cell migration and invasion up to fivefold, whereas cell mobility was abolished by STAT3-DN (>85%). Impairing PTTG expression by siRNA also strongly suppressed STAT3-faciliated cell migration and invasion by up to 90%. Knocking out PTTG in STAT3-C HCT116 stable transfectants strongly decreased tumor metastases in nude mice, indicating the requirement of PTTG for STAT3-promoted metastasis. These results elucidate a mechanism for tumor cell PTTG regulation, whereby STAT3 induces PTTG expression to facilitate tumor growth and metastasis, and further support the rationale for targeting PTTG to abrogate colorectal cancer growth.	[Zhou, C.; Tong, Y.; Wawrowsky, K.; Melmed, S.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Melmed, S (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Room 2015, Los Angeles, CA 90048 USA.	melmed@csmc.edu			National Institutes of Health [CA75979]; Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE [R01CA075979, R00CA138914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Factor Molecular Endocrinology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Bert Vogelstein at Johns Hopkins University (Baltimore, MD, USA) for kindly providing HCT116 PTTG<SUP>+/+</SUP> and HCT116 PTTG<SUP>-/-</SUP> cells; and thank Patricia Lin at the Cedars-Sinai Flow Cytometry Core. This work was supported by National Institutes of Health Grant CA75979 (to SM) and the Doris Factor Molecular Endocrinology Laboratory.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Boelaert K, 2003, J CLIN ENDOCR METAB, V88, P2341, DOI 10.1210/jc.2002-021113; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Horsch M, 2009, BRIT J CANCER, V100, P656, DOI 10.1038/sj.bjc.6604882; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kim CS, 2007, CARCINOGENESIS, V28, P932, DOI 10.1093/carcin/bgl231; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Masuda M, 2002, CANCER RES, V62, P3351; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Ogbagabriel S, 2005, MODERN PATHOL, V18, P985, DOI 10.1038/modpathol.3800382; Panguluri SK, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-6; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Salehi F, 2008, ENDOCR-RELAT CANCER, V15, P721, DOI 10.1677/ERC-08-0012; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; Tsareva SA, 2007, NEOPLASIA, V9, P279, DOI 10.1593/neo.06820; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wicki A, 2010, SWISS MED WKLY, V140, P14, DOI 10.4414/smw.2010.13112; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yan S, 2009, CANCER RES, V69, P3283, DOI 10.1158/0008-5472.CAN-08-0367; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zhou CQ, 2005, INT J CANCER, V113, P891, DOI 10.1002/ijc.20642; Zhou CQ, 2008, ENDOCR-RELAT CANCER, V15, P817, DOI 10.1677/ERC-08-0060; Zhou CQ, 2009, MOL ENDOCRINOL, V23, P2000, DOI 10.1210/me.2009-0161; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	46	39	39	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					851	861		10.1038/onc.2013.16	http://dx.doi.org/10.1038/onc.2013.16			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23416975	Green Accepted			2022-12-25	WOS:000331626900006
J	Cheng, Y; Kawamura, K; Takae, S; Deguchi, M; Yang, Q; Kuo, C; Hsueh, AJW				Cheng, Yuan; Kawamura, Kazuhiro; Takae, Seido; Deguchi, Masashi; Yang, Qing; Kuo, Calvin; Hsueh, Aaron J. W.			Oocyte-derived R-spondin2 promotes ovarian follicle development	FASEB JOURNAL			English	Article						Wnt pathway; follicle development; FSH; ovulation; embryos	WNT SIGNALING PATHWAY; R-SPONDIN; MOUSE OVARIES; BETA-CATENIN; EXPRESSION; MICE; RECEPTORS; GENES; CELLS; NOBOX	R-spondin proteins are adult stem cell growth factors capable of stimulating gut development by activating LGR4, 5, and 6 receptors to promote Wnt signaling. Although multiple Wnt ligands and cognate Frizzled receptors are expressed in the ovary, their physiological roles are unclear. Based on bioinformatic and in situ hybridization analyses, we demonstrated the exclusive expression of R-spondin2 in oocytes of ovarian follicles. In cultured somatic cells from preantral follicles, R-spondin2 treatment (ED50:3 ng/ml) synergized with Wnt3a to stimulate Wnt signaling. In cultured ovarian explants from prepubertal mice containing preantral follicles, treatment with R-spondin2, similar to follicle stimulating hormone, promoted the development of primary follicles to the secondary stage. In vivo administration of an R-spondin agonist stimulated the development of primary follicles to the antral stage in both immature mice and gonadotropin releasing hormone antagonist-treated adult mice. Subsequent treatment with gonadotropins allowed the generation of mature oocytes capable of undergoing early embryonic development and successful pregnancy. Furthermore, R-spondin agonist treatment of immune-deficient mice grafted with human cortical fragments stimulated the development of primary follicles to the secondary stage. Thus, oocyte-derived R-spondin2 is a paracrine factor essential for primary follicle development, and R-spondin agonists could provide a new treatment regimen for infertile women with low responses to the traditional gonadotropin therapy.	[Cheng, Yuan; Takae, Seido; Deguchi, Masashi; Yang, Qing; Kuo, Calvin; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA; [Cheng, Yuan; Kawamura, Kazuhiro; Takae, Seido; Deguchi, Masashi; Yang, Qing; Kuo, Calvin; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Cheng, Yuan; Takae, Seido; Deguchi, Masashi; Yang, Qing; Kuo, Calvin; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Kawamura, Kazuhiro] Akita Univ, Dept Obstet & Gynecol, Akita 010, Japan	Stanford University; Stanford University; Stanford University; Akita University	Hsueh, AJW (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr,Room A344, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu		YANG, QING/0000-0002-5910-458X; Kuo, Calvin/0000-0002-7427-5985	U.S. National Institutes of Health National Institute of Child Health and Human Development [R21 HD071259, U54 HD068158]; Japan Ministry of Education, Culture, Sports, Science, and Technology; Developmental Cycle and Epigenome Network [23013004, 24390376]; Naito Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD068158, R21HD071259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Developmental Cycle and Epigenome Network; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funds from the U.S. National Institutes of Health National Institute of Child Health and Human Development (A.H.; R21 HD071259 and U54 HD068158 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research), the Japan Ministry of Education, Culture, Sports, Science, and Technology (K.K.; Grant-in-Aid for Scientific Research on Priority Area, The Germline: Its Developmental Cycle and Epigenome Network; 23013004 and B: 24390376), the Naito Foundation (K.K.), the Uehara Memorial Foundation (K.K.), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (K.K.). The authors thank Dr. Nihar Nayak (Stanford University) for help with the in situ hybridization procedure.	Bell SM, 2003, MECH DEVELOP, V120, P597, DOI 10.1016/S0925-4773(03)00021-2; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Fauser BCJM, 2008, HUM REPROD UPDATE, V14, P1, DOI 10.1093/humupd/dmm034; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McGee EA, 1997, BIOL REPROD, V57, P990, DOI 10.1095/biolreprod57.5.990; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nayak NR, 2002, J CLIN ENDOCR METAB, V87, P1845, DOI 10.1210/jc.87.4.1845; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Sato Y, 2012, MOL ENDOCRINOL, V26, P1158, DOI 10.1210/me.2012-1027; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	35	35	38	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2175	2184		10.1096/fj.12-223412	http://dx.doi.org/10.1096/fj.12-223412			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23407710	Green Published			2022-12-25	WOS:000319667600009
J	Colletti, E; El Shabrawy, D; Soland, M; Yamagami, T; Mokhtari, S; Osborne, C; Schlauch, K; Zanjani, ED; Porada, CD; Almeida-Porada, G				Colletti, Evan; El Shabrawy, Deena; Soland, Melisa; Yamagami, Takashi; Mokhtari, Saloomeh; Osborne, Craig; Schlauch, Karen; Zanjani, Esmail D.; Porada, Christopher D.; Almeida-Porada, Graca			EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool	FASEB JOURNAL			English	Article						crypts of Lieberkiihn; transcriptome; Musashi-1; epithelial; Lgr5; transplant; niche	MESENCHYMAL STEM-CELLS; HUMAN CORD BLOOD; IN-UTERO TRANSPLANTATION; EPITHELIAL-CELLS; GENE-EXPRESSION; HUMAN HEPATOCYTES; SELF-RENEWAL; MICE; ENGRAFTMENT; PROLIFERATION	To identify human bone marrow stromal cell (BMSC) subsets with enhanced ability to engraft/contribute to the resident intestinal cellular pool, we transplanted clonally derived BMSCs into fetal sheep. Analysis at 75 d post-transplantation showed 2 of the 6 clones engrafting the intestine at 4- to 5-fold higher levels (5.03 +/- 0.089 and 5.04 +/- 0.15%, respectively) than the other clones (P<0.01), correlating with the percentage of donor-derived Musashi-1(+) (12.01-14.17 vs. 1.23.8%; P<0.01) or leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5)(+) cells within the intestinal stem cell (ISC) region. Phenotypic and transcriptome analysis determined that the clones with enhanced intestinal contribution expressed high levels of Ephrin type B receptor 2 (EphB2). Intestinal explants demonstrated proliferation of the engrafted cells and ability to generate crypt-like structures in vitro still expressing EphB2. Additional transplants based on BMSC EphB2 expression demonstrated that, at 7 d post-transplant, the EphB2(high) BMSCs engrafted in the ISC region at levels of 2.1 +/- 0.2%, while control EphB2(low) BMSCs engrafted at 0.3 +/- 0.1% (P<0.01). Therefore we identified a marker for isolating and culturing an expandable subpopulation of BMSCs with enhanced intestinal homing and contribution to the ISC region.	[Colletti, Evan; El Shabrawy, Deena; Soland, Melisa; Yamagami, Takashi; Mokhtari, Saloomeh; Zanjani, Esmail D.; Porada, Christopher D.; Almeida-Porada, Graca] Univ Nevada, Dept Anim Biotechnol, Reno, NV 89557 USA; [Osborne, Craig] Univ Nevada, Nevada Genom Ctr, Reno, NV 89557 USA; [Schlauch, Karen] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Schlauch, Karen] Univ Nevada, Nevada Ctr Bioinformat, Reno, NV 89557 USA; [Soland, Melisa; Mokhtari, Saloomeh; Porada, Christopher D.; Almeida-Porada, Graca] Wake Forest Sch Med, Inst Regenerat Med, Winston Salem, NC 27157 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Wake Forest University	Almeida-Porada, G (corresponding author), Wake Forest Sch Med, Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	galmeida@wakehealth.edu		Almeida-Porada, Maria da Graca/0000-0002-6715-865X; soland, Melisa/0000-0001-8217-9734	U.S. National Heart, Lung, and Blood Institute [HL097623, HL073737]; Idea Network of Biological Research Excellence (INBRE) Program of the National Center for Research Resources [P20 RR-016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073737, R01HL097623] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Idea Network of Biological Research Excellence (INBRE) Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Heart, Lung, and Blood Institute grants HL097623 and HL073737 and grant P20 RR-016464 from the Idea Network of Biological Research Excellence (INBRE) Program of the National Center for Research Resources.	Aliotta JM, 2012, STEM CELLS DEV, V21, P1627, DOI 10.1089/scd.2011.0550; Almeida-Porada G, 2005, BRIT J HAEMATOL, V130, P276, DOI 10.1111/j.1365-2141.2005.05588.x; Almeida-Porada G, 2004, BLOOD, V104, P2582, DOI 10.1182/blood-2004-01-0259; Almeida-Porada G, 2002, EXP HEMATOL, V30, P1454, DOI 10.1016/S0301-472X(02)00967-0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BATMAN PA, 1994, AIDS, V8, P161, DOI 10.1097/00002030-199402000-00003; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Clevers H, 2009, EMBO MOL MED, V1, P255, DOI 10.1002/emmm.200900034; Cogle CR, 2007, STEM CELLS, V25, P1881, DOI 10.1634/stemcells.2007-0163; Colletti EJ, 2009, STEM CELL RES, V2, P125, DOI 10.1016/j.scr.2008.08.002; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dennis JE, 2002, CELLS TISSUES ORGANS, V170, P73, DOI 10.1159/000046182; FLAKE AW, 1986, SCIENCE, V233, P776, DOI 10.1126/science.2874611; Fujiki Y, 2003, TRANSPLANTATION, V75, P916, DOI 10.1097/01.TP.0000057243.12110.7C; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; George MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-209; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; Gronthos Stan, 2008, V449, P45, DOI 10.1007/978-1-60327-169-1_3; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4511, DOI 10.3748/wjg.v11.i29.4511; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024; Hayashi Y, 2007, PHARMACOLOGY, V80, P193, DOI 10.1159/000104148; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Ishikawa F, 2003, ANN NY ACAD SCI, V996, P174, DOI 10.1111/j.1749-6632.2003.tb03245.x; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Koo BK, 2009, GASTROENTEROLOGY, V137, P145, DOI 10.1053/j.gastro.2009.03.046; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kudo K, 2010, J RADIAT RES, V51, P73, DOI 10.1269/jrr.09091; Lanzoni G, 2008, WORLD J GASTROENTERO, V14, P4616, DOI 10.3748/wjg.14.4616; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Montgomery RK, 2008, J ANAT, V213, P52, DOI 10.1111/j.1469-7580.2008.00925.x; Mouiseddine M, 2007, BRIT J RADIOL, V80, pS49, DOI 10.1259/bjr/25927054; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; Okamoto R, 2004, J GASTROENTEROL, V39, P1, DOI 10.1007/s00535-003-1259-8; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Peranteau WH, 2009, BIOL BLOOD MARROW TR, V15, P293, DOI 10.1016/j.bbmt.2008.11.034; PIXLEY JS, 1994, PATHOBIOLOGY, V62, P238, DOI 10.1159/000163916; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Rubin JP, 2001, J SURG RES, V95, P188, DOI 10.1006/jsre.2000.6044; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schoeberlein A, 2004, STEM CELLS DEV, V13, P677, DOI 10.1089/scd.2004.13.677; Semont A, 2006, ADV EXP MED BIOL, V585, P19; Shaw SWS, 2011, CELL TRANSPLANT, V20, P1015, DOI 10.3727/096368910X543402; SHIELDS LE, 1995, AM J OBSTET GYNECOL, V173, P1157, DOI 10.1016/0002-9378(95)91344-0; Simmons P J, 1994, Prog Clin Biol Res, V389, P271; Sun Y, 2007, BIOCHEM BIOPH RES CO, V357, P1160, DOI 10.1016/j.bbrc.2007.04.087; Swenson ES, 2010, CLIN EXP GASTROENTER, V3, P1; Tarantal AF, 2000, TRANSPLANTATION, V69, P1818, DOI 10.1097/00007890-200005150-00015; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Xiao Yan-ping, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P129; Yabana T, 2009, J PATHOL, V218, P350, DOI 10.1002/path.2535; Zhang J, 2008, J BIOMED SCI, V15, P585, DOI 10.1007/s11373-008-9256-9	63	10	10	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2111	2121		10.1096/fj.12-205054	http://dx.doi.org/10.1096/fj.12-205054			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23413357	Green Published			2022-12-25	WOS:000319667600003
J	Kopecny, D; Koncitikova, R; Tylichova, M; Vigouroux, A; Moskalikova, H; Soural, M; Sebela, M; Morera, S				Kopecny, David; Koncitikova, Radka; Tylichova, Martina; Vigouroux, Armelle; Moskalikova, Hana; Soural, Miroslav; Sebela, Marek; Morera, Solange			Plant ALDH10 Family IDENTIFYING CRITICAL RESIDUES FOR SUBSTRATE SPECIFICITY AND TRAPPING A THIOHEMIACETAL INTERMEDIATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETAINE-ALDEHYDE DEHYDROGENASE; PEROXISOMAL POLYAMINE OXIDASE; ACTIVE-SITE; AMINOALDEHYDE DEHYDROGENASE; BIOCHEMICAL-CHARACTERIZATION; GENE SUPERFAMILY; ACID-RESIDUES; ARABIDOPSIS; GLYCINEBETAINE; EXPRESSION	Plant ALDH10 family members are aminoaldehyde dehydrogenases (AMADHs), which oxidize omega-aminoaldehydes to the corresponding acids. They have been linked to polyamine catabolism, osmoprotection, secondary metabolism (fragrance), and carnitine biosynthesis. Plants commonly contain two AMADH isoenzymes. We previously studied the substrate specificity of two AMADH isoforms from peas (PsAMADHs). Here, two isoenzymes from tomato (Solanum lycopersicum), SlAMADHs, and three AMADHs from maize (Zea mays), ZmAMADHs, were kinetically investigated to obtain further clues to the catalytic mechanism and the substrate specificity. We also solved the high resolution crystal structures of SlAMADH1 and ZmAMADH1a because these enzymes stand out from the others regarding their activity. From the structural and kinetic analysis, we can state that five residues at positions 163, 288, 289, 444, and 454 (PsAMADHs numbering) can, directly or not, significantly modulate AMADH substrate specificity. In the SlAMADH1 structure, a PEG aldehyde derived from the precipitant forms a thiohemiacetal intermediate, never observed so far. Its absence in the SlAMADH1-E260A structure suggests that Glu-260 can activate the catalytic cysteine as a nucleophile. We show that the five AMADHs studied here are capable of oxidizing 3-dimethylsulfoniopropionaldehyde to the cryo- and osmoprotectant 3-dimethylsulfoniopropionate. For the first time, we also show that 3-acetamidopropionaldehyde, the third aminoaldehyde besides 3-aminopropionaldehyde and 4-aminobutyraldehyde, is generally oxidized by AMADHs, meaning that these enzymes are unique in metabolizing and detoxifying aldehyde products of polyamine degradation to nontoxic amino acids. Finally, gene expression profiles in maize indicate that AMADHs might be important for controlling omega-aminoaldehyde levels during early stages of the seed development.	[Kopecny, David; Koncitikova, Radka; Tylichova, Martina; Sebela, Marek] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, CZ-78371 Olomouc, Czech Republic; [Koncitikova, Radka; Moskalikova, Hana; Sebela, Marek] Palacky Univ, Fac Sci, Dept Biochem, CZ-78371 Olomouc, Czech Republic; [Vigouroux, Armelle; Morera, Solange] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Soural, Miroslav] Palacky Univ, Dept Organ Chem, Fac Sci, Olomouc 77146, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Palacky University Olomouc	Kopecny, D (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Prot Biochem & Prote, Slechtitelu 11, CZ-78371 Olomouc, Czech Republic.	kopecny_david@yahoo.co.uk; marek.sebela@upol.cz; morera@lebs.cnrs-gif.fr	Kopecny, David/ABH-4250-2020; Kopecna, Martina/H-2188-2014; Koncitikova, Radka/ABA-4128-2021; Sebela, Marek/AAL-2747-2020	Kopecny, David/0000-0002-4309-4284; Koncitikova, Radka/0000-0002-4398-8982; Sebela, Marek/0000-0001-9835-1375; Kopecna, Martina/0000-0003-2136-4615	Czech Science Foundation [P501/11/1591, 522/08/0555]; OP RDI [ED0007/01/01]; CNRS	Czech Science Foundation(Grant Agency of the Czech Republic); OP RDI; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Czech Science Foundation Grants P501/11/1591 and 522/08/0555 and OP RD&I Grant ED0007/01/01 (Centre of the Region Hana for Biotechnological and Agricultural Research) and supported in part by CNRS (to S. M. and A.V.).	Arikit S, 2011, PLANT BIOTECHNOL J, V9, P75, DOI 10.1111/j.1467-7652.2010.00533.x; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; Bradbury LMT, 2008, PLANT MOL BIOL, V68, P439, DOI 10.1007/s11103-008-9381-x; Brauner F, 2003, PLANT PHYSIOL BIOCH, V41, P1, DOI 10.1016/S0981-9428(02)00002-5; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; BROUQUISSE R, 1989, PLANT PHYSIOL, V90, P322, DOI 10.1104/pp.90.1.322; BRUNK DG, 1989, PLANT PHYSIOL, V91, P1122, DOI 10.1104/pp.91.3.1122; Charlton AJ, 2008, METABOLOMICS, V4, P312, DOI 10.1007/s11306-008-0128-0; Charrier A, 2012, PLANTA, V235, P123, DOI 10.1007/s00425-011-1499-4; Chen SH, 2008, PLANT CELL, V20, P1850, DOI 10.1105/tpc.108.058917; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Diaz-Sanchez AG, 2012, PLANT PHYSIOL, V158, P1570, DOI 10.1104/pp.112.194514; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara T, 2008, PHYSIOL PLANTARUM, V134, P22, DOI 10.1111/j.1399-3054.2008.01122.x; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hibino T, 2001, PLANT MOL BIOL, V45, P353, DOI 10.1023/A:1006497113323; HILL EJ, 1975, J BIOL CHEM, V250, P1734; Hjelmqvist L, 2003, CELL MOL LIFE SCI, V60, P2009, DOI 10.1007/s00018-003-3287-1; Holt A, 2007, J NEURAL TRANSM, V114, P733, DOI 10.1007/s00702-007-0680-1; ISHITANI M, 1993, PLANT CELL PHYSIOL, V34, P493; Izaguirre G, 2001, J BIOMOL STRUCT DYN, V19, P429, DOI 10.1080/07391102.2001.10506752; JAMES F, 1995, PLANT PHYSIOL, V108, P1439, DOI 10.1104/pp.108.4.1439; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada-Nobusada T, 2008, PLANT CELL PHYSIOL, V49, P1272, DOI 10.1093/pcp/pcn114; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kopecny D, 2011, FEBS J, V278, P3130, DOI 10.1111/j.1742-4658.2011.08239.x; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; LERMA C, 1991, PLANT PHYSIOL, V95, P1113, DOI 10.1104/pp.95.4.1113; Li W, 2003, BIOCHEM J, V371, P429, DOI 10.1042/BJ20021520; Makela P, 1998, IND CROP PROD, V7, P139, DOI 10.1016/S0926-6690(97)00042-3; Mann CJ, 1999, PROTEIN SCI, V8, P1922, DOI 10.1110/ps.8.10.1922; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Missihoun TD, 2011, PLANTA, V233, P369, DOI 10.1007/s00425-010-1297-4; Moschou PN, 2008, PLANT PHYSIOL, V147, P1845, DOI 10.1104/pp.108.123802; Nakamura T, 1997, PLANT J, V11, P1115, DOI 10.1046/j.1365-313X.1997.11051115.x; Nakamura T, 2001, PLANT CELL PHYSIOL, V42, P1088, DOI 10.1093/pcp/pce136; Niu XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-100; PAQUET L, 1994, AUST J PLANT PHYSIOL, V21, P37, DOI 10.1071/PP9940037; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Raman SB, 2003, PLANT PHYSIOL, V132, P1642, DOI 10.1104/pp.103.020453; RASTOGI R, 1990, PLANT PHYSIOL, V94, P1449, DOI 10.1104/pp.94.3.1449; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Rippa S, 2012, PLANT PHYSIOL BIOCH, V60, P109, DOI 10.1016/j.plaphy.2012.08.001; Sebela M, 2006, PROTEOMICS, V6, P2959, DOI 10.1002/pmic.200500576; Sebela M, 2000, BBA-PROTEIN STRUCT M, V1480, P329, DOI 10.1016/S0167-4838(00)00086-8; Sebela M, 2002, STUDIES NATURAL PR G, V26, P1259; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Takahata Y, 2010, PLANT CELL REP, V29, P535, DOI 10.1007/s00299-010-0842-8; Tavladoraki P, 2006, PLANT PHYSIOL, V141, P1519, DOI 10.1104/pp.106.080911; Trossat C, 1997, PLANT PHYSIOL, V113, P1457, DOI 10.1104/pp.113.4.1457; Tylichova M, 2008, ACTA CRYSTALLOGR F, V64, P88, DOI 10.1107/S1744309107068522; Tylichova M, 2010, J MOL BIOL, V396, P870, DOI 10.1016/j.jmb.2009.12.015; VALENZUELASOTO EM, 1994, J PLANT PHYSIOL, V143, P145, DOI 10.1016/S0176-1617(11)81678-0; Vaz FM, 2000, J BIOL CHEM, V275, P7390, DOI 10.1074/jbc.275.10.7390; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; WEIGEL P, 1986, PLANT PHYSIOL, V82, P753, DOI 10.1104/pp.82.3.753; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wymore T, 2004, PROTEINS, V57, P758, DOI 10.1002/prot.20256; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	67	31	37	0	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9491	9507		10.1074/jbc.M112.443952	http://dx.doi.org/10.1074/jbc.M112.443952			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408433	Green Published, hybrid			2022-12-25	WOS:000316862200065
J	Afrane, YA; Zhou, GF; Githeko, AK; Yan, GY				Afrane, Yaw A.; Zhou, Guofa; Githeko, Andrew K.; Yan, Guiyun			Utility of Health Facility-based Malaria Data for Malaria Surveillance	PLOS ONE			English	Article							AFRICAN CHILDREN; TRANSMISSION; AREA; MANAGEMENT; MISDIAGNOSIS; PNEUMONIA; DIAGNOSIS; MORTALITY; OVERLAP; UGANDA	Background: Currently, intensive malaria control programs are being implemented in Africa to reduce the malaria burden. Clinical malaria data from hospitals are valuable for monitoring trends in malaria morbidity and for evaluating the impacts of these interventions. However, the reliability of hospital-based data for true malaria incidence is often questioned because of diagnosis accuracy issues and variation in access to healthcare facilities among sub-groups of the population. This study investigated how diagnosis and treatment practices of malaria cases in hospitals affect reliability of hospital malaria data. Methodology/Principal Findings: The study was undertaken in health facilities in western Kenya. A total of 3,569 blood smears were analyzed after being collected from patients who were requested by clinicians to go to the hospital's laboratory for malaria testing. We applied several quality control measures for clinical malaria diagnosis. We compared our slide reading results with those from the hospital technicians. Among the 3,390 patients whose diagnoses were analyzed, only 36% had clinical malaria defined as presence of any level of parasitaemia and fever. Sensitivity and specificity of clinicians' diagnoses were 60.1% (95% CI: 61.1-67.5) and 75.0% (95% CI: 30.8-35.7), respectively. Among the 980 patients presumptively treated with an anti-malarial by the clinicians without laboratory diagnosis, only 47% had clinical malaria. Conclusions/Significance: These findings revealed substantial over-prescription of anti-malarials and misdiagnosis of clinical malaria. More than half of the febrile cases were not truly clinical malaria, but were wrongly diagnosed and treated as such. Deficiency in malaria diagnosis makes health facility data unreliable for monitoring trends in malaria morbidity and for evaluating impacts of malaria interventions. Improving malaria diagnosis should be a top priority in rural African health centers.	[Afrane, Yaw A.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Climate & Human Hlth Res Unit, Kisumu, Kenya; [Afrane, Yaw A.] Bondo Univ Coll, Sch Hlth Sci, Bondo, Kenya; [Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA	Kenya Medical Research Institute; University of California System; University of California Irvine	Yan, GY (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA.	guiyuny@uci.edu			National Institute of Health [R01 AI094580, D43 TW01505, R01 A150243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243, R01AI094580] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Health (R01 AI094580, D43 TW01505 and R01 A150243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Font F, 2001, TROP MED INT HEALTH, V6, P423, DOI 10.1046/j.1365-3156.2001.00727.x; Hume JCC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-33; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; *SAS, 1994, JMP US GUID; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wiseman V, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.161; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x	21	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54305	10.1371/journal.pone.0054305	http://dx.doi.org/10.1371/journal.pone.0054305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418427	Green Published, gold			2022-12-25	WOS:000315970300017
J	Yu, YJ; Yang, XJ; Wang, HY; Shi, FX; Liu, Y; Liu, JS; Li, LF; Wang, DL; Liu, B				Yu, Yingjie; Yang, Xuejiao; Wang, Huaying; Shi, Fengxue; Liu, Ying; Liu, Jushan; Li, Linfeng; Wang, Deli; Liu, Bao			Cytosine Methylation Alteration in Natural Populations of Leymus chinensis Induced by Multiple Abiotic Stresses	PLOS ONE			English	Article							ADAPTIVE GENETIC-VARIATION; DNA-METHYLATION; EVOLUTIONARY RESPONSES; EPIGENETIC VARIATION; TRANSPOSON TAM3; CLIMATE-CHANGE; ADAPTATION; CONSEQUENCES; TOLERANCE; TOBACCO	Background: Human activity has a profound effect on the global environment and caused frequent occurrence of climatic fluctuations. To survive, plants need to adapt to the changing environmental conditions through altering their morphological and physiological traits. One known mechanism for phenotypic innovation to be achieved is environment-induced rapid yet inheritable epigenetic changes. Therefore, the use of molecular techniques to address the epigenetic mechanisms underpinning stress adaptation in plants is an important and challenging topic in biological research. In this study, we investigated the impact of warming, nitrogen (N) addition, and warming+nitrogen (N) addition stresses on the cytosine methylation status of Leymus chinensis Tzvel. at the population level by using the amplified fragment length polymorphism (AFLP), methylation-sensitive amplified polymorphism (MSAP) and retrotransposon based sequence-specific amplification polymorphism (SSAP) techniques. Methodology/Principal Findings: Our results showed that, although the percentages of cytosine methylation changes in SSAP are significantly higher than those in MSAP, all the treatment groups showed similar alteration patterns of hypermethylation and hypomethylation. It meant that the abiotic stresses have induced the alterations in cytosine methylation patterns, and the levels of cytosine methylation changes around the transposable element are higher than the other genomic regions. In addition, the identification and analysis of differentially methylated loci (DML) indicated that the abiotic stresses have also caused targeted methylation changes at specific loci and these DML might have contributed to the capability of plants in adaptation to the abiotic stresses. Conclusions/Significance: Our results demonstrated that abiotic stresses related to global warming and nitrogen deposition readily evoke alterations of cytosine methylation, and which may provide a molecular basis for rapid adaptation by the affected plant populations to the changed environments.	[Yu, Yingjie; Liu, Jushan; Wang, Deli] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China; [Yu, Yingjie; Yang, Xuejiao; Wang, Huaying; Shi, Fengxue; Liu, Ying; Li, Linfeng; Liu, Bao] NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China; [Yu, Yingjie; Yang, Xuejiao; Wang, Huaying; Shi, Fengxue; Liu, Ying; Li, Linfeng; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China	Li, LF (corresponding author), NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China.	lilf241@nenu.edu.cn; wangd@nenu.edu.cn		Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	Programme for Introducing Talents to Universities [B07017]; National Natural Science Foundation of China [30870178, 31100157, 31230012]; Fundamental Research Funds for the Central Universities [10QNJJ011, 11CXPY003]	Programme for Introducing Talents to Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the Programme for Introducing Talents to Universities (B07017), National Natural Science Foundation of China (30870178, 31100157 and 31230012) and Fundamental Research Funds for the Central Universities (10QNJJ011, 11CXPY003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Beguiristain T, 2001, PLANT PHYSIOL, V127, P212, DOI 10.1104/pp.127.1.212; Bijlsma R, 2005, J EVOLUTION BIOL, V18, P744, DOI 10.1111/j.1420-9101.2005.00962.x; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Gao Y, 2008, ENVIRON EXP BOT, V63, P113, DOI 10.1016/j.envexpbot.2007.10.030; Grativol C, 2011, BIOCHIM BIOPHYS ACTA, V1819, P176; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Huang NC, 2010, PLANT SCI, V178, P41, DOI 10.1016/j.plantsci.2009.10.005; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Lai CP, 2004, PLANT PHYSIOL, V134, P1586, DOI 10.1104/pp.103.037820; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Li YD, 2008, ECOL RES, V23, P927, DOI 10.1007/s11284-007-0459-8; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; LOVEJOY TE, 2004, CLIMATE CHANGE BIODI; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Manel S, 2012, MOL ECOL, V21, P3729, DOI 10.1111/j.1365-294X.2012.05656.x; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Qi B, 2010, J GENET GENOMICS, V37, P737, DOI 10.1016/S1673-8527(09)60091-6; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Roy SJ, 2011, CURR OPIN PLANT BIOL, V14, P232, DOI 10.1016/j.pbi.2011.03.002; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Santos AP, 2011, CYTOGENET GENOME RES, V132, P297, DOI 10.1159/000322287; Savolainen O, 2004, FOREST ECOL MANAG, V197, P79, DOI 10.1016/j.foreco.2004.05.006; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Trontin C, 2011, CURR OPIN PLANT BIOL, V14, P225, DOI 10.1016/j.pbi.2011.03.024; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Yakovlev IA, 2011, PLANT SCI, V180, P132, DOI 10.1016/j.plantsci.2010.07.004; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhu TC, 2004, BIOL ECOLOGY, P523	76	32	36	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55772	10.1371/journal.pone.0055772	http://dx.doi.org/10.1371/journal.pone.0055772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418457	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300048
J	Liu, YS; Zhao, Y; Zhang, X; Chen, T; Zhao, XH; Ma, GE; Zhou, YS				Liu, Yunsong; Zhao, Yan; Zhang, Xiao; Chen, Tong; Zhao, Xianghui; Ma, Gui-e; Zhou, Yongsheng			Flow Cytometric Cell Sorting and In Vitro Pre-Osteoinduction Are Not Requirements for In Vivo Bone Formation by Human Adipose-Derived Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; TISSUE REGENERATION; CALVARIAL DEFECTS; GROWTH-FACTOR; SCAFFOLDS; MARROW; ENHANCEMENT; REPAIR; INDUCTION	Human adipose-derived stromal cells (hASCs) are a promising cell source for bone tissue engineering. However, before the clinical application of hASCs for the treatment of bone defects, key questions require answers, including whether pre-osteoinduction (OI) and flow cytometric cell purification are indispensible steps for in vivo bone formation by hASCs. In this study, hASCs were purified by flow cytometric cell sorting (FCCS). The osteogenic capabilities of hASCs and purified hASCs with or without pre-osteoinduction were examined through in vitro and in vivo experiments. We found that pre-OI enhanced the in vitro osteogenic capacity of hASCs. However, 8 weeks after in vivo implantation, there were no significant differences between hASCs and hASCs that had undergone OI (hASCs+OI) or between purified hASCs and purified hASCs+OI (P>0.05). Interestingly, we also found that purified hASCs had an osteogenic potential similar to that of unpurified hASCs in vitro and in vivo. These results suggest that FCCS and in vitro pre-OI are not requirements for in vivo bone formation by hASCs.	[Liu, Yunsong; Zhang, Xiao; Chen, Tong; Zhao, Xianghui; Zhou, Yongsheng] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China; [Zhao, Yan] Peking Univ, Sch & Hosp Stomatol, Clin Branch 2, Beijing 100871, Peoples R China; [Ma, Gui-e] Chinese Acad Med Sci, Plast Surg Hosp, Body Sculpture Ctr, Beijing 100730, Peoples R China	Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS	Zhou, YS (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China.	kqzhouysh@hsc.pku.edu.cn			National Natural Science Foundation of China [30901693, 81170937]; Program for New Century Excellent Talents in University from Ministry of Education [BMU20110274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education(Program for New Century Excellent Talents in University (NCET))	This study was supported by grants from the National Natural Science Foundation of China (No. 30901693, No. 81170937), http://www.nsfc.gov.cn/Portal0/default152.htm. This study was also supported by the Program for New Century Excellent Talents in University from Ministry of Education (BMU20110274), http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A16/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Battah F, 2011, THESCIENTIFICWORLDJO, V11, P1568, DOI [10.1100/tsw.2011.146., 10.1100/tsw.2011.146]; Amos PJ, 2008, ANN PLAS SURG, V60, P437, DOI 10.1097/SAP.0b013e318095a771; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Cheng NC, 2012, J BIOMED MATER RES B, V100B, P1369, DOI 10.1002/jbm.b.32706; Coelho PG, 2009, MAT SCI ENG C-MATER, V29, P2085, DOI 10.1016/j.msec.2009.04.013; Cooper MS, 1999, J ENDOCRINOL, V163, P159, DOI 10.1677/joe.0.1630159; Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd; Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Ge WS, 2011, STEM CELLS, V29, P1112, DOI 10.1002/stem.663; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Hong JM, 2012, ACTA BIOMATER, V8, P2578, DOI 10.1016/j.actbio.2012.03.041; Kang JM, 2012, ACTA BIOMATER, V8, P1759, DOI 10.1016/j.actbio.2012.01.005; Kim HP, 2012, CURR STEM CELL RES T, V7, P165; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li XM, 2011, J BIOMED MATER RES B, V97B, P10, DOI 10.1002/jbm.b.31773; Li XY, 2010, ARTIF ORGANS, V34, P46, DOI 10.1111/j.1525-1594.2009.00795.x; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020; Morelhao SL, 2010, EUR BIOPHYS J BIOPHY, V39, P861, DOI 10.1007/s00249-009-0541-y; Niemeyer P, 2008, CYTOTHERAPY, V10, P784, DOI 10.1080/14653240802419302; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Santo VE, 2012, J CONTROL RELEASE, V162, P19, DOI 10.1016/j.jconrel.2012.06.001; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Szpalski C, 2012, J CRANIOFAC SURG, V23, P638, DOI 10.1097/SCS.0b013e31824db8d4; Xu JJ, 2012, CELL TRANSPLANT, V21, P1679, DOI 10.3727/096368911X637434; Ying XZ, 2012, INT ORTHOP, V36, P647, DOI 10.1007/s00264-011-1303-x; Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015; Zhou YL, 2011, TISSUE ENG PT A, V17, P2981, DOI 10.1089/ten.tea.2010.0707; Zhou YS, 2006, CHINESE MED J-PEKING, V119, P1278, DOI 10.1097/00029330-200608010-00008; Zhou YS, 2010, BIOMATERIALS, V31, P5325, DOI 10.1016/j.biomaterials.2010.03.037; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	46	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56002	10.1371/journal.pone.0056002	http://dx.doi.org/10.1371/journal.pone.0056002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409111	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000037
J	van der Groep, P; van Diest, PJ; Smolders, YHCM; Ausems, MGEM; van der Luijt, RB; Menko, FH; Bart, J; de Vries, EGE; van der Wall, E				van der Groep, Petra; van Diest, Paul J.; Smolders, Yvonne H. C. M.; Ausems, Margreet G. E. M.; van der Luijt, Rob B.; Menko, Fred H.; Bart, Joost; de Vries, Elisabeth G. E.; van der Wall, Elsken			HIF-1 alpha Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; COMPARATIVE GENOMIC HYBRIDIZATION; BASAL EPITHELIAL PHENOTYPE; GROWTH-FACTOR EXPRESSION; MOLECULAR CLASSIFICATION; ESTROGEN-RECEPTOR; REDUCES HYPOXIA; HIGH PREVALENCE; TUMOR-GROWTH; CANCER	Recent studies have revealed that BRCA1 and BRCA2 germline mutation-related breast cancers show frequent overexpression of hypoxia inducible factor-1 alpha (HIF-1 alpha), the key regulator of the hypoxia response. However, the question remained whether hypoxia is a late stage bystander or a true carcinogenetic event in patients with hereditary predisposition. We therefore studied HIF-1 alpha overexpression in ductal carcinoma in situ (DCIS), an established precursor of invasive breast cancer. We used immunohistochemistry to examine the expression of the hypoxia markers HIF-1 alpha, CAIX and Glut-1 in DCIS and available invasive carcinoma lesions of 32 BRCA1, 16 BRCA2 and 77 non-BRCA mutation-related cases. HIF-1 alpha expression was detected in 63% of BRCA1 and 62% of BRCA2 as compared to 34% of non-BRCA mutation-related DCIS cases (p = 0.005). CAIX overexpression was present in 56% of BRCA1 and 44% of BRCA2 as compared to 6% of non-BRCA mutation-related DCIS cases (p = 0.000). Glut-1 overexpression was observed in 59% of BRCA1, 75% of BRCA2 and 67% of non-BRCA mutation-related DCIS cases (p = 0.527). Overall, HIF-1 alpha, CAIX and Glut-1 expression in BRCA mutation-related DCIS matched the expression in the accompanying invasive cancers in 60% or more of cases. In non-BRCA mutation-related cases the expression of the hypoxia markers in DCIS matched the expression in the invasive part in 46% or more of the cases. Although BRCA1 and BRCA2 germline mutation-related invasive breast cancers are different in many ways, the hypoxia-related proteins HIF-1 alpha, CAIX and Glut-1 are expressed in both DCIS and invasive lesions of BRCA1 and BRCA2 mutation carriers. This suggests that hypoxia may already play a role in the DCIS stage of BRCA1 and BRCA2 germline mutation related breast carcinogenesis, and may also drive cancer progression. Hypoxia-related proteins are therefore putative targets for therapy and molecular imaging for early detection and monitoring therapy response in BRCA mutation patients.	[van der Groep, Petra; van Diest, Paul J.; Smolders, Yvonne H. C. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Groep, Petra; van der Wall, Elsken] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; [Ausems, Margreet G. E. M.; van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Menko, Fred H.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Bart, Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [de Vries, Elisabeth G. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen; University of Groningen	van der Groep, P (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.vandergroep@umcutrecht.nl	Bart, Joost/A-5642-2013	Bart, Joost/0000-0002-0985-071X; de Vries, Elisabeth/0000-0002-8949-7425; van der Luijt, Rob/0000-0002-0018-1089	Aegon Inc; Pink Ribbon The Netherlands; Aegon	Aegon Inc; Pink Ribbon The Netherlands(Netherlands Government); Aegon	This study has been supported by unrestricted educational grants from Aegon Inc and Pink Ribbon The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received an unrestricted educational grant from Aegon. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Alvarez S, 2005, CLIN CANCER RES, V11, P1146; Arun B, 2009, CANCER PREV RES, V2, P122, DOI 10.1158/1940-6207.CAPR-08-0050; Bane AL, 2009, BREAST CANCER RES TR, V117, P183, DOI 10.1007/s10549-008-0087-1; Blum R, 2005, CANCER RES, V65, P999; Boecker W, 2006, PRENEOPLASIA BREAST, pp407; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Bos R, 2004, BREAST CANCER RES, V6, pR450, DOI 10.1186/bcr813; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Bussolati G, 2000, VIRCHOWS ARCH, V437, P360, DOI 10.1007/s004280000267; Chappuis PO, 2000, SEMIN SURG ONCOL, V18, P287, DOI 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.3.CO;2-X; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Claus EB, 2001, EXP MOL PATHOL, V70, P303, DOI 10.1006/exmp.2001.2366; Claus EB, 2005, JAMA-J AM MED ASSOC, V293, P964, DOI 10.1001/jama.293.8.964; Delmas C, 2003, CLIN CANCER RES, V9, P6062; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Hoogerbrugge N, 2006, EUR J CANCER, V42, P2492, DOI 10.1016/j.ejca.2006.05.027; Hoogerbrugge N, 2003, J CLIN ONCOL, V21, P41, DOI 10.1200/JCO.2003.02.137; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hwang ES, 2007, J CLIN ONCOL, V25, P642, DOI 10.1200/JCO.2005.04.0345; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Kauff ND, 2003, CANCER-AM CANCER SOC, V97, P1601, DOI 10.1002/cncr.11225; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lakhani SR, 1997, LANCET, V349, P1505; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; Ricker JL, 2004, CLIN CANCER RES, V10, P8665, DOI 10.1158/1078-0432.CCR-04-1393; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sgroi DC, 2010, ANNU REV PATHOL-MECH, V5, P193, DOI 10.1146/annurev.pathol.4.110807.092306; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tan C, 2005, CANCER RES, V65, P605; Tirkkonen M, 1997, CANCER RES, V57, P1222; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; van Beers EH, 2005, CANCER RES, V65, P822; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; van der Groep P, 2004, JNCI-J NATL CANCER I, V96, P712, DOI 10.1093/jnci/djh114; van der Groep P, 2009, J CLIN PATHOL, V62, P926, DOI 10.1136/jcp.2009.065524; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Van Diest PJ, 1999, J PATHOL, V187, P383, DOI 10.1002/(SICI)1096-9896(199903)187:4<383::AID-PATH299>3.0.CO;2-H; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Welsh S, 2004, MOL CANCER THER, V3, P233; Wessels LFA, 2002, CANCER RES, V62, P7110; Wykoff CC, 2000, CANCER RES, V60, P7075; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287	59	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56055	10.1371/journal.pone.0056055	http://dx.doi.org/10.1371/journal.pone.0056055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409121	gold, Green Submitted, Green Published			2022-12-25	WOS:000314660300054
J	Bueno, RS; Guevara, R; Ribeiro, MC; Culot, L; Bufalo, FS; Galetti, M				Bueno, Rafael S.; Guevara, Roger; Ribeiro, Milton C.; Culot, Laurence; Bufalo, Felipe S.; Galetti, Mauro			Functional Redundancy and Complementarities of Seed Dispersal by the Last Neotropical Megafrugivores	PLOS ONE			English	Article							ATLANTIC FOREST; FLESHY FRUITS; PATTERNS; SIZE; MONKEYS; DISTANCE; DIET; CONSERVATION; RECRUITMENT; FRUGIVORES	Background: Functional redundancy has been debated largely in ecology and conservation, yet we lack detailed empirical studies on the roles of functionally similar species in ecosystem function. Large bodied frugivores may disperse similar plant species and have strong impact on plant recruitment in tropical forests. The two largest frugivores in the neotropics, tapirs (Tapirus terrestris) and muriquis (Brachyteles arachnoides) are potential candidates for functional redundancy on seed dispersal effectiveness. Here we provide a comparison of the quantitative, qualitative and spatial effects on seed dispersal by these megafrugivores in a continuous Brazilian Atlantic forest. Methodology/Principal Findings: We found a low overlap of plant species dispersed by both muriquis and tapirs. A group of 35 muriquis occupied an area of 850 ha and dispersed 5 times more plant species, and 13 times more seeds than 22 tapirs living in the same area. Muriquis dispersed 2.4 times more seeds in any random position than tapirs. This can be explained mainly because seed deposition by muriquis leaves less empty space than tapirs. However, tapirs are able to disperse larger seeds than muriquis and move them into sites not reached by primates, such as large forest gaps, open areas and fragments nearby. Based on published information we found 302 plant species that are dispersed by at least one of these megafrugivores in the Brazilian Atlantic forest. Conclusions/Significance: Our study showed that both megafrugivores play complementary rather than redundant roles as seed dispersers. Although tapirs disperse fewer seeds and species than muriquis, they disperse larger-seeded species and in places not used by primates. The selective extinction of these megafrugivores will change the spatial seed rain they generate and may have negative effects on the recruitment of several plant species, particularly those with large seeds that have muriquis and tapirs as the last living seed dispersers.	[Bueno, Rafael S.; Culot, Laurence; Bufalo, Felipe S.; Galetti, Mauro] Univ Estadual Paulista, Dept Ecol, Lab Biol Conservacao, Sao Paulo, Brazil; [Guevara, Roger] Inst Ecol, AC Dept Biol Evolut, Xalapa, Veracruz, Mexico; [Ribeiro, Milton C.] Univ Estadual Paulista, Dept Ecol, Lab Ecol Espacial & Conservacao, Sao Paulo, Brazil	Universidade Estadual Paulista; Instituto de Ecologia - Mexico; Universidade Estadual Paulista	Galetti, M (corresponding author), Univ Estadual Paulista, Dept Ecol, Lab Biol Conservacao, Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Culot, Laurence/H-9120-2012; Galetti, Mauro/C-5275-2008; Galetti, Mauro/M-8751-2013; Bufalo, Felipe S./B-2356-2013; Guevara, Roger/F-3287-2010	Culot, Laurence/0000-0002-3353-0134; Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696; Bufalo, Felipe S./0000-0002-2621-9858; Guevara, Roger/0000-0003-0768-3580; Da Silveira Bueno, Rafael/0000-0001-8964-8572	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [BIOTA - FAPESP 2007/03392-6]; FAPESP; CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through the process BIOTA - FAPESP 2007/03392-6. RSB and LC receive a FAPESP fellowship, MG receives a CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, GLOBAL ECOL BIOGEOGR, V17, P503, DOI 10.1111/j.1466-8238.2008.00386.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Beck H, 2006, J MAMMAL, V87, P519, DOI 10.1644/05-MAMM-A-174R1.1; Beisiegel BD, 2004, MAMMALIA, V68, P65, DOI 10.1515/mamm.2004.009; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Donatti C. I., 2007, Seed dispersal: theory and its application in a changing world, P104, DOI 10.1079/9781845931650.0104; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Fragoso JMV, 2000, J TROP ECOL, V16, P369, DOI 10.1017/S0266467400001462; Galetti M, 1997, BIOL CONSERV, V82, P31, DOI 10.1016/S0006-3207(97)00004-9; Galetti M, 2001, BIOTROPICA, V33, P723, DOI 10.1111/j.1744-7429.2001.tb00232.x; GALETTI M, 1994, MAMMALIA, V58, P111, DOI 10.1515/mamm.1994.58.1.111; Galetti M, 2011, BIOTA NEOTROP, V11, P181, DOI 10.1590/S1676-06032011000100019; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; Gayot M, 2004, J TROP ECOL, V20, P31, DOI 10.1017/S0266467404006157; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Hibert F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025850; Holbrook KM, 2011, BIOTROPICA, V43, P357, DOI 10.1111/j.1744-7429.2010.00710.x; Izar P, 2008, PRIMATOLOGIA BRASIL, P8; Jerusalinsky L., 2011, PLANO ACAO NACL CONS; JORDANO P, 1995, ECOLOGY, V76, P2627, DOI 10.2307/2265833; Julliot C, 1997, J ECOL, V85, P431, DOI 10.2307/2960567; Kitamura S, 2002, OECOLOGIA, V133, P559, DOI 10.1007/s00442-002-1073-7; LAWTON JH, 1993, ECOL STU AN, V99, P255; Lima RAF, 2011, BIOTA NEOTROP, P11; Lorenzi H, 1998, ARVORES BRASILEIRAS; Martins MM, 2006, BIOTROPICA, V38, P57, DOI 10.1111/j.1744-7429.2005.00100.x; McConkey KR, 2011, ECOLOGY, V92, P1492, DOI 10.1890/10-1255.1; Medici PE, 2012, INTEGRATIVE IN PRESS; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Moraes PLR, 1992, REV I FLORESTAL, V4, P1193; Mourthe IMC, 2007, AM J PRIMATOL, V69, P706, DOI 10.1002/ajp.20405; O'Farrill G, 2013, INTEGR ZOOL, V8, P4, DOI 10.1111/j.1749-4877.2012.00316.x; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Peres Carlos A., 2002, P407, DOI 10.1079/9780851995250.0407; Petroni LM, 2000, THESIS U SAO PAULO S; Quiroga-Castro VD, 2001, BIOTROPICA, V33, P472, DOI 10.1111/j.1744-7429.2001.tb00200.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rios RS, 2006, BIOTROPICA, V38, P778, DOI 10.1111/j.1744-7429.2006.00209.x; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Russo SE, 2004, ECOL LETT, V7, P1058, DOI 10.1111/j.1461-0248.2004.00668.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Silva Wesley R., 2002, P423, DOI 10.1079/9780851995250.0423; Stevenson P. R., 2007, Seed dispersal: theory and its application in a changing world, P340, DOI 10.1079/9781845931650.0340; Stevenson PR, 2011, BIOTROPICA, V43, P512, DOI 10.1111/j.1744-7429.2010.00708.x; Stevenson PR, 2000, AM J PRIMATOL, V50, P275, DOI 10.1002/(SICI)1098-2345(200004)50:4&lt;275::AID-AJP4&gt;3.0.CO;2-K; STRIER KB, 1992, FACES FOREST ENDANGE; Talebi M, 2005, INT J PRIMATOL, V26, P1175, DOI 10.1007/s10764-005-6463-3; Therneau TM, 2000, MODELING SURVIVAL DA; WHEELWRIGHT NT, 1985, ECOLOGY, V66, P808, DOI 10.2307/1940542; Wotton DM, 2012, J BIOGEOGR, V39, P1973, DOI 10.1111/jbi.12000; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x	61	98	104	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56252	10.1371/journal.pone.0056252	http://dx.doi.org/10.1371/journal.pone.0056252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409161	Green Published, gold			2022-12-25	WOS:000315157200125
J	Chung, RWS; Kamili, A; Tandy, S; Weir, JM; Gaire, R; Wong, G; Meikle, PJ; Cohn, JS; Rye, KA				Chung, Rosanna W. S.; Kamili, Alvin; Tandy, Sally; Weir, Jacquelyn M.; Gaire, Raj; Wong, Gerard; Meikle, Peter J.; Cohn, Jeffrey S.; Rye, Kerry-Anne			Dietary Sphingomyelin Lowers Hepatic Lipid Levels and Inhibits Intestinal Cholesterol Absorption in High-Fat-Fed Mice	PLOS ONE			English	Article							SECRETORY PHOSPHOLIPASE A(2); EGG SPHINGOMYELIN; LXR-ALPHA; METABOLISM; TRANSPORT; CELLS; ATHEROSCLEROSIS; SREBP-1C; MODELS; PLASMA	Controlling intestinal lipid absorption is an important strategy for maintaining lipid homeostasis. Accumulation of lipids in the liver is a major risk factor for metabolic syndrome and nonalcoholic fatty liver disease. It is well-known that sphingomyelin (SM) can inhibit intestinal cholesterol absorption. It is, however, unclear if dietary SM also lowers liver lipid levels. In the present study (i) the effect of pure dietary egg SM on hepatic lipid metabolism and intestinal cholesterol absorption was measured with [C-14] cholesterol and [H-3] sitostanol in male C57BL/6 mice fed a high-fat (HF) diet with or without 0.6% wt/wt SM for 18 days; and (ii) hepatic lipid levels and gene expression were determined in mice given a HF diet with or without egg SM (0.3, 0.6 or 1.2% wt/wt) for 4 weeks. Mice supplemented with SM (0.6% wt/wt) had significantly increased fecal lipid and cholesterol output and reduced hepatic [C-14] cholesterol levels after 18 days. Relative to HF-fed mice, SM-supplemented HF-fed mice had significantly lower intestinal cholesterol absorption (-30%). Liver weight was significantly lower in the 1.2% wt/wt SM-supplemented mice (-18%). Total liver lipid (mg/organ) was significantly reduced in the SM-supplemented mice (-33% and -40% in 0.6% wt/wt and 1.2% wt/wt SM, respectively), as were triglyceride and cholesterol levels. The reduction in liver triglycerides was due to inactivation of the LXR-SREBP-1c pathway. In conclusion, dietary egg SM has pronounced hepatic lipid-lowering properties in mice maintained on an obesogenic diet.	[Chung, Rosanna W. S.; Kamili, Alvin; Tandy, Sally; Cohn, Jeffrey S.] Heart Res Inst, Nutr & Metab Grp, Sydney, NSW, Australia; [Chung, Rosanna W. S.; Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia; [Weir, Jacquelyn M.; Gaire, Raj; Wong, Gerard; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Metabol Lab, Melbourne, Vic, Australia; [Rye, Kerry-Anne] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Sydney; Heart Research Institute; University of Sydney; Heart Research Institute; Baker Heart and Diabetes Institute; University of Sydney; University of Melbourne	Rye, KA (corresponding author), Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia.	karye@ozemail.com.au	Gaire, Raj/H-4553-2014; Meikle, Peter J/B-4023-2009; Gaire, Raj/S-6923-2019	Gaire, Raj/0000-0003-2499-2553; Gaire, Raj/0000-0003-2499-2553; Kamili, Alvin/0000-0002-4864-1195; Meikle, Peter/0000-0002-2593-4665	National Health and Medical Research Council of Australia [482800]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia Grant 482800 (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Eckhardt ERM, 2002, GASTROENTEROLOGY, V122, P948, DOI 10.1053/gast.2002.32539; Feng D, 2010, DIGEST DIS SCI, V55, P3377, DOI 10.1007/s10620-010-1202-9; Greenberg ME, 2009, ARTERIOSCL THROM VAS, V29, P1745, DOI 10.1161/ATVBAHA.109.194605; Kamili A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-90; Koumanov K, 1997, BIOCHEM J, V326, P227, DOI 10.1042/bj3260227; Koumanov KS, 1998, BIOCHEM J, V336, P625, DOI 10.1042/bj3360625; Li ZQ, 2005, BBA-MOL CELL BIOL L, V1735, P130, DOI 10.1016/j.bbalip.2005.05.004; NILSSON A, 1968, BIOCHIM BIOPHYS ACTA, V164, P575, DOI 10.1016/0005-2760(68)90187-2; Noh SK, 2004, J NUTR, V134, P2611, DOI 10.1093/jn/134.10.2611; Noh SK, 2003, J NUTR, V133, P3571, DOI 10.1093/jn/133.11.3571; Nyberg L, 2000, J NUTR BIOCHEM, V11, P244, DOI 10.1016/S0955-2863(00)00069-3; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Sehayek E, 2008, ARTERIOSCL THROM VAS, V28, P1296, DOI 10.1161/ATVBAHA.108.165803; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tandy S, 2010, ATHEROSCLEROSIS, V213, P142, DOI 10.1016/j.atherosclerosis.2010.07.050; Tandy S, 2009, J AGR FOOD CHEM, V57, P9339, DOI 10.1021/jf9016042; TSO P, 1986, AM J PHYSIOL, V250, pG715, DOI 10.1152/ajpgi.1986.250.6.G715; Wang DQH, 2003, J LIPID RES, V44, P1042, DOI 10.1194/jlr.D200041-JLR200; Wang DQH, 2001, J LIPID RES, V42, P1820; Wat E, 2009, ATHEROSCLEROSIS, V205, P144, DOI 10.1016/j.atherosclerosis.2008.12.004; Young SC, 1999, BIOCHEM J, V339, P615, DOI 10.1042/0264-6021:3390615; Yunki K, 2010, J AGR FOOD CHEM, V58, P7030, DOI 10.1021/jf100722f	28	43	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55949	10.1371/journal.pone.0055949	http://dx.doi.org/10.1371/journal.pone.0055949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409094	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200092
J	Fajen, BR; Matthis, JS				Fajen, Brett R.; Matthis, Jonathan S.			Visual and Non-Visual Contributions to the Perception of Object Motion during Self-Motion	PLOS ONE			English	Article							RETINAL MOTION; CUES; INTERCEPTION; INFORMATION; GUIDANCE; PURSUIT; TIME; FLOW	Many locomotor tasks involve interactions with moving objects. When observer (i.e., self-)motion is accompanied by object motion, the optic flow field includes a component due to self-motion and a component due to object motion. For moving observers to perceive the movement of other objects relative to the stationary environment, the visual system could recover the object-motion component - that is, it could factor out the influence of self-motion. In principle, this could be achieved using visual self-motion information, non-visual self-motion information, or a combination of both. In this study, we report evidence that visual information about the speed (Experiment 1) and direction (Experiment 2) of self-motion plays a role in recovering the object-motion component even when non-visual self-motion information is also available. However, the magnitude of the effect was less than one would expect if subjects relied entirely on visual self-motion information. Taken together with previous studies, we conclude that when self-motion is real and actively generated, both visual and non-visual self-motion information contribute to the perception of object motion. We also consider the possible role of this process in visually guided interception and avoidance of moving objects.	[Fajen, Brett R.; Matthis, Jonathan S.] Rensselaer Polytech Inst, Dept Cognit Sci, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Fajen, BR (corresponding author), Rensselaer Polytech Inst, Dept Cognit Sci, Troy, NY 12180 USA.	fajenb@rpi.edu			United States National Institutes of Health [1R01EY019317]; NATIONAL EYE INSTITUTE [R01EY019317] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by a grant from the United States National Institutes of Health (1R01EY019317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin J, 2010, EXP BRAIN RES, V201, P763, DOI 10.1007/s00221-009-2092-y; Bootsma RJ, 2002, PERCEPTION, V31, P901, DOI 10.1068/p3230; Calabro FJ, 2012, EXP BRAIN RES, V221, P177, DOI 10.1007/s00221-012-3159-8; Campos JL, 2010, EUR J NEUROSCI, V31, P1889, DOI 10.1111/j.1460-9568.2010.07212.x; Chardenon A, 2004, EXP BRAIN RES, V158, P100, DOI 10.1007/s00221-004-1880-7; Dyde RT, 2008, J VISION, V8, DOI 10.1167/8.14.5; Fajen BR, 2004, PERCEPTION, V33, P689, DOI 10.1068/p5236; Fajen BR, 2007, EXP BRAIN RES, V180, P303, DOI 10.1007/s00221-007-0859-6; Fajen BR, 2011, J EXP PSYCHOL HUMAN, V37, P1442, DOI 10.1037/a0023510; Fajen BR, 2011, HUM MOVEMENT SCI, V30, P504, DOI 10.1016/j.humov.2010.07.016; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; Gibson JJ, 1950, PERCEPTION VISUAL WO; Harris L. R., 2002, Virtual Reality, V6, P75, DOI 10.1007/s100550200008; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; LANCHESTER BS, 1975, J EXP BIOL, V63, P627; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; Lee D.N., 1980, TUTORIALS MOTOR BEHA, P281; Lenoir M, 1999, J MOTOR BEHAV, V31, P55, DOI 10.1080/00222899909601891; MacNeilage PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040264; Matsumiya K, 2009, J VISION, V9, DOI 10.1167/9.1.15; Niehorster DC, 2012, J VISION, V12, P244, DOI DOI 10.1167/12.9.244; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; Royden CS, 2010, VISION RES, V50, P1014, DOI 10.1016/j.visres.2010.03.008; Rushton SK, 2007, COGNITION, V105, P237, DOI 10.1016/j.cognition.2006.09.004; Rushton SK, 2005, CURR BIOL, V15, pR542, DOI 10.1016/j.cub.2005.07.020; Sedgwick H. A., 1980, PERCEPTION PICTURES, V1, P33; Shaffer DM, 2009, OPEN SPORTS SCI J, V2, P29, DOI DOI 10.2174/1875399X00902010029; Tcheang L, 2005, VISION RES, V45, P2177, DOI 10.1016/j.visres.2005.02.006; WALLACH H, 1987, ANNU REV PSYCHOL, V38, P1, DOI 10.1146/annurev.ps.38.020187.000245; Warren PA, 2008, VISION RES, V48, P655, DOI 10.1016/j.visres.2007.10.023; Warren PA, 2007, J VISION, V7, DOI 10.1167/7.11.2; Warren PA, 2009, CURR BIOL, V19, P1555, DOI 10.1016/j.cub.2009.07.057; Warren PA, 2009, VISION RES, V49, P1406, DOI 10.1016/j.visres.2009.01.016; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081	36	31	31	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55446	10.1371/journal.pone.0055446	http://dx.doi.org/10.1371/journal.pone.0055446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23408983	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200031
J	Kyle, BD; Hurst, S; Swayze, RD; Sheng, JZ; Braun, AP				Kyle, Barry D.; Hurst, Soleil; Swayze, Richard D.; Sheng, Jianzhong; Braun, Andrew P.			Specific phosphorylation sites underlie the stimulation of a large conductance, Ca2+-activated K+ channel by cGMP-dependent protein kinase	FASEB JOURNAL			English	Article						BK channel; protein kinase G; nitric oxide; smooth muscle; modulation	VASCULAR SMOOTH-MUSCLE; ACTIVATED POTASSIUM CHANNELS; NITRIC-OXIDE; SODIUM-NITROPRUSSIDE; BKCA CHANNELS; CELLS; RECONSTITUTION; ENHANCEMENT; MODULATION; INHIBITION	Smooth muscle contractility and neuronal excitability are regulated by large conductance, Ca2+-activated K+ (BKCa) channels, the activity of which can be increased after modulation by type I cGMP-dependent protein kinase (cGKI) via nitric oxide (NO)/cGMP signaling. Our study focused on identifying key phosphorylation sites within the BKCa channel underlying functional enhancement of channel activity by cGKI. BKCa channel phosphorylation by cGKI alpha was characterized biochemically using radiolabeled ATP, and regulation of channel activity by NO/cGMP signaling was quantified in rat aortic A7r5 smooth muscle cells by cell-attached patch-clamp recording. Serine to alanine substitutions at 3 of 6 putative cGKI phosphorylation sites (Ser691, Ser873, and Ser1112) in the BKCa alpha subunit individually reduced direct channel phosphorylation by 25-60% and blocked BKCa activation by either an NO donor or a membrane-permeable cGMP by 80-100%. Acute inhibition of cGKI prevented stimulus-evoked enhancement of BKCa channel activity. Our data further suggest that augmentation of BKCa activity by NO/cGMP/cGKI signaling requires phosphorylation at all 3 sites and is independent of elevations in [Ca2+](i). Phosphorylation of 3 specific Ser residues within the murine BKCa alpha subunit by cGKI alpha accounts for the enhanced BKCa channel activity induced by elevated [cGMP](i) in situ.	Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Libin Cardiovasc Res Inst, Calgary, AB T2N 4N1, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Braun, AP (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	abraun@ucalgary.ca		Kyle, Barry/0000-0003-4304-5762	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada; Kertland Family Fellowship Award; CIHR Rx&D Studentship Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Kertland Family Fellowship Award; CIHR Rx&D Studentship Award(Canadian Institutes of Health Research (CIHR))	The authors thank Connie Liao and Dr. Wayne Chen for their assistance with the Fura-2 imaging experiments and Dr. Michael Walsh for his critical reading of the manuscript. Technical advice provided by Cindy Sutherland regarding thin-layer electrophoresis and TLC protocols is appreciated. This work was supported by research funding from the Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (to A.P.B.). B.D.K. was supported in part by a Kertland Family Fellowship Award, and R.D.S. was supported in part by a CIHR Rx&D Studentship Award.	Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; Brueggemann LI, 2005, AM J PHYSIOL-HEART C, V288, pH923, DOI 10.1152/ajpheart.01126.2003; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; CREST M, 1993, J PHYSIOL-LONDON, V465, P265, DOI 10.1113/jphysiol.1993.sp019676; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Erxleben C, 2003, P NATL ACAD SCI USA, V100, P2929, DOI 10.1073/pnas.2628046100; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Klyachko VA, 2001, NEURON, V31, P1015, DOI 10.1016/S0896-6273(01)00449-4; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lang RJ, 1998, BRIT J PHARMACOL, V123, P505, DOI 10.1038/sj.bjp.0701605; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Lu G, 1998, AM J PHYSIOL-GASTR L, V274, pG848, DOI 10.1152/ajpgi.1998.274.5.G848; MOORE LK, 1995, AM J PHYSIOL-HEART C, V269, pH1481, DOI 10.1152/ajpheart.1995.269.4.H1481; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; Nara M, 2000, AM J PHYSIOL-CELL PH, V279, pC1938, DOI 10.1152/ajpcell.2000.279.6.C1938; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Peng W, 1996, J APPL PHYSIOL, V81, P1264, DOI 10.1152/jappl.1996.81.3.1264; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200; TANIGUCHI J, 1993, PFLUG ARCH EUR J PHY, V423, P167, DOI 10.1007/BF00374390; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; WHITE RE, 1995, CIRC RES, V77, P936, DOI 10.1161/01.RES.77.5.936; Yamakage M, 1996, AM J PHYSIOL-LUNG C, V270, pL338, DOI 10.1152/ajplung.1996.270.3.L338; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107	48	34	35	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					2027	2038		10.1096/fj.12-223669	http://dx.doi.org/10.1096/fj.12-223669			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23407708				2022-12-25	WOS:000318226100022
J	Cheng, XX; Veverka, V; Radhakrishnan, A; Waters, LC; Muskett, FW; Morgan, SH; Huo, JD; Yu, C; Evans, EJ; Leslie, AJ; Griffiths, M; Stubberfield, C; Griffin, R; Henry, AJ; Jansson, A; Ladbury, JE; Ikemizu, S; Carr, MD; Davis, SJ				Cheng, Xiaoxiao; Veverka, Vaclav; Radhakrishnan, Anand; Waters, Lorna C.; Muskett, Frederick W.; Morgan, Sara H.; Huo, Jiandong; Yu, Chao; Evans, Edward J.; Leslie, Alasdair J.; Griffiths, Meryn; Stubberfield, Colin; Griffin, Robert; Henry, Alistair J.; Jansson, Andreas; Ladbury, John E.; Ikemizu, Shinji; Carr, Mark D.; Davis, Simon J.			Structure and Interactions of the Human Programmed Cell Death 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE DETERMINATION; N-TERMINAL DOMAIN; T-CELLS; CRYSTAL-STRUCTURE; PD-1 EXPRESSION; QUANTITATIVE-ANALYSIS; TISSUE INHIBITOR; MOLECULAR-BASIS; NMR ASSIGNMENT; HCV INFECTION	PD-1, a receptor expressed by T cells, B cells, and monocytes, is a potent regulator of immune responses and a promising therapeutic target. The structure and interactions of human PD-1 are, however, incompletely characterized. We present the solution nuclear magnetic resonance (NMR)-based structure of the human PD-1 extracellular region and detailed analyses of its interactions with its ligands, PD-L1 and PD-L2. PD-1 has typical immunoglobulin superfamily topology but differs at the edge of the GFCC' sheet, which is flexible and completely lacks a C '' strand. Changes in PD-1 backbone NMR signals induced by ligand binding suggest that, whereas binding is centered on the GFCC' sheet, PD-1 is engaged by its two ligands differently and in ways incompletely explained by crystal structures of mouse PD-1.ligand complexes. The affinities of these interactions and that of PD-L1 with the costimulatory protein B7-1, measured using surface plasmon resonance, are significantly weaker than expected. The 3-4-fold greater affinity of PD-L2 versus PD-L1 for human PD-1 is principally due to the 3-fold smaller dissociation rate for PD-L2 binding. Isothermal titration calorimetry revealed that the PD-1/PD-L1 interaction is entropically driven, whereas PD-1/PD-L2 binding has a large enthalpic component. Mathematical simulations based on the biophysical data and quantitative expression data suggest an unexpectedly limited contribution of PD-L2 to PD-1 ligation during interactions of activated T cells with antigen-presenting cells. These findings provide a rigorous structural and biophysical framework for interpreting the important functions of PD-1 and reveal that potent inhibitory signaling can be initiated by weakly interacting receptors.	[Cheng, Xiaoxiao; Morgan, Sara H.; Huo, Jiandong; Yu, Chao; Evans, Edward J.; Leslie, Alasdair J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England; [Cheng, Xiaoxiao; Morgan, Sara H.; Huo, Jiandong; Yu, Chao; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford OX3 9DU, England; [Veverka, Vaclav; Waters, Lorna C.; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Veverka, Vaclav] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic; [Radhakrishnan, Anand] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Griffiths, Meryn; Stubberfield, Colin; Griffin, Robert; Henry, Alistair J.] UCB Pharma, Slough SL1 4EN, Berks, England; [Jansson, Andreas; Ladbury, John E.] Univ Skovde, Sch Life Sci, Syst Biol Res Ctr, Skovde, Sweden; [Ikemizu, Shinji] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kumamoto 8620973, Japan	University of Oxford; University of Oxford; University of Leicester; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Texas System; UTMD Anderson Cancer Center; UCB Pharma SA; University of Skovde; Kumamoto University	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk; simon.davis@imm.ox.ac.uk	Huo, Jiandong/AAL-5945-2021; Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019	Huo, Jiandong/0000-0002-7899-1815; Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Ladbury, John/0000-0002-6328-7200; Carr, Mark/0000-0002-3939-0996; leslie, alasdair/0000-0003-2538-6467	Wellcome Trust; United Kingdom Medical Research Council; UCB Celltech Ltd.; G. Harold and Leila Y. Mathers Charitable Foundation; Medical Research Council [MC_UU_12010/4] Funding Source: researchfish; MRC [MC_UU_12010/4] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCB Celltech Ltd.(UCB Pharma SA); G. Harold and Leila Y. Mathers Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, the United Kingdom Medical Research Council, UCB Celltech Ltd., and a grant from the G. Harold and Leila Y. Mathers Charitable Foundation (to J. E. L.).	AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; DAS MRP, 1995, EUR J IMMUNOL, V25, P207, DOI 10.1002/eji.1830250134; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Dong HD, 2003, J CLIN INVEST, V111, P363, DOI 10.1172/JCI200316015; Dong HD, 1999, NAT MED, V5, P1365; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM-US, V50, P2590, DOI 10.1002/art.20436; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; James ES, 2005, GENES IMMUN, V6, P430, DOI 10.1038/sj.gene.6364223; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; Jansson A, 2011, MOL IMMUNOL, V49, P527, DOI 10.1016/j.molimm.2011.09.021; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kong EKP, 2005, ARTHRITIS RHEUM-US, V52, P1058, DOI 10.1002/art.20966; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; SANSOM DM, 1993, EUR J IMMUNOL, V23, P295, DOI 10.1002/eji.1830230148; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shin T, 2005, J EXP MED, V201, P1531, DOI 10.1084/jem.20050072; SPRINGER TA, 1991, NATURE, V353, P704, DOI 10.1038/353704a0; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Wilkinson IC, 2009, J BIOL CHEM, V284, P31928, DOI 10.1074/jbc.M109.025304; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yu C, 2011, J BIOL CHEM, V286, P6685, DOI 10.1074/jbc.M110.182394; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2	65	197	234	2	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11771	11785		10.1074/jbc.M112.448126	http://dx.doi.org/10.1074/jbc.M112.448126			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23417675	Green Published, hybrid			2022-12-25	WOS:000318157600014
J	Song, DS; Li, LS; Heaton-Johnson, KJ; Arsenault, PR; Master, SR; Lee, FS				Song, Daisheng; Li, Lin-Sheng; Heaton-Johnson, Katherine J.; Arsenault, Patrick R.; Master, Stephen R.; Lee, Frank S.			Prolyl Hydroxylase Domain Protein 2 (PHD2) Binds a Pro-Xaa-Leu-Glu Motif, Linking It to the Heat Shock Protein 90 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; TUMOR-SUPPRESSOR PROTEIN; PROLINE HYDROXYLATION; CRYSTAL-STRUCTURE; CO-CHAPERONE; MYND DOMAIN; HIF-ALPHA; HSP90; OXYGEN; ERYTHROCYTOSIS	Prolyl hydroxylase domain protein 2 (PHD2, also known as Egg Laying Defective Nine homolog 1) is a key oxygen-sensing protein in metazoans. In an oxygen-dependent manner, PHD2 site-specifically prolyl hydroxylates the master transcription factor of the hypoxic response, hypoxia-inducible factor-alpha (HIF-alpha), thereby targeting HIF-alpha for degradation. In this report we show that the heat shock protein 90 (HSP90) co-chaperones p23 and FKBP38 interact via a conserved Pro-Xaa-Leu-Glu motif (where Xaa = any amino acid) in these proteins with the N-terminal Myeloid Nervy and DEAF-1 (MYND)-type zinc finger of PHD2. Knockdown of p23 augments hypoxia-induced HIF-1 alpha protein levels and HIF target genes. We propose that p23 recruits PHD2 to the HSP90 machinery to facilitate HIF-1 alpha hydroxylation. These findings identify a link between two ancient pathways, the PHD: HIF and the HSP90 pathways, and suggest that this link was established concurrent with the emergence of the PHD: HIF pathway in evolution.	[Song, Daisheng; Li, Lin-Sheng; Heaton-Johnson, Katherine J.; Arsenault, Patrick R.; Master, Stephen R.; Lee, Frank S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, FS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	Arsenault, Patrick/F-3429-2011	Arsenault, Patrick/0000-0001-6670-0809; Lee, Frank/0000-0003-2511-1834; Master, Stephen/0000-0002-6808-631X	National Institutes of Health [R01-GM090301, R01-CA153347]; NATIONAL CANCER INSTITUTE [R01CA153347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM090301 (to F. S. L. and S. R. M.) and R01-CA153347 (to F. S. L.).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Beall CM, 2011, HIGH ALT MED BIOL, V12, P101, DOI 10.1089/ham.2011.1007; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Edlich F, 2011, CURR OPIN PHARMACOL, V11, P348, DOI 10.1016/j.coph.2011.03.011; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Huang JH, 2010, CANCER BIOL THER, V9, P303, DOI 10.4161/cbt.9.4.10744; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Somarelli JA, 2008, PROTEINS, V72, P197, DOI 10.1002/prot.21908; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; WINIEWSKI JR, 2009, NAT METHODS, V6, P359, DOI DOI 10.1038/NMETH.1322; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu F, 2001, CANCER RES, V61, P4136	55	44	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9662	9674		10.1074/jbc.M112.440552	http://dx.doi.org/10.1074/jbc.M112.440552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413029	Green Published, hybrid			2022-12-25	WOS:000317114000009
J	Bierbaum, V; Lipowsky, R				Bierbaum, Veronika; Lipowsky, Reinhard			Dwell Time Distributions of the Molecular Motor Myosin V	PLOS ONE			English	Article							STEPPING KINETICS; POWER STROKE; PROCESSIVITY; COORDINATION; MODEL; LOAD; MECHANISM; PATHWAYS; WALKING; MOTION	The dwell times between two successive steps of the two-headed molecular motor myosin V are governed by non-exponential distributions. These distributions have been determined experimentally for various control parameters such as nucleotide concentrations and external load force. First, we use a simplified network representation to determine the dwell time distributions of myosin V, with the associated dynamics described by a Markov process on networks with absorbing boundaries. Our approach provides a direct relation between the motor's chemical kinetics and its stepping properties. In the absence of an external load, the theoretical distributions quantitatively agree with experimental findings for various nucleotide concentrations. Second, using a more complex branched network, which includes ADP release from the leading head, we are able to elucidate the motor's gating effect. This effect is caused by an asymmetry in the chemical properties of the leading and the trailing head of the motor molecule. In the case of an external load acting on the motor, the corresponding dwell time distributions reveal details about the motor's backsteps.	[Bierbaum, Veronika; Lipowsky, Reinhard] Max Planck Inst Colloids & Interfaces, Potsdam, Germany	Max Planck Society	Bierbaum, V (corresponding author), Max Planck Inst Colloids & Interfaces, Potsdam, Germany.	bierbaum@mpikg.mpg.de		Lipowsky, Reinhard/0000-0001-8417-8567				Astumian RD, 2010, BIOPHYS J, V98, P2401, DOI 10.1016/j.bpj.2010.02.040; Astumian RD, 1996, BIOPHYS J, V70, P637, DOI 10.1016/S0006-3495(96)79605-4; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Bierbaum V, 2011, BIOPHYS J, V100, P1747, DOI 10.1016/j.bpj.2011.02.012; Cappello G, 2007, P NATL ACAD SCI USA, V104, P15328, DOI 10.1073/pnas.0706653104; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Craig EM, 2009, P NATL ACAD SCI USA, V106, P18261, DOI 10.1073/pnas.0908192106; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Hyeon C, 2009, PHYS CHEM CHEM PHYS, V11, P4899, DOI 10.1039/b903536b; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Komori Y, 2007, NAT STRUCT MOL BIOL, V14, P968, DOI 10.1038/nsmb1298; Liao JC, 2007, P NATL ACAD SCI USA, V104, P3171, DOI 10.1073/pnas.0611519104; Liepelt S, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/50002; Liepelt S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258102; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Pierobon P, 2009, BIOPHYS J, V96, P4268, DOI 10.1016/j.bpj.2009.02.045; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sellers JR, 2010, NAT STRUCT MOL BIOL, V17, P590, DOI 10.1038/nsmb.1820; Shiroguchi K, 2007, SCIENCE, V316, P1208, DOI 10.1126/science.1140468; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Valleriani A, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28011; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732	35	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55366	10.1371/journal.pone.0055366	http://dx.doi.org/10.1371/journal.pone.0055366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418440	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300030
J	Niesen, CE; Xu, J; Fan, XM; Li, XJ; Wheeler, CJ; Mamelak, AN; Wang, C				Niesen, Charles E.; Xu, Jun; Fan, Xuemo; Li, Xiaojin; Wheeler, Christopher J.; Mamelak, Adam N.; Wang, Charles			Transcriptomic Profiling of Human Peritumoral Neocortex Tissues Revealed Genes Possibly Involved in Tumor-Induced Epilepsy	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; TEMPORAL-LOBE EPILEPSY; EPILEPTIFORM ACTIVITY; BRAIN-TUMORS; EXTRACELLULAR-MATRIX; EXPRESSION PROFILES; HIPPOCAMPAL-NEURONS; CELL-MIGRATION; IN-VITRO; FORMALIN	The molecular mechanism underlying tumor-induced epileptogenesis is poorly understood. Alterations in the peritumoral microenvironment are believed to play a significant role in inducing epileptogenesis. We hypothesize that the change of gene expression in brain peritumoral tissues may contribute to the increased neuronal excitability and epileptogenesis. To identify the genes possibly involved in tumor-induced epilepsy, a genome-wide gene expression profiling was conducted using Affymetrix HG U133 plus 2.0 arrays and RNAs derived from formalin-fixed paraffin embedded (FFPE) peritumoral cortex tissue slides from 5-seizure vs. 5-non-seizure low grade brain tumor patients. We identified many differentially expressed genes (DEGs). Seven dysregulated genes (i.e., C1QB, CALCRL, CCR1, KAL1, SLC1A2, SSTR1 and TYRO3) were validated by qRT-PCR, which showed a high concordance. Principal Component Analysis (PCA) showed that epilepsy subjects were clustered together tightly (except one sample) and were clearly separated from the non-epilepsy subjects. Molecular functional categorization showed that significant portions of the DEGs functioned as receptor activity, molecular binding including enzyme binding and transcription factor binding. Pathway analysis showed these DEGs were mainly enriched in focal adhesion, ECM-receptor interaction, and cell adhesion molecules pathways. In conclusion, our study showed that dysregulation of gene expression in the peritumoral tissues may be one of the major mechanisms of brain tumor induced-epilepsy. However, due to the small sample size of the present study, further validation study is needed. A deeper characterization on the dysregulated genes involved in brain tumor-induced epilepsy may shed some light on the management of epilepsy due to brain tumors.	[Niesen, Charles E.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Xu, Jun] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Fan, Xuemo] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Fan, Xuemo; Wang, Charles] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Li, Xiaojin; Wang, Charles] City Hope Comprehens Canc Ctr, Funct Genom Core, Duarte, CA USA; [Li, Xiaojin; Wang, Charles] City Hope Comprehens Canc Ctr, Dept Mol & Cellular Biol, Duarte, CA USA; [Wheeler, Christopher J.; Mamelak, Adam N.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; City of Hope; Cedars Sinai Medical Center	Wang, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	cwang@coh.org	Mamelak, Adam/H-8347-2014	Mamelak, Adam/0000-0002-4245-6431	Cedars-Sinai Medical Center (CSMC); GCRC [2M01 RR00425-38]; NCI cancer center grant at City of Hope Comprehensive Cancer Center [5P30 CA033572-27]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER	Cedars-Sinai Medical Center (CSMC); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI cancer center grant at City of Hope Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by 2 internal grants awarded to CEN and CW respectively from Cedars-Sinai Medical Center (CSMC). CW was supported by the GCRC (2M01 RR00425-38) when the study was carried at CSMC. CW's salary was partially covered by the NCI cancer center grant (5P30 CA033572-27) at City of Hope Comprehensive Cancer Center, while the manuscript was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Aronica E, 2001, NEUROPATH APPL NEURO, V27, P223, DOI 10.1046/j.0305-1846.2001.00314.x; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Beaumont A, 2000, ACTA NEUROCHIR, V142, P1, DOI 10.1007/s007010050001; Berg D, 2012, J CELL PHYSIOL, V227, P204, DOI 10.1002/jcp.22718; BLENDY JA, 1990, J NEUROSCI, V10, P2580; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Budczies J, 2011, J HISTOCHEM CYTOCHEM, V59, P146, DOI 10.1369/jhc.2010.956607; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chung JY, 2006, DIAGN MOL PATHOL, V15, P229, DOI 10.1097/01.pdm.0000213468.91139.2d; Churn SB, 2000, P NATL ACAD SCI USA, V97, P5604, DOI 10.1073/pnas.080071697; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; DELCASTILLO I, 1992, NAT GENET, V2, P305, DOI 10.1038/ng1292-305; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dityatev Alexander, 2006, V43, P69, DOI 10.1007/025; Dityatev A, 2010, EPILEPSIA, V51, P61, DOI 10.1111/j.1528-1167.2010.02612.x; Elmer E, 1997, NEUROREPORT, V8, P1193, DOI 10.1097/00001756-199703240-00027; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; Frank M, 2007, VIRCHOWS ARCH, V450, P699, DOI 10.1007/s00428-007-0412-9; Gall CM, 2004, ADV EXP MED BIOL, V548, P12; GUNDLACH AL, 1995, BRAIN RES, V672, P214, DOI 10.1016/0006-8993(94)01338-I; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; HAMBERGER A, 1991, EPILEPSY RES, V9, P32, DOI 10.1016/0920-1211(91)90044-G; Heck N, 2004, NEUROSCIENCE, V129, P309, DOI 10.1016/j.neuroscience.2004.06.078; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hossmann K A, 1990, Adv Neurol, V52, P449; Hu YL, 2009, J BIOL CHEM, V284, P29905, DOI 10.1074/jbc.M109.049155; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jacobson TAS, 2011, INT J ONCOL, V38, P1075, DOI 10.3892/ijo.2011.936; Jian BX, 2009, CELL CYCLE, V8, P3770, DOI 10.4161/cc.8.22.10066; KEMPSKI O, 1988, STROKE, V19, P385, DOI 10.1161/01.STR.19.3.385; Kohling R, 2006, NEURODEGENER DIS, V3, P56, DOI 10.1159/000092094; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; Kurzwelly D, 2010, ADV TECH STAND NEURO, V35, P80; Lee CH, 2005, WORLD J GASTROENTERO, V11, P1937, DOI 10.3748/wjg.v11.i13.1937; Lerner JT, 2008, CELL MOL LIFE SCI, V65, P1864, DOI 10.1007/s00018-008-8161-8; Librizzi L, 2007, EPILEPSIA, V48, P743, DOI 10.1111/j.1528-1167.2007.01047.x; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Matveeva EA, 2007, EPILEPSY RES, V73, P266, DOI 10.1016/j.eplepsyres.2006.11.003; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Peterson LE, 2003, COMPUT METH PROG BIO, V70, P107, DOI 10.1016/S0169-2607(02)00009-3; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Rajneesh KF, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.5.FOCUS09101; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ricci R, 2007, AM J NEURORADIOL, V28, P1287, DOI 10.3174/ajnr.A0564; Ruda R, 2010, CURR OPIN ONCOL, V22, P611, DOI 10.1097/CCO.0b013e32833de99d; RUTECKI PA, 1995, EPILEPSY RES, V20, P125, DOI 10.1016/0920-1211(94)00078-B; Sadegh M, 2007, NEUROSCIENCE, V150, P396, DOI 10.1016/j.neuroscience.2007.09.068; Salin P, 1995, J NEUROSCI, V15, P8234; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Shamji MF, 2009, NEUROSURG REV, V32, P275, DOI 10.1007/s10143-009-0191-7; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; STANTA G, 1991, BIOTECHNIQUES, V11, P304; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tan YX, 2006, BIOINFORMATICS, V22, P77, DOI 10.1093/bioinformatics/bti737; Tan YX, 2005, NUCLEIC ACIDS RES, V33, P56, DOI 10.1093/nar/gki144; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Veznedaroglu E, 2002, J NEUROSURG, V97, P1125, DOI 10.3171/jns.2002.97.5.1125; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Wolf HK, 1996, ACTA NEUROPATHOL, V91, P376, DOI 10.1007/s004010050439; Xu J, 2008, STEM CELLS DEV, V17, P143, DOI 10.1089/scd.2007.0094; Zucchini S, 2008, J NEUROSCI, V28, P13112, DOI 10.1523/JNEUROSCI.1472-08.2008	68	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56077	10.1371/journal.pone.0056077	http://dx.doi.org/10.1371/journal.pone.0056077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418513	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300105
J	Du, WT; Shen, YW; Lee, WH; Wang, D; Paz, S; Kandeel, F; Liu, CP				Du, Weiting; Shen, Yueh-Wei; Lee, Wen-Hui; Wang, Ding; Paz, Sachiko; Kandeel, Fouad; Liu, Chih-Pin			Foxp3(+) Treg Expanded from Patients with Established Diabetes Reduce Helios Expression while Retaining Normal Function Compared to Healthy Individuals	PLOS ONE			English	Article							REGULATORY T-CELLS; SELF-TOLERANCE; EXPANSION; DEFECTS; DISEASE; FREQUENCY; APOPTOSIS; PREVENT; TARGET; CD25	Foxp3(+) regulatory T cells (Treg) play a crucial role in regulating immune tolerance. The use of Treg to restore immune tolerance is considered an attractive novel approach to inhibit autoimmune disease, including type 1 diabetes (T1D), and to prevent rejection of organ transplants. In view of the goal of developing autologous Treg-based cell therapy for patients with long-term (>15 years) T1D, it will be necessary to expand a sufficient amount of functional Treg in vitro in order to study and compare Treg from T1D patients and healthy subjects. Our results have demonstrated that there is a comparable frequency of Treg in the peripheral blood lymphocytes (PBLs) of patients with long-term T1D relative to those in healthy subjects; however, Th1 cells, but not Th17 cells, were increased in the T1D patients. Further, more Treg in PBLs from T1D patients than from healthy subjects expressed the CD45RO(+) memory cell phenotype, suggesting they were antigen-experienced cells. After isolation, Treg from both T1D patients and healthy subjects were successfully expanded with high purity. Although there was no difference in Helios expression on Treg in PBLs, in vitro expansion led to fewer Helios-expressing Treg from T1D patients than healthy subjects. While more Th1-like Treg expressing IFN-gamma or TNF-alpha were found in the PBLs of T1D patients than healthy controls, there was no such difference in the expanded Treg. Importantly, expanded Treg from both subject groups were able to suppress autologous or allogeneic CD8(+) effector T cells equally well. Our findings demonstrate that a large number of ex vivo expanded functional Treg can be obtained from long-term T1D patients, although fewer expanded Treg expressed a high level of Helios. Thus, based on the positive outcomes, these potent expanded Treg from diabetic human patients may be useful in treating T1D or preventing islet graft rejection.	[Du, Weiting; Shen, Yueh-Wei; Lee, Wen-Hui; Wang, Ding; Paz, Sachiko; Kandeel, Fouad; Liu, Chih-Pin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Liu, Chih-Pin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Liu, CP (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.	cpliu@coh.org	Du, Weiting/C-9971-2014		American Diabetes Association; Juvenile Diabetes Research Foundation; National Institutes of Health; Jonas Brother Funds; H. L. Snyder Medical Foundation	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonas Brother Funds; H. L. Snyder Medical Foundation	This work was supported, in part, by funds from American Diabetes Association, Juvenile Diabetes Research Foundation, National Institutes of Health, the Jonas Brother Funds, and the H. L. Snyder Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Battaglia M, 2011, SEMIN IMMUNOL, V23, P182, DOI 10.1016/j.smim.2011.07.007; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Chen C, 2006, J IMMUNOL, V176, P3449, DOI 10.4049/jimmunol.176.6.3449; Chen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007863; Chen X, 2010, EUR J IMMUNOL, V40, P1099, DOI 10.1002/eji.200940022; Csorba TR, 2010, CRIT REV CL LAB SCI, V47, P51, DOI 10.3109/10408361003787171; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Eisenbarth GS, 2007, J CLIN ENDOCR METAB, V92, P2403, DOI 10.1210/jc.2007-0339; Ferraro A, 2011, DIABETES, V60, P2903, DOI 10.2337/db11-0090; Gavin JR, 1999, DIABETES CARE, V22, pS5; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gottschalk RA, 2011, J IMMUNOL; Hippen KL, 2011, AM J TRANSPLANT, V11, P1148, DOI 10.1111/j.1600-6143.2011.03558.x; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Jaeckel E, 2008, HORM METAB RES, V40, P126, DOI 10.1055/s-2008-1042427; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	43	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56209	10.1371/journal.pone.0056209	http://dx.doi.org/10.1371/journal.pone.0056209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409157	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000046
J	Lin, CT; Chen, YC; Jinn, TR; Wu, CC; Hong, YM; Wu, WH				Lin, Ching-Ting; Chen, Yu-Ching; Jinn, Tzyy-Rong; Wu, Chien-Chen; Hong, Yi-Ming; Wu, Wen-Hao			Role of the cAMP-Dependent Carbon Catabolite Repression in Capsular Polysaccharide Biosynthesis in Klebsiella pneumoniae	PLOS ONE			English	Article							AMP RECEPTOR PROTEIN; CYCLIC-AMP; ESCHERICHIA-COLI; ACTIVATOR PROTEIN; LIVER-ABSCESS; TRANSCRIPTION ACTIVATION; COMMON INFECTIONS; EMERGING DISEASE; GENE-EXPRESSION; HIGH PREVALENCE	K. pneumoniae is the predominant pathogen isolated from liver abscesses of diabetic patients in Asian countries. Although elevated blood glucose levels cause various immune problems, its effects on K. pneumoniae virulence are unknown. This study investigated the regulation of capsular polysaccharide (CPS) biosynthesis, a major determinant for K. pneumoniae virulence, in response to exogenous glucose. We found that K. pneumoniae produce more CPS in glucose-rich medium via reduction in cyclic AMP (cAMP) levels. Individual deletion of cyaA or crp, which respectively encode adenylate cyclase and cAMP receptor protein in K. pneumoniae, markedly increased CPS production, while deletion of cpdA, which encodes cAMP phosphodiesterase, decreased CPS production. These results indicate that K. pneumoniae CPS biosynthesis is controlled by the cAMP-dependent carbon catabolite repression (CCR). To investigate the underlying mechanism, quantitative real-time PCR and promoter-reporter assays were used to verify that the transcription of CPS biosynthesis genes, which are organized into 3 transcription units (orf1-2, orf3-15, and orf16-17), were activated by the deletion of crp. Sequence analysis revealed putative CRP binding sites located on Porf3-15 and Porf16-17, suggesting direct CRP-cAMP regulation on the promoters. These results were then confirmed by electrophoretic mobility shift assay. In addition, we found putative CRP binding sites located in the promoter region of rcsA, which encodes a cps transcriptional activator, demonstrating a direct repression of CRP-cAMP and P-rcsA. The deletion of rcsA in mutation of crp partially reduced CPS biosynthesis and the transcription of orf1-2 but not of orf3-15 or orf16-17. These results suggest that RcsA participates in the CRP-cAMP regulation of orf1-2 transcription and influences CPS biosynthesis. Finally, the effect of glucose and CCR proteins on CPS biosynthesis also reflects bacterial resistance to serum killing. We here provide evidence that K. pneumoniae increases CPS biosynthesis for successful infection in response to exogenous glucose via cAMP-dependent CCR.	[Lin, Ching-Ting; Jinn, Tzyy-Rong; Hong, Yi-Ming; Wu, Wen-Hao] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Yu-Ching] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wu, Chien-Chen] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	China Medical University Taiwan; Asia University Taiwan; National Yang Ming Chiao Tung University	Lin, CT (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	gingting@mail.cmu.edu.tw			National Science Council [NSC 99-2320-B-039-002-MY3]; China Medical University [CMU100-ASIA-12]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	The work is supported by the grants from National Science Council (NSC 99-2320-B-039-002-MY3) and China Medical University (CMU100-ASIA-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA Y, 1995, J BACTERIOL, V177, P1788, DOI 10.1128/jb.177.7.1788-1796.1995; BAGA M, 1985, EMBO J, V4, P3887, DOI 10.1002/j.1460-2075.1985.tb04162.x; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Chen SL, 2009, J UROLOGY, V182, pS51, DOI 10.1016/j.juro.2009.07.090; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; DELORENZO V, 1988, EUR J BIOCHEM, V173, P537; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Fuchs EL, 2010, J BACTERIOL; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P309; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; HAN SHB, 1995, WESTERN J MED, V162, P220; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Inada T, 1996, MOL GEN GENET, V253, P198, DOI 10.1007/s004380050313; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim HS, 2009, J BACTERIOL, V191, P922, DOI 10.1128/JB.01350-08; Lai YC, 2001, INFECT IMMUN, V69, P7140, DOI 10.1128/IAI.69.11.7140-7145.2001; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Lau YJ, 2000, J CLIN MICROBIOL, V38, P412; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2011, MICROBIOL-SGM, V157, P419, DOI 10.1099/mic.0.044065-0; Lin HH, 2011, J BACTERIOL, V193, P5833, DOI 10.1128/JB.05359-11; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Lory S, 2004, INT J MED MICROBIOL, V293, P479, DOI 10.1078/1438-4221-00297; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mendez M, 2008, J BACTERIOL, V190, P48, DOI 10.1128/JB.01407-07; Meyer M, 2001, J BACTERIOL, V183, P5248, DOI 10.1128/JB.183.18.5248-5256.2001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; NASSIF X, 1989, MOL MICROBIOL, V3, P1349, DOI 10.1111/j.1365-2958.1989.tb00116.x; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; PETERKOFSKY A, 1971, P NATL ACAD SCI USA, V68, P2794, DOI 10.1073/pnas.68.11.2794; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Saier MH, 1996, FEMS MICROBIOL LETT, V138, P97; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Stella NA, 2008, RES MICROBIOL, V159, P562, DOI 10.1016/j.resmic.2008.07.003; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vecerek B, 2003, MOL MICROBIOL, V50, P897, DOI 10.1046/j.1365-2958.2003.03727.x; Warren JW, 2001, INT J ANTIMICROB AG, V17, P299, DOI 10.1016/S0924-8579(00)00359-9; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; WEST SEH, 1994, J BACTERIOL, V176, P7532, DOI 10.1128/JB.176.24.7532-7542.1994; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Wu JH, 2005, EXP BIOL MED, V230, P757, DOI 10.1177/153537020523001009; Yang YS, 2009, J CLIN MICROBIOL, V47, P3336, DOI 10.1128/JCM.00918-09; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	72	61	69	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54430	10.1371/journal.pone.0054430	http://dx.doi.org/10.1371/journal.pone.0054430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408939	gold, Green Submitted, Green Published			2022-12-25	WOS:000315100000003
J	Mirkovic, K; Doorenbos, CRC; Dam, WA; Heerspink, HJL; Slagman, MCJ; Nauta, FL; Kramer, AB; Gansevoort, RT; van den Born, J; Navis, G; de Borst, MH				Mirkovic, Katarina; Doorenbos, Carolina R. C.; Dam, Wendy A.; Heerspink, Hiddo J. Lambers; Slagman, Maartje C. J.; Nauta, Ferdau L.; Kramer, Andrea B.; Gansevoort, Ronald T.; van den Born, Jacob; Navis, Gerjan; de Borst, Martin H.			Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis	PLOS ONE			English	Article							DIETARY-SODIUM RESTRICTION; ADRIAMYCIN NEPHROTIC RATS; ACE-INHIBITION; PROGRESSION; DAMAGE; METABOLISM; MECHANISMS; EXCRETION; DISEASE; ALBUMIN	Non-invasive tubulointerstitial damage markers may allow better titration and monitoring of renoprotective therapy. We investigated the value of urinary vitamin D binding protein excretion (uVDBP) as a tubulointerstitial inflammation and fibrosis marker in adriamycin rats, and tested whether uVDBP parallels renal damage and responds to therapy intensification in humans. In adriamycin (ADR) rats, uVDBP was strongly elevated vs controls (CON) already 6 wks after nephrosis induction (ADR: 727+/-674 [mean+/-SD] vs CON: 9+/-12 mu g/d, p<0.01), i.e. before onset of pre-fibrotic and inflammatory tubulointerstitial damage, and at all following 6-wk time points until end of follow up at 30 wks (ADR: 1403+/-1026 vs CON: 206+/-132 mu g/d, p<0.01). In multivariate regression analysis, uVDBP was associated with tubulointerstitial macrophage accumulation (standardized beta = 0.47, p = 0.01) and collagen III expression (standardized beta = 0.44, p = 0.02) independently of albuminuria. In humans, uVDBP was increased in 100 microalbuminuric subjects (44+/-93 mu g/d) and in 47 CKD patients with overt proteinuria (9.2+/-13.0 mg/d) compared to 100 normoalbuminuric subjects (12+/-12 mu g/d, p<0.001). In CKD patients, uVDBP responded to intensification of renoprotective therapy (ACEi+liberal sodium: 9.2+/-13.0 mg/d vs dual RAAS blockade+low sodium: 2747+/-4013, p<0.001), but remained still >100-fold increased during maximal therapy vs normoalbuminurics (p<0.001), consistent with persisting tubulointerstitial damage. UVDBP was associated with tubular and inflammatory damage markers KIM-1 (standardized beta = 0.52, p<0.001), beta-2-microglobuline (st.beta = 0.45, p<0.001), cystatin C (st.beta = 0.40, p<0.001), MCP-1 (st. beta = 0.31, p<0.001) and NGAL (st. beta = 0.20, p = 0.005), independently of albuminuria. UVDBP may be a novel urinary biomarker of tubulointerstitial damage. Prospectively designed studies are required to validate our findings and confirm its relevance in the clinical setting.	[Mirkovic, Katarina; Doorenbos, Carolina R. C.; Dam, Wendy A.; Slagman, Maartje C. J.; Nauta, Ferdau L.; Kramer, Andrea B.; Gansevoort, Ronald T.; van den Born, Jacob; Navis, Gerjan; de Borst, Martin H.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Heerspink, Hiddo J. Lambers] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands	University of Groningen; University of Groningen	de Borst, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands.	m.h.de.borst@umcg.nl	Heerspink, Hiddo J Lambers/K-3358-2014	Heerspink, Hiddo J Lambers/0000-0002-3126-3730; De Borst, Martin/0000-0002-4127-8733	Dutch Kidney foundation [KJPB.08.07]; University Medical Center Groningen; European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid) [241544]; Dutch Kidney Foundation (NIGRAM consortium) [CP10.11]	Dutch Kidney foundation; University Medical Center Groningen; European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid); Dutch Kidney Foundation (NIGRAM consortium)	Dr. de Borst is supported by personal development grants from the Dutch Kidney foundation (KJPB.08.07) and the University Medical Center Groningen (Mandema stipend), and by the European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid), project number 241544). This work is supported by a consortium grant from the Dutch Kidney Foundation (NIGRAM consortium, grant no CP10.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTANI T, 1986, KIDNEY INT, V30, P488, DOI 10.1038/ki.1986.212; De Boer E, 1999, J AM SOC NEPHROL, V10, P2359; de Borst MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037957; Doorenbos CRC, 2012, J STEROID BIOCHEM, V128, P56, DOI 10.1016/j.jsbmb.2011.09.002; Doorenbos CRC, 2009, NAT REV NEPHROL, V5, P691, DOI 10.1038/nrneph.2009.185; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Hamming I, 2006, J PATHOL, V209, P129, DOI 10.1002/path.1956; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Kramer AB, 2005, J PATHOL, V207, P483, DOI 10.1002/path.1856; Kramer AB, 2003, J PATHOL, V201, P160, DOI 10.1002/path.1405; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Malard V, 2009, BBA-PROTEINS PROTEOM, V1794, P882, DOI 10.1016/j.bbapap.2009.01.010; Nauta FL, 2011, DIABETES CARE, V34, P975, DOI 10.2337/dc10-1545; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Perico N, 2009, AM J KIDNEY DIS, V53, P1, DOI 10.1053/j.ajkd.2008.11.002; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Slagman MCJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4366; Thrailkill KM, 2011, J CLIN ENDOCR METAB, V96, P142, DOI 10.1210/jc.2010-0980; Vegter S, 2012, J AM SOC NEPHROL, V23, P165, DOI 10.1681/ASN.2011040430; Verboven C, 2002, NAT STRUCT BIOL, V9, P131, DOI 10.1038/nsb754	23	39	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55887	10.1371/journal.pone.0055887	http://dx.doi.org/10.1371/journal.pone.0055887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409077	Green Published, gold, Green Submitted			2022-12-25	WOS:000315100000030
J	Souaze, F; Bou-Hanna, C; Kandel, C; Leclair, F; Devalliere, J; Charreau, B; Bezieau, S; Mosnier, JF; Laboisse, CL				Souaze, Frederique; Bou-Hanna, Chantal; Kandel, Christine; Leclair, Francois; Devalliere, Julie; Charreau, Beatrice; Bezieau, Stephane; Mosnier, Jean-Francois; Laboisse, Christian L.			Differential Roles of Hath1, MUC2 and P27Kip1 in Relation with Gamma-Secretase Inhibition in Human Colonic Carcinomas: A Translational Study	PLOS ONE			English	Article							CELL-CYCLE; COLORECTAL-CANCER; PROGENITOR CELLS; NOTCH; EXPRESSION; PROLIFERATION; TUMORIGENESIS; P27(KIP1); PATHWAY; LINE	Hath1, a bHLH transcription factor negatively regulated by the gamma-secretase-dependent Notch pathway, is required for intestinal secretory cell differentiation. Our aim was fourfold: 1) determine whether Hath1 is able to alter the phenotype of colon cancer cells that are committed to a differentiated phenotype, 2) determine whether the Hath1-dependent alteration of differentiation is coupled to a restriction of anchorage-dependent growth, 3) decipher the respective roles of three putative tumor suppressor genes Hath1, MUC2 and P27kip1 in this coupling and, 4) examine how our findings translate to primary tumors. Human colon carcinoma cell lines that differentiate along a mucin secreting (MUC2/MUC5AC) and/or enterocytic (DPPIV) lineages were maintained on inserts with or without a gamma-secretase inhibitor (DBZ). Then the cells were detached and their ability to survive/proliferate in the absence of substratum was assessed. gamma-secretase inhibition led to a Hath1-mediated preferential induction of MUC2 over MUC5AC, without DPPIV modification, in association with a decrease in anchorage-independent growth. While P27kip1 silencing relieved the cells from the Hath1-induced decrease of anchorage-independent growth, MUC2 silencing did not modify this parameter. Hath1 ectopic expression in the Hath1 negative enterocytic Caco2 cells led to a decreased anchorage-independent growth in a P27kip1-independent manner. In cultured primary human colon carcinomas, Hath1 was up-regulated in 7 out of 10 tumors upon DBZ treatment. Parallel MUC2 up-regulation occurred in 4 (4/7) and P27kip1 in only 2 (2/7) tumors. Interestingly, the response patterns of primary tumors to DBZ fitted with the hierarchical model of divergent signalling derived from our findings on cell lines.	[Souaze, Frederique; Bou-Hanna, Chantal; Kandel, Christine; Leclair, Francois; Bezieau, Stephane; Mosnier, Jean-Francois; Laboisse, Christian L.] Univ Nantes, EA Biometadys, Nantes, France; [Kandel, Christine; Leclair, Francois; Mosnier, Jean-Francois; Laboisse, Christian L.] CHU Nantes, Serv Anat & Cytol Pathol, F-44035 Nantes 01, France; [Devalliere, Julie; Charreau, Beatrice] Univ Nantes, UMR INSERM, U1064, Nantes, France; [Bezieau, Stephane] CHU Nantes, Serv Genet, F-44035 Nantes 01, France	Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Souaze, F (corresponding author), Univ Nantes, EA Biometadys, Nantes, France.	frederique.souaze@inserm.fr	CHARREAU, Beatrice/AAK-8186-2020; Bézieau, stéphane/G-5621-2015; Souazé, Frédérique/K-7937-2015; souazé, frédérique/AAE-6478-2021	CHARREAU, Beatrice/0000-0001-5870-4615; Bézieau, stéphane/0000-0003-0095-1319; Frederique, Souaze/0000-0003-0476-2603	Ligue Departementale contre le cancer de Loire-Atlantique; GEFLUC (Groupement des Entreprises Francaises dans la Lutte contre le Cancer); Federation Hospitaliere de France	Ligue Departementale contre le cancer de Loire-Atlantique; GEFLUC (Groupement des Entreprises Francaises dans la Lutte contre le Cancer); Federation Hospitaliere de France	This work was supported in part by "Ligue Departementale contre le cancer de Loire-Atlantique'', and GEFLUC (Groupement des Entreprises Francaises dans la Lutte contre le Cancer). CK is a recipient of a predoctoral fellowship from the Federation Hospitaliere de France. FS is recipient of a tenure position supported by the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGERON C, 1984, CANCER RES, V44, P3961; Bara J, 1998, INT J CANCER, V75, P767, DOI 10.1002/(SICI)1097-0215(19980302)75:5<767::AID-IJC17>3.3.CO;2-S; BARA J, 1980, BRIT J CANCER, V41, P209, DOI 10.1038/bjc.1980.32; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; CHANTRET I, 1988, CANCER RES, V48, P1936; CZERNICHOW B, 1989, INT J CANCER, V44, P238, DOI 10.1002/ijc.2910440209; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Fenoglio-Preiser, 2008, GASTRO INTESTINAL PA; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; GRASSET E, 1984, AM J PHYSIOL, V247, pC260, DOI 10.1152/ajpcell.1984.247.3.C260; HO SB, 1989, GASTROENTEROLOGY, V97, P392, DOI 10.1016/0016-5085(89)90075-9; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jarry A, 2006, BRIT J PHARMACOL, V147, P64, DOI 10.1038/sj.bjp.0706449; Jarry A, 2004, CANCER RES, V64, P4227, DOI 10.1158/0008-5472.CAN-04-0254; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kim DH, 2005, INT J ONCOL, V27, P957; Kocer B, 2002, PATHOL INT, V52, P470, DOI 10.1046/j.1440-1827.2002.01369.x; LABOISSE CL, 1981, CANCER RES, V41, P310; LABOISSE CL, 1988, CANCER RES, V48, P2498; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Pandrea IV, 2000, EXP MOL PATHOL, V69, P37, DOI 10.1006/exmp.2000.2309; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Quillard T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008244; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Stanley R, 2000, WHO CLASSIFICATION T; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Veenendaal LM, 2008, CELL ONCOL, V30, P1; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Wang LF, 2009, MOLECULES, V14, P3589, DOI 10.3390/molecules14093589; Yang WC, 2003, CANCER RES, V63, P4990; Yeung TM, 2011, P NATL ACAD SCI USA, V108, P4382, DOI 10.1073/pnas.1014519107	42	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55904	10.1371/journal.pone.0055904	http://dx.doi.org/10.1371/journal.pone.0055904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409082	Green Submitted, gold, Green Published			2022-12-25	WOS:000315100000032
J	Foucher, ED; Blanchard, S; Preisser, L; Garo, E; Ifrah, N; Guardiola, P; Delneste, Y; Jeannin, P				Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale			IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFN gamma	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; STIMULATING FACTOR CSF; LANGERHANS CELLS; EXPRESSION; RECEPTOR; INTERLEUKIN-34; POLARIZATION; GENERATION; PLASTICITY; CYTOKINE	IL-34 is a recently identified cytokine that signals via the M-CSF receptor and promotes monocyte survival. Depending on the environment, monocytes can differentiate into macrophages (M phi) or dendritic cells (DC). A wide spectrum of M phi and DC subsets, with distinct phenotypes and functions, has been described. To date, the phenotype of monocytes exposed to IL-34 remains unexplored. We report here that IL-34 induces the differentiation of monocytes into CD14(high) CD163(high) CD1a(-) M phi (IL-34-M phi). Upon LPS stimulation, IL-34-M phi exhibit an IL-10(high) IL-12(low) M2 profile and express low levels of the costimulatory molecules CD80 and CD86. IL-34-M phi exhibit poor T cell costimulatory properties, and have potent immunosuppressive properties (decrease of TCR-stimulated T cell proliferation). For all the parameters analyzed, IL-34-M phi are phenotypically and functionally similar to M-CSF-M phi. IL-34 appears as efficient as M-CSF in inducing the generation of immunosuppressive M phi. Moreover, the generation of IL-34-M phi is mediated through the M-CSF receptor, is independent of endogenous M-CSF consumption and is potentiated by IL-6. In an attempt to identify strategies to prevent a deleterious M2 cell accumulation in some pathological situations, we observed that IFN gamma and GM-CSF prevent the generation of immunosuppressive M phi induced by IL-34. IFN gamma also switches established IL-34-M phi into immunostimulatory M phi. In conclusion, we demonstrate that IL-34 drives the differentiation of monocytes into immunosuppressive M2, in a manner similar to M-CSF, and that IFN gamma and GM-CSF prevent this effect.	[Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale] Univ Angers, LUNAM Univ, Angers, France; [Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale] INSERM, U892, Angers, France; [Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale] CNRS, Unit 6299, Angers, France; [Blanchard, Simon; Garo, Erwan; Delneste, Yves; Jeannin, Pascale] Univ Angers, Ctr Hosp Univ, Lab Immunol & Allergol, Angers, France; [Ifrah, Norbert] Univ Angers, Ctr Hosp Univ, Serv Malad Sang, Angers, France; [Guardiola, Philippe] CHU Angers, Plateforme SNP, Angers, France	Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Jeannin, P (corresponding author), Univ Angers, LUNAM Univ, Angers, France.	pascale.jeannin@univ-angers.fr	Delneste, Yves/O-3956-2016; preisser, laurence/K-7583-2015; DELNESTE, Yves/K-7367-2015; Blanchard, Simon/L-1417-2015; guardiola, philippe/L-2910-2015; Ifrah, Norbert/L-5238-2015; JEANNIN, Pascale/K-8656-2015; Foucher, Etienne/K-7581-2015	DELNESTE, Yves/0000-0002-2142-596X; JEANNIN, Pascale/0000-0002-3666-3856; IFRAH, Norbert/0000-0003-3063-850X; Garo, Erwan/0000-0003-4411-9161	INSERM (Institut national de la sante et de la recherche medicale); University of Angers; La ligue contre le Cancer (Equipe labellisee)	INSERM (Institut national de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Angers; La ligue contre le Cancer (Equipe labellisee)	This work was supported by institutional grants from INSERM (Institut national de la sante et de la recherche medicale) and the University of Angers and by a grant from La ligue contre le Cancer (Equipe labellisee 2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018689; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Droin N, 2010, J LEUKOCYTE BIOL, V87, P745, DOI 10.1189/jlb.1209780; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; ESPINOZADELGADO I, 1990, J IMMUNOL, V145, P1137; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; GLINIAK BC, 1992, MOL BIOL CELL, V3, P535, DOI 10.1091/mbc.3.5.535; GLINIAK BC, 1990, CELL, V63, P1073, DOI 10.1016/0092-8674(90)90510-L; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hwang SJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3693; Jeannin P, 2011, IMMUNOTHERAPY-UK, V3, P23, DOI [10.2217/IMT.11.30, 10.2217/imt.11.30]; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nandi S., 2012, DEV BIOL; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; PANDIT J, 1992, SCIENCE, V258, P1358, DOI 10.1126/science.1455231; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822	39	115	132	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56045	10.1371/journal.pone.0056045	http://dx.doi.org/10.1371/journal.pone.0056045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409120	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300053
J	Liu, R; Xu, HP; Wang, GP; Li, J; Gou, L; Zhang, LH; Miao, JT; Li, ZY				Liu, Rui; Xu, Hanpeng; Wang, Guiping; Li, Jie; Gou, Lin; Zhang, Lihua; Miao, Jianting; Li, Zhuyi			Extraocular Muscle Characteristics Related to Myasthenia Gravis Susceptibility	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; SAFETY FACTOR; EXPRESSION; ATTACK	Background: The pathogenesis of extraocular muscle (EOM) weakness in myasthenia gravis might involve a mechanism specific to the EOM. The aim of this study was to investigate characteristics of the EOM related to its susceptibility to myasthenia gravis. Methods: Female F344 rats and female Sprague-Dawley rats were assigned to experimental and control groups. The experimental group received injection with Ringer solution containing monoclonal antibody against the acetylcholine receptor (AChR), mAb35 (0.25 mg/kg), to induce experimental autoimmune myasthenia gravis, and the control group received injection with Ringer solution alone. Three muscles were analyzed: EOM, diaphragm, and tibialis anterior. Tissues were examined by light microscopy, fluorescence histochemistry, and transmission electron microscopy. Western blot analysis was used to assess marker expression and ELISA analysis was used to quantify creatine kinase levels. Microarray assay was conducted to detect differentially expressed genes. Results: In the experimental group, the EOM showed a simpler neuromuscular junction (NMJ) structure compared to the other muscles; the NMJ had fewer synaptic folds, showed a lesser amount of AChR, and the endplate was wider compared to the other muscles. Results of microarray assay showed differential expression of 54 genes in the EOM between the experimental and control groups. Conclusion: Various EOM characteristics appear to be related to the increased susceptibility of the EOM and the mechanism of EOM weakness in myasthenia gravis.	[Liu, Rui; Zhang, Lihua] Fourth Mil Med Univ, Tangdu Hosp, Dept Geratol, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Hanpeng; Gou, Lin] Univ Calif Los Angeles, Dept Neurol, LONI, Los Angeles, CA 90024 USA; [Wang, Guiping] 208th Hosp PLA, Dept Neurosurg, Changchun, Jilin Province, Peoples R China; [Li, Jie] 451 Hosp PLA, Dept Endocrinol, Xian, Shaanxi Provinc, Peoples R China; [Miao, Jianting; Li, Zhuyi] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; University of California System; University of California Los Angeles; Air Force Military Medical University	Miao, JT (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Shaanxi Provinc, Peoples R China.	miaojt@163.com; lizhuyi@fmmu.edu.cn			National Natural Science Foundation of China [81200966]; Natural Science Fund of Shaanxi province [2010JQ4014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shaanxi province(Natural Science Foundation of Shaanxi Province)	This research was supported by the National Natural Science Foundation of China (No. 81200966) and Natural Science Fund of Shaanxi province (No. 2010JQ4014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christadoss P, 2000, CLIN IMMUNOL, V94, P75, DOI 10.1006/clim.1999.4807; Crosby LM, 2000, TOXICOL APPL PHARM, V169, P205, DOI 10.1006/taap.2000.9049; ENGEL AG, 1984, ANN NEUROL, V16, P519, DOI 10.1002/ana.410160502; Felice KJ, 1998, J NEUROL SCI, V160, pS30, DOI 10.1016/S0022-510X(98)00195-6; Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004; Heckmann JM, 2010, GENES IMMUN, V11, P1, DOI 10.1038/gene.2009.61; Hughes BW, 2004, SEMIN NEUROL, V24, P21, DOI 10.1055/s-2004-829585; Kaminski HJ, 1997, ANN NEUROL, V41, P419, DOI 10.1002/ana.410410402; Kaminski HJ, 1996, INVEST OPHTH VIS SCI, V37, P345; Kaminski HJ, 2004, EXP NEUROL, V189, P333, DOI 10.1016/j.expneurol.2004.06.005; Kaminski HJ, 2003, ANN NY ACAD SCI, V998, P362, DOI 10.1196/annals.1254.043; Kaminski HJ LZ, 2002, NEW YORK SCI SESS MY; Leite MI, 2007, AM J PATHOL, V171, P893, DOI 10.2353/ajpath.2007.070240; Lin F, 2002, J CLIN INVEST, V110, P1269, DOI 10.1172/JCI200216086; LOUTRARI H, 1992, EUR J IMMUNOL, V22, P2449, DOI 10.1002/eji.1830220939; MAYHEW TM, 1979, J NEUROCYTOL, V8, P121, DOI 10.1007/BF01175556; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; Morgan BP, 2006, CLIN EXP IMMUNOL, V146, P294, DOI 10.1111/j.1365-2249.2006.03205.x; Poulas K, 2000, CLIN EXP IMMUNOL, V120, P363, DOI 10.1046/j.1365-2249.2000.01202.x; Ruff RL, 2008, J NEUROIMMUNOL, V201, P13, DOI 10.1016/j.jneuroim.2008.04.038; Soltys J, 2008, ANN NY ACAD SCI, V1132, P220, DOI 10.1196/annals.1405.037; Wang ZY, 2000, J NEUROIMMUNOL, V108, P29, DOI 10.1016/S0165-5728(00)00250-2; Wood SJ, 1997, J PHYSIOL-LONDON, V500, P165, DOI 10.1113/jphysiol.1997.sp022007	23	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55611	10.1371/journal.pone.0055611	http://dx.doi.org/10.1371/journal.pone.0055611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409007	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300024
J	Deng, YH; Hassan, MM; Mo, JW; Lin, EH				Deng, Yanhong; Hassan, Manal M.; Mo, Jianwen; Lin, Edward H.			Peripheral Blood Mononuclear CD133 mRNA Levels Correlates with Response to Treatment in Patients with Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							CANCER STEM-CELLS; SOLID TUMORS; EXPRESSION; MARKER; SARCOMA	Background: CD133 is a marker that identifies/enriches cancer stem cell implicated in tumor initiation. We hypothesize that changes in the CD133 mRNA expression levels and vascular endothelial growth factor (VEGF) may correlate tumor response in GIST. Methodology/Principal Findings: After informed consent, we obtained peripheral blood samples from 24 evaluable patients with gastrointestinal stromal tumors (GIST). There were 7 -paired samples before and after treatment, We measured CD133 mRNA levels by real time RT-PCR method and vascular endothelial growth factor (VEGF) levels by ELISA. All measurements were done in duplicates in two separate experiments. The treatment resulted in significant reduction of CD133 mRNA expression (p = 0.048) as well as the level of VEGF (p = 0.003). The mean CD133 mRNA levels for GIST patients was 615. We found no correlation between the CD133 mRNA levels and VEGF levels. (p = 0.826). Logistic regression analysis suggested a relationship between elevated CD133 mRNA levels and fitted probability of eventual progressive disease (PD) and mixed response at 37% for CD133 mRNA of 2.25, and the probability of eventual PD/MR is 84% for a CD133 of 2072 (p = 0.08). Conclusions/Significance: CD133 mRNA expression levels in GIST patients measured by real time RT-PCR assay appeared to correlate with tumor response to surgery or imatinib and may be used to predict tumor progression. Additional prospective studies are warranted.	[Lin, Edward H.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA; [Deng, Yanhong; Mo, Jianwen] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Hassan, Manal M.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center	Deng, YH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.	dengyanh@mail.sysu.edu.cn; elin@seattlecca.org			National Natural Science Foundation [81101669]; Sun Yatsen University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Sun Yatsen University	This study was supported by the National Natural Science Foundation (No. 81101669) and the Young Investigator Training Program of Sun Yatsen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arne G, 2011, INT J CANCER, V129, P1149, DOI 10.1002/ijc.25755; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bozzi F, 2011, CYTOM PART B-CLIN CY, V80B, P238, DOI 10.1002/cyto.b.20589; Chen JW, 2012, GENE CHROMOSOME CANC, V51, P186, DOI 10.1002/gcc.20942; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Lin EH, 2007, CANCER-AM CANCER SOC, V110, P534, DOI 10.1002/cncr.22774; Mehra N, 2006, CLIN CANCER RES, V12, P4859, DOI 10.1158/1078-0432.CCR-06-0422; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Terry J, 2010, APPL IMMUNOHISTO M M, V18, P159, DOI 10.1097/PAI.0b013e3181b77451; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012	18	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55520	10.1371/journal.pone.0055520	http://dx.doi.org/10.1371/journal.pone.0055520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408993	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200034
J	Hopkins, PCR				Hopkins, Paul C. R.			Neurodegeneration in a Drosophila Model for the Function of TMCC2, an Amyloid Protein Precursor-Interacting and Apolipoprotein E-Binding Protein	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GLIAL-CELLS; A-BETA; GENE; TAU; MIGRATION; CIRCUITS; MUTATION; SYSTEM; ALTERS	We previously identified TMCC2 as a protein that interacted differentially with normal versus Alzheimer's disease-risk forms of both apolipoprotein E (apoE) and the amyloid protein precursor (APP). We hypothesized that disrupted function of TMCC2 would affect neurodegeneration. To test this hypothesis, we investigated the Drosophila orthologue of TMCC2, that we have named Dementin. We showed that Dementin interacts genetically both with human APP and its Drosophila orthologue, the APP-like protein (APPL). Ectopic expression of Dementin in Drosophila rescued developmental and behavioral defects caused by expression of human APP. Both a hypomorphic lethal mutation in the dementin gene (dmtn(1)) and RNAi for Dementin caused the accumulation of fragments derived from APPL. We found that Dementin was required for normal development of the brain, and that glial Dementin was required for development of the Drosophila medulla neuropil. Expression of wild-type Dementin in either the neurons or glia of dmtn(1) flies rescued developmental lethality. Adult dmtn(1) flies rescued by expression of wild-type Dementin in glia, i.e. whose neurons expressed only dmtn(1), showed pathological features resembling early onset Alzheimer's disease, accumulation of abnormal APPL metabolites, synaptic pathology, mis-localized microtubule-binding proteins, neurodegeneration, and early death.	[Hopkins, Paul C. R.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Hopkins, Paul C. R.] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Hopkins, PCR (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	hopkins.dementin@gmail.com			Alzheimer's Society; Alzheimer's Research UK; Alzheimers Research UK [ART-ESG2009-6] Funding Source: researchfish	Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	The work was funded by grants from the Alzheimer's Society (alzheimers.org.uk) and Alzheimer's Research UK (www.alzheimersresearchuk.org) awarded to PCRH. The author thanks benefactor JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Buttini M, 2002, J NEUROSCI, V22, P10539; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dodart JC, 2002, BRAIN RES, V955, P191, DOI 10.1016/S0006-8993(02)03437-6; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Hopkins PCR, 2011, J ALZHEIMERS DIS, V26, P239, DOI 10.3233/JAD-2011-102115; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li Y, 2004, J NEUROBIOL, V61, P343, DOI 10.1002/neu.20048; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; MARTINMORRIS LE, 1990, DEVELOPMENT, V110, P185; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nochlin D, 1998, ANN NEUROL, V43, P131, DOI 10.1002/ana.410430124; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Van Dooren T, 2006, AM J PATHOL, V168, P245, DOI 10.2353/ajpath.2006.050752; Verkkoniemi A, 2000, NEUROLOGY, V54, P1103, DOI 10.1212/WNL.54.5.1103; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wentzell JS, 2012, NEUROBIOL DIS, V46, P78, DOI 10.1016/j.nbd.2011.12.047; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	45	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55810	10.1371/journal.pone.0055810	http://dx.doi.org/10.1371/journal.pone.0055810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409049	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200069
J	Ting, WC; Chen, LM; Pao, JB; Yang, YP; You, BJ; Chang, TY; Lan, YH; Lee, HZ; Bao, BY				Ting, Wen-Chien; Chen, Lu-Min; Pao, Jiunn-Bey; Yang, Ying-Pi; You, Bang-Jau; Chang, Ta-Yuan; Lan, Yu-Hsuan; Lee, Hong-Zin; Bao, Bo-Ying			Common Genetic Variants in Wnt Signaling Pathway Genes as Potential Prognostic Biomarkers for Colorectal Cancer	PLOS ONE			English	Article							ANTIGEN RECURRENCE; DATABASE	Compelling evidence has implicated the Wnt signaling pathway in the pathogenesis of colorectal cancer. We assessed the use of tag single nucleotide polymorphisms (tSNPs) in adenomatous polyposis coli (APC)/beta-catenin (CTNNB1) genes to predict outcomes in patients with colorectal cancer. We selected and genotyped 10 tSNP to predict common variants across entire APC and CTNNB1 genes in 282 colorectal cancer patients. The associations of these tSNPs with distant metastasis-free survival and overall survival were evaluated by Kaplan-Meier analysis, Cox regression model, and survival tree analysis. The 5-year overall survival rate was 68.3%. Survival tree analysis identified a higher-order genetic interaction profile consisting of the APC rs565453, CTNNB1 2293303, and APC rs1816769 that was significantly associated with overall survival. The 5-year survival overall rates were 89.2%, 66.1%, and 58.8% for the low-, medium-, and high-risk genetic profiles, respectively (log-rank P = 0.001). After adjusting for possible confounders, including age, gender, carcinoembryonic antigen levels, tumor differentiation, stage, lymphovascular invasion, perineural invasion, and lymph node involvement, the genetic interaction profile remained significant. None of the studied SNPs were individually associated with distant metastasis-free survival and overall survival. Our results suggest that the genetic interaction profile among Wnt pathway SNPs might potentially increase the prognostic value in outcome prediction for colorectal cancer.	[Ting, Wen-Chien] China Med Univ Hosp, Dept Colorectal Surg, Taichung, Taiwan; [Ting, Wen-Chien] Chung Shan Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung, Taiwan; [Ting, Wen-Chien] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, Lu-Min] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Pao, Jiunn-Bey; Yang, Ying-Pi] Taipei City Hosp, Yangming Branch, Dept Pharm, Taipei, Taiwan; [You, Bang-Jau] China Med Univ, Dept Chinese Med Resources, Taichung, Taiwan; [Chang, Ta-Yuan] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Lan, Yu-Hsuan; Lee, Hong-Zin; Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei City Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bao, BY (corresponding author), China Med Univ, Dept Pharm, Taichung, Taiwan.	bao@mail.cmu.edu.tw	Chang, Ta-Yuan/P-3126-2015; Bao, Bo-Ying/H-4589-2019; Bao, Bo-Ying/D-1789-2012	Chang, Ta-Yuan/0000-0001-5664-4559; Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513	National Science Council, Taiwan [NSC-98-2320-B-039-019-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU98-N1-21, CMU98-C-12]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	This work was supported by the National Science Council, Taiwan (grant number: grants NSC-98-2320-B-039-019-MY3 and NSC-100-2314-B-039-009-MY3), and China Medical University (grant number: CMU98-N1-21 and CMU98-C-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Huang SP, 2010, ANN SURG ONCOL, V17, P312, DOI 10.1245/s10434-009-0698-8; Huang SP, 2009, CANCER EPIDEM BIOMAR, V18, P3068, DOI 10.1158/1055-9965.EPI-09-0665; Kines KJ, 2012, FRONT BIOSCI-LANDMRK, V17, P1329, DOI 10.2741/3990; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; WANEBO HJ, 1978, NEW ENGL J MED, V299, P448, DOI 10.1056/NEJM197808312990904; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	15	34	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56196	10.1371/journal.pone.0056196	http://dx.doi.org/10.1371/journal.pone.0056196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405266	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400212
J	Dugast, E; Kiss-Toth, E; Docherty, L; Danger, R; Chesneau, M; Pichard, V; Judor, JP; Pettre, S; Conchon, S; Soulillou, JP; Brouard, S; Ashton-Chess, J				Dugast, Emilie; Kiss-Toth, Endre; Docherty, Louise; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie; Soulillou, Jean-Paul; Brouard, Sophie; Ashton-Chess, Joanna			Identification of Tribbles-1 as a Novel Binding Partner of Foxp3 in Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR FOXP3; NF-KAPPA-B; SIGNALING PATHWAYS; GENE-EXPRESSION; PROLIFERATION; TRIB1; MORPHOGENESIS; DROSOPHILA	In a previous study, we identified TRIB1, a serine-threonine kinase-like molecule, as a biomarker of chronic antibody-mediated rejection of human kidneys when measured in peripheral blood mononuclear cells. Here, we focused our analysis on a specific subset of peripheral blood mononuclear cells that play a dominant role in regulating immune responses in health and disease, so-called CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs). We isolated both human and murine Treg and non-Treg counterparts and analyzed TRIB1 and Foxp3 mRNA expression by quantitative PCR on the freshly isolated cells or following 24 h of activation. Physical interaction between the human TRIB1 and Foxp3 proteins was analyzed in live cell lines by protein complementation assay using both flow cytometry and microscopy and confirmed in primary freshly isolated human CD4(+)CD25(hi)CD127(-) Tregs by co-immunoprecipitation. Both TRIB1 and Foxp3 were expressed at significantly higher levels in Tregs than in their CD4(+)CD25(+) counterparts (p < 0.001). Moreover, TRIB1 and Foxp3 mRNA levels correlated tightly in Tregs (Spearman r = 1.0; p < 0.001, n = 7), but not in CD4(+)D25(+) T cells. The protein complementation assay revealed a direct physical interaction between TRIB1 and Foxp3 in live cells. This interaction was impaired upon deletion of the TRIB1 N-terminal but not the C-terminal domain, suggesting an interaction in the nucleus. This direct interaction within the nucleus was confirmed in primary human Tregs by co-immunoprecipitation. These data show a direct relationship between TRIB1 and Foxp3 in terms of their expression and physical interaction and highlight Tribbles-1 as a novel binding partner of Foxp3 in Tregs.	[Dugast, Emilie; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie; Soulillou, Jean-Paul; Brouard, Sophie] Inst Natl Sante & Rech Med, UMR1064, F-44000 Nantes, France; [Dugast, Emilie; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie] Univ Nantes, Fac Med, F-44000 Nantes, France; [Kiss-Toth, Endre; Docherty, Louise] Univ Sheffield, Dept Cardiovasc Sci, Sheffield S10 2TN, S Yorkshire, England; [Dugast, Emilie; Ashton-Chess, Joanna] TcLand Express, F-44200 Nantes, France; [Dugast, Emilie; Danger, Richard; Chesneau, Melanie; Pichard, Virginie; Judor, Jean-Paul; Pettre, Segolene; Conchon, Sophie; Soulillou, Jean-Paul; Brouard, Sophie] Inst Transplantat Urol Nephrol, Inst Rech Transplantat, F-44000 Nantes, France; [Soulillou, Jean-Paul; Brouard, Sophie] CHU Nantes, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; University of Sheffield; Nantes Universite; CHU de Nantes	Ashton-Chess, J (corresponding author), TcLand Express, 21 Rue Noue Bras de Fer, F-44200 Nantes, France.	jashtonchess@tcland-expression.com	Kiss-Toth, Endre/AAC-4252-2020; Kiss-Toth, Endre/A-8596-2014; brouard, sophie c/Q-1285-2016	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Dugast, Emilie/0000-0001-7439-1903; Danger, Richard/0000-0002-5058-795X; Conchon, Sophie/0000-0003-2602-3385	Fondation de Cooperation Scientifique CENTAURE; Convention Industrielle de Formation par la REcherche Grant [717/2008]; ANR [ANR-07-1215-0101]	Fondation de Cooperation Scientifique CENTAURE; Convention Industrielle de Formation par la REcherche Grant; ANR(French National Research Agency (ANR))	This work was supported in part by the Fondation de Cooperation Scientifique CENTAURE.; Recipient of Convention Industrielle de Formation par la REcherche Grant 717/2008.; Recipient of an ANR Grant ANR-07-1215-0101. To whom correspondence may be addressed: Institut de Recherche en Transplantation, ITUN, Nantes 44000, France. Tel.: 33-0-2-40-08-74-10; Fax: 33-0-2-40-08-74-11; E-mail: sophie.brouard@univ-nantes.fr.	Alvarez CM, 2009, TRANSPLANTATION, V87, P857, DOI 10.1097/TP.0b013e318199fa57; Ashton-Chess J, 2008, J AM SOC NEPHROL, V19, P1116, DOI 10.1681/ASN.2007101056; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barbarulo A, 2011, J IMMUNOL, V186, P6199, DOI 10.4049/jimmunol.1002136; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Dedhia PH, 2010, BLOOD, V116, P1321, DOI 10.1182/blood-2009-07-229450; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Eder K, 2008, IMMUNOL LETT, V116, P178, DOI 10.1016/j.imlet.2007.12.011; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gilby DC, 2010, IMMUNOL LETT, V130, P115, DOI 10.1016/j.imlet.2009.12.007; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ostertag A, 2010, DIABETES, V59, P1991, DOI 10.2337/db09-1537; Pichard V, 2013, HUM GENE THER, V24, P143, DOI 10.1089/hum.2011.227; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Puskas LG, 2005, CELL MOL BIOL, V51, P177, DOI 10.1170/T617; Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rothlisberger B, 2007, CANCER GENET CYTOGEN, V176, P58, DOI 10.1016/j.cancergencyto.2007.03.003; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Varbo A, 2011, ARTERIOSCL THROM VAS, V31, P451, DOI 10.1161/ATVBAHA.110.216333; Wang J, 2008, HUM MOL GENET, V17, P2894, DOI 10.1093/hmg/ddn188; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	48	17	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10051	10060		10.1074/jbc.M112.448654	http://dx.doi.org/10.1074/jbc.M112.448654			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417677	hybrid, Green Published			2022-12-25	WOS:000317114000043
J	Chen, JH; Wang, WL; Zhang, QB; Li, F; Lei, TH; Luo, DL; Zhou, H; Yang, BX				Chen, Jihui; Wang, Weiling; Zhang, Quanbin; Li, Fei; Lei, Tianluo; Luo, Dali; Zhou, Hong; Yang, Baoxue			Low Molecular Weight Fucoidan against Renal Ischemia-Reperfusion Injury via Inhibition of the MAPK Signaling Pathway	PLOS ONE			English	Article							UNDARIA-PINNATIFIDA; FREE-RADICALS; PC12 CELLS; APOPTOSIS; JNK; ACTIVATION; ERK; PHOSPHORYLATION; DIFFERENTIATION; POLYSACCHARIDE	Background: Ischemia reperfusion injury (IRI) is a leading cause of acute kidney injury (AKI) in both native and transplanted kidneys. The objective of the present study was to evaluate whether low-molecular-weight fucoidan (LMWF) could attenuate renal IRI in an animal model and in vitro cell models and study the mechanisms in which LMWF protected from IRI. Methodology/Principal Findings: Male mice were subjected to right renal ischemia for 30 min and reperfusion for 24 h, or to a sham operation with left kidney removed. Kidneys undergone IR showed characteristic morphological changes, such as tubular dilatation, and brush border loss. However, LMWF significantly corrected the renal dysfunction and the abnormal levels of MPO, MDA and SOD induced by IR. LMWF also inhibited the activation of MAPK pathways, which consequently resulted in a significant decrease in the release of cytochrome c from mitochondria, ratios of Bax/Bcl-2 and cleaved caspase3/ caspase-3, and phosphorylation of p53. LMWF alleviated hypoxia-reoxygenation or CoCl2 induced cell viability loss and Delta Psi m dissipation in HK2 renal tubular epithelial cells, which indicates LMWF may result in an inhibition of the apoptosis pathway through reducing activity of MAPK pathways in a dose-dependent manner. Conclusions/Significance: Our in vivo and in vitro studies show that LMWF ameliorates acute renal IRI via inhibiting MAPK signaling pathways. The data provide evidence that LMWF may serve as a potential therapeutic agent for acute renal IRI.	[Chen, Jihui; Wang, Weiling; Li, Fei; Lei, Tianluo; Zhou, Hong; Yang, Baoxue] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100871, Peoples R China; [Chen, Jihui; Wang, Weiling; Li, Fei; Lei, Tianluo; Zhou, Hong; Yang, Baoxue] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Zhang, Quanbin] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Luo, Dali] Capital Med Univ, Dept Pharmacol, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Oceanology, CAS; Capital Medical University	Zhou, H (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100871, Peoples R China.	rainbow_zhou@126.com; baoxue@bjmu.edu.cn		Chen, Jihui/0000-0002-9819-9921	National Natural Science Foundation of China [30870921, 31200869, 81170632, 81261160507]; Drug Discovery Program grant [2009ZX09301-010-30]; Doctoral Training Fund [20100001110047]; International Science and Technology Cooperation Program of China [2012DFA11070]; Beijing Natural Science Foundation grant [7102105]; 111 Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Drug Discovery Program grant; Doctoral Training Fund; International Science and Technology Cooperation Program of China; Beijing Natural Science Foundation grant; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China grants 30870921, 31200869, 81170632 and 81261160507, Drug Discovery Program grant 2009ZX09301-010-30, Doctoral Training Fund 20100001110047, 111 Project, International Science and Technology Cooperation Program of China 2012DFA11070 and Beijing Natural Science Foundation grant 7102105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; BECKMAN JK, 1991, FREE RADICAL BIO MED, V11, P335, DOI 10.1016/0891-5849(91)90148-V; Boisson-Vidal C., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P67; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chen SL, 2010, CLIN EXP PHARMACOL P, V37, P316, DOI 10.1111/j.1440-1681.2009.05289.x; Chung HJ, 2010, PHYTOTHER RES, V24, P1078, DOI 10.1002/ptr.3138; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Deux JF, 2002, ARTERIOSCL THROM VAS, V22, P1604, DOI 10.1161/01.ATV.0000032034.91020.0A; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Eschwege P, 1999, J UROLOGY, V162, P553, DOI 10.1016/S0022-5347(05)68626-0; Gao YL, 2012, CELL MOL NEUROBIOL, V32, P523, DOI 10.1007/s10571-011-9792-0; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Hussein AAM, 2012, ACTA PHYSIOL, V204, P308, DOI 10.1111/j.1748-1716.2011.02372.x; IWATA M, 1994, J AM SOC NEPHROL, V5, P1307; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim KJ, 2011, FOOD CHEM TOXICOL, V48, P1101; Kim KJ, 2012, NUTR RES, V32, P439, DOI 10.1016/j.nutres.2012.04.003; Kotake-Nara E, 2006, THESCIENTIFICWORLDJO, V6, P176, DOI 10.1100/tsw.2006.37; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Kyung Jangbeen, 2012, Lab Anim Res, V28, P91, DOI 10.5625/lar.2012.28.2.91; Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Linnemann G, 2000, INTENS CARE MED, V26, P1540, DOI 10.1007/s001340000642; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144; Manzo-Silberman S, 2011, J CARDIOVASC PHARM, V58, P626, DOI 10.1097/FJC.0b013e3182308c64; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; Omata M, 1997, J CARDIOVASC PHARM, V30, P717, DOI 10.1097/00005344-199712000-00003; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Snoeijs MGJ, 2010, CURR OPIN ORGAN TRAN, V15, P190, DOI 10.1097/MOT.0b013e32833593eb; Song MY, 2012, FOOD CHEM TOXICOL, V50, P790, DOI 10.1016/j.fct.2011.11.010; Wang J, 2012, J ETHNOPHARMACOL, V139, P807, DOI 10.1016/j.jep.2011.12.022; Wang J, 2010, INT J BIOL MACROMOL, V46, P6, DOI 10.1016/j.ijbiomac.2009.10.015; WANG XY, 1993, ARCH BIOCHEM BIOPHYS, V306, P402, DOI 10.1006/abbi.1993.1529; Wang Y, 2007, LIFE SCI, V80, P2067, DOI 10.1016/j.lfs.2007.03.010; Wolfs TGAM, 2005, AM J TRANSPLANT, V5, P68, DOI 10.1111/j.1600-6143.2004.00657.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang SJ, 2004, J BIOCHEM MOL BIOL, V37, P480; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005; Zhang QB, 2003, PLANTA MED, V69, P537, DOI 10.1055/s-2003-40634; Zhao X, 2012, THROMB RES, V129, P771, DOI 10.1016/j.thromres.2011.07.041; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118	51	45	54	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56224	10.1371/journal.pone.0056224	http://dx.doi.org/10.1371/journal.pone.0056224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418539	Green Published, gold			2022-12-25	WOS:000315970300131
J	Chowdhury, RA; Lina, JM; Kobayashi, E; Grova, C				Chowdhury, Rasheda Arman; Lina, Jean Marc; Kobayashi, Eliane; Grova, Christophe			MEG Source Localization of Spatially Extended Generators of Epileptic Activity: Comparing Entropic and Hierarchical Bayesian Approaches	PLOS ONE			English	Article							CORTICAL CURRENT-DENSITY; EEG SOURCE LOCALIZATION; SOURCE RECONSTRUCTION; INVERSE PROBLEM; INTERICTAL SPIKES; INTRACRANIAL EEG; LOBE EPILEPSY; HUMAN-BRAIN; MAGNETOENCEPHALOGRAPHY; FMRI	Localizing the generators of epileptic activity in the brain using Electro-EncephaloGraphy (EEG) or Magneto-EncephaloGraphy (MEG) signals is of particular interest during the pre-surgical investigation of epilepsy. Epileptic discharges can be detectable from background brain activity, provided they are associated with spatially extended generators. Using realistic simulations of epileptic activity, this study evaluates the ability of distributed source localization methods to accurately estimate the location of the generators and their sensitivity to the spatial extent of such generators when using MEG data. Source localization methods based on two types of realistic models have been investigated: (i) brain activity may be modeled using cortical parcels and (ii) brain activity is assumed to be locally smooth within each parcel. A Data Driven Parcellization (DDP) method was used to segment the cortical surface into non-overlapping parcels and diffusion-based spatial priors were used to model local spatial smoothness within parcels. These models were implemented within the Maximum Entropy on the Mean (MEM) and the Hierarchical Bayesian (HB) source localization frameworks. We proposed new methods in this context and compared them with other standard ones using Monte Carlo simulations of realistic MEG data involving sources of several spatial extents and depths. Detection accuracy of each method was quantified using Receiver Operating Characteristic (ROC) analysis and localization error metrics. Our results showed that methods implemented within the MEM framework were sensitive to all spatial extents of the sources ranging from 3 cm(2) to 30 cm(2), whatever were the number and size of the parcels defining the model. To reach a similar level of accuracy within the HB framework, a model using parcels larger than the size of the sources should be considered.	[Chowdhury, Rasheda Arman; Grova, Christophe] McGill Univ, Dept Biomed Engn, Multimodal Funct Imaging Lab, Montreal, PQ, Canada; [Kobayashi, Eliane; Grova, Christophe] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Lina, Jean Marc] Ecole Technol Super, Dept Elect Engn, Montreal, PQ, Canada; [Lina, Jean Marc; Grova, Christophe] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal	Chowdhury, RA (corresponding author), McGill Univ, Dept Biomed Engn, Multimodal Funct Imaging Lab, Montreal, PQ, Canada.	rasheda.chowdhury@mail.mcgill.ca		Chowdhury, Rasheda/0000-0001-9691-594X; Kobayashi, Eliane/0000-0002-1713-1563; Grova, Christophe/0000-0003-2775-9968	Natural Sciences and Engineering Research Council of Canada Discovery Grant Program; Canadian Institutes of Health Research [MOP 93614]; Montreal Neurological Institute-CECR; Savoy Foundation scholarship; Fonds de Recherche en Sante du Quebec (FRSQ); American Epilepsy Society Early Career Physician-Scientist award; FRSQ	Natural Sciences and Engineering Research Council of Canada Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Neurological Institute-CECR; Savoy Foundation scholarship; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); American Epilepsy Society Early Career Physician-Scientist award; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant Program (CG and JML), the Canadian Institutes of Health Research MOP 93614 (EK) and the Montreal Neurological Institute-CECR (EK). RC was partially supported by a Savoy Foundation scholarship (http://www.savoy-foundation.ca/index.htm). CG was also supported by a salary award from the Fonds de Recherche en Sante du Quebec (FRSQ). EK was also supported by the American Epilepsy Society Early Career Physician-Scientist award and by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre-Arrizubieta Z, 2009, BRAIN, V132, P3060, DOI 10.1093/brain/awp137; Ahlfors SP, 2009, HUM BRAIN MAPP, P140; Amblard U, 2004, IEEE T BIO-MED ENG, V51, P427, DOI 10.1109/TBME.2003.820999; Attal Y, 2007, P ANN INT IEEE EMBS, P4937, DOI 10.1109/IEMBS.2007.4353448; Baillet S, 1997, IEEE T BIO-MED ENG, V44, P374, DOI 10.1109/10.568913; Baillet S, 2001, IEEE SIGNAL PROCESSI, P1053; BARTH DS, 1984, SCIENCE, V223, P293, DOI 10.1126/science.6422552; Baune A, 1999, NEUROIMAGE, V9, P477, DOI 10.1006/nimg.1999.0429; Bellec P, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00007; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Birot G, 2011, NEUROIMAGE, V56, P102, DOI 10.1016/j.neuroimage.2011.01.054; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Chauvel P, 1996, MULTIMETHODOLOGICAL, P80; Cheyne D., 2010, FRONTIERS NEUROSCIEN, V4; Cosandier-Rimele D, 2008, NEUROIMAGE, V42, P135, DOI 10.1016/j.neuroimage.2008.04.185; Cosandier-Rimele D, 2007, IEEE T BIO-MED ENG, V54, P380, DOI 10.1109/TBME.2006.890489; Cottereau B, 2007, NEUROIMAGE, V38, P439, DOI 10.1016/j.neuroimage.2007.07.046; Dale A., 1993, IMPROVED LOCALIZATIO; Daunizeau J, 2006, IEEE T BIO-MED ENG, V53, P503, DOI 10.1109/TBME.2005.869791; Daunizeau J, 2007, NEUROIMAGE, V36, P69, DOI 10.1016/j.neuroimage.2007.01.044; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; Ding L, 2009, PHYS MED BIOL, V54, P2683, DOI 10.1088/0031-9155/54/9/006; Dorst L, 2005, IEEE T PATTERN ANAL, V27, P221, DOI 10.1109/TPAMI.2005.29; Ebersole JS, 1997, EPILEPSIA, V38, pS1, DOI 10.1111/j.1528-1157.1997.tb04533.x; Ebersole JS, 1997, J CLIN NEUROPHYSIOL, V14, P470, DOI 10.1097/00004691-199711000-00003; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Genow A, 2004, NEUROIMAGE, V21, P444, DOI 10.1016/j.neuroimage.2003.08.029; Grova C, 2008, NEUROIMAGE, V39, P755, DOI 10.1016/j.neuroimage.2007.08.020; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harrison LM, 2007, NEUROIMAGE, V38, P677, DOI 10.1016/j.neuroimage.2007.07.032; Henson RN, 2007, NEUROIMAGE, V38, P422, DOI 10.1016/j.neuroimage.2007.07.026; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Henson RN, 2010, HUM BRAIN MAPP, V31, P1512, DOI 10.1002/hbm.20956; Huiskamp G, 2010, BRAIN TOPOGR, V23, P159, DOI 10.1007/s10548-010-0134-1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jerbi K, 2002, PHYS MED BIOL, V47, P523, DOI 10.1088/0031-9155/47/4/301; Kincses WE, 1999, HUM BRAIN MAPP, V8, P182, DOI 10.1002/(SICI)1097-0193(1999)8:4<182::AID-HBM3>3.0.CO;2-M; Kincses WE, 2003, HUM BRAIN MAPP, V18, P100, DOI 10.1002/hbm.10079; Knowlton RC, 2004, EPILEPSIA, V45, P61, DOI 10.1111/j.0013-9580.2004.04012.x; Kybic J, 2006, PHYS MED BIOL, V51, P1333, DOI 10.1088/0031-9155/51/5/021; Lapalme E, 2006, NEUROIMAGE, V30, P160, DOI 10.1016/j.neuroimage.2005.08.067; LeSage JP, 2007, J ECONOMETRICS, V140, P190, DOI 10.1016/j.jeconom.2006.09.007; Limpiti T, 2006, IEEE T BIO-MED ENG, V53, P1740, DOI 10.1109/TBME.2006.873743; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Litvak V, 2008, NEUROIMAGE, V42, P1490, DOI 10.1016/j.neuroimage.2008.06.022; LUDERS HO, 1992, EPILEPSY SURGERY, P51; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; Mattout J, 2005, NEUROIMAGE, V26, P356, DOI 10.1016/j.neuroimage.2005.01.026; METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009; Mikuni N, 1997, NEUROIMAGE, V5, P298, DOI 10.1006/nimg.1997.0272; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Oishi M, 2002, EPILEPSIA, V43, P1390, DOI 10.1046/j.1528-1157.2002.10702.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ou WM, 2010, NEUROIMAGE, V52, P97, DOI 10.1016/j.neuroimage.2010.03.001; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Phillips C, 2002, NEUROIMAGE, V17, P287, DOI 10.1006/nimg.2002.1175; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Placantonakis DG, 2009, NEUROL CLIN, V27, P1015, DOI 10.1016/j.ncl.2009.08.004; Santiuste M, 2008, J CLIN NEUROPHYSIOL, V25, P331, DOI 10.1097/WNP.0b013e31818e7913; Stefan H, 2003, BRAIN, V126, P2396, DOI 10.1093/brain/awg239; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tao JX, 2007, J CLIN NEUROPHYSIOL, V24, P96, DOI 10.1097/WNP.0b013e31803ecdaf; Thirion B, 2004, MED IMAGE ANAL, V8, P403, DOI 10.1016/j.media.2004.09.001; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008	71	75	75	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55969	10.1371/journal.pone.0055969	http://dx.doi.org/10.1371/journal.pone.0055969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418485	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300077
J	Gao, ZW; Lin, Z; Huang, WD; Lai, CC; Fan, JS; Yang, DW				Gao, Zhenwei; Lin, Zhi; Huang, Weidong; Lai, Chong Cheong; Fan, Jing-song; Yang, Daiwen			Structural Characterization of Minor Ampullate Spidroin Domains and Their Distinct Roles in Fibroin Solubility and Fiber Formation	PLOS ONE			English	Article							SPIDER SILK PROTEINS; NMR; EVOLUTION; PEPTIDE	Spider silk is protein fibers with extraordinary mechanical properties. Up to now, it is still poorly understood how silk proteins are kept in a soluble form before spinning into fibers and how the protein molecules are aligned orderly to form fibers. Minor ampullate spidroin is one of the seven types of silk proteins, which consists of four types of domains: N-terminal domain, C-terminal domain (CTD), repetitive domain (RP) and linker domain (LK). Here we report the tertiary structure of CTD and secondary structures of RP and LK in aqueous solution, and their roles in protein stability, solubility and fiber formation. The stability and solubility of individual domains are dramatically different and can be explained by their distinct structures. For the tri-domain miniature fibroin, RP-LK-CTDMi, the three domains have no or weak interactions with one another at low protein concentrations (<1 mg/ml). The CTD in RP-LK-CTDMi is very stable and soluble, but it cannot stabilize the entire protein against chemical and thermal denaturation while it can keep the entire tri-domain in a highly water-soluble state. In the presence of shear force, protein aggregation is greatly accelerated and the aggregation rate is determined by the stability of folded domains and solubility of the disordered domains. Only the tri-domain RP-LK-CTDMi could form silk-like fibers, indicating that all three domains play distinct roles in fiber formation: LK as a nucleation site for assembly of protein molecules, RP for assistance of the assembly and CTD for regulating alignment of the assembled molecules.	[Gao, Zhenwei; Lin, Zhi; Huang, Weidong; Lai, Chong Cheong; Fan, Jing-song; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Yang, DW (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsydw@nus.edu.sg	LIN, ZHI/B-1254-2016; yang, daiwen/H-8408-2012	yang, daiwen/0000-0002-6804-0071; LIN, ZHI/0000-0002-8902-4935	Ministry of Education, Singapore [R154000453112]	Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by a grant from Ministry of Education, Singapore (R154000453112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013; Challis RJ, 2006, INSECT MOL BIOL, V15, P45, DOI 10.1111/j.1365-2583.2005.00606.x; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Greenwood MJ, 2010, BEHAV ECOL, V21, P1227, DOI 10.1093/beheco/arq140; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; Huang W, 2006, BIOCHIMIE, V88, P849, DOI 10.1016/j.biochi.2006.02.010; La Mattina C, 2008, BIOCHEMISTRY-US, V47, P4692, DOI 10.1021/bi800140q; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Lin Z, 2013, ADV MATER, V25, P1216, DOI 10.1002/adma.201204357; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; Wang SJ, 2012, J BIOMOL NMR, V54, P415, DOI 10.1007/s10858-012-9679-5; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Yang SA, 2009, BIOCHEMISTRY-US, V48, P4040, DOI 10.1021/bi9000936; Zhao AC, 2005, J BIOCHEM, V138, P593, DOI 10.1093/jb/mvi155; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	39	26	29	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56142	10.1371/journal.pone.0056142	http://dx.doi.org/10.1371/journal.pone.0056142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418525	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300117
J	Gutteridge, A; Rukstalis, JM; Ziemek, D; Tie, M; Ji, L; Ramos-Zayas, R; Nardone, NA; Norquay, LD; Brenner, MB; Tang, K; McNeish, JD; Rowntree, RK				Gutteridge, Alex; Rukstalis, J. Michael; Ziemek, Daniel; Tie, Mark; Ji, Lin; Ramos-Zayas, Rebeca; Nardone, Nancy A.; Norquay, Lisa D.; Brenner, Martin B.; Tang, Kim; McNeish, John D.; Rowntree, Rebecca K.			Novel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INTERPRETING TRANSCRIPTIONAL CHANGES; BETA-CELL; EXPRESSION ANALYSIS; SACCHAROMYCES-CEREVISIAE; CHOLESTEROL HOMEOSTASIS; INSULIN-SECRETION; GENE-EXPRESSION; HISTONE H3; IN-VIVO	We have used a previously unavailable model of pancreatic development, derived in vitro from human embryonic stem cells, to capture a time-course of gene, miRNA and histone modification levels in pancreatic endocrine cells. We investigated whether it is possible to better understand, and hence control, the biological pathways leading to pancreatic endocrine formation by analysing this information and combining it with the available scientific literature to generate models using a casual reasoning approach. We show that the embryonic stem cell differentiation protocol is highly reproducible in producing endocrine precursor cells and generates cells that recapitulate many aspects of human embryonic pancreas development, including maturation into functional endocrine cells when transplanted into recipient animals. The availability of whole genome gene and miRNA expression data from the early stages of human pancreatic development will be of great benefit to those in the fields of developmental biology and diabetes research. Our causal reasoning algorithm suggested the involvement of novel gene networks, such as NEUROG3/E2F1/KDM5B and SOCS3/STAT3/IL-6, in endocrine cell development We experimentally investigated the role of the top-ranked prediction by showing that addition of exogenous IL-6 could affect the expression of the endocrine progenitor genes NEUROG3 and NKX2.2.	[Rukstalis, J. Michael; Tie, Mark; Ji, Lin; Ramos-Zayas, Rebeca; Tang, Kim; McNeish, John D.; Rowntree, Rebecca K.] Pfizer Regenerat Med, Cambridge, MA USA; [Gutteridge, Alex] Pfizer Regenerat Med, Cambridge, England; [Ziemek, Daniel] Pfizer Computat Sci Ctr Emphasis, Cambridge, MA USA; [Rukstalis, J. Michael; Ji, Lin; Nardone, Nancy A.; Norquay, Lisa D.; Brenner, Martin B.] Pfizer Cardiovasc & Metab Dis, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer	Gutteridge, A (corresponding author), Pfizer Regenerat Med, Cambridge, England.	alex.gutteridge@pfizer.com; rownrk@yahoo.co.uk		Gutteridge, Alex/0000-0001-7515-634X	Pfizer Inc	Pfizer Inc(Pfizer)	This work was funded by Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bhandare R, 2010, GENOME RES; Billon N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r80; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Champeris Tsaniras S, 2010, J ENDOCRINOLOGY; Chen BZ, 2011, CELL BIOL INT, V35, P29, DOI 10.1042/CBI20090081; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Chindelevitch L, 2011, LECT N BIOINFORMAT, V6577, P34, DOI 10.1007/978-3-642-20036-6_4; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaulton KJ, 2010, NAT GENET; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grouwels G, 2010, DIABETES, V59, P1435, DOI 10.2337/db09-1295; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Heimberg H, 2008, NEW ENGL J MED, V359, P2723, DOI 10.1056/NEJMcibr0807675; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Inoshita S, 1999, KIDNEY INT, V56, P1238, DOI 10.1046/j.1523-1755.1999.00705.x; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kapasa M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-49; Kim SY, 2011, DEVELOPMENT; Kobayashi M, 2008, ENDOCRINOLOGY, V149, P5662, DOI 10.1210/en.2008-0236; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-419; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Li W, 2011, P NATL ACAD SCI US; Liechti R, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq024; Listyorini D, 2006, DEV GROWTH DIFFER, V48, P243, DOI [10.1111/j.1440-169x.2006.00861.x, 10.1111/j.1440-169X.2006.00861.x]; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu F, 2005, CELL CYCLE, V4, P63, DOI 10.4161/cc.4.1.1366; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; Morgan M, 2009, BIOINFORMATICS; Mwangi S, 2008, GASTROENTEROLOGY, V134, P727, DOI 10.1053/j.gastro.2007.12.033; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Pollard Jack Jr, 2005, Diabetes Technol Ther, V7, P323, DOI 10.1089/dia.2005.7.323; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Sarkar SA, 2012, PANCREAS; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; SPENCE JR, 2010, NATURE; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; White P, 2009, METHODS MOL BIOL, V560, P239, DOI 10.1007/978-1-59745-448-3_16; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Woollett LA, 2008, ANNU REV NUTR, V28, P97, DOI 10.1146/annurev.nutr.26.061505.111311; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	83	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56024	10.1371/journal.pone.0056024	http://dx.doi.org/10.1371/journal.pone.0056024			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418498	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300090
J	Salvemini, M; D'Amato, R; Petrella, V; Aceto, S; Nimmo, D; Neira, M; Alphey, L; Polito, LC; Saccone, G				Salvemini, Marco; D'Amato, Rocco; Petrella, Valeria; Aceto, Serena; Nimmo, Derric; Neira, Marco; Alphey, Luke; Polito, Lino C.; Saccone, Giuseppe			The Orthologue of the Fruitfly Sex Behaviour Gene Fruitless in the Mosquito Aedes aegypti: Evolution of Genomic Organisation and Alternative Splicing	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CERATITIS-CAPITATA; TRANSFORMER GENE; FUNCTIONAL CONSERVATION; EXPRESSION PATTERNS; REGULATORY ELEMENTS; NEURAL CIRCUITRY; MUSCA-DOMESTICA; FLIES DIPTERA; DOUBLESEX	In Drosophila melanogaster the doublesex (dsx) and fruitless (fru) regulatory genes act at the bottom of the somatic sex determination pathway. Both are regulated via alternative splicing by an upstream female-specific TRA/TRA-2 complex, recognizing a common cis element. dsx controls somatic sexual differentiation of non-neural as well as of neural tissues. fru, on the other hand, expresses male-specific functions only in neural system where it is required to built the neural circuits underlying proper courtship behaviour. In the mosquito Aedes aegypti sex determination is different from Drosophila. The key male determiner M, which is located on one of a pair of homomorphic sex chromosomes, controls sex-specific splicing of the mosquito dsx orthologue. In this study we report the genomic organization and expression of the fru homologue in Ae. aegypti (Aeafru). We found that it is sex-specifically spliced suggesting that it is also under the control of the sex determination pathway. Comparative analyses between the Aeafru and Anopheles gambiae fru (Angfru) genomic loci revealed partial conservation of exon organization and extensive divergence of intron lengths. We find that Aeadsx and Aeafru share novel cis splicing regulatory elements conserved in the alternatively spliced regions. We propose that in Aedes aegypti sex-specific splicing of dsx and fru is most likely under the control of splicing regulatory factors which are different from TRA and TRA-2 found in other dipteran insects and discuss the potential use of fru and dsx for developing new genetic strategies in vector control.	[Salvemini, Marco; D'Amato, Rocco; Petrella, Valeria; Aceto, Serena; Polito, Lino C.; Saccone, Giuseppe] Univ Naples Federico II, Sect Genet & Mol Biol, Dept Biol Sci, Naples, Italy; [Nimmo, Derric; Neira, Marco; Alphey, Luke] Oxitec Ltd, Oxford, England; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Naples Federico II; University of Oxford	Salvemini, M (corresponding author), Univ Naples Federico II, Sect Genet & Mol Biol, Dept Biol Sci, Naples, Italy.	marco.salvemini@unina.it	saccone, giuseppe/F-8627-2013; Aceto, Serena/E-5350-2010; Salvemini, Marco/AAJ-5560-2021	saccone, giuseppe/0000-0002-9835-3693; Alphey, Luke/0000-0002-2916-3802; SALVEMINI, Marco/0000-0003-2297-9267; Aceto, Serena/0000-0003-3906-4872; Neira, Marco/0000-0001-8068-5772	WHO Grant [A30289]	WHO Grant	This work was funded by WHO Grant A30289 (2004-2006) to Giuseppe Saccone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Arbeitman M, 2010, CURR BIOL, V20, pR804, DOI 10.1016/j.cub.2010.08.021; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Bertossa RC, 2009, MOL BIOL EVOL, V26, P1557, DOI 10.1093/molbev/msp067; Billeter JC, 2002, ADV GENET, V47, P87, DOI 10.1016/S0065-2660(02)47003-4; Boerjan B, 2011, INSECT BIOCHEM MOLEC, V41, P340, DOI 10.1016/j.ibmb.2011.01.012; Brooks AN, 2011, RNA, V17, P1884, DOI 10.1261/rna.2696311; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Churbanov A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-508; Clements A. N., 1999, BIOL MOSQUITOES; Clynen E, 2011, DEV GENES EVOL, V221, P43, DOI 10.1007/s00427-011-0352-x; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Dafa'alla T, 2010, J GENET, V89, P301, DOI 10.1007/s12041-010-0041-y; Dauwalder B, 1996, P NATL ACAD SCI USA, V93, P9004, DOI 10.1073/pnas.93.17.9004; Dauwalder B, 2011, INT REV NEUROBIOL, V99, P87, DOI 10.1016/B978-0-12-387003-2.00004-5; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Dornan AJ, 2005, GENESIS, V42, P236, DOI 10.1002/gene.20143; Ruiz MF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001239; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gailey DA, 2006, MOL BIOL EVOL, V23, P633, DOI 10.1093/molbev/msj070; Goodwin SF, 2000, GENETICS, V154, P725; Graham P, 2003, BIOESSAYS, V25, P1, DOI 10.1002/bies.10207; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; Heinrichs V, 1997, P NATL ACAD SCI USA, V94, P115, DOI 10.1073/pnas.94.1.115; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Hertel KJ, 1996, RNA, V2, P969; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Ibrahim EC, 2005, P NATL ACAD SCI USA, V102, P5002, DOI 10.1073/pnas.0500543102; INOUE K, 1992, P NATL ACAD SCI USA, V89, P8092, DOI 10.1073/pnas.89.17.8092; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Keleman K, 2012, NATURE; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kuhn S, 2000, GENOME, V43, P1011, DOI 10.1139/gen-43-6-1011; Lam BJ, 2003, J BIOL CHEM, V278, P22740, DOI 10.1074/jbc.M301036200; Lee G, 2000, BEHAV GENET, V30, P263, DOI 10.1023/A:1026541215546; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004; Pane A, 2002, DEVELOPMENT, V129, P3715; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Qi JL, 2007, MOL CELL BIOL, V27, P699, DOI 10.1128/MCB.01572-06; Ruiz MF, 2005, GENETICS, V171, P849, DOI 10.1534/genetics.105.044925; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Saccone G, 2011, GENETICA, V139, P99, DOI 10.1007/s10709-010-9503-7; Saccone G, 2008, INT J DEV BIOL, V52, P1051, DOI 10.1387/ijdb.082657gs; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Salvemini M, 2010, J GENET, V89, P287, DOI 10.1007/s12041-010-0040-z; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; Sarno F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-140; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Schetelig MF, 2012, P NATL ACAD SCI USA, V109, P9348, DOI 10.1073/pnas.1203352109; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Shearman DCA, 1998, INSECT MOL BIOL, V7, P355, DOI 10.1046/j.1365-2583.1998.740355.x; Shin D, 2012, J HERED, V103, P303, DOI 10.1093/jhered/esr134; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Song HJ, 2002, GENETICS, V162, P1703; South SH, 2011, ANIM BEHAV, V81, P645, DOI 10.1016/j.anbehav.2010.12.014; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tu ZJ, 1999, MOL BIOL EVOL, V16, P760, DOI 10.1093/oxfordjournals.molbev.a026161; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Ustinova J, 2006, J MOL EVOL, V63, P788, DOI 10.1007/s00239-005-6230-2; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Villella A, 1997, GENETICS, V147, P1107; Yamamoto D, 2008, J NEUROGENET, V22, P309, DOI 10.1080/01677060802298491; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu JY, 2006, CURR BIOL, V16, pR23, DOI 10.1016/j.cub.2005.12.009; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	86	35	39	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e48554	10.1371/journal.pone.0048554	http://dx.doi.org/10.1371/journal.pone.0048554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418412	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300002
J	Sunami, T; Kono, H				Sunami, Tomoko; Kono, Hidetoshi			Local Conformational Changes in the DNA Interfaces of Proteins	PLOS ONE			English	Article							NUCLEIC ACID RECOGNITION; STRUCTURAL ALPHABET; CRYSTAL-STRUCTURE; INTRINSIC DISORDER; BINDING DOMAIN; SEQUENCES; CLASSIFICATION; DEFORMATION; FLEXIBILITY; ALIGNMENT	When a protein binds to DNA, a conformational change is often induced so that the protein will fit into the DNA structure. Therefore, quantitative analyses were conducted to understand the conformational changes in proteins. The results showed that conformational changes in DNA interfaces are more frequent than in non-interfaces, and DNA interfaces have more conformational variations in the DNA-free form. As expected, the former indicates that interaction with DNA has some influence on protein structure. The latter suggests that the intrinsic conformational flexibility of DNA interfaces is important for adjusting their conformation for DNA. The amino acid propensities of the conformationally changed regions in DNA interfaces indicate that hydrophilic residues are preferred over the amino acids that appear in the conformationally unchanged regions. This trend is true for disordered regions, suggesting again that intrinsic flexibility is of importance not only for DNA binding but also for interactions with other molecules. These results demonstrate that fragments destined to be DNA interfaces have an intrinsic flexibility and are composed of amino acids with the capability of binding to DNA. This information suggests that the prediction of DNA binding sites may be improved by the integration of amino acid preference for DNA and one for disordered regions.	[Sunami, Tomoko; Kono, Hidetoshi] Japan Atom Energy Agcy, Mol Modeling & Simulat Grp, Quantum Beam Sci Directorate, Kyoto, Japan	Japan Atomic Energy Agency	Kono, H (corresponding author), Japan Atom Energy Agcy, Mol Modeling & Simulat Grp, Quantum Beam Sci Directorate, Kyoto, Japan.	kono.hidetoshi@jaea.go.jp		Kono, Hidetoshi/0000-0001-5729-8707	Japan Society for the Promotion of Science (JSPS) KAKENHI [23700354]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [23114723]; Grants-in-Aid for Scientific Research [23700354] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 23700354 and The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI grant number 23114723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baussand J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-9; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biswas S, 2008, BIOINFORMATION, V2, P422, DOI 10.6026/97320630002422; BRENNAN RG, 1990, P NATL ACAD SCI USA, V87, P8165, DOI 10.1073/pnas.87.20.8165; Dan A, 2010, PROTEINS, V78, P236, DOI 10.1002/prot.22531; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; Deschavanne P, 2009, PROTEINS, V76, P129, DOI 10.1002/prot.22324; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2012, MOL BIOSYST, V8, P97, DOI 10.1039/c1mb05258f; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Falconi M, 2008, BIOPHYS J, V95, P1108, DOI 10.1529/biophysj.108.130849; Falconi M, 2007, FEBS J, V274, P2385, DOI 10.1111/j.1742-4658.2007.05773.x; Friedberg I, 2007, BIOINFORMATICS, V23, pE219, DOI 10.1093/bioinformatics/btl310; Galburt EA, 2000, J MOL BIOL, V300, P877, DOI 10.1006/jmbi.2000.3874; Gunther S, 2006, BIOSYSTEMS, V85, P126, DOI 10.1016/j.biosystems.2005.12.007; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Hegde RS, 1998, J MOL BIOL, V276, P797, DOI 10.1006/jmbi.1997.1587; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Le Q, 2009, J MOL BIOL, V387, P431, DOI 10.1016/j.jmb.2008.12.044; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; MacDonald JT, 2010, PROTEINS, V78, P1311, DOI 10.1002/prot.22651; Martin J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-12; Mezei M, 1998, PROTEIN ENG, V11, P411, DOI 10.1093/protein/11.6.411; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; NAGADOI A, 1995, STRUCTURE, V3, P1217, DOI 10.1016/S0969-2126(01)00257-X; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; SAUER RT, 1988, GENE DEV, V2, P807, DOI 10.1101/gad.2.7.807; Schrodinger L., 2020, PYMOL; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56080	10.1371/journal.pone.0056080	http://dx.doi.org/10.1371/journal.pone.0056080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418514	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300106
J	Takatalo, J; Karppinen, J; Taimela, S; Niinimaki, J; Laitinen, J; Sequeiros, RB; Samartzis, D; Korpelainen, R; Nayha, S; Remes, J; Tervonen, O				Takatalo, Jani; Karppinen, Jaro; Taimela, Simo; Niinimaki, Jaakko; Laitinen, Jaana; Sequeiros, Roberto Blanco; Samartzis, Dino; Korpelainen, Raija; Nayha, Simo; Remes, Jouko; Tervonen, Osmo			Association of Abdominal Obesity with Lumbar Disc Degeneration - A Magnetic Resonance Imaging Study	PLOS ONE			English	Article							LOW-BACK-PAIN; VISCERAL ADIPOSE-TISSUE; FOLLOW-UP; COMPUTED-TOMOGRAPHY; CARDIOVASCULAR RISK; POPULATION; OVERWEIGHT; SPINE; ATHEROSCLEROSIS; PREVALENCE	Purpose: To evaluate whether midsagittal (abdominal) obesity in magnetic resonance imaging (MRI), waist circumference (WC) and body fat percentage are associated with lumbar disc degeneration in early adulthood. Methods: We obtained the lumbar MRI (1.5-T scanner) of 325 females and 233 males at a mean age of 21 years. Lumbar disc degeneration was evaluated using Pfirrmann classification. We analysed the associations of MRI measures of obesity (abdominal diameter (AD), sagittal diameter (SAD), ventral subcutaneous thickness (VST), and dorsal subcutaneous thickness (DST)), WC and body fat percentage with disc degeneration sum scores using ordinal logistic regression. Results: A total of 155 (48%) females and 147 (63%) males had disc degeneration. AD and SAD were associated with a disc degeneration sum score of >= 3 compared to disc degeneration sum score of 0-2 (OR 1.67; 95% confidence interval (CI) 1.20-2.33 and OR 1.40; 95% CI 1.12-1.75, respectively) among males, but we found no association among females. WC was also associated with disc degeneration among males (OR 1.03 per one cm; 95% CI 1.00-1.05), but not among females. Conclusion: Measures of abdominal obesity in MRI and waist circumference were associated with disc degeneration among 21-year-old males.	[Takatalo, Jani; Karppinen, Jaro] Univ Oulu, Inst Clin Med, Oulu, Finland; [Karppinen, Jaro; Laitinen, Jaana; Remes, Jouko] Finnish Inst Occupat Hlth, Oulu, Finland; [Karppinen, Jaro; Korpelainen, Raija] Oulu Univ Hosp, Oulu, Finland; [Taimela, Simo] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Niinimaki, Jaakko; Sequeiros, Roberto Blanco; Tervonen, Osmo] Univ Oulu, Inst Diagnost, Oulu, Finland; [Samartzis, Dino] Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China; [Korpelainen, Raija; Nayha, Simo] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Korpelainen, Raija] Oulu Deaconess Inst, Dept Sports & Exercise Med, Oulu, Finland	University of Oulu; Finnish Institute of Occupational Health; University of Oulu; University of Helsinki; University of Oulu; University of Hong Kong; University of Oulu	Takatalo, J (corresponding author), Univ Oulu, Inst Clin Med, Oulu, Finland.	jani.takatalo@fimnet.fi	Takatalo, Jani M/H-5395-2016; Niinimäki, Jaakko/O-2186-2014	Takatalo, Jani M/0000-0002-1008-7416; Korpelainen, Raija/0000-0002-3627-0542; Blanco Sequeiros, Roberto/0000-0002-0167-9639; Samartzis, Dino/0000-0002-7473-1311; Niinimaki, Jaakko/0000-0002-5591-3726; Taimela, Simo/0000-0001-6755-2983	TBGS (National Graduate School of Musculoskeletal Disorders and Biomaterials); Yrjo Jahnsson Foundation; Academy of Finland [121620, 129504]; TBDP (National Graduate School of Musculoskeletal Disorders and Biomaterials)	TBGS (National Graduate School of Musculoskeletal Disorders and Biomaterials); Yrjo Jahnsson Foundation; Academy of Finland(Academy of Finland); TBDP (National Graduate School of Musculoskeletal Disorders and Biomaterials)	The first author acknowledges the TBGS (National Graduate School of Musculoskeletal Disorders and Biomaterials) and the Yrjo Jahnsson Foundation for their financial support. This study was partly funded by the Academy of Finland (grants 121620 and 129504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author acknowledges the TBDP (National Graduate School of Musculoskeletal Disorders and Biomaterials) for its support.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Altman DG., 1999, PRACTICAL STAT MED R; American College of Sports Medicine, 2021, ACSMS GUIDELINES EXE; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; Borenstein DG, 2001, J BONE JOINT SURG AM, V83A, P1306, DOI 10.2106/00004623-200109000-00002; Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; ERKINTALO MO, 1995, RADIOLOGY, V196, P529, DOI 10.1148/radiology.196.2.7617872; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Ford ES, 2001, J PEDIATR-US, V138, P486, DOI 10.1067/mpd.2001.112898; Girn HRS, 2007, VASC MED, V12, P299, DOI 10.1177/1358863X07083387; Guzzaloni G, 2009, INT J OBESITY, V33, P233, DOI 10.1038/ijo.2008.271; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; Kautiainen S, 2002, INT J OBESITY, V26, P544, DOI 10.1038/sj.ijo.0801928; Kjaer P, 2005, SPINE, V30, P798, DOI 10.1097/01.brs.0000157424.72598.ec; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Liuke M, 2005, INT J OBESITY, V29, P903, DOI 10.1038/sj.ijo.0802974; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; PRITCHARD JE, 1993, EUR J CLIN NUTR, V47, P216; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roubenoff R, 1996, AM J CLIN NUTR, V64, P459; Salminen JJ, 1999, SPINE, V24, P1316, DOI 10.1097/00007632-199907010-00008; SALMINEN JJ, 1995, SPINE, V20, P2101, DOI 10.1097/00007632-199510000-00006; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568; SEIDELL JC, 1990, AM J CLIN NUTR, V51, P953, DOI 10.1093/ajcn/51.6.953; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Stata Corporation, 2009, STAT STAT SOFTW REL; Stevens J, 2010, EUR J CLIN NUTR, V64, P6, DOI 10.1038/ejcn.2009.101; Takatalo J, 2011, SPINE, V36, P2180, DOI 10.1097/BRS.0b013e3182077122; Takatalo J, 2009, SPINE, V34, P1716, DOI 10.1097/BRS.0b013e3181ac5fec; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Tzotzas Themistoklis, 2004, Pediatr Endocrinol Rev, V1 Suppl 3, P448; Urquhart DM, 2011, SPINE, V36, P1320, DOI 10.1097/BRS.0b013e3181f9fb66; Videman T, 2008, SPINE, V33, P1484, DOI 10.1097/BRS.0b013e3181753bb1; Warnberg J, 2006, AM J CLIN NUTR, V84, P505; Weiler Christoph, 2011, BMC Res Notes, V4, P497, DOI 10.1186/1756-0500-4-497; Williams FMK, 2011, ANN RHEUM DIS, V70, P1203, DOI 10.1136/ard.2010.146001; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Yim JY, 2010, DIABETES CARE, V33, P2665, DOI 10.2337/dc10-0606	50	60	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56244	10.1371/journal.pone.0056244	http://dx.doi.org/10.1371/journal.pone.0056244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418543	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300136
J	Tsai, JS; Wu, CH; Chen, SC; Huang, KC; Chen, CY; Chang, CI; Chuang, LM; Chen, CY				Tsai, Jaw-Shiun; Wu, Chih-Hsun; Chen, Su-Chiu; Huang, Kuo-Chin; Chen, Chin-Ying; Chang, Ching-I; Chuang, Lee-Ming; Chen, Ching-Yu			Plasma Adiponectin Levels Correlate Positively with an Increasing Number of Components of Frailty in Male Elders	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; CIRCULATING ADIPONECTIN; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; POSTMENOPAUSAL WOMEN; INSULIN SENSITIVITY; HEART-FAILURE; OLDER-ADULTS; MEN	Objective: Frailty is an important geriatric syndrome. Adiponectin is an important adipokine that regulates energy homeostasis. The aim of this study is to investigate the relationship between plasma adiponectin levels and frailty in elders. Methods: The demographic data, body weight, metabolic and inflammatory parameters, including plasma glucose, total cholesterol, triglyceride, tumor necrosis factor alpha (TNF-alpha), c-reactive protein (CRP) and adiponectin levels, were assessed. The frailty score was assessed using the Fried Frailty Index (FFI). Results: The mean (SD) age of the 168 participants [83 (49.4%) men and 85 (50.6%) women] was 76.86 (6.10) years. Judged by the FFI score, 42 (25%) elders were robust, 92 (54.7%) were pre-frail, and 34 (20.3%) were frail. The mean body mass index was 25.19 (3.42) kg/m(2). The log-transformed mean (SD) plasma adiponectin (mu g/mL) level was 1.00 (0.26). The logtransformed mean plasma adiponectin (mu g/mL) levels were 0.93 (0.23) in the robust elders, 1.00 (0.27) in the pre-frail elders, and 1.10 (0.22) in the frail elders, and the differences between these values were statistically significant (p = 0.012). Further analysis showed that plasma adiponectin levels rose progressively with an increasing number of components of frailty in all participants as a whole (p for trend = 0.024) and males (p for trend = 0.037), but not in females (p for trend = 0.223). Conclusion: Plasma adiponectin levels correlate positively with an increasing number of components of frailty in male elders. The difference between the sexes suggests that certain sex-specific mechanisms may exist to affect the association between adiponectin levels and frailty.	[Tsai, Jaw-Shiun; Huang, Kuo-Chin; Chen, Chin-Ying; Chen, Ching-Yu] Natl Taiwan Univ, Coll Med, Dept Family Med, Taipei 10764, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, Chih-Hsun] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Su-Chiu] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Chang, Ching-I; Chen, Ching-Yu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Geriatr & Gerontol, Ju Nan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taipei University of Nursing & Health Science (NTUNHS); National Health Research Institutes - Taiwan	Chuang, LM (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	leeming@ntu.edu.tw; chency@nhri.org.tw	Chuang, Lee-Ming/AAF-3324-2019	Tsai, Jaw-Shiun/0000-0002-5227-8894; Wu, Chih-Hsun/0000-0003-4613-5915; HUANG, KUO-CHIN/0000-0002-6029-5520; CHEN, CHING-YU/0000-0002-4095-4197; CHEN, CHIN-YING/0000-0001-7827-8764; CHUANG, LEE-MING/0000-0003-0978-2662	National Science Council [NSC 98-2314-B-002-118-MY2, NSC 97-2314-B-002-178-MY3, PH-098-PP-48]; National Health Research Institute, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work is supported by the grants (NSC 98-2314-B-002-118-MY2 to JST; NSC 97-2314-B-002-178-MY3 and PH-098-PP-48 to Ching-Yu Chen) from the National Science Council (http://web1.nsc.gov.tw) and the National Health Research Institute (http://www.nhri.org.tw), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Dridi S, 2009, J NUTR BIOCHEM, V20, P831, DOI 10.1016/j.jnutbio.2009.06.003; Efstathiou SP, 2009, ATHEROSCLEROSIS, V205, P632, DOI 10.1016/j.atherosclerosis.2009.01.022; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Isobe T, 2005, EUR J ENDOCRINOL, V153, P91, DOI 10.1530/eje.1.01930; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Kalyani RR, 2012, J NUTR HEALTH AGING, V16, P679, DOI [10.1007/s12603-012-0066-4, 10.1007/s12603-012-0369-5]; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Kizer JR, 2011, J GERONTOL A-BIOL, V66, P1100, DOI 10.1093/gerona/glr098; Kizer JR, 2010, J GERONTOL A-BIOL, V65, P1208, DOI 10.1093/gerona/glq122; Komura N, 2008, CIRC J, V72, P23, DOI 10.1253/circj.72.23; Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Liu YM, 2004, THESIS NATL TAIWAN U; Otsuka F, 2009, J CARDIOL, V53, P219, DOI 10.1016/j.jjcc.2008.11.004; Park SH, 2010, CLIN BIOCHEM, V43, P1069, DOI 10.1016/j.clinbiochem.2010.06.002; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rizza S, 2010, J AM GERIATR SOC, V58, P702, DOI 10.1111/j.1532-5415.2010.02773.x; Rizza S, 2009, NUTR METAB CARDIOVAS, V19, P54, DOI 10.1016/j.numecd.2007.12.001; Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Tsou PL, 2004, DIABETES CARE, V27, P308, DOI 10.2337/diacare.27.2.308; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Wu HY, 2010, J CLIN ENDOCR METAB, V95, P4389, DOI 10.1210/jc.2010-0181; Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	38	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56250	10.1371/journal.pone.0056250	http://dx.doi.org/10.1371/journal.pone.0056250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418545	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300138
J	Foerch, C; Rosidi, NL; Schlunk, F; Lauer, A; Cianchetti, FA; Mandeville, E; Arai, K; Yigitkanli, K; Fan, X; Wang, X; van Leyen, K; Steinmetz, H; Schaffer, CB; Lo, EH				Foerch, Christian; Rosidi, Nathanael L.; Schlunk, Frieder; Lauer, Arne; Cianchetti, Flor A.; Mandeville, Emiri; Arai, Ken; Yigitkanli, Kazim; Fan, Xiang; Wang, Xiaoying; van Leyen, Klaus; Steinmetz, Helmuth; Schaffer, Chris B.; Lo, Eng H.			Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; SUBARACHNOID HEMORRHAGE; RAT MODEL; STROKE; THROMBOLYSIS; INHIBITION; PROTEIN; INJURY	Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH). Surprisingly, however, the assumption that tPA will worsen ICH has never been biologically tested. Here, we assessed the effects of tPA in two models of ICH. In a mouse model of collagenase-induced ICH, hemorrhage volumes and neurological deficits after 24 hrs were similar in saline controls and tPA-treated mice, whereas heparin-treated mice had 3-fold larger hematomas. In a model of laser-induced vessel rupture, tPA also did not worsen hemorrhage volumes, while heparin did. tPA is known to worsen neurovascular injury by amplifying matrix metalloproteinases during cerebral ischemia. In contrast, tPA did not upregulate matrix metalloproteinases in our mouse ICH models. In summary, our experimental data do not support the assumption that intravenous tPA has a deleterious effect in acute ICH. However, due to potential species differences and the inability of models to fully capture the dynamics of human ICH, caution is warranted when considering the implications of these findings for human therapy.	[Foerch, Christian; Schlunk, Frieder; Lauer, Arne; Mandeville, Emiri; Arai, Ken; Yigitkanli, Kazim; Fan, Xiang; Wang, Xiaoying; van Leyen, Klaus; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA 02114 USA; [Foerch, Christian; Schlunk, Frieder; Lauer, Arne; Steinmetz, Helmuth] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Rosidi, Nathanael L.; Cianchetti, Flor A.; Schaffer, Chris B.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Goethe University Frankfurt; Cornell University	Foerch, C (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA 02114 USA.	foerch@em.uni-frankfurt.de	yigitkanli, kazım/AAK-6184-2021; van Leyen, Klaus/C-9126-2013; Schaffer, Chris B./A-7409-2008	van Leyen, Klaus/0000-0003-1032-3754; Schaffer, Chris B./0000-0002-7800-9596	National Institutes of Health [R37-NS37074, R01-NS56458, P01-NS55104]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037074, R01NS049430, R01NS069939, R01NS056458, P01NS055104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health grants R37-NS37074, R01-NS56458 and P01-NS55104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Ducruet AF, 2010, NEUROSURGERY, V66, P648, DOI 10.1227/01.NEU.0000360374.59435.60; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Foerch C, 2008, STROKE, V39, P3397, DOI 10.1161/STROKEAHA.108.517482; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; Hogan KA, 2002, THROMB HAEMOSTASIS, V87, P563, DOI 10.1055/s-0037-1613050; Ishii H, 2001, CIRC RES, V89, P1240, DOI 10.1161/hh2401.101066; Ishikawa T, 2006, SURG NEUROL, V66, P269, DOI 10.1016/j.surneu.2006.03.030; JANG IK, 1989, CIRCULATION, V79, P920, DOI 10.1161/01.CIR.79.4.920; Kahles T, 2005, VASC PHARMACOL, V43, P254, DOI 10.1016/j.vph.2005.07.008; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Mihara K, 2005, J NEUROTRAUM, V22, P1362, DOI 10.1089/neu.2005.22.1362; Montagne A, 2012, STROKE, V43, P2774, DOI 10.1161/STROKEAHA.112.669374; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Murray V, 1989, J INTERN MED, V267, P191; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Thiex R, 2004, EXP NEUROL, V189, P25, DOI 10.1016/j.expneurol.2004.05.021; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Xue MZ, 2009, STROKE, V40, P2199, DOI 10.1161/STROKEAHA.108.540393; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhu HH, 2010, J CEREBR BLOOD F MET, V30, P1137, DOI 10.1038/jcbfm.2009.279; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e54203	10.1371/journal.pone.0054203	http://dx.doi.org/10.1371/journal.pone.0054203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408937	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300005
J	Guo, SJ; Li, XB; Gao, M; Li, YQ; Song, B; Niu, WQ				Guo, Shujie; Li, Xiaobo; Gao, Min; Li, Yuqiong; Song, Bei; Niu, Wenquan			The Relationship between XRCC1 and XRCC3 Gene Polymorphisms and Lung Cancer Risk in Northeastern Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; EXCISION-REPAIR; HAN CHINESE; METAANALYSIS; ASSOCIATION; HYPERTENSION	Background: The prevalence of lung cancer in China will be the world's highest if allowed to proceed uncurbed. To unravel its genetic underpinnings, we sought to investigate the association of three well-characterized nonsynonymous polymorphisms in XRCC1 (Arg194Trp and Arg399Gln) and XRCC3 (Thr241Met) genes with lung cancer risk in northeastern Chinese. Methodology/Principal Findings: This study was hospital-based in design, encompassing 684 patients with lung cancer and 604 cancer-free controls. Genotyping was performed using the PCR-LDR (ligase detection reactions) method. Data were analyzed by R language and multifactor dimensionality reduction (MDR) software. Single-locus analysis identified significance in genotype distributions of polymorphism Arg194Trp (P = 0.002) and Arg399Gln (P = 0.017), and in allele distributions of Thr241Met (P = 0.005). Carriers of 399Gln/Gln genotype conferred a 147% increased risk relative to the non-carriers (odds ratio (OR): 2.47; 95% confidence interval (95% CI): 1.48-4.13; P<0.001). For Thr241Met, significance persisted under allelic (OR = 1.63; 95% CI: 1.14-2.33; P = 0.005), additive (OR = 1.64; 95% CI: 1.16-2.32; P = 0.005) and dominant (OR = 1.67; 95% CI: 1.17-2.38; P = 0.004) models. However, common allele combinations were comparable in frequency between patients and controls. In interaction analysis, the overall best MDR model included Arg399Gln and Thr241Met polymorphisms, with a maximal testing accuracy of 63.18% and a maximal cross-validation consistency of 10 out of 10 (P = 0.0175). Conclusions: Our study significantly demonstrated an independent and synergistic contribution of XRCC1 Arg399Gln and XRCC3 Thr241Met polymorphisms to lung cancer susceptibility in northeastern Chinese.	[Guo, Shujie; Li, Xiaobo; Li, Yuqiong; Song, Bei; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Gao, Min] Harbin Med Univ, Affiliated Hosp 4, Dept Resp Med, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Harbin Medical University	Niu, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	niuwenquan@yahoo.cn			Shanghai Rising Star Program [11QA1405500]; National Natural Science Foundation of China [30900808]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising Star Program (11QA1405500), and the National Natural Science Foundation of China (30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cui ZG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-71; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Gao M, 2012, J RENIN ANGIOTENSIN; Guo SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039814; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han SZ, 2006, EUR J HUM GENET, V14, P1136, DOI 10.1038/sj.ejhg.5201681; Hu ZB, 2005, CANCER EPIDEM BIOMAR, V14, P1810, DOI 10.1158/1055-9965.EPI-04-0793; Ma Xj, 2008, Biomed Imaging Interv J, V4, pe39, DOI 10.2349/biij.4.3.e39; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Niu WQ, 2010, CLIN CHIM ACTA, V411, P1491, DOI 10.1016/j.cca.2010.06.004; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; Pachouri SS, 2007, DNA CELL BIOL, V26, P186, DOI 10.1089/dna.2006.9999; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Wang YD, 2009, CANCER LETT, V285, P134, DOI 10.1016/j.canlet.2009.05.005; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Zheng HL, 2009, LUNG CANCER, V65, P268, DOI 10.1016/j.lungcan.2009.02.002	20	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56213	10.1371/journal.pone.0056213	http://dx.doi.org/10.1371/journal.pone.0056213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409158	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300068
J	Mukherjee, R; Evans, P; Singh, LN; Hannenhalli, S				Mukherjee, Rithun; Evans, Perry; Singh, Larry N.; Hannenhalli, Sridhar			Correlated Evolution of Positions within Mammalian cis Elements	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; COMPENSATORY EVOLUTION; MAXIMUM-LIKELIHOOD; RESPONSE ELEMENTS; DNA; SITES; SEQUENCE; GENE; CONSERVATION; SPECIFICITY	Transcriptional regulation critically depends on proper interactions between transcription factors (TF) and their cognate DNA binding sites. The widely used model of TF-DNA binding - the Positional Weight Matrix (PWM) - presumes independence between positions within the binding site. However, there is evidence to show that the independence assumption may not always hold, and the extent of interposition dependence is not completely known. We hypothesize that the interposition dependence should partly be manifested as correlated evolution at the positions. We report a Maximum-Likelihood (ML) approach to infer correlated evolution at any two positions within a PWM, based on a multiple alignment of 5 mammalian genomes. Application to a genome-wide set of putative cis elements in human promoters reveals a prevalence of correlated evolution within cis elements. We found that the interdependence between two positions decreases with increasing distance between the positions. The interdependent positions tend to be evolutionarily more constrained and moreover, the dependence patterns are relatively similar across structurally related transcription factors. Although some of the detected mutational dependencies may be due to context-dependent genomic hyper-mutation, notably CG to TG, the majority is likely due to context-dependent preferences for specific nucleotide combinations within the cis elements. Patterns of evolution at individual nucleotide positions within mammalian TF binding sites are often significantly correlated, suggesting interposition dependence. The proposed methodology is also applicable to other classes of non-coding functional elements. A detailed investigation of mutational dependencies within specific motifs could reveal preferred nucleotide combinations that may help refine the DNA binding models.	[Mukherjee, Rithun] Fred Hutchinson Canc Res Ctr, Computat Biol Program, Seattle, WA 98104 USA; [Evans, Perry] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Singh, Larry N.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Hannenhalli, Sridhar] Univ Maryland, Dept Cell & Mol Biol, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Fred Hutchinson Cancer Center; Yale University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University System of Maryland; University of Maryland College Park	Mukherjee, R (corresponding author), Fred Hutchinson Canc Res Ctr, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA.	rmukherj@fhcrc.org; sridhar@umiacs.umd.edu	Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864	NIH [GM085226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085226] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Source of funding: The work was supported by NIH GM085226 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 1998, DETECTING NONADJOINI, P2; Baines JF, 2002, MOL BIOL EVOL, V19, P989, DOI 10.1093/oxfordjournals.molbev.a004179; Barash Y., 2003, MODELING DEPENDENCIE, P28; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Evans P, 2006, LECT NOTES COMPUT SC, V4205, P186; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kaneko S, 2006, GENETICS, V172, P2421, DOI 10.1534/genetics.105.052910; Kim E, 2003, BIOCHEM CELL BIOL, V81, P141, DOI 10.1139/o03-046; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Ordoukhanian P, 1999, CHEM BIOL, V6, P881, DOI 10.1016/S1074-5521(00)80007-1; Osada R, 2004, BIOINFORMATICS, V20, P3516, DOI 10.1093/bioinformatics/bth438; Pischedda A, 2005, J EVOLUTION BIOL, V18, P1115, DOI 10.1111/j.1420-9101.2005.00915.x; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; PTASHNE M, 2004, GENETIC SWITCH; Raviscioni M, 2005, J MOL BIOL, V350, P402, DOI 10.1016/j.jmb.2005.04.054; Reynolds MG, 2000, GENETICS, V156, P1471; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Williams EJB, 2000, GENE, V253, P313, DOI 10.1016/S0378-1119(00)00233-X; YANG Z, 2007, MOL BIOL EVOL; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55521	10.1371/journal.pone.0055521	http://dx.doi.org/10.1371/journal.pone.0055521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408994	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300020
J	van der Plas, H; Meintjes, G; Schutz, C; Goliath, R; Myer, L; Baatjie, D; Wilkinson, RJ; Maartens, G; Mendelson, M				van der Plas, Helen; Meintjes, Graeme; Schutz, Charlotte; Goliath, Rene; Myer, Landon; Baatjie, Dorothea; Wilkinson, Robert J.; Maartens, Gary; Mendelson, Marc			Complications of Antiretroviral Therapy Initiation in Hospitalised Patients with HIV-Associated Tuberculosis	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; CLINICAL DETERIORATION; INFECTION; AFRICA	Background: HIV-associated tuberculosis is a common coinfection in Sub-Saharan Africa, which causes high morbidity and mortality. A sub-set of HIV-associated tuberculosis patients require prolonged hospital admission, during which antiretroviral therapy initiation may be required. The aim of this study was to document the causes of clinical deterioration of hospitalised patients with HIV-associated tuberculosis starting antiretroviral therapy in order to inform healthcare practice in low-to middle-income countries. Methods: Prospective, observational cohort study of adult inpatients with HIV-associated tuberculosis starting antiretroviral therapy in a dedicated tuberculosis hospital in Cape Town, South Africa. Causes of clinical deterioration and outcome were recorded in the first 12 weeks of antiretroviral therapy. Patients with rifampicin-resistant tuberculosis were excluded. Results: Between May 2009 and November 2010, 112 patients (60% female), with a median age of 32 years were enrolled. At baseline the median CD4 count was 55 cells/mm(3) (IQR 31-106) and HIV viral load 5.6 log copies/mL. All patients had significant comorbidity: 82% were bed-bound, 65% had disseminated tuberculosis and 27% had central nervous system tuberculosis. Seventy six patients (68%) developed 144 clinical events after starting antiretroviral therapy. TB-IRIS, hospital-acquired infections and significant drug toxicities occurred in 42%, 20.5% and 15% of patients respectively. A new opportunistic disease occurred in 15% of patients and a thromboembolic event in 8%. Mortality during the 12 week period was 10.6%. Conclusions: High rates of TB-IRIS, hospital-acquired infections and drug toxicities complicate the course of patients with HIV-associated tuberculosis starting antiretroviral therapy in hospital. Despite the high morbidity, mortality was relatively low. Careful clinical management and adequate resources are needed in hospitalised HIV-TB patients in the 1st three months following ART initiation.	[van der Plas, Helen; Meintjes, Graeme; Wilkinson, Robert J.; Maartens, Gary; Mendelson, Marc] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme; Schutz, Charlotte; Goliath, Rene; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol Res, ZA-7925 Cape Town, South Africa; [Baatjie, Dorothea] Brooklyn Chest Hosp, Cape Town, South Africa; [Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Cape Town; University of Cape Town; Imperial College London; University of Cape Town; MRC National Institute for Medical Research	van der Plas, H (corresponding author), Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa.	Helenvanderplas@gmail.com	Maartens, Gary/F-3836-2014; Schutz, Charlotte/G-6864-2016; Maartens, Gary/S-2788-2019	Maartens, Gary/0000-0003-3080-6606; Schutz, Charlotte/0000-0001-8329-6158; Maartens, Gary/0000-0003-3080-6606; Mendelson, Marc/0000-0001-6668-3893; Wilkinson, Robert/0000-0002-2753-1800; Meintjes, Graeme/0000-0003-1196-4414	United States President's Emergency Plan for AIDS Relief (PEPFAR)/United States Agency for International Development (USAID) through the Anova Health Institute; Fogarty International Center [U2RTW007970/3 ICORTA]; Wellcome Trust [081667, 088316]; Fogarty International Center South Africa TB/AIDS Training Award [NIH/FIC 1U2RTW007373-01A1, U2RTW007373 ICORTA]; MRC [U.1175.02.002.00014.01]	United States President's Emergency Plan for AIDS Relief (PEPFAR)/United States Agency for International Development (USAID) through the Anova Health Institute(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa TB/AIDS Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HvdP, GrM and MM were supported by funding from United States President's Emergency Plan for AIDS Relief (PEPFAR)/United States Agency for International Development (USAID) through the Anova Health Institute. HvdP received research training support from the South African Tuberculosis HIV Training that was funded by the Fogarty International Center grant number U2RTW007970/3 ICORTA. Graeme Meintjes (GrM) received support from the Wellcome Trust (081667) and a Fogarty International Center South Africa TB/AIDS Training Award (NIH/FIC 1U2RTW007373-01A1 and U2RTW007373 ICORTA). RJW received support from Welcome Trust (088316) and MRC (U.1175.02.002.00014.01). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Haddow LJ, 2011, AIDS, V25, P1163, DOI 10.1097/QAD.0b013e3283477d67; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Pepper DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004520; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; van der Plas H, 2011, SAMJ S AFR MED J, V101, P529; Waitt CJ, 2011, J INFECT DIS, V204, P358, DOI 10.1093/infdis/jir265; WHO, GLOB TUB CONTR 2011; World Health Organization, IMPR DIAGN TREATM SM	17	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e54145	10.1371/journal.pone.0054145	http://dx.doi.org/10.1371/journal.pone.0054145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408935	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300003
J	Caorsi, V; Toepfer, C; Sikkel, MB; Lyon, AR; MacLeod, K; Ferenczi, MA				Caorsi, Valentina; Toepfer, Christopher; Sikkel, Markus B.; Lyon, Alexander R.; MacLeod, Ken; Ferenczi, Mike A.			Non-Linear Optical Microscopy Sheds Light on Cardiovascular Disease	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; HEART-FAILURE; IN-VIVO; FIBROSIS; CARDIOMYOPATHY; FLUORESCENCE; TISSUES; CORNEA; CELLS	Many cardiac diseases have been associated with increased fibrosis and changes in the organization of fibrillar collagen. The degree of fibrosis is routinely analyzed with invasive histological and immunohistochemical methods, giving a limited and qualitative understanding of the tissue's morphological adaptation to disease. Our aim is to quantitatively evaluate the increase in fibrosis by three-dimensional imaging of the collagen network in the myocardium using the non-linear optical microscopy techniques Two-Photon Excitation microscopy (TPE) and Second Harmonic signal Generation (SHG). No sample staining is needed because numerous endogenous fluorophores are excited by a two-photon mechanism and highly non-centrosymmetric structures such as collagen generate strong second harmonic signals. We propose for the first time a 3D quantitative analysis to carefully evaluate the increased fibrosis in tissue from a rat model of heart failure post myocardial infarction. We show how to measure changes in fibrosis from the backward SHG (B-SHG) alone, as only backward-propagating SHG is accessible for true in vivo applications. A 5-fold increase in collagen I fibrosis is detected in the remote surviving myocardium measured 20 weeks after infarction. The spatial distribution is also shown to change markedly, providing insight into the morphology of disease progression.	[Caorsi, Valentina; Toepfer, Christopher; Sikkel, Markus B.; Lyon, Alexander R.; Ferenczi, Mike A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Lyon, Alexander R.; MacLeod, Ken] Royal Brompton Hosp, Cardiovasc Biomed Res Unit, London SW3 6LY, England; [Ferenczi, Mike A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Imperial College London; Royal Brompton Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Caorsi, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	v.caorsi@imperial.ac.uk	Ferenczi, Michael/F-9510-2015; Sikkel, Markus/ABC-1043-2020	Ferenczi, Michael/0000-0002-0349-331X; Sikkel, Markus/0000-0001-9801-8978; Toepfer, Christopher/0000-0003-4671-2030	Royal Society (Newton International fellowship); Biotechnology and Biological Sciences Research Council [BB/I019448/1]; Wellcome Trust [091460/Z/10/Z, 092852/Z/10/Z]; British Heart Foundation Intermediate Research Fellowship [FS/11/67/28954]; National Institute for Health Research; British Heart Foundation [RG/11/20/29266, FS/11/67/28954] Funding Source: researchfish; BBSRC [BB/I019448/1] Funding Source: UKRI	Royal Society (Newton International fellowship); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation Intermediate Research Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Society (Newton International fellowship to VC), the Biotechnology and Biological Sciences Research Council [grant number BB/I019448/1] and the Wellcome Trust [grant numbers 091460/Z/10/Z, 092852/Z/10/Z]. ARL was supported by a British Heart Foundation Intermediate Research Fellowship (FS/11/67/28954) and the National Institute for Health Research-funded Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambekar R, 2012, BIOMED OPT EXPRESS, V3, P2021, DOI 10.1364/BOE.3.002021; Booth MJ, 2007, PHILOS T R SOC A, V365, P2829, DOI 10.1098/rsta.2007.0013; Burlew Brad S., 2000, Cardiology Clinics, V18, P435, DOI 10.1016/S0733-8651(05)70154-5; Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325; Campagnola PJ, 1999, BIOPHYS J, V77, P3341, DOI 10.1016/S0006-3495(99)77165-1; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Chen J, 2001, PLOS ONE, V6; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cittadini A, 2003, CARDIOVASC RES, V58, P555, DOI 10.1016/S0008-6363(03)00251-7; Diaspro A, 2006, WILEY ENCY BIOMEDICA; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Francis GS, 1995, EUR HEART J, V16, P31, DOI 10.1093/eurheartj/16.suppl_N.31; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V350, P497, DOI 10.1113/jphysiol.1984.sp015215; Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; He G. S., 1999, PHYS NONLINEAR OPTIC; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; Klein G, 2005, CIRC RES, V96, P748, DOI 10.1161/01.RES.0000161999.86198.1e; LaComb R, 2008, BIOPHYS J, V94, P4504, DOI 10.1529/biophysj.107.114405; LaComb R, 2008, OPT COMMUN, V281, P1823, DOI 10.1016/j.optcom.2007.10.040; LaComb R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907207; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Oheim M, 2006, ADV DRUG DELIVER REV, V58, P788, DOI 10.1016/j.addr.2006.07.005; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Psilodimitrakopoulos S, 2009, OPT EXPRESS, V17, P14418, DOI 10.1364/OE.17.014418; Rivera DR, 2011, P NATL ACAD SCI USA, V108, P17598, DOI 10.1073/pnas.1114746108; Sato M, 2005, GENE THER, V12, P936, DOI 10.1038/sj.gt.3302476; Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966; Schenke-Layland K, 2009, EUR HEART J, V30, P2254, DOI 10.1093/eurheartj/ehp267; See F, 2005, CURR PHARM DESIGN, V11, P477, DOI 10.2174/1381612053382098; Su PJ, 2011, BIOPHYS J, V100, P2053, DOI 10.1016/j.bpj.2011.02.015; Sun WX, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041159; Thayil A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3569614; THIRLWELL H, 1994, BIOPHYS J, V67, P2436, DOI 10.1016/S0006-3495(94)80730-1; Tsai MR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3365943; Wallenburg MA, 2011, J BIOPHOTONICS, V4, P297, DOI 10.1002/jbio.201000059; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Wu YC, 2009, OPT EXPRESS, V17, P7907, DOI 10.1364/OE.17.007907; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	43	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56136	10.1371/journal.pone.0056136	http://dx.doi.org/10.1371/journal.pone.0056136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409139	Green Published, gold			2022-12-25	WOS:000315157200113
J	Ji, HZ; Li, Y; Liang, BH; Pilon, R; MacPherson, P; Bergeron, M; Kim, J; Graham, M; Van Domselaar, G; Sandstrom, P; Brooks, J				Ji, Hezhao; Li, Yang; Liang, Binhua; Pilon, Richard; MacPherson, Paul; Bergeron, Michele; Kim, John; Graham, Morag; Van Domselaar, Gary; Sandstrom, Paul; Brooks, James			Pyrosequencing Dried Blood Spots Reveals Differences in HIV Drug Resistance between Treatment Naive and Experienced Patients	PLOS ONE			English	Article							PERIPHERAL-BLOOD; WHOLE-BLOOD; ANTIRETROVIRAL THERAPY; RNA QUANTIFICATION; STORAGE-CONDITIONS; PCR AMPLIFICATION; GENOTYPING ASSAY; SUBTYPE-C; DNA; PLASMA	Dried blood spots (DBS) are an alternative specimen collection format for HIV-1 genotyping. DBS produce HIV genotyping results that are robust and equivalent to plasma when using conventional sequencing methods. However, using tagged, pooled pyrosequencing, we demonstrate that concordance between plasma and DBS is not absolute and varies according to viral load (VL), duration of HIV infection and antiretroviral therapy (ART) status. The plasma/DBS concordance is the highest when VL is >= 5,000 copies/ml and/or the patient has no ART exposure and/or when the duration of HIV infection is <= 2 years. Stepwise regression analysis revealed that VL is most important independent predictor for concordance of DBS with plasma genotypes. This is the first study to use next generation sequencing to identify discordance between DBS and plasma genotypes. Consideration should be given to VL, duration of infection, and ART exposure when interpreting DBS genotypes produced using next generation sequencing. These findings are of particular significance when DBS are to be used for clinical monitoring purposes.	[Ji, Hezhao; Li, Yang; Pilon, Richard; Bergeron, Michele; Kim, John; Sandstrom, Paul; Brooks, James] Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Liang, Binhua; Van Domselaar, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Bioinformat Core, Winnipeg, MB, Canada; [Liang, Binhua; Graham, Morag] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [MacPherson, Paul] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada; [Graham, Morag] Publ Hlth Agcy Canada, Natl Microbiol Lab, Genom Core Facil, Winnipeg, MB, Canada	Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; Public Health Agency of Canada	Brooks, J (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada.	james_brooks@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407; Ji, Hezhao/0000-0002-5451-6294; Pilon, Richard/0000-0003-0100-6917	federal initiative to address HIV/AIDS in Canada	federal initiative to address HIV/AIDS in Canada	This work was supported by the federal initiative to address HIV/AIDS in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertagnolio S, 2007, ANTIVIR THER, V12, P107; Bertagnolio S, 2010, AIDS REV, V12, P195; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Hallack R, 2008, J CLIN VIROL, V41, P283, DOI 10.1016/j.jcv.2007.12.011; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ji H, 2011, 18 C RETR OPP INF CR; Ji HZ, 2011, ANTIVIR THER, V16, P871, DOI 10.3851/IMP1839; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Johannessen A, 2010, ANTIVIR THER, V15, P1003, DOI 10.3851/IMP1660; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; KROODSMA KL, 1994, J INFECT DIS, V170, P1292, DOI 10.1093/infdis/170.5.1292; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Monleau M, 2009, J CLIN MICROBIOL, V47, P1107, DOI 10.1128/JCM.02255-08; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Steegen K, 2007, J CLIN MICROBIOL, V45, P3342, DOI 10.1128/JCM.00814-07; UNAIDS, 2010, AIDS EP UPD DEC 2009; Vicenti I, 2007, CLIN INFECT DIS, V44, P1657, DOI 10.1086/518287; Wei XR, 2011, J CLIN VIROL, V50, P148, DOI 10.1016/j.jcv.2010.11.006; WHO, 2010, ANT THER HIV INF AD; Ziemniak C, 2006, J VIROL METHODS, V136, P238, DOI 10.1016/j.jviromet.2006.05.030	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56170	10.1371/journal.pone.0056170	http://dx.doi.org/10.1371/journal.pone.0056170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409150	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200121
J	Talavera, D; Sheoran, R; Lovell, SC				Talavera, David; Sheoran, Ritika; Lovell, Simon C.			Analysis of Genetic Interaction Networks Shows That Alternatively Spliced Genes Are Highly Versatile	PLOS ONE			English	Article							MESSENGER-RNA DECAY; C-ELEGANS; PROTEIN-INTERACTION; TRANSCRIPTION; LIN-35/RB; CELL; THERAPY; CONTEXT	Alternative splicing has the potential to increase the diversity of the transcriptome and proteome. Where more than one transcript arises from a gene they are often so different that they are quite unlikely to have the same function. However, it remains unclear if alternative splicing generally leads to a gene being involved in multiple biological processes or whether it alters the function within a single process. Knowing that genetic interactions occur between functionally related genes, we have used them as a proxy for functional versatility, and have analysed the sets of genes of two well-characterised model organisms: Caenorhabditis elegans and Drosophila melanogaster. Using network analyses we find that few genes are functionally homogenous (only involved in a few functionally-related biological processes). Moreover, there are differences between alternatively spliced genes and genes with a single transcript; specifically, genes with alternatively splicing are, on average, involved in more biological processes. Finally, we suggest that factors other than specific functional classes determine whether a gene is alternatively spliced.	[Talavera, David; Sheoran, Ritika; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Talavera, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	David.Talavera@manchester.ac.uk; simon.lovell@manchester.ac.uk	Talavera, David/AAD-2088-2021	Lovell, Simon/0000-0002-4092-8458; Talavera, David/0000-0002-8820-3931	BBSRC [BB/F013337/1, BB/H006818/1]; Biotechnology and Biological Sciences Research Council [BB/H006818/1, BB/F013337/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grants BB/F013337/1 and BB/H006818/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Bellay J, 2011, GENOME RES, V21, P1375, DOI 10.1101/gr.117176.110; Bender AM, 2004, DEV BIOL, V273, P335, DOI 10.1016/j.ydbio.2004.06.009; Bracco L, 2003, TRENDS BIOTECHNOL, V21, P346, DOI 10.1016/S0167-7799(03)00146-X; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cui MX, 2004, GENETICS, V167, P1177, DOI 10.1534/genetics.103.024554; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Deeds EJ, 2007, P NATL ACAD SCI USA, V104, P14952, DOI 10.1073/pnas.0702766104; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Fay DS, 2003, DEVELOPMENT, V130, P3319, DOI 10.1242/dev.00561; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kruse S, 1999, INT IMMUNOL, V11, P1965, DOI 10.1093/intimm/11.12.1965; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Michaut M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001092; Neu-Yilik G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-218; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Talavera D, 2007, PLOS COMPUT BIOL, V3, P375, DOI 10.1371/journal.pcbi.0030033; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zhang L, 2003, BIOCHEM BIOPH RES CO, V303, P1169, DOI 10.1016/S0006-291X(03)00495-9	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55671	10.1371/journal.pone.0055671	http://dx.doi.org/10.1371/journal.pone.0055671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409018	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200049
J	Kong, F; Zhang, J; Li, Y; Hao, X; Ren, X; Li, H; Zhou, P				Kong, F.; Zhang, J.; Li, Y.; Hao, X.; Ren, X.; Li, H.; Zhou, P.			Engineering a single ubiquitin ligase for the selective degradation of all activated ErbB receptor tyrosine kinases	ONCOGENE			English	Article						ubiquitin; ErbB; breast cancer; protein knockout; proteolysis; receptor tyrosine kinase	PHASE-II TRIAL; BREAST-CANCER; BETA-CATENIN; GROWTH; TRASTUZUMAB; TARGET; HER-2; GENE; PROLIFERATION; DESTRUCTION	Interrogating specific cellular activities often entails the dissection of posttranslational modifications or functional redundancy conferred by protein families, which demands more sophisticated research tools than simply eliminating a specific gene product by gene targeting or RNA interference. We have developed a novel methodology that involves engineering a single SCF beta TrCP-based ubiquitin ligase that is capable of not only simultaneously targeting the entire family of ErbB receptor tyrosine kinases for ubiquitination and degradation, but also selectively recruiting only activated ErbBs. The engineered SCF beta TrCP ubiquitin ligase effectively blocked ErbB signaling and attenuated oncogenicity in breast cancer cells, yet had little effect on the survival and growth of non-cancerous breast epithelial cells. Therefore, engineering ubiquitin ligases offers a simple research tool to dissect the specific traits of tumorigenic protein families, and provides a rapid and feasible means to expand the dimensionality of drug discovery by assessing protein families or posttranslational modifications as potential drug targets.	[Kong, F.; Zhang, J.; Li, Y.; Zhou, P.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Kong, F.; Hao, X.; Ren, X.; Li, H.] Tianjin Med Univ, Canc Inst & Hosp, Dept Biotherapy, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China	Cornell University; Tianjin Medical University	Li, H (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Biotherapy, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China.	lihui_0105@yahoo.com; pez2001@med.cornell.edu			National Institutes of Health [CA92792]; Irma T. Hirschl Career Scientist Award; New York Academy of Medicine; Natural Science Foundation of China [30901754]; Innovation Funding for Graduates of Tianjin Medical University; 211 Project for Higher Education [2010GSI01]; NATIONAL CANCER INSTITUTE [R01CA159925, R21CA092792, R33CA092792, R01CA098210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Career Scientist Award; New York Academy of Medicine; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Funding for Graduates of Tianjin Medical University; 211 Project for Higher Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bruce Mayer (University of Connecticut) for Shc plasmids, Alexandra Grassian for helpful discussions, and Jeffrey Hannah and Jennifer Lee for critical reading of the manuscript. This work is supported by National Institutes of Health Grant CA92792, the Irma T. Hirschl Career Scientist Award and the Speakers Fund from the New York Academy of Medicine to P.Z., and the Natural Science Foundation of China (No. 30901754) and Innovation Funding for Graduates of Tianjin Medical University, third Phase of the 211 Project for Higher Education (No. 2010GSI01).	Burstein HJ, 2001, J CLIN ONCOL, V19, P2722, DOI 10.1200/JCO.2001.19.10.2722; Carraway KL, 2010, SEMIN CELL DEV BIOL, V21, P936, DOI 10.1016/j.semcdb.2010.09.006; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chen XA, 2006, MOL CELL, V22, P489, DOI 10.1016/j.molcel.2006.04.021; Cohen J Craig, 2004, BMC Dev Biol, V4, P4; Colomer R, 2000, CLIN CANCER RES, V6, P2356; Cong F, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-10; Faltus T, 2004, NEOPLASIA, V6, P786, DOI 10.1593/neo.04313; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gasparini G, 2007, BREAST CANCER RES TR, V101, P355, DOI 10.1007/s10549-006-9306-9; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hannah J, 2011, CELL RES, V21, P1152, DOI 10.1038/cr.2011.89; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Klapper LN, 2000, CANCER RES, V60, P3384; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Liu J, 2004, BIOCHEM BIOPH RES CO, V313, P1023, DOI 10.1016/j.bbrc.2003.12.035; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Palmieri D, 2006, BREAST CANCER RES TR, V100, P127, DOI 10.1007/s10549-006-9244-6; Panigada M, 2002, J EXP MED, V195, P1585, DOI 10.1084/jem.20020047; Persons DA, 1998, BLOOD CELL MOL DIS, V24, P167, DOI 10.1006/bcmd.1998.0184; Rabindran SK, 2005, CANCER LETT, V227, P9, DOI 10.1016/j.canlet.2004.11.015; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Su YY, 2003, P NATL ACAD SCI USA, V100, P12729, DOI 10.1073/pnas.2133261100; Suenaga A, 2009, BIOPHYS J, V96, P2278, DOI 10.1016/j.bpj.2008.11.018; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986; Yajnik V, 1996, J BIOL CHEM, V271, P1813, DOI 10.1074/jbc.271.4.1813; Yang G, 2004, J BIOL CHEM, V279, P4339, DOI 10.1074/jbc.M311153200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang JX, 2003, P NATL ACAD SCI USA, V100, P14127, DOI 10.1073/pnas.2233012100; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5; Zhou PB, 2005, CURR OPIN CHEM BIOL, V9, P51, DOI 10.1016/j.cbpa.2004.10.012; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	46	11	11	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					986	995		10.1038/onc.2013.33	http://dx.doi.org/10.1038/onc.2013.33			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23416973	Green Accepted			2022-12-25	WOS:000331933200006
J	Streich, FC; Ronchi, VP; Connick, JP; Haas, AL				Streich, Frederick C., Jr.; Ronchi, Virginia P.; Connick, J. Patrick; Haas, Arthur L.			Tripartite Motif Ligases Catalyze Polyubiquitin Chain Formation through a Cooperative Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; GLUTATHIONE-S-TRANSFERASE; RING DOMAIN; MULTIUBIQUITIN CHAIN; PROTEIN INTERACTIONS; E2 ENZYMES; TRIM32; FINGER; DIMERIZATION; TRIM5-ALPHA	Ligation of polyubiquitin chains to proteins is a fundamental post-translational modification, often resulting in targeted degradation of conjugated proteins. Attachment of polyubiquitin chains requires the activities of an E1 activating enzyme, an E2 carrier protein, and an E3 ligase. The mechanism by which polyubiquitin chains are formed remains largely speculative, especially for RING-based ligases. The tripartite motif (TRIM) superfamily of ligases functions in many cellular processes including innate immunity, cellular localization, development and differentiation, signaling, and cancer progression. The present results show that TRIM ligases catalyze polyubiquitin chain formation in the absence of substrate, the rates of which can be used as a functional readout of enzyme function. Initial rate studies under biochemically defined conditions show that TRIM32 and TRIM25 are specific for the Ubc5 family of E2-conjugating proteins and, along with TRIM5 alpha, exhibit cooperative kinetics with respect to Ubc5 concentration, with submicromolar [S](0.5) and Hill coefficients of 3-5, suggesting they possess multiple binding sites for their cognate E2-ubiquitin thioester. Mutation studies reveal a second, non-canonical binding site encompassing the C-terminal Ubc5 alpha-helix. Polyubiquitin chain formation requires TRIM subunit oligomerization through the conserved coiled-coil domain, but can be partially replaced by fusing the catalytic domain to GST to promote dimerization. Other results suggest that TRIM32 assembles polyubiquitin chains as a Ubc5-linked thioester intermediate. These results represent the first detailed mechanistic study of TRIM ligase activity and provide a functional context for oligomerization observed in the superfamily.	[Streich, Frederick C., Jr.; Ronchi, Virginia P.; Connick, J. Patrick; Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu		Streich Jr, Frederick/0000-0002-7549-424X	National Institutes of Health [R01 GM0034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM0034009 (to A.L.H.).	Albor A, 2007, MOL CARCINOGEN, V46, P585, DOI 10.1002/mc.20344; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Guglieri M, 2005, CLIN CHIM ACTA, V361, P54, DOI 10.1016/j.cccn.2005.05.020; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Haas AL, 1997, FASEB J, V11, P1257; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Horn EJ, 2004, CARCINOGENESIS, V25, P157, DOI 10.1093/carcin/bgh003; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Kim I, 2006, SCI STKE, V2006, P18; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; Kumar B, 2010, J BIOL CHEM, V285, P41300, DOI 10.1074/jbc.M110.169136; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Liu YG, 2010, J INVEST DERMATOL, V130, P1384, DOI 10.1038/jid.2009.416; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Muller J, 2010, HUM GENET, V127, P583, DOI 10.1007/s00439-010-0804-9; Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2; Nakajima A, 2007, BIOCHEM BIOPH RES CO, V357, P245, DOI 10.1016/j.bbrc.2007.03.134; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Russell Nathaniel S., 2005, V301, P207; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; SEGAL IH, 1975, ENZYME KINETICS; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Urano T, 2009, BIOCHEM BIOPH RES CO, V383, P263, DOI 10.1016/j.bbrc.2009.04.010; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zou WG, 2007, BIOCHEM BIOPH RES CO, V354, P321, DOI 10.1016/j.bbrc.2006.12.210	74	36	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8209	8221		10.1074/jbc.M113.451567	http://dx.doi.org/10.1074/jbc.M113.451567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23408431	Green Published, hybrid			2022-12-25	WOS:000316564500021
J	Filevich, E; Kuhn, S; Haggard, P				Filevich, Elisa; Kuehn, Simone; Haggard, Patrick			There Is No Free Won't: Antecedent Brain Activity Predicts Decisions to Inhibit	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; FREE WILL; REACTION-TIME; VARIATION CNV; POTENTIALS; MOVEMENTS; MODEL; SPECIALIZATION; PERCEPTION; ATTENTION	Inhibition of prepotent action is an important aspect of self-control, particularly in social contexts. Action inhibition and its neural bases have been extensively studied. However, the neural precursors of free decisions to inhibit have hardly been studied. We asked participants to freely choose to either make a rapid key press in response to a visual cue, or to transiently inhibit action, and briefly delay responding. The task required a behavioural response on each trial, so trials involving inhibition could be distinguished from those without inhibition as those showing slower reaction times. We used this criterion to classify free-choice trials as either rapid or inhibited/delayed. For 13 participants, we measured the mean amplitude of the ERP activity at electrode Cz in three subsequent 50 ms time windows prior to the onset of the signal that either instructed to respond or inhibit, or gave participants a free choice. In two of these 50 ms time windows (-150 to -100, and -100 to -50 ms relative to action onset), the amplitude of prestimulus ERP differed between trials where participants ''freely'' chose whether to inhibit or to respond rapidly. Larger prestimulus ERP amplitudes were associated with trials in which participants decided to act rapidly as compared to trials in which they decided to delay their responses. Last-moment decisions to inhibit or delay may depend on unconscious preparatory neural activity.	[Filevich, Elisa; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Kuehn, Simone] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Kuehn, Simone] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Filevich, Elisa; Kuehn, Simone] Max Planck Inst Human Dev & Educ, Ctr Lifespan Psychol, Berlin, Germany	University of London; University College London; Ghent University; Ghent University; Max Planck Society	Filevich, E (corresponding author), UCL, Inst Cognit Neurosci, London, England.	e.filevich@ucl.ac.uk	Kuehn, Simone/P-6145-2014	Haggard, Patrick/0000-0001-7798-793X; Kuhn, Simone/0000-0001-6823-7969; Filevich, Elisa/0000-0002-1158-8220	Wellcome Trust; Overseas Research Students award from the British Council; Research Foundation Flanders; European Science Foundation-European Collaborative Research Project/Economic and social Research Council grant [RES-062-23-2183]; Leverhulme Trust Major Research Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Overseas Research Students award from the British Council; Research Foundation Flanders(FWO); European Science Foundation-European Collaborative Research Project/Economic and social Research Council grant; Leverhulme Trust Major Research Fellowship	This work was supported by the Wellcome Trust (http://www.wellcome.ac.uk/), an Overseas Research Students award from the British Council (http://www.britishcouncil.org/new/) [EF], a Postdoctoral Fellowship from the Research Foundation Flanders (http://www.fwo.be/) [SK], an European Science Foundation-European Collaborative Research Project/Economic and social Research Council grant (RES-062-23-2183, http://www.esf.org/), and by a Leverhulme Trust Major Research Fellowship (http://www.leverhulme.ac.uk/) [PH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WP, 2009, PSYCHOL SCI, V20, P17, DOI 10.1111/j.1467-9280.2008.02254.x; Bradshaw JL, 2001, TRENDS COGN SCI, V5, P184, DOI 10.1016/S1364-6613(00)01656-9; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Brass M, 2007, J NEUROSCI, V27, P9141, DOI 10.1523/JNEUROSCI.0924-07.2007; Britz J, 2010, NEUROIMAGE, V49, P2774, DOI 10.1016/j.neuroimage.2009.10.033; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Dirnberger G, 1998, EXP BRAIN RES, V120, P263, DOI 10.1007/s002210050400; Dirnberger G, 2011, INT J PSYCHOPHYSIOL, V81, P127, DOI 10.1016/j.ijpsycho.2011.04.008; Filevich E, 2012, NEUROSCI BIOBEHAV R, V36, P1107, DOI 10.1016/j.neubiorev.2012.01.006; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Goldberg I, 2008, CONSCIOUS COGN, V17, P587, DOI 10.1016/j.concog.2007.10.003; Gruber MJ, 2010, J NEUROSCI, V30, P9793, DOI 10.1523/JNEUROSCI.0915-10.2010; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; HILLYARD SA, 1969, PHYSIOL BEHAV, V4, P351, DOI 10.1016/0031-9384(69)90188-7; Hughes G, 2009, PSYCHOPHYSIOLOGY, V46, P1258, DOI 10.1111/j.1469-8986.2009.00873.x; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1982, ELECTROEN CLIN NEURO, V54, P322, DOI 10.1016/0013-4694(82)90181-X; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luck S.J., 2005, INTRO EVENT RELATED; Mazaheri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016243; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Nichols S, 2011, SCIENCE, V331, P1401, DOI 10.1126/science.1192931; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Passingham RE, 2009, TRENDS COGNITIVE SCI; Rigoni D, 2011, PSYCHOL SCI; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SAS Institute, 1999, SAS STAT US GUID VER; Schlaghecken F, 2004, PSYCHON B REV, V11, P463, DOI 10.3758/BF03196596; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Stroop JR, 1935, J EXP PSYCHOL, V18, P3; TECCE JJ, 1972, PSYCHOL BULL, V77, P73, DOI 10.1037/h0032177; Velmans M, 2002, J CONSCIOUSNESS STUD, V9, P3; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Walsh E, 2010, NEUROPSYCHOLOGIA, V48, P619, DOI 10.1016/j.neuropsychologia.2009.10.026; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wittmann M, 2001, COGNITIVE BRAIN RES, V10, P341, DOI 10.1016/S0926-6410(00)00052-5	46	33	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53053	10.1371/journal.pone.0053053	http://dx.doi.org/10.1371/journal.pone.0053053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418420	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300010
J	Kasahara, K; Shirota, M; Kinoshita, K				Kasahara, Kota; Shirota, Matsuyuki; Kinoshita, Kengo			Ion Concentration-Dependent Ion Conduction Mechanism of a Voltage-Sensitive Potassium Channel	PLOS ONE			English	Article							CONSTANT ELECTRIC-FIELD; MOLECULAR-DYNAMICS; K+ CHANNEL; PERMEATION THEORY; FILE; SIMULATIONS; SELECTIVITY; ENERGETICS	Voltage-sensitive potassium ion channels are essential for life, but the molecular basis of their ion conduction is not well understood. In particular, the impact of ion concentration on ion conduction has not been fully studied. We performed several micro-second molecular dynamics simulations of the pore domain of the Kv1.2 potassium channel in KCl solution at four different ion concentrations, and scrutinized each of the conduction events, based on graphical representations of the simulation trajectories. As a result, we observed that the conduction mechanism switched with different ion concentrations: at high ion concentrations, potassium conduction occurred by Hodgkin and Keynes' knock-on mechanism, where the association of an incoming ion with the channel is tightly coupled with the dissociation of an outgoing ion, in a one-step manner. On the other hand, at low ion concentrations, ions mainly permeated by a two-step association/dissociation mechanism, in which the association and dissociation of ions were not coupled, and occurred in two distinct steps. We also found that this switch was triggered by the facilitated association of an ion from the intracellular side within the channel pore and by the delayed dissociation of the outermost ion, as the ion concentration increased.	[Kasahara, Kota; Shirota, Matsuyuki; Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi 980, Japan; [Shirota, Matsuyuki; Kinoshita, Kengo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Kinoshita, K (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi 980, Japan.	kengo@ecei.tohoku.ac.jp	Kinoshita, Kengo/E-9688-2011	Kinoshita, Kengo/0000-0003-3453-2171; Kasahara, Kota/0000-0003-0207-6271	 [22136005]; Grants-in-Aid for Scientific Research [22136005] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the "HD-Physiology'' Grant-in-Aid for Scientific Research on Innovative Areas (22136005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, J GEN PHYSIOL, V137, P397, DOI 10.1085/jgp.201010546; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bowers K.J., 2006, P 2006 ACM IEEE C SU, DOI [10.1109/SC.2006.54, DOI 10.1109/SC.2006.54]; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gumbart J, 2012, BBA-BIOMEMBRANES, V1818, P294, DOI 10.1016/j.bbamem.2011.09.030; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; Kim I, 2011, P NATL ACAD SCI USA, V108, P17963, DOI 10.1073/pnas.1110735108; Kraszewski S, 2007, PHYS CHEM CHEM PHYS, V9, P1219, DOI 10.1039/b613668k; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; Miller C., 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-4-reviews0004.REVIEWS0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004.REVIEWS0004, 10.1186/gb-2000-1-4-reviews0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004]; Miloshevsky GV, 2004, TRENDS NEUROSCI, V27, P308, DOI 10.1016/j.tins.2004.03.013; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nelson PH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3580562; Nelson PH, 2003, J CHEM PHYS, V119, P6981, DOI 10.1063/1.1604112; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oiki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016578; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	42	11	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56342	10.1371/journal.pone.0056342	http://dx.doi.org/10.1371/journal.pone.0056342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418558	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300151
J	Leone, MA; Raymkulova, O; Naldi, P; Lochner, P; Bolamperti, L; Coppo, L; Stecco, A; Liboni, W				Leone, Maurizio A.; Raymkulova, Olga; Naldi, Paola; Lochner, Piergiorgio; Bolamperti, Laura; Coppo, Lorenzo; Stecco, Alessandro; Liboni, William			Chronic Cerebrospinal Venous Insufficiency Is Not Associated with Multiple Sclerosis and Its Severity: A Blind-Verified Study	PLOS ONE			English	Article							HEMODYNAMICS; DISABILITY; ULTRASOUND; FATIGUE; SCALE; CCSVI	Background: Chronic Cerebrospinal Venous Insufficiency (CCSVI) has been associated with multiple sclerosis (MS) with a risk ranging from as high as two-hundred-fold to a protective effect. However, not all studies were blinded, and the efficacy of blinding was never assessed. Objective: To evaluate the association of CCSVI with MS in a cross-sectional blinded study and look for any association of CCSVI with the severity of MS. Methodology/Principal Findings: The Echo-color Doppler examination was carried out in accordance with Zamboni's five criteria in 68 consecutive MS patients and 68 healthy controls, matched by gender and age (+/- 5 years). Four experienced neurosonologists, blinded to the status of cases and controls, performed the study and were then asked to guess the status (case or control) of each participant. The number of positive CCSVI criteria was similar in the two groups. CCSVI, defined as the presence of two or more criteria, was detected in 21 cases (30.9%) and 23 controls (33.8%), with an OR of 0.9 (95%CL = 0.4-1.8, p = 0.71). The prevalence of CCSVI was related to age in cases (OR increasing from 0.2 to 1.4), but not in controls. CCSVI positive (N = 21) and negative (N = 47) MS patients were similar in clinical type, age at disease onset, disability, and fatigue. Disease duration was longer (16.5 +/- 9.8 years) in CCSVI positive than negative patients (11.5 +/- 7.4; p = 0.04). The operators correctly guessed 34/68 cases (50%) and 45/68 controls (66%) (p = 0.06), indicating a different success of blinding. Conclusions/Significance: CCSVI was not associated with MS itself, nor its severity. We cannot rule out the possibility that CCSVI is a consequence of MS or of aging. Blinding of sonographers is a key point in studying CCSVI and its verification should be a requisite of future studies.	[Leone, Maurizio A.; Raymkulova, Olga; Naldi, Paola] AOU Maggiore Carita, Head & Neck Dept, MS Ctr, Novara, Italy; [Leone, Maurizio A.] Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Lochner, Piergiorgio] Hosp Tappeiner, Dept Neurol, Merano, Italy; [Bolamperti, Laura; Coppo, Lorenzo] AOU Maggiore Carita, Head & Neck Dept, SCDU Neurol, Novara, Italy; [Stecco, Alessandro] AOU Maggiore Carita, Ist Radiol Diagnost & Interventist, Novara, Italy; [Liboni, William] Gradenigo Hosp, SNC Neurol, Turin, Italy; [Liboni, William] Fdn Passo Insieme, Valdellatorre, Italy	Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Humanitas Hospital Gradenigo	Leone, MA (corresponding author), AOU Maggiore Carita, Head & Neck Dept, MS Ctr, Novara, Italy.	maurizio.leone@maggioreosp.novara.it	Leone, Maurizio A./J-4130-2016; Lochner, Piergiorgio/AAB-6784-2020; Stecco, Alessandro/O-4872-2018	Leone, Maurizio A./0000-0002-6339-5738; Lochner, Piergiorgio/0000-0002-2101-6066; Stecco, Alessandro/0000-0002-0712-7595	Merck-Serono; Biogen-Idec; Sanofi Aventis	Merck-Serono(Merck & Company); Biogen-Idec(Biogen); Sanofi Aventis(Sanofi-Aventis)	Maurizio A. Leone has received funds for travel, and research grants from Merck-Serono, Biogen-Idec, and Sanofi Aventis, and has been invited to meeting by ESAOTE. He is Associate Editor of the European Journal of Neurology. William Liboni was supported by ESAOTE for his course at the Zamboni laboratory. Paola Naldi has received funds for travel from Merck-Serono. Alessandro Stecco, Laura Bolamperti, Lorenzo Coppo, Piergiorgio Lochner, and Olga Raymkulova have nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials	Al-Omari MH, 2010, INT ANGIOL, V29, P115; Amato MP, 2012, MULT SCLER J, V18, P1791, DOI 10.1177/1352458512445943; [Anonymous], 2011, R LANG ENV STAT COMP; Auriel E, 2011, J NEUROL SCI, V309, P102, DOI 10.1016/j.jns.2011.07.005; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Baracchini C, 2011, NEUROLOGY, V77, P844, DOI 10.1212/WNL.0b013e31822c6208; Baracchini C, 2012, J NEUROL, V259, P2585, DOI 10.1007/s00415-012-6541-3; Baracchini C, 2011, ANN NEUROL, V69, P90, DOI 10.1002/ana.22228; Bastianello S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-132; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Blinkenberg M, 2012, ACTA NEUROL SCAND, V126, P421, DOI 10.1111/j.1600-0404.2012.01671.x; Centonze D, 2011, ANN NEUROL, V70, P51, DOI 10.1002/ana.22436; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Fleiss JL, 2007, STAT METHODS RATES P, P140; Khan O, 2010, ANN NEUROL, V67, P286, DOI 10.1002/ana.22001; Krogias C, 2010, NERVENARZT, V81, P740, DOI 10.1007/s00115-010-2972-1; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laupacis A, 2011, CAN MED ASSOC J, V183, pE1203, DOI 10.1503/cmaj.111074; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Malagoni AM, 2010, INT ANGIOL, V29, P176; Marder E, 2011, ARCH NEUROL-CHICAGO, V68, P1521, DOI 10.1001/archneurol.2011.185; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; Monti L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025012; Patti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041227; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Radak D, 2012, PHLEBOLOGY, V27, P168, DOI 10.1258/phleb.2011.011004; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; SAS Institute Inc, 1999, SUGI SUPPL LIB US GU; Thapar A, 2011, PHLEBOLOGY, V26, P319, DOI 10.1258/phleb.2011.011098; Tsivgoulis G, 2011, NEUROLOGY, V77, P1241, DOI 10.1212/WNL.0b013e318230a149; Zamboni P, 2011, INT ANGIOL, V30, P571; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zaniewski M, 2013, PHLEBOLOGY, V28, P24, DOI 10.1258/phleb.2011.011070; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901	35	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56031	10.1371/journal.pone.0056031	http://dx.doi.org/10.1371/journal.pone.0056031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418501	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300093
J	Dong, J; Chen, Y; Xu, X; Jin, R; Teng, F; Yan, F; Tang, H; Li, PP; Sun, XY; Li, Y; Wu, HN; Zhang, Y; Ge, Q				Dong, Jie; Chen, Yu; Xu, Xi; Jin, Rong; Teng, Fei; Yan, Fan; Tang, Hui; Li, Pingping; Sun, Xiuyuan; Li, Yan; Wu, Hounan; Zhang, Yu; Ge, Qing			Homeostatic Properties and Phenotypic Maturation of Murine CD4(+) Pre-Thymic Emigrants in the Thymus	PLOS ONE			English	Article							T-CELLS; DENDRITIC CELLS; THYMOCYTE DEVELOPMENT; MEDULLARY THYMOCYTES; LYMPHOKINE SECRETION; CENTRAL TOLERANCE; AGED MICE; IN-VIVO; SELECTION; REPERTOIRE	After a tightly regulated developmental program in the thymus, "mature" single positive (SP) thymocytes leave the thymus and enter the periphery. These newly arrived recent thymic emigrants (RTEs) are phenotypically and functionally immature, and will complete a dynamic maturation in the peripheral lymphoid organs before being licensed to be resident naive T cells. To study the early events occurring in the RTE maturation process, we identified the phenotype of CD4(+) pre-RTEs, a population of CD4(+) SP thymocytes that have acquired the thymus egress capability. Compared to peripheral naive T cells, CD4(+) pre-RTEs displayed superior survival capability in lymphoreplete mice and faster proliferation under lymphopenic condition. The differences in Bcl2/Bim expression and/or heightened IL-7 signaling pathway may account for the pre-RTEs' better responsiveness to homeostatic signals. Qa2, the expression of which indicates the phenotypic maturation of SPs and RTEs, was found to be upregulated in CD4(+) pre-RTEs in thymic perivascular space. Migratory dendritic cells that surround this region contribute to Qa2 expression in pre-RTEs. The dendritic cell-driven Qa2 induction of CD4(+) pre-RTEs is independent of MHC class II and Aire molecules.	[Dong, Jie; Chen, Yu; Xu, Xi; Jin, Rong; Teng, Fei; Yan, Fan; Tang, Hui; Li, Pingping; Sun, Xiuyuan; Li, Yan; Zhang, Yu; Ge, Qing] Peking Univ, Dept Immunol, Hlth Sci Ctr, Key Lab Med Immunol,Minist Hlth, Beijing 100871, Peoples R China; [Wu, Hounan] Peking Univ, Med & Hlth Analyt Ctr, Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University; Peking University	Wu, HN (corresponding author), Peking Univ, Med & Hlth Analyt Ctr, Hlth Sci Ctr, Beijing 100871, Peoples R China.	wuhounan@yahoo.com; zhangyu007@bjmu.edu.cn; qingge@bjmu.edu.cn	Li, Ping/GYV-4914-2022		Natural Basic Research Program of China [2010CB945301, 2011CB711000, 2011CB946100]; National Natural Sciences Foundation of China [31070787, 30830091]; Program for New Century Excellent Talents in University [NCET-10-0175/BMU20100005]; Research Fund for the Doctoral Program of Higher Education [20100001110049]	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from the Natural Basic Research Program of China (2010CB945301, QG, 2011CB711000, QG, and 2011CB946100, YZ), the National Natural Sciences Foundation of China (31070787, QG, 30830091, YZ), Program for New Century Excellent Talents in University (NCET-10-0175/BMU20100005), and the Research Fund for the Doctoral Program of Higher Education (20100001110049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Baba T, 2009, J IMMUNOL, V183, P3053, DOI 10.4049/jimmunol.0900438; BENDELAC A, 1991, NATURE, V353, P68, DOI 10.1038/353068a0; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bousso P, 2000, P NATL ACAD SCI USA, V97, P274, DOI 10.1073/pnas.97.1.274; CHANG JF, 1991, J IMMUNOL, V147, P851; Clise-Dwyer K, 2007, J IMMUNOL, V178, P1321, DOI 10.4049/jimmunol.178.3.1321; DYALL R, 1995, J EXP MED, V181, P235, DOI 10.1084/jem.181.1.235; Fink PJ, 2011, NAT REV IMMUNOL, V11, P544, DOI 10.1038/nri3028; FUNAUCHI M, 1995, CLIN EXP IMMUNOL, V101, P82; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2989, DOI 10.1073/pnas.052714099; Ge Q, 1999, IMMUNOLOGY, V97, P665; Ge Q, 2000, INT IMMUNOL, V12, P1127, DOI 10.1093/intimm/12.8.1127; Hadeiba H, 2012, IMMUNITY, V36, P438, DOI 10.1016/j.immuni.2012.01.017; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Houston EG, 2008, J IMMUNOL, V181, P5213, DOI 10.4049/jimmunol.181.8.5213; Houston EG, 2011, P NATL ACAD SCI USA, V108, P5366, DOI 10.1073/pnas.1015286108; Houston Jr EG, 2012, CELL IMMUNOL; Jin R, 2008, J IMMUNOL, V180, P2256, DOI 10.4049/jimmunol.180.4.2256; Jones SC, 2008, J IMMUNOL, V180, P4465, DOI 10.4049/jimmunol.180.7.4465; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Lee CK, 2001, BLOOD, V97, P1360, DOI 10.1182/blood.V97.5.1360; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Li J, 2007, P NATL ACAD SCI USA, V104, P18175, DOI 10.1073/pnas.0708884104; LUCAS B, 1994, J IMMUNOL, V153, P53; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Makaroff LE, 2009, P NATL ACAD SCI USA, V106, P4799, DOI 10.1073/pnas.0812354106; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Mori K, 2007, INT IMMUNOL, V19, P745, DOI 10.1093/intimm/dxm041; NANDA NK, 1991, P NATL ACAD SCI USA, V88, P9503, DOI 10.1073/pnas.88.21.9503; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Priyadharshini B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015038; Proietto AI, 2009, IMMUNOL CELL BIOL, V87, P39, DOI 10.1038/icb.2008.86; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007; Teng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025567; VICARI A, 1994, J IMMUNOL, V152, P2207; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; WOODLAND DL, 1990, J IMMUNOL, V144, P379; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yamano T, 2011, BLOOD, V117, P2640, DOI 10.1182/blood-2010-07-293860; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	47	17	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56378	10.1371/journal.pone.0056378	http://dx.doi.org/10.1371/journal.pone.0056378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409179	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000051
J	Mateo, RG; Vanderpoorten, A; Munoz, J; Laenen, B; Desamore, A				Mateo, Ruben G.; Vanderpoorten, Alain; Munoz, Jesus; Laenen, Benjamin; Desamore, Aurelie			Modeling Species Distributions from Heterogeneous Data for the Biogeographic Regionalization of the European Bryophyte Flora	PLOS ONE			English	Article							DISTRIBUTION PATTERNS; ANNOTATED CHECKLIST; BIODIVERSITY; PLANTS; PERFORMANCE; DIVERSITY; REGIONS; CLIMATE; MOSS; PHYLOGEOGRAPHY	The definition of biogeographic regions provides a fundamental framework for a range of basic and applied questions in biogeography, evolutionary biology, systematics and conservation. Previous research suggested that environmental forcing results in highly congruent regionalization patterns across taxa, but that the size and number of regions depends on the dispersal ability of the taxa considered. We produced a biogeographic regionalization of European bryophytes and hypothesized that (1) regions defined for bryophytes would differ from those defined for other taxa due to the highly specific eco-physiology of the group and (2) their high dispersal ability would result in the resolution of few, large regions. Species distributions were recorded using 10,000 km(2) MGRS pixels. Because of the lack of data across large portions of the area, species distribution models employing macroclimatic variables as predictors were used to determine the potential composition of empty pixels. K-means clustering analyses of the pixels based on their potential species composition were employed to define biogeographic regions. The optimal number of regions was determined by v-fold cross-validation and Moran's I statistic. The spatial congruence of the regions identified from their potential bryophyte assemblages with large-scale vegetation patterns is at odds with our primary hypothesis. This reinforces the notion that post-glacial migration patterns might have been much more similar in bryophytes and vascular plants than previously thought. The substantially lower optimal number of clusters and the absence of nested patterns within the main biogeographic regions, as compared to identical analyses in vascular plants, support our second hypothesis. The modelling approach implemented here is, however, based on many assumptions that are discussed but can only be tested when additional data on species distributions become available, highlighting the substantial importance of developing integrated mapping projects for all taxa in key biogeographically areas of Europe, and the Mediterranean peninsulas in particular.	[Mateo, Ruben G.; Vanderpoorten, Alain; Laenen, Benjamin; Desamore, Aurelie] Univ Liege, Inst Bot, Liege, Belgium; [Munoz, Jesus] CSIC, Real Jardin Bot, Madrid, Spain; [Vanderpoorten, Alain] Univ Acores, Dept Ciencias Agr, Azorean Biodivers Grp CITA A, Terceira, Acores, Portugal; [Vanderpoorten, Alain] Univ Acores, Dept Ciencias Agr, Terceira, Acores, Portugal; [Munoz, Jesus] Univ Tecnol Indoamer, Ambato, Ecuador	University of Liege; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Universidade dos Acores; Universidade dos Acores	Mateo, RG (corresponding author), Univ Liege, Inst Bot, Liege, Belgium.	rubeng.mateo@gmail.com	Munoz, Jesus/B-7809-2008; Mateo, Rubén/M-3545-2015	Mateo, Rubén/0000-0001-8577-001X; Munoz, Jesus/0000-0002-9266-2268; Desamore, Aurelie/0000-0003-1922-3557	Belgian Funds for Scientific Research [1.5036.11, 2.4557.11]; University of Liege [C 11/32]; FP7 Synthesys program of the European Community Research Infrastructure Action at the Real Jardin Botanico (CSIC); Ministry of Science and Technology of Spain [CGL2009-09530-BOS]	Belgian Funds for Scientific Research(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); FP7 Synthesys program of the European Community Research Infrastructure Action at the Real Jardin Botanico (CSIC); Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support from the Belgian Funds for Scientific Research (grants 1.5036.11 and 2.4557.11) and the University of Liege (grant C 11/32) is gratefully acknowledged. AD, BL and AV further acknowledge financial support from the FP7 Synthesys program of the European Community Research Infrastructure Action at the Real Jardin Botanico (CSIC). JM acknowledges the funding of the Ministry of Science and Technology of Spain (grant CGL2009-09530-BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda SC, 2011, ECOGRAPHY, V34, P31, DOI 10.1111/j.1600-0587.2010.06134.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bohn U., 2000, KARTE NATURLICHEN VE; Carine MA, 2009, J BIOGEOGR, V36, P593, DOI 10.1111/j.1365-2699.2008.02016.x; Cox CB, 2010, J BIOGEOGR, V37, P2027, DOI 10.1111/j.1365-2699.2010.02420.x; Cox CB, 2001, J BIOGEOGR, V28, P511; Desamore A, 2012, GLOBAL CHANGE BIOL, V18, P2915, DOI 10.1111/j.1365-2486.2012.02752.x; Desamore A, 2011, J BIOGEOGR, V38, P164, DOI 10.1111/j.1365-2699.2010.02387.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dull R, 1985, BRYOLOGISCHE BEITRAG, V5, P1; DULL R., 1983, BRYOL BEITR, V2, P1; Dull R., 1984, BRYOLOGISCHE BEITRAG, V4, P1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis CJ, 2000, J ECOL, V88, P869, DOI 10.1046/j.1365-2745.2000.00495.x; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finnie TJR, 2007, J BIOGEOGR, V34, P1848, DOI 10.1111/j.1365-2699.2007.01750.x; Gignac LD, 2000, J BIOGEOGR, V27, P1139, DOI 10.1046/j.1365-2699.2000.00458.x; Grolle R, 2000, J BRYOL, V22, P103, DOI 10.1179/jbr.2000.22.2.103; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Heikinheimo H, 2012, J BIOGEOGR, V39, P1633, DOI 10.1111/j.1365-2699.2012.02723.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, SPECIES DISTRIBUTION; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Hutsemekers V, 2008, DIVERS DISTRIB, V14, P483, DOI 10.1111/j.1472-4642.2007.00454.x; Hutsemekersa V, 2011, P NATL ACAD SCI USA, V108, P18989, DOI 10.1073/pnas.1109119108; Jonsgard Birgitte, 1995, Lindbergia, V20, P64; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Laenen B, 2011, J BIOGEOGR, V38, P631, DOI 10.1111/j.1365-2699.2010.02440.x; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Lengyel S, 2008, BIODIVERS CONSERV, V17, P3327, DOI 10.1007/s10531-008-9395-3; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Migliore J, 2012, J BIOGEOGR, V39, P942, DOI 10.1111/j.1365-2699.2011.02646.x; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Ozenda P, 2009, CR BIOL, V332, P1092, DOI 10.1016/j.crvi.2009.09.018; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Preston CD, 1999, J BIOGEOGR, V26, P629, DOI 10.1046/j.1365-2699.1999.00314.x; Preston CD, 1997, BOT J LINN SOC, V124, P1, DOI 10.1006/bojl.1996.0084; Preston CD, 2011, J BRYOL, V33, P3, DOI 10.1179/1743282010Y.0000000001; Proches S, 2001, BIOL J LINN SOC, V74, P197, DOI 10.1006/bijl.2001.0565; Rosenzweig ML, 2005, SPECIES DIVERSITY SP; Rozzi R, 2008, FRONT ECOL ENVIRON, V6, P131, DOI 10.1890/070020; Rueda M, 2010, J BIOGEOGR, V37, P2067, DOI 10.1111/j.1365-2699.2010.02388.x; Rydin H., 2009, BRYOPHYTE BIOL, V104, P393, DOI [10.1093/aob/mcp111, DOI 10.1017/CBO9780511754807.011, 10.1017/CBO9780511754807.011]; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Shaw AJ, 2005, TAXON, V54, P337, DOI 10.2307/25065362; SHAW J, 1985, BRYOLOGIST, V88, P199, DOI 10.2307/3243029; Soderstrom Lars, 1992, P131; Sotiaux A, 2009, J BRYOL, V31, P186, DOI 10.1179/174328209X455299; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; Szovenyi P, 2006, NEW PHYTOL, V172, P784, DOI 10.1111/j.1469-8137.2006.01870.x; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Thompson J., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Van der Velde M, 2003, BIOL J LINN SOC, V78, P203, DOI 10.1046/j.1095-8312.2003.00151.x; van Rooy J, 2011, J BRYOL, V33, P17, DOI 10.1179/1743282010Y.0000000007; Vanderpoorten A, 2007, AM J BOT, V94, P625, DOI 10.3732/ajb.94.4.625; Vanderpoorten A, 1999, BRYOLOGIST, V102, P720, DOI 10.2307/3244258; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vanderpoorten A., 2011, The biology of island floras, P338; Vanderpoorten A, 2002, ECOGRAPHY, V25, P513, DOI 10.1034/j.1600-0587.2002.250501.x; Vanderpoorten A, 2010, PHYTOTAXA, V9, P229; Vanderpoorten A, 2010, BIOL REV, V85, P471, DOI 10.1111/j.1469-185X.2009.00111.x; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Wohlgemuth Thomas, 1996, Biodiversity Letters, V3, P180, DOI 10.2307/2999675; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Zechmeister HG, 2007, APPL VEG SCI, V10, P111, DOI 10.1658/1402-2001(2007)10[111:SDPORM]2.0.CO;2	80	40	43	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55648	10.1371/journal.pone.0055648	http://dx.doi.org/10.1371/journal.pone.0055648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409015	Green Published, gold, Green Submitted			2022-12-25	WOS:000315100000019
J	Johnson, LE; Larsen, M; Perez, MT				Johnson, Leif E.; Larsen, Michael; Perez, Maria-Thereza			Retinal Adaptation to Changing Glycemic Levels in a Rat Model of Type 2 Diabetes	PLOS ONE			English	Article							SCOTOPIC ELECTRORETINOGRAM; PHOTORECEPTOR SENSITIVITY; TRANSIENT HYPERGLYCEMIA; ALTERED EXPRESSION; A-WAVE; RETINOPATHY; INSULIN; ERG; GLUCOSE; ELECTROPHYSIOLOGY	Purpose: Glucose concentrations are elevated in retinal cells in undiagnosed and in undertreated diabetes. Studies of diabetic patients suggest that retinal function adapts, to some extent, to this increased supply of glucose. The aim of the present study was to examine such adaptation in a model of type 2 diabetes and assess how the retina responds to the subsequent institution of glycemic control. Methods: Electroretinography (ERG) was conducted on untreated Zucker diabetic fatty (ZDF) rats and congenic controls from 8-22 weeks of age and on ZDFs treated with daily insulin from 16-22 weeks of age. Retinal sections from various ages were prepared and compared histologically and by immunocytochemistry. Principal Findings/Conclusions: Acute hyperglycemia did not have an effect on control rats while chronic hyperglycemia in the ZDF was associated with scotopic ERG amplitudes which were up to 20% higher than those of age-matched controls. This change followed the onset of hyperglycemia with a delay of over one month, supporting that habituation to hyperglycemia is a slow process. When glycemia was lowered, an immediate decrease in ZDF photoreceptoral activity was induced as seen by a reduction in a-wave amplitudes and maximum slopes of about 30%. A direct effect of insulin on the ERG was unlikely since the expression of phosphorylated Akt kinase was not affected by treatment. The electrophysiological differences between untreated ZDFs and controls preceded an activation of Muller cells in the ZDFs (up-regulation of glial fibrillary acidic protein), which was attenuated by insulin treatment. There were otherwise no signs of cell death or morphological alterations in any of the experimental groups. These data show that under chronic hyperglycemia, the ZDF retina became abnormally sensitive to variations in substrate supply. In diabetes, a similar inability to cope with intensive glucose lowering could render the retina susceptible to damage.	[Johnson, Leif E.; Larsen, Michael; Perez, Maria-Thereza] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark; [Larsen, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Perez, Maria-Thereza] Lund Univ, Div Ophthalmol, Dept Clin Sci, Lund, Sweden	University of Copenhagen; University of Copenhagen; Lund University	Johnson, LE (corresponding author), Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark.	leif.johnson@regionh.dk	Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891	Novo Nordisk Foundation; Danish Council for Independent Research, Medical Sciences [09-071219]; Stiftelsen for synskadade i fd malmohus lan; Kronprisessan Margarettas Arbetsnamnd for synskadade Stiftelser; Ogonfonden Stiftelser; Gun och Bertil Stohnes Stiftelser; Greta och Johan Kocks Stiftelser; Magnus Bergvalls Stiftelser	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Stiftelsen for synskadade i fd malmohus lan; Kronprisessan Margarettas Arbetsnamnd for synskadade Stiftelser; Ogonfonden Stiftelser; Gun och Bertil Stohnes Stiftelser; Greta och Johan Kocks Stiftelser; Magnus Bergvalls Stiftelser	The study was supported by the Novo Nordisk Foundation (www.novonordiskfonden.dk/en/index.asp), the Danish Council for Independent Research, Medical Sciences (09-071219; en.fi.dk/councils-commissions/the-danish-council-forindependent-research/scientific-research-councils/medical-sciences), Stiftelsen for synskadade i fd malmohus lan (www.stiftelsenkma.com/), the Kronprisessan Margarettas Arbetsnamnd for synskadade (www.stiftelsenkma.com/), Ogonfonden (www.ogonfonden.se), and the Gun och Bertil Stohnes (web.comhem.se/stohnes-stiftelse), Greta och Johan Kocks (www.kockskastiftelsen.se/) and Magnus Bergvalls (www.magnbergvallsstiftelse.nu/) Stiftelser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko T, 2003, DIABETES, V52, P829, DOI 10.2337/diabetes.52.3.829; AMOUZADEH HR, 1990, VET HUM TOXICOL, V32, P19; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; Bui BV, 2003, DIABETOLOGIA, V46, P401, DOI 10.1007/s00125-003-1042-7; Charng J, 2011, INVEST OPHTH VIS SCI, V52, P8891, DOI 10.1167/iovs.11-7602; Chung N H, 1993, Korean J Ophthalmol, V7, P43; Dang TM, 2011, DOC OPHTHALMOL, V122, P149, DOI 10.1007/s10633-011-9269-y; DANIS RP, 1993, INVEST OPHTH VIS SCI, V34, P2367; Dawson William W., 2000, Documenta Ophthalmologica, V101, P155, DOI 10.1023/A:1026569701949; Derwent JJK, 2001, VISUAL NEUROSCI, V18, P983, DOI 10.1017/S0952523801186153; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fox DA, 2011, TOXICOL APPL PHARM, V256, P258, DOI 10.1016/j.taap.2011.05.021; GJOTTERBERG M, 1974, ACTA OPHTHALMOL, V52, P521; Goncalves A, 2012, DIABETES OBES METAB, V14, P454, DOI 10.1111/j.1463-1326.2011.01548.x; Gosbell A, 1996, CURR EYE RES, V15, P1132, DOI 10.3109/02713689608995145; HAHN I, 1989, ACTA OPHTHALMOL, V67, P131; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; HARDY KJ, 1995, BRIT J OPHTHALMOL, V79, P35, DOI 10.1136/bjo.79.1.35; HIRSCHHOFFMANN C, 1993, CLIN VISION SCI, V8, P489; Holfort SK, 2011, DIABETOLOGIA, V54, P1853, DOI 10.1007/s00125-011-2149-x; Holfort SK, 2010, EXP EYE RES, V91, P710, DOI 10.1016/j.exer.2010.08.017; Holfort SK, 2010, INVEST OPHTH VIS SCI, V51, P2790, DOI 10.1167/iovs.09-4891; HORSBURGH GM, 1987, J COMP NEUROL, V263, P553, DOI 10.1002/cne.902630407; Huber M, 2011, HYPERTENS RES, V34, P103, DOI 10.1038/hr.2010.168; HUSSAIN AA, 1992, VISION RES, V32, P29, DOI 10.1016/0042-6989(92)90109-V; Iandiev I, 2007, NEUROSCI LETT, V421, P132, DOI 10.1016/j.neulet.2007.04.076; Jamison JA, 2001, VISUAL NEUROSCI, V18, P445, DOI 10.1017/S0952523801183112; JENKINS TCA, 1990, BRIT J OPHTHALMOL, V74, P681, DOI 10.1136/bjo.74.11.681; Kappelgaard P, 2012, DOC OPHTHALMOL, V124, P49, DOI 10.1007/s10633-011-9303-0; Kern TS, 2010, MOL VIS, V16, P1629; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Klemp K, 2005, INVEST OPHTH VIS SCI, V46, P2620, DOI 10.1167/iovs.04-1254; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; Kurtenbach A, 2006, VISUAL NEUROSCI, V23, P651, DOI 10.1017/S095252380623339X; Lansel N, 1997, INVEST OPHTH VIS SCI, V38, P792; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; Matsubara H, 2006, JPN J OPHTHALMOL, V50, P211, DOI 10.1007/s10384-005-0315-8; Misra GP, 2009, BIOMATERIALS, V30, P6541, DOI 10.1016/j.biomaterials.2009.08.025; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Ola MS, 2006, AM J PHYSIOL-ENDOC M, V290, pE1057, DOI 10.1152/ajpendo.00323.2005; Papakostopoulos D, 1996, INT J PSYCHOPHYSIOL, V21, P33, DOI 10.1016/0167-8760(95)00040-2; PARMER R, 1982, COMP BIOCHEM PHYS C, V72, P109, DOI 10.1016/0306-4492(82)90213-1; Paulsen SJ, 2010, J ANAT, V217, P624, DOI 10.1111/j.1469-7580.2010.01285.x; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Puchowicz MA, 2004, J CEREBR BLOOD F MET, V24, P449, DOI 10.1097/00004647-200404000-00010; Reiter CEN, 2003, AM J PHYSIOL-ENDOC M, V285, pE763, DOI 10.1152/ajpendo.00507.2002; RIMMER T, 1993, INVEST OPHTH VIS SCI, V34, P3246; Rothenberg SJ, 2002, INVEST OPHTH VIS SCI, V43, P2036; SAKAI H, 1995, OPHTHALMIC RES, V27, P57, DOI 10.1159/000267571; SANDBERG MA, 1991, INVEST OPHTH VIS SCI, V32, P1508; Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017; SCHNEIDER T, 1986, INVEST OPHTH VIS SCI, V27, P1395; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tyrberg M, 2011, DOC OPHTHALMOL, V123, P193, DOI 10.1007/s10633-011-9298-6; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Wright WS, 2010, EXP EYE RES, V90, P405, DOI 10.1016/j.exer.2009.12.002; Wunderlich KA, 2010, INVEST OPHTH VIS SCI, V51, P4809, DOI 10.1167/iovs.09-5073; Yoshida Y, 2009, DIABETES-METAB RES, V25, P678, DOI 10.1002/dmrr.1007; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9	65	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55456	10.1371/journal.pone.0055456	http://dx.doi.org/10.1371/journal.pone.0055456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408985	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300016
J	Soodgupta, D; Hurchla, MA; Jiang, MJ; Zheleznyak, A; Weilbaecher, KN; Anderson, CJ; Tomasson, MH; Shokeen, M				Soodgupta, Deepti; Hurchla, Michelle A.; Jiang, Majiong; Zheleznyak, Alexander; Weilbaecher, Katherine N.; Anderson, Carolyn J.; Tomasson, Michael H.; Shokeen, Monica			Very Late Antigen-4 (alpha(4)beta(1) Integrin) Targeted PET Imaging of Multiple Myeloma	PLOS ONE			English	Article							MEDIATED DRUG-RESISTANCE; MARROW STROMAL CELLS; BONE-DISEASE; MURINE MODEL; ADHESION MOLECULES; IN-VIVO; VLA-4; BINDING; EXPRESSION; MANAGEMENT	Biomedical imaging techniques such as skeletal survey and F-18-fluorodeoxyglucose (FDG)/Positron Emission Tomography (PET) are frequently used to diagnose and stage multiple myeloma (MM) patients. However, skeletal survey has limited sensitivity as it can detect osteolytic lesions only after 30-50% cortical bone destruction, and FDG is a marker of cell metabolism that has limited sensitivity for intramedullary lesions in MM. Targeted, and non-invasive novel probes are needed to sensitively and selectively image the unique molecular signatures and cellular processes associated with MM. Very late antigen-4 (VLA-4; also called alpha(4)beta(1) integrin) is over-expressed on MM cells, and is one of the key mediators of myeloma cell adhesion to the bone marrow (BM) that promotes MM cell trafficking and drug resistance. Here we describe a proof-of-principle, novel molecular imaging strategy for MM tumors using a VLA-4 targeted PET radiopharmaceutical, Cu-64-CB-TE1A1P-LLP2A. Cell uptake studies in a VLA-4-positive murine MM cell line, 5TGM1, demonstrated receptor specific uptake (P<0.0001, block vs. non-block). Tissue biodistribution at 2 h of Cu-64-CB-TE1A1P-LLP2A in 5TGM1 tumor bearing syngeneic KaLwRij mice demonstrated high radiotracer uptake in the tumor (12 +/- 4.5%ID/g), and in the VLA-4 rich organs, spleen (8.8 +/- 1.0%ID/g) and marrow (11.6 +/- 2.0%ID/g). Small animal PET/CT imaging with Cu-64-CB-TE1A1P-LLP2A demonstrated high uptake in the 5TGM1 tumors (SUV 6.6 +/- 1.1). There was a 3-fold reduction in the in vivo tumor uptake in the presence of blocking agent (2.3 +/- 0.4). Additionally, Cu-64-CB-TE1A1P-LLP2A demonstrated high binding to the human MM cell line RPMI-8226 that was significantly reduced in the presence of the cold targeting agent. These results provide preclinical evidence that VLA-4-targeted imaging using Cu-64-CB-TE1A1P-LLP2A is a novel approach to imaging MM tumors.	[Soodgupta, Deepti; Hurchla, Michelle A.; Weilbaecher, Katherine N.; Tomasson, Michael H.] Washington Univ, Dept Med, St Louis, MO 63130 USA; [Jiang, Majiong] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Jiang, Majiong; Zheleznyak, Alexander; Anderson, Carolyn J.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA; [Anderson, Carolyn J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tomasson, MH (corresponding author), Washington Univ, Dept Med, St Louis, MO 63130 USA.	Tomasson@dom.wustl.edu; mshokeen@wustl.edu	Jiang, Majiong/I-3630-2013	Anderson, Carolyn/0000-0002-5663-282X; Tomasson, Michael/0000-0003-4518-7123	Mallinckrodt Institute of Radiology Imaging grant [10-015]; Multiple Myeloma Research Foundation (MMRF);  [P01-CA100730-06];  [R01-CA097250]; NATIONAL CANCER INSTITUTE [P01CA078378, R01CA176221, P01CA100730, P01CA155258, P30CA091842, P50CA100707, R01CA097250] Funding Source: NIH RePORTER	Mallinckrodt Institute of Radiology Imaging grant; Multiple Myeloma Research Foundation (MMRF); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported in part by funds from the Mallinckrodt Institute of Radiology Imaging grant # 10-015 (MS). KNW and MH were supported by P01-CA100730-06 and R01-CA097250. MHT is also supported by a Senior Research Award from the Multiple Myeloma Research Foundation (MMRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe M, 2009, J BONE MINER METAB, V27, P16, DOI 10.1007/s00774-008-0012-z; Asosingh K, 2000, Hematol J, V1, P351, DOI 10.1038/sj.thj.6200052; Breyer RJ, 2006, SKELETAL RADIOL, V35, P632, DOI 10.1007/s00256-006-0127-z; Collins CD, CANC IMAGING, V10, P20; Dallas SL, 1999, BLOOD, V93, P1697, DOI 10.1182/blood.V93.5.1697.405a17_1697_1706; Damiano JS, 2000, LEUKEMIA LYMPHOMA, V38, P71, DOI 10.3109/10428190009060320; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Durie BGM, 2002, J NUCL MED, V43, P1457; Durie BGM, 2006, EUR J CANCER, V42, P1539, DOI 10.1016/j.ejca.2005.11.037; Eckelman WC, 2009, NUCL MED BIOL, V36, P235, DOI 10.1016/j.nucmedbio.2008.12.002; Ferdani R, DALTON T, V41, P1938; Ferdani R, 2012, DALTON T, V41, P1938, DOI 10.1039/c1dt11743b; Fonti R, 2008, J NUCL MED, V49, P195, DOI 10.2967/jnumed.107.045641; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Hurchla MA, 2012, LEUKEMIA; Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388; Imai Y, 2010, INT J HEMATOL, V91, P569, DOI 10.1007/s12185-010-0555-3; Jiang M, NUCL MED BIOL; Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Kristinsson SY, 2011, EXPERT REV MOL DIAGN, V11, P593, DOI [10.1586/ERM.11.44, 10.1586/erm.11.44]; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lu YY, 2012, CLIN NUCL MED, V37, P833, DOI 10.1097/RLU.0b013e31825b2071; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Michigami T, 2000, BLOOD, V96, P1953, DOI 10.1182/blood.V96.5.1953.h8001953_1953_1960; Mortimer JE, 2001, J CLIN ONCOL, V19, P2797, DOI 10.1200/JCO.2001.19.11.2797; Mulligan ME, 2007, SKELETAL RADIOL, V36, P5, DOI 10.1007/s00256-006-0184-3; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; Olson DL, 2005, MOL CANCER THER, V4, P91; Orchard K, 2002, BRIT J HAEMATOL, V117, P133, DOI 10.1046/j.1365-2141.2002.03407.x; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Palumbo A, 2010, HAEMATOL-HEMATOL J, V95, P1144, DOI 10.3324/haematol.2009.017913; PELLATDECEUNYNCK C, 1995, CANCER RES, V55, P3647; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Qi JY, 2000, IEEE T MED IMAGING, V19, P493, DOI 10.1109/42.870259; RADL J, 1979, J IMMUNOL, V122, P609; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Sanz-Rodriguez F, 2001, LEUKEMIA LYMPHOMA, V41, P239, DOI 10.3109/10428190109057979; Schmidmaier R, 2006, INT J BIOL MARKER, V21, P218, DOI 10.1177/172460080602100404; VACCA A, 1995, AM J HEMATOL, V50, P9, DOI 10.1002/ajh.2830500103; Wagner LI, J PAIN SYMPTOM MANAG, V43, P1094; Zamagni E, 2012, BRIT J HAEMATOL, V159, P499, DOI 10.1111/bjh.12007; Zwingenberger AL, 2012, VET IMMUNOL IMMUNOP, V145, P298, DOI 10.1016/j.vetimm.2011.11.018	44	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55841	10.1371/journal.pone.0055841	http://dx.doi.org/10.1371/journal.pone.0055841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409060	Green Accepted, Green Published, gold			2022-12-25	WOS:000314660300038
J	Tamborero, D; Lopez-Bigas, N; Gonzalez-Perez, A				Tamborero, David; Lopez-Bigas, Nuria; Gonzalez-Perez, Abel			Oncodrive-CIS: A Method to Reveal Likely Driver Genes Based on the Impact of Their Copy Number Changes on Expression	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; ALGORITHMS; PATHWAYS; GROWTH; STAGE	A well-established approach for detecting genes involved in tumorigenesis due to copy number alterations (CNAs) is to assess the recurrence of the alteration across multiple samples. Expression data can be used to filter this list of candidates by assessing whether the gene expression significantly differs between tumors depending on the copy number status. A drawback of this approach is that it may fail to detect low-recurrent drivers. Furthermore, this analysis does not provide information about expression changes for each gene as compared to the whole data set and does not take into consideration the expression of normal samples. Here we describe a novel method (Oncodrive-CIS) aimed at ranking genes according to the expression impact caused by the CNAs. The rationale of Oncodrive-CIS is based on the hypothesis that genes involved in cancer due to copy number changes are more biased towards misregulation than are bystanders. Moreover, to gain insight into the expression changes caused by gene dosage, the expression of samples with CNAs is compared to that of tumor samples with diploid genotype and also to that of normal samples. Oncodrive-CIS demonstrated better performance in detecting putative associations between copy-number and expression in simulated data sets as compared to other methods aimed to this purpose, and picked up genes likely to be related with tumorigenesis when applied to real cancer samples. In summary, Oncodrive-CIS provides a statistical framework to evaluate the in cis effect of CNAs that may be useful to elucidate the role of these aberrations in driving oncogenesis. An implementation of this method and the corresponding user guide are freely available at http://bg.upf.edu/oncodrivecis.	[Tamborero, David; Lopez-Bigas, Nuria; Gonzalez-Perez, Abel] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain; [Lopez-Bigas, Nuria] ICREA, Barcelona, Spain	Pompeu Fabra University; ICREA	Lopez-Bigas, N (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain.	nuria.lopez@upf.edu; abel.gonzalez@upf.edu	tamborero, david/M-5283-2015; Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011	tamborero, david/0000-0002-7218-2806; Lopez-Bigas, Nuria/0000-0003-4925-8988; Gonzalez-Perez, Abel/0000-0002-8582-4660	Spanish Ministry of Science and Technology [SAF2009-06954]; Spanish National Institute of Bioinformatics (INB); ICREA Funding Source: Custom	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute of Bioinformatics (INB); ICREA(ICREA)	The authors acknowledge funding from the Spanish Ministry of Science and Technology (grant number SAF2009-06954) and the Spanish National Institute of Bioinformatics (INB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NATURE, V474, P609; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cowin PA, 2010, ANNU REV GENOM HUM G, V11, P133, DOI 10.1146/annurev-genom-082509-141536; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ghosh AK, 1999, MOL CELL BIOL, V19, P2880; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Louhimo R, 2012, NAT METHODS, V9, P351, DOI [10.1038/NMETH.1893, 10.1038/nmeth.1893]; Louhimo R, 2011, BIOINFORMATICS, V27, P887, DOI 10.1093/bioinformatics/btr019; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Taunk NK, 2012, CANCER-AM CANCER SOC, V118, P888, DOI 10.1002/cncr.26352; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Wang Y, 2000, GENE DEV, V14, P927; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104	24	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55489	10.1371/journal.pone.0055489	http://dx.doi.org/10.1371/journal.pone.0055489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408991	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300019
J	Yang, MM; Zhang, WW; Ji, SY; Cao, PH; Chen, YL; Zhao, X				Yang, Mingming; Zhang, Weiwei; Ji, Shengyue; Cao, Pinghua; Chen, Yulin; Zhao, Xin			Generation of an Artificial Double Promoter for Protein Expression in Bacillus subtilis through a Promoter Trap System	PLOS ONE			English	Article							METHYL PARATHION HYDROLASE; CONSTRUCTION; VECTOR; INTEGRATION; GENE	Bacillus subtilis is an attractive host for production of recombinant proteins. Promoters and expression plasmid backbones have direct impacts on the efficiency of gene expression. To screen and isolate strong promoters, a promoter trap vector pShuttleF was developed in this study. Using the vector, approximately 1000 colonies containing likely promoters from Bacillus licheniformis genomic DNA were obtained. Amongst them, pShuttle-09 exhibited the highest beta-Gal activities in both Escherichia coli and B. subtilis. The activity of pShuttle-09 in B. subtilis was eight times of that of the P43 promoter, a commonly used strong promoter for B. subtilis. A sequence analysis showed that pShuttle-09 contained P-luxS and truncated luxS in-frame fused with the reporter gene as well as another fragment upstream of P-luxS containing a putative promoter. This putative promoter was a hybrid promoter and its beta-Gal activity was higher than P-luxS. Reconstructing the hybrid promoter from pShuttle-09 to P-lapS further improved the beta-Gal production by 60%. The usefulness of our promoter trap system is likely due to random shuffling and recombination of DNA fragments and adoption of a rapid and high-throughput screening. Thus, our data provide additional evidence to support the concept of using a promoter trap system to create new promoters.	[Yang, Mingming; Zhang, Weiwei; Ji, Shengyue; Cao, Pinghua; Chen, Yulin; Zhao, Xin] NW A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada	Northwest A&F University - China; McGill University	Chen, YL (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China.	xylgene@126.com; zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	Chinese National Natural Science Foundation [30871813, 31072060]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Chinese National Natural Science Foundation (30871813 and 31072060). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2002, J MICROBIOL METH, V49, P265, DOI 10.1016/S0167-7012(01)00376-1; Bendtsen KM, 2011, NUCLEIC ACIDS RES, V39, P6879, DOI 10.1093/nar/gkr390; Bhavsar AP, 2001, APPL ENVIRON MICROB, V67, P403, DOI 10.1128/AEM.67.1.403-410.2001; Carroll JA, 2003, MICROBIOL-SGM, V149, P1819, DOI 10.1099/mic.0.26165-0; Cui ZL, 2004, BIOTECHNOL LETT, V26, P1115, DOI 10.1023/B:BILE.0000035481.03854.41; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Gat O, 2003, INFECT IMMUN, V71, P801, DOI 10.1128/IAI.71.2.801-813.2003; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hartl B, 2001, J BACTERIOL, V183, P2696, DOI 10.1128/JB.183.8.2696-2699.2001; Heravi KM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-83; HIRATA H, 1986, J BACTERIOL, V166, P722, DOI 10.1128/jb.166.3.722-727.1986; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kang HK, 2010, WORLD J MICROB BIOT, V26, P1915, DOI 10.1007/s11274-010-0351-5; Kim JH, 2011, WORLD J MICROB BIOT, V27, P2747, DOI 10.1007/s11274-011-0749-8; Lee SJ, 2010, J BIOTECHNOL, V149, P16, DOI 10.1016/j.jbiotec.2010.06.021; Li MJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-19; Li W, 2007, BIOCHEM BIOPH RES CO, V358, P1148, DOI 10.1016/j.bbrc.2007.05.064; Maniatis T., 1982, MOL CLONING LAB MANU; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Ming YM, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-55; Phan TTP, 2010, PROTEIN EXPRES PURIF, V71, P174, DOI 10.1016/j.pep.2009.11.010; Phan TTP, 2006, PROTEIN EXPRES PURIF, V46, P189, DOI 10.1016/j.pep.2005.07.005; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Schumann W, 2007, ADV APPL MICROBIOL, V62, P137, DOI 10.1016/S0065-2164(07)62006-1; Sun TQ, 2010, J BACTERIOL, V192, P2128, DOI 10.1128/JB.01673-09; Trang TPP, 2012, J BIOTECHNOL, V157, P167, DOI 10.1016/j.jbiotec.2011.10.006; WANG PZ, 1984, J BIOL CHEM, V259, P8619; Wang YG, 2012, APPL MICROBIOL BIOT, V93, P1585, DOI 10.1007/s00253-011-3684-6; Widner B, 2000, J IND MICROBIOL BIOT, V25, P204, DOI 10.1038/sj.jim.7000051; Wu SM, 2011, WORLD J MICROB BIOT, V27, P99, DOI 10.1007/s11274-010-0432-5; Yang MM, 2006, BIOTECHNOL LETT, V28, P1713, DOI 10.1007/s10529-006-9146-z; Yang MM, 2010, MOL BIOL REP, V37, P2207, DOI 10.1007/s11033-009-9704-2; Zhang AL, 2007, BIOCHEM BIOPH RES CO, V354, P90, DOI 10.1016/j.bbrc.2006.12.137; Zhang XZ, 2005, APPL ENVIRON MICROB, V71, P4101, DOI 10.1128/AEM.71.7.4101-4103.2005; Zhu FM, 2008, MOL BIOTECHNOL, V39, P225, DOI 10.1007/s12033-008-9030-2	36	37	48	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56321	10.1371/journal.pone.0056321	http://dx.doi.org/10.1371/journal.pone.0056321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409173	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300072
J	Koivuniemi, R; Makela, J; Hokkanen, ME; Bruelle, C; Ho, TH; Ola, R; Korhonen, L; Schroder, J; Kataoka, H; Lindholm, D				Koivuniemi, Raili; Makela, Johanna; Hokkanen, Marie-Estelle; Bruelle, Celine; Ho, Tho Huu; Ola, Roxana; Korhonen, Laura; Schroder, Jim; Kataoka, Hiroaki; Lindholm, Dan			Hepatocyte Growth Factor Activator Inhibitor-1 Is Induced by Bone Morphogenetic Proteins and Regulates Proliferation and Cell Fate of Neural Progenitor Cells	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; TUMOR-SUPPRESSOR GENE; STEM-CELLS; TYPE-1 HAI-1; RAT HIPPOCAMPUS; NEURONAL DIFFERENTIATION; ADULT NEUROGENESIS; GLIOBLASTOMA CELLS; KUNITZ DOMAINS; TUBE CLOSURE	Background: Neural progenitor cells (NPCs) in the developing neuroepithelium are regulated by intrinsic and extrinsic factors. There is evidence that NPCs form a self-supporting niche for cell maintenance and proliferation. However, molecular interactions and cell-cell contacts and the microenvironment within the neuroepithelium are largely unknown. We hypothesized that cellular proteases especially those associated with the cell surface of NPCs play a role in regulation of progenitor cells in the brain. Methodology/Principal Findings: In this work, we show that NPCs, isolated from striatal anlage of developing rat brain, express hepatocyte growth factor activator inhibitor-1 and -2 (HAI-1 and HAI-2) that are cell surface-linked serine protease inhibitors. In addition, radial glia cells derived from mouse embryonic stem cells also express HAI-1 and HAI-2. To study the functional significance of HAI-1 and HAI-2 in progenitor cells, we modulated their levels using expression plasmids or silencing RNA (siRNA) transfected into the NPCs. Data showed that overexpression of HAI-1 or HAI-2 decreased cell proliferation of cultured NPCs, whilst their siRNAs had opposite effects. HAI-1 also influenced NPC differentiation by increasing the number of glial fibrillary acidic protein (GFAP) expressing cells in the culture. Expression of HAI-1 in vivo decreased cell proliferation in developing neuroepithelium in E15 old animals and promoted astrocyte cell differentiation in neonatal animals. Studying the regulation of HAI-1, we observed that Bone morphogenetic protein-2 (BMP-2) and BMP-4 increased HAI-1 levels in the NPCs. Experiments using HAI-1-siRNA showed that these BMPs act on the NPCs partly in a HAI-1-dependent manner. Conclusions: This study shows that the cell-surface serine protease inhibitors, HAI-1 and HAI-2 influence proliferation and cell fate of NPCs and their expression levels are linked to BMP signaling. Modulation of the levels and actions of HAI-1 in NPCs may be of a potential value in stem cell therapies in various brain diseases.	[Koivuniemi, Raili; Makela, Johanna; Bruelle, Celine; Ola, Roxana; Korhonen, Laura; Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland; [Koivuniemi, Raili; Makela, Johanna; Bruelle, Celine; Ho, Tho Huu; Korhonen, Laura; Schroder, Jim; Lindholm, Dan] Minerva Fdn, Biomedicum Helsinki 2, Helsinki, Finland; [Hokkanen, Marie-Estelle] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Kataoka, Hiroaki] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan	University of Helsinki; University of Helsinki; University of Helsinki; University of Miyazaki	Lindholm, D (corresponding author), Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland.	dan.lindholm@helsinki.fi	Korhonen, Laura/AAW-3256-2020; Koivuniemi, Raili/AAF-2173-2021; Lindholm, Dan/B-3777-2014	Koivuniemi, Raili/0000-0002-0359-7178; Korhonen, Laura/0000-0002-1837-5930; Ho, Tho/0000-0002-8363-1427	Sigrid Juselius Foundation; Nona and Kullervo Vare Foundation; Academy of Finland; Liv och Halsa Foundation; Finska Lakaresallskapet; Magnus Ehrnrooth; Minerva Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Nona and Kullervo Vare Foundation; Academy of Finland(Academy of Finland); Liv och Halsa Foundation; Finska Lakaresallskapet; Magnus Ehrnrooth; Minerva Foundation	This work was supported by Sigrid Juselius Foundation, Nona and Kullervo Vare Foundation, Academy of Finland, Liv och Halsa Foundation, Finska Lakaresallskapet, Magnus Ehrnrooth and Minerva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Brannvall K, 2005, EUR J NEUROSCI, V21, P871, DOI 10.1111/j.1460-9568.2005.03942.x; Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Dalgin G, 2007, DEV BIOL, V310, P454, DOI 10.1016/j.ydbio.2007.08.012; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Enarsson M, 2002, MOL CANCER RES, V1, P147; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hallikas OK, 2006, J HISTOCHEM CYTOCHEM, V54, P745, DOI 10.1369/jhc.5A6816.2006; Hamasuna R, 2001, INT J CANCER, V93, P339, DOI 10.1002/ijc.1349; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Itoh H, 2001, BBA-GENE STRUCT EXPR, V1519, P92, DOI 10.1016/S0167-4781(01)00216-0; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kataoka H, 2002, BIOCHEM BIOPH RES CO, V290, P1096, DOI 10.1006/bbrc.2001.6313; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kokuzawa J, 2003, MOL CELL NEUROSCI, V24, P190, DOI 10.1016/S1044-7431(03)00160-X; Kongkham PN, 2008, CANCER RES, V68, P9945, DOI 10.1158/0008-5472.CAN-08-2169; Korhonen L, 2000, EUR J NEUROSCI, V12, P3453, DOI 10.1046/j.1460-9568.2000.00260.x; Korhonen L, 2003, J NEUROSCI RES, V71, P769, DOI 10.1002/jnr.10546; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miyata S, 2005, CANCER LETT, V227, P83, DOI 10.1016/j.canlet.2005.01.010; Miyata S, 2007, HUM CELL, V20, P100, DOI 10.1111/j.1749-0774.2007.00035.x; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Putkonen N, 2011, EUR J NEUROSCI, V34, P1212, DOI 10.1111/j.1460-9568.2011.07858.x; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Sippel M, 2009, FEBS LETT, V583, P2213, DOI 10.1016/j.febslet.2009.06.018; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sundberg M, 2006, J NEUROSCI, V26, P5402, DOI 10.1523/JNEUROSCI.4906-05.2006; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-5698.2005; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tervonen TA, 2009, NEUROBIOL DIS, V33, P250, DOI 10.1016/j.nbd.2008.10.010; Tung HH, 2012, J BIOL CHEM, V287, P22497, DOI 10.1074/jbc.M111.330589; Yamada T, 1998, EXP NEUROL, V153, P60, DOI 10.1006/exnr.1998.6874	53	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56117	10.1371/journal.pone.0056117	http://dx.doi.org/10.1371/journal.pone.0056117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409135	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200110
J	Audet, GN; Fulks, D; Stricker, JC; Olfert, IM				Audet, Gerald N.; Fulks, Daniel; Stricker, Janelle C.; Olfert, I. Mark			Chronic Delivery of a Thrombospondin-1 Mimetic Decreases Skeletal Muscle Capillarity in Mice	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE; TUMOR-GROWTH; ANGIOGENESIS; ABT-510; PEPTIDE; CD36; INFLAMMATION; ACTIVATION	Angiogenesis is an essential process for normal skeletal muscle function. There is a growing body of evidence suggesting that thrombospondin-1 (TSP-1), a potent antiangiogenic protein in tumorigenesis, is an important regulator of both physiological and pathological skeletal muscle angiogenesis. We tested the hypothesis that chronic exposure to a TSP-1 mimetic (ABT-510), which targets the CD36 TSP-1 receptor, would decrease skeletal muscle capillarity as well as alter the balance between positive and negative angiogenic proteins under basal conditions. Osmotic minipumps with either ABT-510 or vehicle (5% dextrose) were implanted subcutaneously in the subscapular region of C57/BL6 mice for 14 days. When compared to the vehicle treated mice, the ABT-510 group had a 20% decrease in capillarity in the superficial region of the gastrocnemius (GA), 11% decrease in the plantaris (PLT), and a 35% decrease in the soleus (SOL). ABT-510 also decreased muscle protein expression of vascular endothelial growth factor (VEGF) in both the GA (-140%) and SOL (-62%); however there was no change in VEGF in the PLT. Serum VEGF was not altered in ABT-510 treated animals. Endogenous TSP-1 protein expression in all muscles remained unaltered. Tunnel staining revealed no difference in muscle apoptosis between ABT-510 and vehicle treated groups. These data provide evidence that the anti-angiogenic effects of TSP-1 are mediated, at least in part, via the CD36 receptor. It also suggests that under physiologic conditions the TSP-1/CD36 axis plays a role in regulating basal skeletal muscle microvessel density.	[Audet, Gerald N.; Fulks, Daniel; Stricker, Janelle C.; Olfert, I. Mark] W Virginia Univ, Sch Med, Ctr Cardiovasc & Resp Sci, Div Exercise Physiol, Morgantown, WV 26506 USA	West Virginia University	Olfert, IM (corresponding author), W Virginia Univ, Sch Med, Ctr Cardiovasc & Resp Sci, Div Exercise Physiol, Morgantown, WV 26506 USA.	molfert@hsc.wvu.edu			National Institutes of Health T32 student training grant [NIH5T32HL090610]; American Heart Association [AHA10BGIA3630002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL090610] Funding Source: NIH RePORTER	National Institutes of Health T32 student training grant; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by funding from the National Institutes of Health T32 student training grant NIH5T32HL090610 (GNA) and by the American Heart Association AHA10BGIA3630002 (IMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Anderson JC, 2007, CANCER BIOL THER, V6, P454, DOI 10.4161/cbt.6.3.3630; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Breen EC, 1996, J APPL PHYSIOL, V81, P355, DOI 10.1152/jappl.1996.81.1.355; Campbell NE, THROMBOSPONDIN 1 MIM; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Dalla Libera L, 1999, AM J PHYSIOL-CELL PH, V277, pC982, DOI 10.1152/ajpcell.1999.277.5.C982; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571; Dimmeler S, 2000, CIRC RES, V87, P434; Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003; Duscha BD, 1999, J AM COLL CARDIOL, V33, P1956, DOI 10.1016/S0735-1097(99)00101-1; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Frazier EP, 2011, MATRIX BIOL; Friedl P, 2002, CELL MOL LIFE SCI, V59, P1347, DOI 10.1007/s00018-002-8512-9; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Greenaway J, 2009, MOL CANCER THER, V8, P64, DOI 10.1158/1535-7163.MCT-08-0864; Guo NH, 1997, CANCER RES, V57, P1735; Gupta K, 1999, Angiogenesis, V3, P147, DOI 10.1023/A:1009018702832; Hasina R, 2009, CANCER PREV RES, V2, P385, DOI 10.1158/1940-6207.CAPR-08-0211; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; Hoekstra R, 2005, J CLIN ONCOL, V23, P5188, DOI 10.1200/JCO.2005.05.013; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Isenberg JS, 2008, BIOCHEM PHARMACOL, V75, P875, DOI 10.1016/j.bcp.2007.10.025; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Joyce D, 2006, J CLIN ONCOL S, V24, P13545; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Kivela R, 2006, FASEB J, V20, P1570, DOI 10.1096/fj.05-4780fje; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Lange-Asschenfeldt B, 2002, BLOOD, V99, P538, DOI 10.1182/blood.V99.2.538; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; LOJDA Z, 1979, HISTOCHEMISTRY, V59, P153, DOI 10.1007/BF00495663; Malek MH, 2009, EXP PHYSIOL, V94, P749, DOI 10.1113/expphysiol.2008.045989; Meeson A, 1996, DEVELOPMENT, V122, P3929; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Miao WM, 2001, CANCER RES, V61, P7830; MRAZKOVA O, 1986, AM J ANAT, V177, P141, DOI 10.1002/aja.1001770203; Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733; Olfert IM, 2006, GROWTH FACTORS, V24, P253, DOI 10.1080/08977190601000111; Olfert IM, 2011, MICROCIRCULATION, V18, P316, DOI 10.1111/j.1549-8719.2011.00092.x; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Olfert IM, 2012, UNPUB; Primo L, 2005, FASEB J, V19, P1713, DOI 10.1096/fj.05-3697fje; Reiher FK, 2002, INT J CANCER, V98, P682, DOI 10.1002/ijc.10247; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Rusk A, 2006, CLIN CANCER RES, V12, P7444, DOI 10.1158/1078-0432.CCR-06-0109; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; Sun JF, 2009, AM J PHYSIOL-HEART C, V296, pH1344, DOI 10.1152/ajpheart.01246.2008; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Wintergerst ES, 2000, EUR J BIOCHEM, V267, P6050, DOI 10.1046/j.1432-1327.2000.01682.x; Yap R, 2005, CLIN CANCER RES, V11, P6678, DOI 10.1158/1078-0432.CCR-05-0621; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	63	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55953	10.1371/journal.pone.0055953	http://dx.doi.org/10.1371/journal.pone.0055953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405239	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400184
J	Gattis, SG; Chung, HS; Trent, MS; Raetz, CRH				Gattis, Samuel G.; Chung, Hak Suk; Trent, M. Stephen; Raetz, Christian R. H.			The Origin of 8-Amino-3,8-dideoxy-D-manno-octulosonic Acid (Kdo8N) in the Lipopolysaccharide of Shewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; LINKED ACYL CHAINS; ESCHERICHIA-COLI; LIPID-A; SP-NOV; IDENTIFICATION; MOLECULES; BACTERIUM; ENZYMES; CLONING	Lipopolysaccharide (LPS; endotoxin) is an essential component of the outer monolayer of nearly all Gram-negative bacteria. LPS is composed of a hydrophobic anchor, known as lipid A, an inner core oligosaccharide, and a repeating O-antigen polysaccharide. In nearly all species, the first sugar bridging the hydrophobic lipid A and the polysaccharide domain is 3-deoxy-D-manno-octulosonic acid (Kdo), and thus it is critically important for LPS biosynthesis. Modifications to lipid A have been shown to be important for resistance to antimicrobial peptides as well as modulating recognition by the mammalian innate immune system. Therefore, lipid A derivatives have been used for development of vaccine strains and vaccine adjuvants. One derivative that has yet to be studied is 8-amino-3,8-dideoxy-D-manno-octulosonic acid (Kdo8N), which is found exclusively in marine bacteria of the genus Shewanella. Using bioinformatics, a candidate gene cluster for Kdo8N biosynthesis was identified in Shewanella oneidensis. Expression of these genes recombinantly in Escherichia coli resulted in lipid A containing Kdo8N, and in vitro assays confirmed their proposed enzymatic function. Both the in vivo and in vitro data were consistent with direct conversion of Kdo to Kdo8N prior to its incorporation into the Kdo8N-lipid A domain of LPS by a metal-dependent oxidase followed by a glutamate-dependent aminotransferase. To our knowledge, this oxidase is the first enzyme shown to oxidize an alcohol using a metal and molecular oxygen, not NAD(P)(+). Creation of an S. oneidensis in-frame deletion strain showed increased sensitivity to the cationic antimicrobial peptide polymyxin as well as bile salts, suggesting a role in outer membrane integrity.	[Gattis, Samuel G.; Chung, Hak Suk; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Chung, Hak Suk] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul 130650, South Korea; [Trent, M. Stephen] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Trent, M. Stephen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Duke University; Korea Institute of Science & Technology (KIST); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Trent, MS (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, 2506 Speedway Stop A5000, Austin, TX 78712 USA.	strent@mail.utexas.edu		Chung, Hak Suk/0000-0003-1166-9909	National Institutes of Health [GM051310, GM069338, AI064184, AI76322]; Korea Institute of Science and Technology Grants; Army Research Office Grant [61789-MA-MUR]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064184, R01AI076322, R56AI076322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM051310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Institute of Science and Technology Grants; Army Research Office Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM051310 (to C. R. H. R.), GM069338 from the Lipid Maps Large Scale Collaborative (to C. R. H. R.), and AI064184 and AI76322 (to M. S. T.).; Supported by Korea Institute of Science and Technology Grants.; Supported by Army Research Office Grant 61789-MA-MUR. To whom correspondence should be addressed: Section of Molecular Genetics and Microbiology, The University of Texas at Austin, 2506 Speedway Stop A5000, Austin, TX 78712-1191. Tel.: 512-232-8371; E-mail: strent@mail.utexas.edu.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Del Rio TG, 2010, STAND GENOMIC SCI, V2, P87, DOI 10.4056/sigs.661199; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; JANNASCH HW, 1985, INT J SYST BACTERIOL, V35, P422, DOI 10.1099/00207713-35-4-422; Jorens PG, 2004, RESPIRATION, V71, P199, DOI 10.1159/000076686; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Otsuka T, 2007, J GASTROENTEROL, V42, P87, DOI 10.1007/s00535-006-1957-0; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Romo AJ, 2011, BBA-PROTEINS PROTEOM, V1814, P1534, DOI 10.1016/j.bbapap.2011.02.003; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Seidman C E, 2001, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0108s37; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P913, DOI [10.1099/ijs.0.02034-0, 10.1099/00207713-52-3-913]; Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200; Sweet CR, 2004, J BIOL CHEM, V279, P25411, DOI 10.1074/jbc.M400597200; Tan CK, 2008, J CLIN MICROBIOL, V46, P2817, DOI 10.1128/JCM.01018-08; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; Vinogradov E, 2004, CARBOHYD RES, V339, P737, DOI 10.1016/j.carres.2003.12.010; Vinogradov E, 2003, CARBOHYD RES, V338, P1991, DOI 10.1016/S0008-6215(03)00325-2; Vinogradov E, 2008, CARBOHYD RES, V343, P2701, DOI 10.1016/j.carres.2008.06.006; Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth	33	13	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9216	9225		10.1074/jbc.M113.453324	http://dx.doi.org/10.1074/jbc.M113.453324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23413030	Green Published, hybrid			2022-12-25	WOS:000316862200040
J	Gabor, CR; Fisher, MC; Bosch, J				Gabor, Caitlin R.; Fisher, Matthew C.; Bosch, Jaime			A Non-Invasive Stress Assay Shows That Tadpole Populations Infected with Batrachochytrium dendrobatidis Have Elevated Corticosterone Levels	PLOS ONE			English	Article							AMPHIBIAN DECLINES; CHYTRIDIOMYCOSIS; DISEASE; METAMORPHOSIS; PREVALENCE; MORTALITY; RESPONSES; GENOTYPE; BEHAVIOR; STEROIDS	Batrachochytrium dendrobatidis (Bd) is a fungus that causes the disease chytridiomycosis and is associated with widespread amphibian declines. Populations vary in their susceptibility to Bd infections, and the virulence of the infecting lineage can also vary. Both of these factors may manifest as a differential physiological stress response. In addition, variation in disease susceptibility across amphibian populations may be influenced by immunosuppression caused by chronic stress imposed by environmental factors. Here, we use a non-invasive water-borne hormone technique to assess stress levels (corticosterone) of free-living tadpole populations that are infected by Bd. We found that corticosterone release rates were higher in infected populations of two species of tadpoles (Alytes obstetricans and A. muletensis) than in an uninfected population for both species. The relationship between corticosterone and the intensity of infection differed between species, with only the infected A. obstetricans population showing a significant positive correlation. The higher corticosterone release rates found in A. obstetricans may be an outcome of infection by a highly virulent lineage of Bd (BdGPL), whereas A. muletensis is infected with a less virulent lineage (BdCAPE). These results suggest that different lineages of Bd impose different levels of stress on the infected animals, and that this may influence survival. The next step is to determine whether higher corticosterone levels make individuals more susceptible to Bd or if Bd infections drive the higher corticosterone levels.	[Gabor, Caitlin R.] Texas State Univ, Dept Biol, San Marcos, TX USA; [Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Texas State University System; Texas State University San Marcos; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Gabor, CR (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX USA.	gabor@txstate.edu	Fisher, Matthew/B-9094-2011; Bosch, Jaime/H-3042-2011; Gabor, Caitlin/AAK-8369-2020	Fisher, Matthew/0000-0002-1862-6402; Bosch, Jaime/0000-0002-0099-7934; 	Cero Project (FGCSIC); Cero Project (Banco de Santander); Biodiversa Project RACE; Natural Environment Research Council [NE/G001944/1] Funding Source: researchfish; NERC [NE/G001944/1] Funding Source: UKRI	Cero Project (FGCSIC); Cero Project (Banco de Santander); Biodiversa Project RACE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by Cero Project (FGCSIC and Banco de Santander to JB) and the Biodiversa Project RACE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Denver RJ, 2009, GEN COMP ENDOCR, V164, P20, DOI 10.1016/j.ygcen.2009.04.016; Dhabhar FS, 2002, INTEGR COMP BIOL, V42, P556, DOI 10.1093/icb/42.3.556; Earley RL, 2008, HORM BEHAV, V53, P442, DOI 10.1016/j.yhbeh.2007.11.017; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Gabor CR, AMPHIBIA RE IN PRESS; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Glennemeier KA, 2002, J EXP ZOOL, V292, P32, DOI 10.1002/jez.1140; Gosner K. L., 1960, Herpetologica, V16, P183; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; JAUDET GJ, 1984, GEN COMP ENDOCR, V56, P59, DOI 10.1016/0016-6480(84)90061-3; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Martin LB, 2010, ANN NY ACAD SCI, V1195, P129, DOI 10.1111/j.1749-6632.2010.05454.x; McMahon TA, 2011, ENVIRON HEALTH PERSP, V119, P1098, DOI 10.1289/ehp.1002956; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Scott AP, 2008, BEHAVIOUR, V145, P1307, DOI 10.1163/156853908785765854; Scott AP, 2007, GEN COMP ENDOCR, V153, P392, DOI 10.1016/j.ygcen.2006.11.006; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	35	52	54	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56054	10.1371/journal.pone.0056054	http://dx.doi.org/10.1371/journal.pone.0056054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418508	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300100
J	Rotman, SR; Bishop, TF				Rotman, Stephen R.; Bishop, Tara F.			Proton Pump Inhibitor Use in the US Ambulatory Setting, 2002-2009	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; HEALTH-CARE SERVICES; ENTERIC INFECTION; ACID SUPPRESSION; UNITED-STATES; HIP FRACTURE; RISK; THERAPY; OVERUSE	Background and Aims: Anecdotal reports and studies of select populations suggest that the use of proton pump inhibitors (PPIs) has increased since their introduction. We sought to determine recent trends in PPI use in the U. S. outpatient setting and characteristics of patients and physicians that may predict their use. Methods: We used data from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) to estimate the prevalence of visits in which patients used PPIs from 2002 to 2009. We tested for associations between PPI use and patient, physician, and practice characteristics using data from 2009. We also estimated the prevalence of visits in which PPIs were used by patients without gastrointestinal complaints, diagnoses, or other indications for their use and tested for associations between patient and physician characteristics and PPI use in patients with no documented indication. Results: PPIs were used in 4.0% of visits in 2002 and 9.2% in 2009 (p < 0.001 for trend across years). The use of omeprazole (0.9% in 2002 to 3.9% in 2009, p < 0.001), esomeprazole (0.9% in 2002 to 2.3% in 2009, p < 0.001), and pantoprazole (0.6% in 2002 to 1.6% in 2009, p < 0.001) increased significantly over the study period. Among visits by patients using PPIs, 62.9% documented no gastrointestinal complaints, gastrointestinal diagnoses, or other indicated reason for their use. Conclusions: We found that PPI use increased significantly from 2002 to 2009 as did documented indications for their use. Newly-prescribed PPI use did not change from 2006 to 2009. More research is needed to determine whether PPIs are overused in the U. S. outpatient setting.	[Rotman, Stephen R.] New York Presbyterian Hosp, Dept Med, New York, NY USA; [Bishop, Tara F.] Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, New York, NY USA; [Bishop, Tara F.] Weill Cornell Med Coll, Dept Med, New York, NY USA	NewYork-Presbyterian Hospital; Cornell University; Cornell University	Bishop, TF (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, New York, NY USA.	tlfernan@med.cornell.edu			National Institute On Aging Career Development Award [K23AG043499]; NATIONAL INSTITUTE ON AGING [K23AG043499] Funding Source: NIH RePORTER	National Institute On Aging Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	TFB is supported by a National Institute On Aging Career Development Award (K23AG043499) and in by funds provided to her as a Nanette Laitman Clinical Scholar in Public Health at Weill Cornell Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality website, UND HEALTHC QUAL; Arasaradnam RP, 2003, CLIN MED, V3, P387, DOI 10.7861/clinmedicine.3-4-387; Barozzi N, 2009, CLIN THER, V31, P849, DOI 10.1016/j.clinthera.2009.04.012; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; Centers for Disease Control and Prevention, NAMCS EST PROC; Centers for Disease Control and Prevention, NAMCS SCOP SAMPL DES; Chen TJ, 2003, INT J CLIN PHARM TH, V41, P207; Friedenberg FK, 2010, DIGEST DIS SCI, V55, P1911, DOI 10.1007/s10620-009-1004-0; George CJ, 2008, AM J GERIATR PHARMAC, V6, P249, DOI 10.1016/j.amjopharm.2008.12.001; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; Gray SL, 2010, ARCH INTERN MED, V170, P765, DOI 10.1001/archinternmed.2010.94; Heidelbaugh JJ, 2010, AM J MANAG CARE, V16, pE228; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hollingworth S, 2010, PHARMACOEPIDEM DR S, V19, P1019, DOI 10.1002/pds.1969; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kantorova I, 2004, HEPATO-GASTROENTEROL, V51, P757; Keyhani S, 2012, MED CARE, V50, P257, DOI 10.1097/MLR.0b013e3182422b0f; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; National Committee for Quality Assurance, 2007, ESS GUID HEALTHC QUA; Polinski JM, 2011, J AM GERIATR SOC, V59, P1922, DOI 10.1111/j.1532-5415.2011.03537.x; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; van der Velden AW, 2010, DIGESTION, V81, P43, DOI 10.1159/000236025; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Yu EW, 2011, AM J MED, V124, P519, DOI 10.1016/j.amjmed.2011.01.007	29	94	96	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56060	10.1371/journal.pone.0056060	http://dx.doi.org/10.1371/journal.pone.0056060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418510	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300102
J	Schmidt, JA; Crowe, FL; Appleby, PN; Key, TJ; Travis, RC				Schmidt, Julie A.; Crowe, Francesca L.; Appleby, Paul N.; Key, Timothy J.; Travis, Ruth C.			Serum Uric Acid Concentrations in Meat Eaters, Fish Eaters, Vegetarians and Vegans: A Cross-Sectional Analysis in the EPIC-Oxford Cohort	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; RANDOMIZED CONTROLLED-TRIAL; CALCIUM SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; ANTIOXIDANT STATUS; WEIGHED RECORDS; NATIONAL-HEALTH; DAIRY-PRODUCTS; RISK; GOUT	Introduction: Circulating concentrations of uric acid may be affected by dietary components such as meat, fish and dairy products, but only a few studies have compared uric acid concentrations among individuals who exclude some or all of these foods from their diet. The aim of this study was to investigate differences in serum uric acid concentrations between meat eaters, fish eaters, vegetarians and vegans. Subjects and Methods: A sample of 670 men and 1,023 women (424 meat eaters, 425 fish eaters, 422 vegetarians and 422 vegans, matched on age and sex) from the European Prospective Investigation into Cancer and Nutrition Oxford cohort were included in this cross-sectional analysis. Diet was assessed using a semi-quantitative food frequency questionnaire and serum concentrations of uric acid were measured. Mean concentrations of uric acid by diet group were calculated after adjusting for age, body mass index, calcium and alcohol intake. Results: In both men and women, serum uric acid concentrations differed significantly by diet group (p<0.0001 and p = 0.01, respectively). The differences between diet groups were most pronounced in men; vegans had the highest concentration (340, 95% confidence interval 329-351 mu mol/l), followed by meat eaters (315, 306-324 mu mol/l), fish eaters (309, 300-318 mu mol/l) and vegetarians (303, 294-312 mu mol/l). In women, serum uric acid concentrations were slightly higher in vegans (241, 234-247 mu mol/l) than in meat eaters (237, 231-242 mu mol/l) and lower in vegetarians (230, 224-236 mu mol/l) and fish eaters (227, 221-233 mu mol/l). Conclusion: Individuals consuming a vegan diet had the highest serum concentrations of uric acid compared to meat eaters, fish eaters and vegetarians, especially in men. Vegetarians and individuals who eat fish but not meat had the lowest concentrations of serum uric acid.	[Schmidt, Julie A.; Crowe, Francesca L.; Appleby, Paul N.; Key, Timothy J.; Travis, Ruth C.] Univ Oxford, Nuffield Dept Med, Canc Epidemiol Unit, Oxford, England	University of Oxford	Schmidt, JA (corresponding author), Univ Oxford, Nuffield Dept Med, Canc Epidemiol Unit, Oxford, England.	julie.schmidt@ceu.ox.ac.uk		Crowe, Francesca/0000-0003-4026-1726	Cancer Research UK [C570/A11692]	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK, grant number: C570/A11692 (www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates CJ, 2005, HUMAN NUTR, P573; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Chan W., 1995, MCCANCE WIDDOWSONS S; CHAN W, 1994, MCCANCE WIDDOWSONS S; Chan W., 1996, MCCANCE WIDDOWSONS S; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Dalbeth N, 2009, RHEUMATOLOGY, V48, P195, DOI 10.1093/rheumatology/ken416; Dalbeth N, 2011, CURR RHEUMATOL REP, V13, P132, DOI 10.1007/s11926-010-0160-8; Dalbeth N, 2010, ANN RHEUM DIS, V69, P1677, DOI 10.1136/ard.2009.124230; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; GHADIRIAN P, 1995, EUR J EPIDEMIOL, V11, P275, DOI 10.1007/BF01719431; Haldar S, 2007, EUR J CLIN NUTR, V61, P1011, DOI 10.1038/sj.ejcn.1602615; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Holland B, 1991, MCCANCE WIDDOWSONS S; Holland B., 1989, MCCANCE WIDDOWSONS S; Holland B, 1993, MCCANCE WIDDOWSONS S; Holland B., 1992, MCCANCE WIDDOWSONS S; Holland B., 1988, MCCANCE WIDDOWSONS S; Kramer HM, 2002, AM J KIDNEY DIS, V40, P37, DOI 10.1053/ajkd.2002.33911; Kuo CS, 2004, EUR J CLIN NUTR, V58, P312, DOI 10.1038/sj.ejcn.1601783; Lee SJ, 2006, CURR OPIN RHEUMATOL, V18, P193, DOI 10.1097/01.bor.0000209434.82096.1f; LOENEN HMJA, 1990, J CLIN EPIDEMIOL, V43, P1297, DOI 10.1016/0895-4356(90)90095-7; McCarthy GT, 2002, CARING CHILDREN LESC; Messina M, 2011, ASIA PAC J CLIN NUTR, V20, P347; Ministry of Agriculture Fisheries and Food, 1993, FOOD PORTION SIZES, V2nd ed; PAN WH, 1993, AM J CLIN NUTR, V58, P354, DOI 10.1093/ajcn/58.3.354; Poornima K, 2003, Indian J Clin Biochem, V18, P197, DOI 10.1007/BF02867387; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stockl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032668; Strasak AM, 2007, ANN ONCOL, V18, P1893, DOI 10.1093/annonc/mdm338; Strasak AM, 2007, CANCER CAUSE CONTROL, V18, P1021, DOI 10.1007/s10552-007-9043-3; Strasak AM, 2009, ANN EPIDEMIOL, V19, P15, DOI 10.1016/j.annepidem.2008.08.009; Szeto YT, 2004, NUTRITION, V20, P863, DOI 10.1016/j.nut.2004.06.006; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Zgaga L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038123; Zoppini G, 2011, J ENDOCRINOL INVEST, V34, P881, DOI 10.1007/BF03346733	41	40	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56339	10.1371/journal.pone.0056339	http://dx.doi.org/10.1371/journal.pone.0056339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418557	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300150
J	Xu, J; Ishikawa, H; Wollstein, G; Bilonick, RA; Folio, LS; Nadler, Z; Kagemann, L; Schuman, JS				Xu, Juan; Ishikawa, Hiroshi; Wollstein, Gadi; Bilonick, Richard A.; Folio, Lindsey S.; Nadler, Zach; Kagemann, Larry; Schuman, Joel S.			Three-Dimensional Spectral-Domain Optical Coherence Tomography Data Analysis for Glaucoma Detection	PLOS ONE			English	Article							NERVE-FIBER-LAYER; OPERATING CHARACTERISTIC CURVES; SEGMENTATION; AREAS	Purpose: To develop a new three-dimensional (3D) spectral-domain optical coherence tomography (SD-OCT) data analysis method using a machine learning technique based on variable-size super pixel segmentation that efficiently utilizes full 3D dataset to improve the discrimination between early glaucomatous and healthy eyes. Methods: 192 eyes of 96 subjects (44 healthy, 59 glaucoma suspect and 89 glaucomatous eyes) were scanned with SD-OCT. Each SD-OCT cube dataset was first converted into 2D feature map based on retinal nerve fiber layer (RNFL) segmentation and then divided into various number of super pixels. Unlike the conventional super pixel having a fixed number of points, this newly developed variable-size super pixel is defined as a cluster of homogeneous adjacent pixels with variable size, shape and number. Features of super pixel map were extracted and used as inputs to machine classifier (LogitBoost adaptive boosting) to automatically identify diseased eyes. For discriminating performance assessment, area under the curve (AUC) of the receiver operating characteristics of the machine classifier outputs were compared with the conventional circumpapillary RNFL (cpRNFL) thickness measurements. Results: The super pixel analysis showed statistically significantly higher AUC than the cpRNFL (0.855 vs. 0.707, respectively, p = 0.031, Jackknife test) when glaucoma suspects were discriminated from healthy, while no significant difference was found when confirmed glaucoma eyes were discriminated from healthy eyes. Conclusions: A novel 3D OCT analysis technique performed at least as well as the cpRNFL in glaucoma discrimination and even better at glaucoma suspect discrimination. This new method has the potential to improve early detection of glaucomatous damage.	[Xu, Juan; Ishikawa, Hiroshi; Wollstein, Gadi; Bilonick, Richard A.; Folio, Lindsey S.; Nadler, Zach; Kagemann, Larry; Schuman, Joel S.] Univ Pittsburgh, Sch Med, Dept Ophthalmol,UPMC, Ophthalmol & Visual Sci Res Ctr,Eye Ctr,Eye & Ear, Pittsburgh, PA 15261 USA; [Ishikawa, Hiroshi; Folio, Lindsey S.; Kagemann, Larry; Schuman, Joel S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wollstein, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol,UPMC, Ophthalmol & Visual Sci Res Ctr,Eye Ctr,Eye & Ear, Pittsburgh, PA 15261 USA.	wollsteing@upmc.edu	Schuman, Joel S/K-7304-2012; Schuman, Joel S/M-2389-2019; Ishikawa, Hiroshi/ABC-6293-2020; Ishikawa, Hiroshi/D-6370-2014	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Ishikawa, Hiroshi/0000-0001-6310-5748; Ishikawa, Hiroshi/0000-0001-6310-5748; Kagemann, Larry/0000-0001-8961-0187	National Institutes of Health [NIH R01-EY013178, R01-EY011289, P30-EY008098]; Eye and Ear Foundation (Pittsburgh, Pennsylvania, United States of America); Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY008098, R01EY011289, R01EY013178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation (Pittsburgh, Pennsylvania, United States of America); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH R01-EY013178; R01-EY011289; P30-EY008098), http://grants.nih.gov/grants/oer.htm; and the Eye and Ear Foundation (Pittsburgh, Pennsylvania, United States of America), http://www.eyeandear.org/; and Research to Prevent Blindness (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajtony C, 2007, INVEST OPHTH VIS SCI, V48, P258, DOI 10.1167/iovs.06-0410; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; Folio LS, 2012, OPTOMETRY VISION SCI, V89, pE554, DOI 10.1097/OPX.0b013e31824eeb43; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Gabriele ML, 2010, PROG RETIN EYE RES, V29, P556, DOI 10.1016/j.preteyeres.2010.05.005; Hanley JA, 1997, ACAD RADIOL, V4, P49, DOI 10.1016/S1076-6332(97)80161-4; Hee MR, 1998, OPHTHALMOLOGY, V105, P360, DOI 10.1016/S0161-6420(98)93601-6; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P325, DOI 10.1001/archopht.1995.01100030081025; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Leung CKS, 2010, OPHTHALMOLOGY, V117, P1684, DOI 10.1016/j.ophtha.2010.01.026; Pons ME, 2000, ARCH OPHTHALMOL-CHIC, V118, P1044, DOI 10.1001/archopht.118.8.1044; PULIAFITO CA, 1995, OPTICAL COHERENCE TO; Schuman Joel S, 2008, Trans Am Ophthalmol Soc, V106, P426; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Townsend KA, 2009, BRIT J OPHTHALMOL, V93, P139, DOI 10.1136/bjo.2008.145540; Xu J, 2007, IEEE T BIO-MED ENG, V54, P473, DOI 10.1109/TBME.2006.888831; Xu JA, 2009, IFMBE PROC, V25, P179	19	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55476	10.1371/journal.pone.0055476	http://dx.doi.org/10.1371/journal.pone.0055476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408988	gold, Green Published, Green Accepted			2022-12-25	WOS:000315100000016
J	Goto, K; Nagano, Y				Goto, Kenta; Nagano, Yukio			Ultra-Low Background DNA Cloning System	PLOS ONE			English	Article							POLYMERASE EXTENSION CLONING; IN-VIVO; NUCLEOTIDE-SEQUENCE; FRAGMENTS; YEAST; TRANSFORMATION; RECOMBINATION; CONSTRUCTION; PURIFICATION; COMPLEX	Yeast-based in vivo cloning is useful for cloning DNA fragments into plasmid vectors and is based on the ability of yeast to recombine the DNA fragments by homologous recombination. Although this method is efficient, it produces some by-products. We have developed an "ultra-low background DNA cloning system" on the basis of yeast-based in vivo cloning, by almost completely eliminating the generation of by-products and applying the method to commonly used Escherichia coli vectors, particularly those lacking yeast replication origins and carrying an ampicillin resistance gene (Amp(r)). First, we constructed a conversion cassette containing the DNA sequences in the following order: an Amp(r) 5' UTR (untranslated region) and coding region, an autonomous replication sequence and a centromere sequence from yeast, a TRP1 yeast selectable marker, and an Amp(r) 3' UTR. This cassette allowed conversion of the Amp(r)-containing vector into the yeast/E. coli shuttle vector through use of the Amp(r) sequence by homologous recombination. Furthermore, simultaneous transformation of the desired DNA fragment into yeast allowed cloning of this DNA fragment into the same vector. We rescued the plasmid vectors from all yeast transformants, and by-products containing the E. coli replication origin disappeared. Next, the rescued vectors were transformed into E. coli and the by-products containing the yeast replication origin disappeared. Thus, our method used yeast-and E. coli-specific "origins of replication" to eliminate the generation of by-products. Finally, we successfully cloned the DNA fragment into the vector with almost 100% efficiency.	[Goto, Kenta; Nagano, Yukio] Saga Univ, Analyt Res Ctr Expt Sci, Honjo, Saga, Japan; [Goto, Kenta] Saga Univ, Dept Appl Biochem & Food Sci, Honjo, Saga, Japan	Saga University; Saga University	Goto, K (corresponding author), Saga Univ, Analyt Res Ctr Expt Sci, Honjo, Saga, Japan.	nagano@cc.saga-u.ac.jp	Nagano, Yukio/H-8734-2019	Nagano, Yukio/0000-0001-5030-676X	A-STEP (FS-stage) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	A-STEP (FS-stage) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Part of this work was supported by A-STEP (FS-stage) from the Japan Science and Technology Agency (JST) and by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; ENGLER JA, 1981, GENE, V14, P155, DOI 10.1016/0378-1119(81)90111-6; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305; Iizasa E, 2006, BIOTECHNIQUES, V40, P79, DOI 10.2144/000112041; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; MARYKWAS DL, 1995, P NATL ACAD SCI USA, V92, P11701, DOI 10.1073/pnas.92.25.11701; Nagano Y, 2007, PLANT CELL REP, V26, P2111, DOI 10.1007/s00299-007-0428-2; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Raymond CK, 2002, GENOME RES, V12, P190, DOI 10.1101/gr.205201; SCHONER B, 1981, GENE, V14, P165, DOI 10.1016/0378-1119(81)90112-8; Spiliotis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035407; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556	21	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56530	10.1371/journal.pone.0056530	http://dx.doi.org/10.1371/journal.pone.0056530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409191	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300077
J	Kamiya, K; Shimizu, K; Kobashi, H; Igarashi, A; Komatsu, M				Kamiya, Kazutaka; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito; Komatsu, Mari			Three-Year Follow-Up of Posterior Chamber Toric Phakic Intraocular Lens Implantation for Moderate to High Myopic Astigmatism	PLOS ONE			English	Article							ADMINISTRATION CLINICAL-TRIAL; COLLAMER LENS; CONTACT-LENS; SURGERY	Purpose: To assess the 3-year clinical outcomes of toric phakic intraocular lens (Visian ICL (TM); STAAR Surgical) implantation for moderate to high myopic astigmatism. Methods: This retrospective study evaluated fifty eyes of 28 patients who underwent toric ICL implantation for the correction of moderate to high myopic astigmatism and who regularly returned for postoperative examination. Before, and 1, 3, and 6 months after, and 1, 2, and 3 years after surgery, we assessed the safety, efficacy, predictability, stability, and adverse events of the surgery in eyes undergoing toric ICL implantation. Results: The logarithm of the minimal angle of resolution (LogMAR) uncorrected visual acuity and LogMAR best spectacle-corrected visual acuity were -0.10 (corresponding to Snellen equivalents 20/16) +/- 0.16 and -0.20 (corresponding to 20/12.5) +/- 0.07, 3 years postoperatively, respectively. The safety and efficacy indices were 1.16 +/- 0.20 and 0.94 +/- 0.28. At 3 year, 82% and 98% of the eyes were within 0.5 and 1.0 D, respectively, of the targeted correction. Manifest refraction changes of -0.15 +/- 0.31 D occurred from 1 month to 3 year. No vision-threatening complications occurred during the observation period. Conclusions: On the basis of the clinical results of this study, toric ICL implantation was good in all measures of safety, efficacy, predictability, and stability for the correction of moderate to high myopic astigmatism throughout a 3-year observation period.	[Kamiya, Kazutaka; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito] Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan; [Komatsu, Mari] Sanno Hosp, Tokyo, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Alfonso JF, 2012, GRAEFES ARCH CLIN EX; Alfonso JF, 2011, J CATARACT REFR SURG, V37, P873, DOI 10.1016/j.jcrs.2010.11.040; Alfonso JF, 2010, J CATARACT REFR SURG, V36, P1349, DOI 10.1016/j.jcrs.2010.02.022; Alfonso JF, 2010, J CATARACT REFR SURG, V36, P906, DOI 10.1016/j.jcrs.2009.11.032; Alfonso JF, 2010, J CATARACT REFR SURG, V36, P568, DOI 10.1016/j.jcrs.2009.10.052; Bhikoo R, 2010, CLIN EXP OPHTHALMOL, V38, P467, DOI 10.1111/j.1442-9071.2010.02273.x; Bloomenstein Marc R, 2002, Optometry, V73, P435; Choi SH, 2011, J REFRACT SURG, V27, P91, DOI 10.3928/1081597X-20100414-01; Fernandes P, 2011, J REFRACT SURG, V27, P765, DOI 10.3928/1081597X-20110617-01; Jimenez-Alfaro I, 2001, J REFRACT SURG, V17, P641; Kamiya K, 2009, BRIT J OPHTHALMOL, V93, P1648, DOI 10.1136/bjo.2009.160044; Kamiya K, 2008, J CATARACT REFR SURG, V34, P1687, DOI 10.1016/j.jcrs.2008.06.030; Kamiya K, 2010, OPHTHALMOLOGY, V117, P2287, DOI 10.1016/j.ophtha.2010.03.054; Kamiya K, 2009, ARCH OPHTHALMOL-CHIC, V127, P845, DOI 10.1001/archophthalmol.2009.67; Lackner B, 2004, J CATARACT REFR SURG, V30, P2269, DOI 10.1016/j.jcrs.2004.07.018; Matsumura K, 2011, IOL RS, V25, P247; Pineda-Fernandez A, 2004, J CATARACT REFR SURG, V30, P2277, DOI 10.1016/j.jcrs.2004.03.035; Sanders DR, 2008, J REFRACT SURG, V24, P566, DOI 10.3928/1081597X-20080601-04; Sanders DR, 2007, OPHTHALMOLOGY, V114, P54, DOI 10.1016/j.ophtha.2006.08.049; Sanders DR, 2004, OPHTHALMOLOGY, V111, P1683, DOI 10.1016/j.ophtha.2004.03.026; Sanders DR, 1998, J CATARACT REFR SURG, V24, P607, DOI 10.1016/S0886-3350(98)80254-X; Sari ES, 2012, GRAEFES ARCH CLIN EX; Sarver EJ, 2004, J REFRACT SURG, V20, P472; Schallhorn S, 2007, J REFRACT SURG, V23, P853, DOI 10.3928/1081-597X-20071101-01; Thibos LN, 2001, J CATARACT REFR SURG, V27, P80, DOI 10.1016/S0886-3350(00)00797-5; Uusitalo RJ, 2002, J CATARACT REFR SURG, V28, P29, DOI 10.1016/S0886-3350(01)01218-4; Vukich JA, 2003, OPHTHALMOLOGY, V110, P255, DOI 10.1016/S0161-6420(02)01771-2; Zaldivar R, 1998, J REFRACT SURG, V14, P294	28	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56453	10.1371/journal.pone.0056453	http://dx.doi.org/10.1371/journal.pone.0056453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409187	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300075
J	Matvienko, M; Kozik, A; Froenicke, L; Lavelle, D; Martineau, B; Perroud, B; Michelmore, R				Matvienko, Marta; Kozik, Alexander; Froenicke, Lutz; Lavelle, Dean; Martineau, Belinda; Perroud, Bertrand; Michelmore, Richard			Consequences of Normalizing Transcriptomic and Genomic Libraries of Plant Genomes Using a Duplex-Specific Nuclease and Tetramethylammonium Chloride	PLOS ONE			English	Article							REFERENCE SEQUENCES REFSEQ; WIDE COMPARATIVE-ANALYSIS; ARABIDOPSIS-THALIANA; CDNA LIBRARIES; RNA-SEQ; DNA; MAIZE; FAMILY; GENES; RETROTRANSPOSONS	Several applications of high throughput genome and transcriptome sequencing would benefit from a reduction of the high-copy-number sequences in the libraries being sequenced and analyzed, particularly when applied to species with large genomes. We adapted and analyzed the consequences of a method that utilizes a thermostable duplex-specific nuclease for reducing the high-copy components in transcriptomic and genomic libraries prior to sequencing. This reduces the time, cost, and computational effort of obtaining informative transcriptomic and genomic sequence data for both fully sequenced and non-sequenced genomes. It also reduces contamination from organellar DNA in preparations of nuclear DNA. Hybridization in the presence of 3 M tetramethylammonium chloride (TMAC), which equalizes the rates of hybridization of GC and AT nucleotide pairs, reduced the bias against sequences with high GC content. Consequences of this method on the reduction of high-copy and enrichment of low-copy sequences are reported for Arabidopsis and lettuce.	[Matvienko, Marta; Kozik, Alexander; Froenicke, Lutz; Lavelle, Dean; Martineau, Belinda; Perroud, Bertrand; Michelmore, Richard] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Michelmore, Richard] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Michelmore, Richard] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Michelmore, Richard] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Michelmore, R (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	rwmichelmore@ucdavis.edu	Martineau, Belinda/GOH-1630-2022		National Science Foundation [DBI0421630]; Division Of Integrative Organismal Systems [0820451] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funding from the National Science Foundation Plant Genome Program (http://www.nsf.gov/bio/pubs/awards/pgr.htm) Grant #DBI0421630 as part of the Compositae Genome Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bogdanova EA, 2008, MOL BIOSYST, V4, P205, DOI 10.1039/b715110c; Britten R J, 1974, Methods Enzymol, V29, P363; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; CHEVET E, 1995, NUCLEIC ACIDS RES, V23, P3343, DOI 10.1093/nar/23.16.3343; Christodoulou Danos C, 2011, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0412s94; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooley MB, 1999, PLANT PHYSIOL, V121, P1339, DOI 10.1104/pp.121.4.1339; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Fritjers ACJ, 1997, THEOR APPL GENET, V94, P390; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; Gurushidze M, 2012, SYST BOT, V37, P96, DOI 10.1600/036364412X616675; Hewitt E. J., 1966, Technical Communications. Commonwealth Bureau of Horticulture and Plantation Crops, P547; Hoagland DR, 1933, P AM SOC HORTIC SCI, V30, P88; HONORE B, 1993, J BIOCHEM BIOPH METH, V27, P39, DOI 10.1016/0165-022X(93)90066-W; Hosouchi T, 2002, DNA RES, V9, P117, DOI 10.1093/dnares/9.4.117; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Kapitonov V.V., 2004, ENCY MOL CELL BIOL M, V1, P251; Kelly LJ, 2011, CHROMOSOME RES, V19, P939, DOI 10.1007/s10577-011-9246-z; KO MSH, 1990, NUCLEIC ACIDS RES, V18, P5705, DOI 10.1093/nar/18.19.5705; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li Y, 2006, GENOMICS, V87, P645, DOI 10.1016/j.ygeno.2005.12.010; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; MELCHIOR WB, 1973, P NATL ACAD SCI USA, V70, P298, DOI 10.1073/pnas.70.2.298; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moolhuijzen P, 2007, AUST J AGR RES, V58, P470, DOI 10.1071/AR06155; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Prokopowich CD, 2003, GENOME, V46, P48, DOI [10.1139/g02-103, 10.1139/G02-103]; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; SASAKI YF, 1994, NUCLEIC ACIDS RES, V22, P987, DOI 10.1093/nar/22.6.987; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Shagina I, 2010, BIOTECHNIQUES, V48, P455, DOI 10.2144/000113422; Shilperoort, 1994, PLANT MOL BIOL MAN D, P1, DOI 10.1007/978-94-011-0511-8_16; Sijak-Yakovev S, 2003, PLANT SYST EVOL, V236, P165, DOI [10.1007/s00606-002-0240-y, 10.1007/S00606-002-0240-y]; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	69	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55913	10.1371/journal.pone.0055913	http://dx.doi.org/10.1371/journal.pone.0055913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409088	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300045
J	McKim-Louder, MI; Hoover, JP; Benson, TJ; Schelsky, WM				McKim-Louder, Matthew I.; Hoover, Jeffrey P.; Benson, Thomas J.; Schelsky, Wendy M.			Juvenile Survival in a Neotropical Migratory Songbird Is Lower than Expected	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PROTHONOTARY WARBLERS; REPRODUCTIVE SUCCESS; NATAL DISPERSAL; PARASITISM; BIRDS; RATES; SIZE; RECRUITMENT; PHILOPATRY	Attempts to estimate and identify factors influencing first-year survival in passerines, survival between fledging and the first reproductive attempt (i.e. juvenile survival), have largely been confounded by natal dispersal, particularly in long-distance migratory passerines. We studied Prothonotary Warblers (Protonotaria citrea) breeding in nest boxes to estimate first-year survival while accounting for biases related to dispersal that are common in mark-recapture studies. The natal dispersal distribution (median = 1420 m; n = 429) and a distance-dependent recruitment rate, which controls for effects of study site configuration, both indicated a pattern of short-distance natal dispersal. This pattern was consistent with results of a systematic survey for birds returning outside the nest box study sites (up to 30 km in all directions) within a majority (81%) of total available bottomland forest habitat, further suggesting that permanent emigration outside of the study system was rare. We used multistate mark-recapture modeling to estimate first-year survival and incorporated factors thought to influence survival while accounting for the potential confounding effects of dispersal on recapture probabilities for warblers that fledged during 2004-2009 (n = 6093). Overall, the average first-year survival for warblers reared without cowbird nestmates was 0.11 (95% CI = 0.09-0.13), decreased with fledging date (0.22 early to 0.03 late) and averaged 40% lower for warblers reared with a brood parasite nestmate. First-year survival was less than half of the rate thought to represent population replacement in migratory passerines (similar to 0.30). This very low rate suggests that surviving the first year of life for many Neotropical migratory species is even more difficult than previously thought, forcing us to rethink estimates used in population models.	[McKim-Louder, Matthew I.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [McKim-Louder, Matthew I.; Hoover, Jeffrey P.; Benson, Thomas J.; Schelsky, Wendy M.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	McKim-Louder, MI (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.	mckimlouder@gmail.com	McKim-Louder, Matthew/G-1596-2013; Benson, Thomas J/B-8526-2013; Schelsky, Wendy/ABF-3948-2020	Benson, Thomas J/0000-0002-7287-7499; Louder, Matthew/0000-0003-4421-541X; Schelsky, Wendy/0000-0002-5742-757X	United States Fish and Wildlife Service [INT 1448-0003-95-1007]; Nature Conservancy; Illinois Department of Natural Resources Wildlife Preservation Fund; University of Illinois; North American Bluebird Society; Champaign County and Decatur Audubon Societies; Sigma Xi	United States Fish and Wildlife Service(US Fish & Wildlife Service); Nature Conservancy; Illinois Department of Natural Resources Wildlife Preservation Fund; University of Illinois; North American Bluebird Society; Champaign County and Decatur Audubon Societies; Sigma Xi	Financial support was provided by the United States Fish and Wildlife Service (INT 1448-0003-95-1007), The Nature Conservancy, the Illinois Department of Natural Resources Wildlife Preservation Fund, the University of Illinois, the North American Bluebird Society, the Champaign County and Decatur Audubon Societies, and Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AAY, 2006, ECOLOGY, V87, P178, DOI 10.1890/04-1922; Anders AD, 2005, CONSERV BIOL, V19, P66, DOI 10.1111/j.1523-1739.2005.00543.x; Anders AD, 1998, AUK, V115, P349, DOI 10.2307/4089193; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Clark ME, 2007, ECOL MODEL, V209, P110, DOI 10.1016/j.ecolmodel.2007.06.008; Cooper CB, 2008, ECOLOGY, V89, P3349, DOI 10.1890/08-0315.1; Donovan TM, 1995, CONSERV BIOL, V9, P1380, DOI 10.1046/j.1523-1739.1995.09061380.x; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Gilroy JJ, 2012, ECOLOGY, V93, P1509, DOI 10.1890/12-0124.1; Gotmark F, 2002, OECOLOGIA, V130, P25, DOI 10.1007/s004420100769; Hoover JP, 2009, WETLANDS, V29, P563, DOI 10.1672/08-75.1; Hoover JP, 2003, ANIM BEHAV, V65, P923, DOI 10.1006/anbe.2003.2155; Hoover JP, 2003, ANIM BEHAV, V65, P935, DOI 10.1006/anbe.2003.2154; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Hoover JP, 2009, TUNDRA TROPICS CONNE, P128; Hoover JP, 2001, EXPT STUDY BEHAV RES; Kilner RM, 2004, SCIENCE, V305, P877, DOI 10.1126/science.1098487; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6; Lichtenstein G, 1998, P ROY SOC B-BIOL SCI, V265, P249, DOI 10.1098/rspb.1998.0289; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Mitchell GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028838; Moller AP, 2004, ECOLOGY, V85, P206, DOI 10.1890/02-0451; MURPHY MT, 1983, ECOLOGY, V64, P914, DOI 10.2307/1937213; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Peterson SM, 2012, WILSON J ORNITHOL, V124, P179, DOI 10.1676/11-050.1; Petit L. J., 1999, BIRDS N AM; Redmond LJ, 2012, J FIELD ORNITHOL, V83, P247, DOI 10.1111/j.1557-9263.2012.00373.x; Reilly JR, 2009, J ANIM ECOL, V78, P990, DOI 10.1111/j.1365-2656.2009.01576.x; Ricklefs R.E., 1973, P366; Ridley AR, 2012, IBIS, V154, P195, DOI 10.1111/j.1474-919X.2011.01190.x; Robinson RA, 2004, J ANIM ECOL, V73, P670, DOI 10.1111/j.0021-8790.2004.00841.x; SAETHER BE, 1988, NATURE, V331, P616, DOI 10.1038/331616a0; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Sim IMW, 2011, J ANIM ECOL, V80, P159, DOI 10.1111/j.1365-2656.2010.01750.x; Stearns S.C., 1992, pi; Tarof SA, 2011, AUK, V128, P716, DOI 10.1525/auk.2011.11087; Tarwater CE, 2011, ECOLOGY, V92, P1271, DOI 10.1890/10-1386.1; Tittler R, 2009, ECOGRAPHY, V32, P1051, DOI 10.1111/j.1600-0587.2009.05680.x; van Noordwijk AJ, 2011, J ORNITHOL, V152, P239, DOI 10.1007/s10336-010-0637-2; vanNoordwijk AJ, 1995, J APPL STAT, V22, P683, DOI 10.1080/02664769524540; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; WEATHERHEAD PJ, 1994, BEHAV ECOL, V5, P426, DOI 10.1093/beheco/5.4.426; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x	51	48	48	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56059	10.1371/journal.pone.0056059	http://dx.doi.org/10.1371/journal.pone.0056059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409122	gold, Green Submitted, Green Published			2022-12-25	WOS:000314660300055
J	Roncaglia-Denissen, MP; Schmidt-Kassow, M; Kotz, SA				Roncaglia-Denissen, Maria Paula; Schmidt-Kassow, Maren; Kotz, Sonja A.			Speech Rhythm Facilitates Syntactic Ambiguity Resolution: ERP Evidence	PLOS ONE			English	Article							WORKING-MEMORY; WORD SEGMENTATION; PROSODY; PERCEPTION; COMPREHENSION; PREFERENCES; RECALL; FRENCH	In the current event-related potential (ERP) study, we investigated how speech rhythm impacts speech segmentation and facilitates the resolution of syntactic ambiguities in auditory sentence processing. Participants listened to syntactically ambiguous German subject-and object-first sentences that were spoken with either regular or irregular speech rhythm. Rhythmicity was established by a constant metric pattern of three unstressed syllables between two stressed ones that created rhythmic groups of constant size. Accuracy rates in a comprehension task revealed that participants understood rhythmically regular sentences better than rhythmically irregular ones. Furthermore, the mean amplitude of the P600 component was reduced in response to object-first sentences only when embedded in rhythmically regular but not rhythmically irregular context. This P600 reduction indicates facilitated processing of sentence structure possibly due to a decrease in processing costs for the less-preferred structure (object-first). Our data suggest an early and continuous use of rhythm by the syntactic parser and support language processing models assuming an interactive and incremental use of linguistic information during language processing.	[Roncaglia-Denissen, Maria Paula; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Schmidt-Kassow, Maren] Goethe Univ Frankfurt, Inst Med Psychol, D-60054 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Roncaglia-Denissen, MP (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	roncaglia@cbs.mpg.de			Max Planck International Research Network on Aging (MaxNetAging); German Research Foundation [DFG SCHM 2693/1, DFG KO 2268/1]	Max Planck International Research Network on Aging (MaxNetAging); German Research Foundation(German Research Foundation (DFG))	M. Paula Roncaglia-Denissen was supported by the Max Planck International Research Network on Aging (MaxNetAging), Maren Schmidt-Kassow by the German Research Foundation (DFG SCHM 2693/1), and Sonja A. Kotz by the German Research Foundation (DFG KO 2268/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH CM, 1991, J MEM LANG, V30, P644, DOI 10.1016/0749-596X(91)90030-N; Bogels S, 2010, J COGNITIVE NEUROSCI, V22, P1036, DOI 10.1162/jocn.2009.21269; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bornkessel I, 2004, J MEM LANG, V51, P495, DOI 10.1016/j.jml.2004.06.011; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Boucher VJ, 2006, LANG SPEECH, V49, P495, DOI 10.1177/00238309060490040301; Carpenter PA, 1989, COMPLEX INFORM PROCE; Carroll Patrick J., 1987, MODULARITY KNOWLEDGE, P221; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; CUTLER A, 1994, COGNITION, V50, P79, DOI 10.1016/0010-0277(94)90021-3; CUTLER A, 1994, LINGUA, V92, P81, DOI 10.1016/0024-3841(94)90338-7; Dilley LC, 2008, J MEM LANG, V59, P294, DOI 10.1016/j.jml.2008.06.006; DOOLING DJ, 1974, J VERB LEARN VERB BE, V13, P255, DOI 10.1016/S0022-5371(74)80062-9; Eckstein K, 2006, J COGNITIVE NEUROSCI, V18, P1696, DOI 10.1162/jocn.2006.18.10.1696; Frazier L, 2006, TRENDS COGN SCI, V10, P244, DOI 10.1016/j.tics.2006.04.002; Friederici AD, 1996, J PSYCHOLINGUIST RES, V25, P157, DOI 10.1007/BF01708424; Friederici AD, 1998, BIOL PSYCHOL, V47, P193, DOI 10.1016/S0301-0511(97)00033-1; Friederici AD, 2001, COGNITIVE BRAIN RES, V11, P305, DOI 10.1016/S0926-6410(00)00065-3; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; Gerken L. A., 1996, SIGNAL SYNTAX BOOTST; Gorrell Paul, 2000, GERMAN SENTENCE PROC, P25; Gussenhoven C, 1984, GRAMMAR SEMANTICS SE; Handy T.C., 2004, EVENT RELATED POTENT; Haupt FS, 2008, J MEM LANG, V59, P54, DOI 10.1016/j.jml.2008.02.003; Hayes Bruce, 1995, METRICAL STRESS THEO; Hayes Bruce, 1989, RHYTHM METER; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hitch GJ, 1996, Q J EXP PSYCHOL-A, V49, P116, DOI 10.1080/713755609; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; JOHNSON RE, 1970, J VERB LEARN VERB BE, V9, P12, DOI 10.1016/S0022-5371(70)80003-2; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; JUSCZYK PW, 1992, COGNITIVE PSYCHOL, V24, P252, DOI 10.1016/0010-0285(92)90009-Q; Jusczyk PW, 2002, CURR DIR PSYCHOL SCI, V11, P15, DOI 10.1111/1467-8721.00159; Kennedy A, 1989, LANG COGNITIVE PROC, V4, pSI51, DOI 10.1080/01690968908406363; Kerkhofs R, 2007, J COGNITIVE NEUROSCI, V19, P1421, DOI 10.1162/jocn.2007.19.9.1421; Kjelgaard MM, 1999, J MEM LANG, V40, P153, DOI 10.1006/jmla.1998.2620; Lehiste I, 1973, PHONETIC DISAMBIGUAT; Lehiste I., 1970, SUPRASEGMENTALS; Magne C, 2004, J MUSIC MEANING; Magne C, 2007, CEREB CORTEX, V17, P2659, DOI 10.1093/cercor/bhl174; MARSLENWILSON WD, 1992, Q J EXP PSYCHOL-A, V45, P73, DOI 10.1080/14640749208401316; MARTIN JG, 1967, J VERB LEARN VERB BE, V6, P903, DOI 10.1016/S0022-5371(67)80157-9; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; MECKLINGER A, 1995, MEM COGNITION, V23, P477, DOI 10.3758/BF03197249; Morgan JL, 1996, LANG COGNITIVE PROC, V11, P69, DOI 10.1080/016909696387222; Murray WS, 1998, PARSING AMBIGU UNPUB; Nazzi T, 2003, SPEECH COMMUN, V41, P233, DOI 10.1016/S0167-6393(02)00106-1; Nespor Marina, 1986, PROSODIC PHONOLOGY; Niebuhr O, 2009, PHONETICA, V66, P95, DOI 10.1159/000208933; Nooteboom S., 1997, HDB PHONETIC SCI, V5, P640; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; PRICE PJ, 1991, J ACOUST SOC AM, V90, P2956, DOI 10.1121/1.401770; Ramus F., 2002, ANN REV LANGUAGE ACQ, V2, P85, DOI [10.1075/arla.2.05ram, DOI 10.1075/ARLA.2.05RAM]; ROBINSON GM, 1977, J EXP PSYCHOL HUMAN, V3, P83; Rothermich K, 2012, NEUROPSYCHOLOGIA, V50, P232, DOI 10.1016/j.neuropsychologia.2011.10.025; Schafer A, 1996, LANG COGNITIVE PROC, V11, P135, DOI 10.1080/016909696387240; Schafer A. J., 1997, PROSODIC PARSING ROL; Schmidt-Kassow M, 2009, J COGNITIVE NEUROSCI, V21, P1693, DOI 10.1162/jocn.2008.21153; Shriberg E, 2000, SPEECH COMMUN, V32, P127, DOI 10.1016/S0167-6393(00)00028-5; Slowiaczek M. L., 1981, PROSODIC UNITS LANGU; Speer SR, 1996, J PSYCHOLINGUIST RES, V25, P249, DOI 10.1007/BF01708573; Steinhauer K, 1997, Z EXP PSYCHOL, V44, P305; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Stirling L, 1996, LANG COGNITIVE PROC, V11, P193, DOI 10.1080/016909696387268; STREETER LA, 1978, J ACOUST SOC AM, V64, P1582, DOI 10.1121/1.382142; Swets B, 2007, J EXP PSYCHOL GEN, V136, P64, DOI 10.1037/0096-3445.136.1.64; TYLER LK, 1987, J MEM LANG, V26, P638, DOI 10.1016/0749-596X(87)90107-0; Vos SH, 2001, LANG COGNITIVE PROC, V16, P65, DOI 10.1080/01690960042000085; WARREN P, 1995, LANG COGNITIVE PROC, V10, P457, DOI 10.1080/01690969508407112; Warren P., 1985, TEMPORAL ORG PERCEPT; Watt SM, 1996, J PSYCHOLINGUIST RES, V25, P291, DOI 10.1007/BF01708575	71	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56000	10.1371/journal.pone.0056000	http://dx.doi.org/10.1371/journal.pone.0056000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23409109	Green Published, gold			2022-12-25	WOS:000314660300050
J	Wang, D; Cao, L; Xu, Z; Fang, LR; Zhong, Y; Chen, QG; Luo, R; Chen, HC; Li, K; Xiao, SB				Wang, Dang; Cao, Lu; Xu, Zheng; Fang, Liurong; Zhong, Yao; Chen, Quangang; Luo, Rui; Chen, Huanchun; Li, Kui; Xiao, Shaobo			MiR-125b Reduces Porcine Reproductive and Respiratory Syndrome Virus Replication by Negatively Regulating the NF-kappa B Pathway	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INTERFERON-BETA PRODUCTION; CELLULAR MICRORNAS; EXPRESSION; MODULATION; INFECTION; PRRSV; SUPPRESSION; ACTIVATION; INHIBITION	Porcine reproductive and respiratory syndrome virus (PRRSV) is an Arterivirus that has been devastating the swine industry worldwide since the late 1980s. To investigate the impact of cellular microRNAs (miRNAs) on the replication of PRRSV, we screened 10 highly conserved miRNAs implicated in innate immunity or antiviral function and identified miR-125b as an inhibitor of PRRSV replication. Virus titer and western blot assays demonstrated that miR-125b reduced PRRSV replication and viral gene expression in a dose-dependent manner in both MARC-145 cell line and primary porcine alveolar macrophages. Mechanistically, miR-125b did not target the PRRSV genome. Rather, it inhibited activation of NF-kappa B, which we found to be required for PRRSV replication. PRRSV, in turn, down-regulated miR-125b expression post-infection to promote viral replication. Collectively, miR-125b is an antiviral host factor against PRRSV, but it is subject to manipulation by PRRSV. Our study reveals an example of manipulation of a cellular miRNA by an arterivirus to re-orchestrate host gene expression for viral propagation and sheds new light on targeting host factors to develop effective control measures for PRRS.	[Wang, Dang; Cao, Lu; Xu, Zheng; Fang, Liurong; Zhong, Yao; Chen, Quangang; Luo, Rui; Chen, Huanchun; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China; [Li, Kui] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Huazhong Agricultural University; University of Tennessee System; University of Tennessee Health Science Center	Xiao, SB (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China.	vet@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188	National Natural Sciences Foundation of China [30972189, 31001054, 31201890, 31225027]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China (30972189, 31001054, 31201890 and 31225027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asamitsu K, 2008, J BIOCHEM, V144, P581, DOI 10.1093/jb/mvn104; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Calzada-Nova G, 2011, J VIROL, V85, P2703, DOI 10.1128/JVI.01616-10; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chaudhuri AA, 2011, J IMMUNOL, V187, P5062, DOI 10.4049/jimmunol.1102001; Chen ZH, 2010, J GEN VIROL, V91, P1047, DOI 10.1099/vir.0.016212-0; Darwich L, 2010, VIRUS RES, V154, P123, DOI 10.1016/j.virusres.2010.07.017; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim O, 2010, VIROLOGY, V402, P315, DOI 10.1016/j.virol.2010.03.039; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kong FF, 2011, J HUAZHONG U SCI-MED, V31, P543, DOI 10.1007/s11596-011-0487-z; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee SM, 2005, VIROLOGY, V342, P47, DOI 10.1016/j.virol.2005.07.034; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li B, 2009, VACCINE, V27, P1957, DOI 10.1016/j.vaccine.2009.01.098; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Luo R, 2011, VIRUS GENES, V42, P76, DOI 10.1007/s11262-010-0548-6; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Meulenberg JJM, 2000, VET RES, V31, P11, DOI 10.1051/vetres:2000054; Muller S, 2007, IMMUNITY, V27, P1, DOI 10.1016/j.immuni.2007.07.003; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Murtaugh MP, 2010, VIRUS RES, V154, P18, DOI 10.1016/j.virusres.2010.08.015; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Roberts APE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-201; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Song C, 2010, VIROLOGY, V407, P268, DOI 10.1016/j.virol.2010.08.025; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Surdziel E, 2011, BLOOD, V117, P4338, DOI 10.1182/blood-2010-06-289058; Wang D, 2010, BIOCHEM BIOPH RES CO, V399, P72, DOI 10.1016/j.bbrc.2010.07.044; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wessner B, 2010, EXERC IMMUNOL REV, V16, P22; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	65	54	61	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55838	10.1371/journal.pone.0055838	http://dx.doi.org/10.1371/journal.pone.0055838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409058	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200074
J	Zhang, W; Fan, XH; Zhu, SF; Zhao, H; Fu, LZ				Zhang, Wei; Fan, Xiaohong; Zhu, Shuifang; Zhao, Hong; Fu, Lianzhong			Species-Specific Identification from Incomplete Sampling: Applying DNA Barcodes to Monitoring Invasive Solanum Plants	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC-RELATIONSHIPS; LAND PLANTS; CHLOROPLAST; SEQUENCE; REGION; RATES; SUBSTITUTION; DISCRIMINATE; CHARACTERS	Comprehensive sampling is crucial to DNA barcoding, but it is rarely performed because materials are usually unavailable. In practice, only a few rather than all species of a genus are required to be identified. Thus identification of a given species using a limited sample is of great importance in current application of DNA barcodes. Here, we selected 70 individuals representing 48 species from each major lineage of Solanum, one of the most species-rich genera of seed plants, to explore whether DNA barcodes can provide reliable specific-species discrimination in the context of incomplete sampling. Chloroplast genes ndhF and trnS-trnG and the nuclear gene waxy, the commonly used markers in Solanum phylogeny, were selected as the supplementary barcodes. The tree-building and modified barcode gap methods were employed to assess species resolution. The results showed that four Solanum species of quarantine concern could be successfully identified through the two-step barcoding sampling strategy. In addition, discrepancies between nuclear and cpDNA barcodes in some samples demonstrated the ability to discriminate hybrid species, and highlights the necessity of using barcode regions with different modes of inheritance. We conclude that efficient phylogenetic markers are good candidates as the supplementary barcodes in a given taxonomic group. Critically, we hypothesized that a specific-species could be identified from a phylogenetic framework using incomplete sampling-through this, DNA barcoding will greatly benefit the current fields of its application.	[Zhang, Wei; Fan, Xiaohong; Zhu, Shuifang] Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China; [Zhang, Wei; Zhao, Hong] Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China; [Fu, Lianzhong] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Chinese Academy of Inspection & Quarantine; Shandong University; Chinese Academy of Sciences; Institute of Botany, CAS	Fan, XH (corresponding author), Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China.	fan98494@sina.com	ZHANG, WEI/AAJ-2716-2020		General Administration of Quality Supervision, Inspection and Quarantine, P. R. China [2010IK268]; Ministry of Science and Technology, P. R. China [2012BAK11B03]; Shandong University (Weihai) [1070501312002, 1070511300001, 2012ZRXT004]	General Administration of Quality Supervision, Inspection and Quarantine, P. R. China; Ministry of Science and Technology, P. R. China(Ministry of Science and Technology, China); Shandong University (Weihai)	This work was supported by a grant from the General Administration of Quality Supervision, Inspection and Quarantine, P. R. China (grant number 2010IK268) to XHF and by a grant from the Ministry of Science and Technology, P. R. China (grant number 2012BAK11B03). Independent innovation youth fund of Shandong University (Weihai) (1070501312002; 1070511300001) and collaborative innovation system construction fund of Shandong University (Weihai) (2012ZRXT004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bohs L, 1997, SYST BOT, V22, P5, DOI 10.2307/2419674; Bohs L., 2005, MONOGRAPHS SYSTEMATI, P27, DOI DOI 10.1111/J.1365-2699.2007.01870.X; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamilton MB, 1999, MOL ECOL, V8, P521; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kovach WL, 1999, MULTIVARIATE STAT PA; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Levin RA, 2006, AM J BOT, V93, P157, DOI 10.3732/ajb.93.1.157; Levin RA, 2005, AM J BOT, V92, P603, DOI 10.3732/ajb.92.4.603; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDERLEIJ FR, 1991, MOL GEN GENET, V228, P240, DOI 10.1007/BF00282472; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671; Wendel J. F, 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; WOLFE KH, 1989, J MOL EVOL, V29, P208, DOI 10.1007/BF02100204; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6	51	17	20	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55927	10.1371/journal.pone.0055927	http://dx.doi.org/10.1371/journal.pone.0055927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409092	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200091
J	Zhu, ZX; Shi, ZX; Yan, WJ; Wei, JC; Shao, DH; Deng, XF; Wang, SH; Li, BB; Tong, GZ; Ma, ZY				Zhu, Zixiang; Shi, Zixue; Yan, Wenjun; Wei, Jianchao; Shao, Donghua; Deng, Xufang; Wang, Shaohui; Li, Beibei; Tong, Guangzhi; Ma, Zhiyong			Nonstructural Protein 1 of Influenza A Virus Interacts with Human Guanylate-Binding Protein 1 to Antagonize Antiviral Activity	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; NS1 PROTEIN; FLUORESCENCE COMPLEMENTATION; INTRACELLULAR PATHOGENS; HOST-DEFENSE; INTERFERON; INHIBITION; GTPASE; ACTIVATION; GAMMA	Human guanylate-binding protein 1 (hGBP1) is an interferon-inducible protein involved in the host immune response against viral infection. In response to infection by influenza A virus (IAV), hGBP1 transcript and protein were significantly upregulated. Overexpression of hGBP1 inhibited IAV replication in a dose-dependent manner in vitro. The lysine residue at position 51 (K51) of hGBP1 was essential for inhibition of IAV replication. Mutation of K51 resulted in an hGBP1 that was unable to inhibit IAV replication. The viral nonstructural protein 1 (NS1) was found to interact directly with hGBP1. K51 of hGBP1 and a region between residues 123 and 144 in NS1 were demonstrated to be essential for the interaction between NS1 and hGBP1. Binding of NS1 to hGBP1 resulted in a significant reduction in both GTPase activity and the anti-IAV activity of hGBP1. These findings indicated that hGBP1 contributed to the host immune response against IAV replication and that hGBP1-mediated antiviral activity was antagonized by NS1 via binding to hGBP1.	[Zhu, Zixiang; Shi, Zixue; Yan, Wenjun; Wei, Jianchao; Shao, Donghua; Deng, Xufang; Wang, Shaohui; Li, Beibei; Ma, Zhiyong] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Vet Publ Hlth, Shanghai, Peoples R China; [Tong, Guangzhi] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Ma, ZY (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Vet Publ Hlth, Shanghai, Peoples R China.	zhiyongma@shvri.ac.cn	Deng, Xufang/I-3001-2013	Deng, Xufang/0000-0002-7604-3627; Shi, Zixue/0000-0001-5357-1171	National Natural Science Foundation of China [30970141, 81171547]; Natural Science Foundation of Shanghai [10JC1417300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was sponsored by the National Natural Science Foundation of China (no. 30970141 and no. 81171547) and the Natural Science Foundation of Shanghai (no. 10JC1417300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1985, J BIOL CHEM, V260, P5834; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Ducatez MF, 2008, VACCINE, V26, pD67, DOI 10.1016/j.vaccine.2008.07.064; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Li G, 2009, MOL BIOL EVOL, V26, P1619, DOI 10.1093/molbev/msp074; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li YT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-398; Lu Yin-ping, 2007, Virologica Sinica, V22, P193, DOI 10.1007/s12250-007-0021-4; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nordmann A, 2012, FASEB J, V26, P1290, DOI 10.1096/fj.11-189886; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ronni T, 1997, J IMMUNOL, V158, P2363; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tripal P, 2007, J INTERF CYTOK RES, V27, P44, DOI 10.1089/jir.2007.0086; Uetani K, 2008, EUR J IMMUNOL, V38, P1559, DOI 10.1002/eji.200737045; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Virreira WS, 2011, PLOS ONE, V6; Wang XD, 2012, J BIOL CHEM, V287, P18366, DOI 10.1074/jbc.M111.335422; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016	42	67	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55920	10.1371/journal.pone.0055920	http://dx.doi.org/10.1371/journal.pone.0055920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405236	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400181
J	Hashimoto, K; Otero, M; Imagawa, K; de Andres, MC; Coico, JM; Roach, HI; Oreffo, ROC; Marcu, KB; Goldring, MB				Hashimoto, Ko; Otero, Miguel; Imagawa, Kei; de Andres, Mara C.; Coico, Jonathan M.; Roach, Helmtrud I.; Oreffo, Richard O. C.; Marcu, Kenneth B.; Goldring, Mary B.			Regulated Transcription of Human Matrix Metalloproteinase 13 (MMP13) and Interleukin-1 beta (IL1B) Genes in Chondrocytes Depends on Methylation of Specific Proximal Promoter CpG Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OSTEOARTHRITIC CHONDROCYTES; HUMAN ARTICULAR CHONDROCYTES; DNA METHYLATION; RHEUMATOID-ARTHRITIS; THERAPEUTIC INTERVENTION; EPIGENETIC MEMORY; MOLECULAR TARGET; SYNOVIAL TISSUE; DOWN-REGULATION; IN-VIVO	The role of DNA methylation in the regulation of catabolic genes such as MMP13 and IL1B, which have sparse CpG islands, is poorly understood in the context of musculoskeletal diseases. We report that demethylation of specific CpG sites at -110 bp and -299 bp of the proximal MMP13 and IL1B promoters, respectively, detected by in situ methylation analysis of chondrocytes obtained directly from human cartilage, strongly correlated with higher levels of gene expression. The methylation status of these sites had a significant impact on promoter activities in chondrocytes, as revealed in transfection experiments with site-directed CpG mutants in a CpG-free luciferase reporter. Methylation of the -110 and -299 CpG sites, which reside within a hypoxia-inducible factor (HIF) consensus motif in the respective MMP13 and IL1B promoters, produced the most marked suppression of their transcriptional activities. Methylation of the -110 bp CpG site in the MMP13 promoter inhibited its HIF-2 alpha-driven transactivation and decreased HIF-2 alpha binding to the MMP13 proximal promoter in chromatin immunoprecipitation assays. In contrast to HIF-2 alpha, MMP13 transcriptional regulation by other positive (RUNX2, AP-1, ELF3) and negative (Sp1, GATA1, and USF1) factors was not affected by methylation status. However, unlike the MMP13 promoter, IL1B was not susceptible to HIF-2 alpha transactivation, indicating that the -299 CpG site in the IL1B promoter must interact with other transcription factors to modulate IL1B transcriptional activity. Taken together, our data reveal that the methylation of different CpG sites in the proximal promoters of the human MMP13 and IL1B genes modulates their transcription by distinct mechanisms.	[Hashimoto, Ko; Otero, Miguel; Coico, Jonathan M.; Goldring, Mary B.] Hosp Special Surg, Div Res, New York, NY 10021 USA; [Hashimoto, Ko; Otero, Miguel; Coico, Jonathan M.; Goldring, Mary B.] Weill Cornell Med Coll, New York, NY 10021 USA; [Hashimoto, Ko] Tohoku Univ, Dept Orthoped, Sendai, Miyagi 9808574, Japan; [Imagawa, Kei; de Andres, Mara C.; Roach, Helmtrud I.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Southampton SO16 6YD, Hants, England; [Marcu, Kenneth B.] Ist Ortoped Rizzoli, Ctr Ric Codivilla Putti, Lab Immunoreumatol & Rigeneraz Tissutale, I-40136 Bologna, Italy; [Marcu, Kenneth B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cornell University; Tohoku University; University of Southampton; IRCCS Istituto Ortopedico Rizzoli; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goldring, MB (corresponding author), Hosp Special Surg, Caspary Res Bldg,5th Fl,535 E 70th St, New York, NY 10021 USA.	goldringm@hss.edu	de+Andrés, María/AAP-1473-2020; de Andrés González, M del Carmen/ABD-7612-2021; Oreffo, Richard OC/A-4615-2011	de Andrés González, M del Carmen/0000-0003-2260-6356; Oreffo, Richard OC/0000-0001-5995-6726; Hashimoto, Ko/0000-0002-9644-054X	National Institutes of Health [R21-AR054887, R01-AG022021, RC4-AR060546]; Arthritis Foundation Postdoctoral Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC) [sLOLA BB/GO10579/1]; BBSRC [BB/G010579/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR054887, RC4AR060546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Postdoctoral Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or part, by National Institutes of Health Grants R21-AR054887, R01-AG022021, and RC4-AR060546 (to M. B. G.), an Arthritis Foundation Postdoctoral Fellowship (to M. O.), and Biotechnology and Biological Sciences Research Council (BBSRC) Grant sLOLA BB/GO10579/1 (to R. O. C. O.).	Aigner T, 2006, ADV DRUG DELIVER REV, V58, P128, DOI 10.1016/j.addr.2006.01.020; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Barter MJ, 2012, OSTEOARTHR CARTILAGE, V20, P339, DOI 10.1016/j.joca.2011.12.012; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bui C, 2012, FASEB J, V26, P3000, DOI 10.1096/fj.12-206367; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Cheung KSC, 2009, RHEUMATOL INT, V29, P525, DOI 10.1007/s00296-008-0744-z; COGSWELL JP, 1994, J IMMUNOL, V153, P712; da Silva MA, 2009, J ORTHOP RES, V27, P593, DOI 10.1002/jor.20799; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ema M, 1996, MOL CELL BIOL, V16, P5865; Fan ZY, 2006, ARTHRITIS RHEUM-US, V54, P2471, DOI 10.1002/art.21961; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring MB, 2012, TRENDS MOL MED, V18, P109, DOI 10.1016/j.molmed.2011.11.005; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hashimoto K, 2007, EPIGENETICS-US, V2, P86, DOI 10.4161/epi.2.2.4203; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Horiuchi M, 2009, J RHEUMATOL, V36, P1580, DOI 10.3899/jrheum.081115; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Huber LC, 2007, ARTHRITIS RHEUM, V56, P1087, DOI 10.1002/art.22512; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Irvine RA, 2002, MOL CELL BIOL, V22, P6689, DOI 10.1128/MCB.22.19.6689-6696.2002; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Kawabata Tomoko, 2010, Arthritis Res Ther, V12, pR133, DOI 10.1186/ar3071; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P513, DOI 10.1016/j.joca.2008.08.003; Maciejewska-Rodrigues H, 2010, J AUTOIMMUN, V35, P15, DOI 10.1016/j.jaut.2009.12.010; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Moffett P, 1997, MOL CELL BIOL, V17, P4933, DOI 10.1128/MCB.17.9.4933; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Neidhart M, 2000, ARTHRITIS RHEUM-US, V43, P2634, DOI 10.1002/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Poschl E, 2005, ANN RHEUM DIS, V64, P477, DOI 10.1136/ard.2004.022509; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reynard LN, 2011, HUM MOL GENET, V20, P3450, DOI 10.1093/hmg/ddr253; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Roach HI, 2007, OSTEOARTHR CARTILAGE, V15, P128, DOI 10.1016/j.joca.2006.07.002; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Saito T, 2010, OSTEOARTHR CARTILAGE, V18, P1552, DOI 10.1016/j.joca.2010.10.006; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Semenza GL, 2000, GENE DEV, V14, P1983; Sesselmann S, 2009, OSTEOARTHR CARTILAGE, V17, P507, DOI 10.1016/j.joca.2008.09.006; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Strietholt S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2500; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Woods S, 2008, NUCLEIC ACIDS RES, V36, P3716, DOI 10.1093/nar/gkn247; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zimmermann P, 2008, ARTHRITIS RHEUM, V58, P2743, DOI 10.1002/art.23736	66	105	111	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10061	10072		10.1074/jbc.M112.421156	http://dx.doi.org/10.1074/jbc.M112.421156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417678	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000317114000044
J	Park, KW; Park, JJ; Kang, J; Jeon, KH; Kang, SH; Han, JK; Lee, SE; Yang, HM; Lee, HY; Kang, HJ; Koo, BK; Oh, BH; Park, YB; Kim, HS				Park, Kyung Woo; Park, Jin Joo; Kang, Jeehoon; Jeon, Ki-Hyun; Kang, Si-Hyuck; Han, Jung-Kyu; Lee, Sang Eun; Yang, Han-Mo; Lee, Hae-Young; Kang, Hyun-Jae; Koo, Bon-Kwon; Oh, Byung-Hee; Park, Young-Bae; Kim, Hyo-Soo			Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PON1 GENE; Q192R POLYMORPHISM; STENT THROMBOSIS; HEART-DISEASE; RISK; EVENTS; ATHEROSCLEROSIS; RESPONSIVENESS; ARYLESTERASE	Background: Paraoxonase (PON) is a high-density-lipoprotein (HDL) associated enzyme with antioxidative and anti-atherogenic property. Its function is associated with coronary artery disease and its activity genetically controlled. We evaluated whether genetic variation of PON-1 is associated with clinical outcome in a large cohort of Korean patients with drug-eluting stents implantation. Methods: A total of 1676 patients with drug-eluting stent implantation were enrolled in the prospective CROSS-VERIFY cohort from June 2006 to June 2010. We genotyped the PON1-Q192R gene, measured clopidogrel on-treatment platelet reactivity (OPR), and analyzed lipid profiles. The primary endpoint was the composite of cardiac death, myocardial infarction, and stent thrombosis at 12 months. Results: PON-1 genotyping data were available in 1336 patients. Since the Q-allele is associated with decreased PON-activity, we analyzed the outcome between patients with QQ/QR (815 patients, 61%) and those with RR-genotype (521 patients, 39%). After adjustment for common cardiac risk factors, the QQ/QR-genotype was an independent predictor of the primary thrombotic endpoint with an 11-fold increased risk (HR 11.6, 95% CI: 1.55-87.0), but not repeat revascularization (HR 1.12, 95% CI: 0.78-1.61). The QQ/QR-genotype was not associated with OPR (QQ/QR: 231 +/- 86 PRU vs. RR 236 +/- 82 PRU, p = 0.342) but higher small-dense LDL levels (1.20 +/- 0.12 mg/dL vs. 0.76 +/- 0.15 mg/dL, p = 0.027). The increased risk of thrombotic outcomes was more profound in acute coronary syndrome (ACS) patients compared with non-ACS patients. Conclusion: PON1 Q-allele is an independent predictor of worse cardiovascular outcome independent of platelet function and is associated with significantly higher levels of small dense LDL-C.	[Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	hyosoo@snu.ac.kr	Kim, Hyo Soo/J-2753-2012; Park, Kyung Woo/AAX-3046-2020; Kang, Si-Hyuck/AAR-9790-2020; Kang, Hyun-Jae/D-6121-2012; Oh, Byung-Hee/G-9875-2011	Kang, Si-Hyuck/0000-0003-4755-6367; Kang, Hyun-Jae/0000-0002-3500-1746; Oh, Byung-Hee/0000-0002-9945-4306; Han, Jung-Kyu/0000-0002-0016-0747; Lee, Hae-Young/0000-0002-9521-4102	Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea [A102065]; Innovative Research Institute for Cell Therapy, Seoul National University Hospital [A062260]; Ministry of Health, Welfare & Family, Republic of Korea; Korean Liver Research Foundation, Seoul, Korea	Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital; Ministry of Health, Welfare & Family, Republic of Korea; Korean Liver Research Foundation, Seoul, Korea	This study was supported by a grant from the Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea (A102065) and a grant from the Innovative Research Institute for Cell Therapy, Seoul National University Hospital (A062260), sponsored by the Ministry of Health, Welfare & Family, Republic of Korea. This study was funded in part by a grant from the Korean Liver Research Foundation, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS S, 1993, AM J HUM GENET, V52, P598; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Campo G, 2011, J THROMB HAEMOST, V9, P2106, DOI 10.1111/j.1538-7836.2011.04457.x; Chen Q, 2003, AM J HUM GENET, V72, P13, DOI 10.1086/345312; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eom SY, 2011, J KOREAN MED SCI, V26, P720, DOI 10.3346/jkms.2011.26.6.720; Fontana P, 2011, J THROMB HAEMOST, V9, P1664, DOI 10.1111/j.1538-7836.2011.04409.x; Gaidukov L, 2006, J LIPID RES, V47, P2492, DOI 10.1194/jlr.M600297-JLR200; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Hoefner DM, 2001, CLIN CHEM, V47, P266; Huang Q, 2006, NEUROL RES, V28, P549, DOI 10.1179/016164106X110337; Krauss Ronald M., 1994, Current Opinion in Lipidology, V5, P339, DOI 10.1097/00041433-199410000-00005; LADU BN, 1993, CHEM-BIOL INTERACT, V87, P25, DOI 10.1016/0009-2797(93)90022-Q; Lee Chul-Ho, 2005, J Prev Med Public Health, V38, P345; Lewis JP, 2011, CLIN PHARMACOL THER, V90, P568, DOI 10.1038/clpt.2011.194; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mackness MI, 1998, CURR OPIN LIPIDOL, V9, P319, DOI 10.1097/00041433-199808000-00006; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; Regieli JJ, 2009, J AM COLL CARDIOL, V54, P1238, DOI 10.1016/j.jacc.2009.05.061; Reny JL, 2012, J THROMB HAEMOST, V10, P1242, DOI 10.1111/j.1538-7836.2012.04756.x; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Slottow TLP, 2007, CATHETER CARDIO INTE, V69, P1064, DOI 10.1002/ccd.21179; Srinivasan SR, 2004, ATHEROSCLEROSIS, V177, P167, DOI 10.1016/j.atherosclerosis.2004.06.013; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Trenk D, 2011, CIRC-CARDIOVASC GENE, V4, P429, DOI 10.1161/CIRCGENETICS.111.960112; Turban S, 2001, ATHEROSCLEROSIS, V154, P633, DOI 10.1016/S0021-9150(00)00495-0; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0	30	22	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e52779	10.1371/journal.pone.0052779	http://dx.doi.org/10.1371/journal.pone.0052779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418418	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300008
J	Raisanen, S; Sokka, A; Georgiadis, L; Harju, M; Gissler, M; Keski-Nisula, L; Kalviainen, R; Heinonen, S				Raisanen, Sari; Sokka, Arja; Georgiadis, Leena; Harju, Maija; Gissler, Mika; Keski-Nisula, Leea; Kalviainen, Reetta; Heinonen, Seppo			Infertility Treatment and Umbilical Cord Length-Novel Markers of Childhood Epilepsy?	PLOS ONE			English	Article							RISK-FACTORS; GESTATIONAL-AGE; INSERTION; WOMEN; EPIDEMIOLOGY; PREGNANCY; FERTILITY; CHILDREN; DOPPLER; FINLAND	Background: Epilepsy is one of the most common neurologic disorders of childhood, affecting about 0.4-0.8% of all children up to the age of 20. Methodology: A population-based retrospective cohort study. Aim was to determine incidence and identify perinatal and reproductive risk factors of epilepsy in children born between 1989 and 2008 among women (n = 43,389) delivered in Kuopio University Hospital. Risk factors of childhood epilepsy were determined by using logistic regression analysis. Principal Findings: The incidence of childhood epilepsy was 0.7% (n = 302 of 43,389). Maternal epilepsy, major congenital anomalies and use of assisted reproductive technology (ART) were associated with 4.25-, 3.61-, and 1.67- fold increased incidence of childhood epilepsy. A 10 cm increase in umbilical cord length was associated with a 15% decrease in the incidence of epilepsy (adjusted OR 0.85, 95% CI 0.78-0.94). However, the above reproductive factors accounted for less than 2% of total incidence, whereas maternal epilepsy proved to be the highest risk factor. Conclusions: Perinatal and reproductive factors were shown to be minor risk factors of childhood epilepsy, implying that little can be done in obstetric care to prevent childhood epilepsy. Infertility treatment and umbilical cord length, independent of gestational age and congenital malformations, may be novel markers of childhood epilepsy.	[Raisanen, Sari; Georgiadis, Leena; Harju, Maija; Keski-Nisula, Leea; Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland; [Sokka, Arja] Kuopio Univ Hosp, Dept Pediat Neurol, SF-70210 Kuopio, Finland; [Sokka, Arja; Georgiadis, Leena; Harju, Maija; Keski-Nisula, Leea; Kalviainen, Reetta; Heinonen, Seppo] Univ Eastern Finland, Kuopio, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Welf & Hlth Data Resources Unit, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Kalviainen, Reetta] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; Kuopio University Hospital; University of Eastern Finland	Raisanen, S (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland.	shraisan@student.uef.fi		Gissler, Mika/0000-0001-8254-7525	Medical Research Council [MR/K006525/1] Funding Source: Medline; MRC [MR/K006525/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Artama M, 2004, AM J EPIDEMIOL, V159, P1057, DOI 10.1093/aje/kwh140; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Ehrenstein V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-23; Ehrenstein V, 2007, PEDIATRICS, V119, pE554, DOI 10.1542/peds.2006-1308; Ericson A, 2002, HUM REPROD, V17, P929, DOI 10.1093/humrep/17.4.929; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Guerrini R, 2006, LANCET, V367, P499, DOI 10.1016/S0140-6736(06)68182-8; Heinonen S, 2001, PLACENTA, V22, P399, DOI 10.1053/plac.2001.0630; Heinonen S, 1996, OBSTET GYNECOL, V87, P112, DOI 10.1016/0029-7844(95)00339-8; Heiskanen JTM, 2001, AM J OBSTET GYNECOL, V185, P600, DOI 10.1067/mob.2001.116722; Izumi K, 2006, FETAL PEDIATR PATHOL, V25, P233, DOI 10.1080/15513810601123326; Krakowiak P, 2004, OBSTET GYNECOL, V103, P119, DOI 10.1097/01.AOG.0000102706.84063.C7; Mann JR, 2011, EPILEPSY BEHAV, V20, P506, DOI 10.1016/j.yebeh.2011.01.006; MOESSINGER AC, 1982, PEDIATR RES, V16, P109, DOI 10.1203/00006450-198202000-00006; NAEYE RL, 1985, J PEDIATR-US, V107, P278, DOI 10.1016/S0022-3476(85)80149-9; Norgaard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030850; Papinniemi M, 2007, AM J PERINAT, V24, P353, DOI 10.1055/s-2007-984403; Raatikainen K, 2012, HUM REPROD IN PRESS, V2012; Raatikainen K, 2007, PREV MED, V44, P59, DOI 10.1016/j.ypmed.2006.07.017; Sarwono E, 1991, Paediatr Indones, V31, P136; Schupf N, 1996, EPILEPSIA, V37, P833, DOI 10.1111/j.1528-1157.1996.tb00035.x; Sen Wu C, 2008, PEDIATRICS, V122, P1072, DOI 10.1542/peds.2007-3666; Sillanpaa M, 2006, EPILEPSY RES, V71, P206, DOI 10.1016/j.eplepsyres.2006.06.017; Sillanpaa M, 2011, EPILEPSIA, V52, P1857, DOI 10.1111/j.1528-1167.2011.03186.x; SORNES T, 1989, ACTA OBSTET GYN SCAN, V68, P439, DOI 10.3109/00016348909021017; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Sun YL, 2007, HUM REPROD, V22, P215, DOI 10.1093/humrep/del333; Sun Y, 2008, AM J EPIDEMIOL, V167, P262, DOI 10.1093/aje/kwm316; Toivonen S, 2002, AM J PERINAT, V19, P451, DOI 10.1055/s-2002-36868; vandeMheen H, 1997, SOC SCI MED, V44, P13, DOI 10.1016/S0277-9536(96)00090-1; Viinikainen K, 2006, EPILEPSIA, V47, P186, DOI 10.1111/j.1528-1167.2006.00386.x; Viinikainen K, 2007, NEUROLOGY, V69, P2107, DOI 10.1212/01.wnl.0000277451.06420.b6; Whitehead E, 2006, PEDIATRICS, V117, P1298, DOI 10.1542/peds.2005-1660	33	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55394	10.1371/journal.pone.0055394	http://dx.doi.org/10.1371/journal.pone.0055394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418441	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300031
J	Samur, MK; Yan, ZY; Wang, XJ; Cao, QY; Munshi, NC; Li, C; Shah, PK				Samur, Mehmet Kemal; Yan, Zhenyu; Wang, Xujun; Cao, Qingyi; Munshi, Nikhil C.; Li, Cheng; Shah, Parantu K.			canEvolve: A Web Portal for Integrative Oncogenomics	PLOS ONE			English	Article							GENE-EXPRESSION OMNIBUS; COPY NUMBER ALTERATIONS; CANCER MICROARRAY; MULTIPLE-MYELOMA; LUNG-CANCER; DATABASE; GENOME; SURVIVAL; QUANTIFICATION; DIAGNOSIS	Background & Objective: Genome-wide profiles of tumors obtained using functional genomics platforms are being deposited to the public repositories at an astronomical scale, as a result of focused efforts by individual laboratories and large projects such as the Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium. Consequently, there is an urgent need for reliable tools that integrate and interpret these data in light of current knowledge and disseminate results to biomedical researchers in a user-friendly manner. We have built the canEvolve web portal to meet this need. Results: canEvolve query functionalities are designed to fulfill most frequent analysis needs of cancer researchers with a view to generate novel hypotheses. canEvolve stores gene, microRNA (miRNA) and protein expression profiles, copy number alterations for multiple cancer types, and protein-protein interaction information. canEvolve allows querying of results of primary analysis, integrative analysis and network analysis of oncogenomics data. The querying for primary analysis includes differential gene and miRNA expression as well as changes in gene copy number measured with SNP microarrays. canEvolve provides results of integrative analysis of gene expression profiles with copy number alterations and with miRNA profiles as well as generalized integrative analysis using gene set enrichment analysis. The network analysis capability includes storage and visualization of gene co-expression, inferred gene regulatory networks and protein-protein interaction information. Finally, canEvolve provides correlations between gene expression and clinical outcomes in terms of univariate survival analysis. Conclusion: At present canEvolve provides different types of information extracted from 90 cancer genomics studies comprising of more than 10,000 patients. The presence of multiple data types, novel integrative analysis for identifying regulators of oncogenesis, network analysis and ability to query gene lists/pathways are distinctive features of canEvolve. canEvolve will facilitate integrative and meta-analysis of oncogenomics datasets.	[Samur, Mehmet Kemal; Yan, Zhenyu; Li, Cheng; Shah, Parantu K.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Samur, Mehmet Kemal; Yan, Zhenyu; Li, Cheng; Shah, Parantu K.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Samur, Mehmet Kemal] Akdeniz Univ, Dept Biostat & Med Informat, TR-07058 Antalya, Turkey; [Wang, Xujun] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Cao, Qingyi] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Munshi, Nikhil C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Munshi, Nikhil C.] Harvard Univ, Sch Med, VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Akdeniz University; Tongji University; Zhejiang University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Li, C (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	cli@hsph.harvard.edu; parantu.shah@gmail.com	Munshi, Nikhil/ABE-2338-2021	Samur, Mehmet/0000-0002-9978-5682; wang, xujun/0000-0002-7152-611X	National Institutes of Health (NIH) [R01 GM077122]; Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development award; National Basic Research [973] Program of China [2010CB944904]; Department of Veterans Affairs Merit Review Awards [NIH RO1-124929, PO1-155258, P50-100007, PO1-78378]; NATIONAL CANCER INSTITUTE [P01CA155258, P01CA078378, P50CA100707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077122] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development award; National Basic Research [973] Program of China(National Basic Research Program of China); Department of Veterans Affairs Merit Review Awards(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R01 GM077122 (C.L.), the Claudia Adams Barr Program in Innovative Basic Cancer Research (P.K.S.), the Multiple Myeloma Career Development award (P.K.S.) and National Basic Research [973] Program of China No. 2010CB944904 (X.W.) This work was also supported in part by NIH RO1-124929, PO1-155258, P50-100007 and PO1-78378 to N.C.M. and C.L. and from the Department of Veterans Affairs Merit Review Awards to N.C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Cao QY, 2011, NUCLEIC ACIDS RES, V39, pD968, DOI 10.1093/nar/gkq997; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chen LJ, 2011, CANCER LETT, V309, P62, DOI 10.1016/j.canlet.2011.05.017; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; Dickens NJ, 2010, CLIN CANCER RES, V16, P1856, DOI 10.1158/1078-0432.CCR-09-2831; Dudoit S, 2008, SPRINGER SER STAT, P1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Fulciniti M, 2011, CLIN CANCER RES, V17, P6500, DOI 10.1158/1078-0432.CCR-11-1036; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Huang N, 2012, BRIEF BIOINFORM, V13, P305, DOI 10.1093/bib/bbr056; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu FL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-46; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miecznikowski JC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-573; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Pennisi E, 2011, SCIENCE, V331, P666, DOI 10.1126/science.331.6018.666; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajkumar SV, 2010, MAYO CLIN PROC, V85, P945, DOI 10.4065/mcp.2010.0520; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028; Yan Z, 2012, NUCL ACIDS RES; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395	52	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56228	10.1371/journal.pone.0056228	http://dx.doi.org/10.1371/journal.pone.0056228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418540	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300132
J	Wu, XQ; Marmarelis, ME; Hodi, FS				Wu, Xinqi; Marmarelis, Melina E.; Hodi, F. Stephen			Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma	PLOS ONE			English	Article							CELL-CYCLE ARREST; HSP90 INHIBITOR; METASTATIC MELANOMA; CANCER-CELLS; B-RAF; ACQUIRED-RESISTANCE; SIGNAL-TRANSDUCTION; BRAF INHIBITION; KINASE CASCADE; IN-VITRO	Heat shock protein 90 (HSP90) is involved in the regulation of diverse biological processes such as cell signaling, proliferation and survival, and has been recently recognized as a potential target for cancer therapy. Ganetespib is a potent ATP competitive inhibitor of HSP90. Ganetespib downregulated the expression of multiple signal transducing molecules including EGFR, IGF-1R, c-Met, Akt, B-RAF and C- RAF, resulting in pronounced decrease in phosphorylation of Akt and Erk1/2 in a panel of five cutaneous melanoma cell lines including those harboring B-RAF and N-RAS mutations. Ganetespib exhibited potent antiproliferative activity on all five of these cell lines, with IC50 values between 37.5 and 84 nM. Importantly, Ganetespib is active on B-RAF mutated melanoma cells that have acquired resistance to B-RAF inhibition. Ganetespib induced apoptosis and cell cycle arrest at G1 and/or G2/M phase. Ganetespib induced cell cycle arrest was accompanied by altered expression of cyclin-dependent kinase inhibitor (CDKI) p21(Cip1) and p27(Kip1), cyclins B1, D1 and E, and/or cyclin-dependent kinases 1, 2 and 4. HSP90 is functionally important for melanoma cells and HSP90 inhibitors such as ganetespib could potentially be effective therapeutics for melanoma with various genetic mutations and acquired resistance to B-RAF inhibition.	[Wu, Xinqi; Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Xinqi; Marmarelis, Melina E.; Hodi, F. Stephen] Harvard Univ, Sch Med, Boston, MA USA; [Wu, Xinqi; Hodi, F. Stephen] Dana Farber Brigham & Womens Canc Ctr, Melanoma Dis Ctr, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Hodi, FS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	stephen_hodi@dfci.harvard.edu			Sharon Crowley Martin Memorial Fund for Melanoma Research at Dana-Farber Cancer Institute; Malcolm and Emily Mac Naught Fund for Melanoma Research at Dana-Farber Cancer Institute	Sharon Crowley Martin Memorial Fund for Melanoma Research at Dana-Farber Cancer Institute; Malcolm and Emily Mac Naught Fund for Melanoma Research at Dana-Farber Cancer Institute	This work was supported in part by Sharon Crowley Martin Memorial Fund for Melanoma Research (F. S. Hodi), the Malcolm and Emily Mac Naught Fund for Melanoma Research (F. S. Hodi) at Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Basto R, 2007, J CELL SCI, V120, P1278, DOI 10.1242/jcs.000604; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Cheung CHA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-77; Cohen-Saidon C, 2006, BLOOD, V107, P1413, DOI 10.1182/blood-2005-07-2648; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guida M, 2012, EXPERT OPIN THER TAR, V16, pS61, DOI 10.1517/14728222.2011.645807; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Hingorani SR, 2003, CANCER RES, V63, P5198; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; Luke JJ, 2012, CLIN CANCER RES, V18, P9, DOI 10.1158/1078-0432.CCR-11-2197; Martins AS, 2008, CANCER RES, V68, P6260, DOI 10.1158/0008-5472.CAN-07-3074; McCleese JK, 2009, INT J CANCER, V125, P2792, DOI 10.1002/ijc.24660; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Miyata Y, 2001, J BIOL CHEM, V276, P21841, DOI 10.1074/jbc.M010944200; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Rassidakis GZ, 2005, BLOOD, V105, P827, DOI 10.1182/blood-2004-06-2125; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schreiber M, 1999, ONCOGENE, V18, P1663, DOI 10.1038/sj.onc.1202466; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slupianek A, 2004, EXP HEMATOL, V32, P1265, DOI 10.1016/j.exphem.2004.11.002; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang S, 2009, CELL CYCLE, V8, P2050, DOI 10.4161/cc.8.13.8861; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wu XQ, 2012, MELANOMA RES, V22, P123, DOI 10.1097/CMR.0b013e3283507ffd; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755	62	31	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56134	10.1371/journal.pone.0056134	http://dx.doi.org/10.1371/journal.pone.0056134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418523	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300115
J	Matsuo, J; Nakamura, S; Ito, A; Yamazaki, T; Ishida, K; Hayashi, Y; Yoshida, M; Takahashi, K; Sekizuka, T; Takeuchi, F; Kuroda, M; Nagai, H; Hayashida, K; Sugimoto, C; Yamaguchi, H				Matsuo, Junji; Nakamura, Shinji; Ito, Atsushi; Yamazaki, Tomohiro; Ishida, Kasumi; Hayashi, Yasuhiro; Yoshida, Mitsutaka; Takahashi, Kaori; Sekizuka, Tsuyoshi; Takeuchi, Fumihiko; Kuroda, Makoto; Nagai, Hiroki; Hayashida, Kyoko; Sugimoto, Chihiro; Yamaguchi, Hiroyuki			Protochlamydia Induces Apoptosis of Human HEp-2 Cells through Mitochondrial Dysfunction Mediated by Chlamydial Protease-Like Activity Factor	PLOS ONE			English	Article							III SECRETION; PARACHLAMYDIA-ACANTHAMOEBAE; INTRACELLULAR BACTERIA; CAUSAL AGENTS; TRACHOMATIS; PNEUMONIAE; CPAF; EXPRESSION; INCLUSION; PROTEINS	Obligate amoebal endosymbiotic bacterium Protochlamydia with ancestral pathogenic chlamydial features evolved to survive within protist hosts, such as Acanthamoba, 0.7-1.4 billion years ago, but not within vertebrates including humans. This observation raises the possibility that interactions between Protochlamydia and human cells may result in a novel cytopathic effect, leading to new insights into host-parasite relationships. Previously, we reported that Protochlamydia induces apoptosis of the immortalized human cell line, HEp-2. In this study, we attempted to elucidate the molecular mechanism underlying this apoptosis. We first confirmed that, upon stimulation with the bacteria, poly (ADP-ribose) polymerase (PARP) was cleaved at an early stage in HEp-2 cells, which was dependent on the amount of bacteria. A pan-caspase inhibitor and both caspase-3 and -9 inhibitors similarly inhibited the apoptosis of HEp-2 cells. A decrease of the mitochondrial membrane potential was also confirmed. Furthermore, lactacystin, an inhibitor of chlamydial protease-like activity factor (CPAF), blocked the apoptosis. Cytochalasin D also inhibited the apoptosis, which was dependent on the drug concentration, indicating that bacterial entry into cells was required to induce apoptosis. Interestingly, Yersinia type III inhibitors (ME0052, ME0053, and ME0054) did not have any effect on the apoptosis. We also confirmed that the Protochlamydia used in this study possessed a homologue of the cpaf gene and that two critical residues, histidine-101 and serine-499 of C. trachomatis CPAF in the active center, were conserved. Thus, our results indicate that after entry, Protochlamydia-secreted CPAF induces mitochondrial dysfunction with a decrease of the membrane potential, followed by caspase-9, caspase-3 and PARP cleavages for apoptosis. More interestingly, because C. trachomatis infection can block the apoptosis, our finding implies unique features of CPAF between pathogenic and primitive chlamydiae.	[Matsuo, Junji; Ito, Atsushi; Yamazaki, Tomohiro; Ishida, Kasumi; Hayashi, Yasuhiro; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Tokyo, Japan; [Yoshida, Mitsutaka; Takahashi, Kaori] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Tokyo, Japan; [Sekizuka, Tsuyoshi; Takeuchi, Fumihiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Nagai, Hiroki] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Hayashida, Kyoko; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Juntendo University; Juntendo University; National Institute of Infectious Diseases (NIID); Osaka University; Hokkaido University	Yamaguchi, H (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp	Ito, Atsushi/GWU-9716-2022; Sugimoto, Chihiro/F-6583-2012; HAYASHIDA, Kyouko/ABH-6260-2020; Nagai, Hiroki/G-4113-2015; Nagai, Hiroki/GXZ-7815-2022	Sugimoto, Chihiro/0000-0002-8708-0140; HAYASHIDA, Kyouko/0000-0001-9266-5162; Nagai, Hiroki/0000-0003-1659-2197; Sekizuka, Tsuyoshi/0000-0002-1302-5472	KAKENHI [21590474, 24659194, 24117501]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants-in-aid for scientific research from KAKENHI [21590474, 24659194, 24117501 "Innovation Areas (Matryoshika-type evolution)"](http://www.jsps.go.jp/j-grantsinaid/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Baud D, 2011, CLIN MICROBIOL INFEC, V17, P1312, DOI 10.1111/j.1469-0691.2011.03604.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Burillo A, 2010, INFECT DIS CLIN N AM, V24, P61, DOI 10.1016/j.idc.2009.10.002; Chen AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002842; Chen D, 2009, ARCH BIOCHEM BIOPHYS, V485, P16, DOI 10.1016/j.abb.2009.01.014; Christian J, 2010, J BIOL CHEM, V285, P41320, DOI 10.1074/jbc.M110.152280; Christian JG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002283; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; Elwell CA, 2012, CELL MICROBIOL, V14, P1010, DOI 10.1111/j.1462-5822.2012.01794.x; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Ito A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030270; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Lamoth F, 2010, EXPERT REV ANTI-INFE, V8, P775, DOI [10.1586/eri.10.52, 10.1586/ERI.10.52]; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; Lutter EI, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/362104; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Matsuo J, 2010, ENV MICROBIOL REP, V2, P524, DOI 10.1111/j.1758-2229.2009.00094.x; Munoz-Pinedo C, 2012, ADV EXP MED BIOL, V738, P124, DOI 10.1007/978-1-4614-1680-7_8; Mylonas I, 2012, ARCH GYNECOL OBSTET, V285, P1271, DOI 10.1007/s00404-012-2240-7; Paschen SA, 2008, J CELL BIOL, V182, P117, DOI 10.1083/jcb.200804023; Perez-Alvarez S, 2009, BRIT J PHARMACOL, V158, P1121, DOI 10.1111/j.1476-5381.2009.00388.x; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Sixt BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029565; Slepenkin A, 2003, INFECT IMMUN, V71, P2555, DOI 10.1128/IAI.71.5.2555-2562.2003; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Ueland Thor, 2012, Curr Heart Fail Rep, V9, P92, DOI 10.1007/s11897-012-0088-6; Wilson DP, 2006, B MATH BIOL, V68, P161, DOI 10.1007/s11538-005-9024-1; Zhong GM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00014	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56005	10.1371/journal.pone.0056005	http://dx.doi.org/10.1371/journal.pone.0056005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409113	gold, Green Published			2022-12-25	WOS:000315100000039
J	Sumagin, R; Robin, AZ; Nusrat, A; Parkos, CA				Sumagin, Ronen; Robin, Alex Z.; Nusrat, Asma; Parkos, Charles A.			Activation of PKC beta II by PMA Facilitates Enhanced Epithelial Wound Repair through Increased Cell Spreading and Migration	PLOS ONE			English	Article							PROTEIN-KINASE-C; EPIDERMAL-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; PHORBOL ESTERS; RHO FAMILY; ALPHA; PAXILLIN; ADHESION; EPSILON; INHIBITOR	Rapid repair of epithelial wounds is essential for intestinal homeostasis, and involves cell proliferation and migration, which in turn are mediated by multiple cellular signaling events including PKC activation. PKC isoforms have been implicated in regulating cell proliferation and migration, however, the role of PKCs in intestinal epithelial cell (IEC) wound healing is still not completely understood. In the current work we used phorbol 12-myristate 13-acetate (PMA), a well recognized agonist of classical and non-conventional PKC subfamilies to investigate the effect of PKC activation on IEC wound healing. We found that PMA treatment of wounded IEC monolayers resulted in 5.8+/-0.7-fold increase in wound closure after 24 hours. The PMA effect was specifically mediated by PKC beta II, as its inhibition significantly diminished the PMA-induced increase in wound closure. Furthermore, we show that the PKC beta II-mediated increase in IEC wound closure after PMA stimulation was mediated by increased cell spreading/cell migration but not proliferation. Cell migration was mediated by PKC beta II dependent actin cytoskeleton reorganization, enhanced formation of lamellipodial extrusions at the leading edge and increased activation of the focal adhesion protein, paxillin. These findings support a role for PKC beta II in IEC wound repair and further demonstrate the ability of epithelial cells to migrate as a sheet thereby efficiently covering denuded surfaces to recover the intestinal epithelial barrier.	[Sumagin, Ronen; Robin, Alex Z.; Nusrat, Asma; Parkos, Charles A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA	Emory University	Sumagin, R (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA.	ronen.sumagin@emory.edu			NIH [DK061379, DK72564, DK079392, DK055679, DK59888]; Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072564, R01DK055679, R01DK079392, R29DK055679, R01DK059888, R01DK061379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH (DK061379, DK72564, DK079392 to C. A. P., DK055679 and DK59888 to A.N.), and Crohn's and Colitis Foundation of America Career Development Award (R. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 1999, GASTROENTEROLOGY, V116, P64, DOI 10.1016/S0016-5085(99)70230-1; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Banan A, 2001, AM J PHYSIOL-GASTR L, V281, pG833, DOI 10.1152/ajpgi.2001.281.3.G833; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chang Q, 2003, BRIT J PHARMACOL, V140, P41, DOI 10.1038/sj.bjp.0705398; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Gao QY, 2009, MOL VIS, V15, P2683; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; He H, 2010, PROSTATE, V70, P1119, DOI 10.1002/pros.21146; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hopkins AM, 2004, AM J PHYSIOL-GASTR L, V287, pG886, DOI 10.1152/ajpgi.00065.2004; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Inagaki K, 2005, CIRCULATION, V111, P44, DOI 10.1161/01.CIR.0000151614.22282.F1; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Koch S, 2009, MOL BIOL CELL, V20, P4816, DOI 10.1091/mbc.E09-05-0415; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Matthews JD, 2009, VIROLOGY, V390, P315, DOI 10.1016/j.virol.2009.05.019; MURPHY TL, 1995, EXP EYE RES, V60, P683, DOI 10.1016/S0014-4835(05)80010-7; Musashi M, 2000, INT J HEMATOL, V72, P12; Nomura N, 2007, MOL VIS, V13, P2320; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; PARKOS CA, 1992, J CELL BIOL, V117, P757, DOI 10.1083/jcb.117.4.757; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RYVES WJ, 1991, FEBS LETT, V288, P5, DOI 10.1016/0014-5793(91)80989-G; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Song JC, 2002, AM J PHYSIOL-CELL PH, V283, pC1548, DOI 10.1152/ajpcell.00105.2002; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Tepperman BL, 2005, EUR J PHARMACOL, V518, P1, DOI 10.1016/j.ejphar.2005.06.008; Umar S, 2000, AM J PHYSIOL-GASTR L, V279, pG223, DOI 10.1152/ajpgi.2000.279.1.G223; Verstovsek G, 1998, GASTROENTEROLOGY, V115, P75, DOI 10.1016/S0016-5085(98)70367-1; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Xu KP, 2002, INVEST OPHTH VIS SCI, V43, P3673	53	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55775	10.1371/journal.pone.0055775	http://dx.doi.org/10.1371/journal.pone.0055775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409039	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000023
J	Koen, EL; Bowman, J; Garroway, CJ; Wilson, PJ				Koen, Erin L.; Bowman, Jeff; Garroway, Colin J.; Wilson, Paul J.			The Sensitivity of Genetic Connectivity Measures to Unsampled and Under-Sampled Sites	PLOS ONE			English	Article							LANDSCAPE GENETICS; SPATIAL-ANALYSIS; MIGRATION RATES; MISSING DATA; POPULATION; FLOW; INFERENCE; SOFTWARE; PACKAGE; MARKERS	Landscape genetic analyses assess the influence of landscape structure on genetic differentiation. It is rarely possible to collect genetic samples from all individuals on the landscape and thus it is important to assess the sensitivity of landscape genetic analyses to the effects of unsampled and under-sampled sites. Network-based measures of genetic distance, such as conditional genetic distance (cGD), might be particularly sensitive to sampling intensity because pairwise estimates are relative to the entire network. We addressed this question by subsampling microsatellite data from two empirical datasets. We found that pairwise estimates of cGD were sensitive to both unsampled and under-sampled sites, and F-ST, D-est, and d(eucl) were more sensitive to under-sampled than unsampled sites. We found that the rank order of cGD was also sensitive to unsampled and under-sampled sites, but not enough to affect the outcome of Mantel tests for isolation by distance. We simulated isolation by resistance and found that although cGD estimates were sensitive to unsampled sites, by increasing the number of sites sampled the accuracy of conclusions drawn from landscape genetic analyses increased, a feature that is not possible with pairwise estimates of genetic differentiation such as F-ST, D-est, and d(eucl). We suggest that users of cGD assess the sensitivity of this measure by subsampling within their own network and use caution when making extrapolations beyond their sampled network.	[Koen, Erin L.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada; [Garroway, Colin J.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Wilson, Paul J.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University; Ministry of Natural Resources & Forestry; University of Oxford; Trent University	Koen, EL (corresponding author), Trent Univ, Peterborough, ON K9J 7B8, Canada.	erinkoen@trentu.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Garroway, Colin/0000-0002-0955-0688	NSERC; Canada Research Chair; Ontario Living Legacy Trust; Ontario Ministry of Natural Resources	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Living Legacy Trust; Ontario Ministry of Natural Resources	Funding was provided by NSERC (Discovery grants to JB and PJW and a scholarship to ELK), a Canada Research Chair to PJW, the Ontario Living Legacy Trust, and the Ontario Ministry of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Carr D, 2007, J WILDLIFE MANAGE, V71, P1853, DOI 10.2193/2006-274; Carr D, 2007, OIKOS, V116, P629, DOI 10.1111/j.2007.0030-1299.15568.x; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Crawford LA, 2011, CONSERV GENET, V12, P991, DOI 10.1007/s10592-011-0202-4; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2012, PACKAGE GSTUDIO VERS; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Frantz TL, 2009, COMPUT MATH ORGAN TH, V15, P303, DOI 10.1007/s10588-009-9063-5; Galpern P, 2012, MOL ECOL, V21, P3996, DOI 10.1111/j.1365-294X.2012.05677.x; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hagerty BE, 2011, LANDSCAPE ECOL, V26, P267, DOI 10.1007/s10980-010-9550-6; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hokit DG, 2010, CONSERV GENET, V11, P149, DOI 10.1007/s10592-009-0014-y; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kim PJ, 2007, EUR PHYS J B, V55, P109, DOI 10.1140/epjb/e2007-00033-7; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; Landguth EL, 2010, MOL ECOL RESOUR, V10, P156, DOI 10.1111/j.1755-0998.2009.02719.x; Lange R, 2012, LANDSCAPE ECOL, V27, P381, DOI 10.1007/s10980-011-9692-1; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Leng L, 2011, MOL ECOL, V20, P2494, DOI 10.1111/j.1365-294X.2011.05108.x; Maindonald JH, 2012, DATA ANAL GRAPHICS U; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MANTEL N, 1967, CANCER RES, V27, P209; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Naujokaitis-Lewis IR, 2013, CONSERV GENET, V14, P287, DOI 10.1007/s10592-012-0385-3; Oyler-McCance SJ, 2013, CONSERV GENET, V14, P275, DOI 10.1007/s10592-012-0415-1; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANG ENV STAT COMP; Robins G, 2004, SOC NETWORKS, V26, P257, DOI 10.1016/j.socnet.2004.05.001; Rogers JS, 1972, STUDIES GENETICS, P145; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; Spear SF, 2012, ECOL APPL, V22, P856, DOI 10.1890/11-0627.1; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Wasserman TN, 2010, LANDSCAPE ECOL, V25, P1601, DOI 10.1007/s10980-010-9525-7; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x	54	20	20	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56204	10.1371/journal.pone.0056204	http://dx.doi.org/10.1371/journal.pone.0056204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409155	gold, Green Published			2022-12-25	WOS:000314660300067
J	Mansure, JJ; Nassim, R; Chevalier, S; Szymanski, K; Rocha, J; Aldousari, S; Kassouf, W				Mansure, Jose Joao; Nassim, Roland; Chevalier, Simone; Szymanski, Konrad; Rocha, Joice; Aldousari, Saad; Kassouf, Wassim			A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR RECEPTOR; LUNG-CANCER; KINASE INHIBITORS; CARCINOMA-CELLS; IN-VITRO; EXPRESSION; GEFITINIB; GENE; MUTATIONS	Background: Two signalling molecules that are attractive for targeted therapy are the epidermal growth factor receptor (EGFR) and the peroxisome proliferator-activated receptor gamma (PPAR gamma). We investigated possible crosstalk between these 2 pathways, particularly in light of the recent evidence implicating PPAR gamma for anticancer therapy. Principal Findings: As evaluated by MTT assays, gefitinib (EGFR inhibitor) and DIM-C (PPAR gamma agonist) inhibited growth of 9 bladder cancer cell lines in a dose-dependent manner but with variable sensitivity. In addition, combination of gefitinib and DIM-C demonstrated maximal inhibition of cell proliferation compared to each drug alone. These findings were confirmed in vivo, where combination therapy maximally inhibited tumor growth in contrast to each treatment alone when compared to control (p<0.04). Induction of PPAR gamma expression along with nuclear accumulation was observed in response to increasing concentrations of gefitinib via activation of the transcription factor CCAT/enhancer-binding protein-beta (CEBP-beta). In these cell lines, DIM-C significantly sensitized bladder cancer cell lines that were resistant to EGFR inhibition in a schedule-specific manner. Conclusion: These results suggest that PPAR gamma agonist DIM-C can be an excellent alternative to bladder tumors resistant to EGFR inhibition and combination efficacy might be achieved in a schedule-specific manner.	[Mansure, Jose Joao; Nassim, Roland; Chevalier, Simone; Szymanski, Konrad; Rocha, Joice; Aldousari, Saad; Kassouf, Wassim] McGill Univ, Div Urol, Ctr Hlth, Montreal, PQ, Canada	McGill University	Kassouf, W (corresponding author), McGill Univ, Div Urol, Ctr Hlth, Montreal, PQ, Canada.	wassim.kassouf@muhc.mcgill.ca			Cancer Research Society; FRSQ	Cancer Research Society; FRSQ(Fonds de la Recherche en Sante du Quebec)	This study was supported by the Cancer Research Society. (http://www.src-crs.ca/en-CA) W. Kassouf is a recipient of a clinical research scholar award from the FRSQ. (http://www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Blehm KN, 2006, CLIN CANCER RES, V12, P4671, DOI 10.1158/1078-0432.CCR-06-0407; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Ciardiello F, 2000, DRUGS, V60, P25, DOI 10.2165/00003495-200060001-00003; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; Emmans VC, 2004, BIOCHEM SOC T, V32, P840, DOI 10.1042/BST0320840; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050; Hau P, 2007, ONCOLOGY-BASEL, V73, P21, DOI 10.1159/000120028; Kassouf W, 2006, CANCER RES, V66, P412, DOI 10.1158/0008-5472.CAN-05-2755; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Kassouf W, 2008, J UROLOGY, V179, P353, DOI 10.1016/j.juro.2007.08.087; Lee SY, 2006, LUNG CANCER, V51, P297, DOI 10.1016/j.lungcan.2005.10.010; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Lin JG, 2008, LAB INVEST, V88, P529, DOI 10.1038/labinvest.2008.20; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mansure J. J., 2009, CANCER BIOL THER, V8, P6, DOI DOI 10.4161/CBT.8.7.7853; Mendelsohn J, 2001, J UROLOGY, V165, P1152, DOI 10.1016/S0022-5347(05)66453-1; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Motomura W, 2000, CANCER RES, V60, P5558; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PETTAWAY CA, 1995, J UROLOGY, V154, P1999, DOI 10.1016/S0022-5347(01)66671-0; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Shrader M, 2007, MOL CANCER THER, V6, P277, DOI 10.1158/1535-7163.MCT-06-0513; Suzuki T, 2003, LUNG CANCER-J IASLC, V42, P35, DOI 10.1016/S0169-5002(03)00278-2; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Zhou YJ, 2007, LAB INVEST, V87, P488, DOI 10.1038/labinvest.3700532; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	31	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55997	10.1371/journal.pone.0055997	http://dx.doi.org/10.1371/journal.pone.0055997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409107	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300049
J	Figueroa, L; Shkryl, VM; Blatter, LA; Rios, E				Figueroa, Lourdes; Shkryl, Vyacheslav M.; Blatter, Lothar A.; Rios, Eduardo			Using Two Dyes with the Same Fluorophore to Monitor Cellular Calcium Concentration in an Extended Range	PLOS ONE			English	Article							MUSCLE; CA2+	We extend the sensitivity of quantitative concentration imaging to an approximately 1000-fold range of concentrations by a method that uses two fluorescent dyes with the same fluorophore, having different affinity for the monitored species. While the formulation and illustration refer to a monitor of calcium concentration, the method is applicable to any species that binds to multiple indicators with the same spectral properties. The use of a common fluorophore has the virtue of leaving vast regions of the electromagnetic spectrum available for other applications. We provide the exact analytic expression relating measured fluorescence to [Ca2+] at equilibrium and an approximate analytic expression that does not require the equilibrium assumption. The sensitivity of the method is calculated numerically for two useful dye pairs. As illustrative application of the enhanced measurement, we use fluo-4 and fluo-4FF to image the calcium wave produced by a cardiac myocyte in response to a small artificial calcium spark.	[Figueroa, Lourdes; Blatter, Lothar A.; Rios, Eduardo] Rush Univ, Dept Mol Biophys & Physiol, Sect Cellular Signaling, Chicago, IL 60612 USA; [Shkryl, Vyacheslav M.] AA Bogomoletz Inst Physiol, Lab Biophys Ion Channels, Dept Gen Physiol Nervous Syst, Kiev, Ukraine	Rush University; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Rios, E (corresponding author), Rush Univ, Dept Mol Biophys & Physiol, Sect Cellular Signaling, Chicago, IL 60612 USA.	erios@rush.edu	Blatter, Lothar/AAC-8431-2020	Figueroa, Lourdes Carolina/0000-0002-4323-4507	National Center for Research Resources; Rush University's Hasterlik Philanthropic Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS [AR049184, AR032808]; National Heart and Lung Institute [HL62231, HL80101, HL101235]; Leducq Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024707] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062231, R01HL101235, P01HL080101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049184, R01AR032808, R37AR032808] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rush University's Hasterlik Philanthropic Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation(Leducq Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Center for Research Resources, Rush University's Hasterlik Philanthropic Fund and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS, (AR049184 and AR032808) to E. Rios, and the National Heart and Lung Institute (HL62231, HL80101 and HL101235) and the Leducq Foundation to L. Blatter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Figueroa L, 2012, J PHYSIOL-LONDON, V590, P1389, DOI 10.1113/jphysiol.2011.225854; Launikonis BS, 2005, J PHYSIOL-LONDON, V567, P523, DOI 10.1113/jphysiol.2005.087973; Shkryl VM, 2012, J GEN PHYSIOL, V139, P189, DOI 10.1085/jgp.201110709	3	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55778	10.1371/journal.pone.0055778	http://dx.doi.org/10.1371/journal.pone.0055778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409040	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200061
J	Li, B; Ze, YG; Sun, QQ; Zhang, T; Sang, XZ; Cui, YL; Wang, XC; Gui, SX; Tan, DL; Zhu, M; Zhao, XY; Sheng, L; Wang, L; Hong, FS; Tang, M				Li, Bing; Ze, Yuguan; Sun, Qingqing; Zhang, Ting; Sang, Xuezi; Cui, Yaling; Wang, Xiaochun; Gui, Suxin; Tan, Danlin; Zhu, Min; Zhao, Xiaoyang; Sheng, Lei; Wang, Ling; Hong, Fashui; Tang, Meng			Molecular Mechanisms of Nanosized Titanium Dioxide-Induced Pulmonary Injury in Mice	PLOS ONE			English	Article							INHALATION EXPOSURE; QUANTITATIVE PCR; IMMUNE-RESPONSES; NANOPARTICLES; EXPRESSION; LUNG; IDENTIFICATION; INFLAMMATION; VALIDATION; PARTICLES	The pulmonary damage induced by nanosized titanium dioxide (nano-TiO2) is of great concern, but the mechanism of how this damage may be incurred has yet to be elucidated. Here, we examined how multiple genes may be affected by nano-TiO2 exposure to contribute to the observed damage. The results suggest that long-term exposure to nano-TiO2 led to significant increases in inflammatory cells, and levels of lactate dehydrogenase, alkaline phosphate, and total protein, and promoted production of reactive oxygen species and peroxidation of lipid, protein and DNA in mouse lung tissue. We also observed nano-TiO2 deposition in lung tissue via light and confocal Raman microscopy, which in turn led to severe pulmonary inflammation and pneumonocytic apoptosis in mice. Specifically, microarray analysis showed significant alterations in the expression of 847 genes in the nano-TiO2-exposed lung tissues. Of 521 genes with known functions, 361 were up-regulated and 160 down-regulated, which were associated with the immune/inflammatory responses, apoptosis, oxidative stress, the cell cycle, stress responses, cell proliferation, the cytoskeleton, signal transduction, and metabolic processes. Therefore, the application of nano-TiO2 should be carried out cautiously, especially in humans.	[Li, Bing; Ze, Yuguan; Sun, Qingqing; Sang, Xuezi; Cui, Yaling; Wang, Xiaochun; Gui, Suxin; Tan, Danlin; Zhu, Min; Zhao, Xiaoyang; Sheng, Lei; Wang, Ling; Hong, Fashui] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Zhang, Ting; Tang, Meng] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med & Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Ting; Tang, Meng] Southeast Univ, Jiangsu Key Lab Biomat & Devices, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Southeast University - China; Southeast University - China	Hong, FS (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	Hongfsh_cn@sina.com; tm@seu.ecu.cn	li, bing/GWQ-9617-2022		National Natural Science Foundation of China [81273036, 30901218, 81172697, 30671782, 30972504]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Major State Basic Research Development Program of China (973 Program) [2006CB705602]; National Important Project on Scientific Research of China [2011CB933404]; National Ideas Foundation of Student of Soochow University [111028534]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Important Project on Scientific Research of China; National Ideas Foundation of Student of Soochow University	This work was supported by the National Natural Science Foundation of China (grant numbers 81273036, 30901218, 81172697), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Major State Basic Research Development Program of China (973 Program) (grant number 2006CB705602), National Important Project on Scientific Research of China (grant number 2011CB933404), National Natural Science Foundation of China (grant numbers 30671782, 30972504) and the National Ideas Foundation of Student of Soochow University (grant number 111028534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque W, 2004, J PEDIATR-US, V144, P278, DOI 10.1016/j.jpeds.2003.10.055; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Cai YP, 2009, J IMMUNOL, V182, P5393, DOI 10.4049/jimmunol.0803874; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Donaldson K, 2001, OCCUP ENVIRON MED, V58, P211, DOI 10.1136/oem.58.3.211; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fozard JR, 1999, PULM PHARMACOL THER, V12, P111, DOI 10.1006/pupt.1999.0191; Fujita K, 2009, TOXICOLOGY, V258, P47, DOI 10.1016/j.tox.2009.01.005; Grassian VH, 2007, ENVIRON HEALTH PERSP, V115, P397, DOI 10.1289/ehp.9469; Hirschorn R, 2006, PRIMARY IMMUNODEFICI, P169; Hoyt VW, 2008, J CHEM HEALTH SAF, V15, P10, DOI 10.1016/j.jchas.2007.07.015; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; Inoue K, 2009, TOXICOL APPL PHARM, V234, P68, DOI 10.1016/j.taap.2008.09.012; Ito Y, 2002, INT J MOL MED, V9, P373; Jacobson Marlene A., 1997, P315; Jortner J, 2002, PURE APPL CHEM, V74, P1491, DOI 10.1351/pac200274091491; Kacharmina JE, 1999, METHOD ENZYMOL, V303, P3; Kajimoto K, 2005, CIRC J, V69, P1029, DOI 10.1253/circj.69.1029; Kaminski Naftali, 2006, Proc Am Thorac Soc, V3, P339, DOI 10.1513/pats.200601-011TK; Katsuma S, 2001, BIOCHEM BIOPH RES CO, V288, P747, DOI 10.1006/bbrc.2001.5853; Ke LD, 2000, MOL CELL PROBE, V14, P127, DOI 10.1006/mcpr.2000.0288; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Li JA, 2007, ENVIRON TOXICOL PHAR, V24, P239, DOI 10.1016/j.etap.2007.06.004; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Liu R, 2009, PROG NAT SCI-MATER, V19, P573, DOI 10.1016/j.pnsc.2008.06.020; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; McDowell SA, 2003, AM J RESP CELL MOL, V28, P188, DOI 10.1165/rcmb.2002-0077OC; Mohsenin A, 2007, AM J PHYSIOL-LUNG C, V293, pL753, DOI 10.1152/ajplung.00187.2007; Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Pan Z, 2009, SMALL, V5, P511, DOI 10.1002/smll.200800798; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Roco M. C., 2001, SOC IMPLICATIONS NAN; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Studer Sean M, 2007, Proc Am Thorac Soc, V4, P85, DOI 10.1513/pats.200607-139JG; Sun QQ, 2012, J HAZARD MATER, V235, P47, DOI 10.1016/j.jhazmat.2012.05.072; Sun QQ, 2012, J BIOMED MATER RES A, V100A, P2554, DOI 10.1002/jbm.a.34190; Thurn KT, 2011, NANOMED-NANOTECHNOL, V7, P123, DOI 10.1016/j.nano.2010.09.004; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Yang P, 2002, MATER LETT, V57, P794, DOI 10.1016/S0167-577X(02)00875-3	48	47	47	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55563	10.1371/journal.pone.0055563	http://dx.doi.org/10.1371/journal.pone.0055563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409001	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200040
J	Lu, L; Dai, YH; Du, XP; She, WD; Zhang, XL; Wu, Q; Yuan, WJ; Chen, F				Lu, Ling; Dai, Yanhong; Du, Xiaoping; She, Wandong; Zhang, Xiuling; Wu, Qin; Yuan, Wenjie; Chen, Feng			Relationship of Glucocorticoid Receptor Expression in Peripheral Blood Mononuclear Cells and the Cochlea of Guinea Pigs and Effects of Dexamethasone Administration	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; RESISTANCE; BETA; MUTATIONS; THERAPY; EAR	Background: Glucocorticoids (GCs) are widely used to treat sudden sensorineural hearing loss (SSNHL) and significantly improve hearing. However, GC insensitivity has been observed in some patients of SSNHL. Objective: To study the correlation between GR expression in peripheral blood mononuclear cells (PBMCs) and in the cochlea of guinea pigs at mRNA and protein levels. Methods: One group of guinea pigs received dexamethasone (10 mg/kg/day) intraperitoneally for 7 consecutive days (dexamethasone group), and another group of guinea pigs received normal saline (control group). Real time PCR and Western blotting were used to detect the expression of GR mRNA and GR protein in PBMCs and the cochleae. Results: The GR mRNA and GR protein were detected in both PBMCs and the cochlear tissue of guinea pigs. GR mRNA and GR protein levels in PBMCs were positively correlated with those in the cochlea. The expression of GR mRNA and GR protein was significantly increased in the dexamethasone group compared to the control group. Conclusions: Levels of GR mRNA and GR protein in the PBMCs were positively correlated with those in the cochlea of guinea pigs. Systemic dexamethasone treatment can significantly up-regulate GR expression in PBMCs and in the cochlea. Measurement of the GR level in PBMCs could be used as an indicator of GR level in the cochlea.	[Lu, Ling; Dai, Yanhong; She, Wandong; Chen, Feng] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Otolaryngol Head & Neck Surg, Nanjing 210008, Jiangsu, Peoples R China; [Du, Xiaoping] Hough Ear Inst, Oklahoma City, OK USA; [Zhang, Xiuling] Southeast Univ, Coll Med, Jiangyin Peoples Hosp, Jiangyin, Jiangsu, Peoples R China; [Wu, Qin; Yuan, Wenjie] Nanjing Univ, Sch Med, Microbiol Lab, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Southeast University - China; Nanjing University	She, WD (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Otolaryngol Head & Neck Surg, Nanjing 210008, Jiangsu, Peoples R China.	shewandong@163.com			Six Talents Peak Projects from Jiangsu Province; Health Bureau of Nanjing City, China [WKK09105]; international cooperation projects from Nanjing Municipal Science and Technology Commission, China [2012sd311038]	Six Talents Peak Projects from Jiangsu Province; Health Bureau of Nanjing City, China; international cooperation projects from Nanjing Municipal Science and Technology Commission, China	The funders included a grant of Six Talents Peak Projects from Jiangsu Province (2009), a grant for the Development of Medical Sciences from the Health Bureau of Nanjing City, China (NO: WKK09105), and a grant of international cooperation projects from Nanjing Municipal Science and Technology Commission, China (NO: 2012sd311038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Charmandari E, 2009, METHODS MOL BIOL, V590, P33, DOI 10.1007/978-1-60327-378-7_3; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1026, DOI 10.1164/ajrccm/144.5.page; Dodson Kelley M, 2004, Ear Nose Throat J, V83, P394; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Fuse T, 2002, ORL J OTO-RHINO-LARY, V64, P6, DOI 10.1159/000049079; Gordijn MS, 2012, COCHRANE DB SYST REV, V5; GREENSTEIN B, 1994, LUPUS, V3, P143, DOI 10.1177/096120339400300302; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; He Xiao-jie, 2005, Zhonghua Er Ke Za Zhi, V43, P109; Jewell CM, 2012, MOL ENDOCRINOL, V26, P244, DOI 10.1210/me.2011-1116; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; KIRKHAM BW, 1991, J RHEUMATOL, V18, P821; Kumagami H, 2013, OTOL NEUROTOL, V34, P151, DOI 10.1097/MAO.0b013e31826a55ad; Leung DYM, 1997, J EXP MED, V186, P1567, DOI 10.1084/jem.186.9.1567; Lewis-Tuffin LJ, 2006, ANN NY ACAD SCI, V1069, P1, DOI 10.1196/annals.1351.001; Mazurek B, 2010, HEARING RES, V259, P55, DOI 10.1016/j.heares.2009.10.006; McMahon SK, 2010, J CLIN ENDOCR METAB, V95, P297, DOI 10.1210/jc.2009-1003; Morawski K, 2009, OTOL NEUROTOL, V30, P851, DOI 10.1097/MAO.0b013e3181b12296; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Pujols L, 2008, ALLERGY, V63, P1377, DOI 10.1111/j.1398-9995.2008.01745.x; Rarey KE, 1996, OTOLARYNG HEAD NECK, V115, P38, DOI 10.1016/S0194-5998(96)70133-X; Rauch SD, 2004, OTOLARYNG CLIN N AM, V37, P1061, DOI 10.1016/j.otc.2004.04.004; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; She WD, 2010, OTOLARYNG HEAD NECK, V142, P266, DOI 10.1016/j.otohns.2009.10.046; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Trune DR, 2006, HEARING RES, V212, P22, DOI 10.1016/j.heares.2005.10.006; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Westerlaken BO, 2007, LARYNGOSCOPE, V117, P684, DOI 10.1097/mlg.0b013e3180316d3b; Yoo YM, 2011, LIFE SCI, V89, P615, DOI 10.1016/j.lfs.2011.08.001	32	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56323	10.1371/journal.pone.0056323	http://dx.doi.org/10.1371/journal.pone.0056323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409174	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200133
J	Malizia, N				Malizia, Nicholas			Inaccuracy, Uncertainty and the Space-Time Permutation Scan Statistic	PLOS ONE			English	Article							POSITIONAL ACCURACY; SPATIOTEMPORAL ANALYSIS; CRIME; CONFIDENTIALITY; INFLUENZA; DIFFUSION; CLUSTERS; CANCER; POINT	The space-time permutation scan statistic (STPSS) is designed to identify hot (and cool) spots of space-time interaction within patterns of spatio-temporal events. While the method has been adopted widely in practice, there has been little consideration of the effect inaccurate and/or incomplete input data may have on its results. Given the pervasiveness of inaccuracy, uncertainty and incompleteness within spatio-temporal datasets and the popularity of the method, this issue warrants further investigation. Here, a series of simulation experiments using both synthetic and real-world data are carried out to better understand how deficiencies in the spatial and temporal accuracy as well as the completeness of the input data may affect results of the STPSS. The findings, while specific to the parameters employed here, reveal a surprising robustness of the method's results in the face of these deficiencies. As expected, the experiments illustrate that greater degradation of input data quality leads to greater variability in the results. Additionally, they show that weaker signals of space-time interaction are those most affected by the introduced deficiencies. However, in stark contrast to previous investigations into the impact of these input data problems on global tests of space-time interaction, this local metric is revealed to be only minimally affected by the degree of inaccuracy and incompleteness introduced in these experiments.	Arizona State Univ, GeoDa Ctr Geospatial Anal & Computat, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Malizia, N (corresponding author), Arizona State Univ, GeoDa Ctr Geospatial Anal & Computat, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA.	nmalizia@asu.edu			U.S. National Science Foundation through a Graduate Research Fellowship; National Institute of Justice, Office of Justice Programs, U.S. Department of Justice;  [2009-SQ-B9-K101]	U.S. National Science Foundation through a Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Justice, Office of Justice Programs, U.S. Department of Justice; 	This work was supported by the U.S. National Science Foundation through a Graduate Research Fellowship to Nicholas Malizia. Additionally, the work was supported by Award No. 2009-SQ-B9-K101 awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the author and do not necessarily reflect those of the Department of Justice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WD, 2007, SOUTH ECON J, V73, P623, DOI 10.2307/20111915; Armstrong MP, 1999, STAT MED, V18, P497, DOI 10.1002/(SICI)1097-0258(19990315)18:5<497::AID-SIM45>3.3.CO;2-R; Bonner MR, 2003, EPIDEMIOLOGY, V14, P408, DOI 10.1097/01.EDE.0000073121.63254.c5; Burra T, 2002, CAN GEOGR-GEOGR CAN, V46, P160, DOI 10.1111/j.1541-0064.2002.tb00737.x; Carcach Carlos A., 1997, TRENDS ISSUES CRIME, V68; Cayo Michael R, 2003, Int J Health Geogr, V2, P10, DOI 10.1186/1476-072X-2-10; Cooper DL, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-16; Curriero FC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008998; DeLuca PF, 2008, J SPAT SCI, V53, P131, DOI 10.1080/14498596.2008.9635141; Diggle P J, 1995, Stat Methods Med Res, V4, P124, DOI 10.1177/096228029500400203; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Duffy KJ, 2011, CONSERV BIOL, V25, P392, DOI 10.1111/j.1523-1739.2010.01612.x; Eterno JA, 2012, ADV POLIC THEOR PRAC, P1, DOI 10.1201/b11477; Fefferman NH, 2005, J PUBLIC HEALTH POL, V26, P430, DOI 10.1057/palgrave.jphp.3200029; Fischer EAJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-126; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Goldberg D W, 2007, URISA J, V19, P33, DOI DOI 10.1079/9781780640891.0051; GOODCHILD MF, 1989, ACCURACY OF SPATIAL DATABASES, P107; Haas AJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-22; Hagerstrand T., 1970, PAPERS REGIONAL SCI, VXXIV, P6, DOI [DOI 10.1007/BF01936872, 10/bkqqfc]; Hyder K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-14; Jacquez Geoffrey M, 2004, Int J Health Geogr, V3, P22, DOI 10.1186/1476-072X-3-22; Jacquez GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-60; Jacquez GM, 1996, STAT MED, V15, P1935, DOI 10.1002/(SICI)1097-0258(19960930)15:18<1935::AID-SIM406>3.0.CO;2-I; Jacquez GM, 2000, QUANTIFYING SPATIAL, P53; Jeffery C, 2009, J AM MED INFORM ASSN, V16, P847, DOI 10.1197/jamia.M2788; KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25; Kravets N, 2007, HEALTH PLACE, V13, P293, DOI 10.1016/j.healthplace.2005.08.006; Krieger N, 2001, AM J PUBLIC HEALTH, V91, P1114, DOI 10.2105/AJPH.91.7.1114; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2010, SATSCAN V9 0 SOFTWAR; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kwan M, 2004, CARTOGRAPHICA, V39, P15, DOI DOI 10.3138/X204-4223-57MK-8273; Malizia N, 2012, T GIS IN PRESS; MANTEL N, 1967, CANCER RES, V27, P209; Mazumdar S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-13; McNally RJQ, 2009, HEPATOLOGY, V50, P1169, DOI 10.1002/hep.23139; Miller H, 2007, GEOGR COMPASS, V1, P503, DOI 10.1111/j.1749-8198.2007.00025.x; Mosher C.J., 2010, MISMEASURE CRIME; O'Loughlin J, 2011, ANN ASSOC AM GEOGR, V101, P178, DOI 10.1080/00045608.2010.534713; O'Loughlin J, 2010, EURASIAN GEOGR ECON, V51, P437, DOI 10.2747/1539-7216.51.4.437; Ozonoff A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-52; Poljak Z, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-59; Ratcliffe J, 1998, INT J GEOGR INF SCI, V12, P751, DOI 10.1080/136588198241644; Ratcliffe JH, 2000, INT J GEOGR INF SCI, V14, P669, DOI 10.1080/136588100424963; Ratcliffe JH, 2002, J QUANT CRIMINOL, V18, P23, DOI 10.1023/A:1013240828824; Ratcliffe JH, 2004, INT J GEOGR INF SCI, V18, P61, DOI 10.1080/13658810310001596076; Ratcliffe JH, 2001, INT J GEOGR INF SCI, V15, P473, DOI 10.1080/13658810110047221; Recuenco S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-14; Rushton G, 2006, AM J PREV MED, V30, pS16, DOI 10.1016/j.amepre.2005.09.011; Seidman D, 1973, LAW SOC REV, V8, P457; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Tango T, 2010, STAT METHODS DIS CLU; Tarling R, 2010, BRIT J CRIMINOL, V50, P474, DOI 10.1093/bjc/azq011; Tuia D, 2008, COMMUN NONLINEAR SCI, V13, P1689, DOI 10.1016/j.cnsns.2007.03.004; Unwin DJ, 1995, PROG HUM GEOG, V19, P549, DOI 10.1177/030913259501900408; VanWey LK, 2005, P NATL ACAD SCI USA, V102, P15337, DOI 10.1073/pnas.0507804102; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Ward MH, 2005, EPIDEMIOLOGY, V16, P542, DOI 10.1097/01.ede.0000165364.54925.f3; Ward MP, 2008, VET RES, V39, DOI 10.1051/vetres:2007063; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; Whitsel Eric A, 2006, Epidemiol Perspect Innov, V3, P8, DOI 10.1186/1742-5573-3-8; Wieland SC, 2008, P NATL ACAD SCI USA, V105, P17608, DOI 10.1073/pnas.0801021105; Zandbergen PA, 2008, COMPUT ENVIRON URBAN, V32, P214, DOI 10.1016/j.compenvurbsys.2007.11.006; Zandbergen PA, 2011, T GIS, V15, P495, DOI 10.1111/j.1467-9671.2011.01277.x; Zandbergen PA, 2011, GEOCARTO INT, V26, P35, DOI 10.1080/10106049.2010.537374; Zandbergen Paul A., 2009, CRIMINAL JUSTICE POL, V20, P62, DOI DOI 10.1177/0887403408323690; Zhan FB, 2006, ANN EPIDEMIOL, V16, P842, DOI 10.1016/j.annepidem.2006.08.001; Zhang J., 2002, UNCERTAINTY GEOGRAPH; Zimmerman DL, 2008, STAT MED, V27, P4254, DOI 10.1002/sim.3288; Zinszer K, 2010, SPAT SPATIO-TEMPORAL, V1, P163, DOI 10.1016/j.sste.2010.03.002	73	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e52034	10.1371/journal.pone.0052034	http://dx.doi.org/10.1371/journal.pone.0052034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408930	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200004
J	Zhang, B; Zhang, L; Dai, RX; Yu, MY; Zhao, GP; Ding, XM				Zhang, Bo; Zhang, Lin; Dai, Ruixue; Yu, Meiying; Zhao, Guoping; Ding, Xiaoming			An Efficient Procedure for Marker-Free Mutagenesis of S. coelicolor by Site-Specific Recombination for Secondary Metabolite Overproduction	PLOS ONE			English	Article							GENE-TARGETING VECTORS; STREPTOMYCES PHAGE PHI-BT1; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; INTEGRATION; CLONING; SYSTEM	Streptomyces bacteria are known for producing important natural compounds by secondary metabolism, especially antibiotics with novel biological activities. Functional studies of antibiotic-biosynthesizing gene clusters are generally through homologous genomic recombination by gene-targeting vectors. Here, we present a rapid and efficient method for construction of gene-targeting vectors. This approach is based on Streptomyces phage phi BT1 integrase-mediated multisite in vitro site-specific recombination. Four 'entry clones' were assembled into a circular plasmid to generate the destination gene-targeting vector by a one-step reaction. The four 'entry clones' contained two clones of the upstream and downstream flanks of the target gene, a selectable marker and an E. coli-Streptomyces shuttle vector. After targeted modification of the genome, the selectable markers were removed by phi C31 integrase-mediated in vivo site-specific recombination between pre-placed attB and attP sites. Using this method, part of the calcium-dependent antibiotic (CDA) and actinorhodin (Act) biosynthetic gene clusters were deleted, and the rrdA encoding RrdA, a negative regulator of Red production, was also deleted. The final prodiginine production of the engineered strain was over five times that of the wildtype strain. This straightforward phi BT1 and phi C31 integrase-based strategy provides an alternative approach for rapid genetargeting vector construction and marker removal in streptomycetes.	[Zhang, Bo; Zhang, Lin; Dai, Ruixue; Yu, Meiying; Zhao, Guoping; Ding, Xiaoming] Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Zhang, Lin; Zhao, Guoping] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Zhao, GP (corresponding author), Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	gpzhao@sibs.ac.cn; xmding74@fudan.edu.cn		Zhao, Guo-Ping/0000-0002-7621-6620; Dai, Ruixue/0000-0002-3703-0153; Zhang, Lin/0000-0001-5431-5006	National High Technology Research and Development Program of China (863 Program) [2007AA021206]; National Basic Research Program of China (973 Program) [2012CB721102]; China Postdoctoral Science Foundation [2012T50444, 2012M520947]; National Natural Science Foundation of China [30600009, 30830002]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (grant number 2007AA021206), National Basic Research Program of China (973 Program) (grant number 2012CB721102), the China Postdoctoral Science Foundation funded project (grant numbers 2012T50444 and 2012M520947) and the National Natural Science Foundation of China (grant numbers 30600009, 30830002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Cotta-De-Almeida V, 2003, GENOME RES, V13, P2190, DOI 10.1101/gr.1356503; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Frandsen RJN, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-70; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2002, STREPTOMYCES COELI A; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Herrmann S, 2012, APPL ENVIRON MICROB, V78, P1804, DOI 10.1128/AEM.06054-11; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Inoue K, 2009, GENE THER, V16, P1383, DOI 10.1038/gt.2009.105; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Ou XJ, 2009, APPL ENVIRON MICROB, V75, P2158, DOI 10.1128/AEM.02209-08; Raynal A, 2006, APPL ENVIRON MICROB, V72, P4839, DOI 10.1128/AEM.00167-06; Sambrook J, 2001, MOL CLONING LAB MANU; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Turakainen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004341; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Vilen H, 2001, TRANSGENIC RES, V10, P69, DOI 10.1023/A:1008959231644; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Williamson NR, 2005, MOL MICROBIOL, V56, P971, DOI 10.1111/j.1365-2958.2005.04602.x; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Zhang CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni014; Zhang L, 2008, J BACTERIOL, V190, P6392, DOI 10.1128/JB.00777-08; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141; Zhang L, 2010, J MOL CELL BIOL, V2, P264, DOI 10.1093/jmcb/mjq025; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	32	11	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55906	10.1371/journal.pone.0055906	http://dx.doi.org/10.1371/journal.pone.0055906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409083	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200086
J	Miyahara, T; Runge, S; Chatterjee, A; Chen, M; Mottola, G; Fitzgerald, JM; Serhan, CN; Conte, MS				Miyahara, Takuya; Runge, Sara; Chatterjee, Anuran; Chen, Mian; Mottola, Giorgio; Fitzgerald, Jonathan M.; Serhan, Charles N.; Conte, Michael S.			D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury	FASEB JOURNAL			English	Article						inflammation; intracellular signaling; resolvin	DOCOSAHEXAENOIC ACID; ANTIINFLAMMATORY PROPERTIES; HUMAN PHAGOCYTES; INFLAMMATION; RESOLUTION; E1; OMEGA-3-FATTY-ACIDS; MEDIATORS; RECEPTOR; LIPOXIN	Recent evidence suggests that specialized lipid mediators derived from polyunsaturated fatty acids control resolution of inflammation, but little is known about resolution pathways in vascular injury. We sought to determine the actions of D-series resolvin (RvD) on vascular smooth muscle cell (VSMC) phenotype and vascular injury. Human VSMCs were treated with RvD1 and RvD2, and phenotype was assessed by proliferation, migration, monocyte adhesion, superoxide production, and gene expression assays. A rabbit model of arterial angioplasty with local delivery of RvD2 (10 nM vs. vehicle control) was employed to examine effects on vascular injury in vivo. Local generation of proresolving lipid mediators (LC-MS/MS) and expression of RvD receptors in the vessel wall were assessed. RvD1 and RvD2 produced dose-dependent inhibition of VSMC proliferation, migration, monocyte adhesion, superoxide production, and proinflammatory gene expression (IC50 approximate to 0.1-1 nM). In balloon-injured rabbit arteries, cell proliferation (51%) and leukocyte recruitment (41%) were reduced at 3 d, and neointimal hyperplasia was attenuated (29%) at 28 d by RvD2. We demonstrate endogenous biosynthesis of proresolving lipid mediators and expression of receptors for RvD1 in the artery wall. RvDs broadly reduce VSMC responses and modulate vascular injury, suggesting that local activation of resolution mechanisms expedites vascular homeostasis.-Miyahara, T., Runge, S., Chatterjee, A., Chen, M., Mottola, G., Fitzgerald, J. M., Serhan, C. N., Conte, M. S. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.	[Miyahara, Takuya; Runge, Sara; Chatterjee, Anuran; Chen, Mian; Mottola, Giorgio; Conte, Michael S.] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94143 USA; [Fitzgerald, Jonathan M.; Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Fitzgerald, Jonathan M.; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA USA	University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Conte, MS (corresponding author), Univ Calif San Francisco, Div Vasc & Endovasc Surg, Lab Accelerated Vasc Res, 400 Parnassus Ave,Ste A581, San Francisco, CA 94143 USA.	michael.conte@ucsfmedctr.org	Mottola, Giorgio/AAO-4375-2021	Mottola, Giorgio/0000-0003-0670-8619	Foundation for Accelerated Vascular Research (Vascular Cures); U.S. National Institutes of Health [1P01GM095467, F32 HL 104851-2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL104851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	Foundation for Accelerated Vascular Research (Vascular Cures); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Rong Wang for critical review of the manuscript. This work was supported in part by funding from the Foundation for Accelerated Vascular Research (Vascular Cures), and U.S. National Institutes of Health grants 1P01GM095467 (C.N.S.), and F32 HL 104851-2 (S.R.). C.N.S. is an inventor on patents (resolvins) assigned to Brigham and Women's Hospital (BWH) and licensed to Resolvyx Pharmaceuticals (Cambridge, MA, USA). C.N.S. is a scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. C.N.S.'s interests were reviewed and are managed by BWH and Partners HealthCare in accordance with their conflict of interest policies.	Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Aoki H, 2010, BIOCHEM BIOPH RES CO, V400, P128, DOI 10.1016/j.bbrc.2010.08.025; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; CONTE MS, 1994, CIRCULATION, V89, P2161, DOI 10.1161/01.CIR.89.5.2161; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; DECATERINA R, 1995, PROSTAG LEUKOTR ESS, V52, P191, DOI 10.1016/0952-3278(95)90021-7; Filion KB, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-24; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Ho KJ, 2008, AM J PHYSIOL-HEART C, V295, pH1132, DOI 10.1152/ajpheart.00079.2008; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LoGerfo F, 2006, J VASC SURG, V43, P750; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; McMahon B, 2000, J BIOL CHEM, V275, P27566; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Mitchell D, 2004, AM J PATHOL, V164, P937, DOI 10.1016/S0002-9440(10)63181-1; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; Qu XL, 2012, J PATHOL, V228, P506, DOI 10.1002/path.4050; Rocha-Singh KJ, 2007, CATHETER CARDIO INTE, V69, P910, DOI 10.1002/ccd.21104; Rodgers K, 2005, AM J PATHOL, V167, P683, DOI 10.1016/S0002-9440(10)62043-3; Schillinger M, 2007, CIRCULATION, V115, P2745, DOI 10.1161/CIRCULATIONAHA.107.688341; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Spite M, 2009, BRIT J PHARMACOL, V158, P1062, DOI 10.1111/j.1476-5381.2009.00234.x; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tian HB, 2009, INVEST OPHTH VIS SCI, V50, P3613, DOI 10.1167/iovs.08-3146; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Wang GJ, 2005, ARTERIOSCL THROM VAS, V25, P2081, DOI 10.1161/01.ATV.0000183885.66153.8a	44	90	94	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2220	2232		10.1096/fj.12-225615	http://dx.doi.org/10.1096/fj.12-225615			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23407709	Green Published			2022-12-25	WOS:000319667600013
J	Di Luccio, E; Ishida, Y; Leal, WS; Wilson, DK				Di Luccio, Eric; Ishida, Yuko; Leal, Walter S.; Wilson, David K.			Crystallographic Observation of pH-Induced Conformational Changes in the Amyelois transitella Pheromone-Binding Protein AtraPBP1	PLOS ONE			English	Article							NAVEL ORANGEWORM MOTH; CRYSTAL-STRUCTURE; MACROMOLECULAR STRUCTURES; RELEASE MECHANISM; LIGAND RELEASE; NMR STRUCTURE; COMMUNICATION	The navel orangeworm, Amyelois transitella is a major agricultural pest causing large losses in a variety of tree crops. Control of this insect pest may be achieved by interfering with olfactory pathways to block detection of female-produced sex pheromones and consequently, disrupt mating. The first component of this pathway is the pheromone-binding protein AtraPBP1, which recognizes the pheromone and presents it to the odorant receptor housed in a sensory neuron of the male antennae. Release of the ligand depends on a pH-induced conformational change associated with the acidity of the membrane surface. To characterize this conformational change and to understand how pheromones bind, we have determined the high resolution crystal structures of AtraPBP1 in complex with two main constituents of the sex pheromone, i.e., (11Z, 13Z)-hexadecadienal and (11Z, 13Z)-hexadecadienol. Comparison with the structure of the unliganded form demonstrates a large similar to 90 degrees movement of the C-terminal helix which is observed in other pheromone- or odorant-binding proteins accompanied by an unpredicted 37 degrees displacement of the N-terminal helix. Molecular dynamic trajectories suggest that the conformational change of the alpha 1 helix facilitates the movement of the C-terminal helix.	[Di Luccio, Eric; Wilson, David K.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Ishida, Yuko; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Wilson, DK (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	dave@alanine.ucdavis.edu	di Luccio, Eric/Z-5388-2019; Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; di Luccio, Eric/0000-0002-2256-2157	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65105-20582]; National Science Foundation [0918177]; National Institutes of Health [1R01AI095514-01A1]; National Research Foundation of Korea [2010-010837]; Kyungpook National University [2010-05950000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095514] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); Kyungpook National University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Agriculture and Food Research Initiative Competitive Grant no. 2010-65105-20582 from the USDA National Institute of Food and Agriculture, the National Science Foundation grant #0918177, National Institutes of Health 1R01AI095514-01A1, the National Research Foundation of Korea (grant 2010-010837 to EDL) and Kyungpook National University (grant 2010-05950000 to EDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burks CS, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.40; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kowcun A, 2001, J BIOL CHEM, V276, P44770, DOI 10.1074/jbc.M104688200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lescop E, 2001, J BIOMOL NMR, V21, P181, DOI 10.1023/A:1012428527813; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pesenti ME, 2008, J MOL BIOL, V380, P158, DOI 10.1016/j.jmb.2008.04.048; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schrodinger L., 2020, PYMOL; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wriggers W, 1997, PROTEINS, V29, P1; Xu W, 2011, BIOCHEM BIOPH RES CO, V404, P335, DOI 10.1016/j.bbrc.2010.11.119; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	35	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53840	10.1371/journal.pone.0053840	http://dx.doi.org/10.1371/journal.pone.0053840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418423	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300013
J	Sun, ZL; Lam, KM; Dong, ZY; Wang, H; Gao, QW; Zheng, CH				Sun, Zhan-Li; Lam, Kin-Man; Dong, Zhao-Yang; Wang, Han; Gao, Qing-Wei; Zheng, Chun-Hou			Face Recognition with Multi-Resolution Spectral Feature Images	PLOS ONE			English	Article							SINGLE EXAMPLE IMAGE; ONE TRAINING IMAGE; EXPRESSION; SAMPLE; FLDA	The one-sample-per-person problem has become an active research topic for face recognition in recent years because of its challenges and significance for real-world applications. However, achieving relatively higher recognition accuracy is still a difficult problem due to, usually, too few training samples being available and variations of illumination and expression. To alleviate the negative effects caused by these unfavorable factors, in this paper we propose a more accurate spectral feature image-based 2DLDA (two-dimensional linear discriminant analysis) ensemble algorithm for face recognition, with one sample image per person. In our algorithm, multi-resolution spectral feature images are constructed to represent the face images; this can greatly enlarge the training set. The proposed method is inspired by our finding that, among these spectral feature images, features extracted from some orientations and scales using 2DLDA are not sensitive to variations of illumination and expression. In order to maintain the positive characteristics of these filters and to make correct category assignments, the strategy of classifier committee learning (CCL) is designed to combine the results obtained from different spectral feature images. Using the above strategies, the negative effects caused by those unfavorable factors can be alleviated efficiently in face recognition. Experimental results on the standard databases demonstrate the feasibility and efficiency of the proposed method.	[Sun, Zhan-Li; Gao, Qing-Wei; Zheng, Chun-Hou] Anhui Univ, Sch Elect Engn & Automat, Hefei 230039, Peoples R China; [Lam, Kin-Man] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China; [Dong, Zhao-Yang] Univ Newcastle, Ctr Intelligent Elect Networks, Newcastle, NSW 2300, Australia; [Wang, Han] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore	Anhui University; Hong Kong Polytechnic University; University of Newcastle; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zheng, CH (corresponding author), Anhui Univ, Sch Elect Engn & Automat, Hefei 230039, Peoples R China.	zhengch99@126.com	han, wang/GXV-3286-2022; Kan, Kin-Man/A-9352-2014; yang, dong zhao/AFP-5094-2022; Wang, Han/GPW-9809-2022; han, wang/GXV-3327-2022; Wang, Han/A-5016-2011	Kan, Kin-Man/0000-0002-0422-8454; Wang, Han/0000-0001-5448-9903; Dong, Zhao Yang/0000-0001-9659-0858	National Science Foundation of China [60905023, 61272339]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from National Science Foundation of China (Nos. 60905023, 61272339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowyer KW, 2006, COMPUT VIS IMAGE UND, V101, P1, DOI 10.1016/j.cviu.2005.05.005; Cai D, 2006, IEEE T IMAGE PROCESS, V15, P3608, DOI 10.1109/TIP.2006.881945; Chen SC, 2004, PATTERN RECOGN LETT, V25, P1173, DOI 10.1016/j.patrec.2004.03.012; Chen SC, 2004, PATTERN RECOGN, V37, P1553, DOI 10.1016/j.patcog.2003.12.010; Chen YM, 2010, NEUROCOMPUTING, V73, P3089, DOI 10.1016/j.neucom.2010.06.007; Chen YM, 2010, PATTERN RECOGN LETT, V31, P1833, DOI 10.1016/j.patrec.2010.03.018; De la Torre F, 2005, PROC CVPR IEEE, P266; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Gao QX, 2008, APPL MATH COMPUT, V205, P726, DOI 10.1016/j.amc.2008.05.019; Huang D.-S., 1996, SYSTEMATIC THEORY NE; Huang DS, 2004, IEEE T NEURAL NETWOR, V15, P477, DOI 10.1109/TNN.2004.824424; Huang G., 2007, LABELED FACES WILD D, P10; Kanan HR, 2008, PATTERN RECOGN, V41, P3799, DOI 10.1016/j.patcog.2008.05.024; Kanan HR, 2010, IMAGE VISION COMPUT, V28, P438, DOI 10.1016/j.imavis.2009.06.013; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Lam KM, 1998, IEEE T PATTERN ANAL, V20, P673, DOI 10.1109/34.689299; Levine MD, 2009, PATTERN RECOGN LETT, V30, P908, DOI 10.1016/j.patrec.2009.03.011; Levine MD, 2006, COMPUT VIS IMAGE UND, V104, P1, DOI 10.1016/j.cviu.2006.06.004; Li M, 2005, PATTERN RECOGN LETT, V26, P527, DOI 10.1016/j.patrec.2004.09.007; Li S. Z., 2011, HDB FACE RECOGNITION; Martinez AM, 2002, IEEE T PATTERN ANAL, V24, P748, DOI 10.1109/TPAMI.2002.1008382; Niyogi P, 1998, P IEEE, V86, P2196, DOI 10.1109/5.726787; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Quaglia A., 2012, FACE RECOGNITION MET; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sun ZL, 2013, IEEE T IMAGE PROCESS, V22, P17, DOI 10.1109/TIP.2012.2204269; Sun ZL, 2010, NEUROCOMPUTING, V73, P2971, DOI 10.1016/j.neucom.2010.07.004; Sun ZL, 2011, IEEE T INF FOREN SEC, V6, P360, DOI 10.1109/TIFS.2011.2118207; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Wu JX, 2002, PATTERN RECOGN LETT, V23, P1711, DOI 10.1016/S0167-8655(02)00134-4; Xie XD, 2008, PATTERN RECOGN, V41, P406, DOI 10.1016/j.patcog.2007.03.020; Yang J, 2010, PATTERN RECOGN, V43, P1454, DOI 10.1016/j.patcog.2009.11.014; Ye J., 2004, P ADV NEUR INF PROC, P1569; Zhang DQ, 2005, APPL MATH COMPUT, V163, P895, DOI 10.1016/j.amc.2004.04.016	34	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55700	10.1371/journal.pone.0055700	http://dx.doi.org/10.1371/journal.pone.0055700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418451	Green Published, gold			2022-12-25	WOS:000315970300042
J	Fujikura, D; Chiba, S; Muramatsu, D; Kazumata, M; Nakayama, Y; Kawai, T; Akira, S; Kida, H; Miyazaki, T				Fujikura, Daisuke; Chiba, Satoko; Muramatsu, Daisuke; Kazumata, Mika; Nakayama, Yosuke; Kawai, Taro; Akira, Shizuo; Kida, Hiroshi; Miyazaki, Tadaaki			Type-I Interferon is Critical for FasL Expression on Lung Cells to Determine the Severity of Influenza	PLOS ONE			English	Article							DENDRITIC CELLS; LIGAND; INFECTION; RESPONSES; IMMUNE; MACROPHAGES; RECEPTORS; APOPTOSIS; EFFECTOR; FAMILY	Infection of influenza A virus in mammals induces hyper lung pneumonia, which often causes lethal diseases. FasL is a specific ligand of Fas, which is a type-I transmembrane protein to induce cell death. Previously, it has been reported that the hyper induction of gene expression associated with Fas signal is observed in lethal influenza A virus infection. More importantly, it was also reported that functional mutation of the FasL gene protects the host against influenza A virus infection. These observations suggest that induction of FasL signal is functionally associated with the severity of influenza. However, regulation of the induction of FasL or Fas by influenza A virus infection is still unknown. Here, we demonstrated that FasL is induced after the viral infection, and inhibition of the Fas/FasL signal by treatment with a recombinant decoy receptor for FasL (Fas-Fc) increases the survival rate of mice after lethal infection of influenza A virus as well as functional mutation of the FasL gene in gld/gld mice. In addition, the induction level of FasL gene expression in the lung was correlated with the severity of influenza. We also showed that a variety of types of cells in the lung express FasL after the viral infection. Furthermore, type-I interferon induced by the viral infection was shown to be critical for induction of FasL protein expression in the lung. These findings suggested that expression of FasL protein induced by type-I IFN on the lung cell surface is critical to determine the severity of influenza.	[Fujikura, Daisuke; Chiba, Satoko; Muramatsu, Daisuke; Kazumata, Mika; Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Kita Ku, Sapporo, Hokkaido, Japan; [Fujikura, Daisuke; Kida, Hiroshi; Miyazaki, Tadaaki] Japan Sci & Technol Agcy, Innovat Plaza Hokkaido, Kita Ku, Sapporo, Hokkaido, Japan; [Muramatsu, Daisuke; Kazumata, Mika] Aureo Sci Co Ltd, Kita Ku, Sapporo, Hokkaido, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] OIE, Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan	Hokkaido University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Hokkaido University; Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Inst Med Genet, Dept Probiot Immunol, Kita Ku, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp	Akira, Shizuo/C-3134-2009	Kawai, Taro/0000-0001-7510-4662	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Science and Technology Agency	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by a grant from the Japan Science and Technology Agency. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Fujimoto I, 1998, CELL DEATH DIFFER, V5, P426, DOI 10.1038/sj.cdd.4400362; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Isaacs JD, 1998, J IMMUNOL, V161, P3862; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Langlois RA, 2010, J IMMUNOL, V184, P4440, DOI 10.4049/jimmunol.0902984; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; Matute-Bello G, 2005, J IMMUNOL, V175, P4069, DOI 10.4049/jimmunol.175.6.4069; Matute-Bello G, 2001, AM J PHYSIOL-LUNG C, V281, pL328, DOI 10.1152/ajplung.2001.281.2.L328; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sivaraman V, 2011, J VIROL, V85, P9243, DOI 10.1128/JVI.00457-11; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	26	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55321	10.1371/journal.pone.0055321	http://dx.doi.org/10.1371/journal.pone.0055321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408968	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300011
J	Kitano, A; Shimasaki, T; Chikano, Y; Nakada, M; Hirose, M; Higashi, T; Ishigaki, Y; Endo, Y; Takino, T; Sato, H; Sai, Y; Miyamoto, K; Motoo, Y; Kawakami, K; Minamoto, T				Kitano, Ayako; Shimasaki, Takeo; Chikano, Yuri; Nakada, Mitsutoshi; Hirose, Mayumi; Higashi, Tomomi; Ishigaki, Yasuhito; Endo, Yoshio; Takino, Takahisa; Sato, Hiroshi; Sai, Yoshimichi; Miyamoto, Ken-ichi; Motoo, Yoshiharu; Kawakami, Kazuyuki; Minamoto, Toshinari			Aberrant Glycogen Synthase Kinase 3 beta Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy	PLOS ONE			English	Article							FACTOR-KAPPA-B; INHIBITION; GSK3-BETA; SURVIVAL; PHOSPHORYLATION; KINASE-3-BETA; MAINTENANCE; GSK-3-BETA; IQGAP1; OVEREXPRESSION	Background and Purpose: The major obstacles to treatment of pancreatic cancer are the highly invasive capacity and resistance to chemo-and radiotherapy. Glycogen synthase kinase 3 beta (GSK3 beta) regulates multiple cellular pathways and is implicated in various diseases including cancer. Here we investigate a pathological role for GSK3 beta in the invasive and treatment resistant phenotype of pancreatic cancer. Methods: Pancreatic cancer cells were examined for GSK3 beta expression, phosphorylation and activity using Western blotting and in vitro kinase assay. The effects of GSK3 beta inhibition on cancer cell survival, proliferation, invasive ability and susceptibility to gemcitabine and radiation were examined following treatment with a pharmacological inhibitor or by RNA interference. Effects of GSK3 beta inhibition on cancer cell xenografts were also examined. Results: Pancreatic cancer cells showed higher expression and activity of GSK3 beta than non-neoplastic cells, which were associated with changes in its differential phosphorylation. Inhibition of GSK3 beta significantly reduced the proliferation and survival of cancer cells, sensitized them to gemcitabine and ionizing radiation, and attenuated their migration and invasion. These effects were associated with decreases in cyclin D1 expression and Rb phosphorylation. Inhibition of GSK3 beta also altered the subcellular localization of Rac1 and F-actin and the cellular microarchitecture, including lamellipodia. Coincident with these changes were the reduced secretion of matrix metalloproteinase-2 (MMP-2) and decreased phosphorylation of focal adhesion kinase (FAK). The effects of GSK3 beta inhibition on tumor invasion, susceptibility to gemcitabine, MMP-2 expression and FAK phosphorylation were observed in tumor xenografts. Conclusion: The targeting of GSK3 beta represents an effective strategy to overcome the dual challenges of invasiveness and treatment resistance in pancreatic cancer.	[Kitano, Ayako; Shimasaki, Takeo; Chikano, Yuri; Hirose, Mayumi; Higashi, Tomomi; Kawakami, Kazuyuki; Minamoto, Toshinari] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 920, Japan; [Takino, Takahisa; Sato, Hiroshi] Kanazawa Univ, Canc Res Inst, Div Mol Virol & Oncol, Kanazawa, Ishikawa 920, Japan; [Endo, Yoshio] Kanazawa Univ, Canc Res Inst, Cent Lab, Kanazawa, Ishikawa 920, Japan; [Kitano, Ayako; Chikano, Yuri; Sai, Yoshimichi; Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Hosp Pharm, Kanazawa, Ishikawa, Japan; [Nakada, Mitsutoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Higashi, Tomomi] Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Kanazawa, Ishikawa, Japan; [Shimasaki, Takeo; Motoo, Yoshiharu] Kanazawa Med Univ, Dept Med Oncol, Uchinada, Ishikawa 92002, Japan; [Shimasaki, Takeo; Ishigaki, Yasuhito] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 92002, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa Medical University; Kanazawa Medical University	Minamoto, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 920, Japan.	minamoto@staff.kanazawa-u.ac.jp	SATO, Hiroshi/D-8454-2015; Motoo, Yoshiharu/E-8277-2011; ENDO, Yoshio/D-8428-2015; SAI, Yoshimichi/L-3828-2015; まゆみ, 廣瀬/AAK-5735-2020; TAKINO, Takahisa/D-8460-2015; Nakada, Mitsutoshi/B-2790-2012	ENDO, Yoshio/0000-0003-0785-2006; SAI, Yoshimichi/0000-0003-2954-1532; Nakada, Mitsutoshi/0000-0001-9419-6101	Japanese Ministry of Education, Science, Sports, Technology and Culture; Japan Society for the Promotion of Science; Japan Society for Technology; Kanazawa University Cancer Research Institute; Grants-in-Aid for Scientific Research [25460793, 23659643] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, Technology and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for Technology; Kanazawa University Cancer Research Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, Technology and Culture; the Japan Society for the Promotion of Science (to KK, TM); the Japan Society for Technology (to KK, TM); the Extramural Collaborative Research Grant of Kanazawa University Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chico LK, 2009, NAT REV DRUG DISCOV, V8, P892, DOI 10.1038/nrd2999; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Furukawa T, 2008, J GASTROENTEROL, V43, P905, DOI 10.1007/s00535-008-2226-1; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holcom B, 2008, PANCREAS, V36, P225, DOI 10.1097/MPA.0b013e31815b3207; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; Kudo T, 2007, CANCER SCI, V98, P563, DOI 10.1111/j.1349-7006.2007.00426.x; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mai W, 2006, ONCOLOGY-BASEL, V71, P297, DOI 10.1159/000106429; Mai W, 2009, CLIN CANCER RES, V15, P6810, DOI 10.1158/1078-0432.CCR-09-0973; Mamaghani S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-132; McDonald KL, 2007, J NEUROPATH EXP NEUR, V66, P405, DOI 10.1097/nen.0b013e31804567d7; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114, DOI 10.2174/187152009789734982; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Morgan MA, 2008, CLIN CANCER RES, V14, P6744, DOI 10.1158/1078-0432.CCR-08-1032; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Shimasaki T, 2012, J GASTROENTEROL, V47, P321, DOI 10.1007/s00535-011-0484-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spalding AC, 2010, NEOPLASIA, V12, P357, DOI 10.1593/neo.92112; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	52	55	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55289	10.1371/journal.pone.0055289	http://dx.doi.org/10.1371/journal.pone.0055289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408967	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300010
J	Mujahid, S; Nielsen, HC; Volpe, MV				Mujahid, Sana; Nielsen, Heber C.; Volpe, MaryAnn V.			MiR-221 and miR-130a Regulate Lung Airway and Vascular Development	PLOS ONE			English	Article							DEVELOPING MOUSE LUNG; BRANCHING MORPHOGENESIS; EMBRYONIC LUNG; IN-VITRO; EXPRESSION; MICRORNAS; HOXA5; ANGIOGENESIS; HOXB-5; GENES	Epithelial-mesenchymal interactions play a crucial role in branching morphogenesis, but very little is known about how endothelial cells contribute to this process. Here, we examined how anti-angiogenic miR-221 and pro-angiogenic miR-130a affect airway and vascular development in the fetal lungs. Lung-specific effects of miR-130a and miR-221 were studied in mouse E14 whole lungs cultured for 48 hours with anti-miRs or mimics to miR-130a and miR-221. Anti-miR 221 treated lungs had more distal branch generations with increased Hoxb5 and VEGFR2 around airways. Conversely, mimic 221 treated lungs had reduced airway branching, dilated airway tips and decreased Hoxb5 and VEGFR2 in mesenchyme. Anti-miR 130a treatment led to reduced airway branching with increased Hoxa5 and decreased VEGFR2 in the mesenchyme. Conversely, mimic 130a treated lungs had numerous finely arborized branches extending into central lung regions with diffusely localized Hoxa5 and increased VEGFR2 in the mesenchyme. Vascular morphology was analyzed by GSL-B4 (endothelial cell-specific lectin) immunofluorescence. Observed changes in airway morphology following miR-221 inhibition and miR-130a enhancement were mirrored by changes in vascular plexus formation around the terminal airways. Mouse fetal lung endothelial cells (MFLM-91U) were used to study microvascular cell behavior. Mimic 221 treatment resulted in reduced tube formation and cell migration, where as the reverse was observed with mimic 130a treatment. From these data, we conclude that miR-221 and miR-130a have opposing effects on airway and vascular morphogenesis of the developing lung.	[Mujahid, Sana; Nielsen, Heber C.] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Sch Med, Boston, MA 02111 USA; [Nielsen, Heber C.] Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; [Nielsen, Heber C.; Volpe, MaryAnn V.] Tufts Med Ctr, Div Newborn Med, Dept Pediat, Floating Hosp Children, Boston, MA USA	Tufts University; Tufts University; Floating Hospital For Children; Tufts Medical Center	Volpe, MV (corresponding author), Tufts Med Ctr, Div Newborn Med, Dept Pediat, Floating Hosp Children, Boston, MA USA.	mvolpe1@tuftsmedicalcenter.org		Nielsen, Heber/0000-0002-9382-0539	National Institutes of Health (NIH) [HL037930, NIH HL085648, NIH P30 NS047243]; Peabody Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085648, R01HL037930, R21HL097231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peabody Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) HL037930, NIH HL085648, NIH P30 NS047243, and the Peabody Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Akeson AL, 2003, DEV BIOL, V264, P443, DOI 10.1016/j.ydbio.2003.09.004; Akeson AL, 2000, DEV DYNAM, V217, P11, DOI 10.1002/(SICI)1097-0177(200001)217:1<11::AID-DVDY2>3.0.CO;2-L; Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Golpon HA, 2001, AM J PATHOL, V158, P955, DOI 10.1016/S0002-9440(10)64042-4; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Kim HJ, 2008, J NUCL MED, V49, P1686, DOI 10.2967/jnumed.108.052894; Kinkead R, 2004, PEDIATR RES, V56, P553, DOI 10.1203/01.PDR.0000139427.26083.3D; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mandeville I, 2006, AM J PATHOL, V169, P1312, DOI 10.2353/ajpath.2006.051333; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rhoads Kim, 2005, Lymphatic Research and Biology, V3, P240, DOI 10.1089/lrb.2005.3.240; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; Volpe MV, 2007, FRONT BIOSCI-LANDMRK, V12, P860, DOI 10.2741/2108; Volpe MV, 2008, BIRTH DEFECTS RES A, V82, P571, DOI 10.1002/bdra.20481; Volpe MV, 2003, MOL GENET METAB, V80, P242, DOI 10.1016/j.ymgme.2003.08.018; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Volpe MV, 1997, HISTOCHEM CELL BIOL, V108, P495, DOI 10.1007/s004180050190; Volpe MV, 2000, BBA-GEN SUBJECTS, V1475, P337, DOI 10.1016/S0304-4165(00)00087-8; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Winnik S, 2009, CARDIOVASC RES, V83, P558, DOI 10.1093/cvr/cvp133; Wu YX, 2003, MOL CELL BIOL, V23, P5680, DOI 10.1128/MCB.23.16.5680-5691.2003; Yang Y, 2012, INT J MOL MED, V29, P393, DOI 10.3892/ijmm.2011.855; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	40	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55911	10.1371/journal.pone.0055911	http://dx.doi.org/10.1371/journal.pone.0055911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409087	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300044
J	Gareau, C; Houssin, E; Martel, D; Coudert, L; Mellaoui, S; Huot, ME; Laprise, P; Mazroui, R				Gareau, Cristina; Houssin, Elise; Martel, David; Coudert, Laetitia; Mellaoui, Samia; Huot, Marc-Etienne; Laprise, Patrick; Mazroui, Rachid			Characterization of Fragile X Mental Retardation Protein Recruitment and Dynamics in Drosophila Stress Granules	PLOS ONE			English	Article							CELL-FREE FORMATION; MESSENGER-RNA; BINDING; PHOSPHORYLATION; NUCLEAR; FMR1; LOCALIZATION; POLYRIBOSOMES; AGGREGATION; ASSOCIATION	The RNA-binding protein Fragile X Mental Retardation (FMRP) is an evolutionarily conserved protein that is particularly abundant in the brain due to its high expression in neurons. FMRP deficiency causes fragile X mental retardation syndrome. In neurons, FMRP controls the translation of target mRNAs in part by promoting dynamic transport in and out neuronal RNA granules. We and others have previously shown that upon stress, mammalian FMRP dissociates from translating polysomes to localize into neuronal-like granules termed stress granules (SG). This localization of FMRP in SG is conserved in Drosophila. Whether FMRP plays a key role in SG formation, how FMRP is recruited into SG, and whether its association with SG is dynamic are currently unknown. In contrast with mammalian FMRP, which has two paralog proteins, Drosophila FMR1 (dFMRP) is encoded by a single gene that has no paralog. Using this genetically simple model, we assessed the role of dFMRP in SG formation and defined the determinants required for its recruitment in SG as well as its dynamics in SG. We show that dFMRP is dispensable for SG formation in vitro and ex vivo. FRAP experiments showed that dFMRP shuttles in and out SG. The shuttling activity of dFMRP is mediated by a protein-protein interaction domain located at the N-terminus of the protein. This domain is, however, dispensable for the localization of dFMRP in SG. This localization of dFMRP in SG requires the KH and RGG motifs which are known to mediate RNA binding, as well as the C-terminal glutamine/asparagine rich domain. Our studies thus suggest that the mechanisms controlling the recruitment of FMRP into SG and those that promote its shuttling between granules and the cytosol are uncoupled. To our knowledge, this is the first demonstration of the regulated shuttling activity of a SG component between RNA granules and the cytosol.	[Gareau, Cristina; Houssin, Elise; Martel, David; Coudert, Laetitia; Mellaoui, Samia; Huot, Marc-Etienne; Laprise, Patrick; Mazroui, Rachid] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Ctr Rech,CHU Quebec, Quebec City, PQ G1K 7P4, Canada	Laval University	Mazroui, R (corresponding author), Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Ctr Rech,CHU Quebec, Quebec City, PQ G1K 7P4, Canada.	rachid.mazroui@crsfa.ulaval.ca			Canadian Institute Health Research (CIHR) [MOP-199572-CP-CFBA]; Natural Sciences and Engineering Research Council of Canada [MOP-CG095386]; Canadian Foundation for Innovation [MOP-GF091050]; Faculty of Medicine at Laval University; CIHR	Canadian Institute Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Faculty of Medicine at Laval University; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute Health Research (CIHR) grant (MOP-199572-CP-CFBA) to P. Laprise, the Natural Sciences and Engineering Research Council of Canada (MOP-CG095386) and by a Canadian Foundation for Innovation grant (MOP-GF091050) to R. Mazroui. C. Gareau is recipient of a scholarship from the Faculty of Medicine at Laval University. P. Laprise and R. Mazroui are both recipients of a CIHR New investigator Scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Banerjee P, 2010, J NEUROSCI, V30, P6782, DOI 10.1523/JNEUROSCI.6369-09.2010; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Chakraborty P, 2006, METHODS, V39, P363, DOI 10.1016/j.ymeth.2006.07.002; Cheever A, 2009, RNA BIOL, V6, P175, DOI 10.4161/rna.6.2.8196; Cheever A, 2009, RNA, V15, P362, DOI 10.1261/rna.1500809; Coffee RL, 2012, HUM MOL GENET, V21, P900, DOI 10.1093/hmg/ddr527; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Didiot MC, 2009, MOL BIOL CELL, V20, P428, DOI 10.1091/mbc.E08-07-0737; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Estes PS, 2008, MOL CELL NEUROSCI, V39, P170, DOI 10.1016/j.mcn.2008.06.012; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khandjian EW, 1999, BIOCHEM CELL BIOL, V77, P331, DOI 10.1139/bcb-77-4-331; KHANDJIAN EW, 1995, HUM MOL GENET, V4, P783, DOI 10.1093/hmg/4.5.783; Kim SH, 2006, J NEUROSCI, V26, P2413, DOI 10.1523/JNEUROSCI.3680-05.2006; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McLennan Y, 2011, CURR GENOMICS, V12, P216, DOI 10.2174/138920211795677886; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wang CY, 2012, RNA, V18, P694, DOI 10.1261/rna.030270.111; XU T, 1994, METHOD CELL BIOL, V44, P655, DOI 10.1016/S0091-679X(08)60937-1; Zurla C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019727	51	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55342	10.1371/journal.pone.0055342	http://dx.doi.org/10.1371/journal.pone.0055342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408971	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200025
J	Liu, J; Fan, HJ; Ma, YY; Liang, DM; Huang, RX; Wang, JS; Zhou, FY; Kan, QC; Ming, L; Li, HX; Giercksky, KE; Nesland, JM; Suo, ZH				Liu, Jian; Fan, Huijie; Ma, Yuanyuan; Liang, Dongming; Huang, Ruixia; Wang, Junsheng; Zhou, Fuyou; Kan, Quancheng; Ming, Liang; Li, Huixiang; Giercksky, Karl-Erik; Nesland, Jahn Martin; Suo, Zhenhe			Notch1 Is a 5-Fluorouracil Resistant and Poor Survival Marker in Human Esophagus Squamous Cell Carcinomas	PLOS ONE			English	Article							SIGNALING PATHWAY; CANCER CELLS; STEM-CELLS; TUMOR-SUPPRESSOR; DIFFERENTIATION; INHIBITORS; APOPTOSIS; TARGETS; GROWTH; ACTIVATION	Notch signaling involves the processes that govern cell proliferation, cell fate decision, cell differentiation and stem cell maintenance. Due to its fundamental role in stem cells, it has been speculated during the recent years that Notch family may have critical functions in cancer stem cells or cancer cells with a stem cell phenotype, therefore playing an important role in the process of oncogenesis. In this study, expression of Notch family in KYSE70, KYSE140 and KYSE450 squamous esophageal cancer cell lines and virus transformed squamous esophageal epithelial cell line Het-1A was examined by quantitative RT-PCR. Compared to the Het-1A cells, higher levels of Nocth1 and Notch3 expression in the cancer cell lines were identified. Due to the finding that NOTCH3 mainly mediates squamous cell differentiation, NOTCH1 expression was further studied in these cell lines. By Western blot analyses, the KYSE70 cell line which derived from a poorly differentiated tumor highly expressed Notch1, and the Notch1 expression in this cell line was hypoxia inducible, while the KYSE450 cell line which derived from a well differentiated tumor was always negative for Notch1, even in hypoxia. Additional studies demonstrated that the KYSE70 cell line was more 5-FU resistant than the KYSE450 cell line and such 5-FU resistance is correlated to Notch1 expression verified by Notch1 knockdown experiments. In clinical samples, Notch1 protein expression was detected in the basal cells of human esophagus epithelia, and its expression in squamous cell carcinomas was significantly associated with higher pathological grade and shorter overall survival. We conclude that Notch1 expression is associated with cell aggressiveness and 5-FU drug resistance in human esophageal squamous cell carcinoma cell lines in vitro and is significantly associated with a poor survival in human esophageal squamous cell carcinomas.	[Liu, Jian; Li, Huixiang] Zhengzhou Univ, Basic Med Coll, Teaching Hosp 1, Dept Pathol, Zhengzhou, Henan Province, Peoples R China; [Liu, Jian; Ma, Yuanyuan; Liang, Dongming; Huang, Ruixia; Nesland, Jahn Martin; Suo, Zhenhe] Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Fan, Huijie; Suo, Zhenhe] Zhengzhou Univ, Teaching Hosp 1, Dept Oncol, Zhengzhou, Henan Province, Peoples R China; [Ma, Yuanyuan; Huang, Ruixia; Nesland, Jahn Martin; Suo, Zhenhe] Univ Oslo, Fac Med, Inst Clin Med, Dept Pathol, Oslo, Norway; [Wang, Junsheng] Anyang Tumor Hosp, Dept Oncol, Anyang, Henan Province, Peoples R China; [Zhou, Fuyou] Anyang Tumor Hosp, Dept Surg, Anyang, Henan Province, Peoples R China; [Kan, Quancheng] Zhengzhou Univ, Teaching Hosp 1, Dept Pharmacol, Zhengzhou, Henan Province, Peoples R China; [Ming, Liang] Zhengzhou Univ, Teaching Hosp 1, Dept Lab Med, Zhengzhou, Henan Province, Peoples R China; [Giercksky, Karl-Erik] Univ Oslo, Oslo Univ Hosp, Norwegian Radium Hosp, Dept Surg,Inst Canc Res, Oslo, Norway	Zhengzhou University; University of Oslo; Zhengzhou University; University of Oslo; Zhengzhou University; Zhengzhou University; University of Oslo	Suo, ZH (corresponding author), Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway.	zhenhesuo@yahoo.com.cn		Huang, Ruixia/0000-0001-7214-647X	Norwegian Radium Hospital Legat	Norwegian Radium Hospital Legat	This work is financially supported by The Norwegian Radium Hospital Legat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Cao HQ, 2012, APMIS, V120, P441, DOI 10.1111/j.1600-0463.2011.02825.x; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Christofori G, 2011, CANCER CELL, V19, P6, DOI 10.1016/j.ccr.2011.01.003; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Katoh M, 2007, INT J ONCOL, V30, P247; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Liu SY, 2009, ANN HEMATOL, V88, P613, DOI 10.1007/s00277-008-0646-x; Lu ZM, 2008, INT J ONCOL, V32, P643; Ma Y, 2012, PLOS ONE, V6; Ma YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033414; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Miyamoto S, 2011, CANCER SCI, V102, P1938, DOI 10.1111/j.1349-7006.2011.02049.x; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2008, BLOOD, V111, P2220, DOI 10.1182/blood-2007-07-102632; Nefedova Y, 2008, DRUG RESIST UPDATE, V11, P210, DOI 10.1016/j.drup.2008.09.002; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nyhan KC, 2010, BBA-MOL CELL RES, V1803, P1386, DOI 10.1016/j.bbamcr.2010.09.001; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Purow B, 2009, CURR PHARM BIOTECHNO, V10, P154, DOI 10.2174/138920109787315060; Raimondi C, 2010, CURR CANCER DRUG TAR, V10, P496, DOI 10.2174/156800910791517154; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Ristorcelli E, 2010, EXPERT OPIN THER TAR, V14, P541, DOI 10.1517/14728221003769895; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Wang ZW, 2010, CURR PROTEIN PEPT SC, V11, P398, DOI 10.2174/138920310791824039; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Yang HH, 2002, ACTA CYTOL, V46, P445, DOI 10.1159/000326859; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Yoon JH, 2009, BIOCHIM BIOPHYS ACTA, V1800, P352; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	49	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56141	10.1371/journal.pone.0056141	http://dx.doi.org/10.1371/journal.pone.0056141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409141	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200115
J	Villalobos, F; Dobrovolski, R; Provete, DB; Gouveia, SF				Villalobos, Fabricio; Dobrovolski, Ricardo; Provete, Diogo B.; Gouveia, Sidney F.			Is Rich and Rare the Common Share? Describing Biodiversity Patterns to Inform Conservation Practices for South American Anurans	PLOS ONE			English	Article							SPECIES RICHNESS; DIVERSITY; HOTSPOTS; CLIMATE; IMPLEMENTATION; ECOREGIONS	Species richness and range size are key features of biogeographic and macroecological analyses, which can yield a first assessment tool to define conservation priorities. Here we combined both features in a simultaneous analysis, based on range-diversity plots, to identify sets of rich-rare (high species richness with restricted ranges) and poor-rare cells (low species richness with restricted ranges). We applied this analysis to the anurans of South America and evaluated the representation of those sets of cells within the protected area system. South American anurans showed high species richness in the Brazilian Atlantic Forest and East Tropical Andes, while regions harboring most of the rare species were concentrated in the Andes and Atlantic Coast from North-Eastern Brazil to River Plate. Based on such patterns, we identified as rich-rare cells the Brazilian Atlantic Forest and Tropical Andes and as poor-rare cells the southern part of Andes and Uruguay. A low fraction of both sets of cells was represented within the protected area system. We show that a simultaneous consideration of species richness and rarity provides a rapid assessment of large-scale biodiversity patterns and may contribute to the definition of conservation priorities.	[Villalobos, Fabricio; Dobrovolski, Ricardo] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Provete, Diogo B.; Gouveia, Sidney F.] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Villalobos, F (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil.	fabricio.villalobos@gmail.com	Gouveia, Sidney F/G-6438-2013; Provete, Diogo B./B-3704-2008; Villalobos, Fabricio/J-6246-2012; Dobrovolski, Ricardo/B-2580-2013	Gouveia, Sidney F/0000-0003-4941-7440; Provete, Diogo B./0000-0002-0097-0651; Villalobos, Fabricio/0000-0002-5230-2217; Dobrovolski, Ricardo/0000-0002-8775-5486	CONACYT [172694]; CNPq [150355/2012-2]; CAPES-DS; PDSE [0278-12-2]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-DS(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PDSE	FV research is supported by grants from CONACYT (#172694) and CNPq (#150355/2012-2). RD is supported by a CNPq fellowship. DBP receives a CAPES-DS doctoral fellowship. SFG receives a CAPES-DS and a PDSE (0278-12-2) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Arita HT, 2008, AM NAT, V172, P519, DOI 10.1086/590954; Arita HT, 2012, GLOBAL ECOL BIOGEOGR, V21, P282, DOI 10.1111/j.1466-8238.2011.00662.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diniz JAF, 2006, ACTA OECOL, V29, P9, DOI 10.1016/j.actao.2005.07.004; Duellman WE, 1994, BIOL AMPHIBIANS; Gaston K.J., 1994, RARITY; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Gouveia SF, 2013, ECOGRAPHY, V36, P104, DOI 10.1111/j.1600-0587.2012.07553.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN Conservation International NatureServe, 2009, GLOB AMPH ASS; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Knight AT, 2011, BIOL CONSERV, V144, P202, DOI 10.1016/j.biocon.2010.08.017; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Loyola RD, 2009, BIODIVERS CONSERV, V18, P2017, DOI 10.1007/s10531-008-9570-6; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Moilanen A, 2011, BIOL CONSERV, V144, P650, DOI 10.1016/j.biocon.2010.09.006; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Ochoa-Ochoa LM, 2012, BIOL CONSERV, V150, P94, DOI 10.1016/j.biocon.2012.03.010; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; R Core Team, 2021, R LANG ENV STAT COMP; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Soberon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019359; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Villalobos F, 2013, BIOL CONSERV, V158, P313, DOI 10.1016/j.biocon.2012.10.002; WDPA Consortium, 2009, WORLD DAT PROT AR; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	48	34	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56073	10.1371/journal.pone.0056073	http://dx.doi.org/10.1371/journal.pone.0056073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409124	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200105
J	Li, Y; Zhang, H; Jiang, CT; Xu, MJ; Pang, YL; Feng, J; Xiang, XX; Kong, W; Xu, GH; Li, Y; Wang, X				Li, Yang; Zhang, Heng; Jiang, Changtao; Xu, Mingjiang; Pang, Yanli; Feng, Juan; Xiang, Xinxin; Kong, Wei; Xu, Guoheng; Li, Yin; Wang, Xian			Hyperhomocysteinemia Promotes Insulin Resistance by Inducing Endoplasmic Reticulum Stress in Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; ACCELERATED ATHEROSCLEROSIS; MACROPHAGE POLARIZATION; TRANSCRIPTION FACTOR; QUALITY CONTROL; MESSENGER-RNA; JNK PATHWAY; OBESITY; HOMOCYSTEINE	Type 2 diabetes is a chronic inflammatory metabolic disease, the key point being insulin resistance. Endoplasmic reticulum (ER) stress plays a critical role in the pathogenesis of type 2 diabetes. Previously, we found that hyperhomocysteinemia (HHcy) induced insulin resistance in adipose tissue. Here, we hypothesized that HHcy induces ER stress, which in turn promotes insulin resistance. In the present study, the direct effect of Hcy on adipose ER stress was investigated by the use of primary rat adipocytes in vitro and mice with HHcy in vivo. The mechanism and the effect of G protein-coupled receptor 120 (GPR120) were also investigated. We found that phosphorylation or expression of variant ER stress markers was elevated in adipose tissue of HHcy mice. HHcy activated c-Jun N-terminal kinase (JNK), the downstream signal of ER stress in adipose tissue, and activated JNK participated in insulin resistance by inhibiting Akt activation. Furthermore, JNK activated c-Jun and p65, which in turn triggered the transcription of proinflammatory cytokines. Both in vivo and in vitro assays revealed that Hcy-promoted macrophage infiltration aggravated ER stress in adipose tissue. Chemical chaperones PBA and TUDCA could reverse Hcy-induced inflammation and restore insulin-stimulated glucose uptake and Akt activation. Activation of GPR120 reversed Hcy-induced JNK activation and prevented inflammation but not ER stress. Therefore, HHcy inhibited insulin sensitivity in adipose tissue by inducing ER stress, activating JNK to promote proinflammatory cytokine production and facilitating macrophage infiltration. These findings reveal a new mechanism of HHcy in the pathogenesis of insulin resistance.	[Li, Yin; Wang, Xian] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 10091, Peoples R China; Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Peking University	Li, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 10091, Peoples R China.	yinli@bjmu.edu.cn; xwang@bjmu.edu.cn	Li, Yin/P-9296-2016	Li, Yin/0000-0002-4019-3391; Jiang, Changtao/0000-0002-5206-2372; Li, Yang/0000-0002-6286-2939	National Natural Science Foundation of China [81070683, 81121061, 31230035, 81170795, 30971085]; Major National Basic Research Program of China [2011CB503904, 2010CB912504]; Program for New Century Excellent Talents in University [NCET-10-0183]; Beijing Natural Science Foundation [7112080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 81070683, 81121061, and 31230035 (to X. W.) and 81170795 and 30971085 (to Y. L.); Major National Basic Research Program of China Grants 2011CB503904 and 2010CB912504 (to X. W.); Program for New Century Excellent Talents in University Grant NCET-10-0183 (to Y. L.); and Beijing Natural Science Foundation Grant 7112080 (to Y. L.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bourlier V, 2009, DIABETES METAB, V35, P251, DOI 10.1016/j.diabet.2009.05.001; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Buysschaert M, 2000, DIABETES CARE, V23, P1816, DOI 10.2337/diacare.23.12.1816; Dai J, 2006, FREE RADICAL BIO MED, V41, P1566, DOI 10.1016/j.freeradbiomed.2006.08.020; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Jakubowski H, 2003, CLIN CHEM LAB MED, V41, P1462, DOI 10.1515/CCLM.2003.224; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Masharani UB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019878; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Robinson K, 1996, CIRCULATION, V94, P2743, DOI 10.1161/01.CIR.94.11.2743; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wei HL, 2010, ANTIOXID REDOX SIGN, V12, P1079, DOI 10.1089/ars.2009.2898; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng XK, 2003, CIRC RES, V93, P311, DOI 10.1161/01.RES.0000087642.01082.E4; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	40	82	93	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9583	9592		10.1074/jbc.M112.431627	http://dx.doi.org/10.1074/jbc.M112.431627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417716	Green Published, hybrid			2022-12-25	WOS:000317114000002
J	Becker, S; Oelschlaeger, TA; Wullaert, A; Pasparakis, M; Wehkamp, J; Stange, EF; Gersemann, M				Becker, Svetlana; Oelschlaeger, Tobias A.; Wullaert, Andy; Pasparakis, Manolis; Wehkamp, Jan; Stange, Eduard F.; Gersemann, Michael			Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo	PLOS ONE			English	Article							COLI NISSLE 1917; CROHNS-DISEASE; ESCHERICHIA-COLI; PORPHYROMONAS-GINGIVALIS; ANTIMICROBIAL PEPTIDES; ALPHA-DEFENSINS; EXPRESSION; ASSOCIATION; CANCER; INDUCTION	Background: The human colon harbours a plethora of bacteria known to broadly impact on mucosal metabolism and function and thought to be involved in inflammatory bowel disease pathogenesis and colon cancer development. In this report, we investigated the effect of colonic bacteria on epithelial cell differentiation factors in vitro and in vivo. As key transcription factors we focused on Hes1, known to direct towards an absorptive cell fate, Hath1 and KLF4, which govern goblet cell. Methods: Expression of the transcription factors Hes1, Hath1 and KLF4, the mucins Muc1 and Muc2 and the defensin HBD2 were measured by real-time PCR in LS174T cells following incubation with several heat-inactivated E. coli strains, including the probiotic E. coli Nissle 1917+/- flagellin, Lactobacilli and Bifidobacteria. For protein detection Western blot experiments and chamber-slide immunostaining were performed. Finally, mRNA and protein expression of these factors was evaluated in the colon of germfree vs. specific pathogen free vs. conventionalized mice and colonic goblet cells were counted. Results: Expression of Hes1 and Hath1, and to a minor degree also of KLF4, was reduced by E. coli K-12 and E. coli Nissle 1917. In contrast, Muc1 and HBD2 expression were significantly enhanced, independent of the Notch signalling pathway. Probiotic E. coli Nissle 1917 regulated Hes1, Hath1, Muc1 and HBD2 through flagellin. In vivo experiments confirmed the observed in vitro effects of bacteria by a diminished colonic expression of Hath1 and KLF4 in specific pathogen free and conventionalized mice as compared to germ free mice whereas the number of goblet cells was unchanged in these mice. Conclusions: Intestinal bacteria influence the intestinal epithelial differentiation factors Hes1, Hath1 and KLF4, as well as Muc1 and HBD2, in vitro and in vivo. The induction of Muc1 and HBD2 seems to be triggered directly by bacteria and not by Notch.	[Becker, Svetlana; Wehkamp, Jan; Gersemann, Michael] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Becker, Svetlana; Wehkamp, Jan; Gersemann, Michael] Univ Tubingen, Tubingen, Germany; [Oelschlaeger, Tobias A.] Univ Wurzburg, Inst Mol Biol Infect, D-97070 Wurzburg, Germany; [Wullaert, Andy; Pasparakis, Manolis] Univ Cologne, Inst Genet, Cologne, Germany; [Pasparakis, Manolis] EMBL Mouse Biol Unit, Monterotondo, Italy; [Wehkamp, Jan; Stange, Eduard F.; Gersemann, Michael] Robert Bosch Krankenhaus, Dept Internal Med 1, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Wurzburg; University of Cologne; European Molecular Biology Laboratory (EMBL); Bosch; Robert Bosch Krankenhaus	Gersemann, M (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, Stuttgart, Germany.	m.gersemann@kk-es.de	Pasparakis, Manolis/H-9292-2017; Wehkamp, Jan/B-7319-2011; Oelschlaeger, Tobias/B-5624-2015; Wullaert, Andy/D-2975-2018; Wullaert, Andy/R-1924-2019; Pasparakis, Manolis/N-4350-2019	Pasparakis, Manolis/0000-0002-9870-0966; Wullaert, Andy/0000-0001-5012-654X; Wullaert, Andy/0000-0001-5012-654X; Pasparakis, Manolis/0000-0002-9870-0966; Wehkamp, Jan/0000-0001-6788-841X	Robert Bosch fundation; Emmy Noether program of the Deutsche Forschungsgemeinschaft (DFG); Robert Bosch Foundation (Stuttgart, Germany); Sonderforschungsbereich (SFB) 685 (University of Tuebingen)	Robert Bosch fundation; Emmy Noether program of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert Bosch Foundation (Stuttgart, Germany); Sonderforschungsbereich (SFB) 685 (University of Tuebingen)(German Research Foundation (DFG))	This work was supported by the Robert Bosch fundation and by Emmy Noether program of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Robert Bosch Foundation (Stuttgart, Germany), the Sonderforschungsbereich (SFB) 685 (University of Tuebingen) and Emmy Noether program (J.W.) of the Deutsche Forschungsgemeinschaft (DFG). The authors are grateful to Dr. Katerina Vlantis, Jutta Bader and Marion Schiffmann for excellent technical support.	Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Abdulamir AS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-403; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Biarc J, 2004, CARCINOGENESIS, V25, P1477, DOI 10.1093/carcin/bgh091; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chen C. C., 2011, BRIT J NUTR, V30, P1; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croix JA, 2011, EXP BIOL MED, V236, P1402, DOI 10.1258/ebm.2011.011186; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Gersemann M, 2008, WORLD J GASTROENTERO, V14, P5499, DOI 10.3748/wjg.14.5499; Gersemann M, 2011, WORLD J GASTROENTERO, V17, P3198, DOI 10.3748/wjg.v17.i27.3198; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x; Henckaerts L, 2007, GUT, V56, P1536, DOI 10.1136/gut.2007.125468; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P1278; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liong MT, 2008, INT J MOL SCI, V9, P854, DOI 10.3390/ijms9050854; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Marteau P, 2011, DIGEST DIS, V29, P166, DOI 10.1159/000323879; MCCORMICK DA, 1990, J CLIN PATHOL, V43, P143, DOI 10.1136/jcp.43.2.143; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Obata Y, 2012, J IMMUNOL, V188, P2427, DOI 10.4049/jimmunol.1101128; Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003; Park ET, 2006, CLIN CANCER RES, V12, P5403, DOI 10.1158/1078-0432.CCR-06-0573; Park JH, 2005, BIOCHEM BIOPH RES CO, V332, P1081, DOI 10.1016/j.bbrc.2005.05.060; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Schmid M, 2007, J LEUKOCYTE BIOL, V81, P907, DOI 10.1189/jlb.0906581; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI 10.1002/jcp.22201; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	66	39	41	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55620	10.1371/journal.pone.0055620	http://dx.doi.org/10.1371/journal.pone.0055620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418447	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300038
J	Chang, TI; Kang, EW; Lee, YK; Shin, SK				Chang, Tae Ik; Kang, Ea Wha; Lee, Yong Kyu; Shin, Sug Kyun			Higher Peritoneal Protein Clearance as a Risk Factor for Cardiovascular Disease in Peritoneal Dialysis Patient	PLOS ONE			English	Article							MEMBRANE-TRANSPORT STATUS; TECHNIQUE FAILURE; CAPACITY TEST; SURVIVAL; MORTALITY; ALBUMIN; HYPOALBUMINEMIA; NUTRITION; INFLAMMATION; SUPERIOR	Background and Aims: Although a number of studies have been published on peritoneal protein clearance (PrCl) and its association with patient outcomes, the results have been inconsistent. Therefore, the intent of this study was to evaluate the impact of PrCl on cardiovascular disease (CVD) and mortality in peritoneal dialysis (PD) patients. Methods: This prospective observational study included a total of 540 incident patients who started PD at NHIC Ilsan Hospital, Korea from January 2000 to December 2009. Two different types of analyses such as intention-to-treat and astreated were used. Results: Correlation analyses revealed that PrCl was positively correlated with diabetes, pulse pressure, C-reactive protein (CRP) level, dialysate/plasma creatinine ratio (D/P cr) at 4 h, and peritoneal Kt/V urea. PrCl was inversely correlated with serum albumin and triglyceride levels. On multivariate analysis, serum albumin, pulse pressure, D/P cr at 4 h, and peritoneal Kt/V urea were found to be independent determinants of PrCl. A total of 129 (23.9%) patients in intention-to-treat analysis and 117 (21.7%) patients in as-treated analysis developed new cardiovascular events. Time to occurrence of cardiovascular event was significantly longer in patients with a value of PrCl below the median (89.4 ml/day). In multivariate analysis, older age, presence of diabetes or previous CVD, and higher PrCl were independent predictors of cardiovascular events. Patients above the median value of PrCl had a significantly lower rate of survival than those below the median. However, a higher PrCl was not associated with increased mortality in multivariate Cox analysis. Conclusions: A higher PrCl is a risk for occurrence of cardiovascular event, but not mortality in PD patients. Large randomized clinical trials are warranted to confirm this finding.	[Chang, Tae Ik; Kang, Ea Wha; Lee, Yong Kyu; Shin, Sug Kyun] Ilsan Hosp, NHIC Med Ctr, Dept Internal Med, Goyangshi, Gyeonggi Do, South Korea	NHIS Ilsan Hospital	Shin, SK (corresponding author), Ilsan Hosp, NHIC Med Ctr, Dept Internal Med, Goyangshi, Gyeonggi Do, South Korea.	sskyun@hotmail.com		Lee, Yong Kyu/0000-0002-8262-601X				Balafa O, 2011, CLIN J AM SOC NEPHRO, V6, P561, DOI 10.2215/CJN.05540610; BLUMENKRANTZ MJ, 1981, KIDNEY INT, V19, P593, DOI 10.1038/ki.1981.57; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; Dukkipati R, 2009, SEMIN NEPHROL, V29, P39, DOI 10.1016/j.semnephrol.2008.10.006; Elsurer R, 2009, NEPHROLOGY, V14, P712, DOI 10.1111/j.1440-1797.2009.01103.x; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Han SH, 2012, NAT REV NEPHROL, V8, P163, DOI 10.1038/nrneph.2012.12; Heaf JG, 2005, NEPHROL DIAL TRANSPL, V20, P2194, DOI 10.1093/ndt/gfi008; Johnson DW, 2010, NEPHROL DIAL TRANSPL, V25, P1973, DOI 10.1093/ndt/gfp780; Kathuria P, 1997, PERITON DIALYSIS INT, V17, P449; Kaysen GA, 1998, J AM SOC NEPHROL, V9, P2368; KOPPLE JD, 1994, AM J KIDNEY DIS, V24, P1002, DOI 10.1016/S0272-6386(12)81075-4; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Lee H, 2009, NEPHROLOGY CARLTON, V16, P656; Malone AF, 2010, PERITON DIALYSIS INT, V30, P265, DOI 10.3747/pdi.2010.00002; Margetts PJ, 2000, PERITON DIALYSIS INT, V20, P14; Nakamoto H, 2002, AM J KIDNEY DIS, V40, P1045, DOI 10.1053/ajkd.2002.36343; NOLPH KD, 1993, PERITON DIALYSIS INT, V13, P178; Oh KH, 2010, NEPHROL DIAL TRANSPL, V25, P1639, DOI 10.1093/ndt/gfp670; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Perl J, 2009, CLIN J AM SOC NEPHRO, V4, P1201, DOI 10.2215/CJN.01910309; Rippe B, 1993, Perit Dial Int, V13 Suppl 2, pS35; Rodrigues AS, 2006, NEPHROL DIAL TRANSPL, V21, P763, DOI 10.1093/ndt/gfi245; Rumpsfeld M, 2006, J AM SOC NEPHROL, V17, P271, DOI 10.1681/ASN.2005050566; Sanchez-Villanueva R, 2009, NEPHROL DIAL TRANSPL, V24, P1009, DOI 10.1093/ndt/gfn595; Szeto CC, 2005, PERITON DIALYSIS INT, V25, P445; Van Biesen W, 2006, CLIN J AM SOC NEPHRO, V1, P269, DOI 10.2215/CJN.00820805; Wang T, 1999, PERITON DIALYSIS INT, V19, P17; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Wiggins KJ, 2007, NEPHROL DIAL TRANSPL, V22, P3005, DOI 10.1093/ndt/gfm324; Zoccali C, 2006, KIDNEY INT, V70, P26, DOI 10.1038/sj.ki.5000417	35	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56223	10.1371/journal.pone.0056223	http://dx.doi.org/10.1371/journal.pone.0056223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418538	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300130
J	Christensen, MHE; Apalset, EM; Nordbo, Y; Varhaug, JE; Mellgren, G; Lien, EA				Christensen, Monika H. E.; Apalset, Ellen M.; Nordbo, Yngve; Varhaug, Jan Erik; Mellgren, Gunnar; Lien, Ernst A.			1,25-Dihydroxyvitamin D and the Vitamin D Receptor Gene Polymorphism Apa1 Influence Bone Mineral Density in Primary Hyperparathyroidism	PLOS ONE			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN D; D INSUFFICIENCY; D DEFICIENCY; D REPLETION; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; ASSOCIATION	Objective: Parathyroid hormone (PTH) and vitamin D are the most important hormones regulating calcium metabolism. In primary hyperparathyroidism (PHPT) excessive amounts of PTH are produced. Bone turnover is enhanced, leading to reduced bone mineral density and elevated levels of serum calcium. The aim of this study was to investigate relations between serum levels of 25-hydroxyvitamin D (25(OH)D), 1,25-dihydroxyvitamin D (1,25(OH)(2)D) and bone mineral density, as well as known genetic polymorphisms in the vitamin D receptor and enzymes metabolising vitamin D in patients with PHPT. Design/Subjects: We conducted a cross-sectional study of 52 patients with PHPT. Results: Mean level of 25(OH)D was 58.2 nmol/L and median 1,25(OH)(2)D level was 157 pmol/L. Among our patients with PHPT 36.5% had 25(OH)D levels below 50 nmol/L. Serum 1,25(OH)(2)D was inversely correlated to bone mineral density in distal radius (p = 0.002), but not to bone mineral density at lumbar spine or femoral neck. The vitamin D receptor polymorphism Apa1 (rs7975232) was associated with bone mineral density in the lumbar spine. Conclusions: The results suggest that PHPT patients with high blood concentrations of 1,25(OH)(2)D may have the most deleterious skeletal effects. Randomized, prospective studies are necessary to elucidate whether vitamin D supplementation additionally increases serum 1,25(OH)(2)D and possibly enhances the adverse effects on the skeleton in patients with PHPT.	[Christensen, Monika H. E.; Mellgren, Gunnar; Lien, Ernst A.] Univ Bergen, Inst Med, Bergen, Norway; [Christensen, Monika H. E.; Mellgren, Gunnar; Lien, Ernst A.] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Apalset, Ellen M.] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway; [Apalset, Ellen M.] Univ Bergen, Res Grp Lifestyle Epidemiol, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Nordbo, Yngve; Varhaug, Jan Erik] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Varhaug, Jan Erik] Univ Bergen, Dept Surg Sci, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Christensen, MHE (corresponding author), Univ Bergen, Inst Med, Bergen, Norway.	monika.christensen@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986	Samarbeidsorganet Helse Vest RHF	Samarbeidsorganet Helse Vest RHF	Funding for this project was provided by Samarbeidsorganet Helse Vest RHF (http://helse-bergen.no/forskning/samarbeidsorganet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bischoff-Ferrari HA, 2008, ADV EXP MED BIOL, V624, P55, DOI 10.1007/978-0-387-77574-6_5; BOLLERSLEV J, 1991, BONE, V12, P339, DOI 10.1016/8756-3282(91)90020-J; Bollerslev J, 2007, J CLIN ENDOCR METAB, V92, P1687, DOI 10.1210/jc.2006-1836; Bollerslev J, 2011, EUR J ENDOCRINOL, V165, P851, DOI 10.1530/EJE-11-0589; Boudou P, 2006, J ENDOCRINOL INVEST, V29, P511, DOI 10.1007/BF03344140; Christensen MHE, 2010, SCAND J CLIN LAB INV, V70, P281, DOI 10.3109/00365511003797172; CHRISTIANSEN P, 1993, BONE, V14, P755, DOI 10.1016/8756-3282(93)90207-Q; Dundar U, 2009, CLIN RHEUMATOL, V28, P1187, DOI 10.1007/s10067-009-1220-1; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; FLICKER L, 1995, J BONE MINER RES, V10, P1607; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Goltzman D, 2004, J STEROID BIOCHEM, V89-90, P485, DOI 10.1016/j.jsbmb.2004.03.058; Grey A, 2005, J CLIN ENDOCR METAB, V90, P2122, DOI 10.1210/jc.2004-1772; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Health Canada, 2010, DIETARY REFERENCE IN; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holm PI, 2003, CLIN CHEM, V49, P286, DOI 10.1373/49.2.286; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Jones G, 2011, ARCH BIOCH BIOPHYS; Kantorovich V, 2000, J CLIN ENDOCR METAB, V85, P3541, DOI 10.1210/jc.85.10.3541; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Langsetmo L, 2012, BONE, V50, P401, DOI 10.1016/j.bone.2011.11.009; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 2010, CLIN ENDOCRINOL, V73, P277, DOI 10.1111/j.1365-2265.2009.03701.x; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; Moosgaard B, 2008, CLIN ENDOCRINOL, V68, P707, DOI 10.1111/j.1365-2265.2007.03109.x; Moosgaard B, 2005, CLIN ENDOCRINOL, V63, P506, DOI 10.1111/j.1365-2265.2005.02371.x; MOSEKILDE L, 1989, BONE MINER, V5, P279, DOI 10.1016/0169-6009(89)90006-8; Norman AW, 2002, STEROIDS, V67, P457, DOI 10.1016/S0039-128X(01)00167-2; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos-Lopez E, 2008, DIABETES OBES METAB, V10, P683, DOI 10.1111/j.1463-1326.2008.00879.x; Rao RR, 2012, ENDOCR CONNECT, V1, P13, DOI 10.1530/EC-12-0008; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Russell RGG, 2006, CURR OPIN RHEUMATOL, V18, pS3, DOI 10.1097/01.bor.0000229521.95384.7d; Shen HQ, 2010, ARTERIOSCL THROM VAS, V30, P2648, DOI 10.1161/ATVBAHA.110.211805; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Simon KC, 2011, J NEUROL, V258, P1676, DOI 10.1007/s00415-011-6001-5; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Tashiro K, 2004, MOL CELL ENDOCRINOL, V226, P27, DOI 10.1016/j.mce.2004.07.012; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje; Vestergaard P, 2000, BRIT MED J, V321, P598, DOI 10.1136/bmj.321.7261.598; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0	49	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56019	10.1371/journal.pone.0056019	http://dx.doi.org/10.1371/journal.pone.0056019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418495	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300087
J	de la Riva, GT; Hart, BL; Farver, TB; Oberbauer, AM; Messam, LLM; Willits, N; Hart, LA				de la Riva, Gretel Torres; Hart, Benjamin L.; Farver, Thomas B.; Oberbauer, Anita M.; Messam, Locksley L. McV; Willits, Neil; Hart, Lynette A.			Neutering Dogs: Effects on Joint Disorders and Cancers in Golden Retrievers	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; RISK-FACTORS; MAMMARY-TUMORS; BREED; GONADECTOMY; SEX; AGE; EPIDEMIOLOGY; BONE	In contrast to European countries, the overwhelming majority of dogs in the U.S. are neutered (including spaying), usually done before one year of age. Given the importance of gonadal hormones in growth and development, this cultural contrast invites an analysis of the multiple organ systems that may be adversely affected by neutering. Using a single breed-specific dataset, the objective was to examine the variables of gender and age at the time of neutering versus leaving dogs gonadally intact, on all diseases occurring with sufficient frequency for statistical analyses. Given its popularity and vulnerability to various cancers and joint disorders, the Golden Retriever was chosen for this study. Veterinary hospital records of 759 client-owned, intact and neutered female and male dogs, 1-8 years old, were examined for diagnoses of hip dysplasia (HD), cranial cruciate ligament tear (CCL), lymphosarcoma (LSA), hemangiosarcoma (HSA), and mast cell tumor (MCT). Patients were classified as intact, or neutered early (<12 mo) or late (>= 12 mo). Statistical analyses involved survival analyses and incidence rate comparisons. Outcomes at the 5 percent level of significance are reported. Of early-neutered males, 10 percent were diagnosed with HD, double the occurrence in intact males. There were no cases of CCL diagnosed in intact males or females, but in early-neutered males and females the occurrences were 5 percent and 8 percent, respectively. Almost 10 percent of early-neutered males were diagnosed with LSA, 3 times more than intact males. The percentage of HSA cases in late-neutered females (about 8 percent) was 4 times more than intact and early-neutered females. There were no cases of MCT in intact females, but the occurrence was nearly 6 percent in late-neutered females. The results have health implications for Golden Retriever companion and service dogs, and for oncologists using dogs as models of cancers that occur in humans.	[de la Riva, Gretel Torres; Farver, Thomas B.; Hart, Lynette A.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [Hart, Benjamin L.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA; [Oberbauer, Anita M.] Univ Calif Davis, Coll Agr & Environm Sci, Dept Anim Sci, Davis, CA 95616 USA; [Messam, Locksley L. McV] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Willits, Neil] Univ Calif Davis, Dept Stat, Stat Lab, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hart, BL (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA.	blhart@ucdavis.edu	Fiumefreddo, Andrea/T-2977-2019; Hart, Lynette/L-4833-2019	Hart, Lynette/0000-0002-7133-6535; Messam, Locksley L. McV./0000-0001-5791-555X; hart, benjamin/0000-0003-2342-6058	Canine Health Foundation [01488-A]; Center for Companion 330 Animal Health University of California, Davis [2009-54-F/M]	Canine Health Foundation; Center for Companion 330 Animal Health University of California, Davis(University of California System)	Supported by the Canine Health Foundation (#01488-A) and the Center for Companion 330 Animal Health University of California, Davis (# 2009-54-F/M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauvais W, 2012, J SMALL ANIM PRACT, V53, P314, DOI 10.1111/j.1748-5827.2011.01220.x; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; Diesel G, 2010, VET REC, V166, P455, DOI 10.1136/vr.b4798; Duerr FM, 2007, JAVMA-J AM VET MED A, V231, P1688, DOI 10.2460/javma.231.11.1688; Duval JM, 1999, J AM VET MED ASSOC, V215, P811; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; Glickman LG., 1999, GOLDEN RETRIEVER CLU; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Hart BL, 2001, J AM VET MED ASSOC, V219, P51, DOI 10.2460/javma.2001.219.51; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasstrom H, 1975, Acta Radiol Suppl, V344, P135; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kustritz MVR, 2007, JAVMA-J AM VET MED A, V231, P1665, DOI 10.2460/javma.231.11.1665; PRYMAK C, 1988, J AM VET MED ASSOC, V193, P706; Rothman K., 1998, MODERN EPIDEMIOLOGY; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; Sallander M, 2001, ACTA VET SCAND, V42, P71, DOI 10.1186/1751-0147-42-71; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; Slattery ML, 2001, CANCER RES, V61, P126; Teske E, 2002, MOL CELL ENDOCRINOL, V197, P251, DOI 10.1016/S0303-7207(02)00261-7; Trevejo R, 2011, JAVMA-J AM VET MED A, V238, P898, DOI 10.2460/javma.238.7.898; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Villamil JA, 2009, J CANCER EPIDEMIOL, V2009, DOI [10.1155/2009/591753, 10.1155/2009/747803]; Ware WA, 1999, J VET INTERN MED, V13, P95, DOI 10.1892/0891-6640(1999)013&lt;0095:CTID&gt;2.3.CO;2; White CR, 2011, J AM ANIM HOSP ASSOC, V47, P210, DOI 10.5326/JAAHA-MS-5621; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Zatloukal J, 2005, ACTA VET BRNO, V74, P103, DOI 10.2754/avb200574010103	28	101	101	1	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55937	10.1371/journal.pone.0055937	http://dx.doi.org/10.1371/journal.pone.0055937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418479	Green Published, gold			2022-12-25	WOS:000315970300071
J	Solimini, AG				Solimini, Angelo G.			Are There Side Effects to Watching 3D Movies? A Prospective Crossover Observational Study on Visually Induced Motion Sickness	PLOS ONE			English	Article							SYMPTOMS; ADAPTATION; DISCOMFORT; VECTION; VISION; IMAGES	Background: The increasing popularity of commercial movies showing three dimensional (3D) images has raised concern about possible adverse side effects on viewers. Methods and Findings: A prospective carryover observational study was designed to assess the effect of exposure (3D vs. 2D movie views) on self reported symptoms of visually induced motion sickness. The standardized Simulator Sickness Questionnaire (SSQ) was self administered on a convenience sample of 497 healthy adult volunteers before and after the vision of 2D and 3D movies. Viewers reporting some sickness (SSQ total score>15) were 54.8% of the total sample after the 3D movie compared to 14.1% of total sample after the 2D movie. Symptom intensity was 8.8 times higher than baseline after exposure to 3D movie (compared to the increase of 2 times the baseline after the 2D movie). Multivariate modeling of visually induced motion sickness as response variables pointed out the significant effects of exposure to 3D movie, history of car sickness and headache, after adjusting for gender, age, self reported anxiety level, attention to the movie and show time. Conclusions: Seeing 3D movies can increase rating of symptoms of nausea, oculomotor and disorientation, especially in women with susceptible visual-vestibular system. Confirmatory studies which include examination of clinical signs on viewers are needed to pursue a conclusive evidence on the 3D vision effects on spectators.	Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy	Sapienza University Rome	Solimini, AG (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.	angelo.solimini@uniroma1.it	Solimini, Angelo G/C-9290-2018	Solimini, Angelo/0000-0002-5281-7624	Sapienza University	Sapienza University	This work has been funded with internal Sapienza University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmericanOptometricAssociation, 2011, CAR PAT ACC VERG DYS; Ames SL, 2005, OPTOMETRY VISION SCI, V82, P168, DOI 10.1097/01.OPX.0000156307.95086.6; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; Bos JE, 2011, DISPLAYS, V32, P189, DOI 10.1016/j.displa.2010.09.005; CUTRER FM, 1992, HEADACHE, V32, P300, DOI 10.1111/j.1526-4610.1992.hed3206300.x; Diels C, 2011, DISPLAYS, V32, P175, DOI 10.1016/j.displa.2011.02.005; Emoto M, 2008, DISPLAYS, V29, P90, DOI 10.1016/j.displa.2007.09.010; Emoto M, 2005, J DISP TECHNOL, V1, P328, DOI 10.1109/JDT.2005.858938; Flanagan MB, 2005, AVIAT SPACE ENVIR MD, V76, P642; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Hakkinen J, 2010, PROC SPIE, V7524, DOI 10.1117/12.838857; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Howarth PA, 2008, DISPLAYS, V29, P45, DOI 10.1016/j.displa.2007.09.012; Howarth PA, 1997, DISPLAYS, V18, P107, DOI 10.1016/S0141-9382(97)00011-5; Ijsselsteijn W, 1998, DISPLAYS, V18, P207, DOI 10.1016/S0141-9382(98)00022-5; Kennedy RS, 2010, APPL ERGON, V41, P494, DOI 10.1016/j.apergo.2009.11.006; Kennedy RS., 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; KURITZKY A, 1981, HEADACHE, V21, P227, DOI 10.1111/j.1526-4610.1981.hed2105227.x; Kuze J, 2008, DISPLAYS, V29, P159, DOI 10.1016/j.displa.2007.09.007; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; Maino D, 2011, REV OPTOMETRY, V148, P54; Maino DM, 2011, REV OPTOMETRY, V148, P28; Palmisano S, 2002, PERCEPTION, V31, P463, DOI 10.1068/p3321; Polonen M, 2009, J SOC INF DISPLAY, V17, P459, DOI 10.1889/JSID17.5.459; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Shibata T, 2011, J VISION, V11, DOI 10.1167/11.8.11; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; Solimini AG, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-779; Turner M, 1999, BRIT J PSYCHOL, V90, P519, DOI 10.1348/000712699161594; Ujike H, 2004, P ANN INT IEEE EMBS, V26, P2399; Ujike H, 2008, DISPLAYS, V29, P81, DOI 10.1016/j.displa.2007.09.003; Ukai K, 2008, DISPLAYS, V29, P106, DOI 10.1016/j.displa.2007.09.004; van Emmerik ML, 2011, DISPLAYS, V32, P169, DOI 10.1016/j.displa.2010.11.003; Wann JP, 2002, HUM FAC ER, P731; Webb NA, 2003, AVIAT SPACE ENVIR MD, V74, P622; Wilkins A.J., 1995, VISUAL STRESS; Wilkins AJ, 2010, APPL ERGON, V41, P509, DOI 10.1016/j.apergo.2009.01.011; Yano S, 2004, DISPLAYS, V25, P141, DOI 10.1016/j.displa.2004.09.002	42	65	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56160	10.1371/journal.pone.0056160	http://dx.doi.org/10.1371/journal.pone.0056160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418530	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300122
J	Yang, XK; Wang, QX; Gao, ZY; Zhou, Z; Peng, S; Chang, WL; Lin, HY; Zhang, WY; Wang, HM				Yang, Xiaokui; Wang, Qingxin; Gao, Zhiying; Zhou, Zhi; Peng, Sha; Chang, Wen-Lin; Lin, Hai-Yan; Zhang, Weiyuan; Wang, Hongmei			Proprotein Convertase Furin Regulates Apoptosis and Proliferation of Granulosa Cells in the Rat Ovary	PLOS ONE			English	Article							LINE IN-VITRO; FOLLICLE DEVELOPMENT; SECRETORY PATHWAY; PROTEASE PC4; CANCER CELLS; EXPRESSION; GROWTH; MICE; OOCYTE; PROGRESSION	Folliculogenesis is tightly controlled by a series of hormones, growth factors and cytokines, many of which are secreted as proproteins and require processing by proteases before becoming functional. Furin is a member of the subtilisin-like proteases that activate large numbers of proprotein substrates and is ubiquitously expressed and implicated in many physiological and pathological processes. However, the precise role of furin during folliculogenesis has not been thoroughly investigated. The goal of the present work is to identify the role of furin in the development of granulosa cells during folliculogenesis, using immunohistochemistry, RT-PCR, Western blot and functional studies in primary cultured rat granulosa cells. Our results demonstrate that furin is highly expressed in granulosa cells and oocytes of the ovary with very limited expression in other ovarian cells such as the epithelial, stromal or theca cells. Furin siRNA significantly increases apoptosis of the granulosa cells from large antral/preovulatory follicles, in part via downregulation of the anti-apoptotic proteins, XIAP and p-AKT. On the contrary, furin siRNA markedly decreases proliferation of granulosa cells based on the downregulation of proliferation cell nuclear antigen (PCNA). Taken together, these data suggest that furin may play an important role in regulating apoptosis and proliferation of granulosa cells.	[Yang, Xiaokui; Wang, Qingxin; Peng, Sha; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Human Reprod Med, Beijing, Peoples R China; [Wang, Qingxin; Zhou, Zhi; Chang, Wen-Lin; Lin, Hai-Yan; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Gao, Zhiying] Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Zhou, Zhi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, WY (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Human Reprod Med, Beijing, Peoples R China.	zhangwy9921@hotmail.com; wanghm@ioz.ac.cn			Natural Science Foundation of China [30872746, 30971088]; Natural Science Foundation of Beijing [7082034]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by funding from the Natural Science Foundation of China (30872746) and Natural Science Foundation of Beijing (7082034) to XKY, and a grant from Natural Science Foundation of China (30971088) to HMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JMJ, 2010, REPROD DOMEST ANIM, V45, P171, DOI 10.1111/j.1439-0531.2008.01302.x; Aerts JMJ, 2010, REPROD DOMEST ANIM, V45, P180, DOI 10.1111/j.1439-0531.2008.01298.x; Antenos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017348; Antenos M, 2008, J BIOL CHEM, V283, P33059, DOI 10.1074/jbc.M804190200; Bae JA, 2008, MOL CELL ENDOCRINOL, V289, P29, DOI 10.1016/j.mce.2008.04.006; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Buratini J, 2011, REPROD FERT DEVELOP, V23, P32, DOI 10.1071/RD10224; Carabatsos MJ, 1998, DEV BIOL, V204, P373, DOI 10.1006/dbio.1998.9087; de Cicco RL, 2005, CANCER RES, V65, P4162, DOI 10.1158/0008-5472.CAN-04-2820; Diaz FJ, 2008, BIOL REPROD, V78, P176, DOI 10.1095/biolreprod.107.063537; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Gosden RG, 1998, REPROD FERT DEVELOP, V10, P73, DOI 10.1071/R98043; Gougeon A, 2010, ANN ENDOCRINOL-PARIS, V71, P132, DOI 10.1016/j.ando.2010.02.021; Gyamera-Acheampong C, 2006, BIOL REPROD, V74, P666, DOI 10.1095/biolreprod.105.046821; Homburg R, 1998, J ENDOCRINOL INVEST, V21, P552, DOI 10.1007/BF03350780; Jin Xuan, 2011, Front Biosci (Schol Ed), V3, P680, DOI 10.2741/s180; Kelty BP, 2010, BIOL REPROD, V83, P147, DOI 10.1095/biolreprod.109.079947; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; Miao S, 2011, INT J MOL SCI, V12, P3831, DOI 10.3390/ijms12063831; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Ogiwara K, 2004, J EXP ZOOL PART A, V301A, P449, DOI 10.1002/jez.a.20071; Page RE, 2007, CELL ONCOL, V29, P289; Sasanami T, 2003, BIOL REPROD, V68, P1613, DOI 10.1095/biolreprod.102.011841; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Tadros H, 2001, J REPROD IMMUNOL, V49, P133, DOI 10.1016/S0165-0378(00)00085-1; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Wang H, 2006, MOL ENDOCRINOL, V20, P2469, DOI 10.1210/me.2005-0446; Webber LJ, 2007, J CLIN ENDOCR METAB, V92, P1975, DOI 10.1210/jc.2006-1422; Wunsch A, 2007, ANN ENDOCRINOL-PARIS, V68, P160, DOI 10.1016/j.ando.2007.04.006; Xu QA, 2011, J ZHEJIANG UNIV-SC B, V12, P247, DOI 10.1631/jzus.B1000373; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou Z, 2009, PLACENTA, V30, P929, DOI 10.1016/j.placenta.2009.09.003	44	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e50479	10.1371/journal.pone.0050479	http://dx.doi.org/10.1371/journal.pone.0050479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418414	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300004
J	Ma, SH; Richardson, JA; Bitmansour, A; Solberg, TD; Pidikiti, R; Song, K; Stojadinovic, S; Vitetta, ES; Meyer, JJ				Ma, Shihong; Richardson, James A.; Bitmansour, Andrew; Solberg, Timothy D.; Pidikiti, Rajesh; Song, Kwang; Stojadinovic, Strahinja; Vitetta, Ellen S.; Meyer, Jeffrey J.			Partial Depletion of Regulatory T Cells Does Not Influence the Inflammation Caused by High Dose Hemi-Body Irradiation	PLOS ONE			English	Article							ANTITUMOR IMMUNITY; RADIATION-THERAPY; ENHANCEMENT; CANCER; TUMORS; STRATEGIES; SYSTEM; BLOOD	There is clinical interest in the modulation of regulatory T cells for cancer therapy. The safety of these therapies in combination with conventional anti-cancer therapies, including radiation therapy, can be studied in animal models. The effects of partial depletion of regulatory T (Treg) cells with an anti-CD25 antibody in conjunction with ionizing radiation on inflammation and tissue injury were analyzed in C57BL/6 mice. An anti-CD25 antibody (PC61) was administered 3 days prior to 13 Gy lower-half hemi-body irradiation (HBI). The blood, spleen, mesenteric lymph nodes (mLNs) and inguinal lymph nodes (iLNs) were harvested at various times thereafter. Alterations in the proportion of leukocyte subsets including CD4(+) T cells, CD8(+) T cells, Treg cells, B cells, NK cells, NK1.1(+) T cells, macrophages and granulocytes were analyzed by FACS. The lungs, liver, pancreas, stomach, jejunum, duodenum, ileum, colon and kidney were harvested and studied by H&E staining. Expression of inflammatory mediators in plasma and tissue were investigated by ELISA. HBI significantly decreased the leukocyte pool though the various leukocyte subsets had different sensitivities to HBI. The administration of PC61 significantly decreased the proportion of Treg cells in spleen, iLN, mLN and blood (reduction of approximately 60%). Irradiation significantly increased the proportion of Treg cells in the spleen, iLN and mLN. HBI induced a systemic inflammatory reaction as demonstrated by increased plasma levels of IL-6, KC/CXCL1 and circulating granulocytes in the blood. Neutrophils also infiltrated the small bowel. The same general patterns were observed whether or not Treg cells were partially depleted with PC61 prior to HBI. These data demonstrate that partial depletion of Treg cells in these mice does not influence HBI-induced inflammatory response and tissue injury, and that combining anti-CD25 therapy with radiation may be safe and well tolerated in a clinical setting.	[Ma, Shihong; Solberg, Timothy D.; Pidikiti, Rajesh; Song, Kwang; Stojadinovic, Strahinja; Meyer, Jeffrey J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Ma, Shihong; Bitmansour, Andrew; Vitetta, Ellen S.] Univ Texas SW Med Ctr Dallas, Canc Immunobiol Cente, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Vitetta, Ellen S.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Vitetta, Ellen S.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Meyer, JJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	Jeffrey.Meyer@UTSouthwestern.edu	Stojadinovic, Strahinja/R-3818-2019; Ma, Shihong/E-1111-2015; Pidikiti, Rajesh/E-2686-2013	Stojadinovic, Strahinja/0000-0002-6840-5747; Solberg, Timothy/0000-0001-8829-7774	Horchow Foundation; Department of Radiation Oncology; Cancer Immunobiology Center, University of Texas Southwestern Medical Center	Horchow Foundation; Department of Radiation Oncology; Cancer Immunobiology Center, University of Texas Southwestern Medical Center	The work was supported by The Horchow Foundation, the Department of Radiation Oncology and the Cancer Immunobiology Center, University of Texas Southwestern Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billiard F, 2011, INT J RADIAT ONCOL, V80, P869, DOI 10.1016/j.ijrobp.2010.12.041; Carrigan SO, 2009, IMMUNOBIOLOGY, V214, P211, DOI 10.1016/j.imbio.2008.07.027; Chambers KA, 1998, CYTOMETRY, V31, P45, DOI 10.1002/(SICI)1097-0320(19980101)31:1<45::AID-CYTO6>3.0.CO;2-I; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Gridley DS, 2002, AM J PHYSIOL-REG I, V282, pR677, DOI 10.1152/ajpregu.00435.2001; JANKOVIC DL, 1990, J IMMUNOL, V145, P4136; Kachikwu EL, 2011, INT J RADIAT ONCOL, V81, P1128, DOI 10.1016/j.ijrobp.2010.09.034; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; Lee H, 2010, KIDNEY INT, V78, P1100, DOI 10.1038/ki.2010.139; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Li JL, 2003, CANCER RES, V63, P8384; Liu RJ, 2010, CELL MOL IMMUNOL, V7, P157, DOI 10.1038/cmi.2009.117; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Moyer JS, 2008, J IMMUNOTHER, V31, P885, DOI 10.1097/CJI.0b013e3181880f1e; Nesslinger NJ, 2007, CLIN CANCER RES, V13, P1493, DOI 10.1158/1078-0432.CCR-06-1772; Ni Choileain N, 2006, J IMMUNOL, V176, P225; Paganetti H. Y. T., 2011, HUMAN RAD INJURY, P114; Pidikiti R, 2011, PHYS MED BIOL, V56, P2585, DOI 10.1088/0031-9155/56/8/016; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1572, DOI 10.1200/JCO.2008.19.6329; Sharp HJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4900, DOI 10.2741/2436; Song KH, 2010, PHYS MED BIOL, V55, P7345, DOI 10.1088/0031-9155/55/23/011; Teitz-Tennenbaum S, 2008, J IMMUNOTHER, V31, P345, DOI 10.1097/CJI.0b013e318163628c; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Woo EY, 2001, CANCER RES, V61, P4766	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56607	10.1371/journal.pone.0056607	http://dx.doi.org/10.1371/journal.pone.0056607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409194	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000059
J	Perganta, G; Barnard, AR; Katti, C; Vachtsevanos, A; Douglas, RH; MacLaren, RE; Votruba, M; Sekaran, S				Perganta, Georgia; Barnard, Alun R.; Katti, Christiana; Vachtsevanos, Athanasios; Douglas, Ron H.; MacLaren, Robert E.; Votruba, Marcela; Sekaran, Sumathi			Non-Image-Forming Light Driven Functions Are Preserved in a Mouse Model of Autosomal Dominant Optic Atrophy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CYCLASE-ACTIVATING POLYPEPTIDE; MASKING RESPONSES; OPA1 DEFICIENCY; MELANOPSIN; SLEEP; NERVE; PROJECTIONS; FEATURES; REVEALS	Autosomal dominant optic atrophy (ADOA) is a slowly progressive optic neuropathy that has been associated with mutations of the OPA1 gene. In patients, the disease primarily affects the retinal ganglion cells (RGCs) and causes optic nerve atrophy and visual loss. A subset of RGCs are intrinsically photosensitive, express the photopigment melanopsin and drive non-image-forming (NIF) visual functions including light driven circadian and sleep behaviours and the pupil light reflex. Given the RGC pathology in ADOA, disruption of NIF functions might be predicted. Interestingly in ADOA patients the pupil light reflex was preserved, although NIF behavioural outputs were not examined. The B6; C3-Opa1(Q285STOP) mouse model of ADOA displays optic nerve abnormalities, RGC dendropathy and functional visual disruption. We performed a comprehensive assessment of light driven NIF functions in this mouse model using wheel running activity monitoring, videotracking and pupillometry. Opa1 mutant mice entrained their activity rhythm to the external light/dark cycle, suppressed their activity in response to acute light exposure at night, generated circadian phase shift responses to 480 nm and 525 nm pulses, demonstrated immobility-defined sleep induction following exposure to a brief light pulse at night and exhibited an intensity dependent pupil light reflex. There were no significant differences in any parameter tested relative to wildtype littermate controls. Furthermore, there was no significant difference in the number of melanopsin-expressing RGCs, cell morphology or melanopsin transcript levels between genotypes. Taken together, these findings suggest the preservation of NIF functions in Opa1 mutants. The results provide support to growing evidence that the melanopsin-expressing RGCs are protected in mitochondrial optic neuropathies.	[Perganta, Georgia; Barnard, Alun R.; Katti, Christiana; Vachtsevanos, Athanasios; MacLaren, Robert E.; Sekaran, Sumathi] Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford OX2 6AW, England; [Douglas, Ron H.] City Univ London, London EC1V 0HB, England; [MacLaren, Robert E.] Moorfields Eye Hosp NHS Fdn Trust, London, England; [MacLaren, Robert E.] NIHR Biomed Res Ctr, London, England; [Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales	University of Oxford; City University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Cardiff University	Sekaran, S (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Walton St, Oxford OX2 6AW, England.	sumathi.sekaran@eye.ox.ac.uk	Votruba, Marcela/B-7306-2015; Votruba, Marcela/A-6182-2011	Votruba, Marcela/0000-0002-7680-9135; Votruba, Marcela/0000-0002-7680-9135; MacLaren, Robert/0000-0002-3096-4682	Biotechnology and Biological Sciences Research Council [BB/G003602/1]; Wellcome Trust [090684, 091984]; Royal College of Surgeons of Edinburgh; Health Foundation; Oxford NIHR Biomedical Research Centre; BBSRC [BB/G003602/1] Funding Source: UKRI; MRC [G0500790, G108/523, G0700949] Funding Source: UKRI; Medical Research Council [G108/523, G0500790, G0700949] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal College of Surgeons of Edinburgh; Health Foundation; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BB/G003602/1 to SS), the Wellcome Trust (090684 to SS; 091984 to REM), the Royal College of Surgeons of Edinburgh (ARB), the Health Foundation (REM, GP, AV), and the Oxford NIHR Biomedical Research Centre (REM, ARB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Barnard AR, 2011, EXP EYE RES, V93, P771, DOI 10.1016/j.exer.2011.07.004; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Benca RM, 1998, SLEEP, V21, P451, DOI 10.1093/sleep/21.5.451; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bremner FD, 2001, INVEST OPHTH VIS SCI, V42, P675; Bremner FD, 1999, INVEST OPHTH VIS SCI, V40, P2528; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606; JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8; Kawasaki A, 2010, CLIN EXP OPHTHALMOL, V38, P322, DOI 10.1111/j.1442-9071.2010.02212.x; KJER P, 1959, Acta Ophthalmol Suppl, V164, P1; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; KLINE LB, 1979, ARCH OPHTHALMOL-CHIC, V97, P1680, DOI 10.1001/archopht.1979.01020020248013; La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Seki T, 2006, ANN NY ACAD SCI, V1070, P531, DOI 10.1196/annals.1317.074; Seki T, 2011, J MOL NEUROSCI, V43, P30, DOI 10.1007/s12031-010-9410-5; Tamas A, 2004, NEUROSCI LETT, V372, P110, DOI 10.1016/j.neulet.2004.09.021; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351; WAKAKURA M, 1995, BRIT J OPHTHALMOL, V79, P442, DOI 10.1136/bjo.79.5.442; White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913; Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	50	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56350	10.1371/journal.pone.0056350	http://dx.doi.org/10.1371/journal.pone.0056350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409176	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000315100000049
J	Shimizu, A; Kobayashi, N; Shimada, K; Oura, K; Tanaka, T; Okamoto, A; Kondo, K				Shimizu, Akihiro; Kobayashi, Nobuyuki; Shimada, Kazuya; Oura, Kuniaki; Tanaka, Tadao; Okamoto, Aikou; Kondo, Kazuhiro			Novel Gene Therapy Viral Vector Using Non-Oncogenic Lymphotropic Herpesvirus	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; SHORT-INTERFERING RNAS; MAMMALIAN-CELLS; CHROMOSOMAL INTEGRATION; HUMAN CYTOMEGALOVIRUS; TARGETED INTEGRATION; TYPE-1 REPLICATION; PACKAGING CAPACITY; CODING CONTENT; IN-VITRO	Despite the use of retroviral vectors, efficiently introducing target genes into immunocytes such as T cells is difficult. In addition, retroviral vectors carry risks associated with the oncogenicity of the native virus and the potential for introducing malignancy in recipients due to genetic carryover from immortalized cells used during vector production. To address these issues, we have established a new virus vector that is based on human herpesvirus 6 (HHV-6), a non-oncogenic lymphotropic herpesvirus that infects CD4(+) T cells, macrophages, and dendritic cells. In the present study, we have altered the cell specificity of the resulting recombinant HHV-6 by knocking out the U2-U8 genes. The resulting virus proliferated only in activated cord blood cells and not in peripheral blood cells. Umbilical cord blood cells produced replication-defective recombinant virus in sufficiently high titer to omit the use of immortalized cells during vector production. HHV-6 vectors led to high rates (>90%) of gene transduction in both CD4(+) and CD8(+) T cells. These viruses showed low-level replication of viral DNA that supported greater expression of the induced genes than that of other methods but that was insufficient to support the production of replication-competent virus. Furthermore, HHV-6 vectors containing short hairpin RNAs against CD4 and HIV Gag remarkably inhibited the production of these proteins and HIV particles. Here we demonstrate the utility of HHV-6 as a new non-carcinogenic viral vector for immunologic diseases and immunotherapy.	[Shimizu, Akihiro; Kobayashi, Nobuyuki; Shimada, Kazuya; Kondo, Kazuhiro] Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan; [Oura, Kuniaki; Tanaka, Tadao; Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan	Jikei University; Jikei University	Kondo, K (corresponding author), Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan.	kkondo@jikei.ac.jp	Kobayashi, Nobuyuki/AAS-9795-2021	Kobayashi, Nobuyuki/0000-0001-8627-515X; dao tian, he ye/0000-0003-1471-8067	Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants from the Japanese Ministry of Health, Labor and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], FIELDS VIROLOGY; Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; BERNEMAN ZN, 1992, P NATL ACAD SCI USA, V89, P10552, DOI 10.1073/pnas.89.21.10552; BERNHEIM JL, 1977, P NATL ACAD SCI USA, V74, P2536, DOI 10.1073/pnas.74.6.2536; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CARRIGAN DR, 1990, J INFECT DIS, V162, P844, DOI 10.1093/infdis/162.4.844; Daibata M, 1999, BLOOD, V94, P1545, DOI 10.1182/blood.V94.5.1545.417a25_1545_1549; Dhepakson P, 2002, J GEN VIROL, V83, P847, DOI 10.1099/0022-1317-83-4-847; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; EFSTATHIOU S, 1992, J GEN VIROL, V73, P1661, DOI 10.1099/0022-1317-73-7-1661; Fan H, 2011, VIRUSES-BASEL, V3, P398, DOI 10.3390/v3040398; Gama-Norton L, 2011, HUM GENE THER, V22, P1269, DOI 10.1089/hum.2010.143; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; GRASSMANN R, 1989, J VIROL, V63, P1818, DOI 10.1128/JVI.63.4.1818-1821.1989; Hanson LK, 2009, J VIROL, V83, P7449, DOI 10.1128/JVI.00325-09; Hermonat PL, 1997, FEBS LETT, V407, P78, DOI 10.1016/S0014-5793(97)00311-6; Isegawa Y, 1999, J VIROL, V73, P8053, DOI 10.1128/JVI.73.10.8053-8063.1999; Kondo K, 2003, J VIROL, V77, P10719, DOI 10.1128/JVI.77.19.10719-10724.2003; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Lilja AE, 2008, J VIROL, V82, P2170, DOI 10.1128/JVI.02316-07; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; LUSSO P, 1988, J EXP MED, V167, P1659, DOI 10.1084/jem.167.5.1659; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Miyagishi M, 2003, OLIGONUCLEOTIDES, V13, P325, DOI 10.1089/154545703322617005; Mocarski ES, 1996, INTERVIROLOGY, V39, P320, DOI 10.1159/000150503; Mori Y, 2000, J VIROL, V74, P6096, DOI 10.1128/JVI.74.13.6096-6104.2000; Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10; OKUNO T, 1990, VIROLOGY, V176, P625, DOI 10.1016/0042-6822(90)90033-N; OKUNO T, 1992, J GEN VIROL, V73, P443, DOI 10.1099/0022-1317-73-2-443; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Robertson ES, 1996, P NATL ACAD SCI USA, V93, P11334, DOI 10.1073/pnas.93.21.11334; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SHELLING AN, 1994, GENE THER, V1, P165; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; TAKAHASHI K, 1989, J VIROL, V63, P3161, DOI 10.1128/JVI.63.7.3161-3163.1989; Takeda K, 1997, J GEN VIROL, V78, P2171, DOI 10.1099/0022-1317-78-9-2171; Tatalick LM, 2005, VACCINE, V23, P2628, DOI 10.1016/j.vaccine.2004.11.027; TORELLI G, 1995, J MED VIROL, V46, P178, DOI 10.1002/jmv.1890460303; YAMANISHI K, 1988, LANCET, V1, P1065; YAMANISHI K, 2007, FIELDS VIROLOGY, P2819; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; ZHOU SZ, 1994, J EXP MED, V179, P1867, DOI 10.1084/jem.179.6.1867; Zou P, 1999, J VIROL, V73, P5926, DOI 10.1128/JVI.73.7.5926-5933.1999	49	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56027	10.1371/journal.pone.0056027	http://dx.doi.org/10.1371/journal.pone.0056027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409116	Green Published, gold, Green Submitted			2022-12-25	WOS:000315100000042
J	Tamokou, JD; Chouna, JR; Fischer-Fodor, E; Chereches, G; Barbos, O; Damian, G; Benedec, D; Duma, M; Efouet, APN; Wabo, HK; Kuiate, JR; Mot, A; Silaghi-Dumitrescu, R				Tamokou, Jean de Dieu; Chouna, Jean Rodolphe; Fischer-Fodor, Eva; Chereches, Gabriela; Barbos, Otilia; Damian, Grigore; Benedec, Daniela; Duma, Mihaela; Efouet, Alango Pepin Nkeng; Wabo, Hippolyte Kamdem; Kuiate, Jules Roger; Mot, Augustin; Silaghi-Dumitrescu, Radu			Anticancer and Antimicrobial Activities of Some Antioxidant-Rich Cameroonian Medicinal Plants	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; INDUCED APOPTOSIS; ANTILEUKEMIC XANTHONE; IN-VITRO; EXTRACTS; PSOROSPERMUM; PROLIFERATION; CONSTITUENTS; ASSAY; PEROXIDASE	Traditional remedies have a long-standing history in Cameroon and continue to provide useful and applicable tools for treating ailments. Here, the anticancer, antimicrobial and antioxidant activities of ten antioxidant-rich Cameroonian medicinal plants and of some of their isolated compounds are evaluated. The plant extracts were prepared by maceration in organic solvents. Fractionation of plant extract was performed by column chromatography and the structures of isolated compounds (emodin, 3-geranyloxyemodin, 2-geranylemodin) were confirmed spectroscopically. The antioxidant activity (AOA) was determined using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) bleaching method, the trolox equivalent antioxidant capacity (TEAC), and the hemoglobin ascorbate peroxidase activity inhibition (HAPX) assays. The anticancer activity was evaluated against A431 squamous epidermal carcinoma, WM35 melanoma, A2780 ovary carcinoma and cisplatin-resistant A2780cis cells, using a direct colorimetric assay. The total phenolic content in the extracts was determined spectrophotometrically by the Folin-Ciocalteu method. Rumex abyssinicus showed the best AOA among the three assays employed. The AOA of emodin was significantly higher than that of 3-geranyloxyemodin and 2-geranylemodin for both TEAC and HAPX methods. The lowest IC50 values (i.e., highest cytotoxicity) were found for the extracts of Vismia laurentii, Psorospermum febrifugum, Pentadesma butyracea and Ficus asperifolia. The Ficus asperifolia and Psorospermum febrifugum extracts are selective against A2780cis ovary cells, a cell line which is resistant to the standard anticancer drug cisplatin. Emodin is more toxic compared to the whole extract, 3-geranyloxyemodin and 2-geranylemodin. Its selectivity against the platinum-resistant A2780cis cell line is highest. All of the extracts display antimicrobial activity, in some cases comparable to that of gentamycin.	[Tamokou, Jean de Dieu; Chouna, Jean Rodolphe; Mot, Augustin; Silaghi-Dumitrescu, Radu] Univ Babes Bolyai, Dept Chem & Chem Engn, R-3400 Cluj Napoca, Romania; [Fischer-Fodor, Eva; Chereches, Gabriela; Barbos, Otilia] I Chiricuta Oncol Inst, Tumor Biol Lab, Cluj Napoca, Romania; [Damian, Grigore] Univ Babes Bolyai, Dept Phys, R-3400 Cluj Napoca, Romania; [Benedec, Daniela] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Cluj Napoca, Romania; [Duma, Mihaela] State Vet Lab Anim Hlth & Safety, Cluj Napoca, Romania; [Tamokou, Jean de Dieu; Kuiate, Jules Roger] Univ Dschang, Dept Biochem, Dschang, Cameroon; [Chouna, Jean Rodolphe; Efouet, Alango Pepin Nkeng; Wabo, Hippolyte Kamdem] Univ Dschang, Dept Chem, Dschang, Cameroon	Babes Bolyai University from Cluj; Oncology Institute Prof. Dr. Ion Chiricuta; Babes Bolyai University from Cluj; Iuliu Hatieganu University of Medicine & Pharmacy	Mot, A (corresponding author), Univ Babes Bolyai, Dept Chem & Chem Engn, R-3400 Cluj Napoca, Romania.	augustinmot@chem.ubbcluj.ro; rsilaghi@chem.ubbcluj.ro	Silaghi-Dumitrescu, Radu/A-2883-2008; Mot, Augustin C./D-3017-2011; Mot, Augustin/AAP-4356-2021; DAMIAN, Grigore/B-6010-2011; Fischer-Fodor, Eva/C-4506-2011	Silaghi-Dumitrescu, Radu/0000-0003-3038-7747; Mot, Augustin C./0000-0002-1679-0487; Mot, Augustin/0000-0002-1679-0487; DAMIAN, Grigore/0000-0003-4127-8140; Fischer-Fodor, Eva/0000-0002-0898-0547; TAMOKOU, Jean de Dieu/0000-0002-8088-463X	Agence Universitaire de la Francophonie (AUF); Romanian Ministry of Education and Research; Romanian Ministry for Education and Research [PCCE 140/2008, POSDRU/88/1.5/S/60185]	Agence Universitaire de la Francophonie (AUF); Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); Romanian Ministry for Education and Research(Ministry of Education and Research - Romania)	JDT acknowledges funding from the Agence Universitaire de la Francophonie (AUF) and the Romanian Ministry of Education and Research through their Eugen-Ionescu fellowship grant. Also acknowledged is funding from the Romanian Ministry for Education and Research grant PCCE 140/2008 (to RSD and EFF) and a PhD scholarship from Contract POSDRU/88/1.5/S/60185-"Innovative doctoral studies in a knowledge based society'' (to ACM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbiw D., 1990, USEFUL PLANTS GHANA, P182; Annan K, 2008, J ETHNOPHARMACOL, V119, P141, DOI 10.1016/j.jep.2008.06.017; Annan K, 2010, J PHARM PHARMACOL, V62, P663, DOI 10.1211/jpp.62.05.0016; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Bamps P, 1966, JARD BOT N AT BRUXEL, V36, P315; BEHRENS BC, 1987, CANCER RES, V47, P414; BOTTA B, 1985, PHYTOCHEMISTRY, V24, P827, DOI 10.1016/S0031-9422(00)84902-X; BOTTA B, 1983, PHYTOCHEMISTRY, V22, P539, DOI 10.1016/0031-9422(83)83041-6; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cooper CE, 2008, BBA-PROTEINS PROTEOM, V1784, P1415, DOI 10.1016/j.bbapap.2008.03.019; Cos P, 2002, PHYTOMEDICINE, V9, P62, DOI 10.1078/0944-7113-00083; Fankam AG, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-104; Foyet HS, 2011, J ETHNOPHARMACOL, V133, P773, DOI 10.1016/j.jep.2010.11.011; Getie M, 2003, FITOTERAPIA, V74, P139, DOI 10.1016/S0367-326X(02)00315-5; Hritcu L, 2011, J ETHNOPHARMACOL, V137, P585, DOI 10.1016/j.jep.2011.06.008; ISO, 2005, 145021 ISO; Jagetia GC, 2004, J MED FOOD, V7, P343, DOI 10.1089/jmf.2004.7.343; Jimoh FO, 2007, J MED FOOD, V10, P707, DOI 10.1089/jmf.2006.253; Karasic TB, 2010, EXP CELL RES, V316, P1994, DOI 10.1016/j.yexcr.2010.04.014; Kerharo J., 1974, PHARMACOPEE SENEGALA; Khan RM, 1999, PHYTOCHEMISTRY, V50, P439, DOI 10.1016/S0031-9422(98)00478-6; Khare C., 2007, INDIAN MED PLANTS AN; Kisangau DP, 2007, AFR J TRADIT COMPLEM, V4, P510; Kofi A, 2009, PHARMACOGN MAG, V5, P119; KOUDOU J, 1994, PLANTA MED, V60, P96, DOI 10.1055/s-2006-959422; Koyama J, 2008, BIOORG MED CHEM LETT, V18, P4106, DOI 10.1016/j.bmcl.2008.05.109; Krishna M.S., 2010, INT J PHARM SCI DRUG, V2, P155; Kuete V, 2007, J ETHNOPHARMACOL, V109, P372, DOI 10.1016/j.jep.2006.07.044; Kuete V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021762; KUPCHAN SM, 1980, J NAT PROD, V43, P296, DOI 10.1021/np50008a010; Lacret R, 2011, J CHEM ECOL, V37, P1341, DOI 10.1007/s10886-011-0048-8; Lad L, 2002, EUR J BIOCHEM, V269, P3182, DOI 10.1046/j.1432-1033.2002.02998.x; Lazar-Molnar E, 2002, EUR J CLIN INVEST, V32, P743, DOI 10.1046/j.1365-2362.2002.01020.x; Lenta BN, 2011, PLANTA MED, V77, P377, DOI 10.1055/s-0030-1250384; Li J, 2009, ONCOL REP, V21, P1605, DOI 10.3892/or_00000394; Liu DL, 2012, INT J ONCOL, V40, P1049, DOI 10.3892/ijo.2011.1285; MAHATO SB, 1994, PHYTOCHEMISTRY, V37, P1517, DOI 10.1016/S0031-9422(00)89569-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mot AC, 2012, PROCESS BIOCHEM, V47, P968, DOI 10.1016/j.procbio.2012.03.006; Mot AC, 2011, J FOOD COMPOS ANAL, V24, P516, DOI 10.1016/j.jfca.2010.11.006; Mot AC, 2009, REDOX REP, V14, P267, DOI 10.1179/135100009X12525712409814; Muscolini M, 2011, J BIOL CHEM, V286, P39693, DOI 10.1074/jbc.M111.279539; Muscolini M, 2009, CELL CYCLE, V8, P3396, DOI 10.4161/cc.8.20.9910; Neamatallah A, 2005, LETT APPL MICROBIOL, V41, P94, DOI 10.1111/j.1472-765X.2005.01680.x; Nguemeving JR, 2006, PHYTOCHEMISTRY, V67, P1341, DOI 10.1016/j.phytochem.2006.03.018; Noungoue DT, 2009, Z NATURFORSCH C, V64, P210; Noungoue DT, 2008, PHYTOCHEMISTRY, V69, P1024, DOI 10.1016/j.phytochem.2007.10.026; Ok S, 2012, IMMUNOPHARM IMMUNOT, V34, P768, DOI 10.3109/08923973.2012.654494; Perde-Schrepler M, 2011, J ENVIRON PATHOL TOX, V30, P323, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i4.50; PERMANA PA, 1994, CANCER RES, V54, P3191; Pietta P, 1998, J AGR FOOD CHEM, V46, P4487, DOI 10.1021/jf980310p; Rao K. N. V., 2011, Hygeia - Journal for Drugs and Medicine, V3, P76; REEVES DS, 1983, PRINCIPLES METHODS A, P140; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sinsin Brice, 2003, Cahiers Agricultures, V12, P75; Su YJ, 2010, MOL PHARMACOL, V77, P633, DOI 10.1124/mol.109.061887; Suboj P, 2012, PHARMACOLOGY, V89, P91, DOI 10.1159/000335659; Tchobo FP, 2007, J AM OIL CHEM SOC, V84, P755, DOI 10.1007/s11746-007-1102-0; Tsaffack M, 2009, CHEM PHARM BULL, V57, P1113, DOI 10.1248/cpb.57.1113; Uphof J.C.T, 1968, DICT EC PLANTS; Virag P, 2009, TOXICOL IND HEALTH, V25, P253, DOI 10.1177/0748233709103411; Vorauer K, 1996, J BIOCHEM BIOPH METH, V32, P85, DOI 10.1016/0165-022X(96)00002-4; Wabo HK, 2007, CHEM PHARM BULL, V55, P1640, DOI 10.1248/cpb.55.1640; Wang XD, 2007, BIOL PHARM BULL, V30, P1113, DOI 10.1248/bpb.30.1113; Watcho P, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep221; Watt JM, 1962, MED POISONOUS PLANTS, P494; Wright CW., 2007, J SCI TECHNOL GHANA, V27, P16; Yan XJ, 2006, GYNECOL ONCOL, V102, P348, DOI 10.1016/j.ygyno.2005.12.033; Zamble A, 2006, J CARDIOVASC PHARM, V47, P599, DOI 10.1097/01.fjc.0000211734.53798.1d; Zelefack F, 2009, J NAT PROD, V72, P954, DOI 10.1021/np8005953	75	44	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55880	10.1371/journal.pone.0055880	http://dx.doi.org/10.1371/journal.pone.0055880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409075	Green Published, gold			2022-12-25	WOS:000315100000029
J	Akash, MSH; Rehman, K; Sun, HY; Chen, SQ				Akash, Muhammad Sajid Hamid; Rehman, Kanwal; Sun, Hongying; Chen, Shuqing			Sustained Delivery of IL-1Ra from PF127-Gel Reduces Hyperglycemia in Diabetic GK-Rats	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; ISLET-ASSOCIATED MACROPHAGES; GOTO-KAKIZAKI RAT; IN-VITRO RELEASE; BETA-CELL; INSULIN-RESISTANCE; HIGH-FAT; TYPE-2; INFLAMMATION; MODEL	Interleukin-1beta (IL-1 beta) is a major cause for induction of various inflammatory mechanisms that are decisively involved to provoke pathogenesis of type 2 diabetes mellitus (T2DM). Interleukin-1 receptor antagonist (IL-1Ra) a naturally occurring anti-inflammatory antagonist of IL-1 beta has been recently approved for treatment of T2DM but due to its short half-life, higher doses and frequent dosing intervals are required. Pluronic F-127 (PF127) has previously shown to prolong the release of various proteinous drugs and their serum half-lives. Subsequently, in our previous work, we developed a new dosage form of IL-1Ra using PF127 and investigated its in-vitro and in-vivo effects. Here in present work, we have extended this approach using diabetic Goto-kakizaki (GK) rats. We administered IL-1Ra loaded in PF127 gel subcutaneously for one month into GK rats. IL-1Ra loaded in PF127 gel exhibited a sustained and prolonged hypoglycemic effects on treated animals. Intraperitoneal glucose tolerance test (IPGTT) results showed that IL-1Ra loaded in PF127 gel increased glucose tolerance along with increased insulin sensitivity and beta-cell's secretory function in treated rats. Moreover, significant reduction in pro-insulin/insulin ratio, lipid profiles and interleukin 6 (IL-6) were also observed. Immunohistochemical analysis showed slight macrophages infiltration in pancreatic islets. Histochemical analysis revealed no PF127-induced alteration in the normal physiology of skin and kidney of treated animals. Hence, we concluded that IL-1Ra loaded in PF127 gel has potential to exhibit broad spectrum anti-inflammatory effects alleviating the symptoms of T2DM.	[Akash, Muhammad Sajid Hamid; Rehman, Kanwal; Sun, Hongying; Chen, Shuqing] Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Akash, Muhammad Sajid Hamid] Govt Coll Univ Faisalabad, Coll Pharm, Faisalabad, Pakistan	Zhejiang University; Government College University Faisalabad	Chen, SQ (corresponding author), Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China.	chenshuqing@zju.edu.cn	Akash, Muhammad Sajid Hamid/C-3477-2018; Rehman, Kanwal/P-7727-2014	Akash, Muhammad Sajid Hamid/0000-0002-9446-5233; Rehman, Kanwal/0000-0001-7873-6681; Chen, Shuqing/0000-0002-0792-3735	China Scholarship Council; Science and Technology Department of Zhejiang Province, China [2010C13006]	China Scholarship Council(China Scholarship Council); Science and Technology Department of Zhejiang Province, China	We acknowledge the China Scholarship Council to award full bright scholarship for PhD to Muhammad Sajid Hamid Akash and Kanwal Rehman. One of the authors would also like to admire her wife Mrs. Akash for her support and motivations. Without her, the writing of this manuscript would not have been possible.; This work was financially supported by the grant (No. 2010C13006) from the Science and Technology Department of Zhejiang Province, China. IL-1Ra was generously provided by Hisun Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IK, 2011, ENDOCRINOLOGY, V152, P1274, DOI 10.1210/en.2010-1319; Akash MSH, 2011, J MED PLANTS RES, V5, P6885, DOI 10.5897/JMPR11.1425; Akash MSH, 2013, EUR J PHARMACOL, V701, P87, DOI 10.1016/j.ejphar.2013.01.008; Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402; Akash MSH, 2012, PHARM RES-DORDR, V29, P3475, DOI 10.1007/s11095-012-0843-0; Akash MSH, 2012, J PHARM SCI-US, V101, P1647, DOI 10.1002/jps.23057; Antuna-Puente B, 2008, DIABETES METAB, V34, P294, DOI 10.1016/j.diabet.2008.02.001; Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Barichello JM, 1999, INT J PHARM, V184, P189, DOI 10.1016/S0378-5173(99)00119-2; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boyko EJ, 2007, DIABETES CARE, V30, P2725, DOI 10.2337/dc07-1248; Briaud I, 2002, DIABETES, V51, P662, DOI 10.2337/diabetes.51.3.662; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CARO JF, 1991, J CLIN ENDOCR METAB, V73, P691, DOI 10.1210/jcem-73-4-691; Chaibva FA, 2007, DISSOLUT TECHNOL, V14, P15, DOI 10.14227/DT140407P15; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Das N, 2012, PHARM DEV TECHNOL, V17, P363, DOI 10.3109/10837450.2010.542164; de Assis AM, 2009, EXP BIOL MED, V234, P1296, DOI 10.3181/0904-RM-126; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Fu JF, 2009, COMPARATIVE MED, V59, P557; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; Gomes MB, 1997, BRAZ J MED BIOL RES, V30, P191, DOI 10.1590/S0100-879X1997000200006; Hiwale P, 2011, BIOMACROMOLECULES, V12, P3186, DOI 10.1021/bm200679w; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; JOHNSTON TP, 1992, PHARM RES-DORDR, V9, P425, DOI 10.1023/A:1015815624334; Kaleem M, 2008, SINGAP MED J, V49, P800; KATAKAM M, 1995, J PHARM SCI-US, V84, P713, DOI 10.1002/jps.2600840609; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Liu Y, 2007, J CONTROL RELEASE, V117, P387, DOI 10.1016/j.jconrel.2006.11.024; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Mansour H. A., 2000, J MED RES I, V21, P115; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Movassat J, 2008, AM J PHYSIOL-ENDOC M, V294, pE168, DOI 10.1152/ajpendo.00501.2007; Murugan P, 2007, BASIC CLIN PHARMACOL, V101, P241, DOI 10.1111/j.1742-7843.2007.00109.x; Navab M, 2008, CURR OPIN CLIN NUTR, V11, P459, DOI 10.1097/MCO.0b013e32830460c2; Ohta T, 2003, EUR J PHARMACOL, V476, P159, DOI 10.1016/S0014-2999(03)02120-4; Pawluczyk IZA, 1997, J AM SOC NEPHROL, V8, P1525; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schrijvers BF, 2004, NEPHROL DIAL TRANSPL, V19, P1092, DOI 10.1093/ndt/gfh107; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shinde UA, 2003, J CELL MOL MED, V7, P322, DOI 10.1111/j.1582-4934.2003.tb00233.x; Sohn EJ, 2007, LIFE SCI, V80, P468, DOI 10.1016/j.lfs.2006.09.037; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Stratton LP, 1997, J PHARM SCI, V86, P1006, DOI 10.1021/js970034d; Wallis RH, 2004, DIABETOLOGIA, V47, P1096, DOI 10.1007/s00125-004-1416-5; WANG PL, 1993, J PARENT SCI TECHN, V47, P183; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	65	40	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55925	10.1371/journal.pone.0055925	http://dx.doi.org/10.1371/journal.pone.0055925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409091	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300046
J	Gracia-Aznarez, FJ; Fernandez, V; Pita, G; Peterlongo, P; Dominguez, O; de la Hoya, M; Duran, M; Osorio, A; Moreno, L; Gonzalez-Neira, A; Rosa-Rosa, JM; Sinilnikova, O; Mazoyer, S; Hopper, J; Lazaro, C; Southey, M; Odefrey, F; Manoukian, S; Catucci, I; Caldes, T; Lynch, HT; Hilbers, FSM; van Asperen, CJ; Vasen, HFA; Goldgar, D; Radice, P; Devilee, P; Benitez, J				Javier Gracia-Aznarez, Francisco; Fernandez, Victoria; Pita, Guillermo; Peterlongo, Paolo; Dominguez, Orlando; de la Hoya, Miguel; Duran, Mercedes; Osorio, Ana; Moreno, Leticia; Gonzalez-Neira, Anna; Manuel Rosa-Rosa, Juan; Sinilnikova, Olga; Mazoyer, Sylvie; Hopper, John; Lazaro, Conchi; Southey, Melissa; Odefrey, Fabrice; Manoukian, Siranoush; Catucci, Irene; Caldes, Trinidad; Lynch, Henry T.; Hilbers, Florentine S. M.; van Asperen, Christi J.; Vasen, Hans F. A.; Goldgar, David; Radice, Paolo; Devilee, Peter; Benitez, Javier			Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OVARIAN-CANCER; CONFER SUSCEPTIBILITY; GERMLINE MUTATIONS; MISSENSE MUTATIONS; GENE; LOCI; VARIANTS; RISK; PROTEIN	The identification of the two most prevalent susceptibility genes in breast cancer, BRCA1 and BRCA2, was the beginning of a sustained effort to uncover new genes explaining the missing heritability in this disease. Today, additional high, moderate and low penetrance genes have been identified in breast cancer, such as P53, PTEN, STK11, PALB2 or ATM, globally accounting for around 35 percent of the familial cases. In the present study we used massively parallel sequencing to analyze 7 BRCA1/BRCA2 negative families, each having at least 6 affected women with breast cancer (between 6 and 10) diagnosed under the age of 60 across generations. After extensive filtering, Sanger sequencing validation and co-segregation studies, variants were prioritized through either control-population studies, including up to 750 healthy individuals, or case-control assays comprising approximately 5300 samples. As a result, a known moderate susceptibility indel variant (CHEK2 1100delC) and a catalogue of 11 rare variants presenting signs of association with breast cancer were identified. All the affected genes are involved in important cellular mechanisms like DNA repair, cell proliferation and survival or cell cycle regulation. This study highlights the need to investigate the role of rare variants in familial cancer development by means of novel high throughput analysis strategies optimized for genetically heterogeneous scenarios. Even considering the intrinsic limitations of exome resequencing studies, our findings support the hypothesis that the majority of non-BRCA1/BRCA2 breast cancer families might be explained by the action of moderate and/or low penetrance susceptibility alleles.	[Javier Gracia-Aznarez, Francisco; Fernandez, Victoria; Osorio, Ana; Benitez, Javier] Spanish Natl Canc Ctr CNIO, Human Genet Grp, Madrid, Spain; [Pita, Guillermo; Moreno, Leticia; Gonzalez-Neira, Anna; Benitez, Javier] Spanish Natl Canc Ctr CNIO, Human Genotyping Unit CEGEN, Madrid, Spain; [Peterlongo, Paolo; Catucci, Irene; Radice, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Peterlongo, Paolo; Catucci, Irene; Radice, Paolo] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Dominguez, Orlando] Spanish Natl Canc Ctr CNIO, Genom Unit, Madrid, Spain; [de la Hoya, Miguel; Caldes, Trinidad] Inst Invest Sanitaria San Carlos IdISSC, Oncol Mol Lab, Madrid, Spain; [Duran, Mercedes] Inst Biol & Genet Mol IBGM UVA CSIC, Valladolid, Spain; [Manuel Rosa-Rosa, Juan] Sistemas Genom, Bioinformat Unit, Valencia, Spain; [Sinilnikova, Olga; Mazoyer, Sylvie] Univ Lyon 1, INSERM U1052, CNRS UMR5286, Canc Res Ctr Lyon,Ctr Leon Berard, Lyon, France; [Sinilnikova, Olga] Hosp Civils Lyon, Unite Mixte Genet Constitut Canc Ferquents, Ctr Leon Berard, Lyon, France; [Hopper, John] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Lazaro, Conchi] Inst Catala Oncol IDIBELL, Hereditary Canc Program, Mol Diagnost Unit, Barcelona, Spain; [Southey, Melissa; Odefrey, Fabrice] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Lynch, Henry T.] Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; [Hilbers, Florentine S. M.; Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Vasen, Hans F. A.] Fdn Detect Hereditary Tumors, Leiden, Netherlands; [Vasen, Hans F. A.] Leiden Univ, Med Ctr, Dept Gastroenterol, Leiden, Netherlands; [Goldgar, David; Devilee, Peter] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Benitez, Javier] Biomed Network Rare Dis CIBERER, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Lyon; UNICANCER; Centre Leon Berard; University of Melbourne; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Melbourne; Fondazione IRCCS Istituto Nazionale Tumori Milan; Creighton University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utah System of Higher Education; University of Utah; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Benitez, J (corresponding author), Spanish Natl Canc Ctr CNIO, Human Genet Grp, Madrid, Spain.	jbenitez@cnio.es	GARCIA, CONXI LAZARO/Q-2410-2016; Dominguez, Orlando/M-7515-2018; Hilbers, Florentine/AAB-8162-2019; Gonzalez-Neira, Anna/C-5791-2015; de la Hoya, MIguel/Z-2911-2019; van Asperen, Christi J/D-3970-2012; Osorio, Ana/I-4324-2014; Mazoyer, Sylvie/N-7559-2017; Gracia Aznarez, Francisco Javier/AFV-2344-2022; Devilee, Peter/GXV-8005-2022; Peterlongo, Paolo/Q-4717-2018; durán, mercedes/H-9240-2015; Pinheiro, Maísa/E-7424-2012; manoukian, siranoush/E-7132-2017; DEVILEE, PETER/ABR-2140-2022; Radice, Paolo/O-3119-2013	GARCIA, CONXI LAZARO/0000-0002-7198-5906; Hilbers, Florentine/0000-0002-6764-3102; Gonzalez-Neira, Anna/0000-0002-5421-2020; van Asperen, Christi J/0000-0002-1436-7650; Osorio, Ana/0000-0001-8124-3984; Peterlongo, Paolo/0000-0001-6951-6855; manoukian, siranoush/0000-0002-6034-7562; duran, Mercedes/0000-0002-6301-9732; Devilee, Peter/0000-0002-8023-2009; de la Hoya, Miguel/0000-0002-8113-1410; Vasen, Hans/0000-0003-2682-2603; Mazoyer, Sylvie/0000-0002-2135-0160; Pita, Guillermo/0000-0003-2393-0510; Southey, Melissa/0000-0002-6313-9005; Radice, Paolo/0000-0001-6298-4111	Dutch Cancer Society [UL 2009-4388]; Australian NHMRC; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); National Cancer Institute, National Institutes of Health under RFA [CA-06-503, U01 CA69467, U01 CA69398, U01 CA69631]; Asociacion Espanola Contra el Cancer, Spanish Health Research Fund; Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (FIS) [09/00859]; Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional [RETICC 06/0020/0021]; Asociacion Espanola Contra el Cancer (AECC);  [ISCIIIRETIC RD06/0020/1051];  [PI10/01422];  [PI10/00748];  [2009SGR290]; NATIONAL CANCER INSTITUTE [U01CA069417, U01CA069467, U01CA069446, U01CA069631, U01CA069398, U01CA069638] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Asociacion Espanola Contra el Cancer, Spanish Health Research Fund; Carlos III Health Institute(Instituto de Salud Carlos III); Catalan Health Institute and Autonomous Government of Catalonia(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional; Asociacion Espanola Contra el Cancer (AECC); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	FSMH is supported by the Dutch Cancer Society (project UL 2009-4388). The Australian Breast Cancer Family Registry (ABCFR; 1992-1995) was supported by the Australian NHMRC, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia). The Breast Cancer Family Registry (BCFR) was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-06-503, and through cooperative agreements with members of the BCFR and Principal Investigators, including Cancer Care Ontario (U01 CA69467), Columbia University (U01 CA69398), Fox Chase Cancer Center (U01 CA69631), Huntsman Cancer Institute (U01 CA69446), Cancer Prevention Institute of California (U01 CA69417), University of Melbourne (U01 CA69638) and Research Triangle Institute Informatics Support Center (RFP No. N02PC45022-46). MCS is a NHMRC Senior Research Fellow and Victorian Breast Cancer Research Consortium (VBCRC) Group Leader. JLH is a NHMRC Australia Fellow and VBCRC Group Leader. The Instituto Catalan de Oncologia (ICO) was granted by Asociacion Espanola Contra el Cancer, Spanish Health Research Fund; Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia. Contract grant numbers: ISCIIIRETIC RD06/0020/1051, PI10/01422, PI10/00748 and 2009SGR290. The Hospital Clinico de San Carlos (HCSC) was supported by Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) Research Grant 09/00859 to MdH. Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional (RETICC 06/0020/0021) supported TC, and MdH. The Spanish National Cancer Research Center (CNIO) was supported by Asociacion Espanola Contra el Cancer (AECC), Fondo de Investigaciones Sanitarias (FIS) Research Grant IP08-1120, RETICC RD06/0020/1106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; BORRESEN AL, 1992, CANCER RES, V52, P3234; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Garcia MJ, 2009, BREAST CANCER RES TR, V113, P545, DOI 10.1007/s10549-008-9945-0; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Rosa-Rosa JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009976; Rosa-Rosa JM, 2009, AM J HUM GENET, V84, P115, DOI 10.1016/j.ajhg.2008.12.013; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sawyer S, 2012, J CLIN ONCOL; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shamseldin HE, 2012, J MED GENET, V49, P184, DOI 10.1136/jmedgenet-2011-100585; Snape K, 2012, BREAST CANC RES TREA; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039	39	76	77	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55681	10.1371/journal.pone.0055681	http://dx.doi.org/10.1371/journal.pone.0055681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409019	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300028
J	Hatten, JR; Batt, TR; Scoppettone, GG; Dixon, CJ				Hatten, James R.; Batt, Thomas R.; Scoppettone, Gary G.; Dixon, Christopher J.			An Ecohydraulic Model to Identify and Monitor Moapa Dace Habitat	PLOS ONE			English	Article							MUDDY RIVER; CLARK COUNTY; FISHES; SELECTION; CLIMATE; SYSTEM	Moapa dace (Moapa coriacea) is a critically endangered thermophilic minnow native to the Muddy River ecosystem in southeastern Nevada, USA. Restricted to temperatures between 26.0 and 32.0 degrees C, these fish are constrained to the upper two km of the Muddy River and several small tributaries fed by warm springs. Habitat alterations, nonnative species invasion, and water withdrawals during the 20th century resulted in a drastic decline in the dace population and in 1979 the Moapa Valley National Wildlife Refuge (Refuge) was created to protect them. The goal of our study was to determine the potential effects of reduced surface flows that might result from groundwater pumping or water diversions on Moapa dace habitat inside the Refuge. We accomplished our goal in several steps. First, we conducted snorkel surveys to determine the locations of Moapa dace on three warm-spring tributaries of the Muddy River. Second, we conducted hydraulic simulations over a range of flows with a two-dimensional hydrodynamic model. Third, we developed a set of Moapa dace habitat models with logistic regression and a geographic information system. Fourth, we estimated Moapa dace habitat over a range of flows (plus or minus 30% of base flow). Our spatially explicit habitat models achieved classification accuracies between 85% and 91%, depending on the snorkel survey and creek. Water depth was the most significant covariate in our models, followed by substrate, Froude number, velocity, and water temperature. Hydraulic simulations showed 2-11% gains in dace habitat when flows were increased by 30%, and 8-32% losses when flows were reduced by 30%. To ensure the health and survival of Moapa dace and the Muddy River ecosystem, groundwater and surface-water withdrawals and diversions need to be carefully monitored, while fully implementing a proactive conservation strategy.	[Hatten, James R.; Batt, Thomas R.; Dixon, Christopher J.] US Geol Survey, Western Fisheries Res Ctr, Columbia River Res Lab, Cook, WA 98605 USA; [Scoppettone, Gary G.] US Geol Survey, Western Fisheries Res Ctr, Reno Field Stn, Reno, NV USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Hatten, JR (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Columbia River Res Lab, Cook, WA 98605 USA.	jhatten@usgs.gov			U.S. Fish and Wildlife Service (Nevada Fish and Wildlife Office) [85320-7-H437, F11RG00507]; Conservation Initiatives portion of the Southern Nevada Public Lands Management Act; Southern Nevada Water Authority	U.S. Fish and Wildlife Service (Nevada Fish and Wildlife Office); Conservation Initiatives portion of the Southern Nevada Public Lands Management Act; Southern Nevada Water Authority	Funding was provided by U.S. Fish and Wildlife Service (Nevada Fish and Wildlife Office) Interagency agreements 85320-7-H437 and F11RG00507; the Conservation Initiatives portion of the Southern Nevada Public Lands Management Act; and the Southern Nevada Water Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Brett JR., 1979, FISH PHYSIOL, P677, DOI [10.1016/S1546-5098(08)60034-5, DOI 10.1016/S1546-5098(08)60034-5]; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; DEACON JE, 1972, T AM FISH SOC, V101, P408, DOI 10.1577/1548-8659(1972)101<408:EDOFOM>2.0.CO;2; EAKIN TE, 1966, WATER RESOUR RES, V2, P251, DOI 10.1029/WR002i002p00251; Egan J.P., 1975, SIGNAL DETECTION THE; Environmental Systems Research Institute (ESRI), 1992, CELL BAS MOD GRID; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Galati L, 2011, WARM SPRINGS NATURAL; Garside LJ, 1979, NEVADA BUREAU MINES, V91; Ghanem A, 1996, REGUL RIVER, V12, P185, DOI 10.1002/(SICI)1099-1646(199603)12:2/3<185::AID-RRR389>3.0.CO;2-4; Ghanem AH, 1995, P 12 CAN HYDR C OTT; Glencross Brett D., 2006, Aquaculture Research, V37, P1055, DOI 10.1111/j.1365-2109.2006.01526.x; Groom M.J., 2006, PRINCIPLES CONSERVAT; Grossman GD, 2002, ECOL FRESHW FISH, V11, P2, DOI 10.1034/j.1600-0633.2002.110102.x; Guthrie CG, 2002, OIKOS, V97, P184, DOI 10.1034/j.1600-0706.2002.970204.x; Hatten JR, 2010, NORTHWEST SCI, V84, P207, DOI 10.3955/046.084.0301; Hatten JR, 2009, N AM J FISH MANAGE, V29, P1379, DOI 10.1577/M08-053.1; Hatten JR, 2003, J WILDLIFE MANAGE, V67, P774, DOI 10.2307/3802685; Hauer F. R., 2006, METHODS STREAM ECOLO; Hauer F. Richard, 2007, P103; Hines, 2017, OCCUPANCY ESTIMATION; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUBBS CARL L., 1948, OCCAS PAPERS MUS ZOOL UNIV MICHIGAN, V507, P1; JOWETT IG, 1991, NEW ZEAL J MAR FRESH, V25, P187, DOI 10.1080/00288330.1991.9516470; JOWETT IG, 1993, NEW ZEAL J MAR FRESH, V27, P241, DOI 10.1080/00288330.1993.9516563; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; KVAMME KL, 1985, CONCORDANCE ARCHAEOL, P208; Lamouroux N, 2006, RIVER RES APPL, V22, P727, DOI 10.1002/rra.931; Lane SN, 2006, PROC MONOGR ENG WATE, P2043; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; LOBB MD, 1991, T AM FISH SOC, V120, P65, DOI 10.1577/1548-8659(1991)120<0065:HUBAAO>2.3.CO;2; Mayer TD, 2008, GROUND WATER, V46, P212, DOI 10.1111/j.1745-6584.2007.00381.x; Minckley WL., 1991, BATTLE EXTINCTION NA; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Scoppettone GG, 1998, SOUTHWEST NAT, V43, P115; SCOPPETTONE GG, 1992, GREAT BASIN NAT, V52, P216; Scoppettone GG, 2005, WEST N AM NATURALIST, V65, P410; Scoppettone GG, 2005, RESTOR ECOL, V13, P247, DOI 10.1111/j.1526-100X.2005.00032.x; SCOPPETTONE GG, 1993, T AM FISH SOC, V122, P599, DOI 10.1577/1548-8659(1993)122<0599:IBNANF>2.3.CO;2; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Stearns S.C., 1992, pi; Steffler P., 2002, RIVER2D 2 DIMENSIONA; Stoddard J. L., 2005, 620R05005 EPA; Stonestrom D., 2007, GROUND WATER RECHARG; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Subhrendu G., 2011, 8668210201101 US DEP; Tiffan KF, 2002, N AM J FISH MANAGE, V22, P713, DOI 10.1577/1548-8675(2002)022<0713:QFDCIS>2.0.CO;2; U.S. Department of the Interior, 1973, US BUR SPORT FISH WI, V114; U.S. Fish and Wildlife Service, 1995, REC PLAN RAR AQ SPEC; Waddle T, 1996, EC 2000 C QUEB CIT J; Waddle T, 2010, RIVER RES APPL, V26, P730, DOI 10.1002/rra.1278; Williams B. K., 2002, ANAL MANAGEMENT ANIM	54	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55551	10.1371/journal.pone.0055551	http://dx.doi.org/10.1371/journal.pone.0055551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408999	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200038
J	Mac Donald, C; Johnson, A; Cooper, D; Malone, T; Sorrell, J; Shimony, J; Parsons, M; Snyder, A; Raichle, M; Fang, R; Flaherty, S; Russell, M; Brody, DL				Mac Donald, Christine; Johnson, Ann; Cooper, Dana; Malone, Thomas; Sorrell, James; Shimony, Joshua; Parsons, Matthew; Snyder, Abraham; Raichle, Marcus; Fang, Raymond; Flaherty, Stephen; Russell, Michael; Brody, David L.			Cerebellar White Matter Abnormalities following Primary Blast Injury in US Military Personnel	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; EXPOSURE; COMBAT; SCALE; IRAQI; DEPRESSION; VETERANS; SEQUELAE	Little is known about the effects of blast exposure on the human brain in the absence of head impact. Clinical reports, experimental animal studies, and computational modeling of blast exposure have suggested effects on the cerebellum and brainstem. In US military personnel with isolated, primary blast-related 'mild' traumatic brain injury and no other known insult, we found diffusion tensor MRI abnormalities consistent with cerebellar white matter injury in 3 of 4 subjects. No abnormalities in other brain regions were detected. These findings add to the evidence supporting the hypothesis that primary blast exposure contributes to brain injury in the absence of head impact and that the cerebellum may be particularly vulnerable. However, the clinical effects of these abnormalities cannot be determined with certainty; none of the subjects had ataxia or other detected evidence of cerebellar dysfunction. The details of the blast events themselves cannot be disclosed at this time, thus additional animal and computational modeling will be required to dissect the mechanisms underlying primary blast-related traumatic brain injury. Furthermore, the effects of possible subconcussive impacts and other military-related exposures cannot be determined from the data presented. Thus many aspects of topic will require further investigation.	[Mac Donald, Christine; Johnson, Ann; Cooper, Dana; Malone, Thomas; Sorrell, James; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Shimony, Joshua; Parsons, Matthew; Snyder, Abraham; Raichle, Marcus] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Fang, Raymond; Flaherty, Stephen] Landstuhl Reg Med Ctr, Dept Trauma Surg, Landstuhl, Germany; [Russell, Michael] USA, Rehabil & Reintegrat Div, San Antonio, TX USA	Washington University (WUSTL); Washington University (WUSTL); Landstuhl Regional Medical Center	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			Congressionally Directed Medical Research Program [W81XWH-08-2-0061]; United States National Institutes of Health [F32NS062529, 5K23HD053212, P30NS048056, P50NS06833, 5K08NS49237]; U.S. Army Medical Research Acquisition Activity [W81XWH-09-2-0057]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD053212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833, P30NS048056, F32NS062529, K08NS049237] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Program(United States Department of Defense); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research Acquisition Activity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants from the Congressionally Directed Medical Research Program (W81XWH-08-2-0061, to Dr. Brody), the United States National Institutes of Health (F32NS062529, to Dr. Mac Donald; 5K23HD053212, to Dr. Shimony; P30NS048056, to Dr. Snyder; P50NS06833, to Drs. Raichle and Snyder; and 5K08NS49237, to Dr. Brody) and U.S. Army Medical Research Acquisition Activity (W81XWH-09-2-0057) to Dr. Russell, under a protocol approved by Brooke Army Medical Center, San Antonio, TX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benton AL, 1983, MULTILINGUAL APHASIA; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Conners CK., 2000, CONNERSCONTINUOUS PE; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Heaton R.K., 1993, WISCONSIN CARD SORTI; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Matthews C, 1964, INSTRUCTION MANUAL A; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1917, J ROY ARMY MED CORPS, V29, P662; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peskind ER, 2010, NEUROIMAGE; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Reitan RM, 1992, TRAIL MAKING TEST MA; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Smith A., 1991, SYMBOL DIGIT MODALIT; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stoodley CJ, 2009, BRAIN LANG, V110, P149, DOI 10.1016/j.bandl.2009.07.006; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Talavage T. M., 2010, J NEUROTRAUMA; Taylor L, 1991, COMPENDIUM NEUROPSYC; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 2001, WECHSLER TEST ADULT; Wilkinson C, 2012, FRONT NEUROTRAUMA, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	53	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55823	10.1371/journal.pone.0055823	http://dx.doi.org/10.1371/journal.pone.0055823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409052	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200070
J	Kemble, DJ; Whitby, FG; Robinson, H; McCullough, LL; Formosa, T; Hill, CP				Kemble, David J.; Whitby, Frank G.; Robinson, Howard; McCullough, Laura L.; Formosa, Tim; Hill, Christopher P.			Structure of the Spt16 Middle Domain Reveals Functional Features of the Histone Chaperone FACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; BINDING; TRANSCRIPTION; REPLICATION; H3-H4; DNA; CHROMATIN	The histone chaperone FACT is an essential and abundant heterodimer found in all eukaryotes. Here we report a crystal structure of the middle domain of the large subunit of FACT (Spt16-M) to reveal a double pleckstrin homology architecture. This structure was found previously in the Pob3-M domain of the small subunit of FACT and in the related histone chaperone Rtt106, although Spt16-M is distinguished from these structures by the presence of an extended alpha-helix and a C-terminal addition. Consistent with our finding that the double pleckstrin homology structure is common to these three histone chaperones and reports that Pob3 and Rtt106 double pleckstrin homology domains bind histones H3-H4, we also find that Spt16-M binds H3-H4 with low micromolar affinity. Our structure provides a framework for interpreting a large body of genetic data regarding the physiological functions of FACT, including the identification of potential interaction surfaces for binding histones or other proteins.	[Kemble, David J.; Whitby, Frank G.; McCullough, Laura L.; Formosa, Tim; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Formosa, T (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	tim@biochem.utah.edu; chris@biochem.utah.edu		Formosa, Tim/0000-0002-8477-2483	National Institutes of Health [R01 GM59135, GM064649]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064649, R01GM059135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM59135 (to C. P. H. and T. F.) and GM064649 (to T. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Hainer SJ, 2012, G3-GENES GENOM GENET, V2, P555, DOI 10.1534/g3.112.002451; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; McCullough L, 2011, GENETICS, V188, P835, DOI 10.1534/genetics.111.128769; Myers CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020847; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0; Zunder RM, 2012, P NATL ACAD SCI USA, V109, pE144, DOI 10.1073/pnas.1119095109	30	44	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10188	10194		10.1074/jbc.C113.451369	http://dx.doi.org/10.1074/jbc.C113.451369			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23417676	Green Published, hybrid			2022-12-25	WOS:000317565000001
J	Lecomte, S; Reverdy, L; Le Quement, C; Le Masson, F; Amon, A; Le Goff, P; Michel, D; Christians, E; Le Drean, Y				Lecomte, Sylvain; Reverdy, Lea; Le Quement, Catherine; Le Masson, Florent; Amon, Axelle; Le Goff, Pascale; Michel, Denis; Christians, Elisabeth; Le Drean, Yves			Unraveling Complex Interplay between Heat Shock Factor 1 and 2 Splicing Isoforms	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION; STRESS; ACTIVATION; GENE; DIFFERENTIATION; DISRUPTION; MEIOSIS; PATHWAY; CELLS	Chaperone synthesis in response to proteotoxic stress is dependent on a family of transcription factors named heat shock factors (HSFs). The two main factors in this family, HSF1 and HSF2, are co-expressed in numerous tissues where they can interact and form heterotrimers in response to proteasome inhibition. HSF1 and HSF2 exhibit two alternative splicing isoforms, called alpha and beta, which contribute to additional complexity in HSF transcriptional regulation, but remain poorly examined in the literature. In this work, we studied the transcriptional activity of HSF1 and HSF2 splicing isoforms transfected into immortalized Mouse Embryonic Fibroblasts (iMEFs) deleted for both Hsf1 and Hsf2, under normal conditions and after proteasome inhibition. We found that HSF1 alpha is significantly more active than the beta isoform after exposure to the proteasome inhibitor MG132. Furthermore, we clearly established that, while HSF2 had no transcriptional activity by itself, short beta isoform of HSF2 exerts a negative role on HSF1 beta-dependent transactivation. To further assess the impact of HSF2 beta inhibition on HSF1 activity, we developed a mathematical modelling approach which revealed that the balance between each HSF isoform in the cell regulated the strength of the transcriptional response. Moreover, we found that cellular stress such as proteasome inhibition could regulate the splicing of Hsf2 mRNA. All together, our results suggest that relative amounts of each HSF1 and HSF2 isoforms quantitatively determine the cellular level of the proteotoxic stress response.	[Lecomte, Sylvain; Reverdy, Lea; Le Quement, Catherine; Le Goff, Pascale; Michel, Denis; Le Drean, Yves] Univ Rennes 1, Transcript Environm & Canc Grp, Inst Rech Sante Environm & Travail, Inserm,U1085, Rennes, France; [Le Masson, Florent; Christians, Elisabeth] Univ Toulouse 3, CNRS, Ctr Dev Biol, UMR 5547, F-31062 Toulouse, France; [Amon, Axelle] Univ Rennes 1, CNRS, Inst Phys Rennes, UMR 6251, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes	Le Drean, Y (corresponding author), Univ Rennes 1, Transcript Environm & Canc Grp, Inst Rech Sante Environm & Travail, Inserm,U1085, Rennes, France.	yves.le-drean@univ-rennes1.fr	LE GOFF, PASCALE/K-1842-2015; Amon, Axelle/N-7470-2014; Le Dréan, Yves/L-4822-2015; Lecomte, Sylvain/K-1745-2015	LE GOFF, PASCALE/0000-0002-3931-2197; Amon, Axelle/0000-0001-9475-4468; Michel, Denis/0000-0002-0643-8025	National Research Agency (ANR), France [10-CESA-017-01]	National Research Agency (ANR), France(French National Research Agency (ANR))	This study was supported by National Research Agency (ANR), France, under Grant No. 10-CESA-017-01 (BioREF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; FIORENZA MT, 1995, NUCLEIC ACIDS RES, V23, P467, DOI 10.1093/nar/23.3.467; GOODSON ML, 1995, BIOCHEM BIOPH RES CO, V211, P943, DOI 10.1006/bbrc.1995.1903; GOODSON ML, 1995, MOL CELL BIOL, V15, P5288; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Le Masson F, 2011, MOL CELL BIOL, V31, P3410, DOI 10.1128/MCB.05237-11; Le Masson F, 2011, CELL STRESS CHAPERON, V16, P275, DOI 10.1007/s12192-010-0239-1; Lecomte S, 2010, ONCOGENE, V29, P4216, DOI 10.1038/onc.2010.171; Leppa S, 1997, J BIOL CHEM, V272, P15293, DOI 10.1074/jbc.272.24.15293; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McMillan DR, 2002, MOL CELL BIOL, V22, P8005, DOI 10.1128/MCB.22.22.8005-8014.2002; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; MEZGER V, 1994, DEV BIOL, V166, P819, DOI 10.1006/dbio.1994.1361; Michel D, 2010, PROG BIOPHYS MOL BIO, V102, P16, DOI 10.1016/j.pbiomolbio.2009.12.007; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Petre I, 2011, NAT COMPUT, V10, P595, DOI 10.1007/s11047-010-9216-y; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Rieger TR, 2005, BIOPHYS J, V88, P1646, DOI 10.1529/biophysj.104.055301; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Szymanska Z, 2009, J THEOR BIOL, V259, P562, DOI 10.1016/j.jtbi.2009.03.021; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yoshima T, 1998, NUCLEIC ACIDS RES, V26, P2580, DOI 10.1093/nar/26.11.2580	29	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56085	10.1371/journal.pone.0056085	http://dx.doi.org/10.1371/journal.pone.0056085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418516	Green Published, gold			2022-12-25	WOS:000315970300108
J	Orsi, W; Biddle, JF; Edgcomb, V				Orsi, William; Biddle, Jennifer F.; Edgcomb, Virginia			Deep Sequencing of Subseafloor Eukaryotic rRNA Reveals Active Fungi across Marine Subsurface Provinces	PLOS ONE			English	Article							BACTERIAL-POPULATIONS; SEDIMENTS; DNA; COMMUNITY; ARCHAEA; PRESERVATION; DIVERSITY; ABUNDANCE; BIOMASS; GROWTH	The deep marine subsurface is a vast habitat for microbial life where cells may live on geologic timescales. Because DNA in sediments may be preserved on long timescales, ribosomal RNA ( rRNA) is suggested to be a proxy for the active fraction of a microbial community in the subsurface. During an investigation of eukaryotic 18S rRNA by amplicon pyrosequencing, unique profiles of Fungi were found across a range of marine subsurface provinces including ridge flanks, continental margins, and abyssal plains. Subseafloor fungal populations exhibit statistically significant correlations with total organic carbon (TOC), nitrate, sulfide, and dissolved inorganic carbon (DIC). These correlations are supported by terminal restriction length polymorphism (TRFLP) analyses of fungal rRNA. Geochemical correlations with fungal pyrosequencing and TRFLP data from this geographically broad sample set suggests environmental selection of active Fungi in the marine subsurface. Within the same dataset, ancient rRNA signatures were recovered from plants and diatoms in marine sediments ranging from 0.03 to 2.7 million years old, suggesting that rRNA from some eukaryotic taxa may be much more stable than previously considered in the marine subsurface.	[Orsi, William; Edgcomb, Virginia] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Biddle, Jennifer F.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Woods Hole Oceanographic Institution; University of Delaware	Orsi, W (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	william.orsi@gmail.com	Edgcomb, Virginia/Q-2434-2019; Biddle, Jennifer F/F-8323-2010	Biddle, Jennifer F/0000-0002-4344-8724; Edgcomb, Virginia/0000-0001-6805-381X	Center for Dark Energy Biosphere Investigations (C-DEBI) [OCE-0939564]; Ocean Life Institute (WHOI) [OLI-27071359]; Office Of The Director [0814251] Funding Source: National Science Foundation	Center for Dark Energy Biosphere Investigations (C-DEBI); Ocean Life Institute (WHOI); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was performed with funding from the Center for Dark Energy Biosphere Investigations (C-DEBI) to William Orsi (OCE-0939564) and The Ocean Life Institute (WHOI) to Virginia Edgcomb (OLI-27071359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Biddle JF, 2005, GEOBIOLOGY, V3, P287, DOI 10.1111/j.1472-4669.2006.00062.x; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Boere AC, 2011, GEOBIOLOGY, V9, P377, DOI 10.1111/j.1472-4669.2011.00290.x; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Buckley DH, 2008, ENVIRON MICROBIOL, V10, P967, DOI 10.1111/j.1462-2920.2007.01517.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Cochrane V.W., 1958, PHYSL FUNGI; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P238, DOI 10.1111/j.1462-2920.2006.01134.x; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Dalpe Y, 1998, CAN J BOT, V76, P1930, DOI 10.1139/cjb-76-11-1930; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Detrick R, 1990, P ODP INIT REPTS, V106/109; DHondt SL, 2003, P OCEAN DRILLING PRO, V201; Douillet P, 1998, J EXP MAR BIOL ECOL, V224, P183, DOI 10.1016/S0022-0981(97)00200-1; Edgcomb VP, 2011, ENVIRON MICROBIOL, V13, P172, DOI 10.1111/j.1462-2920.2010.02318.x; Gamper HA, 2009, NEW PHYTOL, V182, P495, DOI 10.1111/j.1469-8137.2008.02750.x; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Goldhammer T, 2011, GEOCHIM COSMOCHIM AC, V75, P3741, DOI 10.1016/j.gca.2011.04.006; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Gutierrez Juan Carlos, 2001, International Microbiology, V4, P151; HAMLETT NV, 1986, APPL ENVIRON MICROB, V52, P915, DOI 10.1128/AEM.52.4.915-923.1986; HOWES BL, 1994, MAR ECOL PROG SER, V114, P289, DOI 10.3354/meps114289; Inagaki F, 2005, ASTROBIOLOGY, V5, P141, DOI 10.1089/ast.2005.5.141; Inagaki F, 2006, PALEOME LETT ANCIENT; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Karasawa T, 2012, PLANT CELL ENVIRON, V35, P819, DOI 10.1111/j.1365-3040.2011.02455.x; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Liu XL, 2011, ORG GEOCHEM, V42, P368, DOI 10.1016/j.orggeochem.2011.02.003; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Meister P, 2005, P ODP SCI RESULTS, P1; Mills HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00113; Mills HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00049; Mollenhauer G, 2003, GEOCHIM COSMOCHIM AC, V67, P2157, DOI 10.1016/S0016-7037(03)00168-6; Nebel ME, 2011, J BIOINF COMPUT BIOL, V9, P749, DOI 10.1142/S0219720011005781; Niitsuma S, 2006, P ODP SCI RESULTS; Pacini E, 2006, PROTOPLASMA, V228, P73, DOI 10.1007/s00709-006-0169-z; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Schafer H, 2007, AQUAT MICROB ECOL, V50, P1, DOI 10.3354/ame01164; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Schippers A, 2006, ENVIRON MICROBIOL, V8, P1251, DOI 10.1111/j.1462-2920.2006.01019.x; Schippers A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00016; Schussler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023333; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Suess E, 1986, P ODP INIT REPTS; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Tiquia SM, 2005, ENVIRON TECHNOL, V26, P1101, DOI 10.1080/09593332608618482; Trehu AM, 2002, P ODP INIT REPTS, V204; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Ziebis W, 2012, EARTH PLANET SC LETT, V323, P79, DOI 10.1016/j.epsl.2012.01.018	60	173	176	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56335	10.1371/journal.pone.0056335	http://dx.doi.org/10.1371/journal.pone.0056335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418556	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300149
J	Wissner-Gross, ZD; Scott, MA; Steinmeyer, JD; Yanik, MF				Wissner-Gross, Zachary D.; Scott, Mark A.; Steinmeyer, Joseph D.; Yanik, Mehmet Fatih			Synchronous Symmetry Breaking in Neurons with Different Neurite Counts	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; AXON FORMATION; CELL-CULTURE; POLARITY; ESTABLISHMENT; POLARIZATION; MICROTUBULE; MECHANISMS; PROTEIN; LENGTH	As neurons develop, several immature processes (i.e., neurites) grow out of the cell body. Over time, each neuron breaks symmetry when only one of its neurites grows much longer than the rest, becoming an axon. This symmetry breaking is an important step in neurodevelopment, and aberrant symmetry breaking is associated with several neuropsychiatric diseases, including schizophrenia and autism. However, the effects of neurite count in neuronal symmetry breaking have never been studied. Existing models for neuronal polarization disagree: some predict that neurons with more neurites polarize up to several days later than neurons with fewer neurites, while others predict that neurons with different neurite counts polarize synchronously. We experimentally find that neurons with different neurite counts polarize synchronously. We also show that despite the significant differences among the previously proposed models, they all agree with our experimental findings when the expression levels of the proteins responsible for symmetry breaking increase with neurite count. Consistent with these results, we observe that the expression levels of two of these proteins, HRas and shootin1, significantly correlate with neurite count. This coordinated symmetry breaking we observed among neurons with different neurite counts may be important for synchronized polarization of neurons in developing organisms.	[Wissner-Gross, Zachary D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Wissner-Gross, Zachary D.; Scott, Mark A.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Scott, Mark A.; Steinmeyer, Joseph D.; Yanik, Mehmet Fatih] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Yanik, Mehmet Fatih] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yanik, MF (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	yanik@mit.edu		Yanik, Mehmet/0000-0002-8963-2893; Skylar-Scott, Mark/0000-0003-3496-7124	National Institutes of Health (NIH) EUREKA Award [1-R01-NS066352-01]; Packard Fellowship in Science and Engineering; Fannie and John Hertz Foundation/Myhrvold Family fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066352] Funding Source: NIH RePORTER	National Institutes of Health (NIH) EUREKA Award; Packard Fellowship in Science and Engineering; Fannie and John Hertz Foundation/Myhrvold Family fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health (NIH) R01 EUREKA Award Grant 1-R01-NS066352-01 (MFY), a Packard Fellowship in Science and Engineering (MFY), and a Fannie and John Hertz Foundation/Myhrvold Family fellowship (ZWG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bellon A, 2007, MOL PSYCHIATR, V12, P620, DOI 10.1038/sj.mp.4001985; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kempf M, 1996, J NEUROSCI, V16, P5583; Khanin K, 2001, J MATH BIOL, V42, P26, DOI 10.1007/PL00000071; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Samuels DC, 1996, PHILOS T ROY SOC B, V351, P1147, DOI 10.1098/rstb.1996.0099; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Toriyama M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.51; Wissner-Gross ZD, 2011, INTEGR BIOL-UK, V3, P65, DOI 10.1039/c0ib00058b; YU WQ, 1994, J NEUROSCI, V14, P2818	23	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54905	10.1371/journal.pone.0054905	http://dx.doi.org/10.1371/journal.pone.0054905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408951	Green Published, gold, Green Submitted			2022-12-25	WOS:000315100000010
J	Dam, G; Kording, K; Wei, KL				Dam, Gregory; Kording, Konrad; Wei, Kunlin			Credit Assignment during Movement Reinforcement Learning	PLOS ONE			English	Article							COORDINATION; ADAPTATION; VARIABILITY; TASK	We often need to learn how to move based on a single performance measure that reflects the overall success of our movements. However, movements have many properties, such as their trajectories, speeds and timing of end-points, thus the brain needs to decide which properties of movements should be improved; it needs to solve the credit assignment problem. Currently, little is known about how humans solve credit assignment problems in the context of reinforcement learning. Here we tested how human participants solve such problems during a trajectory-learning task. Without an explicitly-defined target movement, participants made hand reaches and received monetary rewards as feedback on a trial-by-trial basis. The curvature and direction of the attempted reach trajectories determined the monetary rewards received in a manner that can be manipulated experimentally. Based on the history of action-reward pairs, participants quickly solved the credit assignment problem and learned the implicit payoff function. A Bayesian credit-assignment model with built-in forgetting accurately predicts their trial-by-trial learning.	[Dam, Gregory] Univ Rio Grande, Dept Behav Sci, Rio Grande, OH USA; [Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Wei, Kunlin] Peking Univ, Beijing Engn Res Ctr Intelligent Rehabil Engn, Minist Educ, Dept Psychol,Key Lab Machine Percept, Beijing 100871, Peoples R China	University of Rio Grande; Northwestern University; Shirley Ryan AbilityLab; Peking University	Wei, KL (corresponding author), Peking Univ, Beijing Engn Res Ctr Intelligent Rehabil Engn, Minist Educ, Dept Psychol,Key Lab Machine Percept, Beijing 100871, Peoples R China.	wei.kunlin@pku.edu.cn	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Dam, Gregory/0000-0002-8370-1632	NIH [R01NS-063399, R01NS-057814]; National Natural Science Foundation of China [31000456, 61020106005]; Fundamental Research Funds for the Central Universities; Beijing Municipal Education Commission; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, R01NS057814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Municipal Education Commission(Beijing Municipal Commission of Education); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been funded by NIH Grants R01NS-063399 and R01NS-057814, the National Natural Science Foundation of China (No. 31000456, and 61020106005), the Fundamental Research Funds for the Central Universities, and the Collaboration Funds from Beijing Municipal Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Bernstein N.A., 1967, COORDINATION REGULAT; Fu WT, 2008, PSYCHOL RES-PSYCH FO, V72, P321, DOI 10.1007/s00426-007-0113-7; Fu WT, 2006, J EXP PSYCHOL GEN, V135, P184, DOI 10.1037/0096-3445.135.2.184; Gordon D, 1994, USERS GUIDE NAVIGATI; Gullapalli V, 1992, REINFORCEMENT LEARNI; Houk JC, 1996, BEHAV BRAIN SCI, V19, P368, DOI 10.1017/S0140525X00081474; Kaelbling L. P., 1996, CS9605103 ARXIV; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kudo K, 2000, J MOTOR BEHAV, V32, P337, DOI 10.1080/00222890009601384; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Martin TA, 2002, J NEUROPHYSIOL, V88, P1685, DOI 10.1152/jn.2002.88.4.1685; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; PENNINGTON N, 1988, J EXP PSYCHOL LEARN, V14, P521, DOI 10.1037/0278-7393.14.3.521; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sternad D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002159; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tolman E.C., 1930, U CALIFORNIA PUBLICA; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	25	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55352	10.1371/journal.pone.0055352	http://dx.doi.org/10.1371/journal.pone.0055352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23408972	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300012
J	Lee, EH; Lee, EJ; Kim, HJ; Jang, AS; Koh, ES; Uh, ST; Kim, YH; Park, SW; Park, CS				Lee, Eun Hee; Lee, Eun-ju; Kim, Hee Jeong; Jang, An Soo; Koh, Eun Suk; Uh, Soo-taek; Kim, Yong Hoon; Park, Sung-woo; Park, Choon-sik			Overexpression of Apolipoprotein A1 in the Lung Abrogates Fibrosis in Experimental Silicosis	PLOS ONE			English	Article							PULMONARY-FIBROSIS; LIPOXIN A(4); APOPTOTIC NEUTROPHILS; INFLAMMATION; BLEOMYCIN; MICE; RESOLUTION; PEPTIDES; ANALOGS; PHAGOCYTOSIS	The inhalation of silica particles induces silicosis, an inflammatory and fibrotic lung disease characterized by the early accumulation of macrophages and neutrophils in the airspace and subsequent appearance of silicotic nodules as a result of progressive fibrosis. This study evaluated whether apolipoprotein A1 (ApoA1) protects against ongoing fibrosis and promotes the resolution of established experimental lung silicosis. Crystallized silica was intratracheally administered to 6- to 8-week-old transgenic mice expressing human ApoA1 in their alveolar epithelial cells (day 0). ApoA1 was overexpressed beginning on day 7 (ApoA1_D7 group) or day 15 (ApoA1_D15 group). The mice were sacrificed on day 30 for an evaluation of lung histology; the measurement of collagen, transforming growth factor-b1 and lipoxin A4; and a TUNEL assay for apoptotic cells. The ApoA1_D7 and D15 groups showed significant reductions in the silica-induced increase in inflammatory cells, silicotic nodule area, and collagen deposition compared with the silica-treated ApoA1 non-overexpressing mice. The level of transforming growth factor-b1 decreased in the bronchoalveolar lavage fluid, whereas lipoxin A4 was increased in the ApoA1_D7 and D15 groups compared with the silica-treated ApoA1 non-overexpressing mice. The silica-induced increase in the number of apoptotic cells was significantly reduced in the lungs of mice overexpressing ApoA1. Overexpression of ApoA1 decreased silica-induced lung inflammation and fibrotic nodule formation. The restoration of lipoxin A4 may contribute to the protective effect of ApoA1 overexpression against silica-induced lung fibrosis.	[Lee, Eun Hee; Lee, Eun-ju; Kim, Hee Jeong; Jang, An Soo; Park, Sung-woo; Park, Choon-sik] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Allergy & Resp Med, Puchon, Gyeonggi Do, South Korea; [Koh, Eun Suk] Soonchunhyang Univ, Bucheon Hosp, Dept Pathol, Puchon, Gyeonggi Do, South Korea; [Uh, Soo-taek] Soonchunhyang Univ, Seoul Hosp, Div Allergy & Resp Med, Seoul, South Korea; [Kim, Yong Hoon] Soonchunhyang Univ, Cheonan Hosp, Div Allergy & Resp Med, Cheonan, Chungcheongnam, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University	Park, SW (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Allergy & Resp Med, Puchon, Gyeonggi Do, South Korea.	swpark@schmc.ac.kr		Park, Choon-Sik/0000-0003-2977-0255	Korea Health 21 R&D Project Ministry of Health & Welfare Republic of Korea [A090548]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0010584]	Korea Health 21 R&D Project Ministry of Health & Welfare Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant of the Korea Health 21 R&D Project Ministry of Health & Welfare Republic of Korea [Grant A090548]. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [Grant 2010-0010584]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett EG, 1999, TOXICOL APPL PHARM, V161, P111, DOI 10.1006/taap.1999.8793; Blake TL, 1996, EXP LUNG RES, V22, P113, DOI 10.3109/01902149609074021; Borgeson E, 2011, FASEB J, V25, P2967, DOI 10.1096/fj.11-185017; Bonnans C, 2004, ALLERGY, V59, P1027, DOI 10.1111/j.1398-9995.2004.00617.x; Borges VM, 2001, J EXP MED, V194, P155, DOI 10.1084/jem.194.2.155; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Faffe DS, 2001, J APPL PHYSIOL, V90, P1400, DOI 10.1152/jappl.2001.90.4.1400; Fujita M, 2006, ANTIMICROB AGENTS CH, V50, P739, DOI 10.1128/AAC.50.2.739-743.2006; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Hnizdo E, 2003, OCCUP ENVIRON MED, V60, P237, DOI 10.1136/oem.60.4.237; Huaux F, 1998, AM J RESP CELL MOL, V18, P51, DOI 10.1165/ajrcmb.18.1.2911; Iyer R, 1996, TOXICOL APPL PHARM, V141, P84, DOI 10.1006/taap.1996.0263; Jagirdar J, 1996, AM J RESP CRIT CARE, V154, P1076, DOI 10.1164/ajrccm.154.4.8887610; Kim TH, 2010, AM J RESP CRIT CARE, V182, P633, DOI 10.1164/rccm.200905-0659OC; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Lardot CG, 1998, AM J RESP CRIT CARE, V157, P617, DOI 10.1164/ajrccm.157.2.9707052; Lassance RM, 2009, RESP PHYSIOL NEUROBI, V169, P227, DOI 10.1016/j.resp.2009.09.004; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Levy BD, 2005, PROSTAG LEUKOTR ESS, V73, P231, DOI 10.1016/j.plefa.2005.05.010; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Maron-Gutierrez T, 2011, EUR RESP J; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Nandedkar SD, 2011, J LIPID RES, V52, P499, DOI 10.1194/jlr.M012724; Navab M, 2005, CIRC RES, V97, P524, DOI 10.1161/01.RES.0000181229.69508.2f; Ortiz LA, 2001, AM J RESP CRIT CARE, V163, P244, DOI 10.1164/ajrccm.163.1.2002123; Papayianni A, 1996, J IMMUNOL, V156, P2264; Park SW, 2009, AM J RESP CRIT CARE, V180, P603, DOI 10.1164/rccm.200811-1768OC; Park SW LE, 2011, INT C AM THOR SOC AT; PHAN SH, 1983, CHEST, V83, pS44; Reddy ST, 2006, EXPERT OPIN INV DRUG, V15, P13, DOI 10.1517/13543784.15.1.13; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Tsuchiya Kimitake, 2007, Journal of Medical and Dental Sciences, V54, P9; Van Lenten BJ, 2008, CURR OPIN INVEST DR, V9, P1157; Wang LY, 2005, AM J PHYSIOL-LUNG C, V288, pL488, DOI 10.1152/ajplung.00123.2003; Weibel ER, 1990, MODELS LUNG DIS MICR, V47, P199	41	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55827	10.1371/journal.pone.0055827	http://dx.doi.org/10.1371/journal.pone.0055827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409054	gold, Green Submitted, Green Published			2022-12-25	WOS:000314660300036
J	Pereira, F; Moreira, C; Fonseca, L; van Asch, B; Mota, M; Abrantes, I; Amorim, A				Pereira, Filipe; Moreira, Claudia; Fonseca, Luis; van Asch, Barbara; Mota, Manuel; Abrantes, Isabel; Amorim, Antonio			New Insights into the Phylogeny and Worldwide Dispersion of Two Closely Related Nematode Species, Bursaphelenchus xylophilus and Bursaphelenchus mucronatus	PLOS ONE			English	Article							PINE WILT DISEASE; B-MUCRONATUS; DNA; PORTUGAL; STEINER; WOOD; APHELENCHOIDIDAE; ALGORITHM; INFERENCE; MRBAYES	The pinewood nematode, Bursaphelenchus xylophilus, is one of the greatest threats to coniferous forests worldwide, causing severe ecological damage and economic loss. The biology of B. xylophilus is similar to that of its closest relative, B. mucronatus, as both species share food resources and insect vectors, and have very similar morphological characteristics, although little pathogenicity to conifers has been associated with B. mucronatus. Using both nuclear and mitochondrial DNA markers, we show that B. xylophilus and B. mucronatus form distinct phylogenetic groups with contrasting phylogeographic patterns. B. xylophilus presents lower levels of intraspecific diversity than B. mucronatus, as expected for a species that evolved relatively recently through geographical or reproductive isolation. Genetic diversity was particularly low in recently colonised areas, such as in southwestern Europe. By contrast, B. mucronatus displays high levels of genetic diversity and two well-differentiated clades in both mitochondrial and nuclear DNA phylogenies. The lack of correlation between genetic and geographic distances in B. mucronatus suggests intense gene flow among distant regions, a phenomenon that may have remained unnoticed due to the reduced pathogenicity of the species. Overall, our findings suggest that B. xylophilus and B. mucronatus have different demographic histories despite their morphological resemblance and ecological overlap. These results suggest that Bursaphelenchus species are a valuable model for understanding the dispersion of invasive species and the risks posed to native biodiversity and ecosystems.	[Pereira, Filipe; Moreira, Claudia; van Asch, Barbara; Amorim, Antonio] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Fonseca, Luis; Abrantes, Isabel] Univ Coimbra, Dept Life Sci, IMAR CMA, Coimbra, Portugal; [Mota, Manuel] Univ Evora, ICAAM, Nucleo Mitra, Evora, Portugal; [Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal	Universidade do Porto; Universidade de Coimbra; University of Evora; Universidade do Porto	Pereira, F (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	fpereirapt@gmail.com	van Asch, Barbara/AAW-5154-2021; van Asch, Barbara/J-3622-2013; Abrantes, Isabel/CAG-1426-2022; Amorim, Antonio/A-7938-2008; Pereira, Filipe/F-6391-2010; van Asch, Barbara/HDN-5674-2022; Mota, Manuel/G-6031-2019	van Asch, Barbara/0000-0002-0171-879X; van Asch, Barbara/0000-0002-0171-879X; Abrantes, Isabel/0000-0002-8761-2151; Amorim, Antonio/0000-0002-7518-6247; Pereira, Filipe/0000-0001-8950-1036; van Asch, Barbara/0000-0002-0171-879X; Mota, Manuel/0000-0002-4145-5031; Fonseca, Luis/0000-0001-7405-8916	Portuguese national project 'O nemaode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' (Fundo Florestal Permanente); Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/44637/2008, SFRH/BPD/73108/2010]; EC 7th Framework project REPHRAME [KBBE.2010.1.4-09]; FCT	Portuguese national project 'O nemaode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' (Fundo Florestal Permanente); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); EC 7th Framework project REPHRAME; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by the Portuguese national project 'O nemaode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' (Fundo Florestal Permanente) and by research grants to FP (SFRH/BPD/44637/2008) and BA (SFRH/BPD/73108/2010) from the Portuguese Foundation for Science and Technology (FCT). MM was partially supported by the EC 7th Framework project REPHRAME (KBBE.2010.1.4-09, 'Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy'). The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; [Anonymous], 2009, B OEPP EPPO, V31, P61; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beckenbach K, 1999, NEMATOLOGY, V1, P539, DOI 10.1163/156854199508531; BOLLA RI, 1993, J NEMATOL, V25, P227; Braasch H., 2004, Nematologia Mediterranea, V32, P71; Cardoso J, 2011, 4 INT C MED PIN AV F, P180; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Cheng XY, 2009, BIOL INVASIONS, V11, P205, DOI 10.1007/s10530-008-9225-2; Drummond A, 2009, GENEIOUS V 5 4; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Fonseca L, 2008, PHYTOPATHOL MEDITERR, V47, P223; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwahori H, 1998, FUND APPL NEMATOL, V21, P655; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Jung J, 2010, GENES GENOM, V32, P151, DOI 10.1007/s13258-009-0842-7; Kang JS, 2004, NEMATOLOGY, V6, P279, DOI 10.1163/1568541041217915; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kanzaki N, 2006, NEMATOLOGY, V8, P485, DOI 10.1163/156854106778613994; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Li HM, 2009, NEMATOLOGY, V11, P375, DOI 10.1163/156854109X446971; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maehara N, 2011, FOREST PATHOL, V41, P477, DOI 10.1111/j.1439-0329.2010.00707.x; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; MARUYAMA T, 1991, GENETICS, V127, P449; Metge K, 2006, J PLANT DIS PROTECT, V113, P275, DOI 10.1007/BF03356193; Mota M, 2008, PINE WILT DIS WORLDI; Mota MM, 2006, J NEMATOL, V38, P429; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; RIGA E, 1992, FUND APPL NEMATOL, V15, P391; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; RUTHERFORD TA, 1992, J NEMATOL, V24, P40; Taga Y, 2011, NEMATOLOGY, V13, P701, DOI 10.1163/138855410X543166; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Tsai YHE, 2011, MOL ECOL RESOUR, V11, P557, DOI 10.1111/j.1755-0998.2010.02964.x; Valadas V, 2012, NEMATOLOGY, V14, P899, DOI 10.1163/156854112X632673; Vieira P, 2007, J NEMATOL, V39, P118; WEBSTER J M, 1990, Revue de Nematologie, V13, P255; WHITEHEAD AG, 1965, ANN APPL BIOL, V55, P25, DOI 10.1111/j.1744-7348.1965.tb07864.x; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006	55	39	43	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56288	10.1371/journal.pone.0056288	http://dx.doi.org/10.1371/journal.pone.0056288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409167	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300071
J	Silvestro, D; Andersen, TG; Schaller, H; Jensen, PE				Silvestro, Daniele; Andersen, Tonni Grube; Schaller, Hubert; Jensen, Poul Erik			Plant Sterol Metabolism. Delta(7)-Sterol-C-5-Desaturase (STE1/DWARF7), Delta(5,7)-Sterol-Delta(7)-Reductase (DWARF5) and Delta(24)-Sterol-Delta(24)-Reductase (DIMINUTO/DWARF1) Show Multiple Subcellular Localizations in Arabidopsis thaliana (Heynh) L	PLOS ONE			English	Article							OXIDOSQUALENE CYCLASE ERG7P; ENDOPLASMIC-RETICULUM; LIPID PARTICLES; CELL-CYCLE; YEAST; BIOSYNTHESIS; GENE; IDENTIFICATION; BINDING; CHOLESTEROL	Sterols are crucial lipid components that regulate membrane permeability and fluidity and are the precursors of bioactive steroids. The plant sterols exist as three major forms, free sterols, steryl glycosides and steryl esters. The storage of steryl esters in lipid droplets has been shown to contribute to cellular sterol homeostasis. To further document cellular aspects of sterol biosynthesis in plants, we addressed the question of the subcellular localization of the enzymes implicated in the final steps of the post-squalene biosynthetic pathway. In order to create a clear localization map of steroidogenic enzymes in cells, the coding regions of Delta(7)-sterol-C-5-desaturase (STE1/DWARF7), Delta(24)-sterol-Delta(24)-reductase (DIMINUTO/DWARF1) and Delta(5,7)-sterol-Delta(7)-reductase (DWARF5) were fused to the yellow fluorescent protein (YFP) and transformed into Arabidopsis thaliana mutant lines deficient in the corresponding enzymes. All fusion proteins were found to localize in the endoplasmic reticulum in functionally complemented plants. The results show that both Delta(5,7)-sterol-Delta(7)-reductase and Delta(24)-sterol-Delta(24)-reductase are in addition localized to the plasma membrane, whereas Delta(7)-sterol-C-5-desaturase was clearly detected in lipid particles. These findings raise new challenging questions about the spatial and dynamic cellular organization of sterol biosynthesis in plants.	[Silvestro, Daniele; Jensen, Poul Erik] Univ Copenhagen, VKR Res Ctr Proact Plants, Villum Kann Rasmussen Fdn, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Silvestro, Daniele; Jensen, Poul Erik] Univ Copenhagen, Ctr Synthet Biol, Fac Sci, Frederiksberg C, Denmark; [Andersen, Tonni Grube] Univ Copenhagen, Fac Sci, Ctr Dynam Mol Interact DynaMo, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Schaller, Hubert] Univ Strasbourg, Inst Biol Mol Plantes CNRS, Dept Reseaux Metab Vegetaux, Strasbourg, France	University of Copenhagen; Villum Fonden; University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Silvestro, D (corresponding author), Univ Copenhagen, VKR Res Ctr Proact Plants, Villum Kann Rasmussen Fdn, Dept Plant & Environm Sci, Frederiksberg C, Denmark.	dasi@life.ku.dk	Jensen, Poul Erik/A-4862-2014	Jensen, Poul Erik/0000-0001-6524-7723; Schaller, Hubert/0000-0002-4099-4447; Andersen, Tonni/0000-0002-8905-0850	Danish Ministry of Food, Agriculture and Fisheries [3304-FVFP-07-774-01]; Villum Kann Rasmussen Foundation (VKR) research centre "Pro-Active Plants"	Danish Ministry of Food, Agriculture and Fisheries; Villum Kann Rasmussen Foundation (VKR) research centre "Pro-Active Plants"	This research was supported by The Danish Ministry of Food, Agriculture and Fisheries (3304-FVFP-07-774-01) and supported by the Villum Kann Rasmussen Foundation (VKR) research centre "Pro-Active Plants". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Athenstaedt K, 2011, EUR J LIPID SCI TECH, V113, P1188, DOI 10.1002/ejlt.201100051; Banas A, 2005, J BIOL CHEM, V280, P34626, DOI 10.1074/jbc.M504459200; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Bouvier-Nave P, 2010, PLANT PHYSIOL, V152, P107, DOI 10.1104/pp.109.145672; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; Chen Q, 2007, PLANT PHYSIOL, V145, P974, DOI 10.1104/pp.107.106278; Choe S, 2000, PLANT J, V21, P431, DOI 10.1046/j.1365-313x.2000.00693.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAHL C, 1987, P NATL ACAD SCI USA, V84, P4012, DOI 10.1073/pnas.84.12.4012; DeBolt S, 2009, PLANT PHYSIOL, V151, P78, DOI 10.1104/pp.109.140582; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; DYAS L, 1993, PHYTOCHEMISTRY, V34, P17, DOI 10.1016/S0031-9422(00)90777-5; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; GACHOTTE D, 1995, PLANT J, V8, P407, DOI 10.1046/j.1365-313X.1995.08030407.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GONDET L, 1994, PLANT PHYSIOL, V105, P509, DOI 10.1104/pp.105.2.509; Greeve I, 2000, J NEUROSCI, V20, P7345; Griebel T, 2010, PLANT J, V63, P254, DOI 10.1111/j.1365-313X.2010.04235.x; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; HAMILTON JA, 1982, J BIOL CHEM, V257, P7318; HARTMANN MA, 2004, LIPID METABOLISM MEM, P57; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Husselstein T, 1999, PLANT MOL BIOL, V39, P891, DOI 10.1023/A:1006113919172; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Lecain E, 1996, J BIOL CHEM, V271, P10866, DOI 10.1074/jbc.271.18.10866; Lin LJ, 2002, PLANT PHYSIOL, V128, P1200, DOI 10.1104/pp.010928; Lucas ME, 2003, MOL GENET METAB, V80, P227, DOI 10.1016/S1096-7192(03)00137-9; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Milla P, 2002, J BIOL CHEM, V277, P2406, DOI 10.1074/jbc.M104195200; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Ott RG, 2005, BBA-MOL CELL BIOL L, V1735, P111, DOI 10.1016/j.bbalip.2005.05.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pose D, 2009, PLANT J, V59, P63, DOI 10.1111/j.1365-313X.2009.03849.x; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Sambrookand Joseph, 2001, MOL CLONING LAB MANU; SATIATJEUNEMAITRE B, 1992, BIOL CELL, V74, P325, DOI 10.1016/0248-4900(92)90044-2; Schaeffer A, 2001, PLANT J, V25, P605, DOI 10.1046/j.1365-313x.2001.00994.x; Schaller H, 2003, PROG LIPID RES, V42, P163, DOI 10.1016/S0163-7827(02)00047-4; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; Schaller H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P755; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2011, PHYTOCHEMISTRY, V72, P465, DOI 10.1016/j.phytochem.2011.01.009; Schulz TA, 2007, BBA-MOL CELL BIOL L, V1771, P769, DOI 10.1016/j.bbalip.2007.03.003; Sharma M, 2010, J VIROL, V84, P2270, DOI 10.1128/JVI.02003-09; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Spanova M, 2010, J BIOL CHEM, V285, P6127, DOI 10.1074/jbc.M109.074229; TAKAHASHI T, 1995, GENE DEV, V9, P97, DOI 10.1101/gad.9.1.97; Valitova JN, 2011, PHYTOCHEMISTRY, V72, P1751, DOI 10.1016/j.phytochem.2011.06.004; Vincill ED, 2012, PLANT PHYSIOL, V159, P40, DOI 10.1104/pp.112.197509; Wahlroos T, 2003, GENESIS, V35, P125, DOI 10.1002/gene.10172; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	69	43	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56429	10.1371/journal.pone.0056429	http://dx.doi.org/10.1371/journal.pone.0056429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409184	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300074
J	Cook, TR; Lescroel, A; Cherel, Y; Kato, A; Bost, CA				Cook, Timothee R.; Lescroel, Amelie; Cherel, Yves; Kato, Akiko; Bost, Charles-Andre			Can Foraging Ecology Drive the Evolution of Body Size in a Diving Endotherm?	PLOS ONE			English	Article							SHAG PHALACROCORAX NIVALIS; SOUTH-GEORGIAN SHAGS; REARING CROZET SHAGS; SEXUAL-DIMORPHISM; KING CORMORANTS; DIET; BEHAVIOR; PATTERNS; ALLOMETRY; ISLAND	Within a single animal species, different morphs can allow for differential exploitation of foraging niches between populations, while sexual size dimorphism can provide each sex with access to different resources. Despite being potentially important agents of evolution, resource polymorphisms, and the way they operate in wild populations, remain poorly understood. In this study, we examine how trophic factors can select for different body sizes between populations and sexes in a diving endotherm. Dive depth and duration are positively related to body size in diving birds and mammals, a relationship explained by a lower mass-specific metabolic rate and greater oxygen stores in larger individuals. Based on this allometry, we predict that selection for exploiting resources situated at different depths can drive the evolution of body size in species of diving endotherms at the population and sexual level. To test this prediction, we studied the foraging ecology of Blue-eyed Shags, a group of cormorants with male-biased sexual size dimorphism from across the Southern Ocean. We found that mean body mass and relative difference in body mass between sexes varied by up to 77% and 107% between neighbouring colonies, respectively. Birds from colonies with larger individuals dived deeper than birds from colonies with smaller individuals, when accounting for sex. In parallel, males dived further offshore and deeper than females and the sexual difference in dive depth reflected the level of sexual size dimorphism at each colony. We argue that body size in this group of birds is under intense selection for diving to depths of profitable benthic prey patches and that, locally, sexual niche divergence selection can exaggerate the sexual size dimorphism of Blue-eyed Shags initially set up by sexual selection. Our findings suggest that trophic resources can select for important geographic micro-variability in body size between populations and sexes.	[Cook, Timothee R.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol,Natl Res Fdn, Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Cook, Timothee R.; Lescroel, Amelie; Cherel, Yves; Bost, Charles-Andre] CNRS, Ctr Etud Biol Chize, Unite Propre Rech 1934, Villiers En Bois, France; [Lescroel, Amelie] CNRS, Ctr Ecol Fonct & Evolut, Unite Mixte Rech 5175, F-34033 Montpellier, France; [Kato, Akiko] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Kato, Akiko] CNRS, Unite Mixte Rech 7178, Strasbourg, France; [Kato, Akiko] Natl Inst Polar Res, Itabashi Ku, Tokyo 1738515, Japan	National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Cook, TR (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol,Natl Res Fdn, Ctr Excellence, ZA-7700 Rondebosch, South Africa.	timothee.cook@gmail.com	Kato, Akiko/W-2447-2019	Kato, Akiko/0000-0002-8947-3634; Cook, Timothee/0000-0003-2354-824X	French polar institute (Institut Paul Emile Victor-IPEV) [394]	French polar institute (Institut Paul Emile Victor-IPEV)	This research was funded by program number 394 of the French polar institute (Institut Paul Emile Victor-IPEV, URL: http://www.institut-polaire.fr/), with the logistical help of the Terres Australes et Antarctiques Francaises (TAAF, URL: http://www.taaf.fr/spip/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; Andersson Malte, 1994; Bergmann C., 1847, GOTT STUD, P1595; BERNSTEIN NP, 1984, CONDOR, V86, P151, DOI 10.2307/1367031; Bevan RM, 1997, J EXP BIOL, V200, P661; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; BOAG PT, 1983, EVOLUTION, V37, P877, DOI 10.1111/j.1558-5646.1983.tb05618.x; BOST CA, 1992, J ZOOL, V226, P135, DOI 10.1111/j.1469-7998.1992.tb06132.x; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Brischoux F, 2008, J EVOLUTION BIOL, V21, P324, DOI 10.1111/j.1420-9101.2007.01438.x; BROWN CR, 1990, TRENDS ECOL EVOL, V5, P398, DOI 10.1016/0169-5347(90)90023-7; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; BURGER AE, 1978, ZOOL AFR, V13, P81, DOI 10.1080/00445096.1978.11447608; BUTLER PJ, 1982, ADV COMP PHYSIOL BIO, V8, P179; CAMPO JJ, 1993, J FIELD ORNITHOL, V64, P135; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Casaux R, 2001, J FIELD ORNITHOL, V72, P22, DOI 10.1648/0273-8570-72.1.22; Casaux R, 2000, WATERBIRDS, V23, P489, DOI 10.2307/1522188; Childress RB, 2002, J AVIAN BIOL, V33, P23, DOI 10.1034/j.1600-048X.2002.330105.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Cook TR, 2007, ANTARCT SCI, V19, P55, DOI 10.1017/S0954102007000089; Cook TR, 2007, ANIM BEHAV, V74, P649, DOI 10.1016/j.anbehav.2006.11.024; Cook TR, 2012, MAR BIOL, V159, P373, DOI 10.1007/s00227-011-1815-3; Cook TR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009839; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; COOPER J, 1986, IBIS, V128, P562, DOI 10.1111/j.1474-919X.1986.tb02707.x; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Darwin C., 1874, DESCENT MAN SELECTIO; Daunt F, 2003, IBIS, V145, P54, DOI 10.1046/j.1474-919X.2003.00120.x; Duhamel G., 2005, POISSONS ILES KERGUE; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FAIRBAIRN J, 1993, OIKOS, V68, P139, DOI 10.2307/3545319; Favero M, 1998, CONDOR, V100, P112, DOI 10.2307/1369902; Fonteneau F, 2009, IBIS, V151, P286, DOI 10.1111/j.1474-919X.2009.00909.x; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Green K, 1997, EMU, V97, P76, DOI 10.1071/MU97008; Green K, 1997, EMU, V97, P60, DOI 10.1071/MU97006; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Kato A, 1999, CR ACAD SCI III-VIE, V322, P557, DOI 10.1016/S0764-4469(00)88525-X; Kato A, 1996, POLAR BIOL, V16, P75, DOI 10.1007/BF02388738; Kato A, 2000, AUK, V117, P718, DOI 10.1642/0004-8038(2000)117[0718:VIFAPB]2.0.CO;2; Kennedy M, 2000, MOL PHYLOGENET EVOL, V17, P345, DOI 10.1006/mpev.2000.0840; KOFFIJBERG K, 1995, ARDEA, V83, P37; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Koubbi P, 1992, THESIS U PIERRE MARI; Lescroel A, 2004, POLAR BIOL, V27, P206, DOI 10.1007/s00300-003-0571-3; Lescroel A, 2005, THESIS U L PASTEUR S; MALACALAZA VE, 1988, COLON WATERBIRD, V11, P32, DOI 10.2307/1521167; Martinez I., 1992, P140; Moe B, 2004, J EXP BIOL, V207, P4067, DOI 10.1242/jeb.01226; Moorhouse Ron J., 1996, Notornis, V43, P19; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Nelson JB, 2005, PELICANS CORMORANTS; Orta J., 1992, P326; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; Radford AN, 2004, AUK, V121, P178, DOI 10.1642/0004-8038(2004)121[0178:ESDIGW]2.0.CO;2; Randall DJ, 2002, ECKERT ANIMAL PHYSL, V5; Rensch B., 1960, EVOLUTION SPECIES LE; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Schew William A., 1998, Oxford Ornithology Series, V8, P288; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; SHINE R, 1988, AM NAT, V131, P124, DOI 10.1086/284778; SHINE R, 1991, AM NAT, V138, P103, DOI 10.1086/285207; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Taylor SS, 2002, CAN J ZOOL, V80, P700, DOI 10.1139/Z02-046; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Walton P, 1998, ANIM BEHAV, V56, P165, DOI 10.1006/anbe.1998.0759; WANLESS S, 1995, CONDOR, V97, P550, DOI 10.2307/1369040; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watanuki Y, 1999, CAN J ZOOL, V77, P1838, DOI 10.1139/cjz-77-11-1838; Watanuki Y, 1996, CAN J ZOOL, V74, P1098, DOI 10.1139/z96-122; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Wilson RP, 1991, ACT 20 C INT ORN CHR, P1852; YDENBERG RC, 1989, J THEOR BIOL, V139, P437, DOI 10.1016/S0022-5193(89)80064-5	92	31	31	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56297	10.1371/journal.pone.0056297	http://dx.doi.org/10.1371/journal.pone.0056297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409169	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200129
J	Hesketh, A; Conti-Ramsden, G				Hesketh, Anne; Conti-Ramsden, Gina			Memory and Language in Middle Childhood in Individuals with a History of Specific Language Impairment	PLOS ONE			English	Article							NON-WORD REPETITION; SHORT-TERM-MEMORY; NONWORD REPETITION; WORKING-MEMORY; READING IMPAIRMENT; CHILDREN; SLI; TENSE; LITERACY; MARKERS	This study reports on the sensitivity of sentence repetition as a marker of specific language impairment (SLI) in different subgroups of children in middle childhood and examines the role of memory and grammatical knowledge in the performance of children with and without language difficulties on this task. Eleven year old children, 197 with a history of SLI and 75 typically developing (TD) peers were administered sentence repetition, phonological short term memory (PSTM) and grammatical morphology tasks. Children with a history of SLI were divided into four subgroups: specific language impairment, non-specific language impairment, low cognition with resolved language and resolved. Performance on the sentence repetition task was significantly impaired in all four subgroups of children with a history of SLI when compared to their age peers. Regression analyses revealed grammatical knowledge was predictive of performance for TD children and children with a history of SLI. However, memory abilities were significantly predictive of sentence repetition task performance for children with a history of SLI only. Processes involved in sentence repetition are more taxing of PSTM for individuals with a history of SLI in middle childhood in a way that does not appear to be the case for TD children.	[Hesketh, Anne; Conti-Ramsden, Gina] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Manchester	Conti-Ramsden, G (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	gina.conti-ramsden@manchester.ac.uk		Hesketh, Anne/0000-0003-0583-0217	Nuffield Foundation [DIR/28]; Economic and Social Research Council [RES-062-23-2745]; Economic and Social Research Council [ES/I00064X/1] Funding Source: researchfish; ESRC [ES/I00064X/1] Funding Source: UKRI	Nuffield Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The sources of funding that have supported the work are the Nuffield Foundation(www.nuffieldfoundation.org) grant number DIR/28 and the Economic and Social Research Council (www.esrc.ac.uk) grant number RES-062-23-2745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald LMD, 2006, J SPEECH LANG HEAR R, V49, P970, DOI 10.1044/1092-4388(2006/070); Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A., 2007, WORKING MEMORY THOUG; Baird G, 2011, DEV MED CHILD NEUROL, V53, P711, DOI 10.1111/j.1469-8749.2011.03936.x; Bedore LM, 1998, J SPEECH LANG HEAR R, V41, P1185, DOI 10.1044/jslhr.4105.1185; Bishop DVM, 2006, CURR DIR PSYCHOL SCI, V15, P217, DOI 10.1111/j.1467-8721.2006.00439.x; Bishop DVM, 2009, CHILD DEV, V80, P593, DOI 10.1111/j.1467-8624.2009.01281.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Bishop DVM, 1982, TEST RECEPTION GRAMM; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Botting N, 2001, INT J LANG COMM DIS, V36, P421, DOI 10.1080/13682820110074971; Bowyer-Crane C, 2008, J CHILD PSYCHOL PSYC, V49, P422, DOI 10.1111/j.1469-7610.2007.01849.x; Coady JA, 2008, INT J LANG COMM DIS, V43, P1, DOI 10.1080/13682820601116485; Conti-Ramsden G, 2003, INT J LANG COMM DIS, V38, P251, DOI 10.1080/1368282031000092339; Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G, 2007, J CHILD PSYCHOL PSYC, V48, P147, DOI 10.1111/j.1469-7610.2006.01703.x; Conti-Ramsden G, 2012, J SPEECH LANG HEAR R, V55, P1716, DOI 10.1044/1092-4388(2012/10-0182); ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; Gathercole S. E., 1996, CHILDRENS TEST NONWO; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); Leonard LB, 2004, J SPEECH LANG HEAR R, V47, P1363, DOI 10.1044/1092-4388(2004/102); Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Marchman VA, 1999, J SPEECH LANG HEAR R, V42, P206, DOI 10.1044/jslhr.4201.206; Marshall C. M., 2003, ED CHILD PSYCHOL, V20, P7; Melby-Lervag M, 2012, DEV PSYCHOL, DOI [10.1037/a0020228, DOI 10.1037/A0020228]; Miller CA, 2001, J SPEECH LANG HEAR R, V44, P416, DOI 10.1044/1092-4388(2001/034); Miller CA, 2008, INT J LANG COMM DIS, V43, P346, DOI 10.1080/13682820701546813; Newbury DF, 2005, TRENDS COGN SCI, V9, P528, DOI 10.1016/j.tics.2005.09.002; Poll GH, 2010, J SPEECH LANG HEAR R, V53, P414, DOI 10.1044/1092-4388(2009/08-0016); RAVEN JC, 1986, COLOURED PROGR MATRI; Rice ML, 2004, J SPEECH LANG HEAR R, V47, P816, DOI 10.1044/1092-4388(2004/061); RICE ML, 1995, J SPEECH HEAR RES, V38, P850, DOI 10.1044/jshr.3804.850; Rice ML, 1996, J SPEECH HEAR RES, V39, P1239, DOI 10.1044/jshr.3906.1239; Rice ML, 1998, J SPEECH HEAR RES, V47, P816; Riches NG, 2010, INT J LANG COMM DIS, V45, P47, DOI 10.3109/13682820802647676; Riches NG, 2012, INT J LANG COMM DIS, V47, P499, DOI 10.1111/j.1460-6984.2012.00158.x; Rispens J, 2012, J SPEECH LANG HEAR R, V55, P683, DOI 10.1044/1092-4388(2011/10-0263); Semel E., 1994, CLIN EVALUATION LANG; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; van der Lely HKJ, 2003, LANGUAGE, V79, P153, DOI 10.1353/lan.2003.0089; Wechsler D., 1992, WECHSLER INTELLIGENC; Weismer SE, 2000, J SPEECH LANG HEAR R, V43, P865, DOI 10.1044/jslhr.4304.865	49	28	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56314	10.1371/journal.pone.0056314	http://dx.doi.org/10.1371/journal.pone.0056314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409172	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200132
J	Roche, S; El Garch, H; Brunet, S; Poulet, H; Iwaz, J; Ecochard, R; Vanhems, P				Roche, Sylvain; El Garch, Hanane; Brunet, Sylvie; Poulet, Herve; Iwaz, Jean; Ecochard, Rene; Vanhems, Philippe			Diversity of Trends of Viremia and T-Cell Markers in Experimental Acute Feline Immunodeficiency Virus Infection	PLOS ONE			English	Article							HIV-1 DISEASE PROGRESSION; VIRAL LOAD; DEVELOPMENTAL TRAJECTORIES; IMMUNE ACTIVATION; DOSE-RESPONSE; CATS; TRANSMISSION; MODEL; FIV; RNA	Objective: The early events of human immunodeficiency virus infection seem critical for progression toward disease and antiretroviral therapy initiation. We wanted to clarify some still unknown prognostic relationships between inoculum size and changes in various immunological and virological markers. Feline immunodeficiency virus infection could be a helpful model. Methods: Viremia and T-cell markers (number of CD4, CD8, CD8 beta(low)CD62L(neg) T-cells, CD4/CD8 ratio, and percentage of CD8 beta(low)CD62L(neg) cells among CD8 T-cells) were measured over 12 weeks in 102 cats infected with different feline immunodeficiency virus strains and doses. Viremia and T-cell markers trajectory groups were determined and the dose-response relationships between inoculum titres and trajectory groups investigated. Results: Cats given the same inoculum showed different patterns of changes in viremia and T-cell markers. A statistically significant positive dose-response relationship was observed between inoculum titre and i) viremia trajectory-groups (r = 0.80, p<0.01), ii) CD8 beta(low)CD62L(neg) cell-fraction trajectory-groups (r = 0.56, p<0.01). Significant correlations were also found between viremia and the CD4/CD8 ratio and between seven out of ten T-cell markers. Conclusions: In cats, the infectious dose determines early kinetics of viremia and initial CD8+ T-cell activation. An expansion of the CD8 beta(low)CD62L(neg) T-cells might be an early predictor of progression toward disease. The same might be expected in humans but needs confirmation.	[Roche, Sylvain; Iwaz, Jean; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Roche, Sylvain; Iwaz, Jean; Ecochard, Rene; Vanhems, Philippe] Univ Lyon, Lyon, France; [Roche, Sylvain; Iwaz, Jean; Ecochard, Rene; Vanhems, Philippe] Univ Lyon 1, F-69622 Villeurbanne, France; [Roche, Sylvain; Iwaz, Jean; Ecochard, Rene] Ctr Natl Rech Sci, Unite Mixte Rech 5558, Equipe Biotat Sante, Villeurbanne, France; [El Garch, Hanane; Brunet, Sylvie; Poulet, Herve] Merial SAS, Discovery Res, Lyon, France; [Vanhems, Philippe] Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France; [Vanhems, Philippe] Ctr Natl Rech Sci, Unite Mixte Rech 5558, Equipe Epidemiol & Sante Publ, Villeurbanne, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Merial SASU; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Roche, S (corresponding author), Hosp Civils Lyon, Serv Biostat, Lyon, France.	sylvain.roche02@chu-lyon.fr			Merial; Direction Generale de la Competitivite de l'Industrie et des Services; Le Grand Lyon; Conseil General de l'Isere; Conseil General du Rhone; Lyon Biopole	Merial; Direction Generale de la Competitivite de l'Industrie et des Services; Le Grand Lyon(Region Auvergne-Rhone-Alpes); Conseil General de l'Isere(Region Auvergne-Rhone-Alpes); Conseil General du Rhone(Region Auvergne-Rhone-Alpes); Lyon Biopole	This study was financially supported by Merial (fr.merial.com), the Direction Generale de la Competitivite de l'Industrie et des Services, Le Grand Lyon, the Conseil General de l'Isere, and the Conseil General du Rhone. The financial coordination was handled by Lyon Biopole (www.lyonbiopole.org), as the FIV-Vax project. Researchers of Merial were responsible for the study design and data collection. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Bajaria SH, 2002, J ACQ IMMUN DEF SYND, V30, P41, DOI 10.1097/00042560-200205010-00006; Buchacz K, 2004, JAIDS-J ACQ IMM DEF, V36, P853, DOI 10.1097/00126334-200407010-00013; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Davenport MP, 2006, JAIDS-J ACQ IMM DEF, V41, P259, DOI 10.1097/01.qai.0000199232.31340.d3; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Gebhard DH, 1999, J INFECT DIS, V180, P1503, DOI 10.1086/315089; Geskus RB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-65; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Ho DD, 1996, SCIENCE, V272, P1124, DOI 10.1126/science.272.5265.1124; Hokanson RM, 2000, VET MICROBIOL, V76, P311, DOI 10.1016/S0378-1135(00)00263-7; Hosie MJ, 2007, AUST VET J, V85, P5, DOI 10.1111/j.1751-0813.2006.00071.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kassutto S, 2004, CLIN INFECT DIS, V38, P1452, DOI 10.1086/420745; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Nagin DS, 2005, CRIMINOLOGY, V43, P873, DOI 10.1111/j.1745-9125.2005.00026.x; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Paillot R, 2005, VET IMMUNOL IMMUNOP, V106, P1, DOI 10.1016/j.vetimm.2004.12.023; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Regoes RR, 2005, PLOS MED, V2, P798, DOI 10.1371/journal.pmed.0020249; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sparger E, 2006, INFECT AGENTS PATHOG, P189; Sprague WS, 2010, VET IMMUNOL IMMUNOP, V134, P115, DOI 10.1016/j.vetimm.2009.10.016; Thiebaut R, 2002, COMPUT METH PROG BIO, V69, P249, DOI 10.1016/S0169-2607(02)00017-2; Tompkins MB, 2008, VET IMMUNOL IMMUNOP, V123, P45, DOI 10.1016/j.vetimm.2008.01.011; TOMPKINS MB, 1991, J AM VET MED ASSOC, V199, P1311; Vanhems P, 1998, CLIN INFECT DIS, V26, P323, DOI 10.1086/516289; Vanhems P, 2000, J INFECT DIS, V182, P334, DOI 10.1086/315687; WILLETT BJ, 1993, IMMUNOLOGY, V78, P1	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56135	10.1371/journal.pone.0056135	http://dx.doi.org/10.1371/journal.pone.0056135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409138	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200112
J	Schulz, E; Piotrowski, V; Clauss, M; Mau, M; Merceron, G; Kaiser, TM				Schulz, Ellen; Piotrowski, Vanessa; Clauss, Marcus; Mau, Marcus; Merceron, Gildas; Kaiser, Thomas M.			Dietary Abrasiveness Is Associated with Variability of Microwear and Dental Surface Texture in Rabbits	PLOS ONE			English	Article							WESTERN CAPE PROVINCE; SOUTH-AFRICA; MAKAPANSGAT-LIMEWORKS; POPULATION VARIANCES; TOOTH MICROWEAR; MAMMALIAN TEETH; EARLY PLIOCENE; LATE MIOCENE; WEAR; PRIMATES	Dental microwear and 3D surface texture analyses are useful in reconstructing herbivore diets, with scratches usually interpreted as indicators of grass dominated diets and pits as indicators of browse. We conducted feeding experiments with four groups of rabbits (Oryctolagus cuniculus) each fed a different uniform, pelleted diet (lucerne, lucerne & oats, grass & oats, grass). The lowest silica content was measured in the lucerne and the highest in the grass diet. After 25 weeks of exposure to the diets, dental castings were made of the rabbit's lower molars. Occlusal surfaces were then investigated using dental microwear and 3D areal surface texture analysis. In terms of traditional microwear, we found our hypothesis supported, as the grass group showed a high proportion of (long) "scratches'' and the lucerne group a high proportion of "pits''. Regardless of the uniform diets, variability of microwear and surface textures was higher when silica content was low. A high variability in microwear and texture analysis thus need not represent dietary diversity, but can also be related to a uniform, low-abrasion diet. The uniformity or variability of microwear/texture analysis results thus might represent varying degrees of abrasion and attrition rather than a variety of diet items per se.	[Schulz, Ellen; Piotrowski, Vanessa; Kaiser, Thomas M.] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Schulz, Ellen; Piotrowski, Vanessa; Kaiser, Thomas M.] Univ Hamburg, Zool Museum, Hamburg, Germany; [Clauss, Marcus] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Mau, Marcus] Kings Coll London, Inst Dent, Guys Hosp, London WC2R 2LS, England; [Merceron, Gildas] Univ Poitiers, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Unite Mixte Rech Ctr Nacl Rech Sci 7262, Poitiers, France	University of Hamburg; University of Hamburg; University of Zurich; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Universite de Poitiers	Schulz, E (corresponding author), Univ Hamburg, Bioctr Grindel, Hamburg, Germany.	ellen.schulz@uni-hamburg.de	Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008; Schulz-Kornas, Ellen/B-8505-2013; Clauss, Marcus/GRR-7996-2022; Merceron, Gildas/C-8648-2012; Kaiser, Thomas/G-8883-2015	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Schulz-Kornas, Ellen/0000-0003-1657-8256; Clauss, Marcus/0000-0003-3841-6207; Merceron, Gildas/0000-0001-5777-7126; Kaiser, Thomas/0000-0002-8154-1751	DFG [KA 1525/8-1]; Humboldt research fellowship for postdoctoral researchers	DFG(German Research Foundation (DFG)); Humboldt research fellowship for postdoctoral researchers	This work was funded by DFG KA 1525/8-1 and a Humboldt research fellowship for postdoctoral researchers (to GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; BUTLER PM, 1972, EVOLUTION, V26, P474, DOI 10.1111/j.1558-5646.1972.tb01951.x; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; Calandra I, 2012, J HUM EVOL, V63, P85, DOI 10.1016/j.jhevol.2012.05.001; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Gidenne T, 2006, FEEDING IN DOMESTIC VERTEBRATES: FROM STRUCTURE TO BEHAVIOUR, P179, DOI 10.1079/9781845930639.0179; Golenishev FN, 1979, J MAMMAL, V60, P397; HEALY W. B., 1965, NEW ZEAL J AGR RES, V8, P737; Hopley PJ, 2006, PALAEOGEOGR PALAEOCL, V233, P235, DOI 10.1016/j.palaeo.2005.09.011; International Organization for Standardization, 2010, 251782 ISOFDIS; Kaiser TM, 2006, PALAEOGEOGR PALAEOCL, V239, P221, DOI 10.1016/j.palaeo.2006.01.013; Kaiser TM, 2011, MAMMAL REV; Leiber F, 2008, LIPIDS, V43, P853, DOI 10.1007/s11745-008-3210-5; Massey FP, 2007, J ECOL, V95, P414, DOI 10.1111/j.1365-2745.2007.01223.x; Massey FP, 2006, P R SOC B, V273, P2299, DOI 10.1098/rspb.2006.3586; MAYLAND HF, 1977, J RANGE MANAGE, V30, P264, DOI 10.2307/3897301; MCNAUGHTON SJ, 1983, P NATL ACAD SCI-BIOL, V80, P790, DOI 10.1073/pnas.80.3.790; Merceron G, 2005, S AFR J SCI, V101, P365; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, SMALL RUMINANT RES, V53, P125, DOI [10.1016/j.smallrumres.2003.10.002, 10.1016/j.smallrumers.2003.10.002]; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Merceron G, 2012, J HUM EVOL, V63, P150, DOI 10.1016/j.jhevol.2012.04.006; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Nelson S, 2005, PALAEONTOL ELECTRON, V8; Parr JF, 2001, J ARCHAEOL SCI, V28, P875, DOI 10.1006/jasc.2000.0623; Purnell MA, 2012, J R SOC INTERFACE, V9, P2225, DOI 10.1098/rsif.2012.0140; Rensberger J.M., 1978, P415; Rivals F, 2005, J ARCHAEOL SCI, V32, P1603, DOI 10.1016/j.jas.2005.04.014; Rodrigues HG, 2009, NATURWISSENSCHAFTEN, V96, P537, DOI 10.1007/s00114-008-0501-x; Rogers AM, 1994, EUROPEAN RABBIT HIST, P22; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schubert BW, 2006, PALAEOGEOGR PALAEOCL, V241, P301, DOI 10.1016/j.palaeo.2006.04.004; Schulz E, 2010, SCANNING, V32, P162, DOI 10.1002/sca.20181; Scott JR, 2009, J HUM EVOL, V56, P405, DOI 10.1016/j.jhevol.2008.11.003; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1988, PALAEOGEOGR PALAEOCL, V65, P149, DOI 10.1016/0031-0182(88)90021-1; SOLOUNIAS N, 1993, LETHAIA, V26, P261, DOI 10.1111/j.1502-3931.1993.tb01529.x; Stones HH, 1948, ORAL DENT DIS; TEAFORD MF, 1983, ARCH ORAL BIOL, V28, P1077, DOI 10.1016/0003-9969(83)90067-5; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Williams J.A., 2005, ENG TRIBOLOGY; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; Winkler DE, 2012, GEOBIOS IN PRESS; YUEN KK, 1974, BIOMETRIKA, V61, P165, DOI 10.2307/2334299	55	110	115	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56167	10.1371/journal.pone.0056167	http://dx.doi.org/10.1371/journal.pone.0056167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405263	Green Published, Green Accepted, gold			2022-12-25	WOS:000315153400209
J	Zhao, NB; Yang, K; Yang, GL; Chen, D; Tang, H; Zhao, D; Zhao, CR				Zhao, Ningbo; Yang, Kai; Yang, Genling; Chen, Dan; Tang, Hong; Zhao, Dan; Zhao, Chunrong			Aberrant Expression of Clock Gene Period1 and Its Correlations with the Growth, Proliferation and Metastasis of Buccal Squamous Cell Carcinoma	PLOS ONE			English	Article							HUMAN ORAL-MUCOSA; CIRCADIAN EXPRESSION; CANCER; PER1; REGULATOR; RHYTHMS; PLAYS	Period1 (PER1) is an important core clock gene, which regulates normal cell proliferations and physiological rhythms of human beings. Recent studies have showed aberrant expressions and altered rhythms of PER1 were highly correlated to the carcinogenesis and development of malignant tumors. However, there is no study on the correlation of aberrant expressions and altered rhythms of PER1 with the growth, proliferation and metastasis of buccal squamous cell carcinoma (BSCC). In this study, PER1 and MMP-2 expression in the cancerous and adjacent noncancerous tissues of 38 patients with BSCC and its correlations with patients' clinical pathologic characteristics were investigated. A mouse model of BSCC was also established and mice were sacrificed at 4 different time points in a period of 24 hours. Xenografted tumor weight, proliferation index (PI), and mitotic index (MI) of tumors in the 4 time groups were detected. Results showed that PER1 expression was significantly down-regulated in cancerous tissues of patients with BSCC (P<0.05). PER1 expression was significantly down-regulated in patients of T3 similar to T4 staging and those with lymph node metastasis compared to that of T1 similar to T2 staging and those without lymph node metastasis (P<0.05), respectively. PER1 mRNA expression, MI and tumor weight had significant differences among the 4 time groups, which PI all confirmed to circadian rhythms. MI, PI, MMP-2 mRNA and tumor weight had negative correlation with PER1 mRNA expression. Peak value of PER1 mRNA expression and trough values of MI, PI and tumor weight all appeared in middle activity phase, whereas trough value of PER1 mRNA expression and peak values of MI, PI and tumor weight all occurred in middle rest phase. Our study suggested that aberrant expression of PER1 had significant correlation with the growth, proliferation and metastasis of BSCC and it might act as an anti-oncogene.	[Zhao, Ningbo; Yang, Kai; Chen, Dan; Tang, Hong; Zhao, Dan; Zhao, Chunrong] Chongqing Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Chongqing, Peoples R China; [Yang, Genling] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Yang, K (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Chongqing, Peoples R China.	cqfyyk@yahoo.com.cn						Badiu C, 2003, J CELL MOL MED, V7, P408, DOI 10.1111/j.1582-4934.2003.tb00243.x; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Cao Q, 2009, CANCER RES, V69, P7619, DOI 10.1158/0008-5472.CAN-08-4199; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Davidson AJ, 2006, INT J CANCER, V118, P1623, DOI 10.1002/ijc.21591; Eismann EA, 2010, PSYCHONEUROENDOCRINO, V35, P963, DOI 10.1016/j.psyneuen.2009.12.011; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Hsu CM, 2012, TUMOR BIOL, V33, P149, DOI 10.1007/s13277-011-0258-2; Innominato PF, 2010, ADV DRUG DELIVER REV, V62, P979, DOI 10.1016/j.addr.2010.06.002; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Koyanagi S, 2003, CANCER RES, V63, P7277; Mostafaie N, 2009, MOL CARCINOGEN, V48, P642, DOI 10.1002/mc.20510; Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798; Murphy PJ, 1996, J CLIN NEUROPHYSIOL, V13, P2, DOI 10.1097/00004691-199601000-00002; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sato F, 2009, J BIOCHEM, V146, P833, DOI 10.1093/jb/mvp126; Smolensky MH, 2007, ADV DRUG DELIVER REV, V59, P828, DOI 10.1016/j.addr.2007.07.001; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yang MY, 2011, J BIOL RHYTHM, V26, P136, DOI 10.1177/0748730410395527; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Yeh KT, 2005, J PATHOL, V206, P111, DOI 10.1002/path.1756; Yoshizaki T, 2002, ONCOL REP, V9, P607; Zieker D, 2010, CELL PHYSIOL BIOCHEM, V26, P155, DOI 10.1159/000320547	28	25	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55894	10.1371/journal.pone.0055894	http://dx.doi.org/10.1371/journal.pone.0055894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405233	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400178
J	Li, W; Anderson, RA				Li, W.; Anderson, R. A.			Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16	ONCOGENE			English	Article						p53; HPV E6; VP-16; Star-PAP; polyadenylation; cell growth and proliferation	CERVICAL-CANCER CELLS; MESSENGER-RNA; E7 ONCOPROTEIN; E6-MEDIATED DEGRADATION; EXPRESSION; RESTORATION; APOPTOSIS; ALPHA; TRANSCRIPTS; COMBINATION	Cervical cancer is the most common genital malignancy and the high-risk human papillomaviruses (HPV type 16, 18 and 31, and so on) are major agents for its cause. A key switch for the onset of cervical cancers by HPVs is the cellular degradation of the tumor-suppressor p53 that is mediated by the HPV-generated E6 protein. E6 forms a complex with the E3 ubiquitin-ligase E6-associated protein (E6AP) leading to p53 degradation. The components that control E6 expression and the mechanisms for regulation of the expression in host cells remain undefined. Here we show that the nuclear noncanonical poly(A) polymerase (PAP) speckle targeted PIPKI alpha regulated PAP (Star-PAP) controls E6 mRNA polyadenylation and expression and modulates wild-type p53 levels as well as cell cycle profile in high-risk HPV-positive cells. In the absence of Star-PAP, treatment of cells with the chemotherapeutic drug VP-16 dramatically reduced E6 and increased p53 levels. This diminished both cell proliferation and anchorage-independent growth required for cancer progression, indicating a synergism between VP-16 treatment and the loss of Star-PAP. This identifies Star-PAP as a potential drug target for the treatment of HPV-positive cancer cells. These data provide a mechanistic basis for increasing the sensitivity and efficiency of chemotherapy in the treatment of cancers that have low levels of wild-type p53.	[Li, W.; Anderson, R. A.] Univ Wisconsin Madison, Mol & Cellular Pharmacol Program, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin Madison, Mol & Cellular Pharmacol Program, 1300 Univ Ave,3750 Med Sci Ctr, Madison, WI 53706 USA.	raanders@wisc.edu		Li, Weimin/0000-0002-2170-7094; Anderson, Richard/0000-0001-6265-8359	US National Institutes of Health [GM051968]; American Heart Association [12SDG12100035]; NATIONAL CANCER INSTITUTE [R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114386, R01GM051968] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Anderson laboratory for discussion and comments, and thank Dr Paul F Lambert's laboratory at UW-Madison for SiHa and CaSki cell lines. This work was supported by a grant (GM051968) from the US National Institutes of Health and a Scientist Development Grant (12SDG12100035) from the American Heart Association.	Clifford B, 2003, CANCER RES, V63, P4074; Fiedler M, 2004, FASEB J, V18, P1120, DOI 10.1096/fj.03-1332fje; Gonzales ML, 2008, J BIOL CHEM, V283, P12665, DOI 10.1074/jbc.M800656200; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Kanduc D, 2002, J VIROL, V76, P7040, DOI 10.1128/JVI.76.14.7040-7048.2002; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Koivusalo R, 2005, MOL PHARMACOL, V68, P372, DOI 10.1124/mol.105.011189; Laishram RS, 2011, NUCLEIC ACIDS RES, V39, P7961, DOI 10.1093/nar/gkr549; Laishram RS, 2010, EMBO J, V29, P4132, DOI 10.1038/emboj.2010.287; Lappalainen K, 1996, ANTICANCER RES, V16, P2485; Li WM, 2007, CIRC RES, V100, P79, DOI 10.1161/01.RES.0000253094.03023.3f; Li W, 2012, MOL CELL, V45, P25, DOI 10.1016/j.molcel.2011.11.017; Li W, 2009, P NATL ACAD SCI USA, V106, P486, DOI 10.1073/pnas.0804177106; Liu YM, 2000, J CELL BIOCHEM, V78, P334, DOI 10.1002/(SICI)1097-4644(20000801)78:2<334::AID-JCB15>3.3.CO;2-6; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Murray EL, 2008, METHOD ENZYMOL, V448, P483, DOI 10.1016/S0076-6879(08)02624-4; Oh KJ, 2006, J VIROL, V80, P7079, DOI 10.1128/JVI.02380-05; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; SALLES FJ, 1995, PCR METH APPL, V4, P317; Sauter ER, 2002, CANCER GENE THER, V9, P807, DOI 10.1038/sj.cgt.7700492; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; Sigal A, 2000, CANCER RES, V60, P6788; Skladanowski A, 1997, CANCER RES, V57, P818; Sotlar K, 2004, J MED VIROL, V74, P107, DOI 10.1002/jmv.20153; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vinther J, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-83; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Wesierska-Gadek J, 2002, INT J CANCER, V101, P128, DOI 10.1002/ijc.10580; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971	34	10	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					928	932		10.1038/onc.2013.14	http://dx.doi.org/10.1038/onc.2013.14			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23416977	Green Accepted			2022-12-25	WOS:000331626900014
J	Goulart, CP; Mahmudi, M; Crona, KA; Jacobs, SD; Kallmann, M; Hall, BG; Greene, DC; Barlow, M				Goulart, Christiane P.; Mahmudi, Mentar; Crona, Kristina A.; Jacobs, Stephen D.; Kallmann, Marcelo; Hall, Barry G.; Greene, Devin C.; Barlow, Miriam			Designing Antibiotic Cycling Strategies by Determining and Understanding Local Adaptive Landscapes	PLOS ONE			English	Article							ANTIMICROBIAL SURVEILLANCE PROGRAM; BETA-LACTAMASE; EUROPEAN SURVEILLANCE; CONSUMPTION ESAC; ESCHERICHIA-COLI; PACIFIC REGION; LATIN-AMERICA; SOUTH-AFRICA; RESISTANCE; EVOLUTION	The evolution of antibiotic resistance among bacteria threatens our continued ability to treat infectious diseases. The need for sustainable strategies to cure bacterial infections has never been greater. So far, all attempts to restore susceptibility after resistance has arisen have been unsuccessful, including restrictions on prescribing [1] and antibiotic cycling [2,3]. Part of the problem may be that those efforts have implemented different classes of unrelated antibiotics, and relied on removal of resistance by random loss of resistance genes from bacterial populations (drift). Here, we show that alternating structurally similar antibiotics can restore susceptibility to antibiotics after resistance has evolved. We found that the resistance phenotypes conferred by variant alleles of the resistance gene encoding the TEM beta-lactamase (bla(TEM)) varied greatly among 15 different beta-lactam antibiotics. We captured those differences by characterizing complete adaptive landscapes for the resistance alleles bla(TEM-50) and bla(TEM-85), each of which differs from its ancestor bla(TEM-1) by four mutations. We identified pathways through those landscapes where selection for increased resistance moved in a repeating cycle among a limited set of alleles as antibiotics were alternated. Our results showed that susceptibility to antibiotics can be sustainably renewed by cycling structurally similar antibiotics. We anticipate that these results may provide a conceptual framework for managing antibiotic resistance. This approach may also guide sustainable cycling of the drugs used to treat malaria and HIV.	[Goulart, Christiane P.; Crona, Kristina A.; Jacobs, Stephen D.; Greene, Devin C.; Barlow, Miriam] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Mahmudi, Mentar; Kallmann, Marcelo] Univ Calif Merced, Sch Engn, Merced, CA USA; [Hall, Barry G.] Bellingham Res Inst, Bellingham, WA USA	University of California System; University of California Merced; University of California System; University of California Merced	Barlow, M (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	miriam.barlow@gmail.com			NIH [1R15GM090164-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090164] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH Grant 1R15GM090164-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Baraniak A, 2005, ANTIMICROB AGENTS CH, V49, P1872, DOI 10.1128/AAC.49.5.1872-1880.2005; Barlow M, 2002, GENETICS, V160, P823; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P923, DOI 10.3934/mbe.2010.7.923; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P527, DOI 10.3934/mbe.2010.7.527; Beerenwinkel N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-60; Bell JM, 2007, J CLIN MICROBIOL, V45, P1478, DOI 10.1128/JCM.02470-06; Bell JM, 2002, INT J ANTIMICROB AG, V19, P125, DOI 10.1016/S0924-8579(01)00475-7; Bell JM, 2002, DIAGN MICR INFEC DIS, V42, P193, DOI 10.1016/S0732-8893(01)00353-4; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Carneiro M, 2010, P NATL ACAD SCI USA, V107, P1747, DOI 10.1073/pnas.0906192106; Coenen S, 2006, J ANTIMICROB CHEMOTH, V58, P413, DOI 10.1093/jac/dkl185; Crona K, 2012, J THEORETICAL BIOL C, V317C, P1; Crona K, 2013, J THEOR BIOL, V317, P1, DOI 10.1016/j.jtbi.2012.09.028; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; DEAN AM, 1988, MOL BIOL EVOL, V5, P469; DEAN AM, 1995, GENETICS, V139, P19; DEAN AM, 1989, GENETICS, V123, P441; DEAN AM, 1986, GENET RES, V48, P1, DOI 10.1017/S0016672300024587; Dean CR, 2003, ANTIMICROB AGENTS CH, V47, P972, DOI 10.1128/AAC.47.3.972-978.2003; DEAN JLE, 1994, BIOCHEM J, V301, P13, DOI 10.1042/bj3010013; Dykhuizen DE, 2004, GENETICS, V167, P2015, DOI 10.1534/genetics.103.025205; DYKHUIZEN DE, 1987, GENETICS, V115, P25; DYKHUIZEN DE, 1994, EVOL ECOL, V8, P524, DOI 10.1007/BF01238256; Fedler KA, 2006, DIAGN MICR INFEC DIS, V56, P427, DOI 10.1016/j.diagmicrobio.2006.07.003; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P408, DOI 10.1093/jac/dkl186; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P423, DOI 10.1093/jac/dkl183; Franke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002134; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; GILLESPIE JH, 1978, THEOR POPUL BIOL, V14, P1, DOI 10.1016/0040-5809(78)90002-3; HARTL DL, 1985, GENETICS, V111, P655; Institute CaLS, 2008, PERF STAND ANT SUSC; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M, 1962, GENETICS, V47, P713; Kimura M., 1983, EVOLUTION GENES PROT; Kimura MA, 1985, NEUTRAL THEORY MOL E; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; Livermore DM, 1996, SCAND J INFECT DIS, P33; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Mendes RE, 2004, ANTIMICROB AGENTS CH, V48, P1433, DOI 10.1128/AAC.48.4.1433-1434.2004; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Mroczkowska JE, 2008, ANTIMICROB AGENTS CH; Mroczkowska JE, 2008, ANTIMICROB AGENTS CH, V52, P3408, DOI 10.1128/AAC.00501-08; Perron GG, 2012, P ROY SOC B-BIOL SCI, V279, P1477, DOI 10.1098/rspb.2011.1933; Sarraf-Yazdi S, 2012, J SURG RES, V176, pE73, DOI 10.1016/j.jss.2011.12.014; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Sirot D, 1997, ANTIMICROB AGENTS CH, V41, P1322, DOI 10.1128/AAC.41.6.1322; Solomon S, 2003, AM J INFECT CONTROL, V31, P481; Steward CD, 2000, DIAGN MICR INFEC DIS, V38, P59, DOI 10.1016/S0732-8893(00)00161-9; Tenover FC, 2003, J CLIN MICROBIOL, V41, P3142, DOI 10.1128/JCM.41.7.3142-3146.2003; Walsh TR, 2003, J ANTIMICROB CHEMOTH, V52, P116, DOI 10.1093/jac/dkg299; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	56	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56040	10.1371/journal.pone.0056040	http://dx.doi.org/10.1371/journal.pone.0056040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418506	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300098
J	Munch, EM; Harris, RA; Mohammad, M; Benham, AL; Pejerrey, SM; Showalter, L; Hu, M; Shope, CD; Maningat, PD; Gunaratne, PH; Haymond, M; Aagaard, K				Munch, Erika M.; Harris, R. Alan; Mohammad, Mahmoud; Benham, Ashley L.; Pejerrey, Sasha M.; Showalter, Lori; Hu, Min; Shope, Cynthia D.; Maningat, Patricia D.; Gunaratne, Preethi H.; Haymond, Morey; Aagaard, Kjersti			Transcriptome Profiling of microRNA by Next-Gen Deep Sequencing Reveals Known and Novel miRNA Species in the Lipid Fraction of Human Breast Milk	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; LACTATION; EVOLUTION; MACRONUTRIENT; DETERMINANTS; MAMMALS; MARKERS	While breast milk has unique health advantages for infants, the mechanisms by which it regulates the physiology of newborns are incompletely understood. miRNAs have been described as functioning transcellularly, and have been previously isolated in cell-free and exosomal form from bodily liquids (serum, saliva, urine) and tissues, including mammary tissue. We hypothesized that breast milk in general, and milk fat globules in particular, contain significant numbers of known and limited novel miRNA species detectable with massively parallel sequencing. Extracted RNA from lactating mothers before and following short-term treatment with recombinant human growth hormone (rhGH) was smRNA-enriched. smRNA-Seq was performed to generate 124,110,646 36-nt reads. Of these, 31,102,927 (25%) exactly matched known human miRNAs; with relaxing of stringency, 74,716,151 (60%) matched known miRNAs including 308 of the 1018 (29%) mature miRNAs (miRBase 16.0). These miRNAs are predicted to target 9074 genes; the 10 most abundant of these predicted to target 2691 genes with enrichment for transcriptional regulation of metabolic and immune responses. We identified 21 putative novel miRNAs, of which 12 were confirmed in a large validation set that included cohorts of lactating women consuming enriched diets. Of particular interest, we observed that expression of several novel miRNAs were altered by the perturbed maternal diet, notably following a high-fat intake (p<0.05). Our findings suggest that known and novel miRNAs are enriched in breast milk fat globules, and expression of several novel miRNA species is regulated by maternal diet. Based on robust pathway mapping, our data supports the notion that these maternally secreted miRNAs (stable in the milk fat globules) play a regulatory role in the infant and account in part for the health benefits of breast milk. We further speculate that regulation of these miRNA by a high fat maternal diet enables modulation of fetal metabolism to accommodate significant dietary challenges.	[Munch, Erika M.; Harris, R. Alan; Showalter, Lori; Hu, Min; Shope, Cynthia D.; Aagaard, Kjersti] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA; [Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mohammad, Mahmoud; Maningat, Patricia D.; Haymond, Morey] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Endocrinol & Metab, Dept Pediat,Childrens Nutr Res Ctr,USDA,ARS, Houston, TX 77030 USA; [Benham, Ashley L.; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Pejerrey, Sasha M.; Aagaard, Kjersti] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Aagaard, K (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.	aagaardt@bcm.edu	Harris, R. Alan/AAI-2784-2020; Mohammad, Mahmoud/GNO-9940-2022	Harris, R. Alan/0000-0002-7333-4752; Mohammad, Mahmoud/0000-0002-6535-5529	National Institutes of Health (NIH) Director New Innovator Award [DP2120OD001500-01]; National Institute of Child Health and Human Development (NICHD)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK080558-01]; NIH Common Fund Human Microbiome-HMP [NIHU54HG004969]; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development (NICHD)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH Common Fund Human Microbiome-HMP; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health (NIH) Director New Innovator Award (DP2120OD001500-01 KA with funded support to RH), National Institute of Child Health and Human Development (NICHD)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) # R01DK080558-01 (KA), the NIH Common Fund Human Microbiome-HMP (KA (NIHU54HG004969)), and the Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative (KA)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Dall SRX, 2004, P ROY SOC B-BIOL SCI, V271, P2049, DOI 10.1098/rspb.2004.2830; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Enright AJ, 2004, GENOME BIOL, V5; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goldman AS, 2002, J MAMMARY GLAND BIOL, V7, P277, DOI 10.1023/A:1022852700266; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Hinde K, 2010, AM J PRIMATOLOGY, V9999; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Liao YL, 2010, J NUTR, V140, P1552, DOI 10.3945/jn.110.124289; Maningat PD, 2011, PHYSIOL GENOMICS, V43, P381, DOI 10.1152/physiolgenomics.00079.2010; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mohammad MA, 2011, AM J CLIN NUTR, V93, P374, DOI 10.3945/ajcn.110.005785; Mohammad MA, 2009, AM J CLIN NUTR, V89, P1821, DOI 10.3945/ajcn.2008.26877; Neville MC, 2005, J MAMMARY GLAND BIOL, V10, P119, DOI 10.1007/s10911-005-5395-z; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Saarela T, 2005, ACTA PAEDIATR, V94, P1176, DOI 10.1080/08035250510036499; Smit AFA, 2010, REPEATMASKER OPEN 3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Stuebe A, 2009, REV OBSTET GYNECOL, V2, P65; Stuebe AM, 2010, J PERINATOL, V30, P155, DOI 10.1038/jp.2009.107; Stuebe AM, 2009, AM J PERINAT, V4, P522; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	48	126	133	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e50564	10.1371/journal.pone.0050564	http://dx.doi.org/10.1371/journal.pone.0050564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418415	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300005
J	Tempesta, D; Curcio, G; De Gennaro, L; Ferrara, M				Tempesta, Daniela; Curcio, Giuseppe; De Gennaro, Luigi; Ferrara, Michele			Long-Term Impact of Earthquakes on Sleep Quality	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; FOLLOW-UP; SURVIVORS; DEPRESSION; PTSD; INDEX; DISTURBANCES; PREVALENCE; NIGHTMARES; VETERANS	Purpose: We investigated the impact of the 6.3 magnitude 2009 L'Aquila (Italy) earthquake on standardized self-report measures of sleep quality (Pittsburgh Sleep Quality Index, PSQI) and frequency of disruptive nocturnal behaviours (Pittsburgh Sleep Quality Index-Addendum, PSQI-A) two years after the natural disaster. Methods: Self-reported sleep quality was assessed in 665 L'Aquila citizens exposed to the earthquake compared with a different sample (n = 754) of L'Aquila citizens tested 24 months before the earthquake. In addition, sleep quality and disruptive nocturnal behaviours (DNB) of people exposed to the traumatic experience were compared with people that in the same period lived in different areas ranging between 40 and 115 km from the earthquake epicenter (n = 3574). Results: The comparison between L'Aquila citizens before and after the earthquake showed a significant deterioration of sleep quality after the exposure to the trauma. In addition, two years after the earthquake L'Aquila citizens showed the highest PSQI scores and the highest incidence of DNB compared to subjects living in the surroundings. Interestingly, above-the-threshold PSQI scores were found in the participants living within 70 km from the epicenter, while trauma-related DNBs were found in people living in a range of 40 km. Multiple regressions confirmed that proximity to the epicenter is predictive of sleep disturbances and DNB, also suggesting a possible mediating effect of depression on PSQI scores. Conclusions: The psychological effects of an earthquake may be much more pervasive and long-lasting of its building destruction, lasting for years and involving a much larger population. A reduced sleep quality and an increased frequency of DNB after two years may be a risk factor for the development of depression and posttraumatic stress disorder.	[Tempesta, Daniela; Curcio, Giuseppe; Ferrara, Michele] Univ Laquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Curcio, Giuseppe] IRCCS S Raffaele, Cassino, FR, Italy; [De Gennaro, Luigi] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	University of L'Aquila; Sapienza University Rome	Ferrara, M (corresponding author), Univ Laquila, Dept Life Hlth & Environm Sci, Laquila, Italy.	michele.ferrara@cc.univaq.it	Kılıç, Cengiz/I-9145-2013; De Gennaro, Luigi/L-8711-2015; Curcio, Giuseppe/M-1635-2014; Tempesta, Daniela/AAB-7539-2022; Ferrara, Michele/AAB-7574-2022	De Gennaro, Luigi/0000-0003-3613-6631; Tempesta, Daniela/0000-0002-6942-5336; Ferrara, Michele/0000-0003-2304-7576; Curcio, Giuseppe/0000-0003-2248-781X				Applewhite L, 2012, MIL MED, V177, P501, DOI 10.7205/MILMED-D-11-00142; ARCHIBALD HC, 1962, AM J PSYCHIAT, V119, P317, DOI 10.1176/ajp.119.4.317; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chou FHC, 2004, QUAL LIFE RES, V13, P1089, DOI 10.1023/B:QURE.0000031337.73269.64; Curcio G, 2012, NEUROL SCI; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Germain A, 2004, J TRAUMA STRESS, V17, P477, DOI 10.1007/s10960-004-5796-6; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; HEFEZ A, 1987, AM J PSYCHIAT, V144, P344; Jackson M, 2011, HUMAN SLEEP COGNITIO, V2; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Krakow B, 2001, JAMA-J AM MED ASSOC, V286, P537, DOI 10.1001/jama.286.5.537; Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; Kuwabara H, 2008, PSYCHIAT CLIN NEUROS, V62, P503, DOI 10.1111/j.1440-1819.2008.01842.x; Lai TJ, 2004, J PSYCHIATR RES, V38, P313, DOI 10.1016/j.jpsychires.2003.08.005; Lau EYY, 2011, J INT NEUROPSYCH SOC, V17, P382, DOI 10.1017/S1355617711000269; LAVIE P, 1979, AM J PSYCHIAT, V136, P175; LEOPOLD RL, 1963, AM J PSYCHIAT, V119, P913, DOI 10.1176/ajp.119.10.913; Mellman TA, 2001, J TRAUMA STRESS, V14, P241, DOI 10.1023/A:1007812321136; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Mellman TA, 1997, ANN NY ACAD SCI, V821, P142, DOI 10.1111/j.1749-6632.1997.tb48275.x; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; POLNER M, 1968, TRANS-ACT-SOC SCI MO, V6, P8; Qu ZY, 2012, ARCH WOMEN MENT HLTH, V15, P49, DOI 10.1007/s00737-011-0255-x; REYNOLDS CF, 1992, BIOL PSYCHIAT, V31, P69, DOI 10.1016/0006-3223(92)90007-M; Simor P, 2012, BRAIN COGNITION, V78, P274, DOI 10.1016/j.bandc.2012.01.006; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Stickgold R, 2002, J CLIN PSYCHOL, V58, P61, DOI 10.1002/jclp.1129; Stickgold R, 2007, NAT NEUROSCI, V10, P540, DOI 10.1038/nn0507-540; Tempesta D, 2012, HIPPOCAMPUS, V22, P1154, DOI 10.1002/hipo.20961; Vingilis E, 1996, ACCIDENT ANAL PREV, V28, P637, DOI 10.1016/0001-4575(96)00036-X; Wang S., 2012, CONFL HEALTH, V6, P1, DOI DOI 10.1186/1752-1505-6-4; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; Xu JP, 2011, COMPR PSYCHIAT, V52, P431, DOI 10.1016/j.comppsych.2010.08.002; Zhang Liping, 2011, Wei Sheng Yan Jiu, V40, P744	38	52	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55936	10.1371/journal.pone.0055936	http://dx.doi.org/10.1371/journal.pone.0055936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418478	Green Published, gold			2022-12-25	WOS:000315970300070
J	Tobon, C; Ruiz-Villa, CA; Heidenreich, E; Romero, L; Hornero, F; Saiz, J				Tobon, Catalina; Ruiz-Villa, Carlos A.; Heidenreich, Elvio; Romero, Lucia; Hornero, Fernando; Saiz, Javier			A Three-Dimensional Human Atrial Model with Fiber Orientation. Electrograms and Arrhythmic Activation Patterns Relationship	PLOS ONE			English	Article							ISOLATED SHEEP HEART; PULMONARY VEINS; CATHETER ABLATION; RADIOFREQUENCY ABLATION; CARDIAC TISSUE; SINUS RHYTHM; INTRACARDIAC ECHOCARDIOGRAPHY; MATHEMATICAL-MODEL; IONIC MECHANISMS; TERMINAL CREST	The most common sustained cardiac arrhythmias in humans are atrial tachyarrhythmias, mainly atrial fibrillation. Areas of complex fractionated atrial electrograms and high dominant frequency have been proposed as critical regions for maintaining atrial fibrillation; however, there is a paucity of data on the relationship between the characteristics of electrograms and the propagation pattern underlying them. In this study, a realistic 3D computer model of the human atria has been developed to investigate this relationship. The model includes a realistic geometry with fiber orientation, anisotropic conductivity and electrophysiological heterogeneity. We simulated different tachyarrhythmic episodes applying both transient and continuous ectopic activity. Electrograms and their dominant frequency and organization index values were calculated over the entire atrial surface. Our simulations show electrograms with simple potentials, with little or no cycle length variations, narrow frequency peaks and high organization index values during stable and regular activity as the observed in atrial flutter, atrial tachycardia (except in areas of conduction block) and in areas closer to ectopic activity during focal atrial fibrillation. By contrast, cycle length variations and polymorphic electrograms with single, double and fragmented potentials were observed in areas of irregular and unstable activity during atrial fibrillation episodes. Our results also show: 1) electrograms with potentials without negative deflection related to spiral or curved wavefronts that pass over the recording point and move away, 2) potentials with a much greater proportion of positive deflection than negative in areas of wave collisions, 3) double potentials related with wave fragmentations or blocking lines and 4) fragmented electrograms associated with pivot points. Our model is the first human atrial model with realistic fiber orientation used to investigate the relationship between different atrial arrhythmic propagation patterns and the electrograms observed at more than 43000 points on the atrial surface.	[Tobon, Catalina; Romero, Lucia; Saiz, Javier] Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, E-46071 Valencia, Spain; [Ruiz-Villa, Carlos A.] Univ Caldas, Dept Sistemas, Manizales, Caldas, Colombia; [Heidenreich, Elvio] Univ Nacl Lomas de Zamora, Buenos Aires, DF, Argentina; [Hornero, Fernando] Hosp Gen Valencia, Serv Cirugia Cardiaca, Valencia, Spain; [Ruiz-Villa, Carlos A.] Univ Nacl Colombia, Dept Informat & Comp, Manizales, Caldas, Colombia	Universitat Politecnica de Valencia; Universidad de Caldas; National University of Lomas de Zamora; Universidad Nacional de Colombia	Saiz, J (corresponding author), Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, E-46071 Valencia, Spain.	jsaiz@gbio.i3bh.es	Saiz, Javier/I-1295-2015; Romero, Lucia/H-6815-2015	Saiz, Javier/0000-0002-9850-0825; Romero, Lucia/0000-0003-4605-8630; Tobon, Catalina/0000-0002-0578-329X	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Ministerio de Ciencia e Innovacion of Spain [TEC2008-02090]; Plan Avanza (Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion), Ministerio de Industria Turismo y Comercio of Spain [TSI-020100-2010-469]; Programa Prometeo of the Generalitat Valenciana; Programa de Apoyo a la Investigacion y Desarrollo de la Universitat Politecnica de Valencia [PAID-06-11-2002]	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Ministerio de Ciencia e Innovacion of Spain; Plan Avanza (Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion), Ministerio de Industria Turismo y Comercio of Spain; Programa Prometeo of the Generalitat Valenciana; Programa de Apoyo a la Investigacion y Desarrollo de la Universitat Politecnica de Valencia	This work was partially supported by the Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Ministerio de Ciencia e Innovacion of Spain (TEC2008-02090), by the Plan Avanza (Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion), Ministerio de Industria Turismo y Comercio of Spain (TSI-020100-2010-469), by the Programa Prometeo 2012 of the Generalitat Valenciana and by the Programa de Apoyo a la Investigacion y Desarrollo de la Universitat Politecnica de Valencia (PAID-06-11-2002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; Antz M, 1998, CIRCULATION, V98, P1790, DOI 10.1161/01.CIR.98.17.1790; Arora R, 2003, CIRCULATION, V107, P1816, DOI 10.1161/01.CIR.0000058461.86339.7E; Ashihara T, 2012, CIRC RES, V110, P275, DOI 10.1161/CIRCRESAHA.111.255026; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Becker R, 2001, CIRCULATION, V103, P2521, DOI 10.1161/01.CIR.103.20.2521; Berenfeld O, 2000, J CARDIOVASC ELECTR, V11, P869, DOI 10.1111/j.1540-8167.2000.tb00066.x; Berenfeld O, 2002, CIRC RES, V90, P1173, DOI 10.1161/01.RES.0000022854.95998.5C; BOINEAU JP, 1988, CIRCULATION, V77, P1221, DOI 10.1161/01.CIR.77.6.1221; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Cabrera JA, 1998, J CARDIOVASC ELECTR, V9, P1186, DOI 10.1111/j.1540-8167.1998.tb00091.x; CANAVAN TE, 1988, ANN THORAC SURG, V46, P232, DOI 10.1016/S0003-4975(10)65904-8; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Chorro FJ, 2003, PACE, V26, P1262, DOI 10.1046/j.1460-9592.2003.t01-1-00178.x; Clayton RH, 2004, PROG BIOPHYS MOL BIO, V85, P473, DOI 10.1016/j.pbiomolbio.2003.12.002; Cohen G I, 1995, J Am Soc Echocardiogr, V8, P221, DOI 10.1016/S0894-7317(05)80031-8; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; Derejko P, 2010, PACE, V33, P1518, DOI 10.1111/j.1540-8159.2010.02847.x; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; DOLBER PC, 1989, AM J PHYSIOL, V257, pH1446, DOI 10.1152/ajpheart.1989.257.5.H1446; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; Everett TH, 2001, IEEE T BIO-MED ENG, V48, P969, DOI 10.1109/10.942586; Everett TH, 2006, AM J PHYSIOL-HEART C, V291, pH2911, DOI 10.1152/ajpheart.01128.2005; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; Franz MR, 1997, J AM COLL CARDIOL, V30, P1785, DOI 10.1016/S0735-1097(97)00385-9; Friedman PA, 2000, CIRCULATION, V101, P1568, DOI 10.1161/01.CIR.101.13.1568; Gaspo R, 1997, CIRCULATION, V96, P4027; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Grimm RA, 1996, AM HEART J, V132, P286, DOI 10.1016/S0002-8703(96)90424-X; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hansson A, 1998, EUR HEART J, V19, P293, DOI 10.1053/euhj.1997.0742; Harrild DM, 2000, CIRC RES, V87, pE25; HAYASHI H, 1982, AM J PHYSIOL, V242, pH421, DOI 10.1152/ajpheart.1982.242.3.H421; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Henriquez CS, 1996, P IEEE, V84, P334, DOI 10.1109/5.486738; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Ho SY, 2002, CARDIOVASC RES, V54, P325, DOI 10.1016/S0008-6363(02)00226-2; Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525; Ho SY, 1998, INT WORKSH COMP SIM, P77; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jalife J, 2003, J CARDIOVASC ELECTR, V14, P776, DOI 10.1046/j.1540-8167.2003.03136.x; Kalifa JM, 2006, CIRCULATION, V113, P626, DOI 10.1161/CIRCULATIONAHA.105.575340; Kalman JM, 1998, J AM COLL CARDIOL, V31, P451, DOI 10.1016/S0735-1097(97)00492-0; Kholova I, 2004, CIRCULATION, V110, P483, DOI 10.1161/01.CIR.0000137117.87589.88; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Konings KTS, 1997, CIRCULATION, V95, P1231; Krogh-Madsen T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002390; Krueger MW, 2011, LECT NOTES COMPUT SC, V6666, P223, DOI 10.1007/978-3-642-21028-0_28; Lazar S, 2004, CIRCULATION, V110, P3181, DOI 10.1161/01.CIR.0000147279.91094.5E; Lemery R, 2003, AM J CARDIOL, V91, P1482, DOI 10.1016/S0002-9149(03)00405-3; Lemery R, 2007, J CARDIOVASC ELECTR, V18, P402, DOI 10.1111/j.1540-8167.2007.00762.x; Lesh MD, 1996, J ELECTROCARDIOL, V29, P101, DOI 10.1016/S0022-0736(96)80039-2; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Lin YJ, 2006, J CARDIOVASC ELECTR, V17, pS44, DOI 10.1111/j.1540-8167.2006.00632.x; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Mandapati R, 2000, CIRCULATION, V101, P194, DOI 10.1161/01.CIR.101.2.194; Mansour M, 2001, CIRCULATION, V103, P2631; Marom EM, 2004, RADIOLOGY, V230, P824, DOI 10.1148/radiol.2303030315; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Nademanee K, 2010, J CARDIOL, V55, P1, DOI 10.1016/j.jjcc.2009.11.002; NATHAN H, 1966, CIRCULATION, V34, P412, DOI 10.1161/01.CIR.34.3.412; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Niederer SA, 2011, PHILOS T R SOC A, V369, P4331, DOI 10.1098/rsta.2011.0139; Nygren A, 1998, CIRC RES, V82, P63; OLSHANSKY B, 1992, PACE, V15, P2308, DOI 10.1111/j.1540-8159.1992.tb04174.x; Pan NH, 2008, CHEST, V133, P190, DOI 10.1378/chest.07-1769; ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Ruiz C, 2010, THESIS U POLITECNICA; Ryu K, 2006, J CARDIOVASC ELECTR, V17, P198, DOI 10.1111/j.1540-8167.2005.00320.x; Sahadevan J, 2004, CIRCULATION, V110, P3293, DOI 10.1161/01.CIR.0000147781.02738.13; Saiz J, 2011, IEEE T BIO-MED ENG, V58, P43, DOI 10.1109/TBME.2010.2077292; Sanchez C, 2012, AM J PHYSIOL-HEART C, V302, pH1146, DOI 10.1152/ajpheart.00668.2011; Sanchez-Quintana D, 2002, HEART, V88, P406, DOI 10.1136/heart.88.4.406; Sanders P, 2005, CIRCULATION, V112, P789, DOI 10.1161/CIRCULATIONAHA.104.517011; Sanders P, 2006, J CARDIOVASC ELECTR, V17, P965, DOI 10.1111/j.1540-8167.2006.00546.x; Saoudi N, 2001, EUR HEART J, V22, P1162, DOI 10.1053/euhj.2001.2658; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; STRANG G, 1968, SIAM J NUMER ANAL, V5, P506, DOI 10.1137/0705041; Takahashi Y, 2006, J CARDIOVASC ELECTR, V17, P382, DOI 10.1111/j.1540-8167.2005.00414.x; Tobon C, 2010, THESIS U POLITECNICA; Tobon C, 2009, THESIS U POLITECNICA; WANG K, 1995, BRIT HEART J, V73, P559; Weigner MJ, 1999, HEART, V82, P555, DOI 10.1136/hrt.82.5.555; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilders R, 2000, PFLUG ARCH EUR J PHY, V441, P301, DOI 10.1007/s004240000413; Wolf PA, 1996, AM HEART J, V131, P790, DOI 10.1016/S0002-8703(96)90288-4; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020; Zhao JC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P361, DOI 10.1161/CIRCEP.111.967950; Zlochiver S, 2008, HEART RHYTHM, V5, P846, DOI 10.1016/j.hrthm.2008.03.010	97	66	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e50883	10.1371/journal.pone.0050883	http://dx.doi.org/10.1371/journal.pone.0050883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408928	Green Published, gold			2022-12-25	WOS:000315100000002
J	Xu, DQ; Fu, HH; Obar, JJ; Park, JJ; Tamada, K; Yagita, H; Lefrancois, L				Xu, Daqi; Fu, Han-Hsuan; Obar, Joshua J.; Park, Jang-June; Tamada, Koji; Yagita, Hideo; Lefrancois, Leo			A Potential New Pathway for PD-L1 Costimulation of the CD8-T Cell Response to Listeria monocytogenes Infection	PLOS ONE			English	Article							T-CELLS; VIRAL-INFECTION; BLOCKADE; DIFFERENTIATION; EXPRESSION; EXPANSION; TOLERANCE; IMMUNITY; EFFECTOR; OX40	Programmed death ligand-1 (PD-L1) is an important negative regulator of T cell immune responses via interactions with PD-1 and CD80. However, PD-L1 can also act as a positive costimulator, but the relevant counterreceptor is not known. We analyzed the role of PD-L1 in CD8-T cell responses to infection with Listeria monocytogenes (LM) or vesicular stomatitis virus (VSV). PD-L1 blockade impaired antigen-specific CD8 effector T cell expansion in response to LM, but not to VSV infection, particularly limiting short-lived effector cell differentiation. Simultaneous CD4-T cell depletion and anti-PD-L1 blockade revealed that PD-L1 provided costimulation even in the absence of CD4-T cells. Most importantly, specific blockade of PD-L1 binding to CD80 or to PD-1 did not recapitulate PDL-1 blockade. The results suggested that PD-L1 plays an important costimulatory role for antigen-specific CD8 T cells during LM infection perhaps through a distinct receptor or interaction epitope.	[Xu, Daqi; Fu, Han-Hsuan; Obar, Joshua J.; Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA; [Park, Jang-June; Tamada, Koji] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Obar, Joshua J.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	University of Connecticut; University System of Maryland; University of Maryland Baltimore; Juntendo University; Montana State University System; Montana State University Bozeman	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu		Obar, Joshua/0000-0003-4068-7911	National Institutes of Health [AI41576, AI76457]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI074277, R01AI041576, R01AI076457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health AI41576, AI76457. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Croft M, 2003, CYTOKINE GROWTH F R, V14, P265, DOI 10.1016/S1359-6101(03)00025-X; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Gough MJ, 2009, ADV EXP MED BIOL, V647, P94, DOI 10.1007/978-0-387-89520-8_6; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kanai T, 2003, J IMMUNOL, V171, P4156, DOI 10.4049/jimmunol.171.8.4156; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Lee SJ, 2010, J IMMUNOL, V185, P2442, DOI 10.4049/jimmunol.1000743; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; Rowe JH, 2012, J IMMUNOL, V189, P876, DOI 10.4049/jimmunol.1103227; Seo SK, 2008, IMMUNOLOGY, V123, P90, DOI 10.1111/j.1365-2567.2007.02708.x; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Yamazaki H, 2005, J IMMUNOL, V175, P1586, DOI 10.4049/jimmunol.175.3.1586; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538	24	17	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56539	10.1371/journal.pone.0056539	http://dx.doi.org/10.1371/journal.pone.0056539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409193	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000058
J	Rice, ES; Silverman, J				Rice, Eleanor Spicer; Silverman, Jules			Propagule Pressure and Climate Contribute to the Displacement of Linepithema humile by Pachycondyla chinensis	PLOS ONE			English	Article							INVASIVE ARGENTINE ANT; IMPORTED FIRE ANT; NATIVE ANTS; ESTABLISHMENT SUCCESS; ABIOTIC FACTORS; PONERINE ANT; SOLENOPSIS-INVICTA; FORAGING ACTIVITY; SPECIES RICHNESS; WORLDWIDE SPREAD	Identifying mechanisms governing the establishment and spread of invasive species is a fundamental challenge in invasion biology. Because species invasions are frequently observed only after the species presents an environmental threat, research identifying the contributing agents to dispersal and subsequent spread are confined to retrograde observations. Here, we use a combination of seasonal surveys and experimental approaches to test the relative importance of behavioral and abiotic factors in determining the local co-occurrence of two invasive ant species, the established Argentine ant (Linepithema humile Mayr) and the newly invasive Asian needle ant (Pachycondyla chinensis Emery). We show that the broader climatic envelope of P. chinensis enables it to establish earlier in the year than L. humile. We also demonstrate that increased P. chinensis propagule pressure during periods of L. humile scarcity contributes to successful P. chinensis early season establishment. Furthermore, we show that, although L. humile is the numerically superior and behaviorally dominant species at baits, P. chinensis is currently displacing L. humile across the invaded landscape. By identifying the features promoting the displacement of one invasive ant by another we can better understand both early determinants in the invasion process and factors limiting colony expansion and survival.	[Rice, Eleanor Spicer; Silverman, Jules] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Silverman, J (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	jules_silverman@gmail.com			Blanton J. Whitmire endowment at North Carolina State University	Blanton J. Whitmire endowment at North Carolina State University	This work was supported by the Blanton J. Whitmire endowment at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril S, 2007, ENVIRON ENTOMOL, V36, P1166, DOI 10.1603/0046-225X(2007)36[1166:FAADSO]2.0.CO;2; Alder P, 2005, J ECON ENTOMOL, V98, P493, DOI 10.1603/0022-0493-98.2.493; Bednar DM, 2011, INSECT SOC, V58, P459, DOI 10.1007/s00040-011-0163-0; Blackburn TM, 2011, BIODIVERS CONSERV, V20, P2189, DOI 10.1007/s10531-011-0081-5; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Bomford M, 2010, BIOL INVASIONS, V12, P2559, DOI 10.1007/s10530-009-9665-3; Bomford M, 2009, WILDLIFE RES, V36, P192, DOI 10.1071/WR08055; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Brenneis VEF, 2011, OECOLOGIA, V167, P169, DOI 10.1007/s00442-011-1962-8; Brightwell RJ, 2010, J ECON ENTOMOL, V103, P1790, DOI 10.1603/EC10150; Brightwell RJ, 2010, ENVIRON ENTOMOL, V39, P1659, DOI 10.1603/EN09345; Brightwell RJ, 2011, ENVIRON ENTOMOL, V40, P1019, DOI 10.1603/EN11038; Brightwell RJ, 2010, BIOL INVASIONS, V12, P2051, DOI 10.1007/s10530-009-9607-0; Campos RBF, 2001, SOCIOBIOLOGY, V38, P539; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019837; Dietrich B, 2003, OECOLOGIA, V136, P63, DOI 10.1007/s00442-003-1245-0; Eschtruth AK, 2011, ECOLOGY, V92, P1314, DOI 10.1890/10-0857.1; Goodenough AE, 2010, COMMUNITY ECOL, V11, P13, DOI 10.1556/ComEc.11.2010.1.3; Green PT, 2011, ECOLOGY, V92, P1758, DOI 10.1890/11-0050.1; Grey EK, 2011, OECOLOGIA, V166, P935, DOI 10.1007/s00442-011-1931-2; Griffen BD, 2011, J EXP MAR BIOL ECOL, V406, P6, DOI 10.1016/j.jembe.2011.06.005; Guenard B, 2011, NATURWISSENSCHAFTEN, V98, P651, DOI 10.1007/s00114-011-0814-z; Guenard B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011614; Hartley S, 2006, ECOL LETT, V9, P1068, DOI 10.1111/j.1461-0248.2006.00954.x; Hartley S, 2010, ECOGRAPHY, V33, P83, DOI 10.1111/j.1600-0587.2009.06037.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hee JJ, 2000, CONSERV BIOL, V14, P559, DOI 10.1046/j.1523-1739.2000.99040.x; Heller NE, 2008, OECOLOGIA, V155, P385, DOI 10.1007/s00442-007-0911-z; Heterick B, 1997, AUST J ECOL, V22, P218, DOI 10.1111/j.1442-9993.1997.tb00661.x; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hooper-Bui LM, 2002, J ECON ENTOMOL, V95, P1222, DOI 10.1603/0022-0493-95.6.1222; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Human KG, 1999, INSECT SOC, V46, P159, DOI 10.1007/s000400050127; Human KG, 1998, ENVIRON ENTOMOL, V27, P822, DOI 10.1093/ee/27.4.822; Ito F, 1997, ETHOL ECOL EVOL, V9, P335, DOI 10.1080/08927014.1997.9522876; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; King JR, 2007, FLA ENTOMOL, V90, P435, DOI 10.1653/0015-4040(2007)90[435:REALPI]2.0.CO;2; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; Kirschenbaum R, 2008, SOCIOBIOLOGY, V51, P543; Kirschenbaum R, 2007, SOCIOBIOLOGY, V50, P1069; Krushelnycky PD, 2005, DIVERS DISTRIB, V11, P319, DOI 10.1111/j.1366-9516.2005.00151.x; Lach L, 2009, ANT ECOLOGY, P257; Lach L, 2008, ECOL ENTOMOL, V33, P155, DOI 10.1111/j.1365-2311.2007.00969.x; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Llewelyn J, 2010, OECOLOGIA, V162, P343, DOI 10.1007/s00442-009-1471-1; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Maschwitz U, 2004, NATURWISSENSCHAFTEN, V91, P40, DOI 10.1007/s00114-003-0487-3; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Meissner HE, 2003, J ECON ENTOMOL, V96, P850, DOI 10.1603/0022-0493-96.3.850; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Menke SB, 2006, J ANIM ECOL, V75, P368, DOI 10.1111/j.1365-2656.2006.01056.x; Mikheyev AS, 2008, DIVERS DISTRIB, V14, P301, DOI 10.1111/j.1472-4642.2007.00463.x; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Nelder MP, 2006, J MED ENTOMOL, V43, P1094, DOI 10.1603/0022-2585(2006)43[1094:EOTIAP]2.0.CO;2; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Oliveras J, 2005, SOCIOBIOLOGY, V45, P643; Orivel J, 1998, BIOTROPICA, V30, P487, DOI 10.1111/j.1744-7429.1998.tb00085.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; PASSERA L, 1992, J ZOOL, V228, P141, DOI 10.1111/j.1469-7998.1992.tb04438.x; Plowes RM, 2007, BIOL INVASIONS, V9, P825, DOI 10.1007/s10530-006-9084-7; Polo-Cavia N, 2011, BIOL INVASIONS, V13, P1387, DOI 10.1007/s10530-010-9897-2; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Raimundo RLG, 2009, ANN ENTOMOL SOC AM, V102, P1151, DOI 10.1603/008.102.0625; Rauschert ESJ, 2010, BIOL INVASIONS, V12, P563, DOI 10.1007/s10530-009-9463-y; Rice ES, 2012, J ECON ENTOMOL, V105, P1751, DOI 10.1603/EC12207; Roche CT, 2003, WEED RES, V43, P177, DOI 10.1046/j.1365-3180.2003.00331.x; Rodriguez-Cabal MA, 2012, BIOL INVASIONS, V14, P557, DOI 10.1007/s10530-011-0097-5; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Rowles AD, 2009, AUSTRAL ECOL, V34, P239, DOI 10.1111/j.1442-9993.2008.01922.x; Sagata K, 2009, J APPL ECOL, V46, P19, DOI 10.1111/j.1365-2664.2008.01523.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; Sarty M, 2007, INSECT SOC, V54, P166, DOI 10.1007/s00040-007-0927-8; Sarty M, 2006, OECOLOGIA, V149, P465, DOI 10.1007/s00442-006-0453-9; Short KH, 2008, ANIM BEHAV, V76, P429, DOI 10.1016/j.anbehav.2008.04.008; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Souza L, 2011, J PLANT ECOL, V4, P123, DOI 10.1093/jpe/rtq027; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Strongin K, 2011, AM MIDL NAT, V166, P224, DOI 10.1674/0003-0031-166.1.224; Stuble KL, 2009, ECOL ENTOMOL, V34, P520, DOI 10.1111/j.1365-2311.2009.01098.x; Suarez AV, 2002, ECOL APPL, V12, P291, DOI 10.2307/3061153; Suarez AV, 2005, P NATL ACAD SCI USA, V102, P17032, DOI 10.1073/pnas.0506119102; Suarez AV, 2005, INSECT SOC, V52, P378, DOI 10.1007/s00040-005-0824-y; Suwabe M, 2009, ECOL RES, V24, P637, DOI 10.1007/s11284-008-0534-9; de Albuquerque FS, 2011, PLANT ECOL, V212, P1901, DOI 10.1007/s11258-011-9962-7; Thomas ML, 2003, NATURWISSENSCHAFTEN, V90, P88, DOI 10.1007/s00114-002-0396-x; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wetterer JK, 2006, ECOL ENTOMOL, V31, P358, DOI 10.1111/j.1365-2311.2006.00790.x; Wetterer JK, 2011, FLA ENTOMOL, V94, P582, DOI 10.1653/024.094.0323; Wetterer JK, 2009, MYRMECOL NEWS, V12, P187; Wetterer JK, 2001, SOCIOBIOLOGY, V38, P709; Wilkins KJ, 2006, AFR ENTOMOL, V14, P367; Witte V, 2002, INSECT SOC, V49, P301, DOI 10.1007/PL00012646; Wittmann MJ, 2011, BIOL INVASIONS, V13, P2477, DOI 10.1007/s10530-011-0074-z; Yashiro T, 2010, ZOOTAXA, P39; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zheng JH, 2008, J ENTOMOL SCI, V43, P331, DOI 10.18474/0749-8004-43.3.331	111	28	28	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56281	10.1371/journal.pone.0056281	http://dx.doi.org/10.1371/journal.pone.0056281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409164	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300070
J	Dixon, LJ; Flask, CA; Papouchado, BG; Feldstein, AE; Nagy, LE				Dixon, Laura J.; Flask, Chris A.; Papouchado, Bettina G.; Feldstein, Ariel E.; Nagy, Laura E.			Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; LIVER-DISEASE; MICE DEFICIENT; STEATOSIS; INFLAMMASOME; PATHOGENESIS; POPULATION; FIBROSIS; OBESITY; ENZYME	Nonalcoholic steatohepatitis (NASH) is associated with caspase activation. However, a role for pro-inflammatory caspases or inflammasomes has not been explored in diet-induced liver injury. Our aims were to examine the role of caspase-1 in high fat-induced NASH. C57BL/6 wild-type and caspase 1-knockout (Casp1(-/-)) mice were placed on a 12-week high fat diet. Wildtype mice on the high fat diet increased hepatic expression of pro-caspase-1 and IL-1 beta. Both wild-type and Casp1(-/-) mice on the high fat diet gained more weight than mice on a control diet. Hepatic steatosis and TG levels were increased in wildtype mice on high fat diet, but were attenuated in the absence of caspase-1. Plasma cholesterol and free fatty acids were elevated in wild-type, but not Casp1(-/-) mice, on high fat diet. ALT levels were elevated in both wild-type and Casp1(-/-) mice on high fat diet compared to control. Hepatic mRNA expression for genes associated with lipogenesis was lower in Casp1(-/-) mice on high fat diet compared to wild-type mice on high fat diet, while genes associated with fatty acid oxidation were not affected by diet or genotype. Hepatic Tnf alpha and Mcp-1 mRNA expression was increased in wild-type mice on high fat diet, but not in Casp1(-/-) mice on high fat diet. alpha SMA positive cells, Sirius red staining, and Col1 alpha 1 mRNA were increased in wildtype mice on high fat diet compared to control. Deficiency of caspase-1 prevented those increases. In summary, the absence of caspase-1 ameliorates the injurious effects of high fat diet-induced obesity on the liver. Specifically, mice deficient in caspase-1 are protected from high fat-induced hepatic steatosis, inflammation and early fibrogenesis. These data point to the inflammasome as an important therapeutic target for NASH.	[Dixon, Laura J.; Nagy, Laura E.] Case Western Reserve Univ, Dept Mol Med, Cleveland, OH 44106 USA; [Flask, Chris A.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA; [Flask, Chris A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Papouchado, Bettina G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nagy, Laura E.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of California System; University of California San Diego; University of California System; University of California San Diego; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Nagy, LE (corresponding author), Case Western Reserve Univ, Dept Mol Med, Cleveland, OH 44106 USA.	nagyL3@ccf.org		Flask, Chris/0000-0002-1066-333X	NIH [P20 AA017837, R37 AA011876, RO1 DK082451, CTSA UL1RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017837, R37AA011876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH Grants (P20 AA017837) and (R37 AA011876) to LEN, (RO1 DK082451) to AEF and (CTSA UL1RR024989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Endo M, 2007, EXP BIOL MED, V232, P614; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ganz M, 2011, WORLD J GASTROENTERO, V17, P4772, DOI 10.3748/wjg.v17.i43.4772; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Johnson DH, 2012, J MAGN RESON IMAGING, V35, P837, DOI 10.1002/jmri.23508; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Larter CZ, 2007, J GASTROEN HEPATOL, V22, P1353, DOI 10.1111/j.1440-1746.2007.05004.x; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; London Roslyn M, 2007, Clin Liver Dis, V11, P55, DOI 10.1016/j.cld.2007.02.010; Mandrekar P, 2010, HEPATOLOGY; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Miura K, 2012, AM J PHYSL GASTROINT; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Nanji Amin A, 2004, Clin Liver Dis, V8, P559, DOI 10.1016/j.cld.2004.04.002; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paschos P, 2009, HIPPOKRATIA, V13, P128; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Roychowdhury S, 2012, ALCOHOL CLIN EXP RES; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Siebler Jurgen, 2008, J Hepatol, V48, P1032, DOI 10.1016/j.jhep.2008.03.007; Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008; Wieckowska A, 2005, CURR OPIN PEDIATR, V17, P636, DOI 10.1097/01.mop.0000172816.79637.c5; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167	42	123	125	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56100	10.1371/journal.pone.0056100	http://dx.doi.org/10.1371/journal.pone.0056100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409132	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200108
J	Hofstra, JJ; Cornet, AD; Declerck, PJ; Dixon, B; Aslami, H; Vlaar, APJ; Roelofs, JJ; van der Poll, T; Levi, M; Schultz, MJ				Hofstra, Jorrit J.; Cornet, Alexander D.; Declerck, Paul J.; Dixon, Barry; Aslami, Hamid; Vlaar, Alexander P. J.; Roelofs, Joris J.; van der Poll, Tom; Levi, Marcel; Schultz, Marcus J.			Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PSEUDOMONAS-AERUGINOSA PNEUMONIA; ACTIVATED PROTEIN-C; PLASMINOGEN-ACTIVATOR; COAGULATION; LIPOPOLYSACCHARIDE; ABNORMALITIES; INTERLEUKIN-1; COAGULOPATHY; REPERFUSION	Background: Critically ill patients frequently develop acute lung injury (ALI). Disturbed alveolar fibrin turnover, a characteristic feature of ALI, is the result of both activation of coagulation and inhibition of fibrinolysis. Nebulized fibrinolytic agents could exert lung-protective effects, via promotion of fibrinolysis as well as anti-inflammation. Methods: Rats were challenged intratracheally with Pseudomonas aeruginosa, resulting in pneumonia as a model for direct ALI, or received an intravenous bolus infusion of lipopolysaccharide, as a model for indirect ALI. Rats were randomized to nebulization of normal saline (placebo), recombinant tissue plasminogen activator (rtPA), or monoclonal antibodies against plasminogen activator inhibitor-type 1 (anti-PAI-1). Results: Nebulized rtPA or anti-PAI-1 enhanced the bronchoalveolar fibrinolytic system, as reflected by a significant reduction of PAI-1 activity levels in bronchoalveolar lavage fluid, and a consequent increase in plasminogen activator activity (PAA) levels to supranormal values. Both treatments also significantly affected systemic fibrinolysis as reflected by a significant increase in PAA levels in plasma to supranormal levels. Neither nebulized rtPA nor anti-PA1-1 affected pulmonary inflammation. Neither treatment affected bacterial clearance of P. aeruginosa from the lungs in case of pneumonia. Conclusions: Local treatment with rtPA or anti-PA1-1 affects pulmonary fibrinolysis but not inflammation in models of direct or indirect ALI in rats.	[Hofstra, Jorrit J.; Cornet, Alexander D.; Aslami, Hamid; Vlaar, Alexander P. J.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Hofstra, Jorrit J.; Aslami, Hamid; Vlaar, Alexander P. J.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands; [Hofstra, Jorrit J.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Hofstra, Jorrit J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Declerck, Paul J.] Univ Leuven, Lab Pharmaceut Biol & Pharmacol, Fac Pharmaceut Sci, Louvain, Belgium; [Dixon, Barry] St Vincents Hosp, Dept Intens Care Med, Melbourne, Vic, Australia; [Vlaar, Alexander P. J.; Levi, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Roelofs, Joris J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Schultz, Marcus J.] HERMES Crit Care Grp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; St Vincent's Hospital Melbourne; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hofstra, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.hofstra@amc.uva.nl	Schultz, Marcus/AAB-6379-2021; Levi, Marcel/AAZ-8559-2020; Declerck, Paul J/A-2330-2017	Schultz, Marcus/0000-0003-3969-7792; Declerck, Paul J/0000-0003-1259-9105; Roelofs, Joris/0000-0001-9595-6571; Cornet, Alexander/0000-0002-9917-5251; Vlaar, Alexander/0000-0002-3453-7186	Academic Medical Centre of the University of Amsterdam	Academic Medical Centre of the University of Amsterdam	This research was funded by the Academic Medical Centre of the University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GB, 2009, AM J PHYSIOL-LUNG C, V296, pL277, DOI 10.1152/ajplung.90475.2008; [Anonymous], 1997, NEW ENGL J MED, V337, P1118, DOI [10.1056/NEJM199710163371603, DOI 10.1056/NEJM199710163371603]; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Choi G, 2007, EUR RESPIR J, V30, P423, DOI 10.1183/09031936.00165606; Choi G, 2006, SWISS MED WKLY, V136, P139; Choi G, 2008, CRIT CARE MED, V36, P204, DOI 10.1097/01.CCM.0000292012.87482.F4; Choi G, 2007, CRIT CARE MED, V35, P1362, DOI 10.1097/01.CCM.0000261888.32654.6D; Dahlem P, 2006, EUR RESPIR J, V28, P992, DOI 10.1183/09031936.06.00133104; Debrock S, 1997, BBA-PROTEIN STRUCT M, V1337, P257, DOI 10.1016/S0167-4838(96)00173-2; Dixon B, 2010, CRIT CARE, V14, DOI 10.1186/cc9286; Dixon B, 2008, CRIT CARE, V12, DOI 10.1186/cc6894; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; HARDAWAY RM, 1990, CRIT CARE MED, V18, P1413, DOI 10.1097/00003246-199012000-00021; Hofstra JJ, 2010, J AEROSOL MED PULM D, V23, P105, DOI 10.1089/jamp.2009.0779; Hua F, 2011, BLOOD COAGUL FIBRIN, V22, P480, DOI 10.1097/MBC.0b013e328346ef56; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; Renckens R, 2008, J THROMB HAEMOST, V6, P660, DOI 10.1111/j.1538-7836.2008.02892.x; Robriquet L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-41; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; Schoots IG, 2004, THROMB HAEMOSTASIS, V91, P497, DOI 10.1160/TH03-08-0529; Schultz MJ, 2006, CRIT CARE MED, V34, P871, DOI 10.1097/01.CCM.0000202136.91651.34; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; SEEGER W, 1992, AM J PHYSIOL, V262, pL286, DOI 10.1152/ajplung.1992.262.3.L286; SEEGER W, 1985, J APPL PHYSIOL, V58, P326, DOI 10.1152/jappl.1985.58.2.326; Stringer KA, 1998, FREE RADICAL BIO MED, V25, P184, DOI 10.1016/S0891-5849(98)00047-1; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Welty-Wolf KE, 2002, THROMB HAEMOSTASIS, V88, P17; Zhao YG, 2011, AM J PHYSIOL-LUNG C, V300, pL718, DOI 10.1152/ajplung.00227.2010	32	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55262	10.1371/journal.pone.0055262	http://dx.doi.org/10.1371/journal.pone.0055262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408962	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200020
J	Kamiyama, N; Yamamoto, M; Saiga, H; Ma, JS; Ohshima, J; Machimura, S; Sasai, M; Kimura, T; Ueda, Y; Kayama, H; Takeda, K				Kamiyama, Naganori; Yamamoto, Masahiro; Saiga, Hiroyuki; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Sasai, Miwa; Kimura, Taishi; Ueda, Yoshiyasu; Kayama, Hisako; Takeda, Kiyoshi			CREBH Determines the Severity of Sulpyrine-Induced Fatal Shock	PLOS ONE			English	Article							NUCLEAR RECEPTOR CAR; RETICULUM STRESS-RESPONSE; TRANSCRIPTION FACTOR; DIPYRONE METABOLITES; TERMINAL KINASE; ACTIVATION; INDUCTION; ELEMENT; BIOTRANSFORMATION; METAMIZOL	Although the pyrazolone derivative sulpyrine is widely used as an antipyretic analgesic drug, side effects, including fatal shock, have been reported. However, the molecular mechanism underlying such a severe side effect is largely unclear. Here, we report that the transcription factor CREBH that is highly expressed in the liver plays an important role in fatal shock induced by sulpyrine in mice. CREBH-deficient mice were resistant to experimental fatal sulpyrine shock. We found that sulpyrine-induced expression of cytochrome P450 2B (CYP2B) family genes, which are involved in sulpyrine metabolism, in the liver was severely impaired in CREBH-deficient mice. Moreover, introduction of CYP2B in CREBH-deficient liver restored susceptibility to sulpyrine. Furthermore, ectopic expression of CREBH up-regulated CYP2B10 promoter activity, and in vivo knockdown of CREBH in wild-type mice conferred a significant resistance to fatal sulpyrine shock. These data demonstrate that CREBH is a positive regulator of CYP2B in response to sulpyrine administration, which possibly results in fatal shock.	[Kamiyama, Naganori; Yamamoto, Masahiro; Saiga, Hiroyuki; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Kimura, Taishi; Ueda, Yoshiyasu; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, Suita, Osaka, Japan; [Kamiyama, Naganori; Yamamoto, Masahiro; Saiga, Hiroyuki; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Kimura, Taishi; Ueda, Yoshiyasu; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Lab Mucosal Immunol, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kamiyama, Naganori; Yamamoto, Masahiro; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Sasai, Miwa] Osaka Univ, Lab Immunoparasitol, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kamiyama, Naganori; Yamamoto, Masahiro; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Sasai, Miwa] Osaka Univ, Microbial Dis Res Inst, Dept Immunoparasitol, Suita, Osaka 565, Japan; [Yamamoto, Masahiro; Kayama, Hisako; Takeda, Kiyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yamamoto, M (corresponding author), Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, Suita, Osaka, Japan.	myamamoto@biken.osaka-u.ac.jp; ktakeda@ongene.med.osaka-u.ac.jp	Takeda, Kiyoshi/C-9331-2009	Sasai, Miwa/0000-0001-6440-3958; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology; Strategic International Cooperative Program (Research Exchange Type); Japan Science and Technology Agency (JST); Kato Memorial Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Waksman Foundation of Japan INC; Senri Life Science Foundation; Tokyo Biochemical Research Foundation; Research Foundation for Microbial Diseases of Osaka University; NAKAJIMA FOUNDATION; ASAHI GLASS FOUNDATION; Osaka Foundation for Promotion of Clinical Immunology; Sumitomo Foundation; Sagawa Foundation of Promotion of Cancer Research; Suzuken Memorial Foundation; Osaka Cancer Research Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Cooperative Program (Research Exchange Type); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Kato Memorial Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Waksman Foundation of Japan INC(Waksman Foundation of Japan Inc.); Senri Life Science Foundation; Tokyo Biochemical Research Foundation; Research Foundation for Microbial Diseases of Osaka University; NAKAJIMA FOUNDATION; ASAHI GLASS FOUNDATION; Osaka Foundation for Promotion of Clinical Immunology; Sumitomo Foundation; Sagawa Foundation of Promotion of Cancer Research; Suzuken Memorial Foundation; Osaka Cancer Research Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Strategic International Cooperative Program (Research Exchange Type), the Japan Science and Technology Agency (JST), and; Kato Memorial Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; The Waksman Foundation of Japan INC, Senri Life Science Foundation; The Tokyo Biochemical Research Foundation; The Research Foundation for Microbial Diseases of Osaka University; THE NAKAJIMA FOUNDATION; THE ASAHI GLASS FOUNDATION; The Osaka Foundation for Promotion of Clinical Immunology; The Sumitomo Foundation; The Sagawa Foundation of Promotion of Cancer Research; Suzuken Memorial Foundation; Osaka Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Cohen SD, 1997, DRUG METAB REV, V29, P59, DOI 10.3109/03602539709037573; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Fendrich Z, 2000, Cas Lek Cesk, V139, P440; Geisslinger G, 1996, PHARMACEUT RES, V13, P1272, DOI 10.1023/A:1016088925786; GLADTKE E, 1983, AM J MED, V75, P121, DOI 10.1016/0002-9343(83)90243-7; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; HENSCHEL L, 1991, Z GASTROENTEROL, V29, P645; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Janke C, 2003, ANAESTHESIST, V52, P321, DOI 10.1007/s00101-003-0455-5; Jaszczuk E, 1999, Przegl Lek, V56, P175; Johannesdottir SA, 2012, CANCER; KATZ EZ, 1984, J CHROMATOGR, V305, P477; KRAUL H, 1991, EUR J CLIN PHARMACOL, V41, P475, DOI 10.1007/BF00626373; Lautenschlager MT, 1996, PHARMAZIE, V51, P750; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Liska D J, 1998, Altern Med Rev, V3, P187; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mizushima T, 2008, YAKUGAKU ZASSHI, V128, P255, DOI 10.1248/yakushi.128.255; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Mori K, 2010, MOL BIOL CELL, V21, P1435, DOI 10.1091/mbc.E09-07-0600; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Okamura M, 2008, AM J PHYSIOL-RENAL, V295, pF1495, DOI 10.1152/ajprenal.00602.2007; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Pavitt GD, 2012, COLD SPRING HARB PER; Pierre SC, 2007, BRIT J PHARMACOL, V151, P494, DOI 10.1038/sj.bjp.0707239; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; Reznik N D, 1972, Klin Med (Mosk), V50, P133; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Singh Gurkirpal, 1998, American Journal of Medicine, V105, p31S, DOI 10.1016/S0002-9343(98)00072-2; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Swaminathan J, 2009, SPECTROCHIM ACTA A, V73, P593, DOI 10.1016/j.saa.2009.03.009; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Tekkok IH, 2011, TURK NEUROSURG, V21, P116; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; VOLZ M, 1980, BRIT J CLIN PHARMACO, V10, pS299, DOI 10.1111/j.1365-2125.1980.tb01813.x; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wessel JC, 2006, EUR J PHARM SCI, V28, P15, DOI 10.1016/j.ejps.2005.11.010; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang H, 2010, CARCINOGENESIS, V31, P703, DOI 10.1093/carcin/bgq008; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	59	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55800	10.1371/journal.pone.0055800	http://dx.doi.org/10.1371/journal.pone.0055800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409047	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200067
J	Phong, WY; Lin, WW; Rao, SPS; Dick, T; Alonso, S; Pethe, K				Phong, Wai Yee; Lin, Wenwei; Rao, Srinivasa P. S.; Dick, Thomas; Alonso, Sylvie; Pethe, Kevin			Characterization of Phosphofructokinase Activity in Mycobacterium tuberculosis Reveals That a Functional Glycolytic Carbon Flow Is Necessary to Limit the Accumulation of Toxic Metabolic Intermediates under Hypoxia	PLOS ONE			English	Article							ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; GROWTH; GENE; GLUCOSE-6-PHOSPHATE; GLUCOSE; MICE; PURIFICATION; MACROPHAGES; PERSISTENCE	Metabolic versatility has been increasingly recognized as a major virulence mechanism that enables Mycobacterium tuberculosis to persist in many microenvironments encountered in its host. Glucose is one of the most abundant carbon sources that is exploited by many pathogenic bacteria in the human host. M. tuberculosis has an intact glycolytic pathway that is highly conserved in all clinical isolates sequenced to date suggesting that glucose may represent a non-negligible source of carbon and energy for this pathogen in vivo. Fructose-6-phosphate phosphorylation represents the key-committing step in glycolysis and is catalyzed by a phosphofructokinase (PFK) activity. Two genes, pfkA and pfkB have been annotated to encode putative PFK in M. tuberculosis. Here, we show that PFKA is the sole PFK enzyme in M. tuberculosis with no functional redundancy with PFKB. PFKA is required for growth on glucose as sole carbon source. In co-metabolism experiments, we report that disruption of the glycolytic pathway at the PFK step results in intracellular accumulation of sugar-phosphates that correlated with significant impairment of the cell viability. Concomitantly, we found that the presence of glucose is highly toxic for the long-term survival of hypoxic non-replicating mycobacteria, suggesting that accumulation of glucose-derived toxic metabolites does occur in the absence of sustained aerobic respiration. The culture medium traditionally used to study the physiology of hypoxic mycobacteria is supplemented with glucose. In this medium, M. tuberculosis can survive for only 7-10 days in a true non-replicating state before death is observed. By omitting glucose in the medium this period could be extended for up to at least 40 days without significant viability loss. Therefore, our study suggests that glycolysis leads to accumulation of glucose-derived toxic metabolites that limits long-term survival of hypoxic mycobacteria. Such toxic effect is exacerbated when the glycolytic pathway is disrupted at the PKF step.	[Phong, Wai Yee; Rao, Srinivasa P. S.; Dick, Thomas; Pethe, Kevin] Novartis Inst Trop Dis, Singapore, Singapore; [Phong, Wai Yee; Lin, Wenwei; Alonso, Sylvie] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol,Immunol Programme, Singapore 117595, Singapore; [Lin, Wenwei; Alonso, Sylvie] Singapore Massachusetts Inst Technol Alliance Res, Singapore, Singapore	Novartis; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Alonso, S (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol,Immunol Programme, Singapore 117595, Singapore.	micas@nus.edu.sg	Pethe, Kevin/F-9495-2015; Dick, Thomas/AAB-4109-2019; Pethe, Kevin/L-1199-2013; Dick, Thomas/AAC-4824-2019	Dick, Thomas/0000-0002-9604-9452; Pethe, Kevin/0000-0003-0297-0150; Pethe, Kevin/0000-0003-0916-8873	Novartis Institute of Tropical Diseases; Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology (SMART)	Novartis Institute of Tropical Diseases; Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology (SMART)(Singapore-MIT Alliance for Research & Technology Centre (SMART)National Research Foundation, Singapore)	This work was funded by the Novartis Institute of Tropical Diseases and the Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology (SMART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice AF, 2002, APPL ENVIRON MICROB, V68, P6410, DOI 10.1128/aem.68.12.6410-6415.2002; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; [Anonymous], 2011, GLOB TUB CONTR; BABUL J, 1978, J BIOL CHEM, V253, P4350; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; BUSCHMEIER B, 1985, FEMS MICROBIOL LETT, V29, P231, DOI 10.1111/j.1574-6968.1985.tb00868.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daldal F, 1982, EUR J BIOCHEM, V379, P373; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; DUBOS RJ, 1947, AM REV TUBERC PULM, V56, P334; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; FRAENKEL DG, 1986, ANNU REV BIOCHEM, V55, P317, DOI 10.1146/annurev.biochem.55.1.317; Hasan MR, 2010, J BIOL CHEM, V285, P19135, DOI 10.1074/jbc.M109.074310; Hsieh PC, 1996, J BIOL CHEM, V271, P4909; Jayanthi Bai N, 1975, Can J Microbiol, V21, P1688; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; KAPOOR R, 1981, BIOCHEM J, V193, P435, DOI 10.1042/bj1930435; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lovingshimer MR, 2006, PROTEIN EXPRES PURIF, V46, P475, DOI 10.1016/j.pep.2005.09.015; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miallau L, 2007, J BIOL CHEM, V282, P19948, DOI 10.1074/jbc.M701480200; Morita T, 2003, J BIOL CHEM, V278, P15608, DOI 10.1074/jbc.M300177200; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; ORCHARD LMD, 1990, P ROY SOC B-BIOL SCI, V242, P87, DOI 10.1098/rspb.1990.0108; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Paterson GK, 2009, MICROB PATHOGENESIS, V46, P261, DOI 10.1016/j.micpath.2009.01.008; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schumacher MA, 2000, J MOL BIOL, V296, P549, DOI 10.1006/jmbi.1999.3474; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	43	39	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56037	10.1371/journal.pone.0056037	http://dx.doi.org/10.1371/journal.pone.0056037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409118	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200103
J	Wang, XJ; Li, Y; Huang, H; Zhang, XJ; Xie, PW; Hu, W; Li, DD; Wang, SQ				Wang, Xue-jun; Li, Ying; Huang, Hai; Zhang, Xiu-juan; Xie, Pei-wen; Hu, Wei; Li, Dan-dan; Wang, Sheng-qi			A Simple and Robust Vector-Based shRNA Expression System Used for RNA Interference	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; MAMMALIAN-CELLS; HAIRPIN RNA; KNOCKDOWN; LIBRARY; LENGTH; MICE	Background: RNA interference (RNAi) mediated by small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) has become a powerful genetic tool for conducting functional studies. Previously, vector-based shRNA-expression strategies capable of inducing RNAi in viable cells have been developed, however, these vector systems have some disadvantages, either because they were error-prone or cost prohibitive. Results: In this report we described the development of a simple, robust shRNA expression system utilizing 1 long oligonucleotide or 2 short oligonucleotides for half the cost of conventional shRNA construction methods and with a>95% cloning success rate. The shRNA loop sequence and stem structure were also compared and carefully selected for better RNAi efficiency. Furthermore, an easier strategy was developed based on isocaudomers which permit rapid combination of the most efficient promoter-shRNA cassettes. Finally, using this method, the conservative target sites for hepatitis B virus (HBV) knockdown were systemically screened and HBV antigen expression shown to be successfully suppressed in the presence of connected multiple shRNAs both in vitro and in vivo. Conclusion: This novel design describes an inexpensive and effective way to clone and express single or multiple shRNAs from the same vector with the capacity for potent and effective silencing of target genes.	[Wang, Xue-jun; Li, Ying; Huang, Hai; Zhang, Xiu-juan; Xie, Pei-wen; Hu, Wei; Li, Dan-dan; Wang, Sheng-qi] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Wang, SQ (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	sqwang@bmi.ac.cn		Wang, Xue-jun/0000-0001-5895-936X	National Natural Science Foundation of China [81202562, 81230089]; Chinese Science and Technology Key Projects [2012ZX10004503-011, 2012ZX09103301-044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Science and Technology Key Projects	This work was financially supported by the National Natural Science Foundation of China 81202562 and 81230089, and the Chinese Science and Technology Key Projects grants 2012ZX10004503-011 and 2012ZX09103301-044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen CC, 2007, GENE THER, V14, P11, DOI 10.1038/sj.gt.3302846; Chen YC, 2010, J VIROL, V84, P7983, DOI 10.1128/JVI.00068-10; Chumakov SP, 2010, PLASMID, V63, P143, DOI 10.1016/j.plasmid.2009.12.003; Flores-Jasso CF, 2005, ACTA PHARMACOL SIN, V26, P1467, DOI 10.1111/j.1745-7254.2005.00230.x; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034165; Jun C, 2007, PROG BIOCHEM BIOPHYS, V34, P389; Khurana A, 2012, MOL CARCINOGEN, V51, P565, DOI 10.1002/mc.20824; Li LM, 2007, RNA, V13, P1765, DOI 10.1261/rna.599107; Li XX, 2008, ANAL BIOCHEM, V381, P163, DOI 10.1016/j.ab.2008.06.011; Mcintyre GJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-34; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Wu HL, 2005, GASTROENTEROLOGY, V128, P708, DOI 10.1053/j.gastro.2004.12.007; Xu XM, 2009, NAT PROTOC, V4, P1338, DOI 10.1038/nprot.2009.145; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031	24	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56110	10.1371/journal.pone.0056110	http://dx.doi.org/10.1371/journal.pone.0056110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405258	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400204
J	Chorny, M; Fishbein, I; Tengood, JE; Adamo, RF; Alferiev, IS; Levy, RJ				Chorny, Michael; Fishbein, Ilia; Tengood, Jillian E.; Adamo, Richard F.; Alferiev, Ivan S.; Levy, Robert J.			Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors	FASEB JOURNAL			English	Article						physical targeting; in-stent restenosis; rat model	LOCAL-DELIVERY; VIRAL VECTORS; THERAPY; ENCAPSULATION; RESTENOSIS; SURFACES; CELLS; OXIDE	Gene therapeutic strategies have shown promise in treating vascular disease. However, their translation into clinical use requires pharmaceutical carriers enabling effective, site-specific delivery as well as providing sustained transgene expression in blood vessels. While replication-deficient adenovirus (Ad) offers several important advantages as a vector for vascular gene therapy, its clinical applicability is limited by rapid inactivation, suboptimal transduction efficiency in vascular cells, and serious systemic adverse effects. We hypothesized that novel zinc oleate-based magnetic nanoparticles (MNPs) loaded with Ad would enable effective arterial cell transduction by shifting vector processing to an alternative pathway, protect Ad from inactivation by neutralizing factors, and allow site-specific gene transfer to arteries treated with stent angioplasty using a 2-source magnetic guidance strategy. Ad-loaded MNPs effectively transduced cultured endothelial and smooth muscle cells under magnetic conditions compared to controls and retained capacity for gene transfer after exposure to neutralizing antibodies and lithium iodide, a lytic agent causing disruption of free Ad. Localized arterial gene expression significantly stronger than in control animal groups was demonstrated after magnetically guided MNP delivery in a rat stenting model 2 and 9 d post-treatment, confirming feasibility of using Ad-loaded MNPs to achieve site-specific transduction in stented blood vessels. In conclusion, Ad-loaded MNPs formed by controlled precipitation of zinc oleate represent a novel delivery system, well-suited for efficient, magnetically targeted vascular gene transfer.-Chorny, M., Fishbein, I., Tengood, J. E., Adamo, R. F., Alferiev, I. S., Levy, R. J. Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors.	[Chorny, Michael; Fishbein, Ilia; Tengood, Jillian E.; Adamo, Richard F.; Alferiev, Ivan S.; Levy, Robert J.] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chorny, M (corresponding author), Childrens Hosp Philadelphia, Abramson Res Bldg,Ste 702,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	chorny@email.chop.edu	Chorny, Michael/O-1313-2017		American Heart Association; U.S. National Heart, Lung, and Blood Institute [HL 094816]; William J. Rashkind Endowment of The Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007915, R21HL094816] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); William J. Rashkind Endowment of The Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Gary Friedman (Drexel University, Philadelphia, PA, USA) for advising on the magnetic delivery strategy, and NuMED, Inc. (New York, NY, USA) for providing rat angioplasty catheters. This research was supported in part by American Heart Association Scientist Development grants (I.F. and M.C.), U.S. National Heart, Lung, and Blood Institute grant HL 094816 (R.J.L.), and The William J. Rashkind Endowment of The Children's Hospital of Philadelphia.	Alfonso F, 2010, J AM COLL CARDIOL, V55, P2717, DOI 10.1016/j.jacc.2010.03.026; Aminian A, 2009, CATHETER CARDIO INTE, V74, P108, DOI 10.1002/ccd.21938; Barman S, 2006, J PHYS CHEM B, V110, P651, DOI 10.1021/jp055814m; Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647; Beringer G. M., 1890, PHARM J T, V20, P676; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Carpi F, 2009, EXPERT REV MED DEVIC, V6, P487, DOI [10.1586/erd.09.32, 10.1586/ERD.09.32]; Chorny M., 2012, METHODIST DEBAKEY CA, V8, P25; Chorny M, 2006, MOL THER, V14, P382, DOI 10.1016/j.ymthe.2006.03.023; Chorny M, 2010, J CONTROL RELEASE, V146, P144, DOI 10.1016/j.jconrel.2010.05.003; Chorny M, 2010, P NATL ACAD SCI USA, V107, P8346, DOI 10.1073/pnas.0909506107; Coughlan L., 2012, VIRUSES, V2, P2290; Coughlan L, 2012, HUM GENE THER, V23, P960, DOI 10.1089/hum.2011.218; Di Paolo NC, 2009, CURR OPIN MOL THER, V11, P523; Duffy MR, 2012, NANOMEDICINE-UK, V7, P271, DOI [10.2217/nnm.11.186, 10.2217/NNM.11.186]; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fishbein I, 2008, CIRCULATION, V117, P2096, DOI 10.1161/CIRCULATIONAHA.107.746412; Fishbein I, 2010, CURR OPIN DRUG DISC, V13, P203; Gruchala M, 2004, CURR PHARM DESIGN, V10, P407, DOI 10.2174/1381612043453379; Kempe H, 2011, EXPERT REV MED DEVIC, V8, P291, DOI [10.1586/ERD.10.94, 10.1586/erd.10.94]; Lee DS, 2009, BIOCHEM BIOPH RES CO, V378, P640, DOI 10.1016/j.bbrc.2008.11.096; Li QG, 1997, ARCH VIROL, V142, P1307, DOI 10.1007/s007050050162; Mok H, 2007, PHARM RES, V24, P2263, DOI 10.1007/s11095-007-9441-y; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; NEURATH AR, 1970, J VIROL, V5, P173, DOI 10.1128/JVI.5.2.173-178.1970; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pandori MW, 2005, GENE THER, V12, P521, DOI 10.1038/sj.gt.3302420; Pfeifer A, 2012, PHARM RES-DORDR, V29, P1161, DOI 10.1007/s11095-012-0736-2; Polyak B, 2008, P NATL ACAD SCI USA, V105, P698, DOI 10.1073/pnas.0708338105; Ridgway JP, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-71; Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175; Seymour LW, 2011, HUM GENE THER, V22, P1041, DOI 10.1089/hum.2011.2517; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Singh R, 2009, TRENDS BIOTECHNOL, V27, P220, DOI 10.1016/j.tibtech.2009.01.003; Talsma H, 1997, INT J PHARMACEUT, V157, P233, DOI 10.1016/S0378-5173(97)00244-5; Tresilwised N, 2012, BIOMATERIALS, V33, P256, DOI 10.1016/j.biomaterials.2011.09.028; Turner P, 2007, BIOTECHNOL PROGR, V23, P423, DOI 10.1021/bp0600177; van Beusekom HM, 2007, NETH HEART J, V15, P395, DOI 10.1007/BF03086022; Volpers C, 2004, J GENE MED, V6, pS164, DOI 10.1002/jgm.496; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Williams PD, 2010, VIRUSES-BASEL, V2, P334, DOI 10.3390/v2020334; Wolfrum C, 2000, EUR J LIPID SCI TECH, V102, P746, DOI 10.1002/1438-9312(200012)102:12<746::AID-EJLT746>3.0.CO;2-R; Yellen BB, 2005, J MAGN MAGN MATER, V293, P647, DOI 10.1016/j.jmmm.2005.01.083	43	29	29	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2198	2206		10.1096/fj.12-224659	http://dx.doi.org/10.1096/fj.12-224659			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23407712	Green Published			2022-12-25	WOS:000319667600011
J	Buckley, DM; Burroughs-Garcia, J; Lewandoski, M; Waters, ST				Buckley, Desire M.; Burroughs-Garcia, Jessica; Lewandoski, Mark; Waters, Samuel T.			Characterization of the Gbx1(-/-) Mouse Mutant: A Requirement for Gbx1 in Normal Locomotion and Sensorimotor Circuit Development	PLOS ONE			English	Article							DORSAL SPINAL-CORD; MOTOR-NEURON IDENTITY; ROOT GANGLION NEURONS; MID/HINDBRAIN ORGANIZER; TRANSCRIPTIONAL CODES; SUBTYPE IDENTITY; NERVOUS-SYSTEM; GENE-FUNCTION; SPECIFICATION; EXPRESSION	The Gbx class of homeobox genes encodes DNA binding transcription factors involved in regulation of embryonic central nervous system (CNS) development. Gbx1 is dynamically expressed within spinal neuron progenitor pools and becomes restricted to the dorsal mantle zone by embryonic day (E) 12.5. Here, we provide the first functional analysis of Gbx1. We generated mice containing a conditional Gbx1 allele in which exon 2 that contains the functional homeodomain is flanked with loxP sites (Gbx1(flox)); Cre-mediated recombination of this allele results in a Gbx1 null allele. In contrast to mice homozygous for a loss-of-function allele of Gbx2, mice homozygous for the Gbx1 null allele, Gbx1(-/-), are viable and reproductively competent. However, Gbx1(-/-) mice display a gross locomotive defect that specifically affects hindlimb gait. Analysis of embryos homozygous for the Gbx1 null allele reveals disrupted assembly of the proprioceptive sensorimotor circuit within the spinal cord, and a reduction in ISL1(+) ventral motor neurons. These data suggest a functional requirement for Gbx1 in normal development of the neural networks that contribute to locomotion. The generation of this null allele has enabled us to functionally characterize a novel role for Gbx1 in development of the spinal cord.	[Buckley, Desire M.; Burroughs-Garcia, Jessica; Waters, Samuel T.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Buckley, Desire M.; Burroughs-Garcia, Jessica; Waters, Samuel T.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Lewandoski, Mark] NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21701 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waters, ST (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	waterssa@missouri.edu		Lewandoski, Mark/0000-0002-1066-3735	University of Missouri; National Science Foundation [1021288]; NATIONAL CANCER INSTITUTE [ZIABC011321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056901] Funding Source: NIH RePORTER	University of Missouri; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by startup funds from the University of Missouri (STW) and by the National Science Foundation award 1021288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; BRODY BA, 1989, J NEUROSCI, V9, P2391; Brown A. G., 1981, ORG SPINAL CORD, P154; Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x; Burroughs-Garcia J, 2011, DEV DYNAM, V240, P828, DOI 10.1002/dvdy.22589; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ESCURAT M, 1990, J NEUROSCI, V10, P764; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Inoue K, 2003, BLOOD CELL MOL DIS, V30, P157, DOI 10.1016/S1079-9796(03)00032-9; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Klein C, 2005, J INHERIT METAB DIS, V28, P425, DOI 10.1007/s10545-005-7495-8; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lin ZS, 2005, DEVELOPMENT, V132, P2309, DOI 10.1242/dev.01804; Liu AM, 2001, DEVELOPMENT, V128, P181; Luu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020940; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ozaki S, 1997, J COMP NEUROL, V380, P215; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Portier Marie-Madeleine, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1124; Posada A, 1999, BIOL CYBERN, V81, P239, DOI 10.1007/s004220050559; Rhinn M, 2004, DEV DYNAM, V229, P334, DOI 10.1002/dvdy.10435; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Siembab VC, 2010, J COMP NEUROL, V518, P4675, DOI 10.1002/cne.22441; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Vidal PP, 2004, J PHYSIOL-LONDON, V559, P625, DOI 10.1113/jphysiol.2004.063883; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Waters ST, 2006, DEVELOPMENT, V133, P1991, DOI 10.1242/dev.02364; Waters ST, 2003, GENE EXPR PATTERNS, V3, P313, DOI 10.1016/S1567-133X(03)00041-3; Zhuang BQ, 2006, CURR OPIN NEUROBIOL, V16, P20, DOI 10.1016/j.conb.2005.11.001	59	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56214	10.1371/journal.pone.0056214	http://dx.doi.org/10.1371/journal.pone.0056214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418536	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300128
J	Dale, NM; Myatt, M; Prudhon, C; Briend, A				Dale, Nancy M.; Myatt, Mark; Prudhon, Claudine; Briend, Andre			Using Mid-Upper Arm Circumference to End Treatment of Severe Acute Malnutrition Leads to Higher Weight Gains in the Most Malnourished Children	PLOS ONE			English	Article								Objective: The World Health Organization recommends discharging children admitted to nutrition programs treating severe acute malnutrition, with a low mid-upper arm circumference (MUAC <115 mm) when weight gain is >15%. When this recommendation is followed, the most severely malnourished children receive a shorter treatment compared to children that are less severely malnourished. This study assesses whether using MUAC >125 mm as discharge criteria eliminates this effect. Methods and Findings: Data from 753 children cured from a Medecins Sans Frontieres outpatient nutrition program in Gedaref, North Sudan were analyzed. MUAC >125 mm was used as discharge criteria. Length of stay and percent weight gain of children were compared in relation to nutritional status on admission. Children with low MUAC on admission had a longer duration of treatment (p = 0.000) and also a higher percent weight gain (p = 0.000) than children with higher MUAC. Similar results with weight-for-height z-scores categories were shown with both duration of treatment (p = 0.000) and percent weight gain (p = 0.000). Conclusion: This study shows that using MUAC as the discharge criteria eliminates the effect of shorter treatment in most severely malnourished children compared to least severely malnourished, as is observed with percent weight gain. The findings directly address the main concern that has been identified with the current WHO recommendation of using percent weight gain. MUAC could be used as discharge criteria, instead of percent weight gain, as having a longer duration of treatment and a higher percent weight gain for the most malnourished is highly desirable.	[Dale, Nancy M.; Briend, Andre] Univ Tampere, Dept Int Hlth, Sch Med, FIN-33101 Tampere, Finland; [Dale, Nancy M.] Med Sans Frontieres, Geneva, Switzerland; [Myatt, Mark] Brixton Hlth, Llawryglyn, Wales; [Prudhon, Claudine] Hlth & Nutr Tracking Serv, Geneva, Switzerland	Tampere University; Doctors Without Borders	Dale, NM (corresponding author), Univ Tampere, Dept Int Hlth, Sch Med, FIN-33101 Tampere, Finland.	dalenmca@yahoo.com			Medecins sans Frontieres Switzerland; Ministry of Health, Gedaref	Medecins sans Frontieres Switzerland; Ministry of Health, Gedaref	This study was funded by Medecins sans Frontieres Switzerland. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Medecins sans Frontieres teams in Gedaref for their hard work with special attention to Dr. Khalid Ahmed (medical coordinator) and Dr. Philippa Boulle (field coordinator) for their commitment to the program and collection of data. The authors would also like to thank Dr Phil Humphris and Bruno Jochum of Medecins Sans Frontieres Switzerland for their operational guidance throughout the program and their support for this study. We also thank the Ministry of Health, Gedaref, for their support.	[Anonymous], [No title captured]; [Anonymous], 2008, INT WORKSH INT COMM; COLLINS S, 2004, 48 OV DEV I HUM PRAC; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Goossens S, 2012, PLOS ONE IN PRESS; Guerrero S, 2010, DISASTERS, V34, P571, DOI 10.1111/j.1467-7717.2009.01144.x; Medecins Sans Frontieres Switzerland, 2010, PROT PAED NUTR CAS M; Mwangome MK, 2012, TROP MED INT HEALTH, V17, P622, DOI 10.1111/j.1365-3156.2012.02959.x; Myatt M, 2006, FOOD NUTR B S, V27; Sphere Standards, 2011, HUM CHART MIN STAND; VELZEBOER MI, 1983, J TROP PEDIATRICS, V29, P159, DOI 10.1093/tropej/29.3.159; Waterlow JC, 1992, PROTEIN ENERGY MALNU, P173; World Health Organization United Nations Children's Fund, 2002, IMCI AD GUID GUID C; World Health Organization World Food Program United Nations Standing Committee on Nutrition United Nations Children's Fund, 2007, COMM BAS MAN MALN	16	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55404	10.1371/journal.pone.0055404	http://dx.doi.org/10.1371/journal.pone.0055404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418442	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300033
J	Daschkey, S; Rottgers, S; Giri, A; Bradtke, J; Teigler-Schlegel, A; Meister, G; Borkhardt, A; Landgraf, P				Daschkey, Svenja; Roettgers, Silja; Giri, Anamika; Bradtke, Jutta; Teigler-Schlegel, Andrea; Meister, Gunter; Borkhardt, Arndt; Landgraf, Pablo			MicroRNAs Distinguish Cytogenetic Subgroups in Pediatric AML and Contribute to Complex Regulatory Networks in AML-Relevant Pathways	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; RIBONUCLEOPROTEIN COMPLEXES; WIDE IDENTIFICATION; C/EBP-ALPHA; RIP-CHIP; PROTEIN; DIFFERENTIATION; PATTERNS; ASSOCIATION	Background: The role of microRNAs (miRNAs), important post-transcriptional regulators, in the pathogenesis of acute myeloid leukemia (AML) is just emerging and has been mainly studied in adults. First studies in children investigate single selected miRNAs, however, a comprehensive overview of miRNA expression and function in children and young adults is missing so far. Methodology/Principal Findings: We here globally identified differentially expressed miRNAs between AML subtypes in a survey of 102 children and adolescent. Pediatric samples with core-binding factor AML and promyelocytic leukemia could be distinguished from each other and from MLL-rearranged AML subtypes by differentially expressed miRNAs including miR-126, -146a, -181a/b, -100, and miR-125b. Subsequently, we established a newly devised immunoprecipitation assay followed by rapid microarray detection for the isolation of Argonaute proteins, the hallmark of miRNA targeting complexes, from cell line models resembling core-binding factor and promyelocytic leukemia. Applying this method, we were able to identify Ago-associated miRNAs and their targeted mRNAs. Conclusions/Significance: miRNAs as well as their mRNA-targets showed binding preferences for the different Argonaute proteins in a cell context-dependent manner. Bioinformatically-derived pathway analysis suggested a concerted action of all four Argonaute complexes in the regulation of AML-relevant pathways. For the first time, to our knowledge, a complete AML data set resulting from carefully devised biochemical isolation experiments and analysis of Ago-associated miRNAs and their target-mRNAs is now available.	[Daschkey, Svenja; Giri, Anamika; Borkhardt, Arndt; Landgraf, Pablo] Univ Dusseldorf, Fac Med, Clin Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Roettgers, Silja; Bradtke, Jutta; Teigler-Schlegel, Andrea] Univ Giessen, Dept Pediat Hematol & Oncol, Oncogenet Lab, D-35390 Giessen, Germany; [Meister, Gunter] Univ Regensburg, Dept Biochem, Lab RNA Biol, D-93053 Regensburg, Germany	Heinrich Heine University Dusseldorf; Justus Liebig University Giessen; University of Regensburg	Landgraf, P (corresponding author), Univ Dusseldorf, Fac Med, Clin Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany.	pablo.landgraf@uni-duesseldorf.de			Research Commission of the Medical Faculty of the University of Dusseldorf; German Research Foundation (DFG) [LA 2983/2-1]; Bavarian Genome Research Network (BayGene); European Research Council (ERC); Giessen Parents Foundation; German-Israeli-Foundation (GIF)	Research Commission of the Medical Faculty of the University of Dusseldorf; German Research Foundation (DFG)(German Research Foundation (DFG)); Bavarian Genome Research Network (BayGene); European Research Council (ERC)(European Research Council (ERC)); Giessen Parents Foundation; German-Israeli-Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Research Commission of the Medical Faculty of the University of Dusseldorf (http://forschungskommission.uniduesseldorf.de/), by the German Research Foundation (DFG http://www.dfg.de, grant LA 2983/2-1), the Bavarian Genome Research Network (BayGene, http://www.baygene.genzentrum.lmu.de/), the European Research Council (ERC, http://erc.europa.eu/), by the Giessen Parents Foundation, and by the German-Israeli-Foundation (GIF, http://www.gif.org.il/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beghini A, 2004, HAEMATOLOGICA, V89, P920; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Creutzig U, 2005, LEUKEMIA, V19, P2030, DOI 10.1038/sj.leu.2403920; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Danen-van Oorschot AA, 2012, PEDIATR BLOOD CANCER, V58, P715, DOI 10.1002/pbc.23279; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; OCARROLL D, 2007, GENES DEV; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schoch C, 2004, HAEMATOLOGICA, V89, P1082; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Starczynowski DT, 2011, EXP HEMATOL, V39, P167, DOI 10.1016/j.exphem.2010.09.011; Starczynowski DT, 2011, BLOOD, V117, P595, DOI 10.1182/blood-2010-03-277012; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; von Neuhoff C, 2010, J CLIN ONCOL, V28, P2682, DOI 10.1200/JCO.2009.25.6321; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567; Zhang H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-108; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826	72	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56334	10.1371/journal.pone.0056334	http://dx.doi.org/10.1371/journal.pone.0056334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418555	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300148
J	Turingan, RS; Thomann, HU; Zolotova, A; Tan, E; Selden, RF				Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Tan, Eugene; Selden, Richard F.			Rapid Focused Sequencing: A Multiplexed Assay for Simultaneous Detection and Strain Typing of Bacillus anthracis, Francisella tularensis, and Yersinia pestis	PLOS ONE			English	Article							NUMBER TANDEM REPEAT; FRAGMENT LENGTH POLYMORPHISM; CLOSELY-RELATED BACTERIA; IN-SITU HYBRIDIZATION; 23S RIBOSOMAL-RNA; TIME PCR ASSAY; NEXT-GENERATION; CEREUS GROUP; GENETIC-VARIABILITY; PLASMID	Background: The intentional release of Bacillus anthracis in the United States in 2001 has heightened concern about the use of pathogenic microorganisms in bioterrorism attacks. Many of the deadliest bacteria, including the Class A Select Agents Bacillus anthracis, Francisella tularensis, and Yersinia pestis, are highly infectious via the pulmonary route when released in aerosolized form. Hence, rapid, sensitive, and reliable methods for detection of these biothreats and characterization of their potential impact on the exposed population are of critical importance to initiate and support rapid military, public health, and clinical responses. Methodology/Principal Findings: We have developed microfluidic multiplexed PCR and sequencing assays based on the simultaneous interrogation of three pathogens per assay and ten loci per pathogen. Microfluidic separation of amplified fluorescently labeled fragments generated characteristic electrophoretic signatures for identification of each agent. The three sets of primers allowed significant strain typing and discrimination from non-pathogenic closely-related species and environmental background strains based on amplicon sizes alone. Furthermore, sequencing of the 10 amplicons per pathogen, termed "Rapid Focused Sequencing," allowed an even greater degree of strain discrimination and, in some cases, can be used to determine virulence. Both amplification and sequencing assays were performed in microfluidic biochips developed for fast thermal cycling and requiring 7 mu L per reaction. The 30-plex sequencing assay resulted in genotypic resolution of 84 representative strains belonging to each of the three biothreat species. Conclusions/Significance: The microfluidic multiplexed assays allowed identification and strain differentiation of the biothreat agents Bacillus anthracis, Francisella tularensis, and Yersinia pestis and clear discrimination from closely-related species and several environmental background strains. The assays may be extended to detect a large number of pathogens, are applicable to the evaluation of both environmental and clinical samples, and have the potential to be applied in military, public health, and clinical diagnostic settings.	[Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Tan, Eugene; Selden, Richard F.] NetBio, Waltham, MA USA		Selden, RF (corresponding author), NetBio, Waltham, MA USA.	richard.selden@netbio.com			Department of Homeland Security Science and Technology Directorate [HSHQDC-09-C-0082]	Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS))	This work was supported by an award from the Department of Homeland Security Science and Technology Directorate (contract HSHQDC-09-C-0082) (http://www.dhs.gov/xabout/structure/editorial_0530.shtm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Adair DM, 2000, J CLIN MICROBIOL, V38, P1516, DOI 10.1128/JCM.38.4.1516-1519.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bavykin SG, 2004, J CLIN MICROBIOL, V42, P3711, DOI 10.1128/jcm.42.8.3711-3730.2004; Bhaduri S, 2008, J FOOD SAFETY, V28, P453, DOI 10.1111/j.1745-4565.2008.00123.x; Bode E, 2004, J CLIN MICROBIOL, V42, P5825, DOI 10.1128/JCM.42.12.5825-5831.2004; CDC. [Date unknown.] National Center for Emerging and Zoonotic Diseases, ANTHR STERN STRAIN 3; CROSS JT, 2000, PRINCIPLES PRACTICE, P2393; Daffonchio D, 2006, APPL ENVIRON MICROB, V72, P1295, DOI 10.1128/AEM.72.2.1295-1301.2006; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Eubanks LM, 2007, CHEM SOC REV, V36, P458, DOI 10.1039/b615227a; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Giese H, 2009, J FORENSIC SCI, V54, P1287, DOI 10.1111/j.1556-4029.2009.01200.x; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Graham Bob, 2008, WORLD RISK REPORT CO; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; HARRELL LJ, 1995, J CLIN MICROBIOL, V33, P1847, DOI 10.1128/JCM.33.7.1847-1850.1995; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Huang XZ, 2006, CLIN MED RES, V4, P189, DOI 10.3121/cmr.4.3.189; Ingmar J, 2010, RELIABLE DETECTION B; Jackson PJ, 1999, J APPL MICROBIOL, V87, P263, DOI 10.1046/j.1365-2672.1999.00884.x; Janse I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031958; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2001, J CLIN MICROBIOL, V39, P3140, DOI 10.1128/JCM.39.9.3140-3146.2001; Keim P, 1997, J BACTERIOL, V179, P818, DOI 10.1128/jb.179.3.818-824.1997; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; La Scola B, 2008, GENOME RES, V18, P742, DOI 10.1101/gr.071266.107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Motin VL, 2002, J BACTERIOL, V184, P1019, DOI 10.1128/jb.184.4.1019-1027.2002; Nubel U, 2006, J BACTERIOL, V188, P5319, DOI 10.1128/JB.01662-05; O'Toole T, 2009, BIOSECUR BIOTERROR, V7, P25, DOI 10.1089/bsp.2009.1001; Page R, DIVISION ECOLOGY EVO; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Pannucci J, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-34; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Price LB, 1999, J BACTERIOL, V181, P2358, DOI 10.1128/JB.181.8.2358-2362.1999; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Read TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010595; Schumm J, 2012, J FORENSIC IN PRESS; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sjostedt A, 2003, BERGEYS MANUAL SYSTE, P111; Splettstoesser WD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-72; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stewart A, 2008, J MED MICROBIOL, V57, P324, DOI 10.1099/jmm.0.47485-0; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tomioka K, 2005, J MOL DIAGN, V7, P486, DOI 10.1016/S1525-1578(10)60579-X; Trebesius K, 1998, J CLIN MICROBIOL, V36, P2557, DOI 10.1128/JCM.36.9.2557-2564.1998; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005	61	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56093	10.1371/journal.pone.0056093	http://dx.doi.org/10.1371/journal.pone.0056093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418519	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300111
J	Deneke, C; Lipowsky, R; Valleriani, A				Deneke, Carlus; Lipowsky, Reinhard; Valleriani, Angelo			Complex Degradation Processes Lead to Non-Exponential Decay Patterns and Age-Dependent Decay Rates of Messenger RNA	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN ABUNDANCE; GLOBAL ANALYSIS; STABILITY; TRANSCRIPTOME; DISTRIBUTIONS; LIFE	Experimental studies on mRNA stability have established several, qualitatively distinct decay patterns for the amount of mRNA within the living cell. Furthermore, a variety of different and complex biochemical pathways for mRNA degradation have been identified. The central aim of this paper is to bring together both the experimental evidence about the decay patterns and the biochemical knowledge about the multi-step nature of mRNA degradation in a coherent mathematical theory. We first introduce a mathematical relationship between the mRNA decay pattern and the lifetime distribution of individual mRNA molecules. This relationship reveals that the mRNA decay patterns at steady state expression level must obey a general convexity condition, which applies to any degradation mechanism. Next, we develop a theory, formulated as a Markov chain model, that recapitulates some aspects of the multi-step nature of mRNA degradation. We apply our theory to experimental data for yeast and explicitly derive the lifetime distribution of the corresponding mRNAs. Thereby, we show how to extract single-molecule properties of an mRNA, such as the age-dependent decay rate and the residual lifetime. Finally, we analyze the decay patterns of the whole translatome of yeast cells and show that yeast mRNAs can be grouped into three broad classes that exhibit three distinct decay patterns. This paper provides both a method to accurately analyze non-exponential mRNA decay patterns and a tool to validate different models of degradation using decay data.	[Deneke, Carlus; Lipowsky, Reinhard; Valleriani, Angelo] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany	Max Planck Society	Valleriani, A (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	angelo.valleriani@mpikg.mpg.de		Deneke, Carlus/0000-0002-2509-4950; Valleriani, Angelo/0000-0001-6591-5824; Lipowsky, Reinhard/0000-0001-8417-8567				Andersson AF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r99; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Berger F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208101; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; Deneke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035044; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Elgart V, 2010, BIOPHYS J, V98, P2780, DOI 10.1016/j.bpj.2010.03.022; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Keller P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747337; KEPES A, 1963, BIOCHIM BIOPHYS ACTA, V76, P293; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Liou JJ, 1997, CHEM ENG SCI, V52, P1529, DOI 10.1016/S0009-2509(96)00510-6; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Nagar A, 2011, J STAT PHYS, V145, P1385, DOI 10.1007/s10955-011-0347-z; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; PETERSEN C, 1987, MOL GEN GENET, V209, P179, DOI 10.1007/BF00329856; Rading MM, 2011, J STAT PHYS, V145, P1, DOI 10.1007/s10955-011-0305-9; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TAYLOR H., 1998, INTRO STOCHASTIC MOD; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Valleriani A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58003; Valleriani A, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28011; Valleriani A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042903; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Xie SN, 2001, SINGLE MOL, V2, P229, DOI 10.1002/1438-5171(200112)2:4<229::AID-SIMO229>3.0.CO;2-9; Zimmer SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037639	44	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55442	10.1371/journal.pone.0055442	http://dx.doi.org/10.1371/journal.pone.0055442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408982	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000014
J	Silden, E; Hjelle, SM; Wergeland, L; Sulen, A; Andresen, V; Bourdon, JC; Micklem, DR; McCormack, E; Gjertsen, BT				Silden, Elisabeth; Hjelle, Sigrun M.; Wergeland, Line; Sulen, Andre; Andresen, Vibeke; Bourdon, Jean-Christophe; Micklem, David R.; McCormack, Emmet; Gjertsen, Bjorn Tore			Expression of TP53 Isoforms p53 beta or p53 gamma Enhances Chemosensitivity in TP53(null) Cell Lines	PLOS ONE			English	Article							P53 ISOFORMS; DNA-DAMAGE; LEUKEMIA	The carboxy-terminal truncated p53 alternative spliced isoforms, p53 beta and p53 gamma, are expressed at disparate levels in cancer and are suggested to influence treatment response and therapy outcome. However, their functional role in cancer remains to be elucidated. We investigated their individual functionality in the p53(null) background of cell lines H1299 and SAOS-2 by stable retroviral transduction or transient transfection. Expression status of p53 beta and p53 gamma protein was found to correlate with increased response to camptothecin and doxorubicin chemotherapy. Decreased DNA synthesis and clonogenicity in p53 beta and p53 gamma congenic H1299 was accompanied by increased p21((CIP1/WAF1)), Bax and Mdm2 proteins. Chemotherapy induced p53 isoform degradation, most prominent for p53 gamma. The proteasome inhibitor bortezomib substantially increased basal p53 gamma protein level, while the level of p53 beta protein was unaffected. Treatment with dicoumarol, a putative blocker of the proteasome-related NAD(P)H quinone oxidoreductase NQO1, effectively attenuated basal p53 gamma protein level in spite of bortezomib treatment. Although in vitro proliferation and clonogenicity assays indicated a weak suppressive effect by p53 beta and p53 gamma expression, studies of in vivo subcutaneous H1299 tumor growth demonstrated a significantly increased growth by expression of either p53 isoforms. This study suggests that p53 beta and p53 gamma share functionality in chemosensitizing and tumor growth enhancement but comprise distinct regulation at the protein level.	[Silden, Elisabeth; Hjelle, Sigrun M.; Wergeland, Line; Sulen, Andre; Andresen, Vibeke; McCormack, Emmet; Gjertsen, Bjorn Tore] Univ Bergen, Inst Med, Hematol Sect, Bergen, Norway; [Bourdon, Jean-Christophe] Univ Dundee, Sch Med, Dept Surg & Mol Oncol, INSERM,European Associated Lab,U858, Dundee, Scotland; [Micklem, David R.] Univ Bergen, Inst Biomed, Bergen, Norway; [Gjertsen, Bjorn Tore] Haukeland Hosp, Dept Internal Med, Hematol Sect, N-5021 Bergen, Norway	University of Bergen; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Dundee; University of Bergen; University of Bergen; Haukeland University Hospital	Gjertsen, BT (corresponding author), Univ Bergen, Inst Med, Hematol Sect, Bergen, Norway.	bjorn.gjertsen@med.uib.no	Sulen, André/GSD-5586-2022; Gjertsen, Bjorn T/O-1542-2015; JC, Bourdon/A-4439-2008; Andresen, Vibeke/I-9482-2018; Hjelle, Sigrun M./AAZ-5585-2020; Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjørn T/AAP-3281-2020	Gjertsen, Bjorn T/0000-0001-9358-9704; JC, Bourdon/0000-0003-4623-9386; Andresen, Vibeke/0000-0002-2368-2978; Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjørn T/0000-0001-9358-9704; Micklem, David/0000-0003-2756-2591; Sulen, Andre/0000-0002-2053-1760	Norwegian Cancer Society; Solveig og Ove Lund's legacy; Western Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); Solveig og Ove Lund's legacy; Western Norway Regional Health Authority	This work was supported by grants from the Norwegian Cancer Society with Solveig og Ove Lund's legacy and the Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Anensen N, 2012, ONCOGENE, V31, P1533, DOI 10.1038/onc.2011.348; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Boldrup L, 2007, EUR J CANCER, V43, P617, DOI 10.1016/j.ejca.2006.10.019; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Camus S, 2012, CELL CYCLE, V11, P1646, DOI 10.4161/cc.20119; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Graupner V, 2009, CELL CYCLE, V8, P1238, DOI 10.4161/cc.8.8.8251; Hofstetter G, 2010, ONCOGENE, V29, P1997, DOI 10.1038/onc.2009.482; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Mc Cormack E, 2005, LEUKEMIA, V19, P687, DOI 10.1038/sj.leu.2403670; Peltonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012996; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sellmann L, 2012, LEUKEMIA LYMPHOMA, V53, P1282, DOI 10.3109/10428194.2011.654115; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Song W, 2009, CHINESE MED J-PEKING, V122, P921, DOI 10.3760/cma.j.issn.0366-6999.2009.08.008; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tronstad KJ, 2001, LIPIDS, V36, P305, DOI 10.1007/s11745-001-0722-8; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wei JX, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/687359; Wergeland L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-33	35	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56276	10.1371/journal.pone.0056276	http://dx.doi.org/10.1371/journal.pone.0056276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409163	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000047
J	Gorkiewicz, G; Thallinger, GG; Trajanoski, S; Lackner, S; Stocker, G; Hinterleitner, T; Gully, C; Hogenauer, C				Gorkiewicz, Gregor; Thallinger, Gerhard G.; Trajanoski, Slave; Lackner, Stefan; Stocker, Gernot; Hinterleitner, Thomas; Guelly, Christian; Hoegenauer, Christoph			Alterations in the Colonic Microbiota in Response to Osmotic Diarrhea	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; INTESTINAL MICROBIOTA; PSEUDOMONAS-PUTIDA; GUT MICROBIOME; GASTROINTESTINAL-TRACT; SPATIAL-ORGANIZATION; ESCHERICHIA-COLI; BACTERIAL; DIVERSITY; COMMUNITIES	Background & Aims: Diseases of the human gastrointestinal (GI) tract are often accompanied by diarrhea with profound alterations in the GI microbiota termed dysbiosis. Whether dysbiosis is due to the disease itself or to the accompanying diarrhea remains elusive. With this study we characterized the net effects of osmotic diarrhea on the composition of the GI microbiota in the absence of disease. Methods: We induced osmotic diarrhea in four healthy adults by oral administration of polyethylene glycol 4000 (PEG). Stool as well as mucosa specimens were collected before, during and after diarrhea and 16S rDNA-based microbial community profiling was used to assess the microbial community structure. Results: Stool and mucosal microbiotas were strikingly different, with Firmicutes dominating the mucosa and Bacteroidetes the stools. Osmotic diarrhea decreased phylotype richness and showed a strong tendency to equalize the otherwise individualized microbiotas on the mucosa. Moreover, diarrhea led to significant relative shifts in the phyla Bacteroidetes and Firmicutes and to a relative increase in the abundance of Proteobacteria on the mucosa, a phenomenon also noted in several inflammatory and diarrheal GI diseases. Conclusions: Changes in microbial community structure induced by osmotic diarrhea are profound and show similarities to changes observed in other GI diseases including IBD. These effects so must be considered when specimens from diarrheal diseases (i.e. obtained by stratification of samples according to diarrheal status) or conditions wherein bowel preparations like PEG (i.e. specimens obtained during endoscopy) are used.	[Gorkiewicz, Gregor; Lackner, Stefan] Med Univ Graz, Inst Pathol, Graz, Austria; [Thallinger, Gerhard G.; Stocker, Gernot] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Trajanoski, Slave; Lackner, Stefan; Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Hinterleitner, Thomas; Hoegenauer, Christoph] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria	Medical University of Graz; Graz University of Technology; Medical University of Graz; Medical University of Graz	Gorkiewicz, G (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	gregor.gorkiewicz@medunigraz.at; christoph.hoegenauer@medunigraz.at	Gorkiewicz, Gregor/ABF-1602-2021; Stocker, Gernot/Q-2461-2019	Gorkiewicz, Gregor/0000-0003-1149-4782; Thallinger, Gerhard G./0000-0002-2864-5404; Stocker, Gernot/0000-0001-8326-1852; Hogenauer, Christoph/0000-0003-4566-0806	Austrian Ministry of Science and Research, GEN AU Bioinformatics Integration Network	Austrian Ministry of Science and Research, GEN AU Bioinformatics Integration Network	GGT and GS were supported by the Austrian Ministry of Science and Research, GEN AU Bioinformatics Integration Network; http://www.gen-au.at/index.jsp?lang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bakker MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044357; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouhnik Y, 2004, ALIMENT PHARM THER, V19, P889, DOI 10.1111/j.1365-2036.2004.01918.x; Bounaix MS, 2010, FEMS MICROBIOL LETT, V311, P18, DOI 10.1111/j.1574-6968.2010.02067.x; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CHAO A, 1984, SCAND J STAT, V11, P265; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cremon C, 2010, EXPERT REV MOL DIAGN, V10, P389, DOI 10.1586/ERM.10.33; Cuiv PO, 2011, MICROB ECOL, V61, P353, DOI 10.1007/s00248-010-9771-x; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Durban A, 2011, MICROB ECOL, V61, P123, DOI 10.1007/s00248-010-9738-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FINE KD, 1992, GASTROENTEROLOGY, V102, P1936, DOI 10.1016/0016-5085(92)90316-Q; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Guirl MJ, 2003, AM J GASTROENTEROL, V98, P2219, DOI 10.1016/S0002-9270(03)00701-9; HAMMER HF, 1989, J CLIN INVEST, V84, P1056, DOI 10.1172/JCI114267; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kindt R., 2005, WORLD; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lee KW, 2012, ANAEROBE, V18, P96, DOI 10.1016/j.anaerobe.2011.12.015; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; READ NW, 1986, CLIN GASTROENTEROL, V15, P657; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schiller LR, 1987, GASTROENTEROLOGY, V92, P151, DOI 10.1016/0016-5085(87)90852-3; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Stocker G, 2010, P 110 ASM GEN M 23 5; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Walker AW, 2008, ENVIRON MICROBIOL, V10, P3275, DOI 10.1111/j.1462-2920.2008.01717.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yang CH, 1996, J FORMOS MED ASSOC, V95, P754; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	82	83	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55817	10.1371/journal.pone.0055817	http://dx.doi.org/10.1371/journal.pone.0055817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409050	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300035
J	Patterson, JEH; Neuhaus, P; Kutz, SJ; Ruckstuhl, KE				Patterson, Jesse E. H.; Neuhaus, Peter; Kutz, Susan J.; Ruckstuhl, Kathreen E.			Parasite Removal Improves Reproductive Success of Female North American Red Squirrels (Tamiasciurus hudsonicus)	PLOS ONE			English	Article							LIFE-HISTORY; TROGLODYTES-AEDON; ENERGETIC COST; GREAT TIT; ECTOPARASITE; MITE; CONSEQUENCES; EVOLUTION; SURVIVAL; ECOLOGY	In order to evaluate potential reproductive costs associated with parasitism, we experimentally removed ectoparasites from reproductive female North American red squirrels (Tamiasciurus hudsonicus). Body mass and overwinter survival of mothers, days to juvenile emergence, juvenile survival from birth to emergence, and body mass of juveniles at emergence were all compared to those of untreated (control) animals. Ectoparasite removal did not affect the body mass of mothers throughout the lactation period and overwinter survival of mothers did not differ between treatments and controls. Likewise, there was no effect of treatment on the number of days to juvenile emergence. However, treated mothers raised offspring that were significantly heavier (11%) than controls at emergence. Juveniles from treated mothers were also 24% more likely to survive from birth to emergence. Our results indicate that ectoparasites impose costs on the reproductive success of female red squirrels and that ectoparasites have the potential to influence red squirrel life-histories and population dynamics.	[Patterson, Jesse E. H.; Neuhaus, Peter; Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Kutz, Susan J.] Univ Calgary, Fac Vet Med, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Patterson, JEH (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jesse.patterson@ucalgary.ca	Ruckstuhl, Kathreen Eva/B-4469-2013	kutz, susan/0000-0003-2352-8687; Ruckstuhl, Kathreen/0000-0002-2949-242X	Natural Sciences and Engineering Research Council of Canada; American Society of Mammalogists; University of Calgary	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); American Society of Mammalogists; University of Calgary	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (Graduate Scholarship), American Society of Mammalogists (Grants-in-Aid of Research), and the University of Calgary (Thesis Dissertation Grant, Graduate Scholarships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander K, 1998, CAN J ZOOL, V76, P19, DOI 10.1139/cjz-76-1-19; [Anonymous], 2010, R LANG ENV STAT COMP; ARNOLD W, 1993, BEHAV ECOL, V4, P36, DOI 10.1093/beheco/4.1.36; Berteaux D, 2000, ECOLOGY, V81, P1311, DOI 10.1890/0012-9658(2000)081[1311:BDIFNA]2.0.CO;2; BOOTH DT, 1993, P ROY SOC B-BIOL SCI, V253, P125, DOI 10.1098/rspb.1993.0091; BOUTIN S, 1993, J ANIM ECOL, V62, P364, DOI 10.2307/5367; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Careau V, 2010, OECOLOGIA, V162, P303, DOI 10.1007/s00442-009-1466-y; Chadwick W, 2005, P ROY SOC B-BIOL SCI, V272, P505, DOI 10.1098/rspb.2004.2959; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Lope F, 1998, OECOLOGIA, V114, P188, DOI 10.1007/s004420050435; DELOPE F, 1993, OIKOS, V67, P557, DOI 10.2307/3545368; Descamps S, 2007, J ANIM ECOL, V76, P1192, DOI 10.1111/j.1365-2656.2007.01301.x; Fitze PS, 2004, J ANIM ECOL, V73, P216, DOI 10.1111/j.0021-8790.2004.00799.x; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Gooderham K, 2011, BEHAV ECOL, V22, P1195, DOI 10.1093/beheco/arr112; Harriman VB, 2010, J AVIAN BIOL, V41, P573, DOI 10.1111/j.1600-048X.2010.05013.x; Hillegass MA, 2010, BEHAV ECOL, V21, P696, DOI 10.1093/beheco/arq041; HIRSHFIELD MF, 1975, P NATL ACAD SCI USA, V72, P2227, DOI 10.1073/pnas.72.6.2227; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; JOHNSON LS, 1993, OIKOS, V66, P255, DOI 10.2307/3544812; Kerr TD, 2007, BIOLOGY LETT, V3, P289, DOI 10.1098/rsbl.2006.0615; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; Larsen K S, 2005, Parasitol Res, V97 Suppl 1, pS107, DOI 10.1007/s00436-005-1453-0; LARSEN KW, 1995, CAN J ZOOL, V73, P1115, DOI 10.1139/z95-133; MAHRT JL, 1972, J PARASITOL, V58, P639, DOI 10.2307/3278230; Mcadam AG, 2007, ECOSCIENCE, V14, P362, DOI 10.2980/1195-6860(2007)14[362:LHOFRS]2.0.CO;2; McFarlane SE, 2011, BIOL LETTERS, V7, P368, DOI 10.1098/rsbl.2010.1003; Metzger ME, 2002, J MED ENTOMOL, V39, P152, DOI 10.1603/0022-2585-39.1.152; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; MOLLER AP, 1990, ECOLOGY, V71, P2345, DOI 10.2307/1938645; MOSS WW, 1970, SCIENCE, V168, P1000, DOI 10.1126/science.168.3934.1000; Ohlberger J, 2011, P ROY SOC B-BIOL SCI, V278, P35, DOI 10.1098/rspb.2010.0960; OPPLIGER A, 1994, BEHAV ECOL, V5, P130, DOI 10.1093/beheco/5.2.130; Pacejka AJ, 1998, ECOLOGY, V79, P1797, DOI 10.1890/0012-9658(1998)079[1797:DPVMAH]2.0.CO;2; Prendergast JA, 2011, WEST N AM NATURALIST, V71, P516, DOI 10.3398/064.071.0409; PRICE K, 1993, BEHAV ECOL, V4, P144, DOI 10.1093/beheco/4.2.144; RICHNER H, 1993, J ANIM ECOL, V62, P703, DOI 10.2307/5390; RITTER RC, 1974, BEHAV BIOL, V11, P581, DOI 10.1016/S0091-6773(74)90935-3; Rogmann JJ, 2012, ORDINAL DOMINANCE ST; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; SMITH CC, 1968, ECOL MONOGR, V38, P31, DOI 10.2307/1948536; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stearns S., 1992, EVOLUTION LIFE HIST; Steele Michael A., 1998, Mammalian Species, V586, P1; TRIVERS RL, 1974, AM ZOOL, V14, P249; [No title captured]	52	24	24	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55779	10.1371/journal.pone.0055779	http://dx.doi.org/10.1371/journal.pone.0055779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409041	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300034
J	Yan, D; Luo, JY; Han, YM; Peng, C; Dong, XP; Chen, SL; Sun, LG; Xiao, XH				Yan, Dan; Luo, Jiao Y.; Han, Yu M.; Peng, Cheng; Dong, Xiao P.; Chen, Shi L.; Sun, Li G.; Xiao, Xiao H.			Forensic DNA Barcoding and Bio-Response Studies of Animal Horn Products Used in Traditional Medicine	PLOS ONE			English	Article							COMPLEMENTARY MEDICINE; RIBOSOMAL-RNA; CONSERVATION; REMEDIES; IDENTIFICATION; COMMERCIALIZATION; PHYLOGENY; REGION; FAUNA; GENE	Background: Animal horns (AHs) have been applied to traditional medicine for more than thousands of years, of which clinical effects have been confirmed by the history. But now parts of AHs have been listed in the items of wildlife conservation, which limits the use for traditional medicine. The contradiction between the development of traditional medicine and the protection of wild resources has already become the common concern of zoophilists, traditional medical professionals, economists, sociologists. We believe that to strengthen the identification for threatened animals, to prevent the circulation of them, and to seek fertile animals of corresponding bioactivities as substitutes are effective strategies to solve this problem. Methodology/Principal Findings: A powerful technique of DNA barcoding based on the mitochondrial gene cytochrome c oxidase I (COI) was used to identify threatened animals of Bovidae and Cervidae, as well as their illegal adulterants (including 10 species and 47 specimens). Meanwhile, the microcalorimetric technique was used to characterize the differences of bio-responses when those animal specimens acted on model organism (Escherichia coli). We found that the COI gene could be used as a universal primer to identify threatened animals and illegal adulterants mentioned above. By analyzing 223 mitochondrial COI sequences, a 100% identification success rate was achieved. We further found that the horns of Mongolian Gazelle and Red Deer could be exploited as a substitute for some functions of endangered Saiga Antelope and Sika Deer in traditional medicine, respectively. Conclusion/Significance: Although it needs a more comprehensive evaluation of bioequivalence in order to completely solve the problem of substitutes for threatened animals, we believe that the identification (DNA barcoding) of threatened animals combined with seeking substitutions (bio-response) can yet be regarded as a valid strategy for establishing a balance between the protection of threatened animals and the development of traditional medicine.	[Yan, Dan; Luo, Jiao Y.; Xiao, Xiao H.] Mil 302 Hosp, China Mil Inst Chinese Mat Med, Beijing, Peoples R China; [Luo, Jiao Y.; Chen, Shi L.] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Han, Yu M.; Peng, Cheng; Dong, Xiao P.] Chengdu Univ Chinese Tradit Med, Coll Pharm, Chengdu, Peoples R China; [Sun, Li G.] Beijing Phys Examinat Ctr, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chengdu University of Traditional Chinese Medicine	Chen, SL (corresponding author), Mil 302 Hosp, China Mil Inst Chinese Mat Med, Beijing, Peoples R China.	medplant@163.com; pharmsci@126.com	xiao, xiang/GWU-6035-2022	Peng, Cheng/0000-0003-3303-906X	National Natural Science Foundation of China [30873385, 81274078]; Beijing Natural Science Foundation [7112128]; Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicinal Resources	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicinal Resources	This work was supported by the National Natural Science Foundation of China (Grants No. 30873385 and No. 81274078), the Beijing Natural Science Foundation (Grants No. 7112128) and the Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicinal Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RRN, 2007, BIOSCIENCE, V57, P949, DOI 10.1641/B571107; Alves RRN, 2007, J ETHNOPHARMACOL, V113, P541, DOI 10.1016/j.jep.2007.07.015; Alves RRN, 2006, J ETHNOPHARMACOL, V107, P259, DOI 10.1016/j.jep.2006.03.007; Alves RRN, 2011, J ETHNOBIOL ETHNOMED, V7, DOI [10.1186/1746-4269-7-22, 10.1186/1746-4269-7-9]; Alves RRN, 2010, MAMMAL REV, V40, P155, DOI 10.1111/j.1365-2907.2010.00158.x; Alves RRN, 2009, J ETHNOPHARMACOL, V124, P600, DOI 10.1016/j.jep.2009.04.049; Alves RRN, 2008, BIODIVERS CONSERV, V17, P2037, DOI 10.1007/s10531-007-9305-0; Arif IA, 2012, EVOL BIOINFORM, V8, P139, DOI 10.4137/EBO.S8897; Ben-Nun IF, 2011, NAT METHODS, V8, P829, DOI [10.1038/NMETH.1706, 10.1038/nmeth.1706]; Benitez G, 2011, J ETHNOPHARMACOL, V137, P1113, DOI 10.1016/j.jep.2011.07.036; Bitanyi S, 2011, MOL ECOL RESOUR, V11, P442, DOI 10.1111/j.1755-0998.2011.02980.x; Bruce SJ, 2009, ANAL CHEM, V81, P3285, DOI 10.1021/ac8024569; Cleland LG, 2003, DRUGS, V63, P845, DOI 10.2165/00003495-200363090-00001; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Alves RRD, 2007, BIODIVERS CONSERV, V16, P969, DOI 10.1007/s10531-006-9036-7; Jacobo-Salcedo MD, 2011, J ETHNOPHARMACOL, V133, P902, DOI 10.1016/j.jep.2010.10.005; Feng YB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-2; Guha S, 2007, MOL PHYLOGENET EVOL, V42, P585, DOI 10.1016/j.ympev.2006.06.020; Haddad NM, 2012, NAT METHODS, V9, P794, DOI 10.1038/nmeth.2107; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Koo I, 2011, ANAL CHEM, V83, P5631, DOI 10.1021/ac200740w; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leal IR, 2005, CONSERV BIOL, V19, P701, DOI 10.1111/j.1523-1739.2005.00703.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo JY, 2011, J PHARM PHARM SCI, V14, P358, DOI 10.18433/J3N017; Magnacca KN, 2012, MOL ECOL RESOUR, V12, P990, DOI 10.1111/1755-0998.12001; Marschall J, 2012, CLIN INFECT DIS, V16, P11; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mishra N, 2011, AFR J PHARM PHARMACO, V5, P6; NEI M, 2000, MOL EVOLUTION PHYLOG; Alves RRN, 2010, HUM ECOL, V38, P691, DOI 10.1007/s10745-010-9352-0; Alves RRN, 2010, BIODIVERS CONSERV, V19, P1513, DOI 10.1007/s10531-010-9805-1; Oliveira ES, 2010, J ETHNOPHARMACOL, V130, P54, DOI 10.1016/j.jep.2010.04.010; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Taglietti A, 2012, LANGMUIR, V16, P11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; United States Food and Drug Administration Public Health Service, 1973, GRAS MON SER FISH OI, P3; Wang F, 2010, CHEMOSPHERE, V78, P319, DOI 10.1016/j.chemosphere.2009.10.030; Whiting MJ, 2011, J ZOOL, V284, P84, DOI 10.1111/j.1469-7998.2010.00784.x	49	32	40	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55854	10.1371/journal.pone.0055854	http://dx.doi.org/10.1371/journal.pone.0055854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409064	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300040
J	Kondrychyn, I; Teh, C; Sin, M; Korzh, V				Kondrychyn, Igor; Teh, Cathleen; Sin, Melvin; Korzh, Vladimir			Stretching Morphogenesis of the Roof Plate and Formation of the Central Canal	PLOS ONE			English	Article							NEURAL-TUBE MORPHOGENESIS; CELL-SHAPE CHANGE; SPINAL-CORD; EMBRYONIC-DEVELOPMENT; ZIC GENES; ZEBRAFISH; SPECIFICATION; NEURULATION; ACTIN; MECHANISMS	Background: Neurulation is driven by apical constriction of actomyosin cytoskeleton resulting in conversion of the primitive lumen into the central canal in a mechanism driven by F-actin constriction, cell overcrowding and buildup of axonal tracts. The roof plate of the neural tube acts as the dorsal morphogenetic center and boundary preventing midline crossing by neural cells and axons. Methodology/Principal Findings: The roof plate zebrafish transgenics expressing cytosolic GFP were used to study and describe development of this structure in vivo for a first time ever. The conversion of the primitive lumen into the central canal causes significant morphogenetic changes of neuroepithelial cells in the dorsal neural tube. We demonstrated that the roof plate cells stretch along the D-V axis in parallel with conversion of the primitive lumen into central canal and its ventral displacement. Importantly, the stretching of the roof plate is well-coordinated along the whole spinal cord and the roof plate cells extend 3x in length to cover 2/3 of the neural tube diameter. This process involves the visco-elastic extension of the roof place cytoskeleton and depends on activity of Zic6 and the Rho-associated kinase (Rock). In contrast, stretching of the floor plate is much less extensive. Conclusions/Significance: The extension of the roof plate requires its attachment to the apical complex of proteins at the surface of the central canal, which depends on activity of Zic6 and Rock. The D-V extension of the roof plate may change a range and distribution of morphogens it produces. The resistance of the roof plate cytoskeleton attenuates ventral displacement of the central canal in illustration of the novel mechanical role of the roof plate during development of the body axis.	[Kondrychyn, Igor; Teh, Cathleen; Sin, Melvin; Korzh, Vladimir] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Korzh, Vladimir] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Korzh, V (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.	vlad@imcb.a-star.edu.sg	Korzh, Vladimir P/H-1596-2011; Kondrychyn, Igor/AAC-6237-2022; Kondrychyn, Igor/C-2621-2016	Korzh, Vladimir P/0000-0002-6580-7986; Kondrychyn, Igor/0000-0002-2268-7291; Kondrychyn, Igor/0000-0002-2268-7291	Agency for Science, Technology and Research (A-STAR) of Singapore	Agency for Science, Technology and Research (A-STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the grant of the Agency for Science, Technology and Research (A-STAR) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; BOHME G, 1988, J ANAT, V159, P37; Brand M, 1996, DEVELOPMENT, V123, P129; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Cui WW, 2005, J NEUROSCI, V25, P6610, DOI 10.1523/JNEUROSCI.5009-04.2005; Elmonem MEA, 2007, ANAT HISTOL EMBRYOL, V36, P43, DOI 10.1111/j.1439-0264.2006.00716.x; Elsen GE, 2008, DEV BIOL, V314, P376, DOI 10.1016/j.ydbio.2007.12.006; Garcia-Lecea M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003090; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Harris MJ, 2001, TERATOLOGY, V63, P165, DOI 10.1002/tera.1030; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang YJ, 1996, DEVELOPMENT, V123, P205; KARFUNKEL P, 1974, INT REV CYTOL, V38, P245, DOI 10.1016/S0074-7696(08)60927-4; Keller MJ, 2007, DEV GENES EVOL, V217, P541, DOI 10.1007/s00427-007-0161-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; KORZH V, 1993, DEVELOPMENT, V118, P417; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Li YC, 2009, J HISTOCHEM CYTOCHEM, V57, P741, DOI 10.1369/jhc.2009.953646; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; McMahon Ariel R, 2010, BMC Res Notes, V3, P167, DOI 10.1186/1756-0500-3-167; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; MESTRES P, 1980, Scanning Electron Microscopy, P465; Millen KJ, 2004, DEV BIOL, V270, P382, DOI 10.1016/j.ydbio.2004.03.008; MORRISSKAY G, 1985, J EMBRYOL EXP MORPH, V88, P333; Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; NAGELE RG, 1987, J EXP ZOOL, V244, P425, DOI 10.1002/jez.1402440309; Nakano Y, 2004, DEV BIOL, V269, P381, DOI 10.1016/j.ydbio.2004.01.022; Nyholm MK, 2009, J CELL SCI, V122, P2137, DOI 10.1242/jcs.043471; Papan C, 1999, DEV GENES EVOL, V209, P135, DOI 10.1007/s004270050237; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; SADLER TW, 1982, SCIENCE, V215, P172, DOI 10.1126/science.7031898; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sevc J, 2009, CELL MOL NEUROBIOL, V29, P927, DOI 10.1007/s10571-009-9377-3; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; SMEDLEY MJ, 1986, J EMBRYOL EXP MORPH, V93, P167; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; STURROCK RR, 1981, J ANAT, V132, P119; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wu M, 1996, P NATL ACAD SCI USA, V93, P2110, DOI 10.1073/pnas.93.5.2110; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	70	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56219	10.1371/journal.pone.0056219	http://dx.doi.org/10.1371/journal.pone.0056219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409159	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200123
J	Kumari, J; Bogwald, J; Dalmo, RA				Kumari, Jaya; Bogwald, Jarl; Dalmo, Roy A.			Eomesodermin of Atlantic Salmon: An Important Regulator of Cytolytic Gene and Interferon Gamma Expression in Spleen Lymphocytes	PLOS ONE			English	Article							CELL-MEDIATED CYTOTOXICITY; BOX TRANSCRIPTION FACTOR; T-BET; RAINBOW-TROUT; EFFECTOR; PROMOTER; PROTEIN; PERFORIN; TH1	Eomesodermin (Eomes), a T-bet homologue expressed in activated CD8+T cells was recently proposed to act as a master regulator of cytotoxic CD8+T cell effector function and offers an exciting avenue for future exploration. Here, we have identified and characterized the full-length Atlantic salmon Eomes cDNA (2477 bp). Promoter analysis of the salmon Eomes showed the presence of important putative transcription binding sites like SP1, FOXO, Oct-1, SMAD, STAT, IRF, and Ets-1. The basal core region responsible for the promoter activity was located between base 2199 and +59. Quantitative PCR analysis revealed that the Atlantic salmon Eomes was ubiquitously expressed in all the tissues studied but strongly expressed in the ovary, spleen, brain, and the head kidney. Moreover, the involvement of Eomes in Atlantic salmon immune response and its relation with the cytolytic activity was demonstrated by investigating the early time dependent expression profile of Eomes and CD8 alpha followed by high interferon gamma (IFN-gamma) and granzyme A expression during challenge with live Aeromonas salmonicida and Infectious Pancreatic Necrosis (IPN) virus. Therefore, we further analyzed the regulated expression and function of this transcription factor in spleen lymphocytes. Overexpression of Eomes induced IFN-gamma, and granzyme A expression but not perforin expression, whereas small interfering RNA (siRNA) mediated suppression of Eomes expression led to significantly reduced IFN-gamma production. Thus, Eomes may be critical in cytolytic gene expression and function in fish similar to mammals. Furthermore, IFN-alpha, and mitogens induced Eomes expression. Taken together, this is the first study on the promoter activity and regulatory role of Eomes in fish.	[Kumari, Jaya; Bogwald, Jarl; Dalmo, Roy A.] Univ Tromso, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway	UiT The Arctic University of Tromso	Kumari, J (corresponding author), Univ Tromso, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway.	jaya.kumari@uit.no; roy.dalmo@uit.no	Dalmo, Roy Ambli/B-8437-2011; Dalmo, Roy Ambli/AAN-5157-2021; Bøgwald, Jarl/AAH-2515-2019; Swain, Jaya Kumari/AAT-1102-2020	Dalmo, Roy Ambli/0000-0002-6181-9859; Dalmo, Roy Ambli/0000-0002-6181-9859; Swain, Jaya Kumari/0000-0003-1787-5498	University of Tromso; European Commission [007103]; Research Council of Norway [183204/S40]; Tromso Research Foundation	University of Tromso; European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council of Norway(Research Council of Norway); Tromso Research Foundation	This work was supported by the University of Tromso, the European Commission grant IMAQUANIM (contract no. 007103), the Research Council of Norway (contract no. 183204/S40) and the Tromso Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2007, GUT, V56, P1572, DOI 10.1136/gut.2006.117812; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bjornson CRR, 2005, DEV CELL, V9, P523, DOI 10.1016/j.devcel.2005.08.010; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Bruce AEE, 2005, DEV DYNAM, V233, P105, DOI 10.1002/dvdy.20305; Bruce AEE, 2003, DEVELOPMENT, V130, P5503, DOI 10.1242/dev.00763; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Eshima K, 2012, IMMUNOL LETT, V144, P7, DOI 10.1016/j.imlet.2012.02.013; Fischer U, 2003, DEV COMP IMMUNOL, V27, P323, DOI 10.1016/S0145-305X(02)00100-3; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; He WF, 2010, J IMMUNOL, V185, P126, DOI 10.4049/jimmunol.0903767; HERRMANN BG, 1992, CIBA F SYMP, V165, P78; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kim MK, 1996, MOL CELL BIOL, V16, P4366; KLIMPEL GR, 1990, CELL IMMUNOL, V128, P603, DOI 10.1016/0008-8749(90)90052-S; Kumari J, 2009, MOL IMMUNOL, V46, P3099, DOI 10.1016/j.molimm.2009.06.008; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Narayanan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010636; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pipkin ME, 2010, IMMUNOL REV, V235, P55, DOI 10.1111/j.0105-2896.2010.00905.x; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Robertsen B, 2003, J INTERF CYTOK RES, V23, P601, DOI 10.1089/107999003322485107; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 2000, MECH DEVELOP, V94, P133, DOI 10.1016/S0925-4773(00)00300-2; Sever-Chroneos Z, 1999, AM J PHYSIOL-LUNG C, V277, pL79, DOI 10.1152/ajplung.1999.277.1.L79; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; Takizawa F, 2007, MOL IMMUNOL, V44, P2324, DOI 10.1016/j.molimm.2006.11.018; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toda H, 2009, DEV COMP IMMUNOL, V33, P646, DOI 10.1016/j.dci.2008.11.008; Utke K, 2007, FISH SHELLFISH IMMUN, V22, P182, DOI 10.1016/j.fsi.2006.04.008; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Zhou H, 2001, J IMMUNOL, V167, P1325, DOI 10.4049/jimmunol.167.3.1325; Zhu YB, 2010, J IMMUNOL, V184; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	37	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55893	10.1371/journal.pone.0055893	http://dx.doi.org/10.1371/journal.pone.0055893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409078	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200083
J	Takhar, HK; Kemp, K; Kim, M; Howell, PL; Burrows, LL				Takhar, Herlinder K.; Kemp, Kevin; Kim, Melissa; Howell, P. Lynne; Burrows, Lori L.			The Platform Protein Is Essential for Type IV Pilus Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; NEISSERIA-GONORRHOEAE; THERMUS-THERMOPHILUS; SUBCELLULAR-LOCALIZATION; RETRACTION MOTOR; COMPLEX; COMPONENT; PHAGE	A systematic genetic analysis was performed to identify the inner membrane proteins essential for type IV pilus (T4P) expression in Pseudomonas aeruginosa. By inactivating the retraction aspect of pilus function, genes essential for T4P assembly were discriminated. In contrast to previous studies in the T4P system of Neisseria spp., we found that components of the inner membrane subcomplex consisting of PilMNOP were not essential for surface pilus expression, whereas the highly conserved inner membrane protein PilC was essential. Here, we present data that PilC may coordinate the activity of cytoplasmic polymerization (PilB) and depolymerization (PilT) ATPases via their interactions with its two cytoplasmic domains. Using in vitro co-affinity purification, we show that PilB interacts with the N-terminal cytoplasmic domain of PilC. We hypothesized that PilT similarly interacts with the PilC C-terminal cytoplasmic domain. Overexpression of that domain in the wild-type protein reduced twitching motility by similar to 50% compared with the vector control. Site-directed mutagenesis of conserved T4P-specific residues in the PilC C-terminal domain yielded mutant proteins that supported wild-type pilus assembly but had a reduced capacity to support twitching motility, suggesting impairment of putative PilC-PilT interactions. Taken together, our results show that PilC is an essential inner membrane component of the T4P system, controlling both pilus assembly and disassembly.	[Takhar, Herlinder K.; Kemp, Kevin; Kim, Melissa; Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Takhar, Herlinder K.; Kemp, Kevin; Kim, Melissa; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca; burrowl@mcmaster.ca			Canadian Institutes of Health Research [MOP 93585]; Canadian Institutes of Health Research Banting studentship; Ontario graduate scholarship; Cystic Fibrosis Canada studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Banting studentship(Canadian Institutes of Health Research (CIHR)); Ontario graduate scholarship(Ontario Graduate Scholarship); Cystic Fibrosis Canada studentship	This work was supported in part by Operating Grant MOP 93585 from the Canadian Institutes of Health Research (to L. L. B. and P. L. H.).; Recipient of a Canadian Institutes of Health Research Banting studentship and an Ontario graduate scholarship.; Recipient of a Cystic Fibrosis Canada studentship.	Abendroth J, 2009, J STRUCT BIOL, V166, P303, DOI 10.1016/j.jsb.2009.03.009; Albers SV, 2009, EXTREMOPHILES, V13, P403, DOI 10.1007/s00792-009-0241-7; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; BRADLEY DE, 1972, BIOCHEM BIOPH RES CO, V47, P142, DOI 10.1016/S0006-291X(72)80021-4; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Collins RF, 2007, J BACTERIOL, V189, P6389, DOI 10.1128/JB.00648-07; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Harvey H, 2009, J BACTERIOL, V191, P6513, DOI 10.1128/JB.00943-09; Herdendorf TJ, 2002, J BACTERIOL, V184, P6465, DOI 10.1128/JB.184.23.6465-6471.2002; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Koo J, 2012, FEMS MICROBIOL LETT, V328, P1, DOI 10.1111/j.1574-6968.2011.02464.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Milgotina EI, 2011, MOL MICROBIOL, V81, P1125, DOI 10.1111/j.1365-2958.2011.07771.x; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; NUNN D, 1990, J BACTERIOL, V172, P2911, DOI 10.1128/jb.172.6.2911-2919.1990; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Ramer SW, 2002, J BACTERIOL, V184, P3457, DOI 10.1128/JB.184.13.3457-3465.2002; Roux N, 2012, RES MICROBIOL, V163, P659, DOI 10.1016/j.resmic.2012.10.015; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Savvides SN, 2007, STRUCTURE, V15, P255, DOI 10.1016/j.str.2007.02.003; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Semmler ABT, 1999, MICROBIOL-SGM, V145, P2863, DOI 10.1099/00221287-145-10-2863; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; WHITCHURCH CB, 1994, MOL MICROBIOL, V13, P1079, DOI 10.1111/j.1365-2958.1994.tb00499.x; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wolfgang M, 1998, P NATL ACAD SCI USA, V95, P14973, DOI 10.1073/pnas.95.25.14973; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544	52	79	79	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9721	9728		10.1074/jbc.M113.453506	http://dx.doi.org/10.1074/jbc.M113.453506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413032	hybrid, Green Published			2022-12-25	WOS:000317114000014
J	Biswas, S; Sharma, S; Saroha, A; Bhakuni, DS; Malhotra, R; Zahur, M; Oellerich, M; Das, HR; Asif, AR				Biswas, Sagarika; Sharma, Saurabh; Saroha, Ashish; Bhakuni, D. S.; Malhotra, Rajesh; Zahur, Muzna; Oellerich, Michael; Das, Hasi R.; Asif, Abdul R.			Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CITRULLINATED PROTEIN; IMMUNE-RESPONSE; ANTIBODIES; AUTOANTIBODIES; SPECIFICITY; DIAGNOSIS; VIMENTIN; ISOFORMS; SERUM	Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diagnosis this disease. The present study was aimed to identify novel autoantigens involved in rheumatoid arthritis (RA) pathogenesis through immune-proteomic strategy. Synovial fluid samples from clinically diagnosed RA patients were separated on two-dimensional gel electrophoresis (2-DE). Samples from patients with non-RA rheumatisms (osteoarthritis and trauma) were used as controls. Immunoreactive proteins were spotted by Western blotting followed by identification through Q-TOF mass spectrometer analysis. Forty Western blots were generated using plasma from ten individual RA patients and 33 reactive spots were identified, 20 from the high molecular weight (HMW) gel and 13 from the low molecular weight (LMW) gel. Among the 33 common immunogenic spots, 18 distinct autoantigens were identified, out of which 14 are novel proteins in this context. Expression analysis of five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and alpha 1 beta-glycoprotein (A1BG) by Western blot analysis using their specific antibodies revealed their higher expression in RA synovial fluid as compared to non-RA samples. Recombinantly expressed GFAP and A1BG protein were used to develop an in-house ELISA to quantify the amount of autoantibodies in the RA patients. RA patients revealed an increase in the expression of GFAP and A1BG in the plasma as compared to osteoarthritis patients. Therefore, GFAP and A1BG can be proposed as potential new autoantigens of diagnostic importance for RA subjects. Further characterization of these proteins in rheumatoid arthritis will be helpful in understanding the role of these proteins in the disease pathogenesis providing new diagnostic tool with better specificity and accurate detection of the disease.	[Biswas, Sagarika; Sharma, Saurabh; Saroha, Ashish; Das, Hasi R.] Inst Genom & Integrat Biol, Dept Genom & Mol Med, New Delhi, India; [Biswas, Sagarika; Oellerich, Michael; Asif, Abdul R.] Univ Med Ctr Goettingen, Dept Clin Chem, Gottingen, Germany; [Bhakuni, D. S.] Army Hosp Res & Referral, Dept Clin Immunol & Rheumatol, New Delhi, India; [Malhotra, Rajesh] All India Inst Med Sci, Dept Orthopaed, New Delhi, India; [Zahur, Muzna] Univ Gujrat, Dept Biochem & Mol Biol, Gujrat, Pakistan	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Gottingen; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Gujrat	Asif, AR (corresponding author), Univ Med Ctr Goettingen, Dept Clin Chem, Gottingen, Germany.	asif@med.uni-goettingen.de	Asif, Abdul R./A-9432-2016; Saroha, Ashish/A-3208-2019	Asif, Abdul R./0000-0002-8581-3187; Saroha, Ashish/0000-0001-6787-8633	Indian Council of Medical Research; Council of Scientific and Industrial Research, New Delhi, India; Department of Clinical Chemistry, University Medical Center, Goettingen, Germany	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Clinical Chemistry, University Medical Center, Goettingen, Germany	Financial assistance has been provided partly by Indian Council of Medical Research, Council of Scientific and Industrial Research, New Delhi, India, and Department of Clinical Chemistry, University Medical Center, Goettingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal N, 2011, CLIN LAB, V57, P895; Alam M, 2010, J SEP SCI, V33, P1723, DOI 10.1002/jssc.200900756; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Asif AR, 2006, J PROTEOME RES, V5, P954, DOI 10.1021/pr0504586; Biswas S, 2009, BIOCHEMISTRY-MOSCOW+, V74, P329, DOI 10.1134/S0006297909030122; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Friese MA, 2000, CLIN EXP IMMUNOL, V121, P406, DOI 10.1046/j.1365-2249.2000.01285.x; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; Gupta B, 2006, J AUTOIMMUN, V27, P125, DOI 10.1016/j.jaut.2006.07.002; Hoffmann MH, 2007, J IMMUNOL, V179, P7568, DOI 10.4049/jimmunol.179.11.7568; Hong SH, 2004, CANCER RES, V64, P5504, DOI 10.1158/0008-5472.CAN-04-0077; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Lernmark A, 2001, J CLIN INVEST, V108, P1091, DOI 10.1172/JCI200114234; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Liao H, 2004, ARTHRITIS RHEUM-US, V50, P3792, DOI 10.1002/art.20720; Lopez-Avila V, 2009, HEALTH, V1, P104, DOI [10.4236/health.2009.12017, DOI 10.4236/HEALTH.2009.12017]; Moore AR, 1999, ANN RHEUM DIS, V58, P109, DOI 10.1136/ard.58.2.109; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; Osborn TM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2520; Poulsom H, 2008, CLIN REV ALLERG IMMU, V34, P4, DOI 10.1007/s12016-007-8016-3; Sato H, 2007, INTERNAL MED, V46, P1685, DOI 10.2169/internalmedicine.46.6269; SHADFORTH MF, 1978, ANN RHEUM DIS, V37, P18, DOI 10.1136/ard.37.1.18; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Takemura M, 2002, GENES CELLS, V7, P295, DOI 10.1046/j.1365-2443.2002.00513.x; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Tilleman K, 2008, RHEUMATOLOGY, V47, P597, DOI 10.1093/rheumatology/ken077; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Trouw LA, 2012, AUTOIMMUN REV, V12, P318, DOI 10.1016/j.autrev.2012.05.007; Udby L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/bi048823e; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; Verpoort KN, 2007, ARTHRITIS RHEUM, V56, P3949, DOI 10.1002/art.23127; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, P107, DOI 10.1186/ar1184; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149	36	64	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56246	10.1371/journal.pone.0056246	http://dx.doi.org/10.1371/journal.pone.0056246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418544	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300137
J	Holiga, S; Mueller, K; Moller, HE; Sieger, T; Schroeter, ML; Vymazal, J; Ruzicka, E; Jech, R				Holiga, Stefan; Mueller, Karsten; Moeller, Harald E.; Sieger, Tomas; Schroeter, Matthias L.; Vymazal, Josef; Ruzicka, Evzen; Jech, Robert			Motor Matters: Tackling Heterogeneity of Parkinson's Disease in Functional MRI Studies	PLOS ONE			English	Article							LEVODOPA; FMRI; MOVEMENTS; REORGANIZATION; CONNECTIVITY; PERFORMANCE; ACTIVATION; MECHANISMS; AMPLITUDE; TASK	To tackle the heterogeneity of Parkinson's disease symptoms, most functional imaging studies tend to select a uniform group of subjects. We hypothesize that more profound considerations are needed to account for intra/inter-subject clinical variability and possibly for differing pathophysiological processes. Twelve patients were investigated using functional magnetic resonance imaging during visually-guided finger tapping. To account for disease heterogeneity, the motor score and individual symptom scores from the Unified Parkinson's Disease Rating Scale (UPDRS-III) were utilized in the group-level model using two approaches either as the explanatory variable or as the effect of interest. Employment of the UPDRS-III score and symptom scores was systematically tested on the resulting group response to the levodopa challenge, which further accentuated the diversity of the diseased state of participants. Statistics revealed a bilateral group response to levodopa in the basal ganglia. Interestingly, systematic incorporation of individual motor aspects of the disease in the modelling amended the resulting activity patterns conspicuously, evidencing a manifold amount of explained variability by the particular score. In conclusion, the severity of clinical symptoms expressed in the UPDRS-III scores should be considered in the analysis to attain unbiased statistics, draw reliable conclusions and allow for comparisons between research groups studying Parkinson's disease using functional magnetic resonance imaging.	[Holiga, Stefan; Mueller, Karsten; Moeller, Harald E.; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Sieger, Tomas; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Dept Neurol, Prague, Czech Republic; [Sieger, Tomas; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Ctr Clin Neurosci, Prague, Czech Republic; [Sieger, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany; [Schroeter, Matthias L.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Schroeter, Matthias L.] FTLD Consortium, Leipzig, Germany; [Vymazal, Josef] Homolce Hosp, Dept Radiol, Prague, Czech Republic	Max Planck Society; Charles University Prague; Charles University Prague; Czech Technical University Prague; Leipzig University; Leipzig University; Na Homolce Hospital	Jech, R (corresponding author), Charles Univ Prague, Dept Neurol, Prague, Czech Republic.	jech@cesnet.cz	Möller, Harald/AAB-4679-2019; Moller, Harald E/A-1565-2008; Růžička, Evžen/F-9299-2017; Sieger, Tomas/AAD-9342-2019; Jech, Robert/HHY-7342-2022	Möller, Harald/0000-0002-5659-1925; Moller, Harald E/0000-0002-5659-1925; Růžička, Evžen/0000-0002-4893-9661; Jech, Robert/0000-0002-9732-8947; Sieger, Tomas/0000-0003-4960-1934	Czech Science Foundation [309/09/1145]; Czech Ministry of Health [IGA MZ CR NT12282-5/2011, IGA MZ CR NT12288-5/2011, IGA MZ CR NT 11331-6/2010]; Czech Ministry of Education [MSM 0021620849]; Charles University in Prague [PRVOUK-P26/LF1/4]; Czech Technical University in Prague [SGS10/279/OHK3/3T/13]; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom); LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; Czech Technical University in Prague; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom); LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Czech Science Foundation, grant project 309/09/1145; by the Czech Ministry of Health, IGA MZ CR NT12282-5/2011, IGA MZ CR NT12288-5/2011, IGA MZ CR NT 11331-6/2010; by the Czech Ministry of Education, research project MSM 0021620849; by the Charles University in Prague, research project PRVOUK-P26/LF1/4; and by the Czech Technical University in Prague, grant project SGS10/279/OHK3/3T/13. Stefan Holiga has been supported by a stipend from the International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom). Matthias Schroeter has been supported by LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig - funded by European Union, European Regional Development Fund and by Free State of Saxony within the framework of the excellence initiative, and by the German Consortium for Frontotemporal Lobar Degeneration, funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 2012, NEUROLOGY, V79, P202, DOI 10.1212/WNL.0b013e31825dd3d0; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Cerasa A, 2012, MOVEMENT DISORD, V27, P364, DOI 10.1002/mds.24017; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Gonzalez-Garcia N, 2011, J NEUROL, V258, P1268, DOI 10.1007/s00415-011-5923-2; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Helmich RC, 2011, HUM BRAIN MAPP; Holden A, 2006, PARKINSONISM RELAT D, V12, P73, DOI 10.1016/j.parkreldis.2005.11.001; Holiga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036271; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jech R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049056; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kalmar Z, 2011, EUR NEUROL, V66, P220, DOI 10.1159/000330658; Kraft E, 2009, PARKINSONISM RELAT D, V15, P558, DOI 10.1016/j.parkreldis.2009.02.005; Macri MA, 2006, MAGN RESON IMAGING, V24, P419, DOI 10.1016/j.mri.2005.12.035; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; Martinu K, 2012, EUR J NEUROSCI, V35, P572, DOI 10.1111/j.1460-9568.2011.07979.x; Moraschi M, 2010, MAGN RESON IMAGING, V28, P1152, DOI 10.1016/j.mri.2010.03.025; Ng B, 2010, HUM BRAIN MAPP, V31, P88, DOI 10.1002/hbm.20847; Palmer SJ, 2010, NEUROSCIENCE, V166, P1110, DOI 10.1016/j.neuroscience.2010.01.012; Palmer SJ, 2009, NEUROSCIENCE, V158, P693, DOI 10.1016/j.neuroscience.2008.06.053; Palmer SJ, 2009, EUR J NEUROSCI, V29, P2187, DOI 10.1111/j.1460-9568.2009.06753.x; Pinto S, 2011, MOVEMENT DISORD, V26, P2212, DOI 10.1002/mds.23799; Prodoehl J, 2010, MOVEMENT DISORD, V25, P2035, DOI 10.1002/mds.23360; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Schiess MC, 2000, PARKINSONISM RELAT D, V6, P69, DOI 10.1016/S1353-8020(99)00051-6; Sen S, 2010, NEUROSCIENCE, V166, P712, DOI 10.1016/j.neuroscience.2009.12.036; Spraker MB, 2010, HUM BRAIN MAPP, V31, P1928, DOI 10.1002/hbm.20987; Tedroff J, 1996, NEUROLOGY, V46, P1430, DOI 10.1212/WNL.46.5.1430; Tessa C, 2012, NEURORADIOLOGY, V54, P261, DOI 10.1007/s00234-011-0955-y; Tessa C, 2010, EXP NEUROL, V224, P299, DOI 10.1016/j.expneurol.2010.04.005; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2011, NEUROIMAGE, V55, P204, DOI 10.1016/j.neuroimage.2010.11.074; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151	41	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56133	10.1371/journal.pone.0056133	http://dx.doi.org/10.1371/journal.pone.0056133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418522	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300114
J	Liu, F; Guo, FQ				Liu, Fang; Guo, Fang-Qing			Nitric Oxide Deficiency Accelerates Chlorophyll Breakdown and Stability Loss of Thylakoid Membranes during Dark-Induced Leaf Senescence in Arabidopsis	PLOS ONE			English	Article							HARVESTING COMPLEX-II; STAY-GREEN PROTEIN; METHYL JASMONATE; CELL-DEATH; FUNCTIONAL EXPRESSION; REGULATES CHLOROPHYLL; CATABOLITE REDUCTASE; MOLECULAR-CLONING; HIGHER-PLANTS; DEGRADATION	Nitric oxide (NO) has been known to preserve the level of chlorophyll (Chl) during leaf senescence. However, the mechanism by which NO regulates Chl breakdown remains unknown. Here we report that NO negatively regulates the activities of Chl catabolic enzymes during dark-induced leaf senescence. The transcriptional levels of the major enzyme genes involving Chl breakdown pathway except for RED CHL CATABOLITE REDUCTASE (RCCR) were dramatically up-regulated during dark-induced Chl degradation in the leaves of Arabidopsis NO-deficient mutant nos1/noa1 that exhibited an early-senescence phenotype. The activity of pheide a oxygenase (PAO) was higher in the dark-induced senescent leaves of nos1/noa1 compared with wild type. Furthermore, the knockout of PAO in nos1/noa1 background led to pheide a accumulation in the double mutant pao1 nos1/noa1, which retained the level of Chl during dark-induced leaf senescence. The accumulated pheide a in darkened leaves of pao1 nos1/noa1 was likely to inhibit the senescence-activated transcriptional levels of Chl catabolic genes as a feed-back inhibitory effect. We also found that NO deficiency led to decrease in the stability of photosynthetic complexes in thylakoid membranes. Importantly, the accumulation of pheide a caused by PAO mutations in combination with NO deficiency had a synergistic effect on the stability loss of thylakoid membrane complexes in the double mutant pao1 nos1/noa1 during dark-induced leaf senescence. Taken together, our findings have demonstrated that NO is a novel negative regulator of Chl catabolic pathway and positively functions in maintaining the stability of thylakoid membranes during leaf senescence.	[Liu, Fang; Guo, Fang-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Liu, Fang; Guo, Fang-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Plant Gene Res Shanghai, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Guo, FQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	fqguo@sibs.ac.cn		Guo, Fang-Qing/0000-0001-6889-394X	Ministry of Science and Technology of China [2012CB944802, 2012AA101103]; Ministry of Agriculture of China [2011ZX08009-003-002]; National Natural Science Foundation of China [31170244, 30770198]; CAS/SAFEA International Partnership Program for Creative Research Teams	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This research was supported in parts by the Ministry of Science and Technology of China (2012CB944802 and 2012AA101103), the Ministry of Agriculture of China (2011ZX08009-003-002), the National Natural Science Foundation of China (31170244 and 30770198) and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armstead I, 2007, SCIENCE, V315, P73, DOI 10.1126/science.1132912; Armstead I, 2006, NEW PHYTOL, V172, P592, DOI 10.1111/j.1469-8137.2006.01922.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Aubry S, 2008, PLANT MOL BIOL, V67, P243, DOI 10.1007/s11103-008-9314-8; Barry CS, 2008, PLANT PHYSIOL, V147, P179, DOI 10.1104/pp.108.118430; Barry CS, 2009, PLANT SCI, V176, P325, DOI 10.1016/j.plantsci.2008.12.013; Benedetti CE, 1998, PLANT PHYSIOL, V116, P1037, DOI 10.1104/pp.116.3.1037; Borovsky Y, 2008, THEOR APPL GENET, V117, P235, DOI 10.1007/s00122-008-0768-5; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Del Rio LA, 2004, PHYTOCHEMISTRY, V65, P783, DOI 10.1016/j.phytochem.2004.02.001; DRAZKIEWICZ M, 1994, PHOTOSYNTHETICA, V30, P321; Eum HL, 2007, HORTSCIENCE, V42, P927; Eum HL, 2009, FOOD SCI TECHNOL INT, V15, P223, DOI 10.1177/1082013208339706; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Guo FG, 2006, TRENDS PLANT SCI, V11, P527, DOI 10.1016/j.tplants.2006.09.006; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; Hinder B, 1996, J BIOL CHEM, V271, P27233, DOI 10.1074/jbc.271.44.27233; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hortensteiner S, 2009, TRENDS PLANT SCI, V14, P155, DOI 10.1016/j.tplants.2009.01.002; HORTENSTEINER S, 1995, NEW PHYTOL, V129, P237, DOI 10.1111/j.1469-8137.1995.tb04293.x; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Hung KT, 2004, J PLANT PHYSIOL, V161, P43, DOI 10.1078/0176-1617-01178; Jacob-Wilk D, 1999, PLANT J, V20, P653, DOI 10.1046/j.1365-313X.1999.00637.x; Jasid S, 2009, PLANT SCI, V176, P662, DOI 10.1016/j.plantsci.2009.02.007; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Jing HC, 2003, PLANT BIOLOGY, V5, P455, DOI 10.1055/s-2003-44779; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; LANGMEIER M, 1993, PHYSIOL PLANTARUM, V89, P347, DOI 10.1111/j.1399-3054.1993.tb00165.x; Laxalt AM, 1997, EUR J PLANT PATHOL, V103, P643, DOI 10.1023/A:1008604410875; Leshem YY, 2000, J EXP BOT, V51, P1471, DOI 10.1093/jexbot/51.349.1471; Leshem YY, 1998, PLANT PHYSIOL BIOCH, V36, P825, DOI 10.1016/S0981-9428(99)80020-5; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu HJ, 2010, NEW PHYTOL, V187, P83, DOI 10.1111/j.1469-8137.2010.03264.x; Mach JM, 2001, P NATL ACAD SCI USA, V98, P771, DOI 10.1073/pnas.021465298; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Mishina TE, 2007, PLANT CELL ENVIRON, V30, P39, DOI 10.1111/j.1365-3040.2006.01604.x; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Pruzinska A, 2007, PLANT CELL, V19, P369, DOI 10.1105/tpc.106.044404; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Ren GD, 2007, PLANT PHYSIOL, V144, P1429, DOI 10.1104/pp.107.100172; Rodoni S, 1997, PLANT PHYSIOL, V115, P669, DOI 10.1104/pp.115.2.669; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Sato Y, 2007, P NATL ACAD SCI USA, V104, P14169, DOI 10.1073/pnas.0705521104; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schenk N, 2007, FEBS LETT, V581, P5517, DOI 10.1016/j.febslet.2007.10.060; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tanaka R, 2003, PLANT CELL PHYSIOL, V44, P1266, DOI 10.1093/pcp/pcg172; THOMAS H, 1987, THEOR APPL GENET, V73, P551, DOI 10.1007/BF00289193; Tommasini R, 1998, PLANT J, V13, P773, DOI 10.1046/j.1365-313X.1998.00076.x; Tsuchiya T, 1999, P NATL ACAD SCI USA, V96, P15362, DOI 10.1073/pnas.96.26.15362; Van Ree K, 2011, PLANT J, V68, P225, DOI 10.1111/j.1365-313X.2011.04680.x; Wuthrich KL, 2000, PLANT J, V21, P189, DOI 10.1046/j.1365-313x.2000.00667.x; Yang ML, 2004, PLANT MOL BIOL, V54, P175, DOI 10.1023/B:PLAN.0000028789.51807.6a; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	74	60	62	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56345	10.1371/journal.pone.0056345	http://dx.doi.org/10.1371/journal.pone.0056345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418559	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300152
J	Mito, T; Kikkawa, Y; Shimizu, A; Hashizume, O; Katada, S; Imanishi, H; Ota, A; Kato, Y; Nakada, K; Hayashi, JI				Mito, Takayuki; Kikkawa, Yoshiaki; Shimizu, Akinori; Hashizume, Osamu; Katada, Shun; Imanishi, Hirotake; Ota, Azusa; Kato, Yukina; Nakada, Kazuto; Hayashi, Jun-Ichi			Mitochondrial DNA Mutations in Mutator Mice Confer Respiration Defects and B-Cell Lymphoma Development	PLOS ONE			English	Article							OXIDATIVE STRESS; POINT MUTATIONS; MITO-MICE; MTDNA; PHENOTYPES; GENERATION; COMPLEMENTATION; DYSFUNCTION; DAMAGE; GENES	Mitochondrial DNA (mtDNA) mutator mice are proposed to express premature aging phenotypes including kyphosis and hair loss (alopecia) due to their carrying a nuclear-encoded mtDNA polymerase with a defective proofreading function, which causes accelerated accumulation of random mutations in mtDNA, resulting in expression of respiration defects. On the contrary, transmitochondrial mito-mice Delta carrying mtDNA with a large-scale deletion mutation (Delta mtDNA) also express respiration defects, but not express premature aging phenotypes. Here, we resolved this discrepancy by generating mtDNA mutator mice sharing the same C57BL/6J (B6J) nuclear background with that of mito-mice Delta. Expression patterns of premature aging phenotypes are very close, when we compared between homozygous mtDNA mutator mice carrying a B6J nuclear background and selected mito-mice Delta only carrying predominant amounts of Delta mtDNA, in their expression of significant respiration defects, kyphosis, and a short lifespan, but not the alopecia. Therefore, the apparent discrepancy in the presence and absence of premature aging phenotypes in mtDNA mutator mice and mito-mice Delta, respectively, is partly the result of differences in the nuclear background of mtDNA mutator mice and of the broad range of Delta mtDNA proportions of mito-mice Delta used in previous studies. We also provided direct evidence that mtDNA abnormalities in homozygous mtDNA mutator mice are responsible for respiration defects by demonstrating the co-transfer of mtDNA and respiration defects from mtDNA mutator mice into mtDNA-less (rho(0)) mouse cells. Moreover, heterozygous mtDNA mutator mice had a normal lifespan, but frequently developed B-cell lymphoma, suggesting that the mtDNA abnormalities in heterozygous mutator mice are not sufficient to induce a short lifespan and aging phenotypes, but are able to contribute to the B-cell lymphoma development during their prolonged lifespan.	[Mito, Takayuki; Shimizu, Akinori; Hashizume, Osamu; Katada, Shun; Imanishi, Hirotake; Ota, Azusa; Kato, Yukina; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan	University of Tsukuba; Tokyo Metropolitan Institute of Medical Science	Hayashi, JI (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp	Kikkawa, Yoshiaki/AAI-7229-2020	Kikkawa, Yoshiaki/0000-0001-8859-4998	Scientific Research on Innovative Areas from Japan Society for the Promotion of Science (JSPS) [24117503]; Scientific Research A from Japan Society for the Promotion of Science (JSPS) [23240058]; Grants-in-Aid for Scientific Research [23240058] Funding Source: KAKEN	Scientific Research on Innovative Areas from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research A from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Scientific Research on Innovative Areas 24117503 (to JIH) and Scientific Research A 23240058 (to KN) from Japan Society for the Promotion of Science (JSPS http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Krupke DM, 2008, NAT REV CANCER, V8, P459, DOI 10.1038/nrc2390; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048	32	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55789	10.1371/journal.pone.0055789	http://dx.doi.org/10.1371/journal.pone.0055789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418460	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300051
J	Schreiber, D; Fonzo, G; Simmons, AN; Dawes, CT; Flagan, T; Fowler, JH; Paulus, MP				Schreiber, Darren; Fonzo, Greg; Simmons, Alan N.; Dawes, Christopher T.; Flagan, Taru; Fowler, James H.; Paulus, Martin P.			Red Brain, Blue Brain: Evaluative Processes Differ in Democrats and Republicans	PLOS ONE			English	Article							DECISION-MAKING; POLITICAL ORIENTATIONS; ACTIVATION; AMYGDALA; INSULA; MECHANISMS; COGNITION; EMOTION; HUMANS	Liberals and conservatives exhibit different cognitive styles and converging lines of evidence suggest that biology influences differences in their political attitudes and beliefs. In particular, a recent study of young adults suggests that liberals and conservatives have significantly different brain structure, with liberals showing increased gray matter volume in the anterior cingulate cortex, and conservatives showing increased gray matter volume in the in the amygdala. Here, we explore differences in brain function in liberals and conservatives by matching publicly-available voter records to 82 subjects who performed a risk-taking task during functional imaging. Although the risk-taking behavior of Democrats (liberals) and Republicans (conservatives) did not differ, their brain activity did. Democrats showed significantly greater activity in the left insula, while Republicans showed significantly greater activity in the right amygdala. In fact, a two parameter model of partisanship based on amygdala and insula activations yields a better fitting model of partisanship than a well-established model based on parental socialization of party identification long thought to be one of the core findings of political science. These results suggest that liberals and conservatives engage different cognitive processes when they think about risk, and they support recent evidence that conservatives show greater sensitivity to threatening stimuli.	[Schreiber, Darren] Univ Exeter, Dept Polit, Exeter, Devon, England; [Schreiber, Darren] Cent European Univ, Dept Polit Sci, Budapest, Hungary; [Fonzo, Greg] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Simmons, Alan N.; Flagan, Taru; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Simmons, Alan N.; Paulus, Martin P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Dawes, Christopher T.] NYU, Dept Polit, New York, NY USA; [Flagan, Taru; Paulus, Martin P.] Univ Calif San Diego, Lab Biol Dynam & Theoret Med, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA	University of Exeter; Central European University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; New York University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Schreiber, D (corresponding author), Univ Exeter, Dept Polit, Exeter, Devon, England.	darren.schreiber@gmail.com	Fonzo, Gregory/AAG-8824-2020; Simmons, Alan N/A-9815-2008; Fowler, James H/C-2750-2008	Simmons, Alan N/0000-0003-3963-2112; Fowler, James H/0000-0001-7795-1638; Fonzo, Gregory/0000-0002-0213-1034	Collaboratories Grant from the University of California, San Diego	Collaboratories Grant from the University of California, San Diego	Funding was provided by a Collaboratories Grant from the University of California, San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz AI, 1998, J POLIT, V60, P634, DOI 10.2307/2647642; Abramowitz AI, 2008, J POLIT, V70, P542, DOI 10.1017/S0022381608080493; Achen CH, 2002, POLIT BEHAV, V24, P151, DOI 10.1023/A:1021278208671; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Arce E, 2006, PSYCHOPHARMACOLOGY, V189, P105, DOI 10.1007/s00213-006-0519-8; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Canli T, 2000, J NEUROSCI, V20; CONVERSE PE, 1964, IDEOLOGY DISCONTENT; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Fowler JH, 2008, SCIENCE, V322, P912, DOI 10.1126/science.1158188; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Huettel SA, 2004, BRAIN RES, V1000, P78, DOI 10.1016/j.brainres.2003.11.041; JACOBSON GC, 2004, STATE POLITICS POLIC, V0004; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kam CD, 2010, J POLIT, V72, P381, DOI 10.1017/S0022381609990806; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LANG PJ, 1984, J BEHAV ASSESS, V6, P369, DOI 10.1007/BF01321326; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Levine DS, 2009, NEURAL NETWORKS, V22, P286, DOI 10.1016/j.neunet.2009.03.003; Lieberman MD, 2003, POLIT PSYCHOL, V24, P681, DOI 10.1046/j.1467-9221.2003.00347.x; MOGG K, 1989, BEHAV RES THER, V27, P317, DOI 10.1016/0005-7967(89)90001-6; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Poole KT, 2005, SPATIAL MODELS PARLI, Vxviii; Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Scholz J., 2009, NAT NEUROSCI; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Settle JE, 2009, POLIT RES QUART, V62, P601, DOI 10.1177/1065912908327607; Slovic P, 2000, PERCEPTION RISK, Vxxxvii; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vorhold V, 2008, ANN NY ACAD SCI, V1128, P41, DOI 10.1196/annals.1399.006; Woollett K, 2011, CURRENT BIOL	57	86	87	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e52970	10.1371/journal.pone.0052970	http://dx.doi.org/10.1371/journal.pone.0052970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418419	gold, Green Published			2022-12-25	WOS:000315970300009
J	van de Weijer, T; Sparks, LM; Phielix, E; Meex, RC; van Herpen, NA; Hesselink, MKC; Schrauwen, P; Schrauwen-Hinderling, VB				van de Weijer, Tineke; Sparks, Lauren Marie; Phielix, Esther; Meex, Ruth Carla; van Herpen, Noud Antonius; Hesselink, Matthijs Karel C.; Schrauwen, Patrick; Schrauwen-Hinderling, Vera Bettina			Relationships between Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							INTRAMYOCELLULAR LIPID-CONTENT; FATTY-ACID-METABOLISM; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-METABOLISM; RESPIRATION; EXERCISE; OBESE; ASSOCIATION; DYSFUNCTION	Introduction: Mitochondrial dysfunction, lipid accumulation, insulin resistance and metabolic inflexibility have been implicated in the etiology of type 2 diabetes (T2D), yet their interrelationship remains speculative. We investigated these interrelationships in a group of T2D and obese normoglycemic control subjects. Methods: 49 non-insulin dependent male T2D patients and 54 male control subjects were enrolled, and a hyperinsulinemic-euglycemic clamp and indirect calorimetry were performed. A muscle biopsy was taken and intramyocellular lipid (IMCL) was measured. In vivo mitochondrial function was measured by PCr recovery in 30 T2D patients and 31 control subjects. Results: Fasting NEFA levels were significantly elevated in T2D patients compared with controls, but IMCL was not different. Mitochondrial function in T2D patients was compromised by 12.5% (p<0.01). Whole body glucose disposal (WGD) was higher at baseline and lower after insulin stimulation. Metabolic flexibility (Delta RER) was lower in the type 2 diabetic patients (0.050 +/- 0.033 vs. 0.093 +/- 0.050, p<0.01). Mitochondrial function was the sole predictor of basal respiratory exchange ratio (RER) (R-2 = 0.18, p<0.05); whereas WGD predicted both insulin-stimulated RER (R-2 = 0.29, p<0.001) and metabolic flexibility (R-2 = 0.40, p<0.001). Conclusions: These results indicate that defects in skeletal muscle in vivo mitochondrial function in type 2 diabetic patients are only reflected in basal substrate oxidation and highlight the importance of glucose disposal rate as a determinant of substrate utilization in response to insulin.	[van de Weijer, Tineke; Sparks, Lauren Marie; Phielix, Esther; van Herpen, Noud Antonius; Schrauwen, Patrick] Maastricht Univ Med Ctr, Dept Human Biol, Maastricht, Netherlands; [van de Weijer, Tineke; Sparks, Lauren Marie; Phielix, Esther; Meex, Ruth Carla; van Herpen, Noud Antonius; Hesselink, Matthijs Karel C.; Schrauwen, Patrick; Schrauwen-Hinderling, Vera Bettina] Maastricht Univ Med Ctr, Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Meex, Ruth Carla; Hesselink, Matthijs Karel C.] Maastricht Univ Med Ctr, Dept Human Movement Sci, Maastricht, Netherlands; [Schrauwen-Hinderling, Vera Bettina] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Schrauwen-Hinderling, VB (corresponding author), Maastricht Univ Med Ctr, Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	v.schrauwen@maastrichtuniversity.nl		schrauwen, patrick/0000-0002-0973-847X; Sparks, Lauren/0000-0002-9257-5666	Center for Translational Molecular Medicine; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation (PREDICCt); VENI grant [916.11.136]; VICI grant from the Netherlands Organization for Scientific Research (NWO) [918.96.618]	Center for Translational Molecular Medicine; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation (PREDICCt); VENI grant; VICI grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Center for Translational Molecular Medicine and the Netherlands Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation (PREDICCt); see URL: http://www.ctmm.nl/pro1/general/home.asp. Also V. S. is supported by a VENI grant (Grant 916.11.136) and P.S. is supported by a VICI grant (Grant 918.96.618) from the Netherlands Organization for Scientific Research (NWO); also see URL: http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Galgani JE, 2008, DIABETES, V57, P841, DOI 10.2337/db08-0043; Galgani JE, 2012, OBESITY, V20, P1387, DOI 10.1038/oby.2011.166; GOLAY A, 1988, DIABETOLOGIA, V31, P585, DOI 10.1007/BF00264764; GOLAY A, 1988, DIABETES METAB, V14, P443; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Hoeks J, 2006, DIABETOLOGIA, V49, P2419, DOI 10.1007/s00125-006-0369-2; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; Mensink M, 2001, DIABETES, V50, P2548, DOI 10.2337/diabetes.50.11.2548; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; RANDLE PJ, 1963, LANCET, V1, P785; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Schrauwen-Hinderling VB, 2008, J CLIN ENDOCR METAB, V93, P2917, DOI 10.1210/jc.2008-0267; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Snel M, 2012, J CLIN ENDOCR METAB, V97, P2512, DOI 10.1210/jc.2011-3178; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; van Herpen NA, 2011, J CLIN ENDOCR METAB, V96, pE691, DOI 10.1210/jc.2010-2243	39	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e51648	10.1371/journal.pone.0051648	http://dx.doi.org/10.1371/journal.pone.0051648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418416	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300006
J	Wang, CM; Zhang, YY; Wu, B; Liu, SL; Xu, P; Lu, YM; Luo, J; Nolte, DL; Deliberto, TJ; Duan, MX; Zhang, H; He, HX				Wang, Chengmin; Zhang, Yanyu; Wu, Bin; Liu, Shelan; Xu, Ping; Lu, Yanmin; Luo, Jing; Nolte, Dale Louis; Deliberto, Thomas Jude; Duan, Mingxing; Zhang, Hong; He, Hongxuan			Evolutionary Characterization of the Pandemic H1N1/2009 Influenza Virus in Humans Based on Non-Structural Genes	PLOS ONE			English	Article							AMINO-ACID SITES; H1N1 INFLUENZA; REPLICATION; SELECTION; PROTEIN; NUCLEOPROTEIN	The 2009 influenza pandemic had a tremendous social and economic impact. To study the genetic diversity and evolution of the 2009 H1N1 virus, a mutation network for the non-structural (NS) gene of the virus was constructed. Strains of the 2009 H1N1 pandemic influenza A virus could be divided into two categories based on the V123I mutation in the NS1 gene: G1 (characterized as 123 Val) and G2 (characterized as 123 Ile). Sequence homology analysis indicated that one type of NS sequence, primarily isolated from Mexico, was likely the original type in this pandemic. The two genotypes of the virus presented distinctive clustering features in their geographic distributions. These results provide additional insight into the genetics and evolution of human pandemic influenza H1N1.	[Wang, Chengmin; Wu, Bin; Xu, Ping; Lu, Yanmin; Luo, Jing; Zhang, Hong; He, Hongxuan] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China; [Nolte, Dale Louis; Deliberto, Thomas Jude] Wildlife Serv, Natl Wildlife Res Ctr, USDA, APHIS, Ft Collins, CO USA; [Duan, Mingxing] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Liu, Shelan] Zhejiang Ctr Dis Control & Prevent, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanyu] Acad Mil Med Sci, Beijing Inst Transfus Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; United States Department of Agriculture (USDA); Tsinghua University; Academy of Military Medical Sciences - China	He, HX (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China.	hehx@ioz.ac.cn		Zhang, Hong/0000-0002-3930-6731	Chinese academy of sciences [KSCX2-EW-J-2]; National Science and Technology Ministry [2009BAI83B01]; National Natural Sciences Foundation of China [31101806]; USDA/APHIS/WS-IOZ CAS joint project [0760621234]	Chinese academy of sciences(Chinese Academy of Sciences); National Science and Technology Ministry; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); USDA/APHIS/WS-IOZ CAS joint project	This study was supported by the knowledge innovation program of the Chinese academy of sciences (KSCX2-EW-J-2), the National Science and Technology Ministry (2009BAI83B01), National Natural Sciences Foundation of China (31101806) and USDA/APHIS/WS-IOZ CAS joint project (0760621234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Christopher FB, 2001, P NATL ACAD SCI USA, V98, P2746; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Hans-Jurgen B, 1999, MOL BIOL EVOL, V16, P37; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; LAMB RA, 1980, P NATL ACAD SCI-BIOL, V77, P1857, DOI 10.1073/pnas.77.4.1857; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Nielsen R, 1998, GENETICS, V148, P929; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2007, PHYLOGENETIC HDB PRA, P1; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rolland M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012463; Schmitt AP, 2005, ADV VIRUS RES, V64, P383, DOI 10.1016/S0065-3527(05)64012-2; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Thomas MA, 2003, MOL BIOL EVOL, V20, P964, DOI 10.1093/molbev/msg110; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	24	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56201	10.1371/journal.pone.0056201	http://dx.doi.org/10.1371/journal.pone.0056201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418535	Green Published, gold			2022-12-25	WOS:000315970300127
J	Zhu, JP; Luo, Z; Wang, J; Xu, ZG; Chen, H; Fan, DY; Gao, N; Ping, GL; Zhou, Z; Zhang, Y; An, J				Zhu, Junping; Luo, Zhen; Wang, Juan; Xu, Zigang; Chen, Hui; Fan, Dongying; Gao, Na; Ping, Guoling; Zhou, Zhen; Zhang, Yan; An, Jing			Phylogenetic Analysis of Enterovirus 71 Circulating in Beijing, China from 2007 to 2009	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MOUTH-DISEASE; COMPLETE GENOME; STRAINS; EVOLUTION; OUTBREAK; HAND; FOOT; VP1; INFECTION	The major pathogens of hand, foot and mouth disease (HFMD) in Beijing, China from 2007 to 2009 were identified in this study. A total of 186 HFMD cases were included, and 136 cases (73%) were positive for enterovirus (EV). In 2007, 75% (27/36) were Coxsackievirus A16 (CA16) positive and 19% (7/36) were Enterovirus 71 (EV71) positive cases. However, EV71 was the predominant virus in 2008, when 56% (31/55) of the cases were positive for EV71 and 22% (12/55) were positive for CA16. In 2009, EV71 and CA16, with positive rates of 36% (16/45) and 29% (13/45), respectively, were still the major pathogens of HFMD. Phylogenetic analysis revealed that the dominant genotype of EV71 was C4, with co-circulation of genotype A in 2009. The prevalent cluster of the EV71 subgenotype C4 changed over time. A proposed new sublineage of EV71, C4a-2, was the predominant virus associated with the Beijing and nationwide HFMD outbreaks since 2008 and amino acid substitution, which possibly link to the central nervous system tropism of EV71, was found in genotype A viruses. Persistent surveillance of HFMD-associated pathogens is required for predicting potential emerging viruses and related disease outbreaks.	[Zhu, Junping; Wang, Juan; Chen, Hui; Fan, Dongying; Gao, Na; Ping, Guoling; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Beijing, Peoples R China; [Luo, Zhen; Xu, Zigang] Capital Med Univ, Dept Dermatol, Beijing Childrens Hosp, Beijing, Peoples R China; [Zhou, Zhen] Capital Med Univ, Dept Biomed Engn, Sch Biomed Engn, Beijing, Peoples R China; [Zhang, Yan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	An, J (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Beijing, Peoples R China.	anjing@ccmu.edu.cn			Beijing Nature Science Foundation [7072009]; National Key Programs on Basic Research of China [2011CB504703]; National Natural Science Foundation of China [81271839, 30901259]	Beijing Nature Science Foundation(Beijing Natural Science Foundation); National Key Programs on Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Beijing Nature Science Foundation (Grant No. 7072009, http://www.nsfc.gov.cn/), the National Key Programs on Basic Research of China (Grant No. 2011CB504703, http://www.973.gov.cn/English/Index.aspx) and the National Natural Science Foundation of China (Grant No. 81271839 and 30901259, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chen TC, 2008, J BIOMED SCI, V15, P291, DOI 10.1007/s11373-007-9228-5; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; Guan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044386; Hafliger D, 1997, INT J FOOD MICROBIOL, V37, P27, DOI 10.1016/S0168-1605(97)00041-X; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tao ZX, 2012, J CLIN MICROBIOL, V50, P1823, DOI 10.1128/JCM.06850-11; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Yang F, 2001, SCI CHINA SER C, V44, P178, DOI 10.1007/BF02879323; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	34	32	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56318	10.1371/journal.pone.0056318	http://dx.doi.org/10.1371/journal.pone.0056318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418551	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300144
J	Fowler, MS; Ruokolainen, L				Fowler, Mike S.; Ruokolainen, Lasse			Confounding Environmental Colour and Distribution Shape Leads to Underestimation of Population Extinction Risk	PLOS ONE			English	Article							SPECTRAL COLOR; NOISE COLOR; DYNAMICS; VARIABILITY; FLUCTUATIONS; TERRESTRIAL; UNCERTAINTY; EVOLUTION; SYNCHRONY; PATTERNS	The colour of environmental variability influences the size of population fluctuations when filtered through density dependent dynamics, driving extinction risk through dynamical resonance. Slow fluctuations (low frequencies) dominate in red environments, rapid fluctuations (high frequencies) in blue environments and white environments are purely random (no frequencies dominate). Two methods are commonly employed to generate the coloured spatial and/or temporal stochastic (environmental) series used in combination with population (dynamical feedback) models: autoregressive [AR(1)] and sinusoidal (1/f) models. We show that changing environmental colour from white to red with 1/f models, and from white to red or blue with AR(1) models, generates coloured environmental series that are not normally distributed at finite time-scales, potentially confounding comparison with normally distributed white noise models. Increasing variability of sample Skewness and Kurtosis and decreasing mean Kurtosis of these series alter the frequency distribution shape of the realised values of the coloured stochastic processes. These changes in distribution shape alter patterns in the probability of single and series of extreme conditions. We show that the reduced extinction risk for undercompensating (slow growing) populations in red environments previously predicted with traditional 1/f methods is an artefact of changes in the distribution shapes of the environmental series. This is demonstrated by comparison with coloured series controlled to be normally distributed using spectral mimicry. Changes in the distribution shape that arise using traditional methods lead to underestimation of extinction risk in normally distributed, red 1/f environments. AR(1) methods also underestimate extinction risks in traditionally generated red environments. This work synthesises previous results and provides further insight into the processes driving extinction risk in model populations. We must let the characteristics of known natural environmental covariates (e. g., colour and distribution shape) guide us in our choice of how to best model the impact of coloured environmental variation on population dynamics.	[Fowler, Mike S.] Inst Mediterrani Estudis Avancats UIB CSIC, Populat Ecol Grp, Esporles, Illes Balears, Spain; [Fowler, Mike S.] Swansea Univ, Dept Biosci, Swansea, W Glam, Wales; [Ruokolainen, Lasse] Univ Helsinki, Dept Biosci, Helsinki, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); Swansea University; University of Helsinki	Fowler, MS (corresponding author), Univ Illes Balears, Consejo Super Invest Cient CSIC, Palma De Mallorca, Spain.	m.s.fowler@swansea.ac.uk	Fowler, Mike/H-5092-2013	Fowler, Mike/0000-0003-1544-0407; Ruokolainen, Lasse/0000-0003-0951-9100	JAE-Doc fellowship; Spanish Ministry of Science Innovation [CGL2006-04325/BOS]; Finnish Academy	JAE-Doc fellowship; Spanish Ministry of Science Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Finnish Academy(Academy of Finland)	Financial support came from a JAE-Doc fellowship and grant ref. CGL2006-04325/BOS from the Spanish Ministry of Science & Innovation to MSF and the Finnish Academy to LR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocedi G, 2012, AM NAT, V179, P606, DOI 10.1086/665004; Caughley G., 1996, CONSERVATION BIOL TH; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen JE, 1999, CIRC SYST SIGNAL PR, V18, P431, DOI 10.1007/BF01200792; Cuddington KM, 1999, P ROY SOC B-BIOL SCI, V266, P969, DOI 10.1098/rspb.1999.0731; Gonzalez A, 2002, P NATL ACAD SCI USA, V99, P14872, DOI 10.1073/pnas.232589299; Greenman JV, 2005, THEOR POPUL BIOL, V68, P217, DOI 10.1016/j.tpb.2005.06.007; Halley JM, 2005, MAR ECOL PROG SER, V304, P274; Halley JM, 2004, FLUCT NOISE LETT, V4, pR1, DOI 10.1142/S0219477504001884; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; Heino M, 2000, ECOGRAPHY, V23, P177, DOI 10.1111/j.1600-0587.2000.tb00273.x; Inchausti P, 2002, EVOL ECOL RES, V4, P1033; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Laakso J, 2004, OIKOS, V104, P142, DOI 10.1111/j.0030-1299.2004.12197.x; Laakso J, 2003, OIKOS, V102, P663, DOI 10.1034/j.1600-0706.2003.12319.x; Li W, 2011, BIBLIO GENE GENOME D; Logdberg F, 2012, THEOR ECOL-NETH, V5, P545, DOI 10.1007/s12080-011-0145-x; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Petchey OL, 1997, P ROY SOC B-BIOL SCI, V264, P1841, DOI 10.1098/rspb.1997.0254; Petchey OL, 2000, P ROY SOC B-BIOL SCI, V267, P747, DOI 10.1098/rspb.2000.1066; Reed DH, 2003, ANIM CONSERV, V6, P109, DOI 10.1017/S1367943003003147; Ripa J, 1999, ECOL LETT, V2, P219; Ripa J, 1996, P ROY SOC B-BIOL SCI, V263, P1751, DOI 10.1098/rspb.1996.0256; ROUGHGARDEN J, 1975, AM NAT, V109, P713, DOI 10.1086/283039; Ruokolainen L, 2008, P ROY SOC B-BIOL SCI, V275, P1775, DOI 10.1098/rspb.2008.0193; Ruokolainen L, 2007, OIKOS, V116, P439, DOI 10.1111/j.2006.0030-1299.15586.x; Ruokolainen L, 2009, J THEOR BIOL, V261, P379, DOI 10.1016/j.jtbi.2009.08.010; Ruokolainen L, 2009, TRENDS ECOL EVOL, V24, P555, DOI 10.1016/j.tree.2009.04.009; Ruokolainen L, 2009, ECOL LETT, V12, P909, DOI 10.1111/j.1461-0248.2009.01346.x; SAUPE D, 1988, SCI FRACTAL IMAGES, P71; Schwager M, 2006, AM NAT, V167, P879, DOI 10.1086/503609; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Vasseur DA, 2007, OIKOS, V116, P1726, DOI 10.1111/j.2007.0030-1299.16101.x; Vasseur DA, 2007, THEOR POPUL BIOL, V72, P186, DOI 10.1016/j.tpb.2007.06.002; Vucetich JA, 2000, CONSERV BIOL, V14, P1704, DOI 10.1111/j.1523-1739.2000.99359.x; Ward L. M., 2007, SCHOLARPEDIA, V2, P1537, DOI [DOI 10.4249/SCH0LARPEDIA.1537, 10.4249/scholarpedia.1537, DOI 10.4249/SCHOLARPEDIA.1537]; WEST BJ, 1994, PHYS REP, V246, P2; Wichmann MC, 2005, THEOR POPUL BIOL, V68, P29, DOI 10.1016/j.tpb.2005.03.001; Yaari G, 2012, ECOLOGY, V93, P1214, DOI 10.1890/11-1077.1	48	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55855	10.1371/journal.pone.0055855	http://dx.doi.org/10.1371/journal.pone.0055855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409065	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000026
J	Koyama, MS; Di Martino, A; Kelly, C; Jutagir, DR; Sunshine, J; Schwartz, SJ; Castellanos, FX; Milham, MP				Koyama, Maki S.; Di Martino, Adriana; Kelly, Clare; Jutagir, Devika R.; Sunshine, Jessica; Schwartz, Susan J.; Castellanos, Francisco X.; Milham, Michael P.			Cortical Signatures of Dyslexia and Remediation: An Intrinsic Functional Connectivity Approach	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; RESTING-STATE FMRI; WORD FORM AREA; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; SPATIAL ATTENTION; DEFAULT NETWORK; NEURAL SYSTEMS; BRAIN NETWORKS; GLOBAL SIGNAL	This observational, cross-sectional study investigates cortical signatures of developmental dyslexia, particularly from the perspective of behavioral remediation. We employed resting-state fMRI, and compared intrinsic functional connectivity (iFC) patterns of known reading regions (seeds) among three dyslexia groups characterized by (a) no remediation (current reading and spelling deficits), (b) partial remediation (only reading deficit remediated), and (c) full remediation (both reading and spelling deficits remediated), and a group of age-and IQ-matched typically developing children (TDC) (total N = 44, age range = 7-15 years). We observed significant group differences in iFC of two seeds located in the left posterior reading network - left intraparietal sulcus (L.IPS) and left fusiform gyrus (L.FFG). Specifically, iFC between L.IPS and left middle frontal gyrus was significantly weaker in all dyslexia groups, irrespective of remediation status/literacy competence, suggesting that persistent dysfunction in the fronto-parietal attention network characterizes dyslexia. Additionally, relative to both TDC and the no remediation group, the remediation groups exhibited stronger iFC between L.FFG and right middle occipital gyrus (R.MOG). The full remediation group also exhibited stronger negative iFC between the same L.FFG seed and right medial prefrontal cortex (R.MPFC), a core region of the default network These results suggest that behavioral remediation may be associated with compensatory changes anchored in L.FFG, which reflect atypically stronger coupling between posterior visual regions (L.FFG-R.MOG) and greater functional segregation between task-positive and task-negative regions (L.FFG-R.MPFC). These findings were bolstered by significant relationships between the strength of the identified functional connections and literacy scores. We conclude that examining iFC can reveal cortical signatures of dyslexia with particular promise for monitoring neural changes associated with behavioral remediation.	[Koyama, Maki S.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Koyama, Maki S.; Di Martino, Adriana; Kelly, Clare; Jutagir, Devika R.; Sunshine, Jessica; Castellanos, Francisco X.] NYU, Ctr Child Study, NYU Langone Med Ctr, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY USA; [Schwartz, Susan J.; Milham, Michael P.] Child Mind Inst, Ctr Developing Brain, New York, NY USA; [Castellanos, Francisco X.; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	Rutgers State University Newark; Rutgers State University New Brunswick; New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research	Koyama, MS (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	makisophiakoyama@gmail.com	Milham, Michael P./Y-3160-2019; Kelly, Clare/H-4629-2016; Milham, Michael P/K-9501-2014; Castellanos, Francisco Xavier/K-1892-2014; Di Martino, Adriana/X-5030-2019; Di Martino, Adriana/L-2497-2014	Kelly, Clare/0000-0001-8253-357X; Castellanos, Francisco Xavier/0000-0001-9192-9437; Di Martino, Adriana/0000-0001-6927-290X	NIMH [R01MH081218, K23MH087770]; Stavros Niarchos Foundation; Leon Levy Foundation	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stavros Niarchos Foundation; Leon Levy Foundation	This study was supported by grants from NIMH [R01MH081218, K23MH087770], the Stavros Niarchos Foundation, and the Leon Levy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson JLR, 2007, NONLINEAR REGISTRATI; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blau V, 2010, BRAIN, V133, P868, DOI 10.1093/brain/awp308; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Carp J., 2011, NEUROIMAGE; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chabernaud C, 2012, BIOL PSYCHIAT, V71, P434, DOI 10.1016/j.biopsych.2011.08.013; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Conners C.K., 1997, CONNERS RATING SCALE; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davis N, 2011, DEV NEUROPSYCHOL, V36, P288, DOI 10.1080/87565641.2010.549875; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Demb JB, 1998, J NEUROSCI, V18, P6939; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Duff FJ, 2011, J CHILD PSYCHOL PSYC, V52, P3, DOI 10.1111/j.1469-7610.2010.02310.x; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Eden GF, 1996, NEUROIMAGE, V4, pS108, DOI 10.1006/nimg.1996.0061; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Farrant E, 2011, RSC DRUG DISCOV, V11, P1, DOI 10.1039/9781849733052-00001; Ferrer E, 2010, PSYCHOL SCI, V21, P93, DOI 10.1177/0956797609354084; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Gaab N, 2007, RESTOR NEUROL NEUROS, V25, P295; Georgiou GK, 2012, DYSLEXIA, V18, P110, DOI 10.1002/dys.1439; Goswami U, 2002, P NATL ACAD SCI USA, V99, P10911, DOI 10.1073/pnas.122368599; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamalainen J., 2012, J LEARNING DISABILIT, DOI http://dx.doi.org/10.1177/0022219411436213; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hoeft F, 2006, J NEUROSCI, V26, P10700, DOI 10.1523/JNEUROSCI.4931-05.2006; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kaufman J, 1996, SCHEDULE AFFECTIVE D; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; KRAEMER HC, 1991, PSYCHOPHARMACOL BULL, V27, P217; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; McCloskey M, 2000, J EXP PSYCHOL HUMAN, V26, P917, DOI 10.1037/0096-1523.26.3.917; Moats LC, 1996, READ WRIT, V8, P105, DOI 10.1007/BF00423928; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Odegard TN, 2008, ANN DYSLEXIA, V58, P1, DOI 10.1007/s11881-008-0014-5; Pennington BF, 2012, J ABNORM PSYCHOL, V121, P212, DOI 10.1037/a0025823; Pessoa L, 2009, BRAIN RES, V1247, P149, DOI 10.1016/j.brainres.2008.10.010; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sarkari Shirin, 2002, Semin Pediatr Neurol, V9, P229, DOI 10.1053/spen.2002.35506; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Simos PG, 2007, NEUROPSYCHOLOGY, V21, P485, DOI 10.1037/0894-4105.21.4.485; Snowling M., 1998, CHILD PSYCHOL PSYCHI, V3, P4, DOI [10.1111/1475-3588.00201, DOI 10.1111/1475-3588.00201, DOI 10.1017/S1360641797001366]; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stoodley CJ, 2011, CORTEX, V47, P101, DOI 10.1016/j.cortex.2009.10.005; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Torgesen J.K., 1999, TOWRE TEST WORD READ; Torgesen JK, 2001, J LEARN DISABIL-US, V34, P33, DOI 10.1177/002221940103400104; Valdois S, 2011, CORTEX, V47, P1197, DOI 10.1016/j.cortex.2011.05.011; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; von dem Hagen EA, 2012, SOCIAL COGNITIVE AFF; Wagner R, 1999, CTOPP COMPREHENSIVE; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; Willcutt EG, 2007, AM J MED GENET B, V144B, P709, DOI 10.1002/ajmg.b.30310; Wolf M, 2000, J LEARN DISABIL-US, V33, P387, DOI 10.1177/002221940003300409; Zorzi M., 2012, P NATL ACAD SCI US	107	80	81	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55454	10.1371/journal.pone.0055454	http://dx.doi.org/10.1371/journal.pone.0055454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23408984	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000015
J	Lourenco, AB; Roque, FC; Teixeira, MC; Ascenso, JR; Sa-Correia, I				Lourenco, Artur B.; Roque, Filipa C.; Teixeira, Miguel C.; Ascenso, Jose R.; Sa-Correia, Isabel			Quantitative H-1-NMR-Metabolomics Reveals Extensive Metabolic Reprogramming and the Effect of the Aquaglyceroporin FPS1 in Ethanol-Stressed Yeast Cells	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; IN-VIVO ACTIVATION; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; GENE-EXPRESSION; LIPID-COMPOSITION; BUDDING YEAST; H+-ATPASE; TOLERANCE; GLYCEROL	A metabolomic analysis using high resolution H-1 NMR spectroscopy coupled with multivariate statistical analysis was used to characterize the alterations in the endo-and exo-metabolome of S. cerevisiae BY4741 during the exponential phase of growth in minimal medium supplemented with different ethanol concentrations (0, 2, 4 and 6% v/v). This study provides evidence that supports the notion that ethanol stress induces reductive stress in yeast cells, which, in turn, appears to be counteracted by the increase in the rate of NAD(+) regenerating bioreactions. Metabolomics data also shows increased intra-and extra-cellular accumulation of most amino acids and TCA cycle intermediates in yeast cells growing under ethanol stress suggesting a state of overflow metabolism in turn of the pyruvate branch-point. Given its previous implication in ethanol stress resistance in yeast, this study also focused on the effect of the expression of the aquaglyceroporin encoded by FPS1 in the yeast metabolome, in the absence or presence of ethanol stress. The metabolomics data collected herein shows that the deletion of the FPS1 gene in the absence of ethanol stress partially mimics the effect of ethanol stress in the parental strain. Moreover, the results obtained suggest that the reported action of Fps1 in mediating the passive diffusion of glycerol is a key factor in the maintenance of redox balance, an important feature for ethanol stress resistance, and may interfere with the ability of the yeast cell to accumulate trehalose. Overall, the obtained results corroborate the idea that metabolomic approaches may be crucial tools to understand the function and/or the effect of membrane transporters/porins, such as Fps1, and may be an important tool for the clear-cut design of improved process conditions and more robust yeast strains aiming to optimize industrial fermentation performance.	[Lourenco, Artur B.; Roque, Filipa C.; Teixeira, Miguel C.; Sa-Correia, Isabel] Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, IBB, P-1096 Lisbon, Portugal; [Ascenso, Jose R.] Univ Tecn Lisboa, Inst Super Tecn, Ctr Quim Estrutural, P-1096 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Sa-Correia, I (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, Ctr Biol & Chem Engn, IBB, P-1096 Lisbon, Portugal.	isacorreia@ist.utl.pt	Sá-Correia, Isabel/H-4054-2011; Bastos Lourenço, Artur/AEN-1450-2022; Teixeira, Miguel Cacho/A-3870-2008	Sá-Correia, Isabel/0000-0003-2208-5183; Bastos Lourenço, Artur/0000-0002-9379-9231; Teixeira, Miguel Cacho/0000-0002-5676-6174; Ascenso, Jose/0000-0002-5535-2500	FEDER, Fundacao para a Ciencia e a Tecnologia (FCT) [ERA-IB/0002/2010]	FEDER, Fundacao para a Ciencia e a Tecnologia (FCT)	This research was supported by FEDER, Fundacao para a Ciencia e a Tecnologia (FCT) (ERA-IB/0002/2010 and PhD grants to ABL and FCR). The Portuguese National NMR Network is acknowledged for providing the authors with the NMR facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera F, 2006, INT J FOOD MICROBIOL, V110, P34, DOI 10.1016/j.ijfoodmicro.2006.02.002; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Ansanay-Geleote V, 2001, BIOTECHNOL LETT, V23, P677, DOI 10.1023/A:1010396232420; Baerends RJS, 2009, APPL ENVIRON MICROB, V75, P6055, DOI 10.1128/AEM.00989-09; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; BOLES E, 1993, EUR J BIOCHEM, V217, P469, DOI 10.1111/j.1432-1033.1993.tb18266.x; Cabrito TR, 2011, BIOCHEM J, V440, P195, DOI 10.1042/BJ20110876; Camarasa C, 2003, MICROBIOL-SGM, V149, P2669, DOI 10.1099/mic.0.26007-0; CASEY GP, 1986, CRC CR REV MICROBIOL, V13, P219, DOI 10.3109/10408418609108739; Chandler M, 2004, ANN MICROBIOL, V54, P427; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cheraiti N, 2005, APPL ENVIRON MICROB, V71, P255, DOI 10.1128/AEM.71.1.255-260.2005; Chi Z, 1999, J APPL MICROBIOL, V86, P1047, DOI 10.1046/j.1365-2672.1999.00793.x; DAMORE T, 1987, ENZYME MICROB TECH, V9, P322, DOI 10.1016/0141-0229(87)90053-6; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Devantier R, 2005, BIOTECHNOL BIOENG, V90, P703, DOI 10.1002/bit.20457; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Ding MZ, 2010, OMICS, V14, P553, DOI 10.1089/omi.2010.0015; dos Santos MM, 2003, FEMS YEAST RES, V4, P59, DOI 10.1016/S1567-1356(03)00155-7; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Fujita K, 2004, J APPL MICROBIOL, V97, P57, DOI 10.1111/j.1365-2672.2004.02290.x; Fujita K, 2006, FEMS YEAST RES, V6, P744, DOI 10.1111/j.1567-1364.2006.00040.x; Gawel R, 2007, AUST J GRAPE WINE R, V13, P38, DOI 10.1111/j.1755-0238.2007.tb00070.x; Gawel R, 2007, J AGR FOOD CHEM, V55, P2683, DOI 10.1021/jf0633950; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Guillamon JM, 2001, FEMS YEAST RES, V1, P169, DOI 10.1111/j.1567-1364.2001.tb00031.x; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Jain VK, 2012, APPL MICROBIOL BIOT, V93, P131, DOI 10.1007/s00253-011-3431-z; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Kubota S, 2004, BIOSCI BIOTECH BIOCH, V68, P968, DOI 10.1271/bbb.68.968; Kutyna DR, 2010, TRENDS FOOD SCI TECH, V21, P293, DOI 10.1016/j.tifs.2010.03.004; Leskovac V, 2002, FEMS YEAST RES, V2, P481, DOI 10.1111/j.1567-1364.2002.tb00116.x; Li H, 2012, INT J BIOCHEM CELL B, V44, P1087, DOI 10.1016/j.biocel.2012.03.017; Lourenc AB, 2011, METABOLOMICS, V7, P457, DOI 10.1007/s11306-010-0264-1; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Ma MG, 2010, APPL MICROBIOL BIOT, V87, P829, DOI 10.1007/s00253-010-2594-3; Martini S, 2006, BIOPHYS CHEM, V120, P135, DOI 10.1016/j.bpc.2005.10.010; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Monteiro GA, 1998, BBA-BIOMEMBRANES, V1370, P310, DOI 10.1016/S0005-2736(97)00281-2; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Ogawa Y, 2000, J BIOSCI BIOENG, V90, P313, DOI 10.1016/S1389-1723(00)80087-0; ROSA MF, 1991, APPL ENVIRON MICROB, V57, P830, DOI 10.1128/AEM.57.3.830-835.1991; Rosa MF, 1996, FEMS MICROBIOL LETT, V135, P271, DOI 10.1016/0378-1097(95)00465-3; SALGUEIRO SP, 1988, APPL ENVIRON MICROB, V54, P903, DOI 10.1128/AEM.54.4.903-909.1988; Schoondermark-Stolk SA, 2005, FEMS YEAST RES, V5, P757, DOI 10.1016/j.femsyr.2005.02.005; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Stanley D, 2010, APPL MICROBIOL BIOT, V88, P231, DOI 10.1007/s00253-010-2760-7; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Takagi H, 2005, APPL ENVIRON MICROB, V71, P8656, DOI 10.1128/AEM.71.12.8656-8662.2005; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Teixeira MC, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-98; Teixeira MC, 2009, APPL ENVIRON MICROB, V75, P5761, DOI 10.1128/AEM.00845-09; Toh TH, 2001, FEMS YEAST RES, V1, P205, DOI 10.1111/j.1567-1364.2001.tb00035.x; van Uden N., 1985, THES U AD, V8, P11; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Vriesekoop F, 2007, BIOTECHNOL LETT, V29, P1099, DOI 10.1007/s10529-007-9367-9; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x	66	18	21	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55439	10.1371/journal.pone.0055439	http://dx.doi.org/10.1371/journal.pone.0055439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408980	Green Submitted, gold, Green Published			2022-12-25	WOS:000314660300014
J	Absood, A; Gandomani, B; Zaki, A; Nasta, V; Michail, A; Habib, PMW; Hodish, I				Absood, Afaf; Gandomani, Benjamin; Zaki, Anthony; Nasta, Vlad; Michail, Andrew; Habib, Peter M. W.; Hodish, Israel			Insulin Therapy for Pre-Hyperglycemic Beta-Cell Endoplasmic Reticulum Crowding	PLOS ONE			English	Article							DIABETIC MUTANT MOUSE; IMPAIRED GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; PANCREATIC ISLETS; METABOLIC-CONTROL; FASTING GLUCOSE; ER STRESS; US ADULTS; MICE; PROINSULIN	Insulin therapy improves beta-cell function in early stages of diabetes by mechanisms that may exceed alleviation of glucotoxicity. In advance type 2 diabetes, hyperglycemia causes beta-cell damage and ultimately beta-cell loss. At such an advanced stage, therapeutic modalities are often inadequate. Growing evidence indicates that in early stages of type-2 diabetes and some types of monogenic diabetes linked with malfunctioning endoplasmic-reticulum (ER), the beta-cell ER fails to process sufficient proinsulin once it becomes overloaded. These changes manifest with ER distention (ER-crowding) and deficiency of secretory granules. We hypothesize that insulin therapy may improves beta-cell function by alleviating ER-crowding. To support this hypothesis, we investigated pre-diabetic beta-cell changes in hProC(A7)Y-CpepGFP transgenic mice that develop prolonged pre-diabetes due to proinsulin dysmaturation and ER-crowding. We attenuated the beta-cell ER proinsulin synthesis with a treat-to-target insulin therapy while avoiding hypoglycemia and weight gain. Alleviation of ER-crowding resulted in temporary improvement in proinsulin maturation, insulin secretion and glucose tolerance. Our observations suggest that alleviation of pre-diabetic ER-crowding using a treat-to-target insulin therapy may improve b-cell function and may prevent further metabolic deterioration.	[Absood, Afaf; Gandomani, Benjamin; Zaki, Anthony; Nasta, Vlad; Hodish, Israel] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Michail, Andrew; Habib, Peter M. W.] Wayne State Univ, Detroit, MI USA	University of Michigan System; University of Michigan; Wayne State University	Hodish, I (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	ihodish@umich.edu		Michail, Andrew/0000-0002-5744-2067; Zaki, Anthony/0000-0001-8190-7939	National Institutes of Health [R00 DK077441A]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by National Institutes of Health R00 DK077441A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Alvarsson M, 2003, DIABETES CARE, V26, P2231, DOI 10.2337/diacare.26.8.2231; Bache I, 1997, DIABETES RES CLIN PR, V37, P9, DOI 10.1016/S0168-8227(97)00056-9; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bo S, 2000, ACTA DIABETOL, V37, P125, DOI 10.1007/s005920070014; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chen HS, 2008, DIABETES CARE, V31, P1927, DOI 10.2337/dc08-0075; CHICK WL, 1970, DIABETOLOGIA, V6, P243, DOI 10.1007/BF01212233; Despa F, 2009, BIOPHYS CHEM, V140, P115, DOI 10.1016/j.bpc.2008.12.003; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; ESCHWEGE E, 1985, HORM METAB RES, V15, P41; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; FLAX H, 1991, DIABETOLOGIA, V34, P570, DOI 10.1007/BF00400275; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; FREYCHET P, 1974, J CLIN INVEST, V54, P1020, DOI 10.1172/JCI107845; Garcia-Estevez DA, 2002, METABOLISM, V51, P1047, DOI 10.1053/meta.2002.33340; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Hodish I, 2011, DIABETES, V60, P2092, DOI 10.2337/db10-1671; Hodish I, 2010, J BIOL CHEM, V285, P685, DOI 10.1074/jbc.M109.038042; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Junger E, 2002, LAB INVEST, V82, P843, DOI 10.1097/01.LAB.0000018917.69993.BA; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Karve A, 2010, DIABETES CARE, V33, P2355, DOI 10.2337/dc09-1957; Kautz S, 2012, DIABETOLOGIA, V55, P382, DOI 10.1007/s00125-011-2362-7; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; LEITER EH, 1989, FASEB J, V3, P2231, DOI 10.1096/fasebj.3.11.2673897; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Li HQ, 2011, METABOLISM, V60, P1566, DOI 10.1016/j.metabol.2011.01.018; Li YB, 2004, DIABETES CARE, V27, P2597, DOI 10.2337/diacare.27.11.2597; LIKE AA, 1970, DIABETOLOGIA, V6, P207, DOI 10.1007/BF01212231; LIKE AA, 1970, DIABETOLOGIA, V6, P216, DOI 10.1007/BF01212232; Magami Y, 2002, PANCREAS, V24, P153, DOI 10.1097/00006676-200203000-00006; Manzella D, 2003, CLIN SCI, V105, P113, DOI 10.1042/CS20020291; Manzella D, 2002, CLIN ENDOCRINOL, V57, P259, DOI 10.1046/j.1365-2265.2002.01596.x; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Panero F, 2009, DIABETES CARE, V32, P301, DOI 10.2337/dc08-1241; Porcellati F, 2011, DIABETES TECHNOL THE, V13, DOI 10.1089/dia.2011.0038; Rosenthal EB, 2011, J DIABETES IN PRESS; Ryan EA, 2004, DIABETES CARE, V27, P1028, DOI 10.2337/diacare.27.5.1028; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Sandefur CI, 2011, BIOPHYS J, V100, P1864, DOI 10.1016/j.bpj.2011.03.006; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	54	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54351	10.1371/journal.pone.0054351	http://dx.doi.org/10.1371/journal.pone.0054351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408938	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200008
J	Huang, WS; Pike, DA				Huang, Wen-San; Pike, David A.			Testing Cost-Benefit Models of Parental Care Evolution Using Lizard Populations Differing in the Expression of Maternal Care	PLOS ONE			English	Article							LIFE-HISTORY CHANGES; MABUYA-LONGICAUDATA; BEHAVIOR; PREDATION; SKINK	Parents are expected to evolve tactics to care for eggs or offspring when providing such care increases fitness above the costs incurred by this behavior. Costs to the parent include the energetic demands of protecting offspring, delaying future fecundity, and increased risk of predation. We used cost-benefit models to test the ecological conditions favoring the evolution of parental care, using lizard populations that differ in whether or not they express maternal care. We found that predators play an important role in the evolution of maternal care because: (1) evolving maternal care is unlikely when care increases predation pressure on the parents; (2) maternal care cannot evolve under low levels of predation pressure on both parents and offspring; and (3) maternal care evolves only when parents are able to successfully defend offspring from predators without increasing predation risk to themselves. Our studies of one of the only known vertebrate species to exhibit interpopulation differences in the expression of maternal care provide clear support for some of the hypothesized circumstances under which maternal care should evolve (e.g., when nests are in exposed locations, parents are able to defend the eggs from predators, and egg incubation periods are brief), but do not support others (e.g., when nest-sites are scarce, life history strategies are "risky", reproductive frequency is low, and environmental conditions are harsh). We conclude that multiple pathways can lead to the evolution of parental care from a non-caring state, even in a single population of a widespread species.	[Huang, Wen-San] Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan; [Huang, Wen-San] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Pike, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	National Chung Hsing University; James Cook University	Huang, WS (corresponding author), Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan.	wshuang@mail.nmns.edu.tw	Pike, David A/B-2032-2012	Huang, Wen-San/0000-0003-0073-3557	Kuo Wu Hsiu Luan Culture and Education Foundation; National Science Council of Taiwan [NSC 99-2621-B-178-001-MY3]	Kuo Wu Hsiu Luan Culture and Education Foundation; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by the Kuo Wu Hsiu Luan Culture and Education Foundation and the National Science Council of Taiwan (NSC 99-2621-B-178-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 1996, ECOLOGY, V77, P1116, DOI 10.2307/2265580; Besnard A, 2002, EVOL ECOL, V16, P489, DOI 10.1023/A:1020809528816; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; Chivers DP, 2001, OIKOS, V92, P135, DOI 10.1034/j.1600-0706.2001.920116.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; deFraipont M, 1996, EVOLUTION, V50, P391, DOI 10.1111/j.1558-5646.1996.tb04501.x; Girondot M, 2002, ANIM CONSERV, V5, P75, DOI 10.1017/S1367943002001099; Greene Harry W., 2002, P179; Huang WS, 2007, ECOL RES, V22, P659, DOI 10.1007/s11284-006-0068-y; Huang WS, 2006, ANIM BEHAV, V72, P791, DOI 10.1016/j.anbehav.2005.12.011; Huang Wen-San, 1994, Journal of Taiwan Museum, V47, P45; Huang WS, 2006, COPEIA, P293; Huang WS, 2011, FUNCT ECOL, V25, P1125, DOI 10.1111/j.1365-2435.2011.01855.x; Huang WS, 2011, P NATL ACAD SCI USA, V108, P7455, DOI 10.1073/pnas.1101804108; Huang WS, 2010, ZOOLOGY, V113, P85, DOI 10.1016/j.zool.2009.06.003; Huang WS, 2004, THESIS CORNELL U NY; Huang WS, J ANIM ECOL IN PRESS; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Maynard-Smith J, 1977, ANIM BEHAV, V25, P1, DOI [10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8)]; NOBLE G. K., 1933, AMER MUS NOVITATES, V619, P1; RAND AS, 1968, COPEIA, P552, DOI 10.2307/1442024; Reguera P, 1999, BEHAV ECOL, V10, P541, DOI 10.1093/beheco/10.5.541; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; Rosenheim JA, 1999, EVOL ECOL, V13, P141, DOI 10.1023/A:1006612519265; Schmitz OJ, 1998, EVOL ECOL, V12, P73, DOI 10.1023/A:1006559007590; Shine R., 1988, BIOL REPTILIA, P275; Stearns S.C., 1992, pi; Tinkle D.W, 1977, Miscellaneous Publs Mus Zool Univ Michigan, VNo. 154, P1; TINKLE DW, 1969, AM NAT, V103, P501, DOI 10.1086/282617; Tseng Hui-Yun, 2012, Herpetological Review, V43, P141; Williams G. C., 1966, P307; WINKLER DW, 1987, AM NAT, V130, P526, DOI 10.1086/284729	33	6	6	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54065	10.1371/journal.pone.0054065	http://dx.doi.org/10.1371/journal.pone.0054065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408934	Green Accepted, gold, Green Published			2022-12-25	WOS:000315157200007
J	Lindsley, DL; Roote, J; Kennison, JA				Lindsley, Dan L.; Roote, John; Kennison, James A.			Anent the Genomics of Spermatogenesis in Drosophila melanogaster	PLOS ONE			English	Article							BIASED GENE-EXPRESSION; STERILE MUTATIONS; MALE-FERTILITY; X-CHROMOSOME; DEMASCULINIZATION; REGION; LETHAL	An appreciable fraction of the Drosophila melanogaster genome is dedicated to male fertility. One approach to characterizing this subset of the genome is through the study of male-sterile mutations. We studied the relation between vital and male-fertility genes in three large autosomal regions that were saturated for lethal and male-sterile mutations. The majority of male-sterile mutations affect genes that are exclusively expressed in males. These genes are required only for male fertility, and several mutant alleles of each such gene were encountered. A few male-sterile mutations were alleles of vital genes that are expressed in both males and females. About one-fifth of the genes in Drosophila melanogaster show male-specific expression in adults. Although some earlier studies found a paucity of genes on the X chromosome showing male-biased expression, we did not find any significant differences between the X chromosome and the autosomes either in the relative frequencies of mutations to male sterility or in the frequencies of genes with male-specific expression in adults. Our results suggest that as much as 25% of the Drosophila genome may be dedicated to male fertility.	[Lindsley, Dan L.] Univ Calif San Diego, Dept Cell & Dev Biol, La Jolla, CA 92093 USA; [Roote, John] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Kennison, James A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Diego; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kennison, JA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	Jim_Kennison@nih.gov			Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Department of Genetics, University of Cambridge; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001005] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Department of Genetics, University of Cambridge(University of Cambridge); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Department of Genetics, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 1999, GENETICS, V153, P179; Belote JM, 2009, HEREDITY, V103, P23, DOI 10.1038/hdy.2009.23; Cooper MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023509; Cooper MT, 2010, GENETICS, V185, P811, DOI 10.1534/genetics.110.115121; EPLER JL, 1966, GENETICS, V54, P31; GANS M, 1975, GENETICS, V81, P683; GEER BW, 1983, J EXP ZOOL, V225, P107, DOI 10.1002/jez.1402250113; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hahn MW, 2005, CURR BIOL, V15, pR192, DOI 10.1016/j.cub.2005.03.005; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Joslyn GL, 1988, THESIS U CALIFORNIA; Kemkemer C, 2011, MOL BIOL EVOL, V28, P1561, DOI 10.1093/molbev/msq355; KENNISON JA, 1983, GENETICS, V103, P219; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; LIFSCHYTZ E, 1978, MOL GEN GENET, V161, P275, DOI 10.1007/BF00331001; Lindsley D.L., 1980, Genetics and Biology of Drosophila, V2d, P225; Lindsley D. L., 1972, The genetics of the spermatozoon. Proceedings, International Symposium, Edinburgh, 16-20 August, 1971., P203; Meiklejohn CD, 2012, GENOME BIOL EVOL, V4, P1007, DOI 10.1093/gbe/evs077; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; MOHLER JD, 1977, GENETICS, V85, P259; NASH D, 1983, GENETICS, V105, P957; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; SCHUPBACH T, 1989, GENETICS, V121, P101; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002	29	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55915	10.1371/journal.pone.0055915	http://dx.doi.org/10.1371/journal.pone.0055915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409089	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200089
J	Ma, B; Liu, JN; Zhang, Q; Ying, HJ; Jiye, A; Sun, JG; Wu, D; Wang, YL; Li, J; Liu, YH				Ma, Bo; Liu, Jiannan; Zhang, Qi; Ying, Hanjie; Jiye, A.; Sun, Jianguo; Wu, Di; Wang, Yonglu; Li, Jing; Liu, Yinhui			Metabolomic Profiles Delineate Signature Metabolic Shifts during Estrogen Deficiency-Induced Bone Loss in Rat by GC-TOF/MS	PLOS ONE			English	Article							MINERAL DENSITY; POSTMENOPAUSAL WOMEN; ARACHIDONIC-ACID; OLDER WOMEN; OVARIECTOMIZED RATS; BIOCHEMICAL MARKERS; BLOOD-PLASMA; FATTY-ACIDS; OSTEOPOROSIS; TURNOVER	Postmenopausal osteoporosis is a complicated and multi-factorial disease. To study the metabolic profiles and pathways activated in osteoporosis, Eight rats were oophorectomized (OVX group) to represent postmenopausal osteoporosis and the other eight rats were sham operated (Sham group) to be the control. The biochemical changes were assessed with metabolomics using a gas chromatography/time-of-flight mass spectrometry. Metabolomic profile using serial blood samples obtained prior to and at different time intervals after OVX were analyzed by principal component analysis (PCA) and Partial least squares-discriminant analysis (PLS-DA). The conventional indicators (bone mineral density, serum Bone alkaline phosphatase (B-ALP) and N-telopeptide of type I collagen (NTx) of osteoporosis in rats were also determined simultaneously. In OVX group, the metabolomics method could describe the endogenous changes of the disease more sensitively and systematically than the conventional criteria during the progression of osteoporosis. Significant metabolomic difference was also observed between the OVX and Sham groups. The metabolomic analyses of rat plasma showed that levels of arachidonic acid, octadecadienoic acid, branched-chain amino acids (valine, leucine and isoleucine), homocysteine, hydroxyproline and ketone bodies (3-Hydroxybutyric Acid) significantly elevated, while levels of docosahexaenoic acid, dodecanoic acid and lysine significantly decreased in OVX group compared with those in the homeochronous Sham group. Considering such metabolites are closely related to the pathology of the postmenopausal osteoporosis, the results suggest that potential biomarkers for the early diagnosis or the pathogenesis of osteoporosis might be identified via metabolomic study.	[Ma, Bo; Zhang, Qi; Wang, Yonglu; Li, Jing; Liu, Yinhui] Nanjing Univ Technol, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China; [Liu, Jiannan] Jiangsu Geriatr Hosp, Dept Respirat, Nanjing, Jiangsu, Peoples R China; [Ying, Hanjie] Nanjing Univ Technol, Sch Life Sci & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Jiye, A.; Sun, Jianguo] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Wu, Di] Childrens Hosp Philadelphia, Lab Syst Biol, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA; [Wu, Di] Univ Penn, Kinet Modeling & Simulat KMAS Core, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	Nanjing Tech University; Nanjing Tech University; China Pharmaceutical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Zhang, Q (corresponding author), Nanjing Univ Technol, Sch Pharmaceut Sci, Nanjing, Jiangsu, Peoples R China.	nancyzhang03@hotmail.com; yinghanjie134@163.com		Ying, Hanjie/0000-0002-4061-0001	"333 High Level Talent Cultivation Project'' of Jiangsu Province	"333 High Level Talent Cultivation Project'' of Jiangsu Province	The study was supported by a grant from the "333 High Level Talent Cultivation Project'' of Jiangsu Province (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, TOHOKU J EXP MED, V214, P51, DOI 10.1620/tjem.214.51; Abrahamsen B, 2000, J BONE MINER RES, V15, P1545, DOI 10.1359/jbmr.2000.15.8.1545; Bayhan I, 2009, RHEUMATOL INT, V29, P263, DOI 10.1007/s00296-008-0693-6; Bhattacharyya S, 2008, J BONE MINER RES, V23, P1106, DOI 10.1359/JBMR.080235; Bonnelye E, 2005, J CLIN ENDOCR METAB, V90, P3115, DOI 10.1210/jc.2004-2168; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Coetzee M, 2007, J NUTR BIOCHEM, V18, P54, DOI 10.1016/j.jnutbio.2006.03.002; De Leo V, 2001, AM J OBSTET GYNECOL, V184, P350, DOI 10.1067/mob.2001.111065; Dimitrova KR, 2002, CARDIOVASC RES, V53, P577, DOI 10.1016/S0008-6363(01)00462-X; FERRANDEZ L, 1990, ARCH ORTHOP TRAUM SU, V109, P181, DOI 10.1007/BF00453137; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Jinno Y, 2009, CLIN ORAL IMPLAN RES, V20, P756, DOI 10.1111/j.1600-0501.2008.01665.x; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kahl KG, 2005, AM J PSYCHIAT, V162, P168, DOI 10.1176/appi.ajp.162.1.168; Koh JM, 2006, J BONE MINER RES, V21, P1003, DOI [10.1359/jbmr.060406, 10.1359/JBMR.060406]; Leslie RD, 2011, DIABETES, V60, P2688, DOI 10.2337/db11-1177; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Lu YH, 2008, RAPID COMMUN MASS SP, V22, P2882, DOI 10.1002/rcm.3670; Ma B, 2012, ACTA PHARMACOL SIN, V33, P479, DOI 10.1038/aps.2011.177; Ma B, 2011, ACTA PHARMACOL SIN, V32, P270, DOI 10.1038/aps.2010.196; Ma YFL, 2002, J BONE MINER RES, V17, P2256, DOI 10.1359/jbmr.2002.17.12.2256; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Omoigui S, 2005, MED HYPOTHESES, V65, P559, DOI 10.1016/j.mehy.2005.03.012; PACIFICI R, 1987, P NATL ACAD SCI USA, V84, P4616, DOI 10.1073/pnas.84.13.4616; PACIFICI R, 1993, J CLIN ENDOCR METAB, V77, P1135, DOI 10.1210/jc.77.5.1135; Parhami F, 2002, J BONE MINER RES, V17, P1997, DOI 10.1359/jbmr.2002.17.11.1997; Patel MI, 2008, J UROLOGY, V179, P1668, DOI 10.1016/j.juro.2007.12.037; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Qian S, 2010, PLOS ONE, V5; Reginster JY, 2008, BONE, V42, P832, DOI 10.1016/j.bone.2008.01.021; Schmolke B, 2001, ORTHOPADE, V30, P425, DOI 10.1007/s001320170073; Shi XL, 2012, J BIOL CHEM, V287, P6336, DOI 10.1074/jbc.M111.312199; Spencer TA, 2004, J SURG RES, V118, P83, DOI 10.1016/j.jss.2004.01.021; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Trygg J., 2005, ANAL CHEM, V77, P8086; Vasikaran SD, 2008, CRIT REV CL LAB SCI, V45, P221, DOI [10.1080/10408360801949442, 10.1080/10408360801949442 ]; Villareal DT, 2001, JAMA-J AM MED ASSOC, V286, P815, DOI 10.1001/jama.286.7.815; Watkins BA, 2000, J NUTR, V130, P2274, DOI 10.1093/jn/130.9.2274; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Weiss LA, 2005, AM J CLIN NUTR, V81, P934, DOI 10.1093/ajcn/81.4.934; Whitney C, 2004, SPORTS MED, V34, P779, DOI 10.2165/00007256-200434120-00001; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; You L, 2011, ACTA PHARMACOL SIN, V32, P1498, DOI 10.1038/aps.2011.135; Zhang Q, 2010, BIOMARKERS, V15, P205, DOI 10.3109/13547500903419049; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002	53	28	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54965	10.1371/journal.pone.0054965	http://dx.doi.org/10.1371/journal.pone.0054965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408954	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200014
J	Narne, VK				Narne, Vijaya Kumar			Temporal Processing and Speech Perception in Noise by Listeners with Auditory Neuropathy	PLOS ONE			English	Article							FINE-STRUCTURE CUES; FREQUENCY DISCRIMINATION; CARRIER FREQUENCY; MODULATION RATE; ENVELOPE; INDIVIDUALS; INTELLIGIBILITY; CONSEQUENCES; CHILDREN	Aim: The present study evaluated the relation between speech perception in the presence of background noise and temporal processing ability in listeners with Auditory Neuropathy (AN). Method: The study included two experiments. In the first experiment, temporal resolution of listeners with normal hearing and those with AN was evaluated using measures of temporal modulation transfer function and frequency modulation detection at modulation rates of 2 and 10 Hz. In the second experiment, speech perception in quiet and noise was evaluated at three signal to noise ratios (SNR) (0, 5, and 10 dB). Results: Results demonstrated that listeners with AN performed significantly poorer than normal hearing listeners in both amplitude modulation and frequency modulation detection, indicating significant impairment in extracting envelope as well as fine structure cues from the signal. Furthermore, there was significant correlation seen between measures of temporal resolution and speech perception in noise. Conclusion: Results suggested that an impaired ability to efficiently process envelope and fine structure cues of the speech signal may be the cause of the extreme difficulties faced during speech perception in noise by listeners with AN.	All India Inst Speech & Hearing, Mysore, Karnataka, India		Narne, VK (corresponding author), All India Inst Speech & Hearing, Mysore, Karnataka, India.	vijaynarne@gmail.com	Narne, Vijaya K/AAS-7643-2020; Narne, Vijaya/AAU-9326-2020	Narne, Vijaya/0000-0002-6531-8015				American National Standards Institute, 1996, S361996 ANSI; ANSI, 2018, S311999 ANSI; Berlin CI, 2003, PEDIATR CLIN N AM, V50, P331, DOI 10.1016/S0031-3955(03)00031-2; Buss E, 2004, EAR HEARING, V25, P242, DOI 10.1097/01.AUD.0000130796.73809.09; DRULLMAN R, 1995, J ACOUST SOC AM, V97, P585, DOI 10.1121/1.413112; DRULLMAN R, 1995, J ACOUST SOC AM, V98, P1796, DOI 10.1121/1.413378; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; HALL JW, 1994, J ACOUST SOC AM, V96, P150, DOI 10.1121/1.410474; Hopkins K, 2008, J ACOUST SOC AM, V123, P1140, DOI 10.1121/1.2824018; Hopkins K, 2009, J ACOUST SOC AM, V125, P442, DOI 10.1121/1.3037233; HOUTGAST T, 1985, J ACOUST SOC AM, V77, P1069, DOI 10.1121/1.392224; International Standards Organization, 1994, 3983 ISO; Kraus N, 2000, JARO-J ASSOC RES OTO, V1, P33, DOI 10.1007/s101620010004; Kumar AU, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-21; Lacher-Fougere S, 1998, AUDIOLOGY, V37, P109; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liu S, 2004, J ACOUST SOC AM, V116, P2374, DOI 10.1121/1.1787528; Lorenzi C, 2000, NEUROCASE, V6, P231; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Moore BCJ, 2002, J ACOUST SOC AM, V111, P327, DOI 10.1121/1.1424871; MOORE BCJ, 1995, J ACOUST SOC AM, V97, P2468, DOI 10.1121/1.411967; Moore BCJ, 2003, SPEECH COMMUN, V41, P81, DOI 10.1016/S0167-6393(02)00095-X; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1722, DOI 10.1121/1.398603; Narne VK, 2009, INT J AUDIOL, V48, P700, DOI 10.1080/14992020902931574; Narne VK, 2009, EAR HEARING, V30, P136, DOI 10.1097/AUD.0b013e3181926545; Narne VK, 2007, FRONT RES SPEECH MUS, P130; Rance G, 2004, EAR HEARING, V25, P34, DOI 10.1097/01.AUD.0000111259.59690.B8; Rance G, 2007, EAR HEARING, V28, P351, DOI 10.1097/AUD.0b013e3180479404; Rance Gary, 2005, Trends Amplif, V9, P1, DOI 10.1177/108471380500900102; SEK A, 1995, J ACOUST SOC AM, V97, P2479, DOI 10.1121/1.411968; SININGER Y, 2001, AUDITORY NEUROPATHY, P15; Starr A, 2003, BRAIN, V126, P1604, DOI 10.1093/brain/awg156; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; Vinay, 2007, INT J AUDIOL, V46, P39, DOI 10.1080/14992020601077992; Yathiraj A, 2005, AUDITORY MEMORY TEST; Zeng FG, 2006, J SPEECH LANG HEAR R, V49, P367, DOI 10.1044/1092-4388(2006/029); Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zeng FG, 1999, NEUROREPORT, V10, P3429, DOI 10.1097/00001756-199911080-00031; Zeng FG, 2001, AUDITORY NEUROPATHY, P141; Zwicker E., 1956, ACUSTICA, V6, P356	44	13	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55995	10.1371/journal.pone.0055995	http://dx.doi.org/10.1371/journal.pone.0055995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409105	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200099
J	Zheng, YW; Wilson, G; Stiles, L; Smith, PF				Zheng, Yiwen; Wilson, Georgina; Stiles, Lucy; Smith, Paul F.			Glutamate Receptor Subunit and Calmodulin Kinase II Expression, with and without T Maze Training, in the Rat Hippocampus following Bilateral Vestibular Deafferentation	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM CHANGES; NMDA RECEPTORS; FORAGING TASK; C57BL/6J MICE; THETA-RHYTHM; BETA-IMAGER; NEURONS; LESIONS; MEMORY	Many previous studies have shown that lesions of the peripheral vestibular system result in spatial memory deficits and electrophysiological dysfunction in the hippocampus. Given the importance of glutamate as a neurotransmitter in the hippocampus, it was predicted that bilateral vestibular deafferentation (BVD) would alter the expression of NMDA and AMPA receptors in this area of the brain. Methods: The expression of the NR1, NR2A, NR2B, GluR1, GluR2, GluR3 and GluR 4 glutamate receptor subunits, as well as calmodulin kinase II alpha (CaMKII alpha) and phosphorylated CaMKII alpha (pCaMKII alpha), was measured in the rat CA1, CA2/3 and dentate gyrus (DG) subregions of the hippocampus, at 24 h, 72 h, 1 week, 1 month and 6 months following BVD, using western blotting. In the 6 month group, half of the animals underwent spatial forced alternating training in a T-maze. Results and Discussion: For the 24 h, 72 h, 1 week and 1 month data, there was no significant effect of surgery for any hippocampal subregion. However, for the 6 month data set, T maze training had a significant effect independently of surgery. The results of these experiments suggest that BVD is not associated with large changes in glutamate receptor subunit or CaMKII alpha expression in the rat hippocampus, at least in terms of both the intra-cytoplasmic and membrane receptor subunits together, that western blotting can measure. However, spatial training-associated increases in glutamate receptor and CaMKII alpha expression can be induced in BVD rats with impaired spatial performance. Therefore, the neurophysiological changes underlying BVD-induced spatial learning and memory deficits are more likely to be due to up and down regulation or changes in affinity/efficacy of glutamate receptors at the membrane level than changes in subunit transcription and transduction at the intra-cytoplasmic level.	[Smith, Paul F.] Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Sch Med Sci, Dunedin, New Zealand; Univ Otago, Brain Hlth Res Ctr, Sch Med, Dunedin, New Zealand	University of Otago; University of Otago	Smith, PF (corresponding author), Univ Otago, Sch Med, Dept Pharmacol & Toxicol, Sch Med Sci, Dunedin, New Zealand.	paul.smith@stonebow.otago.ac.nz		Zheng, Yiwen/0000-0002-2439-0715	Sir Charles Hercus Research Fellowship; Jean Cathie Estate	Sir Charles Hercus Research Fellowship; Jean Cathie Estate	This research was supported by a Sir Charles Hercus Research Fellowship to YZ. LS was supported by a grant from the Jean Cathie Estate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2010, NEUROBIOL LEARN MEM, V94, P402, DOI 10.1016/j.nlm.2010.08.007; Bakshi K, 2009, J NEUROSCI, V29, P6308, DOI 10.1523/JNEUROSCI.5485-08.2009; Bannerman DM, 2003, BEHAV NEUROSCI, V117, P866, DOI 10.1037/0735-7044.117.4.866; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dhar SS, 2009, J NEUROCHEM, V108, P1595, DOI 10.1111/j.1471-4159.2009.05929.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Ghafari M, 2012, BRAIN STRUCT FUNCT, V217, P353, DOI 10.1007/s00429-011-0335-8; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goddard M, 2008, BEHAV NEUROSCI, V122, P448, DOI 10.1037/0735-7044.122.2.448; Han X, 2008, J NEUROCHEM, V107, P1566, DOI 10.1111/j.1471-4159.2008.05729.x; Heo S, 2012, BRAIN STRUCT FUNCT, V217, P363, DOI 10.1007/s00429-011-0362-5; Hitier M, 2010, SURG RADIOL ANAT, V32, P835, DOI 10.1007/s00276-010-0690-9; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kennard JTT, 2011, NEUROBIOL DIS, V42, P48, DOI 10.1016/j.nbd.2011.01.003; Kojundzic SL, 2010, J COMP NEUROL, V518, P64, DOI 10.1002/cne.22209; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Langlois X, 2001, J PHARMACOL EXP THER, V299, P712; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Little GH, 2009, J BIOL CHEM, V284, P24857, DOI 10.1074/jbc.M109.003186; Liu P, 2003, NEUROSCIENCE, V117, P965, DOI 10.1016/S0306-4522(02)00878-3; Manly B. F. J., 2005, MULTIVARIATE STAT ME; Marcoulides GA, 1997, MULTIVARIATE STAT ME; McHugh SB, 2008, BEHAV BRAIN RES, V186, P41, DOI 10.1016/j.bbr.2007.07.021; Neo P, 2012, HIPPOCAMPUS, V22, P1176, DOI 10.1002/hipo.20963; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Poisnel G, 2006, J NEUROSCI METH, V154, P60, DOI 10.1016/j.jneumeth.2005.11.012; Roscioli E, 2012, J CELL BIOL, V196, P435, DOI 10.1083/jcb.201109104; Russell NA, 2003, J VESTIBUL RES-EQUIL, V13, P9; Russell NA, 2003, J NEUROSCI, V23, P6490; Russell NA, 2006, J NEUROPHYSIOL, V96, P4, DOI 10.1152/jn.00953.2005; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Stackman RW, 2002, BEHAV BRAIN RES, V128, P27, DOI 10.1016/S0166-4328(01)00270-4; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tai SK, 2012, HIPPOCAMPUS, V22, P914, DOI 10.1002/hipo.20955; Vignaux G, 2012, TOXICOL APPL PHARM, V258, P61, DOI 10.1016/j.taap.2011.10.008; Wallace DG, 2002, J NEUROSCI, V22, P10009; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WILLIAMS K, 1994, MOL PHARMACOL, V45, P803; Yun-Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007138; Zheng Y, 2001, NEUROSCIENCE, V105, P1, DOI 10.1016/S0306-4522(01)00217-2; Zheng YW, 2007, HIPPOCAMPUS, V17, P253, DOI 10.1002/hipo.20266; Zheng YW, 2010, HIPPOCAMPUS, V20, P461, DOI 10.1002/hipo.20645; Zheng YW, 2009, HIPPOCAMPUS, V19, P480, DOI 10.1002/hipo.20533; Zheng YJ, 2012, MATH PROBL ENG, V2012, DOI [10.3389/fneur.2012.00020, 10.1155/2012/207318]; Zheng YW, 2006, HIPPOCAMPUS, V16, P368, DOI 10.1002/hipo.20149; Zheng YW, 2003, HIPPOCAMPUS, V13, P873, DOI 10.1002/hipo.10174	53	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54527	10.1371/journal.pone.0054527	http://dx.doi.org/10.1371/journal.pone.0054527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408944	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200010
J	Beversdorf, LJ; Miller, TR; McMahon, KD				Beversdorf, Lucas J.; Miller, Todd R.; McMahon, Katherine D.			The Role of Nitrogen Fixation in Cyanobacterial Bloom Toxicity in a Temperate, Eutrophic Lake	PLOS ONE			English	Article							LIMITED MICROCYSTIS-AERUGINOSA; ENVIRONMENTAL-FACTORS; GENETIC DIVERSITY; GROWTH; PHOSPHORUS; WATERS; LR; COMMUNITY; STRAINS; MENDOTA	Toxic cyanobacterial blooms threaten freshwaters worldwide but have proven difficult to predict because the mechanisms of bloom formation and toxin production are unknown, especially on weekly time scales. Water quality management continues to focus on aggregated metrics, such as chlorophyll and total nutrients, which may not be sufficient to explain complex community changes and functions such as toxin production. For example, nitrogen (N) speciation and cycling play an important role, on daily time scales, in shaping cyanobacterial communities because declining N has been shown to select for N fixers. In addition, subsequent N pulses from N-2 fixation may stimulate and sustain toxic cyanobacterial growth. Herein, we describe how rapid early summer declines in N followed by bursts of N fixation have shaped cyanobacterial communities in a eutrophic lake (Lake Mendota, Wisconsin, USA), possibly driving toxic Microcystis blooms throughout the growing season. On weekly time scales in 2010 and 2011, we monitored the cyanobacterial community in a eutrophic lake using the phycocyanin intergenic spacer (PC-IGS) region to determine population dynamics. In parallel, we measured microcystin concentrations, N-2 fixation rates, and potential environmental drivers that contribute to structuring the community. In both years, cyanobacterial community change was strongly correlated with dissolved inorganic nitrogen (DIN) concentrations, and Aphanizomenon and Microcystis alternated dominance throughout the pre-toxic, toxic, and post-toxic phases of the lake. Microcystin concentrations increased a few days after the first significant N-2 fixation rates were observed. Then, following large early summer N-2 fixation events, Microcystis increased and became most abundant. Maximum microcystin concentrations coincided with Microcystis dominance. In both years, DIN concentrations dropped again in late summer, and N-2 fixation rates and Aphanizomenon abundance increased before the lake mixed in the fall. Estimated N inputs from N-2 fixation were large enough to supplement, or even support, the toxic Microcystis blooms.	[Beversdorf, Lucas J.; McMahon, Katherine D.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [McMahon, Katherine D.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Miller, Todd R.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Milwaukee	Beversdorf, LJ (corresponding author), Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA.	lbeversdorf@wisc.edu	Miller, Todd/Y-3612-2019	Miller, Todd/0000-0002-2113-1662; McMahon, Katherine D./0000-0002-7038-026X	UW-Madison Biotechnology Training Program (BTP); National Institutes of Health [NIH 5 T32 GM08349]; Wisconsin SeaGrant [R/BT-24]; National Science Foundation [CAREER CBET-0644949]; NTL-Microbial Observatory [MCB-0702395]; NTL-LTER [DEB-0822700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	UW-Madison Biotechnology Training Program (BTP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin SeaGrant; National Science Foundation(National Science Foundation (NSF)); NTL-Microbial Observatory; NTL-LTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by the UW-Madison Biotechnology Training Program (BTP), a National Institutes of Health training grant (NIH 5 T32 GM08349; http://www.nih.gov/), a Wisconsin SeaGrant (R/BT-24; http://www.seagrant.wisc.edu/home/), and the National Science Foundation (CAREER CBET-0644949; NTL-Microbial Observatory MCB-0702395; NTL-LTER DEB-0822700; http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agawin NSR, 2007, LIMNOL OCEANOGR, V52, P2233, DOI 10.4319/lo.2007.52.5.2233; Alexova R, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003749; Birge EA, 1922, INLAND LAKES WISCONS, P222; Brock TD, 1985, EUTROPHIC LAKE MENDO; CAPONE DG, 1994, APPL ENVIRON MICROB, V60, P3989, DOI 10.1128/AEM.60.11.3989-3995.1994; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carpenter SR, 1998, AUST J ECOL, V23, P68, DOI 10.1111/j.1442-9993.1998.tb00706.x; Clarke K.R, 2006, PRIMER V6 USER MANUA; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; DEMARSAC NT, 1988, METHOD ENZYMOL, V167, P318; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dolman Andrew M, 2012, PLoS One, V7, pe38757, DOI 10.1371/journal.pone.0038757; Downing TG, 2005, ENVIRON TOXICOL, V20, P257, DOI 10.1002/tox.20106; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Eaglesham GK, 1999, ENVIRON TOXICOL, V14, P151, DOI 10.1002/(SICI)1522-7278(199902)14:1<151::AID-TOX19>3.3.CO;2-4; FALLON RD, 1980, LIMNOL OCEANOGR, V25, P72, DOI 10.4319/lo.1980.25.1.0072; Flowers JJ, 2009, ENV MICROBIOL REP, V1, P583, DOI 10.1111/j.1758-2229.2009.00090.x; GARDNER WS, 1975, LIMNOL OCEANOGR, V20, P379, DOI 10.4319/lo.1975.20.3.0379; GERLOFF GC, 1957, ECOLOGY, V38, P556, DOI 10.2307/1943119; Ginn HP, 2010, APPL ENVIRON MICROB, V76, P4362, DOI 10.1128/AEM.01862-09; Glibert PM, 2011, CHIN J OCEANOL LIMN, V29, P724, DOI 10.1007/s00343-011-0502-z; GLIBERT PM, 1994, APPL ENVIRON MICROB, V60, P3996, DOI 10.1128/AEM.60.11.3996-4000.1994; Gondwe MJ, 2008, HYDROBIOLOGIA, V596, P251, DOI 10.1007/s10750-007-9101-6; Greenberg A.E., 1992, STANDARD METHODS EXA, V18; HARADA KI, 1988, J CHROMATOGR, V448, P275, DOI 10.1016/S0021-9673(01)84589-1; Jahnichen S, 2011, HARMFUL ALGAE, V12, P95, DOI 10.1016/j.hal.2011.09.002; JENSEN BB, 1983, APPL ENVIRON MICROB, V45, P1331, DOI 10.1128/AEM.45.4.1331-1337.1983; Jones SE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00318; Jones SE, 2009, ENVIRON MICROBIOL, V11, P905, DOI 10.1111/j.1462-2920.2008.01814.x; Kotak BG, 1996, CAN J FISH AQUAT SCI, V53, P1974, DOI 10.1139/cjfas-53-9-1974; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 1998, DEV ENV MODELLING, V20; Lenes JM, 2010, J PLANKTON RES, V32, P1421, DOI 10.1093/plankt/fbq061; Li JH, 2003, MICROBIOL-SGM, V149, P3257, DOI 10.1099/mic.0.26462-0; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Miller TR, 2011, FEMS MICROBIOL ECOL, V78, P336, DOI 10.1111/j.1574-6941.2011.01162.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P3875, DOI 10.1128/AEM.61.11.3875-3883.1995; Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000; Oh HM, 2001, APPL ENVIRON MICROB, V67, P1484, DOI 10.1128/AEM.67.4.1484-1489.2001; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; Palmer MA, 2012, SCIENCE, V336, P1393, DOI 10.1126/science.1223250; Pattanaik B, 2010, HARMFUL ALGAE, V10, P30, DOI 10.1016/j.hal.2010.06.001; Read JS, 2011, ENVIRON MODELL SOFTW, V26, P1325, DOI 10.1016/j.envsoft.2011.05.006; Redfield A. C., 1934, P176; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2658, DOI 10.1128/AEM.56.9.2658-2666.1990; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; STEWART WDP, 1967, P NATL ACAD SCI USA, V58, P2071, DOI 10.1073/pnas.58.5.2071; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; TETT P, 1975, LIMNOL OCEANOGR, V20, P887, DOI 10.4319/lo.1975.20.5.0887; TORREY MS, 1976, LIMNOL OCEANOGR, V21, P365, DOI 10.4319/lo.1976.21.3.0365; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; Vezie C, 1998, MICROBIAL ECOL, V35, P126, DOI 10.1007/s002489900067; WATANABE MF, 1985, APPL ENVIRON MICROB, V49, P1342, DOI 10.1128/AEM.49.5.1342-1344.1985; White A, 2010, LIBR J, V135, P101; WHO, 1996, GUID DRINK WAT QUAL; WICKS RJ, 1990, ENVIRON SCI TECHNOL, V24, P1413, DOI 10.1021/es00079a017; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Xu Y, 2010, ENVIRON SCI POLLUT R, V17, P1581, DOI 10.1007/s11356-010-0345-8; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	68	106	111	3	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56103	10.1371/journal.pone.0056103	http://dx.doi.org/10.1371/journal.pone.0056103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405255	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400201
J	Marom, N; Bar-Oz, G				Marom, Nimrod; Bar-Oz, Guy			The Prey Pathway: A Regional History of Cattle (Bos taurus) and Pig (Sus scrofa) Domestication in the Northern Jordan Valley, Israel	PLOS ONE			English	Article							HUNTING PRESSURE; FORAGING MODELS; LATE HOLOCENE; DNA ANALYSIS; WILD BOAR; BODY-SIZE; TERRITORIALITY; SURVIVORSHIP; CALIFORNIA; BEHAVIOR	The faunal assemblage from the 9th-8th millennium BP site at Sha'ar Hagolan, Israel, is used to study human interaction with wild suids and cattle in a time period just before the appearance of domesticated animals of these species in the Jordan Valley. Our results, based on demographic and osteometric data, indicate that full domestication of both cattle and suids occurred at the site during the 8th millennium. Importantly, domestication was preceded in both taxa by demographic and metric population parameters indicating severe overhunting. The possible role of overhunting in shaping the characteristics of domesticated animals and the social infrastructure to ownership of herds is then explored.	[Marom, Nimrod; Bar-Oz, Guy] Univ Haifa, Lab Archaeozool, IL-31999 Haifa, Israel	University of Haifa	Marom, N (corresponding author), Univ Haifa, Lab Archaeozool, IL-31999 Haifa, Israel.	nmarom02@campus.haifa.ac.il	BarOz, Guy/ABF-6518-2020	BarOz, Guy/0000-0002-1009-5619; Marom, Nimrod/0000-0002-1057-154X	Irene Levi Sala Care Archaeological Foundation: "Taphonomy and Subsistence Economy at the Yarmukian Site of Sha'ar Hagolan''; Israeli Council for Higher Education through a Rotenstreich Fellowship for Outstanding Doctoral Students in the Humanities	Irene Levi Sala Care Archaeological Foundation: "Taphonomy and Subsistence Economy at the Yarmukian Site of Sha'ar Hagolan''; Israeli Council for Higher Education through a Rotenstreich Fellowship for Outstanding Doctoral Students in the Humanities	This work was supported by a research grant from the 1) Irene Levi Sala Care Archaeological Foundation: "Taphonomy and Subsistence Economy at the Yarmukian Site of Sha'ar Hagolan''; 2) The Israeli Council for Higher Education through a Rotenstreich Fellowship for Outstanding Doctoral Students in the Humanities (http://che.org.il/en/?page_id=9074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvard MS, 2001, AM ANTHROPOL, V103, P295, DOI 10.1525/aa.2001.103.2.295; [Anonymous], [No title captured]; Barzilai O, 2011, STATE STONE TERMINOL, P305; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BocquetAppel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0; Broughton JM, 2010, J ARCHAEOL METHOD TH, V17, P371, DOI 10.1007/s10816-010-9095-7; BROUGHTON JM, 1994, J ARCHAEOL SCI, V21, P501, DOI 10.1006/jasc.1994.1050; BROUGHTON JM, 1994, J ANTHROPOL ARCHAEOL, V13, P371, DOI 10.1006/jaar.1994.1019; Broughton JM, 2002, WORLD ARCHAEOL, V34, P60, DOI 10.1080/00438240220134269; Clutton-Brock J, 1999, NATURAL HIST DOMESTI, P32; Dahl G, 1976, STUDIES SOCIAL ANTHR; Davis S., 1982, PALEORIENT, V8, P5; Davis SJM., 2012, VILLAGE COMMUNITIES, VIII, P1258; Demsetz H, 1967, AM ECON REV, V57, P347; Ducos P, 1969, DOMESTICATION EXPLOI, P265; DYSONHUDSON R, 1978, AM ANTHROPOL, V80, P21, DOI 10.1525/aa.1978.80.1.02a00020; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Edwards CJ, 2004, J ARCHAEOL SCI, V31, P695, DOI 10.1016/j.jas.2003.11.001; Gamelon M, 2011, EVOLUTION, V65, P3100, DOI 10.1111/j.1558-5646.2011.01366.x; Goring-Morris AN, 2011, CURR ANTHROPOL, V52, pS195, DOI 10.1086/658860; GRAVES HB, 1984, J ANIM SCI, V58, P482, DOI 10.2527/jas1984.582482x; Grigson C., 1989, BAR International Series, P77; Haber A, 2004, J ARCHAEOL SCI, V31, P1587, DOI 10.1016/j.jas.2004.04.001; Hall SJG, 2008, ECOGRAPHY, V31, P187, DOI 10.1111/j.0906-7590.2008.5193.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hongo H., 1998, MASCA RES PAPERS SCI, V15, P77; Horwitz Liora Kolska, 2000, Paleorient, V25, P63; Horwitz Liora Kolska, 2005, Revue de Paleobiologie, P209; Jarman M.R., 1972, PAPERS EC PREHISTORY, P83; Klein R.G., 1984, ANAL ANIMAL BONES AR; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Leacock E., 1954, MONTAGNAIS HUNTING T, DOI 10.5962/bhl.title.35991; LINARES OF, 1976, HUM ECOL, V4, P331, DOI 10.1007/BF01557917; Lupo KD, 2007, J ARCHAEOL RES, V15, P143, DOI 10.1007/s10814-007-9011-1; LYMAN RL, 1984, J ANTHROPOL ARCHAEOL, V3, P259, DOI 10.1016/0278-4165(84)90004-7; LYMAN RL, 1987, AM ANTIQUITY, V52, P125, DOI 10.2307/281064; Marom N, 2009, FARMING, V2009, P1; Marom N, 2012, J ANTHROPOL ARCHAEOL, V31, P573, DOI 10.1016/j.jaa.2012.06.002; Munro ND, 2004, CURR ANTHROPOL, V45, pS5, DOI 10.1086/422084; Munson PJ, 2003, J ARCHAEOL SCI, V30, P405, DOI 10.1006/jasc.2002.0850; Redding Richard W., 2005, P41; Rosenberg M, 1998, CURR ANTHROPOL, V39, P653, DOI 10.1086/204787; Russell N, 2012, SOCIAL ZOOARCHAEOLOG, P174; Silver I.A, 1969, SCI ARCHAEOLOGY SURV, V2nd, P283; Smith Bruce D., 2011, Biology Theory, V6, P260, DOI 10.1007/s13752-012-0028-4; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stephens D.W., 1986, pi; TCHERNOV E, 1991, J ANTHROPOL ARCHAEOL, V10, P54, DOI 10.1016/0278-4165(91)90021-O; Vigne J-D., 2005, 1 STEPS ANIMAL DOMES; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; Von Den Driesch A., 1976, GUIDE MEASUREMENT AN; Wolverton S, 2008, AM ANTIQUITY, V73, P179, DOI 10.2307/25470475; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P171; Zeder MA, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P227; Zeuner FE, 1963, HIST DOMESTICATED AN, P54; Zeuner FE, 1963, HIST DOMESTICATED AN, P17	58	34	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55958	10.1371/journal.pone.0055958	http://dx.doi.org/10.1371/journal.pone.0055958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	092WJ	23405240	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400185
J	Walczynski, J; Lyons, S; Jones, N; Breitwieser, W				Walczynski, J.; Lyons, S.; Jones, N.; Breitwieser, W.			Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2	ONCOGENE			English	Article						ATF2; ATF7; JNK; c-MYC; B lymphoma; apoptosis	ACTIVATING TRANSCRIPTION FACTOR-2; JUN NH2-TERMINAL KINASE; JNK; SUPPRESSOR; INDUCTION; SURVIVAL; PROLIFERATION; PATHWAY; TARGET; ROLES	Transcription factors ATF2 (activating transcription factor 2) and ATF7 (activating transcription factor 7) are highly homologous members of the activator protein 1 (AP-1) family. Their activities are growth factor and stress stimulated and they strictly require phosphorylation by mitogen-activated protein (MAP) kinases for their transcriptional functions. In samples of human B-cell lymphomas as well as E mu-Myc-driven mouse B-cell lymphomas, we find that ATF2 as well as MAP kinase c-Jun N-terminal kinase (JNK) are significantly up-regulated compared with normal human B-cell lines and mouse B cells, respectively. The B cell-specific deletion of ATF2 and ATF7 in mice results in significantly accelerated onset of E mu-Myc-induced lymphoma. In addition, loss of ATF2/7 desensitises E mu-Myc lymphoma cells to spontaneous as well as stress-induced apoptosis. Our results therefore suggest that c-MYC induces stress-mediated activation of ATF2 and ATF7 and that these transcription factors regulate apoptosis in response to oncogenic transformation of B cells.	[Walczynski, J.; Lyons, S.; Jones, N.; Breitwieser, W.] Univ Manchester, Paterson Inst Canc Res, Dept Cell Regulat, Manchester, Lancs, England	Paterson Institute for Cancer Research; University of Manchester	Breitwieser, W (corresponding author), Paterson Inst Canc Res, Cell Regulat Lab, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	WBreitwieser@PICR.man.ac.uk			Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank Professor Tim Illidge and members of the Targeted Therapy Group for useful discussions and suggestions, and Debby Burt for cell lines. We are grateful to the members of the Paterson Institute Biological Resource Unit, the Histology Department, the Molecular Biology Core Facility and the Flow Cytometry Department for their services and support. We also thank the members of the Cell Regulation Department for their discussions, encouragement and support. The project was entirely funded by a core grant provided by Cancer Research UK.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ASKEW DS, 1991, ONCOGENE, V6, P1915; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; El Btaouri H, 2011, BBA-MOL CELL RES, V1813, P695, DOI 10.1016/j.bbamcr.2011.02.004; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Grassilli E, 2004, J BIOL CHEM, V279, P21318, DOI 10.1074/jbc.M313532200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sargent LM, 1996, CANCER RES, V56, P2137; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	40	9	11	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					1027	1036		10.1038/onc.2013.28	http://dx.doi.org/10.1038/onc.2013.28			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23416976				2022-12-25	WOS:000331933200010
J	Dehennaut, V; Loison, I; Dubuissez, M; Nassour, J; Abbadie, C; Leprince, D				Dehennaut, Vanessa; Loison, Ingrid; Dubuissez, Marion; Nassour, Joe; Abbadie, Corinne; Leprince, Dominique			DNA Double-strand Breaks Lead to Activation of Hypermethylated in Cancer 1 (HIC1) by SUMOylation to Regulate DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; IIA HISTONE DEACETYLASES; KAPPA-B ACTIVATION; GENOTOXIC STRESS; DAMAGE RESPONSE; TRANSCRIPTIONAL REPRESSION; TARGET GENES; SUMO; PATHWAY; CELLS	HIC1 (hypermethylated in cancer 1) is a tumor suppressor gene frequently epigenetically silenced in human cancers. HIC1 encodes a transcriptional repressor involved in the regulation of growth control and DNA damage response. We previously demonstrated that HIC1 can be either acetylated or SUMOylated on lysine 314. This deacetylation/SUMOylation switch is governed by an unusual complex made up of SIRT1 and HDAC4 which deacetylates and thereby favors SUMOylation of HIC1 by a mechanism not yet fully deciphered. This switch regulates the interaction of HIC1 with MTA1, a component of the NuRD complex and potentiates the repressor activity of HIC1. Here, we show that HIC1 silencing in human fibroblasts impacts the repair of DNA double-strand breaks whereas ectopic expression of wild-type HIC1, but not of nonsumoylatable mutants, leads to a reduced number of gamma H2AX foci induced by etoposide treatment. In this way, we demonstrate that DNA damage leads to (i) an enhanced HDAC4/Ubc9 interaction, (ii) the activation of SIRT1 by SUMOylation (Lys-734), and (iii) the SUMO-dependent recruitment of HDAC4 by SIRT1 which permits the deacetylation/SUMOylation switch of HIC1. Finally, we show that this increase of HIC1 SUMOylation favors the HIC1/MTA1 interaction, thus demonstrating that HIC1 regulates DNA repair in a SUMO-dependent way. Therefore, epigenetic HIC1 inactivation, which is an early step in tumorigenesis, could contribute to the accumulation of DNA mutations through impaired DNA repair and thus favor tumorigenesis.	[Dehennaut, Vanessa; Loison, Ingrid; Dubuissez, Marion; Nassour, Joe; Abbadie, Corinne; Leprince, Dominique] Univ Lille Nord France, CNRS UMR 8161, Inst Biol Lille, Inst Pasteur Lille,IFR 142, F-59017 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Leprince, D (corresponding author), Univ Lille Nord France, CNRS UMR 8161, Inst Biol Lille, Inst Pasteur Lille,IFR 142, 1 Rue Calmette,BP447, F-59017 Lille, France.	dominique.leprince@ibl.fr	dehennaut, vanessa/I-7435-2018; ABBADIE, Corinne/F-4949-2018	dehennaut, vanessa/0000-0001-6421-0793; ABBADIE, Corinne/0000-0002-8174-2393; Leprince, Dominique/0000-0002-1999-0775	CNRS; "Association pour la Recherche sur le Cancer" (ARC); "Ligue Nationale Contre le Cancer," Comite du Pas de Calais; Association pour la Recherche sur le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); "Association pour la Recherche sur le Cancer" (ARC)(Fondation ARC pour la Recherche sur le Cancer); "Ligue Nationale Contre le Cancer," Comite du Pas de Calais; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the CNRS, the "Association pour la Recherche sur le Cancer" (ARC), and the "Ligue Nationale Contre le Cancer," Comite du Pas de Calais.; Recipient of a postdoctoral fellowship from the Association pour la Recherche sur le Cancer.	Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Boulay G, 2012, J BIOL CHEM, V287, P10509, DOI 10.1074/jbc.M111.320234; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Britschgi C, 2006, ONCOGENE, V25, P2030, DOI 10.1038/sj.onc.1209240; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dehennaut V, 2009, B CANCER, V96, pE66, DOI 10.1684/bdc.2009.0959; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Lee FY, 2011, DEV CELL, V21, P315, DOI 10.1016/j.devcel.2011.06.028; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stankovic-Valentin N, 2006, FEBS J, V273, P2879, DOI 10.1111/j.1742-4658.2006.05301.x; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Xu XA, 2010, J BIOL CHEM, V285, P18139, DOI 10.1074/jbc.C110.131599; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	46	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10254	10264		10.1074/jbc.M112.421610	http://dx.doi.org/10.1074/jbc.M112.421610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23417673	hybrid, Green Published			2022-12-25	WOS:000317565000007
J	Spitzmaul, G; Tolosa, L; Winkelman, BHJ; Heidenreich, M; Frens, MA; Chabbert, C; de Zeeuw, CI; Jentsch, TJ				Spitzmaul, Guillermo; Tolosa, Leonardo; Winkelman, Beerend H. J.; Heidenreich, Matthias; Frens, Maarten A.; Chabbert, Christian; de Zeeuw, Chris I.; Jentsch, Thomas J.			Vestibular Role of KCNQ4 and KCNQ5 K+ Channels Revealed by Mouse Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HAIR-CELLS; INNER-EAR; POTASSIUM CHANNELS; DOMINANT DEAFNESS; ION CHANNELS; HEARING-LOSS; RAT UTRICLE; CALYX; EXPRESSION; CONDUCTANCES	The function of sensory hair cells of the cochlea and vestibular organs depends on an influx of K+ through apical mechanosensitive ion channels and its subsequent removal over their basolateral membrane. The KCNQ4 (K(v)7.4) K+ channel, which is mutated in DFNA2 human hearing loss, is expressed in the basal membrane of cochlear outer hair cells where it may mediate K+ efflux. Like the related K+ channel KCNQ5 (K(v)7.5), KCNQ4 is also found at calyx terminals ensheathing type I vestibular hair cells where it may be localized pre- or postsynaptically. Making use of Kcnq4(-/-) mice lacking KCNQ4, as well as Kcnq4(dn/dn) and Kcnq5(dn/dn) mice expressing dominant negative channel mutants, we now show unambiguously that in adult mice both channels reside in postsynaptic calyx-forming neurons, but cannot be detected in the innervated hair cells. Accordingly, whole cell currents of vestibular hair cells did not differ between genotypes. Neither Kcnq4(-/-), Kcnq5(dn/dn) nor Kcnq4(-/-)/Kcnq5(dn/dn) double mutant mice displayed circling behavior found with severe vestibular impairment. However, a milder form of vestibular dysfunction was apparent from altered vestibulo-ocular reflexes in Kcnq4(-/-)/Kcnq5(dn/dn) and Kcnq4(-/-) mice. The larger impact of KCNQ4 may result from its preferential expression in central zones of maculae and cristae, which are innervated by phasic neurons that are more sensitive than the tonic neurons present predominantly in the surrounding peripheral zones where KCNQ5 is found. The impact of postsynaptic KCNQ4 on vestibular function may be related to K+ removal and modulation of synaptic transmission.	[Spitzmaul, Guillermo; Heidenreich, Matthias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Spitzmaul, Guillermo; Heidenreich, Matthias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Tolosa, Leonardo; Winkelman, Beerend H. J.; de Zeeuw, Chris I.] Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Frens, Maarten A.; de Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Chabbert, Christian] Inst Neurosci Montpellier, INSERM, U1051, F-30491 Montpellier 5, France; [Jentsch, Thomas J.] Charite, Cluster Excellence NeuroCure, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	de Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl; jentsch@fmp-berlin.de	Spitzmaul, Guillermo/AAM-4785-2021	Spitzmaul, Guillermo/0000-0001-5123-8914; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [Exc 257]; Prix Louis-Jeantet de Medecine; Alexander von Humboldt Foundation; Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (Neuro-Basic); CEREBNET; C7 programs of the European Community; ERC (European Research Council)-advanced grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Prix Louis-Jeantet de Medecine; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); Senter (Neuro-Basic); CEREBNET; C7 programs of the European Community; ERC (European Research Council)-advanced grant	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Exc 257) and the Prix Louis-Jeantet de Medecine (to T. J. J.), by a stipend from the Alexander von Humboldt Foundation (to G. S.), by the Dutch Organization for Medical Sciences (ZonMw; to C. I. d. Z.), Life Sciences (ALW; to C. I. d. Z.), Senter (Neuro-Basic; to C. I. d. Z.), CEREBNET (to C. I. d. Z.), C7 programs of the European Community (to C. I. d. Z.), and ERC (European Research Council)-advanced grant (to C. I. d. Z.).	Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Chen JWY, 2000, J NEUROPHYSIOL, V84, P139, DOI 10.1152/jn.2000.84.1.139; Contini D, 2012, NEUROSCIENCE, V227, P232, DOI 10.1016/j.neuroscience.2012.09.051; CORREIA MJ, 1990, NEUROSCI LETT, V116, P106, DOI 10.1016/0304-3940(90)90394-O; De Leenheer EMR, 2002, ANN OTO RHINOL LARYN, V111, P267, DOI 10.1177/000348940211100312; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Eatock RA, 2008, J EXP BIOL, V211, P1764, DOI 10.1242/jeb.017350; Gaboyard S, 2005, NEUROSCIENCE, V133, P253, DOI 10.1016/j.neuroscience.2005.02.011; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; GOLDBERG JM, 1992, ANN NY ACAD SCI, V656, P92, DOI 10.1111/j.1749-6632.1992.tb25202.x; Goldberg JM, 1996, ANN NY ACAD SCI, V781, P474, DOI 10.1111/j.1749-6632.1996.tb15721.x; Goldberg JM, 1996, J NEUROPHYSIOL, V76, P1942, DOI 10.1152/jn.1996.76.3.1942; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kalluri R, 2010, J NEUROPHYSIOL, V104, P2034, DOI 10.1152/jn.00396.2010; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Lim R, 2011, EXP BRAIN RES, V210, P607, DOI 10.1007/s00221-011-2592-4; Lysakowski A, 1999, HEARING RES, V133, P149, DOI 10.1016/S0378-5955(99)00065-9; Lysakowski A, 2011, J NEUROSCI, V31, P10101, DOI 10.1523/JNEUROSCI.0521-11.2011; Marres H, 1997, ARCH OTOLARYNGOL, V123, P573; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Rennie KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC473, DOI 10.1152/ajpcell.2001.280.3.C473; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rocha-Sanchez SMS, 2007, BRAIN RES, V1139, P117, DOI 10.1016/j.brainres.2006.12.087; Rusch A, 1996, J NEUROPHYSIOL, V76, P995, DOI 10.1152/jn.1996.76.2.995; Rusch A, 1998, J NEUROSCI, V18, P7487; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Sogaard R, 2001, AM J PHYSIOL-CELL PH, V280, pC859; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Sousa AD, 2009, J NEUROSCI, V29, P3103, DOI 10.1523/JNEUROSCI.4868-08.2009; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Udagawa T, 2012, NEUROSCIENCE, V215, P209, DOI 10.1016/j.neuroscience.2012.04.037; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Zhang XM, 2011, AM J PHYSIOL-CELL PH, V301, pC1017, DOI 10.1152/ajpcell.00185.2011	49	24	24	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9334	9344		10.1074/jbc.M112.433383	http://dx.doi.org/10.1074/jbc.M112.433383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408425	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000316862200051
J	Ballarin-Gonzalez, B; Lassen, LB; Jessen, R; Fuchtbauer, A; Fuchtbauer, EM; Pedersen, FS				Ballarin-Gonzalez, Borja; Lassen, Louise Berkhoudt; Jessen, Randi; Fuchtbauer, Annette; Fuchtbauer, Ernst-Martin; Pedersen, Finn Skou			Deregulated Nras Expression in Knock-In Animals Harboring a Gammaretroviral Long Terminal Repeat at the Nras/Csde1 Locus	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; RETROVIRAL INTEGRATIONS; PROTEIN ISOFORMS; CELL LYMPHOMAS; MICE; DNA; ACTIVATION; REVEALS; GENES; SITE	To investigate mechanisms and phenotypic effects of insertional mutagenesis by gammaretroviruses, we have developed mouse lines containing a single Akv 1-99 long terminal repeat (LTR) and a floxed PGK/Tn5 neomycin cassette at the Nras proto-oncogene at positions previously identified as viral integration sites in Akv 1-99 induced tumors. The insert did not compromise the embryonic development, however, the cassette had an effect on Nras expression in all tissues analyzed. Cre-mediated excision of the PGK/Tn5 neomycin cassette in two of the lines caused upregulation of Nras. Altogether, the knock-in alleles are characterized by modulation of expression of the target gene from more than ten-fold upregulation to three-fold downregulation and exemplify various mechanisms of deregulation by insertional mutagenesis. LTR knock-in mice may serve as a tool to investigate mechanisms of retroviral insertional mutagenesis and as a way of constitutive or induced modulation of expression of a target gene.	[Ballarin-Gonzalez, Borja; Lassen, Louise Berkhoudt; Jessen, Randi; Fuchtbauer, Annette; Fuchtbauer, Ernst-Martin; Pedersen, Finn Skou] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University	Pedersen, FS (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	fsp@mb.au.dk			Danish Cancer Society; Danish Medical Research Council; Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	This study was supported in part by grants from the Danish Cancer Society, the Danish Medical Research Council and the Danish Genetically Modified Animal Resource (DAGMAR) funded by the Danish Agency for Science, Technology, and Innovation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasco L, 2012, MOL THER, V20, P709, DOI 10.1038/mt.2011.289; Blyth K, 2006, CANCER RES, V66, P2195, DOI 10.1158/0008-5472.CAN-05-3558; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Kool J, 2010, CANCER RES, V70, P520, DOI 10.1158/0008-5472.CAN-09-2736; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lassen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042216; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Martin-Hernandez J, 2001, J VIROL, V75, P11907, DOI 10.1128/JVI.75.23.11907-11912.2001; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pyrz M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-86; Rasmussen MH, 2010, J VIROL, V84, P3780, DOI 10.1128/JVI.02088-09; Rasmussen MH, 2009, NUCLEIC ACIDS RES, V37, P4657, DOI 10.1093/nar/gkp469; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; WERTZ K, 1994, TRANSGENICS, V1, P277; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56029	10.1371/journal.pone.0056029	http://dx.doi.org/10.1371/journal.pone.0056029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418499	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300091
J	Leonard, AS; Brent, J; Papaj, DR; Dornhaus, A				Leonard, Anne S.; Brent, Joshua; Papaj, Daniel R.; Dornhaus, Anna			Floral Nectar Guide Patterns Discourage Nectar Robbing by Bumble Bees	PLOS ONE			English	Article							IPOMOPSIS-AGGREGATA; EVOLUTION; POLLINATION; BEHAVIOR; PREFERENCE; SUCCESS; REDUCE; BIAS	Floral displays are under selection to both attract pollinators and deter antagonists. Here we show that a common floral trait, a nectar guide pattern, alters the behavior of bees that can act opportunistically as both pollinators and as antagonists. Generally, bees access nectar via the floral limb, transporting pollen through contact with the plant's reproductive structures; however bees sometimes extract nectar from a hole in the side of the flower that they or other floral visitors create. This behavior is called "nectar robbing" because bees may acquire the nectar without transporting pollen. We asked whether the presence of a symmetric floral nectar guide pattern on artificial flowers affected bumble bees' (Bombus impatiens) propensity to rob or access nectar "legitimately." We discovered that nectar guides made legitimate visits more efficient for bees than robbing, and increased the relative frequency of legitimate visits, compared to flowers lacking nectar guides. This study is the first to show that beyond speeding nectar discovery, a nectar guide pattern can influence bees' flower handling in a way that could benefit the plant.	[Leonard, Anne S.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Brent, Joshua; Papaj, Daniel R.; Dornhaus, Anna] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Arizona	Leonard, AS (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	anneleonard@unr.edu			University of Arizona Center for Insect Science through National Institutes of Health (NIH) [1K12 GM000708]; National Science Foundation (NSF) Grant [IOS-0921280]; University of Arizona Undergraduate Biology Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	University of Arizona Center for Insect Science through National Institutes of Health (NIH); National Science Foundation (NSF) Grant(National Science Foundation (NSF)); University of Arizona Undergraduate Biology Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Arizona Center for Insect Science through National Institutes of Health (NIH) Training Grant # 1K12 GM000708 and by National Science Foundation (NSF) Grant # IOS-0921280. J. Brent was supported by the University of Arizona Undergraduate Biology Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2005, ECOLOGY, V86, P2968, DOI 10.1890/05-0118; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; [Anonymous], 2012, EVOLUTION PLANT POLL; Barth F. G., 1991, INSECTS FLOWERS BIOL; Biesmeijer JC, 2005, NATURWISSENSCHAFTEN, V92, P444, DOI 10.1007/s00114-005-0017-6; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Castellan NJ, 1988, NONPARAMETRIC STAT B; Castro S, 2009, ECOL RES, V24, P47, DOI 10.1007/s11284-008-0481-5; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Darwin C, 1892, EFFECTS CROSS SELF F; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Dedej S, 2005, BEHAV ECOL SOCIOBIOL, V57, P398, DOI 10.1007/s00265-004-0852-z; FREE J B, 1970, Behaviour, V37, P269, DOI 10.1163/156853970X00376; FREE JB, 1968, J APPL ECOL, V5, P631, DOI 10.2307/2401637; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Goulson D., 2003, BUMBLEBEES BEHAV ECO; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; Hansen DM, 2012, P ROY SOC B-BIOL SCI, V279, P634, DOI 10.1098/rspb.2011.1349; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; Inouye D.W., 1983, P153; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Irwin RE, 2004, ECOLOGY, V85, P1503, DOI 10.1890/03-0390; Irwin RE, 1999, ECOLOGY, V80, P1703; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; Knuth P, 1893, BOTANISCHE CENTRALBL, V48, P160; LAVERTY TM, 1988, ANIM BEHAV, V36, P733, DOI 10.1016/S0003-3472(88)80156-8; Leadbeater E, 2008, P ROY SOC B-BIOL SCI, V275, P1669, DOI 10.1098/rspb.2008.0270; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI DOI 10.1098/rstb.1995.0017; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Morris WF, 1996, ECOLOGY, V77, P1451, DOI 10.2307/2265542; Naug D, 2007, BIOL LETTERS, V3, P635, DOI 10.1098/rsbl.2007.0436; Navarro L, 2009, BIOL J LINN SOC, V96, P392, DOI 10.1111/j.1095-8312.2008.01146.x; Newman DA, 2005, OIKOS, V110, P309, DOI 10.1111/j.0030-1299.2005.13884.x; PENNY JHJ, 1983, NEW PHYTOL, V95, P707, DOI 10.1111/j.1469-8137.1983.tb03534.x; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Richardson SC, 2004, OECOLOGIA, V139, P246, DOI 10.1007/s00442-004-1504-8; Schaefer HM, 2009, TRENDS ECOL EVOL, V24, P676, DOI 10.1016/j.tree.2009.06.006; Schiestl FP, 2010, TRENDS ECOL EVOL, V25, P382, DOI 10.1016/j.tree.2010.03.004; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Sprengel CK, 1793, ENTDECKE GEHEIMNISS; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; WASER NM, 1985, OECOLOGIA, V67, P121, DOI 10.1007/BF00378462; Willmer P., 2011, POLLINATION FLORAL E; Zar J. H., 2009, BIOSTATISTICAL ANAL	54	28	32	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55914	10.1371/journal.pone.0055914	http://dx.doi.org/10.1371/journal.pone.0055914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418475	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300066
J	Fox, EJ; Baweja, HS; Kim, C; Kennedy, DM; Vaillancourt, DE; Christou, EA				Fox, Emily J.; Baweja, Harsimran S.; Kim, Changki; Kennedy, Deanna M.; Vaillancourt, David E.; Christou, Evangelos A.			Modulation of Force below 1 Hz: Age-Associated Differences and the Effect of Magnified Visual Feedback	PLOS ONE			English	Article							MOTOR UNIT DISCHARGE; CONSTANT ISOMETRIC CONTRACTIONS; OLDER-ADULTS; PARKINSONS-DISEASE; HAND MUSCLE; OUTPUT VARIABILITY; SYNAPTIC NOISE; GREATER AMOUNT; LOW-FREQUENCY; FLUCTUATIONS	Oscillations in force output change in specific frequency bins and have important implications for understanding aging and pathological motor control. Although previous studies have demonstrated that oscillations from 0-1 Hz can be influenced by aging and visuomotor processing, these studies have averaged power within this bandwidth and not examined power in specific frequencies below 1 Hz. The purpose was to determine whether a differential modulation of force below 1 Hz contributes to changes in force control related to manipulation of visual feedback and aging. Ten young adults (25+/-4 yrs, 5 men) and ten older adults (71+/-5 yrs, 4 men) were instructed to accurately match a target force at 2% of their maximal isometric force for 35 s with abduction of the index finger. Visual feedback was manipulated by changing the visual angle (0.05 degrees, 0.5 degrees, 1.5 degrees) or removing it after 15 s. Modulation of force below 1 Hz was quantified by examining the absolute and normalized power in seven frequency bins. Removal of visual feedback increased normalized power from 0-0.33 Hz and decreased normalized power from 0.66-1.0 Hz. In contrast, magnification of visual feedback (visual angles of 0.5 degrees and 1.5 degrees) decreased normalized power from 0-0.16 Hz and increased normalized power from 0.66-1.0 Hz. Older adults demonstrated a greater increase in the variability of force with magnification of visual feedback compared with young adults (P = 0.05). Furthermore, older adults exhibited differential force modulation of frequencies below 1 Hz compared with young adults (P<0.05). Specifically, older adults exhibited greater normalized power from 0-0.16 Hz and lesser normalized power from 0.66-0.83 Hz. The changes in force modulation predicted the changes in the variability of force with magnification of visual feedback (R-2=0.80). Our findings indicate that force oscillations below 1 Hz are associated with force control and are modified by aging and visual feedback.	[Fox, Emily J.; Baweja, Harsimran S.; Kim, Changki; Kennedy, Deanna M.; Vaillancourt, David E.; Christou, Evangelos A.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Christou, EA (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	eachristou@hhp.ufl.edu		Fox, Emily/0000-0003-0142-3497	National Institutes of Health [R01-NS-058487, R01-NS-052318, R01-AG-031769]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052318, R01NS058487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health Grants R01-NS-058487 and R01-NS-052318 to DE Vaillancourt and R01-AG-031769 to EA Christou. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Baweja HS, 2011, HUM MOVEMENT SCI, V30, P1022, DOI 10.1016/j.humov.2010.09.007; Baweja HS, 2010, EUR J APPL PHYSIOL, V108, P935, DOI 10.1007/s00421-009-1301-5; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; Chao E.Y., 1989, BIOMECHANICS HAND BA; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Christou EA, 2005, MED SCI SPORT EXER, V37, P2126, DOI 10.1249/01.mss.0000178103.72988.cd; Christou EA, 2004, J APPL PHYSIOL, V97, P225, DOI 10.1152/japplphysiol.00066.2004; Christou EA, 2005, MOVEMENT SYSTEM VARI, P199; Christou EA, 2007, EXP BRAIN RES, V178, P285, DOI 10.1007/s00221-006-0739-5; Christou EA, 2011, EXERC SPORT SCI REV, V39, P77, DOI 10.1097/JES.0b013e31820b85ab; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; Elble R, 2011, MOVEMENT DISORD, V26, P1096, DOI 10.1002/mds.23579; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hyngstrom AS, 2012, AM J PHYS MED REHAB, V91, P33, DOI 10.1097/PHM.0b013e31823caac0; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Keogh J, 2006, EUR J APPL PHYSIOL, V97, P76, DOI 10.1007/s00421-006-0151-7; Kim CK, 2011, NEUR M PLANN WASH DC; Kornatz KW, 2005, J APPL PHYSIOL, V98, P2072, DOI 10.1152/japplphysiol.01149.2004; Kouzaki M, 2010, MUSCLE NERVE, V42, P78, DOI 10.1002/mus.21599; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Matthews PBC, 1996, J PHYSIOL-LONDON, V492, P597, DOI 10.1113/jphysiol.1996.sp021332; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Mottram CJ, 2005, J NEUROPHYSIOL, V94, P2878, DOI 10.1152/jn.00390.2005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prakash RS, 2009, BRAIN COGNITION, V71, P328, DOI 10.1016/j.bandc.2009.07.005; Prodoehl J, 2006, J NEUROL NEUROSUR PS, V77, P909, DOI 10.1136/jnnp.2006.091363; Rassler B, 2000, CLIN NEUROPHYSIOL, V111, P2180, DOI 10.1016/S1388-2457(00)00483-1; Robichaud JA, 2005, MOVEMENT DISORD, V20, P441, DOI 10.1002/mds.20350; Salkind Neil J., 2002, USING SPSS WINDOWS M; Schmied A, 2000, EXP BRAIN RES, V133, P377, DOI 10.1007/s002210000421; Semmler JG, 2003, J NEUROPHYSIOL, V90, P1346, DOI 10.1152/jn.00941.2002; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sosnoff JJ, 2007, EXP AGING RES, V33, P399, DOI 10.1080/03610730701525311; Sosnoff JJ, 2006, EXP BRAIN RES, V170, P423, DOI 10.1007/s00221-005-0225-5; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; Taylor AM, 2004, J COMPUT NEUROSCI, V16, P139, DOI 10.1023/B:JCNS.0000014107.16610.2e; Tracy BL, 2005, MUSCLE NERVE, V32, P533, DOI 10.1002/mus.20392; Tracy BL., 2009, ADV NEUROMUSCULAR PH, P39; Tracy BL, 2007, MED SCI SPORT EXER, V39, P469, DOI 10.1249/mss.0b013e31802d3ad3; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaillancourt DE, 2001, CLIN NEUROPHYSIOL, V112, P1594, DOI 10.1016/S1388-2457(01)00593-4; Vaillancourt DE, 2001, NEUROPSYCHOLOGIA, V39, P1410, DOI 10.1016/S0028-3932(01)00061-6; Westgaard RH, 2002, J NEUROPHYSIOL, V88, P1177, DOI 10.1152/jn.2002.88.3.1177	50	35	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55970	10.1371/journal.pone.0055970	http://dx.doi.org/10.1371/journal.pone.0055970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409099	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000035
J	Nicolo, C; Di Sante, G; Procoli, A; Migliara, G; Piermattei, A; Valentini, M; Delogu, G; Cittadini, A; Constantin, G; Ria, F				Nicolo, Chiara; Di Sante, Gabriele; Procoli, Annabella; Migliara, Giuseppe; Piermattei, Alessia; Valentini, Mariagrazia; Delogu, Giovanni; Cittadini, Achille; Constantin, Gabriela; Ria, Francesco			M tuberculosis in the Adjuvant Modulates Time of Appearance of CNS-Specific Effector T Cells in the Spleen through a Polymorphic Site of TLR2	PLOS ONE			English	Article							DENDRITIC CELLS; TOXOPLASMA-GONDII; RECEPTOR; ANTIGEN; LYMPHOCYTES; EXPRESSION; RESPONSES; DISTINCT; DISEASE; MICE	DC deliver information regulating trafficking of effector T cells along T-cell priming. However, the role of pathogen-derived motives in the regulation of movement of T cells has not been studied. We hereinafter report that amount of M tuberculosis in the adjuvant modulates relocation of PLP139-151 specific T cells. In the presence of a low dose of M tuberculosis in the adjuvant, T cells (detected by CDR3 BV-BJ spectratyping, the so-called "immunoscope'') mostly reach the spleen by day 28 after immunization ("late relocation'') in the SJL strain, whereas T cells reach the spleen by d 14 with a high dose of M tuberculosis ("early relocation''). The C57Bl/6 background confers a dominant "early relocation'' phenotype to F1 (SJLxC57Bl/6) mice, allowing early relocation of T cells in the presence of low dose M tuberculosis. A single non-synonymous polymorphism of TLR2 is responsible for "early/late'' relocation phenotype. Egress of T lymphocytes is regulated by TLR2 expressed on T cells. Thus, pathogens engaging TLR2 on T cells regulate directly T-cell trafficking, and polymorphisms of TLR2 condition T-cell trafficking upon a limiting concentration of ligand.	[Nicolo, Chiara; Di Sante, Gabriele; Migliara, Giuseppe; Piermattei, Alessia; Valentini, Mariagrazia; Cittadini, Achille; Ria, Francesco] Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy; [Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Procoli, Annabella] Univ Cattolica Sacro Cuore, Inst Gynecol, Rome, Italy; [Constantin, Gabriela] Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, I-37100 Verona, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona	Ria, F (corresponding author), Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy.	fria@rm.unicatt.it	Delogu, Giovanni/I-3701-2012; Ria, Francesco/AAD-1174-2022; Di Sante, Gabriele/K-8629-2016; Di Sante, Gabriele/AHD-9850-2022; Di Sante, Gabriele/N-5294-2018; Di Sante, Gabriele/N-5280-2018; Migliara, Giuseppe/AAN-2138-2021	Delogu, Giovanni/0000-0003-0182-8267; Ria, Francesco/0000-0001-7455-4290; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Constantin, Gabriela/0000-0001-8978-3539; Migliara, Giuseppe/0000-0002-4573-6025; piermattei, alessia/0000-0001-7164-4952	Fondazione Italiana Sclerosi Multipla (FISM) [28/2010/R]; PRIN from the Ministry of Education and Research (MIUR) [70103553]; European Research Council [261079]; Fondazione Cariverona	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); PRIN from the Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Research Council(European Research Council (ERC)European Commission); Fondazione Cariverona(Fondazione Cariverona)	This work was supported by: Fondazione Italiana Sclerosi Multipla (FISM) grant Nr. 28/2010/R (FR); PRIN grant from the Ministry of Education and Research (MIUR) Nr. 70103553 (FR and GD); FP7 Program, European Research Council Grant 261079 "Neurotrafficking'' (GC); PRIN grant from the Ministry of Education and Research (MIUR) and Fondazione Cariverona (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caetano BC, 2011, EUR J IMMUNOL, V41, P3627, DOI 10.1002/eji.201141876; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Guery JC, 1997, INT IMMUNOL, V9, P9, DOI 10.1093/intimm/9.1.9; Holley MM, 2012, J IMMUNOL, V188, P1360, DOI 10.4049/jimmunol.1101660; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Ley K, 2005, NAT IMMUNOL, V6, P1215, DOI 10.1038/ni1205-1215; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mercier BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042170; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Morrison VL, 2010, J IMMUNOL, V185, P2737, DOI 10.4049/jimmunol.1000758; Nicolo C, 2006, INT IMMUNOL, V18, P363, DOI 10.1093/intimm/dxh376; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Penitente R, 2008, J IMMUNOL, V180, P6611, DOI 10.4049/jimmunol.180.10.6611; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; PIRCHER H, 1987, EUR J IMMUNOL, V17, P1843, DOI 10.1002/eji.1830171226; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Ria F, 2004, J IMMUNOL, V172, P3447, DOI 10.4049/jimmunol.172.6.3447; Ria F., 2001, Current Molecular Medicine (Hilversum), V1, P297, DOI 10.2174/1566524013363690; Ria F, 1998, EUR J IMMUNOL, V28, P2003, DOI 10.1002/(SICI)1521-4141(199806)28:06<2003::AID-IMMU2003>3.0.CO;2-S; Ria F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2553; Rolla S, 2006, J IMMUNOL, V177, P7626, DOI 10.4049/jimmunol.177.11.7626; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Wrenshall L, 2003, SPRINGER SEMIN IMMUN, V25, P199, DOI 10.1007/s00281-003-0138-y; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55819	10.1371/journal.pone.0055819	http://dx.doi.org/10.1371/journal.pone.0055819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409051	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000024
J	Yong, MH; Allen, JC; Prakash, KM; Tan, EK				Yong, Ming-Hui; Allen, John C., Jr.; Prakash, Kumar M.; Tan, Eng-King			Differentiating Non-Motor Symptoms in Parkinson's Disease from Controls and Hemifacial Spasm	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; MULTICENTER; DYSFUNCTION; MANAGEMENT; DIAGNOSIS; SCALE	Background and Aims: Non-motor symptoms (NMS) are important manifestations of Parkinson's disease (PD) that reduce patients' health-related quality of life. Some NMS may also be caused by age-related changes, or manifested as a psychological reaction to a chronic neurological condition. This case-control study compared the NMS burden among PD patients, healthy controls and hemifacial spasm (HFS) patients. In addition, we determined the NMS that discriminated between PD and non-PD subjects. Methods: 425 subjects were recruited from a tertiary hospital in Singapore (200 PD patients, 150 healthy controls and 75 HFS patients). NMS burden in subjects was measured using the Non-Motor Symptoms Scale (NMSS). Results: NMSS total score was significantly higher in PD patients (37.9 +/- 2.6) compared to healthy controls (11.2 +/- 0.9) (p<0.0001) and HFS patients (18.0 +/- 2.1) (p<0.0001). In addition, NMSS total score was significantly higher in HFS patients compared to healthy controls (p = 0.003). PD patients experienced a higher NMS burden than healthy controls in all domains, and a higher NMS burden than HFS patients in all but attention/memory and urinary domains. NMS burden for HFS and healthy controls differed only in the sleep/fatigue and urinary domains. Using stepwise logistic regression, problems of 'constipation', 'restless legs', 'dribbling saliva', 'altered interest in sex' and 'change in taste or smell' were found to have significant discriminative power in differentiating between PD patients and healthy controls and between PD patients and HFS patients. Conclusion: PD patients experienced a greater overall NMS burden compared to both healthy controls and HFS patients. HFS patients demonstrated a higher NMS burden than controls, and some NMS may be common to chronic neurological conditions while others are more specific to PD. Differentiating patients using NMS domains may help refine the clinical management of NMS in PD patients.	[Yong, Ming-Hui; Prakash, Kumar M.; Tan, Eng-King] Natl Inst Neurosci, Dept Neurol, Singapore, Singapore; [Yong, Ming-Hui; Allen, John C., Jr.; Prakash, Kumar M.; Tan, Eng-King] Duke NUS Grad Med Sch, Singapore, Singapore	National Neuroscience Institute (NNI); National University of Singapore	Tan, EK (corresponding author), Natl Inst Neurosci, Dept Neurol, Singapore, Singapore.	gnrtek@sgh.com.sg			Duke Graduate Medical School; National Neuroscience Institute; Singapore Millennium Foundation	Duke Graduate Medical School; National Neuroscience Institute; Singapore Millennium Foundation(Singapore Millennium Foundation)	This work was supported in part by Duke Graduate Medical School, National Neuroscience Institute and Singapore Millennium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Defazio G, 2008, ARCH NEUROL-CHICAGO, V65, P1191, DOI 10.1001/archneurol.2008.2; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Diederich NJ, 2010, MOVEMENT DISORD, V25, P882, DOI 10.1002/mds.22963; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Findley L, 2002, MOVEMENT DISORD, V17, P60; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jain S, 2011, PARKINSONISM RELAT D, V17, P77, DOI 10.1016/j.parkreldis.2010.08.022; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kim HJ, 2009, J NEUROL SCI, V287, P200, DOI 10.1016/j.jns.2009.07.026; Krishnan S, 2011, MOVEMENT DISORD, V26, P2110, DOI 10.1002/mds.23826; KUA EH, 1992, ACTA PSYCHIAT SCAND, V85, P119, DOI 10.1111/j.1600-0447.1992.tb01454.x; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Lim SY, 2010, MOVEMENT DISORD, V25, pS123, DOI 10.1002/mds.22786; Martinez-Martin P, 2009, NEUROLOGY, V73, P1584, DOI 10.1212/WNL.0b013e3181c0d416; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Tan EK, 2006, MOVEMENT DISORD, V21, P2145, DOI 10.1002/mds.21150; Tan NC, 2002, QJM-INT J MED, V95, P493, DOI 10.1093/qjmed/95.8.493; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Truong DD, 2008, J NEUROL SCI, V266, P216, DOI 10.1016/j.jns.2007.08.015; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Ziemssen T, 2007, PARKINSONISM RELAT D, V13, P323, DOI 10.1016/j.parkreldis.2006.12.014	33	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e49596	10.1371/journal.pone.0049596	http://dx.doi.org/10.1371/journal.pone.0049596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408927	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000001
J	Pruss, H; Rosche, B; Sullivan, AB; Brommer, B; Wengert, O; Gronert, K; Schwab, JM				Pruess, Harald; Rosche, Berit; Sullivan, Aaron B.; Brommer, Benedikt; Wengert, Oliver; Gronert, Karsten; Schwab, Jan M.			Proresolution Lipid Mediators in Multiple Sclerosis - Differential, Disease Severity-Dependent Synthesis - A Clinical Pilot Trial	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INFLAMMATION; RESOLUTION	Background: The severity and longevity of inflammation is controlled by endogenous counter-regulatory signals. Among them are long-chain polyunsaturated fatty acid (PUFA)-derived lipid mediators, which promote the resolution of inflammation, an active process for returning to tissue homeostasis. Objective: To determine whether endogenous production of lipid-derived resolution agonists is regulated differentially in patients with highly active and less active multiple sclerosis (MS). Design: Matched-pairs study in University hospital Neurology department. Patients: Based on clinical (relapse frequency) and paraclinical (MRI lesions, contrast enhancement) criteria, 10 pairs of age- and sex-matched patients with relapsing-remitting MS were assigned either to a group with highly active or less active MS. Lipid mediators were quantified in serum and cerebrospinal fluid using LC-MS/MS-based lipidomics. Results: Levels of the key arachidonic (omega-6) and docosahexaenoic acid (omega-6)-derived mediators prostaglandins (PG), leukotrienes, hydroxyeicosatetraenoic acids (HETE) and resolution agonists lipoxin A(4) (LXA(4)), resolvin D1 (RvD1) and neuroprotectin D1 (NPD1) were quantified. In the patient group with highly active MS, 15-HETE and PGE(2) were increased, which are products of the 15-lipoxygenase and cyclooxygenase pathways. The proresolution mediator RvD1 was significantly upregulated and NPD1 was detected in the highly active group only. LXA(4) levels were not increased in patients with highly active MS. Conclusions: Lipid mediator pathways are regulated differentially in the cerebrospinal fluid of MS patients, depending on disease severity. Non-exhaustive or possibly 'delayed' resolution pathways may suggest a defective resolution program in patients with highly active MS. Longitudinal analyses are required to hetero-typify this differential resolution capacity, which may be associated with disease progression, longevity and eventual termination.	[Pruess, Harald; Rosche, Berit; Brommer, Benedikt; Wengert, Oliver; Schwab, Jan M.] Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Sullivan, Aaron B.; Gronert, Karsten] Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Berkeley	Pruss, H (corresponding author), Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany.	harald.pruess@charite.de; jan.schwab@charite.de		Schwab, Jan/0000-0001-6784-4919	Berlin-Brandenburg Center for Regenerative Therapies (BCRT) [81717034]; Wings for Life Spinal Cord Research Foundation, Austria; National Institutes of Health [EY022208, EY016136]; Bayer-Schering; NATIONAL EYE INSTITUTE [R01EY022208, R01EY016136] Funding Source: NIH RePORTER	Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Wings for Life Spinal Cord Research Foundation, Austria; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer-Schering(Bayer AG); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	JS is supported by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT, #81717034) and the Wings for Life Spinal Cord Research Foundation, Austria (travel grant). The authors also acknowledge support from the National Institutes of Health (EY022208 and EY016136) to KG and from a restricted research grant covering some costs for laboratory material from "Bayer-Schering" to BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad A, 2010, J NEUROIMMUNOL, V219, P1, DOI 10.1016/j.jneuroim.2009.09.002; BATES D, 1978, BMJ-BRIT MED J, V2, P1390, DOI 10.1136/bmj.2.6149.1390; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Greco A, 1999, NEUROLOGY, V53, P1876, DOI 10.1212/WNL.53.8.1876; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Spite M, 2009, BRIT J PHARMACOL, V158, P1062, DOI 10.1111/j.1476-5381.2009.00234.x; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	19	67	67	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55859	10.1371/journal.pone.0055859	http://dx.doi.org/10.1371/journal.pone.0055859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409068	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300041
J	De Marco, C; Rinaldo, N; Bruni, P; Malzoni, C; Zullo, F; Fabiani, F; Losito, S; Scrima, M; Zito Marino, F; Franco, R; Quintiero, A; Agosti, V; Viglietto, G				De Marco, Carmela; Rinaldo, Nicola; Bruni, Paola; Malzoni, Carmine; Zullo, Fulvio; Fabiani, Fernanda; Losito, Simona; Scrima, Marianna; Zito Marino, Federica; Franco, Renato; Quintiero, Alfina; Agosti, Valter; Viglietto, Giuseppe			Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma	PLOS ONE			English	Article							SIGNALING PATHWAY; PHOSPHORYLATED AKT; THERAPEUTIC TARGET; PROGNOSTIC VALUE; PIK3CA GENE; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; PTEN EXPRESSION; IN-VITRO; CANCER	The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is activated in multiple cancers including ovarian carcinoma (OC). However, the relative contribution of the single components within the PI3K pathway to AKT activation in OC is still unclear. We examined 98 tumor samples from Italian OC patients for alterations in the members of the PI3K pathway. We report that AKT is significantly hyperactive in OC compared to normal tissue (n = 93; p<0.0001) and that AKT activation is preferentially observed in the elderly (>58 years old; n = 93; p<0.05). The most frequent alteration is the overexpression of the p110 alpha catalytic subunit of PI3K (63/93, similar to 68%); less frequent alterations comprise the loss of PTEN (24/89, 27%) and the overexpression of AKT1 (18/96, 19%) or AKT2 (11/88,12.5%). Mutations in the PIK3CA or KRAS genes were detected at lower frequency (12% and 10%, respectively) whereas mutations in AKT1 or AKT2 genes were absent. Although many tumors presented a single lesion (28/93, of which 23 overexpressed PIK3CA, 1 overexpressed AKT and 4 had lost PTEN), many OC (35/93) presented multiple alterations within the PI3K pathway. Apparently, aberrant PI3K signalling was mediated by activation of the canonical downstream AKT-dependent mTOR/S6K1/4EBP1 pathway and by regulation of expression of oncogenic transcription factors that include HMGA1, JUN-B, FOS and MYC but not by AKT-independent activation of SGK3. FISH analysis indicated that gene amplification of PIK3CA, AKT1 and AKT2 (but not of PI3KR1) and the loss of PTEN are common and may account for changes in the expression of the corresponding proteins. In conclusion, our results indicate that p110 alpha overexpression represents the most frequent alteration within the PI3K/AKT pathway in OC. However, p110 alpha overexpression may not be sufficient to activate AKT signalling and drive ovarian tumorigenesis since many tumors overexpressing PI3K presented at least one additional alteration.	[De Marco, Carmela; Zullo, Fulvio; Fabiani, Fernanda; Scrima, Marianna; Quintiero, Alfina; Agosti, Valter; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [De Marco, Carmela; Rinaldo, Nicola; Scrima, Marianna; Viglietto, Giuseppe] Inst Genet Res Gaetano Salvatore, Biogem Scarl, Avellino, Italy; [Bruni, Paola; Malzoni, Carmine] Casa Cura Malzoni Villa Platani, Avellino, Italy; [Losito, Simona; Zito Marino, Federica; Franco, Renato] Fdn G Pascale, NCI, Naples, Italy	Magna Graecia University of Catanzaro; IRCCS Fondazione Pascale	Viglietto, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	viglietto@unicz.it	scrima, marianna/ABE-3003-2021; scrima, marianna/J-7431-2016; losito, Nunzia/Y-6339-2018; Viglietto, Giuseppe/AAC-2852-2019; Marino, Federica ZMF Zito/K-8634-2016; De Marco, Carmela/J-6797-2015; Scrima, Marianna/S-3320-2017; Zullo, Fulvio/K-3396-2016	scrima, marianna/0000-0003-4636-7695; scrima, marianna/0000-0003-4636-7695; losito, Nunzia/0000-0001-9045-0328; Viglietto, Giuseppe/0000-0003-2327-7515; De Marco, Carmela/0000-0002-4893-4246; Scrima, Marianna/0000-0003-4636-7695; AGOSTI, Valter/0000-0001-6785-093X; Zullo, Fulvio/0000-0003-3726-7561; Zito Marino, Federica/0000-0002-1071-757X; Franco, Renato/0000-0002-8340-3184; Zullo, Fulvio/0000-0003-4006-3287	MIUR (PRIN) [20087FSFFP_001, PON_02782]; Fondazione per il Sud	MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione per il Sud	This work was supported by MIUR (PRIN, 20087FSFFP_001; PON_02782) to GV. CDM was supported by a fellowship from 'Fondazione per il Sud'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-51; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auner V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-111; Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Barda G, 2004, AM J OBSTET GYNECOL, V190, P1039, DOI 10.1016/j.ajog.2003.09.073; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carvalho S, 2010, VIRCHOWS ARCH, V456, P235, DOI 10.1007/s00428-010-0881-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; de Graeff P, 2008, BRIT J CANCER, V99, P341, DOI 10.1038/sj.bjc.6604471; ENOMOTO T, 1991, AM J PATHOL, V139, P777; Fader AN, 2007, J CLIN ONCOL, V25, P2873, DOI 10.1200/JCO.2007.11.0932; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Fishman DA, 2001, CANC TREATMENT RES O, P3; Gemignani ML, 2003, GYNECOL ONCOL, V90, P378, DOI 10.1016/S0090-8258(03)00264-6; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hu LM, 2002, CANCER RES, V62, P1087; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kawano O, 2007, LUNG CANCER, V58, P159, DOI 10.1016/j.lungcan.2007.06.020; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Kirkegaard T, 2010, HISTOPATHOLOGY, V56, P203, DOI 10.1111/j.1365-2559.2009.03467.x; Kurose K, 2001, AM J PATHOL, V158, P2097, DOI 10.1016/S0002-9440(10)64681-0; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lee SH, 2002, APMIS, V110, P587, DOI 10.1034/j.1600-0463.2002.11007811.x; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Lin Y, 2009, ENDOCR-RELAT CANCER, V16, P301, DOI 10.1677/ERC-08-0167; Liu JF, 2010, WORLD J GASTROENTERO, V16, P4986, DOI 10.3748/wjg.v16.i39.4986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Mayr D, 2006, GYNECOL ONCOL, V103, P883, DOI 10.1016/j.ygyno.2006.05.029; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; [Natioanl Institute of Health website National Library of Medicine], OV CANC; National Cancer Institute website, CANC TOP OV CANC; No JH, 2011, GYNECOL ONCOL, V121, P8, DOI 10.1016/j.ygyno.2010.12.364; Obata K, 1998, CANCER RES, V58, P2095; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Philp AJ, 2001, CANCER RES, V61, P7426; Rimm DL, 2001, CANCER J, V7, P24; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Russel P, 1995, BLAUSTEINS PATHOLOGY, P705; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sambrook J, 1992, MOL CLONING LAB MANU, V2; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; SATO T, 1991, CANCER RES, V51, P5118; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Trinh XB, 2009, BRIT J CANCER, V100, P971, DOI 10.1038/sj.bjc.6604921; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang GX, 2010, CLIN NEUROL NEUROSUR, V112, P324, DOI 10.1016/j.clineuro.2010.01.003; Wang Y, 2005, AM J CLIN PATHOL, V124, P392, DOI 10.1309/BL7EMW66LQX6GFRP; Willner J, 2007, HUM PATHOL, V38, P607, DOI 10.1016/j.humpath.2006.10.007; Woenckhaus J, 2007, VIRCHOWS ARCH, V450, P387, DOI 10.1007/s00428-006-0358-3; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yuan ZQ, 2000, ONCOGENE, V19, P2324, DOI 10.1038/sj.onc.1203598; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhang X, 2009, ONCOLOGY-BASEL, V77, P22, DOI 10.1159/000218201	71	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55362	10.1371/journal.pone.0055362	http://dx.doi.org/10.1371/journal.pone.0055362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408974	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200027
J	Papadakos, KS; Sougleri, IS; Mentis, AF; Hatziloukas, E; Sgouras, DN				Papadakos, Konstantinos S.; Sougleri, Ioanna S.; Mentis, Andreas F.; Hatziloukas, Efstathios; Sgouras, Dionyssios N.			Presence of Terminal EPIYA Phosphorylation Motifs in Helicobacter pylori CagA Contributes to IL-8 Secretion, Irrespective of the Number of Repeats	PLOS ONE			English	Article							NF-KAPPA-B; GASTRIC EPITHELIAL-CELLS; VIRULENCE FACTOR CAGA; PEPTIC-ULCER DISEASE; TYROSINE PHOSPHORYLATION; PATHOGENICITY ISLAND; VACA POLYMORPHISMS; EFFECTOR PROTEIN; IN-VITRO; KINASE	CagA protein contributes to pro-inflammatory responses during H. pylori infection, following its intracellular delivery to gastric epithelial cells. Here, we report for the first time in an isogenic background, on the subtle role of CagA phosphorylation on terminal EPIYA-C motifs in the transcriptional activation and expression of IL-8. We utilized isogenic H. pylori mutants of P12 reference strain, expressing CagA with varying number of EPIYA-C motifs and the corresponding phosphorylation defective EPIFA-C motifs while preserving intact the CM multimerization motifs. These mutants had been previously closely scrutinized in terms of type IV secretion system functionality, CagA translocation and its subsequent phosphorylation. Following infection of gastric epithelial cell lines, transcriptional activation of IL-8 gene and secreted IL-8 levels were found to be strictly dependent upon the functionality of the EPIYA-C phosphorylation motifs, as EPIFA-C phosphorylation-deficient CagA expression failed to induce full IL-8 transcriptional activity. Interestingly, levels of IL-8 gene activation and of secreted IL-8 were the same, irrespective of the number of EPIYA-C terminal repeats. We monitored IkB alpha phosphorylation and confirmed CagA involvement in NF-kB activation. Furthermore, we observed that presence of EPIYA-C functional phosphorylation motifs contributed to NF-kB activation. NF-kB upstream signaling events, such as early ERK1/2 and AKT activation were confirmed to be independent of EPIYA-C phosphorylation. On the contrary, use of TAK1 specific inhibitor 5Z-7-Oxozeaenol resulted in complete arrest of IL-8 secretion, in a dose-dependent manner, irrespective of CagA status. H. pylori-infected TAK1(-/-) mouse embryonic fibroblasts (MEFs) failed to induce NF-kB activity, unlike the respective control MEFs. CagA and TAK1 were found to immunoprecipitate together, irrespective of CagA EPIYA-C status, thus confirming earlier reports of TAK1 and CagA protein interaction. Our data suggest that CagA may potentially interfere with TAK1 activity during NF-kB activation for IL-8 induction in early H. pylori infection.	[Papadakos, Konstantinos S.; Sougleri, Ioanna S.; Mentis, Andreas F.; Sgouras, Dionyssios N.] Hellenic Pasteur Inst, Lab Med Microbiol, Athens, Greece; [Hatziloukas, Efstathios] Univ Ioannina, Dept Biol Applicat & Technol, Mol Biol Lab, GR-45110 Ioannina, Greece	University of Ioannina	Sgouras, DN (corresponding author), Hellenic Pasteur Inst, Lab Med Microbiol, Athens, Greece.	sgouras@pasteur.gr	Papadakos, Konstantinos/AAD-7417-2020; Sgouras, Dionyssios Nicholas/D-9943-2012	Sgouras, Dionyssios Nicholas/0000-0003-0975-2607; Papadakos, Konstantinos/0000-0001-5834-1447	Hellenic Pasteur Institute [HPI-922616]; ANR ERANET Pathogenomics [ANR-06-PATHO-007-01]	Hellenic Pasteur Institute; ANR ERANET Pathogenomics(French National Research Agency (ANR))	Study was supported mainly by a Hellenic Pasteur Institute grant (HPI-922616) and in part by ANR 2006 ERANET Pathogenomics ANR-06-PATHO-007-01. KSP was supported throughout his studies by a Hellenic Pasteur Institute Ph.D. studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Ando T, 1996, AM J GASTROENTEROL, V91, P1150; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Ayers S, 2011, J NAT PROD, V74, P1126, DOI 10.1021/np200062x; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; GIONCHETTI P, 1994, AM J GASTROENTEROL, V89, P883; Gobert AP, 2013, CELL MICROBIOL, V15, P145, DOI 10.1111/cmi.12039; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lamb A, 2010, GUT MICROBES, V1, P109, DOI 10.4161/gmic.1.2.11587; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lesouhaitier O, 2001, ENDOCRINOLOGY, V142, P4320, DOI 10.1210/en.142.10.4320; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Nomura AMY, 2002, AM J EPIDEMIOL, V155, P1054, DOI 10.1093/aje/155.11.1054; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Panayotopoulou EG, 2010, J CLIN MICROBIOL, V48, P2237, DOI 10.1128/JCM.00662-10; Papadakos KS, 2013, HELICOBACTER, V18, P229, DOI 10.1111/hel.12029; Peek RM, 1995, LAB INVEST, V73, P760; Pera T, 2011, AM J PHYSIOL-LUNG C, V301, pL822, DOI 10.1152/ajplung.00017.2011; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Sgouras DN, 2009, J CLIN MICROBIOL, V47, P2426, DOI 10.1128/JCM.00159-09; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; SOBALA GM, 1991, GUT, V32, P1415, DOI 10.1136/gut.32.11.1415; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang Z, 2011, MOL VIS, V17, P3137; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Witherell HL, 1997, J INFECT DIS, V176, P1641, DOI 10.1086/517346	60	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56291	10.1371/journal.pone.0056291	http://dx.doi.org/10.1371/journal.pone.0056291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409168	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200128
J	Plovanich, M; Bogorad, RL; Sancak, Y; Kamer, KJ; Strittmatter, L; Li, AA; Girgis, HS; Kuchimanchi, S; De Groot, J; Speciner, L; Taneja, N; Oshea, J; Koteliansky, V; Mootha, VK				Plovanich, Molly; Bogorad, Roman L.; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Kuchimanchi, Satya; De Groot, Jack; Speciner, Lauren; Taneja, Nathan; Oshea, Jonathan; Koteliansky, Victor; Mootha, Vamsi K.			MICU2, a Paralog of MICU1, Resides within the Mitochondrial Uniporter Complex to Regulate Calcium Handling	PLOS ONE			English	Article							RAT KIDNEY MITOCHONDRIA; CA2+ UPTAKE; ESSENTIAL COMPONENT; RNAI THERAPEUTICS; RESPIRATION; METABOLISM; DELIVERY; PROTEIN; MCU; OSCILLATIONS	Mitochondrial calcium uptake is present in nearly all vertebrate tissues and is believed to be critical in shaping calcium signaling, regulating ATP synthesis and controlling cell death. Calcium uptake occurs through a channel called the uniporter that resides in the inner mitochondrial membrane. Recently, we used comparative genomics to identify MICU1 and MCU as the key regulatory and putative pore-forming subunits of this channel, respectively. Using bioinformatics, we now report that the human genome encodes two additional paralogs of MICU1, which we call MICU2 and MICU3, each of which likely arose by gene duplication and exhibits distinct patterns of organ expression. We demonstrate that MICU1 and MICU2 are expressed in HeLa and HEK293T cells, and provide multiple lines of biochemical evidence that MCU, MICU1 and MICU2 reside within a complex and cross-stabilize each other's protein expression in a cell-type dependent manner. Using in vivo RNAi technology to silence MICU1, MICU2 or both proteins in mouse liver, we observe an additive impairment in calcium handling without adversely impacting mitochondrial respiration or membrane potential. The results identify MICU2 as a new component of the uniporter complex that may contribute to the tissue-specific regulation of this channel.	[Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA; [Bogorad, Roman L.; Koteliansky, Victor] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kuchimanchi, Satya; De Groot, Jack; Speciner, Lauren; Taneja, Nathan; Oshea, Jonathan] Alnylam Pharmaceut Inc, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	vamsi@hms.harvard.edu		Kamer, Kimberli/0000-0001-8728-7793; Li, Andrew/0000-0002-1295-8115	National Institutes of Health [GM0077465, DK080261]; Alnylam; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alnylam; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM0077465, DK080261) awarded to VKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Please note that in this paper, the authors' academic laboratory (based at Massachusetts General Hospital/Harvard Medical School) collaborated with Alnylam Pharmaceuticals (co-authors include JDG, L. Speciner, NT, JO, VK). As employees, they received compensation/stock from Alnylam. The authors do not believe that the fact that they are employees of a company, receiving salary/equity from this company, represents a competing interest that compromises the objectivity of the work. This does not alter the authors' adherence to all the PLOS ONE policies on data sharing and materials.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2	32	302	312	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55785	10.1371/journal.pone.0055785	http://dx.doi.org/10.1371/journal.pone.0055785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409044	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200064
J	Page, S; Birerdinc, A; Estep, M; Stepanova, M; Afendy, A; Petricoin, E; Younossi, Z; Chandhoke, V; Baranova, A				Page, Sandra; Birerdinc, Aybike; Estep, Michael; Stepanova, Maria; Afendy, Arian; Petricoin, Emanuel; Younossi, Zobair; Chandhoke, Vikas; Baranova, Ancha			Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; FAS LIGAND; ADIPOKINES; DISCOVERY; CIRRHOSIS	The discovery of biomarkers is often performed using high-throughput proteomics-based platforms and is limited to the molecules recognized by a given set of purified and validated antigens or antibodies. Knowledge-based, or systems biology, approaches that involve the analysis of integrated data, predominantly molecular pathways and networks may infer quantitative changes in the levels of biomolecules not included by the given assay from the levels of the analytes profiled. In this study we attempted to use a knowledge-based approach to predict biomarkers reflecting the changes in underlying protein phosphorylation events using Nonalcoholic Fatty Liver Disease (NAFLD) as a model. Two soluble biomarkers, CCL-2 and FasL, were inferred in silico as relevant to NAFLD pathogenesis. Predictive performance of these biomarkers was studied using serum samples collected from patients with histologically proven NAFLD. Serum levels of both molecules, in combination with clinical and demographic data, were predictive of hepatic fibrosis in a cohort of NAFLD patients. Our study suggests that (1) NASH-specific disruption of the kinase-driven signaling cascades in visceral adipose tissue lead to detectable changes in the levels of soluble molecules released into the bloodstream, and (2) biomarkers discovered in silico could contribute to predictive models for non-malignant chronic diseases.	[Page, Sandra; Birerdinc, Aybike; Stepanova, Maria; Petricoin, Emanuel; Chandhoke, Vikas; Baranova, Ancha] George Mason Univ, Coll Sci, Sch Syst Biol, Ctr Study Chron Metab Dis, Fairfax, VA 22030 USA; [Page, Sandra; Birerdinc, Aybike; Estep, Michael; Stepanova, Maria; Afendy, Arian; Younossi, Zobair; Baranova, Ancha] Inova Hlth Syst, Betty & Guy Beatty Liver & Obes Program, Falls Church, VA USA; [Estep, Michael; Afendy, Arian; Younossi, Zobair] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA; [Estep, Michael; Afendy, Arian; Younossi, Zobair] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA; [Petricoin, Emanuel] George Mason Univ, Coll Sci, Sch Syst Biol, Ctr Appl Prote & Mol Med, Fairfax, VA 22030 USA; [Baranova, Ancha] Res Ctr Med Genet RAMS, Moscow, Russia; [Page, Sandra] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	George Mason University; Inova Health System; Inova Fairfax Hospital; Inova Fairfax Hospital; George Mason University; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Baranova, A (corresponding author), George Mason Univ, Coll Sci, Sch Syst Biol, Ctr Study Chron Metab Dis, Fairfax, VA 22030 USA.	abaranov@gmu.edu	Baranova, Anna/HGB-3721-2022; , Ancha/B-4608-2012	, Ancha/0000-0001-6810-5982; Estep, J. Michael/0000-0001-7735-2133				Baranova A, 2008, HEPATOLOGY, V47, P373, DOI 10.1002/hep.22140; Baranova A, 2007, EXPERT REV MOL DIAGN, V7, P195, DOI 10.1586/14737159.7.2.195; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bell LN, 2010, HEPATOLOGY, V51, P111, DOI 10.1002/hep.23271; Emanuel E, 2008, HEPATOLOGY, V48, P2086, DOI 10.1002/hep.22622; Fierbinteanu-Braticevici C, 2011, J GASTROINTEST LIVER, V20, P153; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Jarrar MH, 2008, ALIMENT PHARM THER, V27, P412, DOI 10.1111/j.1365-2036.2007.03586.x; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Ochs MF, 2010, BRIEF BIOINFORM, V11, P30, DOI 10.1093/bib/bbp044; Panasiuk A, 2005, WORLD J GASTROENTERO, V11, P7661, DOI 10.3748/wjg.v11.i48.7661; Sanchez-Carbayo M, 2011, METHODS MOL BIOL, V785, P159, DOI 10.1007/978-1-61779-286-1_11; Singhal S, 2009, BIOMARKERS, V14, P347, DOI 10.1080/13547500903013664; Song LH, 2004, J MED VIROL, V73, P244, DOI 10.1002/jmv.20082; Stephen S, 2012, EXPERT REV GASTROENT, V6, P163, DOI [10.1586/EGH.11.97, 10.1586/egh.11.97]; Szuster-Ciesielska A, 2005, TOXICOLOGY, V212, P124, DOI 10.1016/j.tox.2005.04.009; Tokar Jeffrey L., 2002, Curr Treat Options Gastroenterol, V5, P425, DOI 10.1007/s11938-002-0030-1; Wilson B, 2010, DIS MARKERS, V28, P225, DOI [10.1155/2010/240248, 10.3233/DMA-2010-0705]; Yilmaz Y, 2009, WORLD J GASTROENTERO, V15, P4387, DOI 10.3748/wjg.15.4387; Younossi ZM, 2010, J PROTEOME RES, V9, P3218, DOI 10.1021/pr100069e	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56009	10.1371/journal.pone.0056009	http://dx.doi.org/10.1371/journal.pone.0056009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405244	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400189
J	Wang, L; Pawlak, EA; Johnson, PJ; Belknap, JK; Eades, S; Stack, S; Cousin, H; Black, SJ				Wang, Le; Pawlak, Erica A.; Johnson, Philip J.; Belknap, James K.; Eades, Susan; Stack, Sharon; Cousin, Helene; Black, Samuel J.			Impact of Laminitis on the Canonical Wnt Signaling Pathway in Basal Epithelial Cells of the Equine Digital Laminae	PLOS ONE			English	Article							BETA-CATENIN; GENE-EXPRESSION; VERSICAN PROMOTER; INTEGRIN; HORSES; HEMIDESMOSOMES; TRANSITION; VIMENTIN; CLEAVAGE; MODEL	The digital laminae is a two layer tissue that attaches the distal phalanx to the inner hoof wall, thus suspending the horse's axial skeleton in the hoof capsule. This tissue fails at the epidermal: dermal junction in laminitic horses, causing crippling disease. Basal epithelial cells line the laminar epidermal: dermal junction, undergo physiological change in laminitic horses, and lose versican gene expression. Versican gene expression is purportedly under control of the canonical Wnt signaling pathway and is a trigger for mesenchymal-to-epithelial transition; thus, its repression in laminar epithelial cells of laminitic horses may be associated with suppression of the canonical Wnt signaling pathway and loss of the epithelial cell phenotype. In support of the former contention, we show, using laminae from healthy horses and horses with carbohydrate overload-induced laminitis, quantitative real-time polymerase chain reaction, Western blotting after sodium dodecylsulfate polyacrylamide gel electrophoresis, and immunofluorescent tissue staining, that positive and negative regulatory components of the canonical Wnt signaling pathway are expressed in laminar basal epithelial cells of healthy horses. Furthermore, expression of positive regulators is suppressed and negative regulators elevated in laminae of laminitic compared to healthy horses. We also show that versican gene expression in the epithelial cells correlates positively with that of beta-catenin and T-cell Factor 4, consistent with regulation by the canonical Wnt signaling pathway. In addition, gene and protein expression of beta-catenin correlates positively with that of integrin beta 4 and both are strongly suppressed in laminar basal epithelial cells of laminitic horses, which remain E-cadherin(+)/vimentin(-), excluding mesenchymal transition as contributing to loss of the adherens junction and hemidesmosome components. We propose that suppression of the canonical Wnt signaling pathway, and accompanying reduced expression of beta catenin and integrin beta 4 in laminar basal epithelial cells reduces cell: cell and cell: basement membrane attachment, thus, destabilizing the laminar epidermal: dermal junction.	[Wang, Le; Pawlak, Erica A.; Cousin, Helene; Black, Samuel J.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Johnson, Philip J.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Belknap, James K.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Eades, Susan] Louisiana State Sch Vet Med, Baton Rouge, LA USA; [Stack, Sharon] Univ Notre Dame, Notre Dame, IN 46556 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Missouri System; University of Missouri Columbia; Ohio State University; University of Notre Dame	Black, SJ (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	sblack@vasci.umass.edu	Black, Samuel/L-8429-2016; BELKNAP, JAMES K/A-9877-2013	BELKNAP, JAMES K/0000-0003-2682-4991	Morris Animal Foundation [D08EQ-054]; United States Department of Agriculture (USDA) National Research Initiative Cooperative State Research, Education, and Extension Service (CSREES) [2007-35204-18313]; USDA CSREES [MAS00907]; Lotta M. Crabtree Fellowship in Agriculture; National Institutes of Health [DE016289]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016289] Funding Source: NIH RePORTER	Morris Animal Foundation; United States Department of Agriculture (USDA) National Research Initiative Cooperative State Research, Education, and Extension Service (CSREES); USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Lotta M. Crabtree Fellowship in Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study was supported by D08EQ-054 from the Morris Animal Foundation (http://www.morrisanimalfoundation.org/), by 2007-35204-18313 from United States Department of Agriculture (USDA) National Research Initiative Cooperative State Research, Education, and Extension Service (CSREES) and by MAS00907 from USDA CSREES to SJB. EAP was supported by a Lotta M. Crabtree Fellowship in Agriculture. HC was supported by a grant from National Institutes of Health (DE016289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Coyne MJ, 2009, VET IMMUNOL IMMUNOP, V129, P231, DOI 10.1016/j.vetimm.2008.11.022; Crampton SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007841; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Eades SC, 2010, VET CLIN N AM-EQUINE, V26, P51, DOI 10.1016/j.cveq.2010.01.001; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Faleiros RR, 2011, J VET INTERN MED, V25, P107, DOI 10.1111/j.1939-1676.2010.0650.x; FERRIER AF, 1992, J CELL BIOCHEM, V50, P245, DOI 10.1002/jcb.240500305; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; French KR, 2004, EQUINE VET J, V36, P299, DOI 10.2746/0425164044877206; French KR, 2004, EQUINE VET J, V36, P242, DOI 10.2746/0425164044877134; French KR, 2004, EQUINE VET J, V36, P230, DOI 10.2746/0425164044877125; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; GARNER HE, 1975, AM J VET RES, V36, P441; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hatfield CL, 2001, AM J VET RES, V62, P1387, DOI 10.2460/ajvr.2001.62.1387; Heymering HW, 2010, VET CLIN N AM-EQUINE, V26, P1, DOI 10.1016/j.cveq.2009.12.004; Johnson PJ, 2000, EQUINE VET J, V32, P462, DOI 10.2746/042516400777584695; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Leise BS, 2011, EQUINE VET J, V43, P54, DOI 10.1111/j.2042-3306.2010.00122.x; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nourian AR, 2009, EQUINE VET J, V41, P671, DOI 10.2746/042516409X407648; OBEL NJ, 1948, ACTA PHARMACOL TOX, V4, P71; Oh DY, 2010, SCIENCE, V329, P397, DOI 10.1126/science.1193404; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Pollitt CC, 2010, VET CLIN N AM-EQUINE, V26, P29, DOI 10.1016/j.cveq.2010.01.005; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rahmani M, 2012, METHODS MOL BIOL, V836, P35, DOI 10.1007/978-1-61779-498-8_3; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2007, J CELL PHYSIOL, V211, P213, DOI 10.1002/jcp.20921; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Wang L, 2012, AM J VET RES, V73, P1047, DOI 10.2460/ajvr.73.7.1047; WYCKOFF M, 1977, ANAL BIOCHEM, V78, P459, DOI 10.1016/0003-2697(77)90107-5; Xu HX, 2010, PHOTODERMATOL PHOTO, V26, P198, DOI 10.1111/j.1600-0781.2010.00522.x	46	12	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56025	10.1371/journal.pone.0056025	http://dx.doi.org/10.1371/journal.pone.0056025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405249	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400194
J	Saito, A; Ochiai, H; Okada, S; Miyata, N; Azuma, T				Saito, Akiko; Ochiai, Hiromi; Okada, Shoko; Miyata, Naoteru; Azuma, Toshifumi			Suppression of Lefty expression in induced pluripotent cancer cells	FASEB JOURNAL			English	Article						DNA methylation; TGF beta; Ras-MAPK signaling	EMBRYONIC STEM-CELLS; METASTATIC TUMOR-CELLS; TGF-BETA; PANCREATIC-CANCER; DEFINED FACTORS; EPIGENETICS; LINE; MICROENVIRONMENT; PATHWAYS; LINKING	Cancer and stem cells share the ability to silence tumor suppressors. We focused on Lefty, which encodes one of the most abundant tumor suppressors in embryonic stem (ES) cells and is not expressed in somatic cancer cells. We found that transforming growth factor beta (TGF-beta) induced demethylation of the Lefty B cytosine-phosphate-guanine (CpG) island and increased Lefty expression (10-200 times) in human pancreatic cancer cells and human liver cancer cells (PLC/PRF/5 and HLF). Expression of Cripto, another important factor in Nodal-Lefty signaling, was not increased after adding TGF-beta. We generated reprogrammed cancer cells that revealed high expression of immature marker proteins, high proliferation, and the potential to express morphological patterns of ectoderm, mesoderm, and endoderm, suggesting that these cells may have cancer stem cell-like phenotypes. We investigated Lefty and found that reprogrammed human liver cancer cells (induced pluripotent cancer cells) displayed a much lower ability to express Lefty, although less Lefty B CpG methylation was also observed. We also found that a MEK inhibitor dramatically enhanced Lefty expression in human pancreatic cancers with mutated ras, whereas Lefty B CpG methylation was not decreased. These observations indicate that despite the demethylation of DNA strands in promoter regions of pluripotency-associated genes, including Lefty gene, Lefty expression was not induced well in reprogrammed cells. Of note was the fact that Lefty is abundantly expressed in human ES cells but not in induced pluripotent stem (iPS) cells. We thus think that reprogrammed cancer cells share the mechanism for expression of Lefty with iPS cells. This shared mechanism may contribute to the cancerous transformation of iPS cells.	[Saito, Akiko; Ochiai, Hiromi; Okada, Shoko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Chiba 2618502, Japan; [Ochiai, Hiromi; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr Hrc8, Chiba 2618502, Japan; [Miyata, Naoteru] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; Keio University	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	tazuma@tdc.ac.jp						Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Bellini MF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/891961; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Brait M, 2011, TOXICOL MECH METHOD, V21, P275, DOI 10.3109/15376516.2011.562671; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; DAEMER RJ, 1980, INFECT IMMUN, V30, P607; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Falzacappa MVV, 2012, FEBS J, V279, P3559, DOI 10.1111/j.1742-4658.2012.08727.x; Furukawa T, 2009, CLIN GASTROENTEROL H, V7, pS35, DOI 10.1016/j.cgh.2009.07.035; Gouas DA, 2010, CARCINOGENESIS, V31, P1475, DOI 10.1093/carcin/bgq118; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Joan M., 2008, CELL, V134, P215; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Malchenko S, 2010, J CELL PHYSIOL, V225, P390, DOI 10.1002/jcp.22280; MARION PL, 1979, J VIROL, V32, P796, DOI 10.1128/JVI.32.3.796-802.1979; Miyata N, 2012, PANCREAS, V41, P745, DOI 10.1097/MPA.0b013e31823b66d3; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; MOTOO Y, 1986, BIOCHEM BIOPH RES CO, V135, P262, DOI 10.1016/0006-291X(86)90971-X; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; SUMI S, 1994, PANCREAS, V9, P657, DOI 10.1097/00006676-199409000-00018; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337	48	16	16	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2165	2174		10.1096/fj.12-221432	http://dx.doi.org/10.1096/fj.12-221432			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23407711				2022-12-25	WOS:000319667600008
J	Tyagarajan, SK; Ghosh, H; Yevenes, GE; Imanishi, SY; Zeilhofer, HU; Gerrits, B; Fritschy, JM				Tyagarajan, Shiva K.; Ghosh, Himanish; Yevenes, Gonzalo E.; Imanishi, Susumu Y.; Zeilhofer, Hanns Ulrich; Gerrits, Bertran; Fritschy, Jean-Marc			Extracellular Signal-regulated Kinase and Glycogen Synthase Kinase 3 beta Regulate Gephyrin Postsynaptic Aggregation and GABAergic Synaptic Function in a Calpain-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTOR; INHIBITORY SYNAPSES; PHOSPHORYLATION SITES; SPLICE VARIANTS; PLASTICITY; PROTEIN; TRAFFICKING; COLLYBISTIN; NEURONS; MEMORY	Molecular mechanisms of plasticity at GABAergic synapses are currently poorly understood. To identify signaling cascades that converge onto GABAergic postsynaptic density proteins, we performed MS analysis using gephyrin isolated from rat brain and identified multiple novel phosphorylation and acetylation residues on gephyrin. Here, we report the characterization of one of these phosphoresidues, Ser-268, which when dephosphorylated leads to the formation of larger postsynaptic scaffolds. Using a combination of mutagenesis, pharmacological treatment, and biochemical assays, we identify ERK as the kinase phosphorylating Ser-268 and describe a functional interaction between residues Ser-268 and Ser-270. We further demonstrate that alterations in gephyrin clustering via ERK modulation are reflected by amplitude and frequency changes in miniature GABAergic postsynaptic currents. We unravel novel mechanisms for activity-and ERK-dependent calpain action on gephyrin, which are likely relevant in the context of cellular signaling affecting GABAergic transmission and homeostatic synaptic plasticity in pathology.	[Tyagarajan, Shiva K.; Ghosh, Himanish; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Zeilhofer, Hanns Ulrich] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Gerrits, Bertran] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Tyagarajan, Shiva K.; Ghosh, Himanish; Zeilhofer, Hanns Ulrich; Fritschy, Jean-Marc] Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Imanishi, Susumu Y.] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Imanishi, Susumu Y.] Abo Akad Univ, FIN-20520 Turku, Finland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Turku; Abo Akademi University	Tyagarajan, SK (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	tyagarajan@pharma.uzh.ch	Tyagarajan, Shiva/P-3135-2015; Imanishi, Susumu/B-8697-2014; Zeilhofer, Hanns Ulrich/A-4600-2008	Tyagarajan, Shiva/0000-0003-0074-1805; Imanishi, Susumu/0000-0002-3641-4390; Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Fritschy, Jean-Marc/0000-0002-8552-3702; Yevenes, Gonzalo/0000-0003-0294-4075	Forschungskredit of the University of Zurich; EMDO Foundation; Hartmann Muller Foundation; Swiss National Science Foundation	Forschungskredit of the University of Zurich; EMDO Foundation; Hartmann Muller Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Forschungskredit of the University of Zurich, the EMDO Foundation, and the Hartmann Muller Foundation (to S. K. T.) and from the Swiss National Science Foundation (to J. M. F.).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Herweg J, 2012, J BIOL CHEM, V287, P12645, DOI 10.1074/jbc.M112.341826; Houston CM, 2008, J NEUROSCI, V28, P7574, DOI 10.1523/JNEUROSCI.5531-07.2008; Imanishi SY, 2007, MOL CELL PROTEOMICS, V6, P1380, DOI 10.1074/mcp.M600480-MCP200; Jacob TC, 2009, P NATL ACAD SCI USA, V106, P12500, DOI 10.1073/pnas.0903943106; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; Lardi-Studler B, 2007, J CELL SCI, V120, P1371, DOI 10.1242/jcs.003905; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Vlachos A., 2012, CEREBRAL CO IN PRESS; Wuchter J, 2012, J NEUROSCI, V32, P14821, DOI 10.1523/JNEUROSCI.1261-12.2012; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	31	79	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9634	9647		10.1074/jbc.M112.442616	http://dx.doi.org/10.1074/jbc.M112.442616			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408424	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-25	WOS:000317114000007
J	Sharma, J; Mukherjee, D; Rao, SNR; Iyengar, S; Shankar, SK; Satishchandra, P; Jana, NR				Sharma, Jaiprakash; Mukherjee, Diptendu; Rao, Sudheendra N. R.; Iyengar, Soumya; Shankar, Susarla Krishna; Satishchandra, Parthasarathy; Jana, Nihar Ranjan			Neuronatin-mediated Aberrant Calcium Signaling and Endoplasmic Reticulum Stress Underlie Neuropathology in Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; E3 UBIQUITIN LIGASE; PROTEASOMAL FUNCTION; GLYCOGEN-SYNTHESIS; MESSENGER-RNA; MOUSE MODEL; MALIN; PROTEIN; GENE; DEGRADATION	Lafora disease (LD) is a teenage-onset inherited progressive myoclonus epilepsy characterized by the accumulations of intracellular inclusions called Lafora bodies and caused by mutations in protein phosphatase laforin or ubiquitin ligase malin. But how the loss of function of either laforin or malin causes disease pathogenesis is poorly understood. Recently, neuronatin was identified as a novel substrate of malin that regulates glycogen synthesis. Here we demonstrate that the level of neuronatin is significantly up-regulated in the skin biopsy sample of LD patients having mutations in both malin and laforin. Neuronatin is highly expressed in human fetal brain with gradual decrease in expression in developing and adult brain. However, in adult brain, neuronatin is predominantly expressed in parvalbumin-positive GABAergic interneurons and localized in their processes. The level of neuronatin is increased and accumulated as insoluble aggregates in the cortical area of LD brain biopsy samples, and there is also a dramatic loss of parvalbumin-positive GABAergic interneurons. Ectopic expression of neuronatin in cultured neuronal cells results in increased intracellular Ca2+, endoplasmic reticulum stress, proteasomal dysfunction, and cell death that can be partially rescued by malin. These findings suggest that the neuronatin-induced aberrant Ca2+ signaling and endoplasmic reticulum stress might underlie LD pathogenesis.	[Sharma, Jaiprakash; Mukherjee, Diptendu; Rao, Sudheendra N. R.; Jana, Nihar Ranjan] Natl Brain Res Ctr, Manesar 122050, Gurgaon, India; [Iyengar, Soumya] Natl Brain Res Ctr, Neuroanat Lab, Manesar 122050, Gurgaon, India; [Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Satishchandra, Parthasarathy] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Jana, NR (corresponding author), Natl Brain Res Ctr, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in	Rao, Sudheendra/K-3017-2014	Rao, Sudheendra/0000-0001-7576-1718; Jana, Nihar/0000-0002-6549-4211	Department of Biotechnology to National Brain Research Centre, Government of India; Extramural Grant from the Department of Biotechnology, Government of India [BT/PR13590/MED/30/286/2009]; Department of Biotechnology, Government of India	Department of Biotechnology to National Brain Research Centre, Government of India; Extramural Grant from the Department of Biotechnology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a core grant from the Department of Biotechnology to National Brain Research Centre, Government of India, and Extramural Grant BT/PR13590/MED/30/286/2009 from the Department of Biotechnology, Government of India.; Supported by a research fellowship from Department of Biotechnology, Government of India.	ACHARYA JN, 1993, EPILEPSIA, V34, P476, DOI 10.1111/j.1528-1157.1993.tb02588.x; Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Arava Y, 1999, DIABETES, V48, P552, DOI 10.2337/diabetes.48.3.552; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CARPENTER S, 1981, NEUROLOGY, V31, P1564, DOI 10.1212/WNL.31.12.1564; Chan EM, 2004, NEUROLOGY, V63, P565, DOI 10.1212/01.WNL.0000133215.65836.03; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dou DX, 1996, BRAIN RES, V723, P8, DOI 10.1016/0006-8993(96)00167-9; Dou DX, 1996, GENOMICS, V33, P292, DOI 10.1006/geno.1996.0195; Dugu L, 2010, J DERMATOL, V37, P846, DOI 10.1111/j.1346-8138.2010.00873.x; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; JOSEPH R, 1995, BRAIN RES, V690, P92, DOI 10.1016/0006-8993(95)00621-V; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Lin HH, 2010, STEM CELLS, V28, P1950, DOI 10.1002/stem.530; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mzhavia N, 2008, DIABETES, V57, P2774, DOI 10.2337/db07-1746; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Sharma J, 2011, NEUROBIOL DIS, V44, P133, DOI 10.1016/j.nbd.2011.06.013; Singh S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039479; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Sinha S, 2007, J NEUROL SCI, V252, P16, DOI 10.1016/j.jns.2006.09.021; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200	47	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9482	9490		10.1074/jbc.M112.416180	http://dx.doi.org/10.1074/jbc.M112.416180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408434	Green Published, hybrid			2022-12-25	WOS:000316862200064
J	Li, YR; Ma, WX; Che, YZ; Zou, LF; Zakria, M; Zou, HS; Chen, GY				Li, Yu-Rong; Ma, Wen-Xiu; Che, Yi-Zhou; Zou, Li-Fang; Zakria, Muhammad; Zou, Hua-Song; Chen, Gong-You			A Highly-Conserved Single-Stranded DNA-Binding Protein in Xanthomonas Functions as a Harpin-Like Protein to Trigger Plant Immunity	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; SYRINGAE PV. PHASEOLICOLA; HYPERSENSITIVE RESPONSE; INNATE IMMUNITY; GENOME SEQUENCE; SALICYLIC-ACID; CELL-DEATH; TRANSCRIPTION FACTORS; DISEASE RESISTANCE; ERWINIA-AMYLOVORA	Harpins are produced by Gram-negative phytopathogenic bacteria and typically elicit hypersensitive response (HR) in non-host plants. The characterization of harpins in Xanthomonas species is largely unexplored. Here we demonstrate that Xanthomonas produce a highly conserved single-stranded DNA-binding protein (SSBX) that elicits HR in tobacco as by harpin Hpa1. SSBX, like Hpa1, is an acidic, glycine-rich, heat-stable protein that lacks cysteine residues. SSBX-triggered HR in tobacco, as by Hpa1, is characterized by the oxidative burst, the expression of HR markers (HIN1, HSR203J), pathogenesis-related genes, and callose deposition. Both SSBX-and Hpa1-induced HRs can be inhibited by general metabolism inhibitors actinomycin D, cycloheximide, and lanthanum chloride. Furthermore, those HRs activate the expression of BAK1 and BIK1 genes that are essential for induction of mitogen-activated protein kinase (MAPK) and salicylic acid pathways. Once applied to plants, SSBX induces resistance to the fungal pathogen Alternaria alternata and enhances plant growth. When ssb(X) was deleted in X. oryzae pv. oryzicola, the causal agent of bacterial leaf streak in rice, the resulting ssb(Xoc) mutant was reduced in virulence and bacterial growth in planta, but retained its ability to trigger HR in tobacco. Interestingly, ssbXoc contains an imperfect PIP-box (plant-inducible promoter) and the expression of ssb(Xoc) is regulated by HrpX, which belongs to the AraC family of transcriptional activators. Immunoblotting evidence showed that SSBx secretion requires a functional type-III secretion system as Hpa1 does. This is the first report demonstrating that Xanthomonas produce a highly-conserved SSBX that functions as a harpin-like protein for plant immunity.	[Li, Yu-Rong; Ma, Wen-Xiu; Che, Yi-Zhou; Zou, Li-Fang; Zakria, Muhammad; Zou, Hua-Song; Chen, Gong-You] Shanghai Jiao Tong Univ, Key Lab Urban South, Minist Agr China, Sch Agr & Biol, Shanghai 200030, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Zou, HS (corresponding author), Shanghai Jiao Tong Univ, Key Lab Urban South, Minist Agr China, Sch Agr & Biol, Shanghai 200030, Peoples R China.	hszou@sjtu.edu.cn; gyouchen@sjtu.edu.cn	CHEN, Gongyou/AAA-9694-2019; Zou, Huasong/GLN-3569-2022	CHEN, Gongyou/0000-0003-1979-2880; Zou, Huasong/0000-0001-5758-1975	National Natural Science Foundation of China [31230059, 31071656, 31171832]; State Key Basic Research and Development Project of China [2012CB114003]; Key Basic Research Project of the Shanghai Committee of Science and Technology [11JC1406300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China); Key Basic Research Project of the Shanghai Committee of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (31230059 and 31071656 to GC and 31171832 to HZ), the State Key Basic Research and Development Project of China (2012CB114003), and the Key Basic Research Project of the Shanghai Committee of Science and Technology (11JC1406300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Ahmad M, 2001, MOL PLANT MICROBE IN, V14, P1223, DOI 10.1094/MPMI.2001.14.10.1223; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Altenbach D, 2007, MOL PLANT MICROBE IN, V20, P1031, DOI 10.1094/MPMI-20-9-1031; ARLAT M, 1994, EMBO J, V13, P543, DOI 10.1002/j.1460-2075.1994.tb06292.x; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Che Yi-Zhou, 2011, Microb Biotechnol, V4, P777, DOI 10.1111/j.1751-7915.2011.00281.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Danna CH, 2011, P NATL ACAD SCI USA, V108, P9286, DOI 10.1073/pnas.1106366108; Danon A, 2000, PLANT PHYSIOL BIOCH, V38, P647, DOI 10.1016/S0981-9428(00)01178-5; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; DOW JM, 1990, APPL ENVIRON MICROB, V56, P2994, DOI 10.1128/AEM.56.10.2994-2998.1990; Durner J, 1997, TRENDS PLANT SCI, V2, P266, DOI 10.1016/S1360-1385(97)86349-2; Engelhardt S, 2009, PLANT J, V57, P706, DOI 10.1111/j.1365-313X.2008.03723.x; Fedorov R, 2006, NUCLEIC ACIDS RES, V34, P6708, DOI 10.1093/nar/gkl1002; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Furutani A, 2006, FEMS MICROBIOL LETT, V259, P133, DOI 10.1111/j.1574-6968.2006.00265.x; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Gimenez-Ibanez S, 2010, MICROBES INFECT, V12, P428, DOI 10.1016/j.micinf.2010.03.002; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; Haapalainen M, 2011, MOL PLANT PATHOL, V12, P151, DOI 10.1111/j.1364-3703.2010.00655.x; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnsen K, 1999, FEMS MICROBIOL LETT, V173, P155, DOI 10.1111/j.1574-6968.1999.tb13497.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim CY, 2004, PLANT J, V38, P142, DOI 10.1111/j.1365-313X.2004.02033.x; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JG, 2010, MOL PLANT PATHOL, V11, P371, DOI [10.1111/j.1364-3703.2010.00610.x, 10.1111/J.1364-3703.2010.00610.X]; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; Li YR, 2012, ARCH MICROBIOL, V194, P281, DOI 10.1007/s00203-011-0758-x; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Mersmann S, 2010, PLANT PHYSIOL, V154, P391, DOI 10.1104/pp.110.154567; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oh CS, 2007, PLANT PHYSIOL, V145, P426, DOI 10.1104/pp.107.103432; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; PRESTON G, 1995, MOL PLANT MICROBE IN, V8, P717, DOI 10.1094/MPMI-8-0717; Reboutier D, 2007, MOL PLANT MICROBE IN, V20, P94, DOI 10.1094/MPMI-20-0094; Reboutier D, 2008, PLANT SIGNAL BEHAV, V3, P314, DOI 10.4161/psb.3.5.5304; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J., 2001, MOL CLONING LAB MANU; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Sharma PC, 2003, MOL GENET GENOMICS, V269, P583, DOI 10.1007/s00438-003-0872-9; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Takahashi Y, 2004, PLANT J, V40, P586, DOI 10.1111/j.1365-313X.2004.02234.x; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuge S, 2005, J BACTERIOL, V187, P2308, DOI 10.1128/JB.187.7.2308-2314.2005; Upton JP, 2007, CELL DEATH DIFFER, V14, P932, DOI 10.1038/sj.cdd.4402092; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YinPeng, 2009, Acta Phytopathologica Sinica, V39, P392; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Xiao You-lun, 2007, Weishengwu Xuebao, V47, P396; Yang SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013472; Yap MN, 2006, J BACTERIOL, V188, P2280, DOI 10.1128/JB.188.6.2280-2284.2006; Yeam I, 2010, PLANT J, V61, P16, DOI 10.1111/j.1365-313X.2009.04028.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06; Zou LF, 2011, AGR SCI CHINA, V10, P1139, DOI 10.1016/S1671-2927(11)60104-1	99	10	14	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56240	10.1371/journal.pone.0056240	http://dx.doi.org/10.1371/journal.pone.0056240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418541	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300134
J	Nestorov, P; Battke, F; Levesque, MP; Gerberding, M				Nestorov, Peter; Battke, Florian; Levesque, Mitchell P.; Gerberding, Matthias			The Maternal Transcriptome of the Crustacean Parhyale hawaiensis Is Inherited Asymmetrically to Invariant Cell Lineages of the Ectoderm and Mesoderm	PLOS ONE			English	Article							AMPHIPOD CRUSTACEAN; EARLY EMBRYOS; EXPRESSION; LOCALIZATION; AXIS; ARTHROPODS; EVOLUTION; PROTEINS; REVEALS; PATTERN	Background: The embryo of the crustacean Parhyale hawaiensis has a total, unequal and invariant early cleavage pattern. It specifies cell fates earlier than other arthropods, including Drosophila, as individual blastomeres of the 8-cell stage are allocated to the germ layers and the germline. Furthermore, the 8-cell stage is amenable to embryological manipulations. These unique features make Parhyale a suitable system for elucidating germ layer specification in arthropods. Since asymmetric localization of maternally provided RNA is a widespread mechanism to specify early cell fates, we asked whether this is also true for Parhyale. A candidate gene approach did not find RNAs that are asymmetrically distributed at the 8-cell stage. Therefore, we designed a high-density microarray from 9400 recently sequenced ESTs (1) to identify maternally provided RNAs and (2) to find RNAs that are differentially distributed among cells of the 8-cell stage. Results: Maternal-zygotic transition takes place around the 32-cell stage, i.e. after the specification of germ layers. By comparing a pool of RNAs from early embryos without zygotic transcription to zygotic RNAs of the germband, we found that more than 10% of the targets on the array were enriched in the maternal transcript pool. A screen for asymmetrically distributed RNAs at the 8-cell stage revealed 129 transcripts, from which 50% are predominantly expressed in the early embryonic stages. Finally, we performed knockdown experiments for two of these genes and observed cell-fate-related defects of embryonic development. Conclusions: In contrast to Drosophila, the four primary germ layer cell lineages in Parhyale are specified during the maternal control phase of the embryo. A key step in this process is the asymmetric distribution of a large number of maternal RNAs to the germ layer progenitor cells.	[Nestorov, Peter; Levesque, Mitchell P.; Gerberding, Matthias] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Battke, Florian] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Gerberding, M (corresponding author), Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany.	matthias.gerberding@medizin.uni-tuebingen.de		Battke, Florian/0000-0001-6021-5837	Max Planck Society (Max Planck Gesellschaft)	Max Planck Society (Max Planck Gesellschaft)(Max Planck Society)	This work was funded by project grants from the Max Planck Society (Max Planck Gesellschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Nadine Heckmann for her excellent support regarding molecular biology and animal care and for her spirit and willingness to help in many situations. Kerstin Miller is thanked for great animal care as well. Gunes Ozhan Kizil and Johanna Havemann helped to bring this project about by developing and sharing protocols and by discussing our and their own results. We thank Claas aufm Kampe for the data administration and Vikram Alva for help with data processing and analysis. Christa Lanz and Nadine Heckmann, Tubingen and Vertis, Munich, were instrumental in our EST project. In Hohenheim, we would like to thank Sandra Reineke for help with molecular biology and Martin Blum for space, equipment and discussions. We would like to thank Nipam Patel for his generous support in access to EST reads. Tom Gingeras, Jan Lohmann, Bettina Harr and Michael Kohn all gave encouraging input to this project. We thank Andrei Lupas for support for the GBM (Gesellschaft fur Biochemie und Molekularbiologie) diploma thesis award and the GBM and Bernd Hamprecht for the diploma thesis award. This work was supported by the Max Planck Society.	Abzhanov A, 2008, TRENDS GENET, V24, P353, DOI 10.1016/j.tig.2008.04.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON KV, 1984, NATURE, V311, P223, DOI 10.1038/311223a0; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Baroux C, 2009, COLD SPRING HARB S Q; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Blythe MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033784; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Browne WE, 2006, DEV GENES EVOL, V216, P581, DOI 10.1007/s00427-006-0074-7; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuykendall TN, 2009, DEVELOPMENT, V136, P3057, DOI 10.1242/dev.036855; da Fonseca RN, 2009, CURR OPIN GENET DEV, V19, P404, DOI 10.1016/j.gde.2009.04.009; Extavour CG, 2005, DEV BIOL, V277, P387, DOI 10.1016/j.ydbio.2004.09.030; Gerberding M, 2002, DEVELOPMENT, V129, P5789, DOI 10.1242/dev.00155; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kizil GO, 2008, DEV BIOL; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Lawrence PA, 2006, CURR BIOL, V16, pR236, DOI 10.1016/j.cub.2006.03.016; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lorenzini DM, 2003, DEV COMP IMMUNOL, V27, P781, DOI 10.1016/S0145-305X(03)00058-2; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; McClintock TS, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-312; McGregor AP, 2008, BIOESSAYS, V30, P487, DOI 10.1002/bies.20744; Parchem RJ, 2010, GENOMICS, V95, P261, DOI 10.1016/j.ygeno.2010.03.005; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Price AL, 2009, DEV BIOL; Price AL, 2008, J EXP ZOOL PART B, V310B, P24, DOI 10.1002/jez.b.21135; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; SAMBROOK J, 2000, MOL CLONING LAB MANU; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Wilson MJ, 2011, EVOL DEV, V13, P127, DOI 10.1111/j.1525-142X.2011.00463.x; Yamada L, 2005, DEV BIOL, V284, P536, DOI 10.1016/j.ydbio.2005.05.027; Yatsu J, 2008, INT J DEV BIOL, V52, P913, DOI 10.1387/ijdb.082576jy; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x	42	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56049	10.1371/journal.pone.0056049	http://dx.doi.org/10.1371/journal.pone.0056049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418507	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300099
J	Ramirez, SH; Fan, SS; Dykstra, H; Rom, S; Mercer, A; Reichenbach, NL; Gofman, L; Persidsky, Y				Ramirez, Servio H.; Fan, Shongshan; Dykstra, Holly; Rom, Slava; Mercer, Aaron; Reichenbach, Nancy L.; Gofman, Larisa; Persidsky, Yuri			Inhibition of Glycogen Synthase Kinase 3 beta Promotes Tight Junction Stability in Brain Endothelial Cells by Half-Life Extension of Occludin and Claudin-5	PLOS ONE			English	Article							PROTEIN OCCLUDIN; BARRIER FUNCTION; BETA-CATENIN; MDCK CELLS; ACTIVATION; EXPRESSION; PHOSPHORYLATION; PERMEABILITY; IMPEDANCE; ATROGIN-1	Neuroinflammatory conditions often involve dysfunction of the Blood-Brain Barrier (BBB). Therefore, identifying molecular targets that can maintain barrier fidelity is of clinical importance. We have previously reported on the anti-inflammatory effects that glycogen synthase kinase 3 beta (GSK3 beta) inhibition has on primary human brain endothelial cells. Here we show that GSK3 beta inhibitors also promote barrier tightness by affecting tight junction (TJ) protein stability. Transendothelial electrical resistance (TEER) was used to evaluate barrier integrity with both pharmacological inhibitors and mutants of GSK3 beta. Inhibition of GSK3 beta produced a gradual and sustained increase in TEER (as much as 22% over baseline). Analysis of subcellular membrane fractions revealed an increase in the amount of essential tight junction proteins, occludin and claudin-5, but not claudin-3. This phenomenon was attributed to a decrease in TJ protein turnover and not transcriptional regulation. Using a novel cell-based assay, inactivation of GSK3 beta significantly increased the half-life of occludin and claudin-5 by 32% and 43%, respectively. A correlation was also established between the enhanced association of beta-catenin with ZO-1 as a function of GSK3 beta inhibition. Collectively, our findings suggest the possibility of using GSK3 beta inhibitors as a means to extend the half-life of key tight junction proteins to promote re-sealing of the BBB during neuroinflammation.	[Ramirez, Servio H.; Fan, Shongshan; Dykstra, Holly; Rom, Slava; Reichenbach, Nancy L.; Gofman, Larisa; Persidsky, Yuri] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Ramirez, Servio H.; Persidsky, Yuri] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA; [Mercer, Aaron] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Michigan System; University of Michigan	Ramirez, SH (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.	servio@temple.edu	Ramirez, Servio/F-8277-2014; Rom, Slava/AAF-6872-2020	ramirez, servio/0000-0002-4609-5653	National Institutes of Health [RO1MH065151, R37AA015913]; Temple University development grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA015913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple University development grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported (in part) by research funding from the National Institutes of Health: RO1MH065151 and R37AA015913 (YP) and a Temple University development grant (SHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DeBellefeuille S, 2003, ENDOCRINOLOGY, V144, P5040, DOI 10.1210/en.2002-0139; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; DePaola N, 2001, ANN BIOMED ENG, V29, P648, DOI 10.1114/1.1385811; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Fan SS, 2004, MOL BRAIN RES, V132, P38, DOI 10.1016/j.molbrainres.2004.09.003; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Herve JC, 2007, J MEMBRANE BIOL, V217, P21, DOI 10.1007/s00232-007-9054-8; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Klamer G, 2010, CURR MED CHEM, V17, P2873, DOI 10.2174/092986710792065090; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Mandel I, 2012, J CELL BIOCH; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Raikwar NS, 2010, AM J PHYSIOL-RENAL, V299, pF436, DOI 10.1152/ajprenal.00674.2009; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Severson EA, 2010, BIOCHEM BIOPH RES CO, V397, P592, DOI 10.1016/j.bbrc.2010.05.164; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Wang Z, 2007, ONCOGENE, V26, P1222, DOI 10.1038/sj.onc.1209902; Watanabe K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002436; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang L, 2011, J BIOL CHEM, V286, P16879, DOI 10.1074/jbc.M110.186932; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	41	78	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55972	10.1371/journal.pone.0055972	http://dx.doi.org/10.1371/journal.pone.0055972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418486	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300078
J	Samusik, N; Krukovskaya, L; Meln, I; Shilov, E; Kozlov, AP				Samusik, Nikolay; Krukovskaya, Larisa; Meln, Irina; Shilov, Evgeny; Kozlov, Andrey P.			PBOV1 Is a Human De Novo Gene with Tumor-Specific Expression That Is Associated with a Positive Clinical Outcome of Cancer	PLOS ONE			English	Article							BREAST-CANCER; HUMAN GENOME; STRUCTURE PREDICTION; ANTIGENS; PATHWAY; IDENTIFICATION; TRANSCRIPTION; RESOLUTION; EVOLUTION; PROSTATE	PBOV1 is a known human protein-coding gene with an uncharacterized function. We have previously found that PBOV1 lacks orthologs in non-primate genomes and is expressed in a wide range of tumor types. Here we report that PBOV1 protein-coding sequence is human-specific and has originated de novo in the primate evolution through a series of frame shift and stop codon mutations. We profiled PBOV1 expression in multiple cancer and normal tissue samples and found that it was expressed in 19 out of 34 tumors of various origins but completely lacked expression in any of the normal adult or fetal human tissues. We found that, unlike the cancer/testis antigens that are typically controlled by CpG island-containing promoters, PBOV1 was expressed from a GC-poor TATA-containing promoter which was not influenced by CpG demethylation and was inactive in testis. Our analysis of public microarray data suggests that PBOV1 activation in tumors could be dependent on the Hedgehog signaling pathway. Despite the recent de novo origin and the lack of identifiable functional signatures, a missense SNP in the PBOV1 coding sequence has been previously associated with an increased risk of breast cancer. Using publicly available microarray datasets, we found that high levels of PBOV1 expression in breast cancer and glioma samples were significantly associated with a positive outcome of the cancer disease. We also found that PBOV1 was highly expressed in primary but not in recurrent high-grade gliomas, suggesting the presence of a negative selection against PBOV1-expressing cancer cells. Our findings could contribute to the understanding of the mechanisms behind de novo gene origin and the possible role of tumors in this process.	[Samusik, Nikolay] Max Planck Inst Cell Biol & Genet, Dresden, Germany; [Krukovskaya, Larisa; Shilov, Evgeny; Kozlov, Andrey P.] Biomed Ctr, St Petersburg 197110, Russia; [Meln, Irina] VA Almazov Fed Heart Blood & Endocrinol Ctr, Inst Haematol, St Petersburg, Russia; [Kozlov, Andrey P.] St Petersburg State Univ, Dept Biochem, St Petersburg, Russia	Max Planck Society; Almazov National Medical Research Centre; Saint Petersburg State University	Samusik, N (corresponding author), Max Planck Inst Cell Biol & Genet, Dresden, Germany.	samusik@mpi-cbg.de	Kozlov, Andrei P/H-2117-2016; Shilov, Evgeny/ABG-3200-2021	Kozlov, Andrei P/0000-0003-4611-1534; Meln, Irina/0000-0001-5737-4167; Shilov, Evgeny/0000-0002-8933-7843	Russian-Belorussian program [K-32-NIR/111-3]; Biomedical Centre	Russian-Belorussian program; Biomedical Centre	This work was funded by the Biomedical Centre and by the Russian-Belorussian program #K-32-NIR/111-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except for Prof. Andrey P. Kozlov who, being the head of the Biomedical Centre, simultaneously authorized the funding and supervised this work.	An G, 2000, CANCER RES, V60, P7014; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Aydin Z, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-178; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Chomez P, 2001, CANCER RES, V61, P5544; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Coggin JH, 2005, ANTICANCER RES, V25, P2345; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; de Magalhaes JP, 2007, MECH AGEING DEV, V128, P355, DOI 10.1016/j.mad.2007.03.004; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; FALKMER S, 1976, PROG EXP TUMOR RES, V20, P217; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Fisher MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015364; Guigo R., 1999, GENETIC DATABASES; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kamagata C, 2002, ANTICANCER RES, V22, P4087; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kozlov AP, 2010, MED HYPOTHESES, V74, P177, DOI 10.1016/j.mehy.2009.07.027; Kozlov Andrei P, 2006, Infect Agent Cancer, V1, P8, DOI 10.1186/1750-9378-1-8; Kozlov AP, 1996, MED HYPOTHESES, V46, P81, DOI 10.1016/S0306-9877(96)90005-5; Krukovskaja L. L., 2010, Voprosy Onkologii (St. Petersburg), V56, P327; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000734; Li D, 2010, CELL RES, V20, P408, DOI 10.1038/cr.2010.31; Loizidou MA, 2010, BREAST CANCER RES TR, V121, P147, DOI 10.1007/s10549-009-0518-7; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mansour AA, 2011, MOL CELL NEUROSCI, V46, P187, DOI 10.1016/j.mcn.2010.09.002; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nuber N, 2010, P NATL ACAD SCI USA, V107, P15187, DOI 10.1073/pnas.1002155107; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Sambrook J, 2001, MOL CLONING LAB MANU, P130; Samusik N. A., 2011, RUSS J GENET APPL RE, V1, P138; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; SCHREIBER H, 1988, ANNU REV IMMUNOL, V6, P465; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Stauffer Yves, 2004, Cancer Immun, V4, P2; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Valen E, 2011, TRENDS GENET, V27, P475, DOI 10.1016/j.tig.2011.08.001; Vasudevan S, 2002, BIOESSAYS, V24, P785, DOI 10.1002/bies.10153; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	57	25	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56162	10.1371/journal.pone.0056162	http://dx.doi.org/10.1371/journal.pone.0056162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418531	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300123
J	Uhart, M; Bustos, DM				Uhart, Marina; Bustos, Diego M.			Human 14-3-3 Paralogs Differences Uncovered by Cross-Talk of Phosphorylation and Lysine Acetylation	PLOS ONE			English	Article							INTRINSIC DISORDER; PROTEIN DISORDER; IN-VIVO; NETWORK; COMPLEXES; CYTOSCAPE; RESIDUES; CANCER; FOCUS; MOTIF	The 14-3-3 protein family interacts with more than 700 different proteins in mammals, in part as a result of its specific phospho-serine/phospho-threonine binding activity. Upon binding to 14-3-3, the stability, subcellular localization and/or catalytic activity of the ligands are modified. Seven paralogs are strictly conserved in mammalian species. Although initially thought as redundant, the number of studies showing specialization is growing. We created a protein-protein interaction network for 14-3-3, kinases and their substrates signaling in human cells. We included information of phosphorylation, acetylation and other PTM sites, obtaining a complete representation of the 14-3-3 binding partners and their modifications. Using a computational system approach we found that networks of each 14-3-3 isoform are statistically different. It was remarkable to find that Tyr was the most phosphorylatable amino acid in domains of 14-3-3 epsilon partners. This, together with the over-representation of SH3 and Tyr_Kinase domains, suggest that epsilon could be involved in growth factors receptors signaling pathways particularly. We also found that within zeta's network, the number of acetylated partners (and the number of modify lysines) is significantly higher compared with each of the other isoforms. Our results imply previously unreported hidden differences of the 14-3-3 isoforms interaction networks. The phosphoproteome and lysine acetylome within each network revealed post-transcriptional regulation intertwining phosphorylation and lysine acetylation. A global understanding of these networks will contribute to predict what could occur when regulatory circuits become dysfunctional or are modified in response to external stimuli.	[Uhart, Marina; Bustos, Diego M.] Univ Nacl San Martin UNSAM, Lab Biol Estruct & Celular Modificac Posttraducc, Inst Invest Biotecnol, Inst Tecnol Chascomus IIB INTECH,Consejo Nacl Inv, Chascomus, Argentina		Bustos, DM (corresponding author), Univ Nacl San Martin UNSAM, Lab Biol Estruct & Celular Modificac Posttraducc, Inst Invest Biotecnol, Inst Tecnol Chascomus IIB INTECH,Consejo Nacl Inv, Int Marino Km 8-2, Chascomus, Argentina.	dbustos@intech.gov.ar			ANPCyT [PICT-1495]; CONICET [PIP 0304, 2519]	ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	ANPCyT (PICT-1495) and CONICET (PIP 0304 and 2519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BURNETT G, 1954, J BIOL CHEM, V211, P969; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Caetano-Anolles G., 2010, EVOLUTIONARY GENOMIC; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dunker A K, 1998, Pac Symp Biocomput, P473; Fernandez A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-604; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gough NR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137eg6; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kjarland E, 2006, CURR PHARM BIOTECHNO, V7, P217, DOI 10.2174/138920106777549777; Lu ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028228; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Mogk A, 2010, SCIENCE, V327, P966, DOI 10.1126/science.1187274; Moore B. W., 1967, PHYSL BIOCH ASPECTS, P343; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Panni S, 2011, PROTEOMICS, V11, P128, DOI 10.1002/pmic.201000030; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun SY, 2009, J ENDOCRINOL, V202, P327, DOI 10.1677/JOE-09-0041; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Uhart M, 2011, J MOL BIOL, V406, P552, DOI 10.1016/j.jmb.2010.12.043; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101	53	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55703	10.1371/journal.pone.0055703	http://dx.doi.org/10.1371/journal.pone.0055703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418452	Green Published, gold			2022-12-25	WOS:000315970300043
J	Umene-Nakano, W; Kato, TA; Kikuchi, S; Tateno, M; Fujisawa, D; Hoshuyama, T; Nakamura, J				Umene-Nakano, Wakako; Kato, Takahiro A.; Kikuchi, Saya; Tateno, Masaru; Fujisawa, Daisuke; Hoshuyama, Tsutomu; Nakamura, Jun			Nationwide Survey of Work Environment, Work-Life Balance and Burnout among Psychiatrists in Japan	PLOS ONE			English	Article							MENTAL-HEALTH PROFESSIONALS; JOB-SATISFACTION; STRESS; PREDICTORS; STAFF; PHYSICIANS; CONFLICT; NURSES; CARE; SWITZERLAND	Background: Psychiatry has been consistently shown to be a profession characterised by 'high-burnout'; however, no nationwide surveys on this topic have been conducted in Japan. Aims: The objective of this study was to estimate the prevalence of burnout and to ascertain the relationship between work environment satisfaction, work-life balance satisfaction and burnout among psychiatrists working in medical schools in Japan. Method: We mailed anonymous questionnaires to all 80 psychiatry departments in medical schools throughout Japan. Work-life satisfaction, work-environment satisfaction and social support assessments, as well as the Maslach Burnout Inventory (MBI), were used. Results: Sixty psychiatric departments (75.0%) responded, and 704 psychiatrists provided answers to the assessments and MBI. Half of the respondents (n = 311, 46.0%) experienced difficulty with their work-life balance. Based on the responses to the MBI, 21.0% of the respondents had a high level of emotional exhaustion, 12.0% had a high level of depersonalisation, and 72.0% had a low level of personal accomplishment. Receiving little support, experiencing difficulty with work-life balance, and having less work-environment satisfaction were significantly associated with higher emotional exhaustion. A higher number of nights worked per month was significantly associated with higher depersonalisation. Conclusions: A low level of personal accomplishment was quite prevalent among Japanese psychiatrists compared with the results of previous studies. Poor work-life balance was related to burnout, and social support was noted to mitigate the impact of burnout.	[Umene-Nakano, Wakako; Nakamura, Jun] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan; [Kato, Takahiro A.] Kyushu Univ, Dept Neuropsychiat, Grad Sch Med Sci, Fukuoka 812, Japan; [Kato, Takahiro A.] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Kikuchi, Saya] Tohoku Univ, Grad Sch Med, Dept Psychiat, Sendai, Miyagi 980, Japan; [Tateno, Masaru] Sapporo Med Univ, Dept Neuropsychiat, Sapporo, Hokkaido, Japan; [Fujisawa, Daisuke] Natl Canc Ctr Hosp East, Psychooncol Div, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Hoshuyama, Tsutomu] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Hoshuyama, Tsutomu] Ushibuka City Hosp, Ushibuka, Amakusa, Japan	University of Occupational & Environmental Health - Japan; Kyushu University; Kyushu University; Tohoku University; Sapporo Medical University; National Cancer Center - Japan; University of Occupational & Environmental Health - Japan	Umene-Nakano, W (corresponding author), Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan.	wakako-u@med.uoeh-u.ac.jp	Fujisawa, Daisuke/AAR-5808-2021; Kato, Takahiro/R-7665-2019; kikuchi, saya/E-3755-2017	Kato, Takahiro/0000-0001-5169-2930; 				Alexander H., 2008, AAMC ANAL BRIEF, V8, P1; Allen T D, 2000, J Occup Health Psychol, V5, P278, DOI 10.1037/1076-8998.5.2.278; Asai M, 2007, PSYCHO-ONCOLOGY, V16, P421, DOI 10.1002/pon.1066; Barkil-Oteo A, 2012, LANCET, V379, P2428, DOI 10.1016/S0140-6736(12)61067-8; Bressi C, 2009, PSYCHIAT SERV, V60, P985, DOI 10.1176/appi.ps.60.7.985; Brown G T, 1992, Can J Occup Ther, V59, P258; Bryson L, 2007, SOC SCI MED, V65, P1142, DOI 10.1016/j.socscimed.2007.04.027; Bunton SA, 2012, ACAD MED, V87, P574, DOI 10.1097/ACM.0b013e31824d2b37; CHEMTOB CM, 1988, AM J PSYCHIAT, V145, P224; Chung KC, 2010, MED EDUC, V44, P985, DOI 10.1111/j.1365-2923.2010.03766.x; Dallender J, 1999, J ADV NURS, V29, P36, DOI 10.1046/j.1365-2648.1999.00858.x; Deahl M, 1997, BRIT J PSYCHIAT, V171, P6, DOI 10.1192/bjp.171.1.6; Fereday J, 2010, MIDWIFERY, V26, P311, DOI 10.1016/j.midw.2008.06.004; Fothergill A, 2004, INT J SOC PSYCHIATR, V50, P54, DOI 10.1177/0020764004040953; Fujiwara K, 2003, J OCCUP HEALTH, V45, P313, DOI 10.1539/joh.45.313; Fuyuno I, 2012, NATURE INT WEEKLY J; Garfinkel PE, 2001, CAN J PSYCHIAT, V46, P835, DOI 10.1177/070674370104600907; Hammig O, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13577; Hammig O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-435; Hammer TH, 2004, J OCCUP HEALTH PSYCH, V9, P83, DOI 10.1037/1076-8998.9.1.83; Hammig O, 2009, INT J PUBLIC HEALTH, V54, P88, DOI 10.1007/s00038-009-8031-7; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; Higashiguchi K, 1998, Nihon Eiseigaku Zasshi, V53, P447; HISCOTT RD, 1990, CAN J PUBLIC HEALTH, V81, P422; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Komaki K., 1994, JAPANESE J HLTH PSYC, V7, P2, DOI 10.11560/jahp.7.2_2; Kumar S, 2007, WORLD PSYCHIATRY, V6, P186; Kumar S, 2007, INT J SOC PSYCHIATR, V53, P306, DOI 10.1177/0020764006074534; Lasalvia A, 2009, BRIT J PSYCHIAT, V195, P537, DOI 10.1192/bjp.bp.108.060871; Leiter MP, 1996, INT J SOC PSYCHIATR, V42, P90, DOI 10.1177/002076409604200203; LOONEY JG, 1980, AM J PSYCHIAT, V137, P32; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; Montgomery D. C., 2021, INTRO LINEAR REGRESS, P12; Narumoto J, 2008, PSYCHIAT CLIN NEUROS, V62, P174, DOI 10.1111/j.1440-1819.2008.01751.x; Nomura K, 2008, J GEN INTERN MED, V23, P1105, DOI 10.1007/s11606-008-0644-7; Nomura Kyoko, 2011, Nihon Eiseigaku Zasshi, V66, P22, DOI 10.1265/jjh.66.22; PINES A, 1978, HOSP COMMUNITY PSYCH, V29, P233; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; Prosser D, 1999, SOC PSYCH PSYCH EPID, V34, P295, DOI 10.1007/s001270050147; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Sano Akira, 2009, Seishin Shinkeigaku Zasshi, V111, P1303; Sasaki M, 2009, J NURS MANAGE, V17, P359, DOI 10.1111/j.1365-2834.2008.00960.x; Shitara S, 2009, JAPANESE J ADM SCI, V22, P223; SNIBBE JR, 1989, PSYCHOL REP, V65, P775, DOI 10.2466/pr0.1989.65.3.775; Tang CS, 1998, J CLIN PSYCHOL, V54, P55, DOI 10.1002/(SICI)1097-4679(199801)54:1<55::AID-JCLP6>3.0.CO;2-T; Teo A, 2007, MED EDUC, V41, P302, DOI 10.1111/j.1365-2929.2007.02691.x; Thomsen S, 1999, PSYCHOTHER PSYCHOSOM, V68, P157, DOI 10.1159/000012325; Umene-Nakano Wakako, 2011, Seishin Shinkeigaku Zasshi, V113, P271; Webster L, 1999, ADM POLICY MENT HLTH, V26, P387, DOI 10.1023/A:1021382806009	51	44	44	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55189	10.1371/journal.pone.0055189	http://dx.doi.org/10.1371/journal.pone.0055189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418435	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300025
J	Wang, AY; Du, Y; He, QC; Zhou, CX				Wang, Anyou; Du, Ying; He, Qianchuan; Zhou, Chunxiao			A Quantitative System for Discriminating Induced Pluripotent Stem Cells, Embryonic Stem Cells and Somatic Cells	PLOS ONE			English	Article							DNA METHYLATION; MICROARRAY; NETWORKS	Induced pluripotent stem cells (iPSCs) derived from somatic cells (SCs) and embryonic stem cells (ESCs) provide promising resources for regenerative medicine and medical research, leading to a daily identification of new cell lines. However, an efficient system to discriminate the different types of cell lines is lacking. Here, we develop a quantitative system to discriminate the three cell types, iPSCs, ESCs, and SCs. The system consists of DNA-methylation biomarkers and mathematical models, including an artificial neural network and support vector machines. All biomarkers were unbiasedly selected by calculating an eigengene score derived from analysis of genome-wide DNA methylations. With 30 biomarkers, or even with as few as 3 top biomarkers, this system can discriminate SCs from pluripotent cells (PCs, including ESCs and iPSCs) with almost 100% accuracy. With approximately 100 biomarkers, the system can distinguish ESCs from iPSCs with an accuracy of 95%. This robust system performs precisely with raw data without normalization as well as with converted data in which the continuous methylation levels are accounted. Strikingly, this system can even accurately predict new samples generated from different microarray platforms and the next-generation sequencing. The subtypes of cells, such as female and male iPSCs and fetal and adult SCs, can also be discriminated with this method. Thus, this novel quantitative system works as an accurate framework for discriminating the three cell types, iPSCs, ESCs, and SCs. This strategy also supports the notion that DNA-methylation generally varies among the three cell types.	[Wang, Anyou; Du, Ying] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [He, Qianchuan] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Zhou, Chunxiao] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Wang, AY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	anyou.wang@alumni.ucr.edu	W, Andrew/ABE-8298-2020	W, Andrew/0000-0002-4981-3606; He, Qianchuan/0000-0001-7044-6591				Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; DAVIS S, 2012, METHYLUMI HANDLE ILL; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Goldman B, 2008, NATURE REPORTS STEM, DOI [10.1038/stemcells.2008.26, DOI 10.1038/STEMCELLS.2008.26]; Goldstein DR, 2002, STAT SINICA, V12, P219; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han MY, 2012, ONCOL REP, V28, P2233, DOI 10.3892/or.2012.2037; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones R, 2010, NATURE, V466, pS11, DOI 10.1038/466S11a; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Oshima Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316296; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rolston DW, 1988, PRINCIPLES ARTIFICIA; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shen RL, 2006, BIOINFORMATICS, V22, P2635, DOI 10.1093/bioinformatics/btl442; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang AY, 2011, STEM CELLS DEV, V20, P1937, DOI 10.1089/scd.2010.0574; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	31	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56095	10.1371/journal.pone.0056095	http://dx.doi.org/10.1371/journal.pone.0056095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418520	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300112
J	Agarwal, A; Boettcher, A; Kneuer, R; Sari-Sarraf, F; Donovan, A; Woelcke, J; Simic, O; Brandl, T; Krucker, T				Agarwal, Abhiruchi; Boettcher, Andreas; Kneuer, Rainer; Sari-Sarraf, Farid; Donovan, Adriana; Woelcke, Julian; Simic, Oliver; Brandl, Trixi; Krucker, Thomas			In Vivo Imaging with Fluorescent Smart Probes to Assess Treatment Strategies for Acute Pancreatitis	PLOS ONE			English	Article							IDIOPATHIC CHRONIC-PANCREATITIS; HUMAN CATHEPSIN-L; HEREDITARY PANCREATITIS; TRYPSINOGEN; SECRETAGOGUE; MUTATIONS; MICE; ACTIVATION; DIAGNOSIS; TUMORS	Background and Aims: Endoprotease activation is a key step in acute pancreatitis and early inhibition of these enzymes may protect from organ damage. In vivo models commonly used to evaluate protease inhibitors require animal sacrifice and therefore limit the assessment of dynamic processes. Here, we established a non-invasive fluorescence imaging-based biomarker assay to assess real-time protease inhibition and disease progression in a preclinical model of experimental pancreatitis. Methods: Edema development and trypsin activation were imaged in a rat caerulein-injection pancreatitis model. A fluorescent "smart'' probe, selectively activated by trypsin, was synthesized by labeling with Cy5.5 of a pegylated poly-L-lysine copolymer. Following injection of the probe, trypsin activation was monitored in the presence or absence of inhibitors by in vivo and ex vivo imaging. Results: We established the trypsin-selectivity of the fluorescent probe in vitro using a panel of endopeptidases and specific inhibitor. In vivo, the probe accumulated in the liver and a region attributed to the pancreas by necropsy. A dose dependent decrease of total pancreatic fluorescence signal occurred upon administration of known trypsin inhibitors. The fluorescence-based method was a better predictor of trypsin inhibition than pancreatic to body weight ratio. Conclusions: We established a fluorescence imaging assay to access trypsin inhibition in real-time in vivo. This method is more sensitive and dynamic than classic tissue sample readouts and could be applied to preclinically optimize trypsin inhibitors towards intrapancreatic target inhibition.	[Agarwal, Abhiruchi; Sari-Sarraf, Farid; Donovan, Adriana; Krucker, Thomas] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Boettcher, Andreas; Kneuer, Rainer; Woelcke, Julian; Simic, Oliver; Brandl, Trixi] Novartis Inst BioMed Res, Basel, Switzerland; [Krucker, Thomas] Novartis Inst BioMed Res, Emeryville, CA USA	Novartis; Novartis; Novartis	Krucker, T (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	thomas.krucker@novartis.com			Novartis organization	Novartis organization	Funding of this research was provided solely within the Novartis organization as per standard research activities. The funders (NIBR) had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was assessed by the Novartis legal department as well as senior management in chemistry and biology (Infectious diseases and Center for Proteomic Chemistry) to ascertain that release of this manuscript did not contravene Novartis policy regarding release of proprietary information, but this was limited only to approval for release of the material and was not related to the results or interpretations/conclusions contained in the manuscript.	Bhoomagoud M, 2009, GASTROENTEROLOGY, V137, P1083, DOI 10.1053/j.gastro.2009.05.041; Bouchard MB, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799188; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Carroll JK, 2007, AM FAM PHYSICIAN, V75, P1513; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; Chen CC, 2007, J PANCREAS, V8, P488; Festugato M, 2008, J PANCREAS, V9, P275; Fujishima A, 1997, FEBS LETT, V407, P47, DOI 10.1016/S0014-5793(97)00216-0; Hohenblum H, 2004, J BIOTECHNOL, V109, P3, DOI 10.1016/j.jbiotec.2003.10.022; Ishikura H, 2007, LIFE SCI, V80, P1999, DOI 10.1016/j.lfs.2007.02.044; Kobayashi H, 2011, ACCOUNTS CHEM RES, V44, P83, DOI 10.1021/ar1000633; Kobayashi H, 2010, LANCET ONCOL, V11, P589, DOI 10.1016/S1470-2045(10)70009-7; Kylanpaa-Back Marja Leena, 2002, JOP, V3, P34; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Law B, 2004, CHEM BIOL, V11, P99, DOI 10.1016/j.chembiol.2003.12.017; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Levenson RM, 2008, ILAR J, V49, P78, DOI 10.1093/ilar.49.1.78; Mansfield JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032458; Marten K, 2002, GASTROENTEROLOGY, V122, P406, DOI 10.1053/gast.2002.30990; Masson E, 2008, CLIN GASTROENTEROL H, V6, P82, DOI 10.1016/j.cgh.2007.10.004; Nomura T, 1997, BIOCHEM BIOPH RES CO, V230, P143, DOI 10.1006/bbrc.1996.5905; Nomura T, 1996, BIOCHEM BIOPH RES CO, V228, P792, DOI 10.1006/bbrc.1996.1733; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Rickes S, 2009, POSTGRAD MED J, V85, P208, DOI 10.1136/pgmj.2008.070615; Sah RP, 2011, GUT; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Schneider A, 2004, SCAND J GASTROENTERO, V39, P903, DOI 10.1080/00365520410006710; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; Spanier BWM, 2008, BEST PRACT RES CL GA, V22, P45, DOI 10.1016/j.bpg.2007.10.007; SWEIRY JH, 1991, AM J PHYSIOL, V261, pG685, DOI 10.1152/ajpgi.1991.261.4.G685; TANI S, 1987, INT J PANCREATOL, V2, P337; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Tung CH, 1999, BIOCONJUGATE CHEM, V10, P892, DOI 10.1021/bc990052h; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; Van Acker GJD, 2007, AM J PHYSIOL-GASTR L, V292, pG1738, DOI 10.1152/ajpgi.00543.2006; Warzecha Z, 2010, J PHYSIOL PHARMACOL, V61, P419; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; WISNER JR, 1989, INT J PANCREATOL, V4, P383	43	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55959	10.1371/journal.pone.0055959	http://dx.doi.org/10.1371/journal.pone.0055959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409095	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000034
J	Cao, GJ; Meng, JH; Strain, E; Stones, R; Pettengill, J; Zhao, SH; McDermott, P; Brown, E; Allard, M				Cao, Guojie; Meng, Jianghong; Strain, Errol; Stones, Robert; Pettengill, James; Zhao, Shaohua; McDermott, Patrick; Brown, Eric; Allard, Marc			Phylogenetics and Differentiation of Salmonella Newport Lineages by Whole Genome Sequencing	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; FIELD GEL-ELECTROPHORESIS; ESCHERICHIA-COLI; POSITIVE SELECTION; ENTERICA; RECOMBINATION; EVOLUTION; CRISPR; ALIGNMENT; STRAINS	Salmonella Newport has ranked in the top three Salmonella serotypes associated with foodborne outbreaks from 1995 to 2011 in the United States. In the current study, we selected 26 S. Newport strains isolated from diverse sources and geographic locations and then conducted 454 shotgun pyrosequencing procedures to obtain 16-24 x coverage of high quality draft genomes for each strain. Comparative genomic analysis of 28 S. Newport strains (including 2 reference genomes) and 15 outgroup genomes identified more than 140,000 informative SNPs. A resulting phylogenetic tree consisted of four sublineages and indicated that S. Newport had a clear geographic structure. Strains from Asia were divergent from those from the Americas. Our findings demonstrated that analysis using whole genome sequencing data resulted in a more accurate picture of phylogeny compared to that using single genes or small sets of genes. We selected loci around the mutS gene of S. Newport to differentiate distinct lineages, including those between invH and mutS genes at the 39 end of Salmonella Pathogenicity Island 1 (SPI-1), ste fimbrial operon, and Clustered, Regularly Interspaced, Short Palindromic Repeats (CRISPR) associated-proteins (cas). These genes in the outgroup genomes held high similarity with either S. Newport Lineage II or III at the same loci. S. Newport Lineages II and III have different evolutionary histories in this region and our data demonstrated genetic flow and homologous recombination events around mutS. The findings suggested that S. Newport Lineages II and III diverged early in the serotype evolution and have evolved largely independently. Moreover, we identified genes that could delineate sublineages within the phylogenetic tree and that could be used as potential biomarkers for trace-back investigations during outbreaks. Thus, whole genome sequencing data enabled us to better understand the genetic background of pathogenicity and evolutionary history of S. Newport and also provided additional markers for epidemiological response.	[Cao, Guojie; Meng, Jianghong] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Strain, Errol] US FDA, Biostat Branch, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Stones, Robert] Food & Environm Res Agcy, York, N Yorkshire, England; [Pettengill, James; Brown, Eric; Allard, Marc] US FDA, Div Microbiol, Off Regular Sci, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Zhao, Shaohua; McDermott, Patrick] US FDA, Div Anim & Food Microbiol, Res Off, Ctr Vet Med, Laurel, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); Food & Environment Research Agency; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Allard, M (corresponding author), US FDA, Div Microbiol, Off Regular Sci, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	marc.allard@fda.hhs.gov	McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096	U.S. Food and Drug Administration	U.S. Food and Drug Administration	Research funds were provided by the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; [Anonymous], 2007, ANTIGENIC FORMULAE S; Attorney S, 2011, SPROUT SALMONELLA NE; Attorney S, 2009, MULTISTATE SALMONELL; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bell RL, 2012, SALMONELLA IN PRESS; BELTRAN P, 1988, P NATL ACAD SCI USA, V85, P7753, DOI 10.1073/pnas.85.20.7753; Brown EW, 2003, P NATL ACAD SCI USA, V100, P15676, DOI 10.1073/pnas.2634406100; Brown EW, 2002, MOL PHYLOGENET EVOL, V24, P102, DOI 10.1016/S1055-7903(02)00222-1; *CDC, 2010, INV UPD MULT OUTBR H; *CDC, 2006, SALM SURV ANN SUMM; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; Harbottle H, 2006, J CLIN MICROBIOL, V44, P2449, DOI 10.1128/JCM.00019-06; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Lama A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034037; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Maki DG, 2009, NEW ENGL J MED, V360, P949, DOI 10.1056/NEJMp0806575; Matsumura K, 2011, BIOCONTROL SCI, V16, P69, DOI 10.4265/bio.16.69; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Orsi RH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-233; Osborne SE, 2012, J BIOL CHEM; Park AK, 2010, FEMS MICROBIOL LETT, V309, P151, DOI 10.1111/j.1574-6968.2010.02031.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Porwollik S, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P1; Sangal V, 2010, J BACTERIOL, V192, P6465, DOI 10.1128/JB.00969-10; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SELANDER RK, 1990, INFECT IMMUN, V58, P2262, DOI 10.1128/IAI.58.7.2262-2275.1990; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torpdahl M, 2005, J MICROBIOL METH, V63, P173, DOI 10.1016/j.mimet.2005.03.006; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yamasaki S, 2011, J ANTIBIOT, V64, P433, DOI 10.1038/ja.2011.28	62	48	48	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55687	10.1371/journal.pone.0055687	http://dx.doi.org/10.1371/journal.pone.0055687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409020	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000020
J	Esse, R; Rocha, MS; Barroso, M; Florindo, C; Teerlink, T; Kok, RM; Smulders, YM; Rivera, I; Leandro, P; Koolwijk, P; Castro, R; Blom, HJ; de Almeida, IT				Esse, Ruben; Rocha, Monica S.; Barroso, Madalena; Florindo, Cristina; Teerlink, Tom; Kok, Robert M.; Smulders, Yvo M.; Rivera, Isabel; Leandro, Paula; Koolwijk, Pieter; Castro, Rita; Blom, Henk J.; de Almeida, Isabel Tavares			Protein Arginine Methylation Is More Prone to Inhibition by S-Adenosylhomocysteine than DNA Methylation in Vascular Endothelial Cells	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; HOMOCYSTEINE; PLASMA; ADENOSYLMETHIONINE; METABOLISM; SYNTHASE; HYPOMETHYLATION; IDENTIFICATION; MECHANISM; INCREASE	Methyltransferases use S-adenosylmethionine (AdoMet) as methyl group donor, forming S-adenosylhomocysteine (AdoHcy) and methylated substrates, including DNA and proteins. AdoHcy inhibits most methyltransferases. Accumulation of intracellular AdoHcy secondary to Hcy elevation elicits global DNA hypomethylation. We aimed at determining the extent at which protein arginine methylation status is affected by accumulation of intracellular AdoHcy. AdoHcy accumulation in human umbilical vein endothelial cells was induced by inhibition of AdoHcy hydrolase by adenosine-2,3-dialdehyde (AdOx). As a measure of protein arginine methylation status, the levels of monomethylarginine (MMA) and asymmetric and symmetric dimethylated arginine residues (ADMA and SDMA, respectively) in cell protein hydrolysates were measured by HPLC. A 10% decrease was observed at a 2.5-fold increase of intracellular AdoHcy. Western blotting revealed that the translational levels of the main enzymes catalyzing protein arginine methylation, protein arginine methyl transferases (PRMTs) 1 and 5, were not affected by AdoHcy accumulation. Global DNA methylation status was evaluated by measuring 5-methylcytosine and total cytosine concentrations in DNA hydrolysates by LC-MS/MS. DNA methylation decreased by 10% only when intracellular AdoHcy concentration accumulated to 6-fold of its basal value. In conclusion, our results indicate that protein arginine methylation is more sensitive to AdoHcy accumulation than DNA methylation, pinpointing a possible new player in methylation-related pathology.	[Esse, Ruben; Rocha, Monica S.; Barroso, Madalena; Florindo, Cristina; Rivera, Isabel; Leandro, Paula; Castro, Rita; de Almeida, Isabel Tavares] Univ Lisbon, Fac Pharm, Inst Med & Pharmaceut Sci IMed UL, P-1699 Lisbon, Portugal; [Esse, Ruben; Rocha, Monica S.; Teerlink, Tom; Kok, Robert M.; Blom, Henk J.] Vrije Univ Amsterdam, Med Ctr, Metab Unit, Dept Clin Chem, Amsterdam, Netherlands; [Teerlink, Tom; Smulders, Yvo M.; Koolwijk, Pieter; Blom, Henk J.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands; [Smulders, Yvo M.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Rivera, Isabel; Leandro, Paula; Castro, Rita; de Almeida, Isabel Tavares] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal; [Koolwijk, Pieter] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Amsterdam, Netherlands	Universidade de Lisboa; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Universidade de Lisboa; Vrije Universiteit Amsterdam	de Almeida, IT (corresponding author), Univ Lisbon, Fac Pharm, Inst Med & Pharmaceut Sci IMed UL, P-1699 Lisbon, Portugal.	italmeida@ff.ul.pt	Rivera, Isabel/A-5863-2014; Leandro, Paula/A-8323-2014; Rivera, Isabel/AAS-3204-2021; Smulders, YM/AAG-7506-2021; de Almeida, Isabel Tavares/F-8319-2014; Castro, Rita/J-7672-2019; Barroso, Madalena/AAT-9916-2020; iMed.ULisboa, MetGen/B-5293-2014	Rivera, Isabel/0000-0001-6892-729X; Leandro, Paula/0000-0002-2946-9342; Rivera, Isabel/0000-0001-6892-729X; Castro, Rita/0000-0002-4585-0741; Barroso, Madalena/0000-0002-1600-890X; , Ruben/0000-0002-8381-0628; Blom, Henk/0000-0001-5202-9241; Florindo, Cristina/0000-0002-0664-5411; Tavares de Almeida, Isabel/0000-0002-4024-8305	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/SAU-ORG/112683/2009, SFRH/BD/48585/2008, SFRH/BD/41970/2007]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (grants PTDC/SAU-ORG/112683/2009 to RC, SFRH/BD/48585/2008 to RE, SFRH/BD/41970/2007 to MSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Blom HJ, 2011, J INHERIT METAB DIS, V34, P75, DOI 10.1007/s10545-010-9177-4; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Boger RH, 2000, ARTERIOSCL THROM VAS, V20, P1557, DOI 10.1161/01.ATV.20.6.1557; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Castro R, 2005, J MOL MED, V83, P831, DOI 10.1007/s00109-005-0679-8; Choumenkovitch SF, 2002, J NUTR, V132, P2157, DOI 10.1093/jn/132.8.2157; Clarke R, 2011, J INHERIT METAB DIS, V34, P83, DOI 10.1007/s10545-010-9235-y; Clarke S., 2011, HOMOCYSTEINE HLTH DI, P63; de Jong S, 2006, ANAL BIOCHEM, V353, P287, DOI 10.1016/j.ab.2006.03.010; Fickling SA, 1993, ENDOTHELIUM, V1, P137; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Flynn J, 1998, BIOCHEMISTRY-US, V37, P15162, DOI 10.1021/bi9810609; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Green TJ, 2010, BRIT J NUTR, V103, P1629, DOI 10.1017/S0007114509993552; Grillo MA, 2008, AMINO ACIDS, V34, P187, DOI 10.1007/s00726-007-0500-9; Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Kielstein JT, 2008, KIDNEY BLOOD PRESS R, V31, P259, DOI 10.1159/000142725; Kok RM, 2007, CLIN CHEM LAB MED, V45, P903, DOI 10.1515/CCLM.2007.137; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Menon V, 2006, CIRCULATION, V113, P1572, DOI 10.1161/CIRCULATIONAHA.105.570127; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rocha MS, 2010, CLIN CHEM LAB MED, V48, P1793, DOI 10.1515/CCLM.2010.346; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Struys EA, 2000, CLIN CHEM, V46, P1650; Teerlink T, 2007, J CHROMATOGR B, V851, P21, DOI 10.1016/j.jchromb.2006.07.024; UELAND PM, 1982, PHARMACOL REV, V34, P223; vanderMolen EF, 1997, THROMB HAEMOSTASIS, V78, P827; Wagner C, 2007, AM J CLIN NUTR, V86, P1581; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	40	16	17	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55483	10.1371/journal.pone.0055483	http://dx.doi.org/10.1371/journal.pone.0055483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408989	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300018
J	Mori, T; Koyama, N; Guillot-Sestier, MV; Tan, J; Town, T				Mori, Takashi; Koyama, Naoki; Guillot-Sestier, Marie-Victoire; Tan, Jun; Town, Terrence			Ferulic Acid Is a Nutraceutical beta-Secretase Modulator That Improves Behavioral Impairment and Alzheimer-like Pathology in Transgenic Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MOUSE MODEL; OXIDATIVE STRESS; A-BETA; COGNITIVE IMPAIRMENT; CEREBRAL AMYLOIDOSIS; ASPARTYL PROTEASE; MEMORY DEFICITS; IN-VITRO; DISEASE	Amyloid precursor protein (APP) proteolysis is required for production of amyloid-beta (A beta) peptides that comprise beta-amyloid plaques in brains of Alzheimer's disease (AD) patients. Recent AD therapeutic interest has been directed toward a group of anti-amyloidogenic compounds extracted from plants. We orally administered the brain penetrant, small molecule phenolic compound ferulic acid (FA) to the transgenic PSAPP mouse model of cerebral amyloidosis (bearing mutant human APP and presenilin-1 transgenes) and evaluated behavioral impairment and AD-like pathology. Oral FA treatment for 6 months reversed transgene-associated behavioral deficits including defective: hyperactivity, object recognition, and spatial working and reference memory, but did not alter wild-type mouse behavior. Furthermore, brain parenchymal and cerebral vascular beta-amyloid deposits as well as abundance of various A beta species including oligomers were decreased in FA-treated PSAPP mice. These effects occurred with decreased cleavage of the beta-carboxyl-terminal APP fragment, reduced beta-site APP cleaving enzyme 1 protein stability and activity, attenuated neuroinflammation, and stabilized oxidative stress. As in vitro validation, we treated well-characterized mutant human APP-overexpressing murine neuron-like cells with FA and found significantly decreased A beta production and reduced amyloidogenic APP proteolysis. Collectively, these results highlight that FA is a beta-secretase modulator with therapeutic potential against AD.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr & Univ, Dept Biomed Sci, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Ctr & Univ, Dept Pathol, Kawagoe, Saitama, Japan; [Guillot-Sestier, Marie-Victoire; Town, Terrence] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Neuroimmunol Lab, Tampa, FL USA; [Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Neural Program, Los Angeles, CA 90048 USA; [Town, Terrence] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Saitama Medical University; Saitama Medical University; Cedars Sinai Medical Center; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Biomed Sci, Kawagoe, Saitama, Japan.	t_mori@saitama-med.ac.jp; terrence.town@csmc.edu		Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114	National Institute of Neurological Disorders and Stroke [5R00AG029726-04, 3R00AG029726-04S1, 1R01NS076794-01]; Japan Society for the Promotion of Science [22500320]; Alzheimer's Association Zenith Fellows Award [ZEN-10-174633]; American Federation of Aging Research/Ellison, and Medical Foundation Julie Martin Mid-Career Award in Aging Research [M11472]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032432, R00AG029726] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association Zenith Fellows Award(Alzheimer's Association); American Federation of Aging Research/Ellison, and Medical Foundation Julie Martin Mid-Career Award in Aging Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute of Neurological Disorders and Stroke(5R00AG029726-04, 3R00AG029726-04S1, and 1R01NS076794-01) to T. T., Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (22500320) to T. M., Alzheimer's Association Zenith Fellows Award (ZEN-10-174633) to T. T., and an American Federation of Aging Research/Ellison, and Medical Foundation Julie Martin Mid-Career Award in Aging Research (M11472) to T. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Breitner J, 2007, AM J MED, V120, pE3, DOI 10.1016/j.amjmed.2006.09.022; Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U; Cheng CY, 2008, BRAIN RES, V1209, P136, DOI 10.1016/j.brainres.2008.02.090; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Georgiou NA, 2011, EUR J PHARMACOL, V651, P1, DOI 10.1016/j.ejphar.2010.11.007; Goldsbury C, 2008, AGING CELL, V7, P771, DOI 10.1111/j.1474-9726.2008.00423.x; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Kawabata K, 2000, CANCER LETT, V157, P15, DOI 10.1016/S0304-3835(00)00461-4; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Koh PO, 2012, NEUROSCI LETT, V507, P156, DOI 10.1016/j.neulet.2011.12.012; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Laghmouch A, 1997, BEHAV GENET, V27, P67, DOI 10.1023/A:1025667426222; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Montine TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009340; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Qin J, 2008, DRUG DEV IND PHARM, V34, P602, DOI [10.1080/03639040701833559, 10.1080/03639040701833559 ]; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tan J, 2000, J NEUROSCI, V20, P7587; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083; Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011	84	119	125	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55774	10.1371/journal.pone.0055774	http://dx.doi.org/10.1371/journal.pone.0055774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409038	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300033
J	Chakrabarti, M; Banik, NL; Ray, SK				Chakrabarti, Mrinmay; Banik, Naren L.; Ray, Swapan K.			Photofrin Based Photodynamic Therapy and miR-99a Transfection Inhibited FGFR3 and PI3K/Akt Signaling Mechanisms to Control Growth of Human Glioblastoma In Vitro and In Vivo	PLOS ONE			English	Article							MALIGNANT BRAIN-TUMORS; ANTITUMOR IMMUNITY; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GLIOMA-CELLS; HUMAN CANCER; MICRORNAS; APOPTOSIS; SURVIVAL; RADIOTHERAPY	Glioblastoma is the most common malignant brain tumor in humans. We explored the molecular mechanisms how the efficacy of photofrin based photodynamic therapy (PDT) was enhanced by miR-99a transfection in human glioblastoma cells. Our results showed almost similar uptake of photofrin after 24 h in different glioblastoma cells, but p53 wild-type cells were more sensitive to radiation and photofrin doses than p53 mutant cells. Photofrin based PDT induced apoptosis, inhibited cell invasion, prevented angiogenic network formation, and promoted DNA fragmentation and laddering in U87MG and U118MG cells harvoring p53 wild-type. Western blotting showed that photofrin based PDT was efficient to block the angiogenesis and cell survival pathways. Further, photofrin based PDT followed by miR-99a transfection dramatically increased miR-99a expression and also increased apoptosis in glioblastoma cell cultures and drastically reduced tumor growth in athymic nude mice, due to down regulation of fibroblast growth factor receptor 3 (FGFR3) and PI3K/Akt signaling mechanisms leading to inhibition of cell proliferation and induction of molecular mechanisms of apoptosis. Therefore, our results indicated that the anti-tumor effects of photofrin based PDT was strongly augmented by miR-99a overexpression and this novel combination therapeutic strategy could be used for controlling growth of human p53 wildtype glioblastomas both in vitro and in vivo.	[Chakrabarti, Mrinmay; Ray, Swapan K.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Banik, Naren L.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Ray, SK (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	swapan.ray@uscmed.sc.edu	CHAKRABARTI, MRINMAY/M-5652-2019					Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Au CM, 2006, J PHOTOCH PHOTOBIO B, V85, P92, DOI 10.1016/j.jphotobiol.2006.06.002; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eljamel MS, 2008, LASER MED SCI, V23, P361, DOI 10.1007/s10103-007-0494-2; Eljamel MS, 2003, TECHNOL CANCER RES T, V2, P303, DOI 10.1177/153303460300200404; Eljamel S, 2010, PHOTODIAGN PHOTODYN, V7, P76, DOI 10.1016/j.pdpdt.2010.02.002; Engbrecht BW, 1999, CANCER RES, V59, P4334; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gollnick SO, 2010, IMMUNOL RES, V46, P216, DOI 10.1007/s12026-009-8119-4; Goodell T T, 2001, J Neurosci Nurs, V33, P296; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gupta AK, 2002, CLIN CANCER RES, V8, P885; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hirschberg H, 2008, LASER SURG MED, V40, P535, DOI 10.1002/lsm.20670; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; Karmakar S, 2008, CANCER, V112, P596, DOI 10.1002/cncr.23223; Karmakar Surajit, 2010, J Cancer Sci Ther, V2, P107; Krishnamurthy S, 2000, LASER SURG MED, V27, P224, DOI 10.1002/1096-9101(2000)27:3<224::AID-LSM4>3.0.CO;2-#; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Marcu LG, 2010, CANCER TREAT REV, V36, P606, DOI 10.1016/j.ctrv.2010.04.004; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; O'Gorman DM, 2001, LEUKEMIA, V15, P21, DOI 10.1038/sj.leu.2401998; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stylli SS, 2004, J CLIN NEUROSCI, V11, P584, DOI 10.1016/j.jocn.2004.02.001; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yang VXD, 2003, LASER SURG MED, V32, P224, DOI 10.1002/lsm.10131; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zimmermann A, 2001, PHOTOCHEM PHOTOBIOL, V74, P611, DOI 10.1562/0031-8655(2001)074<0611:MMPDOM>2.0.CO;2	54	41	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55652	10.1371/journal.pone.0055652	http://dx.doi.org/10.1371/journal.pone.0055652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409016	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200048
J	Laperchia, C; Mascaro, ALA; Sacconi, L; Andrioli, A; Matte, A; De Franceschi, L; Grassi-Zucconi, G; Bentivoglio, M; Buffelli, M; Pavone, FS				Laperchia, Claudia; Mascaro, Anna L. Allegra; Sacconi, Leonardo; Andrioli, Anna; Matte, Alessandro; De Franceschi, Lucia; Grassi-Zucconi, Gigliola; Bentivoglio, Marina; Buffelli, Mario; Pavone, Francesco S.			Two-Photon Microscopy Imaging of thy1GFP-M Transgenic Mice: A Novel Animal Model to Investigate Brain Dendritic Cell Subsets In Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHOROID-PLEXUS; FLUORESCENT PROTEIN; CRANIAL WINDOW; LONG-TERM; MACROPHAGES; NEOCORTEX; MENINGES; MARKER	Transgenic mice expressing fluorescent proteins in specific cell populations are widely used for in vivo brain studies with two-photon fluorescence (TPF) microscopy. Mice of the thy1GFP-M line have been engineered for selective expression of green fluorescent protein (GFP) in neuronal populations. Here, we report that TPF microscopy reveals, at the brain surface of these mice, also motile non-neuronal GFP+ cells. We have analyzed the behavior of these cells in vivo and characterized in brain sections their immunophenotype. With TPF imaging, motile GFP+ cells were found in the meninges, subarachnoid space and upper cortical layers. The striking feature of these cells was their ability to move across the brain parenchyma, exhibiting evident shape changes during their scanning-like motion. In brain sections, GFP+ cells were immunonegative to antigens recognizing motile cells such as migratory neuroblasts, neuronal and glial precursors, mast cells, and fibroblasts. GFP+ non-neuronal cells exhibited instead the characteristic features and immunophenotype (CD11c and major histocompatibility complex molecule class II immunopositivity) of dendritic cells (DCs), and were immunonegative to the microglial marker Iba-1. GFP+ cells were also identified in lymph nodes and blood of thy1GFP-M mice, supporting their identity as DCs. Thus, TPF microscopy has here allowed the visualization for the first time of the motile behavior of brain DCs in situ. The results indicate that the thy1GFP-M mouse line provides a novel animal model for the study of subsets of these professional antigen-presenting cells in the brain. Information on brain DCs is still very limited and imaging in thy1GFP-M mice has a great potential for analyses of DC-neuron interaction in normal and pathological conditions.	[Laperchia, Claudia; Andrioli, Anna; Grassi-Zucconi, Gigliola; Bentivoglio, Marina; Buffelli, Mario] Univ Verona, Dept Neurol Sci, I-37100 Verona, Italy; [Laperchia, Claudia; Andrioli, Anna; Grassi-Zucconi, Gigliola; Bentivoglio, Marina; Buffelli, Mario] Natl Inst Neurosci, Verona, Italy; [Mascaro, Anna L. Allegra; Sacconi, Leonardo; Pavone, Francesco S.] Univ Florence, European Lab Nonlinear Spect, Sesto Fiorentino, Italy; [Sacconi, Leonardo; Pavone, Francesco S.] CNR, Natl Inst Opt, Florence, Italy; [Matte, Alessandro; De Franceschi, Lucia] Univ Verona, Dept Med, I-37100 Verona, Italy; [Buffelli, Mario] Univ Verona, Ctr Biomed Comp, I-37100 Verona, Italy; [Pavone, Francesco S.] Univ Florence, Dept Phys, Sesto Fiorentino, Italy; [Pavone, Francesco S.] Int Ctr Computat Neurophoton, Sesto Fiorentino, Italy	University of Verona; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Verona; University of Verona; University of Florence	Buffelli, M (corresponding author), Univ Verona, Dept Neurol Sci, I-37100 Verona, Italy.	mario.buffelli@univr.it	pavone, francesco s/F-4945-2015; DE FRANCESCHI, Lucia/AAB-8652-2022; Bentivoglio, Marina/K-1008-2016; Matte, Alessandro/AAB-3496-2022; Sacconi, Leonardo/B-8904-2015; ALLEGRA MASCARO, ANNA LETIZIA/L-3229-2018; Buffelli, Mario/C-6953-2018	DE FRANCESCHI, Lucia/0000-0001-7093-777X; Bentivoglio, Marina/0000-0003-4958-9795; Sacconi, Leonardo/0000-0002-9320-5085; ALLEGRA MASCARO, ANNA LETIZIA/0000-0002-8489-0076; Buffelli, Mario/0000-0002-3709-013X; pavone, francesco saverio/0000-0002-0675-3981	University of Verona; Fondazione Cariverona; Verona Nanomedicine Initiative; European Union [228334]; Human Frontier Science Program Research Grant [RGP0027/2009]; Ente Cassa di Risparmio di Firenze; Flagship Nanomax Project	University of Verona; Fondazione Cariverona(Fondazione Cariverona); Verona Nanomedicine Initiative; European Union(European Commission); Human Frontier Science Program Research Grant(Human Frontier Science Program); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Flagship Nanomax Project	This work was supported by funds of University of Verona, "Fondazione Cariverona" project 2007 and "Verona Nanomedicine Initiative". The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 228334. This research project was also supported by Human Frontier Science Program Research Grant RGP0027/2009, by the "Ente Cassa di Risparmio di Firenze" and the Flagship Nanomax Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra Mascaro AL, 2010, FRONT NEUROENERGETIC, P2; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bobryshev YV, 2010, LAB INVEST, V90, P970, DOI 10.1038/labinvest.2010.94; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Comabella M, 2010, NAT REV NEUROL, V6, P499, DOI 10.1038/nrneurol.2010.112; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gommet C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001421; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Ishifune C, 2011, EUR J IMMUNOL, V41, P1309, DOI 10.1002/eji.201041159; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Lai L, 1998, J IMMUNOL, V160, P3861; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matyszak MK, 1996, NEUROSCIENCE, V74, P599, DOI 10.1016/0306-4522(96)00160-1; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; McMenamin PG, 2003, CELL TISSUE RES, V313, P259, DOI 10.1007/s00441-003-0779-0; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pashenkov M, 2002, TRENDS IMMUNOL, V23, P69, DOI 10.1016/S1471-4906(01)02114-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peters JH, 1996, IMMUNOL TODAY, V17, P273, DOI 10.1016/0167-5699(96)80544-5; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Sacconi L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798723; Sagar D, 2012, J NEUROIMMUNE PHARM, V7, P74, DOI 10.1007/s11481-011-9302-7; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Sigler A, 2010, STROKE, V41, pS117, DOI 10.1161/STROKEAHA.110.594648; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; VIDAL J, 1994, J GEN PSYCHOL, V121, P85, DOI 10.1080/00221309.1994.9711175; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	46	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56144	10.1371/journal.pone.0056144	http://dx.doi.org/10.1371/journal.pone.0056144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409142	gold, Green Submitted, Green Published			2022-12-25	WOS:000315157200116
J	Marchocki, Z; Collins, K; Lehane, E; O' Reilly, P; O'Donoghue, K				Marchocki, Zbigniew; Collins, Kevin; Lehane, Eimear; O' Reilly, Paddy; O'Donoghue, Keelin			Staphylococcus lugdunensis Cultured from the Amniotic Fluid at Caesarean Section	PLOS ONE			English	Article								Staphylococcus lugdunensis is a virulent coagulase-negative staphylococcus. It behaves like and can be mistaken in culture for Staphylococcus aureus. While originally thought to be a skin commensal rarely responsible for opportunistic infection, it was rapidly established as a significant human pathogen. It has been mainly associated with native and prosthetic valve endocarditis, osteomyelitis, and skin and soft tissue cellulitis, but has also been reported as a cause of fasciitis as well as peritonitis. Staphylococcus lugdunensis has been reported as a cause of endometritis but has not been previously isolated from amniotic fluid. Here, amniotic fluid samples were collected in the course of a larger study on amniotic fluid bacteriology, with prior ethical approval and informed patient consent. Amniotic fluid was obtained at Caesarean Section by direct needle aspiration from the intact amnion. Analysis with Staphylococcal API test kits led to identification of Staphylococcus lugdunensis in two cases. The clinical significance of the finding in these reported cases is undetermined. Staphylococcus lugdunensis has been shown to be a cause of serious and potentially fatal morbidities, but this is the first report of its culture from amniotic fluid. As caesarean delivery is accepted as the single most important factor associated with post-partum infectious complications in both mother and neonate, the identification of this pathogen is a new concern.	[Marchocki, Zbigniew; O'Donoghue, Keelin] Natl Univ Ireland Univ Coll Cork, Cork Univ Matern Hosp, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland; [Collins, Kevin; Lehane, Eimear; O' Reilly, Paddy] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland	University College Cork; University College Cork	O'Donoghue, K (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork Univ Matern Hosp, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland.	k.odonoghue@ucc.ie		O'Donoghue, Keelin/0000-0002-4616-2887				Babu E, 2011, EXPERT REV ANTI-INFE, V9, P901, DOI [10.1586/eri.11.110, 10.1586/ERI.11.110]; Bello C, 2007, West Afr J Med, V26, P243; Bouziri Asma, 2011, Tunis Med, V89, P206; Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; FRENEY J, 1988, INT J SYST BACTERIOL, V38, P168, DOI 10.1099/00207713-38-2-168; Harris JW, 1927, AM J OBSTET GYNECOL, V13, P133, DOI 10.1016/S0002-9378(27)90506-7; Hung T, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/453685; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P193, DOI 10.1111/j.1471-0528.2010.02729.x; National Institute for Clinical Excellence, 2011, NICE CLIN GUID; Shaaban HS, 2011, J GLOB INFECT DIS, V3, P101, DOI 10.4103/0974-777X.77311; van der Mee-Marquet N, 2003, J CLIN MICROBIOL, V41, P1404, DOI 10.1128/JCM.41.4.1404-1409.2003	11	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56373	10.1371/journal.pone.0056373	http://dx.doi.org/10.1371/journal.pone.0056373			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409177	gold, Green Submitted, Green Published			2022-12-25	WOS:000315157200134
J	van der Hoek, Y; Renfrew, R; Manne, LL				van der Hoek, Yntze; Renfrew, Rosalind; Manne, Lisa L.			Assessing Regional and Interspecific Variation in Threshold Responses of Forest Breeding Birds through Broad Scale Analyses	PLOS ONE			English	Article							HABITAT FRAGMENTATION; EXTINCTION THRESHOLDS; SPATIAL AUTOCORRELATION; ECOLOGICAL THRESHOLDS; RELATIVE IMPORTANCE; SPECIES RESPONSES; LANDSCAPE; MANAGEMENT; OCCUPANCY; COVER	Background: Identifying persistence and extinction thresholds in species-habitat relationships is a major focal point of ecological research and conservation. However, one major concern regarding the incorporation of threshold analyses in conservation is the lack of knowledge on the generality and transferability of results across species and regions. We present a multi-region, multi-species approach of modeling threshold responses, which we use to investigate whether threshold effects are similar across species and regions. Methodology/Principal Findings: We modeled local persistence and extinction dynamics of 25 forest-associated breeding birds based on detection/non-detection data, which were derived from repeated breeding bird atlases for the state of Vermont. We did not find threshold responses to be particularly well-supported, with 9 species supporting extinction thresholds and 5 supporting persistence thresholds. This contrasts with a previous study based on breeding bird atlas data from adjacent New York State, which showed that most species support persistence and extinction threshold models (15 and 22 of 25 study species respectively). In addition, species that supported a threshold model in both states had associated average threshold estimates of 61.41% (SE = 6.11, persistence) and 66.45% (SE = 9.15, extinction) in New York, compared to 51.08% (SE = 10.60, persistence) and 73.67% (SE = 5.70, extinction) in Vermont. Across species, thresholds were found at 19.45-87.96% forest cover for persistence and 50.82-91.02% for extinction dynamics. Conclusions/Significance: Through an approach that allows for broad-scale comparisons of threshold responses, we show that species vary in their threshold responses with regard to habitat amount, and that differences between even nearby regions can be pronounced. We present both ecological and methodological factors that may contribute to the different model results, but propose that regardless of the reasons behind these differences, our results merit a warning that threshold values cannot simply be transferred across regions or interpreted as clear-cut targets for ecosystem management and conservation.	[van der Hoek, Yntze; Manne, Lisa L.] CUNY Coll Staten Isl, Dept Biol Sci, New York, NY 10314 USA; [van der Hoek, Yntze] CUNY, Grad Ctr, New York, NY USA; [Renfrew, Rosalind] Vermont Ctr Ecostudies, White River Jct, VT USA	City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System	van der Hoek, Y (corresponding author), CUNY Coll Staten Isl, Dept Biol Sci, New York, NY 10314 USA.	yvan_der_hoek@gc.cuny.edu			Graduate Center and College of Staten Island of the City University of New York; USGS Patuxent Wildlife Research Center; Vermont Center for Ecostudies; Vermont Fish and Wildlife Department	Graduate Center and College of Staten Island of the City University of New York; USGS Patuxent Wildlife Research Center(United States Geological Survey); Vermont Center for Ecostudies; Vermont Fish and Wildlife Department	This research has received support from the Graduate Center and College of Staten Island of the City University of New York, the USGS Patuxent Wildlife Research Center, the Vermont Center for Ecostudies, and the Vermont Fish and Wildlife Department's Nongame Wildlife Fund and State Wildlife Grants (SWG) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; Andren H, 1996, OIKOS, V76, P235, DOI 10.2307/3546195; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2010, R LANG ENV STAT COMP; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Betts MG, 2006, ECOL APPL, V16, P1076, DOI 10.1890/1051-0761(2006)016[1076:IEOFOF]2.0.CO;2; Betts MG, 2006, ECOL MODEL, V191, P197, DOI 10.1016/j.ecolmodel.2005.04.027; Blanchet S, 2010, EVOL APPL, V3, P291, DOI 10.1111/j.1752-4571.2009.00110.x; Boyle SA, 2010, BIOL CONSERV, V143, P1134, DOI 10.1016/j.biocon.2010.02.008; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Burnham KP, 2002, MULTIMODEL INFERENCE; Davies KF, 2000, ECOLOGY, V81, P1450, DOI 10.2307/177221; Desrochers A, 2010, ECOGRAPHY, V33, P921, DOI 10.1111/j.1600-0587.2009.06061.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Digiovinazzo P, 2010, FOREST ECOL MANAG, V259, P343, DOI 10.1016/j.foreco.2009.10.027; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; dos Anjos L, 2011, BIOL CONSERV, V144, P2213, DOI 10.1016/j.biocon.2011.05.013; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Eastman J. R., 2009, IDRISI TAIGA; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jones JE, 2011, ECOLOGY, V92, P2299, DOI 10.1890/10-2403.1; Juutinen A, 2008, ENVIRON SCI POLICY, V11, P613, DOI 10.1016/j.envsci.2008.05.004; Kato S, 2011, LANDSC ECOL ENG, V7, P275, DOI 10.1007/s11355-010-0135-y; Kennedy CM, 2010, BIOL CONSERV, V143, P2136, DOI 10.1016/j.biocon.2010.05.025; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; Laughlin SB, 1985, ATLAS BREEDING BIRDS; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Monkkonen M, 1999, OIKOS, V84, P302, DOI 10.2307/3546725; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; MUGGEO VMR, 2008, SEGMENTED PACKAGE R; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Radford JQ, 2004, BIOL CONSERV, V117, P375, DOI 10.1016/j.biocon.2003.08.002; Renfrew RB, 2 ATLAS BREEDING BIR; Rhodes JR, 2008, J APPL ECOL, V45, P549, DOI 10.1111/j.1365-2664.2007.01407.x; Richmond M. E., 2008, 2 ATLAS BREEDING BIR, P258; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rompre G, 2010, FOREST CHRON, V86, P572, DOI 10.5558/tfc86572-5; Schooley RL, 2011, BIODIVERS CONSERV, V20, P1611, DOI 10.1007/s10531-011-0049-5; Shanahan DF, 2009, J APPL ECOL, V46, P1026, DOI 10.1111/j.1365-2664.2009.01694.x; SIMBERLOFF D, 1995, IBIS, V137, pS105, DOI 10.1111/j.1474-919X.1995.tb08430.x; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Stehman SV, 2003, REMOTE SENS ENVIRON, V86, P500, DOI 10.1016/S0034-4257(03)00128-7; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Tischendorf L, 2005, ECOL SOC, V10; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Vance MD, 2003, ECOLOGY, V84, P2643, DOI 10.1890/02-0159; Venier LA, 1999, J BIOGEOGR, V26, P315, DOI 10.1046/j.1365-2699.1999.00273.x; Villard MA, 1999, CONSERV BIOL, V13, P774, DOI 10.1046/j.1523-1739.1999.98059.x; WENNY DG, 1993, CONDOR, V95, P968, DOI 10.2307/1369432; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Zitske BP, 2011, CONSERV BIOL, V25, P993, DOI 10.1111/j.1523-1739.2011.01709.x; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	75	9	10	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55996	10.1371/journal.pone.0055996	http://dx.doi.org/10.1371/journal.pone.0055996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409106	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200100
J	Yoo, HJ; Hwang, SY; Hong, HC; Choi, HY; Yang, SJ; Choi, DS; Baik, SH; Bluher, M; Youn, BS; Choi, KM				Yoo, Hye Jin; Hwang, Soon Young; Hong, Ho Cheol; Choi, Hae Yoon; Yang, Sae Jeong; Choi, Dong Seop; Baik, Sei Hyun; Blueher, Matthias; Youn, Byung-Soo; Choi, Kyung Mook			Implication of Progranulin and C1q/TNF-Related Protein-3 (CTRP3) on Inflammation and Atherosclerosis in Subjects with or without Metabolic Syndrome	PLOS ONE			English	Article							GROWTH-FACTOR; EPITHELIN PRECURSOR; INSULIN-RESISTANCE; SERUM PROGRANULIN; ADIPOKINE; OBESITY; GLUCOSE; PLASMA; TISSUE; BINDS	Objective: Progranulin and C1q/TNF-related protein-3 (CTRP3) were recently discovered as novel adipokines which may link obesity with altered regulation of glucose metabolism, chronic inflammation and insulin resistance. Research Design and Methods: We examined circulating progranulin and CTRP3 concentrations in 127 subjects with (n = 44) or without metabolic syndrome (n = 83). Furthermore, we evaluated the relationship of progranulin and CTRP3 levels with inflammatory markers and cardiometabolic risk factors, including high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), estimated glomerular filtration rate (eGFR), and adiponectin serum concentrations, as well as carotid intima-media thickness (CIMT). Results: Circulating progranulin levels are significantly related with inflammatory markers, hsCRP (r = 0.30, P = 0.001) and IL-6 (r = 0.30, P = 0.001), whereas CTRP3 concentrations exhibit a significant association with cardiometabolic risk factors, including waist circumference (r = -0.21), diastolic blood pressure (r = -0.21), fasting glucose (r = -0.20), triglyceride (r = -0.34), total cholesterol (r = -0.25), eGFR (r = 0.39) and adiponectin (r = 0.26) levels. Serum progranulin concentrations were higher in patients with metabolic syndrome than those of the control group (199.55 [179.33, 215.53] vs. 185.10 [160.30, 204.90], P = 0.051) and the number of metabolic syndrome components had a significant positive correlation with progranulin levels (r = 0.227, P = 0.010). In multiple regression analysis, IL-6 and triglyceride levels were significant predictors of serum progranulin levels (R-2 = 0.251). Furthermore, serum progranulin level was an independent predictor for increased CIMT in subjects without metabolic syndrome after adjusting for other cardiovascular risk factors (R-2 = 0.365). Conclusions: Serum progranulin levels are significantly associated with systemic inflammatory markers and were an independent predictor for atherosclerosis in subjects without metabolic syndrome.	[Yoo, Hye Jin; Hong, Ho Cheol; Choi, Hae Yoon; Yang, Sae Jeong; Choi, Dong Seop; Baik, Sei Hyun; Choi, Kyung Mook] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Hwang, Soon Young] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Youn, Byung-Soo] AdipoGen Inc, Inchon, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Leipzig University	Choi, KM (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	bsyoun@gmail.com; medica7@gmail.com	Choi, Kyung Mook/C-4195-2018	Choi, Kyung Mook/0000-0001-6175-0225; Hwang, Soon Young/0000-0001-7474-1803; Yoo, Hye Jin/0000-0003-0600-0266	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012006363, 2012R1A1A1005257]; Ministry of Education and Human Resources Development, Republic of Korea [A102065-1011-1070100]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education and Human Resources Development, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	Dr. KMC was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012006363) and Drs. SHB and KMC were supported by the Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea (A102065-1011-1070100). Dr. HJY was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1005257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Kojima Y, 2009, ATHEROSCLEROSIS, V206, P102, DOI 10.1016/j.atherosclerosis.2009.02.017; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Svestak M, 2010, BIOMED PAP, V154, P199, DOI 10.5507/bp.2010.030; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu H, 2011, SCIENCE, V332, P427, DOI 10.1126/science.1205992; Yilmaz Y, 2011, DIS MARKERS, V31, P205, DOI [10.1155/2011/126240, 10.3233/DMA-2011-0815]; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; ZHOU J, 1993, J BIOL CHEM, V268, P10863	28	74	82	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55744	10.1371/journal.pone.0055744	http://dx.doi.org/10.1371/journal.pone.0055744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409033	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200058
J	Chaix, A; Arcangeli, ML; Lopez, S; Voisset, E; Yang, Y; Vita, M; Letard, S; Audebert, S; Finetti, P; Birnbaum, D; Bertucci, F; Aurrand-Lions, M; Dubreuil, P; De Sepulveda, P				Chaix, A.; Arcangeli, M-L; Lopez, S.; Voisset, E.; Yang, Y.; Vita, M.; Letard, S.; Audebert, S.; Finetti, P.; Birnbaum, D.; Bertucci, F.; Aurrand-Lions, M.; Dubreuil, P.; De Sepulveda, P.			KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570	ONCOGENE			English	Article						receptor; tyrosine kinase; mastocytosis; oncogene; leukemia; mast cell	STEM-CELL FACTOR; RECEPTOR TYROSINE KINASE; C-KIT MUTATIONS; GASTROINTESTINAL STROMAL TUMORS; ACUTE MYELOID-LEUKEMIA; SRC FAMILY KINASES; DOMAIN MUTATIONS; PEDIATRIC MASTOCYTOSIS; ACTIVATING MUTATIONS; SIGNALING PATHWAYS	Mutation of KIT receptor tyrosine kinase at residue D816 results in ligand-independent constitutive kinase activity. This mutation occurs in most patients with mastocytosis, a myeloproliferative neoplasm, and is detected at lower frequencies in acute myeloid leukemia and in germ cell tumors. Other KIT mutations occur in gastrointestinal stromal tumors (GIST) and mucosal melanoma. KIT is considered as a bona fide therapeutic target as c-kit mutations are driving oncogenes in these pathologies. However, several evidences suggest that KIT-D816V mutant is not as aggressive as other KIT mutants. Here, we show that an intracellular docking site in the juxtamembrane region of KIT maintains a negative regulation on KIT-D816V transforming potential. Sixteen signaling proteins were shown to interact with this motif. We further demonstrate that mutation of this site results in signaling modifications, altered gene expression profile and increased transforming activity of KIT-D816V mutant. This result was unexpected as mutations of the homologous sites on wild-type (WT) KIT, or on the related oncogenic FLT3-ITD receptor, impair their function. Our results support the hypothesis that, KIT-D816V mutation is a mild oncogenic event that is sufficient to confer partial transforming properties, but requires additional mutations to acquire its full transforming potential.	[Chaix, A.; Arcangeli, M-L; Lopez, S.; Voisset, E.; Yang, Y.; Vita, M.; Letard, S.; Audebert, S.; Finetti, P.; Birnbaum, D.; Bertucci, F.; Aurrand-Lions, M.; Dubreuil, P.; De Sepulveda, P.] Ctr Rech Cancerol Marseille, INSERM, U1068, F-13009 Marseille, France; [Chaix, A.; Arcangeli, M-L; Lopez, S.; Voisset, E.; Yang, Y.; Vita, M.; Letard, S.; Audebert, S.; Finetti, P.; Birnbaum, D.; Bertucci, F.; Aurrand-Lions, M.; Dubreuil, P.; De Sepulveda, P.] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Chaix, A.; Arcangeli, M-L; Lopez, S.; Voisset, E.; Yang, Y.; Vita, M.; Letard, S.; Audebert, S.; Finetti, P.; Birnbaum, D.; Bertucci, F.; Aurrand-Lions, M.; Dubreuil, P.; De Sepulveda, P.] Aix Marseille Univ, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	De Sepulveda, P (corresponding author), Ctr Rech Cancerol Marseille, INSERM, U1068, 27 Blvd Lei Roure, F-13009 Marseille, France.	paulo.de-sepulveda@inserm.fr	De sepulveda, paulo/K-6043-2015; Voisset, Edwige/AAM-3503-2021; LOPEZ, SOPHIE/R-1917-2016; Aurrand-Lions, Michel/O-9953-2016; Arcangeli, Marie-Laure/L-5991-2017; Dubreuil, Patrice/V-4816-2019; Voisset, Edwige/GSE-5113-2022; dubreuil, patrice/F-5346-2011; Finetti, Pascal/O-8669-2017	De sepulveda, paulo/0000-0001-8295-5414; Voisset, Edwige/0000-0002-0943-4847; LOPEZ, SOPHIE/0000-0002-5009-5533; Aurrand-Lions, Michel/0000-0002-8361-3034; Arcangeli, Marie-Laure/0000-0002-1726-1472; Dubreuil, Patrice/0000-0003-1155-1150; Voisset, Edwige/0000-0002-0943-4847; dubreuil, patrice/0000-0003-1155-1150; Audebert, Stephane/0000-0002-9409-2588; LETARD, Sebastien/0000-0002-6508-7376; Finetti, Pascal/0000-0002-2674-3123	Ministere de la Recherche-ENS; ARC; French Society of Hematology; FRM; Institut Lilly; INCa; OSEO; la Ligue Contre le Cancer	Ministere de la Recherche-ENS; ARC(Australian Research Council); French Society of Hematology; FRM(Fondation pour la Recherche Medicale); Institut Lilly; INCa(Institut National du Cancer (INCA) France); OSEO; la Ligue Contre le Cancer(Ligue nationale contre le cancer)	We thank Cyndie Mosca, F Bardin and K Hanssens for technical assistance. AC is a recipient of PhD fellowships from Ministere de la Recherche-ENS, ARC and a financial support from the French Society of Hematology. We acknowledge postdoctoral fellowships from FRM and Institut Lilly to MLA, from INCa and OSEO to SL and from FRM to MV. This project was supported by grants from la Ligue Contre le Cancer and INCa.	Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; Agosti V, 2009, EXP HEMATOL, V37, P159, DOI 10.1016/j.exphem.2008.10.009; Bayle J, 2004, J BIOL CHEM, V279, P12249, DOI 10.1074/jbc.M313381200; Beghini A, 2004, HAEMATOLOGICA, V89, P920; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; Bougherara H, 2009, MOL CANCER RES, V7, P1525, DOI 10.1158/1541-7786.MCR-09-0138; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chaix A, 2011, J BIOL CHEM, V286, P5956, DOI 10.1074/jbc.M110.182642; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; DeBerry C, 1997, BIOCHEM J, V327, P73, DOI 10.1042/bj3270073; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; GLOVER HR, 1995, ONCOGENE, V11, P1347; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hong L, 2004, MOL CELL BIOL, V24, P1401, DOI 10.1128/MCB.24.3.1401-1410.2004; Hongyo T, 2000, CANCER RES, V60, P2345; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Looijenga LHJ, 2003, CANCER RES, V63, P7674; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Mayerhofer M, 2008, J IMMUNOL, V180, P5466, DOI 10.4049/jimmunol.180.8.5466; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Sattler M, 1997, J BIOL CHEM, V272, P10248; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon C, 2008, BLOOD, V112, P1039, DOI 10.1182/blood-2008-05-154849; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Sun JM, 2009, J BIOL CHEM, V284, P11039, DOI 10.1074/jbc.M808058200; Tan BL, 2003, J BIOL CHEM, V278, P11686, DOI 10.1074/jbc.M207068200; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; Valent P, 2005, LEUKEMIA LYMPHOMA, V46, P35, DOI 10.1080/10428190400010775; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Voisset E, 2010, BIOCHEM BIOPH RES CO, V393, P174, DOI 10.1016/j.bbrc.2010.01.116; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Yang Y, 2010, BLOOD, V116, P1114, DOI 10.1182/blood-2009-06-226027; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807	50	17	17	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					872	881		10.1038/onc.2013.12	http://dx.doi.org/10.1038/onc.2013.12			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23416972				2022-12-25	WOS:000331626900008
J	Berger, C; Berger, M; Beard, BC; Kiem, HP; Gooley, TA; Riddell, SR				Berger, Carolina; Berger, Michael; Beard, Brian C.; Kiem, Hans-Peter; Gooley, Theodore A.; Riddell, Stanley R.			Proliferation-Linked Apoptosis of Adoptively Transferred T Cells after IL-15 Administration in Macaques	PLOS ONE			English	Article							IN-VIVO PERSISTENCE; METASTATIC MELANOMA; MEDIATED REJECTION; MEMORY; CANCER; IMMUNOTHERAPY; INTERLEUKIN-15; LYMPHOCYTES; IMMUNITY; THERAPY	The adoptive transfer of antigen-specific effector T cells is being used to treat human infections and malignancy. T cell persistence is a prerequisite for therapeutic efficacy, but reliably establishing a high-level and durable T cell response by transferring cultured CD8(+) T cells remains challenging. Thus, strategies that promote a transferred high-level T cell response may improve the efficacy of T cell therapy. Lymphodepletion enhances persistence of transferred T cells in mice in part by reducing competition for IL-15, a common gamma-chain cytokine that promotes T cell memory, but lymphodepleting regimens have toxicity. IL-15 can be safely administered and has minimal effects on CD4(+) regulatory T cells at low doses, making it an attractive adjunct in adoptive T cell therapy. Here, we show in lymphoreplete macaca nemestrina, that proliferation of adoptively transferred central memory-derived CD8(+) effector T (T-CM/E) cells is enhanced in vivo by administering IL-15. TCM/E cells migrated to memory niches, persisted, and acquired both central memory and effector memory phenotypes regardless of the cytokine treatment. Unexpectedly, despite maintaining T cell proliferation, IL-15 did not augment the magnitude of the transferred T cell response in blood, bone marrow, or lymph nodes. T cells induced to proliferate by IL-15 displayed increased apoptosis demonstrating that enhanced cycling was balanced by cell death. These results suggest that homeostatic mechanisms that regulate T cell numbers may interfere with strategies to augment a high-level T cell response by adoptive transfer of CD8(+) T-CM/E cells in lymphoreplete hosts.	[Berger, Carolina; Berger, Michael; Beard, Brian C.; Kiem, Hans-Peter; Gooley, Theodore A.; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Berger, Carolina; Beard, Brian C.; Kiem, Hans-Peter; Riddell, Stanley R.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Riddell, Stanley R.] Tech Univ Munich, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, D-80290 Munich, Germany	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Technical University of Munich	Berger, C (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	cberger@fhcrc.org			National Institutes of Health [CA114536, AI053193, P51-RR000166-48S2]; NATIONAL CANCER INSTITUTE [R01CA114536] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants CA114536 (SRR), AI053193 (SRR), and P51-RR000166-48S2 (CB, SRR) (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003425; Baerlocher GM, 2003, CYTOM PART A, V55A, P1, DOI 10.1002/cyto.a.10064; Beard BC, 2007, MOL THER, V15, P1356, DOI 10.1038/sj.mt.6300159; Berger C, 2011, J MED PRIMATOL, V40, P88, DOI 10.1111/j.1600-0684.2010.00451.x; Berger C, 2001, J VIROL, V75, P799, DOI 10.1128/JVI.75.2.799-808.2001; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Berger C, 2009, CURR OPIN IMMUNOL, V21, P224, DOI 10.1016/j.coi.2009.02.010; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Chapuis AG, 2012, P NATL ACAD SCI USA, V109, P4592, DOI 10.1073/pnas.1113748109; Chapuis AG, 2011, BLOOD, V117, P5391, DOI 10.1182/blood-2010-11-320226; Dudley ME, 2001, J IMMUNOTHER, V24, P363, DOI 10.1097/00002371-200107000-00012; Eisenman J, 2002, CYTOKINE, V20, P121, DOI 10.1006/cyto.2002.1989; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Markley JC, 2010, BLOOD, V115, P3508, DOI 10.1182/blood-2009-09-241398; Nolz JC, 2012, P NATL ACAD SCI USA, V109, P6199, DOI 10.1073/pnas.1118868109; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Riddell SR, 2004, J EXP MED, V200, P1533, DOI 10.1084/jem.20042004; RIDDELL SR, 1992, SCIENCE, V257, P238; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Roychowdhury S, 2004, CANCER RES, V64, P8062, DOI 10.1158/0008-5472.CAN-04-1860; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang AR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004306; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Wei Xunbin, 2005, Mol Imaging, V4, P415; Yang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022560; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56268	10.1371/journal.pone.0056268	http://dx.doi.org/10.1371/journal.pone.0056268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418547	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300140
J	Chang, B; Kustra, R; Tian, WD				Chang, Billy; Kustra, Rafal; Tian, Weidong			Functional-Network-Based Gene Set Analysis Using Gene-Ontology	PLOS ONE			English	Article							P53; EXPRESSION; AMPLIFICATION; BIOLOGY; ARREST; CELLS	To account for the functional non-equivalence among a set of genes within a biological pathway when performing gene set analysis, we introduce GOGANPA, a network-based gene set analysis method, which up-weights genes with functions relevant to the gene set of interest. The genes are weighted according to its degree within a genome-scale functional network constructed using the functional annotations available from the gene ontology database. By benchmarking GOGANPA using a well-studied P53 data set and three breast cancer data sets, we will demonstrate the power and reproducibility of our proposed method over traditional unweighted approaches and a competing network-based approach that involves a complex integrated network. GOGANPA's sole reliance on gene ontology further allows GOGANPA to be widely applicable to the analysis of any gene-ontology-annotated genome.	[Chang, Billy; Tian, Weidong] Fudan Univ, State Key Lab Genet Engn, Inst Biostat, Shanghai 200433, Peoples R China; [Chang, Billy; Kustra, Rafal] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada	Fudan University; University of Toronto	Tian, WD (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Biostat, Shanghai 200433, Peoples R China.	weidong.tian@fudan.edu.cn			National Basic Research Program of China [2010CB529505, 2012CB316505]; National Natural Science Foundation of China [30971643, 31071113]; Ontario Graduate Scholarship	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the National Basic Research Program of China (Grant No. 2010CB529505, 2012CB316505); the National Natural Science Foundation of China (Grant No. 30971643, 31071113); and the Ontario Graduate Scholarship [to BC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fang ZY, 2012, CELL RES, V22, P565, DOI 10.1038/cr.2011.149; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Hoshino M, 2001, J ALLERGY CLIN IMMUN, V107, P1034, DOI 10.1067/mai.2001.115626; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r23; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ovaska K, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-11; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	29	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55635	10.1371/journal.pone.0055635	http://dx.doi.org/10.1371/journal.pone.0055635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418449	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300040
J	Zhang, XZ; Daucher, M; Armistead, D; Russell, R; Kottilil, S				Zhang, Xiaozhen; Daucher, Marybeth; Armistead, David; Russell, Rodney; Kottilil, Shyam			MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-alpha	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; CELLULAR MICRORNAS; PLUS RIBAVIRIN; LIVER-DISEASES; GENE; MET; MODULATION; MECHANISM	Objective: Increasing evidence suggests that miRNAs have a profound impact on host defense to Hepatitis C virus (HCV) infection and clinical outcome of standard HCV therapy. In this study, we investigated modulation of miRNA expression in Huh7.5 hepatoma cells by HCV infection and in vitro interferon-alpha treatment. Methods: MiRNA expression profiling was determined using Human miRNA TaqMan (R) Arrays followed by rigorous pairwise statistical analysis. MiRNA inhibitors assessed the functional effects of miRNAs on HCV replication. Computational analysis predicted anti-correlated mRNA targets and their involvement in host cellular pathways. Quantitative RTPCR confirmed the expression of predicted miRNA-mRNA correlated pairs in HCV-infected Huh7.5 cells with and without interferon-alpha. Results: Seven miRNAs (miR-30b, miR-30c, miR-130a, miR-192, miR-301, miR-324-5p, and miR-565) were down-regulated in HCV-infected Huh7.5 cells (p<0.05) and subsequently up-regulated following interferon-alpha treatment (p<0.01). The miR-30(a-d) cluster and miR-130a/301 and their putative mRNA targets were predicted to be associated with cellular pathways that involve Hepatitis C virus entry, propagation and host response to viral infection. Conclusions: HCV differentially modulates miRNAs to facilitate entry and early establishment of infection in vitro. Interferon-alpha appears to neutralize the effect of HCV replication on miRNA regulation thus providing a potential mechanism of action in eradicating HCV from hepatocytes.	[Zhang, Xiaozhen; Daucher, Marybeth; Kottilil, Shyam] NIAID, Immunopathogenesis Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Armistead, David] Life Technol Inc, Gaithersburg, MD USA; [Russell, Rodney] Mem Univ Newfoundland, Fac Med, Hlth Sci Ctr, St John, NF, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Thermo Fisher Scientific; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba	Kottilil, S (corresponding author), NIAID, Immunopathogenesis Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	skottilil@niaid.nih.gov	Russell, Rod/AAU-3109-2021; Kottilil, Shyam/ABF-7605-2021		Intramural Research Program of the NIH, [National Institute of Allergy and Infectious Diseases]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors declare that they do not have anything to disclose regarding the funding or conflict of interest with respect to this manuscript. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. This research was supported in whole by the Intramural Research Program of the NIH, [National Institute of Allergy and Infectious Diseases]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen LM, 2010, J GEN VIROL, V91, P382, DOI 10.1099/vir.0.015388-0; Chen QY, 1997, HEPATOLOGY, V26, P59; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S20; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Scagnolari C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-311; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sidorkiewicz M, 2010, ACTA VIROL, V54, P75, DOI 10.4149/av_2010_01_75; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Wang Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2316, DOI 10.2741/2234; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; ZHANG ZX, 1994, BIOCHEM BIOPH RES CO, V202, P1352, DOI 10.1006/bbrc.1994.2079	35	55	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55733	10.1371/journal.pone.0055733	http://dx.doi.org/10.1371/journal.pone.0055733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418453	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300044
J	Chavalarias, D; Cointet, JP				Chavalarias, David; Cointet, Jean-Philippe			Phylomemetic Patterns in Science Evolution-The Rise and Fall of Scientific Fields	PLOS ONE			English	Article							KNOWLEDGE DOMAIN; WORD; NETWORKS	We introduce an automated method for the bottom-up reconstruction of the cognitive evolution of science, based on big-data issued from digital libraries, and modeled as lineage relationships between scientific fields. We refer to these dynamic structures as phylomemetic networks or phylomemies, by analogy with biological evolution; and we show that they exhibit strong regularities, with clearly identifiable phylomemetic patterns. Some structural properties of the scientific fields - in particular their density -, which are defined independently of the phylomemy reconstruction, are clearly correlated with their status and their fate in the phylomemy (like their age or their short term survival). Within the framework of a quantitative epistemology, this approach raises the question of predictibility for science evolution, and sketches a prototypical life cycle of the scientific fields: an increase of their cohesion after their emergence, the renewal of their conceptual background through branching or merging events, before decaying when their density is getting too low.	[Chavalarias, David; Cointet, Jean-Philippe] Complex Syst Inst Paris Ile de France ISC PIF, Paris, France; [Chavalarias, David] CNRS EHESS, CAMS, Paris, France; [Cointet, Jean-Philippe] INRA, INRA SenS, Marne La Vallee, France	Centre National de la Recherche Scientifique (CNRS); INRAE	Chavalarias, D (corresponding author), Complex Syst Inst Paris Ile de France ISC PIF, Paris, France.	david.chavalarias@ehess.fr	cointet, jean-philippe/AAX-3720-2021	cointet, jean-philippe/0000-0002-3172-3960; Chavalarias, David/0000-0001-9485-1399	Paris Ile-de-France Complex Systems Institute (ISC-PIF); Ecole Polytechnique; Centre National de la Recherche Scientifique (CNRS); INRA (INRA-SenS); ADEME [1204C0003]	Paris Ile-de-France Complex Systems Institute (ISC-PIF); Ecole Polytechnique; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INRA (INRA-SenS); ADEME	This research has been supported by the Paris Ile-de-France Complex Systems Institute (ISC-PIF), the Ecole Polytechnique, the Centre National de la Recherche Scientifique (CNRS), the INRA (INRA-SenS) and the ADEME (grant no1204C0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijker WE, 2007, HANDBOOK OF SCIENCE AND TECHNOLOGY STUDIES, THIRD EDITION, pXI; Bonaccorsi A, 2008, MINERVA, V46, P285, DOI 10.1007/s11024-008-9101-3; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; CALLON M, 1983, SOC SCI INFORM, V22, P191, DOI 10.1177/053901883022002003; CALLON M, 1991, SCIENTOMETRICS, V22, P155, DOI 10.1007/BF02019280; Callon M, 1986, PUTTING TEXTS THEIR, P221; Callon M., 1986, MAPPING DYNAMICS SCI, P9; Chavalarias D, 2011, STREAMS MEDIA ISSUES; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Cui WW, 2011, IEEE T VIS COMPUT GR, V17, P2412, DOI 10.1109/TVCG.2011.239; Dawkins R, 2006, SELFISH GENE; GARFIELD E, 1964, SCIENCE, V144, P649, DOI 10.1126/science.144.3619.649; He Q, 1999, LIBR TRENDS, V48, P133; Herrera M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010355; Howe CJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001069; Kageura K., 1996, Terminology, V3, P259, DOI 10.1075/term.3.2.03kag; Kuhn T., 1970, STRUCTURE SCI REVOLU; Lakatos I., 1980, METHODOLOGY SCI RES, V1; Latour B., 1979, LAB LIFE SOCIAL CONS; Newman MEJ, 2004, LECT NOTES PHYS, V650, P337; Nowotny H., 2001, RETHINKING SCI KNOWL; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE; Palla G, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/186; Popper K.R., 2002, CONJECTURES REFUTATI; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Simmel G., 1898, AM J SOCIOL, V3, P662, DOI DOI 10.1086/AJS.1898.3.ISSUE-5; Skupin A, 2004, P NATL ACAD SCI USA, V101, P5274, DOI 10.1073/pnas.0307654100; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; WHITTAKER J, 1989, SOC STUD SCI, V19, P473, DOI 10.1177/030631289019003004; Zitt M, 2006, INFORM PROCESS MANAG, V42, P1513, DOI 10.1016/j.ipm.2006.03.016	32	60	61	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54847	10.1371/journal.pone.0054847	http://dx.doi.org/10.1371/journal.pone.0054847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23408947	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000007
J	Hambolu, D; Freeman, J; Taddese, HB				Hambolu, Dupe; Freeman, Jenny; Taddese, Henock B.			Predictors of Bovine TB Risk Behaviour amongst Meat Handlers in Nigeria: A Cross-Sectional Study Guided by the Health Belief Model	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; TUBERCULOSIS; INFECTION; ETHIOPIA; GENDER	Background: Bovine Tuberculosis (bTB) is still a serious public health threat in developing countries. The aim of this study is to determine the social and cognitive factors predicting one of the risk behaviours amongst meat handlers in Nigeria, namely, eating Fuku Elegusi. This is the practice of eating the visibly infected parts of the lung in-order to convince customers to buy meat. The study is guided by the health belief model (HBM). Methods: This is a cross-sectional study of 349 randomly selected meat handlers in Oko-Oba Abattoir, in Lagos State. Descriptive statistics and multiple logistic regression analysis were employed to determine perceptions and prevalence of risk behaviours and to identify predictors of eating Fuku Elegusi. Results: Just over a quarter (28.1%) of the study participants knew that eating Fuku Elegusi could be a source of bTB in humans. The prevalence of eating Fuku Elegusi was found to be 22%. Across all knowledge indicators related to bTB, those who don't eat Fuku Elegusi exhibited better knowledge. Strong predictors of eating Fuku Elegusi were: being male (OR: 2.39, 95% CI: 1.10 to 5.19; p = 0.03), not knowing that eating Fuku Elegusi exposes to bTB (OR: 3.72, 95% CI: 1.69 to 8.22; p = 0.001), and the perception that one cannot sell meat without tasting it (perceived barrier) (OR: 1.35, 95% CI: 1.13 to 1.60; p = 0.001). Lower risk of eating Fuku Elegusi was predicted by perceived susceptibility to bTB due to another risk behaviour, namely, not washing hands after handling meat (OR: 0.78, 95% CI: 0.64 to 0.96; p-value = 0.021). Television and radio were the most acceptable media for TB prevention messages (78.5% and 75.6% respectively). Conclusion: Meat handlers in developing countries bear high risk to bTB owing to prevailing social and cognition determinants. Findings were largely consistent with the propositions of HBM.	[Hambolu, Dupe] Fed Minist Agr & Water Resources, Fed Dept Livestock & Pest Control Serv, Abuja, Nigeria; [Freeman, Jenny; Taddese, Henock B.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England	University of Sheffield	Taddese, HB (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England.	h.taddese@sheffield.ac.uk						Abubakar U. B., 2011, Veterinary Research (Pakistan), V4, P24; Ademola A. I., 2010, Veterinary Research (Pakistan), V3, P54; Adesokan HK, 2012, INT J TUBERC LUNG D, V16, P1388, DOI 10.5588/ijtld.12.0109; Amenu K., 2010, Tropicultura, V28, P205; Anaelom N. J., 2010, Journal of Public Health and Epidemiology, V2, P118; [Anonymous], 1994, B WORLD HEALTH ORGAN, V72, P851; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bowling A., 2014, RES METHODS HLTH INV; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus S.I.B., 2008, NIG VET J, V45, P150; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Creswell J. W.., 2018, SAGE PUBLICATIONS; Daborn CJ, 1996, J APPL BACTERIOL, V81, pS27; Davidson KW, 2006, HEALTH EDUC BEHAV, V33, P731, DOI 10.1177/1090198106288043; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Glanz K., 2015, HLTH BEHAV HLTH ED T; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Ibironke AA, 2010, EUR J TRANSL MYOL, V20, P13, DOI 10.4081/ejtm.2010.1871; IDIGBE EO, 1986, J TROP MED HYG, V89, P143; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Mfinanga SG, 2003, INT J TUBERC LUNG D, V7, P933; Moda G, 1996, TUBERCLE LUNG DIS, V77, P103, DOI 10.1016/S0962-8479(96)90022-2; OKOLO MIO, 1992, MICROBIOS, V69, P105; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rosenstock IM, 1994, HLTH BELIEF MODEL HI; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Strecher VJ, 1997, HLTH BELIEF MODEL; Swai E. S., 2010, Tanzania Journal of Health Research, V12, P272; Taylor D., 2007, REV USE HLTH BELIEF; WHO, 2011, WHO GLOBAL TUBERCULO	31	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56091	10.1371/journal.pone.0056091	http://dx.doi.org/10.1371/journal.pone.0056091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409127	Green Published, gold, Green Accepted			2022-12-25	WOS:000315100000044
J	Dunnick, WA; Shi, J; Fontaine, C; Collins, JT				Dunnick, Wesley A.; Shi, Jian; Fontaine, Clinton; Collins, John T.			Transgenes of the Mouse Immunoglobulin Heavy Chain Locus, Lacking Distal Elements in the 3 ' Regulatory Region, Are Impaired for Class Switch Recombination	PLOS ONE			English	Article							B-CELL DIFFERENTIATION; IGH LOCUS; CONSTANT-REGION; ENHANCER; EXPRESSION; DELETION; END; DNA; IDENTIFICATION; TRANSCRIPTION	The immunoglobulin heavy (H) chain class switch is mediated by a deletional recombination event between mu and gamma, alpha, or epsilon constant region genes. This recombination event is upregulated during immune responses by a regulatory region that lies 3' of the constant region genes. We study switch recombination using a transgene of the entire murine H chain constant region locus. We isolated two lines of mice in which the H chain transgenes were truncated at their 3' ends. The truncation in both transgenic lines results in deletion of the 3'-most enhancer (HS4) and a region with insulator-like structure and activities. Even though both truncated transgenes express the mu H chain gene well, they undergo very low or undetectable switch recombination to transgenic gamma and alpha constant region genes. For both transgenic lines, germline transcription of some H chain constant regions genes is severely impaired. However, the germline transcription of the gamma 1 and gamma 2a genes is at wild type levels for the transgenic line with the larger truncation, but at reduced levels for the transgenic line with the smaller truncation. The dramatic reduction in class switch recombination for all H chain genes and the varied reduction in germline transcription for some H chain genes could be caused by (i) insertion site effects or (ii) deletion of enhancer elements for class switch recombination and transcription, or (iii) a combination of both effects.	[Dunnick, Wesley A.; Shi, Jian; Fontaine, Clinton; Collins, John T.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Dunnick, WA (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	wesadunn@umich.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [AI076057]; National Institutes of Health [CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076057] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (AI076057)(http://www.niaid.nih.gov) Core support for the production of transgenic mice was provided by a grant from the National Institutes of Health to the University of Michigan Cancer Center (CA46592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulampalam V, 1996, INT IMMUNOL, V8, P1149; Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; BISHOP GA, 1995, EUR J IMMUNOL, V25, P1230, DOI 10.1002/eji.1830250515; Chauveau C, 1999, J IMMUNOL, V163, P4637; Chauveau C, 1998, EUR J IMMUNOL, V28, P3048, DOI 10.1002/(SICI)1521-4141(199810)28:10<3048::AID-IMMU3048>3.0.CO;2-V; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Cogne M, 2004, MOL BIOL B CELLS, P289; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dunnick WA, 2004, J IMMUNOL, V173, P5531, DOI 10.4049/jimmunol.173.9.5531; Dunnick WA, 2011, J IMMUNOL, V187, P4733, DOI 10.4049/jimmunol.1101808; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; DURDIK J, 1989, P NATL ACAD SCI USA, V86, P2346, DOI 10.1073/pnas.86.7.2346; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S; GIANNINI SL, 1993, J IMMUNOL, V150, P1772; GIUSTI AM, 1993, J EXP MED, V177, P797, DOI 10.1084/jem.177.3.797; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Manis JP, 2003, MOL IMMUNOL, V39, P753, DOI 10.1016/S0161-5890(02)00256-0; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Ong J, 1998, J IMMUNOL, V160, P4896; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; Shansab M, 2011, EUR J IMMUNOL, V41, P1456, DOI 10.1002/eji.201041077; Shi XR, 2001, INT IMMUNOL, V13, P1003, DOI 10.1093/intimm/13.8.1003; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Yan Y, 2011, J BIOL CHEM, V286, P27123, DOI 10.1074/jbc.M111.230995	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55842	10.1371/journal.pone.0055842	http://dx.doi.org/10.1371/journal.pone.0055842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409061	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300039
J	Raeven, P; Salibasic, A; Drechsler, S; Weixelbaumer, KM; Jafarmadar, M; van Griensven, M; Bahrami, S; Osuchowski, MF				Raeven, Pierre; Salibasic, Alma; Drechsler, Susanne; Weixelbaumer, Katrin Maria; Jafarmadar, Mohammad; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip			A Non-Lethal Traumatic/Hemorrhagic Insult Strongly Modulates the Compartment-Specific PAI-1 Response in the Subsequent Polymicrobial Sepsis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; MULTIPLE ORGAN DYSFUNCTION; HIGH-DOSE ANTITHROMBIN; SEPTIC SHOCK; SOLUBLE THROMBOMODULIN; HEMORRHAGIC-SHOCK; TRAUMA PATIENTS; MORTALITY; EPIDEMIOLOGY; COAGULOPATHY	Introduction: Plasminogen activator inhibitor 1 (PAI-1) is a key factor in trauma-and sepsis-induced coagulopathy. We examined how trauma-hemorrhage (TH) modulates PAI-1 responses in subsequent cecal ligation and puncture (CLP)-induced sepsis, and the association of PAI-1 with septic outcomes. Methods: Mice underwent TH and CLP 48 h later in three separate experiments. In experiment 1, mice were sacrificed pre-and post-CLP to characterize the trajectory of PAI-1 in plasma (protein) and tissues (mRNA). Post-CLP dynamics in TH-CLP (this study) and CLP-Only mice (prior study) were then compared for modulatory effects of TH. In experiment 2, to relate PAI-1 changes to outcome, mice underwent TH-CLP and were sampled daily and followed for 14 days to compare non-survivors (DEAD) and survivors (SUR). In experiment 3, plasma and tissue PAI-1 expression were compared between mice predicted to die (P-DIE) and to live (P-LIVE). Results: In experiment 1, an early post-TH rise of circulating PAI-1 was contrasted by a delayed (post-TH) decrease of PAI-1 mRNA in organs. In the post-CLP phase, profiles of circulating PAI-1 were similar between TH-CLP and CLP-Only mice. Conversely, PAI-1 mRNA declined in the liver and heart of TH-CLP mice versus CLP-Only. In experiment 2, there were no DEAD/SUR differences in circulating PAI-1 prior to CLP. Post-CLP, circulating PAI-1 in DEAD was 2-4-fold higher than in SUR. PAI-1 increase heralded septic deaths up to 48 h prior but DEAD/SUR thrombomodulin (endothelial injury marker) levels were identical. In experiment 3, levels of circulating PAI-1 and its hepatic gene expression were higher in P-DIE versus P-LIVE mice and those increases closely correlated with liver dysfunction. Conclusions: Trauma modulated septic PAI-1 responses in a compartment-specific fashion. Only post-CLP increases in circulating PAI-1 predicted septic outcomes. In posttraumatic sepsis, pre-lethal release of PAI-1 was mostly of hepatic origin and was independent of endothelial injury.	[Raeven, Pierre; Salibasic, Alma; Drechsler, Susanne; Weixelbaumer, Katrin Maria; Jafarmadar, Mohammad; van Griensven, Martijn; Bahrami, Soheyl; Osuchowski, Marcin Filip] Trauma Res Ctr Allgemeine Unfallversicherungsanst, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Ludwig Boltzmann Institute	Osuchowski, MF (corresponding author), Trauma Res Ctr Allgemeine Unfallversicherungsanst, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.	Marcin.Osuchowski@trauma.lbg.ac.at	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Drechsler, Susanne/0000-0002-0758-303X; Bahrami, Soheyl/0000-0002-4563-6251; Osuchowski, Marcin/0000-0002-1321-9883	WWTF Grant [LS07-065]	WWTF Grant	The study was funded by WWTF Grant LS07-065 (awarded to MFO and SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY GJ, 1980, J SURG RES, V29, P110, DOI 10.1016/0022-4804(80)90028-1; Barkhausen T, 2009, CRIT CARE, V13, DOI 10.1186/cc7963; Bochicchio GV, 2002, J TRAUMA, V53, P245, DOI 10.1097/00005373-200208000-00010; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brunnemer U, 2011, J ORTHOP TRAUMA, V25, P511, DOI 10.1097/BOT.0b013e3182251044; Cauvi DM, 2012, J BIOL CHEM, V287, P19804, DOI 10.1074/jbc.M112.359562; Claridge JA, 2002, CRIT CARE MED, V30, P1815, DOI 10.1097/00003246-200208000-00024; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Desai KH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001093; Drechsler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051457; Drechsler S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/357926; Ebong S, 1999, INFECT IMMUN, V67, P6603; Fan J, 2000, AM J RESP CELL MOL, V22, P412, DOI 10.1165/ajrcmb.22.4.3857; Ganopolsky JG, 2004, AM J PATHOL, V165, P1433, DOI 10.1016/S0002-9440(10)63401-3; Garcia-Segarra G, 2007, INTENS CARE MED, V33, P1354, DOI 10.1007/s00134-007-0695-y; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Ikegami K, 1998, J TRAUMA, V44, P789, DOI 10.1097/00005373-199805000-00008; Iskander KN, 2012, CRIT CARE MED; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Kurosawa S, 2008, CRIT CARE MED, V36, P985, DOI 10.1097/CCM.0B013E318165FDA7; Kwak SH, 2006, THROMB HAEMOSTASIS, V95, P829, DOI 10.1160/TH05-12-0782; Lagoa CE, 2005, HEPATOLOGY, V42, P390, DOI 10.1002/hep.20797; Levi M, 2012, SEMIN IMMUNOPATHOL, V34, P167, DOI 10.1007/s00281-011-0283-7; Lijnen HR, 2005, J THROMB HAEMOST, V3, P35, DOI 10.1111/j.1538-7836.2004.00827.x; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Madach K, 2010, CRIT CARE, V14, DOI 10.1186/cc8992; Mailman D, 1999, SHOCK, V12, P208, DOI 10.1097/00024382-199909000-00007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Osuchowski MF, 2007, J IMMUNOL, V179, P623, DOI 10.4049/jimmunol.179.1.623; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Osuchowski MF, 2009, CRIT CARE MED, V37, P1567, DOI 10.1097/CCM.0b013e31819df06b; Park YJ, 2008, P NATL ACAD SCI USA, V105, P11784, DOI 10.1073/pnas.0801394105; Peden M, 2000, INJURY LEADING CAUSE; Pfeifer R, 2012, CYTOKINE; PRALONG G, 1989, THROMB HAEMOSTASIS, V61, P459; Raaphorst J, 2001, THROMB HAEMOSTASIS, V86, P543, DOI 10.1055/s-0037-1616084; Raeven P, 2012, THROMB RES, V129, pE238, DOI 10.1016/j.thromres.2012.02.004; REDL H, 1993, BEHR INST MITT, V92, P218; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schochl H, 2012, HAMOSTASEOLOGIE, V32, P22, DOI 10.5482/ha-1178; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; Shapiro NI, 2009, J VASC RES, V46, P495, DOI 10.1159/000210662; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Tarlowe MH, 2005, AM J RESP CRIT CARE, V171, P753, DOI 10.1164/rccm.200307-917OC; van der Poll T, 2011, CURR OPIN INFECT DIS, V24, P273, DOI 10.1097/QCO.0b013e328344c078; van Griensven M, 2002, EXP TOXICOL PATHOL, V54, P203, DOI 10.1078/0940-2993-00247; van Veen SQ, 2006, CRIT CARE MED, V34, P2799, DOI 10.1097/01.CCM.0000243795.04284.2A; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Waydhas C, 1998, J TRAUMA, V45, P931, DOI 10.1097/00005373-199811000-00015; Weixelbaumer KM, 2010, SHOCK, V34, P420, DOI 10.1097/SHK.0b013e3181dc0918; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; YAMASHITA M, 1995, AM J PHYSIOL-ENDOC M, V268, pE1065, DOI 10.1152/ajpendo.1995.268.6.E1065	61	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55467	10.1371/journal.pone.0055467	http://dx.doi.org/10.1371/journal.pone.0055467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408987	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300017
J	Cignetti, F; Zedka, M; Vaugoyeau, M; Assaiante, C				Cignetti, Fabien; Zedka, Milan; Vaugoyeau, Marianne; Assaiante, Christine			Independent Walking as a Major Skill for the Development of Anticipatory Postural Control: Evidence from Adjustments to Predictable Perturbations	PLOS ONE			English	Article							LATERAL BALANCE CONTROL; MUSCLE-ACTIVITY; GAIT INITIATION; INFANTS; STABILIZATION; MOVEMENTS; ORGANIZATION; SPECIFICITY; PARAMETERS; PATTERNS	Although there is suggestive evidence that a link exists between independent walking and the ability to establish anticipatory strategy to stabilize posture, the extent to which this skill facilitates the development of anticipatory postural control remains largely unknown. Here, we examined the role of independent walking on the infants' ability to anticipate predictable external perturbations. Non-walking infants, walking infants and adults were sitting on a platform that produced continuous rotation in the frontal plane. Surface electromyography (EMG) of neck and lower back muscles and the positions of markers located on the platform, the upper body and the head were recorded. Results from cross-correlation analysis between rectified and filtered EMGs and platform movement indicated that although muscle activation already occurred before platform movement in non-walking infants, only walking infants demonstrated an adult-like ability for anticipation. Moreover, results from further cross-correlation analysis between segmental angular displacement and platform movement together with measures of balance control at the end-points of rotation of the platform evidenced two sorts of behaviour. The adults behaved as a non-rigid non-inverted pendulum, rather stabilizing head in space, while both the walking and non-walking infants followed the platform, behaving as a rigid inverted pendulum. These results suggest that the acquisition of independent walking plays a role in the development of anticipatory postural control, likely improving the internal model for the sensorimotor control of posture. However, despite such improvement, integrating the dynamics of an external object, here the platform, within the model to maintain balance still remains challenging in infants.	[Cignetti, Fabien; Vaugoyeau, Marianne; Assaiante, Christine] CNRS, LNC, UMR 7291, Marseille, France; [Cignetti, Fabien; Vaugoyeau, Marianne; Assaiante, Christine] Aix Marseille Univ, Marseille, France; [Cignetti, Fabien; Vaugoyeau, Marianne; Assaiante, Christine] Comportement Cerveau Cognit, Federat Rech N3512, Marseille, France; [Zedka, Milan] Univ Bern, Inselspital, Dept Paediat, Div Paediat Nephrol, CH-3010 Bern, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Bern; University Hospital of Bern	Assaiante, C (corresponding author), CNRS, LNC, UMR 7291, Marseille, France.	christine.assaiante@univ-provence.fr	Cignetti, Fabien/P-4551-2015	Cignetti, Fabien/0000-0002-9050-8056	French National Center for Scientific Research (CNRS)	French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This research was supported by funding from the French National Center for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph K., 2006, HDB CHILD DEV COGNIT, P161, DOI [10.1002/9780470147658.chpsy0204, DOI 10.1002/9780470147658.CHPSY0204]; Adolph KE, 2000, PSYCHOL SCI, V11, P290, DOI 10.1111/1467-9280.00258; Adolph KE, 1997, MONOGR SOC RES CHILD, V62, pR5; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; ASSAIANTE C, 1993, NEUROREPORT, V4, P875, DOI 10.1097/00001756-199307000-00009; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante C, 2000, J MOTOR BEHAV, V32, P211, DOI 10.1080/00222890009601373; Assaiante C, 1998, J MOTOR BEHAV, V30, P114, DOI 10.1080/00222899809601329; ASSAIANTE C, 1993, EXP BRAIN RES, V93, P499; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Barela JA, 1999, INFANT BEHAV DEV, V22, P87, DOI 10.1016/S0163-6383(99)80007-1; Bertenthal BI, 1997, J EXP PSYCHOL HUMAN, V23, P1631, DOI 10.1037/0096-1523.23.6.1631; Bertenthal BI, 2000, INFANT BEHAV DEV, V23, P299, DOI 10.1016/S0163-6383(01)00046-7; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Brogren E, 1996, DEV MED CHILD NEUROL, V38, P379; Buchanan JJ, 1999, J NEUROPHYSIOL, V81, P2325, DOI 10.1152/jn.1999.81.5.2325; Campos JJ, 2000, INFANCY, V1, P149, DOI 10.1207/S15327078IN0102_1; Chen LC, 2007, INFANT BEHAV DEV, V30, P16, DOI 10.1016/j.infbeh.2006.07.005; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Corna S, 1999, EXP BRAIN RES, V124, P331, DOI 10.1007/s002210050630; de Graaf-Peters VB, 2007, EXP BRAIN RES, V181, P647, DOI 10.1007/s00221-007-0964-6; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; De Nunzio AM, 2007, EXP BRAIN RES, V178, P18, DOI 10.1007/s00221-006-0708-z; Dingwell JB, 2008, IEEE T BIO-MED ENG, V55, P2666, DOI 10.1109/TBME.2008.2001130; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; HaddersAlgra M, 1996, J PHYSIOL-LONDON, V493, P289, DOI 10.1113/jphysiol.1996.sp021383; HaddersAlgra M, 1996, J PHYSIOL-LONDON, V493, P273, DOI 10.1113/jphysiol.1996.sp021382; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hore J, 1999, J NEUROPHYSIOL, V82, P1187, DOI 10.1152/jn.1999.82.3.1187; Isableu B, 2003, EXP BRAIN RES, V150, P208, DOI 10.1007/s00221-003-1446-0; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; Malouin F, 2000, GAIT POSTURE, V11, P239, DOI 10.1016/S0966-6362(00)00051-5; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; NARDONE A, 1988, EXP BRAIN RES, V69, P469; OMalley MJ, 1996, J BIOMECH, V29, P619, DOI 10.1016/0021-9290(95)00088-7; Orfanidis S. J., 1996, OPTIMUM SIGNAL PROCE; Ornitz EM, 1983, DEV AUDITORY VESTIBU, P479; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P388, DOI 10.1016/j.jelekin.2009.06.006; Schieppati M, 2002, EXP BRAIN RES, V144, P200, DOI 10.1007/s00221-002-1028-6; Shiratori T, 2001, CLIN NEUROPHYSIOL, V112, P1250, DOI 10.1016/S1388-2457(01)00553-3; van Balen LC, 2012, EXP BRAIN RES, V220, P109, DOI 10.1007/s00221-012-3121-9; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; Van der Fits IBM, 1999, EXP BRAIN RES, V126, P517, DOI 10.1007/s002210050760; Van Der Fits IBM, 1998, NEUROSCI BIOBEHAV R, V22, P521, DOI 10.1016/S0149-7634(97)00039-0; von Hofsten C, 2004, TRENDS COGN SCI, V8, P266, DOI 10.1016/j.tics.2004.04.002; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; Witherington DC, 2002, INFANCY, V3, P495, DOI 10.1207/S15327078IN0304_05	49	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56313	10.1371/journal.pone.0056313	http://dx.doi.org/10.1371/journal.pone.0056313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409171	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200131
J	Hoch, T; Kreitz, S; Gaffling, S; Pischetsrieder, M; Hess, A				Hoch, Tobias; Kreitz, Silke; Gaffling, Simone; Pischetsrieder, Monika; Hess, Andreas			Manganese-Enhanced Magnetic Resonance Imaging for Mapping of Whole Brain Activity Patterns Associated with the Intake of Snack Food in Ad Libitum Fed Rats	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; BODY-WEIGHT; RECEPTOR ANTAGONIST; COCAINE-SEEKING; REM-SLEEP; NUCLEUS; ADDICTION; DOPAMINE; BEHAVIOR; REWARD	Non-homeostatic hyperphagia, which is a major contributor to obesity-related hyperalimentation, is associated with the diet's molecular composition influencing, for example, the energy content. Thus, specific food items such as snack food may induce food intake independent from the state of satiety. To elucidate mechanisms how snack food may induce non-homeostatic food intake, it was tested if manganese-enhanced magnetic resonance imaging (MEMRI) was suitable for mapping the whole brain activity related to standard and snack food intake under normal behavioral situation. Application of the MnCl2 solution by osmotic pumps ensured that food intake was not significantly affected by the treatment. After z-score normalization and a non-affine three-dimensional registration to a rat brain atlas, significantly different grey values of 80 predefined brain structures were recorded in ad libitum fed rats after the intake of potato chips compared to standard chow at the group level. Ten of these areas had previously been connected to food intake, in particular to hyperphagia (e.g. dorsomedial hypothalamus or the anterior paraventricular thalamic nucleus) or to the satiety system (e.g. arcuate hypothalamic nucleus or solitary tract); 27 areas were related to reward/addiction including the core and shell of the nucleus accumbens, the ventral pallidum and the ventral striatum (caudate and putamen). Eleven areas associated to sleep displayed significantly reduced Mn2+-accumulation and six areas related to locomotor activity showed significantly increased Mn2+-accumulation after the intake of potato chips. The latter changes were associated with an observed significantly higher locomotor activity. Osmotic pump-assisted MEMRI proved to be a promising technique for functional mapping of whole brain activity patterns associated to nutritional intake under normal behavior.	[Hoch, Tobias; Pischetsrieder, Monika] Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Kreitz, Silke; Hess, Andreas] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Gaffling, Simone] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Gaffling, Simone] Univ Erlangen Nurnberg, SAOT, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Pischetsrieder, M (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, Emil Fischer Ctr, D-91054 Erlangen, Germany.	monika.pischetsrieder@lmchemie.uni-erlangen.de			Emerging Fields Initiative of the Friedrich-Alexander-University Erlangen-Nuremberg	Emerging Fields Initiative of the Friedrich-Alexander-University Erlangen-Nuremberg	The study is part of the Neurotrition Project, which is supported by the Emerging Fields Initiative of the Friedrich-Alexander-University Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard SM, 2005, J NEUROSCI, V25, P3578, DOI 10.1523/JNEUROSCI.4177-04.2005; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Chase MH, 2008, SLEEP, V31, P1487, DOI 10.1093/sleep/31.11.1487; Daum V, 2012, MODEL CONSTRAINED NO; Denbleyker M, 2009, NEUROSCIENCE, V162, P224, DOI 10.1016/j.neuroscience.2009.04.071; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Epping-Jordan MP, 1998, BRAIN RES, V784, P105, DOI 10.1016/S0006-8993(97)01190-6; Eschenko O, 2010, NEUROIMAGE, V49, P2544, DOI 10.1016/j.neuroimage.2009.10.079; Fischer B, 2003, J MATH IMAGING VIS, V18, P81, DOI 10.1023/A:1021897212261; Glick SD, 2006, EUR J PHARMACOL, V537, P94, DOI 10.1016/j.ejphar.2006.03.045; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harris Cameron D, 2005, Respir Care Clin N Am, V11, P567; Harrold JA, 2012, NEUROPHARMACOLOGY, V63, P3, DOI 10.1016/j.neuropharm.2012.01.007; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Kawagoe T, 2007, NEUROREPORT, V18, P683, DOI 10.1097/WNR.0b013e3280bef9a6; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Kranz GS, 2010, NEUROSCIENCE, V166, P1023, DOI 10.1016/j.neuroscience.2010.01.036; Lenard NR, 2008, OBESITY, V16, pS11, DOI 10.1038/oby.2008.511; Mansur SS, 2011, APPETITE, V57, P498, DOI 10.1016/j.appet.2011.06.017; Martin-Fardon R, 2008, NEUROPSYCHOPHARMACOL, V33, P1827, DOI 10.1038/sj.npp.1301589; McCrory MA, 2000, J NUTR, V130, p276S, DOI 10.1093/jn/130.2.276S; Morales L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036139; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Roncari CF, 2011, NEUROSCIENCE, V196, P147, DOI 10.1016/j.neuroscience.2011.08.042; Santis S, 2009, N-S ARCH PHARMACOL, V379, P181, DOI 10.1007/s00210-008-0346-z; Scopinho AA, 2008, BRIT J PHARMACOL, V155, P752, DOI 10.1038/bjp.2008.295; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2012, NEUROIMAGE, V62, P1009, DOI 10.1016/j.neuroimage.2012.01.008; Sirieix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028724; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Stratford TR, 2013, BRAIN RES, V1490, P128, DOI 10.1016/j.brainres.2012.10.043; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Sun WL, 2003, J NEUROSCI, V23, P10258; Tham WWP, 2009, BRAIN RES REV, V62, P109, DOI 10.1016/j.brainresrev.2009.09.007; Trepel M, 2003, NEUROANATOMIE STRUKT; Tzschentke TM, 1999, EUR J NEUROSCI, V11, P4099, DOI 10.1046/j.1460-9568.1999.00834.x; Valdes JL, 2006, EUR J NEUROSCI, V23, P1352, DOI 10.1111/j.1460-9568.2006.04659.x; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011	54	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55354	10.1371/journal.pone.0055354	http://dx.doi.org/10.1371/journal.pone.0055354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408973	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200026
J	Lu, SS; Liu, S; Zu, QQ; Xu, XQ; Yu, J; Wang, JW; Zhang, Y; Shi, HB				Lu, Shan-shan; Liu, Sheng; Zu, Qing-quan; Xu, Xiao-quan; Yu, Jing; Wang, Jian-wei; Zhang, Yu; Shi, Hai-bin			In Vivo MR Imaging of Intraarterially Delivered Magnetically Labeled Mesenchymal Stem Cells in a Canine Stroke Model	PLOS ONE			English	Article							MARROW STROMAL CELLS; CEREBRAL-ARTERY OCCLUSION; BONE-MARROW; ISCHEMIC-STROKE; TRANSPLANTATION; INJURY; RATS; INFARCTION; MIGRATION; BLOOD	Background: This study aimed to evaluate the feasibility of intraarterial (IA) delivery and in vivo MR imaging of superparamagnetic iron oxide (SPIO)-labeled mesenchymal stem cells (MSCs) in a canine stroke model. Methodology: MSCs harvested from beagles' bone marrow were labeled with home-synthesized SPIO. Adult beagle dogs (n = 12) were subjected to left proximal middle cerebral artery (MCA) occlusion by autologous thrombus, followed by two-hour left internal carotid artery (ICA) occlusion with 5 French vertebral catheter. One week later, dogs were classified as three groups before transplantation: group A: complete MCA recanalization, group B: incomplete MCA recanalization, group C: no MCA recanalization. 3x10(6) labeled-MSCs were delivered through left ICA. Series in vivo MRI images were obtained before cell grafting, one and 24 hours after transplantation and weekly thereafter until four weeks. MRI findings were compared with histological studies at the time point of 24 hours and four weeks. Principal Findings: Home-synthesized SPIO was useful to label MSCs without cell viability compromise. MSCs scattered widely in the left cerebral hemisphere in group A, while fewer grafted cells were observed in group B and no cell was detected in group C at one hour after transplantation. A larger infarction on the day of cell transplantation was associated with more grafted cells in the brain. Grafted MSCs could be tracked effectively by MRI within four weeks and were found in peri-infarction area by Prussian blue staining. Conclusion: It is feasible of IA MSCs transplantation in a canine stroke model. Both the ipsilateral MCA condition and infarction volume before transplantation may affect the amount of grafted cells in target brain. In vivo MR imaging is useful for tracking IA delivered MSCs after SPIO labeling.	[Lu, Shan-shan; Liu, Sheng; Zu, Qing-quan; Xu, Xiao-quan; Yu, Jing; Wang, Jian-wei; Shi, Hai-bin] Nanjing Med Univ, Dept Radiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Yu] Southeast Univ, State Key Lab Bioelect, Jiangsu Key Lab Biomat & Devices, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Shi, HB (corresponding author), Nanjing Med Univ, Dept Radiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	shihb@vip.sina.com			National Natural Science Foundation of China [30870710, 81000653]; foundation of Research and Innovation Program for postgraduates in Jiangsu Province [CXZZ11.0718]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation of Research and Innovation Program for postgraduates in Jiangsu Province	This study was supported by National Natural Science Foundation of China (30870710 to Hai-bin Shi, 81000653 to Sheng Liu) and foundation of Research and Innovation Program for postgraduates in Jiangsu Province (CXZZ11.0718 to Shan-shan Lu). http://www.nsfc.gov.cn/Portalo/default152.htm; http://www.ec.js.edu.cn/art/2011/6/11/art_4266_26988.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Ben-Hur T, 2003, GLIA, V41, P73, DOI 10.1002/glia.10159; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Criado FJ, 2002, J VASC SURG, V35, P430, DOI 10.1067/mva.2002.121209; Guzman R, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E14; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ju SH, 2006, MAGN RESON IMAGING, V24, P611, DOI 10.1016/j.mri.2005.12.017; Kang BT, 2007, J VET SCI, V8, P369, DOI 10.4142/jvs.2007.8.4.369; Kang BT, 2009, COMPARATIVE MED, V59, P459; Komatsu K, 2010, BRAIN RES, V1334, P84, DOI 10.1016/j.brainres.2010.04.006; Li L, 2006, J CEREBR BLOOD F MET, V26, P1366, DOI 10.1038/sj.jcbfm.9600288; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu S, 2012, J NEUROSCI METH, V209, P90, DOI 10.1016/j.jneumeth.2012.06.009; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Rice HE, 2007, AM J ROENTGENOL, V188, P1101, DOI 10.2214/AJR.06.0663; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Song M, 2009, NEUROSCI RES, V64, P235, DOI 10.1016/j.neures.2009.03.006; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Thu MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007218; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Weon YC, 2006, AM J ROENTGENOL, V186, P1148, DOI 10.2214/AJR.05.0683; Yocum GT, 2005, RADIOLOGY, V235, P547, DOI 10.1148/radiol.2352040383; Zhou B, 2010, MAGN RESON IMAGING, V28, P394, DOI 10.1016/j.mri.2009.12.005	34	37	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54963	10.1371/journal.pone.0054963	http://dx.doi.org/10.1371/journal.pone.0054963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408953	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200013
J	Stergiou, L; Bauer, M; Mair, W; Bausch-Fluck, D; Drayman, N; Wollscheid, B; Oppenheim, A; Pelkmans, L				Stergiou, Lilli; Bauer, Manuel; Mair, Waltraud; Bausch-Fluck, Damaris; Drayman, Nir; Wollscheid, Bernd; Oppenheim, Ariella; Pelkmans, Lucas			Integrin-Mediated Signaling Induced by Simian Virus 40 Leads to Transient Uncoupling of Cortical Actin and the Plasma Membrane	PLOS ONE			English	Article							ERM PROTEINS; EXTRACELLULAR-MATRIX; CAVEOLAR ENDOCYTOSIS; LINKED KINASE; CELLS; CYTOSKELETON; EZRIN/RADIXIN/MOESIN; PHOSPHORYLATION; DOMAINS; VIRUS	Simian Virus 40 (SV40) is a paradigm pathogen with multivalent binding sites for the sphingolipid GM1, via which it induces its endocytosis for infection. Here we report that SV40 also utilizes cell surface integrins to activate signaling networks required for infection, even in the absence of the previously implicated glycosphingolipids. We identify ILK, PDK1, the RhoGAP GRAF1 and RhoA as core nodes of the signaling network activated upon SV40 engagement of integrins. We show that integrin-mediated signaling through host SV40 engagement induces the de-phosphorylation of Ezrin leading to uncoupling of the plasma membrane and cortical actin. Our results provide functional evidence for a mechanism by which SV40 activates signal transduction in human epithelial cells via integrins in the context of clathrin-independent endocytosis.	[Stergiou, Lilli; Bauer, Manuel; Mair, Waltraud; Bausch-Fluck, Damaris; Wollscheid, Bernd; Pelkmans, Lucas] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Bausch-Fluck, Damaris; Wollscheid, Bernd] UZH ETH Zurich, NCCR, Neuro Ctr Prote, Zurich, Switzerland; [Drayman, Nir; Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hebrew University of Jerusalem	Pelkmans, L (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch	Wollscheid, Bernd/E-8909-2010	Wollscheid, Bernd/0000-0002-3923-1610; Pelkmans, Lucas/0000-0002-6754-9730	Bonizzi-Theler Foundation; Swiss National Science Foundation; National Center of Competence in Research (NCCR) Neural Plasticity and Repair; InfectX project within the Swiss Initiative in Systems Biology	Bonizzi-Theler Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); InfectX project within the Swiss Initiative in Systems Biology	This work was supported by the Bonizzi-Theler Foundation (LS), the Swiss National Science Foundation (LP), the National Center of Competence in Research (NCCR) Neural Plasticity and Repair (BW), and the InfectX project within the Swiss Initiative in Systems Biology (BW, LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Butin-Israeli V, 2010, J VIROL, V84, P3431, DOI 10.1128/JVI.01735-09; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chen YZ, 1999, EXP CELL RES, V246, P83, DOI 10.1006/excr.1998.4301; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hofmann A, 2010, BLOOD, V116, pE26, DOI 10.1182/blood-2010-02-271270; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Shibata H, 2001, J BIOCHEM, V130, P23, DOI 10.1093/oxfordjournals.jbchem.a002958; Siebers MC, 2008, J MATER SCI-MATER M, V19, P861, DOI 10.1007/s10856-007-0166-6; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Smith AE, 2003, FEBS LETT, V555, P199, DOI 10.1016/S0014-5793(03)01220-1; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200	50	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55799	10.1371/journal.pone.0055799	http://dx.doi.org/10.1371/journal.pone.0055799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409046	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000315157200066
J	Zhang, HX; Zhou, F; Li, C; Kong, M; Liu, H; Zhang, P; Zhang, S; Cao, JL; Zhang, LC; Ma, H				Zhang, Hongxing; Zhou, Fang; Li, Chen; Kong, Min; Liu, He; Zhang, Peng; Zhang, Song; Cao, Junli; Zhang, Licai; Ma, Hong			Molecular Mechanisms Underlying the Analgesic Property of Intrathecal Dexmedetomidine and Its Neurotoxicity Evaluation: An In Vivo and In Vitro Experimental Study	PLOS ONE			English	Article							LOCAL-ANESTHETICS; MICE; APOPTOSIS; PAIN; INVOLVEMENT; MODULATION; RECEPTORS; INDUCTION; PROTEIN; ERK	Background: Dexmedetomidine (DEX) has been used under perioperative settings as an adjuvant to enhance the analgesic property of local anesthetics by some anesthesiologists. However, the analgesic mechanisms and neurotoxicity of DEX were poorly understood. This study examined the effect of DEX alone on inflammatory pain, and it also examined the underlying molecular mechanisms of DEX in the spinal cord. Furthermore, in vivo and in vitro experiments were performed to investigate the neurotoxicity of DEX on the spinal cord and cortical neurons. Methods: This study used adult, male Kunming mice. In the acute inflammatory model, the left hind-paws of mice were intradermally injected with pH 5.0 PBS while chronic constrictive injury (CCI) of the sciatic nerve was used to duplicate the neuropathic pain condition. Thermal paw withdrawal latency and mechanical paw withdrawal threshold were tested with a radiant heat test and the Von Frey method, respectively. Locomotor activity and motor coordination were evaluated using the inverted mesh test. Western blotting examined spinal ERK1/2, p-ERK1/2, caspase-3 and beta-actin expressions, while spinal c-Fos protein expression was realized with immunohistochemical staining. Hematoxylin eosin (HE) staining was used to examine the pathological impacts of intrathecal DEX on the spinal cord. DAPI (4',6-diamidino-2-phenylindole) staining was used to observe cell death under an immunofluorescence microscope. Results: Intra-plantar pH 5.0 PBS-induced acute pain required spinal ERK1/2 activation. Inhibition of spinal ERK1/2 signaling by intrathecal injection of DEX displayed a robust analgesia, via a alpha 2-receptor dependent manner. The analgesic properties of DEX were validated in CCI mice. In vivo studies showed that intrathecal DEX has no significant pathological impacts on the spinal cord, and in vitro experiments indicated that DEX has potential protective effects of lidocaine-induced neural cell death. Conclusion: Intrathecal injection of DEX alone or as an adjuvant might be potential for pain relief.	[Zhang, Hongxing; Zhou, Fang; Liu, He] China Med Univ, Clin Coll 1, Shenyang, Liaoning, Peoples R China; [Zhang, Hongxing; Ma, Hong] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China; [Zhou, Fang; Li, Chen; Kong, Min; Liu, He; Zhang, Peng; Zhang, Song; Cao, Junli; Zhang, Licai] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Zhou, Fang] Xuzhou Med Coll, Sch Nursing, Xuzhou, Jiangsu, Peoples R China; [Cao, Junli] Xuzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China	China Medical University; China Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Ma, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China.	mahong5466@hotmail.com	Liu, He/C-9799-2012	Liu, He/0000-0002-4103-312X; Cao, Jun-Li/0000-0002-8932-4743	National Nature Science Foundation of China [81230025, 81200862]; Jiangsu Province University Graduate Student Science and Technology Innovation Project [CXLX12_0997]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province University Graduate Student Science and Technology Innovation Project	The study was supported by National Nature Science Foundation of China (81230025 and 81200862); Jiangsu Province University Graduate Student Science and Technology Innovation Project (CXLX12_0997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummett Chad M, 2009, J Opioid Manag, V5, P175; Bruzzone A, 2008, BRIT J PHARMACOL, V155, P494, DOI 10.1038/bjp.2008.278; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Drizin I, 2006, BIOORGAN MED CHEM, V14, P4740, DOI 10.1016/j.bmc.2006.03.027; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Grosu Irina, 2010, F1000 Med Rep, V2, P90, DOI 10.3410/M2-90; Guan XH, 2010, PHARMACOL BIOCHEM BE, V95, P315, DOI 10.1016/j.pbb.2010.02.007; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Hwang YP, 2011, MOL NUTR FOOD RES, V55, P594, DOI 10.1002/mnfr.201000292; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; KALSO EA, 1991, PHARMACOL TOXICOL, V68, P140, DOI 10.1111/j.1600-0773.1991.tb02052.x; Konakci S, 2008, EUR J ANAESTH, V25, P403, DOI 10.1017/S0265021507003079; Lee MJ, 2010, PHARMACOL BIOCHEM BE, V97, P198, DOI 10.1016/j.pbb.2010.07.018; Lee YJ, 2011, J NEUROCHEM, V119, P1262, DOI 10.1111/j.1471-4159.2011.07529.x; LESZCZYNSKA K, 1992, J PHARMACOL TOXICOL, V27, P85, DOI 10.1016/1056-8719(92)90026-W; Li LY, 2012, J MOL NEUROSCI; Liu H, 2011, PLOS ONE US; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Perez-Castro R, 2009, ANESTH ANALG, V108, P997, DOI 10.1213/ane.0b013e31819385e1; Ries CR, 2009, ANESTHESIOLOGY, V111, P122, DOI 10.1097/ALN.0b013e3181a9160e; Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Sites BD, 2012, REGION ANESTH PAIN M, V37, P478, DOI 10.1097/AAP.0b013e31825cb3d6; Tashiro A, 2009, NEUROSCIENCE, V164, P1813, DOI 10.1016/j.neuroscience.2009.09.058; Werdehausen R, 2009, BRIT J ANAESTH, V103, P711, DOI 10.1093/bja/aep236; Werdehausen R, 2007, ANESTHESIOLOGY, V107, P136, DOI 10.1097/01.anes.0000268389.39436.66; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	30	42	42	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55556	10.1371/journal.pone.0055556	http://dx.doi.org/10.1371/journal.pone.0055556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409000	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200039
J	Ironside, JE				Ironside, Joseph Edward			Diversity and Recombination of Dispersed Ribosomal DNA and Protein Coding Genes in Microsporidia	PLOS ONE			English	Article							RNA-POLYMERASE-II; NOSEMA TRICHOPLUSIAE; CHROMOSOMAL DNA; DEATH EVOLUTION; LARGEST SUBUNIT; BOMBUS SPP.; 5S RDNA; SEQUENCE; LEPIDOPTERA; VAIRIMORPHA	Microsporidian strains are usually classified on the basis of their ribosomal DNA (rDNA) sequences. Although rDNA occurs as multiple copies, in most non-microsporidian species copies within a genome occur as tandem arrays and are homogenised by concerted evolution. In contrast, microsporidian rDNA units are dispersed throughout the genome in some species, and on this basis are predicted to undergo reduced concerted evolution. Furthermore many microsporidian species appear to be asexual and should therefore exhibit reduced genetic diversity due to a lack of recombination. Here, DNA sequences are compared between microsporidia with different life cycles in order to determine the effects of concerted evolution and sexual reproduction upon the diversity of rDNA and protein coding genes. Comparisons of cloned rDNA sequences between microsporidia of the genus Nosema with different life cycles provide evidence of intragenomic variability coupled with strong purifying selection. This suggests a birth and death process of evolution. However, some concerted evolution is suggested by clustering of rDNA sequences within species. Variability of protein-coding sequences indicates that considerable intergenomic variation also occurs between microsporidian cells within a single host. Patterns of variation in microsporidian DNA sequences indicate that additional diversity is generated by intragenomic and/or intergenomic recombination between sequence variants. The discovery of intragenomic variability coupled with strong purifying selection in microsporidian rRNA sequences supports the hypothesis that concerted evolution is reduced when copies of a gene are dispersed rather than repeated tandemly. The presence of intragenomic variability also renders the use of rDNA sequences for barcoding microsporidia questionable. Evidence of recombination in the single-copy genes of putatively asexual microsporidia suggests that these species may undergo cryptic sexual reproduction, a possibility with profound implications for the evolution of virulence, host range and drug resistance in these species.	Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Ironside, JE (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	jei@aber.ac.uk		Ironside, Joseph/0000-0001-6292-4768	Royal Society [2004/R2]	Royal Society(Royal Society of London)	The research presented in this article was supported by a Royal Society research grant (Ref: 2004/R2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MD, 1994, J INVERTEBR PATHOL, V64, P100, DOI 10.1006/jipa.1994.1077; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Canning EU, 1999, PARASITOLOGY, V119, P273, DOI 10.1017/S0031182099004734; Cheney SA, 2001, J EUKARYOT MICROBIOL, V48, P111, DOI 10.1111/j.1550-7408.2001.tb00422.x; Choi Y, 2011, J INVERTEBR PATHOL, V107, P86, DOI 10.1016/j.jip.2011.02.005; Cordes N, 2012, J INVERTEBR PATHOL, V109, P209, DOI 10.1016/j.jip.2011.11.005; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001277; CREASE TJ, 1991, MOL BIOL EVOL, V8, P620; DOVER G, 1981, NATURE, V290, P731, DOI 10.1038/290731a0; Dunn AM, 1998, PARASITOLOGY, V117, P21, DOI 10.1017/S0031182098002753; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Freire R, 2010, J MOL EVOL, V70, P413, DOI 10.1007/s00239-010-9341-3; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Goldman ASH, 1996, GENETICS, V144, P43; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Huang WF, 2008, J INVERTEBR PATHOL, V97, P9, DOI 10.1016/j.jip.2007.07.001; Huang WF, 2004, FUNGAL GENET BIOL, V41, P473, DOI 10.1016/j.fgb.2003.12.005; Iiyama K, 2004, J EUKARYOT MICROBIOL, V51, P598, DOI 10.1111/j.1550-7408.2004.tb00592.x; Ironside JE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-48; KAWAKAMI Y, 1994, APPL ENTOMOL ZOOL, V29, P120, DOI 10.1303/aez.29.120; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Lee SC, 2010, PLOS ONE, P5; Li JL, 2012, INT J PARASITOL, V42, P49, DOI 10.1016/j.ijpara.2011.10.005; Liu HD, 2008, J INVERTEBR PATHOL, V99, P235, DOI 10.1016/j.jip.2008.06.012; MALONE LA, 1993, J INVERTEBR PATHOL, V61, P203, DOI 10.1006/jipa.1993.1036; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McTaggart S, 2007, GENETICS, V175, P311, DOI 10.1534/genetics.105.050229; MUNDERLOH UG, 1990, J INVERTEBR PATHOL, V56, P243, DOI 10.1016/0022-2011(90)90107-H; Nassonova E, 2005, FOLIA PARASIT, V52, P145, DOI 10.14411/fp.2005.019; Negi MS, 2002, GENOME, V45, P1181, DOI 10.1139/G02-094; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; O'Mahony EM, 2007, J EUKARYOT MICROBIOL, V54, P103, DOI 10.1111/j.1550-7408.2006.00232.x; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pieniazek NJ, 1996, J INVERTEBR PATHOL, V67, P316, DOI 10.1006/jipa.1996.0049; PILLEY BM, 1976, J INVERTEBR PATHOL, V28, P177, DOI 10.1016/0022-2011(76)90119-1; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; Sagastume S, 2011, ENVIRON MICROBIOL, V13, P84, DOI 10.1111/j.1462-2920.2010.02311.x; Sak B, 2011, FOLIA PARASIT, V58, P81, DOI 10.14411/fp.2011.008; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Schoch CL, 2012, NUCL RIBOSO IN PRESS; SMITH JM, 1992, J MOL EVOL, V34, P126; STREETT DA, 1984, J PARASITOL, V70, P452, DOI 10.2307/3281586; TANABE AM, 1967, J INVERTEBR PATHOL, V9, P188, DOI 10.1016/0022-2011(67)90007-9; Tay WT, 2005, J EUKARYOT MICROBIOL, V52, P505, DOI 10.1111/j.1550-7408.2005.00057.x; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Vierna J, 2009, BIOCHEM GENET, V47, P635, DOI 10.1007/s10528-009-9255-1; Voigt K, 2011, APPL MICROBIOL BIOT, V90, P41, DOI 10.1007/s00253-011-3143-4; Vrba V, 2011, VET PARASITOL, V183, P47, DOI 10.1016/j.vetpar.2011.06.020; Weedall RT, 2006, INT J PARASITOL, V36, P749, DOI 10.1016/j.ijpara.2006.02.020; Wilkinson TJ, 2011, INT J PARASITOL, V41, P959, DOI 10.1016/j.ijpara.2011.04.002	59	41	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55878	10.1371/journal.pone.0055878	http://dx.doi.org/10.1371/journal.pone.0055878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405227	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400172
J	Lu, X; Boora, U; Seabra, L; Rabai, EM; Fenton, J; Reiman, A; Nagy, Z; Maher, ER				Lu, X.; Boora, U.; Seabra, L.; Rabai, E. M.; Fenton, J.; Reiman, A.; Nagy, Z.; Maher, E. R.			Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dube tumour suppressor gene (FLCN)	ONCOGENE			English	Article						Birt-Hogg-Dube; folicullin; Slingshot phosphatases; synthetic lethality; caspase; therapeutic target	POLYCYSTIC KIDNEYS; RENAL-CARCINOMA; CANCER-THERAPY; MUTATIONS; PATHWAY; INHIBITION; FAMILIES; PROTEIN; MODEL	Birt-Hogg-Dube (BHD) syndrome, is a dominantly inherited familial cancer syndrome associated with susceptibility to renal cell carcinoma (RCC) caused by inactivating mutations in the folliculin (FLCN) gene. The precise functions of the FLCN gene product are still under investigation but RCC from BHD patients show loss of the wild-type allele consistent with a tumor suppressor gene function. In a search for potential synthetic-lethal targets for FLCN using a phosphatase siRNA library screening approach, we found that knockdown of SSH2 serine phosphatase (one of the three members of Slingshot family and previously implicated in actin reorganization) specifically induced Caspase3/7 activity in a dose-dependent manner (up to six-fold increase, 10 nM, 72 h) in two human FLCN-deficient cell lines (BHD-origin renal cell carcinoma UOK257 and thyroid carcinoma FTC133) but not in their folliculin expressing isogenic cell lines. SSH2 siRNA-induced knockdown was accompanied by increased expression of SSH1 and SSH3 (suggesting a compensatory regulatory mechanism among members of SSH family). FLCN-null cells exhibited evidence of dysregulated cofilin de/phosphorylation pathways. Knockdown of SSH2 in FLCN-null cells was associated with an alteration in cell cycle kinetics (20% increase in G1, 30% and 40% decrease in S and G2M, respectively). Combination treatment of multiple SSH family (SSH2 plus SSH1 and/or SSH3) siRNAs potentiated induction of Caspase3/7 activity and changes in the cell cycle kinetics. These data indicate that: (a) apoptotic cell death in FLCN-null cells can be triggered by SSH2 knockdown through cell cycle arrest; (b) SSH2 represents a potential therapeutic target for the development of agents for the treatment of BHD syndrome and, possibly, related tumors.	[Lu, X.; Boora, U.; Seabra, L.; Fenton, J.; Reiman, A.; Maher, E. R.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Ctr Rare Dis & Personalised Med, Birmingham B15 2TT, W Midlands, England; [Rabai, E. M.; Nagy, Z.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Maher, ER (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Ctr Rare Dis & Personalised Med, Birmingham B15 2TT, W Midlands, England.	E.R.MAHER@bham.ac.uk	MAHER, EAMONN R/A-9507-2008; Nagy, Zsuzsanna/L-8446-2013	MAHER, EAMONN R/0000-0002-6226-6918; Nagy, Zsuzsanna/0000-0002-6700-4829	Myrovlytis Trust	Myrovlytis Trust	We thank the Myrovlytis Trust for financial support.	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; da Silva NF, 2003, J MED GENET, V40, P820; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lim DHK, 2010, HUM MUTAT, V31, pE1043, DOI 10.1002/humu.21130; Lu XH, 2001, CLIN CANCER RES, V7, P2114; Lu XH, 2011, MOL CANCER THER, V10, P80, DOI 10.1158/1535-7163.MCT-10-0628; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Motzer RJ, 2009, CLIN GENITOURIN CANC, V7, P28, DOI 10.3816/CGC.2009.n.005; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Patel PH, 2006, CLIN CANCER RES, V12, P7215, DOI 10.1158/1078-0432.CCR-06-2254; Plastino J, 2005, CURR OPIN CELL BIOL, V17, P62, DOI 10.1016/j.ceb.2004.12.001; Posadas I, 2012, J NEUROCHEM, V120, P515, DOI 10.1111/j.1471-4159.2011.07599.x; Rehman FL, 2010, NAT REV CLIN ONCOL, V7, P718, DOI 10.1038/nrclinonc.2010.172; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Reinhardt HC, 2009, CELL CYCLE, V8, P3112, DOI 10.4161/cc.8.19.9626; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Yang Y, 2008, CANCER GENET CYTOGEN, V180, P100, DOI 10.1016/j.cancergencyto.2007.10.010	30	8	9	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					956	965		10.1038/onc.2013.27	http://dx.doi.org/10.1038/onc.2013.27			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23416984				2022-12-25	WOS:000331933200003
J	Nakanishi, H; Taccioli, C; Palatini, J; Fernandez-Cymering, C; Cui, R; Kim, T; Volinia, S; Croce, CM				Nakanishi, H.; Taccioli, C.; Palatini, J.; Fernandez-Cymering, C.; Cui, R.; Kim, T.; Volinia, S.; Croce, C. M.			Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway	ONCOGENE			English	Article						miRNA; MAPK; TACSTD2; HNSCC; miR-125b	SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR; MICRORNA SIGNATURES; ORAL-CANCER; EXPRESSION; IDENTIFICATION; TROP2; HETEROZYGOSITY; PROLIFERATION; DEREGULATION	MicroRNAs (miRNAs) have important roles in the initiation and progression of human cancer, but their role in head and neck cancer development and progression is not well defined. We aimed to determine whether specific miRNAs and their target mRNAs contribute to head and neck cancer pathogenesis and progression. To identify miRNAs associated with head and neck squamous cell carcinomas (HNSCCs), we analyzed HNSCC cell lines, normal head and neck tissues and normal keratinocytes by miRNA profiling; a group of differentially expressed miRNAs was identified, which includes miR-125b. Decreased expression of miR-125b is known to occur in epithelial cancers and many target mRNAs for this miR have been reported. We found decreased expression of miR-125b-1 and hypermethylation of its promoter in HNSCC compared with its non-malignant counterpart. The TACSTD2 (also known as TROP2) gene was identified and validated as a direct target of miR-125b-1. Abnormal expression of TACSTD2 cell-surface glycoprotein has been reported in most epithelial tumors, and the overexpressions of this mRNA and protein product has been considered a useful tumor marker. We report that miR-125b-1 causes mitogen-activated protein kinase pathway dysfunction through regulation of TACSTD2 expression. Thus, loss of miR-125b-1 may have a key role in the pathogenesis and progression of squamous cell carcinomas of head and neck and possibly of other tumors.	[Nakanishi, H.; Taccioli, C.; Palatini, J.; Fernandez-Cymering, C.; Cui, R.; Kim, T.; Volinia, S.; Croce, C. M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nakanishi, H.; Taccioli, C.; Palatini, J.; Fernandez-Cymering, C.; Cui, R.; Kim, T.; Volinia, S.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Croce, CM (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Carlo.Croce@osumc.edu	Volinia, Stefano/AAA-9264-2019; Young, Richard A/F-6495-2012; Cui, Ri/P-8507-2014; Taccioli, Cristian/F-8801-2010; Taccioli, Cristian/ABC-3379-2020; Volinia, Stefano/A-3029-2010; Kim, Taewan/M-5867-2013	Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Cui, Ri/0000-0001-6202-8779; Taccioli, Cristian/0000-0003-2995-5612; Taccioli, Cristian/0000-0003-2995-5612; Volinia, Stefano/0000-0003-0910-3893; Kim, Taewan/0000-0002-7202-009X; Palatini, Jeffrey/0000-0001-9280-4417	NATIONAL CANCER INSTITUTE [P30CA016058, U01CA166905, P01CA129242] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, U01 CA166905, P01 CA129242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fong D, 2008, BRIT J CANCER, V99, P1290, DOI 10.1038/sj.bjc.6604677; Fong D, 2008, MODERN PATHOL, V21, P186, DOI 10.1038/modpathol.3801001; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; GUPTA S, 1994, FEBS LETT, V353, P281, DOI 10.1016/0014-5793(94)01052-8; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Kimura S, 2010, ONCOL REP, V23, P1625, DOI 10.3892/or_00000804; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Muhlmann G, 2009, J CLIN PATHOL, V62, P152, DOI 10.1136/jcp.2008.060590; Nakanishi H, 2007, P NATL ACAD SCI USA, V104, P14442, DOI 10.1073/pnas.0703211104; Nakashima K, 2004, INT J CANCER, V112, P1029, DOI 10.1002/ijc.20517; NEGRINI M, 1995, CANCER RES, V55, P3003; Ohmachi T, 2006, CLIN CANCER RES, V12, P3057, DOI 10.1158/1078-0432.CCR-05-1961; RASIO D, 1995, CANCER RES, V55, P3988; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yamamoto N, 1999, ONCOL REP, V6, P1223; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	40	57	59	5	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					702	712		10.1038/onc.2013.13	http://dx.doi.org/10.1038/onc.2013.13			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23416980	Green Accepted, Green Published			2022-12-25	WOS:000331129200005
J	Kimura, Y; Mikami, Y; Osumi, K; Tsugane, M; Oka, J; Kimura, H				Kimura, Yuka; Mikami, Yoshinori; Osumi, Kimiko; Tsugane, Mamiko; Oka, Jun-ichiro; Kimura, Hideo			Polysulfides are possible H2S-derived signaling molecules in rat brain	FASEB JOURNAL			English	Article						persulfide; hydrogen sulfide; Ca2+ influx; TRP channels	CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; TRPA1; H2S; PRESERVATION; PROTECTS; CHANNEL	Accumulating evidence shows that hydrogen sulfide (H2S) has a variety of physiological functions. H2S is produced from cysteine by 3 sulfurtransferases. H2S, in turn, generates polysulfides, the functions of which are not well understood. H2S induces Ca2+ influx in astrocytes, a type of glia. However, the receptor that mediates the response has not been identified. Here, we have shown that polysulfides induce Ca2+ influx by activating transient receptor potential (TRP) A1 channels in rat astrocytes (EC50 91 nM, Hill coefficient value 1.77 +/- 0.26) and that the maximum response was induced at 0.5 mu M, which is 1/320 of the concentration of H2S required to achieve a response of similar magnitude (160 mu M, EC50 116 mu M). TRPA1-selective agonists, allyl isothiocyanate and cinnamaldehyde, induced Ca2+ influx, and responses to polysulfides were suppressed by TRPA1-selective inhibitors, HC-030031 and AP-18, as well as by siRNAs selective to TRPA1. The present study suggests that polysulfides are possible H2S-derived signaling molecules that stimulate TRP channels in the brain.-Kimura, Y., Mikami, Y., Osumi, K., Tsugane, M., Oka, J., Kimura, H. Polysulfides are possible H2S-derived signaling molecules in rat brain.	[Kimura, Yuka; Mikami, Yoshinori; Osumi, Kimiko; Tsugane, Mamiko; Kimura, Hideo] Natl Inst Neurosci, Dept Mol Pharmacol, Tokyo, Japan; [Oka, Jun-ichiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Chiba, Japan	National Center for Neurology & Psychiatry - Japan; Tokyo University of Science	Kimura, H (corresponding author), NCNP, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 1878502, Japan.	kimura@ncnp.go.jp	Kimura, Hideo/AGK-0606-2022; Mikami, Yoshinori/W-3056-2019; Kimura, Hideo/J-6811-2016; Mikami, Yoshinori/G-6174-2011	Kimura, Hideo/0000-0002-6069-0475; Mikami, Yoshinori/0000-0002-4335-4170; Mikami, Yoshinori/0000-0002-4335-4170	Japan National Institute of Neuroscience; KAKENHI [23790316, 22590258];  [23659089]; Grants-in-Aid for Scientific Research [23790316] Funding Source: KAKEN	Japan National Institute of Neuroscience; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan National Institute of Neuroscience, a Grant-in-Aid for Scientific Research (KAKENHI) for Challenging Exploratory Research (23659089) to H. K., a KAKENHI for Young Scientists (B) (23790316) to Y.M., and a KAKENHI (C) (22590258) to Y.K.	Abe K, 1996, J NEUROSCI, V16, P1066; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GIGGENBACH W, 1972, INORG CHEM, V11, P1201, DOI 10.1021/ic50112a009; Gun J, 2004, MICROCHIM ACTA, V146, P229, DOI 10.1007/s00604-004-0179-5; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kleinjan WE, 2005, IND ENG CHEM RES, V44, P309, DOI 10.1021/ie049579q; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Munchberg U, 2007, ORG BIOMOL CHEM, V5, P1505, DOI 10.1039/b703832a; Nagai Y, 2006, J PHARMACOL SCI, V100, p200P; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nagy P, 2010, CHEM RES TOXICOL, V23, P1541, DOI 10.1021/tx100266a; Nielsen RW, 2011, ANTIOXID REDOX SIGN, V15, P67, DOI 10.1089/ars.2010.3677; Ogawa H, 2012, NEUROSCIENCE, V218, P335, DOI 10.1016/j.neuroscience.2012.05.044; Oosumi K., 2010, B JPN SOC NEUROCHEM, V49, P517; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Predmore BL, 2012, AM J PHYSIOL-HEART C, V302, pH2410, DOI 10.1152/ajpheart.00044.2012; Searcy DG, 1998, J EXP ZOOL, V282, P310, DOI 10.1002/(SICI)1097-010X(19981015)282:3<310::AID-JEZ4>3.0.CO;2-P; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044; Tsugane M, 2007, ANTIOXID REDOX SIGN, V9, P257, DOI 10.1089/ars.2007.9.257; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wintner EA, 2010, BRIT J PHARMACOL, V160, P941, DOI 10.1111/j.1476-5381.2010.00704.x; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	38	253	264	0	82	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2451	2457		10.1096/fj.12-226415	http://dx.doi.org/10.1096/fj.12-226415			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23413359				2022-12-25	WOS:000319667600032
J	Romero-Silva, MJ; Mendez, V; Agullo, L; Seeger, M				Jose Romero-Silva, Maria; Mendez, Valentina; Agullo, Loreine; Seeger, Michael			Genomic and Functional Analyses of the Gentisate and Protocatechuate Ring-Cleavage Pathways and Related 3-Hydroxybenzoate and 4-Hydroxybenzoate Peripheral Pathways in Burkholderia xenovorans LB400	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE M5A1; SP STRAIN LB400; PSEUDOMONAS-PUTIDA; AROMATIC-COMPOUNDS; ACINETOBACTER-CALCOACETICUS; EVOLUTIONARY DIVERGENCE; BETA-KETOADIPATE; ACTIVE-SITE; DEGRADATION; PURIFICATION	In this study, the gentisate and protocatechuate pathways in Burkholderia xenovorans LB400 were analyzed by genomic and functional approaches, and their role in 3-hydroxybenzoate (3-HBA) and 4-hydroxybenzoate (4-HBA) degradation was proposed. The LB400 genome possesses two identical mhbRTDHI gene clusters encoding the gentisate pathway and one mhbM gene encoding a 3-HBA 6-hydroxylase that converts 3-HBA into gentisate. The pca genes encoding the protocatechuate pathway and the pobA gene encoding the 4-HBA 3-monooxygenase that oxidizes 4-HBA into protocatechuate are arranged in gene clusters and single genes mainly at the minor chromosome, but also at the major chromosome and the megaplasmid. Strain LB400 was able to grow on gentisate, protocatechuate, 3-HBA and 4-HBA. Transcriptional analyses showed that the mhbD gene encoding the gentisate 1,2-dioxygenase was expressed during growth on 3-HBA, 4-HBA and gentisate, whereas the pcaG gene encoding the protocatechuate 3,4-dioxygenase was expressed only during growth on 4-HBA and protocatechuate. The mhbM gene encoding the 3-HBA 6-hydroxylase was transcribed in strain LB400 during growth on HBAs, gentisate, protocatechuate and glucose. The pobA gene encoding the 4-HBA 3-monooxygenase was expressed during growth on HBAs and glucose. 3-HBA- and 4-HBA-grown LB400 cells showed gentisate 1,2-dioxygenase activity, whereas protocatechuate 3,4-dioxygenase activity was observed only in 4-HBA-grown cells. The mhbR gene encoding a MarR-type transcriptional regulator that probably regulates the expression of the MhbT transporter, and the pcaQ and pcaR genes encoding LysR-type transcriptional regulators that regulate pcaHG and pcaIJBDC genes, respectively, were transcribed during growth on both HBAs, gentisate, protocatechuate and glucose, suggesting a basal constitutive expression. The results indicate active gentisate, protocatechuate, 3-HBA and 4-HBA catabolic pathways in B. xenovorans LB400 and suggest that 3-HBA is channeled exclusively through the gentisate route, whereas 4-HBA is funneled into the protocatechuate central pathway and potentially into the gentisate pathway.	[Seeger, Michael] Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile; Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria	Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile.	michael.seeger@usm.cl	Agullo, Loreine/AAH-2424-2019; Seeger, Michael/AFK-3436-2022	Agullo Carvajal, Loreine Joselyn/0000-0003-4789-2686	FONDECYT [1110992, 1070507]; Center for Nanotechnology and Systems Biology; USM [131109, 130948]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center for Nanotechnology and Systems Biology; USM	M.S. acknowledges financial support from FONDECYT (1110992 and 1070507) (http://www.fondecyt.cl), Center for Nanotechnology and Systems Biology (http://www.usm.cl) and USM (131109, 130948) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Buchan A, 2000, APPL ENVIRON MICROB, V66, P4662, DOI 10.1128/AEM.66.11.4662-4672.2000; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; CRAWFORD RL, 1976, J BACTERIOL, V127, P204, DOI 10.1128/JB.127.1.204-210.1976; Fairley DJ, 2002, APPL ENVIRON MICROB, V68, P6246, DOI 10.1128/AEM.68.12.6246-6255.2002; GOETZ FE, 1992, FEMS MICROBIOL LETT, V97, P45; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; HARPEL MR, 1990, J BIOL CHEM, V265, P22187; HARTNETT C, 1990, J BACTERIOL, V172, P956, DOI 10.1128/jb.172.2.956-966.1990; HARTNETT GB, 1994, GENE, V142, P23, DOI 10.1016/0378-1119(94)90350-6; HARWOOD CS, 1994, J BACTERIOL, V176, P6479, DOI 10.1128/JB.176.21.6479-6488.1994; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; JONES DCN, 1990, ARCH MICROBIOL, V154, P489, DOI 10.1007/BF00245233; Khang HY, 2002, BIOCHEM BIOPH RES CO, V295, P903; Lin LX, 2010, MICROBIOL RES, V165, P66, DOI 10.1016/j.micres.2008.08.001; Liu TT, 2011, APPL MICROBIOL BIOT, V90, P671, DOI 10.1007/s00253-010-3033-1; Ma YF, 2009, APPL ENVIRON MICROB, V75, P6812, DOI 10.1128/AEM.00933-09; MacLean AM, 2011, MICROBIOL-SGM, V157, P2522, DOI 10.1099/mic.0.050542-0; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; MICHALOVER JL, 1973, BIOCHEM BIOPH RES CO, V55, P888, DOI 10.1016/0006-291X(73)91227-8; Nichols NN, 1997, J BACTERIOL, V179, P5056, DOI 10.1128/jb.179.16.5056-5061.1997; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; PARALES RE, 1992, J BACTERIOL, V174, P4657, DOI 10.1128/JB.174.14.4657-4666.1992; Parke D, 1996, J BACTERIOL, V178, P266, DOI 10.1128/jb.178.1.266-272.1996; Perera IC, 2011, PROTEIN SCI, V20, P621, DOI 10.1002/pro.588; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; POH C L, 1980, Journal of Bacteriology, V143, P59; Ponce BL, 2011, ENZYME MICROB TECH, V49, P509, DOI 10.1016/j.enzmictec.2011.04.021; Robson ND, 1996, MICROBIOL-SGM, V142, P2115, DOI 10.1099/13500872-142-8-2115; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; SEEGER M, 1995, APPL ENVIRON MICROB, V61, P2654, DOI 10.1128/AEM.61.7.2654-2658.1995; Seibold B, 1996, EUR J BIOCHEM, V239, P469, DOI 10.1111/j.1432-1033.1996.0469u.x; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Suarez M, 1996, FEMS MICROBIOL LETT, V143, P89, DOI 10.1016/0378-1097(96)00299-6; SUAREZ M, 1995, ARCH MICROBIOL, V164, P70; VANBERKEL W, 1992, EUR J BIOCHEM, V210, P411; Vanelli T, 1995, BIOCHEMISTRY-US, V34, P11743; WANG LH, 1987, BIOCHEMISTRY-US, V26, P1099, DOI 10.1021/bi00378a017; Weilharter A, 2011, J BACTERIOL, V193, P3383, DOI 10.1128/JB.05055-11; WHEELIS ML, 1967, ARCH MIKROBIOL, V59, P302, DOI 10.1007/BF00406344; WILLIAMS SE, 1992, BIOCHEMISTRY-US, V31, P9768, DOI 10.1021/bi00155a033; WRIGHT JD, 1991, APPL MICROBIOL BIOT, V35, P94, DOI 10.1007/BF00180643; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x	49	44	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56038	10.1371/journal.pone.0056038	http://dx.doi.org/10.1371/journal.pone.0056038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418504	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300096
J	Komarova, NL; Jameson, KA				Komarova, Natalia L.; Jameson, Kimberly A.			A Quantitative Theory of Human Color Choices	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; EVOLUTIONARY MODELS; CATEGORIZATION; UNIVERSALITY; VISION	The system for colorimetry adopted by the Commission Internationale de l'Eclairage (CIE) in 1931, along with its subsequent improvements, represents a family of light mixture models that has served well for many decades for stimulus specification and reproduction when highly controlled color standards are important. Still, with regard to color appearance many perceptual and cognitive factors are known to contribute to color similarity, and, in general, to all cognitive judgments of color. Using experimentally obtained odd-one-out triad similarity judgments from 52 observers, we demonstrate that CIE-based models can explain a good portion (but not all) of the color similarity data. Color difference quantified by CIELAB Delta E explained behavior at levels of 81% (across all colors), 79% (across red colors), and 66% (across blue colors). We show that the unexplained variation cannot be ascribed to inter-or intra-individual variations among the observers, and points to the presence of additional factors shared by the majority of responders. Based on this, we create a quantitative model of a lexicographic semiorder type, which shows how different perceptual and cognitive influences can trade-off when making color similarity judgments. We show that by incorporating additional influences related to categorical and lightness and saturation factors, the model explains more of the triad similarity behavior, namely, 91% (all colors), 90% (reds), and 87% (blues). We conclude that distance in a CIE model is but the first of several layers in a hierarchy of higher-order cognitive influences that shape color triad choices. We further discuss additional mitigating influences outside the scope of CIE modeling, which can be incorporated in this framework, including well-known influences from language, stimulus set effects, and color preference bias. We also discuss universal and cultural aspects of the model as well as non-uniformity of the color space with respect to different cultural biases.	[Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Jameson, Kimberly A.] Univ Calif Irvine, Inst Math & Behav Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Science Foundation (NSF) from the Methodology, Measurement, and Statistics (MMS) Program of the Division of Social and Economic Sciences (SES) [NSF 07724228]	National Science Foundation (NSF) from the Methodology, Measurement, and Statistics (MMS) Program of the Division of Social and Economic Sciences (SES)(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Partial support was provided by National Science Foundation (NSF) grant NSF 07724228 from the Methodology, Measurement, and Statistics (MMS) Program of the Division of Social and Economic Sciences (SES). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Barratt L. B., 1996, INT J LEXICOGR, V9, P102, DOI DOI 10.1093/IJL/9.2.102; Bartleson C.J., 1976, COLOR RES APPL, V1, P181; Battistella EL., 1996, LOGIC MARKEDNESS; Berlin B., 1969, BASIC COLOR TERMS TH; Bimler D, 2004, BEHAV RES METH INS C, V36, P69, DOI 10.3758/BF03195550; Bostock J., 1855, NATURAL HIST PLINY E; Brown AM, 2011, J VISION, V11, DOI 10.1167/11.12.2; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; Diaz JA, 1998, COLOR RES APPL, V23, P379, DOI 10.1002/(SICI)1520-6378(199812)23:6<379::AID-COL6>3.0.CO;2-E; Fairchild M. D., 2005, COLOR APPEARANCE MOD; FAIRCHILD MD, 1993, COLOR RES APPL, V18, P178, DOI 10.1002/col.5080180308; Fernandez-Maloigne C., 2013, ADV COLOR IMAGE PROC; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; HELM CE, 1962, AM J PSYCHOL, V75, P437, DOI 10.2307/1419867; Jameson K., 1997, COLOR CATEGORIES THO, P295, DOI DOI 10.1017/CBO9780511519819.014; Jameson KA, 2003, COLOR RES APPL, V28, P113, DOI 10.1002/col.10131; Jameson KA, 2005, J COGN CULT, V5, P293, DOI 10.1163/156853705774648527; Jameson KA, 2009, J OPT SOC AM A, V26, P1424, DOI 10.1364/JOSAA.26.001424; Jameson KA, 2009, J OPT SOC AM A, V26, P1414, DOI 10.1364/JOSAA.26.001414; Komarova NI, 2008, J THEOR BIOL, V253, P680, DOI 10.1016/j.jtbi.2008.03.030; Lindsey DT, 2006, P NATL ACAD SCI USA, V103, P16608, DOI 10.1073/pnas.0607708103; MacLaury RE, 2007, ANTHROPOLOGY OF COLOR: INTERDISCIPLINARY MULTILEVEL MODELING, P1; MACLAURY RE, 1992, CURR ANTHROPOL, V33, P137, DOI 10.1086/204049; Moore CC, 2000, P NATL ACAD SCI USA, V97, P5007, DOI 10.1073/pnas.97.9.5007; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Paramei GV, 2005, CROSS-CULT RES, V39, P10, DOI 10.1177/1069397104267888; Paramei GV, 1998, VISION RES, V38, P3397, DOI 10.1016/S0042-6989(97)00454-9; Regier T, 2005, P NATL ACAD SCI USA, V102, P8386, DOI 10.1073/pnas.0503281102; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Sayim B, 1988, J COGNITION CULTURE, V5, P427; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; WEBSTER MA, 1988, J OPT SOC AM A, V5, P1722, DOI 10.1364/JOSAA.5.001722; WYSECKI G, 1982, COLOR SCI CONCEPTS M; Xiao YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024994; Zhang XM, 1997, COMPCON IEEE, P44, DOI 10.1109/CMPCON.1997.584669	39	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55986	10.1371/journal.pone.0055986	http://dx.doi.org/10.1371/journal.pone.0055986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23409103	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000036
J	Cloward, JM; Shafer, WM				Cloward, Jason M.; Shafer, William M.			MtrR Control of a Transcriptional Regulatory Pathway in Neisseria meningitidis That Influences Expression of a Gene (nadA) Encoding a Vaccine Candidate	PLOS ONE			English	Article							EFFLUX PUMP; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CORREIA ELEMENT; PHASE VARIATION; DNA-SEQUENCE; HUMAN SALIVA; GONORRHOEAE; RESISTANCE; PROTEIN	The surface-exposed NadA adhesin produced by a subset of capsular serogroup B strains of Neisseria meningitidis is currently being considered as a vaccine candidate to prevent invasive disease caused by a hypervirulent lineage of meningococci. Levels of NadA are known to be controlled by both transcriptional regulatory factors and a component of human saliva, 4-hydroxyphenylacetic acid. Herein, we confirmed the capacity of a DNA-binding protein termed FarR to negatively control nadA expression. We also found that a known transcriptional regulator of farR in N. gonorrhoeae termed MtrR can have a negative regulatory impact on farR and nadA expression, especially when over-expressed. MtrR-mediated repression of nadA was found to be direct, and its binding to a target DNA sequence containing the nadA promoter influenced formation and/or stability of FarR:: nadA complexes. The complexity of the multi-layered regulation of nadA uncovered during this investigation suggests that N. meningitidis modulates NadA adhesin protein levels for the purpose of interacting with host cells yet avoiding antibody directed against surface exposed epitopes.	[Cloward, Jason M.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Cloward, Jason M.; Shafer, William M.] Vet Affairs Med Ctr Atlanta, Labs Bacterial Pathogenesis, Decatur, GA USA	Emory University	Shafer, WM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	wshafer@emory.edu			NIH [AI021150-28]; VA Merit award; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021150, R37AI021150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit award(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI021150-28 and a VA Merit award to W. M. S. W. M. S. is the recipient of a Senior Research Career Scientist Award from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Cartwright K., 1995, MENINGOCOCCAL DIS, P115; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Enriquez R, 2010, J MED MICROBIOL, V59, P1055, DOI 10.1099/jmm.0.021220-0; Fagnocchi L, 2012, J BACTERIOL, V194, P460, DOI 10.1128/JB.06161-11; Folster JP, 2007, J BACTERIOL, V189, P4569, DOI 10.1128/JB.00286-07; Folster JP, 2009, J BACTERIOL, V191, P287, DOI 10.1128/JB.01165-08; HAGMAN KE, 1995, J BACTERIOL, V177, P4162, DOI 10.1128/jb.177.14.4162-4165.1995; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Johnson PJT, 2011, ANTIMICROB AGENTS CH, V55, P2559, DOI 10.1128/AAC.00010-11; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EH, 2003, J BACTERIOL, V185, P7145, DOI 10.1128/JB.185.24.7145-7152.2003; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lucas CE, 1997, J BACTERIOL, V179, P4123, DOI 10.1128/jb.179.13.4123-4128.1997; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; MENARD R, 1993, J BACTERIOL, V175, P5899; Metruccio MME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000710; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Ohneck EA, 2011, MBIO, V2; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rouquette-Loughlin CE, 2004, MOL MICROBIOL, V54, P731, DOI 10.1111/j.1365-2958.2004.04299.x; Sambrook J., 2002, MOL CLONING LAB MANU; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; Schielke S, 2011, INT J MED MICROBIOL, V301, P325, DOI 10.1016/j.ijmm.2010.11.007; Schielke S, 2010, APPL ENVIRON MICROB, V76, P3160, DOI 10.1128/AEM.02833-09; Schielke S, 2009, MOL MICROBIOL, V72, P1054, DOI 10.1111/j.1365-2958.2009.06710.x; SHAFER WM, 1984, ANTIMICROB AGENTS CH, V25, P767, DOI 10.1128/AAC.25.6.767; SHAFER WM, 1995, MICROBIOL-UK, V141, P907, DOI 10.1099/13500872-141-4-907; Sharip A, 2006, PEDIATR INFECT DIS J, V25, P191, DOI 10.1097/01.inf.0000202065.03366.0c; SILVER LE, 1995, GENE, V166, P101, DOI 10.1016/0378-1119(95)00605-6; SIMON D, 1992, P NATL ACAD SCI USA, V89, P5512, DOI 10.1073/pnas.89.12.5512; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; Takahama U, 2002, FEBS LETT, V518, P116, DOI 10.1016/S0014-5793(02)02659-5; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Zalucki YM, 2011, FUNCTION REGULATION	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56097	10.1371/journal.pone.0056097	http://dx.doi.org/10.1371/journal.pone.0056097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409129	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300056
J	Alvarez-Castelao, B; Losada, F; Ahicart, P; Castano, JG				Alvarez-Castelao, Beatriz; Losada, Fernando; Ahicart, Patricia; Castano, Jose G.			The N-Terminal Region of Nurr1 (a.a 1-31) Is Essential for Its Efficient Degradation by the Ubiquitin Proteasome Pathway	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; MIDBRAIN DOPAMINERGIC-NEURONS; TYROSINE-HYDROXYLASE GENE; PARKINSONS-DISEASE; TRANSCRIPTION FACTOR; PROGENITOR CELLS; ALPHA-SYNUCLEIN; IN-VITRO; EXPRESSION; MUTANT	NURR1/NR4A2 is an orphan nuclear receptor that is critical for the development and maintenance of mesencephalic dopaminergic neurons and regulates transcription of genes involved in the function of dopaminergic neurons directly via specific NGFI-B response elements (NBRE). and substantial data support a possible role of Nurr1 in the pathogenesis of Parkinson's disease (PD). Here we show that Nurr1 is degraded by the ubiquitin-proteasome pathway and determined that N-terminal region (a. a 1-31) of Nurr1 is essential for an efficient targeting of Nurr1 to degradation in the cell. Nurr1 Delta 1-31 has a much longer half-life, and as a consequence its steady-state protein levels were higher, than full-length Nurr1 in the cell. Nurr1 Delta 1-31 was as potent as Nurr1 full length in transcriptional luciferase reporter assays after normalization with the corresponding steady-state protein expression levels, either in trans-activation of NBRE or trans-repression of iNOS (inducible NO synthase) reporters. These results suggest that Nurr1 Delta 1-31, because of longer persistence in the cell, can be a good candidate for gene and cell therapies in the treatment of PD.	[Alvarez-Castelao, Beatriz; Losada, Fernando; Ahicart, Patricia; Castano, Jose G.] Univ Autonoma Madrid, Fac Med,Inst Invest Biomed Alberto Sols, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Consejo Super Invest Cient,Dept Bioquim, Madrid, Spain	Autonomous University of Madrid; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Castano, JG (corresponding author), Univ Autonoma Madrid, Fac Med,Inst Invest Biomed Alberto Sols, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Consejo Super Invest Cient,Dept Bioquim, Madrid, Spain.	joseg.castano@uam.es	Alvarez-castelao, Beatriz/ABG-8826-2021; alvarez-castelao, beatriz/W-1707-2018	alvarez-castelao, beatriz/0000-0001-7505-1855; G. Castano, Jose/0000-0002-6579-8442	MINECO [SAF-2011-22643]; Fundacion Mutua Madrilena; Comunidad de Madrid [P2010_BMD-2331]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas	MINECO(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas	This work was supported by grants from MINECO SAF-2011-22643, Fundacion Mutua Madrilena, Comunidad de Madrid P2010_BMD-2331 & Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas to JGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Chu YP, 2006, J COMP NEUROL, V494, P495, DOI 10.1002/cne.20828; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Eells JB, 2002, BEHAV BRAIN RES, V136, P267, DOI 10.1016/S0166-4328(02)00185-7; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Jacobsen KX, 2008, NEUROBIOL DIS, V29, P117, DOI 10.1016/j.nbd.2007.08.003; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Jo AY, 2009, STEM CELLS, V27, P2238, DOI 10.1002/stem.146; Jorgensen JR, 2006, EXP NEUROL, V198, P427, DOI 10.1016/j.expneurol.2005.12.023; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kessler MA, 2003, MOL BRAIN RES, V112, P8, DOI 10.1016/S0169-328X(02)00694-0; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Kim SJ, 2006, NEUROREPORT, V17, P1729, DOI 10.1097/01.wnr.0000239951.14954.10; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; MAGES HW, 1994, MOL ENDOCRINOL, V8, P1583, DOI 10.1210/me.8.11.1583; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Nordzell M, 2004, BIOCHEM BIOPH RES CO, V313, P205, DOI 10.1016/j.bbrc.2003.11.079; Park CH, 2012, DEVELOPMENT, V139, P2447, DOI 10.1242/dev.075978; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SaucedoCardenas O, 1996, J MOL NEUROSCI, V7, P51, DOI 10.1007/BF02736848; Sleiman PMA, 2009, NEUROSCI LETT, V457, P75, DOI 10.1016/j.neulet.2009.03.021; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Vila-Del Sol V, 2007, J LEUKOCYTE BIOL, V81, P272, DOI 10.1189/jlb.0905529; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Witta J, 2000, MOL BRAIN RES, V84, P67, DOI 10.1016/S0169-328X(00)00211-4; Xu PY, 2002, NEUROLOGY, V58, P881, DOI 10.1212/WNL.58.6.881; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041	38	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55999	10.1371/journal.pone.0055999	http://dx.doi.org/10.1371/journal.pone.0055999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409108	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200101
J	Dumitru, CA; Bankfalvi, A; Gu, X; Zeidler, R; Brandau, S; Lang, S				Dumitru, Claudia A.; Bankfalvi, Agnes; Gu, Xiang; Zeidler, Reinhard; Brandau, Sven; Lang, Stephan			AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; NECK-CANCER; DESMOYOKIN/AHNAK PROTEIN; CELL; NEUTROPHILS; IDENTIFICATION; HEAD; BIOLOGY; TARGET; LINK	AHNAK/Desmoyokin is a giant protein which has been recently linked to reorganization of the actin cytoskeleton, cellular migration and invasion. Here, we investigated the role of AHNAK in the pathophysiology of larynx carcinoma-one of the major subtypes of head and neck cancer. To this end, we analysed AHNAK expression in tumor tissues from 83 larynx carcinoma patients in relation to overall survival. We found that tumoral AHNAK overexpression significantly associated with poor survival of these patients both in univariate and multivariate analysis. In further studies, we combined the prognostic value of AHNAK with selected markers of inflammation, such as macrophage migration inhibitory factor (MIF) and tumor-infiltrating neutrophils (CD66b-positive cells). Both MIF and neutrophils have been linked to enhanced tumoral migration and poor clinical outcome in patients with orohypopharynx carcinoma-another major subtype of head and neck cancer. Interestingly, we found that synchronous high levels of AHNAK and MIF or AHNAK and neutrophils, respectively, were stronger predictors of poor survival than AHNAK alone. Synchronous high levels of all three markers were the strongest predictors of poor survival in our patient cohort. Taken together, our findings propose novel strategies for an accurate prognosis in larynx carcinoma and suggest potential mechanisms of inflammation-mediated tumor progression.	[Dumitru, Claudia A.; Gu, Xiang; Brandau, Sven; Lang, Stephan] Univ Duisburg Essen, Dept Otorhinolaryngol, Essen, Germany; [Bankfalvi, Agnes] Univ Duisburg Essen, Dept Pathol Neuropathol, Essen, Germany; [Zeidler, Reinhard] Univ Munich, Dept Otorhinolaryngol, Munich, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Munich	Dumitru, CA (corresponding author), Univ Duisburg Essen, Dept Otorhinolaryngol, Essen, Germany.	claudia.dumitru@uni-due.de	Zeidler, Reinhard/M-9837-2014	Zeidler, Reinhard/0000-0002-3357-4954; Brandau, Sven/0000-0002-2702-4163	Bundesministerium fA1/4Jr Bildung und Forschung (BMBF)	Bundesministerium fA1/4Jr Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was in part supported by the Bundesministerium fA1/4Jr Bildung und Forschung (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Brandau S, 2013, SEMIN IMMUNOPATHOL, V35, P163, DOI 10.1007/s00281-012-0344-6; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Choong N, 2008, CA-CANCER J CLIN, V58, P32, DOI 10.3322/CA.2007.0004; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Dumitru CA, 2012, J LEUKOCYTE BIOL, V91, P591, DOI 10.1189/jlb.0411193; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Leong S, 2012, J PROTEOME RES, V11, P3561, DOI 10.1021/pr2012335; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; MASUNAGA T, 1995, J INVEST DERMATOL, V104, P941, DOI 10.1111/1523-1747.ep12606213; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Rauch J, 2004, BIOCHEM BIOPH RES CO, V323, P156, DOI 10.1016/j.bbrc.2004.08.071; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Tanaka M, 2008, CANCER SCI, V99, P979, DOI 10.1111/j.1349-7006.2008.00757.x; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892	29	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56420	10.1371/journal.pone.0056420	http://dx.doi.org/10.1371/journal.pone.0056420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409183	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200135
J	Esfandiarei, M; Fameli, N; Choi, YYH; Tehrani, AY; Hoskins, JG; van Breemen, C				Esfandiarei, Mitra; Fameli, Nicola; Choi, Yohan Y. H.; Tehrani, Arash Y.; Hoskins, Jeremy G.; van Breemen, Cornelis			Waves of Calcium Depletion in the Sarcoplasmic Reticulum of Vascular Smooth Muscle Cells: An Inside View of Spatiotemporal Ca2+ Regulation	PLOS ONE			English	Article							LUMINAL CA2+; INOSITOL 1,4,5-TRISPHOSPHATE; INDUCED CONTRACTION; RELEASE; CHANNEL; ACTIVATION; VISUALIZATION; OSCILLATIONS; MITOCHONDRIA; DYNAMICS	Agonist-stimulated smooth muscle Ca2+ waves regulate blood vessel tone and vasomotion. Previous studies employing cytoplasmic Ca2+ indicators revealed that these Ca2+ waves were stimulated by a combination of inositol 1,4,5trisphosphate- and Ca2+-induced Ca2+ release from the endo/sarcoplasmic reticulum. Herein, we present the first report of endothelin-1 stimulated waves of Ca2+ depletion from the sarcoplasmic reticulum of vascular smooth muscle cells using a calsequestrin-targeted Ca2+ indicator. Our findings confirm that these waves are due to regenerative Ca2+-induced Ca2+ release by the receptors for inositol 1,4,5-trisphosphate. Our main new finding is a transient elevation in SR luminal Ca2+ concentration ([Ca2+](SR)) both at the site of wave initiation, just before regenerative Ca2+ release commences, and at the advancing wave front, during propagation. This strongly suggests a role for [Ca2+](SR) in the activation of inositol 1,4,5-trisphosphate receptors during agonist-induced calcium waves. In addition, quantitative analysis of the gradual decrease in the velocity of the depletion wave, observed in the absence of external Ca2+, indicates continuity of the lumen of the sarcoplasmic reticulum network. Finally, our observation that the depletion wave was arrested by the nuclear envelope may have implications for selective Ca2+ signalling.	[Esfandiarei, Mitra; Fameli, Nicola; Choi, Yohan Y. H.; Tehrani, Arash Y.; Hoskins, Jeremy G.; van Breemen, Cornelis] Univ British Columbia, Child & Family Res Inst, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia	Esfandiarei, M (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	mesfandiarei@gmail.com	Esfandiarei, Mitra/R-9903-2019; Esfandiarei, Mitra/V-1258-2019; Fameli, Nicola/AAB-7934-2019	Esfandiarei, Mitra/0000-0003-3218-7781; Fameli, Nicola/0000-0002-2022-7048	Canadian Institutes of Health Research [84309]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the operating grant (FRN#84309) from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1994, MOL CELL ENDOCRINOL, V98, P119, DOI 10.1016/0303-7207(94)90129-5; BERRIDGE MJ, 1991, CELL CALCIUM, V12, P63, DOI 10.1016/0143-4160(91)90009-4; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gordienko DV, 2001, CELL CALCIUM, V29, P13, DOI 10.1054/ceca.2000.0180; IINO M, 1987, BIOCHEM BIOPH RES CO, V142, P47, DOI 10.1016/0006-291X(87)90449-9; IINO M, 1994, EMBO J, V13, P5026, DOI 10.1002/j.1460-2075.1994.tb06831.x; Iino M, 2010, P JPN ACAD B-PHYS, V86, P244, DOI 10.2183/pjab.86.244; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; Lee CH, 2002, AM J PHYSIOL-HEART C, V282, pH1768, DOI 10.1152/ajpheart.00637.2001; Lee CH, 2002, AM J PHYSIOL-HEART C, V282, pH1571, DOI 10.1152/ajpheart.01035.2001; Lee CH, 2002, NOVART FDN SYMP, V246, P48; Lee Cheng-Han, 2002, Novartis Found Symp, V246, P26; LEIJTEN PAA, 1986, BRIT J PHARMACOL, V89, P739, DOI 10.1111/j.1476-5381.1986.tb11178.x; LoRusso A, 1996, BRIT J PHARMACOL, V118, P885; McCarron JG, 2008, J CELL SCI, V121, P86, DOI 10.1242/jcs.017541; McCarron JG, 2010, J CELL PHYSIOL, V224, P334, DOI 10.1002/jcp.22103; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; Dai JM, 2010, EUR J PHARMACOL, V629, P82, DOI 10.1016/j.ejphar.2009.11.055; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; Missiaen L, 1996, CELL CALCIUM, V19, P91, DOI 10.1016/S0143-4160(96)90016-0; NEYLON CB, 1990, AM J PHYSIOL, V259, pC675, DOI 10.1152/ajpcell.1990.259.4.C675; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Poburko D, 2004, TRENDS PHARMACOL SCI, V25, P8, DOI 10.1016/j.tips.2003.10.011; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; Rainbow RD, 2009, CELL CALCIUM, V46, P313, DOI 10.1016/j.ceca.2009.09.001; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Shmygol A, 2005, CELL CALCIUM, V37, P215, DOI 10.1016/j.ceca.2004.10.002; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Swillens S, 1998, CELL CALCIUM, V23, P291, DOI 10.1016/S0143-4160(98)90025-2; Syyong HT, 2009, BRIT J PHARMACOL, V156, P587, DOI 10.1111/j.1476-5381.2008.00063.x; Takeda Y, 2011, AM J PHYSIOL-HEART C, V301, pH2285, DOI 10.1152/ajpheart.00488.2011; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Thomas D, 1998, J BIOL CHEM, V273, P27130, DOI 10.1074/jbc.273.42.27130; Vallot O, 2000, ARTERIOSCL THROM VAS, V20, P1225, DOI 10.1161/01.ATV.20.5.1225; van Breemen C, 2006, CIRC RES, V98, P446, DOI 10.1161/01.RES.0000214329.10320.fb; Wu GS, 2009, P NATL ACAD SCI USA, V106, P10829, DOI 10.1073/pnas.0903408106; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009	49	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55333	10.1371/journal.pone.0055333	http://dx.doi.org/10.1371/journal.pone.0055333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408969	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200023
J	Turner, JW; Paranjpye, RN; Landis, ED; Biryukov, SV; Gonzalez-Escalona, N; Nilsson, WB; Strom, MS				Turner, Jeffrey W.; Paranjpye, Rohinee N.; Landis, Eric D.; Biryukov, Stanley V.; Gonzalez-Escalona, Narjol; Nilsson, William B.; Strom, Mark S.			Population Structure of Clinical and Environmental Vibrio parahaemolyticus from the Pacific Northwest Coast of the United States	PLOS ONE			English	Article							SEROVARS O3-K6; SEQUENCE; STRAINS; DIVERSITY; HEMOLYSIN; OYSTERS; SPREAD; PCR; GASTROENTERITIS; DISSEMINATION	Vibrio parahaemolyticus is a common marine bacterium and a leading cause of seafood-borne bacterial gastroenteritis worldwide. Although this bacterium has been the subject of much research, the population structure of cold-water populations remains largely undescribed. We present a broad phylogenetic analysis of clinical and environmental V. parahaemolyticus originating largely from the Pacific Northwest coast of the United States. Repetitive extragenic palindromic PCR (REP-PCR) separated 167 isolates into 39 groups and subsequent multilocus sequence typing (MLST) separated a subset of 77 isolates into 24 sequence types. The Pacific Northwest population exhibited a semi-clonal structure attributed to an environmental clade (ST3, N = 17 isolates) clonally related to the pandemic O3:K6 complex and a clinical clade (ST36, N = 20 isolates) genetically related to a regionally endemic O4:K12 complex. Further, the identification of at least five additional clinical sequence types (i.e., ST43, 50, 65, 135 and 417) demonstrates that V. parahaemolyticus gastroenteritis in the Pacific Northwest is polyphyletic in nature. Recombination was evident as a significant source of genetic diversity and in particular, the recA and dtdS alleles showed strong support for frequent recombination. Although pandemic-related illnesses were not documented during the study, the environmental occurrence of the pandemic clone may present a significant threat to human health and warrants continued monitoring. It is evident that V. parahaemolyticus population structure in the Pacific Northwest is semi-clonal and it would appear that multiple sequence types are contributing to the burden of disease in this region.	[Turner, Jeffrey W.; Paranjpye, Rohinee N.; Biryukov, Stanley V.; Nilsson, William B.; Strom, Mark S.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Turner, Jeffrey W.] Univ Washington, Sch Oceanog, Ctr Environm Genom, Seattle, WA 98195 USA; [Landis, Eric D.] US FDA, Ctr Vet Med, Rockville, MD 20857 USA; [Gonzalez-Escalona, Narjol] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Turner, JW (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	jeff.turner@noaa.gov	Gonzalez-Escalona, Narjol/A-7598-2009; Gonzalez-Escalona, Narjol/H-6161-2019	Gonzalez-Escalona, Narjol/0000-0003-4568-0022	National Oceanic and Atmospheric Administration's (NOAA) Oceans and Human Health Initiative (OHHI); NOAA's National Marine Fisheries Service (NMFS); National Research Council's Research Associateship Program (NRC-RAP)	National Oceanic and Atmospheric Administration's (NOAA) Oceans and Human Health Initiative (OHHI); NOAA's National Marine Fisheries Service (NMFS); National Research Council's Research Associateship Program (NRC-RAP)	Funding sources for this study include National Oceanic and Atmospheric Administration's (NOAA) Oceans and Human Health Initiative (OHHI) (http://oceansandhumanhealth.noaa.gov), NOAA's National Marine Fisheries Service (NMFS) (http://www.nmfs.noaa.gov) and the National Research Council's Research Associateship Program (NRC-RAP) (http://sites.nationalacademies.org/pga/rap/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT SL, 1989, J CLIN MICROBIOL, V27, P2891, DOI 10.1128/JCM.27.12.2891-2893.1989; Ansaruzzaman M, 2008, J MED MICROBIOL, V57, P1502, DOI 10.1099/jmm.0.2008/004275-0; Ansaruzzaman M, 2005, J CLIN MICROBIOL, V43, P2559, DOI 10.1128/JCM.43.6.2559-2562.2005; Bag PK, 1999, J CLIN MICROBIOL, V37, P2354, DOI 10.1128/JCM.37.7.2354-2357.1999; Balter S., 2006, Morbidity and Mortality Weekly Report, V55, P854; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chowdhury NR, 2000, EPIDEMIOL INFECT, V125, P17, DOI 10.1017/S0950268899004070; Chowdhury NR, 2004, J CLIN MICROBIOL, V42, P1280, DOI 10.1128/JCM.42.3.1280-1282.2004; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; Cook DW, 2003, J FOOD PROTECT, V66, P2276, DOI 10.4315/0362-028X-66.12.2276; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis CN, 2012, APPL ENVIRON MICROB, V78, P3778, DOI 10.1128/AEM.07794-11; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Harth E, 2009, EMERG INFECT DIS, V15, P163, DOI 10.3201/eid1502.071269; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hazen TH, 2009, ENVIRON MICROBIOL, V11, P1254, DOI 10.1111/j.1462-2920.2008.01853.x; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Iwamoto M, 2010, CLIN MICROBIOL REV, V23, P399, DOI 10.1128/CMR.00059-09; Johnson CN, 2009, MICROB ECOL, V57, P437, DOI 10.1007/s00248-008-9418-3; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; JOSEPH SW, 1982, CRC CR REV MICROBIOL, V10, P77, DOI 10.3109/10408418209113506; JUKES T H, 1969, P21; KANEKO T, 1978, MICROBIAL ECOL, V4, P135, DOI 10.1007/BF02014284; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; KAYSNER CA, 1994, APPL ENVIRON MICROB, V60, P3020, DOI 10.1128/AEM.60.8.3020-3022.1994; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; NEI M, 1986, MOL BIOL EVOL, V3, P418; Okuda N, 1997, J CLIN MICROBIOL, V35, P3150, DOI 10.1128/JCM.35.12.3150-3155.1997; Paranjpye R, 2012, APPL ENVIRON MICROB, V78, P8631, DOI 10.1128/AEM.01531-12; Parvathi A, 2006, ENVIRON MICROBIOL, V8, P997, DOI 10.1111/j.1462-2920.2006.00990.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quilici ML, 2005, EMERG INFECT DIS, V11, P1148; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SHIRAI H, 1990, INFECT IMMUN, V58, P3568, DOI 10.1128/IAI.58.11.3568-3573.1990; Sloan E, 2003, J RAPID METH AUT MIC, V11, P297, DOI 10.1111/j.1745-4581.2003.tb00269.x; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; Wilkes JG, 2005, ANTON LEEUW INT J G, V88, P151, DOI 10.1007/s10482-005-3990-z; Wong HC, 2001, J CLIN MICROBIOL, V39, P4233, DOI 10.1128/JCM.39.12.4233-4240.2001; Yan YF, 2011, INT J FOOD MICROBIOL, V145, P106, DOI 10.1016/j.ijfoodmicro.2010.11.038; Yeung PSM, 2002, APPL ENVIRON MICROB, V68, P2901, DOI 10.1128/AEM.68.6.2901-2909.2002; Yu Y, 2011, FOODBORNE PATHOG DIS, V8, P1169, DOI 10.1089/fpd.2011.0865	56	82	86	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55726	10.1371/journal.pone.0055726	http://dx.doi.org/10.1371/journal.pone.0055726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409028	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200053
J	Vaneckova, P; Bambrick, H				Vaneckova, Pavla; Bambrick, Hilary			Cause-Specific Hospital Admissions on Hot Days in Sydney, Australia	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; CASE-CROSSOVER; CARDIOVASCULAR-DISEASES; HIGH-TEMPERATURES; SOUTH-AUSTRALIA; AIR-POLLUTION; WAVE; RISK; DEATHS; PEOPLE	Background: While morbidity outcomes for major disease categories during extreme heat have received increasing research attention, there has been very limited investigation at the level of specific disease subcategories. Methodology/Principal Findings: We analyzed daily hospital admissions for cardiovascular (CVD), respiratory (RD), genitourinary (GU) and mental diseases (MD), diabetes (DIA), dehydration (DEH) and 'the effects of heat and light' (HEAT) in Sydney between 1991 and 2009. We further investigated the sensitivity to heat of subcategories within the major disease groups. We defined hot days as those with temperatures in the 95th and 99th percentiles within the study period. We applied time-stratified case-crossover analysis to compare the hospital admissions on hot days with those on non-hot days matched by day of the week. We calculated the odds ratios (OR) of admissions between the two types of days, accounting for other environmental variables (relative humidity, ozone and particulate matter) and non-environmental trends (public and school holidays). On hot days, hospital admissions increased for all major categories except GU. This increase was not shared homogeneously across all diseases within a major category: within RD, only 'other diseases of the respiratory system' (includes pleurisy or empyema) increased significantly, while admissions for asthma decreased. Within MD, hospital admissions increased only for psychoses. Admissions due to some major categories increased one to three days after a hot day (e.g., DIA, RD and CVD) and on two and three consecutive days (e.g., HEAT and RD). Conclusions/Significance: High ambient temperatures were associated with increased hospital admissions for several disease categories, with some within-category variation. Future analyses should focus on subgroups within broad disease categories to pinpoint medical conditions most affected by ambient heat.	[Vaneckova, Pavla; Bambrick, Hilary] Univ Western Sydney, Sch Med, Sydney, NSW, Australia	Western Sydney University	Vaneckova, P (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.	p.vaneckova@uws.edu.au		Bambrick, Hilary/0000-0001-5361-950X; Vaneckova, Pavla/0000-0001-9213-8733	'Flagship: Urbanism, Climate Adaptation and Health Collaboration Cluster'; CSIRO Climate Adaptation	'Flagship: Urbanism, Climate Adaptation and Health Collaboration Cluster'; CSIRO Climate Adaptation	The CSIRO Climate Adaptation. This study was funded by the 'Flagship: Urbanism, Climate Adaptation and Health Collaboration Cluster' grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2012, 2001 CENS QUICKSTATS; Bark N, 1998, PSYCHIATR SERV, V49, P1088, DOI 10.1176/ps.49.8.1088; Barnett, 2010, ANAL SEASONAL HLTH D; Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006; Batscha C L, 1997, J Psychosoc Nurs Ment Health Serv, V35, P12; Bayentin L, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-5; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton D, 2009, APPETITE, V53, P143, DOI 10.1016/j.appet.2009.05.006; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Bureau of Meteorology (BoM), 2012, CLIM DAT ONL; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; CSIRO, 2007, CLIM CHANG SYDN METR; Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; FAUNT JD, 1995, AUST NZ J MED, V25, P117, DOI 10.1111/j.1445-5994.1995.tb02822.x; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Johnson Helen, 2005, Health Stat Q, P6; Khalaj B, 2010, INT ARCH OCC ENV HEA, V83, P833, DOI 10.1007/s00420-010-0534-2; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; LAVIZZOMOUREY RJ, 1987, J NATL MED ASSOC, V79, P1033; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Linares C, 2008, EUR J PUBLIC HEALTH, V18, P317, DOI 10.1093/eurpub/ckm108; Loughnan ME, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-42; Lu Y, 2008, EPIDEMIOLOGY, V19, P169, DOI 10.1097/EDE.0b013e3181632c24; Lu Y, 2007, BIOSTATISTICS, V8, P337, DOI 10.1093/biostatistics/kxl013; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Martin-Latry K, 2007, EUR PSYCHIAT, V22, P335, DOI 10.1016/j.eurpsy.2007.03.007; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Naughton MP, 2002, AM J PREV MED, V22, P221, DOI 10.1016/S0749-3797(02)00421-X; Nitschke M, 2007, MED J AUSTRALIA, V187, P662, DOI 10.5694/j.1326-5377.2007.tb01466.x; Nitschke M, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-42; Nordon C, 2009, AM J GERIAT PSYCHIAT, V17, P1059, DOI 10.1097/JGP.0b013e3181b7ef6e; Page LA, 2012, BRIT J PSYCHIAT, V200, P485, DOI 10.1192/bjp.bp.111.100404; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Pudpong N, 2011, SCI TOTAL ENVIRON, V409, P5260, DOI 10.1016/j.scitotenv.2011.09.005; Ren CZ, 2006, ENVIRON HEALTH PERSP, V114, P1690, DOI 10.1289/ehp.9266; Rydman R J, 1999, J Med Syst, V23, P41, DOI 10.1023/A:1020871528086; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Vaneckova P, 2011, J APPL METEOROL CLIM, V50, P1165, DOI 10.1175/2011JAMC2632.1; Wichmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022904; Williams S, 2012, SCI TOTAL ENVIRON, V414, P126, DOI 10.1016/j.scitotenv.2011.11.038; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]	51	67	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55459	10.1371/journal.pone.0055459	http://dx.doi.org/10.1371/journal.pone.0055459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408986	gold, Green Submitted, Green Published			2022-12-25	WOS:000315157200032
J	Zhou, CX; Steplowski, TA; Dickens, HK; Malloy, KM; Gehrig, PA; Boggess, JF; Bae-Jump, VL				Zhou, Chunxiao; Steplowski, Tara A.; Dickens, Hallum K.; Malloy, Kimberly M.; Gehrig, Paola A.; Boggess, John F.; Bae-Jump, Victoria L.			Estrogen Induction of Telomerase Activity through Regulation of the Mitogen-Activated Protein Kinase (MAPK) Dependent Pathway in Human Endometrial Cancer Cells	PLOS ONE			English	Article; Proceedings Paper	43rd Annual Meeting of the Society-of-Gynecologic-Oncology	MAR 24-27, 2012	Austin, TX	Soc Gynecol Oncol			REVERSE-TRANSCRIPTASE GENE; CATALYTIC SUBUNIT HTERT; RECEPTOR-ALPHA; EXPRESSION; PROMOTER; PHOSPHORYLATION; PROLIFERATION; IDENTIFICATION; STIMULATION; SENESCENCE	Given that prolonged exposure to estrogen and increased telomerase activity are associated with endometrial carcinogenesis, our objective was to evaluate the interaction between the MAPK pathway and estrogen induction of telomerase activity in endometrial cancer cells. Estradiol (E2) induced telomerase activity and hTERT mRNA expression in the estrogen receptor (ER)-alpha positive, Ishikawa endometrial cancer cell line. UO126, a highly selective inhibitor of MEK1/MEK2, inhibited telomerase activity and hTERT mRNA expression induced by E2. Similar results were also found after transfection with ERK 1/2-specific siRNA. Treatment with E2 resulted in rapid phosphorylation of p44/42 MAPK and increased MAPK activity which was abolished by UO126. The hTERT promoter contains two estrogen response elements (EREs), and luciferase assays demonstrate that these EREs are activated by E2. Exposure to UO126 or ERK 1/2-specific siRNA in combination with E2 counteracted the stimulatory effect of E2 on luciferase activity from these EREs. These findings suggest that E2-induction of telomerase activity is mediated via the MAPK pathway in human endometrial cancer cells.	[Zhou, Chunxiao; Dickens, Hallum K.; Malloy, Kimberly M.; Gehrig, Paola A.; Boggess, John F.; Bae-Jump, Victoria L.] Univ N Carolina, Dept Obstet & Gynecol, Div Gynecol Oncol, Chapel Hill, NC 27515 USA; [Steplowski, Tara A.] Univ N Carolina, Dept Otolaryngol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bae-Jump, VL (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Div Gynecol Oncol, Chapel Hill, NC 27515 USA.	vbae@unch.unc.edu			NATIONAL CANCER INSTITUTE [K23CA143154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Baykal A, 2004, ADV ANAT PATHOL, V11, P262, DOI 10.1097/01.pap.0000138145.19258.64; Bieche I, 2000, CLIN CANCER RES, V6, P452; Boggess JF, 2006, GYNECOL ONCOL, V103, P417, DOI 10.1016/j.ygyno.2006.03.032; Braunstein I, 2001, CANCER RES, V61, P5529; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673; Ebina Y, 1999, INT J CANCER, V84, P529, DOI 10.1002/(SICI)1097-0215(19991022)84:5<529::AID-IJC15>3.0.CO;2-J; Gao H, 2011, MOL CELL ENDOCRINOL, V334, P83, DOI 10.1016/j.mce.2010.09.002; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Horikawa I, 1999, CANCER RES, V59, P826; Kato  S, 2001, Breast Cancer, V8, P3, DOI 10.1007/BF02967472; Kimura A, 2004, ONCOGENE, V23, P4505, DOI 10.1038/sj.onc.1207582; Kondoh K, 2007, EXP CELL RES, V313, P3486, DOI 10.1016/j.yexcr.2007.06.028; Kurarmoto Hiroyuki, 2002, Hum Cell, V15, P81, DOI 10.1111/j.1749-0774.2002.tb00103.x; Kyo S, 1999, INT J CANCER, V80, P60, DOI 10.1002/(SICI)1097-0215(19990105)80:1<60::AID-IJC12>3.3.CO;2-5; Kyo S, 1999, CANCER RES, V59, P5917; Lee H, 2000, MOL ENDOCRINOL, V14, P1882, DOI 10.1210/me.14.11.1882; Lehner R, 2002, GYNECOL ONCOL, V84, P120, DOI 10.1006/gyno.2001.6474; Lessey BA, 2003, CELL AND MOLECULAR BIOLOGY OF ENDOMETRIAL CARCINOMA, P267; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Marino M, 2001, J CELL PHYSIOL, V188, P170, DOI 10.1002/jcp.1105; Menon Malini M, 2003, Indian J Pathol Microbiol, V46, P394; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takakura M, 1999, CANCER RES, V59, P551; Tanaka M, 1998, AM J PATHOL, V153, P1985, DOI 10.1016/S0002-9440(10)65712-4; Tzukerman M, 2000, MOL BIOL CELL, V11, P4381, DOI 10.1091/mbc.11.12.4381; Wang Z, 2000, CANCER RES, V60, P5376; Williams CD, 2001, J CLIN ENDOCR METAB, V86, P3912, DOI 10.1210/jc.86.8.3912; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0	38	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55730	10.1371/journal.pone.0055730	http://dx.doi.org/10.1371/journal.pone.0055730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Science & Technology - Other Topics	092XV	23409030	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200055
J	Gagliano, M; Depczynski, M				Gagliano, Monica; Depczynski, Martial			Spot the Difference: Mimicry in a Coral Reef Fish	PLOS ONE			English	Article							EYESPOT PLASTICITY; SEXUAL SELECTION; MATURATION; HISTORIES; MALES; EYE	Eyespots on the body of many animals have long been assumed to confer protection against predators, but empirical evidence has recently demonstrated that this may not always be the case and suggested that such markings may also serve other purposes. Clearly, this raises the unresolved question of what functions do these markings have and do they contribute to an individual's evolutionary fitness in the wild. Here, we examined the occurrence of eyespots on the dorsal fin of a coral reef damselfish (Pomacentrus amboinensis), where these markings are typical of the juvenile stage and fade away as the fish approaches sexual maturation to then disappear completely in the vast majority of, but not all, adult individuals. By exploring differences in body shape among age and gender groups, we found that individuals retaining the eyespot into adulthood are all sexually mature males, suggesting that these eyespots may be an adult deceptive signal. Interestingly, the body shape of these individuals resembled more closely that of immature females than mature dominant males. These results suggest that eyespots have multiple roles and their functional significance changes within the lifetime of an animal from being a juvenile advertisement to a deceptive adult signal. Male removal experiments or colour manipulations may be necessary to establish specific functions.	[Gagliano, Monica] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Gagliano, Monica] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA, Australia; [Depczynski, Martial] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley, WA, Australia	University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia	Gagliano, M (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia.	monica.gagliano@uwa.edu.au	Gagliano, Monica/A-3129-2012; depczynski, martial/B-7689-2008	Gagliano, Monica/0000-0002-2414-6990; depczynski, martial/0000-0001-8723-0076	Research Fellowships from the University of Western Australia; Australian Research Council	Research Fellowships from the University of Western Australia; Australian Research Council(Australian Research Council)	MG was supported by Research Fellowships from the University of Western Australia and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2000, AM NAT, V156, P266, DOI 10.1086/303391; Alonzo SH, 2000, BEHAV ECOL, V11, P56, DOI 10.1093/beheco/11.1.56; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; Carter AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042440; Endler J.A., 1986, Monographs in Population Biology, pviii; Gagliano M, 2008, BEHAV ECOL, V19, P733, DOI 10.1093/beheco/arn013; Gagliano M, 2007, OIKOS, V116, P111, DOI 10.1111/j.2006.0030-1299.15418.x; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; JONES GP, 1987, ECOLOGY, V68, P1534, DOI 10.2307/1939237; Kerrigan BA, 1995, THESIS J COOK U AUST; Klingenberg CP, 2003, BIOL J LINN SOC, V80, P397, DOI 10.1046/j.1095-8312.2003.00246.x; LYON BE, 1986, EVOLUTION, V40, P605, DOI 10.1111/j.1558-5646.1986.tb00511.x; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Mank JE, 2006, EVOLUTION, V60, P1311; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; Monteiro A, 1997, EVOLUTION, V51, P1207, DOI 10.1111/j.1558-5646.1997.tb03968.x; Munday PL, 2006, P ROY SOC B-BIOL SCI, V273, P2845, DOI 10.1098/rspb.2006.3666; NEUDECKER S, 1989, ENVIRON BIOL FISH, V25, P142; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Olofsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010798; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; ROHWER S, 1980, AM NAT, V115, P400, DOI 10.1086/283569; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Siebeck U. E., 2002, THESIS U QUEENSLAND; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; Stevens M, 2008, BEHAV ECOL, V19, P525, DOI 10.1093/beheco/arm162; Stevens M, 2007, ANIM BEHAV, V74, P1215, DOI 10.1016/j.anbehav.2007.01.031; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Vallin A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1419, DOI 10.1007/s00265-007-0374-6; Vallin A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1629, DOI 10.1007/s00265-011-1173-7; Van Buskirk J, 2004, COPEIA, P599, DOI 10.1643/CE-03-283R; Vlieger L, 2007, BIOL J LINN SOC, V92, P661, DOI 10.1111/j.1095-8312.2007.00863.x; Walker SPW, 2009, BIOL LETTERS, V5, P73, DOI 10.1098/rsbl.2008.0555; WARNER RR, 1984, EVOLUTION, V38, P148, DOI 10.1111/j.1558-5646.1984.tb00268.x; Wilson DT, 1997, MAR ECOL PROG SER, V153, P259, DOI 10.3354/meps153259	39	9	9	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55938	10.1371/journal.pone.0055938	http://dx.doi.org/10.1371/journal.pone.0055938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418480	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300072
J	Zou, HC; Wu, ZY; Yu, JP; Li, M; Ablimit, M; Li, F; Poundstone, K				Zou, Huachun; Wu, Zunyou; Yu, Jianping; Li, Min; Ablimit, Muhtar; Li, Fan; Poundstone, Katharine			Internet-Facilitated, Voluntary Counseling and Testing (VCT) Clinic-Based HIV Testing among Men Who Have Sex with Men in China	PLOS ONE			English	Article							TARGETING RURAL MSM; RECRUITMENT TOOL; RISK BEHAVIOR; PREVALENCE; INTERVENTION; INFECTION; EFFICACY	Objective: To explore the feasibility of using Internet outreach to encourage men who have sex with men (MSM) to get tested for HIV at voluntary counseling and testing (VCT) clinics in Beijing and Urumqi, China. Methods: From June to August 2007, two volunteers contacted MSM using instant messaging, online chat rooms, mobile phone, and e-mail (active recruitment). Banners with study information were put at the front pages of three major Chinese gay websites (passive recruitment). Those contacted were offered a modest financial incentive to seek HIV testing at existing VCT clinics. Those who subsequently sought HIV testing services at VCT clinics and provided informed consent completed a questionnaire and a blood draw to test for HIV and syphilis. Results: A total of 3,332 MSM were contacted and 429 attended VCT clinics. One out of every 4 men that were recruited through instant messaging actually went for HIV testing, while the recruitment yields for online gay chat rooms, mobile phone contact, and email were 1:6, 1:10, and 1:140, respectively. The majority of participants (80%, 317/399) reported being motivated to seek HIV testing out of concern for their health, and only 3% (11/399) reported being motivated by the financial incentive. Active recruitment tend to recruit MSM who are younger (X-2 = 11.400, P = 0.001), never tested for HIV (X-2 = 4.281, P = 0.039), tested less often (X-2 = 5.638, P = 0.018). Conclusion: Internet outreach is a promising way to encourage MSM to seek HIV testing at existing VCT clinics. Active recruitment can target MSM who are younger, never tested for HIV and tested less often.	[Zou, Huachun; Wu, Zunyou; Poundstone, Katharine] Chinese Ctr Dis Control & Prevent, Div Hlth Educ & Behav Intervent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zou, Huachun] Univ Melbourne, Sch Populat Hlth, Sexual Hlth Unit, Melbourne, Vic 3010, Australia; [Yu, Jianping; Li, Min] Xicheng Dist Ctr Dis Control & Prevent, Div AIDS STD, Beijing, Peoples R China; [Ablimit, Muhtar; Li, Fan] Xingjiang Uyghur Autonomous Reg Ctr Dis Control &, Ctr AIDS STD Control & Prevent, Urumqi, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of Melbourne	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Div Hlth Educ & Behav Intervent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	Zou, Huachun/AAU-6097-2020		Multidisciplinary HIV and TB Implementation Sciences Training in China [U2R TW 006918]; National Institutes of Health; Fogarty International Center; National Institute of Drug Abuse; FOGARTY INTERNATIONAL CENTER [U2RTW006918] Funding Source: NIH RePORTER	Multidisciplinary HIV and TB Implementation Sciences Training in China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported by the Multidisciplinary HIV and TB Implementation Sciences Training in China with grant number U2R TW 006918, funded by the National Institutes of Health, the Fogarty International Center and the National Institute of Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PCG, 2009, JAIDS-J ACQ IMM DEF, V52, pS143, DOI 10.1097/QAI.0b013e3181baf111; [Anonymous], 2007, NCAIDS PLAN HIV AIDS; [Anonymous], 2011, HIGH IMP HIV PREV CD; Blas MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010448; Bolding G, 2007, AIDS BEHAV, V11, P522, DOI 10.1007/s10461-007-9224-9; Bowen A, 2004, AIDS BEHAV, V8, P311, DOI 10.1023/B:AIBE.0000044078.43476.1f; Bowen AM, 2008, J BEHAV MED, V31, P463, DOI 10.1007/s10865-008-9171-6; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Carballo-Dieguez A, 2006, ARCH SEX BEHAV, V35, P473, DOI 10.1007/s10508-006-9078-7; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P129; Chen H, 2012, SEX TRANSM INFECT; Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Feng Lian-gui, 2008, Zhonghua Yufang Yixue Zazhi, V42, P870; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Fernandez MI, 2004, AIDS CARE, V16, P953, DOI 10.1080/09540120412331292480; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1001; Koo Malcolm, 2005, J Med Internet Res, V7, pe6, DOI 10.2196/jmir.7.1.e6; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; Ning Zhen, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P848; Ouyang Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1001; Rhodes SD, 2011, HEALTH EDUC BEHAV, V38, P311, DOI 10.1177/1090198110379572; United Nations General Assembly, 2010, UNGASS COUNTR PROGR; Zhang R, 2008, THESIS KUNMING MED U; ZHONG F, 2009, AIDS BEHAV; Zou H, 2012, AIDS BEHAV; Zou H, 2012, SEXUALLY TRANSMITTED; Zou HC, 2010, JAIDS-J ACQ IMM DEF, V53, pS81, DOI 10.1097/QAI.0b013e3181c7dd2b	30	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e51919	10.1371/journal.pone.0051919	http://dx.doi.org/10.1371/journal.pone.0051919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418417	gold, Green Published			2022-12-25	WOS:000315970300007
J	Bomholt, J; Helix-Nielsen, C; Scharff-Poulsen, P; Pedersen, PA				Bomholt, Julie; Helix-Nielsen, Claus; Scharff-Poulsen, Peter; Pedersen, Per Amstrup			Recombinant Production of Human Aquaporin-1 to an Exceptional High Membrane Density in Saccharomyces cerevisiae	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN OVEREXPRESSION; FUNCTIONAL EXPRESSION; WATER CHANNELS; PURIFICATION; OPTIMIZATION; RECEPTOR; FACILITATE; DIFFUSION	In the present paper we explored the capacity of yeast Saccharomyces cerevisiae as host for heterologous expression of human Aquaporin-1. Aquaporin-1 cDNA was expressed from a galactose inducible promoter situated on a plasmid with an adjustable copy number. Human Aquaporin-1 was C-terminally tagged with yeast enhanced GFP for quantification of functional expression, determination of sub-cellular localization, estimation of in vivo folding efficiency and establishment of a purification protocol. Aquaporin-1 was found to constitute 8.5 percent of total membrane protein content after expression at 15 degrees C in a yeast host over-producing the Gal4p transcriptional activator and growth in amino acid supplemented minimal medium. In-gel fluorescence combined with western blotting showed that low accumulation of correctly folded recombinant Aquaporin-1 at 30 degrees C was due to in vivo mal-folding. Reduction of the expression temperature to 15 degrees C almost completely prevented Aquaporin-1 mal-folding. Bioimaging of live yeast cells revealed that recombinant Aquaporin-1 accumulated in the yeast plasma membrane. A detergent screen for solubilization revealed that CYMAL-5 was superior in solubilizing recombinant Aquaporin-1 and generated a monodisperse protein preparation. A single Ni-affinity chromatography step was used to obtain almost pure Aquaporin-1. Recombinant Aquaporin-1 produced in S. cerevisiae was not N-glycosylated in contrast to the protein found in human erythrocytes.	[Bomholt, Julie; Helix-Nielsen, Claus] Aquaporin AS, Copenhagen, Denmark; [Helix-Nielsen, Claus] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; [Scharff-Poulsen, Peter; Pedersen, Per Amstrup] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Pedersen, PA (corresponding author), Univ Copenhagen, Dept Biol, August Krogh Bldg, Copenhagen, Denmark.	PAPedersen@bio.ku.dk	Hélix-Nielsen, Claus/N-1054-2019; Helix-Nielsen, Claus/A-5979-2011; Scharff-Poulsen, Peter/A-3556-2014; Pedersen, Per Amstrup/M-4592-2014	Hélix-Nielsen, Claus/0000-0002-9392-7133; Scharff-Poulsen, Peter/0000-0002-5332-9331; Pedersen, Per Amstrup/0000-0001-8648-9748	Danish Research Council; Aquaporin A/S	Danish Research Council(Det Frie Forskningsrad (DFF)); Aquaporin A/S	The present work was supported by the Danish Research Council and Aquaporin A/S. The funders had no role on study design, data collection, decision to publish, or preparation of the manuscript.	Agre P, 1999, Methods Enzymol, V294, P550; AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; Arinaminpathy Y, 2009, DRUG DISCOV TODAY, V14, P1130, DOI 10.1016/j.drudis.2009.08.006; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Cesareni G, 1987, GENETIC ENG PRINCIPL, V9, P135, DOI DOI 10.1007/978-1-4684-5377-5_9; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Erhat E., 1983, J BACTERIOL, V156, P625; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hansen MK, 1999, RECEPTOR CHANNEL, V6, P271; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jorgensen JR, 2001, BIOCHEMISTRY-US, V40, P7301, DOI 10.1021/bi0029503; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laize V, 1997, PROTEIN EXPRES PURIF, V11, P284, DOI 10.1006/prep.1997.0798; Lohr C, 2009, METHOD ENZYMOL, V465, P143, DOI 10.1016/S0076-6879(09)65008-4; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Pedersen PA, 1996, J BIOL CHEM, V271, P2514, DOI 10.1074/jbc.271.5.2514; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Shiroishi M, 2011, METHODS, V55, P281, DOI 10.1016/j.ymeth.2011.08.015; Steffensen L, 2006, EUKARYOT CELL, V5, P248, DOI 10.1128/EC.5.2.248-261.2006; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Verkman AS, 2002, EXP NEPHROL, V10, P235; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xu GY, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-68	48	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56431	10.1371/journal.pone.0056431	http://dx.doi.org/10.1371/journal.pone.0056431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409185	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000054
J	Kewitz, S; Staege, MS				Kewitz, Stefanie; Staege, Martin S.			Knock-Down of PRAME Increases Retinoic Acid Signaling and Cytotoxic Drug Sensitivity of Hodgkin Lymphoma Cells	PLOS ONE			English	Article							REED-STERNBERG CELLS; GENE-EXPRESSION; CISPLATIN SENSITIVITY; CLINICAL-IMPLICATIONS; ANTIGEN PRAME; CHEMOTHERAPY; DISEASE; LINES; HYPOMETHYLATION; ADENOCARCINOMA	The prognosis for patients with Hodgkin lymphoma (HL) has improved in recent decades. On the other hand, not all patients can be cured with the currently established therapy regimes and this therapy is associated with several adverse late effects. Therefore it is necessary to develop new therapy strategies. After treatment of L-540 HL cells with 5'-azacytidine (5AC), we observed increased expression of the preferentially expressed antigen in melanoma (PRAME). In addition, we detected an increased resistance of 5AC-treated cells against cytotoxic drugs. We analyzed the influence of PRAME on cell survival of HL cells by knocking down PRAME in the chemotherapy resistant cell line L-428, a cell line that express PRAME at a high level. After knock-down of PRAME using vector based RNA interference we observed increased sensitivity for cisplatin, etoposide and retinoic acid. DNA microarray analysis of HL cells after PRAME knock-down indicated regulation of several genes including down-regulation of known anti-apoptotic factors. Increased retinoic acid signaling in these cells was revealed by increased expression of the retinoic acid metabolizing cytochrome P450 (CYP26B1), a transcriptional target of retinoic acid signaling. Our data suggest that PRAME inhibits retinoic acid signaling in HL cells and that the knock-down of PRAME might be an interesting option for the development of new therapy strategies for patients with chemo-resistant HL.	[Kewitz, Stefanie; Staege, Martin S.] Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany.	martin.staege@medizin.uni-halle.de	Staege, Martin/AAX-8994-2021	Staege, Martin/0000-0003-3765-7068	Peter-Escher-Foundation for children with cancer	Peter-Escher-Foundation for children with cancer	This work was supported by grants from Peter-Escher-Foundation for children with cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 1997, CLIN CANCER RES, V3, P2033; Affer M, 2001, J ONCOL, V2011; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; De Carvalho DD, 2011, ONCOGENE, V30, P223, DOI 10.1038/onc.2010.409; DIEHL V, 1982, CANCER TREAT REP, V66, P615; Drexler H G, 1992, Hum Cell, V5, P42; DREXLER HG, 1986, LEUKEMIA RES, V10, P487, DOI 10.1016/0145-2126(86)90084-6; Epping MT, 2006, CANCER RES, V66, P10639, DOI 10.1158/0008-5472.CAN-06-2522; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Foell JL, 2008, ANTICANCER RES, V28, P887; Grunt TW, 1998, BRIT J CANCER, V78, P79, DOI 10.1038/bjc.1998.446; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Jozan S, 1998, ANTI-CANCER DRUG, V9, P229, DOI 10.1097/00001813-199803000-00005; KAMESAKI H, 1986, BLOOD, V68, P285; Kawano R, 2009, J CLIN EXP HEMATOP, V49, P1, DOI 10.3960/jslrt.49.1; Kewitz S., 2012, RETINOIC ACID STRUCT, P87; Kewitz S, 2012, LEUKEMIA RES, V36, P773, DOI 10.1016/j.leukres.2012.02.021; Korholz D, 2004, KLIN PADIATR, V216, P150, DOI 10.1055/s-2004-822627; Lin HMJ, 2005, J PEDIAT HEMATOL ONC, V27, P28, DOI 10.1097/01.mph.0000150740.80690.d4; Luetkens T, 2010, LEUKEMIA RES, V34, P1647, DOI 10.1016/j.leukres.2010.03.039; Mauz-Korholz C, 2010, J CLIN ONCOL, V28, P3680, DOI 10.1200/JCO.2009.26.9381; Metkar SS, 2001, CANCER BIOTHER RADIO, V16, P85, DOI 10.1089/108497801750096104; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Neumann I, 2010, PEDIATR BLOOD CANCER, V55, P464, DOI 10.1002/pbc.22603; Ng AK, 2011, BRIT J HAEMATOL, V154, P23, DOI 10.1111/j.1365-2141.2011.08713.x; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; Ocaya PA, 2011, J VASC RES, V48, P23, DOI 10.1159/000317397; Oehler VG, 2009, BLOOD, V114, P3299, DOI 10.1182/blood-2008-07-170282; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; Passeron T, 2009, J CLIN INVEST, V119, P954, DOI 10.1172/JCI34015; Pettersson F, 2001, PANCREAS, V23, P273, DOI 10.1097/00006676-200110000-00008; Quintarelli C, 2011, BLOOD, V117, P3353, DOI 10.1182/blood-2010-08-300376; Roman-Gomez O, 2007, LEUKEMIA RES, V31, P1521, DOI 10.1016/j.leukres.2007.02.016; Sahin U, 2002, BLOOD, V100, P4139, DOI 10.1182/blood.V100.12.4139; SCHAADT M, 1979, BLUT, V38, P185, DOI 10.1007/BF01007965; Schenk T, 2007, GENE CHROMOSOME CANC, V46, P796, DOI 10.1002/gcc.20465; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Staege MS, 2008, EXP HEMATOL, V36, P886, DOI 10.1016/j.exphem.2008.02.014; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Steinbach D, 2002, CANCER GENET CYTOGEN, V133, P118, DOI 10.1016/S0165-4608(01)00570-2; Tzankov A, 2006, PATHOBIOLOGY, V73, P107, DOI 10.1159/000095558; van der Kaaij MAE, 2010, HEMATOL ONCOL, V28, P168, DOI 10.1002/hon.939; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wadelin F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-226; Winkler C, 2012, CANCER IMMUNOL IMMUN, V61, P1769, DOI 10.1007/s00262-012-1239-z; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Yan MY, 2011, CANCER IMMUNOL IMMUN, V60, P1243, DOI 10.1007/s00262-011-1024-4	50	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55897	10.1371/journal.pone.0055897	http://dx.doi.org/10.1371/journal.pone.0055897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409080	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000031
J	Luger, R; Valookaran, S; Knapp, N; Vizzardelli, C; Dohnal, AM; Felzmann, T				Luger, Romana; Valookaran, Sneha; Knapp, Natalie; Vizzardelli, Caterina; Dohnal, Alexander M.; Felzmann, Thomas			Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode	PLOS ONE			English	Article							T-CELLS; IN-VIVO; TUMOR; IL-12; ANTIGEN; CANCER; INTERLEUKIN-12; ACTIVATION; GENERATION; MATURATION	The dendritic cell (DC) coordinates innate and adaptive immunity to fight infections and cancer. Our observations reveal that DCs exposed to the microbial danger signal lipopolysaccharide (LPS) in the presence of interferon-gamma (IFN-gamma) acquire a continuously changing activation/maturation phenotype. The DCs' initial mode of action is pro-inflammatory via up-regulation among others of the signaling molecule interleukin (IL) 12, which polarizes IFN-gamma secreting type 1 helper T-cells (Th1). Within 24 hours the same DC switches from the pro- into an anti-inflammatory phenotype. This is mediated by autocrine IL-10 release and secretion of soluble IL-2 receptor alpha (sIL-2RA) molecules. T-cells, when contacted with DCs during their anti-inflammatory phase loose their proliferative capacity and develop regulatory T-cell (Treg) -like anti-inflammatory functions indicated by IL-10 secretion and elevated FoxP3 levels. Studying the kinetics of IL-12 and IL-10 expression from LPS/IFN-gamma activated myeloid DCs on a single cell level confirmed these observations. When T-cells are separated from DCs within 24 hours, they are spared from the anti-inflammatory DC activity. We conclude that, in addition to differentiation of DCs into distinct subsets, the observed sequential functional phases of DC differentiation permit the fine-tuning of an immune response. A better understanding of time-kinetic DC features is required for optimally exploiting the therapeutic capacity of DCs in cancer immune therapy.	[Luger, Romana; Valookaran, Sneha; Knapp, Natalie; Vizzardelli, Caterina; Dohnal, Alexander M.; Felzmann, Thomas] Med Univ Vienna, Dept Pediat, Lab Tumor Immunol, St Anna Childrens Canc Res Inst, Vienna, Austria; [Felzmann, Thomas] Activartis Biotech GmbH, Vienna, Austria	Medical University of Vienna; Saint Anna Children's Hospital	Felzmann, T (corresponding author), Med Univ Vienna, Dept Pediat, Lab Tumor Immunol, St Anna Childrens Canc Res Inst, Vienna, Austria.	thomas.felzmann@activartis.com		Dohnal, Alexander/0000-0002-5844-7329; Vizzardelli, Caterina/0000-0001-9262-6710	St. Anna Children's Cancer Research Institute (CCRI); City of Vienna (Vienna Business Agency, WWFF/ZIT); Austrian government (Austrian Research Promotion Fund); Austrian government (FFG); Austrian government (FWF); EU (EU Framework Program 7); Activartis Biotech GmbH	St. Anna Children's Cancer Research Institute (CCRI); City of Vienna (Vienna Business Agency, WWFF/ZIT); Austrian government (Austrian Research Promotion Fund); Austrian government (FFG); Austrian government (FWF); EU (EU Framework Program 7); Activartis Biotech GmbH	The authors are grateful to the The St. Anna Children's Cancer Research Institute (CCRI) and its many private donors for financing this research project. The work was also supported by grants from the City of Vienna (Vienna Business Agency, WWFF/ZIT), the Austrian government (Austrian Research Promotion Fund, FFG and FWF), and the EU (EU Framework Program 7) awarded to the CCRI and to Activartis Biotech GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: As CEO of Activartis Biotech GmbH, a biotech company that develops a DC based cancer vaccine technology, T.F. discloses conflicting financial interests in the data presented in this paper. Activartis Biotech GmbH is a funder of this research. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials All other authors have no conflicting financial interests.	Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Battye FL, 2000, J IMMUNOL METHODS, V243, P25, DOI 10.1016/S0022-1759(00)00225-8; Benencia F, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-21; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Camporeale A, 2003, CANCER RES, V63, P3688; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cobb A, 2011, J IMMUNOL METHODS, V365, P27, DOI 10.1016/j.jim.2010.11.002; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Dohnal AM, 2007, CYTOTHERAPY, V9, P755, DOI 10.1080/14653240701589221; Dohnal AM, 2009, J CELL MOL MED, V13, P1741, DOI 10.1111/j.1582-4934.2008.00584.x; Dohnal AM, 2009, J CELL MOL MED, V13, P125, DOI 10.1111/j.1582-4934.2008.00304.x; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; Felzmann T, 2005, CANCER IMMUNOL IMMUN, V54, P769, DOI 10.1007/s00262-004-0637-2; Felzmann T, 2003, CYTOTHERAPY, V5, P391, DOI 10.1080/14653240310003053; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Han TH, 2009, J IMMUNOTHER, V32, P399, DOI 10.1097/CJI.0b013e31819e1773; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Huttner KG, 2005, CANCER IMMUNOL IMMUN, V54, P67, DOI 10.1007/s00262-004-0571-3; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Kaiser A, 2003, EUR J IMMUNOL, V33, P162, DOI 10.1002/immu.200390019; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee JJ, 2008, J LEUKOCYTE BIOL, V84, P319, DOI 10.1189/jlb.1107737; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mitchell DA, 2011, BLOOD, V118, P3003, DOI 10.1182/blood-2011-02-334565; Mnasria K, 2008, J LEUKOCYTE BIOL, V84, P460, DOI 10.1189/jlb.1007712; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saraiva M, 2010, NAT REV IMMUNOL; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Traxlmayr MW, 2010, J IMMUNOTHER, V33, P40, DOI 10.1097/CJI.0b013e3181b51447; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Wieckowski E, 2011, PROSTATE, V71, P125, DOI 10.1002/pros.21228; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zobywalski A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-18	51	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54879	10.1371/journal.pone.0054879	http://dx.doi.org/10.1371/journal.pone.0054879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408948	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000008
J	Ni, Y; Song, L; Qian, XH; Sun, ZH				Ni, Ye; Song, Liang; Qian, Xiaohong; Sun, Zhihao			Proteomic Analysis of Pseudomonas putida Reveals an Organic Solvent Tolerance-Related Gene mmsB	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; EXPRESSION PROFILES; DNA MICROARRAYS; ACTIVE EFFLUX; DOT-T1E; TOLUENE; INVOLVEMENT; BACTERIUM; SYSTEM; S12	Organic solvents are toxic to most microorganisms. However, some organic-solvent-tolerant (OST) bacteria tolerate the destructive effects of organic solvent through various accommodative mechanisms. In this work, we developed an OST adapted strain Pseudomonas putida JUCT1 that could grow in the presence of 60% (v/v) cyclohexane. Two-dimensional gel electrophoresis was used to compare and analyze the total cellular protein of P. putida JUCT1 growing with or without 60% (v/v) cyclohexane. Under different solvent conditions, five high-abundance protein spots whose intensity values show over 60% discrepancies were identified by MALDI-TOF/TOF spectra. Specifically, they are arginine deiminase, carbon-nitrogen hydrolase family putative hydrolase, 3-hydroxyisobutyrate dehydrogenase, protein chain elongation factor EF-Ts, and isochorismatase superfamily hydrolase. The corresponding genes of the latter three proteins, mmsB, tsf, and PSEEN0851, were separately expressed in Escherichia coli to evaluate their effect on OST properties of the host strain. In the presence of 4% (v/v) cyclohexane, E. coli harboring mmsB could grow to 1.70 OD660, whereas cell growth of E. coli JM109 (the control) was completely inhibited by 2% (v/v) cyclohexane. Transformants carrying tsf or PSEEN0851 also showed an increased resistance to cyclohexane and other organic solvents compared with the control. Of these three genes, mmsB exhibited the most prominent effect on increasing OST of E. coli. Less oxidation product of cyclohexane was detected because mmsB transformants might help keep a lower intracellular cyclohexane level. This study demonstrates a feasible approach for elucidating OST mechanisms of microorganisms, and provides molecular basis to construct organic-solvent-tolerant strains for industrial applications.	[Ni, Ye; Song, Liang; Qian, Xiaohong; Sun, Zhihao] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Ni, Y (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	yni@jiangnan.edu.cn	NI, YE/P-3977-2019		Natural Science Foundation of China [21276112]; National High Technology Research and Development Program of China [2011CB710800]; New Century Excellent Talents in University [NCET-11-0658]; Natural Science Foundation of Jiangsu Province [BK2011150]; Program of Introducing Talents of Discipline to Universities [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	The authors gratefully thank the financial support from the Natural Science Foundation of China (21276112), the National High Technology Research and Development Program of China (2011CB710800), New Century Excellent Talents in University (NCET-11-0658), Natural Science Foundation of Jiangsu Province (BK2011150), the Program of Introducing Talents of Discipline to Universities No. 111-2-06, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; AONO R, 1994, BIOSCI BIOTECH BIOCH, V58, P2009, DOI 10.1271/bbb.58.2009; Aono R, 1997, APPL ENVIRON MICROB, V63, P3637, DOI 10.1128/AEM.63.9.3637-3642.1997; AONO R, 1991, AGR BIOL CHEM TOKYO, V55, P1935, DOI 10.1080/00021369.1991.10870883; Aono R, 1998, J BACTERIOL, V180, P938, DOI 10.1128/JB.180.4.938-944.1998; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1658, DOI 10.1111/j.1462-2920.2007.01283.x; Cheng ZY, 2009, PROTEOMICS, V9, P4271, DOI 10.1002/pmic.200900142; Chowdhury EK, 2003, BIOSCI BIOTECH BIOCH, V67, P438, DOI 10.1271/bbb.67.438; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Godoy P, 2001, J BACTERIOL, V183, P5285, DOI 10.1128/JB.183.18.5285-5292.2001; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; Husken LE, 2002, J BIOTECHNOL, V96, P281, DOI 10.1016/S0168-1656(02)00045-7; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Isken S, 1996, J BACTERIOL, V178, P6056, DOI 10.1128/jb.178.20.6056-6058.1996; Kawarai T, 2005, J BIOSCI BIOENG, V100, P613, DOI 10.1263/jbb.100.613; Kieboom J, 1998, J BACTERIOL, V180, P6769, DOI 10.1128/JB.180.24.6769-6772.1998; Kobayashi H, 1998, MICROBIOL-UK, V144, P353, DOI 10.1099/00221287-144-2-353; Okochi M, 2007, APPL MICROBIOL BIOT, V73, P1394, DOI 10.1007/s00253-006-0624-y; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; Rojas A, 2003, J BACTERIOL, V185, P4755, DOI 10.1128/JB.185.16.4755-4763.2003; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Sardessai Y, 2002, RES MICROBIOL, V153, P263, DOI 10.1016/S0923-2508(02)01319-0; Segura A, 2005, J BACTERIOL, V187, P5937, DOI 10.1128/JB.187.17.5937-5945.2005; Segura A, 2004, J BACTERIOL, V186, P1905, DOI 10.1128/JB.186.6.1905-1909.2004; Shimizu K, 2005, J BIOSCI BIOENG, V99, P72, DOI 10.1263/jbb.99.72; Shimizu K, 2005, APPL ENVIRON MICROB, V71, P1093, DOI 10.1128/AEM.71.2.1093-1096.2005; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Volkers RJM, 2006, ENVIRON MICROBIOL, V8, P1674, DOI 10.1111/j.1462-2920.2006.01056.x; Wierckx NJP, 2005, APPL ENVIRON MICROB, V71, P8221, DOI 10.1128/AEM.71.12.8221-8227.2005; Zhang W, 2009, PROCESS BIOCHEM, V44, P1270, DOI 10.1016/j.procbio.2009.07.011	33	13	15	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55858	10.1371/journal.pone.0055858	http://dx.doi.org/10.1371/journal.pone.0055858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409067	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000027
J	Iqbal, Z; Aleem, A; Iqbal, M; Naqvi, MI; Gill, A; Taj, AS; Qayyum, A; ur-Rehman, N; Khalid, AM; Shah, IH; Khalid, M; Haq, R; Khan, M; Baig, SM; Jamil, A; Abbas, MN; Absar, M; Mahmood, A; Rasool, M; Akhtar, T				Iqbal, Zafar; Aleem, Aamer; Iqbal, Mudassar; Naqvi, Mubashar Iqbal; Gill, Ammara; Taj, Abid Sohail; Qayyum, Abdul; ur-Rehman, Najeeb; Khalid, Ahmad Mukhtar; Shah, Ijaz Hussain; Khalid, Muhammad; Haq, Riazul; Khan, Mahwish; Baig, Shahid Mahmood; Jamil, Abid; Abbas, Muhammad Naeem; Absar, Muhammad; Mahmood, Amer; Rasool, Mahmood; Akhtar, Tanveer			Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; THERAPY; CML; MESYLATE; GENE; INHIBITOR; QUIESCENT; TIME; MECHANISMS	Background: BCR-ABL kinase domain mutations are infrequently detected in newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients. Recent studies indicate the presence of pre-existing BCR-ABL mutations in a higher percentage of CML patients when CD34+ stem/progenitor cells are investigated using sensitive techniques, and these mutations are associated with imatinib resistance and disease progression. However, such studies were limited to smaller number of patients. Methods: We investigated BCR-ABL kinase domain mutations in CD34+ cells from 100 chronic-phase CML patients by multiplex allele-specific PCR and sequencing at diagnosis. Mutations were re-investigated upon manifestation of imatinib resistance using allele-specific PCR and direct sequencing of BCR-ABL kinase domain. Results: Pre-existing BCR-ABL mutations were detected in 32/100 patients and included F311L, M351T, and T315I. After a median follow-up of 30 months (range 8-48), all patients with pre-existing BCR-ABL mutations exhibited imatinib resistance. Of the 68 patients without pre-existing BCR-ABL mutations, 24 developed imatinib resistance; allele-specific PCR and BCR-ABL kinase domain sequencing detected mutations in 22 of these patients. All 32 patients with pre-existing BCR-ABL mutations had the same mutations after manifestation of imatinib-resistance. In imatinib-resistant patients without preexisting BCR-ABL mutations, we detected F311L, M351T, Y253F, and T315I mutations. All imatinib-resistant patients except T315I and Y253F mutations responded to imatinib dose escalation. Conclusion: Pre-existing BCR-ABL mutations can be detected in a substantial number of chronic-phase CML patients by sensitive allele-specific PCR technique using CD34+ cells. These mutations are associated with imatinib resistance if affecting drug binding directly or indirectly. After the recent approval of nilotinib, dasatinib, bosutinib and ponatinib for treatment of chronic myeloid leukemia along with imatinib, all of which vary in their effectiveness against mutated BCR-ABL forms, detection of pre-existing BCR-ABL mutations can help in selection of appropriate first-line drug therapy. Thus, mutation testing using CD34+ cells may facilitate improved, patient-tailored treatment.	[Iqbal, Zafar] King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Natl Guards Hlth Affairs, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Aleem, Aamer] King Saud Univ, Coll Med, Dept Med, Div Hematol Oncol, Riyadh 11461, Saudi Arabia; [Aleem, Aamer] King Saud Univ, King Khalid Univ Hosp, Riyadh, Saudi Arabia; [Iqbal, Mudassar] Natl Surg Ctr, Asian Med Inst, Foreign Fac, Bishkek, Kyrgyzstan; [Naqvi, Mubashar Iqbal] Govt Elementary Sch Chak 19 SB, Comp Sci & Bioinformat Lab, Sargodha, Pakistan; [Taj, Abid Sohail] Inst Radiotherapy & Nucl Med, Peshawar, Pakistan; [Qayyum, Abdul] Pakistan Inst Med Sci, Dept Oncol, Islamabad, Pakistan; [ur-Rehman, Najeeb] Medilaser, Lahore, Pakistan; [Iqbal, Zafar; Khalid, Ahmad Mukhtar] Univ Sargodha, Sch Biol Sci, Sargodha, Pakistan; [Shah, Ijaz Hussain; Khalid, Muhammad] Allied Hosp, Dept Oncol, Faisalabad, Pakistan; [Shah, Ijaz Hussain; Khalid, Muhammad] Punjab Med Coll, Faisalabad, Pakistan; [Haq, Riazul] Univ Texas San Antonio, Ctr Hlth, San Antonio, TX USA; [Iqbal, Zafar; Haq, Riazul; Khan, Mahwish] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan; [Iqbal, Zafar; Haq, Riazul; Khan, Mahwish] Univ Lahore, Ctr Res Mol Med, Lahore, Pakistan; [Baig, Shahid Mahmood] Natl Inst Biotechnol & Genet Engn, Hlth Biotechnol Div, Human Mol Genet Grp, Faisalabad, Pakistan; [Jamil, Abid] Postgrad Med Inst, Peshawar, Pakistan; [Iqbal, Zafar; Iqbal, Mudassar; Naqvi, Mubashar Iqbal; Gill, Ammara; Khan, Mahwish; Abbas, Muhammad Naeem; Absar, Muhammad; Akhtar, Tanveer] Univ Punjab, Dept Zool, Hlth Sci Res Labs,Program Hematol Oncol & Pharmac, HOPES Grp,Higher Educ Commiss, Lahore, Pakistan; [Mahmood, Amer] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [Rasool, Mahmood] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Saud University; King Saud University; King Khalid University Hospital; Asian Medical Institute; Ministry of Health - Kyrgyzstan; Pakistan Institute of Medical Sciences; University of Sargodha; Punjab Medical College; University of Texas System; University of Texas at San Antonio (UTSA); University of Lahore; University of Lahore; Pakistan Institute of Engineering & Applied Science; University of Punjab; King Saud University; King Abdulaziz University	Iqbal, Z (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Natl Guards Hlth Affairs, Coll Appl Med Sci, Riyadh, Saudi Arabia.	iqbalz@ksau-hs.edu.sa	Akhtar, Tanveer/N-9178-2013; Rasool, Mahmood/H-9475-2012; Khalid, Ahmad Mukhtar/I-6764-2015; BAig, Shahid Mahmood/AAS-8365-2020; Absar, Muhammad/W-5615-2019; Baig, Shahid Mahmood/I-7309-2015	Akhtar, Tanveer/0000-0002-7269-4684; Rasool, Mahmood/0000-0003-2997-5891; Absar, Muhammad/0000-0002-1284-2673; Iqbal, Zafar/0000-0002-1334-6372; Mahmood, Amer/0000-0002-9199-0120	College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia; Higher Education Commission Pakistan	College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia; Higher Education Commission Pakistan(Higher Education Commission of Pakistan)	This work was partially supported by the College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia. Research funding provided by Higher Education Commission Pakistan is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baranska M, 2008, J APPL GENET, V49, P201, DOI 10.1007/BF03195613; Branford S, 2004, BLOOD, V104, P2926, DOI 10.1182/blood-2004-03-1134; Branford S, 2006, METH MOLEC MED, V125, P93; Carella AM, 2010, LEUKEMIA LYMPHOMA, V51, P275, DOI 10.3109/10428190903503446; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; Chu S, 2011, BLOOD, V118, P5565, DOI 10.1182/blood-2010-12-327437; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes Jorge, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS22; Dolgin E, 2013, NAT MED, V19, P7, DOI 10.1038/nm0113-7; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Goldman JM, 2007, BLOOD, V110, P2828, DOI 10.1182/blood-2007-04-038943; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hao QL, 1998, BLOOD, V91, P4145, DOI 10.1182/blood.V91.11.4145.411a10_4145_4151; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Iqbal Z, 2004, THERAPY, V1, P249; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Jiang XY, 2007, J NATL CANCER I, V99, P680, DOI 10.1093/jnci/djk150; Jiang XY, 2010, BLOOD, V116, P2112, DOI 10.1182/blood-2009-05-222471; Kang HY, 2006, HAEMATOLOGICA, V91, P659; Kantarjian Hagop, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS37; Kantarjian HM, 2003, BLOOD, V101, P473, DOI 10.1182/blood-2002-05-1451; Khorashad JS, 2008, J CLIN ONCOL, V26, P4806, DOI 10.1200/JCO.2008.16.9953; Kreuzer KA, 2003, ANN HEMATOL, V82, P284, DOI 10.1007/s00277-003-0644-y; Leder K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027682; Lucas CM, 2008, LEUKEMIA, V22, P1963, DOI 10.1038/leu.2008.225; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Nicolini FE, 2006, LEUKEMIA, V20, P1061, DOI 10.1038/sj.leu.2404236; O'Brien S, 2011, J NATL COMPR CANC NE, V9, pS1; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Pfeifer H, 2007, BLOOD, V110, P727, DOI 10.1182/blood-2006-11-052373; RADICH JP, 1995, BLOOD, V85, P2632, DOI 10.1182/blood.V85.9.2632.bloodjournal8592632; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sherbenou DW, 2007, LEUKEMIA, V21, P489, DOI 10.1038/sj.leu.2404554; Sorel N, 2004, BIOCHEM BIOPH RES CO, V323, P728, DOI 10.1016/j.bbrc.2004.08.169; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Soverini S, 2011, HAEMATOL-HEMATOL J, V96, P552, DOI 10.3324/haematol.2010.034173; Wang L, 2008, CLIN PHARMACOL THER, V83, P258, DOI 10.1038/sj.clpt.6100268; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Wongboonma W, 2012, EXP MOL PATHOL, V92, P259, DOI 10.1016/j.yexmp.2012.01.007	46	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55717	10.1371/journal.pone.0055717	http://dx.doi.org/10.1371/journal.pone.0055717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409026	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300031
J	Yan, HL; Xu, T; Zhao, HF; Lee, KC; Wang, HY; Zhang, Y				Yan, Hailiang; Xu, Tao; Zhao, Hongfeng; Lee, Kuo-Chieh; Wang, Hoau-Yan; Zhang, Yan			Isoflurane Increases Neuronal Cell Death Vulnerability by Downregulating miR-214	PLOS ONE			English	Article							NITROUS OXIDE ANESTHESIA; DEVELOPING RAT-BRAIN; ALZHEIMERS-DISEASE; GENERAL-ANESTHESIA; APOPTOSIS; OLIGOMERIZATION; SEVOFLURANE; EXPOSURE; HYPERPHOSPHORYLATION; ACQUISITION	Since accumulating evidence suggests the application of anesthetics may increase the risk of Alzheimer's disease (AD), we investigated the cytotoxicity of inhaled general anesthesia in neurons and its underlying mechanism. Using primary cultured rat hippocampal neurons as the study model, here we show that isoflurane increases vulnerability to intracellular or extracellular amyloid b with or without serum deprivation. This isoflurane-induced effect is mediated by the downregulation of miR-214 level that lead to an elevated expression of Bax, a prominent target for miR-214. We conclude that isoflurane increases cell death in the presence of amyloid b by increasing Bax level through downregulating miR-214. Our data provide a new insight for inhaled anesthetics toxicity and indicate a possible mechanistic link between anesthetic application and neurodegenration in AD.	[Yan, Hailiang; Xu, Tao; Zhang, Yan] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Lee, Kuo-Chieh; Wang, Hoau-Yan] CUNY, Sch Med, Sophie Davis Sch Biomed Educ, Dept Pharmacol Physiol & Neurosci, New York, NY 10031 USA; [Zhao, Hongfeng] Beijing 4 High Sch, Beijing, Peoples R China; [Yan, Hailiang; Xu, Tao; Zhang, Yan] Peking Univ Peoples Hosp, Dept Urol, Beijing, Peoples R China	Peking University; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education; Peking University	Zhang, Y (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	yanzhang@pku.edu.cn	Zhang, Yan/AAX-8786-2021		National Program of Basic Research; Ministry of Science and Technology of China [2009CB941301]; National Science Foundation of China (NSFC) [91132718]; Roche	National Program of Basic Research(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Roche(Roche Holding)	This work was supported by the National Program of Basic Research sponsored by the Ministry of Science and Technology of China (2009CB941301), National Science Foundation of China (NSFC) Major Research Grant (91132718) and Roche research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; BOHNEN NILJ, 1994, J AM GERIATR SOC, V42, P198, DOI 10.1111/j.1532-5415.1994.tb04952.x; BRETELER MMB, 1991, INT J EPIDEMIOL, V20, pS36, DOI 10.1093/ije/20.Supplement_2.S36; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Dong YL, 2009, ARCH NEUROL-CHICAGO, V66, P620, DOI 10.1001/archneurol.2009.48; Eckenhoff R G, 2001, Mol Interv, V1, P258; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Eckenhoff RG, 1997, PHARMACOL REV, V49, P343; Fodale V, 2006, BRIT J ANAESTH, V97, P445, DOI 10.1093/bja/ael233; Fodale V, 2003, ACTA ANAESTH SCAND, V47, P1180, DOI 10.1034/j.1399-6576.2003.00226.x; Gasparini M, 2002, NEUROL SCI, V23, P11, DOI 10.1007/s100720200017; Ghirlanda G, 2004, FEBS LETT, V578, P140, DOI 10.1016/j.febslet.2004.10.087; Hudson AE, 2011, BRIT J ANAESTH, V107, P30, DOI 10.1093/bja/aer122; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Mallick B, 2011, RNA BIOL, V8, P665, DOI 10.4161/rna.8.4.15584; Mandal PK, 2009, BIOCHEM BIOPH RES CO, V379, P716, DOI 10.1016/j.bbrc.2008.12.092; Mandal PK, 2008, BBA-BIOMEMBRANES, V1778, P2633, DOI 10.1016/j.bbamem.2008.07.002; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MURAVCHICK S, 1995, ANESTHESIOLOGY, V82, P305, DOI 10.1097/00000542-199501000-00039; Olney JW, 2004, ANESTHESIOLOGY, V101, P273, DOI 10.1097/00000542-200408000-00004; Papon MA, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00272; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Rodriguez JA, 2002, CELL MOL BIOL, V48, P103; Run XQ, 2010, J ALZHEIMERS DIS, V22, pS49, DOI 10.3233/JAD-2010-100813; Su DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027632; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Whittington RA, 2010, CURR ALZHEIMER RES, V7, P717; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhang B, 2008, J BIOL CHEM, V283, P11866, DOI 10.1074/jbc.M800199200; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang Y, 2003, J NEUROSCI, V23, P7385; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664; Zhen Y, 2009, ANESTHESIOLOGY, V111, P741, DOI 10.1097/ALN.0b013e3181b27fd4; Zuo CS, 2010, DEMENT GERIATR COGN, V29, P233, DOI 10.1159/000295114	53	29	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55276	10.1371/journal.pone.0055276	http://dx.doi.org/10.1371/journal.pone.0055276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408966	Green Published, gold			2022-12-25	WOS:000314660300009
J	Luijten, M; Singh, AV; Bastian, CA; Westerman, A; Pisano, MM; Pennings, JLA; Verhoef, A; Green, ML; Piersma, AH; de Vries, A; Knudsen, TB				Luijten, Mirjam; Singh, Amar V.; Bastian, Caleb A.; Westerman, Anja; Pisano, M. Michele; Pennings, Jeroen L. A.; Verhoef, Aart; Green, Maia L.; Piersma, Aldert H.; de Vries, Annemieke; Knudsen, Thomas B.			Lasting Effects on Body Weight and Mammary Gland Gene Expression in Female Mice upon Early Life Exposure to n-3 but Not n-6 High-Fat Diets	PLOS ONE			English	Article							BREAST-CANCER RISK; PREPUBERTAL LOW-FAT; INSULIN-RESISTANCE; METABOLIC SYNDROME; MATERNAL DIET; DEVELOPMENTAL ORIGINS; ADIPOSE-TISSUE; ACID DIETS; SEX-RATIO; OBESITY	Exposure to an imbalance of nutrients prior to conception and during critical developmental periods can have lasting consequences on physiological processes resulting in chronic diseases later in life. Developmental programming has been shown to involve structural and functional changes in important tissues. The aim of the present study was to investigate whether early life diet has a programming effect on the mammary gland. Wild-type mice were exposed from 2 weeks prior to conception to 6 weeks of age to a regular low-fat diet, or to high-fat diets based on either corn oil or flaxseed oil. At 6 weeks of age, all mice were shifted to the regular low-fat diet until termination at 10 weeks of age. Early life exposure to a high-fat diet, either high in n-6 (corn oil) or in n-3 (flaxseed oil) polyunsaturated fatty acids, did not affect birth weight, but resulted in an increased body weight at 10 weeks of age. Transcriptome analyses of the fourth abdominal mammary gland revealed differentially expressed genes between the different treatment groups. Exposure to high-fat diet based on flaxseed oil, but not on corn oil, resulted in regulation of pathways involved in energy metabolism, immune response and inflammation. Our findings suggest that diet during early life indeed has a lasting effect on the mammary gland and significantly influences postnatal body weight gain, metabolic status, and signaling networks in the mammary gland of female offspring.	[Luijten, Mirjam; Westerman, Anja; Pennings, Jeroen L. A.; Verhoef, Aart; Piersma, Aldert H.; de Vries, Annemieke] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Singh, Amar V.; Bastian, Caleb A.; Pisano, M. Michele; Green, Maia L.; Knudsen, Thomas B.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, Louisville, KY 40292 USA; [Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA	Netherlands National Institute for Public Health & the Environment; University of Louisville; United States Environmental Protection Agency	Knudsen, TB (corresponding author), Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, Louisville, KY 40292 USA.	knudsen.thomas@epa.gov	Singh, Amar/K-4400-2013	Singh, Amar/0000-0003-3780-8233; Pennings, Jeroen L.A./0000-0002-9188-6358; Luijten, Mirjam/0000-0002-5277-1443; Green, Maia/0000-0002-8397-2299	NIH [R21 ES013821, R25 CA044789, P30 ES014443]; National Institute of Environmental Health Sciences; National Cancer Institute; Bioinformatics and Biostatistics Core, University of Louisville Center for Integrative Biology and Environmental Genomics; NATIONAL CANCER INSTITUTE [R25CA044789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013821, P30ES014443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bioinformatics and Biostatistics Core, University of Louisville Center for Integrative Biology and Environmental Genomics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by NIH grant R21 ES013821, National Institute of Environmental Health Sciences (http://www.niehs.nih.gov). C.B. was supported on a fellowship from NIH grant R25 CA044789, National Cancer Institute (http://www.cancer.gov) Additional support is acknowledged from Bioinformatics and Biostatistics Core, University of Louisville Center for Integrative Biology and Environmental Genomics, funded by NIH grant P30 ES014443, National Institute of Environmental Health Sciences (http://www.niehs.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexenko AP, 2007, BIOL REPROD, V77, P599, DOI 10.1095/biolreprod.107.062174; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; BARKER DJP, 1986, LANCET, V1, P1077; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Boyd NF, 2003, BRIT J CANCER, V89, P1672, DOI 10.1038/sj.bjc.6601314; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bruins W, 2007, CARCINOGENESIS, V28, P1814, DOI 10.1093/carcin/bgm041; Burdge GC, 2009, BRIT J NUTR, V101, P619, DOI 10.1017/S0007114508145883; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Cottam DR, 2004, OBES SURG, V14, P589, DOI 10.1381/096089204323093345; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Das UN, 2002, NUTRITION, V18, P430, DOI 10.1016/S0899-9007(01)00747-X; De Assis S, 2006, ANN NY ACAD SCI, V1089, P14, DOI 10.1196/annals.1386.039; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; FAIL CHD, 1995, ARCH DIS CHILD, V73, P287; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Fay MP, 1997, CANCER RES, V57, P3979; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Gardner DS, 2007, CURR DRUG TARGETS, V8, P894; Grimble RF, 2002, CURR OPIN CLIN NUTR, V5, P551, DOI 10.1097/00075197-200209000-00015; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hilakivi-Clarke L, 2002, CLIN CANCER RES, V8, P3601; Hilakivi-Clarke L, 1999, BRIT J CANCER, V80, P1682, DOI 10.1038/sj.bjc.6690584; Hilakivi-Clarke L, 1999, NUTRITION, V15, P392, DOI 10.1016/S0899-9007(99)00029-5; Hilakivi-Clarke L, 1998, CANCER RES, V58, P654; Hilakivi-Clarke L, 2007, CURR CANCER DRUG TAR, V7, P465; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; HOWE GR, 1990, JNCI-J NATL CANCER I, V82, P561, DOI 10.1093/jnci/82.7.561; Ion G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-81; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kalupahana NS, 2011, OBESITY, V19, P245, DOI 10.1038/oby.2010.196; Kavanagh K, 2010, NUTR RES, V30, P418, DOI 10.1016/j.nutres.2010.06.006; Khalid S, 2010, BREAST CANCER RES TR, V122, P647, DOI 10.1007/s10549-009-0586-8; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; Luijten M, 2007, REPROD TOXICOL, V23, P407, DOI 10.1016/j.reprotox.2006.12.001; MacLennan M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2646; Mamalakis G, 2006, EUR J CLIN NUTR, V60, P1016, DOI 10.1038/sj.ejcn.1602413; Martin-Gronert MS, 2005, EARLY HUM DEV, V81, P981, DOI 10.1016/j.earlhumdev.2005.10.006; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Mora S, 2002, DIABETES-METAB RES, V18, P345, DOI 10.1002/dmrr.321; Moral R, 2011, NUTR CANCER, V63, P410, DOI 10.1080/01635581.2011.535956; Muhlhausler BS, 2007, J NEUROENDOCRINOL, V19, P67, DOI 10.1111/j.1365-2826.2006.01505.x; Olivo SE, 2005, CARCINOGENESIS, V26, P1563, DOI 10.1093/carcin/bgi118; Olivo-Marston SE, 2008, CANCER PREV RES, V1, P532, DOI 10.1158/1940-6207.CAPR-08-0030; Olson LK, 2010, INT J OBESITY, V34, P1415, DOI 10.1038/ijo.2010.51; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reusens B, 2007, CURR DRUG TARGETS, V8, P935; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Rossmeisl M, 2009, OBESITY, V17, P1023, DOI 10.1038/oby.2008.602; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Sieri S, 2008, AM J CLIN NUTR, V88, P1304, DOI 10.3945/ajcn.2008.26090; Silberstein GB, 2006, J ENDOCRINOL, V190, P225, DOI 10.1677/joe.1.06725; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiebaut ACM, 2007, JNCI-J NATL CANCER I, V99, P451, DOI 10.1093/jnci/djk094; van Dielen FMH, 2004, J CLIN ENDOCR METAB, V89, P4062, DOI 10.1210/jc.2003-032125; WELSCH CW, 1992, CANCER RES, V52, pS2040; White PJ, 2010, DIABETES; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	72	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55603	10.1371/journal.pone.0055603	http://dx.doi.org/10.1371/journal.pone.0055603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409006	gold, Green Submitted, Green Published			2022-12-25	WOS:000315157200043
J	Ather, F; Hamidi, H; Fejzo, MS; Letrent, S; Finn, RS; Kabbinavar, F; Head, C; Wong, SG				Ather, Ferdows; Hamidi, Habib; Fejzo, Marlena S.; Letrent, Stephen; Finn, Richard S.; Kabbinavar, Fairooz; Head, Christian; Wong, Steven G.			Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RECEPTOR TYROSINE KINASE; HUMAN-BREAST-CANCER; METASTATIC COLORECTAL-CANCER; LUNG-CANCER; IN-VITRO; PROGNOSTIC-SIGNIFICANCE; PLUS CETUXIMAB; EGFR; LINES	Aberrant epidermal growth factor (EGF) signaling is associated with tumor growth in squamous cell carcinoma of the head and neck in humans (HNSCC), and is a major focus of targeted therapy. Cetuximab, a monoclonal antibody against EGFR, has been successful at prolonging survival but has only a 10% tumor shrinkage response rate in a clinical setting. The goal of this study was to compare dacomitinib (PF-00299804), a next generation small molecule tyrosine kinase inhibitor that irreversibly blocks multiple HER family receptors (HER-1 (EGFR), HER-2 and HER-4 tyrosine kinases), to cetuximab, the current FDA approved anti-EGFR medication for HNSCC and erlotinib, an EGFR specific small molecule tyrosine kinase inhibitor. Dacomitinib, erlotinib and cetuximab were tested in a panel of 27 HNSCC cell lines. Treatment with 100 ug/ml of cetuximab or 1 uM of erlotinib inhibited growth by at least 50% in 7/27 cell lines, while treatment with 1 uM of dacomitinib had similar growth inhibition in 17/27 lines. Cell lines representing three levels of sensitivity to dacomitinib were further examined using Western blots, cell cycle and apoptosis analysis. Treatment with 100 nM of dacomitinib reduced EGFR activity and downstream AKT and ERK pathways more effectively than treatment with 100 ug/ml of cetuximab in all ten tested lines. Although both compounds induced apoptosis at similar levels, dacomitinib caused greater G0/G1 arrest. Sensitivity to EGFR blockade was associated with levels of EGFR and ERK and was not associated with common oncogenic mutations and copy number variations. Phosphorylated and total EGFR and ERK levels correlate with sensitivity to both cetuximab and dacomitinib. Three of the four lines in the exquisitely sensitive group had the highest levels of phosphorylated and total EGFR and ERK among the ten lines selected, while the three resistant lines collectively had the lowest levels. Neither pAKT nor tAKT was associated with sensitivity.	[Ather, Ferdows; Hamidi, Habib; Fejzo, Marlena S.; Finn, Richard S.; Kabbinavar, Fairooz; Head, Christian; Wong, Steven G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Letrent, Stephen] Pfizer Oncol, Clin Dev & Med Affairs, San Diego, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pfizer	Hamidi, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	hhamidi@mednet.ucla.edu	Hamidi, Habib/H-8030-2016	Hamidi, Habib/0000-0003-0196-9852; Fejzo, Marlena/0000-0001-6800-687X				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Britten CD, 2004, MOL CANCER THER, V3, P1335; Butowski Nicholas, 2005, Cancer Control, V12, P116; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; Demiral A, 2004, AURIS NASUS LARYNX, V31, P417, DOI 10.1016/j.anl.2004.05.003; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Garon EB, 2010, MOL CANCER THER, V9, P1985, DOI 10.1158/1535-7163.MCT-10-0037; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; Gonzales AJ, 2008, MOL CANCER THER, V7, P1880, DOI 10.1158/1535-7163.MCT-07-2232; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Janne P, 2009, J CLIN ONCOL, V27, pS; Kalous O, 2012, MOL CANCER THER, V11, P1978, DOI 10.1158/1535-7163.MCT-11-0730; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lammering G, 2003, ONCOGENE, V22, P5545, DOI 10.1038/sj.onc.1206788; Lee JW, 2005, CLIN CANCER RES, V11, P2879, DOI 10.1158/1078-0432.CCR-04-2029; LEONARD JH, 1991, INT J CANCER, V48, P511, DOI 10.1002/ijc.2910480406; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Maurizi M, 1996, BRIT J CANCER, V74, P1253, DOI 10.1038/bjc.1996.525; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Moyer JD, 1997, CANCER RES, V57, P4838; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Qiu WL, 2006, CLIN CANCER RES, V12, P1441, DOI 10.1158/1078-0432.CCR-05-2173; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Uphoff CC, 2002, LEUKEMIA, V16, P289, DOI 10.1038/sj.leu.2402365; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wainberg ZA, 2010, CLIN CANCER RES, V16, P1509, DOI 10.1158/1078-0432.CCR-09-1112; WARD WHJ, 1994, BIOCHEM PHARMACOL, V48, P659, DOI 10.1016/0006-2952(94)90042-6; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965	43	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56112	10.1371/journal.pone.0056112	http://dx.doi.org/10.1371/journal.pone.0056112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405260	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400206
J	Sen, R; Lahudkar, S; Durairaj, G; Bhaumik, SR				Sen, Rwik; Lahudkar, Shweta; Durairaj, Geetha; Bhaumik, Sukesh R.			Functional Analysis of Bre1p, an E3 Ligase for Histone H2B Ubiquitylation, in Regulation of RNA Polymerase II Association with Active Genes and Transcription in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ELONGATION-FACTORS; H3 METHYLATION; PAF1 COMPLEX; DNA-DAMAGE; YEAST; UBIQUITINATION; PROTEIN; EXPRESSION; SAGA	H2B ubiquitylation is carried out by Bre1p, an E3 ligase, along with an E2 conjugase, Rad6p. H2B ubiquitylation has been previously implicated in promoting the association of RNA polymerase II with the coding sequence of the active GAL1 gene, and hence transcriptional elongation. Intriguingly, we find here that the association of RNA polymerase II with the active GAL1 coding sequence is not decreased in Delta bre1, although it is required for H2B ubiquitylation. In contrast, the loss of Rad6p significantly impairs the association of RNA polymerase II with GAL1. Likewise, the point mutation of lysine 123 (ubiquitylation site) to arginine of H2B (H2B-K123R) also lowers the association of RNA polymerase II with GAL1, consistent with the role of H2B ubiquitylation in promoting RNA polymerase II association. Surprisingly, unlike the Delta rad6 and H2B-K123R strains, complete deletion of BRE1 does not impair the association of RNA polymerase II with GAL1. However, deletion of the RING domain of Bre1p (that is essential for H2B ubiquitylation) impairs RNA polymerase II association with GAL1. These results imply that a non-RING domain of Bre1p counteracts the stimulatory role of the RING domain in regulating the association of RNA polymerase II with GAL1, and hence RNA polymerase II occupancy is not impaired in Delta bre1. Consistently, GAL1 transcription is impaired in the absence of the RING domain of Bre1p, but not in Delta bre1. Similar results are also obtained at other genes. Collectively, our results implicate both the stimulatory and repressive roles of Bre1p in regulation of RNA polymerase II association with active genes (and hence transcription) in vivo.	[Sen, Rwik; Lahudkar, Shweta; Durairaj, Geetha; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu		Sen, Rwik/0000-0003-2853-2378	National Institutes of Health [1R15GM088798-01]; American Heart Association (Greater Midwest Affiliate) [10GRNT4300059]; Mallinckrodt Foundation; Excellence in Academic Medicine awards of the Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Greater Midwest Affiliate)(American Heart Association); Mallinckrodt Foundation; Excellence in Academic Medicine awards of the Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01 (to S. R. B.), Grant-in-aid 10GRNT4300059 from the American Heart Association (Greater Midwest Affiliate), a Mallinckrodt Foundation grant, and Excellence in Academic Medicine awards of the Southern Illinois University School of Medicine.	Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costa PJ, 2000, GENETICS, V156, P535; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Game JC, 2009, DNA REPAIR, V8, P470, DOI 10.1016/j.dnarep.2009.01.007; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Malik S, 2009, J BIOL CHEM, V284, P35714, DOI 10.1074/jbc.M109.035709; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Muren E, 2001, YEAST, V18, P163, DOI 10.1002/1097-0061(20010130)18:2<163::AID-YEA659>3.0.CO;2-#; Mutiu AI, 2007, MOL GENET GENOMICS, V277, P491, DOI 10.1007/s00438-007-0212-6; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Shukla A, 2007, BIOCHEM BIOPH RES CO, V359, P214, DOI 10.1016/j.bbrc.2007.05.105; SIKORSKI RS, 1989, GENETICS, V122, P19; Song YH, 2010, J BIOL CHEM, V285, P2361, DOI 10.1074/jbc.M109.039255; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Trujillo KM, 2012, MOL CELL, V48, P734, DOI 10.1016/j.molcel.2012.09.019; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; Walter D, 2010, J CELL SCI, V123, P1931, DOI 10.1242/jcs.065938; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005	56	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9619	9633		10.1074/jbc.M113.450403	http://dx.doi.org/10.1074/jbc.M113.450403			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23417674	Green Published, hybrid			2022-12-25	WOS:000317114000006
J	Poteet, E; Choudhury, GR; Winters, A; Li, WJ; Ryou, MG; Liu, R; Tang, L; Ghorpade, A; Wen, Y; Yuan, F; Keir, ST; Yan, H; Bigner, DD; Simpkins, JW; Yang, SH				Poteet, Ethan; Choudhury, Gourav Roy; Winters, Ali; Li, Wenjun; Ryou, Myoung-Gwi; Liu, Ran; Tang, Lin; Ghorpade, Anuja; Wen, Yi; Yuan, Fang; Keir, Stephen T.; Yan, Hai; Bigner, Darell D.; Simpkins, James W.; Yang, Shao-Hua			Reversing the Warburg Effect as a Treatment for Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; CANCER CELLS; GROWTH; AMPK; PHOSPHORYLATION; METABOLISM; ACTIVATION; MULTIFORME; TEMOZOLOMIDE; SURVIVAL	Glioblastoma multiforme (GBM), like most cancers, possesses a unique bioenergetic state of aerobic glycolysis known as the Warburg effect. Here, we documented that methylene blue (MB) reverses the Warburg effect evidenced by the increasing of oxygen consumption and reduction of lactate production in GBM cell lines. MB decreases GBM cell proliferation and halts the cell cycle in S phase. Through activation of AMP-activated protein kinase, MB inactivates downstream acetyl-CoA carboxylase and decreases cyclin expression. Structure-activity relationship analysis demonstrated that toluidine blue O, an MB derivative with similar bioenergetic actions, exerts similar action in GBM cell proliferation. In contrast, two other MB derivatives, 2-chlorophenothiazine and promethazine, exert no effect on cellular bioenergetics and do not inhibit GBM cell proliferation. MB inhibits cell proliferation in both temozolomide-sensitive and -insensitive GBM cell lines. In a human GBM xenograft model, a single daily dosage of MB does not activate AMP-activated protein kinase signaling, and no tumor regression was observed. In summary, the current study provides the first in vitro proof of concept that reversal of Warburg effect might be a novel therapy for GBM.	[Poteet, Ethan; Choudhury, Gourav Roy; Winters, Ali; Li, Wenjun; Ryou, Myoung-Gwi; Liu, Ran; Wen, Yi; Simpkins, James W.; Yang, Shao-Hua] Univ N Texas, Dept Pharmacol & Neurosci, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Tang, Lin; Ghorpade, Anuja] Univ N Texas, Dept Cell Biol & Anat, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Yuan, Fang; Yang, Shao-Hua] Capital Med Univ, Beijing Neurosurg Inst, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Keir, Stephen T.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Beijing Neurosurgical Institute; Capital Medical University; Duke University	Yang, SH (corresponding author), Univ N Texas, Dept Pharmacol & Neurosci, Hlth Sci Ctr, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu	Choudhury, Gourav Roy/L-7707-2016	Choudhury, Gourav Roy/0000-0001-8664-7638; Liu, Ran/0000-0002-3882-0616	National Institutes of Health [R01NS054687, R01NS054651, T32 AG020494]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054651, R01NS054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054687 and R01NS054651 (to S. Y.). The University of North Texas Health Science Center has filed a Patent Cooperation Treaty patent application titled "Compounds that enable alternative mitochondrial electron transfer."; A predoctoral trainee supported by National Institute of Health Grant T32 AG020494.	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Callaway NL, 2002, NEUROSCI LETT, V332, P83, DOI 10.1016/S0304-3940(02)00827-3; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; FRIEDMAN HS, 1988, CANCER RES, V48, P4189; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; McCarty MF, 2010, ALTERN MED REV, V15, P264; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Nieder C, 2006, REV RECENT CLIN TRIA, V1, P43, DOI 10.2174/157488706775246148; Oertel Joachim, 2005, Neurosurg Focus, V18, pe12; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Pepponi R, 2003, J PHARMACOL EXP THER, V304, P661, DOI 10.1124/jpet.102.043950; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarica EB, 2010, J NEUROSURG SCI, V54, P7; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Sontag EM, 2012, J NEUROSCI, V32, P11109, DOI 10.1523/JNEUROSCI.0895-12.2012; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEINSTEIN J, 1964, J BIOL CHEM, V239, P3031; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo_2011_06_482; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Youn SH, 2012, BIOL PHARM BULL, V35, P105, DOI 10.1248/bpb.35.105; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63	50	65	65	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9153	9164		10.1074/jbc.M112.440354	http://dx.doi.org/10.1074/jbc.M112.440354			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408428	Green Published, hybrid			2022-12-25	WOS:000316862200035
J	Duffy, JE; Macdonald, KS; Hultgren, KM; Chak, TCS; Rubenstein, DR				Duffy, J. Emmett; Macdonald, Kenneth S., III; Hultgren, Kristin M.; Chak, Tin Chi Solomon; Rubenstein, Dustin R.			Decline and Local Extinction of Caribbean Eusocial Shrimp	PLOS ONE			English	Article							CLIMATE-CHANGE; CORAL-REEFS; SPONGE; BIODIVERSITY; DEMOSPONGIAE; ABUNDANCE; PORIFERA; SCALE	The tropical shrimp genus Synalpheus includes the only eusocial marine animals. In much of the Caribbean, eusocial species have dominated the diverse fauna of sponge-dwelling shrimp in coral rubble for at least the past two decades. Here we document a recent, dramatic decline and apparent local extinction of eusocial shrimp species on the Belize Barrier Reef. Our collections from shallow reefs in central Belize in 2012 failed to locate three of the four eusocial species formerly abundant in the area, and showed steep declines in colony size and increases in frequency of queenless colonies prior to their disappearance. Concordant with these declines, several nonsocial, pair-forming Synalpheus species increased in frequency. The decline in eusocial shrimp is explained in part by disappearance of two sponge species on which they specialize. Eusocial shrimp collections from Jamaica in 2012 showed similar patterns of decline in colony size and increased queenlessness compared with prior Jamaican collections. The decline and local extinction of eusocial shrimp happened against a backdrop of changes in coral assemblages during recent decades, and may reflect changes in abundance and quality of dead coral substratum and succession of the diverse cryptic organisms living within it. These changes document potentially worrisome declines in a unique taxon of eusocial marine animals.	[Duffy, J. Emmett; Chak, Tin Chi Solomon] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Macdonald, Kenneth S., III] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Hultgren, Kristin M.] Seattle Univ, Dept Biol, Seattle, WA 98122 USA; [Rubenstein, Dustin R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	William & Mary; Virginia Institute of Marine Science; New Mexico State University; Seattle University; Columbia University	Duffy, JE (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	jeduffy@vims.edu	Macdonald, Kenneth/F-9822-2011; Rubenstein, Dustin R/A-3451-2015; Duffy, J. Emmett/ABF-9200-2020; Rubenstein, Dustin R./N-9302-2019	Rubenstein, Dustin R/0000-0002-4999-3723; Duffy, J. Emmett/0000-0001-8595-6391; Rubenstein, Dustin R./0000-0002-4999-3723; Chak, Tin Chi Solomon/0000-0002-6362-4414	Smithsonian Institution's Caribbean Coral Reef Ecosystem program; National Science Foundation [IOS-1121716, IOS-1121435]; Direct For Biological Sciences [1121716] Funding Source: National Science Foundation	Smithsonian Institution's Caribbean Coral Reef Ecosystem program; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors are grateful to the Smithsonian Institution's Caribbean Coral Reef Ecosystem program and to the National Science Foundation, most recently via grants IOS-1121716 (JED) and IOS-1121435 (DRR), for supporting the authors' research on sponge-dwelling Synalpheus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeier H, 2011, FEMS MICROBIOL ECOL, V75, P218, DOI 10.1111/j.1574-6941.2010.01001.x; Anker A, 2008, ZOOTAXA, P1; Aronson R, 2008, IUCN 2012 IUCN RED L; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Butler MJ, 1995, MAR ECOL PROG SER, V129, P119, DOI 10.3354/meps129119; Campos M, 2005, ZOOTAXA, P1, DOI 10.11646/zootaxa.963.1.1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CORREDOR JE, 1988, LIMNOL OCEANOGR, V33, P114, DOI 10.4319/lo.1988.33.1.0114; De Grave S, 2009, RAFFLES B ZOOL, P1; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Duffy J. Emmett, 2003, P217; Duffy JE, 2010, P ROY SOC B-BIOL SCI, V277, P575, DOI 10.1098/rspb.2009.1483; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Duffy JE, 2002, BEHAV ECOL SOCIOBIOL, V51, P488, DOI 10.1007/s00265-002-0455-5; DUFFY JE, 1992, MAR ECOL PROG SER, V90, P127, DOI 10.3354/meps090127; Duffy JE, 1996, BIOL J LINN SOC, V58, P307, DOI 10.1111/j.1095-8312.1996.tb01437.x; Duffy JE, 2007, EVOLUTIONARY ECOLOGY, P388; Duris Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021987; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Hultgren KM, 2011, ZOOTAXA, P1; Hultgren KM, 2010, ZOOTAXA, P221; Hultgren KM, 2011, J CRUSTACEAN BIOL, V31, P352, DOI 10.1651/10-3382.1; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Locke JM, 2007, P BIOL SOC WASH, V120, P214, DOI 10.2988/0006-324X(2007)120[214:ANDSOM]2.0.CO;2; MacDonald KS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3543[1:TNSOSS]2.0.CO;2; Macdonald KS, 2009, ZOOTAXA, P1; Macdonald KS, 2006, DIVERS DISTRIB, V12, P165, DOI 10.1111/j.1366-9516.2005.00213.x; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; PEARSE AS, 1950, ECOLOGY, V31, P149, DOI 10.2307/1931369; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; Rios R, 2007, ZOOTAXA, P1; Rutzler K., 1976, Tethys, V7, P249; Toth E, 2005, BIOL LETT-UK, V1, P49, DOI 10.1098/rsbl.2004.0237; Wapnick CM, 2004, ECOL LETT, V7, P354, DOI 10.1111/j.1461-0248.2004.00586.x; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WESTINGA E, 1981, MAR BIOL, V62, P139, DOI 10.1007/BF00388176; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007	45	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54637	10.1371/journal.pone.0054637	http://dx.doi.org/10.1371/journal.pone.0054637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418429	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300019
J	Frobert, O; Sarno, G; James, SK; Saleh, N; Lagerqvist, B				Frobert, Ole; Sarno, Giovanna; James, Stefan K.; Saleh, Nawsad; Lagerqvist, Bo			Effect of Stent Inflation Pressure and Post-Dilatation on the Outcome of Coronary Artery Intervention. A Report of More than 90 000 Stent Implantations	PLOS ONE			English	Article							DRUG-ELUTING STENTS; INTIMAL HYPERPLASIA; BALLOON PRESSURE; ULTRASOUND; DEPLOYMENT; ANGIOPLASTY; MULTICENTER; THROMBOSIS; IMPACT; TRIAL	Background: Percutaneous coronary intervention (PCI) stent inflation pressure correlates to angiographic lumen improvement and stent expansion but the relation to outcome is not clarified. Using comprehensive registry data our aim was to evaluate how stent inflation pressure influences restenosis, stent thrombosis and death following PCI. Methods: We evaluated all consecutive coronary stent implantations in Sweden during 46 months from 2008 using data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). We used logistic regression and Cox proportional hazard modeling to estimate risk of outcomes with different balloon pressures. Results: In total, 93 697 stents were eligible for analysis and divided into five different pressure interval groups: <= 15 atm, 16-17 atm, 18-19 atm, 20-21 atm and >= 22 atm. The risks of stent thrombosis and restenosis were significantly higher in the <= 15 atm, 18-19 atm and >= 22 atm groups (but not in the 16-17 atm group) compared to the 20-21 atm group. There were no differences in mortality. Post-dilatation was associated with a higher restenosis risk ratio (RR) of 1.22 (95% confidence interval (CI) 1.14-1.32, P < 0.001) but stent thrombosis did not differ statistically between procedures with or without post-dilatation. The risk of death was lower following post-dilatation (RR 0.81 (CI 0.71-0.93) P = 0.003) and the difference compared to no post-dilatation was seen immediately after PCI. Conclusion: Our retrospective study of stent inflation pressure identified a possible biological pattern-the risks of stent thrombosis and of restenosis appeared to be higher with low and very high pressures. Post-dilatation might increase restenosis risk.	[Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Sarno, Giovanna; James, Stefan K.; Lagerqvist, Bo] Uppsala Univ, Inst Med Sci, Uppsala, Sweden; [Saleh, Nawsad] Karolinska Hosp, Dept Cardiol, S-10401 Stockholm, Sweden	Orebro University; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Frobert, O (corresponding author), Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden.	ole.frobert@orebroll.se	James, Stefan K/J-4554-2014	Frobert, Ole/0000-0002-5846-345X				Blackman DJ, 2004, AM J CARDIOL, V94, P922, DOI 10.1016/j.amjcard.2004.06.029; Brasselet C, 2007, CLIN CHEM LAB MED, V45, P526, DOI 10.1515/CCLM.2007.088; Cheneau E, 2003, CIRCULATION, V108, P43, DOI 10.1161/01.CIR.0000078636.71728.40; Costa JD, 2005, AM J CARDIOL, V96, P74, DOI 10.1016/j.amjcard.2005.02.049; de Jaegere P, 1998, EUR HEART J, V19, P1214, DOI 10.1053/euhj.1998.1012; Dirschinger J, 1999, CIRCULATION, V100, P918, DOI 10.1161/01.CIR.100.9.918; Frobert O, 1997, INT J EXP PATHOL, V78, P421, DOI 10.1046/j.1365-2613.1997.470374.x; GOLDBERG SL, 1994, J AM COLL CARDIOL, V24, P996, DOI 10.1016/0735-1097(94)90861-3; Hoffmann R, 2005, CATHETER CARDIO INTE, V66, P499, DOI 10.1002/ccd.20542; Hoffmann R, 2001, EUR HEART J, V22, P2015, DOI 10.1053/euhj.2001.2609; Hovasse T, 2013, CATHETER CARDIO INTE, V81, P446, DOI 10.1002/ccd.23343; James SK, 2009, NEW ENGL J MED, V360, P1933, DOI 10.1056/NEJMoa0809902; Karabulut A, 2011, KARDIOL POL, V69, P183; Kim JS, 2008, AM J CARDIOL, V102, P304, DOI 10.1016/j.amjcard.2008.03.059; Lagerqvist B, 2009, CIRC-CARDIOVASC INTE, V2, P401, DOI 10.1161/CIRCINTERVENTIONS.108.844985; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Muraoka Y, 2011, HEART VESSELS, V26, P565, DOI 10.1007/s00380-010-0094-0; Olbrich T, 2006, PHYSIOL MEAS, V27, P213, DOI 10.1088/0967-3334/27/3/001; Ozaki Y, 2010, EUR HEART J, V31, P1470, DOI 10.1093/eurheartj/ehq066; Romagnoli E, 2008, JACC-CARDIOVASC INTE, V1, P22, DOI 10.1016/j.jcin.2007.10.005; SAREMBOCK IJ, 1989, CIRCULATION, V80, P1029, DOI 10.1161/01.CIR.80.4.1029; Tahara S, 2011, CIRC J, V75, P2113, DOI 10.1253/circj.CJ-10-0647; van der Hoeven BL, 2008, JACC-CARDIOVASC INTE, V1, P192, DOI 10.1016/j.jcin.2008.02.003; Williams PD, 2012, EUROINTERVENTION, V8, P267, DOI 10.4244/EIJV8I2A41	24	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56348	10.1371/journal.pone.0056348	http://dx.doi.org/10.1371/journal.pone.0056348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418560	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300153
J	Hollingsworth, TN; Johnstone, JF; Bernhardt, EL; Chapin, FS				Hollingsworth, Teresa N.; Johnstone, Jill F.; Bernhardt, Emily L.; Chapin, F. Stuart, III			Fire Severity Filters Regeneration Traits to Shape Community Assembly in Alaska's Boreal Forest	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; VEGETATION RESPONSE; SPECIES COMPOSITION; TREE RECRUITMENT; INTERIOR ALASKA; SCALE; ECOSYSTEMS; CLIMATE; BIOMASS; REGIME	Disturbance can both initiate and shape patterns of secondary succession by affecting processes of community assembly. Thus, understanding assembly rules is a key element of predicting ecological responses to changing disturbance regimes. We measured the composition and trait characteristics of plant communities early after widespread wildfires in Alaska to assess how variations in disturbance characteristics influenced the relative success of different plant regeneration strategies. We compared patterns of post-fire community composition and abundance of regeneration traits across a range of fire severities within a single pre-fire forest type-black spruce forests of Interior Alaska. Patterns of community composition, as captured by multivariate ordination with nonmetric multidimensional scaling, were primarily related to gradients in fire severity (biomass combustion and residual vegetation) and secondarily to gradients in soil pH and regional climate. This pattern was apparent in both the full dataset (n = 87 sites) and for a reduced subset of sites (n = 49) that minimized the correlation between site moisture and fire severity. Changes in community composition across the fire-severity gradient in Alaska were strongly correlated to variations in plant regeneration strategy and rooting depth. The tight coupling of fire severity with regeneration traits and vegetation composition after fire supports the hypothesis that disturbance characteristics influence patterns of community assembly by affecting the relative success of different regeneration strategies. This study further demonstrated that variations in disturbance characteristics can dominate over environmental constraints in determining early patterns of community assembly. By affecting the success of regeneration traits, changes in fire regime directly shape the outcomes of community assembly, and thus may override the effects of slower environmental change on boreal forest composition.	[Hollingsworth, Teresa N.] US Forest Serv, USDA, Pacific NW Res Stn, Fairbanks, AK USA; [Johnstone, Jill F.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Bernhardt, Emily L.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Chapin, F. Stuart, III] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA	United States Department of Agriculture (USDA); United States Forest Service; University of Saskatchewan; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Hollingsworth, TN (corresponding author), US Forest Serv, USDA, Pacific NW Res Stn, Fairbanks, AK USA.	thollingsworth@fs.fed.us	Chapin, F Stuart/AAZ-3931-2020; Johnstone, Jill F./C-9204-2009	Chapin, F Stuart/0000-0002-2558-9910; Johnstone, Jill F./0000-0001-6131-9339	U. S. Joint Fire Science Program [05-1-2-06]; NSERC; Direct For Biological Sciences [1026415] Funding Source: National Science Foundation	U. S. Joint Fire Science Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by funding from the U. S. Joint Fire Science Program (project 05-1-2-06), a NSERC Discovery grant to JFJ, and in-kind support from the Bonanza Creek Long-Term Ecological Research site and U. S. Forest Service PNW Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ROLE FIRE NO CIRCUMP; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P578, DOI 10.1111/j.1365-2486.2008.01679.x; BERGERON Y, 1993, J VEG SCI, V4, P827, DOI 10.2307/3235621; Bernhardt EL, 2011, J VEG SCI, V22, P32, DOI 10.1111/j.1654-1103.2010.01231.x; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Chapin FS, 2004, AMBIO, V33, P361, DOI 10.1639/0044-7447(2004)033[0361:GCATBF]2.0.CO;2; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Donato DC, 2009, J ECOL, V97, P142, DOI 10.1111/j.1365-2745.2008.01456.x; Elven R., 2011, ANNOTATED CHECKLIST; ESSLINGER TL, 1997, CUMULATIVE CHECKLIST; Fenton NJ, 2007, CAN J BOT, V85, P43, DOI 10.1139/B06-148; Greene DF, 2007, CAN J FOREST RES, V37, P1012, DOI 10.1139/X06-245; Hinzman L.D., 2006, ALASKAS CHANGING BOR, P39; Hollingsworth TN, 2006, CAN J FOREST RES, V36, P1781, DOI 10.1139/X06-061; HU FS, 1993, CAN J BOT, V71, P1133, DOI 10.1139/b93-133; Johnstone J, 2006, ECOSYSTEMS, V9, P14, DOI 10.1007/s10021-004-0042-x; Johnstone JF, 2010, GLOBAL CHANGE BIOL, V16, P1281, DOI 10.1111/j.1365-2486.2009.02051.x; Kane ES, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000458; Kasischke ES, 2010, CAN J FOREST RES, V40, P1313, DOI 10.1139/X10-098; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keith DA, 2007, J ECOL, V95, P1324, DOI 10.1111/j.1365-2745.2007.01302.x; Key CH, 2005, FIREMON FIRE EFFECTS, P25; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; Lynch JA, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000332; Mack MC, 2008, ECOSYSTEMS, V11, P209, DOI 10.1007/s10021-007-9117-9; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; NOBLE IR, 1980, VEGETATIO, V43, P5, DOI 10.1007/BF00121013; Ozinga WA, 2005, OIKOS, V108, P555, DOI 10.1111/j.0030-1299.2005.13632.x; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; PAYETTE S, 1992, P144, DOI 10.1017/CBO9780511565489.006; Rydgren K, 2004, ECOLOGY, V85, P1906, DOI 10.1890/03-0276; Schimmel J, 1996, ECOLOGY, V77, P1436, DOI 10.2307/2265541; Siegwart-Collier L.C., 2010, OECOLOGIA, V164, P465, DOI [10.1007/s00442-010-1642-0, DOI 10.1007/S00442-010-1642-0]; Todd SK., 2006, FIRE ALASKA HIST ORG; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Turner MG, 1999, INT J WILDLAND FIRE, V9, P21, DOI 10.1071/WF99003; VANCLEVE K, 1991, BIOSCIENCE, V41, P78, DOI 10.2307/1311560; Wang GG, 2005, CAN J FOREST RES, V35, P254, DOI [10.1139/x04-177, 10.1139/X04-177]; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Wolken JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00288.1	43	79	81	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56033	10.1371/journal.pone.0056033	http://dx.doi.org/10.1371/journal.pone.0056033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418503	Green Published, gold			2022-12-25	WOS:000315970300095
J	Malcolm, P; Derave, W; Galle, S; De Clercq, D				Malcolm, Philippe; Derave, Wim; Galle, Samuel; De Clercq, Dirk			A Simple Exoskeleton That Assists Plantarflexion Can Reduce the Metabolic Cost of Human Walking	PLOS ONE			English	Article							ENERGY-EXPENDITURE; MECHANICAL WORK; LEVEL WALKING; ANKLE; ENERGETICS; MASS; BIOMECHANICS; PERFORMANCE; LOCOMOTION; POWER	Background: Even though walking can be sustained for great distances, considerable energy is required for plantarflexion around the instant of opposite leg heel contact. Different groups attempted to reduce metabolic cost with exoskeletons but none could achieve a reduction beyond the level of walking without exoskeleton, possibly because there is no consensus on the optimal actuation timing. The main research question of our study was whether it is possible to obtain a higher reduction in metabolic cost by tuning the actuation timing. Methodology/Principal Findings: We measured metabolic cost by means of respiratory gas analysis. Test subjects walked with a simple pneumatic exoskeleton that assists plantarflexion with different actuation timings. We found that the exoskeleton can reduce metabolic cost by 0.18 +/- 0.06 W kg(-1) or 6 +/- 2% (standard error of the mean) (p = 0.019) below the cost of walking without exoskeleton if actuation starts just before opposite leg heel contact. Conclusions/Significance: The optimum timing that we found concurs with the prediction from a mathematical model of walking. While the present exoskeleton was not ambulant, measurements of joint kinetics reveal that the required power could be recycled from knee extension deceleration work that occurs naturally during walking. This demonstrates that it is theoretically possible to build future ambulant exoskeletons that reduce metabolic cost, without power supply restrictions.	[Malcolm, Philippe; Derave, Wim; Galle, Samuel; De Clercq, Dirk] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	Ghent University	Malcolm, P (corresponding author), Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.	philippe.malcolm@ugent.be	Derave, Wim/B-2554-2014	Derave, Wim/0000-0002-2225-5587; Galle, Samuel/0000-0002-1928-7764	Ghent University	Ghent University(Ghent University)	This research was funded by the Ghent University (it was conducted during the appointment of the corresponding author as an assistant/PhD student). There was no external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au SK, 2006, IEEE INT CONF ROBOT, P2939, DOI 10.1109/ROBOT.2006.1642148; Bogue R, 2009, IND ROBOT, V36, P421, DOI 10.1108/01439910910980141; Bregman DJJ, 2011, CLIN BIOMECH, V26, P955, DOI 10.1016/j.clinbiomech.2011.05.007; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Dempster W.T., 1955, 55159 WADC, P55; Ferris DP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-17; Fornaris E, 1998, Hist Sci Med, V32, P161; Galle S, 2013, GAIT POSTURE; GIVONI B, 1971, J APPL PHYSIOL, V30, P429, DOI 10.1152/jappl.1971.30.3.429; Gordon KE, 2006, J BIOMECH, V39, P1832, DOI 10.1016/j.jbiomech.2005.05.018; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Gregorczyk KN, 2010, ERGONOMICS, V53, P1263, DOI 10.1080/00140139.2010.512982; Herr H, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-21; HRELJAC A, 1993, MED SCI SPORT EXER, V25, P1158; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Li QG, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-22; Malcolm P, 2009, GAIT POSTURE, V30, P322, DOI 10.1016/j.gaitpost.2009.06.002; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Norris JA, 2007, GAIT POSTURE, V25, P620, DOI 10.1016/j.gaitpost.2006.07.002; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Sawicki GS, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-3; Sawicki GS, 2009, J EXP BIOL, V212, P21, DOI 10.1242/jeb.017269; Smith AE, 1982, ORTHOTICS PROSTHET, V36, P49; Thirunarayan M.A., 1996, GAIT POSTURE, P306, DOI 10.1016/0966-6362(95)01058-0; van den Bogert AJ, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-17; van Dijk W., 2011, P 2011 IEEE INT C RE, P1, DOI [DOI 10.1109/ICORR.2011.5975470, 10.1109/ICORR.2011.5975470]; Walsh CJ, 2007, INT J HUM ROBOT, V4, P487, DOI 10.1142/S0219843607001126; Wiggin M. B., 2012, P 7 ANN DYN WALK C, P24; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147	35	247	257	11	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56137	10.1371/journal.pone.0056137	http://dx.doi.org/10.1371/journal.pone.0056137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418524	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300116
J	Qin, AL; Wang, MM; Cun, YZ; Yang, FS; Wang, SS; Ran, JH; Wang, XQ				Qin, Ai-Li; Wang, Ming-Ming; Cun, Yu-Zhi; Yang, Fu-Sheng; Wang, Shan-Shan; Ran, Jin-Hua; Wang, Xiao-Quan			Phylogeographic Evidence for a Link of Species Divergence of Ephedra in the Qinghai-Tibetan Plateau and Adjacent Regions to the Miocene Asian Aridification	PLOS ONE			English	Article							PINUS-DENSATA; PHYLOGENETIC-RELATIONSHIPS; QUATERNARY CLIMATE; NONCODING REGIONS; UNIVERSAL PRIMERS; CHLOROPLAST DNA; EVOLUTION; GNETALES; SPECIATION; PINACEAE	The Qinghai-Tibetan Plateau (QTP) has become one of the hotspots for phylogeographical studies due to its high species diversity. However, most previous studies have focused on the effects of the Quaternary glaciations on phylogeographical structures and the locations of glacial refugia, and little is known about the effects of the aridization of interior Asia on plant population structure and speciation. Here the chloroplast DNA (cpDNA) trnT-trnF and trnS-trnfM sequences were used to investigate the differentiation and phylogeographical history of 14 Ephedra species from the QTP and northern China, based on a sampling of 107 populations. The phylogeographical analysis, together with phylogenetic reconstruction based on combined four cpDNA fragments (rbcL, rpl16, rps4, and trnS-trnfM), supports three main lineages (eastern QTP, southern QTP, and northern China) of these Ephedra species. Divergence of each lineage could be dated to the Middle or Late Miocene, and was very likely linked to the uplift of the QTP and the Asian aridification, given the high drought and/or cold tolerance of Ephedra. Most of the Ephedra species had low intraspecific variation and lacked a strong phylogeographical structure, which could be partially attributed to clonal reproduction and a relatively recent origin. In addition, ten of the detected 25 cpDNA haplotypes are shared among species, suggesting that a wide sampling of species is helpful to investigate the origin of observed haplotypes and make reliable phylogeographical inference. Moreover, the systematic positions of some Ephedra species are discussed.	[Qin, Ai-Li; Wang, Ming-Ming; Cun, Yu-Zhi; Yang, Fu-Sheng; Wang, Shan-Shan; Ran, Jin-Hua; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Qin, Ai-Li; Wang, Ming-Ming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XQ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828	National Natural Science Foundation of China [31170197, 30730010]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by by the National Natural Science Foundation of China (grants 31170197, 30730010) and the Chinese Academy of Sciences (the 100-Talent Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; CUTLER H. C., 1939, ANN MISSOURI BOT GARD, V26, P373, DOI 10.2307/2394299; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fu LK, 1999, FLORA CHINA, P97; Gao J, 2012, MOL ECOL, V21, P4811, DOI 10.1111/j.1365-294X.2012.05712.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Huang JL, 2003, MOL BIOL EVOL, V20, P435, DOI 10.1093/molbev/msg049; Ickert-Bond SM, 2004, SYST BOT, V29, P834, DOI 10.1600/0363644042451143; Ickert-Bond SM, 2011, INT J PLANT SCI, V172, P36, DOI 10.1086/657299; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; Jiang HC, 2008, PALAEOGEOGR PALAEOCL, V265, P30, DOI 10.1016/j.palaeo.2008.04.016; Li Xi-Wen, 1993, Acta Botanica Yunnanica, V15, P217; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Loera I, 2012, MOL PHYLOGENET EVOL, V65, P437, DOI 10.1016/j.ympev.2012.06.025; MANTEL N, 1967, CANCER RES, V27, P209; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Nei M., 1975, MOL POPULATION GENET; Nylander J, 2004, MR MODELTEST V2 PROG; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Rambaut A, 2007, TRACER V1 4 MOL EVOL; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Rydin C, 2010, BOT J LINN SOC, V163, P387, DOI 10.1111/j.1095-8339.2010.01066.x; Rydin C, 2009, INT J PLANT SCI, V170, P1031, DOI 10.1086/605116; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Shimono A, 2010, HEREDITY, V104, P534, DOI 10.1038/hdy.2009.158; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Song BH, 2003, MOL ECOL, V12, P2995, DOI 10.1046/j.1365-294X.2003.01962.x; Song BH, 2002, MOL ECOL, V11, P1057, DOI 10.1046/j.1365-294X.2002.01502.x; [宋之琛 SONG Zhichen], 2008, [古生物学报, Acta Palaeontologica Sinica], V47, P265; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Sun JM, 2008, GLOBAL PLANET CHANGE, V64, P53, DOI 10.1016/j.gloplacha.2008.09.001; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang KF, 1975, CHINESE J GEOL, V4, P366; Wang X, 2010, CHINESE SCI BULL, V55, P1511, DOI 10.1007/s11434-010-3069-8; Wang XR, 2001, GENETICS, V159, P337; Wei XX, 2004, MOL ECOL, V13, P3115, DOI 10.1111/j.1365-294X.2004.02299.x; Wei XX, 2003, J MOL EVOL, V57, P623, DOI 10.1007/s00239-003-2512-8; Wendt Tom, 1993, Phytologia, V74, P141; Wu, 1988, J JPN BOT, V63, P297; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Yang Y, 2002, SYSTEMATICS EVOLUTIO; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1	74	37	39	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56243	10.1371/journal.pone.0056243	http://dx.doi.org/10.1371/journal.pone.0056243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418542	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300135
J	Thompson, KA; Pappachan, JV; Bennett, AM; Mittal, H; Macken, S; Dove, BK; Nguyen-Van-Tam, JS; Copley, VR; O'Brien, S; Hoffman, P; Parks, S; Bentley, A; Isalska, B; Thomson, G				Thompson, Katy-Anne; Pappachan, John V.; Bennett, Allan M.; Mittal, Himanshu; Macken, Susan; Dove, Brian K.; Nguyen-Van-Tam, Jonathan S.; Copley, Vicky R.; O'Brien, Sarah; Hoffman, Peter; Parks, Simon; Bentley, Andrew; Isalska, Barbara; Thomson, Gail		EASE Study Consortium	Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic - The Risk of Aerosol Generation during Medical Procedures	PLOS ONE			English	Article							VIRAL LOAD; VIRUS; INFECTION; TRANSMISSION; TORONTO; SARS	Background: Nosocomial infection of health-care workers (HCWs) during outbreaks of respiratory infections (e. g. Influenza A H1N1 (2009)) is a significant concern for public health policy makers. World Health Organization (WHO)-defined 'aerosol generating procedures' (AGPs) are thought to increase the risk of aerosol transmission to HCWs, but there are presently insufficient data to quantify risk accurately or establish a hierarchy of risk-prone procedures. Methodology/Principal Findings: This study measured the amount of H1N1 (2009) RNA in aerosols in the vicinity of H1N1 positive patients undergoing AGPs to help quantify the potential risk of transmission to HCWs. There were 99 sampling occasions (windows) producing a total of 198 May stages for analysis in the size ranges 0.86-7.3 mu m. Considering stages 2 (4-7.3 mu m) and 3 (0.86-4 mu m) as comprising one sample, viral RNA was detected in 14 (14.1%) air samples from 10 (25.6%) patients. Twenty three air samples were collected while potential AGPs were being performed of which 6 (26.1%) contained viral RNA; in contrast, 76 May samples were collected when no WHO 2009 defined AGP was being performed of which 8 (10.5%) contained viral RNA (unadjusted OR = 2.84 (95% CI 1.11-7.24) adjusted OR = 4.31 (0.83-22.5)). Conclusions/Significance: With our small sample size we found that AGPs do not significantly increase the probability of sampling an H1N1 (2009) positive aerosol (OR (95% CI) = 4.31 (0.83-22.5). Although the probability of detecting positive H1N1 (2009) positive aerosols when performing various AGPs on intensive care patients above the baseline rate (i.e. in the absence of AGPs) did not reach significance, there was a trend towards hierarchy of AGPs, placing bronchoscopy and respiratory and airway suctioning above baseline (background) values. Further, larger studies are required but these preliminary findings may be of benefit to infection control teams.	[Thompson, Katy-Anne; Bennett, Allan M.; Macken, Susan; Parks, Simon] Hlth Protect Agcy, Biosafety Invest Unit, Porton Down, Wilts, England; [Pappachan, John V.] Univ Hosp Southampton NHS Fdn Trust, Paediat Intens Care Unit, Southampton, Hants, England; [Mittal, Himanshu] Hlth Protect Agcy, Biosafety Invest Unit, London, England; [Dove, Brian K.] Hlth Protect Agcy, Influenza Grp, Porton Down, Wilts, England; [Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Hlth Protect & Influenza Res Grp, Nottingham NG7 2RD, England; [Copley, Vicky R.] Hlth Protect Agcy, Microbial Risk Assessment Grp, Porton Down, Wilts, England; [O'Brien, Sarah] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Hoffman, Peter] Hlth Protect Agcy, Antimicrobial Resistance & Healthcare Associated, London, England; [Bentley, Andrew] Univ S Manchester Hosp, Acute Intens Care Unit, Manchester M20 8LR, Lancs, England; [Isalska, Barbara] Univ S Manchester Hosp, Dept Microbiol, Manchester M20 8LR, Lancs, England; [Thomson, Gail] Hlth Protect Agcy, Porton Down, Wilts, England	Health Protection Agency; University of Southampton; University Hospital Southampton NHS Foundation Trust; Health Protection Agency; Health Protection Agency; University of Nottingham; Health Protection Agency; University of Liverpool; Health Protection Agency; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Health Protection Agency	Thompson, KA (corresponding author), Hlth Protect Agcy, Biosafety Invest Unit, Porton Down, Wilts, England.	Katy-Anne.Thompson@hpa.org.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Bentley, Andrew/0000-0002-6883-9246; O'Brien, Sarah Jane/0000-0003-2896-8999; Pappachan, John/0000-0002-3559-0595; Bennett, Allan/0000-0001-7448-8182	Health Protection Agency; GlaxoSmithKline plc (GSK)	Health Protection Agency; GlaxoSmithKline plc (GSK)	This study was funded by the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KAT, BD, SM, SP, JP, GT, VC, HM, SO, PH, AB and BI have no conflict of interest. JVT: The University of Nottingham Health Protection Research Group is currently in receipt of research funds from GlaxoSmithKline plc (GSK), who are manufacturers/distributors of a virucidal respirator; this research funding is entirely unrelated to the performance or use of the virucidal respirator. Furthermore the research funding from GSK did not support any aspect of the work described in this manuscript. JVT has also received consultancy fees from GSK; but all forms of personal remuneration ceased in September, 2010. JVT is a former employee of SmithKline Beecham plc. (now GSK) prior to 2002, with no outstanding pecuniary interests in GSK by way of shareholdings, share options or accrued pension rights. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	ALFORD RH, 1967, AM J EPIDEMIOL, V86, P185, DOI 10.1093/oxfordjournals.aje.a120723; Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; [Anonymous], 2008, PANDEMIC INFLUENZA G; [Anonymous], 2007, INFECT PREVENTION CO; [Anonymous], 2007, ISOTS169761; [Anonymous], 2009, NAT PLAN INFL PAND N; [Anonymous], 2009, INTERIM GUIDANCE INF; [Anonymous], 2009, PANDEMIC H1N1 2009 I; [Anonymous], 2009, INFECT PREVENTION CO; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P461; Cox CS., 1987, AEROBIOLOGICAL PATHW; Davies A., 2009, Journal of Infection Prevention, V10, P122, DOI 10.1177/1757177409106456; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2011, J AEROSOL MED PULM D, V24, P137, DOI 10.1089/jamp.2010.0815; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; HALL CB, 1979, J INFECT DIS, V140, P610, DOI 10.1093/infdis/140.4.610; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Killingley B, 2010, HEALTH TECHNOL ASSES, V14, P237, DOI 10.3310/hta14460-04; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; MAY KR, 1966, BACTERIOL REV, V30, P559, DOI 10.1128/MMBR.30.3.559-570.1966; McDonald LC, 2004, EMERG INFECT DIS, V10, P777, DOI 10.3201/eid1005.030791; Milton DK, 2010, AM J RESP CRIT CARE, V181; Nicas M, 2006, RISK ANAL, V26, P1085, DOI 10.1111/j.1539-6924.2006.00802.x; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; SODERHOLM SC, 1989, ANN OCCUP HYG, V33, P301, DOI 10.1093/annhyg/33.3.301; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; The Influenza Pandemic Preparedness Team, 2011, ROUT TRANSM INFL VIR; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664	38	90	94	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56278	10.1371/journal.pone.0056278	http://dx.doi.org/10.1371/journal.pone.0056278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418548	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000315970300141
J	Uchida, S; Itaka, K; Uchida, H; Hayakawa, K; Ogata, T; Ishii, T; Fukushima, S; Osada, K; Kataoka, K				Uchida, Satoshi; Itaka, Keiji; Uchida, Hirokuni; Hayakawa, Kentaro; Ogata, Toru; Ishii, Takehiko; Fukushima, Shigeto; Osada, Kensuke; Kataoka, Kazunori			In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; GENE DELIVERY; VACCINATION TRIAL; DIRECT-INJECTION; LINKING INNATE; CELLS; PSEUDOURIDINE; TRANSFECTION; EXPRESSION; EFFICIENT	Messenger RNA (mRNA) introduction is a promising approach to produce therapeutic proteins and peptides without any risk of insertion mutagenesis into the host genome. However, it is difficult to introduce mRNA in vivo mainly because of the instability of mRNA under physiological conditions and its strong immunogenicity through the recognition by Toll-like receptors (TLRs). We used a novel carrier based on self-assembly of a polyethylene glycol (PEG)-polyamino acid block copolymer, polyplex nanomicelle, to administer mRNA into the central nervous system (CNS). The nanomicelle with 50 nm in diameter has a core-shell structure with mRNA-containing inner core surrounded by PEG layer, providing the high stability and stealth property to the nanomicelle. The functional polyamino acids possessing the capacity of pH-responsive membrane destabilization allows smooth endosomal escape of the nanomicelle into the cytoplasm. After introduction into CNS, the nanomicelle successfully provided the sustained protein expression in the cerebrospinal fluid for almost a week. Immune responses after mRNA administration into CNS were effectively suppressed by the use of the nanomicelle compared with naked mRNA introduction. In vitro analyses using specific TLR expressing HEK293 cells confirmed that the nanomicelle inclusion prevented mRNA from the recognition by TLRs. Thus, the polyplex nanomicelle is a promising system that simultaneously resolved the two major problems of in vivo mRNA introduction, the instability and immunogenicity, opening the door to various new therapeutic strategies using mRNA.	[Uchida, Satoshi; Itaka, Keiji; Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol,Bunkyo Ku, Tokyo, Japan; [Uchida, Hirokuni; Ishii, Takehiko; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Hayakawa, Kentaro; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Fukushima, Shigeto; Osada, Kensuke; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Itaka, K (corresponding author), Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol,Bunkyo Ku, Tokyo, Japan.	itaka-ort@umin.net; kataoka@bmw.t.u-tokyo.ac.jp	Ogata, Toru/ADC-3560-2022; UCHIDA, SATOSHI/H-6112-2018; Osada, Kensuke/V-3322-2017; Kataoka, Kazunori/K-7108-2012	Ogata, Toru/0000-0001-9011-8640; UCHIDA, SATOSHI/0000-0001-8726-0478; Osada, Kensuke/0000-0001-9557-6851; Kataoka, Kazunori/0000-0002-8591-413X	Core Research Program for Evolutional Science and Technology (CREST) from Japan Science and Technology Corporation (JST); Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Global COE Program 'Medical System Innovation through Multidisciplinary Integration' from MEXT, Japan; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS)	Core Research Program for Evolutional Science and Technology (CREST) from Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program 'Medical System Innovation through Multidisciplinary Integration' from MEXT, Japan; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported in part by the Core Research Program for Evolutional Science and Technology (CREST) from Japan Science and Technology Corporation (JST) (K.K., http://www.jst.go.jp/kisoken/crest/en/index.html), Grants-in-Aid for Scientific Research form the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) (K.I., http://www.jsps.go.jp/english/e-grants/index.html), Global COE Program 'Medical System Innovation through Multidisciplinary Integration' from MEXT, Japan(http://park.itc.u-tokyo.ac.jp/CMSI/e/index.html) and Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Bettinger T, 2001, NUCLEIC ACIDS RES, V29, P3882, DOI 10.1093/nar/29.18.3882; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CALLIS J, 1987, NUCLEIC ACIDS RES, V15, P5823; Charette M, 2000, IUBMB LIFE, V49, P341; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Itaka K, 2011, CURR GENE THER, V11, P457, DOI 10.2174/156652311798192879; Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072; Itaka K, 2009, EUR J PHARM BIOPHARM, V71, P475, DOI 10.1016/j.ejpb.2008.09.019; Kanayama N, 2006, CHEMMEDCHEM, V1, P439, DOI 10.1002/cmdc.200600008; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Listvanova S, 2003, J IMMUNOL METHODS, V281, P27, DOI 10.1016/S0022-1759(03)00267-9; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Masago K, 2007, BIOMATERIALS, V28, P5169, DOI 10.1016/j.biomaterials.2007.07.019; Mitchell DA, 2000, J CLIN INVEST, V106, P1065, DOI 10.1172/JCI11405; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Plews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014397; Probst J, 2007, GENE THER, V14, P1175, DOI 10.1038/sj.gt.3302964; Qiu P, 1996, GENE THER, V3, P262; Reijneveld JC, 1999, J NEURO-ONCOL, V42, P137, DOI 10.1023/A:1006237917632; Rejman J, 2010, J CONTROL RELEASE, V147, P385, DOI 10.1016/j.jconrel.2010.07.124; Scheel B, 2005, EUR J IMMUNOL, V35, P1557, DOI 10.1002/eji.200425656; Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tavernier G, 2011, BIOMATERIALS; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Van Tendeloo VF, 2007, CURR OPIN MOL THER, V9, P423; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weide B, 2008, J IMMUNOTHER, V31, P180, DOI 10.1097/CJI.0b013e31815ce501; Weide B, 2009, J IMMUNOTHER, V32, P498, DOI 10.1097/CJI.0b013e3181a00068; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Zou S, 2010, INT J PHARMACEUT, V389, P232, DOI 10.1016/j.ijpharm.2010.01.019	45	69	79	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56220	10.1371/journal.pone.0056220	http://dx.doi.org/10.1371/journal.pone.0056220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418537	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300129
J	Vignier, N; Amor, F; Fogel, P; Duvallet, A; Poupiot, J; Charrier, S; Arock, M; Montus, M; Nelson, I; Richard, I; Carrier, L; Servais, L; Voit, T; Bonne, G; Israeli, D				Vignier, Nicolas; Amor, Fatima; Fogel, Paul; Duvallet, Angelique; Poupiot, Jerome; Charrier, Sabine; Arock, Michel; Montus, Marie; Nelson, Isabelle; Richard, Isabelle; Carrier, Lucie; Servais, Laurent; Voit, Thomas; Bonne, Gisele; Israeli, David			Distinctive Serum miRNA Profile in Mouse Models of Striated Muscular Pathologies	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; CIRCULATING MICRORNAS; DYSTROPHY; MUSCLE; CANCER; CARDIOMYOPATHY; BIOMARKERS; DEFICIENCY; MUTATIONS; ALPHA	Biomarkers are critically important for disease diagnosis and monitoring. In particular, close monitoring of disease evolution is eminently required for the evaluation of therapeutic treatments. Classical monitoring methods in muscular dystrophies are largely based on histological and molecular analyses of muscle biopsies. Such biopsies are invasive and therefore difficult to obtain. The serum protein creatine kinase is a useful biomarker, which is however not specific for a given pathology and correlates poorly with the severity or course of the muscular pathology. The aim of the present study was the systematic evaluation of serum microRNAs )miRNAs) as biomarkers in striated muscle pathologies. Mouse models for five striated muscle pathologies were investigated: Duchenne muscular dystrophy (DMD), limb-girdle muscular dystrophy type 2D (LGMD2D), limb-girdle muscular dystrophy type 2C (LGMD2C), Emery-Dreifuss muscular dystrophy )EDMD) and hypertrophic cardiomyopathy (HCM). Two-step RT-qPCR methodology was elaborated, using two different RT-qPCR miRNA quantification technologies. We identified miRNA modulation in the serum of all the five mouse models. The most highly dysregulated serum miRNAs were found to be commonly upregulated in DMD, LGMD2D and LGMD2C mouse models, which all exhibit massive destruction of striated muscle tissues. Some of these miRNAs were down rather than upregulated in the EDMD mice, a model without massive myofiber destruction. The dysregulated miRNAs identified in the HCM model were different, with the exception of one dysregulated miRNA common to all pathologies. Importantly, a specific and distinctive circulating miRNA profile was identified for each studied pathological mouse model. The differential expression of a few dysregulated miRNAs in the DMD mice was further evaluated in DMD patients, providing new candidates of circulating miRNA biomarkers for DMD.	[Vignier, Nicolas; Nelson, Isabelle; Carrier, Lucie; Voit, Thomas; Bonne, Gisele] INSERM, UMRS 974, Paris, France; [Vignier, Nicolas; Nelson, Isabelle; Carrier, Lucie; Voit, Thomas; Bonne, Gisele] Univ Paris 06, CNRS, UM 76, UMR 7215,Inst Myol,IFR14, Paris, France; [Amor, Fatima; Duvallet, Angelique; Poupiot, Jerome; Charrier, Sabine; Montus, Marie; Richard, Isabelle; Israeli, David] Genethon, Evry, France; [Fogel, Paul] Stat Consulting, Paris, France; [Arock, Michel] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Unite Fonct Hematol & Hemostase, Paris, France; [Richard, Isabelle] CNRS, UMR8587, LAMBE, Evry, France; [Carrier, Lucie] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany; [Servais, Laurent] Inst Myol, Dept Therapeut Trials & Databases, Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, UF Cardiogenet & Myogenet, Serv Biochim Metab, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Israeli, D (corresponding author), Genethon, Evry, France.		Bonne, Gisèle/G-3121-2013; Richard, isabelle/J-8298-2013; Vignier, Nicolas/AAW-8289-2021; Servais, Laurent/AAL-7384-2020	Bonne, Gisèle/0000-0002-2516-3258; Vignier, Nicolas/0000-0003-2663-4864; nelson, isabelle/0000-0001-6390-622X; Fogel, Paul/0000-0002-5398-6622; CHARRIER, Sabine/0000-0001-9399-7492; Servais, Laurent/0000-0001-9270-4061	Association Francaise contre les Myopathies (AFM); ADNA (Advanced Diagnostics for New Therapeutic Approaches); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique (CNRS); bi-national grant from the Agence Nationale de la Recherche (ANR, France); Bundesministerium fur Bildung und Forshung (BMBF, Germany) [ANR-BMBF-09-GENO-107]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); ADNA (Advanced Diagnostics for New Therapeutic Approaches); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); bi-national grant from the Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); Bundesministerium fur Bildung und Forshung (BMBF, Germany)(Federal Ministry of Education & Research (BMBF))	This study was financially supported by the Association Francaise contre les Myopathies (AFM); by ADNA (Advanced Diagnostics for New Therapeutic Approaches); the Institut National de la Sante et de la Recherche Medicale (INSERM); the Universite Pierre et Marie Curie Paris 06; the Centre National de la Recherche Scientifique (CNRS); the bi-national grant from the Agence Nationale de la Recherche (ANR, France) and the Bundesministerium fur Bildung und Forshung (BMBF, Germany) (ANR-BMBF-09-GENO-107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fougerousse F, 1998, CIRC RES, V82, P130; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Gasper Mason C, 2005, Med Health R I, V88, P400; Gasper MC, 2005, MED HLTH R I, V88, P400; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hermans MCE, 2010, NEUROMUSCULAR DISORD, V20, P479, DOI 10.1016/j.nmd.2010.04.008; Jacoby D, 2012, EUR HEART J, V33, P296, DOI 10.1093/eurheartj/ehr260; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lancioni A, 2011, HUM MOL GENET, V20, P4644, DOI 10.1093/hmg/ddr398; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meune C, 2011, INT J CARDIOL, V151, P160, DOI 10.1016/j.ijcard.2010.05.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Olivotto I, 2011, J AM COLL CARDIOL, V58, P839, DOI 10.1016/j.jacc.2011.05.018; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sveen ML, 2008, ARCH NEUROL-CHICAGO, V65, P1196, DOI 10.1001/archneur.65.9.1196; Sylvius N, 2011, FASEB J, V25, P3966, DOI 10.1096/fj.11-182915; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Vignier N, 2009, CIRC RES, V105, P239, DOI 10.1161/CIRCRESAHA.109.201251; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028	47	77	80	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55281	10.1371/journal.pone.0055281	http://dx.doi.org/10.1371/journal.pone.0055281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418438	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300028
J	Campioni, D; Zauli, G; Gambetti, S; Campo, G; Cuneo, A; Ferrari, R; Secchiero, P				Campioni, Diana; Zauli, Giorgio; Gambetti, Stefania; Campo, Gianluca; Cuneo, Antonio; Ferrari, Roberto; Secchiero, Paola			In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CFU-EN; ANGIOGENESIS; NEOVASCULARIZATION; VASCULOGENESIS; MARKERS	Background: The current understanding of the functional characteristics of circulating endothelial progenitor cells (EPC) is limited, especially in patients affected by cardiovascular diseases. In this study, we have analyzed the in vitro clonogenic capacity of circulating EPC, also known as endothelial colony-forming cells (ECFC), in patients with acute coronary syndrome (ACS), in comparison to the colony forming unit-endothelial-like cells (CFU-EC) of hematopoietic/monocytic origin. Methodology/Principal Findings: By culturing peripheral blood mononuclear cells (PBMC) of patients with ACS (n = 70), CFU-EC were frequently isolated (from 77% of ACS patients), while EPC/ECFC were obtained only in a small subset (13%) of PBMC samples, all harvested between 7-14 days after the acute cardiovascular event. Notably, ex-vivo generation of EPC/ECFC was correlated to a higher in vitro release of PDGF-AA by the corresponding ACS patient PBMC. By using specific endothelial culture media, EPC/ECFC displayed in vitro expansion capacity, allowing the phenotypic and functional characterization of the cells. Indeed, after expansion, EPC/ECFC exhibited a normal diploid chromosomal setting by FISH analysis and an immunophenotype characterized by: i) uniform positivity for the expression of CD105, CD31, CD146 and Factor VIII, i) variable expression of the CD34, CD106 and CD184 markers, and iii) negativity for CD45, CD90, CD117 and CD133. Of interest, in single-cell replanting assays EPC/ECFC exhibited clonogenic expansion capacity, forming secondary colonies characterized by variable proliferation capacities. Conclusion/Significance: Our data indicate that a careful characterization of true EPC is needed in order to design future studies in the clinical autologous setting of patients with ACS.	[Campioni, Diana; Cuneo, Antonio] Univ Ferrara, Azienda Osped Univ, Dept Med Sci, Sect Hematol, I-44100 Ferrara, Italy; [Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Gambetti, Stefania; Campo, Gianluca; Ferrari, Roberto] Univ Ferrara, Azienda Osped Univ, Dept Med Sci, Cardiovasc Sect, I-44100 Ferrara, Italy; [Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy	University of Ferrara; Arcispedale Sant'Anna; IRCCS Burlo Garofolo; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Ferrara	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	Cuneo, Antonio/K-7617-2016; Zauli, Giorgio/ABE-8001-2020; secchiero, paola/G-9689-2015; FERRARI, ROBERTO/ABD-5169-2020; Campioni, Diana/O-4552-2015	secchiero, paola/0000-0003-4101-7987; Campioni, Diana/0000-0003-1650-8354; Campo, Gianluca/0000-0002-5150-188X; Zauli, Giorgio/0000-0002-3750-8698; Ferrari, Roberto/0000-0003-2046-9175	Regione Emilia Romagna- Programma di Ricerca Medicina Rigenerativa, Regione-Universita	Regione Emilia Romagna- Programma di Ricerca Medicina Rigenerativa, Regione-Universita	This work was supported by Regione Emilia Romagna- Programma di Ricerca Medicina Rigenerativa, Regione-Universita 2007/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Campioni D, 2004, LEUKEMIA RES, V28, P9, DOI 10.1016/S0145-2126(03)00123-1; Campioni D, 2008, HAEMATOL-HEMATOL J, V93, P1233, DOI 10.3324/haematol.12526; Cangiano E, 2011, J THROMB THROMBOLYS, V32, P1, DOI 10.1007/s11239-010-0543-8; Dignat-George F, 2003, PATHOPHYSIOL HAEMO T, V33, P495, DOI 10.1159/000083851; Dominici M, 2001, LEUKEMIA, V15, P171, DOI 10.1038/sj.leu.2401984; Goon PKY, 2007, CYTOM PART B-CLIN CY, V72B, P416, DOI 10.1002/cyto.b.20355; Heldin CH, 2012, UPSALA J MED SCI, V117, P83, DOI 10.3109/03009734.2012.658119; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Lanza F, 2003, BONE MARROW TRANSPL, V32, P1165, DOI 10.1038/sj.bmt.1704279; Lee MJ, 2011, CYTOTHERAPY, V13, P165, DOI 10.3109/14653249.2010.512632; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Massa M, 2009, EXP HEMATOL, V37, P8, DOI 10.1016/j.exphem.2008.09.007; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Pakala Rajbabu, 2002, Cardiovasc Radiat Med, V3, P95; Pearson JD, 2009, J THROMB HAEMOST, V7, P255, DOI 10.1111/j.1538-7836.2008.03214.x; Pujol BF, 2001, EUR J CELL BIOL, V80, P99, DOI 10.1078/0171-9335-00136; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Schmeisser A, 2002, J HEMATOTH STEM CELL, V11, P69, DOI 10.1089/152581602753448540; Shah P, 2012, J ORAL IMPLANTOL; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Strijbos MH, 2007, CYTOM PART B-CLIN CY, V72B, P86, DOI 10.1002/cyto.b.20156; Strijbos MH, 2009, CLIN CANCER RES, V15, P3640, DOI 10.1158/1078-0432.CCR-09-0160; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	37	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56377	10.1371/journal.pone.0056377	http://dx.doi.org/10.1371/journal.pone.0056377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409178	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000050
J	Johannessen, LE; Spilsberg, B; Wiik-Nielsen, CR; Kristoffersen, AB; Holst-Jensen, A; Berdal, KG				Johannessen, Lene E.; Spilsberg, Bjorn; Wiik-Nielsen, Christer R.; Kristoffersen, Anja B.; Holst-Jensen, Arne; Berdal, Knut G.			DNA-Fragments Are Transcytosed across CaCo-2 Cells by Adsorptive Endocytosis and Vesicular Mediated Transport	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NUCLEIC-ACID CHANNEL; COLONIC HOMEOSTASIS; MAMMALIAN-CELLS; TH1/TH2 BALANCE; BACTERIAL-DNA; DIETARY DNA; FOREIGN DNA; PROTEINS; IMMUNITY	Dietary DNA is degraded into shorter DNA-fragments and single nucleosides in the gastrointestinal tract. Dietary DNA is mainly taken up as single nucleosides and bases, but even dietary DNA-fragments of up to a few hundred bp are able to cross the intestinal barrier and enter the blood stream. The molecular mechanisms behind transport of DNA-fragments across the intestine and the effects of this transport on the organism are currently unknown. Here we investigate the transport of DNA-fragments across the intestinal barrier, focusing on transport mechanisms and rates. The human intestinal epithelial cell line CaCo-2 was used as a model. As DNA material a PCR-fragment of 633 bp was used and quantitative real time PCR was used as detection method. DNA-fragments were found to be transported across polarized CaCo-2 cells in the apical to basolateral direction (AB). After 90 min the difference in directionality AB vs. BA was >10(3) fold. Even undegraded DNA-fragments of 633 bp could be detected in the basolateral receiver compartment at this time point. Transport of DNA-fragments was sensitive to low temperature and inhibition of endosomal acidification. DNA-transport across CaCo-2 cells was not competed out with oligodeoxynucleotides, fucoidan, heparin, heparan sulphate and dextrane sulphate, while linearized plasmid DNA, on the other hand, reduced transcytosis of DNA-fragments by a factor of approximately 2. Our findings therefore suggest that vesicular transport is mediating transcytosis of dietary DNA-fragments across intestinal cells and that DNA binding proteins are involved in this process. If we extrapolate our findings to in vivo conditions it could be hypothesized that this transport mechanism has a function in the immune system.	[Johannessen, Lene E.; Spilsberg, Bjorn; Wiik-Nielsen, Christer R.; Kristoffersen, Anja B.; Holst-Jensen, Arne; Berdal, Knut G.] Norwegian Vet Inst, Oslo, Norway	Norwegian Veterinary Institute	Holst-Jensen, A (corresponding author), Norwegian Vet Inst, Oslo, Norway.	arne.holst-jensen@vetinst.no	Holst-Jensen, Arne/F-8531-2019	Holst-Jensen, Arne/0000-0002-5111-7765	Norwegian Research Council [172151/S40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council (www.forskningsradet.no), grant number 172151/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADSON A, 1994, J PHARM SCI, V83, P1529, DOI 10.1002/jps.2600831103; Altschuler Y, 2003, CURR OPIN CELL BIOL, V15, P423, DOI 10.1016/S0955-0674(03)00084-X; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Basner-Tschakarjan E, 2004, GENE THER, V11, P765, DOI 10.1038/sj.gt.3302221; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Doerfler W, 2012, EPIGENOMICS-UK, V4, P41, DOI [10.2217/EPI.11.111, 10.2217/epi.11.111]; Einspanier R, 2001, EUR FOOD RES TECHNOL, V212, P129, DOI 10.1007/s002170000248; Forsman A, 2003, MOL GENET GENOMICS, V270, P362, DOI 10.1007/s00438-003-0930-3; Gil A, 2002, EUR J CLIN NUTR, V56, pS1, DOI 10.1038/sj.ejcn.1601475; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gursel M, 2006, J IMMUNOL, V177, P1575, DOI 10.4049/jimmunol.177.3.1575; Hanss B, 1998, P NATL ACAD SCI USA, V95, P1921, DOI 10.1073/pnas.95.4.1921; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Incorporated C, 2002, CELL CULT PROT CLS A; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leal-Pinto E, 2005, AM J PHYSIOL-RENAL, V289, pF97, DOI 10.1152/ajprenal.00196.2004; Lee J, 2008, SEMIN IMMUNOPATHOL, V30, P3, DOI 10.1007/s00281-007-0099-7; Lee JD, 2007, CURR OPIN GASTROEN, V23, P27, DOI 10.1097/MOG.0b013e3280118272; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lehmann MJ, 2005, GENE THER, V12, P446, DOI 10.1038/sj.gt.3302428; Liu JW, 2007, WORLD J GASTROENTERO, V13, P3847; Mazzara M, 2005, 21825ENJRC32103 EUR; Nielsen C, 2005, EUR FOOD RES TECHNOL, V221, P1, DOI 10.1007/s00217-005-1160-1; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI 10.1007/s00217-002-0642-7; Schubbert R, 1997, P NATL ACAD SCI USA, V94, P961, DOI 10.1073/pnas.94.3.961; Shi FX, 2007, OLIGONUCLEOTIDES, V17, P122, DOI 10.1089/oli.2007.0034; Sissener NH, 2010, BRIT J NUTR, V103, P3, DOI 10.1017/S0007114509991401; Sudo N, 2000, CLIN EXP ALLERGY, V30, P979, DOI 10.1046/j.1365-2222.2000.00811.x; Sudo N, 2004, INT ARCH ALLERGY IMM, V135, P132, DOI 10.1159/000080655; Wang HP, 2012, VIRUS RES, V167, P48, DOI 10.1016/j.virusres.2012.04.001; Watanabe T, 2010, BIOL PHARM BULL, V33, P796, DOI 10.1248/bpb.33.796; Wittrup A, 2007, J BIOL CHEM, V282, P27897, DOI 10.1074/jbc.M701611200; Wu-Pong S, 1999, BIOPHARM DRUG DISPOS, V20, P411, DOI 10.1002/1099-081X(199912)20:9<411::AID-BDD208>3.0.CO;2-4	35	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56671	10.1371/journal.pone.0056671	http://dx.doi.org/10.1371/journal.pone.0056671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409196	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000060
J	Jenke, AC; Postberg, J; Raine, T; Nayak, KM; Molitor, M; Wirth, S; Kaser, A; Parkes, M; Heuschkel, RB; Orth, V; Zilbauer, M				Jenke, Andreas C.; Postberg, Jan; Raine, Timothy; Nayak, Komal M.; Molitor, Malte; Wirth, Stefan; Kaser, Arthur; Parkes, Miles; Heuschkel, Robert B.; Orth, Valerie; Zilbauer, Matthias			DNA Methylation Analysis in the Intestinal Epithelium-Effect of Cell Separation on Gene Expression and Methylation Profile	PLOS ONE			English	Article							DITHIOTHREITOL; DISEASE	Background: Epigenetic signatures are highly cell type specific. Separation of distinct cell populations is therefore desirable for all epigenetic studies. However, to date little information is available on whether separation protocols might influence epigenetic and/or gene expression signatures and hence might be less beneficial. We investigated the influence of two frequently used protocols to isolate intestinal epithelium cells (IECs) from 6 healthy individuals. Materials and Methods: Epithelial cells were isolated from small bowel (i.e. terminal ileum) biopsies using EDTA/DTT and enzymatic release followed by magnetic bead sorting via EPCAM labeled microbeads. Effects on gene/mRNA expression were analyzed using a real time PCR based expression array. DNA methylation was assessed by pyrosequencing of bisulfite converted DNA and methylated DNA immunoprecipitation (MeDIP). Results: While cell purity was >95% using both cell separation approaches, gene expression analysis revealed significantly higher mRNA levels of several inflammatory genes in EDTA/DTT when compared to enzymatically released cells. In contrast, DNA methylation of selected genes was less variable and only revealed subtle differences. Comparison of DNA methylation of the epithelial cell marker EPCAM in unseparated whole biopsy samples with separated epithelium (i.e. EPCAM positive and negative fraction) demonstrated significant differences in DNA methylation between all three tissue fractions indicating cell type specific methylation patterns can be masked in unseparated tissue samples. Conclusions: Taken together, our data highlight the importance of considering the potential effect of cell separation on gene expression as well as DNA methylation signatures. The decision to separate tissue samples will therefore depend on study design and specific separation protocols.	[Jenke, Andreas C.; Nayak, Komal M.; Molitor, Malte; Heuschkel, Robert B.; Zilbauer, Matthias] Univ Cambridge, Addenbrookes Hosp, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge CB2 2QQ, England; [Jenke, Andreas C.; Postberg, Jan; Molitor, Malte; Wirth, Stefan; Orth, Valerie] Univ Witten Herdecke, HELIOS Childrens Hosp, Dept Neonatol, Wuppertal, Germany; [Raine, Timothy; Kaser, Arthur; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Witten Herdecke University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Zilbauer, M (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge CB2 2QQ, England.	mz304@medschl.cam.ac.uk	Jenke, Andreas/AAO-2291-2020; Zilbauer, Matthias/AAZ-2740-2020	Jenke, Andreas/0000-0002-4008-7185; Zilbauer, Matthias/0000-0002-7272-0547; Parkes, Miles/0000-0002-6467-0631; Postberg, Jan/0000-0002-8562-3316; Raine, Tim/0000-0002-5855-9873	CICRA (Crohn's in Childhood Research Association); 3Cs (Crohn's and Colitis in Childhood)	CICRA (Crohn's in Childhood Research Association); 3Cs (Crohn's and Colitis in Childhood)	This work was supported by CICRA (Crohn's in Childhood Research Association) and the 3Cs (Crohn's and Colitis in Childhood). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTNIK W, 1980, GASTROENTEROLOGY, V78, P976; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; Cooke J, 2012, INFLAMM BOWEL DIS, V18, P2128, DOI 10.1002/ibd.22942; EVANS GS, 1992, J CELL SCI, V101, P219; GIBSON PR, 1989, GASTROENTEROLOGY, V96, P283, DOI 10.1016/0016-5085(89)91549-7; HELD KD, 1987, RADIAT RES, V112, P544, DOI 10.2307/3577106; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Uematsu S, 2010, MICROBIOL IMMUNOL, V54, P645, DOI 10.1111/j.1348-0421.2010.00267.x; VALETTI C, 1994, MOL BIOL CELL, V5, P1311, DOI 10.1091/mbc.5.12.1311; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	16	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55636	10.1371/journal.pone.0055636	http://dx.doi.org/10.1371/journal.pone.0055636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409010	gold, Green Submitted, Green Published			2022-12-25	WOS:000314660300025
J	Brzoska, AJ; Hassan, KA; de Leon, EJ; Paulsen, IT; Lewis, PJ				Brzoska, Anthony J.; Hassan, Karl A.; de Leon, Ellen J.; Paulsen, Ian T.; Lewis, Peter J.			Single-Step Selection of Drug Resistant Acinetobacter baylyi ADP1 Mutants Reveals a Functional Redundancy in the Recruitment of Multidrug Efflux Systems	PLOS ONE			English	Article							MESSENGER-RNA; BAUMANNII; PUMP; SUSCEPTIBILITY; TRANSPORTERS; ANTIBIOTICS; EXPRESSION; STABILITY; ADEIJK	Members of the genus Acinetobacter have been the focus recent attention due to both their clinical significance and application to molecular biology. The soil commensal bacterium Acinetobacter baylyi ADP1 has been proposed as a model system for molecular and genetic studies, whereas in a clinical environment, Acinetobacter spp. are of increasing importance due to their propensity to cause serious and intractable systemic infections. Clinically, a major factor in the success of Acinetobacter spp. as opportunistic pathogens can be attributed to their ability to rapidly evolve resistance to common antimicrobial compounds. Whole genome sequencing of clinical and environmental Acinetobacter spp. isolates has revealed the presence of numerous multidrug transporters within the core and accessory genomes, suggesting that efflux is an important host defense response in this genus. In this work, we used the drug-susceptible organism A. baylyi ADP1 as a model for studies into the evolution of efflux mediated resistance in genus Acinetobacter, due to the high level of conservation of efflux determinants across four diverse Acinetobacter strains, including clinical isolates. A single exposure of therapeutic concentrations of chloramphenicol to populations of A. baylyi ADP1 cells produced five individual colonies displaying multidrug resistance. The major facilitator superfamily pump craA was upregulated in one mutant strain, whereas the resistance nodulation division pump adeJ was upregulated in the remaining four. Within the adeJ upregulated population, two different levels of adeJ mRNA transcription were observed, suggesting at least three separate mutations were selected after single-step exposure to chloramphenicol. In the craA upregulated strain, a T to G substitution 12 nt upstream of the craA translation initiation codon was observed. Subsequent mRNA stability analyses using this strain revealed that the half-life of mutant craA mRNA was significantly greater than that of wild-type craA mRNA.	[Brzoska, Anthony J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Brzoska, Anthony J.; Hassan, Karl A.; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Brzoska, Anthony J.; Lewis, Peter J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [de Leon, Ellen J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Sydney; Macquarie University; University of Newcastle; University of Queensland	Brzoska, AJ (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	Anthony.Brzoska@sydney.edu.au	Paulsen, Ian/K-3832-2012; Hassan, Karl/B-2802-2013	Paulsen, Ian/0000-0001-9015-9418; Hassan, Karl/0000-0003-2031-9679	National Health and Medical Research Council (NHMRC) [APP1021479, 535053]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au/) project grant APP1021479 to PJL and by NHMRC project grant 535053 to ITP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Beceiro A, 2007, J ANTIMICROB CHEMOTH, V59, P996, DOI 10.1093/jac/dkm070; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chastre J, 2000, Semin Respir Infect, V15, P287; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P333, DOI 10.1128/AAC.01037-09; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; de Berardinis V, 2009, CURR OPIN MICROBIOL, V12, P568, DOI 10.1016/j.mib.2009.07.005; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Elliott KT, 2011, IUBMB LIFE, V63, P1075, DOI 10.1002/iub.530; Fournier B, 2001, J BACTERIOL, V183, P2367, DOI 10.1128/JB.183.7.2367-2371.2001; Lee A, 2000, J BACTERIOL, V182, P3142, DOI 10.1128/JB.182.11.3142-3150.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Michalopoulos A, 2010, EXPERT OPIN PHARMACO, V11, P779, DOI 10.1517/14656561003596350; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohki R, 2004, J BACTERIOL, V186, P7450, DOI 10.1128/JB.186.21.7450-7455.2004; Petersen C, 1993, CONTROL MESSENGER RN, P117; RAINEY FA, 1994, FEMS MICROBIOL LETT, V124, P349, DOI 10.1016/0378-1097(94)00453-6; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P228, DOI 10.1093/jac/dkp427; Reams AB, 2003, MOL MICROBIOL, V47, P1291, DOI 10.1046/j.1365-2958.2003.03342.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Rosenfeld N, 2012, ANTIMICROB AGENTS CH, V56, P2504, DOI 10.1128/AAC.06422-11; Rozen S, 2000, Methods Mol Biol, V132, P365; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; VILA J, 1993, ANTIMICROB AGENTS CH, V37, P138, DOI 10.1128/AAC.37.1.138; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; Wieczorek P, 2008, FOLIA HISTOCHEM CYTO, V46, P257, DOI 10.2478/v10042-008-0056-x; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	32	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56090	10.1371/journal.pone.0056090	http://dx.doi.org/10.1371/journal.pone.0056090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409126	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200106
J	Kim, MJ; Park, HS; Seo, KH; Yang, HJ; Kim, SK; Choi, JH				Kim, Min-Ji; Park, Hyun Soo; Seo, Kyung Hye; Yang, Hyo-Jin; Kim, Sook-Kyung; Choi, Jun-Hyuk			Complete Solubilization and Purification of Recombinant Human Growth Hormone Produced in Escherichia coli	PLOS ONE			English	Article							SECONDARY STRUCTURE; INCLUSION-BODIES; PROTEIN; EXPRESSION; QUANTIFICATION; AUTOINDUCTION; STRATEGIES; RETENTION; PROLACTIN; SECRETION	High-level expression of recombinant human growth hormone (hGH) in Escherichia coli (E. coli) leads to the formation of insoluble aggregates as inclusion bodies devoid of biological activity. Until recently, significant efforts have been made to improve the recovery of active hGH from inclusion bodies. Here, we developed an efficient procedure for the production of completely soluble hGH by minimizing the formation of inclusion bodies and optimizing protein purification conditions. Under the newly established conditions we were able to obtain most of the total hGH in the soluble fraction. We show that the soluble protein can be efficiently purified in high yield by a series of chromatographic procedures. We analyzed the resulting hGH using various analytical techniques such as reversed-phase high-performance liquid chromatography (RP-HPLC), size-exclusion chromatography (SEC), matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry, and circular dichroism (CD). These multiple analyses support the conclusion that we obtained highly pure hGH with the expected molecular mass and intact secondary structure. The biological activity of purified hGH was also confirmed by evaluating its growth-promoting effect using a cell proliferation assay. Taken together, we describe a straightforward strategy for the production of completely soluble and biologically active hGH in E. coli.	[Kim, Min-Ji; Park, Hyun Soo; Seo, Kyung Hye; Yang, Hyo-Jin; Kim, Sook-Kyung; Choi, Jun-Hyuk] Korea Res Inst Stand & Sci, Dept Metrol Qual Life, Ctr Bioanal, Taejon, South Korea; [Kim, Min-Ji; Yang, Hyo-Jin; Kim, Sook-Kyung] Univ Sci & Technol, Dept Bioanalyt Sci, Daejion, South Korea	Korea Research Institute of Standards & Science (KRISS)	Choi, JH (corresponding author), Korea Res Inst Stand & Sci, Dept Metrol Qual Life, Ctr Bioanal, 1 Doryong Dong, Taejon, South Korea.	junchoi@kriss.re.kr	kim, minji/GRX-9996-2022	Kim, Doeun/0000-0001-9579-3071	Korea Research Institute of Standards and Science [12011021]	Korea Research Institute of Standards and Science	This work was supported by the Korea Research Institute of Standards and Science under the project "Development of Protein Measurement Standards", Grant 12011021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BECKER GW, 1986, FEBS LETT, V204, P145, DOI 10.1016/0014-5793(86)81403-X; BEWLEY TA, 1969, BIOCHEMISTRY-US, V8, P4701, DOI 10.1021/bi00840a007; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL RM, 1990, P SOC EXP BIOL MED, V193, P269; CHANG CN, 1987, GENE, V55, P189, DOI 10.1016/0378-1119(87)90279-4; DATAR RV, 1993, BIO-TECHNOL, V11, P349, DOI 10.1038/nbt0393-349; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIXON JS, 1966, SCIENCE, V154, P785, DOI 10.1126/science.154.3750.785; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Francis DM, 2010, CURR PROTOC PROTEIN, V24, P21; Garcia-Barros M, 2000, HORM RES, V53, P40, DOI 10.1159/000023512; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GOEDDEL DV, 1979, NATURE, V281, P544, DOI 10.1038/281544a0; GRAY GL, 1985, GENE, V39, P247, DOI 10.1016/0378-1119(85)90319-1; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; IKEHARA M, 1984, P NATL ACAD SCI-BIOL, V81, P5956, DOI 10.1073/pnas.81.19.5956; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; Jeong JS, 2011, J CHROMATOGR A, V1218, P6596, DOI 10.1016/j.chroma.2011.07.053; Khan RH, 1998, BIOTECHNOL PROGR, V14, P722, DOI 10.1021/bp980071q; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NECESSARY PC, 1985, MOL CELL ENDOCRINOL, V39, P247, DOI 10.1016/0303-7207(85)90068-1; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Sadaf S, 2007, BIOTECHNOL APPL BIOC, V47, P21, DOI 10.1042/BA20060154; Shin NK, 1998, J BIOTECHNOL, V62, P143, DOI 10.1016/S0168-1656(98)00054-6; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Soares CRJ, 2003, PROTEIN ENG, V16, P1131, DOI 10.1093/protein/gzg114; Sonoda H, 2008, BIOSCI BIOTECH BIOCH, V72, P2675, DOI 10.1271/bbb.80332; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; St John RJ, 2001, J BIOL CHEM, V276, P46856, DOI 10.1074/jbc.M107671200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058	35	35	41	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56168	10.1371/journal.pone.0056168	http://dx.doi.org/10.1371/journal.pone.0056168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409149	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200120
J	Romero, MC; Van Dromme, ICL; Janssen, P				Romero, Maria C.; Van Dromme, Ilse C. L.; Janssen, Peter			The Role of Binocular Disparity in Stereoscopic Images of Objects in the Macaque Anterior Intraparietal Area	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; MONKEY PARIETAL CORTEX; 3-DIMENSIONAL SHAPE; INFEROTEMPORAL CORTEX; SURFACE-ORIENTATION; VISUAL CONTROL; HAND ACTION; NEURONS; REPRESENTATION; PERCEPTION	Neurons in the macaque Anterior Intraparietal area (AIP) encode depth structure in random-dot stimuli defined by gradients of binocular disparity, but the importance of binocular disparity in real-world objects for AIP neurons is unknown. We investigated the effect of binocular disparity on the responses of AIP neurons to images of real-world objects during passive fixation. We presented stereoscopic images of natural and man-made objects in which the disparity information was congruent or incongruent with disparity gradients present in the real-world objects, and images of the same objects where such gradients were absent. Although more than half of the AIP neurons were significantly affected by binocular disparity, the great majority of AIP neurons remained image selective even in the absence of binocular disparity. AIP neurons tended to prefer stimuli in which the depth information derived from binocular disparity was congruent with the depth information signaled by monocular depth cues, indicating that these monocular depth cues have an influence upon AIP neurons. Finally, in contrast to neurons in the inferior temporal cortex, AIP neurons do not represent images of objects in terms of categories such as animate-inanimate, but utilize representations based upon simple shape features including aspect ratio.	[Romero, Maria C.; Van Dromme, Ilse C. L.; Janssen, Peter] KULeuven, Lab Neuro & Psychofysiol, Louvain, Belgium	KU Leuven	Janssen, P (corresponding author), KULeuven, Lab Neuro & Psychofysiol, Louvain, Belgium.	Peter.Janssen@med.kuleuven.be	Romero, Maria/AAA-2826-2020	Romero, Maria C/0000-0001-7758-2211	Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0713.09]; Geconcerteerde Onderzoeksacties GOA [10/19]; Interuniversitaire Attractiepolen IUAP [P6/29];  [ERC-StG-260607];  [PFV10/008]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Geconcerteerde Onderzoeksacties GOA; Interuniversitaire Attractiepolen IUAP; ; 	This work was supported by Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0713.09), ERC-StG-260607, Programmafinanciering PFV10/008, Geconcerteerde Onderzoeksacties GOA 10/19, and Interuniversitaire Attractiepolen IUAP P6/29. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Durand JB, 2007, NEURON, V55, P493, DOI 10.1016/j.neuron.2007.06.040; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2008, J NEUROSCI, V28, P6679, DOI 10.1523/JNEUROSCI.0499-08.2008; Katsuyama N, 2010, NEUROSCIENCE, V167, P1, DOI 10.1016/j.neuroscience.2010.01.028; Keefe BD, 2009, EXP BRAIN RES, V194, P435, DOI 10.1007/s00221-009-1718-4; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nelissen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008306; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Romero MC, 2012, EUR J NEUROSCI, V36, P2324, DOI 10.1111/j.1460-9568.2012.08135.x; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sakuraba S, 2012, J NEUROSCI, V32, P3949, DOI 10.1523/JNEUROSCI.3973-11.2012; Srivastava S, 2009, J NEUROSCI, V29, P10613, DOI 10.1523/JNEUROSCI.6016-08.2009; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theys T, 2012, J NEUROPHYSIOL, V107, P995, DOI 10.1152/jn.00248.2011; Todd JT, 2007, J VIS, V7, P91; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Verhoef BE, 2012, NEURON, V73, P171, DOI 10.1016/j.neuron.2011.10.031; Verhoef BE, 2011, J NEUROPHYSIOL, V105, P2030, DOI 10.1152/jn.00924.2010; Verhoef BE, 2010, CURR BIOL, V20, P909, DOI 10.1016/j.cub.2010.03.058; Watt SJ, 2003, J EXP PSYCHOL HUMAN, V29, P404, DOI 10.1037/0096-1523.29.2.404	27	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55340	10.1371/journal.pone.0055340	http://dx.doi.org/10.1371/journal.pone.0055340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408970	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000315157200024
J	Capocasa, M; Battaggia, C; Anagnostou, P; Montinaro, F; Boschi, I; Ferri, G; Alu, M; Coia, V; Crivellaro, F; Bisol, GD				Capocasa, Marco; Battaggia, Cinzia; Anagnostou, Paolo; Montinaro, Francesco; Boschi, Ilaria; Ferri, Gianmarco; Alu, Milena; Coia, Valentina; Crivellaro, Federica; Bisol, Giovanni Destro			Detecting Genetic Isolation in Human Populations: A Study of European Language Minorities	PLOS ONE			English	Article							Y-CHROMOSOME; LINKAGE DISEQUILIBRIUM; MITOCHONDRIAL; GENOME; MTDNA; SHOW; LANDSCAPE; MIGRATION; TOOLS; RATES	The identification of isolation signatures is fundamental to better understand the genetic structure of human populations and to test the relations between cultural factors and genetic variation. However, with current approaches, it is not possible to distinguish between the consequences of long-term isolation and the effects of reduced sample size, selection and differential gene flow. To overcome these limitations, we have integrated the analysis of classical genetic diversity measures with a Bayesian method to estimate gene flow and have carried out simulations based on the coalescent. Combining these approaches, we first tested whether the relatively short history of cultural and geographical isolation of four "linguistic islands'' of the Eastern Alps (Lessinia, Sauris, Sappada and Timau) had left detectable signatures in their genetic structure. We then compared our findings to previous studies of European population isolates. Finally, we explored the importance of demographic and cultural factors in shaping genetic diversity among the groups under study. A combination of small initial effective size and continued genetic isolation from surrounding populations seems to provide a coherent explanation for the diversity observed among Sauris, Sappada and Timau, which was found to be substantially greater than in other groups of European isolated populations. Simulations of micro-evolutionary scenarios indicate that ethnicity might have been important in increasing genetic diversity among these culturally related and spatially close populations.	[Battaggia, Cinzia; Anagnostou, Paolo; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Capocasa, Marco; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy; [Capocasa, Marco; Anagnostou, Paolo] Ist Italiano Antropol, Rome, Italy; [Montinaro, Francesco; Boschi, Ilaria] Univ Cattolica, Fac Med, Ist Med Legale, Rome, Italy; [Ferri, Gianmarco; Alu, Milena] Univ Modena & Reggio Emilia, Dipartimento ad Attivita Integrata Lab, Modena, Italy; [Coia, Valentina] Univ Trento, Dipartimento Filosofia Storia & Beni Culturali, Trento, Italy; [Crivellaro, Federica] Leverhulme Ctr Human Evolutionary Studies, Div Biol Anthropol, Cambridge, England	Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universita di Modena e Reggio Emilia; University of Trento; University of Cambridge	Bisol, GD (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	destrobisol@uniroma1.it	Capocasa, Marco/AAF-8315-2021; Montinaro, Francesco/HDM-8551-2022	Destro Bisol, Giovanni/0000-0002-4232-9715; Crivellaro, Federica/0000-0003-1656-8605; Anagnostou, Paolo/0000-0003-0768-4612; Montinaro, Francesco/0000-0002-4506-963X	Ministero dell'Istruzione, dell'Universita e della Ricerca [2007TYXE3X, 200975T9EW]; Istituto Italiano di Antropologia	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Italiano di Antropologia	The authors' research was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2007-2009, prot n. 2007TYXE3X; PRIN 2009-2011, prot. n. 200975T9EW) and the Istituto Italiano di Antropologia (project Atlante bioculturale Italiano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; Boattini A, 2011, J ANTHROPOL SCI, V89, P161, DOI 10.4436/jass.89014; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Bosch E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-338; Brandstatter A, 2007, ANN HUM GENET, V71, P791, DOI 10.1111/j.1469-1809.2007.00371.x; Brunettin G., 1998, SAURIS ZAHRE COMUNIT, P43; Cavalli Sforza LL, 1993, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Coia V, 2012, J HUM GENET, V57, P254, DOI 10.1038/jhg.2012.14; Congiu A, 2012, J ANTHROPOL SCI, V90, P201, DOI 10.4436/jass.90020; De Concini W, 1997, ALTRI ALPI MINORANZE; Delfin F, 2011, EUR J HUM GENET, V19, P224, DOI 10.1038/ejhg.2010.162; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gri GP, 1998, SAURIS ZAHRE COMUNIT, P9; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Heutink P, 2002, HUM MOL GENET, V11, P2507, DOI 10.1093/hmg/11.20.2507; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; ISTAT, 2010, BIL DEM POP RES SESS; Kramer J, 2004, ARCH AKTO ADIGE, V98, P277; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Loose R, 1996, TIROLER HEIMAT, V60, P5; Maurer-Lausegger Herta., 2004, TIDSSKRIFT SPROGFORS, V2, P5; Nasidze I, 2006, ANN HUM GENET, V71, P379; Navarra E., 2002, UOMINI COMUNITA MONT, P113; Navarra E, 1998, RICERCA FOLKLORICA, V38, P49; Neel J, 1992, MINORITY POPULATIONS; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Ottoni C, 2011, EUR J HUM GENET, V19, P571, DOI 10.1038/ejhg.2010.230; Pellegrini Giovan Battista, 1991, GENESI RETOROMANZO O; Peratoner A., 2002, SAPPADA PLODN STORIA; Petris B., 1980, TISCHLBONG TAMAU TIM; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rapelli G, 2004, ISOLE CULTURA SAGGI, P243; REYNOLDS J, 1983, GENETICS, V105, P767; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Steinicke E., 2011, J ALPINE RES, V99, P2, DOI DOI 10.4000/RGA.1469; Steinicke E, 2002, TISCHLBONGARA PIACHL, V6, P300; Steinicke E, 2001, ANNALES, V11, P259; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Thomas MG, 2008, EUR J HUM GENET, V16, P124, DOI 10.1038/sj.ejhg.5201906; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tofanelli S, 2011, J ANTHROPOL SCI, V89, P201, DOI 10.4436/jass.89017; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Toso Fiorenzo, 2008, MINORANZE LINGUISTIC; van Oven M, 2011, MOL BIOL EVOL, V28, P1349, DOI 10.1093/molbev/msq300; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Viazzo P.P., 1989, UPLAND COMMUNITIES E; Volpato G, 1988, RICERCA FOLKLORICA, V18, P117	67	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56371	10.1371/journal.pone.0056371	http://dx.doi.org/10.1371/journal.pone.0056371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418562	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300155
J	Jeruschke, S; Buscher, AK; Oh, J; Saleem, MA; Hoyer, PF; Weber, S; Nalbant, P				Jeruschke, Stefanie; Buescher, Anja Katrin; Oh, Jun; Saleem, Moin Ahson; Hoyer, Peter Friedrich; Weber, Stefanie; Nalbant, Perihan			Protective Effects of the mTOR Inhibitor Everolimus on Cytoskeletal Injury in Human Podocytes Are Mediated by RhoA Signaling	PLOS ONE			English	Article							ACTIN STRESS FIBERS; KIDNEY-TRANSPLANT RECIPIENTS; FOCAL ADHESIONS; NEPHROTIC SYNDROME; CALCINEURIN-INHIBITOR; DIABETIC-NEPHROPATHY; BASEMENT-MEMBRANE; SLIT DIAPHRAGM; CELL-MIGRATION; SIROLIMUS	Podocytes are highly differentiated kidney cells playing an important role in maintaining the glomerular filtration barrier. Particularly, the integrity of the actin cytoskeleton is crucial as cytoskeletal damage associated with foot process effacement and loss of slit diaphragms constitutes a major aspect of proteinuria. Previously, the mammalian target of rapamycin (mTOR) was linked to actin regulation and aberrant activity of the kinase was associated with renal disease. In this study, actin-related effects of mTOR inhibition by the immunosuppressant everolimus (EV) were investigated in human podocytes using an in vitro model of puromycin aminonucleoside (PAN) induced proteinuria. EV substantially recovered aberrant podocyte behavior by re-establishing a stationary phenotype with decreased migration efficiency, enhanced cell adhesion and recovery of actin stress fibers. Biochemical studies revealed substantial increase in the activity of RhoA and the effector pathway Rho-associated protein kinase (ROCK) and myosin light chain (MLC) by EV, all known regulators of stress fiber generation. Taken together, we show for the first time cytoskeleton stabilizing effects of the mTOR inhibitor EV and establish RhoA signaling as a key mediator in this process.	[Jeruschke, Stefanie; Buescher, Anja Katrin; Hoyer, Peter Friedrich; Weber, Stefanie] Univ Duisburg Essen, Essen, Germany; [Oh, Jun] Univ Bristol, Bristol Royal Hosp Children, Childrens Renal Unit, Bristol, Avon, England; [Saleem, Moin Ahson] Univ Med Ctr, Childrens Hosp, Dept Pediat Nephrol, Hamburg, Germany; [Nalbant, Perihan] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany	University of Duisburg Essen; Bristol Royal Hospital For Children; University of Bristol; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen	Nalbant, P (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany.	perihan.nalbant@uni-due.de		Saleem, Moin/0000-0002-9808-4518	Deutsche Forschungsgemeinschaft [BU 2602/3-1]; Forschungsunterstutzungskreis Kindernephrologie e.V; Novartis Pharmaceuticals Corporation; Novartis Pharmaceuticals (Basic Research Grant)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsunterstutzungskreis Kindernephrologie e.V; Novartis Pharmaceuticals Corporation(Novartis); Novartis Pharmaceuticals (Basic Research Grant)	Anja Buescher and Stefanie Weber received financial support from the Deutsche Forschungsgemeinschaft (BU 2602/3-1) and the Forschungsunterstutzungskreis Kindernephrologie e.V. Jun Oh has received research funding from Novartis Pharmaceuticals Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare they have received financial support from Novartis Pharmaceuticals (Basic Research Grant). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. No other commercial funding was acquired. No other relevant agreements relating to employment, consultancy, patents, products in development or marketed products etc. have been stipulated with Novartis or any other pharmaceutical company.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Buchler M, 2007, AM J TRANSPLANT, V7, P2522, DOI 10.1111/j.1600-6143.2007.01976.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Butani L, 2004, TRANSPLANTATION, V78, P1362, DOI 10.1097/01.TP.0000140868.88149.63; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Daniel C, 2005, AM J TRANSPLANT, V5, P2849, DOI 10.1111/j.1600-6143.2005.01120.x; Daniel C, 2000, EXP NEPHROL, V8, P52; Dantal J, 2010, TRANSPL INT, V23, P1084, DOI 10.1111/j.1432-2277.2010.01094.x; Diekmann F, 2004, AM J TRANSPLANT, V4, P1869, DOI 10.1111/j.1600-6143.2004.00590.x; Dittrich E, 2004, TRANSPL INT, V17, P215, DOI 10.1007/s00147-004-0700-0; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eto N, 2007, KIDNEY INT, V72, P455, DOI 10.1038/sj.ki.5002311; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fuchshofer R, 2011, HISTOCHEM CELL BIOL, V136, P301, DOI 10.1007/s00418-011-0844-9; Gallegos L, 2011, NAT CELL BIOL, V13, P344, DOI [10.1038/ncb0411-344, 10.1038/ncb2230]; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Inoki K, 2008, DIABETES RES CLIN PR, V82, pS59, DOI 10.1016/j.diabres.2008.09.028; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Kummer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027457; Lebranchu Y, 2009, AM J TRANSPLANT, V9, P1115, DOI 10.1111/j.1600-6143.2009.02615.x; Mancini M, 2010, J CELL BIOCHEM, V109, P320, DOI 10.1002/jcb.22380; Markova B, 2012, J CANCER RES CLIN, V138, P545, DOI 10.1007/s00432-011-1123-9; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roodnat JL, 2001, TRANSPLANTATION, V72, P438, DOI 10.1097/00007890-200108150-00014; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; WHITESIDE CI, 1993, AM J PATHOL, V142, P1641; Yan K, 2012, CELL CYCLE, V11, P1504, DOI 10.4161/cc.19825; Yost SE, 2011, NAT REV NEPHROL, V7, P553, DOI 10.1038/nrneph.2011.125; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	59	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55980	10.1371/journal.pone.0055980	http://dx.doi.org/10.1371/journal.pone.0055980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418489	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300081
J	Singh, N; Chikara, S; Sundar, S				Singh, Neeloo; Chikara, Surendra; Sundar, Shyam			SOLiD (TM) Sequencing of Genomes of Clinical Isolates of Leishmania donovani from India Confirm Leptomonas Co-Infection and Raise Some Key Questions	PLOS ONE			English	Article							KALA-AZAR; VISCERAL LEISHMANIASIS; HIMACHAL-PRADESH; IN-VITRO; RESISTANCE; INFECTION; SANDFLIES; VALLEY; CATTLE	Background: Known as 'neglected disease' because relatively little effort has been applied to finding cures, leishmaniasis kills more than 150,000 people every year and debilitates millions more. Visceral leishmaniasis (VL), also called Kala Azar (KA) or black fever in India, claims around 20,000 lives every year. Whole genome analysis presents an excellent means to identify new targets for drugs, vaccine and diagnostics development, and also provide an avenue into the biological basis of parasite virulence in the L. donovani complex prevalent in India. Methodology/Principal Findings: In our presently described study, the next generation SOLiD (TM) platform was successfully utilized for the first time to carry out whole genome sequencing of L. donovani clinical isolates from India. We report the exceptional occurrence of insect trypanosomatids in clinical cases of visceral leishmaniasis (Kala Azar) patients in India. We confirm with whole genome sequencing analysis data that isolates which were sequenced from Kala Azar (visceral leishmaniasis) cases were genetically related to Leptomonas. The co-infection in splenic aspirate of these patients with a species of Leptomonas and how likely is it that the infection might be pathogenic, are key questions which need to be investigated. We discuss our results in the context of some important probable hypothesis in this article. Conclusions/Significance: Our intriguing results of unusual cases of Kala Azar found to be most similar to Leptomonas species put forth important clinical implications for the treatment of Kala Azar in India. Leptomonas have been shown to be highly susceptible to several standard leishmaniacides in vitro. There is very little divergence among these two species viz. Leishmania sp. and L. seymouri, in terms of genomic sequence and organization. A more extensive perception of the phenomenon of co-infection needs to be addressed from molecular pathogenesis and eco-epidemiological standpoint.	[Singh, Neeloo] Cent Drug Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India; [Chikara, Surendra] Xcelris Genom, Ahmadabad, Gujarat, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Singh, N (corresponding author), Cent Drug Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India.	neeloo888@yahoo.com			Department of Biotechnology(DBT), India [BT/PR13384/MED/29/166/2009]	Department of Biotechnology(DBT), India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Biotechnology(DBT), India, BT/PR13384/MED/29/166/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Alam MS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-27; BACCHI CJ, 1975, ANTIMICROB AGENTS CH, V8, P688, DOI 10.1128/AAC.8.6.688; Baker J. R., 1965, P1; Basile C., 1920, Parasitology Cambridge, V12, DOI 10.1017/S0031182000014359; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Bhattarai NR, 2009, T ROY SOC TROP MED H, V103, P1087, DOI 10.1016/j.trstmh.2009.03.008; Chakravarty A.K., 1980, Journal of Communicable Diseases, V11, P219; Cheeran MM, 2010, REV CLIN TRIALS TREA; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Deane M. P., 1954, Hospital, V45, P697; Dedet JP, 1995, T ROY SOC TROP MED H, V89, P644, DOI 10.1016/0035-9203(95)90427-1; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; DUJARDIN JC, 1995, ACTA TROP, V59, P293, DOI 10.1016/0001-706X(95)00094-U; Fantham HB, 1912, BRIT MED J, P1196; Garin YJF, 2001, J EUKARYOT MICROBIOL, V48, P170, DOI 10.1111/j.1550-7408.2001.tb00299.x; GARNHAM PCC, 1971, B WORLD HEALTH ORGAN, V44, P477; Ghosh S, 2012, J CLIN MICROBIOL, V50, P2774, DOI 10.1128/JCM.00966-12; Hamad S. H., 2011, Journal of Microbiology and Antimicrobials, V3, P142; Jimenez MI, 1996, LANCET, V347, P264, DOI 10.1016/S0140-6736(96)90441-9; KELLY JM, 1991, MOL BIOCHEM PARASIT, V46, P253, DOI 10.1016/0166-6851(91)90049-C; KILLICKKENDRICK R, 1975, PROC R SOC SER B-BIO, V188, P229, DOI 10.1098/rspb.1975.0015; KUTISH GF, 1981, J PARASITOL, V67, P457, DOI 10.2307/3280474; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Lynn MA, 2008, TRENDS PARASITOL, V24, P103, DOI 10.1016/j.pt.2007.11.006; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; Mehta Vandana, 2009, Dermatol Online J, V15, P9; Morio F, 2008, J CLIN MICROBIOL, V46, P3845, DOI 10.1128/JCM.01098-08; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; Pacheco RS, 1998, MEM I OSWALDO CRUZ, V93, P531, DOI 10.1590/S0074-02761998000400021; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Rastogi V, 2007, Indian J Med Microbiol, V25, P272; Rougeron V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001004; Sharma NL, 2009, J VECTOR DIS, V46, P136; Sharma NL, 2005, AM J TROP MED HYG, V72, P819, DOI 10.4269/ajtmh.2005.72.819; Sharma Umakant, 2007, Journal of Vector Borne Diseases, V44, P230; Singh N, 2003, J INFECT DIS, V188, P600, DOI 10.1086/377133; SRIVASTAVA L, 1984, ANN TROP MED PARASIT, V78, P501, DOI 10.1080/00034983.1984.11811855; Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Sundar S, 2001, AM J TROP MED HYG, V65, P193, DOI 10.4269/ajtmh.2001.65.193; Sundar S, 2000, EXPERT OPINION PHARM, V6, P2821; Vickerman K., 1976, P35; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Waki K, 2009, EUKARYOT CELL, V6, P198; WALLACE FG, 1983, J PROTOZOOL, V30, P308, DOI 10.1111/j.1550-7408.1983.tb02921.x; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11	50	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55738	10.1371/journal.pone.0055738	http://dx.doi.org/10.1371/journal.pone.0055738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418454	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300045
J	Sreekar, R; Purushotham, CB; Saini, K; Rao, SN; Pelletier, S; Chaplod, S				Sreekar, Rachakonda; Purushotham, Chetana B.; Saini, Katya; Rao, Shyam N.; Pelletier, Simon; Chaplod, Saniya			Photographic Capture-Recapture Sampling for Assessing Populations of the Indian Gliding Lizard Draco dussumieri	PLOS ONE			English	Article							WESTERN-GHATS; FLYING LIZARDS; GENUS-DRACO; PHOTOIDENTIFICATION; IDENTIFICATION; AMPHIBIANS; REPTILES; WILD	The usage of invasive tagging methods to assess lizard populations has often been criticised, due to the potential negative effects of marking, which possibly cause increased mortality or altered behaviour. The development of safe, less invasive techniques is essential for improved ecological study and conservation of lizard populations. In this study, we describe a photographic capture-recapture (CR) technique for estimating Draco dussumieri (Agamidae) populations. We used photographs of the ventral surface of the patagium to identify individuals. To establish that the naturally occurring blotches remained constant through time, we compared capture and recapture photographs of 45 pen-marked individuals after a 30 day interval. No changes in blotches were observed and individual lizards could be identified with 100% accuracy. The population density of D. dussumieri in a two hectare areca-nut plantation was estimated using the CR technique with ten sampling occasions over a ten day period. The resulting recapture histories for 24 individuals were analysed using population models in the program CAPTURE. All models indicated that nearly all individuals were captured. The estimated probability for capturing D. dussumieri on at least one occasion was 0.92 and the estimated population density was 13 +/- 1.65 lizards/ha. Our results demonstrate the potential for applying CR to population studies in gliding lizards (Draco spp.) and other species with distinctive markings.	[Sreekar, Rachakonda] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Sreekar, Rachakonda; Purushotham, Chetana B.; Saini, Katya; Rao, Shyam N.; Pelletier, Simon; Chaplod, Saniya] Agumbe Rainforest Res Stn, Agumbe, Karnataka, India; [Purushotham, Chetana B.; Saini, Katya] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Rao, Shyam N.] Colorado State Univ, Ft Collins, CO 80523 USA; [Sreekar, Rachakonda] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Colorado State University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sreekar, R (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	sreekar1988@gmail.com	Sreekar, Rachakonda/C-4377-2008	Sreekar, Rachakonda/0000-0001-5445-6589	Agumbe Rainforest Research Station; The Gerry Martin Project	Agumbe Rainforest Research Station; The Gerry Martin Project	This study was undertaken with the support of Agumbe Rainforest Research Station (http://www.agumberainforest.com) and The Gerry Martin Project (http://www.gerrymartin.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interest. This study was partly funded by The Gerry Martin Project. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bloch N, 2005, J HERPETOL, V39, P288, DOI 10.1670/97-04N; Dahanukar N, 2004, J BIOGEOGR, V31, P123, DOI 10.1046/j.0305-0270.2003.01016.x; Daniel, 2002, BOOK INDIAN REPTILES; DANIELS RJR, 1992, J BIOGEOGR, V19, P521, DOI 10.2307/2845771; den Hartog J, 2008, I3S MANTA MANUAL VER; ELBIN SB, 1994, WILDLIFE SOC B, V22, P677; Ferner JW, 1979, HERPETOLOGICAL CIRCU; FISHER M, 1989, Herpetological Review, V20, P45; Funk WC, 2005, NATURE, V433, P193, DOI 10.1038/433193c; Golay Nils, 1994, Amphibia-Reptilia, V15, P81, DOI 10.1163/156853894X00560; Honda M, 1999, ZOOL SCI, V16, P535, DOI 10.2108/zsj.16.535; Ishwar N.M., 2003, CONSERV SOC, V1, P269; Jacobs GJ, 1983, 57 SMITHS HERP INF S; John K.O., 1962, Journal of the Bombay Natural History Society, V59, P298; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 1998, ECOLOGY, V79, P2852; Lettink M, 2011, NEW ZEAL J ECOL, V35, P236; Martin-Smith KM, 2011, J FISH BIOL, V78, P1757, DOI 10.1111/j.1095-8649.2011.02966.x; McGuire JA, 2011, INTEGR COMP BIOL, V51, P983, DOI 10.1093/icb/icr090; MORI A, 1994, COPEIA, P124; MORI A, 1993, RAFFLES B ZOOL, V41, P83; Oosthuizen WC, 2010, MAR MAMMAL SCI, V26, P350, DOI 10.1111/j.1748-7692.2009.00328.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Ottenwalder J.A., 2000, W INDIAN IGUANAS STA, P51; Perry G, 2011, J HERPETOL, V45, P547, DOI 10.1670/11-037.1; Phillott AD, 2011, WILDLIFE RES, V38, P204, DOI 10.1071/WR10154; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rexstad E., 1991, USERS GUIDE INTERACT; Sacchi R, 2010, AMPHIBIA-REPTILIA, V31, P489, DOI 10.1163/017353710X521546; Smith M.A., 1935, FAUNA BRIT INDIA INC, VII; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Venugopal PD, 2010, HERPETOL J, V20, P69; WOODBURY AM, 1948, COPEIA, P127	34	16	17	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55935	10.1371/journal.pone.0055935	http://dx.doi.org/10.1371/journal.pone.0055935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418477	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300069
J	Yan, Q; Li, W; Tang, Q; Yao, SH; Lv, ZG; Feng, NH; Ma, XT; Bai, ZQ; Zeng, Y; Qin, D; Lu, C				Yan, Qin; Li, Wan; Tang, Qiao; Yao, Shuihong; Lv, Zhigang; Feng, Ninghan; Ma, Xinting; Bai, Zhiqiang; Zeng, Yi; Qin, Di; Lu, Chun			Cellular MicroRNAs 498 and 320d Regulate Herpes Simplex Virus 1 Induction of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Targeting RTA	PLOS ONE			English	Article							CYCLE REPLICATION; HUMAN CYTOMEGALOVIRUS; EXPRESSION PROFILE; ENDOTHELIAL-CELLS; INFECTION; TYPE-1; LATENCY; IDENTIFICATION; SUPPRESSION; ACTIVATION	Kaposi's sarcoma-associated herpesvirus (KSHV) infection was necessary but not sufficient for KS development without other cofactors. We have previously reported that herpes simplex virus (HSV)-1 was an important cofactor that reactivated KSHV from latency by inducing the expression of KSHV replication and transcription activator (RTA), the lytic switch protein. Here, we further investigated the possible cellular microRNAs (miRNAs) involved in regulation of RTA during HSV-1-induced KSHV replication. The differential profiles of miRNAs expression between Mock- and HSV-1-infected body cavity-based lymphoma (BCBL-1) cells were identified by miRNA microarray analysis. Bioinformatics and luciferase reporter analyses showed that two of the HSV-1-downregulated cellular miRNAs, miR-498 and miR-320d, directly targeted the 3' untranslated region (UTR) of KSHV RTA. As a result, overexpression of these two miRNAs significantly inhibited HSV-1-induced KSHV replication, whereas repression of these miRNAs with specific suppressors enhanced HSV-1-mediated KSHV replication. In addition, miR-498 or miR-320d alone, without HSV-1 infection, regulated KSHV replication in BCBL-1 cells. Finally, bioinformatics Gene Ontology (GO) analysis indicated that targets of HSV-1-regulated miRNAs were enriched for proteins, whose roles were involved in protein binding, enzyme activity, biological regulation, and several potential signaling pathways including transforming growth factor (TGF)-beta were likely to participate in HSV-1-induced KSHV replication. Collectively, these novel findings demonstrated that host-encoded miR-498 and miR-320d regulated HSV-1 induction of KSHV lytic replication by targeting RTA, which provided further insights into the molecular mechanisms controlling KSHV lytic replication.	[Yan, Qin; Qin, Di; Lu, Chun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yan, Qin; Qin, Di; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Yan, Qin; Li, Wan; Tang, Qiao; Lv, Zhigang; Ma, Xinting; Bai, Zhiqiang; Qin, Di; Lu, Chun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao] Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Yao, Shuihong] Quzhou Coll, Dept Med, Quzhou, Peoples R China; [Lv, Zhigang] Jiangsu Prov Official Hosp, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Zeng, Yi] Youjiang Med Coll Nationalities, Dept Microbiol & Immunol, Bose, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Quzhou University; Nanjing Medical University; Youjiang Medical University for Nationalities	Qin, D (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	diqin@njmu.edu.cn; clu@njmu.edu.cn	Feng, Ninghan/ABA-8996-2021; Feng, ninghan/ABB-3726-2021	Lu, Chun/0000-0002-6078-9352	National Basic Research Program of China (973 Program) [2011CB504803]; National Natural Science Foundation of China [81171552, 81210108028, 30972619, 30900064, 31270199, 81071345, 81272831]; Natural Science Foundation of Ministry of Education of Jiangsu Province [10KJA310032]; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund) [20093234120004]; Natural Science Foundation of Jiangsu Province [BK2010577]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC201178]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ministry of Education of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504803) (http://www.973.gov.cn/English/Index.aspx), National Natural Science Foundation of China (grants 81171552, 81210108028, and 30972619 to CL, 30900064 to DQ, 31270199 to ZB, 81071345 to YZ, and 81272831 to NF) (http://www.nsfc.gov.cn/Portal0/default152.htm), Natural Science Foundation of Ministry of Education of Jiangsu Province (great project 10KJA310032 to CL) (http://www.jsjyt.gov.cn/), Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund, grant 20093234120004 to DQ) (http://www.cutech.edu.cn/cn/index.htm), Natural Science Foundation of Jiangsu Province (BK2010577 to NF) (http://www.jsnsf.gov.cn/Index.aspx), and Jiangsu Province's Outstanding Medical Academic Leader Program (RC201178 to NF) (http://www.jswst.gov.cn/gb/jsswst/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Berrington WR, 2009, CLIN INFECT DIS, V49, P1295, DOI 10.1086/606053; Birek Catalena, 2006, Curr Infect Dis Rep, V8, P181, DOI 10.1007/s11908-006-0057-x; Boivin G, 2009, CAN J INFECT DIS MED, V20, P122, DOI 10.1155/2009/482407; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Casper C, 2002, J INFECT DIS, V185, P990, DOI 10.1086/339605; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Chen TS, 2006, MODERN PATHOL, V19, P726, DOI 10.1038/modpathol.3800584; Cheng B, 2009, J CLIN VIROL, V46, P244, DOI 10.1016/j.jcv.2009.07.025; Duan HH, 2010, TOXICOL IN VITRO, V24, P928, DOI 10.1016/j.tiv.2009.11.013; Ellis-Connell AL, 2010, J VIROL, V84, P10329, DOI 10.1128/JVI.00923-10; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Han ZB, 2012, MOL ONCOL, V6, P445, DOI 10.1016/j.molonc.2012.04.001; Hansen A, 2010, GENE DEV, V24, P195, DOI 10.1101/gad.553410; Harel L, 2004, CLIN INFECT DIS, V39, P636, DOI 10.1086/422643; Holzinger Dirk, 2010, J Pediatr Hematol Oncol, V32, pe19, DOI 10.1097/MPH.0b013e3181b79669; Ishida H, 2011, BIOCHEM BIOPH RES CO, V412, P92, DOI 10.1016/j.bbrc.2011.07.049; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; KEY NS, 1990, P NATL ACAD SCI USA, V87, P7095, DOI 10.1073/pnas.87.18.7095; Kumar N, 2007, J MED VIROL, V79, P52, DOI 10.1002/jmv.20728; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; LAMONTAGNE L, 1994, CLIN IMMUNOL IMMUNOP, V73, P38, DOI 10.1006/clin.1994.1167; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Liang DG, 2011, CELL RES, V21, P793, DOI 10.1038/cr.2011.5; Lin SS, 2005, MICROBES INFECT, V7, P635, DOI 10.1016/j.micinf.2004.12.023; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; Lu C, 2005, AM J PATHOL, V166, P173, DOI 10.1016/S0002-9440(10)62242-0; Lu CC, 2010, EMBO REP, V11, P784, DOI 10.1038/embor.2010.132; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Miller CS, 2005, J CLIN MICROBIOL, V43, P2173, DOI 10.1128/JCM.43.5.2173-2180.2005; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Qin D, 2008, CELL MICROBIOL, V10, P713, DOI 10.1111/j.1462-5822.2007.01079.x; Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Scheglovitova Olga N., 2000, Russ J Immunol, V5, P133; Scheglovitova Olga N., 2001, Russ J Immunol, V6, P367; Scheglovitova Olga N, 2002, Russ J Immunol, V7, P115; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shang YL, 2012, AMINO ACIDS, V42, P1879, DOI 10.1007/s00726-011-0907-1; Shaoqing Y, 2011, AM J RHINOL ALLERGY, V25, pe242, DOI DOI 10.2500/AJRA.2011.25.3682; Shen YL, 2009, BIOMED ENVIRON SCI, V22, P14, DOI 10.1016/S0895-3988(09)60016-7; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Tang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031652; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; van Benthem BHB, 2001, SEX TRANSM INFECT, V77, P120, DOI 10.1136/sti.77.2.120; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Ye FC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002054; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhang HL, 2011, BIOCHEM BIOPH RES CO, V404, P273, DOI 10.1016/j.bbrc.2010.11.106; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055	69	29	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55832	10.1371/journal.pone.0055832	http://dx.doi.org/10.1371/journal.pone.0055832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418466	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300057
J	Travis, JMJ; Palmer, SCF; Coyne, S; Millon, A; Lambin, X				Travis, Justin M. J.; Palmer, Stephen C. F.; Coyne, Steven; Millon, Alexandre; Lambin, Xavier			Evolution of Predator Dispersal in Relation to Spatio-Temporal Prey Dynamics: How Not to Get Stuck in the Wrong Place!	PLOS ONE			English	Article							SPATIALLY-STRUCTURED POPULATIONS; TRAVELING-WAVES; CONDITIONAL DISPERSAL; DEPENDENT DISPERSAL; CYCLIC POPULATIONS; MICROTUS-AGRESTIS; FIELD VOLES; DISTANCE; ENVIRONMENTS; EMIGRATION	The eco-evolutionary dynamics of dispersal are recognised as key in determining the responses of populations to environmental changes. Here, by developing a novel modelling approach, we show that predators are likely to have evolved to emigrate more often and become more selective over their destination patch when their prey species exhibit spatio-temporally complex dynamics. We additionally demonstrate that the cost of dispersal can vary substantially across space and time. Perhaps as a consequence of current environmental change, many key prey species are currently exhibiting major shifts in their spatio-temporal dynamics. By exploring similar shifts in silico, we predict that predator populations will be most vulnerable when prey dynamics shift from stable to complex. The more sophisticated dispersal rules, and greater variance therein, that evolve under complex dynamics will enable persistence across a broader range of prey dynamics than the rules which evolve under relatively stable prey conditions.	[Travis, Justin M. J.; Palmer, Stephen C. F.; Coyne, Steven; Millon, Alexandre; Lambin, Xavier] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Millon, Alexandre] CNRS, Inst Mediterraneen Ecol & Paleoecol, Aix En Provence, France	University of Aberdeen; Centre National de la Recherche Scientifique (CNRS)	Travis, JMJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	justin.travis@abdn.ac.uk	Lambin, Xavier/E-8284-2011; Millon, Alexandre/AAF-8624-2020; Travis, Justin/B-8571-2014; Millon, Alexandre/R-6464-2017; Palmer, Steve/GSE-1103-2022	Lambin, Xavier/0000-0003-4643-2653; Millon, Alexandre/0000-0002-9475-4123; Travis, Justin/0000-0002-5785-4272; Millon, Alexandre/0000-0002-9475-4123; 	NERC [NE/E010660/1, NE/F021402/1]; BiodivERsA project "Ecocycle" NERC [NE/G002045/1]; NERC [NE/G002045/1] Funding Source: UKRI; Natural Environment Research Council [NE/F021402/1, NE/G002045/1, NE/E010660/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BiodivERsA project "Ecocycle" NERC; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NERC grants NE/E010660/1 and NE/F021402/1 and BiodivERsA project "Ecocycle" NERC NE/G002045/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1980, J ANIM ECOL, V49, P175, DOI 10.2307/4282; Baalen MV, 1999, AM NAT, V154, P69; Bach LA, 2007, EVOL ECOL RES, V9, P663; Barton KA, 2009, OIKOS, V118, P309, DOI 10.1111/j.1600-0706.2008.16936.x; Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bocedi G, 2012, AM NAT, V179, P606, DOI 10.1086/665004; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; COMINS HN, 1992, J ANIM ECOL, V61, P735, DOI 10.2307/5627; COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; CROWLEY PH, 1981, AM NAT, V118, P673, DOI 10.1086/283861; Dytham C, 2009, P ROY SOC B-BIOL SCI, V276, P1407, DOI 10.1098/rspb.2008.1535; Green DM, 2009, POPUL ECOL, V51, P253, DOI 10.1007/s10144-008-0131-3; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HASSELL MP, 1976, THEOR POPUL BIOL, V9, P202, DOI 10.1016/0040-5809(76)90045-9; Henden JA, 2009, J ANIM ECOL, V78, P636, DOI 10.1111/j.1365-2656.2008.01510.x; Hiebeler D, 2004, THEOR POPUL BIOL, V66, P205, DOI 10.1016/j.tpb.2004.06.004; Holt RD, 1996, AM NAT, V148, P709, DOI 10.1086/285949; Holyoak M, 1996, J ANIM ECOL, V65, P640, DOI 10.2307/5743; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Johnson DM, 2004, ECOL LETT, V7, P967, DOI 10.1111/j.1461-0248.2004.00659.x; Kaitala V, 1998, ECOL LETT, V1, P186; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Lachmuth S, 2011, NEW PHYTOL, V192, P529, DOI 10.1111/j.1469-8137.2011.03808.x; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; Mathias A, 2001, EVOLUTION, V55, P246; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; NACHMAN G, 1987, J ANIM ECOL, V56, P267, DOI 10.2307/4814; North A, 2011, EVOLUTION, V65, P1739, DOI 10.1111/j.1558-5646.2011.01254.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Poethke HJ, 2011, J THEOR BIOL, V282, P93, DOI 10.1016/j.jtbi.2011.05.012; Poethke HJ, 2010, AM NAT, V175, P577, DOI 10.1086/651595; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Saitoh T, 2006, CLIM RES, V32, P109, DOI 10.3354/cr032109; Savill NJ, 1998, P ROY SOC B-BIOL SCI, V265, P25, DOI 10.1098/rspb.1998.0259; Schreiber SJ, 2009, AM NAT, V174, P68, DOI 10.1086/599296; Sherratt TN, 2000, J APPL ECOL, V37, P148, DOI 10.1046/j.1365-2664.2000.00472.x; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Snyder RE, 2011, P ROY SOC B-BIOL SCI, V278, P739, DOI 10.1098/rspb.2010.1549; Travis JMJ, 1998, P ROY SOC B-BIOL SCI, V265, P17, DOI 10.1098/rspb.1998.0258; Travis JMJ, 2001, ECOL RES, V16, P157, DOI 10.1046/j.1440-1703.2001.00381.x; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; ZEIGLER BP, 1977, J THEOR BIOL, V67, P687, DOI 10.1016/0022-5193(77)90255-7	49	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54453	10.1371/journal.pone.0054453	http://dx.doi.org/10.1371/journal.pone.0054453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23408940	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000004
J	Ataollahi, F; Mohri, M; Seifi, HA; Pingguan-Murphy, B; Abas, WAW; Abu Osman, NA				Ataollahi, Forough; Mohri, Mehrdad; Seifi, Hesam A.; Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Abu Osman, Noor Azuan			Evaluation of Copper Concentration in Subclinical Cases of White Muscle Disease and Its Relationship with Cardiac Troponin I	PLOS ONE			English	Article							TRACE-ELEMENTS; NITRIC-OXIDE; SELENIUM; STRESS; LAMBS; LIVER; ZINC	The present study aims to evaluate the serum level of copper (Cu) in lambs suffering from subclinical forms of white muscle disease (WMD) and its relationship with cardiac troponin I (cTn-I) as a novel biomarker of cardiovascular disorders. Ten milliliters of jugular blood were taken from 200 lambs less than one year old to measure serum concentrations of Cu, selenium (Se), and cTn-I. The subjects were divided into 2 groups, namely, the deficient group which included 36 lambs, and the control group which included 164 lambs according to the reference serum Se concentration (50 ng/mL). Serum Se levels in the deficient group were lower than 50 ng/mL. By contrast, the control group showed Se levels higher than 50 ng/mL. Differences among the serum Cu and cTn-I levels were determined in both groups. The mean +/- SD and median of serum Cu and cTn-I levels in the deficient group were lower and higher than those in the control group, respectively. A significant positive correlation was observed between serum Cu and Se levels, and also serum Cu and Se levels showed a negative correlation with serum cTn-I concentrations. Stepwise linear regression analysis showed that serum Cu levels were correlated positively with serum Se levels (p<0.05). Receiver operating characteristic (ROC) curve analysis indicated that the area under curve (AUC) of Cu was significantly higher than that of cTn-I based on the reference diagonal line. It is important to keep in mind that the value of AUC for the ROC curve is between 0.5 and 1.00, in which the lowest accuracy is related to the reference diagonal line with AUC of 0.5. A cut-off was determined to indicate which Cu level can discriminate between affected and healthy lambs. The cut-off level, sensitivity, and specificity of Cu in this study were 144.5 ng/mL, 74%, and 61%, respectively.	[Ataollahi, Forough; Mohri, Mehrdad; Seifi, Hesam A.] Ferdowsi Univ Mashhad, Dept Clin Sci, Sch Vet Med, Mashhad, Iran; [Mohri, Mehrdad; Seifi, Hesam A.] Ferdowsi Univ Mashhad, Ctr Excellence Ruminant Abort & Neonatal Mortal, Sch Vet Med, Mashhad, Iran; [Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Abu Osman, Noor Azuan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia	Ferdowsi University Mashhad; Ferdowsi University Mashhad; Universiti Malaya	Ataollahi, F (corresponding author), Ferdowsi Univ Mashhad, Dept Clin Sci, Sch Vet Med, Mashhad, Iran.	forough_at@yahoo.com	Ataollahi, Forough/S-7275-2017; Mohri, Mehrdad/B-2355-2009; Pingguan-Murphy, Belinda/B-8332-2010; ABU OSMAN, NOOR AZUAN/B-9265-2010; Ataollahi, Forough/AAM-4156-2020; Seifi, Hesam/B-2300-2015; Ataollahi, Forough/O-9254-2019	Ataollahi, Forough/0000-0002-6538-8566; Pingguan-Murphy, Belinda/0000-0001-5567-1141; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Ataollahi, Forough/0000-0002-6538-8566; Mohri, Mehrdad/0000-0003-3756-8890; Seifi, Hesam A./0000-0003-3460-2301	Ministry of Higher Education (MOHE) of Malaysia [UM.C/HIR/MOHE/ENG/10 D000010-16001]; University of Malaya Faculty of Engineering	Ministry of Higher Education (MOHE) of Malaysia; University of Malaya Faculty of Engineering	This study was funded and will be funded by Ministry of Higher Education (MOHE) of Malaysia, grant number UM.C/HIR/MOHE/ENG/10 D000010-16001-"Biomechanical System for Hard Tissues of Normal and Disable Subjects" and supported by University of Malaya Faculty of Engineering. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Altekin E, 2005, J TRACE ELEM MED BIO, V18, P235, DOI 10.1016/j.jtemb.2004.12.002; Archer J, 2003, COMP CLIN PATH, V12, P121, DOI DOI 10.1007/S00580-003-0488-9; Blood DC, 2000, J EQUINE VET SCI; da Cunha Sergio, 2002, Arq Bras Cardiol, V79, P454; Fonfara S, 2010, VET J, V184, P334, DOI 10.1016/j.tvjl.2009.04.004; Gunes V, 2010, VET J, V184, P376, DOI 10.1016/j.tvjl.2009.03.001; Jihen EH, 2009, ECOTOX ENVIRON SAFE, V72, P1559, DOI 10.1016/j.ecoenv.2008.12.006; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kosar Feridun, 2006, Anadolu Kardiyol Derg, V6, P216; Kozat S, 2011, KAFKAS UNIV VET FAK, V17, P441; Kutil B, 2010, MOL CELL BIOCHEM, V345, P23, DOI 10.1007/s11010-010-0555-x; Maggini S, 2007, BRIT J NUTR, V98, pS29, DOI 10.1017/S0007114507832971; Navarro-Alarcon M, 2000, SCI TOTAL ENVIRON, V249, P347, DOI 10.1016/S0048-9697(99)00526-4; Orun I, 2008, ECOTOX ENVIRON SAFE, V71, P71, DOI 10.1016/j.ecoenv.2007.07.008; Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11; Pilarczyk B, 2009, EUR J WILDLIFE RES, V55, P279, DOI 10.1007/s10344-008-0247-y; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sahin T, 2009, J ANIM VET ADV, V8, P2223; Shokrzadeh M, 2009, BIOL TRACE ELEM RES, V127, P116, DOI 10.1007/s12011-008-8237-1; Tekin S, 2009, J ANIM VET ADV; Tunca R, 2009, TURK J VET ANIM SCI, V33, P53; Whitley E, 2002, CRIT CARE, V6, P509, DOI 10.1186/cc1820	22	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56163	10.1371/journal.pone.0056163	http://dx.doi.org/10.1371/journal.pone.0056163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409147	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000314660300061
J	Kretschmer, S; Dethlefsen, I; Hagner-Benes, S; Marsh, LM; Garn, H; Konig, P				Kretschmer, Sarah; Dethlefsen, Ina; Hagner-Benes, Stefanie; Marsh, Leigh M.; Garn, Holger; Koenig, Peter			Visualization of Intrapulmonary Lymph Vessels in Healthy and Inflamed Murine Lung Using CD90/Thy-1 as a Marker	PLOS ONE			English	Article							THY-1 CD90; T-CELLS; EXPRESSION; ANTIGEN; SUBPOPULATIONS	Background: Lymphatic vessels play a pivotal role in fluid drainage and egress of immune cells from the lung. However, examining murine lung lymphatics is hampered by the expression of classical lymph endothelial markers on other cell types, which hinders the unambiguous identification of lymphatics. The expression of CD90/Thy-1 on lymph endothelium was recently described and we therefore examined its suitability to identify murine pulmonary lymph vessels under healthy and inflammatory conditions. Methodology/Principal Findings: Immunohistochemistry with a monoclonal antibody against CD90.2/Thy-1.2 on 200 mu thick precision cut lung slices labeled a vascular network that was distinct from blood vessels. Preembedding immunostaining and electron microscopy verified that the anti-CD90.2/Thy-1.2 antibody labeled lymphatic endothelium. Absence of staining in CD90.1/Thy-1.1 expressing FVB mice indicated that CD90/Thy-1 was expressed on lymph endothelium and labeling was not due to antibody cross reactivity. Double-labeling immunohistochemistry for CD90/Thy-1 and alpha-smooth muscle actin identified two routes for lymph vessel exit from the murine lung. One started in the parenchyma or around veins and left via venous blood vessels. The other began in the space around airways or in the space between airways and pulmonary arteries and left via the main bronchi. As expected from the pulmonary distribution of lymph vessels, intranasal application of house dust mite led to accumulation of T cells around veins and in the connective tissue between airways and pulmonary arteries. Surprisingly, increased numbers of T cells were also detected around intraacinar arteries that lack lymph vessels. This arterial T cell sheath extended to the pulmonary arteries where lymph vessels were located. Conclusions/Significance: These results indicate that CD90/Thy-1 is expressed on lymphatic endothelial cells and represents a suitable marker for murine lung lymph vessels. Combining CD90/Thy-1 labeling with precision cut lung slices allows visualizing the anatomy of the lymphatic system in normal and inflamed conditions.	[Kretschmer, Sarah; Dethlefsen, Ina; Koenig, Peter] Med Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany; [Hagner-Benes, Stefanie; Marsh, Leigh M.; Garn, Holger] Univ Marburg, Inst Lab Med & Pathobiochem, Marburg, Germany; [Marsh, Leigh M.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	University of Lubeck; Philipps University Marburg; Ludwig Boltzmann Institute	Konig, P (corresponding author), Med Univ Lubeck, Inst Anat, Zentrum Med Struktur & Zellbiol, D-23538 Lubeck, Germany.	koenig@anat.uni-luebeck.de	König, Peter/AAK-2021-2020; Marsh, Leigh/AAB-5125-2021	Marsh, Leigh/0000-0002-1754-9249; Garn, Holger/0000-0002-5178-4023	DFG (German Research Foundation) [Transergio 22 Z2, Z5]; section of Medicine of the University of Lubeck (Stipendium Exzellenzmedizin [E21-2008, PI-E11B-2009]	DFG (German Research Foundation)(German Research Foundation (DFG)); section of Medicine of the University of Lubeck (Stipendium Exzellenzmedizin	This work was funded by the DFG (German Research Foundation) (Transergio 22 Z2 to Holger Garn and Z5 to Peter Konig) and by the section of Medicine of the University of Lubeck (Stipendium Exzellenzmedizin to Ina Dethlefsen and E21-2008 and PI-E11B-2009 to Peter Konig). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; LEDBETTER JA, 1980, J EXP MED, V152, P280, DOI 10.1084/jem.152.2.280; McDonald Donald M, 2011, Proc Am Thorac Soc, V8, P504, DOI 10.1513/pats.201102-022MW; MCINTOSH JC, 1994, EUR RESPIR J, V7, P2131, DOI 10.1183/09031936.94.07122131; Miserocchi G, 2009, EUR RESPIR REV, V18, P244, DOI 10.1183/09059180.00002709; Pabst R, 2004, PATHOBIOLOGY, V71, P287, DOI 10.1159/000081723; Pabst R, 2002, J ALLERGY CLIN IMMUN, V110, P209, DOI 10.1067/mai.2002.126836; Paddenberg R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-93; PHIPPS RP, 1990, EUR J IMMUNOL, V20, P1723, DOI 10.1002/eji.1830200815; SCHRADER JW, 1982, P NATL ACAD SCI-BIOL, V79, P4161, DOI 10.1073/pnas.79.13.4161; Schubert K, 2011, EUR J IMMUNOL, V41, P645, DOI 10.1002/eji.201041117; Sleeman JP, 2001, MICROSC RES TECHNIQ, V55, P61, DOI 10.1002/jemt.1157; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Wandel E, 2012, J IMMUNOL, V188, P1442, DOI 10.4049/jimmunol.1003944; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Wetzel A, 2006, J INVEST DERMATOL, V126, P441, DOI 10.1038/sj.jid.5700072; Yao LC, 2010, AM J PATHOL, V176, P1525, DOI 10.2353/ajpath.2010.090909	24	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55201	10.1371/journal.pone.0055201	http://dx.doi.org/10.1371/journal.pone.0055201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408960	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300007
J	Low, CG; Luk, ISU; Lin, D; Fazli, L; Yang, K; Xu, Y; Gleave, M; Gout, PW; Wang, YZ				Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Fazli, Ladan; Yang, Kuo; Xu, Yong; Gleave, Martin; Gout, Peter W.; Wang, Yuzhuo			BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells	PLOS ONE			English	Article							X-LINKED INHIBITOR; EMBRYONIC-DEVELOPMENT; TUMOR-SUPPRESSOR; GENE-EXPRESSION; AUTOPHAGY GENE; APOLLON; PATHWAY; BRUCE; IAP; BECLIN-1	Background: BIRC6 is a member of the Inhibitors of Apoptosis Protein (IAP) family which is thought to protect a variety of cancer cells from apoptosis. The main objective of the present study was to investigate whether BIRC6 plays a role in prostate cancer and could be useful as a novel therapeutic target. Methods: BIRC6 expression in cell lines was assessed using Western blot analysis and in clinical samples using immunohistochemistry of tissue microarrays. The biological significance of BIRC6 was determined by siRNA-induced reduction of BIRC6 expression in LNCaP cells followed by functional assays. Results: Elevated BIRC6 protein expression was found in prostate cancer cell lines and clinical specimens as distinct from their benign counterparts. Increased BIRC6 expression was associated with Gleason 6-8 cancers and castration resistance. Reduction of BIRC6 expression in LNCaP cells led to a marked reduction in cell proliferation which was associated with an increase in apoptosis and a decrease in autophagosome formation. Doxorubicin-induced apoptosis was found to be coupled to a reduction in BIRC6 protein expression. Conclusion: The data suggest a role for BIRC6 in prostate cancer progression and treatment resistance, and indicate for the first time that the BIRC6 gene and its product are potentially valuable targets for treatment of prostate cancers.	[Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Fazli, Ladan; Yang, Kuo; Gleave, Martin; Wang, Yuzhuo] Univ British Columbia, Vancouver Prostate Ctr, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; [Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Fazli, Ladan; Yang, Kuo; Gleave, Martin; Wang, Yuzhuo] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Gout, Peter W.; Wang, Yuzhuo] BC Canc Agcy, Dept Expt Therapeut, Vancouver, BC, Canada; [Yang, Kuo; Xu, Yong] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; Tianjin Medical University	Wang, YZ (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada.	ywang@bccrc.ca		Wang, Yuzhuo/0000-0002-9749-8591; Gleave, Martin/0000-0003-4235-0167	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantana A, 2004, MOL CANCER THER, V3, P699; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bianchini M, 2006, INT J ONCOL, V29, P83; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Chu L, 2008, GENE THER, V15, P484, DOI 10.1038/gt.2008.6; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gleave M, 2005, CANCER CHEMOTH PHARM, V56, pS47, DOI 10.1007/s00280-005-0098-0; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Iqbal J, 2009, LEUKEMIA, V23, P1139, DOI 10.1038/leu.2009.3; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LaCasse EC, 2006, CLIN CANCER RES, V12, P5231, DOI 10.1158/1078-0432.CCR-06-0608; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lopergolo A, 2009, BRIT J CANCER, V100, P739, DOI 10.1038/sj.bjc.6604927; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; Miyake H, 2000, ENDOCRINOLOGY, V141, P2257, DOI 10.1210/en.141.6.2257; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Parikh A, 2010, PROSTATE, V70, P971, DOI 10.1002/pros.21131; Petrioli R, 2008, CANCER TREAT REV, V34, P710, DOI 10.1016/j.ctrv.2008.05.004; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Qiu XB, 2005, J BIOL CHEM, V280, P174, DOI 10.1074/jbc.M411430200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Rocchi P, 2004, CANCER RES, V64, P6595, DOI 10.1158/0008-5472.CAN-03-3998; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sekine K, 2005, BIOCHEM BIOPH RES CO, V330, P279, DOI 10.1016/j.bbrc.2005.02.165; Sowery RD, 2008, BJU INT, V102, P389, DOI 10.1111/j.1464-410X.2008.07618.x; Sung KW, 2007, CLIN CANCER RES, V13, P5109, DOI 10.1158/1078-0432.CCR-07-0693; van Houdt WJ, 2011, MOL CELLULAR PROTEOM; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	40	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55837	10.1371/journal.pone.0055837	http://dx.doi.org/10.1371/journal.pone.0055837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409057	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300037
J	Ma, MX; Liu, JH; Song, YJ; Li, L; Li, YF				Ma Mingxiao; Liu Jinhua; Song Yingjin; Li Li; Li Yongfei			TaqMan MGB Probe Fluorescence Real-Time Quantitative PCR for Rapid Detection of Chinese Sacbrood Virus	PLOS ONE			English	Article							DEFORMED WING VIRUS; HONEYBEE	Sacbrood virus (SBV) is a picorna-like virus that affects honey bees (Apis mellifera) and results in the death of the larvae. Several procedures are available to detect Chinese SBV (CSBV) in clinical samples, but not to estimate the level of CSBV infection. The aim of this study was develop an assay for rapid detection and quantification of this virus. Primers and probes were designed that were specific for CSBV structural protein genes. A TaqMan minor groove binder (MGB) probe-based, fluorescence real-time quantitative PCR was established. The specificity, sensitivity and stability of the assay were assessed; specificity was high and there were no cross-reactivity with healthy larvae or other bee viruses. The assay was applied to detect CSBV in 37 clinical samples and its efficiency was compared with clinical diagnosis, electron microscopy observation, and conventional RT-PCR. The TaqMan MGB-based probe fluorescence real-time quantitative PCR for CSBV was more sensitive than other methods tested. This assay was a reliable, fast, and sensitive method that was used successfully to detect CSBV in clinical samples. The technology can provide a useful tool for rapid detection of CSBV. This study has established a useful protocol for CSBV testing, epidemiological investigation, and development of animal models.	[Ma Mingxiao; Li Li; Li Yongfei] Liaoning Med Univ, Dept Lab Anim Ctr, Jinzhou, Peoples R China; [Liu Jinhua] Jilin Entry Exit Inspect & Quarantine Bur, Changchun, Peoples R China; [Song Yingjin] Tianjin Univ, Agr & Biol Engn Coll, Tianjin 300072, Peoples R China	Jinzhou Medical University; Tianjin University	Ma, MX (corresponding author), Liaoning Med Univ, Dept Lab Anim Ctr, Jinzhou, Peoples R China.	nnxx8@yahoo.com.cn			National Natural Science Foundation of China [30972200]; Science and Technology Department of Liaoning Province of China [2011408004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province of China	This work was supported by grants from the National Natural Science Foundation of China (No. 30972200) and the Science and Technology Department of Liaoning Province of China (No. 2011408004). The funders had no role in study design, data collection and analysis, decision to publish.	ANDERSON DL, 1989, ANN APPL BIOL, V114, P1, DOI 10.1111/j.1744-7348.1989.tb06781.x; Bailey L, 1976, Adv Virus Res, V20, P271, DOI 10.1016/S0065-3527(08)60507-2; Bailey L., 1975, Bee World, V56, P55; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Kukielka D, 2008, J VIROL METHODS, V147, P275, DOI 10.1016/j.jviromet.2007.09.008; Kukielka D, 2009, J VIROL METHODS, V161, P240, DOI 10.1016/j.jviromet.2009.06.014; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Ma Ming-xiao, 2010, Chinese Journal of Biologicals, V23, P425; Ma MX, 2011, J VIROL METHODS, V176, P115, DOI 10.1016/j.jviromet.2011.05.028; Ritter W., 1996, DIAGNOSTIK BEKAMPFUN, P104; Sambrook J, 2001, MOL CLONING LAB MANU; WANG DI, 1970, J ECON ENTOMOL, V63, P1539, DOI 10.1093/jee/63.5.1539; Wernike K, 2010, DETECTION TYPING HIG; Yan X, 2009, SOCIOBIOLOGY, V53, P687	16	12	19	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e52670	10.1371/journal.pone.0052670	http://dx.doi.org/10.1371/journal.pone.0052670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408931	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300002
J	Fink, K; Busch, HJ; Bourgeois, N; Schwarz, M; Wolf, D; Zirlik, A; Peter, K; Bode, C; von zur Muhlen, C				Fink, Katrin; Busch, Hans-Joerg; Bourgeois, Natascha; Schwarz, Meike; Wolf, Dennis; Zirlik, Andreas; Peter, Karlheinz; Bode, Christoph; von zur Muhlen, Constantin			Mac-1 Directly Binds to the Endothelial Protein C-Receptor: A Link between the Protein C Anticoagulant Pathway and Inflammation?	PLOS ONE			English	Article							CD11B/CD18; ACTIVATION; EXPRESSION; INVOLVEMENT; APOPTOSIS; ADHESION; DISEASE; HEPARIN; SEPSIS; PLASMA	Objective: The endothelial protein C-receptor (EPCR) is an endothelial transmembrane protein that binds protein C and activated protein C (APC) with equal affinity, thereby facilitating APC formation. APC has anticoagulant, antiapoptotic and antiinflammatory properties. Soluble EPCR, released by the endothelium, may bind activated neutrophils, thereby modulating cell adhesion. EPCR is therefore considered as a possible link between the anticoagulant properties of protein C and the inflammatory response of neutrophils. In the present study, we aimed to provide proof of concept for a direct binding of EPCR to the beta(2)-integrin Mac-1 on monocytic cells under static and physiological flow conditions. Measurements and Main Results: Under static conditions, human monocytes bind soluble EPCR in a concentration dependent manner, as demonstrated by flow cytometry. Binding can be inhibited by specific antibodies (anti-EPCR and anti-Mac-1). Specific binding was confirmed by a static adhesion assay, where a transfected Mac-1 expressing CHO cell line (Mac-1+ cells) bound significantly more recombinant EPCR compared to Mac-1+ cells blocked by anti-Mac-1-antibody and native CHO cells. Under physiological flow conditions, monocyte binding to the endothelium could be significantly blocked by both, anti-EPCR and anti-Mac-1 antibodies in a dynamic adhesion assay at physiological flow conditions. Pre-treatment of endothelial cells with APC (drotrecogin alfa) diminished monocyte adhesion significantly in a comparable extent to antiEPCR. Conclusions: In the present study, we demonstrate a direct binding of Mac-1 on monocytes to the endothelial protein C receptor under static and flow conditions. This binding suggests a link between the protein C anticoagulant pathway and inflammation at the endothelium side, such as in acute vascular inflammation or septicaemia.	[Fink, Katrin; Bourgeois, Natascha; Schwarz, Meike; Wolf, Dennis; Zirlik, Andreas; Bode, Christoph; von zur Muhlen, Constantin] Univ Heart Ctr Freiburg, Dept Cardiol & Angiol 1, Freiburg, Germany; [Busch, Hans-Joerg] Univ Hosp Freiburg, Dept Emergency Med, Freiburg, Germany; [Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Universitats Herzzentrum Freiburg; University of Freiburg; Baker Heart and Diabetes Institute	Fink, K (corresponding author), Univ Heart Ctr Freiburg, Dept Cardiol & Angiol 1, Freiburg, Germany.	katrin.fink@universitaets-herzzentrum.de	Peter, Karlheinz/E-8772-2010; Wolf, Dennis/S-9217-2018; Wolf, Dennis/G-8299-2012; /S-2765-2019; Zirlik, Andreas/A-6400-2011	Peter, Karlheinz/0000-0002-8040-2258; Wolf, Dennis/0000-0003-1525-4348; /0000-0002-8040-2258; Zirlik, Andreas/0000-0001-6290-3297				ALTIERI DC, 1990, J BIOL CHEM, V265, P12119; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Franscini N, 2004, CIRCULATION, V110, P2903, DOI 10.1161/01.CIR.0000146344.49689.BB; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; Grinnell BW, 2001, CRIT CARE MED S, V53-0, P60; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Laszik Z, 1997, CIRCULATION, V96, P3633; Mizutani A, 2000, BLOOD, V95, P3781; Murakami K, 1996, BLOOD, V87, P642, DOI 10.1182/blood.V87.2.642.bloodjournal872642; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Schuler P, 2003, CELL COMMUN ADHES, V10, P17, DOI 10.1080/15419060302065; Schwarz M, 2002, THROMB RES, V107, P121, DOI 10.1016/S0049-3848(02)00207-4; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Xia Y, 1999, J IMMUNOL, V162, P2281; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038	29	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e53103	10.1371/journal.pone.0053103	http://dx.doi.org/10.1371/journal.pone.0053103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408932	gold, Green Published			2022-12-25	WOS:000315157200005
J	Mathiharan, YK; Pappachan, A; Savithri, HS; Murthy, MRN				Mathiharan, Yamuna Kalyani; Pappachan, Anju; Savithri, H. S.; Murthy, Mathur R. N.			Dramatic Structural Changes Resulting from the Loss of a Crucial Hydrogen Bond in the Hinge Region Involved in C-Terminal Helix Swapping in SurE: A Survival Protein from Salmonella typhimurium	PLOS ONE			English	Article							STATIONARY-PHASE SURVIVAL; CRYSTAL-STRUCTURE; PHOSPHATASE; ALIGNMENT; SEQUENCE	Domain swapping is an interesting feature of some oligomeric proteins in which each protomer of the oligomer provides an identical surface for exclusive interaction with a segment or domain belonging to another protomer. Here we report results of mutagenesis experiments on the structure of C-terminal helix swapped dimer of a stationary phase survival protein from Salmonella typhimurium (StSurE). Wild type StSurE is a dimer in which a large helical segment at the C-terminus and a tetramerization loop comprising two beta strands are swapped between the protomers. Key residues in StSurE that might promote C-terminal helix swapping were identified by sequence and structural comparisons. Three mutants in which the helix swapping is likely to be avoided were constructed and expressed in E. coli. Three-dimensional X-ray crystal structures of the mutants H234A and D230A/H234A could be determined at 2.1 angstrom and 2.35 angstrom resolutions, respectively. Contrary to expectations, helix swapping was mostly retained in both the mutants. The loss of the crucial D230 OD2- H234 NE2 hydrogen bond (2.89 angstrom in the wild type structure) in the hinge region was compensated by new inter and intra-chain interactions. However, the two fold molecular symmetry was lost and there were large conformational changes throughout the polypeptide. In spite of these changes, the dimeric structure and an approximate tetrameric organization were retained, probably due to the interactions involving the tetramerization loop. Mutants were mostly functionally inactive, highlighting the importance of precise inter-subunit interactions for the symmetry and function of StSurE.	[Mathiharan, Yamuna Kalyani; Pappachan, Anju; Murthy, Mathur R. N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Savithri, H. S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Murthy, MRN (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	mrn@mbu.iisc.ernet.in		Mathiharan, Yamuna Kalyani/0000-0003-4042-6199	DST, Government of India; DBT, Government of India; MHRD, Government of India	DST, Government of India(Department of Science & Technology (India)); DBT, Government of India(Department of Biotechnology (DBT) India); MHRD, Government of India(Ministry of Human Resource Development (MHRD), Government of India)	M.R.N. Murthy and H. S. Savithri thank DST and the DBT, Government of India for funding. Yamuna Kalyani Mathiharan thanks the MHRD, Government of India, for the award of a Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Antonyuk SV, 2009, ACTA CRYSTALLOGR F, V65, P1204, DOI 10.1107/S1744309109043814; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENNETT MJ, 1994, PROTEIN SCI, V3, P1444, DOI 10.1002/pro.5560030911; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P5741, DOI 10.1073/pnas.77.10.5741; Iwasaki W, 2007, J MOL BIOL, V371, P123, DOI 10.1016/j.jmb.2007.05.007; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2001, NAT STRUCT BIOL, V8, P789, DOI 10.1038/nsb0901-789; Li C, 1997, MICROBIOL-UK, V143, P3513, DOI 10.1099/00221287-143-11-3513; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mura C, 2003, J MOL BIOL, V326, P1559, DOI 10.1016/S0022-2836(03)00056-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ostermeier M, 2001, ADV PROTEIN CHEM, V55, P29, DOI 10.1016/S0065-3233(01)55002-0; Pappachan A, 2008, FEBS J, V275, P5855, DOI 10.1111/j.1742-4658.2008.06715.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55978	10.1371/journal.pone.0055978	http://dx.doi.org/10.1371/journal.pone.0055978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409101	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200096
J	Oxborough, RM; Kitau, J; Matowo, J; Feston, E; Mndeme, R; Mosha, FW; Rowland, MW				Oxborough, Richard M.; Kitau, Jovin; Matowo, Johnson; Feston, Emmanuel; Mndeme, Rajab; Mosha, Franklin W.; Rowland, Mark W.			ITN Mixtures of Chlorfenapyr (Pyrrole) and Alphacypermethrin (Pyrethroid) for Control of Pyrethroid Resistant Anopheles arabiensis and Culex quinquefasciatus	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; HOUSE-FREQUENTING HABITS; MALARIA VECTOR CONTROL; VERANDAH-TRAP HUT; BED NETS; GAMBIAE; MOSQUITOS; DIPTERA; POPULATIONS; AREA	Pyrethroid resistant Anopheles gambiae malaria vectors are widespread throughout sub-Saharan Africa and continued efficacy of pyrethroid ITNs is under threat. Chlorfenapyr is a promising pyrrole insecticide with a unique mechanism of action conferring no cross-resistance to existing public health insecticides. Mixtures of chlorfenapyr (CFP) and alphacypermethrin (alpha) may provide additional benefits over chlorfenapyr or alphacypermethrin used alone. An ITN mixture of CFP 100 mg/m(2)+alpha 25 mg/m(2) was compared with CFP 100 mg/m(2) and alpha 25 mg/m(2) in a small-scale experimental hut trial in an area of wild An. arabiensis. The same treatments were evaluated in tunnel tests against insectary-reared pyrethroid susceptible and resistant Culex quinquefasciatus. Performance was measured in terms of insecticide-induced mortality, and blood-feeding inhibition. Tunnel tests showed that mixtures of CFP 100+ alpha 25 were 1.2 and 1.5 times more effective at killing susceptible Cx. quinquefasciatus than either Alpha 25 (P = 0.001) or CFP 100 (P = 0.001) ITNs. Mixtures of CFP100+ alpha 25 were 2.2 and 1.2 times more effective against resistant Cx. quinquefasciatus than either alpha 25 (P = 0.001) or CFP100 (P = 0.003) ITNs. CFP 100+ alpha 25 produced higher levels of blood-feeding inhibition than CFP alone for susceptible (94 vs 46%, P = 0.001) and resistant (84 vs 53%, P = 0.001) strains. In experimental huts the mixture of CFP 100+ Alpha 25 killed 58% of An. arabiensis, compared with 50% for alpha and 49% for CFP, though the differences were not significant. Blood-feeding inhibition was highest in the mixture with a 76% reduction compared to the untreated net (P = 0.001). ITN mixtures of chlorfenapyr and alphacypermethrin should restore effective control of resistant populations of An. gambiae malaria vectors, provide protection from blood-feeding, and may have benefits for resistance management, particularly in areas with low or moderate frequency of pyrethroid resistance. A wash-resistant mixture should be developed urgently.	[Oxborough, Richard M.; Rowland, Mark W.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Oxborough, Richard M.; Kitau, Jovin; Matowo, Johnson; Feston, Emmanuel; Mndeme, Rajab; Mosha, Franklin W.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll KCMUCo, Dept Entomol & Parasitol, Moshi, Kilimanjaro, Tanzania; [Oxborough, Richard M.; Kitau, Jovin; Matowo, Johnson; Feston, Emmanuel; Mndeme, Rajab; Mosha, Franklin W.; Rowland, Mark W.] PAMVERC, Pan African Malaria Vector Res Consortium, Dept Entomol, Moshi, Kilimanjaro, Tanzania	University of London; London School of Hygiene & Tropical Medicine	Oxborough, RM (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Richard.Oxborough@lshtm.ac.uk			Innovative Vector Control Consortium (IVCC), Liverpool, United Kingdom	Innovative Vector Control Consortium (IVCC), Liverpool, United Kingdom	This work was supported by Innovative Vector Control Consortium (IVCC), Liverpool, United Kingdom. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders were consulted regarding publication and approved submission.	[Anonymous], 2004, COCHRANE DB SYST REV; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Beiersmann C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-296; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Guglielmone AA, 2000, VET PARASITOL, V93, P77, DOI 10.1016/S0304-4017(00)00335-6; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Irish SR, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-17; Jones CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-24; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kulkarni MA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-56; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Matowo J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-193; MILLER JE, 1994, J MED ENTOMOL, V31, P114, DOI 10.1093/jmedent/31.1.114; Mosha FW, 2008, TROP MED INT HEALTH, V13, P644, DOI 10.1111/j.1365-3156.2008.02058.x; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Oliver SV, 2010, TROP MED INT HEALTH, V15, P127, DOI 10.1111/j.1365-3156.2009.02416.x; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Oxborough RM, 2010, T ROY SOC TROP MED H, V104, P639, DOI 10.1016/j.trstmh.2010.07.008; Raghavendra K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-16; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; SMITH A, 1969, B ENTOMOL RES, V59, P33, DOI 10.1017/S000748530000300X; SMITH A, 1965, B ENTOMOL RES, V56, P161, DOI 10.1017/S0007485300057114; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1170, DOI 10.1093/jee/83.4.1170; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2007, WHO REC INS PROD TRE; WHO, 2005, WHOCDSWHOPESGCDPP200; World Health Organization, WHOCDSNTDWHOPESGCDPP; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	43	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55781	10.1371/journal.pone.0055781	http://dx.doi.org/10.1371/journal.pone.0055781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409042	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000315157200062
J	Pietrosemoli, N; Garcia-Martin, JA; Solano, R; Pazos, F				Pietrosemoli, Natalia; Garcia-Martin, Juan A.; Solano, Roberto; Pazos, Florencio			Genome-Wide Analysis of Protein Disorder in Arabidopsis thaliana: Implications for Plant Environmental Adaptation	PLOS ONE			English	Article							INTRINSIC DISORDER; STRUCTURAL DISORDER; WEB SERVER; PREDICTION; SEQUENCE; RECOGNITION; COMPLEXITY; DOMAINS; REGIONS; LIGHT	Intrinsically Disordered Proteins/Regions (IDPs/IDRs) are currently recognized as a widespread phenomenon having key cellular functions. Still, many aspects of the function of these proteins need to be unveiled. IDPs conformational flexibility allows them to recognize and interact with multiple partners, and confers them larger interaction surfaces that may increase interaction speed. For this reason, molecular interactions mediated by IDPs/IDRs are particularly abundant in certain types of protein interactions, such as those of signaling and cell cycle control. We present the first large-scale study of IDPs in Arabidopsis thaliana, the most widely used model organism in plant biology, in order to get insight into the biological roles of these proteins in plants. The work includes a comparative analysis with the human proteome to highlight the differential use of disorder in both species. Results show that while human proteins are in general more disordered, certain functional classes, mainly related to environmental response, are significantly more enriched in disorder in Arabidopsis. We propose that because plants cannot escape from environmental conditions as animals do, they use disorder as a simple and fast mechanism, independent of transcriptional control, for introducing versatility in the interaction networks underlying these biological processes so that they can quickly adapt and respond to challenging environmental conditions.	[Pietrosemoli, Natalia; Pazos, Florencio] Natl Ctr Biotechnol CNB CSIC, Computat Syst Biol Grp, Madrid, Spain; [Garcia-Martin, Juan A.; Solano, Roberto] Natl Ctr Biotechnol CNB CSIC, Plant Mol Genet Dept, Madrid, Spain; [Pietrosemoli, Natalia] Rice Univ, Dept Bioengn, Houston, TX USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Rice University	Solano, R (corresponding author), Natl Ctr Biotechnol CNB CSIC, Plant Mol Genet Dept, Madrid, Spain.	rsolano@cnb.csic.es; fpazos@cnb.csic.es	Solano, Roberto/O-5908-2017; Garcia-Martin, Juan Antonio/K-5956-2017; Garcia-Martin, Juan Antonio/HDN-5951-2022	Solano, Roberto/0000-0001-5459-2417; Garcia-Martin, Juan Antonio/0000-0003-0993-4064; 	Spanish Ministry for Science and Innovation [BIO2010-22109, BIO2010-21739, CSD2007-00057, EUI2008- 03666]	Spanish Ministry for Science and Innovation(Spanish Government)	This project was funded by the Spanish Ministry for Science and Innovation grants BIO2010-22109 to FP and BIO2010-21739, CSD2007-00057, and EUI2008- 03666 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Casal JJ, 2004, TRENDS PLANT SCI, V9, P309, DOI 10.1016/j.tplants.2004.04.007; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; RHODES MJC, 1994, PLANT MOL BIOL, V24, P1, DOI 10.1007/BF00040570; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero P, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P90, DOI 10.1109/ICNN.1997.611643; Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Seigler D.S., 1998, PLANT SECONDARY META, DOI 10.1007/978-1-4615-4913-0; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tantos A, 2009, FEBS LETT, V583, P465, DOI 10.1016/j.febslet.2008.12.054; Thomas PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002386; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Yruela I, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-165	56	47	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55524	10.1371/journal.pone.0055524	http://dx.doi.org/10.1371/journal.pone.0055524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408995	gold, Green Submitted, Green Published			2022-12-25	WOS:000315157200035
J	Conrad, KD; Giering, F; Erfurth, C; Neumann, A; Fehr, C; Meister, G; Niepmann, M				Conrad, K. Dominik; Giering, Florian; Erfurth, Corinna; Neumann, Angelina; Fehr, Carmen; Meister, Gunter; Niepmann, Michael			microRNA-122 Dependent Binding of Ago2 Protein to Hepatitis C Virus RNA Is Associated with Enhanced RNA Stability and Translation Stimulation	PLOS ONE			English	Article							LONG-RANGE RNA; 3'-UNTRANSLATED REGION; RIBOSOME; INITIATION; ELEMENT; IDENTIFICATION; STABILIZATION; ACTIVATION; REPRESSION; MECHANISM	Translation of Hepatitis C Virus (HCV) RNA is directed by an internal ribosome entry site (IRES) in the 5'-untranslated region (5'-UTR). HCV translation is stimulated by the liver-specific microRNA-122 (miR-122) that binds to two binding sites between the stem-loops I and II near the 5'-end of the 5'-UTR. Here, we show that Argonaute (Ago) 2 protein binds to the HCV 5'-UTR in a miR-122-dependent manner, whereas the HCV 3'-UTR does not bind Ago2. miR-122 also recruits Ago1 to the HCV 5'-UTR. Only miRNA duplex precursors of the correct length stimulate HCV translation, indicating that the duplex miR-122 precursors are unwound by a complex that measures their length. Insertions in the 5'-UTR between the miR-122 binding sites and the IRES only slightly decrease translation stimulation by miR-122. In contrast, partially masking the miR-122 binding sites in a stem-loop structure impairs Ago2 binding and translation stimulation by miR-122. In an RNA decay assay, also miR-122-mediated RNA stability contributes to HCV translation stimulation. These results suggest that Ago2 protein is directly involved in loading miR-122 to the HCV RNA and mediating RNA stability and translation stimulation.	[Conrad, K. Dominik; Giering, Florian; Erfurth, Corinna; Neumann, Angelina; Fehr, Carmen; Niepmann, Michael] Univ Giessen, Fac Med, Inst Biochem, D-35390 Giessen, Germany; [Meister, Gunter] Univ Regensburg, Inst Biochem, Fac Biol & Preclin Med, D-93053 Regensburg, Germany	Justus Liebig University Giessen; University of Regensburg	Niepmann, M (corresponding author), Univ Giessen, Fac Med, Inst Biochem, D-35390 Giessen, Germany.	michael.niepmann@biochemie.med.uni-giessen.de			Deutsche Forschungsgemeinschaft, Germany (DFG) [SFB 535, Ni 604/1-1, /2-1, GRK 1384]	Deutsche Forschungsgemeinschaft, Germany (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Germany (DFG) (SFB 535, Ni 604/1-1 and /2-1, GRK 1384) and the Universitatsklinikum Giessen und Marburg GmbH (KOOPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beguiristain N, 2005, NUCLEIC ACIDS RES, V33, P5250, DOI 10.1093/nar/gki822; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Berezhna SY, 2011, RNA, V17, P1831, DOI 10.1261/rna.2523911; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Bung C, 2010, FEBS LETT, V584, P837, DOI 10.1016/j.febslet.2010.01.015; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Diaz-Toledano R, 2009, NUCLEIC ACIDS RES, V37, P5498, DOI 10.1093/nar/gkp553; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fehr C, 2012, CELL CYCLE, V11, P277, DOI 10.4161/cc.11.2.18699; Friebe P, 2009, J VIROL, V83, P11989, DOI 10.1128/JVI.01508-09; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Goergen D, 2012, VIRUS RES, V167, P343, DOI 10.1016/j.virusres.2012.05.022; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hoffman B, 2011, LIVER INT, V31, P1449, DOI 10.1111/j.1478-3231.2011.02543.x; Honda M, 1999, J VIROL, V73, P4941, DOI 10.1128/JVI.73.6.4941-4951.1999; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim YK, 2003, RNA, V9, P599, DOI 10.1261/rna.2185603; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Niepmann M, 2009, BBA-GENE REGUL MECH, V1789, P529, DOI 10.1016/j.bbagrm.2009.05.002; Niepmann M, 2009, CELL CYCLE, V8, P1473, DOI 10.4161/cc.8.10.8349; Ochs K, 1999, J VIROL, V73, P7505, DOI 10.1128/JVI.73.9.7505-7514.1999; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Perrault M, 2009, BIOCHEM J, V423, P303, DOI 10.1042/BJ20091000; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Petri S, 2011, RNA, V17, P737, DOI 10.1261/rna.2348111; Poenisch M, 2010, SEMIN LIVER DIS, V30, P333, DOI 10.1055/s-0030-1267535; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shimakami T, 2012, J VIROL, V86, P7372, DOI 10.1128/JVI.00513-12; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Villanueva RA, 2010, ANTIVIR RES, V88, P119, DOI 10.1016/j.antiviral.2010.07.004; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Zhang C, 2012, VIROLOGY, V433, P479, DOI 10.1016/j.virol.2012.08.039	57	64	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56272	10.1371/journal.pone.0056272	http://dx.doi.org/10.1371/journal.pone.0056272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405269	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400215
J	Legrand, AJ; Choul-Li, S; Spriet, C; Idziorek, T; Vicogne, D; Drobecq, H; Dantzer, F; Villeret, V; Aumercier, M				Legrand, Arnaud J.; Choul-Li, Souhaila; Spriet, Corentin; Idziorek, Thierry; Vicogne, Dorothee; Drobecq, Herve; Dantzer, Francoise; Villeret, Vincent; Aumercier, Marc			The Level of Ets-1 Protein Is Regulated by Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Cancer Cells to Prevent DNA Damage	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ETS-1; BINDING-SITES; STROMELYSIN-1 PROMOTER; GENE-EXPRESSION; ANGIOTENSIN-II; ACTIVATION; INHIBITION; PROTOONCOGENE; CARCINOMA; OVEREXPRESSION	Ets-1 is a transcription factor that regulates many genes involved in cancer progression and in tumour invasion. It is a poor prognostic marker for breast, lung, colorectal and ovary carcinomas. Here, we identified poly(ADP-ribose) polymerase-1 (PARP-1) as a novel interaction partner of Ets-1. We show that Ets-1 activates, by direct interaction, the catalytic activity of PARP-1 and is then poly(ADP-ribosyl)ated in a DNA-independent manner. The catalytic inhibition of PARP-1 enhanced Ets-1 transcriptional activity and caused its massive accumulation in cell nuclei. Ets-1 expression was correlated with an increase in DNA damage when PARP-1 was inhibited, leading to cancer cell death. Moreover, PARP-1 inhibitors caused only Ets-1-expressing cells to accumulate DNA damage. These results provide new insight into Ets-1 regulation in cancer cells and its link with DNA repair proteins. Furthermore, our findings suggest that PARP-1 inhibitors would be useful in a new therapeutic strategy that specifically targets Ets-1-expressing tumours.	[Legrand, Arnaud J.; Spriet, Corentin; Vicogne, Dorothee; Villeret, Vincent; Aumercier, Marc] Univ Lille Nord France, Inst Rech Interdisciplinaire, CNRS, USR 3078,IFR 147, Villeneuve Dascq, France; [Choul-Li, Souhaila; Drobecq, Herve] Univ Lille Nord France, Inst Biol Lille, Inst Pasteur Lille, CNRS,UMR 8161,IFR 142, Lille, France; [Idziorek, Thierry] Univ Lille Nord France, Inst Rech Canc Lille, INSERM, U837,IFR 114, Lille, France; [Dantzer, Francoise] Univ Strasbourg, Ecole Super Biotechnol Strasbourg, Ecole Biotechnol Strasbourg, CNRS,UMR 7242,Inst Rech, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Aumercier, M (corresponding author), Univ Lille Nord France, Inst Rech Interdisciplinaire, CNRS, USR 3078,IFR 147, Campus CNRS Haute Borne,BP 70478, Villeneuve Dascq, France.	marc.aumercier@iri.univ-lille1.fr	Dantzer, Françoise/O-2126-2016; CHOUL-LI, Souhaila/ABA-2431-2020; Spriet, Corentin/ABE-4215-2021	CHOUL-LI, Souhaila/0000-0003-0682-4214; Spriet, Corentin/0000-0002-5805-3426; Villeret, Vincent/0000-0003-4504-056X; Drobecq, Herve/0000-0002-4081-1575; Legrand, Arnaud/0000-0002-9429-813X; Dantzer, Francoise/0000-0003-0945-8483; Aumercier, Marc/0000-0002-0370-3452	Centre National de la Recherche Scientifique (CNRS); la Ligue contre le Cancer, Comite du Pas-de-Calais; Ministere de la Recherche et de l'Enseignement Superieur; Fondation ARC pour la Recherche sur le cancer; CNRS; Conseil Regional du Nord-Pas-de-Calais	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); la Ligue contre le Cancer, Comite du Pas-de-Calais; Ministere de la Recherche et de l'Enseignement Superieur; Fondation ARC pour la Recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional du Nord-Pas-de-Calais(Region Hauts-de-FranceRegion Ile-de-France)	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and by grants from la Ligue contre le Cancer, Comite du Pas-de-Calais. The Ministere de la Recherche et de l'Enseignement Superieur and the Fondation ARC pour la Recherche sur le cancer provided a PhD fellowship to Arnaud J. Legrand. The CNRS and the Conseil Regional du Nord-Pas-de-Calais provided a PhD fellowship (BDI) to Souhaila Choul-li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillat D, 2006, ONCOGENE, V25, P5764, DOI 10.1038/sj.onc.1209583; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Choul-li S, 2009, BIOCHEM BIOPH RES CO, V390, P839, DOI 10.1016/j.bbrc.2009.10.059; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Davidson B, 2001, CLIN CANCER RES, V7, P551; de Nigris F, 2001, CANCER RES, V61, P2267; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gebhard C, 2011, BIOCHEM BIOPH RES CO, V414, P641, DOI 10.1016/j.bbrc.2011.09.029; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Higuchi T, 2007, MOL CELL BIOL, V27, P3353, DOI 10.1128/MCB.01871-06; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Ibrahim YH, 2012, CANC DISCOV; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kars MD, 2010, BIOMED PHARMACOTHER, V64, P458, DOI 10.1016/j.biopha.2010.01.008; Katayama S, 2005, HISTOL HISTOPATHOL, V20, P119, DOI 10.14670/HH-20.119; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kita D, 2001, CANCER RES, V61, P7985; Laitem C, 2009, ONCOGENE, V28, P2087, DOI 10.1038/onc.2009.72; Laitem C, 2008, PROTEIN EXPRES PURIF, V62, P53, DOI 10.1016/j.pep.2008.06.010; Ledford H, 2012, NATURE, V483, P519, DOI 10.1038/483519a; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Leprivier G, 2009, NUCLEIC ACIDS RES, V37, P4341, DOI 10.1093/nar/gkp307; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Lulli V, 2006, CELL DEATH DIFFER, V13, P1064, DOI 10.1038/sj.cdd.4401811; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Madison DL, 2011, DNA REPAIR, V10, P1003, DOI 10.1016/j.dnarep.2011.07.006; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; Ni W, 2007, CIRC RES, V101, P985, DOI 10.1161/CIRCRESAHA.107.152439; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raffetseder U, 2004, KIDNEY INT, V66, P622, DOI 10.1111/j.1523-1755.2004.00782.x; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Takanami I, 2001, TUMOR BIOL, V22, P205, DOI 10.1159/000050617; Taniguchi H, 2007, INT J CANCER, V121, P1609, DOI 10.1002/ijc.22870; Teruyama K, 2001, J CELL PHYSIOL, V188, P243, DOI 10.1002/jcp.1112; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang H, 2004, J BIOL CHEM, V279, P25241, DOI 10.1074/jbc.M401356200; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417	55	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55883	10.1371/journal.pone.0055883	http://dx.doi.org/10.1371/journal.pone.0055883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405229	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400174
J	Shukla, A; Edwards, R; Yang, Y; Hahn, A; Folkers, K; Ding, J; Padmakumar, VC; Cataisson, C; Suh, KS; Yuspa, SH				Shukla, A.; Edwards, R.; Yang, Y.; Hahn, A.; Folkers, K.; Ding, J.; Padmakumar, V. C.; Cataisson, C.; Suh, K. S.; Yuspa, S. H.			CLIC4 regulates TGF-beta-dependent myofibroblast differentiation to produce a cancer stroma	ONCOGENE			English	Article						CLIC; alpha-SMA; p38; microenvironment; PPM1a	EPITHELIAL-MESENCHYMAL TRANSITION; CHLORIDE CHANNEL PROTEIN; MUSCLE ACTIN EXPRESSION; CONTRACTILE ACTIVITY; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; CELL CARCINOMA; FIBROBLASTS; GROWTH; PHOSPHATASE	Cancer stroma has a profound influence on tumor development and progression. The conversion of fibroblasts to activated myofibroblasts is a hallmark of reactive tumor stroma. Among a number of factors involved in this conversion, transforming growth factor (TGF)-beta has emerged as a major regulator. CLIC4, an integral protein in TGF-beta signaling, is highly upregulated in stroma of multiple human cancers, and overexpression of CLIC4 in stromal cells enhances the growth of cancer xenografts. In this study, we show that conditioned media from tumor cell lines induces expression of both CLIC4 and the myofibroblast marker alpha smooth muscle actin (alpha-SMA) in stromal fibroblasts via TGF-beta signaling. Genetic ablation of CLIC4 in primary fibroblasts prevents or reduces constitutive or TGF-beta-induced expression of alpha-SMA and extracellular matrix components that are markers of myofibroblasts. CLIC4 is required for the activation of p38 map kinase by TGF-beta, a pathway that signals myofibroblast conversion in stromal cells. This requirement involves the interaction of CLIC4 with PPM1a, the selective phosphatase of activated p38. Conditioned media from fibroblasts overexpressing CLIC4 increases tumor cell migration and invasion in a TGF-beta-dependent manner and promotes epithelial to mesenchymal transition indicating that high stromal CLIC4 serves to enhance tumor invasiveness and progression. Thus, CLIC4 is significantly involved in the development of a nurturing tumor microenvironment by enhancing TGF-beta signaling in a positive feedback loop. Targeting CLIC4 in tumor stroma should be considered as a strategy to mitigate some of the tumor enhancing effects of the cancer stroma.	[Shukla, A.; Edwards, R.; Yang, Y.; Hahn, A.; Folkers, K.; Padmakumar, V. C.; Cataisson, C.; Yuspa, S. H.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Ding, J.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Suh, K. S.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Hackensack University Medical Center	Yuspa, SH (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, 37 Convent Dr, Bethesda, MD 20892 USA.	yuspas@mail.nih.gov	Shukla, Anjali/G-4046-2014	Edwards Mayhew, Rebecca/0000-0003-3503-9637	Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Lalage Wakefield, National Cancer Institute, Bethesda for providing Smad3 KO mice and MI, MII, MIII, MIV cell lines, Dr Ed Leof, Department of Biochemistry and Molecular Biology, Mayo Clinic, Minnesota for providing anti-phospho Smad3 antibody and Dr Akira Oshima, National Cancer Institute for help with immunofluorescence. This work was supported by the intramural research program of the Center for Cancer Research, National Cancer Institute.	Adegboyega PA, 2010, HUM PATHOL, V41, P1128, DOI 10.1016/j.humpath.2009.12.014; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; Brenmoehl J, 2009, WORLD J GASTROENTERO, V15, P1431, DOI 10.3748/wjg.15.1431; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Connolly EC, 2011, CANCER RES, V71, P2339, DOI 10.1158/0008-5472.CAN-10-2941; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Liu M, 2011, INT J CANCER, V129, P1795, DOI 10.1002/ijc.26116; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Padmakumar VC, 2012, AM J PATHOL, V181, P74, DOI 10.1016/j.ajpath.2012.03.025; Qian ZJ, 1999, J BIOL CHEM, V274, P1621, DOI 10.1074/jbc.274.3.1621; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Shorning BY, 2003, DEV GENES EVOL, V213, P514, DOI 10.1007/s00427-003-0356-2; Shukla A, 2010, NUCLEUS-PHILA, V1, P144; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Suh KS, 2005, CURR PHARM DESIGN, V11, P2753, DOI 10.2174/1381612054546806; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Tung JJ, 2009, ANGIOGENESIS, V12, P209, DOI 10.1007/s10456-009-9139-3; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Uemura M, 2005, MOL BIOL CELL, V16, P4214, DOI 10.1091/mbc.E05-02-0149; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; Yao Q, 2009, ONCOL REP, V22, P541, DOI 10.3892/or_00000469; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	54	47	51	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					842	850		10.1038/onc.2013.18	http://dx.doi.org/10.1038/onc.2013.18			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23416981	Green Accepted			2022-12-25	WOS:000331626900005
J	Ingvarsen, S; Porse, A; Erpicum, C; Maertens, L; Jurgensen, HJ; Madsen, DH; Melander, MC; Gardsvoll, H; Hoyer-Hansen, G; Noel, A; Holmbeck, K; Engelholm, LH; Behrendt, N				Ingvarsen, Signe; Porse, Astrid; Erpicum, Charlotte; Maertens, Ludovic; Jurgensen, Henrik J.; Madsen, Daniel H.; Melander, Maria C.; Gardsvoll, Henrik; Hoyer-Hansen, Gunilla; Noel, Agnes; Holmbeck, Kenn; Engelholm, Lars H.; Behrendt, Niels			Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP IMPACT ON LYMPHANGIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TYPE-1 METALLOPROTEINASE; EXTRACELLULAR-MATRIX; GELATINASE-A; MT-MMP; MULTICENTRIC OSTEOLYSIS; COMPLEX-FORMATION; IV COLLAGENASE; CELL-SURFACE; TUMOR-GROWTH; ACTIVATION	The group of matrix metalloproteases (MMPs) is responsible for multiple processes of extracellular matrix remodeling in the healthy body but also for matrix and tissue destruction during cancer invasion and metastasis. The understanding of the contributions from each individual MMP, both in healthy and pathological events, has been complicated by the lack of specific inhibitors and the fact that some of the potent MMPs are multifunctional enzymes. These factors have also hampered the setup of therapeutic strategies targetingMMPactivity. A tempting target is the membrane-associated MT1-MMP, which has well-documented importance in matrix degradation but which takes part in more than one pathway in this regard. In this report, we describe the selective targeting of a single function of this enzyme by means of a specific monoclonal antibody against MT1-MMP, raised in an MT1-MMP knock-out mouse. The antibody blocks the enzyme ability to activate proMMP-2 without interfering with the collagenolytic function or the general proteolytic activity of MT1-MMP. Using this antibody, we have shown that the MT1-MMP-catalyzed activation of proMMP-2 is involved in the outgrowth of cultured lymphatic endothelial cells in a collagen matrix in vitro, as well as in lymphatic vessel sprouting assayed ex vivo. This is the first example of the complete inactivation of a single function of a multifunctional MMP and the use of this strategy to pursue its role.	[Madsen, Daniel H.; Melander, Maria C.; Gardsvoll, Henrik; Hoyer-Hansen, Gunilla; Engelholm, Lars H.; Behrendt, Niels] Rigshosp, Finsen Lab, BRIC, DK-2200 Copenhagen N, Denmark; [Ingvarsen, Signe] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Erpicum, Charlotte; Maertens, Ludovic; Noel, Agnes] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, B-4000 Liege, Belgium; [Holmbeck, Kenn] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	Rigshospitalet; University of Copenhagen; University of Liege; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Behrendt, N (corresponding author), Rigshosp, Finsen Lab, BRIC, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	niels.behrendt@finsenlab.dk	Ingvarsen, Signe Ziir/AAT-3296-2020	Madsen, Daniel Hargboel/0000-0002-3183-6201; Noel, Agnes/0000-0002-7670-6179; Engelholm, Lars/0000-0002-6616-1232; Ingvarsen, Signe Ziir/0000-0001-7800-6443; Behrendt, Niels/0000-0003-1833-3922	National Institutes of Health, NIDCR; Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium); Foundation against Cancer (Foundation of Public Interest, Belgium); Plan National Cancer (Service Public Federal, Belgium); European Community [201279]; "Grosserer Alfred Nielsen og Hustrus" Foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation [R118-2012-11578, R67-2010-6200] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002353] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000676] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Foundation against Cancer (Foundation of Public Interest, Belgium); Plan National Cancer (Service Public Federal, Belgium); European Community(European Commission); "Grosserer Alfred Nielsen og Hustrus" Foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NIDCR (to K. H.), the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer), the Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium), the Foundation against Cancer (Foundation of Public Interest, Belgium), the Plan National Cancer (Service Public Federal, Belgium), the European Community's Seventh Framework Programme FP7/2007-2011 under Grant Agreement n 201279 (to N.B., G. H.-H., and A.N.), and the "Grosserer Alfred Nielsen og Hustrus" Foundation (to L. H. E.). The work was also supported by personal grants from Copenhagen University Hospital (to A. P., D. H. M., and H.J.J.), from the Lundbeck Foundation (to D. H. M.) and from the University of Copenhagen, Faculty of Science (to S.I.).	Almholt K, 2008, MOL CANCER THER, V7, P2758, DOI 10.1158/1535-7163.MCT-08-0251; Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basu B, 2012, INT J BIOCHEM CELL B, V44, P393, DOI 10.1016/j.biocel.2011.11.015; Bigg HF, 2001, CANCER RES, V61, P3610; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Devy L, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/191670; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159; Evans BR, 2012, AM J HUM GENET, V91, P572, DOI 10.1016/j.ajhg.2012.07.022; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh T, 1998, CANCER RES, V58, P1048; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; List K, 1999, J IMMUNOL METHODS, V222, P125, DOI 10.1016/S0022-1759(98)00189-6; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Matsuo M, 2007, CANCER LETT, V251, P288, DOI 10.1016/j.canlet.2006.11.027; Mols J, 2005, IN VITRO CELL DEV-AN, V41, P83; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Naito S, 2012, BIOCHEMISTRY-US, V51, P8877, DOI 10.1021/bi301228d; Nakamura H, 1999, CANCER RES, V59, P467; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Polette M, 1996, VIRCHOWS ARCH, V428, P29; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Sounni NE, 2002, INT J CANCER, V98, P23, DOI 10.1002/ijc.10134; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Su JM, 2003, CANCER RES, V63, P600; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; TOKURAKU M, 1995, INT J CANCER, V64, P355, DOI 10.1002/ijc.2910640513; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; WINCHESTER P, 1969, AMER J ROENTGENOL RA, V106, P121, DOI 10.2214/ajr.106.1.121; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	53	44	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10195	10204		10.1074/jbc.M112.447169	http://dx.doi.org/10.1074/jbc.M112.447169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23413031	Green Published, hybrid			2022-12-25	WOS:000317565000002
J	Arai, Y; Totoki, Y; Takahashi, H; Nakamura, H; Hama, N; Kohno, T; Tsuta, K; Yoshida, A; Asamura, H; Mutoh, M; Hosoda, F; Tsuda, H; Shibata, T				Arai, Yasuhito; Totoki, Yasushi; Takahashi, Hiroyuki; Nakamura, Hiromi; Hama, Natsuko; Kohno, Takashi; Tsuta, Koji; Yoshida, Akihiko; Asamura, Hisao; Mutoh, Michihiro; Hosoda, Fumie; Tsuda, Hitoshi; Shibata, Tatsuhiro			Mouse Model for ROS1-Rearranged Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE; GENE FUSIONS; TARGETED THERAPY; ROS1; IDENTIFICATION; LANDSCAPE	Genetic rearrangement of the ROS1 receptor tyrosine kinase was recently identified as a distinct molecular signature for human non-small cell lung cancer (NSCLC). However, direct evidence of lung carcinogenesis induced by ROS1 fusion genes remains to be verified. The present study shows that EZR-ROS1 plays an essential role in the oncogenesis of NSCLC harboring the fusion gene. EZR-ROS1 was identified in four female patients of lung adenocarcinoma. Three of them were never smokers. Interstitial deletion of 6q22-q25 resulted in gene fusion. Expression of the fusion kinase in NIH3T3 cells induced anchorage-independent growth in vitro, and subcutaneous tumors in nude mice. This transforming ability was attributable to its kinase activity. The ALK/MET/ROS1 kinase inhibitor, crizotinib, suppressed fusion-induced anchorage-independent growth of NIH3T3 cells. Most importantly, established transgenic mouse lines specifically expressing EZR-ROS1 in lung alveolar epithelial cells developed multiple adenocarcinoma nodules in both lungs at an early age. These data suggest that the EZR-ROS1 is a pivotal oncogene in human NSCLC, and that this animal model could be valuable for exploring therapeutic agents against ROS1-rearranged lung cancer.	[Arai, Yasuhito; Totoki, Yasushi; Takahashi, Hiroyuki; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Tsuta, Koji; Yoshida, Akihiko; Tsuda, Hitoshi] Natl Canc Ctr, Div Pathol & Clin Labs, Chuo Ku, Tokyo, Japan; [Asamura, Hisao] Natl Canc Ctr, Thorac Surg Div, Chuo Ku, Tokyo, Japan; [Mutoh, Michihiro] Natl Canc Ctr, Res Inst, Div Canc Prevent Res, Chuo Ku, Tokyo 104, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Shibata, T (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan.	tashibat@ncc.go.jp	Mutoh, Michihiro/AAB-1868-2022; Shibata, Tatsuhiro/AAO-1278-2021; Shibata, Tatsuhiro/ABA-8234-2020	Arai, Yasuhito/0000-0001-6306-9409	Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, National Cancer Center Research and Development Fund [23-A-7, 23-B-28]; Research Grant of the Princess Takamatsu Cancer Research Fund; Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; National Cancer Center Research and Development Fund, Japan	Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, National Cancer Center Research and Development Fund; Research Grant of the Princess Takamatsu Cancer Research Fund; Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; National Cancer Center Research and Development Fund, Japan	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, National Cancer Center Research and Development Funds (23-A-7 and 23-B-28), Research Grant of the Princess Takamatsu Cancer Research Fund and Grants-in-Aid from the Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control. National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Birch AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028250; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Lovly CM, 2011, NAT REV CLIN ONCOL, V8, P68, DOI 10.1038/nrclinonc.2010.224; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Medves S, 2012, J CELL MOL MED, V16, P237, DOI 10.1111/j.1582-4934.2011.01415.x; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Mishra A, 2001, J BIOL CHEM, V276, P8453, DOI 10.1074/jbc.M009481200; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Park BS, 2009, BIOORG MED CHEM LETT, V19, P4720, DOI 10.1016/j.bmcl.2009.06.066; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Sasaki T, 2011, CLIN CANCER RES, V17, P7213, DOI 10.1158/1078-0432.CCR-11-1404; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Yoshida A, AM J SURG P IN PRESS; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Yoshikawa D, 2009, BRIT J CANCER, V100, P1257, DOI 10.1038/sj.bjc.6604988	32	47	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56010	10.1371/journal.pone.0056010	http://dx.doi.org/10.1371/journal.pone.0056010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418494	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300086
J	Broch, O; Gruenewald, M; Renner, J; Meybohm, P; Schottler, J; Hess, K; Steinfath, M; Bein, B				Broch, Ole; Gruenewald, Matthias; Renner, Jochen; Meybohm, Patrick; Schoettler, Jan; Hess, Katharina; Steinfath, Markus; Bein, Berthold			Dynamic and Volumetric Variables Reliably Predict Fluid Responsiveness in a Porcine Model with Pleural Effusion	PLOS ONE			English	Article							PULSE PRESSURE VARIATION; CHEST-WALL MECHANICS; END-DIASTOLIC VOLUME; HIGH-RISK SURGERY; CARDIAC PRELOAD; HOSPITAL STAY; LUNG; ESOPHAGEAL; MANAGEMENT; EXPANSION	Background: The ability of stroke volume variation (SVV), pulse pressure variation (PPV) and global end-diastolic volume (GEDV) for prediction of fluid responsiveness in presence of pleural effusion is unknown. The aim of the present study was to challenge the ability of SVV, PPV and GEDV to predict fluid responsiveness in a porcine model with pleural effusions. Methods: Pigs were studied at baseline and after fluid loading with 8 ml kg(-1) 6% hydroxyethyl starch. After withdrawal of 8 ml kg(-1) blood and induction of pleural effusion up to 50 ml kg(-1) on either side, measurements at baseline and after fluid loading were repeated. Cardiac output, stroke volume, central venous pressure (CVP) and pulmonary occlusion pressure (PAOP) were obtained by pulmonary thermodilution, whereas GEDV was determined by transpulmonary thermodilution. SVV and PPV were monitored continuously by pulse contour analysis. Results: Pleural effusion was associated with significant changes in lung compliance, peak airway pressure and stroke volume in both responders and non-responders. At baseline, SVV, PPV and GEDV reliably predicted fluid responsiveness (area under the curve 0.85 (p<0.001), 0.88 (p<0.001), 0.77 (p=0.007). After induction of pleural effusion the ability of SVV, PPV and GEDV to predict fluid responsiveness was well preserved and also PAOP was predictive. Threshold values for SVV and PPV increased in presence of pleural effusion. Conclusions: In this porcine model, bilateral pleural effusion did not affect the ability of SVV, PPV and GEDV to predict fluid responsiveness.	[Broch, Ole; Gruenewald, Matthias; Renner, Jochen; Steinfath, Markus; Bein, Berthold] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Schleswig Holstein, Germany; [Meybohm, Patrick] Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Hessen, Germany; [Schoettler, Jan] Univ Hosp Schleswig Holstein, Dept Cardiothorac & Vasc Surg, Schleswig Holstein, Germany; [Hess, Katharina] Univ Kiel, Schleswig Holstein, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Broch, O (corresponding author), Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Schleswig Holstein, Germany.	ole.broch@uksh.de	Gruenewald, Matthias/F-9485-2012; Meybohm, Patrick/K-4066-2017	Meybohm, Patrick/0000-0002-2666-8696; Hess, Katharina/0000-0003-3922-6413	Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig Holstein, Campus Kiel, Germany	Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig Holstein, Campus Kiel, Germany	The present study was supported by departmental funding only (Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig Holstein, Campus Kiel, Germany). There were no commercial funding sources supporting the submitted study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2003, CURR OPIN PULM MED, V9, P291, DOI 10.1097/00063198-200307000-00008; Balik M, 2006, INTENS CARE MED, V32, P318, DOI 10.1007/s00134-005-0024-2; Broch O, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.073; Cannesson M, 2011, CRIT CARE, V15, DOI 10.1186/cc10364; Cannesson M, 2011, ANESTHESIOLOGY, V115, P231, DOI 10.1097/ALN.0b013e318225b80a; De Backer D, 2005, INTENS CARE MED, V31, P517, DOI 10.1007/s00134-005-2586-4; De Backer D, 2009, ANESTHESIOLOGY, V110, P1092, DOI 10.1097/ALN.0b013e31819db2a1; de Waal EEC, 2009, CRIT CARE MED, V37, P510, DOI 10.1097/CCM.0b013e3181958bf7; DECHMAN G, 1993, EUR RESPIR J, V6, P219; Graf J, 2011, CRIT CARE MED, V39, P2294, DOI 10.1097/CCM.0b013e3182227bb5; Hadian M, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.08.018; Heenen S, 2006, CRIT CARE, V10, DOI 10.1186/cc4970; JACOB R, 1992, EUR HEART J, V13, P7, DOI 10.1093/eurheartj/13.suppl_E.7; Kumar A, 2004, CRIT CARE MED, V32, P691, DOI 10.1097/01.CCM.0000114996.68110.C9; Lopes MR, 2007, CRIT CARE, V11, DOI 10.1186/cc6117; Loring SH, 2010, J APPL PHYSIOL, V108, P515, DOI 10.1152/japplphysiol.00835.2009; Magder S, 2004, AM J RESP CRIT CARE, V169, P151, DOI 10.1164/rccm.200211-1360CC; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; Mayer J, 2010, CRIT CARE, V14, DOI 10.1186/cc8875; Michard F, 1999, AM J RESP CRIT CARE, V159, P935, DOI 10.1164/ajrccm.159.3.9805077; Michard F, 2003, CHEST, V124, P1900, DOI 10.1378/chest.124.5.1900; Nishida O, 1999, CRIT CARE MED, V27, P583, DOI 10.1097/00003246-199903000-00040; Osman D, 2007, CRIT CARE MED, V35, P64, DOI 10.1097/01.CCM.0000249851.94101.4F; Pearse R, 2005, CRIT CARE, V9, pR687, DOI 10.1186/cc3887; Pelosi P, 1996, CHEST, V109, P144, DOI 10.1378/chest.109.1.144; Peris A, 2010, ANESTH ANALG, V111, P687, DOI 10.1213/ANE.0b013e3181e7cc42; Pinsky MR, 2005, CHEST, V128, p592S, DOI 10.1378/chest.128.5_suppl_2.592S; Renner J, 2007, ANESTH ANALG, V105, P1243, DOI 10.1213/01.ane.0000281152.72734.d0; Renner J, 2009, CRIT CARE MED, V37, P650, DOI 10.1097/CCM.0b013e3181959864; Reuter DA, 2005, BRIT J ANAESTH, V94, P318, DOI 10.1093/bja/aei043; Rex S, 2007, ACTA ANAESTH SCAND, V51, P1258, DOI 10.1111/j.1399-6576.2007.01423.x; Rex S, 2004, BRIT J ANAESTH, V93, P782, DOI 10.1093/bja/aeh280; Rhodes A, 2010, INTENS CARE MED, V36, P1327, DOI 10.1007/s00134-010-1869-6; Sagrista-Sauleda J, 2008, CIRCULATION, V117, P1545, DOI 10.1161/CIRCULATIONAHA.107.737841; Sakka SG, 2000, INTENS CARE MED, V26, P180, DOI 10.1007/s001340050043; Talmor D, 2006, CRIT CARE MED, V34, P1389, DOI 10.1097/01.CCM.0000215515.49001.A2; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Trof RJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10062; VASKA K, 1992, CIRCULATION, V86, P609, DOI 10.1161/01.CIR.86.2.609	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56267	10.1371/journal.pone.0056267	http://dx.doi.org/10.1371/journal.pone.0056267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418546	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300139
J	Essabbani, A; Garcia, L; Zonetti, MJ; Fisco, T; Pucci, S; Chiocchia, G				Essabbani, Abdellatif; Garcia, Luis; Zonetti, Maria Jose; Fisco, Tommaso; Pucci, Sabina; Chiocchia, Gilles			Exon-Skipping Strategy by Ratio Modulation between Cytoprotective versus Pro-Apoptotic Clusterin Forms Increased Sensitivity of LNCaP to Cell Death	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; PROSTATE-CANCER; IN-VITRO; CLUSTERIN/APOLIPOPROTEIN-J; SULFATED GLYCOPROTEIN-2; NUCLEAR CLUSTERIN; OXIDATIVE STRESS; OVEREXPRESSION; EXPRESSION; PROTEIN	Background: In prostate cancer the secreted form of clusterin (sCLU) has been described as an anti-apoptotic protein whose expression is increased after therapeutic intervention, whereas, the nuclear protein form nCLU was reported to have pro-apoptotic properties. Methodology: In order to provide new therapeutic approaches targeting CLU, we developed a strategy based on exon skipping by using a lentiviral construct to preferentially induce the nuclear spliced form of the protein. The molecular construct was transduced in LNCaP cells for testing the modulation of sensitivity of the transduced cells to pro-apoptotic stress. Results and Conclusions: We showed an increase of nCLU/sCLU expression ratio in the prostate cancer cell line "LNCaP'' after lentiviral vector-U7 nCLU transduction. Moreover, we showed a significant inhibition of cell proliferation in nCLU-U7 LNCaP cells after treatment with cisplatin and after exposure to ionizing radiation compared to control cells. Finally, we showed that nCLU-U7 LNCaP cells exposure to UV-C significantly reduced an increase of cell death compared to control. Finally, we showed that modulating nCLU expression had profound impact on Ku70/Bax interaction as well as Rad17 expression which could be a key mechanism in sensitizing cells to cell death. In conclusion, this is the first report showing that increasing of nCLU/sCLU expression ratio by using an "on demand alternative splicing'' strategy successfully increased sensitivity to radiotherapy and chemotherapy of prostate cancer cells.	[Essabbani, Abdellatif; Chiocchia, Gilles] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Essabbani, Abdellatif; Chiocchia, Gilles] Univ Paris 05, CNRS, UMR 8104, Lab Excellence INFLAMEX, Paris, France; [Essabbani, Abdellatif; Garcia, Luis; Chiocchia, Gilles] Univ Versailles, F-78000 Versailles, France; [Garcia, Luis] Univ Paris 06, INSERM, Grp Hosp Pitie Salpetriere, UMR S 974,CNRS,UMR 7215,Inst Myol, Paris, France; [Zonetti, Maria Jose; Fisco, Tommaso; Pucci, Sabina] Univ Rome Tor Vergata Policlin, Dept Biopathol, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Rome Tor Vergata	Chiocchia, G (corresponding author), Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.	gilles.chiocchia@inserm.fr	García, Luis V/GQA-9712-2022; CHIOCCHIA, Gilles R/F-6287-2013	CHIOCCHIA, Gilles R/0000-0001-9973-0940; Pucci, Sabina/0000-0002-2418-6482; Zonetti, Maria Jose/0000-0002-5451-0626; Fisco, Tommaso/0000-0002-6687-3264	Inserm; CNRS; Societe Francaise de Rhumatologie; Arthritis Fondation Courtin; Association pour la Recherche sur le Cancer (ARC)	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Societe Francaise de Rhumatologie; Arthritis Fondation Courtin; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	The work was supported by Inserm and CNRS. This work was supported by grants from Societe Francaise de Rhumatologie, and Arthritis Fondation Courtin. A.E. was supported by Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016; Caccamo AE, 2005, CELL DEATH DIFFER, V12, P101, DOI 10.1038/sj.cdd.4401491; Caccamo AE, 2003, ANN NY ACAD SCI, V1010, P514, DOI 10.1196/annals.1299.095; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chung J, 2004, CANCER LETT, V203, P155, DOI 10.1016/j.canlet.2003.07.008; Essabbani A, 2010, J BIOL CHEM, V285, P4273, DOI 10.1074/jbc.C109.057133; Falgarone G, 2009, ADV CANCER RES, V104, P139, DOI 10.1016/S0065-230X(09)04008-1; FRENCH LE, 1994, J CLIN INVEST, V93, P877, DOI 10.1172/JCI117043; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Gleave M, 2005, WORLD J UROL, V23, P38, DOI 10.1007/s00345-004-0474-0; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Humphreys D, 1997, BIOCHEMISTRY-US, V36, P15233, DOI 10.1021/bi9703507; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Lee CH, 2002, UROLOGY, V60, P516, DOI 10.1016/S0090-4295(02)01806-X; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Markopoulou S, 2009, FEBS J, V276, P4208, DOI 10.1111/j.1742-4658.2009.07093.x; Miyake H, 2004, PROSTATE, V61, P318, DOI 10.1002/pros.20087; Park IS, 1999, J ENDOCRINOL, V162, P57, DOI 10.1677/joe.0.1620057; Rizzi F, 2008, J PHYSIOL PHARMACOL, V59, P265; SENSIBAR JA, 1995, CANCER RES, V55, P2431; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Trougakos IP, 2004, ANN NY ACAD SCI, V1019, P206, DOI 10.1196/annals.1297.033; Yang CR, 1999, NUCLEIC ACIDS RES, V27, P2165, DOI 10.1093/nar/27.10.2165; Zellweger T, 2002, CLIN CANCER RES, V8, P3276; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54920	10.1371/journal.pone.0054920	http://dx.doi.org/10.1371/journal.pone.0054920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418433	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300023
J	Ballarini, A; Segata, N; Huttenhower, C; Jousson, O				Ballarini, Annalisa; Segata, Nicola; Huttenhower, Curtis; Jousson, Olivier			Simultaneous Quantification of Multiple Bacteria by the BactoChip Microarray Designed to Target Species-Specific Marker Genes	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PHYLOGENETIC MICROARRAY; DIVERSITY; IDENTIFICATION; MICROBIOTA; VIRULENCE; DATABASE; EVOLUTION; SURFACES; STRAINS	Bacteria are ubiquitous throughout the environment, the most abundant inhabitants of the healthy human microbiome, and causal pathogens in a variety of diseases. Their identification in disease is often an essential step in rapid diagnosis and targeted intervention, particularly in clinical settings. At present, clinical bacterial detection and discrimination is primarily culture-based, requiring both time and microbiological expertise, especially for bacteria that are not easily cultivated. Higher-throughput molecular methods based on PCR amplification or, recently, microarrays are reaching the clinic as well. However, these methods are currently restricted to a small set of microbes or based on conserved phylogenetic markers such as the 16S rRNA gene, which are difficult to resolve at the species or strain levels. Here, we designed and experimentally validated the BactoChip, an oligonucleotide microarray for bacterial detection and quantification. The chip allows the culture-independent identification of bacterial species, also determining their relative abundances in complex communities as occur in the commensal microbiota or in clinical settings. The microarray successfully distinguished among bacterial species from 21 different genera using 60-mer probes targeting a novel set of in silico identified high-resolution marker genes. The BactoChip additionally proved accurate in determining species-level relative abundances over a 100-fold dynamic range in complex bacterial communities and with a low limit of detection (0.1%). In combination with the continually increasing number of sequenced bacterial genomes, future iterations of the technology could enable to highly accurate clinically-oriented tools for rapid assessment of bacterial community composition and relative abundances.	[Ballarini, Annalisa; Segata, Nicola; Jousson, Olivier] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Segata, Nicola; Huttenhower, Curtis] Harvard Univ, Dept Biostat, Boston, MA 02115 USA	University of Trento; Harvard University	Ballarini, A (corresponding author), Univ Trento, Ctr Integrat Biol, Trento, Italy.	ballarini@science.unitn.it	Segata, Nicola/AAB-2980-2019; Jousson, Olivier/S-4397-2019; Jousson, Olivier/N-7000-2013; Segata, Nicola/K-7240-2016	Jousson, Olivier/0000-0003-3344-7194; Segata, Nicola/0000-0002-1583-5794; Huttenhower, Curtis/0000-0002-1110-0096	Autonomous Province of Trento; Centre for Integrative Biology of the University of Trento; National Institutes of Health (NIH) [1RO1HG005969]; National Science Foundation (NSF) [DBI-1053486]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005969] Funding Source: NIH RePORTER	Autonomous Province of Trento(Autonomous Province of Trento); Centre for Integrative Biology of the University of Trento; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Progetti speciali PAT-CRS 2007" from the Autonomous Province of Trento (AB), by a startup grant from the Centre for Integrative Biology of the University of Trento (AB), and by National Institutes of Health (NIH) 1RO1HG005969 and National Science Foundation (NSF) DBI-1053486 (CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Andam CP, 2011, NAT REV MICROBIOL, V9, P543, DOI 10.1038/nrmicro2593; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Brenner D. J., 2005, PROTEOBACTERIA B; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Funke G, 2004, J CLIN MICROBIOL, V42, P4067, DOI 10.1128/JCM.42.9.4067-4071.2004; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Jackson DA, 1997, ECOLOGY, V78, P929; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Janse I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031958; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lin S, 2010, LANCET, V375, P178, DOI 10.1016/S0140-6736(09)61791-8; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lukjancenko O, 2010, COMM COM INF SC, V115, P165, DOI 10.1007/978-3-642-16750-8_15; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Murray PR, 2003, STORAGE SHELF LIFE S, V30, P2; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Relogio A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e51; Rigsbee L, 2011, FEMS MICROBIOL ECOL, V75, P332, DOI 10.1111/j.1574-6941.2010.01009.x; Sakamoto M, 2004, J MED MICROBIOL, V53, P563, DOI 10.1099/jmm.0.45576-0; Schutzer SE, 2005, PLOS MED, V2, P1242, DOI 10.1371/journal.pmed.0020337; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sharma R, 2005, CURR SCI INDIA, V89, P72; Slany M, 2010, CAN J MICROBIOL, V56, P1040, DOI 10.1139/W10-091; Takahashi T, 1999, INT J SYST BACTERIOL, V49, P725, DOI 10.1099/00207713-49-2-725; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	54	14	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55764	10.1371/journal.pone.0055764	http://dx.doi.org/10.1371/journal.pone.0055764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409037	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000022
J	Boon, CM; Ng, MH; Choo, YM; Mok, SL				Boon, Chee-Meng; Ng, Mei-Han; Choo, Yuen-May; Mok, Shiueh-Lian			Super, Red Palm and Palm Oleins Improve the Blood Pressure, Heart Size, Aortic Media Thickness and Lipid Profile in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; FATTY-ACIDS; OLIVE OIL; SODIUM; MEMBRANE; DIETS; SALT; ATHEROSCLEROSIS; CONSUMPTION; ACTIVATION	Background: Oleic acid has been shown to lower high blood pressure and provide cardiovascular protection. Curiosity arises as to whether super olein (SO), red palm olein (RPO) and palm olein (PO), which have high oleic acid content, are able to prevent the development of hypertension. Methodology/Principal Findings: Four-week-old male spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were fed 15% SO, RPO or PO supplemented diet for 15 weeks. After 15 weeks of treatment, the systolic blood pressure (SBP) of SHR treated with SO, RPO and PO were 158.4+/-5.0 mmHg (p<0.001), 178.9+/-2.7 mmHg (p<0.001) and 167.7+/-2.1 mmHg (p<0.001), respectively, compared with SHR controls (220.9+/-1.5 mmHg). Bradycardia was observed with SO and PO. In contrast, the SBP and heart rate of treated WKY rats were not different from those of WKY controls. The SO and PO significantly reduced the increased heart size and thoracic aortic media thickness observed in untreated SHR but RPO reduced only the latter. No such differences, however, were observed between the treated and untreated WKY rats. Oil Red O enface staining of thoracic-abdominal aorta did not show any lipid deposition in all treated rats. The SO and RPO significantly raised serum alkaline phosphatase levels in the SHR while body weight and renal biochemical indices were unaltered in both strains. Serum lipid profiles of treated SHR and WKY rats were unchanged, with the exception of a significant reduction in LDL-C level and total cholesterol/HDL ratio (atherogenic index) in SO and RPO treated SHR compared with untreated SHR. Conclusion: The SO, RPO and PO attenuate the rise in blood pressure in SHR, accompanied by bradycardia and heart size reduction with SO and PO, and aortic media thickness reduction with SO, RPO and PO. The SO and RPO are antiatherogenic in nature by improving blood lipid profiles in SHR.	[Boon, Chee-Meng; Mok, Shiueh-Lian] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Ng, Mei-Han; Choo, Yuen-May] Malaysian Palm Oil Board, Kajang, Selangor, Malaysia	Universiti Malaya; Malaysian Palm Oil Board	Mok, SL (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	josephinemok@um.edu.my	MOK, SHIUEH LIAN/B-9146-2010		University of Malaya [RG061/11BIO, PV059/2011B, PS188/2010B]	University of Malaya(Universiti Malaya)	This research was supported by the University of Malaya with research grants (RG061/11BIO, PV059/2011B and PS188/2010B) and a Fellowship Scheme (CMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Aguila MB, 2005, INT J CARDIOL, V100, P461, DOI 10.1016/j.ijcard.2004.12.008; Al-Saqer JM, 2004, FOOD CHEM, V85, P579, DOI 10.1016/j.foodchem.2003.08.003; Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747; AOKI K, 1972, JPN CIRCULATION J, V36, P539, DOI 10.1253/jcj.36.539; Bartolomucci F, 2011, AM J HYPERTENS, V24, P750, DOI 10.1038/ajh.2011.66; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bott-Flugel L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018048; Brodde OE, 1999, PHARMACOL REV, V51, P651; Carmosino M, 2011, PFLUG ARCH EUR J PHY, V462, P281, DOI 10.1007/s00424-011-0967-9; Choo YM, 1993, PALM OIL DEV, V19, P30; COTTRELL RC, 1991, AM J CLIN NUTR, V53, pS989, DOI 10.1093/ajcn/53.4.989Sb; DEEMS RO, 1994, J CLIN GASTROENTEROL, V18, P304, DOI 10.1097/00004836-199406000-00009; DINICOLANTONIO R, 1988, CLIN EXP PHARMACOL P, V15, P741; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; EDEM DO, 2002, PLANT FOOD HUM NUTR, V57, P319, DOI DOI 10.1023/A:1021828132707; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fife B, 2007, PALM OIL MIRACLE DIS, P73; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Frenoux JMR, 2001, J NUTR, V131, P39, DOI 10.1093/jn/131.1.39; Grassi G, 1998, J HYPERTENS, V16, P1979, DOI 10.1097/00004872-199816121-00019; Grundtman C., 2012, INFLAMMATION ATHEROS, VVol. 1, P133, DOI [10.1007/978-3-7091-0338-8_8, DOI 10.1007/978-3-7091-0338-8_8]; GRUNDY SM, 1990, J LIPID RES, V31, P1149; GRUNERT RR, 1950, J NUTR, V42, P609, DOI 10.1093/jn/42.4.609; Grynberg A, 2005, J HUM HYPERTENS, V19, pS25, DOI 10.1038/sj.jhh.1001957; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hozawa A, 2009, J HYPERTENS, V27, P237, DOI 10.1097/HJH.0b013e32832258c9; JESPERSEN LT, 1985, HYPERTENSION, V7, P734, DOI 10.1161/01.HYP.7.5.734; Kokkinos Peter, 2005, J Clin Hypertens (Greenwich), V7, P165, DOI 10.1111/j.1524-6175.2005.04079.x; KRISETHERTON PM, 1984, J NUTR, V114, P1675, DOI 10.1093/jn/114.9.1675; Loganathan R, 2008, PALM OIL DEV, V50, P16; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; Marque V, 1999, HYPERTENSION, V34, P415, DOI 10.1161/01.HYP.34.3.415; Martus W, 2005, AM J PHYSIOL-RENAL, V288, pF428, DOI 10.1152/ajprenal.00310.2004; Medeiros FJ, 2005, PROSTAG OTH LIPID M, V78, P231, DOI 10.1016/j.prostaglandins.2005.09.001; MENSINK RP, 1988, AM J CLIN NUTR, V47, P976, DOI 10.1093/ajcn/47.6.976; Mukherjee Sutapa, 2009, Journal of Human Ecology, V26, P197; Owu DU, 1998, ACTA TROP, V69, P65, DOI 10.1016/S0001-706X(97)00115-0; Perona JS, 2007, J GERONTOL A-BIOL, V62, P256, DOI 10.1093/gerona/62.3.256; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; ROMAN RJ, 1985, AM J PHYSIOL, V248, pF199, DOI 10.1152/ajprenal.1985.248.2.F199; RuizGutierrez V, 1997, J NUTR BIOCHEM, V8, P689, DOI 10.1016/S0955-2863(97)00120-4; Saleh FH, 2001, J PATHOL, V193, P415; Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1; Sarafidis P, 2010, J HYPERTENS, V28, pE508; Sarikonda KV, 2009, J AM SOC HYPERTENS, V3, P158, DOI 10.1016/j.jash.2009.02.003; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; SUNDRAM K, 1990, LIPIDS, V25, P187, DOI 10.1007/BF02535746; Takishita S, 1996, HYPERTENSION, V27, P90, DOI 10.1161/01.HYP.27.1.90; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; Thapa BR, 2007, INDIAN J PEDIATR, V74, P663, DOI 10.1007/s12098-007-0118-7; Thijssen MA, 2005, HANDB EXP PHARM, V170, P165; TOAL CB, 1983, AM J PHYSIOL, V245, P1081; TOBIAN L, 1991, HYPERTENSION, V17, pI52, DOI 10.1161/01.HYP.17.1_Suppl.I52; Udenfriend S., 1976, ILAR News, V19, pG1; Ward NC, 2004, FREE RADICAL BIO MED, V36, P226, DOI 10.1016/j.freeradbiomed.2003.10.021; WINTERNITZ SR, 1982, CLIN EXP HYPERTENS, V4, P751, DOI 10.3109/10641968209061611; Yang Q, 2005, MOL PHARMACOL, V68, P210, DOI 10.1124/mol.105.011692; Yen PL, 2010, NUTRITION, V26, P331, DOI 10.1016/j.nut.2009.04.020	61	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55908	10.1371/journal.pone.0055908	http://dx.doi.org/10.1371/journal.pone.0055908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409085	Green Submitted, gold, Green Published			2022-12-25	WOS:000315100000033
J	Rahman, S; Yamato, I; Saijo, S; Mizutani, K; Ishizuka-Katsura, Y; Ohsawa, N; Terada, T; Shirouzu, M; Yokoyama, S; Iwata, S; Murata, T				Rahman, Suhaila; Yamato, Ichiro; Saijo, Shinya; Mizutani, Kenji; Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi			Biochemical and Biophysical Properties of Interactions between Subunits of the Peripheral Stalk Region of Human V-ATPase	PLOS ONE			English	Article							YEAST VACUOLAR ATPASE; N-TERMINAL DOMAIN; H+-ATPASE; A(1)A(0)-ATP SYNTHASE; STATOR COMPLEX; STOICHIOMETRY; LOCALIZATION; ACIDIFICATION; PURIFICATION; MUTATIONS	Peripheral stalk subunits of eukaryotic or mammalian vacuolar ATPases (V-ATPases) play key roles in regulating its assembly and disassembly. In a previous study, we purified several subunits and their isoforms of the peripheral stalk region of Homo sapiens (human) V-ATPase; such as C1, E1G1, H, and the N-terminal cytoplasmic region of V-o, a1. Here, we investigated the in vitro binding interactions of the subunits at the stalk region and measured their specific affinities. Surface plasmon resonance experiments revealed that the subunit C1 binds the E1G1 heterodimer with both high and low affinities (2.8 nM and 1.9 mu M, respectively). In addition, an E1G1-H complex can be formed with high affinity (48 nM), whereas affinities of other subunit pairs appeared to be low (similar to 0.21-23.0 mu M). The putative ternary complex of C1-H-E1G1 was not much strong on co-incubation of these subunits, indicating that the two strong complexes of C1-E1G1 and H-E1G1 in cooperation with many other weak interactions may be sufficiently strong enough to withstand the torque of rotation during catalysis. We observed a partially stable quaternary complex (consisting of E1G1, C1, a1(NT), and H subunits) resulting from discrete peripheral subunit interactions stabilizing the complex through their intrinsic affinities. No binding was observed in the absence of E1G1 (using only H, C1, and a1(NT)); therefore, it is likely that, in vivo, the E1G1 heterodimer has a significant role in the initiation of subunit assembly. Multiple interactions of variable affinity in the stalk region may be important to the mechanism of reversible dissociation of the intact V-ATPase.	[Rahman, Suhaila; Yamato, Ichiro; Saijo, Shinya; Mizutani, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Saijo, Shinya] RIKEN SPring 8, Harima Science City, Hyogo, Japan; [Mizutani, Kenji; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan; [Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Iwata, So] Kyoto Univ, Fac Med, Dept Cell Biol, Kyoto, Japan; [Murata, Takeshi] JST, PRESTO, Chiba, Japan	Tokyo University of Science; RIKEN; Chiba University; RIKEN; University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Rahman, S (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan.	srahman@rs.tus.ac.jp	Murata, Takeshi/J-6181-2017; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Murata, Takeshi/0000-0002-5748-4670; Yokoyama, Shigeyuki/0000-0003-3133-7338; 	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT; Biotechnology and Biological Sciences Research Council [BBS/B/06458] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Targeted Proteins Research Program (T. M., S. I. and S.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and by Special Coordination Funds for Promoting Science and Technology (T. M.) from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster A, 2004, FEBS LETT, V570, P119, DOI 10.1016/j.febslet.2004.06.029; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hahn H, 2003, AM J KIDNEY DIS, V41, P238, DOI 10.1053/ajkd.2003.50014; Hildenbrand ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012588; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kish-Trier E, 2009, J BIOL CHEM, V284, P12031, DOI 10.1074/jbc.M808962200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rahman S, 2011, ANAL BIOCHEM, V418, P301, DOI 10.1016/j.ab.2011.07.009; Rahman S, 2011, PROTEIN EXPRES PURIF, V78, P181, DOI 10.1016/j.pep.2011.02.012; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	38	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55704	10.1371/journal.pone.0055704	http://dx.doi.org/10.1371/journal.pone.0055704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409023	Green Published, Green Submitted, gold			2022-12-25	WOS:000315100000021
J	Rao, SS; Mohan, KVK; Atreya, CD				Rao, Shilpakala Sainath; Mohan, Ketha V. K.; Atreya, Chintamani D.			A Peptide Derived from Phage Display Library Exhibits Antibacterial Activity against E. coli and Pseudomonas aeruginosa	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; POSITIVELY CHARGED RESIDUES; ESCHERICHIA-COLI; BIOLOGICAL-ACTIVITY; PROTEIN DOCKING; NET CHARGE; HYDROPHOBICITY; ANTIBIOTICS; DISCOVERY; MEMBRANE	Emergence of drug resistant strains to currently available antibiotics has resulted in the quest for novel antimicrobial agents. Antimicrobial peptides (AMPs) are receiving attention as alternatives to antibiotics. In this study, we used phage-display random peptide library to identify peptides binding to the cell surface of E. coli. The peptide with sequence RLLFRKIRRLKR (EC5) bound to the cell surface of E. coli and exhibited certain features common to AMPs and was rich in Arginine and Lysine residues. Antimicrobial activity of the peptide was tested in vitro by growth inhibition assays and the bacterial membrane permeabilization assay. The peptide was highly active against Gram-negative organisms and showed significant bactericidal activity against E. coli and P. aeruginosa resulting in a reduction of 5 log(10) CFU/ml. In homologous plasma and platelets, incubation of EC5 with the bacteria resulted in significant reduction of E. coli and P. aeruginosa, compared to the peptide-free controls. The peptide was non-hemolytic and non-cytotoxic when tested on eukaryotic cells in culture. EC5 was able to permeabilize the outer membrane of E. coli and P. aeruginosa causing rapid depolarization of cytoplasmic membrane resulting in killing of the cells at 5 minutes of exposure. The secondary structure of the peptide showed a a-helical conformation in the presence of aqueous environment. The bacterial lipid interaction with the peptide was also investigated using Molecular Dynamic Simulations. Thus this study demonstrates that peptides identified to bind to bacterial cell surface through phage-display screening may additionally aid in identifying and developing novel antimicrobial peptides.	[Rao, Shilpakala Sainath; Mohan, Ketha V. K.; Atreya, Chintamani D.] US FDA, Sect Cell Biol, Lab Cellular Hematol, Div Hematol,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Mohan, KVK (corresponding author), US FDA, Sect Cell Biol, Lab Cellular Hematol, Div Hematol,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	krishna.ketha@fda.hhs.gov; chintamani.atreya@fda.hhs.gov	Rao, Shilpakala Sainath/AAQ-8394-2021		Center for Biologics Evaluation and Research (CBER)	Center for Biologics Evaluation and Research (CBER)	SSR is a recipient of a postdoctoral fellowship at the Center for Biologics Evaluation and Research (CBER) administered by the Oak Ridge Institute for Science and Education (ORISE) through an intra -agency agreement between the U. S. Department of Energy and the U. S. Food and Drug Administration. Review of the manuscript by Drs. Salim Haddad and Xuan Chi, CBER is highly appreciated. The findings and conclusions in this report have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.	ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Azad MA, 2011, ANTIMICROB AGENTS CH, V55, P2137, DOI 10.1128/AAC.01148-10; Bishop-Hurley SL, 2010, PROTEIN ENG DES SEL, V23, P751, DOI 10.1093/protein/gzq050; Bishop-Hurley SL, 2005, ANTIMICROB AGENTS CH, V49, P2972, DOI 10.1128/AAC.49.7.2972-2978.2005; Bishop-Hurley SL, 2002, APPL ENVIRON MICROB, V68, P3315, DOI 10.1128/AEM.68.7.3315-3320.2002; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chen PW, 2003, AM J VET RES, V64, P1088, DOI 10.2460/ajvr.2003.64.1088; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fang ZD, 2006, P NATL ACAD SCI USA, V103, P18444, DOI 10.1073/pnas.0605542103; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hadley EB, 2010, CURR TOP MED CHEM, V10, P1872; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jiang ZQ, 2008, CHEM BIOL DRUG DES, V72, P483, DOI 10.1111/j.1747-0285.2008.00728.x; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Jiang ZQ, 2009, ADV EXP MED BIOL, V611, P561, DOI 10.1007/978-0-387-73657-0_246; Kay BK, 2001, METHODS, V24, P240, DOI 10.1006/meth.2001.1185; Kay Brian K, 2003, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1704s17; Knurr J, 2003, APPL ENVIRON MICROB, V69, P6841, DOI 10.1128/AEM.69.11.6841-6847.2003; Lin KC, 2012, APPL MICROBIOL BIOT, V94, P755, DOI 10.1007/s00253-011-3857-3; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mohan KVK, 2010, TRANSFUSION, V50, P166, DOI 10.1111/j.1537-2995.2009.02376.x; Mukhija S, 1997, MOL MICROBIOL, V25, P1159, DOI 10.1046/j.1365-2958.1997.5501910.x; Pathak S, 2011, ANTIMICROB AGENTS CH, V55, P2178, DOI 10.1128/AAC.01493-10; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Rao SS, 2013, MICROBIOL RES, V168, P106, DOI 10.1016/j.micres.2012.07.004; Rao SS, 2010, BIOCHEM BIOPH RES CO, V395, P93, DOI 10.1016/j.bbrc.2010.03.145; Rathinakumar R, 2010, FASEB J, V24, P3232, DOI 10.1096/fj.10-157040; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rishi P, 2011, ANTIMICROB AGENTS CH, V55, P4176, DOI 10.1128/AAC.00273-11; Sainathrao S, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-67; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Shepherd CM, 2001, BIOPHYS J, V80, P579, DOI 10.1016/S0006-3495(01)76039-0; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; Tachi T, 2002, BIOCHEMISTRY-US, V41, P10723, DOI 10.1021/bi0256983; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaara M, 2008, ANTIMICROB AGENTS CH, V52, P3229, DOI 10.1128/AAC.00405-08; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yount NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026727; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	57	27	33	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56081	10.1371/journal.pone.0056081	http://dx.doi.org/10.1371/journal.pone.0056081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409125	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000043
J	Seyedarabi, A; Cheng, LL; Zachary, I; Djordjevic, S				Seyedarabi, Arefeh; Cheng, Lili; Zachary, Ian; Djordjevic, Snezana			Production of Soluble Human Vascular Endothelial Growth Factor VEGF-A(165)-Heparin Binding Domain in Escherichia coli	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; GENE-PRODUCT; NEUROPILIN-1; RECEPTOR; HEPARIN; OVEREXPRESSION; CYTOPLASM; VEGF(165); PROTEINS; AFFINITY	We report a method for production of soluble heparin binding domain (HBD) of human vascular endothelial growth factor VEGF-A(165). Recombinant VEGF-A(165)-HBD that contains four disulphide bridges was expressed in specialised E. coli SHuffle cells and its activity has been confirmed through interactions with neuropilin and heparin. The ability to produce significant quantities of a soluble active form of VEGF-A(165)-HBD will enable further studies addressing the role of VEGF-A in essential processes such as angiogenesis, vasculogenesis and vascular permeability.	[Seyedarabi, Arefeh; Djordjevic, Snezana] UCL, Inst Struct & Mol Biol, London, England; [Cheng, Lili] Ark Therapeut Ltd, London, England; [Cheng, Lili; Zachary, Ian] UCL, British Heart Fdn Labs, Ctr Cardiovasc Biol & Med, London, England	University of London; Birkbeck University London; University College London; University of London; University College London	Djordjevic, S (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	s.djordjevic@ucl.ac.uk			British Heart Foundation [PG/10/52/28448]; British Heart Foundation [RG/11/11/29050, RG/06/003/21131] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by funding from the British Heart Foundation (AS, SD, IZ) PG/10/52/28448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Christinger HW, 1996, PROTEINS, V26, P353, DOI 10.1002/(SICI)1097-0134(199611)26:3<353::AID-PROT9>3.0.CO;2-E; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Fuh G, 2000, J BIOL CHEM, V275, P26690; Geretti E, 2007, J BIOL CHEM, V282, P25698, DOI 10.1074/jbc.M702942200; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Jeong KW, 2011, BIOCHEMISTRY-US, V50, P4843, DOI 10.1021/bi2000752; Jia H, 2010, BRIT J CANCER, V102, P541, DOI 10.1038/sj.bjc.6605539; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kong JS, 2010, ARTHRITIS RHEUM-US, V62, P179, DOI 10.1002/art.27243; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Levy R, 2001, PROTEIN EXPRES PURIF, V23, P338, DOI 10.1006/prep.2001.1520; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Pace N. C., 1995, PROTEIN SCI, V4, P2411; Parker MW, 2012, J BIOL CHEM, V287, P11082, DOI 10.1074/jbc.M111.331140; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; SEIDEL HM, 1992, BIOCHEMISTRY-US, V31, P2598, DOI 10.1021/bi00124a021; TISCHER E, 1991, J BIOL CHEM, V266, P11947	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55690	10.1371/journal.pone.0055690	http://dx.doi.org/10.1371/journal.pone.0055690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409021	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300029
J	Zhang, QB; Sun, HC; Zhang, KZ; Jia, QA; Bu, Y; Wang, M; Chai, ZT; Zhang, QB; Wang, WQ; Kong, LQ; Zhu, XD; Lu, L; Wu, WZ; Wang, L; Tang, ZY				Zhang, Qiang-Bo; Sun, Hui-Chuan; Zhang, Ke-Zhi; Jia, Qing-An; Bu, Yang; Wang, Miao; Chai, Zong-Tao; Zhang, Quan-Bao; Wang, Wen-Quan; Kong, Ling-Qun; Zhu, Xiao-dong; Lu, Lu; Wu, Wei-Zhong; Wang, Lu; Tang, Zhao-You			Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; LIVER-CANCER; LYMPHOCYTES; ACTIVATION; SUNITINIB; RECEPTOR; MOBILIZATION; PROGRESSION; PATHWAY; TRIGGER	Sorafenib, a multi-tyrosine kinase inhibitor, is a standard treatment for advanced hepatocellular carcinoma (HCC). The present study was undertaken to determine whether the growth and metastasis of HCC were influenced in mice receiving sorafenib prior to implantation with tumors, and to investigate the in-vivo and in-vitro effect of sorafenib on natural killer (NK) cells. In sorafenib-pretreated BALB/c nu/nu mice and C57BL/6 mice, tumor growth was accelerated, mouse survival was decreased, and lung metastasis was increased. However, the depletion of NK1.1(+) cells in C57BL/6 mice eliminated sorafenib-mediated pro-metastatic effects. Sorafenib significantly reduced the number of NK cells and inhibited reactivity of NK cells against tumor cells, in both tumor-bearing and tumor-free C57BL/6 mice. Sorafenib down-regulated the stimulatory receptor CD69 in NK cells of tumor-bearing mice, but not in tumor-free mice, and inhibited proliferation of NK92-MI cells, which is associated with the blocking of the PI3K/AKT pathway, and inhibited cytotoxicity of NK cells in response to tumor targets, which was due to impaired ERK phosphorylation. These results suggest immunotherapeutic approaches activating NK cells may enhance the therapeutic efficacy of sorafenib in HCC patients.	[Tang, Zhao-You] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Liver Canc Inst, Shanghai, Peoples R China; Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Zhongshan Hosp, Shanghai, Peoples R China	Fudan University; Fudan University	Tang, ZY (corresponding author), Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Liver Canc Inst, Shanghai, Peoples R China.	zytang88@163.com	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [8102010802, 811018715, 81020108025, 81101871, 81101564]; National Key Project for Infectious Diseases [2012ZX10002012-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Infectious Diseases	This work was supported jointly by the National Natural Science Foundation of China (No. 8102010802, 811018715, 81020108025, 81101871, 81101564), the National Key Project for Infectious Diseases (2012ZX10002012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Andrews P, 2008, CANCER CHEMOTH PHARM, V61, P203, DOI 10.1007/s00280-007-0462-3; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Cao M, 2011, LAB INVEST; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiu TL, 2009, INT J ONCOL, V35, P1361, DOI 10.3892/ijo_00000454; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson P, 2009, LANCET ONCOL, V10, P4, DOI 10.1016/S1470-2045(08)70317-6; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Krusch M, 2009, J IMMUNOL, V183, P8286, DOI 10.4049/jimmunol.0902404; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393; Nokihara H, 2000, CANCER RES, V60, P7002; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Palmer DH, 2008, NEW ENGL J MED, V359, P2498; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shao YY, 2011, ONCOLOGIST, V16, P82, DOI 10.1634/theoncologist.2010-0272; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Taguchi Y, 2004, BLOOD, V104, P3285, DOI 10.1182/blood-2004-03-0900; Tai WT, 2011, J HEPATOL, V55, P1041, DOI 10.1016/j.jhep.2011.06.005; Trotta R, 1998, J IMMUNOL, V161, P6648; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wai LE, 2008, TRANSPLANTATION, V85, P145, DOI 10.1097/01.tp.0000296817.28053.7b; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Wei S, 2000, J IMMUNOL, V165, P3811, DOI 10.4049/jimmunol.165.7.3811; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yang BW, 2008, EUR J GASTROEN HEPAT, V20, P1077, DOI 10.1097/MEG.0b013e3283050a67; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao W, 2008, LEUKEMIA, V22, P1226, DOI 10.1038/leu.2008.58; Zimmer J, 2005, LEUKEMIA, V19, P1849, DOI 10.1038/sj.leu.2403906	40	37	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55945	10.1371/journal.pone.0055945	http://dx.doi.org/10.1371/journal.pone.0055945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409093	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300047
J	Cuerrier, CM; Chen, YX; Tremblay, D; Rayner, K; McNulty, M; Zhao, XL; Kennedy, CRJ; de BelleRoche, J; Pelling, AE; O'Brien, ER				Cuerrier, Charles M.; Chen, Yong-Xiang; Tremblay, Dominique; Rayner, Katey; McNulty, Melissa; Zhao, XiaoLing; Kennedy, Christopher R. J.; de BelleRoche, Jacqueline; Pelling, Andrew E.; O'Brien, Edward R.			Chronic Over-Expression of Heat Shock Protein 27 Attenuates Atherogenesis and Enhances Plaque Remodeling: A Combined Histological and Mechanical Assessment of Aortic Lesions	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; HEAT-SHOCK-PROTEIN-27; ATHEROSCLEROSIS; APOPTOSIS; ARTERIES; HSP27	Aims: Expression of Heat Shock Protein-27 (HSP27) is reduced in human coronary atherosclerosis. Over-expression of HSP27 is protective against the early formation of lesions in atherosclerosis-prone apoE(-/-) mice (apoE(-/-) HSP27(o/e)) - however, only in females. We now seek to determine if chronic HSP27 over-expression is protective in a model of advanced atherosclerosis in both male and female apoE(-/-) mice. Methods and Results: After 12 weeks on a high fat diet, serum HSP27 levels rose more than 16-fold in male and female apoE(-/-) HSP27(o/e) mice, although females had higher levels than males. Relative to apoE(-/-) mice, female apoE(-/-) HSP27(o/e) mice showed reductions in aortic lesion area of 35% for en face and 30% for cross-sectional sinus tissue sections - with the same parameters reduced by 21% and 24% in male cohorts; respectively. Aortic plaques from apoE(-/-) HSP27(o/e) mice showed almost 50% reductions in the area occupied by cholesterol clefts and free cholesterol, with fewer macrophages and reduced apoptosis but greater intimal smooth muscle cell and collagen content. The analysis of the aortic mechanical properties showed increased vessel stiffness in apoE(-/-) HSP27(o/e) mice (41% in female, 34% in male) compare to apoE(-/-) counterparts. Conclusions: Chronic over-expression of HSP27 is atheroprotective in both sexes and coincides with reductions in lesion cholesterol accumulation as well as favorable plaque remodeling. These data provide new clues as to how HSP27 may improve not only the composition of atherosclerotic lesions but potentially their stability and resilience to plaque rupture.	[Cuerrier, Charles M.; Chen, Yong-Xiang; Rayner, Katey; McNulty, Melissa; Zhao, XiaoLing; O'Brien, Edward R.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Cuerrier, Charles M.; Tremblay, Dominique; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ctr Interdisciplinary NanoPhys, Ottawa, ON K1N 6N5, Canada; [Kennedy, Christopher R. J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Kennedy, Christopher R. J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [de BelleRoche, Jacqueline] Univ London Imperial Coll Sci Technol & Med, London, England; [Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada; [O'Brien, Edward R.] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; University of Ottawa; Imperial College London; University of Ottawa; University of Ottawa; Libin Cardiovascular Institute Of Alberta	O'Brien, ER (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	ed.obrien@albertahealthservices.ca	O'Brien, Edward R/J-6621-2013	O'Brien, Edward R/0000-0003-1039-9425; Rayner, Katey/0000-0001-6230-426X; Pelling, Andrew/0000-0003-3732-7472	Canadian Institute for Health Research (CIHR) [MOP80204]; Heart and Stroke Foundation of Ontario [T6335]; Fonds de Recherche en Sante du Quebec (FRSQ); Ernest and Margaret Ford cardiology endowed research fellowship from the University of Ottawa Heart Institute; Fonds de Recherche du Quebec- Nature et Technologies (FQRNT); MITACS Elevate Strategic Fellowship; Heart and Stroke Foundation of Ontario; CIHR's Institute of Gender and Health; Ontario Women's Health Council; Natural Sciences and Engineering Research Council (NSERC) Discovery Grant, an NSERC Discovery Accelerator Supplement; Canada Research Chairs (CRC) program; Early Researcher Award from the Province of Ontario	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Ernest and Margaret Ford cardiology endowed research fellowship from the University of Ottawa Heart Institute; Fonds de Recherche du Quebec- Nature et Technologies (FQRNT)(FQRNT); MITACS Elevate Strategic Fellowship; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); CIHR's Institute of Gender and Health(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council; Natural Sciences and Engineering Research Council (NSERC) Discovery Grant, an NSERC Discovery Accelerator Supplement(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) program(Canada Research Chairs); Early Researcher Award from the Province of Ontario	This work was supported by operating grants MOP80204 from the Canadian Institute for Health Research (CIHR) and T6335 from the Heart and Stroke Foundation of Ontario. CMC was supported by a postdoctoral studentship from le Fonds de Recherche en Sante du Quebec (FRSQ) and the Ernest and Margaret Ford cardiology endowed research fellowship from the University of Ottawa Heart Institute. DT was supported by a postdoctoral studentship from le Fonds de Recherche du Quebec- Nature et Technologies (FQRNT) and a MITACS Elevate Strategic Fellowship. KR was supported by studentships from both the Heart and Stroke Foundation of Ontario and the CIHR's Institute of Gender and Health in collaboration with the Ontario Women's Health Council. AEP is funded by the Natural Sciences and Engineering Research Council (NSERC) Discovery Grant, an NSERC Discovery Accelerator Supplement and gratefully acknowledges the support of the Canada Research Chairs (CRC) program and an Early Researcher Award from the Province of Ontario. The CIHR and Medtronic collectively provide EOB with a peer-reviewed Research Chair (URC #57093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chen YX, 2004, CIRCULATION, V110, P3721, DOI 10.1161/01.CIR.0000146790.51331.BA; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Harrington SC, 2007, CIRC RES, V100, P1696, DOI 10.1161/CIRCRESAHA.106.146183; Henderson B, 2009, CELL STRESS CHAPERON, V14, P329, DOI 10.1007/s12192-008-0087-4; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KRUTH HS, 1984, AM J PATHOL, V114, P201; Labinaz M, 1999, CARDIOVASC RES, V41, P255, DOI 10.1016/S0008-6363(98)00203-X; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Raizman JE, 2012, ARTERIOSCLER THROMB, V32, pA544; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Rayner K, 2008, J STEROID BIOCHEM, V108, P72, DOI 10.1016/j.jsbmb.2007.07.006; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rekhter MD, 1996, CARDIOVASC RES, V32, P496, DOI 10.1016/S0008-6363(96)00097-1; Rippstein P, 2006, J HISTOCHEM CYTOCHEM, V54, P673, DOI 10.1369/jhc.5A6824.2006; Salari S, 2012, CELL STRESS IN PRESS; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tremblay D, 2009, ANN THORAC SURG, V88, P1484, DOI 10.1016/j.athoracsur.2009.07.023	23	28	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55867	10.1371/journal.pone.0055867	http://dx.doi.org/10.1371/journal.pone.0055867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409070	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200079
J	Lan, YY; Yeh, TH; Lin, WH; Wu, SY; Lai, HC; Chang, FH; Takada, K; Chang, Y				Lan, Yu-Yan; Yeh, Tzu-Hao; Lin, Wei-Hung; Wu, Shih-Yi; Lai, Hsiao-Ching; Chang, Fang-Hsin; Takada, Kenzo; Chang, Yao			Epstein-Barr Virus Zta Upregulates Matrix Metalloproteinases 3 and 9 That Synergistically Promote Cell Invasion In Vitro	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; GENOME INSTABILITY; C-FOS; EXPRESSION; GENE; PROTEIN; MATRIX-METALLOPROTEINASE-9; BZLF1; EBV; INDUCTION	Zta is a lytic transactivator of Epstein-Barr virus (EBV) and has been shown to promote migration and invasion of epithelial cells. Although previous studies indicate that Zta induces expression of matrix metalloproteinase (MMP) 9 and MMP1, direct evidence linking the MMPs to Zta-induced cell migration and invasion is still lacking. Here we performed a series of in vitro studies to re-examine the expression profile and biologic functions of Zta-induced MMPs in epithelial cells derived from nasopharyngeal carcinoma. We found that, in addition to MMP9, MMP3 was a new target gene upregulated by Zta. Ectopic Zta expression in EBV-negative cells increased both mRNA and protein production of MMP3. Endogenous Zta also contributed to induction of MMP3 expression, migration and invasion of EBV-infected cells. Zta activated the MMP3 promoter through three AP-1 elements, and its DNA-binding domain was required for the promoter binding and MMP3 induction. We further tested the effects of MMP3 and MMP9 on cell motility and invasiveness in vitro. Zta-promoted cell migration required MMP3 but not MMP9. On the other hand, both MMP3 and MMP9 were essential for Zta-induced cell invasion, and co-expression of the two MMPs synergistically increased cell invasiveness. Therefore, this study provides integrated evidence demonstrating that, at least in the in vitro cell models, Zta drives cell migration and invasion through MMPs.	[Lan, Yu-Yan; Yeh, Tzu-Hao; Lin, Wei-Hung; Wu, Shih-Yi; Lai, Hsiao-Ching; Chang, Fang-Hsin; Chang, Yao] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Lan, Yu-Yan; Lai, Hsiao-Ching; Chang, Yao] Natl Cheng Kung Univ, Med Coll & Hosp, Grad Inst Basic Med Sci, Tainan 70101, Taiwan; [Yeh, Tzu-Hao; Lin, Wei-Hung; Chang, Fang-Hsin; Chang, Yao] Natl Cheng Kung Univ, Med Coll & Hosp, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Dept Tumor Virol, Sapporo, Hokkaido, Japan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; Hokkaido University	Chang, Y (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan.	yaochang@nhri.org.tw	Lin, Wei-Hung/ABE-1927-2021; Chang, Yao/B-2653-2010	Lan, Yu-Yan/0000-0003-4436-2057	National Health Research Institutes, Taiwan [ID-099-PP-16, ID-100-PP-16, IV-101-PP-18, IV-102-PP-19]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by the National Health Research Institutes, Taiwan (ID-099-PP-16, ID-100-PP-16, IV-101-PP-18 and IV-102-PP-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANCO SC, 1983, CANCER RES, V43, P1703; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; BOUVIER G, 1995, CARCINOGENESIS, V16, P1879, DOI 10.1093/carcin/16.8.1879; Bu XM, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/214269; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; COCHET C, 1993, VIROLOGY, V197, P358, DOI 10.1006/viro.1993.1597; Couillard J, 2006, BIOCHEM BIOPH RES CO, V342, P1233, DOI 10.1016/j.bbrc.2006.02.068; DEVATHAIRE F, 1988, INT J CANCER, V42, P176, DOI 10.1002/ijc.2910420206; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Fauquier L, 2008, FASEB J, V22, P3337, DOI 10.1096/fj.07-104604; FLEMINGTON E, 1990, J VIROL, V64, P4549, DOI 10.1128/JVI.64.9.4549-4552.1990; FLEMINGTON EK, 1994, MOL CELL BIOL, V14, P3041, DOI 10.1128/MCB.14.5.3041; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; GROGAN E, 1987, P NATL ACAD SCI USA, V84, P1332, DOI 10.1073/pnas.84.5.1332; HENLE W, 1977, INT J CANCER, V20, P663, DOI 10.1002/ijc.2910200504; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Hsu M, 2008, J VIROL, V82, P3679, DOI 10.1128/JVI.02301-07; Huang SY, 2012, J GEN VIROL, V93, P139, DOI 10.1099/vir.0.034405-0; Huang SY, 2010, CHEM-BIOL INTERACT, V188, P623, DOI 10.1016/j.cbi.2010.09.020; Hung WC, 2010, CANCER LETT, V288, P156, DOI 10.1016/j.canlet.2009.06.032; Inoue K, 2000, CANCER RES, V60, P2290; JOAB I, 1991, INT J CANCER, V48, P647, DOI 10.1002/ijc.2910480503; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KOUZARIDES T, 1991, ONCOGENE, V6, P195; Lan YY, 2012, J VIROL, V86, P6656, DOI 10.1128/JVI.00174-12; Lee CH, 2011, J VIROL, V85, P7333, DOI 10.1128/JVI.00182-11; Lee DCW, 2007, BIOMED PHARMACOTHER, V61, P520, DOI 10.1016/j.biopha.2007.08.007; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Lu J, 2000, J VIROL, V74, P7391, DOI 10.1128/JVI.74.16.7391-7399.2000; Lu J, 2003, CANCER RES, V63, P256; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Mahot S, 2003, J GEN VIROL, V84, P965, DOI 10.1099/vir.0.18845-0; MARTELRENOIR D, 1995, J GEN VIROL, V76, P1401, DOI 10.1099/0022-1317-76-6-1401; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Mendes O, 2005, CLIN EXP METASTAS, V22, P237, DOI 10.1007/s10585-005-8115-6; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; RHEINWALD JG, 1981, CANCER RES, V41, P1657; ROONEY CM, 1989, J VIROL, V63, P3109, DOI 10.1128/JVI.63.7.3109-3116.1989; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SHAO YM, 1988, CARCINOGENESIS, V9, P1455, DOI 10.1093/carcin/9.8.1455; Sheu BC, 2001, CANCER RES, V61, P237; Shih WL, 2008, CANCER LETT, V270, P202, DOI 10.1016/j.canlet.2008.05.005; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; YIP TTC, 1994, CANCER, V74, P2414, DOI 10.1002/1097-0142(19941101)74:9<2414::AID-CNCR2820740905>3.0.CO;2-8; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Yoshizaki T, 1999, CLIN EXP METASTAS, V17, P431, DOI 10.1023/A:1006699003525; Yu FL, 2005, J HEPATOL, V42, P520, DOI 10.1016/j.jhep.2004.11.031; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zang XP, 2006, ANTICANCER RES, V26, P961	67	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56121	10.1371/journal.pone.0056121	http://dx.doi.org/10.1371/journal.pone.0056121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409137	gold, Green Submitted, Green Published			2022-12-25	WOS:000315157200111
J	Loov, C; Shevchenko, G; Nadadhur, AG; Clausen, F; Hillered, L; Wetterhall, M; Erlandsson, A				Loov, Camilla; Shevchenko, Ganna; Nadadhur, Aishwarya Geeyarpuram; Clausen, Fredrik; Hillered, Lars; Wetterhall, Magnus; Erlandsson, Anna			Identification of Injury Specific Proteins in a Cell Culture Model of Traumatic Brain Injury	PLOS ONE			English	Article							IN-VITRO MODELS; MEMBRANE; ASSOCIATION; EXPRESSION; MIGRATION; CYTOKINES; PATHWAY; BINDING; FUSION; ACTIN	The complicated secondary molecular and cellular mechanisms following traumatic brain injury (TBI) are still not fully understood. In the present study, we have used mass spectrometry to identify injury specific proteins in an in vitro model of TBI. A standardized injury was induced by scalpel cuts through a mixed cell culture of astrocytes, oligodendrocytes and neurons. Twenty-four hours after the injury, cell culture medium and whole-cell fractions were collected for analysis. We found 53 medium proteins and 46 cell fraction proteins that were specifically expressed after injury and the known function of these proteins was elucidated by an extensive literature survey. By using time-lapse microscopy and immunostainings we could link a large proportion of the proteins to specific cellular processes that occur in response to trauma; including cell death, proliferation, lamellipodia formation, axonal regeneration, actin remodeling, migration and inflammation. A high percentage of the proteins uniquely expressed in the medium after injury were actin-related proteins, which normally are situated intracellularly. We show that two of these, ezrin and moesin, are expressed by astrocytes both in the cell culture model and in mouse brain subjected to experimental TBI. Interestingly, we found many inflammation-related proteins, despite the fact that cells were present in the culture. This study contributes with important knowledge about the cellular responses after trauma and identifies several potential cell-specific biomarkers.	[Loov, Camilla; Nadadhur, Aishwarya Geeyarpuram; Clausen, Fredrik; Hillered, Lars; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Shevchenko, Ganna; Wetterhall, Magnus] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden	Uppsala University; Uppsala University	Erlandsson, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anna.erlandsson@neuro.uu.se		G Nadadhur, Aishwarya/0000-0003-0468-9135; Hillered, Lars/0000-0002-2808-9292; Clausen, Fredrik/0000-0003-3592-4417	Jeanssons Foundation; Tore Nilssons Foundation; Swedish Society of Medicine [SLS-251631]; Magnus Bergvall foundation [24942*1*2011]; Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University; Uppsala University Hospital	Jeanssons Foundation; Tore Nilssons Foundation; Swedish Society of Medicine; Magnus Bergvall foundation; Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University; Uppsala University Hospital	This study was supported by grants from Jeanssons Foundation, Tore Nilssons Foundation, the Swedish Society of Medicine (SLS-251631), Magnus Bergvall foundation (24942*1*2011) and the Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University and Uppsala University Hospital. MW further acknowledges Lars Hiertas Minne Foundation (FO2009-0695) and Signe och Olof Wallenius Foundation (R103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell J.N., 2011, J NEUROTRAUMA; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Chen XQ, 2005, J CEREBR BLOOD F MET, V25, P338, DOI 10.1038/sj.jcbfm.9600032; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Fiedler LR, 2009, BIOCHEM SOC T, V37, P1243, DOI 10.1042/BST0371243; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion S, 2011, TRAFFIC, V12, P421, DOI 10.1111/j.1600-0854.2011.01158.x; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Rao MS, 1999, ANAT RECORD, V257, P137; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Shevchenko G, 2012, J PROTEOME RES, V11, P2441, DOI 10.1021/pr201169q; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Wolk K, 2005, GENES IMMUN, V6, P452, DOI 10.1038/sj.gene.6364224; Wright KT, 2010, BIOCHEM BIOPH RES CO, V398, P79, DOI 10.1016/j.bbrc.2010.06.039; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108	43	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55983	10.1371/journal.pone.0055983	http://dx.doi.org/10.1371/journal.pone.0055983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409102	Green Submitted, gold, Green Published			2022-12-25	WOS:000315157200097
J	Marmamula, S; Narsaiah, S; Shekhar, K; Khanna, RC				Marmamula, Srinivas; Narsaiah, Saggam; Shekhar, Konegari; Khanna, Rohit C.			Visual Impairment among Weaving Communities in Prakasam District in South India	PLOS ONE			English	Article							CENTRAL SRI-LANKA; RAPID ASSESSMENT; AVOIDABLE BLINDNESS; CATARACT; PREVALENCE; SERVICES; BARRIERS	Purpose: To assess the prevalence and causes of visual impairment in weaving communities in Prakasam district in South India state of Andhra Pradesh. Methods: Using Rapid Assessment of Visual Impairment (RAVI) methodology, a population based cross-sectional study was conducted. A two-stage sampling strategy was used to select 3000 participants aged >= 40 years. Visual Acuity (VA) was assessed using a tumbling E chart and ocular examinations were performed by trained Para medical ophthalmic personnel. A questionnaire was used to collect personal and demographic information. Blindness and moderate Visual Impairment (VI) was defined as presenting VA <6/60 and <6/18 to 6/60 respectively. VI included blindness and moderate VI. Results: 2848 of 3000 enumerated subjects (94.0%) participated. 39% were in 40-49 years age group and 11.8% were aged >= 70 years, 55% were women and nearly half of them had no formal education. 400 (14%; 95% CI: 12.8-15.3) subjects had VI, including blindness in 131 (4.6%; 95% CI: 3.8-5.4) and moderate VI in 269 (9.4%; 95% CI: 8.3-10.5) individuals. On applying multiple logistic regression, VI was significantly associated with older age and no formal education. Though the odds of having VI were higher in females, it was of borderline statistical significance (p = 0.06). Refractive error was the leading cause of all VI followed by cataract (56%). However, refractive errors were the leading cause of moderate VI (73.2%) and cataract was the leading cause of blindness (62.6%). 'Cannot afford the cost of services' was the leading barrier for utilization of eye care services (47%). Conclusions: There is a significant burden of VI in weaving communities in Andhra Pradesh, India most of which is avoidable. With this information as baseline, services need to be streamlined to address this burden.	[Marmamula, Srinivas; Narsaiah, Saggam; Shekhar, Konegari; Khanna, Rohit C.] LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Int Ctr Adv Rural Eye Care, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas] LV Prasad Eye Inst, Bausch & Lomb Sch Optometry, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas] Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21287 USA	L. V. Prasad Eye Institute; Bausch Health; Bausch + Lomb; L. V. Prasad Eye Institute; Johns Hopkins University; Johns Hopkins Medicine	Marmamula, S (corresponding author), LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Int Ctr Adv Rural Eye Care, Hyderabad, Andhra Pradesh, India.	srioptom@lvpei.org			OneSight Luxottica Foundation; Hyderabad Eye Research Foundation	OneSight Luxottica Foundation; Hyderabad Eye Research Foundation	Financial support for this study was provided by OneSight Luxottica Foundation and Hyderabad Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiov PA, 2009, CLIN EXP OPHTHALMOL, V37, P780, DOI 10.1111/j.1442-9071.2009.02152.x; Census of India, 2001, PRIM CENS ABSTRACT G; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Edussuriya K, 2009, OPHTHALMOLOGY, V116, P52, DOI 10.1016/j.ophtha.2008.08.034; Jadoon MZ, 2006, INVEST OPHTH VIS SCI, V47, P4749, DOI 10.1167/iovs.06-0374; Kovai Vilas, 2007, Indian Journal of Ophthalmology, V55, P365; Limburg H, 1997, INT J EPIDEMIOL, V26, P1049, DOI 10.1093/ije/26.5.1049; Marmamula S, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-26; Mohan M., 1989, NATL SURVEY BLINDNES; Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751; Narasaiah L, 1999, CRISIS HANDLOOM IND; Neena J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002867; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Polack S, 2012, OPHTHALMOLOGY, V119, P1033, DOI 10.1016/j.ophtha.2011.11.002; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Sapkota YD, 2006, BRIT J OPHTHALMOL, V90, P411, DOI 10.1136/bjo.2005.082503; Sapkota YD, 2012, OPHTHAL EPIDEMIOL, V17, P82; Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; *WHO, 1988, COD INSTR WHO PBL EY; World Health Organization, 1991, TRAIN MIDL MAN EPI C	21	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55924	10.1371/journal.pone.0055924	http://dx.doi.org/10.1371/journal.pone.0055924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409090	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200090
J	Prestinicola, L; Boglione, C; Makridis, P; Spano, A; Rimatori, V; Palamara, E; Scardi, M; Cataudella, S				Prestinicola, Loredana; Boglione, Clara; Makridis, Pavlos; Spano, Attilio; Rimatori, Valentina; Palamara, Elisa; Scardi, Michele; Cataudella, Stefano			Environmental Conditioning of Skeletal Anomalies Typology and Frequency in Gilthead Seabream (Sparus aurata L., 1758) Juveniles	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; DIPLODUS-PUNTAZZO CETTI; ZEBRAFISH DANIO-RERIO; EUROPEAN FISH LARVAE; BONE-RESORBING CELLS; SEA BREAM; CAUDAL FIN; OSTEOLOGICAL DEVELOPMENT; SADDLEBACK-SYNDROME; QUALITY ASSESSMENT	In this paper, 981 reared juveniles of gilthead seabream (Sparus aurata) were analysed, 721 of which were from a commercial hatchery located in Northern Italy (Venice, Italy) and 260 from the Hellenic Center for Marine Research (Crete, Greece). These individuals were from 4 different egg batches, for a total of 10 different lots. Each egg batch was split into two lots after hatching, and reared with two different methodologies: intensive and semi-intensive. All fish were subjected to processing for skeletal anomaly and meristic count analysis. The aims involved: (1) quantitatively and qualitatively analyzing whether differences in skeletal elements arise between siblings and, if so, what they are; (2) investigating if any skeletal bone tissue/ossification is specifically affected by changing environmental rearing conditions; and (3) contributing to the identification of the best practices for gilthead seabream larval rearing in order to lower the deformity rates, without selections. The results obtained in this study highlighted that: i) in all the semi-intensive lots, the bones having intramembranous ossification showed a consistently lower incidence of anomalies; ii) the same clear pattern was not observed in the skeletal elements whose ossification process requires a cartilaginous precursor. It is thus possible to ameliorate the morphological quality (by reducing the incidence of severe skeletal anomalies and the variability in meristic counts of dermal bones) of reared seabream juveniles by lowering the stocking densities (maximum 16 larvae/L) and increasing the volume of the hatchery rearing tanks (minimum 40 m(3)). Feeding larvae with a wide variety of live (wild) preys seems further to improve juvenile skeletal quality. Additionally, analysis of the morphological quality of juveniles reared under two different semi-intensive conditions, Mesocosm and Large Volumes, highlighted a somewhat greater capacity of Large Volumes to significantly augment the gap with siblings reared in intensive (conventional) modality.	[Prestinicola, Loredana; Boglione, Clara; Spano, Attilio; Rimatori, Valentina; Palamara, Elisa; Scardi, Michele; Cataudella, Stefano] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Makridis, Pavlos] Univ Patras, Dept Biol, Patras, Greece	University of Rome Tor Vergata; University of Patras	Boglione, C (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	boglione@uniroma2.it	Boglione, Clara/B-5633-2013	Boglione, Clara/0000-0002-8313-0542	Italian Ministry for Agriculture, Food and Forestry Policy [Law 41/82]; Commission of the European Communities [SSP-2005-44483]	Italian Ministry for Agriculture, Food and Forestry Policy; Commission of the European Communities(European Commission)	This study was funded by the Italian Ministry for Agriculture, Food and Forestry Policy (Law 41/82) and by the Commission of the European Communities (specific RTD programme "Specific Support to Policies", SSP-2005-44483 "SEACASE - Sustainable extensive and semi-intensive coastal aquaculture in Southern Europe"). It does not necessarily reflect the Italian Ministry for Agriculture, Food and Forestry Policy and the European Commission views. In no way anticipates the Commissions future policy in this area. This work benefits also from participation in LARVANET COST action FA0801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso JM, 2000, FISH PHYSIOL BIOCHEM, V22, P159, DOI 10.1023/A:1007811702624; Allaby M, 2004, OXFORD DICT ECOLOGY, P201; Almeida D, 2008, AQUACULTURE, V279, P120, DOI 10.1016/j.aquaculture.2008.04.003; Andrades JA, 1996, AQUACULTURE, V141, P1, DOI 10.1016/0044-8486(95)01226-5; Balbelona MC, 1993, B EUR ASSOC FISH PAT, V13, P33; Beer A-M, 2011, MMW Fortschr Med, V153 Suppl 1, P14, DOI 10.1007/BF03367581; Benzecri JP, 1973, ANAL DONNEES ANAL CO, V2, P628; Beyers R. J., 1993, ECOLOGICAL MICROCOSM; BIANCHI G, 1984, Cybium, V8, P31; Bird NC, 2009, ZOOLOGY, V112, P97, DOI 10.1016/j.zool.2008.05.003; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; Boglione C., 1993, EAS (European Aquaculture Society) Special Publication, V18, P189; Boglione C, 2001, AQUACULTURE, V192, P1, DOI 10.1016/S0044-8486(00)00446-4; Boglione C, 1995, ICES MAR SC, V201, P163; Boglione C, 2006, ECOL INDIC, V6, P712, DOI 10.1016/j.ecolind.2005.08.032; Boglione C, 2003, AQUACULTURE, V227, P373, DOI 10.1016/S0044-8486(03)00515-5; Boglione C, 2013, REV AQUACULT, V5, pS99, DOI 10.1111/raq.12015; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; Boglione Clara, 2011, P233; Boglione C, 2009, AQUACULTURE, V291, P48, DOI 10.1016/j.aquaculture.2009.02.041; Cahu C, 2003, AQUACULTURE, V227, P245, DOI 10.1016/S0044-8486(03)00507-6; Castro J, 2008, AQUACULTURE, V279, P18, DOI 10.1016/j.aquaculture.2008.04.023; Cataudella S, 2002, SEAFARMING TODAY TOM, P177; Cataudella S, 2003, INT AQ C FISH FARM M; CHATAIN B, 1994, AQUACULTURE, V119, P371, DOI 10.1016/0044-8486(94)90301-8; Costa C, 2010, BIOL J LINN SOC, V101, P427, DOI 10.1111/j.1095-8312.2010.01512.x; Dhert P, 1998, REARING TECHNIQUES D, P48; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Divanach P, 1997, AQUACULTURE, V156, P145, DOI 10.1016/S0044-8486(97)00072-0; Divanach P., 2000, Cahiers Options Mediterraneennes, V47, P75; Estevao MD, 2011, CELL TISSUE RES, V343, P619, DOI 10.1007/s00441-010-1109-y; Faustino M, 1999, J FISH BIOL, V54, P1094; Faustino M, 1998, J FISH BIOL, V52, P11, DOI 10.1111/j.1095-8649.1998.tb01548.x; Favaloro E, 2000, AQUACULT INT, V8, P417, DOI 10.1023/A:1009284421354; Favaloro E, 2003, FISH PHYSIOL BIOCHEM, V32, P159; Favaloro E, 2006, FISH PHYSIOL BIOCHEM, V32, P159, DOI 10.1007/s10695-006-0008-3; Fernandez I, 2010, J APPL ICHTHYOL, V26, P344, DOI 10.1111/j.1439-0426.2010.01432.x; Fernandez I, 2008, AQUACULTURE, V283, P102, DOI 10.1016/j.aquaculture.2008.06.037; Fischer W., 1987, MEDITERRANEE MER NOI, V37, P761; FOWLER JA, 1970, Q REV BIOL, V45, P148, DOI 10.1086/406492; Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010; Georgalas V, 2007, AQUACULTURE, V264, P418, DOI 10.1016/j.aquaculture.2006.09.035; Haga Y, 2002, ZOOL SCI, V19, P1105, DOI 10.2108/zsj.19.1105; Hall B.K., 2015, BONES CARTILAGE DEV; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harder W, 1975, ANATOMY FISHES 1; HilomenGarcia GV, 1997, AQUACULTURE, V152, P155, DOI 10.1016/S0044-8486(96)01518-9; Hough C, 2009, MANUAL CONTROL MALFO, P150; Imsland AK, 2006, AQUAC RES, V37, P1015, DOI 10.1111/j.1365-2109.2006.01523.x; Izquierdo MS, 2012, BRIT J NUTR IN PRESS; Jofre J, 1988, PATOLOGIA ACUICULTUR, P1; Kause A, 2007, GENET SEL EVOL, V39, P529, DOI 10.1051/gse:2007019; Kentouri M, 1995, COMP STUDY COST EFFE; KITAJIMA C, 1981, B JPN SOC SCI FISH, V47, P1289; Koumoundouros G, 1997, AQUACULTURE, V149, P215, DOI 10.1016/S0044-8486(96)01443-3; Koumoundouros G, 2008, J FISH BIOL, V72, P737, DOI 10.1111/j.1095-8649.2007.01714.x; Koumoundouros G, 2002, AQUACULTURE, V209, P49, DOI 10.1016/S0044-8486(01)00821-3; Koumoundouros G, 2001, AQUACULTURE, V200, P285, DOI 10.1016/S0044-8486(01)00552-X; Koumoundouros G, 1997, AQUACULTURE, V156, P165, DOI 10.1016/S0044-8486(97)89294-0; Koumoundourous G, 1995, EUROPEAN AQUACULTURE, V23, p[16, 413]; Kouttouki S, 2006, AQUAC RES, V37, P655, DOI 10.1111/j.1365-2109.2006.01475.x; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Le Vay L, 2007, AQUACULTURE, V268, P169, DOI 10.1016/j.aquaculture.2007.04.041; Lewis LM, 2004, AQUACULTURE, V241, P47, DOI 10.1016/j.aquaculture.2004.08.018; Malavasi S, 2004, J FISH BIOL, V65, P143, DOI 10.1111/j.0022-1112.2004.00545.x; Marino G., 1993, Aquaculture and Fisheries Management, V24, P445, DOI 10.1111/j.1365-2109.1993.tb00568.x; Marino G, 1989, EUR ACQ SOC S BORD O, P313; Matsuoka M, 2003, JARQ-JPN AGR RES Q, V37, P21, DOI 10.6090/jarq.37.21; Matsuoka M., 1987, B SEIKAI REG FISH RE, V65, P1; Papandroulakis N, 2002, AQUACULTURE, V204, P45, DOI 10.1016/S0044-8486(01)00643-3; PAPERNA I, 1977, AQUACULTURE, V10, P195, DOI 10.1016/0044-8486(77)90001-1; PAPERNA I, 1978, J FISH BIOL, V12, P109, DOI 10.1111/j.1095-8649.1978.tb04157.x; Puvanendran V, 2009, AQUAC RES, V40, P1653, DOI 10.1111/j.1365-2109.2009.02268.x; Russo T, 2007, J FISH BIOL, V71, P629, DOI 10.1111/j.1095-8649.2007.01528.x; Russo T, 2011, AQUACULTURE, V315, P69, DOI 10.1016/j.aquaculture.2010.11.030; Russo T, 2010, J APPL ICHTHYOL, V26, P360, DOI 10.1111/j.1439-0426.2010.01435.x; Russo T, 2009, AQUACULTURE, V289, P289, DOI 10.1016/j.aquaculture.2009.01.021; SCHULTZE HP, 1989, ZOOL J LINN SOC-LOND, V97, P189, DOI 10.1111/j.1096-3642.1989.tb00547.x; Sfakianakis DG, 2005, AQUACULTURE, V250, P36, DOI 10.1016/j.aquaculture.2005.03.042; Shields RJ, 1999, J NUTR, V129, P1186, DOI 10.1093/jn/129.6.1186; Sire JY, 2003, BIOL REV, V78, P219, DOI 10.1017/S1464793102006073; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Spedicato M. T., 2000, Cahiers Options Mediterraneennes, V47, P227; TANING AV, 1952, BIOL REV, V27, P169, DOI 10.1111/j.1469-185X.1952.tb01392.x; Tesseyre C, 1979, THESIS U MONTPELLIER; Verhaegen Y, 2007, AQUACULTURE, V268, P156, DOI 10.1016/j.aquaculture.2007.04.037; Witten PE, 2010, J APPL ICHTHYOL, V26, P225, DOI 10.1111/j.1439-0426.2010.01410.x; Witten P. Eckhard, 2007, P79; Witten PE, 2001, J MORPHOL, V250, P197, DOI 10.1002/jmor.1065.abs	89	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55736	10.1371/journal.pone.0055736	http://dx.doi.org/10.1371/journal.pone.0055736			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409031	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200056
J	Voigt, T; Sebald, HJ; Schoenauer, R; Levano, S; Girard, T; Hoppeler, HH; Babiychuk, EB; Draeger, A				Voigt, Tilman; Sebald, Hans-Joerg; Schoenauer, Roman; Levano, Soledad; Girard, Thierry; Hoppeler, Hans H.; Babiychuk, Eduard B.; Draeger, Annette			Annexin A1 is a biomarker of T-tubular repair in skeletal muscle of nonmyopathic patients undergoing statin therapy	FASEB JOURNAL			English	Article						plasma membrane repair; Ca2+-dependent translocation; dysferlin	MEMBRANE REPAIR; MUSCULAR-DYSTROPHY; TRANSVERSE TUBULES; DYSFERLIN; SYSTEM; DIFFERENTIATION; VACUOLATION; MECHANISMS; CAVEOLIN-3; EXPRESSION	Skeletal muscle complaints are a common consequence of cholesterol-lowering therapy. Transverse tubular (T-tubular) vacuolations occur in patients having statin-associated myopathy and, to a lesser extent, in statin-treated patients without myopathy. We have investigated quantitative changes in T-tubular morphology and looked for early indicators of T-tubular membrane repair in skeletal muscle biopsy samples from patients receiving cholesterol-lowering therapy who do not have myopathic side effects. Gene expression and protein levels of incipient membrane repair proteins were monitored in patients who tolerated statin treatment without myopathy and in statinnaive subjects. In addition, morphometry of the T-tubular system was performed. Only the gene expression for annexin A1 was up-regulated, whereas the expression of other repair genes remained unchanged. However, annexin A1 and dysferlin protein levels were significantly increased. In statin-treated patients, the volume fraction of the T-tubular system was significantly increased, but the volume fraction of the sarcoplasmic reticulum remained unchanged. A complex surface structure in combination with high mechanical loads makes skeletal muscle plasma membranes susceptible to injury. Ca2+-dependent membrane repair proteins such as dysferlin and annexin A1 are deployed at T-tubular sites. The up-regulation of annexin A1 gene expression and protein points to this protein as a biomarker for T-tubular repair.	[Voigt, Tilman; Schoenauer, Roman; Hoppeler, Hans H.; Babiychuk, Eduard B.; Draeger, Annette] Univ Bern, Inst Anat, CH-3012 Bern, Switzerland; [Sebald, Hans-Joerg] Univ Bern, Dept Orthoped Surg, Inselspital, CH-3012 Bern, Switzerland; [Levano, Soledad; Girard, Thierry] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Levano, Soledad; Girard, Thierry] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland	University of Bern; University of Bern; University of Basel; University of Basel	Draeger, A (corresponding author), Univ Bern, Inst Anat, Baltzerstr 2, CH-3012 Bern, Switzerland.	draeger@ana.unibe.ch	Babiychuk, Eduard/AAV-7223-2021	Levano, Soledad/0000-0002-0963-7951; Babiychuk, Eduard/0000-0003-1786-0085	Swiss National Science Foundation [320030_ 128064/1, 3100A0-121980/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors acknowledge the excellent technical assistance of Andrea Hostettler and Catherine Allemann. The study was supported by grants from the Swiss National Science Foundation (320030_ 128064/1 to A.D. and 3100A0-121980/1 to E.B.). T.V., R.S., S.L., and T.G. performed experiments; H.-J.S. provided medical expertise and the biopsy samples; A.D., E.B., and H.H.H. designed the study; and A.D. wrote the manuscript. The authors declare no conflicts of interest.	Abd TT, 2011, EXPERT OPIN DRUG SAF, V10, P373, DOI 10.1517/14740338.2011.540568; Al-Qusairi L, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-26; Arcuri C, 2002, NEUROSCIENCE, V109, P371, DOI 10.1016/S0306-4522(01)00330-X; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barrientos G, 2002, J MEMBRANE BIOL, V188, P163, DOI 10.1007/s00232-001-0179-x; Bizzarro V, 2012, J CELL PHYSIOL, V227, P3007, DOI 10.1002/jcp.24032; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Draeger A, 2003, DEV BIOL, V262, P324, DOI 10.1016/S0012-1606(03)00398-1; Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Draeger A, 2010, AM J PATHOL, V177, P291, DOI 10.2353/ajpath.2010.091140; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; EISENBERG BR, 1974, J CELL BIOL, V60, P732, DOI 10.1083/jcb.60.3.732; Engel A.G., 2004, MYOLOGY; Evesson FJ, 2010, J BIOL CHEM, V285, P28529, DOI 10.1074/jbc.M110.111120; Faure AV, 2002, EXP CELL RES, V276, P79, DOI 10.1006/excr.2002.5512; FRANZINIARMSTRONG C, 1991, DEV BIOL, V146, P353, DOI 10.1016/0012-1606(91)90237-W; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Han R, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-35; Han RZ, 2011, SKELET MUSCLE, V1, DOI [10.1186/2044-5040-1-10, 10.1186/2044-5040-1-35]; HOPPELER H, 1986, INT J SPORTS MED, V7, P187, DOI 10.1055/s-2008-1025758; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; KROLENKO SA, 1995, J MUSCLE RES CELL M, V16, P401, DOI 10.1007/BF00114505; Krolenko SA, 2002, CELL BIOL INT, V26, P893, DOI 10.1006/cbir.2002.0945; Lannergren J, 2002, CELL BIOL INT, V26, P911, DOI 10.1006/cbir.2002.0941; Launikonis BS, 2004, J GEN PHYSIOL, V123, P231, DOI 10.1085/jgp.200308946; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Lo HP, 2008, NEUROMUSCULAR DISORD, V18, P34, DOI 10.1016/j.nmd.2007.08.009; Marg A, 2010, BIOCHEM BIOPH RES CO, V401, P143, DOI 10.1016/j.bbrc.2010.09.030; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Meador BM, 2010, MUSCLE NERVE, V42, P469, DOI 10.1002/mus.21817; Mohaupt MG, 2009, CAN MED ASSOC J, V181, pE11, DOI 10.1503/cmaj.081785; Moyer MW, 2010, NAT MED, V16, P150, DOI 10.1038/nm0210-150; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PEDERSEN TR, 1994, LANCET, V344, P1383; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008; Schache AG, 2010, GAIT POSTURE, V32, P136, DOI 10.1016/j.gaitpost.2010.03.006; Selbert S, 1996, EXP CELL RES, V222, P199, DOI 10.1006/excr.1996.0025; Takekura H, 2001, DEV BIOL, V239, P204, DOI 10.1006/dbio.2001.0437; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; Voigt T, 2001, J NEUROCYTOL, V30, P159, DOI 10.1023/A:1011943324781; Waddell LB, 2011, J NEUROPATH EXP NEUR, V70, P302, DOI 10.1097/NEN.0b013e31821350b0; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wang PC, 2007, AM J RESP CELL MOL, V37, P467, DOI 10.1165/rcmb.2006-0447OC; WEIBEL ER, 1979, B EUR PHYSIOPATH RES, V15, P999	56	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2156	2164		10.1096/fj.12-219345	http://dx.doi.org/10.1096/fj.12-219345			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23413360				2022-12-25	WOS:000319667600007
J	Heiss, C; Skowyra, ML; Liu, H; Klutts, JS; Wang, ZR; Williams, M; Srikanta, D; Beverley, SM; Azadi, P; Doering, TL				Heiss, Christian; Skowyra, Michael L.; Liu, Hong; Klutts, J. Stacey; Wang, Zhirui; Williams, Matthew; Srikanta, Deepa; Beverley, Stephen M.; Azadi, Parastoo; Doering, Tamara L.			Unusual Galactofuranose Modification of a Capsule Polysaccharide in the Pathogenic Yeast Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-ANALYSIS; O-ANTIGEN; GALACTOXYLOMANNAN; GENE; GLUCURONOXYLOMANNAN; LIPOPOLYSACCHARIDE; VIRULENCE; METABOLISM; EXPRESSION; APOPTOSIS	Galactofuranose (Galf) is the five-membered ring form of galactose. Although it is absent from mammalian glycans, it occurs as a structural and antigenic component of important cell surface molecules in a variety of microbes, ranging from bacteria to parasites and fungi. One such organism is Cryptococcus neoformans, a pathogenic yeast that causes lethal meningoencephalitis in immunocompromised individuals, particularly AIDS patients. C. neoformans is unique among fungal pathogens in bearing a complex polysaccharide capsule, a critical virulence factor reported to include Galf. Notably, how Galf modification contributes to the structure and function of the cryptococcal capsule is not known. We have determined that Galf is beta 1,2-linked to an unusual tetrasubstituted galactopyranose of the glucuronoxylomannogalactan (GXMGal) capsule polysaccharide. This discovery fills a longstanding gap in our understanding of a major polymer of the cryptococcal capsule. We also engineered a C. neoformans strain that lacks UDP-galactopyranose mutase; this enzyme forms UDP-Galf, the nucleotide sugar donor required for Galf addition. Mutase activity was required for the incorporation of Galf into glucuronoxylomannogalactan but was dispensable for vegetative growth, cell integrity, and virulence in a mouse model.	[Heiss, Christian; Wang, Zhirui; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Skowyra, Michael L.; Liu, Hong; Klutts, J. Stacey; Williams, Matthew; Srikanta, Deepa; Beverley, Stephen M.; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University System of Georgia; University of Georgia; Washington University (WUSTL)	Doering, TL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	doering@borcim.wustl.edu	Skowyra, Michal Leszek/AAS-4850-2020; Heiss, Christian/GPX-7678-2022	Skowyra, Michal Leszek/0000-0002-1365-034X; Heiss, Christian/0000-0003-1118-8953; Beverley, Stephen/0000-0001-5319-0811; Klutts, James/0000-0003-3788-1940	National Institutes of Health [R01 GM071007, R01 AI031078]; United States Department of Energy [DE-FG02-09ER20097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM071007 (to T. L. D.) and R01 AI031078 (to S. M. B.). This work was also supported by United States Department of Energy Grant DE-FG02-09ER20097 (to P. A.).	BERST M, 1969, EUR J BIOCHEM, V11, P353, DOI 10.1111/j.1432-1033.1969.tb00779.x; Bertozzi C. R., 2009, ESSENTIALS GLYCOBIOL, P23; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; CHERNIAK R, 1988, CARBOHYD RES, V172, P113, DOI 10.1016/S0008-6215(00)90846-2; CHERNIAK R, 1982, CARBOHYD RES, V103, P239, DOI 10.1016/S0008-6215(00)80686-2; Cordeiro LMC, 2008, INT J BIOL MACROMOL, V42, P436, DOI 10.1016/j.ijbiomac.2008.02.002; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; De Jesus M, 2009, J IMMUNOL, V183, P3885, DOI 10.4049/jimmunol.0900449; Delfino D, 1997, INFECT IMMUN, V65, P2454, DOI 10.1128/IAI.65.6.2454-2456.1997; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; EVANS EE, 1950, J IMMUNOL, V64, P423; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Fries BC, 1999, INFECT IMMUN, V67, P6076, DOI 10.1128/IAI.67.11.6076-6083.1999; Gates-Hollingsworth MA, 2009, MOL MICROBIOL, V74, P126, DOI 10.1111/j.1365-2958.2009.06855.x; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Heitman J, 1999, FUNGAL GENET BIOL, V28, P1, DOI 10.1006/fgbi.1999.1155; HEUSER J, 1981, TRENDS BIOCHEM SCI, V6, P64, DOI 10.1016/0968-0004(81)90024-4; Ingavale SS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000155; JACOBSON ES, 1982, J BACTERIOL, V150, P1292, DOI 10.1128/JB.150.3.1292-1296.1982; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kumar CPG, 2010, MYCOSES, V53, P262, DOI 10.1111/j.1439-0507.2009.01699.x; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; Lee SHC, 1995, LAB INVEST, V73, P871; Leone MR, 2010, ANGEW CHEM INT EDIT, V49, P7476, DOI 10.1002/anie.201003301; Levery SB, 1998, BIOCHEMISTRY-US, V37, P8764, DOI 10.1021/bi9730083; LIPKIND GM, 1988, CARBOHYD RES, V175, P59, DOI 10.1016/0008-6215(88)80156-3; Ma N, 2010, J NAT PROD, V73, P590, DOI 10.1021/np9007188; Marino C., 2012, GLYCANS BIOCH CHARAC, P207; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Oppenheimer M, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/415976; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; Raso TF, 2004, MED MYCOL, V42, P355, DOI 10.1080/13693780410001712061; Rivera J, 1998, INFECT IMMUN, V66, P5027, DOI 10.1128/IAI.66.10.5027-5030.1998; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; Sassaki GL, 2005, AN ACAD BRAS CIENC, V77, P223, DOI 10.1590/S0001-37652005000200003; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; SETHI KK, 1968, J INFECT DIS, V118, P135, DOI 10.1093/infdis/118.2.135; Slavikova Elzbieta, 1995, Acta Microbiologica Polonica, V44, P181; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Srikanta D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022773; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Suzuki E, 2002, INFECT IMMUN, V70, P6592, DOI 10.1128/IAI.70.12.6592-6596.2002; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; ToneShimokawa Y, 1996, J BACTERIOL, V178, P317, DOI 10.1128/jb.178.1.317-320.1996; Toukach FV, 1996, CARBOHYD RES, V295, P117, DOI 10.1016/S0008-6215(96)90130-5; Trivedi SR, 2011, JAVMA-J AM VET MED A, V239, P357, DOI 10.2460/javma.239.3.357; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005	77	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10994	11003		10.1074/jbc.M112.441998	http://dx.doi.org/10.1074/jbc.M112.441998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23408430	hybrid, Green Published			2022-12-25	WOS:000317915500006
J	Sand, R; Sharmin, N; Morgan, C; Gallin, WJ				Sand, Rheanna; Sharmin, Nazlee; Morgan, Carla; Gallin, Warren J.			Fine-tuning of Voltage Sensitivity of the K(v)1.2 Potassium Channel by Interhelix Loop Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNEL; ELECTROSTATIC INTERACTIONS; POLYORCHIS PENICILLATUS; GATING KINETICS; XENOPUS OOCYTES; LIPID-MEMBRANE; S3-S4 LINKER; SENSOR; KV1.2; ACTIVATION	Many proteins function by changing conformation in response to ligand binding or changes in other factors in their environment. Any change in the sequence of a protein, for example during evolution, which alters the relative free energies of the different functional conformations changes the conditions under which the protein will function. Voltage-gated ion channels are membrane proteins that open and close an ion-selective pore in response to changes in transmembrane voltage. The charged S4 transmembrane helix transduces changes in transmembrane voltage into a change in protein internal energy by interacting with the rest of the channel protein through a combination of non-covalent interactions between adjacent helices and covalent interactions along the peptide backbone. However, the structural basis for the wide variation in the V-50 value between different voltage-gated potassium channels is not well defined. To test the role of the loop linking the S3 helix and the S4 helix in voltage sensitivity, we have constructed a set of mutants of the rat K(v)1.2 channel that vary solely in the length and composition of the extracellular loop that connects S4 to S3. We evaluated the effect of these different loop substitutions on the voltage sensitivity of the channel and compared these experimental results with molecular dynamics simulations of the loop structures. Here, we show that this loop has a significant role in setting the precise V-50 of activation in K(v)1 family channels.	[Sand, Rheanna; Sharmin, Nazlee; Morgan, Carla; Gallin, Warren J.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Gallin, Warren J.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Gallin, WJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	wgallin@ualberta.ca		Sharmin, Nazlee/0000-0002-2408-2333; Sand, Rheanna/0000-0002-8936-0234	Canadian Institutes for Health Research; National Science and Engineering Research Council of Canada; National Science and Engineering Research Council	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by grants from The Canadian Institutes for Health Research and the National Science and Engineering Research Council of Canada (to W. J. G.); Supported by an National Science and Engineering Research Council postgraduate scholarship.	Baumgartner W, 1999, BIOPHYS J, V77, P1980, DOI 10.1016/S0006-3495(99)77039-6; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Gonzalez C, 2000, J GEN PHYSIOL, V115, P193, DOI 10.1085/jgp.115.2.193; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Grigoriev NG, 1999, J NEUROPHYSIOL, V82, P1728, DOI 10.1152/jn.1999.82.4.1728; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B., 2001, ION CHANNELS EXCITAB, P131; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; HUANG QQ, 1993, J BIOL CHEM, V268, P20613; Jegla T, 1995, J NEUROSCI, V15, P7989; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kim M, 1997, J NEUROSCI, V17, P8213; Klassen TL, 2008, J EXP BIOL, V211, P3442, DOI 10.1242/jeb.022608; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Radley TL, 2003, J MOL BIOL, V332, P529, DOI 10.1016/S0022-2836(03)00925-2; RAMASWAMI M, 1990, Molecular and Cellular Neuroscience, V1, P214, DOI 10.1016/1044-7431(90)90004-N; Sand RM, 2011, J EXP BIOL, V214, P3124, DOI 10.1242/jeb.057000; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Vargas E, 2012, J GEN PHYSIOL, V140, P587, DOI 10.1085/jgp.201210873; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Xu YP, 2010, CELL, V142, P580, DOI 10.1016/j.cell.2010.07.013; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	47	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9686	9695		10.1074/jbc.M112.437483	http://dx.doi.org/10.1074/jbc.M112.437483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23413033	hybrid, Green Published			2022-12-25	WOS:000317114000011
J	Kayser, G; Csanadi, A; Otto, C; Plones, T; Bittermann, N; Rawluk, J; Passlick, B; Werner, M				Kayser, Gian; Csanadi, Agnes; Otto, Claudia; Ploenes, Till; Bittermann, Nicola; Rawluk, Justyna; Passlick, Bernward; Werner, Martin			Simultaneous Multi-Antibody Staining in Non-Small Cell Lung Cancer Strengthens Diagnostic Accuracy Especially in Small Tissue Samples	PLOS ONE			English	Article							QUALITY-OF-LIFE; MARKERS; CLASSIFICATION; CHEMOTHERAPY; SURVIVAL; P63; SUBCLASSIFICATION; DIFFERENTIATION; ASSOCIATION; CARCINOMAS	Histological subclassification of non-small cell lung cancer (NSCLC) has growing therapeutic impact. In advanced cancer stages tissue specimens are usually bioptically collected. These small samples are of extraordinary value since molecular analyses are gaining importance for targeted therapies. We therefore studied the feasibility, diagnostic accuracy, economic and prognostic effects of a tissue sparing simultaneous multi-antibody assay for subclassification of NSCLC. Of 265 NSCLC patients tissue multi arrays (TMA) were constructed to simulate biopsy samples. TMAs were stained by a simultaneous bicolor multi-antibody assay consisting of TTF1, Vimentin, p63 and neuroendocrine markers (CD56, chromogranin A, synaptophysin). Classification was based mainly on the current proposal of the IASLC with a hierarchical decision tree for subclassification into adenocarcinoma (LAC), squamous cell carcinoma (SCC), large cell neuroendocrine carcinoma (LCNEC) and NSCLC not otherwise specified. Investigation of tumor heterogeneity showed an explicit lower variation for immunohistochemical analyses compared to conventional classification. Furthermore, survival analysis of our combined immunohistochemical classification revealed distinct separation of each entity's survival curve. This was statistically significant for therapeutically important subgroups (p = 0.045). As morphological and molecular cancer testing is emerging, our multi-antibody assay in combination with standardized classification delivers accurate and reliable separation of histomorphological diagnoses. Additionally, it permits clinically relevant subtyping of NSCLC including LCNEC. Our multi-antibody assay may therefore be of special value, especially in diagnosing small biopsies. It futher delivers substantial prognostic information with therapeutic consequences. Integration of immunohistochemical subtyping including investigation of neuroendocrine differentiation into standard histopathological classification of NSCLC must, therefore, be considered.	[Kayser, Gian; Csanadi, Agnes; Otto, Claudia; Bittermann, Nicola; Werner, Martin] Univ Hosp Freiburg, Inst Pathol, Freiburg, Germany; [Ploenes, Till; Passlick, Bernward] Univ Hosp Freiburg, Dept Thorac Surg, Freiburg, Germany; [Rawluk, Justyna] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Kayser, G (corresponding author), Univ Hosp Freiburg, Inst Pathol, Freiburg, Germany.	gian.kayser@uniklinik-freiburg.de	Plönes, Till/AAK-8208-2021	Plönes, Till/0000-0003-4839-2130	Deutsche Forschungsgemeinschaft [SFB 850]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study has been financially supported by the Deutsche Forschungsgemeinschaft, SFB 850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aggarwal C, 2010, J NATL COMPR CANC NE, V8, P822, DOI 10.6004/jnccn.2010.0059; Andrews J, 2011, CANCER J, V17, P104, DOI 10.1097/PPO.0b013e318213f3cf; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Bryant AS, 2012, J THORAC CARDIOV SUR, V144, P1139, DOI 10.1016/j.jtcvs.2012.07.083; Chen Y, 2011, ONCOLOGY-BASEL, V80, P333, DOI 10.1159/000329098; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Coghlin CL, 2010, J THORAC ONCOL, V5, P448, DOI 10.1097/JTO.0b013e3181ca12c4; de Marinis F, 2011, LUNG CANCER, V73, P1, DOI 10.1016/j.lungcan.2011.02.022; Goeckenjan G, 2010, Pneumologie, V64 Suppl 2, pe1, DOI 10.1055/s-0029-1243837; Gollard R, 2010, LUNG CANCER, V69, P13, DOI 10.1016/j.lungcan.2009.12.011; Husmann G, 2010, KREBS DEUTSCHLAND 20; Ionescu DN, 2007, AM J SURG PATHOL, V31, P26, DOI 10.1097/01.pas.0000213319.04919.97; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Konopa K, 2010, ANN ONCOL, V21, P199, DOI 10.1093/annonc/mdq452; La Rosa S, 2010, VIRCHOWS ARCH, V457, P497, DOI 10.1007/s00428-010-0954-0; Ureste MM, 2010, CLIN TRANSL ONCOL, V12, P92, DOI 10.1007/S12094-010-0475-y; Menna C, 2012, MINERVA CHIR, V67, P219; Mukhopadhyay S, 2011, AM J SURG PATHOL, V35, P15, DOI 10.1097/PAS.0b013e3182036d05; Noh S, 2012, LUNG CANCER, V76, P51, DOI 10.1016/j.lungcan.2011.09.008; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Pelosi G, 2011, J THORAC ONCOL, V6, P1039, DOI 10.1097/JTO.0b013e318211dd16; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; Righi L, 2011, CANCER-AM CANCER SOC, V117, P3416, DOI 10.1002/cncr.25830; Rodriguez KA, 2012, ANN THORAC SURG; Rueth NM, 2011, ANN SURG, V254, P368, DOI 10.1097/SLA.0b013e31822150fe; Sangoi AR, 2011, AM J SURG PATHOL, V35, P678, DOI 10.1097/PAS.0b013e3182152629; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Sterlacci W, 2012, AM J CLIN PATHOL, V137, P946, DOI 10.1309/AJCP77KMKJXNMPMS; Sun JM, 2012, LUNG CANC; Travis W, 2004, TUMOURS LUNG PLEURA; Travis WD, 2010, ANN ONCOL, V21, P65, DOI 10.1093/annonc/mdq380; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Perez JMT, 2010, CLIN TRANSL ONCOL, V12, P735, DOI 10.1007/s12094-010-0588-3; Wahidi MM, 2010, RESPIRATION, V79, P137, DOI 10.1159/000235818; Yanagita E, 2011, APPL IMMUNOHISTOCHEM	38	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56333	10.1371/journal.pone.0056333	http://dx.doi.org/10.1371/journal.pone.0056333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418554	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300147
J	Lundblom, K; Murungi, L; Nyaga, V; Olsson, D; Rono, J; Osier, F; Ogada, E; Montgomery, S; Scott, JAG; Marsh, K; Farnert, A				Lundblom, Klara; Murungi, Linda; Nyaga, Victoria; Olsson, Daniel; Rono, Josea; Osier, Faith; Ogada, Edna; Montgomery, Scott; Scott, J. Anthony G.; Marsh, Kevin; Farnert, Anna			Plasmodium falciparum Infection Patterns Since Birth and Risk of Severe Malaria: A Nested Case-Control Study in Children on the Coast of Kenya	PLOS ONE			English	Article							CLINICAL-PROTECTION; CEREBRAL MALARIA; AFRICAN INFANTS; REDUCED RISK; TRANSMISSION; IMMUNITY; INDICATORS; ANTIBODIES; MORBIDITY; DISEASE	Children in malaria endemic areas acquire immunity to severe malaria faster than to mild malaria. Only a minority of children suffers from severe malaria and it is not known what determines this. The aim of this study was to establish how P. falciparum infections during the first years of life affect the risk of severe malaria. A matched case-control study was nested within a large birth cohort set up to study the immunoepidemiology of pneumococci on the Kenyan coast. Infection patterns in three-monthly blood samples in cohort children admitted to hospital with severe malaria were compared to controls matched on age, residential location and time of sampling. P. falciparum detected at least once from birth conferred an increased risk of severe malaria and particularly if multiclonal infections, as characterized by genotyping of a polymorphic antigen gene, were ever detected. The results show for the first time that children with severe malaria have more infections early in life compared to community controls. These findings provide important insights on the immunity to severe disease, knowledge essential for the development of a vaccine against severe malaria.	[Lundblom, Klara; Rono, Josea; Farnert, Anna] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Murungi, Linda; Nyaga, Victoria; Rono, Josea; Osier, Faith; Ogada, Edna; Scott, J. Anthony G.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Olsson, Daniel] Karolinska Inst, Inst Environm Med, Dept Epidemiol, Unit Biostat, S-10401 Stockholm, Sweden; [Montgomery, Scott] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Montgomery, Scott] Univ Orebro, Orebro Univ Hosp, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Montgomery, Scott] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Primary Care & Publ Hlth, London, England; [Scott, J. Anthony G.; Marsh, Kevin] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England	Karolinska Institutet; Kenya Medical Research Institute; Karolinska Institutet; Karolinska Institutet; Orebro University; Imperial College London; University of Oxford	Lundblom, K (corresponding author), Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.	klara.lundblom@ki.se	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494; Ogada, Edna/0000-0003-0181-2505; Olsson, Daniel/0000-0003-0535-2729; Osier, Faith/0000-0001-7133-5375; NYAGA, Victoria/0000-0002-8381-9964; Farnert, Anna/0000-0001-7583-282X	Wellcome Trust; Swedish Research Council; Swedish International Development Agency; Swedish Society of Medicine; Karolinska Institutet Faculty	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency; Swedish Society of Medicine; Karolinska Institutet Faculty(Karolinska Institutet)	Financial support has been granted from the Wellcome Trust, the Swedish Research Council, the Swedish International Development Agency and the Swedish Society of Medicine. K.L. was supported by Karolinska Institutet Faculty funding for doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Branch OH, 2001, INFECT IMMUN, V69, P7783, DOI 10.1128/IAI.69.12.7783-7792.2001; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Culleton RL, 2011, PARASITE IMMUNOL, V33, P73, DOI 10.1111/j.1365-3024.2010.01251.x; English M, 1996, AM J TROP MED HYG, V55, P521, DOI 10.4269/ajtmh.1996.55.521; Farnert A, 2008, TRENDS PARASITOL, V24, P340, DOI 10.1016/j.pt.2008.04.008; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; Franks S, 2001, J INFECT DIS, V183, P796, DOI 10.1086/318834; Gupta S, 1999, P ROY SOC B-BIOL SCI, V266, P33, DOI 10.1098/rspb.1999.0600; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Lundblom K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-229; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MOLYNEUX ME, 1989, Q J MED, V71, P441; Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Osier FHA, 2010, PARASITE IMMUNOL, V32, P193, DOI 10.1111/j.1365-3024.2009.01178.x; RAZANAMPARANY M, 1989, Parassitologia (Rome), V31, P89; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Wagner G, 1998, AM J TROP MED HYG, V59, P115, DOI 10.4269/ajtmh.1998.59.115; World Health Organization, WORLD MALARIA REPORT	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56032	10.1371/journal.pone.0056032	http://dx.doi.org/10.1371/journal.pone.0056032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418502	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000315970300094
J	Shafique, K; Morrison, DS				Shafique, Kashif; Morrison, David S.			Socio-Economic Inequalities in Survival of Patients with Prostate Cancer: Role of Age and Gleason Grade at Diagnosis	PLOS ONE			English	Article							NEW-ZEALAND; ENGLAND; POPULATION; WALES; MANAGEMENT; NORTHERN; TRENDS; IMPACT; STAGE; CARE	In the United Kingdom, survival of prostate cancer patients has improved since the 1990s. A deprivation gap in survival (better survival for the least deprived compared with the most deprived) has been reported but it is not known if differential distribution of earlier age or lower grade disease at diagnosis might explain such patterns. We therefore investigated the impact of age and Gleason grade at diagnosis on the deprivation gap in survival of prostate cancer patients over time. Incident cases of prostate cancer (ICD 10 C61) from the West of Scotland were extracted from the Scottish Cancer Registry from 1991 to 2007. Socio-economic circumstances were measured using the Scottish Index for Multiple Deprivation 2004 (SIMD). Age and deprivation specific mortality rates were obtained from the General Registrar Office for Scotland (GRO( S)). The survival gradient across the five deprivation categories was estimated with linear regression, weighted by the variance of the relative survival estimate. We examined the data for 15,292 adults diagnosed with prostate cancer between 1991 and 2007. Despite substantial improvements in survival of prostate cancer patients, a deprivation gap persists throughout the three periods of diagnoses. The deprivation gap in five year relative survival widened from 24.76 in 1991-1996 to 210.08 in 2003-2007. On age and grade-specific analyses, a significant deprivation gap in five year survival existed between all age groups except among patients' age >= 75 and both low and high grade disease. On multivariate analyses, deprivation was significantly associated with increased excess risk of death (RER 1.48, 95% CI 1.31-1.68, p-value, 0.001) independent of age, Gleason grade and period of diagnosis. The deprivation gap in survival from prostate cancer cannot be wholly explained by socio-economic differentials in early detection of disease. Further research is needed to understand whether differences in comorbidities or treatment explain inequalities in prostate cancer outcomes.	[Shafique, Kashif; Morrison, David S.] Univ Glasgow, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Shafique, Kashif] Dow Univ Hlth Sci, Dow Med Coll, Dept Community Med, Karachi, Pakistan; [Morrison, David S.] West Scotland Canc Surveillance Unit, Glasgow, Lanark, Scotland	University of Glasgow; Dow University of Health Sciences	Shafique, K (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	k.shafique.1@research.gla.ac.uk		Morrison, David/0000-0002-0617-3047; Shafique, Kashif/0000-0001-7151-5122				Borre Michael, 2011, Clin Epidemiol, V3 Suppl 1, P41, DOI 10.2147/CLEP.S20625; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; COX DR, 1972, J R STAT SOC B, V34, P187; Cremers RGHM, 2010, EUR J CANCER, V46, P2077, DOI 10.1016/j.ejca.2010.03.040; Drummond FJ, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-3; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Evans S, 2010, BRIT J CANCER, V102, P249, DOI 10.1038/sj.bjc.6605461; Fairley L, 2009, BRIT J CANCER, V101, P1839, DOI 10.1038/sj.bjc.6605424; Hall SE, 2005, BJU INT, V95, P51, DOI 10.1111/j.1464-410X.2005.05248.x; Haynes R, 2008, SOC SCI MED, V67, P928, DOI 10.1016/j.socscimed.2008.05.005; Jack RH, 2010, BJU INT, V105, P1226, DOI 10.1111/j.1464-410X.2009.08940.x; Jeffreys M, 2009, CANCER EPIDEM BIOMAR, V18, P915, DOI 10.1158/1055-9965.EPI-08-0685; Lawder R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-330; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Lund L, 2007, SCAND J UROL NEPHROL, V41, P308, DOI 10.1080/00365590701365149; Lyratzopoulos G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1928; Mokete M, 2006, BJU INT, V97, P266, DOI 10.1111/j.1464-410X.2005.06011.x; Moore AL, 2009, BJU INT, V104, P1592, DOI 10.1111/j.1464-410X.2009.08652.x; Rachet B, 2008, BRIT J CANCER, V99, pS2, DOI 10.1038/sj.bjc.6604571; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rowan S, 2008, BRIT J CANCER, V99, pS75, DOI 10.1038/sj.bjc.6604595; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schwartz K, 2009, UROLOGY, V74, P1296, DOI 10.1016/j.urology.2009.02.058; Scottish Government, 2006, US SCOTT IND MULT DE; Shack LG, 2007, BRIT J CANCER, V97, P999, DOI 10.1038/sj.bjc.6603980; Shafique K, 2012, BRIT J CANCER, V107, P575, DOI 10.1038/bjc.2012.289; SOGANI PC, 1985, UROLOGY, V25, P223, DOI 10.1016/0090-4295(85)90316-4; White A, 2011, CANCER-AM CANCER SOC, V117, P1080, DOI 10.1002/cncr.25671	29	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56184	10.1371/journal.pone.0056184	http://dx.doi.org/10.1371/journal.pone.0056184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418534	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000315970300126
J	Molyneux, S; Njue, M; Boga, M; Akello, L; Olupot-Olupot, P; Engoru, C; Kiguli, S; Maitland, K				Molyneux, Sassy; Njue, Maureen; Boga, Mwanamvua; Akello, Lilian; Olupot-Olupot, Peter; Engoru, Charles; Kiguli, Sarah; Maitland, Kathryn			'The Words Will Pass with the Blowing Wind': Staff and Parent Views of the Deferred Consent Process, with Prior Assent, Used in an Emergency Fluids Trial in Two African Hospitals	PLOS ONE			English	Article							CLINICAL-RESEARCH; INFORMED-CONSENT; DEVELOPING-COUNTRIES; COMMUNITY; CHILDREN; CARE; ILLNESS; IF	Objective: To document and explore the views and experiences of key stakeholders regarding the consent procedures of an emergency research clinical trial examining immediate fluid resuscitation strategies, and to discuss the implications for similar trials in future. Methods: A social science sub-study of the FEAST (Fluid Expansion As Supportive Therapy) trial. Interviews were held with trial team members (n = 30), health workers (n = 15) and parents (n = 51) from two purposively selected hospitals in Soroti, Uganda, and Kilifi, Kenya. Findings: Overall, deferred consent with prior assent was seen by staff and parents as having the potential to protect the interests of both patients and researchers, and to avoid delays in starting treatment. An important challenge is that the validity of verbal assent is undermined when inadequate initial information is poorly understood. This concern needs to be balanced against the possibility that full prior consent on admission potentially causes harm through introducing delays. Full prior consent also potentially imposes worries on parents that clinicians are uncertain about how to proceed and that clinicians want to absolve themselves of any responsibility for the child's outcome (some parents' interpretation of the need for signed consent). Voluntariness is clearly compromised for both verbal assent and full prior consent in a context of such vulnerability and stress. Further challenges in obtaining verbal assent were: what to do in the absence of the household decision-maker (often the father); and how medical staff handle parents not giving a clear agreement or refusal. Conclusion: While the challenges identified are faced in all research in low-income settings, they are magnified for emergency trials by the urgency of decision making and treatment needs. Consent options will need to be tailored to particular studies and settings, and might best be informed by consultation with staff members and community representatives using a deliberative approach.	[Molyneux, Sassy; Njue, Maureen] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Hlth Syst & Social Sci Res Grp, Kilifi, Kenya; [Molyneux, Sassy] Univ Oxford, Ctr Trop Med, Oxford, England; [Molyneux, Sassy] Univ Oxford, Dept Publ Hlth & Primary Hlth Care, Ethox Ctr, Oxford, England; [Boga, Mwanamvua; Maitland, Kathryn] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi Clin Trials Facil, Kilifi, Kenya; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, Wellcome Trust Ctr Clin Trop Med, London, England; [Kiguli, Sarah] Makerere Univ, Mulago Natl Referral Hosp, Dept Paediat, Kampala, Uganda; [Olupot-Olupot, Peter] Mbale Reg Referral Hosp, Mbale, Uganda; [Engoru, Charles] Soroti Reg Referral Hosp, Soroti, Uganda; [Akello, Lilian] Malaria Consortium, Kampala, Uganda	Kenya Medical Research Institute; University of Oxford; University of Oxford; Kenya Medical Research Institute; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Makerere University; Mulago National Referral Hospital	Molyneux, S (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Hlth Syst & Social Sci Res Grp, Kilifi, Kenya.	SMolyneux@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Maitland, Kathryn/0000-0002-0007-0645	Wellcome Trust, United Kingdom [WT085418]; Medical Research Council, United Kingdom [G0801439]; MRC [G0801439, G0601027] Funding Source: UKRI; Medical Research Council [G0801439, G0601027] Funding Source: researchfish	Wellcome Trust, United Kingdom(Wellcome Trust); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, United Kingdom (WT085418 to S.M.) (http://www.wellcome.ac.uk), and Medical Research Council, United Kingdom (G0801439 to K.M.) (http://www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmark P, 2006, J MED ETHICS, V32, P439, DOI 10.1136/jme.2005.013722; Boga M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001089; Brierley J, 2011, J MED ETHICS, V37, P429, DOI 10.1136/jme.2010.040667; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Chuma J, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-15; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2005, LANCET, V366, P336, DOI 10.1016/S0140-6736(05)66992-9; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Gamble T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035982, 10.1371/journal.pone.0039429]; Green J, 2009, QUALITATIVE METHODS; Jansen TC, 2007, INTENS CARE MED, V33, P894, DOI 10.1007/s00134-007-0580-8; Jansen TC, 2010, INTENS CARE MED, V36, P1962, DOI 10.1007/s00134-010-1988-0; Kamuya D, 2013, DEV WORLD B IN PRESS, V13; Lairumbi Geoffrey M, 2012, Philos Ethics Humanit Med, V7, P7, DOI 10.1186/1747-5341-7-7; Largent EA, 2010, ARCH INTERN MED, V170, P668, DOI 10.1001/archinternmed.2010.80; Lindegger G, 2000, S AFR J SCI, V96, P313; Luce JM, 2003, CRIT CARE MED, V31, pS153, DOI 10.1097/01.CCM.0000054901.80339.01; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Maitland K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-90; Manning DJ, 2000, J MED ETHICS, V26, P249, DOI 10.1136/jme.26.4.249; Marsh VM, 2011, PUBLIC HEALTH ETH-UK, V4, P26, DOI 10.1093/phe/phr007; Molyneux CS, 2005, SOC SCI MED, V61, P1463, DOI 10.1016/j.socscimed.2004.11.073; Molyneux CS, 2005, SOC SCI MED, V61, P443, DOI 10.1016/j.socscimed.2004.12.003; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; Myburgh JA, 2011, NEW ENGL J MED, V364, P2543, DOI 10.1056/NEJMe1105490; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Van Loon K, 2009, INFORM CONSENT CLIN, P14; World Health Organization, 2005, EM TRIAG ASS TREATM	30	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54894	10.1371/journal.pone.0054894	http://dx.doi.org/10.1371/journal.pone.0054894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23408950	Green Published, gold, Green Submitted			2022-12-25	WOS:000315100000009
J	Tahara, EB; Cunha, FM; Basso, TO; Della Bianca, BE; Gombert, AK; Kowaltowski, AJ				Tahara, Erich B.; Cunha, Fernanda M.; Basso, Thiago O.; Della Bianca, Bianca E.; Gombert, Andreas K.; Kowaltowski, Alicia J.			Calorie Restriction Hysteretically Primes Aging Saccharomyces cerevisiae toward More Effective Oxidative Metabolism	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; MITOCHONDRIAL RESPIRATION; YEAST; SKELETAL; BIOGENESIS; EXPRESSION; LONGEVITY; MECHANISM; EXTENSION; CAPACITY	Calorie restriction (CR) is an intervention known to extend the lifespan of a wide variety of organisms. In S. cerevisiae, chronological lifespan is prolonged by decreasing glucose availability in the culture media, a model for CR. The mechanism has been proposed to involve an increase in the oxidative (versus fermentative) metabolism of glucose. Here, we measured wild-type and respiratory incompetent (rho(0)) S. cerevisiae biomass formation, pH, oxygen and glucose consumption, and the evolution of ethanol, glycerol, acetate, pyruvate and succinate levels during the course of 28 days of chronological aging, aiming to identify metabolic changes responsible for the effects of CR. The concomitant and quantitative measurements allowed for calculations of conversion factors between different pairs of substrates and products, maximum specific substrate consumption and product formation rates and maximum specific growth rates. Interestingly, we found that the limitation of glucose availability in CR S. cerevisiae cultures hysteretically increases oxygen consumption rates many hours after the complete exhaustion of glucose from the media. Surprisingly, glucose-to-ethanol conversion and cellular growth supported by glucose were not quantitatively altered by CR. Instead, we found that CR primed the cells for earlier, faster and more efficient metabolism of respiratory substrates, especially ethanol. Since lifespan-enhancing effects of CR are absent in respiratory incompetent rho(0) cells, we propose that the hysteretic effect of glucose limitation on oxidative metabolism is central toward chronological lifespan extension by CR in this yeast.	[Tahara, Erich B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Sao Paulo, Escola deArtes Ciencias & Humanidades, Sao Paulo, Brazil; [Basso, Thiago O.; Della Bianca, Bianca E.; Gombert, Andreas K.] Univ Sao Paulo, Dept Engn Quim, Escola Politecn, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Gombert, AK (corresponding author), Univ Sao Paulo, Dept Engn Quim, Escola Politecn, Sao Paulo, Brazil.	andreas.gombert@poli.usp.br; alicia@iq.usp.br	Basso, Thiago Olitta/H-9312-2012; Gombert, Andreas K/F-3764-2010; Kowaltowski, Alicia J/H-8698-2012; Della-Bianca, Bianca E/E-6042-2018; DA CUNHA, FERNANDA MARQUES/AAY-4000-2020; da Cunha, Fernanda M/G-3575-2012	Basso, Thiago Olitta/0000-0001-7765-4297; Gombert, Andreas K/0000-0001-9557-3773; Della-Bianca, Bianca E/0000-0002-0169-1048; da Cunha, Fernanda M/0000-0002-1583-5380	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); John Simon Guggenheim Memorial Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); John Simon Guggenheim Memorial Foundation	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma), Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma) and the John Simon Guggenheim Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barros MH, 2010, MECH AGEING DEV, V131, P494, DOI 10.1016/j.mad.2010.04.008; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cerqueira FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031155; Cerqueira FM, 2012, FREE RADICAL BIO MED, V52, P1236, DOI 10.1016/j.freeradbiomed.2012.01.011; Cerqueira FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018433; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Crabtree HG, 1928, BIOCHEM J, V22, P1289, DOI 10.1042/bj0221289; Doran P.M., 1995, BIOPROCESS ENG PRINC; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goldberg AA, 2009, EXP GERONTOL, V44, P555, DOI 10.1016/j.exger.2009.06.001; Hempenstall S, 2012, MECH AGEING DEV, V133, P37, DOI 10.1016/j.mad.2011.12.002; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; Jazwinski SM, 2005, MECH AGEING DEV, V126, P243, DOI 10.1016/j.mad.2004.08.016; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Li Bin, 2011, J Aging Res, V2011, P673185, DOI 10.4061/2011/673185; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Maskell DL, 2003, FEMS YEAST RES, V3, P201, DOI 10.1016/S1567-1356(02)00199-X; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Murakami C, 2012, CELL CYCLE, V11, P3087, DOI 10.4161/cc.21465; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Oliveira GA, 2008, J BIOENERG BIOMEMBR, V40, P381, DOI 10.1007/s10863-008-9159-5; Olsson L, 1997, APPL ENVIRON MICROB, V63, P2366, DOI 10.1128/AEM.63.6.2366-2371.1997; Piper PW, 2006, MECH AGEING DEV, V127, P733, DOI 10.1016/j.mad.2006.05.004; POLAKIS ES, 1965, BIOCHEM J, V97, P284, DOI 10.1042/bj0970284; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Tahara EB, 2011, J BIOENERG BIOMEMBR, V43, P483, DOI 10.1007/s10863-011-9377-0; Woo DK, 2009, EXP GERONTOL, V44, P390, DOI 10.1016/j.exger.2009.03.001; YOTSUYANAGI Y, 1962, J ULTRA MOL STRUCT R, V7, P141, DOI 10.1016/S0022-5320(62)80032-X; Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1	43	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56388	10.1371/journal.pone.0056388	http://dx.doi.org/10.1371/journal.pone.0056388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409181	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000053
J	Xu, XL; Zhang, YH; Meng, QC; Meng, K; Zhang, W; Zhou, XJ; Luo, HY; Chen, RM; Yang, PL; Yao, B				Xu, Xiaolu; Zhang, Yuhong; Meng, Qingchang; Meng, Kun; Zhang, Wei; Zhou, Xiaojin; Luo, Huiying; Chen, Rumei; Yang, Peilong; Yao, Bin			Overexpression of a Fungal beta-Mannanase from Bispora sp MEY-1 in Maize Seeds and Enzyme Characterization	PLOS ONE			English	Article							GENE CLONING; PICHIA-PASTORIS; EXPRESSION; PLANTS; BOMBARDMENT; PROGENY; PHYTASE; DIETS	Background: Mannans and heteromannans are widespread in plants cell walls and are well-known as anti-nutritional factors in animal feed. To remove these factors, it is common practice to incorporate endo-beta-mannanase into feed for efficient nutrition absorption. The objective of this study was to overexpress a beta-mannanase gene directly in maize, the main ingredient of animal feed, to simplify the process of feed production. Methodology/Principal Findings: The man5A gene encoding an excellent beta-mannanase from acidophilic Bispora sp. MEY-1 was selected for heterologous overexpression. Expression of the modified gene (man5As) was driven by the embryo-specific promoter ZM-leg1A, and the transgene was transferred to three generations by backcrossing with commercial inbred Zheng58. Its exogenous integration into the maize embryonic genome and tissue specific expression in seeds were confirmed by PCR and Southern blot and Western blot analysis, respectively. Transgenic plants at BC3 generation showed agronomic traits statistically similar to Zheng58 except for less plant height (154.0 cm vs 158.3 cm). The expression level of MAN5AS reached up to 26,860 units per kilogram of maize seeds. Compared with its counterpart produced in Pichia pastoris, seed-derived MAN5AS had higher temperature optimum (90 degrees C), and remained more beta-mannanase activities after pelleting at 80 degrees C, 100 degrees C or 120 degrees C. Conclusion/Significance: This study shows the genetically stable overexpression of a fungal beta-mannanase in maize and offers an effective and economic approach for transgene containment in maize for direct utilization without any purification or supplementation procedures.	[Xu, Xiaolu; Meng, Kun; Luo, Huiying; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Minist Agr, Feed Res Inst, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Zhang, Yuhong; Zhang, Wei; Zhou, Xiaojin; Chen, Rumei] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Meng, Qingchang] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Jiangsu Academy of Agricultural Sciences	Yang, PL (corresponding author), Chinese Acad Agr Sci, Minist Agr, Feed Res Inst, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	yangpl@mail.caas.cn; binyao@caas.cn			Key Program of Transgenic Plant Breeding [2009ZX08003-020B]; China Modern Agriculture Research System [CARS-42]; National Natural Science Foundation of China [31172235]	Key Program of Transgenic Plant Breeding; China Modern Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Key Program of Transgenic Plant Breeding (2009ZX08003-020B) and the China Modern Agriculture Research System (CARS-42) and the National Natural Science Foundation of China (31172235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; ARAUJO A, 1990, J APPL BACTERIOL, V68, P253, DOI 10.1111/j.1365-2672.1990.tb02572.x; Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Cohen J. I., 2002, AgBiotechNet, V4, P1; Dale N, 1997, HEMICELL POULTRY SWI; Deng LF, 2009, CHIN AGR SCI B, V25, P7; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; DIRK LMA, 1995, PHYTOCHEMISTRY, V40, P1045, DOI 10.1016/0031-9422(95)00296-J; Do BC, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-59; GREEN CE, 1982, PLANT TISSUE CULTURE, P107; Hiwasa-Tanase K, 2011, PLANT CELL REP, V30, P113, DOI 10.1007/s00299-010-0949-y; Hoshikawa K, 2012, PLANT BIOTECHNOL REP, V6, P243, DOI 10.1007/s11816-012-0219-2; HUANG N, 1990, J CAASS, V1, P73; Jackson ME, 1999, POULTRY SCI, V78, P1737, DOI 10.1093/ps/78.12.1737; Jiang XR, 2011, BIOTECHNOL LETT, V33, P1797, DOI 10.1007/s10529-011-0642-4; Jiang ZQ, 2006, CARBOHYD POLYM, V66, P88, DOI 10.1016/j.carbpol.2006.02.030; Kim SW, 2003, PIG NEWS INFO, V24, p91N; KLEIN TM, 1988, P NATL ACAD SCI USA, V85, P4305, DOI 10.1073/pnas.85.12.4305; Li J, 1997, PLANT PHYSIOL, V114, P1103, DOI 10.1104/pp.114.3.1103; [李圣彦 Li Shengyan], 2011, [中国农业科技导报, Journal of Agricultural Science and Technology], V13, P20; Li YN, 2008, J MICROBIOL BIOTECHN, V18, P160; Li Z, 2011, FUNCT INTEGR GENOMIC, V11, P63, DOI 10.1007/s10142-011-0211-x; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Liu HM, 2010, MOL BIOL REP, V37, P677, DOI 10.1007/s11033-009-9521-7; Luo HY, 2009, APPL MICROBIOL BIOT, V82, P453, DOI 10.1007/s00253-008-1766-x; MATHESON NK, 1985, POLYSACCHARIDES, V3, P1; MCCLEARY BV, 1988, METHOD ENZYMOL, V160, P596; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nandi S, 2002, PLANT SCI, V163, P713, DOI 10.1016/S0168-9452(02)00165-6; Odetallah NH, 2002, POULTRY SCI, V81, P1322, DOI 10.1093/ps/81.9.1322; Petkowicz CLD, 2001, CARBOHYD POLYM, V44, P107, DOI 10.1016/S0144-8617(00)00212-5; Qiao HY, 2010, J VET MED ANIM HUSB, V42, P15; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Song JM, 2008, COMP BIOCHEM PHYS B, V151, P32, DOI 10.1016/j.cbpb.2008.05.005; Songstad DD, 1996, IN VITRO CELL DEV-PL, V32, P179; Sun ZW, 2005, ACTA ZOONUTRIMENTA S, V17, P20; Tomes D. T., 1995, P197; TOMES DT, 1990, PLANT MOL BIOL, V14, P261, DOI 10.1007/BF00018566; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; Whittle CA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-169; Yang PL, 2009, APPL BIOCHEM BIOTECH, V159, P85, DOI 10.1007/s12010-008-8364-3; Yao B, 1998, SCI CHINA SER C, V41, P330, DOI 10.1007/BF02895110; Yoon KH, 2008, J MICROBIOL, V46, P344, DOI 10.1007/s12275-008-0045-y; Ziegler MT, 2000, MOL BREEDING, V6, P37, DOI 10.1023/A:1009667524690	47	8	12	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56146	10.1371/journal.pone.0056146	http://dx.doi.org/10.1371/journal.pone.0056146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409143	Green Submitted, Green Published, gold			2022-12-25	WOS:000315100000045
J	Hill, TA; Ashrafi, H; Reyes-Chin-Wo, S; Yao, JQ; Stoffel, K; Truco, MJ; Kozik, A; Michelmore, RW; Van Deynze, A				Hill, Theresa A.; Ashrafi, Hamid; Reyes-Chin-Wo, Sebastian; Yao, JiQiang; Stoffel, Kevin; Truco, Maria-Jose; Kozik, Alexander; Michelmore, Richard W.; Van Deynze, Allen			Characterization of Capsicum annuum Genetic Diversity and Population Structure Based on Parallel Polymorphism Discovery with a 30K Unigene Pepper GeneChip	PLOS ONE			English	Article							SINGLE-FEATURE POLYMORPHISMS; GENOMIC SELECTION; L.; MARKERS; TOMATO; IDENTIFICATION; DOMESTICATION; TRANSCRIPTOME; EVOLUTIONARY; SOLANACEAE	The widely cultivated pepper, Capsicum spp., important as a vegetable and spice crop world-wide, is one of the most diverse crops. To enhance breeding programs, a detailed characterization of Capsicum diversity including morphological, geographical and molecular data is required. Currently, molecular data characterizing Capsicum genetic diversity is limited. The development and application of high-throughput genome-wide markers in Capsicum will facilitate more detailed molecular characterization of germplasm collections, genetic relationships, and the generation of ultra-high density maps. We have developed the Pepper GeneChip (R) array from Affymetrix for polymorphism detection and expression analysis in Capsicum. Probes on the array were designed from 30,815 unigenes assembled from expressed sequence tags (ESTs). Our array design provides a maximum redundancy of 13 probes per base pair position allowing integration of multiple hybridization values per position to detect single position polymorphism (SPP). Hybridization of genomic DNA from 40 diverse C. annuum lines, used in breeding and research programs, and a representative from three additional cultivated species (C. frutescens, C. chinense and C. pubescens) detected 33,401 SPP markers within 13,323 unigenes. Among the C. annuum lines, 6,426 SPPs covering 3,818 unigenes were identified. An estimated three-fold reduction in diversity was detected in non-pungent compared with pungent lines, however, we were able to detect 251 highly informative markers across these C. annuum lines. In addition, an 8.7 cM region without polymorphism was detected around Pun1 in non-pungent C. annuum. An analysis of genetic relatedness and diversity using the software Structure revealed clustering of the germplasm which was confirmed with statistical support by principle components analysis (PCA) and phylogenetic analysis. This research demonstrates the effectiveness of parallel high-throughput discovery and application of genome-wide transcript-based markers to assess genetic and genomic features among Capsicum annuum.	[Hill, Theresa A.; Ashrafi, Hamid; Reyes-Chin-Wo, Sebastian; Yao, JiQiang; Stoffel, Kevin; Van Deynze, Allen] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Reyes-Chin-Wo, Sebastian; Truco, Maria-Jose; Kozik, Alexander; Michelmore, Richard W.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Hill, Theresa A.; Ashrafi, Hamid; Stoffel, Kevin; Michelmore, Richard W.; Van Deynze, Allen] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Van Deynze, A (corresponding author), Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA.	avandeynze@ucdavis.edu		Ashrafi, Hamid/0000-0002-2094-2367	University of California [bio06-10565]; Rijk Zwaan BV; Enza Zaden BV; DeRuiter Seeds B.V.; Nunhems USA; Seminis Vegetable Seeds, Inc.; Syngenta Seeds, Inc.; Vilmorin Co.; University of California Davis	University of California(University of California System); Rijk Zwaan BV; Enza Zaden BV; DeRuiter Seeds B.V.; Nunhems USA; Seminis Vegetable Seeds, Inc.; Syngenta Seeds, Inc.(Syngenta); Vilmorin Co.; University of California Davis(University of California System)	This project was supported by an award from the University of California UC Discovery Program bio06-10565 with matching funds from Rijk Zwaan BV, Enza Zaden BV, DeRuiter Seeds B.V., Nunhems USA, Seminis Vegetable Seeds, Inc., Syngenta Seeds, Inc., and Vilmorin Co.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the University of California Davis, UC Discovery program, which received matching funds from these commercial entities: Rijk Zwaan BV, Enza Zaden BV, DeRuiter Seeds B. V., Nunhems USA, Seminis Vegetable Seeds, Inc., Syngenta Seeds, Inc., and Vilmorin Co.. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The role of the commercial entities was limited to providing funds for research. The funds were to the Regents of the University of California. The authors have not personally taken money from the funders.	Adetula OA, 2006, AFR J BIOTECHNOL, V5, P120; *AFF, 2007, QUAL ASS EX GEN ARR; Aguilar-Melendez A, 2009, AM J BOT, V96, P1190, DOI 10.3732/ajb.0800155; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS J, 1993, GEOGR REV, V83, P194, DOI 10.2307/215257; Andrews J., 1984, PEPPERS DOMESTICATED; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Ashrafi Hamid, 2012, BMC Genomics, V13, P571, DOI 10.1186/1471-2164-13-571; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bosland P. W., 2012, Peppers: vegetable and spice capsicums, DOI 10.1079/9781845938253.0000; BOSLAND PW, 1991, PLANT DIS, V75, P1048, DOI 10.1094/PD-75-1048; Das S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-107; Eshbaugh W. H., 1993, New crops., P132; Falush D, 2003, GENETICS, V164, P1567; FAO, 1996, REP STAT WORLDS PLAN; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Greenleaf WH, 1986, BREEDING VEGETABLE C, P67; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; HEISER C B JR, 1969, Taxon, V18, P277, DOI 10.2307/1218828; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; IPGRI AVRDC, 1995, DESCR CAPS CAPS SPP; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; Jung JK, 2010, EUPHYTICA, V175, P91, DOI 10.1007/s10681-010-0191-2; Kaeuffer R, 2007, HEREDITY, V99, P374, DOI 10.1038/sj.hdy.6801010; Kim H, 2008, I S MOD ANAL SIM COM, P181, DOI 10.1186/1471-2229-8-101; Kochieva EZ, 2003, RUSS J GENET+, V39, P1345, DOI 10.1023/B:RUGE.0000009146.54565.94; Kraft KH, 2009, DOMESTICATION CHILE; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Lane RP, 1997, HORTSCIENCE, V32, P333, DOI 10.21273/HORTSCI.32.2.333; LEFEBVRE V, 1993, EUPHYTICA, V71, P189, DOI 10.1007/BF00040408; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Moscone EA, 2003, ANN BOT-LONDON, V92, P21, DOI 10.1093/aob/mcg105; Nazia Akbar, 2010, Asian Journal of Agricultural Sciences, V2, P53; Neitzke RS, 2010, HORTIC BRAS, V28, P47, DOI 10.1590/S0102-05362010000100009; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; ORTEGA RG, 1992, PLANT BREEDING, V108, P118, DOI 10.1111/j.1439-0523.1992.tb00110.x; Paran I, 1998, EUPHYTICA, V99, P167, DOI 10.1023/A:1018301215945; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; PRINCE JP, 1995, GENOME, V38, P224, DOI 10.1139/g95-027; Pritchard JK, 2000, GENETICS, V155, P945; Riztyan, 2011, POULTRY SCI, V90, P2471, DOI 10.3382/ps.2011-01450; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; SMITH PG, 1951, AM J BOT, V38, P362, DOI 10.2307/2437824; SMITH PG, 1987, HORTSCIENCE, V22, P11; Souza MM, 2012, CROP BREED APPL BIOT, V12, P138, DOI 10.1590/S1984-70332012000200007; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stoffel K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-185; Tam SM, 2009, THEOR APPL GENET, V119, P973, DOI 10.1007/s00122-009-1102-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Todorovska E, 2010, GENETIKA-BELGRADE, V42, P177, DOI 10.2298/GENSR1001175T; USDA-ARS, 2011, GRIN SPEC REC CAPS; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; Varshney RK, 2009, J PLANT BIOCHEM BIOT, V18, P127, DOI 10.1007/BF03263311; Votava EJ, 2005, ECON BOT, V59, P8, DOI 10.1663/0013-0001(2005)059[0008:GDOCCA]2.0.CO;2; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xu Y. B., 2003, Rice science: innovations and impact for livelihood. Proceedings of the International Rice Research Conference, Beijing, China, 16-19 September 2002, P213; Zewdie Y, 2004, GENET RESOUR CROP EV, V51, P147, DOI 10.1023/B:GRES.0000020858.96226.38	72	71	75	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56200	10.1371/journal.pone.0056200	http://dx.doi.org/10.1371/journal.pone.0056200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409153	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300065
J	Toledo, JB; Da, X; Bhatt, P; Wolk, DA; Arnold, SE; Shaw, LM; Trojanowski, JQ; Davatzikos, C				Toledo, Jon B.; Da, Xiao; Bhatt, Priyanka; Wolk, David A.; Arnold, Steven E.; Shaw, Leslie M.; Trojanowski, John Q.; Davatzikos, Christos		Alzheimer's Dis Neuroimaging	Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CORTICOTROPIN-RELEASING-FACTOR; FRONTOTEMPORAL LOBAR DEGENERATION; NEUROIMAGING INITIATIVE ADNI; MEDIAL PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; AMYLOID-BETA; TAU PATHOLOGY; IN-VIVO; SYNAPTIC ALTERATIONS	Different inflammatory and metabolic pathways have been associated with Alzheimers disease (AD). However, only recently multi-analyte panels to study a large number of molecules in well characterized cohorts have been made available. These panels could help identify molecules that point to the affected pathways. We studied the relationship between a panel of plasma biomarkers (Human DiscoveryMAP (R)) and presence of AD-like brain atrophy patterns defined by a previously published index (SPARE-AD) at baseline in subjects of the ADNI cohort. 818 subjects had MRI-derived SPARE-AD scores, of these subjects 69% had plasma biomarkers and 51% had CSF tau and A beta measurements. Significant analyte-SPARE-AD and analytes correlations were studied in adjusted models. Plasma cortisol and chromogranin A showed a significant association that did not remain significant in the CSF signature adjusted model. Plasma macrophage inhibitory protein-1 alpha and insulin-like growth factor binding protein 2 showed a significant association with brain atrophy in the adjusted model. Cortisol levels showed an inverse association with tests measuring processing speed. Our results indicate that stress and insulin responses and cytokines associated with recruitment of inflammatory cells in MCI-AD are associated with its characteristic AD-like brain atrophy pattern and correlate with clinical changes or CSF biomarkers.	[Toledo, Jon B.; Shaw, Leslie M.; Trojanowski, John Q.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging,Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Da, Xiao; Bhatt, Priyanka; Davatzikos, Christos] Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA 19104 USA; [Wolk, David A.; Arnold, Steven E.] Univ Penn, Penn Memory Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Davatzikos, C (corresponding author), Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA 19104 USA.	christos@rad.upenn.edu	Davatzikos, Christos/ABE-2057-2021; Da, Xiao/F-8738-2015	Da, Xiao/0000-0001-9898-8130; Davatzikos, Christos/0000-0002-1025-8561; Toledo, Jon/0000-0003-4366-9268	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; Alfonso Martin Escudero foundation; Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; NATIONAL INSTITUTE ON AGING [U01AG024904, P30AG010129, K01AG030514, U19AG010483, R01AG039478, R01AG014971] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Alfonso Martin Escudero foundation; Abbott(Abbott Laboratories); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca(AstraZeneca); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (NIH) (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. JQT is the William Maul Measy-Truman G. Schnabel Jr. M. D. Professor of Geriatric Medicine and Gerontology. JBT's work was supported by a grant from the Alfonso Martin Escudero foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Baena N, 2011, LANCET NEUROL, V10, P213, DOI 10.1016/S1474-4422(10)70323-9; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bian H, 2008, NEUROLOGY, V70, P1827, DOI 10.1212/01.wnl.0000311445.21321.fc; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Britschgi M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008862; Brown SM, 2005, CEREB CORTEX, V15, P1714, DOI 10.1093/cercor/bhi048; Buchhave P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006294; Budas G, 1999, NEUROSCI LETT, V276, P61, DOI 10.1016/S0304-3940(99)00790-9; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Filipovych R, 2011, NEUROIMAGE, V55, P1109, DOI 10.1016/j.neuroimage.2010.12.066; Friedman B, 2005, J AM GERIATR SOC, V53, P1570, DOI 10.1111/j.1532-5415.2005.53461.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gold SM, 2005, J CLIN ENDOCR METAB, V90, P3262, DOI 10.1210/jc.2004-2181; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Hoefer M, 2008, BRAIN, V131, P1646, DOI 10.1093/brain/awn082; Hoeflich A, 2001, ENDOCRINOLOGY, V142, P1889, DOI 10.1210/en.142.5.1889; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hooper C, 2009, FEBS LETT, V583, P3461, DOI 10.1016/j.febslet.2009.09.049; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Huang CW, 2009, J CLIN NEUROSCI, V16, P1283, DOI 10.1016/j.jocn.2008.12.026; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Kadir A, 2011, BRAIN, V134, P301, DOI 10.1093/brain/awq349; Kalaria RN, 2012, J NEUROL SCI; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Kester M I, 2011, NEUROBIOL AGING; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Kiepe D, 2002, KIDNEY INT, V62, P1591, DOI 10.1046/j.1523-1755.2002.00603.x; Kling MA, 2012, ALZHEIMERS DEMENT; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994; MacDonald D.J., 1998, NEUROIMAGE, V7, pS717, DOI [10.1016/S1053-8119(18)31550-7, DOI 10.1016/S1053-8119(18)31550-7]; Man SM, 2007, NEUROBIOL AGING, V28, P485, DOI 10.1016/j.neurobiolaging.2006.02.013; MANCARDI GL, 1983, ACTA NEUROPATHOL, V61, P76, DOI 10.1007/BF00688390; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Rissman RA, 2007, J NEUROSCI, V27, P6552, DOI 10.1523/JNEUROSCI.5173-06.2007; Ryan J.J., 1992, CLIN NEUROPSYCHOL, V6, P53, DOI DOI 10.1080/; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; SCHEFF SW, 1993, ANN NEUROL, V33, P190, DOI 10.1002/ana.410330209; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shen X, 2012, MOL CELL BIOL; Soares HD, 2012, ARCH NEUROL-CHICAGO, P1, DOI DOI 10.1001/ARCHNEUROL.2012.1070; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Sotiropoulos I, 2008, J NEUROCHEM, V107, P385, DOI 10.1111/j.1471-4159.2008.05613.x; Sotiropoulos I, 2011, J NEUROSCI, V31, P7840, DOI 10.1523/JNEUROSCI.0730-11.2011; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Toledo JB, 2012, ACTA NEUROPATHOL; Toledo JB, 2012, ALZHEIMERS DEMENT, V8, P483, DOI 10.1016/j.jalz.2011.08.008; Toledo JB, 2011, ACTA NEUROPATHOL, V122, P401, DOI 10.1007/s00401-011-0861-8; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Weisberg S, 2005, APPL LINEAR REGRESSI, V3rd, DOI DOI 10.1002/0471704091; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yau JLW, 2011, J NEUROSCI, V31, P4188, DOI 10.1523/JNEUROSCI.6145-10.2011; Young AH, 1999, PSYCHOPHARMACOLOGY, V145, P260, DOI 10.1007/s002130051057; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	102	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55531	10.1371/journal.pone.0055531	http://dx.doi.org/10.1371/journal.pone.0055531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408997	Green Published, gold, Green Submitted			2022-12-25	WOS:000314660300021
J	Tombline, G; Schwingel, JM; Lapek, JD; Friedman, AE; Darrah, T; Maguire, M; Van Alst, NE; Filiatrault, MJ; Iglewski, BH				Tombline, Gregory; Schwingel, Johanna M.; Lapek, John D., Jr.; Friedman, Alan E.; Darrah, Thomas; Maguire, Michael; Van Alst, Nadine E.; Filiatrault, Melanie J.; Iglewski, Barbara H.			Pseudomonas aeruginosa PA1006 Is a Persulfide-Modified Protein That Is Critical for Molybdenum Homeostasis	PLOS ONE			English	Article							ESCHERICHIA-COLI; CYSTEINE DESULFURASE; MOLYBDOPTERIN SYNTHASE; BIOSYNTHESIS; INSIGHTS; DATABASE; CLONING; YHHP; SCOP	A companion manuscript revealed that deletion of the Pseudomonas aeruginosa (Pae) PA1006 gene caused pleiotropic defects in metabolism including a loss of all nitrate reductase activities, biofilm maturation, and virulence. Herein, several complementary approaches indicate that PA1006 protein serves as a persulfide-modified protein that is critical for molybdenum homeostasis in Pae. Mutation of a highly conserved Cys22 to Ala or Ser resulted in a loss of PA1006 activity. Yeast-two-hybrid and a green-fluorescent protein fragment complementation assay (GFP-PFCA) in Pae itself revealed that PA1006 interacts with Pae PA3667/CsdA and PA3814/IscS Cys desulfurase enzymes. Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) "top-down" analysis of PA1006 purified from Pae revealed that conserved Cys22 is post-translationally modified in vivo in the form a persulfide. Inductively-coupled-plasma (ICP)-MS analysis of Delta PA1006 mutant extracts revealed that the mutant cells contain significantly reduced levels of molybdenum compared to wild-type. GFP-PFCA also revealed that PA1006 interacts with several molybdenum cofactor (MoCo) biosynthesis proteins as well as nitrate reductase maturation factor NarJ and component NarH. These data indicate that a loss of PA1006 protein's persulfide sulfur and a reduced availability of molybdenum contribute to the phenotype of a Delta PA1006 mutant.	[Tombline, Gregory; Schwingel, Johanna M.; Maguire, Michael; Van Alst, Nadine E.; Filiatrault, Melanie J.; Iglewski, Barbara H.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Lapek, John D., Jr.; Friedman, Alan E.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Darrah, Thomas] Duke Univ, Nicholas Sch Environm, Div Earth & Ocean Sci, Durham, NC 27708 USA	University of Rochester; University of Rochester; Duke University	Tombline, G (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	gtombline@urmc.rochester.edu; Barbara_Iglewski@URMC.Rochester.edu	Friedman, Alan/Q-4858-2018; Darrah, Tom H/I-2253-2016	Friedman, Alan/0000-0002-4764-8168; 	NIH [5R37AI0337131, 1 UL1 RR024160-1]; Cystic Fibrosis Foundation [IGLEWS00V0]; NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) [F32AI056825]; National Institute of Environmental Health Sciences [ES07026]; U of R start-up funds; National Institute of Environmental Health Sciences Training Center [ES01247]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI056825, R37AI033713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NRSA Postdoctoral fellowship from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U of R start-up funds; National Institute of Environmental Health Sciences Training Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant NIH 5R37AI033713 and the Cystic Fibrosis Foundation Therapeutics grant IGLEWS00V0 to B. H. I. M. J. F. performed this work as a postdoctoral fellow at the University of Rochester and was supported by a NRSA Postdoctoral fellowship from the National Institutes of Health (NIH) (F32AI056825). A. E. F. was funded by 1 UL1 RR024160-1 (NIH), National Institute of Environmental Health Sciences Training Grant ES07026, and Center Grant ES01247 and U of R start-up funds. J. L. was supported by a National Institute of Environmental Health Sciences Training Grant (ES07026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency USEP, 1991, AN SOILS SED IND COU; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Darrah TH, 2009, METALLOMICS, V1, P479, DOI 10.1039/b905145g; Filiatrault MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055594; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Hagen WR, 2011, COORDIN CHEM REV, V255, P1117, DOI 10.1016/j.ccr.2011.02.009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; Katoh E, 2000, J MOL BIOL, V304, P219, DOI 10.1006/jmbi.2000.4170; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; PASSADOR L, 1989, J BACTERIOL, V171, P6234, DOI 10.1128/jb.171.11.6234-6242.1989; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rudolph MJ, 2003, J BIOL CHEM, V278, P14514, DOI 10.1074/jbc.M300449200; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; US Environmental Protection Agency OoRaD, 1994, DET TRAC EL WAT WAST; Wagner Victoria E., 2008, P129; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Yang Z, 2011, J STRUCT BIOL	43	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55593	10.1371/journal.pone.0055593	http://dx.doi.org/10.1371/journal.pone.0055593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409003	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300022
J	Eberhard, J; Grote, K; Luchtefeld, M; Heuer, W; Schuett, H; Divchev, D; Scherer, R; Schmitz-Streit, R; Langfeldt, D; Stumpp, N; Staufenbiel, I; Schieffer, B; Stiesch, M				Eberhard, Joerg; Grote, Karsten; Luchtefeld, Maren; Heuer, Wieland; Schuett, Harald; Divchev, Dimitar; Scherer, Ralph; Schmitz-Streit, Ruth; Langfeldt, Daniela; Stumpp, Nico; Staufenbiel, Ingmar; Schieffer, Bernhard; Stiesch, Meike			Experimental Gingivitis Induces Systemic Inflammatory Markers in Young Healthy Individuals: A Single-Subject Interventional Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; C-REACTIVE PROTEIN; ATHEROSCLEROTIC PLAQUES; PERIODONTAL PATHOGENS; SUPRAGINGIVAL PLAQUE; MICROBIAL COMPLEXES; SUBGINGIVAL PLAQUE; RISK-FACTORS; DISEASE; IDENTIFICATION	Objectives: We here investigated whether experimental gingivitis enhances systemic markers of inflammation which are also known as surrogate markers of atherosclerotic plaque development. Background: Gingivitis is a low-level oral infection induced by bacterial deposits with a high prevalence within Western populations. A potential link between the more severe oral disease periodontitis and cardiovascular disease has already been shown. Methods: 37 non-smoking young volunteers with no inflammatory disease or any cardiovascular risk factors participated in this single-subject interventional study with an intra-individual control. Intentionally experimental oral inflammation was induced by the interruption of oral hygiene for 21 days, followed by a 21-days resolving phase after reinitiation of oral hygiene. Primary outcome measures at baseline, day 21 and 42 were concentrations of hsCRP, IL-6, and MCP-1, as well as adhesion capacity and oxLDL uptake of isolated blood monocytes. Results: The partial cessation of oral hygiene procedures was followed by the significant increase of gingival bleeding (34.0%, P<0.0001). This local inflammation was associated with a systemic increase in hsCRP (0.24 mg/L, P = 0.038), IL-6 (12.52 ng/L, P = 0.0002) and MCP-1 (9.10 ng/l, P = 0.124) in peripheral blood samples between baseline and day 21, which decreased at day 42. Monocytes showed an enhanced adherence to endothelial cells and increased foam cell formation after oxLDL uptake (P<0.050) at day 21 of gingivitis. Conclusions: Bacterial-induced gingival low-level inflammation induced a systemic increase in inflammatory markers. Dental hygiene almost completely reversed this experimental inflammatory process, suggesting that appropriate dental prophylaxis may also limit systemic markers of inflammation in subjects with natural gingivitis. International Clinical Trials Register Platform of the World Health Organization, registry number: DRKS00003366, URL: http://apps.who.int/trialsearch/Default.aspx.	[Eberhard, Joerg; Heuer, Wieland; Stumpp, Nico; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomat Sci, Hannover, Germany; [Grote, Karsten; Luchtefeld, Maren; Schuett, Harald; Divchev, Dimitar; Schieffer, Bernhard] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Scherer, Ralph] Hannover Med Sch, Dept Med Stat, Hannover, Germany; [Staufenbiel, Ingmar] Hannover Med Sch, Dept Operat Dent & Periodontol, Hannover, Germany; [Schmitz-Streit, Ruth; Langfeldt, Daniela] Univ Kiel, Inst Microbiol, Kiel, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Kiel	Eberhard, J (corresponding author), Hannover Med Sch, Dept Prosthet Dent & Biomat Sci, Hannover, Germany.	eberhard.joerg@mh-hannover.de	Eberhard, Joerg/AAY-9034-2020; Eberhard, Jörg/G-1103-2012; Staufenbiel, Ingmar/K-7675-2018; Stefanadis, Christodoulos/ABH-2232-2020	Eberhard, Joerg/0000-0001-8060-2893; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829; Divchev, Dimitar/0000-0002-3062-3271; Grote, Karsten/0000-0001-7914-3159; Stefanadis, Christodoulos/0000-0001-5974-6454	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany [Eb 223/5-1]; Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft DFG, Bonn, Germany(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was in part supported by the Deutsche Forschungsgemeinschaft DFG, Bonn, Germany (Eb 223/5-1). The authors acknowledge funding of the publication costs by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja OM, 2009, J PERIODONTOL, V80, P307, DOI [10.1902/jop.2009.080385, 10.1902/jop.2009.080385 ]; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Baumgartner JC, 1999, J ENDODONT, V25, P413, DOI 10.1016/S0099-2399(99)80268-4; Boucelma M, 2011, INT ANGIOL, V30, P18; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; Conrads G, 1997, J ENDODONT, V23, P433, DOI 10.1016/S0099-2399(97)80297-X; Conrads G, 1996, J PERIODONTOL, V67, P994, DOI 10.1902/jop.1996.67.10.994; De Groot L, 2010, EUR J CLIN INVEST, V40, P835, DOI 10.1111/j.1365-2362.2010.02333.x; Demmer RT, 2010, PERIODONTOL 2000, V53, P28, DOI 10.1111/j.1600-0757.2009.00326.x; Drakopoulou M, 2009, ATHEROSCLEROSIS, V206, P335, DOI 10.1016/j.atherosclerosis.2009.01.041; Eberhard J, 2005, BIOMATERIALS, V26, P1545, DOI 10.1016/j.biomaterials.2004.05.005; Eberhard J, 2000, ANAL BIOCHEM, V280, P258, DOI 10.1006/abio.2000.4540; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Elter JR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.002; Ericsson JS, 2009, SWED DENT J, V33, P131; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gaetti-Jardim E, 2009, J MED MICROBIOL, V58, P1568, DOI 10.1099/jmm.0.013383-0; Haffajee AD, 2008, ORAL MICROBIOL IMMUN, V23, P196, DOI 10.1111/j.1399-302X.2007.00411.x; Haffajee AD, 2009, J PERIODONTAL RES, V44, P511, DOI 10.1111/j.1600-0765.2008.01154.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Honda T, 2006, CLIN EXP IMMUNOL, V144, P35, DOI 10.1111/j.1365-2249.2006.03028.x; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; Igarashi E, 2009, ORAL MICROBIOL IMMUN, V24, P310, DOI 10.1111/j.1399-302X.2009.00513.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kim SG, 2005, J MICROBIOL, V43, P209; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Li YM, 2010, AM J DENT, V23, P9; Libby P, 1997, CIRCULATION, V96, P4095; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lu QA, 2010, J CLIN PERIODONTOL, V37, P789, DOI 10.1111/j.1600-051X.2010.01600.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; SAGLIE FR, 1987, J PERIODONTOL, V58, P837, DOI 10.1902/jop.1987.58.12.837; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Slawik S, 2011, EUR J CLIN NUTR, V65, P857, DOI 10.1038/ejcn.2011.45; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Uno K, 2010, BIOMARK MED, V4, P361, DOI [10.2217/bmm.10.57, 10.2217/BMM.10.57]; Wahaidi VY, 2011, J CLIN PERIODONTOL, V38, P412, DOI 10.1111/j.1600-051X.2011.01710.x; Wohifeil M, 2009, CLIN CHIM ACTA, V401, P105, DOI 10.1016/j.cca.2008.11.017; Ylostalo PV, 2006, J CLIN PERIODONTOL, V33, P92, DOI 10.1111/j.1600-051X.2005.00875.x; Zee KY, 1996, J CLIN PERIODONTOL, V23, P1025, DOI 10.1111/j.1600-051X.1996.tb00532.x	46	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55265	10.1371/journal.pone.0055265	http://dx.doi.org/10.1371/journal.pone.0055265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408963	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200021
J	Guillemot, L; Spadaro, D; Citi, S				Guillemot, Laurent; Spadaro, Domenica; Citi, Sandra			The Junctional Proteins Cingulin and Paracingulin Modulate the Expression of Tight Junction Protein Genes through GATA-4	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEART TUBE FORMATION; SMALL GTPASE RHOA; CLAUDIN-2 EXPRESSION; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; VENTRAL MORPHOGENESIS; SEQUENCE SIMILARITY; ADHERENS JUNCTIONS; DIFFERENTIATION	The cytoplamic junctional proteins cingulin and paracingulin have been implicated in the regulation of gene expression in different cultured cell models. In renal epithelial MDCK cells, depletion of either protein results in a Rho-dependent increase in the expression of claudin-2. Here we examined MDCK cell clones depleted of both cingulin and paracingulin (double-KD cells), and we found that unexpectedly the expression of claudin-2, and also the expression of ZO-3 and claudin-3, were decreased, while RhoA activity was still higher than in control cells. The decreased expression of claudin-2 and other TJ proteins in double-KD cells correlated with reduced levels of the transcription factor GATA-4, and was rescued by overexpression of GATA-4, but not by inhibiting RhoA activity. These results indicate that in MDCK cells GATA-4 is required for the expression of claudin-2 and other TJ proteins, and that maintenance of GATA-4 expression requires either cingulin or paracingulin. These results and previous studies suggest a model whereby cingulin and paracingulin redundantly control the expression of specific TJ proteins through distinct GATA-4- and RhoA-dependent mechanisms, and that in the absence of sufficient levels of GATA-4 the RhoA-mediated upregulation of claudin-2 is inhibited.	[Guillemot, Laurent; Spadaro, Domenica; Citi, Sandra] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Spadaro, Domenica; Citi, Sandra] Univ Geneva, Dept Cell Biol, Geneva, Switzerland; [Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.	sandra.citi@unige.ch	Citi, Sandra/E-4514-2014	Citi, Sandra/0000-0002-6537-4818	Swiss National Science Foundation [31003A103637, 31003A116763]; State of Geneva; Section of Biology of the University of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Geneva; Section of Biology of the University of Geneva	This study was funded by the Swiss National Science Foundation (grants n. 31003A103637, 31003A116763), the State of Geneva, and the Section of Biology of the University of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Carrozzino F, 2005, AM J PHYSIOL-CELL PH, V289, pC1002, DOI 10.1152/ajpcell.00175.2005; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; Citi S, 2001, CELL CELL INTERACTIO, P153; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2012, J CELL SCI IN PRESS; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot Laurent, 2006, P54; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Meng W, 2009, COLD SPRING HARBOR P, DOI [10.1101/cshper-spect.a002899, DOI 10.1101/CSHPER-SPECT.A002899]; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Sakaguchi T, 2002, J BIOL CHEM, V4, P4; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Spadaro D, 2012, ESSAYS BIOC IN PRESS; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	45	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55873	10.1371/journal.pone.0055873	http://dx.doi.org/10.1371/journal.pone.0055873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409073	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200081
J	Ikenaka, K; Kawai, K; Katsuno, M; Huang, Z; Jiang, YM; Iguchi, Y; Kobayashi, K; Kimata, T; Waza, M; Tanaka, F; Mori, I; Sobue, G				Ikenaka, Kensuke; Kawai, Kaori; Katsuno, Masahisa; Huang, Zhe; Jiang, Yue-Mei; Iguchi, Yohei; Kobayashi, Kyogo; Kimata, Tsubasa; Waza, Masahiro; Tanaka, Fumiaki; Mori, Ikue; Sobue, Gen			dnc-1/dynactin 1 Knockdown Disrupts Transport of Autophagosomes and Induces Motor Neuron Degeneration	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; MUTANT DYNACTIN; SPINAL-CORD; LIFE-SPAN; DYNEIN; TUBULIN; PATHWAY; PROTEIN; CELLS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. We previously showed that the expression of dynactin 1, an axon motor protein regulating retrograde transport, is markedly reduced in spinal motor neurons of sporadic ALS patients, although the mechanisms by which decreased dynactin 1 levels cause neurodegeneration have yet to be elucidated. The accumulation of autophagosomes in degenerated motor neurons is another key pathological feature of sporadic ALS. Since autophagosomes are cargo of dynein/dynactin complexes and play a crucial role in the turnover of several organelles and proteins, we hypothesized that the quantitative loss of dynactin 1 disrupts the transport of autophagosomes and induces the degeneration of motor neuron. In the present study, we generated a Caenorhabditis elegans model in which the expression of DNC-1, the homolog of dynactin 1, is specifically knocked down in motor neurons. This model exhibited severe motor defects together with axonal and neuronal degeneration. We also observed impaired movement and increased number of autophagosomes in the degenerated neurons. Furthermore, the combination of rapamycin, an activator of autophagy, and trichostatin which facilitates axonal transport dramatically ameliorated the motor phenotype and axonal degeneration of this model. Thus, our results suggest that decreased expression of dynactin 1 induces motor neuron degeneration and that the transport of autophagosomes is a novel and substantial therapeutic target for motor neuron degeneration.	[Ikenaka, Kensuke; Kawai, Kaori; Katsuno, Masahisa; Huang, Zhe; Jiang, Yue-Mei; Iguchi, Yohei; Waza, Masahiro; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kobayashi, Kyogo; Kimata, Tsubasa; Mori, Ikue] Nagoya Univ, Grp Mol Neurobiol, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Sobue, Gen] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Sobue, G (corresponding author), Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	sobueg@med.nagoya-u.ac.jp	KATSUNO, MASAHISA/I-7502-2014	KATSUNO, MASAHISA/0000-0001-9453-9311; Kobayashi, Kyogo/0000-0002-2769-9646	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25293207] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research and Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology, Grants-in-Aid for Scientific Research from the Ministry of Health, Labor, and Welfare, a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology", and Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; BRENNER S, 1974, GENETICS, V77, P71; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Comley LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017639; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hall DH, 1997, J NEUROSCI, V17, P1033; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Ishigaki S, 2002, J NEUROCHEM, V82, P576, DOI 10.1046/j.1471-4159.2002.00998.x; Jiang YM, 2007, J NEUROPATH EXP NEUR, V66, P617, DOI 10.1097/nen.0b013e318093ece3; Katsumata K, 2010, AUTOPHAGY, V6, P378, DOI 10.4161/auto.6.3.11262; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koushika SP, 2004, J NEUROSCI, V24, P3907, DOI 10.1523/JNEUROSCI.5039-03.2004; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Miyara A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001384; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ohara S, 2004, EXP NEUROL, V187, P289, DOI 10.1016/j.expneurol.2004.03.002; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; Paredez AR, 2008, PLANT PHYSIOL, V147, P1723, DOI 10.1104/pp.108.120196; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stiernagle Theresa, 2006, WormBook, P1; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Takada T, 2005, INT J DEV BIOL, V49, P891, DOI 10.1387/ijdb.052031tt; THOMAS JH, 1990, GENETICS, V124, P855; Welte MA, 2010, CURR BIOL, V20, pR410, DOI 10.1016/j.cub.2010.03.018; Yang Y, 2008, AUTOPHAGY, V4, P243, DOI 10.4161/auto.5431; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang X, 2011, AUTOPHAGY, V7	55	68	71	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e54511	10.1371/journal.pone.0054511	http://dx.doi.org/10.1371/journal.pone.0054511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408943	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200009
J	Luiz, RD; Silva, KAS; Rampaso, RR; Antonio, EL; Montemor, J; Bocalini, DS; dos Santos, L; Moura, L; Tucci, PJF; de Abreu, NP; Schor, N				Luiz, Rafael da Silva; Santos Silva, Kleiton Augusto; Rampaso, Rodolfo Rosseto; Antonio, Ednei Luiz; Montemor, Jairo; Bocalini, Danilo Sales; dos Santos, Leonardo; Moura, Luiz; Ferreira Tucci, Paulo Jose; de Abreu, Nayda Parisio; Schor, Nestor			Exercise Attenuates Renal Dysfunction with Preservation of Myocardial Function in Chronic Kidney Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; 5/6 NEPHRECTOMIZED RATS; HEART-FAILURE; POSTEXERCISE HYPOTENSION; SUBTOTAL NEPHRECTOMY; SWIMMING EXERCISE; AEROBIC EXERCISE; NITRIC-OXIDE; PROGRESSION; THERAPY	Previous studies have suggested that exercise improves renal and cardiac functions in patients with chronic kidney disease. The aim of this study was to evaluate the effects of long-term aerobic swimming exercise with overload on renal and cardiac function in rats with 5/6 nefrectomy (5/6Nx). Eight Wistar rats were placed into 4 groups: Control (C), Control+Exercise (E), Sedentary 5/6Nx (NxS) and 5/6Nx+Exercise (NxE). The rats were subjected to swimming exercise sessions with overload for 30 min five days per week for five weeks. Exercise reduced the effect of 5/6Nx on creatinine clearance compared to the NxS group. In addition, exercise minimized the increase in mean proteinuria compared to the NxS group (96.9 +/- 10.0 vs. 51.4 +/- 9.9 mg/24 h; p<0.05). Blood pressure was higher in the NxS and NxE groups compared to the C and E groups (216 +/- 4 and 178 +/- 3 vs. 123 +/- 2 and 124 +/- 2 mm Hg, p<0.05). In the 200 glomeruli that were evaluated, the NxS group had a higher sclerosis index than did the NxE group (16% vs. 2%, p<0.05). Echocardiography demonstrated a higher anterior wall of the left ventricle (LV) in diastole in the NxS group compared with the C, E and NxE groups. The NxS group also had a higher LV posterior wall in diastole and systole compared with the E group. The developed isometric tension in Lmax of the heart papillary muscle was lower in the NxS group compared with the C, E and NxE groups. These results suggested that exercise in 5/6Nx animals might reduce the progression of renal disease and lessen the cardiovascular impact of a reduction in renal mass.	[Luiz, Rafael da Silva; Santos Silva, Kleiton Augusto; Rampaso, Rodolfo Rosseto; Moura, Luiz; de Abreu, Nayda Parisio; Schor, Nestor] Univ Fed Sao Paulo, UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Antonio, Ednei Luiz; Montemor, Jairo; Bocalini, Danilo Sales; Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo, Cardiophysiol & Pathophysiol Lab, Sao Paulo, Brazil; [dos Santos, Leonardo] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Luiz, RD (corresponding author), Univ Fed Sao Paulo, UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil.	rafakarate@hotmail.com	Schor, Nestor/K-4364-2013; Bocalini, Danilo/J-1997-2014; Antonio, Ednei/AGG-9987-2022; dos Santos, Leonardo/B-6509-2013; Batista, Marcelo/K-4305-2013	Antonio, Ednei/0000-0002-8254-5762; dos Santos, Leonardo/0000-0002-4340-6364; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Oswaldo Ramos (FOR) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; Antonio EL, 2009, J CARD FAIL, V15, P540, DOI 10.1016/j.cardfail.2009.01.007; Bellinghieri G, 2008, J RENAL NUTR, V18, P158, DOI 10.1053/j.jrn.2007.10.031; Bergamaschi CT, 1997, MED SCI SPORT EXER, V29, P169, DOI 10.1097/00005768-199702000-00001; Bocalini DS, 2010, EUR J APPL PHYSIOL, V109, P909, DOI 10.1007/s00421-010-1406-x; Bocalini DS, 2009, INT HEART J, V50, P643, DOI 10.1536/ihj.50.643; Bohm CJ, 2010, J NEPHROL, V23, P235; Burke SW, 2000, ADV RENAL REPLACE TH, V7, P210, DOI 10.1053/jarr.2000.8120; Chaykovska L, 2011, CLIN LAB, V57, P455; Coelho BLP, 2010, J RENAL NUTR, V20, P169, DOI 10.1053/j.jrn.2009.10.007; Deguchi T, 2005, J PHARMACOL EXP THER, V314, P932, DOI 10.1124/jpet.105.085613; Derumeaux G, 2002, CIRCULATION, V105, P1602, DOI 10.1161/01.CIR.0000012943.91101.D7; dos Santos L, 2010, CAN J PHYSIOL PHARM, V88, P724, DOI [10.1139/Y10-062, 10.1139/y10-062]; Evangelista FS, 2003, BRAZ J MED BIOL RES, V36, P1751, DOI 10.1590/S0100-879X2003001200018; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; GOLDBERG AP, 1986, NEPHRON, V42, P311, DOI 10.1159/000183694; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Gunduz F, 2003, J APPL PHYSIOL, V95, P1867, DOI 10.1152/japplphysiol.00599.2003; Halliwill JR, 2000, J APPL PHYSIOL, V89, P1830, DOI 10.1152/jappl.2000.89.5.1830; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Hayashi SY, 2006, NEPHROL DIAL TRANSPL, V21, P125, DOI 10.1093/ndt/gfi075; HEIFETS M, 1987, KIDNEY INT, V32, P815, DOI 10.1038/ki.1987.281; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Johansen KL, 2007, J AM SOC NEPHROL, V18, P1845, DOI 10.1681/ASN.2007010009; Kanazawa M, 2006, AM J HYPERTENS, V19, P80, DOI 10.1016/j.amjhyper.2005.07.009; KLAHR S, 1987, KIDNEY INT, V32, pS35; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Knap B, 2005, THER APHER DIAL, V9, P211, DOI 10.1111/j.1774-9987.2005.00256.x; Kohzuki M, 2001, J HYPERTENS, V19, P1877, DOI 10.1097/00004872-200110000-00024; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; Moinuddin I, 2008, ADV CHRONIC KIDNEY D, V15, P83, DOI 10.1053/j.ackd.2007.10.004; Moraes MR, 2007, BIOL CHEM, V388, P533, DOI 10.1515/BC.2007.055; Henrique DMN, 2010, ARQ BRAS CARDIOL, V94, P823, DOI 10.1590/S0066-782X2010005000043; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; OSATO S, 1990, NEPHRON, V55, P306, DOI 10.1159/000185980; Osorio RAL, 2003, COMP BIOCHEM PHYS A, V135, P605, DOI 10.1016/S1095-6433(03)00144-2; Paterno JC, 2008, KIDNEY BLOOD PRESS R, V31, P367, DOI 10.1159/000176189; Portes LA, 2009, CLIN EXP PHARMACOL P, V36, P394, DOI 10.1111/j.1440-1681.2008.05070.x; Remuzzi G, 2005, KIDNEY INT, V68, P57; Salgado JV, 2010, BRAZ J MED BIOL RES, V43, P528, DOI 10.1590/S0100-879X2010000600002; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Windt WAKM, 2008, NEPHROL DIAL TRANSPL, V23, P3103, DOI 10.1093/ndt/gfn233; Wu X M, 1999, Nihon Jinzo Gakkai Shi, V41, P35; Zelle DM, 2011, CLIN J AM SOC NEPHRO, V6, P898, DOI 10.2215/CJN.03340410	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55363	10.1371/journal.pone.0055363	http://dx.doi.org/10.1371/journal.pone.0055363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408975	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200028
J	Steidinger, TU; Slone, SR; Ding, HP; Standaert, DG; Yacoubian, TA				Steidinger, Trent U.; Slone, Sunny R.; Ding, Huiping; Standaert, David G.; Yacoubian, Talene A.			Angiogenin in Parkinson Disease Models: Role of Akt Phosphorylation and Evaluation of AAV-Mediated Angiogenin Expression in MPTP Treated Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROBLASTOMA-CELLS; ENDOTHELIAL-CELLS; ANG GENE; MUTATIONS; VARIANTS; SURVIVAL; MOTONEURONS; ACTIVATION; MECHANISMS	The angiogenic factor, angiogenin, has been recently linked to both Amyotrophic Lateral Sclerosis (ALS) and Parkinson Disease (PD). We have recently shown that endogenous angiogenin levels are dramatically reduced in an alpha-synuclein mouse model of PD and that exogenous angiogenin protects against cell loss in neurotoxin-based cellular models of PD. Here, we extend our studies to examine whether activation of the prosurvival Akt pathway is required for angiogenin's neuroprotective effects against 1-methyl-4-phenylpyridinium (MPP+), as observed in ALS models, and to test the effect of virally-mediated overexpression of angiogenin in an in vivo PD model. Using a dominant negative Akt construct, we demonstrate that inhibition of the Akt pathway does not reduce the protective effect of angiogenin against MPP+ toxicity in the dopaminergic SH-SY5Y cell line. Furthermore, an ALS-associated mutant of angiogenin, K40I, which fails to induce Akt phosphorylation, was similar to wildtype angiogenin in protection against MPP+. These results confirm previous work showing neuroprotective effects of angiogenin against MPP+, and indicate that Akt is not required for this protective effect. We also investigated whether adeno-associated viral serotype 2 (AAV2)-mediated overexpression of angiogenin protects against dopaminergic neuron loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model. We found that angiogenin overexpression using this approach does not reduce the MPTP-induced degeneration of dopaminergic cells in the substantia nigra, nor limit the depletion of dopamine and its metabolites in the striatum. Together, these findings extend the evidence for protective effects of angiogenin in vitro, but also suggest that further study of in vivo models is required to translate these effects into meaningful therapies.	[Steidinger, Trent U.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Slone, Sunny R.; Ding, Huiping; Standaert, David G.; Yacoubian, Talene A.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yacoubian, TA (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA.	tyacoub@uab.edu		Ding, Huiping/0000-0001-5783-0759; Standaert, David/0000-0003-2921-8348	National Institutes of Health - National Institute of Neurological Disorders and Stroke [K08 (NS060948)]; American Parkinson Disease Association; Parkinson's Association of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060948] Funding Source: NIH RePORTER	National Institutes of Health - National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association; Parkinson's Association of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health - National Institute of Neurological Disorders and Stroke K08 (NS060948), by the American Parkinson Disease Association, and by the Parkinson's Association of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BICKNELL R, 1988, P NATL ACAD SCI USA, V85, P5961, DOI 10.1073/pnas.85.16.5961; Cho GW, 2010, MOL CELL BIOCHEM, V340, P133, DOI 10.1007/s11010-010-0410-0; Conforti FL, 2008, NEUROMUSCULAR DISORD, V18, P68, DOI 10.1016/j.nmd.2007.07.003; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim HM, 2007, BIOCHEM BIOPH RES CO, V352, P509, DOI 10.1016/j.bbrc.2006.11.047; Lambrechts D, 2006, TRENDS MOL MED, V12, P345, DOI 10.1016/j.molmed.2006.06.008; Li S, 2011, J CELL PHYSL, V227, P1639, DOI DOI 10.1002/JCP.22881; Li SP, 2010, FEBS J, V277, P3575, DOI 10.1111/j.1742-4658.2010.07766.x; Liu SM, 2001, BIOCHEM BIOPH RES CO, V287, P305, DOI 10.1006/bbrc.2001.5568; Paubel A, 2008, ARCH NEUROL-CHICAGO, V65, P1333, DOI 10.1001/archneur.65.10.1333; Rayaprolu S, 2012, ANN NEUROL, V71, P725, DOI 10.1002/ana.23586; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Tanno B, 2002, J BIOL CHEM, V277, P23172, DOI 10.1074/jbc.M200141200; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Xu ZP, 2001, BIOCHEM BIOPH RES CO, V285, P909, DOI 10.1006/bbrc.2001.5255; Yacoubian TA, 2008, NEUROBIOL DIS, V29, P515, DOI 10.1016/j.nbd.2007.11.008	35	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56092	10.1371/journal.pone.0056092	http://dx.doi.org/10.1371/journal.pone.0056092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409128	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200107
J	Dayaram, T; Lemoine, FJ; Donehower, LA; Marriott, SJ				Dayaram, Tajhal; Lemoine, Francene J.; Donehower, Lawrence A.; Marriott, Susan J.			Activation of WIP1 Phosphatase by HTLV-1 Tax Mitigates the Cellular Response to DNA Damage	PLOS ONE			English	Article							VIRUS TYPE-I; NUCLEOTIDE EXCISION-REPAIR; ONCOGENE PRODUCT TAX; NF-KAPPA-B; TYPE-1 TAX; CYCLE PROGRESSION; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TRANSACTIVATOR TAX; HUMAN-LYMPHOCYTES	Genomic instability stemming from dysregulation of cell cycle checkpoints and DNA damage response (DDR) is a common feature of many cancers. The cancer adult T cell leukemia (ATL) can occur in individuals infected with human T cell leukemia virus type 1 (HTLV-1), and ATL cells contain extensive chromosomal abnormalities, suggesting that they have defects in the recognition or repair of DNA damage. Since Tax is the transforming protein encoded by HTLV-1, we asked whether Tax can affect cell cycle checkpoints and the DDR. Using a combination of flow cytometry and DNA repair assays we showed that Tax-expressing cells exit G(1) phase and initiate DNA replication prematurely following damage. Reduced phosphorylation of H2AX (gamma H2AX) and RPA2, phosphoproteins that are essential to properly initiate the DDR, was also observed in Tax-expressing cells. To determine the cause of decreased DDR protein phosphorylation in Tax-expressing cells, we examined the cellular phosphatase, WIP1, which is known to dephosphorylate gamma H2AX. We found that Tax can interact with Wip1 in vivo and in vitro, and that Tax-expressing cells display elevated levels of Wip1 mRNA. In vitro phosphatase assays showed that Tax can enhance Wip1 activity on a gamma H2AX peptide target by 2-fold. Thus, loss of gamma H2AX in vivo could be due, in part, to increased expression and activity of WIP1 in the presence of Tax. siRNA knockdown of WIP1 in Tax-expressing cells rescued gamma H2AX in response to damage, confirming the role of WIP1 in the DDR. These studies demonstrate that Tax can disengage the G(1)/S checkpoint by enhancing WIP1 activity, resulting in reduced DDR. Premature G(1) exit of Tax-expressing cells in the presence of DNA lesions creates an environment that tolerates incorporation of random mutations into the host genome.	[Dayaram, Tajhal; Donehower, Lawrence A.; Marriott, Susan J.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.; Marriott, Susan J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Lemoine, Francene J.] NW State Univ Louisiana, Dept Biol Sci, Natchitoches, LA USA	Baylor College of Medicine; Baylor College of Medicine; University of Louisiana System; Northwestern State University of Louisiana	Marriott, SJ (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA.	susanm@bcm.tmc.edu			United States Public Service Grant, National Cancer Institute, National Institutes of Health [CA-77371]; NATIONAL CANCER INSTITUTE [R01CA077371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	United States Public Service Grant, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the United States Public Service Grant CA-77371 from National Cancer Institute, National Institutes of Health, awarded to SJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADYA N, 1995, J VIROL, V69, P1834, DOI 10.1128/JVI.69.3.1834-1841.1995; Al-Mohanna MA, 2001, CARCINOGENESIS, V22, P573, DOI 10.1093/carcin/22.4.573; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bullock SK, 2001, CARCINOGENESIS, V22, P233, DOI 10.1093/carcin/22.2.233; Cereseto A, 1996, BLOOD, V88, P1551, DOI 10.1182/blood.V88.5.1551.bloodjournal8851551; Chandhasin C, 2008, J VIROL, V2, P46; Chuman Y, 2008, PROTEIN PEPTIDE LETT, V15, P938, DOI 10.2174/092986608785849236; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3551; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Haller K, 2002, MOL CELL BIOL, V22, P3327, DOI 10.1128/MCB.22.10.3327-3338.2002; Han HS, 2009, MOL CANCER RES, V7, P713, DOI 10.1158/1541-7786.MCR-08-0247; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; HINRICHS SH, 1987, SCIENCE, V237, P1340, DOI 10.1126/science.2888191; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; KANNO T, 1994, MOL CELL BIOL, V14, P6443, DOI 10.1128/MCB.14.10.6443; Kao SY, 2000, J BIOL CHEM, V275, P35926, DOI 10.1074/jbc.M004397200; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; KORBER B, 1991, J VIROL, V65, P5471, DOI 10.1128/JVI.65.10.5471-5476.1991; Lemoine FJ, 2002, ONCOGENE, V21, P7230, DOI 10.1038/sj.onc.1205898; Lemoine FJ, 2001, J BIOL CHEM, V276, P31851, DOI 10.1074/jbc.M105195200; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LOW KG, 1994, MOL CELL BIOL, V14, P4958, DOI 10.1128/MCB.14.7.4958; Low KG, 1997, J VIROL, V71, P1956, DOI 10.1128/JVI.71.3.1956-1962.1997; Lowe JM, 2009, J BIOL CHEM; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CELL CYCLE, V7, P164, DOI 10.4161/cc.7.2.5299; McDonald ER, 2001, ANN MED, V33, P113, DOI 10.3109/07853890109002066; Miyake H, 1999, VIROLOGY, V253, P155, DOI 10.1006/viro.1998.9500; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Mulloy JC, 1998, J VIROL, V72, P8852, DOI 10.1128/JVI.72.11.8852-8860.1998; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Nakayama K, 2000, LEUKEMIA RES, V24, P299, DOI 10.1016/S0145-2126(99)00186-1; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; Neuveut C, 1998, MOL CELL BIOL, V18, P3620, DOI 10.1128/MCB.18.6.3620; Nguyen TA, 2010, DNA REPAIR, V9, P813, DOI 10.1016/j.dnarep.2010.04.005; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Reddy TR, 1997, ONCOGENE, V14, P2785, DOI 10.1038/sj.onc.1201119; RIMSKY L, 1988, NATURE, V335, P738, DOI 10.1038/335738a0; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; SMITH MR, 1991, J CLIN INVEST, V88, P1038, DOI 10.1172/JCI115364; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; Suzuki T, 1999, VIROLOGY, V259, P384, DOI 10.1006/viro.1999.9760; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; YAMAGUCHI K, 1983, BLOOD, V62, P758; YAMAOKA S, 1992, ONCOGENE, V7, P433; Zane L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-114	66	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55989	10.1371/journal.pone.0055989	http://dx.doi.org/10.1371/journal.pone.0055989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405243	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400188
J	Grezes, J; Philip, L; Chadwick, M; Dezecache, G; Soussignan, R; Conty, L				Grezes, Julie; Philip, Leonor; Chadwick, Michele; Dezecache, Guillaume; Soussignan, Robert; Conty, Laurence			Self-Relevance Appraisal Influences Facial Reactions to Emotional Body Expressions	PLOS ONE			English	Article							ELECTROMYOGRAPHIC RESPONSES; GAZE DIRECTION; SOCIAL-INTERACTION; TIME-COURSE; BEHAVIOR; AMYGDALA; MIMICRY; FACES; COGNITION; RECOGNITION	People display facial reactions when exposed to others' emotional expressions, but exactly what mechanism mediates these facial reactions remains a debated issue. In this study, we manipulated two critical perceptual features that contribute to determining the significance of others' emotional expressions: the direction of attention (toward or away from the observer) and the intensity of the emotional display. Electromyographic activity over the corrugator muscle was recorded while participants observed videos of neutral to angry body expressions. Self-directed bodies induced greater corrugator activity than other-directed bodies; additionally corrugator activity was only influenced by the intensity of anger expresssed by self-directed bodies. These data support the hypothesis that rapid facial reactions are the outcome of self-relevant emotional processing.	[Grezes, Julie; Philip, Leonor; Chadwick, Michele; Dezecache, Guillaume; Conty, Laurence] INSERM, U960, LNC, F-75005 Paris, France; [Grezes, Julie; Philip, Leonor; Chadwick, Michele; Dezecache, Guillaume; Conty, Laurence] ENS, IEC, F-75005 Paris, France; [Soussignan, Robert] Univ Bourgogne, CNRS, CSGA, UMR 6265,INRA 1324, F-21000 Dijon, France; [Conty, Laurence] Univ Paris 08, EA2027, LPN, F-93526 St Denis, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite Paris-VIII	Grezes, J (corresponding author), INSERM, U960, LNC, F-75005 Paris, France.	julie.grezes@ens.fr	Grèzes, Julie/E-5060-2016; Grezes, julie/I-3012-2019	Grèzes, Julie/0000-0002-5066-9154; Grezes, julie/0000-0002-5066-9154; Dezecache, Guillaume/0000-0002-9366-6287	Agence National of Research (ANR); INSERM	Agence National of Research (ANR)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Agence National of Research (ANR) "Emotion(s), Cognition, Comportement'' 2011 program (Selfreademo) and by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; [Anonymous], 2000, SER AFFECTIVE SCI; Argyle M., 1975, BODILY COMMUNICATION; Aue T, 2011, BIOL PSYCHOL, V86, P65, DOI 10.1016/j.biopsycho.2010.10.008; Balconi M, 2011, NEUROSCI RES, V71, P251, DOI 10.1016/j.neures.2011.07.1833; Bindemann M, 2008, VIS COGN, V16, P733; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; BUCK R, 1994, BIOL PSYCHOL, V38, P95, DOI 10.1016/0301-0511(94)90032-9; BUSH L, 1986, PSYCHOPHYSIOLOGY, V23, P427; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Conty L, 2012, J NEUROSCI, V32, P4531, DOI 10.1523/JNEUROSCI.5636-11.2012; Cristinzio C, 2010, BRAIN, V133, P248, DOI 10.1093/brain/awp255; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dimberg U, 2011, J PSYCHOPHYSIOL, V25, P26, DOI 10.1027/0269-8803/a000029; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fischer AH., 2008, HDB EMOTIONS, P456, DOI DOI 10.2307/2076468; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Frijda N.H.., 1986, REV PHILOS LOUVAIN; Frijda NH, 2010, BIOL PSYCHOL, V84, P570, DOI 10.1016/j.biopsycho.2010.01.005; HESS U, 1995, J PERS SOC PSYCHOL, V69, P280, DOI 10.1037/0022-3514.69.2.280; Hess U, 1998, COGNITION EMOTION, V12, P509, DOI 10.1080/026999398379547; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2007, MOTIV EMOTION, V31, P137, DOI 10.1007/s11031-007-9057-x; Hietanen JK, 1998, PSYCHOPHYSIOLOGY, V35, P530, DOI 10.1017/S0048577298970445; Keltner D, 2001, EMO SOC BEH, P192; Loveland KA, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P17; Magnee MJCM, 2007, NEUROREPORT, V18, P369, DOI 10.1097/WNR.0b013e32801776e6; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31, DOI DOI 10.3389/FPSYG.2016.00458; Mojzisch A, 2006, SOC NEUROSCI-UK, V1, P184, DOI 10.1080/17470910600985621; Moody E.J., 2006, IMITATION SOCIAL MIN, P71; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Moody EJ, 2011, SOC PSYCHOL PERS SCI, V2, P679, DOI 10.1177/1948550611406741; N'Diaye K, 2009, EMOTION, V9, P798, DOI 10.1037/a0017845; Roseman I.J., 2001, APPRAISAL PROCESSES, P3, DOI DOI 10.1080/02699939108411034; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Sander D, 2007, EUR J COGN PSYCHOL, V19, P470, DOI 10.1080/09541440600757426; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schrammel F, 2009, PSYCHOPHYSIOLOGY, V46, P922, DOI 10.1111/j.1469-8986.2009.00831.x; SMITH CA, 1989, J PERS SOC PSYCHOL, V56, P339, DOI 10.1037/0022-3514.56.3.339; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Soussignan R, 2013, EMOTION, V13, P330, DOI 10.1037/a0029892; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; van der Schalk J, 2011, EMOTION, V2, P298; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6	55	26	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55885	10.1371/journal.pone.0055885	http://dx.doi.org/10.1371/journal.pone.0055885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405230	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400175
J	Lin, GHY; Wortzman, ME; Girardin, SE; Philpott, DJ; Watts, TH				Lin, Gloria H. Y.; Wortzman, Michael E.; Girardin, Stephen E.; Philpott, Dana J.; Watts, Tania H.			T Cell Intrinsic NOD2 Is Dispensable for CD8 T Cell Immunity	PLOS ONE			English	Article							TOXOPLASMA-GONDII; PEPTIDOGLYCAN; HOMEOSTASIS; INFECTION; DISEASE	NOD2 is an intracellular pattern recognition receptor that provides innate sensing of bacterial muramyl dipeptide by host cells, such as dendritic cells, macrophages and epithelial cells. While NOD2's role as an innate pathogen sensor is well established, NOD2 is also expressed at low levels in T cells and there are conflicting data as to whether NOD2 plays an intrinsic role in T cell function. Here we show that following adoptive transfer into WT hosts, NOD2(-/-) OT-I T cells show a small decrease in the number of OVA-specific CD8 T cells recovered at the peak of the response to respiratory influenza virus infection. On the other hand, no such defect was observed upon intranasal immunization with a replication defective adenovirus carrying the OVA epitope recognized by OT-I, or when OVA was delivered with LPS subcutaneously, or when influenza-OVA was delivered intraperitoneally. Thus we observed a selective defect in NOD2-deficient T cell responses only during a live viral infection. Moreover, there was no apparent defect when NOD2(-/-) OT-I T cells were stimulated in vitro. Finally, this selective defect in recovery of NOD2-deficient CD8 T cells was not observed in a non-transgenic respiratory infection model in which mixed bone marrow chimeras were used such that the NOD2(-/-) T cells were allowed to develop and respond in a NOD2-sufficient host. Taken together our data indicate that T cell intrinsic NOD2 is not required for CD8 T cell responses to antigen delivered under a variety of conditions in vitro and in vivo. However, CD8 T cells that have developed in the absence of NOD2 show a selective and modest impairment in their response to live respiratory influenza infection.	[Lin, Gloria H. Y.; Wortzman, Michael E.; Philpott, Dana J.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP 84419]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This research was funded by grant number MOP 84419 from the Canadian Institutes of Health Research (CIHR) to THW as well as CIHR grants to DJP and SEG. THW holds the Sanofi Pasteur chair in Human Immunology at the University of Toronto; GHYL was funded by a CIHR doctoral award. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscripts.	Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; Caetano BC, 2011, EUR J IMMUNOL, V41, P3627, DOI 10.1002/eji.201141876; COTTEY R, 2001, CURRENT PROTOCOLS IM, V4; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Yang TC, 2003, J VIROL, V77, P13407, DOI 10.1128/JVI.77.24.13407-13411.2003	13	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56014	10.1371/journal.pone.0056014	http://dx.doi.org/10.1371/journal.pone.0056014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405246	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400191
J	Ng, YK; Ehsaan, M; Philip, S; Collery, MM; Janoir, C; Collignon, A; Cartman, ST; Minton, NP				Ng, Yen Kuan; Ehsaan, Muhammad; Philip, Sheryl; Collery, Mark M.; Janoir, Clare; Collignon, Anne; Cartman, Stephen T.; Minton, Nigel P.			Expanding the Repertoire of Gene Tools for Precise Manipulation of the Clostridium difficile Genome: Allelic Exchange Using pyrE Alleles	PLOS ONE			English	Article							ESCHERICHIA-COLI; SYSTEM; TOXIN; EXPRESSION; PROTEINS; PHOSPHOENOLPYRUVATE; INTEGRATION; CHROMOSOME; SELECTION; PLASMIDS	Sophisticated genetic tools to modify essential biological processes at the molecular level are pivotal in elucidating the molecular pathogenesis of Clostridium difficile, a major cause of healthcare associated disease. Here we have developed an efficient procedure for making precise alterations to the C. difficile genome by pyrE-based allelic exchange. The robustness and reliability of the method was demonstrated through the creation of in-frame deletions in three genes (spo0A, cwp84, and mtlD) in the non-epidemic strain 630 Delta erm and two genes (spo0A and cwp84) in the epidemic PCR Ribotype 027 strain, R20291. The system is reliant on the initial creation of a pyrE deletion mutant, using Allele Coupled Exchange (ACE), that is auxotrophic for uracil and resistant to fluoroorotic acid (FOA). This enables the subsequent modification of target genes by allelic exchange using a heterologous pyrE allele from Clostridium sporogenes as a counter-/negative-selection marker in the presence of FOA. Following modification of the target gene, the strain created is rapidly returned to uracil prototrophy using ACE, allowing mutant phenotypes to be characterised in a PyrE proficient background. Crucially, wild-type copies of the inactivated gene may be introduced into the genome using ACE concomitant with correction of the pyrE allele. This allows complementation studies to be undertaken at an appropriate gene dosage, as opposed to the use of multicopy autonomous plasmids. The rapidity of the 'correction' method (5-7 days) makes pyrE(-) strains attractive hosts for mutagenesis studies.	[Ng, Yen Kuan; Ehsaan, Muhammad; Philip, Sheryl; Collery, Mark M.; Cartman, Stephen T.; Minton, Nigel P.] Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Clostridia Res Grp,NIHR Biomed Res Unit GI Dis, Nottingham NG7 2RD, England; [Janoir, Clare; Collignon, Anne] Univ Paris 11, Fac Pharm, Dept Microbiol, Unite EA 40 43, F-92290 Chatenay Malabry, France	University of Nottingham; UDICE-French Research Universities; Universite Paris Saclay	Minton, NP (corresponding author), Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Clostridia Res Grp,NIHR Biomed Res Unit GI Dis, Nottingham NG7 2RD, England.	Nigel.Minton@nottingham.ac.uk	Ehsaan, Muhammad/Z-3697-2019	Minton, Nigel/0000-0002-9277-1261; EHSAAN, MUHAMMAD/0000-0003-1393-5246	MRC [G0601176]; European Community [HEALTH-F3-2008-223585]; Biotechnology and Biological Sciences Research Council [BB/G016224/1]; TMO686 Renewables Ltd.; TMO Renewables Ltd.; University from TMO; Medical Research Council [G0601176] Funding Source: researchfish; BBSRC [BB/G016224/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); TMO686 Renewables Ltd.; TMO Renewables Ltd.; University from TMO; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge the financial support of the MRC (G0601176), the European Community's Seventh Framework Programme 'HYPERDIFF' (HEALTH-F3-2008-223585), the Biotechnology and Biological Sciences Research Council (BB/G016224/1), and TMO686 Renewables Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, Muhammad Ehsaan is a PhD student sponsored by TMO Renewables Ltd. His stipend and fee is received by the University from TMO and administered by them. Neither he nor Nigel P. Minton have any other association with this company (neither in terms of salary, consultancy or shares). The work has not been patented. The funding of Muhammad Ehsaan's studentship does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; CHAMBERS SP, 1988, GENE, V68, P139, DOI 10.1016/0378-1119(88)90606-3; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Henstra SA, 1996, J BACTERIOL, V178, P5586, DOI 10.1128/jb.178.19.5586-5591.1996; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; IWEN PC, 1989, J CLIN MICROBIOL, V27, P2105, DOI 10.1128/JCM.27.9.2105-2106.1989; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; Kennedy CL, 2005, MOL MICROBIOL, V57, P1357, DOI 10.1111/j.1365-2958.2005.04774.x; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Knipfer N, 1997, PLASMID, V37, P129, DOI 10.1006/plas.1997.1286; Li JH, 2011, INFECT IMMUN, V79, P2451, DOI 10.1128/IAI.00169-11; Liyanage H, 2001, APPL ENVIRON MICROB, V67, P2004, DOI 10.1128/AEM.67.5.2004-2010.2001; MINTON N, 1981, J GEN MICROBIOL, V127, P325; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Poxton IR, 2001, CLIN MICROBIOL INFEC, V7, P421, DOI 10.1046/j.1198-743x.2001.00287.x; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Rabinowitz J, 1972, Methods Enzymol, V24, P431; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; Sambrook J, 2001, MOL CLONING LAB MANU; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SMITH CJ, 1981, ANTIMICROB AGENTS CH, V19, P997, DOI 10.1128/AAC.19.6.997; Takamizawa A, 2004, PROTEIN EXPRES PURIF, V36, P70, DOI 10.1016/j.pep.2004.03.004; Theys J, 2006, BRIT J CANCER, V95, P1212, DOI 10.1038/sj.bjc.6603367; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; WILLIAMS DR, 1990, J GEN MICROBIOL, V136, P819, DOI 10.1099/00221287-136-5-819	45	74	76	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56051	10.1371/journal.pone.0056051	http://dx.doi.org/10.1371/journal.pone.0056051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405251	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400196
J	Yang, YF; Sun, L; Tala; Gao, JM; Li, DW; Zhou, J; Liu, M				Yang, Yunfan; Sun, Lei; Tala; Gao, Jinmin; Li, Dengwen; Zhou, Jun; Liu, Min			CYLD Regulates RhoA Activity by Modulating LARG Ubiquitination	PLOS ONE			English	Article							TUMOR-SUPPRESSOR CYLD; NF-KAPPA-B; NUCLEOTIDE-EXCHANGE FACTORS; MICROTUBULE DYNAMICS; NEGATIVE REGULATOR; GTPASES; CYTOKINESIS; MIGRATION	Rho family guanosine triphosphatases (GTPases), such as RhoA, Cdc42, and Rac1, play a fundamental role in various cellular processes. The activation of Rho proteins is catalyzed by guanine nucleotide-exchange factors (GEFs), which promote the exchange of GDP for GTP. The precise mechanisms regulating the activation of Rho proteins are not fully understood. Herein, we demonstrate that RhoA activity is regulated by cylindromatosis (CYLD), a deubiquitinase harboring multiple functions. In addition, we find that RhoA-mediated cytoskeletal rearrangement, chromosome separation, and cell polarization are altered in CYLD-depleted cells. Mechanistically, CYLD does not interact with RhoA; instead, it interacts with and deubiquitinates leukemia-associated RhoGEF (LARG). Our data further show that CYLD-mediated deubiquitination of LARG enhances its ability to stimulate the GDP/GTP exchange on RhoA. These data thus identify LARG as a new substrate of CYLD and provide novel insights into the regulation of RhoA activation. Our results also suggest that the LARG-RhoA signaling pathway may play a role in diverse CYLD-mediated cellular events.	[Yang, Yunfan; Sun, Lei; Tala; Gao, Jinmin; Li, Dengwen; Zhou, Jun] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Yang, Yunfan; Sun, Lei; Tala; Gao, Jinmin; Li, Dengwen; Zhou, Jun] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China; [Liu, Min] Tianjin Med Univ, Basic Med Coll, Dept Biochem, Tianjin, Peoples R China	Nankai University; Nankai University; Tianjin Medical University; Tianjin Medical University	Liu, M (corresponding author), Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China.	queyuezhai@163.com	Zhou, Jun/D-4654-2017; Yang, Yunfan/AAN-9231-2020; Sun, Lei/N-4783-2018; Gao, Jinmin/J-8967-2015	Zhou, Jun/0000-0001-7858-8260; Yang, Yunfan/0000-0002-5266-7208; 	National Basic Research Program of China [2010CB912204, 2012CB945002]; National Natural Science Foundation of China [31170820, 31271437]; 111 project [B08011]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Basic Research Program of China (2010CB912204 and 2012CB945002), the National Natural Science Foundation of China (31170820 and 31271437), and the 111 project (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Dutartre H, 1996, J CELL SCI, V109, P367; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Gao JM, 2010, BLOOD, V115, P4130, DOI 10.1182/blood-2009-10-248526; Goulimari P, 2008, MOL BIOL CELL, V19, P30, DOI 10.1091/mbc.E06-11-1045; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036389; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Shi XJ, 2012, CELL CYCLE, V11, P1554, DOI 10.4161/cc.19954; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Sun L, 2010, J PATHOL, V221, P425, DOI 10.1002/path.2723; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vazquez-Prado J, 2004, METHOD ENZYMOL, V390, P259; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200	23	9	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55833	10.1371/journal.pone.0055833	http://dx.doi.org/10.1371/journal.pone.0055833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405219	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400164
J	Arensman, MD; Kovochich, AN; Kulikauskas, RM; Lay, AR; Yang, PT; Li, X; Donahue, T; Major, MB; Moon, RT; Chien, AJ; Dawson, DW				Arensman, M. D.; Kovochich, A. N.; Kulikauskas, R. M.; Lay, A. R.; Yang, P-T; Li, X.; Donahue, T.; Major, M. B.; Moon, R. T.; Chien, A. J.; Dawson, D. W.			WNT7B mediates autocrine Wnt/beta-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma	ONCOGENE			English	Article						pancreatic cancer; WNT7B; Wnt/beta-catenin signaling	BETA-CATENIN; HUMAN-DISEASE; TUMOR-CELLS; E-CADHERIN; CANCER; EXPRESSION; PATHWAY; SURVIVAL; TUMORIGENICITY; STABILIZATION	Developmental and cancer models show Wnt/beta-catenin-dependent signaling mediates diverse phenotypic outcomes in the pancreas that are dictated by context, duration and strength of activation. While generally assumed to be pro-tumorigenic, it is unclear to what extent dysregulation of Wnt/beta-catenin signaling impacts tumor progression in pancreatic adenocarcinoma (PDAC). In the present study, Wnt/beta-catenin activity was characterized across a spectrum of PDAC cell lines and primary tumors. Reporter and gene expression-based assays revealed wide heterogeneity in Wnt/beta-catenin transcriptional activity across PDAC cell lines and patient tumors, as well as variable responsiveness to exogenous Wnt ligand stimulation. An experimentally generated, pancreas-specific gene expression signature of Wnt/beta-catenin transcriptional activation was used to stratify pathway activation across a cohort of resected, early-stage PDAC tumors (N = 41). In this cohort, higher Wnt/beta-catenin activation was found to significantly correlate with lymphvascular invasion and worse disease-specific survival (median survival time 20.3 versus 43.9 months, log-rank P = 0.03). Supporting the importance of Wnt ligand in mediating autocrine Wnt signaling, Wnt/beta-catenin activity was significantly inhibited in PDAC cell lines by WLS gene silencing and the small-molecule inhibitor IWP-2, both of which functionally block Wnt ligand processing and secretion. Transcriptional profiling revealed elevated expression of WNT7B occurred in PDAC cell lines with high levels of cell autonomous Wnt/beta-catenin activity. Gene-knockdown studies in AsPC-1 and HPAF-2 cell lines confirmed WNT7B-mediated cell autonomous Wnt/beta-catenin activation, as well as an anchorage-independent growth phenotype. Our findings indicate WNT7B can serve as a primary determinant of differential Wnt/beta-catenin activation in PDAC. Disrupting the interaction between Wnt ligands and their receptors may be a particularly suitable approach for therapeutic modulation of Wnt/beta-catenin signaling in PDAC and other cancer contexts where Wnt activation is mediated by ligand expression rather than mutations in canonical pathway members.	[Arensman, M. D.; Kovochich, A. N.; Lay, A. R.; Li, X.; Dawson, D. W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kulikauskas, R. M.; Yang, P-T; Moon, R. T.; Chien, A. J.] Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Kulikauskas, R. M.; Yang, P-T; Moon, R. T.; Chien, A. J.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Li, X.; Donahue, T.; Dawson, D. W.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Donahue, T.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med & Mol & Med Pharmacol, Dept Surg,Div Gen Surg, Los Angeles, CA 90095 USA; [Major, M. B.] Univ North Carolina Chapel Hill, Sch Med, Lineberger Comprehens Canc Ctr, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Chien, A. J.] Univ Washington, Sch Med, Dept Med, Div Dermatol, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Washington; University of Washington Seattle	Chien, AJ (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	chien@u.washington.edu; ddawson@mednet.ucla.edu	Moon, Randall T/B-1743-2014; Dawson, David/I-5917-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Major, Michael/0000-0002-6753-8513	American Cancer Society Research Scholar Grant; American Association for Cancer Research/Pancreatic Cancer Action Network; UCLA Department of Pathology; NCI/NIH [1K08128565]; University of Washington Office of the Provost; UCLA Tumor Biology Program (USHHS Ruth L. Kirschstein Institutional National Research Service Award) [T32 CA009056]; NATIONAL CANCER INSTITUTE [P30CA016042, P01CA163200, K08CA128565, T32CA009056] Funding Source: NIH RePORTER	American Cancer Society Research Scholar Grant(American Cancer Society); American Association for Cancer Research/Pancreatic Cancer Action Network; UCLA Department of Pathology; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Washington Office of the Provost; UCLA Tumor Biology Program (USHHS Ruth L. Kirschstein Institutional National Research Service Award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DWD was supported by an American Cancer Society Research Scholar Grant, an American Association for Cancer Research/Pancreatic Cancer Action Network Career Development Award in memory of Seena Magowitz and a Research Services Research Fund Grant from the UCLA Department of Pathology. AJC was supported by a Career Development Award (1K08128565) from the NCI/NIH and Bridge Funding from the University of Washington Office of the Provost. MDA was supported by the UCLA Tumor Biology Program (USHHS Ruth L. Kirschstein Institutional National Research Service Award # T32 CA009056).	American Council of the Teaching of Foreign Language, 2012, CLEARVOICETM TECHN F, P1; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Kovochich AN, 2013, CANCER-AM CANCER SOC, V119, P529, DOI 10.1002/cncr.27725; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Chang JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-443; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chien AJ, 2007, FRONT BIOSCI-LANDMRK, V12, P448, DOI 10.2741/2074; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Donahue TR, 2012, CLIN CANCER RES, V18, P1352, DOI 10.1158/1078-0432.CCR-11-1539; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Froeling FEM, 2009, AM J PATHOL, V175, P636, DOI 10.2353/ajpath.2009.090131; Gerdes B, 1999, DIGESTION, V60, P544, DOI 10.1159/000007704; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Heiser PW, 2008, GASTROENTEROLOGY, V135, P1288, DOI 10.1053/j.gastro.2008.06.089; Hong SM, 2011, ARCH PATHOL LAB MED, V135, P716, DOI 10.1043/2010-0566-RA.1; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	38	77	81	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					899	908		10.1038/onc.2013.23	http://dx.doi.org/10.1038/onc.2013.23			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23416978	Green Submitted, Green Accepted			2022-12-25	WOS:000331626900011
J	Sayegh, J; Cao, J; Zou, MR; Morales, A; Blair, LP; Norcia, M; Hoyer, D; Tackett, AJ; Merkel, JS; Yan, Q				Sayegh, Joyce; Cao, Jian; Zou, Mike Ran; Morales, Alfonso; Blair, Lauren P.; Norcia, Michael; Hoyer, Denton; Tackett, Alan J.; Merkel, Jane S.; Yan, Qin			Identification of Small Molecule Inhibitors of Jumonji AT-rich Interactive Domain 1B (JARID1B) Histone Demethylase by a Sensitive High Throughput Screen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; LYSINE DEMETHYLASES; CELL-PROLIFERATION; TUMOR-GROWTH; BINDING; TUMORIGENESIS; PROMOTE; ASSAYS; PLU-1	JARID1B (also known as KDM5B or PLU1) is a member of the JARID1 family of histone lysine demethylases responsible for the demethylation of trimethylated lysine 27 in histone H3 (H3K4me3), a mark for actively transcribed genes. JARID1B is overexpressed in several cancers, including breast cancer, prostate cancer, and lung cancer. In addition, JARID1B is required for mammary tumor formation in syngeneic or xenograft mouse models. JARID1B-expressing melanoma cells are associated with increased self-renewal character. Therefore, JARID1B represents an attractive target for cancer therapy. Here we characterized JARID1B using a homogeneous luminescence-based demethylase assay. We then conducted a high throughput screen of over 15,000 small molecules to identify inhibitors of JARID1B. From this screen, we identified several known JmjC histone demethylase inhibitors, including 2,4-pyridinedicarboxylic acid and catechols. More importantly, we identified several novel inhibitors, including 2-4(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one (PBIT), which inhibits JARID1B with an IC50 of about 3 mu M in vitro. Consistent with this, PBIT treatment inhibited removal of H3K4me3 by JARID1B in cells. Furthermore, this compound inhibited proliferation of cells expressing higher levels of JARID1B. These results suggest that this novel small molecule inhibitor is a lead compound that can be further optimized for cancer therapy.	[Sayegh, Joyce; Cao, Jian; Zou, Mike Ran; Morales, Alfonso; Blair, Lauren P.; Yan, Qin] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Norcia, Michael; Hoyer, Denton; Merkel, Jane S.] Yale Univ, Yale Ctr Mol Discovery, West Haven, CT 06516 USA; [Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Yale University; Yale University; University of Arkansas System; University of Arkansas Medical Sciences	Yan, Q (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St,BML 348C,POB 208023, New Haven, CT 06510 USA.	qin.yan@yale.edu	Yan, Qin/E-8893-2012; Cao, Jian/K-2440-2014	Yan, Qin/0000-0003-4077-453X; Cao, Jian/0000-0003-3424-6802; Morales, Alfonso/0000-0002-8713-7100	Yale Center for Molecular Discovery; Alexander and Margaret Stewart Trust Fellowship; Breast Cancer Alliance Young Investigator Grant; Melanoma Research Foundation Career Development Award; Developmental Research Award from Yale Specialized Programs of Research Excellence (YSPORE) in Skin Cancer; National Institutes of Health [CA16359, R01 DA025755]; CTSA Grant from the National Center for Advancing Translational Sciences [UL1 RR024139]; Clinical and Translational Science Award (CTSA) Scholar Award from Yale Center for Clinical Investigation; NATIONAL CANCER INSTITUTE [P30CA016359, P50CA121974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025755] Funding Source: NIH RePORTER	Yale Center for Molecular Discovery; Alexander and Margaret Stewart Trust Fellowship; Breast Cancer Alliance Young Investigator Grant; Melanoma Research Foundation Career Development Award; Developmental Research Award from Yale Specialized Programs of Research Excellence (YSPORE) in Skin Cancer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA Grant from the National Center for Advancing Translational Sciences; Clinical and Translational Science Award (CTSA) Scholar Award from Yale Center for Clinical Investigation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by a pilot grant from the Yale Center for Molecular Discovery, Clinical and Translational Science Award (CTSA) Scholar Award from Yale Center for Clinical Investigation, the Alexander and Margaret Stewart Trust Fellowship, Breast Cancer Alliance Young Investigator Grant, Melanoma Research Foundation Career Development Award, a Developmental Research Award from Yale Specialized Programs of Research Excellence (YSPORE) in Skin Cancer (all to Q. Y.) and by National Institutes of Health Grants CA16359 (to the Yale Comprehensive Cancer Center) and R01 DA025755 (to A. J. T.). This work was made possible by CTSA Grant UL1 RR024139 from the National Center for Advancing Translational Sciences.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Blair LP, 2012, DNA CELL BIOL, V31, pS49, DOI 10.1089/dna.2012.1654; Blair Lauren P, 2011, Cancers (Basel), V3, P1383, DOI 10.3390/cancers3011383; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dou DF, 2011, BIOORGAN MED CHEM, V19, P5782, DOI 10.1016/j.bmc.2011.08.029; Gauthier N, 2012, J BIOMOL SCREEN, V17, P49, DOI 10.1177/1087057111416659; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Hou JL, 2012, AM J TRANSL RES, V4, P247; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jorgensen WL, 2011, BIOORG MED CHEM LETT, V21, P4545, DOI 10.1016/j.bmcl.2011.05.127; Kawamura A, 2010, ANAL BIOCHEM, V404, P86, DOI 10.1016/j.ab.2010.04.030; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kristensen LH, 2012, FEBS J, V279, P1905, DOI 10.1111/j.1742-4658.2012.08567.x; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Nielsen AL, 2012, FEBS LETT, V586, P1190, DOI 10.1016/j.febslet.2012.03.001; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Suzuki T, 2011, J MED CHEM, V54, P8236, DOI 10.1021/jm201048w; Thalhammer A, 2011, ORG BIOMOL CHEM, V9, P127, DOI 10.1039/c0ob00592d; Vasan M, 2010, CHEMMEDCHEM, V5, P2079, DOI 10.1002/cmdc.201000275; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010	38	91	95	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9408	9417		10.1074/jbc.M112.419861	http://dx.doi.org/10.1074/jbc.M112.419861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408432	hybrid, Green Published			2022-12-25	WOS:000316862200057
J	Li, LL; Voullaire, L; Sandi, C; Pook, MA; Ioannou, PA; Delatycki, MB; Sarsero, JP				Li, Lingli; Voullaire, Lucille; Sandi, Chiranjeevi; Pook, Mark A.; Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.			Pharmacological Screening Using an FXN-EGFP Cellular Genomic Reporter Assay for the Therapy of Friedreich Ataxia	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; GAA REPEAT LENGTH; YEAST FRATAXIN; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; TRIPLET-REPEAT; PPAR-GAMMA; EPIGENETIC CHANGES; GENE-EXPRESSION; UP-REGULATION	Friedreich ataxia (FRDA) is an autosomal recessive disorder characterized by neurodegeneration and cardiomyopathy. The presence of a GAA trinucleotide repeat expansion in the first intron of the FXN gene results in the inhibition of gene expression and an insufficiency of the mitochondrial protein frataxin. There is a correlation between expansion length, the amount of residual frataxin and the severity of disease. As the coding sequence is unaltered, pharmacological up-regulation of FXN expression may restore frataxin to therapeutic levels. To facilitate screening of compounds that modulate FXN expression in a physiologically relevant manner, we established a cellular genomic reporter assay consisting of a stable human cell line containing an FXN-EGFP fusion construct, in which the EGFP gene is fused in-frame with the entire normal human FXN gene present on a BAC clone. The cell line was used to establish a fluorometric cellular assay for use in high throughput screening (HTS) procedures. A small chemical library containing FDA-approved compounds and natural extracts was screened and analyzed. Compound hits identified by HTS were further evaluated by flow cytometry in the cellular genomic reporter assay. The effects on FXN mRNA and frataxin protein levels were measured in lymphoblast and fibroblast cell lines derived from individuals with FRDA and in a humanized GAA repeat expansion mouse model of FRDA. Compounds that were established to increase FXN gene expression and frataxin levels included several anti-cancer agents, the iron-chelator deferiprone and the phytoalexin resveratrol.	[Li, Lingli; Voullaire, Lucille; Ioannou, Panos A.; Sarsero, Joseph P.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Li, Lingli; Delatycki, Martin B.; Sarsero, Joseph P.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic, Australia; [Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Delatycki, Martin B.] Austin Hlth, Dept Clin Genet, Heidelberg, Vic, Australia; [Sandi, Chiranjeevi; Pook, Mark A.] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge UB8 3PH, Middx, England	Murdoch Children's Research Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Brunel University	Sarsero, JP (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	joe@sarsero.com			Muscular Dystrophy Association (USA) [3657, 3725, 69033]; National Health and Medical Research Council (Australia) [491234]; Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Friedreich Ataxia Research Association (Australasia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Friedreich Ataxia Research Association (Australasia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	This work was supported by the Muscular Dystrophy Association (USA) (grants 3657, 3725, 69033), the National Health and Medical Research Council (Australia) (grant 491234), the Friedreich's Ataxia Research Alliance (USA), the Brockhoff Foundation (Australia), the Friedreich Ataxia Research Association (Australasia), Seek A Miracle (USA) and the Victorian Government's Operational Infrastructure Support Program. MBD is a National Health and Medical Research Council Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2008, CEREBELLUM; Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Boesch S, 2008, MOVEMENT DISORD, V23, P1940, DOI 10.1002/mds.22294; Boulikas T, 2003, ONCOL REP, V10, P1663; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; De Michele G, 1998, J NEUROL, V245, P166, DOI 10.1007/s004150050198; Delatycki MB, 1999, AM J MED GENET, V87, P168, DOI 10.1002/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filla A, 1996, AM J HUM GENET, V59, P554; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Ghazizadeh Mohammad, 2003, Journal of Nippon Medical School, V70, P367; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098; Koeppen AH, 2007, ACTA NEUROPATHOL, V114, P163, DOI 10.1007/s00401-007-0220-y; Koeppen AH, 2009, ACTA NEUROPATHOL, V118, P763, DOI 10.1007/s00401-009-0589-x; la Porte C, 2010, CLIN PHARMACOKINET, V49, P449, DOI 10.2165/11531820-000000000-00000; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Marmolino D, 2009, CEREBELLUM, V8, P98, DOI 10.1007/s12311-008-0087-z; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pandolfo M, 2008, NAT CLIN PRACT NEURO, V4, P86, DOI 10.1038/ncpneuro0704; Pandolfo M, 2006, METH MOLEC MED, V126, P197; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puspasari N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022001; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sacca F, 2011, MOVEMENT DISORD, V26, P739, DOI 10.1002/mds.23435; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Santoro L, 2000, CLIN NEUROPHYSIOL, V111, P1023, DOI 10.1016/S1388-2457(00)00290-X; Sarsero JP, 2005, MAMM GENOME, V16, P228, DOI 10.1007/s00335-004-3021-9; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Soragni E, 2011, METHODS MOL BIOL, V793, P495, DOI 10.1007/978-1-61779-328-8_32; Tomassini B, 2012, HUM MOL GENET, V21, P2855, DOI 10.1093/hmg/dds110; Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	78	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55940	10.1371/journal.pone.0055940	http://dx.doi.org/10.1371/journal.pone.0055940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418481	Green Published, gold			2022-12-25	WOS:000315970300073
J	Martin, M; Benzina, O; Szabo, V; Vegh, AG; Lucas, O; Cloitre, T; Scamps, F; Gergely, C				Martin, Marta; Benzina, Ouafa; Szabo, Vivien; Vegh, Attila-Gergely; Lucas, Olivier; Cloitre, Thierry; Scamps, Frederique; Gergely, Csilla			Morphology and Nanomechanics of Sensory Neurons Growth Cones following Peripheral Nerve Injury	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; GENE-EXPRESSION; SCIATIC-NERVE; NKCC1 PHOSPHORYLATION; MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; LIVING CELLS; REGENERATION; ADULT; IDENTIFICATION	A prior peripheral nerve injury in vivo, promotes a rapid elongated mode of sensory neurons neurite regrowth in vitro. This in vitro model of conditioned axotomy allows analysis of the cellular and molecular mechanisms leading to an improved neurite re-growth. Our differential interference contrast microscopy and immunocytochemistry results show that conditioned axotomy, induced by sciatic nerve injury, did not increase somatic size of adult lumbar sensory neurons from mice dorsal root ganglia sensory neurons but promoted the appearance of larger neurites and growth cones. Using atomic force microscopy on live neurons, we investigated whether membrane mechanical properties of growth cones of axotomized neurons were modified following sciatic nerve injury. Our data revealed that neurons having a regenerative growth were characterized by softer growth cones, compared to control neurons. The increase of the growth cone membrane elasticity suggests a modification in the ratio and the inner framework of the main structural proteins.	[Martin, Marta; Benzina, Ouafa; Szabo, Vivien; Cloitre, Thierry; Gergely, Csilla] Univ Montpellier 2, Lab Charles Coulomb, UMR 5221, Montpellier, France; [Martin, Marta; Benzina, Ouafa; Szabo, Vivien; Cloitre, Thierry; Gergely, Csilla] CNRS, Lab Charles Coulomb, UMR 5221, Montpellier, France; [Benzina, Ouafa] Ctr Biotechnol Sfax, Lab LVBPPE, Sfax, Tunisia; [Vegh, Attila-Gergely] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Lucas, Olivier; Scamps, Frederique] INM Hop St Eloi, INSERM, U1051, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Centre de Biotechnologie de Sfax; Universite de Sfax; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Scamps, F (corresponding author), INM Hop St Eloi, INSERM, U1051, Montpellier, France.	frederique.scamps@inserm.fr; csilla.gergely@univ-montp2.fr	Végh, Attila Gergely/A-4789-2011; Scamps, Frédérique/M-5268-2018; cloitre, thierry/M-1976-2018	Végh, Attila Gergely/0000-0003-0524-0946; Scamps, Frédérique/0000-0001-9545-407X; cloitre, thierry/0000-0001-6058-4050; Szabo, Vivien/0000-0002-0079-7596; Gergely, Csilla/0000-0003-1229-6761	COST-EU Action on "Applications of Atomic Force Microscopy to NanoMedecine and Life Sciences'' [TD1002-AFM4NanoMedBio]; Association francaise contre les myopathies (AFM)	COST-EU Action on "Applications of Atomic Force Microscopy to NanoMedecine and Life Sciences''; Association francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the COST-EU Action on "Applications of Atomic Force Microscopy to NanoMedecine and Life Sciences'' (TD1002-AFM4NanoMed&Bio) and by the Association francaise contre les myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; Araki T, 2001, J BIOL CHEM, V276, P34131, DOI 10.1074/jbc.M104271200; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Butt H. J., 2010, SURFACE INTERFACIAL; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Chumakova OV, 2000, B EXP BIOL MED+, V130, P921, DOI 10.1007/BF02682270; Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dupont-Gillain CC, 2004, J MATER SCI-MATER M, V15, P347, DOI 10.1023/B:JMSM.0000021100.71256.29; EVANS E, 1984, J CLIN INVEST, V73, P477, DOI 10.1172/JCI111234; Garcia R, 2007, NAT MATER, V6, P405, DOI 10.1038/nmat1925; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Goldberg JL, 2008, GENE DEV, V17, P941; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Heinrich V, 2001, BIOPHYS J, V81, P1452, DOI 10.1016/S0006-3495(01)75800-6; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Hilaire C, 2005, NEUROSCI LETT, V380, P330, DOI 10.1016/j.neulet.2005.01.068; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Laishram J, 2009, J STRUCT BIOL, V168, P366, DOI 10.1016/j.jsb.2009.09.005; LAL R, 1995, AM J PHYSIOL-CELL PH, V269, pC275, DOI 10.1152/ajpcell.1995.269.1.C275; Lankford KL, 1998, J COMP NEUROL, V391, P11, DOI 10.1002/(SICI)1096-9861(19980202)391:1<11::AID-CNE2>3.0.CO;2-U; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; McNally HA, 2005, J NEUROSCI METH, V142, P177, DOI 10.1016/j.jneumeth.2004.08.018; Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004; Mustata M, 2010, J NEUROSCI METH, V186, P35, DOI 10.1016/j.jneumeth.2009.10.021; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Pieraut S, 2011, J NEUROSCI, V31, P13516, DOI 10.1523/JNEUROSCI.3382-11.2011; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Sleep J, 1999, BIOPHYS J, V77, P3085, DOI 10.1016/S0006-3495(99)77139-0; Smith DS, 1997, J NEUROSCI, V17, P646; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Svaldo Lanero T, 2006, J BIOTECHNOL, V124, P723, DOI 10.1016/j.jbiotec.2006.02.016; TANAKA K, 1992, EXP NEUROL, V118, P53, DOI 10.1016/0014-4886(92)90022-I; Tojima T, 2000, NEUROSCIENCE, V101, P471, DOI 10.1016/S0306-4522(00)00320-1; Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xiong Y, 2009, BIOPHYS J, V96, P5060, DOI 10.1016/j.bpj.2009.03.032	51	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56286	10.1371/journal.pone.0056286	http://dx.doi.org/10.1371/journal.pone.0056286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418549	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000315970300142
J	Nye, MD; Hoyo, C; Huang, ZQ; Vidal, AC; Wang, F; Overcash, F; Smith, JS; Vasquez, B; Hernandez, B; Swai, B; Oneko, O; Mlay, P; Obure, J; Gammon, MD; Bartlett, JA; Murphy, SK				Nye, Monica D.; Hoyo, Cathrine; Huang, Zhiqing; Vidal, Adriana C.; Wang, Frances; Overcash, Francine; Smith, Jennifer S.; Vasquez, Brandi; Hernandez, Brenda; Swai, Britta; Oneko, Olola; Mlay, Pendo; Obure, Joseph; Gammon, Marilie D.; Bartlett, John A.; Murphy, Susan K.			Associations between Methylation of Paternally Expressed Gene 3 (PEG3), Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; WOMEN; RISK; BAX	Cytology-based screening for invasive cervical cancer (ICC) lacks sensitivity and specificity to discriminate between cervical intraepithelial neoplasia (CIN) likely to persist or progress from cases likely to resolve. Genome-wide approaches have been used to identify DNA methylation marks associated with CIN persistence or progression. However, associations between DNA methylation marks and CIN or ICC remain weak and inconsistent. Between 2008-2009, we conducted a hospital-based, case-control study among 213 Tanzania women with CIN 1/2/3 or ICC. We collected questionnaire data, biopsies, peripheral blood, cervical scrapes, Human papillomavirus (HPV) and HIV-1 infection status. We assessed PEG3 methylation status by bisulfite pyrosequencing. Multinomial logistic regression was used to estimate odds ratios (OR) and confidence intervals (CI 95%) for associations between PEG3 methylation status and CIN or ICC. After adjusting for age, gravidity, hormonal contraceptive use and HPV infection, a 5% increase in PEG3 DNA methylation was associated with increased risk for ICC (OR = 1.6; 95% CI 1.2-2.1). HPV infection was associated with a higher risk of CIN1-3 (OR = 15.7; 95% CI 5.7-48.6) and ICC (OR = 29.5, 95% CI 6.3-38.4). Infection with high risk HPV was correlated with mean PEG3 differentially methylated regions (DMRs) methylation (r = 0.34 p<0.0001), while the correlation with low risk HPV infection was weaker (r = 0.16 p = 0.047). Although small sample size limits inference, these data support that PEG3 methylation status has potential as a molecular target for inclusion in CIN screening to improve prediction of progression. Impact statement: We present the first evidence that aberrant methylation of the PEG3 DMR is an important co-factor in the development of Invasive cervical carcinoma (ICC), especially among women infected with high risk HPV. Our results show that a five percent increase in DNA methylation of PEG3 is associated with a 1.6-fold increase ICC risk. Suggesting PEG3 methylation status may be useful as a molecular marker for CIN screening to improve prediction of cases likely to progress.	[Nye, Monica D.; Huang, Zhiqing; Overcash, Francine; Murphy, Susan K.] Duke Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27706 USA; [Hoyo, Cathrine; Vidal, Adriana C.] Duke Univ, Sch Med, Dept Obstet & Gynecol, Program Canc Detect, Durham, NC USA; [Wang, Frances] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Smith, Jennifer S.; Gammon, Marilie D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Vasquez, Brandi] Kilmanjaro Christian Med Ctr, Moshi, Tanzania; [Hernandez, Brenda] Univ Hawaii, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA; [Swai, Britta] Tumaini Univ, Kilimanjaro Christian Med Ctr, Dept Pathol, Moshi, Tanzania; [Oneko, Olola; Mlay, Pendo; Obure, Joseph] Tumaini Univ, Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Tanzania; [Bartlett, John A.] Duke Univ, Sch Med, Dept Med, Div Infect Dis, Durham, NC 27706 USA; [Bartlett, John A.] Duke Univ, Sch Med, Duke Global Hlth Inst, Durham, NC USA; [Nye, Monica D.] Univ N Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Vasquez, Brandi] Duke Womens Hlth Collaborat, Durham, NC USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Cancer Research Center of Hawaii; University of Hawaii System; Kilimanjaro Christian Medical Centre; Kilimanjaro Christian Medical Centre; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Murphy, SK (corresponding author), Duke Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27706 USA.	susan.murphy@duke.edu	Vidal, Adriana/AAG-8944-2021; Murphy, Susan/R-3903-2019	Murphy, Susan/0000-0001-8298-7272	Duke CFAR [P30 AI 064518, R01CA142983, R01CA142983S1, R25CA057726];  [K01104517]; NATIONAL CANCER INSTITUTE [R25CA057726, R01CA142983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085173] Funding Source: NIH RePORTER	Duke CFAR; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants K01104517, Duke CFAR P30 AI 064518, R01CA142983, R01CA142983S1 and R25CA057726. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonen SE, 2008, EUR J HUM GENET, V16, P453, DOI 10.1038/sj.ejhg.5201993; Crum CP, 1995, J CELL BIOCHEM, P71; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Duenas-Gonzalez A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-38; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franco EL, 2010, JNCI-J NATL CANCER I, V102, P1451, DOI 10.1093/jnci/djq357; Gloss BS, 2011, CANC LETT; Gravitt PE, 2002, INT J CANCER, V100, P729, DOI 10.1002/ijc.10538; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Otsuka S, 2009, P JPN ACAD B-PHYS, V85, P157, DOI 10.2183/pjab.85.157; Paskett ED, 2010, PREV MED, V50, P74, DOI 10.1016/j.ypmed.2009.09.001; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Vidal AC, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-20; Virmani AK, 2001, CLIN CANCER RES, V7, P584; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012	23	68	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56325	10.1371/journal.pone.0056325	http://dx.doi.org/10.1371/journal.pone.0056325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418553	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300146
J	Woodfield, SE; Graves, HK; Hernandez, JA; Bergmann, A				Woodfield, Sarah E.; Graves, Hillary K.; Hernandez, Jacob A.; Bergmann, Andreas			De-Regulation of JNK and JAK/STAT Signaling in ESCRT-II Mutant Tissues Cooperatively Contributes to Neoplastic Tumorigenesis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TUMOR-SUPPRESSOR GENE; DROSOPHILA-MELANOGASTER; ENDOCYTIC CONTROL; ENDOSOMAL ENTRY; APAF-1 HOMOLOG; PATHWAY; GROWTH; ACTIVATION; TSG101	Multiple genes involved in endocytosis and endosomal protein trafficking in Drosophila have been shown to function as neoplastic tumor suppressor genes (nTSGs), including Endosomal Sorting Complex Required for Transport-II (ESCRT-II) components vacuolar protein sorting 22 (vps22), vps25, and vps36. However, most studies of endocytic nTSGs have been done in mosaic tissues containing both mutant and non-mutant populations of cells, and interactions among mutant and non-mutant cells greatly influence the final phenotype. Thus, the true autonomous phenotype of tissues mutant for endocytic nTSGs remains unclear. Here, we show that tissues predominantly mutant for ESCRT-II components display characteristics of neoplastic transformation and then undergo apoptosis. These neoplastic tissues show upregulation of c-Jun N-terminal Kinase (JNK), Notch, and Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) signaling. Significantly, while inhibition of JNK signaling in mutant tissues partially inhibits proliferation, inhibition of JAK/STAT signaling rescues other aspects of the neoplastic phenotype. This is the first rigorous study of tissues predominantly mutant for endocytic nTSGs and provides clear evidence for cooperation among de-regulated signaling pathways leading to tumorigenesis.	[Woodfield, Sarah E.; Bergmann, Andreas] Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; [Woodfield, Sarah E.; Graves, Hillary K.; Hernandez, Jacob A.; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bergmann, Andreas] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Massachusetts System; University of Massachusetts Worcester	Bergmann, A (corresponding author), Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA.	Andreas.Bergmann@umassmed.edu	Woodfield, Sarah/AAG-9602-2022; Woodfield, Sarah/AEW-0563-2022		National Insitutes of Health [R01 GM068016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068016] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM068016 from the National Insitutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Devergne O, 2007, J CELL SCI, V120, P3457, DOI 10.1242/jcs.005926; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Gilbert MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007083; Graves HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037615; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Koon N, 2004, GUT, V53, P235, DOI 10.1136/gut.2003.021238; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Li J, 2008, CELL CYCLE, V7, P2886, DOI 10.4161/cc.7.18.6677; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Liu RT, 2002, ONCOGENE, V21, P4830, DOI 10.1038/sj.onc.1205612; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Luo H, 2002, MOL GENET GENOMICS, V267, P57, DOI 10.1007/s00438-001-0632-7; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Mills K, 2006, J CELL BIOL, V172, P809, DOI 10.1083/jcb.200512126; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Ring JM, 1993, DEVELOPMENT S, V121, P251; Robinson BS, 2011, CELL CYCLE, V10, P4110, DOI 10.4161/cc.10.23.18243; Rodahl LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004354; Rodrigues AB, 2012, DEVELOPMENT, V139, P4051, DOI 10.1242/dev.076760; Rodriguez A, 2002, EMBO J, V21, P2189, DOI 10.1093/emboj/21.9.2189; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shlevkov E, 2012, CELL DEATH DIFFER, V19, P451, DOI 10.1038/cdd.2011.113; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Stowers RS, 1999, GENETICS, V152, P1631; Suissa Y, 2011, J BIOL CHEM, V286, P15556, DOI 10.1074/jbc.M110.193235; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; Walker GE, 2006, ONCOGENE, V25, P1943, DOI 10.1038/sj.onc.1209213; Xu ZH, 2003, BIOCHEM BIOPH RES CO, V311, P1057, DOI 10.1016/j.bbrc.2003.10.109; Young TW, 2007, MOL CELL PROTEOMICS, V6, P294, DOI 10.1074/mcp.M600305-MCP200; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8	65	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56021	10.1371/journal.pone.0056021	http://dx.doi.org/10.1371/journal.pone.0056021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418496	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300088
J	Betti, L; von Cramon-Taubadel, N; Manica, A; Lycett, SJ				Betti, Lia; von Cramon-Taubadel, Noreen; Manica, Andrea; Lycett, Stephen J.			Global Geometric Morphometric Analyses of the Human Pelvis Reveal Substantial Neutral Population History Effects, Even across Sexes	PLOS ONE			English	Article							HUMAN GENETIC DIVERSITY; BODY-SIZE; DIFFERENTIAL PRESERVATION; CRANIOMETRIC VARIATION; MULTIVARIATE-ANALYSIS; NATURAL-SELECTION; SEXUAL-DIMORPHISM; PATTERNS; EVOLUTION; DISTANCE	Recent applications of population genetic models to human craniodental traits have revealed a strong neutral component to patterns of global variation. However, little work has been undertaken to determine whether neutral processes might also be influencing the postcranium, perhaps due to substantial evidence for selection and plastic environmental responses in these regions. Recent work has provided evidence for neutral effects in the pelvis, but has been limited in regard to shape data (small numbers of linear measurements) and restricted only to males. Here, we use geometric morphometric methods to examine population variation in the human os coxae (pelvic bone) in both males and females. Neutrality is examined via apportionment of variance patterns and fit to an Out-of-Africa serial founder effect model, which is known to structure neutral genetic patterns. Moreover, we compare males and females directly, and the true versus false pelvis, in order to examine potential obstetrical effects. Our results indicate evidence for substantial neutral population history effects on pelvic shape variation. They also reveal evidence for the effect of obstetrical constraints, but these affect males and females to equivalent extents. Our results do not deny an important role for selection in regard to specific aspects of human pelvic variation, especially in terms of features associated with body size and proportions. However, our analyses demonstrate that at a global level, the shape of the os coxae reveals substantial evidence for neutral variation. Our analyses thus indicate that population variation in the human pelvis might be used to address important questions concerning population history, just as the human cranium has done.	[Betti, Lia; von Cramon-Taubadel, Noreen; Lycett, Stephen J.] Univ Kent, Dept Anthropol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Betti, Lia] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England	University of Kent; University of Cambridge; University of Cambridge	Betti, L (corresponding author), Univ Kent, Dept Anthropol, Sch Anthropol & Conservat, Canterbury, Kent, England.	lb386@cam.ac.uk	Manica, Andrea/N-9013-2019; Manica, Andrea/B-5497-2008	Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X; Betti, Lia/0000-0003-2895-9718	Wenner-Gren Foundation for Anthropological Research; University of Kent; Sigma Xi [G20100315153260]; SYNTHESYS Project; European Community Research Infrastructure Action; American Museum of Natural History	Wenner-Gren Foundation for Anthropological Research; University of Kent; Sigma Xi; SYNTHESYS Project; European Community Research Infrastructure Action(European Commission); American Museum of Natural History	This study was funded by the Wenner-Gren Foundation for Anthropological Research (http://www.wennergren.org/, fieldwork dissertation grant #8289), a Ian and Christine Bolt scholarship from the University of Kent (http://www.kent.ac.uk/scholarships/postgraduate/christine_bolt.html), Sigma Xi (http://www.sigmaxi.org/, grant G20100315153260), two grants from the SYNTHESYS Project (http://www.synthesys.info/) which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program, the American Museum of Natural History (http://www.amnh.org/, collection study grant), and a University of Kent Ph.D. research scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BERGE C, 1984, J HUM EVOL, V13, P555, DOI 10.1016/S0047-2484(84)80027-5; Betti L, 2012, HUM BIOL, V84, P139, DOI 10.3378/027.084.0203; Betti L, 2010, AM J PHYS ANTHROPOL, V141, P76, DOI 10.1002/ajpa.21115; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Correia H, 2005, HOMO, V56, P153, DOI 10.1016/j.jchb.2005.05.003; COX M, 1992, AM J PHYS ANTHROPOL, V89, P431, DOI 10.1002/ajpa.1330890404; CURREY J, 1984, AM ZOOL, V24, P5; de Azevedo S, 2011, AM J PHYS ANTHROPOL, V146, P539, DOI 10.1002/ajpa.21564; DeSilva JM, 2011, P NATL ACAD SCI USA, V108, P1022, DOI 10.1073/pnas.1003865108; DEVOR EJ, 1987, J CRAN GENET DEV BIO, V7, P95; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; Eller E, 1999, AM J PHYS ANTHROPOL, V108, P147, DOI 10.1002/(SICI)1096-8644(199902)108:2<147::AID-AJPA2>3.0.CO;2-E; Franklin D, 2010, AM J HUM BIOL, V22, P23, DOI 10.1002/ajhb.20908; Gonzalez-Jose R, 2004, AM J PHYS ANTHROPOL, V123, P69, DOI 10.1002/ajpa.10302; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; Harvati K, 2007, VERTEBR PALEOBIOL PA, P239; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Holliday TW, 2010, AM J PHYS ANTHROPOL, V142, P287, DOI 10.1002/ajpa.21226; Holliday TW, 1997, AM J PHYS ANTHROPOL, V104, P245, DOI 10.1002/(SICI)1096-8644(199710)104:2<245::AID-AJPA10>3.3.CO;2-8; Holliday TW, 1997, J HUM EVOL, V32, P423, DOI 10.1006/jhev.1996.0111; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P442, DOI 10.1002/ajpa.21425; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; ISCAN M Y, 1984, Florida Scientist, V47, P94; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Krogman WM, 1951, AM J PHYS ANTHROP-NE, V9, P211, DOI 10.1002/ajpa.1330090208; Kurki HK, 2007, AM J PHYS ANTHROPOL, V133, P1152, DOI 10.1002/ajpa.20636; Kurki HK, 2011, J HUM EVOL, V61, P631, DOI 10.1016/j.jhevol.2011.07.006; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lieberman DE, 1996, AM J PHYS ANTHROPOL, V101, P217, DOI 10.1002/(SICI)1096-8644(199610)101:2<217::AID-AJPA7>3.0.CO;2-Z; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Long JC, 2009, HUM BIOL, V81, P799, DOI 10.3378/027.081.0622; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; MCHENRY HM, 1978, AM J PHYS ANTHROPOL, V48, P215, DOI 10.1002/ajpa.1330480216; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Relethford JH, 1997, HUM BIOL, V69, P443; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; Relethford JH, 2004, AM J HUM BIOL, V16, P379, DOI 10.1002/ajhb.20045; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P53, DOI 10.1002/ajpa.1330950105; Relethford JH, 2010, AM J PHYS ANTHROPOL, V142, P105, DOI 10.1002/ajpa.21207; Reynolds E, 1931, PAP PEABODY MUS AM A, V11, P255; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1990, ANNU REV ECOL SYST, V21, P299, DOI 10.1146/annurev.es.21.110190.001503; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Roseman CC, 2007, BIOESSAYS, V29, P1185, DOI 10.1002/bies.20678; Rosenberg Karen, 1995, Evolutionary Anthropology, V4, P161, DOI 10.1002/evan.1360040506; ROSENBERG KR, 1992, YEARB PHYS ANTHROPOL, V35, P89; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; Ruff C, 2010, J HUM EVOL, V58, P166, DOI 10.1016/j.jhevol.2009.10.003; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Ruff Christopher B., 1993, Evolutionary Anthropology, V2, P53, DOI 10.1002/evan.1360020207; RYMAN N, 1983, HUM HERED, V33, P93, DOI 10.1159/000153357; Schultz AH, 1936, Q REV BIOL, V11, P425, DOI 10.1086/394517; Slice DE, 1996, NATO ADV SCI INST SE, V284, P179; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; Smith HF, 2011, J EVOLUTION BIOL, V2011; STEUDEL K, 1978, J HUM EVOL, V7, P583, DOI 10.1016/S0047-2484(78)80044-X; Stock J, 2001, AM J PHYS ANTHROPOL, V115, P337, DOI 10.1002/ajpa.1090; Stock JT, 2006, AM J PHYS ANTHROPOL, V131, P194, DOI 10.1002/ajpa.20398; SUTHERLAND LD, 1991, J FORENSIC SCI, V36, P501; TAGUE RG, 1989, AM J PHYS ANTHROPOL, V80, P59, DOI 10.1002/ajpa.1330800108; TAGUE RG, 1995, AM J PHYS ANTHROPOL, V97, P213, DOI 10.1002/ajpa.1330970302; TAGUE RG, 1992, AM J PHYS ANTHROPOL, V88, P1, DOI 10.1002/ajpa.1330880102; Thomas H, 1939, AM J OBSTET GYNECOL, V38, P634, DOI 10.1016/S0002-9378(39)90362-5; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; von Cramon-Taubadel N, 2011, P NATL ACAD SCI USA, V108, P19546, DOI 10.1073/pnas.1113050108; von Cramon-Taubadel N, 2011, AM J PHYS ANTHROPOL, V146, P83, DOI 10.1002/ajpa.21550; von Cramon-Taubadel N, 2011, P ROY SOC B-BIOL SCI, V278, P2874, DOI 10.1098/rspb.2010.2678; von Cramon-Taubadel N, 2009, EVOL ANTHROPOL, V18, P237, DOI 10.1002/evan.20233; von Cramon-Taubadel N, 2009, AM J PHYS ANTHROPOL, V140, P205, DOI 10.1002/ajpa.21041; von Cramon-Taubadel N, 2009, J HUM EVOL, V57, P179, DOI 10.1016/j.jhevol.2009.05.009; Walker PL, 2005, AM J PHYS ANTHROPOL, V127, P385, DOI 10.1002/ajpa.10422; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; WASHBURN SL, 1960, SCI AM, V203, P63; Waterman HC, 1929, B AM MUS NAT HIST, V58, P585; Weaver TD, 2002, THESIS STANFORD U PA; Weaver TD, 2008, P NATL ACAD SCI USA, V105, P4645, DOI 10.1073/pnas.0709079105; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P8151, DOI 10.1073/pnas.0812554106; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; WILLIAMSBLANGERO S, 1992, HUM BIOL, V64, P35; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	104	53	53	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55909	10.1371/journal.pone.0055909	http://dx.doi.org/10.1371/journal.pone.0055909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409086	Green Submitted, Green Published, gold			2022-12-25	WOS:000315157200088
J	Borissoff, JI; Otten, JJT; Heeneman, S; Leenders, P; van Oerle, R; Soehnlein, O; Loubele, STBG; Hamulyak, K; Hackeng, TM; Daemen, MJAP; Degen, JL; Weiler, H; Esmon, CT; van Ryn, J; Biessen, EAL; Spronk, HMH; ten Cate, H				Borissoff, Julian I.; Otten, Jeroen J. T.; Heeneman, Sylvia; Leenders, Peter; van Oerle, Rene; Soehnlein, Oliver; Loubele, Sarah T. B. G.; Hamulyak, Karly; Hackeng, Tilman M.; Daemen, Mat J. A. P.; Degen, Jay L.; Weiler, Hartmut; Esmon, Charles T.; van Ryn, Joanne; Biessen, Erik A. L.; Spronk, Henri M. H.; ten Cate, Hugo			Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner	PLOS ONE			English	Article							SUDDEN CORONARY DEATH; COLONY-STIMULATING FACTOR; PLAQUE STABILITY; P-SELECTIN; INFLAMMATION; ATHEROGENESIS; COAGULATION; MECHANISMS; DISEASE; ACTIVATION	Background: Variations in the blood coagulation activity, determined genetically or by medication, may alter atherosclerotic plaque progression, by influencing pleiotropic effects of coagulation proteases. Published experimental studies have yielded contradictory findings on the role of hypercoagulability in atherogenesis. We therefore sought to address this matter by extensively investigating the in vivo significance of genetic alterations and pharmacologic inhibition of thrombin formation for the onset and progression of atherosclerosis, and plaque phenotype determination. Methodology/Principal Findings: We generated transgenic atherosclerosis-prone mice with diminished coagulant or hypercoagulable phenotype and employed two distinct models of atherosclerosis. Gene-targeted 50% reduction in prothrombin (FII-/WT:ApoE(-/-)) was remarkably effective in limiting disease compared to control ApoE(-/-) mice, associated with significant qualitative benefits, including diminished leukocyte infiltration, altered collagen and vascular smooth muscle cell content. Genetically-imposed hypercoagulability in TMPro/Pro:ApoE(-/-) mice resulted in severe atherosclerosis, plaque vulnerability and spontaneous atherothrombosis. Hypercoagulability was associated with a pronounced neutrophilia, neutrophil hyper-reactivity, markedly increased oxidative stress, neutrophil intraplaque infiltration and apoptosis. Administration of either the synthetic specific thrombin inhibitor Dabigatran etexilate, or recombinant activated protein C (APC), counteracted the pro-inflammatory and pro-atherogenic phenotype of pro-thrombotic TMPro/Pro:ApoE(-/-) mice. Conclusions/Significance: We provide new evidence highlighting the importance of neutrophils in the coagulation-inflammation interplay during atherogenesis. Our findings reveal that thrombin-mediated proteolysis is an unexpectedly powerful determinant of atherosclerosis in multiple distinct settings. These studies suggest that selective anticoagulants employed to prevent thrombotic events may also be remarkably effective in clinically impeding the onset and progression of cardiovascular disease.	[Borissoff, Julian I.; Leenders, Peter; van Oerle, Rene; Loubele, Sarah T. B. G.; Hamulyak, Karly; Spronk, Henri M. H.; ten Cate, Hugo] Maastricht Univ, Med Ctr, Lab Clin Thrombosis & Hemostasis, Dept Internal Med,Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Borissoff, Julian I.] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston Childrens Hosp, Boston, MA USA; [Borissoff, Julian I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Otten, Jeroen J. T.; Heeneman, Sylvia; Daemen, Mat J. A. P.; Biessen, Erik A. L.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Expt Vasc Pathol Res Grp, Dept Pathol, Maastricht, Netherlands; [Soehnlein, Oliver] Rhein Westfal TH Aachen, Fac Med, Inst Cardiovasc Mol Res, Aachen, Germany; [Hackeng, Tilman M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Med Ctr, Maastricht, Netherlands; [Degen, Jay L.] Univ Cincinnati, Coll Med, Childrens Hosp Res Fdn, Cincinnati, OH USA; [Weiler, Hartmut] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53233 USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK USA; [van Ryn, Joanne] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, Biberach, Germany	Maastricht University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Maastricht University; RWTH Aachen University; Maastricht University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Versiti Blood Center of Wisconsin; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute; Boehringer Ingelheim	Borissoff, JI (corresponding author), Maastricht Univ, Med Ctr, Lab Clin Thrombosis & Hemostasis, Dept Internal Med,Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	j.ilcheff@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021	Daemen, Mat/0000-0003-1076-199X; Spronk, Henri/0000-0002-3858-334X; Biessen, Erik/0000-0002-6454-8548; Hackeng, Tilman/0000-0003-0142-0843; ten Cate, Hugo/0000-0001-7796-4463	European Commission [MEST-CT-2005-020706]; SenterNovem grant; Maastricht University; Netherlands Organization for Scientific Research (NWO) [825.11.019]; Deutsche Forschungsgemeinschaft [SO876/3-1, SO876/4-1]; Gutenberg Research College Fellowship (Gutenberg University, Mainz, Germany); Bayer; Boehringer Ingelheim; GlaxoSmithKline; Leo Pharma	European Commission(European CommissionEuropean Commission Joint Research Centre); SenterNovem grant; Maastricht University; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gutenberg Research College Fellowship (Gutenberg University, Mainz, Germany); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Leo Pharma(LEO Pharma)	Boehringer Ingelheim GmbH provided Dabigatran etexilate-supplemented and placebo diets. This study was supported by a Marie Curie fellowship (MEST-CT-2005-020706) from the European Commission (to Dr. J.I. Borissoff) and a SenterNovem grant (to Cardiovascular Research Institute Maastricht (CARIM)). Dr. J.I. Borissoff is a recipient of a Kootstra Talent Fellowship (2011) from Maastricht University and is supported by a Rubicon fellowship (825.11.019), granted by the Netherlands Organization for Scientific Research (NWO). Dr. Oliver Soehnlein is supported by the Deutsche Forschungsgemeinschaft (SO876/3-1 and SO876/4-1). Dr. Hugo ten Cate is sponsored by a Gutenberg Research College Fellowship (Gutenberg University, Mainz, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Boehringer Ingelheim GmbH provided Dabigatran etexilate-supplemented and placebo diets for this study and is the employer of Joanne van Ryn. Dr. ten Cate has received speaker fees from Bayer, Boehringer Ingelheim, GlaxoSmithKline and Leo Pharma. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Bea F, 2006, ARTERIOSCL THROM VAS, V26, P2787, DOI 10.1161/01.ATV.0000246797.05781.ad; Borissoff JI, 2012, JACC-CARDIOVASC IMAG, V5, P1201, DOI 10.1016/j.jcmg.2012.01.023; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Burke AP, 2001, CIRCULATION, V103, P934; Burns AR, 1999, J LEUKOCYTE BIOL, V65, P299, DOI 10.1002/jlb.65.3.299; Castellino FJ, 2006, THROMB HAEMOSTASIS, V96, P794, DOI 10.1160/TH06-08-0430; Cella G, 2006, LEUKEMIA, V20, P1430, DOI 10.1038/sj.leu.2404271; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Drechsler M, 2011, THROMB HAEMOSTASIS, V106, P839, DOI 10.1160/TH11-07-0501; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Eitzman DT, 2005, CIRCULATION, V111, P1822, DOI 10.1161/01.CIR.0000160854.75779.E8; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Falanga A, 1999, BLOOD, V93, P2506, DOI 10.1182/blood.V93.8.2506.408k31_2506_2514; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Iwaki T, 2006, BLOOD, V107, P3883, DOI 10.1182/blood-2005-09-3780; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P973, DOI 10.1161/01.ATV.0000261545.53586.f0; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; Kadoglou NP, 2012, CARDIOVASC DRUGS THE; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; Kramer MCA, 2010, J AM COLL CARDIOL, V55, P122, DOI 10.1016/j.jacc.2009.09.007; Lee IO, 2012, J PHARM EXP THER; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Nasr N, 2009, ATHEROSCLEROSIS, V207, P519, DOI 10.1016/j.atherosclerosis.2009.05.003; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Seehaus S, 2009, CIRCULATION, V120, P774, DOI 10.1161/CIRCULATIONAHA.109.849539; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Vicente CP, 2007, BLOOD, V110, P4261, DOI 10.1182/blood-2007-04-086611; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wei HJ, 2011, CARDIOVASC RES, V92, P317, DOI 10.1093/cvr/cvr220; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Westrick RJ, 2001, CIRCULATION, V103, P3044, DOI 10.1161/hc2501.092492; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391	55	99	102	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55784	10.1371/journal.pone.0055784	http://dx.doi.org/10.1371/journal.pone.0055784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409043	Green Submitted, gold, Green Published			2022-12-25	WOS:000315157200063
J	Luo, Z; Liu, HM; Sun, XM; Guo, R; Cui, RB; Ma, XX; Yan, M				Luo, Zheng; Liu, Huimin; Sun, Xiaomeng; Guo, Rong; Cui, Ruibing; Ma, Xiangxing; Yan, Ming			RNA Interference against Discoidin Domain Receptor 2 Ameliorates Alcoholic Liver Disease in Rats	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; FAT-STORING CELLS; MATRIX METALLOPROTEINASE-2; GENE-EXPRESSION; COLLAGEN I; EXTRACELLULAR-MATRIX; HSC-T6 CELLS; FIBROSIS; ACTIVATION; APOPTOSIS	Discoidin domain receptor 2 (DDR2) is involved in fibrotic disease. However, the exact pathogenic implications of the receptor in early alcoholic liver disease are still controversial. We constructed plasmid vectors encoding short-hairpin RNA against DDR2 to investigate its role in alcoholic liver disease in an immortalized rat hepatic stellate cell line, HSC-T6, and in rats by MTT, RT-PCR and western blot analyses; immunohistochemistry and electron microscopy. Alcohol-induced upregulation of DDR2 was associated with the expression of matrix metalloproteinase 2, the transforming growth factor beta 1 signaling pathway and tissue inhibitor of metalloproteinase 1; collagen deposition; and extracellular matrix remodeling. Inhibition of DDR2 decreased HSC-T6 cell proliferation and liver injury in rats with 10-week-induced alcoholic liver disease. DDR2 may have an important role in the pathogenesis of early-stage alcoholic liver disease. Silencing DDR2 may be effective in preventing early-stage alcoholic liver disease.	[Luo, Zheng; Sun, Xiaomeng; Guo, Rong; Cui, Ruibing; Yan, Ming] Shandong Univ, Dept Geriatr Gastroenterol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Luo, Zheng] Shandong Univ, Key Lab Cardiovasc Remodeling, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Liu, Huimin] Qingdao Univ, Dept Gastroenterol & Hepatol, Yantai Yuhuangding Hosp, Coll Med, Yantai, Shandong, Peoples R China; [Ma, Xiangxing] Shandong Univ, Dept Radiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Qingdao University; Shandong University	Ma, XX (corresponding author), Shandong Univ, Dept Radiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	maxiangxing@yahoo.com; ymylh@163.com	罗, 争/GYU-2181-2022		Science and Technology Planning Project of Shandong Province, China [2007GG30002002]	Science and Technology Planning Project of Shandong Province, China	This work was supported by Science and Technology Planning Project of Shandong Province, China (grant number 2007GG30002002). We declare that funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2005, DIGEST DIS, V23, P255, DOI 10.1159/000090173; Agarwal G, 2002, BIOCHEMISTRY-US, V41, P11091, DOI 10.1021/bi020087w; Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Badiola I, 2011, ONCOL REP, V26, P971, DOI 10.3892/or.2011.1356; Bartalis J, 2011, BIOORGAN MED CHEM, V19, P2757, DOI 10.1016/j.bmc.2011.01.037; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; CASINI A, 1991, HEPATOLOGY, V13, P758, DOI 10.1016/0270-9139(91)92576-T; CASINI A, 1994, LIFE SCI, V55, P1311, DOI 10.1016/0024-3205(94)00763-2; Chen A, 2002, BIOCHEM J, V368, P683, DOI 10.1042/BJ20020949; Friedman SL, 1999, ALCOHOL CLIN EXP RES, V23, P904, DOI 10.1097/00000374-199905000-00020; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gukovsky I, 2008, AM J PHYSIOL-GASTR L, V294, pG68, DOI 10.1152/ajpgi.00006.2007; Haas SL, 2012, CURR OPIN CLIN NUTR, V15, P457, DOI 10.1097/MCO.0b013e3283566699; Hartland SN, 2009, LIVER INT, V29, P966, DOI 10.1111/j.1478-3231.2009.02070.x; Huang ZS, 1999, WORLD J GASTROENTERO, V5, P362; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548; Jeong WI, 2004, LIVER INT, V24, P658, DOI 10.1111/j.1478-3231.2004.0961.x; Jiang YA, 2005, WORLD J GASTROENTERO, V11, P6780, DOI 10.3748/wjg.v11.i43.6780; Kano K, 2010, MOL REPROD DEV, V77, P29, DOI 10.1002/mrd.21093; Kazuo I, 2003, CONNECT TISSUE, V35, P165; Lim CS, 2010, BIOSCI BIOTECH BIOCH, V74, P477, DOI 10.1271/bbb.90435; Liu Hui-min, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P425; Mihai C, 2006, J MOL BIOL, V361, P864, DOI 10.1016/j.jmb.2006.06.067; Morales MO, 2005, MICROSC MICROANAL, V11, P260, DOI 10.1017/S1431927605050518; Neuman MG, 2012, INT J HEPATOL, V2012, DOI DOI 10.1155/2012/231210; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Olaso E, 2011, AM J PATHOL, V179, P2894, DOI 10.1016/j.ajpath.2011.09.002; Plewka K, 2009, POSTEP HIG MED DOSW, V63, P303; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Rahn S B, 2001, J Insur Med, V33, P110; SAVOLAINEN V, 1995, J HEPATOL, V23, P524, DOI 10.1016/0168-8278(95)80057-3; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; Sivakumar L, 2010, BIOMATERIALS, V31, P4802, DOI 10.1016/j.biomaterials.2010.02.070; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Tang LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031350; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; URASHIMA S, 1993, ALCOHOL ALCOHOLISM, V28, P77, DOI 10.1093/alcalc/28.Supplement_1B.77; Vogel S, 2000, J LIPID RES, V41, P882; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Wall SJ, 2005, J BIOL CHEM, V280, P40187, DOI 10.1074/jbc.M508226200; Wang Lei, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P281; WITTE MH, 1992, ALCOHOL, V9, P473, DOI 10.1016/0741-8329(92)90083-M; Yin M, 2000, HEPATOLOGY, V31, P117, DOI 10.1002/hep.510310119; Zhang XH, 2010, ARCH MED RES, V41, P586, DOI 10.1016/j.arcmed.2010.10.010	52	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55860	10.1371/journal.pone.0055860	http://dx.doi.org/10.1371/journal.pone.0055860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409069	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200078
J	Moraes, CB; Dorval, T; Contreras-Dominguez, M; Dossin, FD; Hansen, MAE; Genovesio, A; Freitas-Junior, LH				Moraes, Carolina B.; Dorval, Thierry; Contreras-Dominguez, Monica; Dossin, Fernando de M.; Hansen, Michael A. E.; Genovesio, Auguste; Freitas-Junior, Lucio H.			Transcription Sites Are Developmentally Regulated during the Asexual Cycle of Plasmodium falciparum	PLOS ONE			English	Article							RNA-POLYMERASE-II; MUTUALLY EXCLUSIVE EXPRESSION; ANTIGENIC VARIATION; VIRULENCE GENES; DNA-BINDING; PROTEIN; ORGANIZATION; COMPARTMENT; DISCOVERY; CLUSTERS	Increasing evidence shows that the spatial organization of transcription is an important epigenetic factor in eukaryotic gene regulation. The malaria parasite Plasmodium falciparum shows a remarkably complex pattern of gene expression during the erythrocytic cycle, paradoxically contrasting with the relatively low number of putative transcription factors encoded by its genome. The spatial organization of nuclear subcompartments has been correlated with the regulation of virulence genes. Here, we investigate the nuclear architecture of transcription during the asexual cycle of malaria parasites. As in mammals, transcription is organized into discrete nucleoplasmic sites in P. falciparum, but in a strikingly lower number of foci. An automated analysis of 3D images shows that the number and intensity of transcription sites vary significantly between rings and trophozoites, although the nuclear volume remains constant. Transcription sites are spatially reorganized during the asexual cycle, with a higher proportion of foci located in the outermost nuclear region in rings, whereas in trophozoites, foci are evenly distributed throughout the nucleoplasm. As in higher eukaryotes, transcription sites are predominantly found in areas of low chromatin density. Immunofluorescence analysis shows that transcription sites form an exclusive nuclear compartment, different from the compartments defined by the silenced or active chromatin markers. In conclusion, these data suggest that transcription is spatially contained in discrete foci that are developmentally regulated during the asexual cycle of malaria parasites and located in areas of low chromatin density.	[Moraes, Carolina B.; Contreras-Dominguez, Monica; Dossin, Fernando de M.; Freitas-Junior, Lucio H.] Inst Pasteur Korea, CND3, Gyeonggi Do, South Korea; [Dorval, Thierry] Inst Pasteur Korea, Cell Differentiat & Tox Grp, Gyeonggi Do, South Korea; [Hansen, Michael A. E.; Genovesio, Auguste] Inst Pasteur Korea, Image Min Grp, Gyeonggi Do, South Korea	Institut Pasteur Korea; Institut Pasteur Korea; Institut Pasteur Korea	Freitas-Junior, LH (corresponding author), Inst Pasteur Korea, CND3, Gyeonggi Do, South Korea.	freitasjunior@ip-korea.org	Hansen, Michael Adsetts Edberg/C-9028-2011; Moraes, Carolina Borsoi/I-4408-2014; Freitas-Junior, Lucio H/C-8677-2011; GENOVESIO, Auguste/I-1656-2017	Hansen, Michael Adsetts Edberg/0000-0001-7879-2106; Moraes, Carolina Borsoi/0000-0002-0689-2770; Freitas-Junior, Lucio H/0000-0002-8904-7897; Genovesio, Auguste/0000-0003-1877-5595	National Research Foundation of Korea (NRF); Korea government (MEST), Gyeonggi-do [2012-00011]; KISTI	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST), Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST - grant no. 2012-00011), Gyeonggi-do and KISTI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Callebaut I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-100; Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Dorval T, 2009, I S BIOMED IMAGING, P1119, DOI 10.1109/ISBI.2009.5193253; Dossin FD, 2005, EUKARYOT CELL, V4, P960, DOI 10.1128/EC.4.5.960-970.2005; Dossin FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002313; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Faro-Trindade I, 2006, MOL BIOL CELL, V17, P2910, DOI 10.1091/mbc.E05-11-1024; Figueiredo LM, 2005, NUCLEIC ACIDS RES, V33, P1111, DOI 10.1093/nar/gki260; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Gopalakrishnan AM, 2009, EXP PARASITOL, V121, P46, DOI 10.1016/j.exppara.2008.09.016; GRITZMACHER CA, 1984, J BACTERIOL, V160, P1165, DOI 10.1128/JB.160.3.1165-1167.1984; Hazoume A, 2011, MOL BIOCHEM PARASIT, V176, P127, DOI 10.1016/j.molbiopara.2010.12.013; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Iborra FJ, 1996, J CELL SCI, V109, P1427; Issar N, 2009, MICROBES INFECT, V11, P403, DOI 10.1016/j.micinf.2008.12.010; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kishore SP, 2009, J MOL EVOL, V68, P706, DOI 10.1007/s00239-009-9245-2; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Llinas M, 2008, TRENDS PARASITOL, V24, P551, DOI 10.1016/j.pt.2008.08.010; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Mancio-Silva L, 2010, P NATL ACAD SCI USA, V107, P15117, DOI 10.1073/pnas.1001045107; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Papantonis A, 2010, CURR OPIN CELL BIOL, V22, P271, DOI 10.1016/j.ceb.2010.03.004; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Ruvalcaba-Salazar OK, 2005, MOL BIOCHEM PARASIT, V140, P183, DOI 10.1016/j.molbiopara.2005.01.002; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Shiels C, 2007, PLOS COMPUT BIOL, V3, P1161, DOI 10.1371/journal.pcbi.0030138; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Volz J, 2010, INT J PARASITOL, V40, P109, DOI 10.1016/j.ijpara.2009.09.002; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Zirbel RM, 1993, CHROMOSOME RES, V1, P93, DOI 10.1007/BF00710032	45	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55539	10.1371/journal.pone.0055539	http://dx.doi.org/10.1371/journal.pone.0055539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408998	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200037
J	Sheikh, MA; Malik, YS; Yu, HL; Lai, MM; Wang, XZ; Zhu, XJ				Sheikh, Muhammad Abid; Malik, Yousra Saeed; Yu, Huali; Lai, Mingming; Wang, Xingzhi; Zhu, Xiaojuan			Epigenetic Regulation of Dpp6 Expression by Dnmt3b and Its Novel Role in the Inhibition of RA Induced Neuronal Differentiation of P19 Cells	PLOS ONE			English	Article							DNA METHYLTRANSFERASES DNMT3A; DIPEPTIDYL PEPTIDASE-IV; EMBRYONAL CARCINOMA-CELLS; RECEPTOR EXPRESSION; BINDING-PROTEINS; GENE-EXPRESSION; STEM-CELLS; METHYLATION; REPRESSOR; UNIQUE	DNA methylation is an important mechanism of gene silencing in mammals catalyzed by a group of DNA methyltransferases including Dnmt1, Dnmt3a, and Dnmt3b which are required for the establishment of genomic methylation patterns during development and differentiation. In this report, we studied the role of DNA methyltransferases during retinoic acid induced neuronal differentiation of P19 cells. We observed an increase in the mRNA and protein level of Dnmt3b, whereas the expression of Dnmt1 and Dnmt3a was decreased after RA treatment of P19 cells which indicated that Dnmt3b is more important during neuronal differentiation of P19 cells. Dnmt3b enriched chromatin library from RA treated P19 cells identified dipeptidyl peptidase 6 (Dpp6) gene as a novel target of Dnmt3b. Further, quantitative ChIP analysis showed that the amount of Dnmt3b recruited on Dpp6 promoter was equal in both RA treated as well as untreated p19 cells. Bisulfite genomic sequencing, COBRA, and methylation specific PCR analysis revealed that Dpp6 promoter was heavily methylated in both RA treated and untreated P19 cells. Dnmt3b was responsible for transcriptional silencing of Dpp6 gene as depletion of Dnmt3b resulted in increased mRNA and protein expression of Dpp6. Consequently, the average methylation of Dpp6 gene promoter was reduced to half in Dnmt3b knockdown cells. In the absence of Dnmt3b, Dnmt3a was associated with Dpp6 gene promoter and regulated its expression and methylation in P19 cells. RA induced neuronal differentiation was inhibited upon ectopic expression of Dpp6 in P19 cells. Taken together, the present study described epigenetic silencing of Dpp6 expression by DNA methylation and established that its ectopic expression can act as negative signal during RA induced neuronal differentiation of P19 cells.	[Sheikh, Muhammad Abid; Malik, Yousra Saeed; Yu, Huali; Lai, Mingming; Wang, Xingzhi; Zhu, Xiaojuan] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China	Northeast Normal University - China	Zhu, XJ (corresponding author), NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China.	zhuxj720@nenu.edu.cn		Zhu, Xiao-Juan/0000-0001-8386-8064	Program for New Century Excellent Talents in University [NCET-07-0173, 111496019]; National Natural Science Foundation of China [30670689, 30871302, 31171042]; Scientific Research Foundation from Northeast Normal University [09ZDQD04]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation from Northeast Normal University	This work was supported by the Program for New Century Excellent Talents in University (NCET-07-0173, 111496019), the National Natural Science Foundation of China (30670689, 30871302 and 31171042), and the Scientific Research Foundation from Northeast Normal University (09ZDQD04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Boatright JH, 2000, BRAIN RES, V887, P211, DOI 10.1016/S0006-8993(00)02990-5; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; D'Aiuto L, 2011, DIFFERENTIATION, V82, P9, DOI 10.1016/j.diff.2011.03.003; DELECEA L, 1994, MOL BRAIN RES, V25, P286, DOI 10.1016/0169-328X(94)90164-3; Deplus R, 2002, NUCLEIC ACIDS RES, V30, P3831, DOI 10.1093/nar/gkf509; Du J, 2011, ACTA HISTOCHEM, V113, P636, DOI 10.1016/j.acthis.2010.08.001; Fan GP, 2005, CELL RES, V15, P255, DOI 10.1038/sj.cr.7290294; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hough RB, 1998, P NATL ACAD SCI USA, V95, P13800, DOI 10.1073/pnas.95.23.13800; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kotackova L, 2009, FOLIA BIOL-PRAGUE, V55, P77; Lan J, 2010, ACTA BIOCH BIOPH SIN, V42, P243, DOI 10.1093/abbs/gmq015; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Liu YL, 1996, NUCLEIC ACIDS RES, V24, P2718, DOI 10.1093/nar/24.14.2718; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pachernik J, 2005, PHYSIOL RES, V54, P115, DOI 10.33549/physiolres.930526; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Resende RR, 2007, NEUROSCIENCE, V146, P1169, DOI 10.1016/j.neuroscience.2007.02.041; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saied MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033213; Schroeder DI, 2011, GENOME RES, V21, P1583, DOI 10.1101/gr.119131.110; Sedo A, 1994, Sb Lek, V95, P285; SEDO A, 1991, PHYSIOL RES, V40, P359; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Stremenova J, 2007, INT J ONCOL, V31, P785; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; Ulrich H, 2006, CELL PROLIFERAT, V39, P281, DOI 10.1111/j.1365-2184.2006.00385.x; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55826	10.1371/journal.pone.0055826	http://dx.doi.org/10.1371/journal.pone.0055826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409053	gold, Green Published, Green Submitted			2022-12-25	WOS:000315157200071
J	Walker, KA; Sims-Lucas, S; Di Giovanni, VE; Schaefer, C; Sunseri, WM; Novitskaya, T; de Caestecker, MP; Chen, F; Bates, CM				Walker, Kenneth A.; Sims-Lucas, Sunder; Di Giovanni, Valeria E.; Schaefer, Caitlin; Sunseri, Whitney M.; Novitskaya, Tatiana; de Caestecker, Mark P.; Chen, Feng; Bates, Carlton M.			Deletion of Fibroblast Growth Factor Receptor 2 from the Peri-Wolffian Duct Stroma Leads to Ureteric Induction Abnormalities and Vesicoureteral Reflux	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; KIDNEY DEVELOPMENT; DUPLEX KIDNEYS; MUTANT MICE; EXPRESSION; MESENCHYME; PROTEIN; ORIFICE; BUD	Purpose: Pax3cre-mediated deletion of fibroblast growth factor receptor 2 (Fgfr2) broadly in renal and urinary tract mesenchyme led to ureteric bud (UB) induction defects and vesicoureteral reflux (VUR), although the mechanisms were unclear. Here, we investigated whether Fgfr2 acts specifically in peri Wolffian duct stroma (ST) to regulate UB induction and development of VUR and the mechanisms of Fgfr2 activity. Methods: We conditionally deleted Fgfr2 in ST (Fgfr2(ST-/-)) using Tbx18cre mice. To look for ureteric bud induction defects in young embryos, we assessed length and apoptosis of common nephric ducts (CNDs). We performed 3D reconstructions and histological analyses of urinary tracts of embryos and postnatal mice and cystograms in postnatal mice to test for VUR. We performed in situ hybridization and real-time PCR in young embryos to determine mechanisms underlying UB induction defects. Results: We confirmed that Fgfr2 is expressed in ST and that Fgfr2 was efficiently deleted in this tissue in Fgfr2(ST-/-) mice at embryonic day (E) 10.5. E11.5 Fgfr2(ST-/-) mice had randomized UB induction sites with approximately 1/3 arising too high and 1/3 too low from the Wolffian duct; however, apoptosis was unaltered in E12.5 mutant CNDs. While ureters were histologically normal, E15.5 Fgfr2(ST-/-) mice exhibit improper ureteral insertion sites into the bladder, consistent with the ureteric induction defects. While ureter and bladder histology appeared normal, postnatal day (P) 1 mutants had high rates of VUR versus controls (75% versus 3%, p = 0.001) and occasionally other defects including renal hypoplasia and duplex systems. P1 mutant mice also had improper ureteral bladder insertion sites and shortened intravesicular tunnel lengths that correlated with VUR. E10.5 Fgfr2(ST-/-) mice had decreases in Bmp4 mRNA in stromal tissues, suggesting a mechanism underlying the ureteric induction and VUR phenotypes. Conclusion: Mutations in FGFR2 could possibly cause VUR in humans.	[Walker, Kenneth A.; Sims-Lucas, Sunder; Di Giovanni, Valeria E.; Schaefer, Caitlin; Sunseri, Whitney M.] UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, Pittsburgh, PA USA; [Novitskaya, Tatiana; de Caestecker, Mark P.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN USA; [Chen, Feng] Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Bates, Carlton M.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bates, CM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA.	batescm@upmc.edu		Sims-Lucas, Sunder/0000-0003-1908-4809	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK081128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081592, R01DK087960, R01DK104374, R01DK081128] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK081128 (to CMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena S, 2007, BJU INT, V100, P407, DOI 10.1111/j.1464-410X.2007.06921.x; Bates CM, 2011, AM J PHYSIOL-RENAL, V301, pF245, DOI 10.1152/ajprenal.00186.2011; Cain JE, 2006, J ANAT, V209, P745, DOI 10.1111/j.1469-7580.2006.00655.x; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Hains D, 2008, PEDIATR RES, V64, P592, DOI 10.1203/PDR.0b013e318187cc12; Hains DS, 2010, J UROLOGY, V183, P2077, DOI 10.1016/j.juro.2009.12.095; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hoshino T, 2008, GENES CELLS, V13, P159, DOI 10.1111/j.1365-2443.2007.01158.x; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; MACKIE GG, 1975, J PEDIATR SURG, V10, P473, DOI 10.1016/0022-3468(75)90187-6; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Murawski IJ, 2006, CLIN GENET, V69, P105, DOI 10.1111/j.1399-0004.2005.00562.x; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Sims-Lucas S, 2012, J AM SOC NEPHROLOGY; Sims-Lucas S, 2011, DEVELOPMENT, V138, P1275, DOI 10.1242/dev.062158; Sims-Lucas S, 2011, DEV DYNAM, V240, P240, DOI 10.1002/dvdy.22501; Sims-Lucas S, 2009, J AM SOC NEPHROL, V20, P2525, DOI 10.1681/ASN.2009050532; Sims-Lucas S, 2009, AM J PHYSIOL-RENAL, V297, pF1208, DOI 10.1152/ajprenal.00262.2009; Tabatabaeifar M, 2009, PEDIATR NEPHROL, V24, P2361, DOI 10.1007/s00467-009-1287-6; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Wang Y, 2009, GENESIS; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	28	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56062	10.1371/journal.pone.0056062	http://dx.doi.org/10.1371/journal.pone.0056062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409123	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000315157200104
J	Wu, S; Tan, GG; Dong, X; Zhu, ZY; Li, WH; Lou, ZY; Chai, YF				Wu, Si; Tan, Guangguo; Dong, Xin; Zhu, Zhenyu; Li, Wuhong; Lou, Ziyang; Chai, Yifeng			Metabolic Profiling Provides a System Understanding of Hypothyroidism in Rats and Its Application	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TRADITIONAL CHINESE MEDICINE; YANG DEFICIENCY SYNDROME; MASS-SPECTROMETRY; THYROID-HORMONES; TAURINE SUPPLEMENTATION; SINI DECOCTION; PLASMA; LIVER; IDENTIFICATION	Background: Hypothyroidism is a chronic condition of endocrine disorder and its precise molecular mechanism remains obscure. In spite of certain efficacy of thyroid hormone replacement therapy in treating hypothyroidism, it often results in other side effects because of its over-replacement, so it is still urgent to discover new modes of treatment for hypothyroidism. Sini decoction (SND) is a well-known formula of Traditional Chinese Medicine (TCM) and is considered as efficient agents against hypothyroidism. However, its holistic effect assessment and mechanistic understanding are still lacking due to its complex components. Methodology/Principal Findings: A urinary metabonomic method based on ultra performance liquid chromatography coupled to mass spectrometry was employed to explore global metabolic characters of hypothyroidism. Three typical hypothyroidism models (methimazole-, propylthiouracil-and thyroidectomy-induced hypothyroidism) were applied to elucidate the molecular mechanism of hypothyroidism. 17, 21, 19 potential biomarkers were identified with these three hypothyroidism models respectively, primarily involved in energy metabolism, amino acid metabolism, sphingolipid metabolism and purine metabolism. In order to avert the interference of drug interaction between the antithyroid drugs and SND, the thyroidectomy-induced hypothyroidism model was further used to systematically assess the therapeutic efficacy of SND on hypothyroidism. A time-dependent recovery tendency was observed in SND-treated group from the beginning of model to the end of treatment, suggesting that SND exerted a recovery effect on hypothyroidism in a time-dependent manner through partially regulating the perturbed metabolic pathways. Conclusions/Significance: Our results showed that the metabonomic approach is instrumental to understand the pathophysiology of hypothyroidism and offers a valuable tool for systematically studying the therapeutic effects of SND on hypothyroidism.	[Wu, Si; Tan, Guangguo; Dong, Xin; Zhu, Zhenyu; Li, Wuhong; Lou, Ziyang; Chai, Yifeng] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Wu, Si; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng] Shanghai Key Lab Pharmaceut Metabolite Res, Shanghai, Peoples R China; [Tan, Guangguo] Chinese Peoples Liberat Army, Hosp 22, Geermu, Peoples R China	Naval Medical University	Chai, YF (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	yfchai@smmu.edu.cn			National Natural Science Foundation of China [30873196]; Project of Modernization of Traditional Chinese Medicine of Shanghai [09dZ1975100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Modernization of Traditional Chinese Medicine of Shanghai	The authors appreciate the financial support from the National Natural Science Foundation of China (NO. 30873196) and Project of Modernization of Traditional Chinese Medicine of Shanghai (NO. 09dZ1975100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoubi KH, 2009, HIPPOCAMPUS, V19, P66, DOI 10.1002/hipo.20476; Babenko NA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P912; Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; BECKETT GJ, 1985, BRIT MED J, V291, P427, DOI 10.1136/bmj.291.6493.427; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Briere JJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1114, DOI 10.1152/ajpcell.00216.2006; Cai D, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P415; CAREW LB, 1983, J NUTR, V113, P1756, DOI 10.1093/jn/113.9.1756; Chen J, 2009, ANAL CHIM ACTA, V650, P3, DOI 10.1016/j.aca.2009.03.039; Chinese Pharmacopoeia Commission, 2010, PHARM PEOPL REP CHIN; Clarke Nick, 2004, Treat Endocrinol, V3, P217, DOI 10.2165/00024677-200403040-00003; Constantinou C, 2011, J PROTEOME RES, V10, P869, DOI 10.1021/pr100699m; Ding WJ, 2009, AM J CHINESE MED, V37, P427, DOI 10.1142/S0192415X09006953; Dirican M, 2007, CLIN EXP PHARMACOL P, V34, P833, DOI 10.1111/j.1440-1681.2007.04615.x; Ermantas N, 2010, CLIN APPL THROMB-HEM, V16, P568, DOI 10.1177/1076029609350890; Fegert I, 2012, REPROD TOXICOL, V34, P331, DOI 10.1016/j.reprotox.2012.05.096; Fernstrom J.D., 2007, J NUTR S1, V137, p1548S; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gorska M, 2003, J PHYSIOL PHARMACOL, V54, P89; He LP, 2009, J ANAL TOXICOL, V33, P588, DOI 10.1093/jat/33.9.588; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Jena S, 2012, MOL BIOL REP, V39, P1193, DOI 10.1007/s11033-011-0849-4; Koromilas C, 2010, METAB BRAIN DIS, V25, P339, DOI 10.1007/s11011-010-9208-8; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Kulikov A, 1999, NEUROENDOCRINOLOGY, V69, P453, DOI 10.1159/000054449; La Vignera S, 2008, Minerva Ginecol, V60, P475; Liang XP, 2011, J PROTEOME RES, V10, P790, DOI 10.1021/pr1009299; Liu Ying, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1269; Liu Yong, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1559; Lu XM, 2011, TALANTA, V83, P700, DOI 10.1016/j.talanta.2010.09.026; LYMAN EM, 1976, CAN J BIOCHEM CELL B, V54, P15, DOI 10.1139/o76-003; Ma T, 2010, MOL BIOSYST, V6, P613, DOI 10.1039/b914024g; MANNISTO PT, 1978, ACTA ENDOCRINOL-COP, V89, P100, DOI 10.1530/acta.0.0890100; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; Miaorong P, 2010, CHINA J TRADITIONAL; Min Z., 2006, COMP STUDIES CHINESE, P75; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Rahimpour S, 2012, J SURG RES; Sanchez-Huerta KB, 2012, J NEUROSCI RES, V90, P905, DOI 10.1002/jnr.22806; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Singhuber J, 2009, J ETHNOPHARMACOL, V126, P18, DOI 10.1016/j.jep.2009.07.031; Sjoberg S, 1998, EUR J ENDOCRINOL, V139, P493, DOI 10.1530/eje.0.1390493; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stabouli S, 2010, EXPERT REV CARDIOVAS, V8, P1559, DOI [10.1586/erc.10.141, 10.1586/ERC.10.141]; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; Tan GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027683; Tan GG, 2011, BIOMED CHROMATOGR, V25, P913, DOI 10.1002/bmc.1544; Tas S, 2006, CELL BIOCHEM FUNCT, V24, P153, DOI 10.1002/cbf.1198; VACCARI A, 1990, NEUROSCIENCE, V35, P699, DOI 10.1016/0306-4522(90)90340-A; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; van Ravenzwaay B, 2012, MUTAT RES-GEN TOX EN, V746, P144, DOI 10.1016/j.mrgentox.2012.01.006; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang XY, 2009, J PROTEOME RES, V8, P2511, DOI 10.1021/pr801086k; Wei J, 2012, J PROTEOME RES, V11, P1302, DOI 10.1021/pr2009725; Wiersinga WM, 2001, HORM RES, V56, P74, DOI 10.1159/000048140; Williams GR, 2009, ENDOKRYNOL POL, V60, P380; Xiang N, 2005, HYPOTHYROIDISM; Xie GX, 2010, J PROTEOME RES, V9, P125, DOI 10.1021/pr900333h; Yao ZZ, 2011, MOL BIOSYST, V7, P2608, DOI 10.1039/c1mb05029j; Yu Z, 1996, HEILONGJIANG MED PHA, V19, P13; Zha LL, 1993, CHINESE J INTEGRATED, V13, P195; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhao Dan-Yang, 2008, Zhong Yao Cai, V31, P1681; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zhao Ming-qi, 2009, Zhong Yao Cai, V32, P1860	68	150	153	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55599	10.1371/journal.pone.0055599	http://dx.doi.org/10.1371/journal.pone.0055599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409005	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200042
J	Callahan, DM; Umberger, BR; Kent-Braun, JA				Callahan, Damien M.; Umberger, Brian R.; Kent-Braun, Jane A.			A Computational Model of Torque Generation: Neural, Contractile, Metabolic and Musculoskeletal Components	PLOS ONE			English	Article							RATE CODING ORGANIZATION; HUMAN SKELETAL-MUSCLE; HUMAN MOTOR UNITS; TIBIALIS ANTERIOR; MOMENT ARM; MATHEMATICAL-MODEL; ATP SYNTHESIS; TIME-COURSE; FATIGUE; RECRUITMENT	The pathway of voluntary joint torque production includes motor neuron recruitment and rate-coding, sarcolemmal depolarization and calcium release by the sarcoplasmic reticulum, force generation by motor proteins within skeletal muscle, and force transmission by tendon across the joint. The direct source of energetic support for this process is ATP hydrolysis. It is possible to examine portions of this physiologic pathway using various in vivo and in vitro techniques, but an integrated view of the multiple processes that ultimately impact joint torque remains elusive. To address this gap, we present a comprehensive computational model of the combined neuromuscular and musculoskeletal systems that includes novel components related to intracellular bioenergetics function. Components representing excitatory drive, muscle activation, force generation, metabolic perturbations, and torque production during voluntary human ankle dorsiflexion were constructed, using a combination of experimentally-derived data and literature values. Simulation results were validated by comparison with torque and metabolic data obtained in vivo. The model successfully predicted peak and submaximal voluntary and electrically-elicited torque output, and accurately simulated the metabolic perturbations associated with voluntary contractions. This novel, comprehensive model could be used to better understand impact of global effectors such as age and disease on various components of the neuromuscular system, and ultimately, voluntary torque output.	[Callahan, Damien M.; Umberger, Brian R.; Kent-Braun, Jane A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Callahan, DM (corresponding author), Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA.	dmcallah@uvm.edu		Umberger, Brian/0000-0002-5780-2405	National Insitutes of Health [K02A6023582]; Faculty Research Grant, University of Massachusetts Amherst; NATIONAL INSTITUTE ON AGING [K02AG023582] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Research Grant, University of Massachusetts Amherst; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided in part by the following funding sources: National Insitutes of Health K02A6023582 (JAKB) and a Faculty Research Grant, University of Massachusetts Amherst (BRU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHASIOTIS D, 1982, J APPL PHYSIOL, V53, P708, DOI 10.1152/jappl.1982.53.3.708; Connelly DM, 1999, J APPL PHYSIOL, V87, P843, DOI 10.1152/jappl.1999.87.2.843; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; Debold EP, 2008, AM J PHYSIOL-CELL PH, V295, pC173, DOI 10.1152/ajpcell.00172.2008; Debold EP, 2006, AM J PHYSIOL-CELL PH, V290, pC1041, DOI 10.1152/ajpcell.00342.2005; Ding J, 2002, IEEE T NEUR SYS REH, V10, P48, DOI 10.1109/TNSRE.2002.1021586; Dudel J, 2009, EUR J NEUROSCI, V30, P1219, DOI 10.1111/j.1460-9568.2009.06915.x; Fortune E, 2009, ANN BIOMED ENG, V37, P2105, DOI 10.1007/s10439-009-9756-4; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Fuglevand AJ, 1997, J APPL PHYSIOL, V83, P1223, DOI 10.1152/jappl.1997.83.4.1223; Giat Y, 1996, J BIOMECH ENG-T ASME, V118, P357, DOI 10.1115/1.2796018; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V357, P453, DOI 10.1113/jphysiol.1984.sp015511; HANSON J, 1953, NATURE, V172, P530, DOI 10.1038/172530b0; HARRIS RC, 1974, SCAND J CLIN LAB INV, V33, P109; Hasson CJ, 2009, EXP BRAIN RES, V196, P413, DOI 10.1007/s00221-009-1865-7; HAWKINS DA, 1992, J BIOMECH, V25, P1467, DOI 10.1016/0021-9290(92)90059-A; HE JP, 1991, IEEE T AUTOMAT CONTR, V36, P322, DOI 10.1109/9.73565; HILL AV, 1949, PROC R SOC SER B-BIO, V136, P195, DOI 10.1098/rspb.1949.0019; HILL TL, 1983, BIOPHYS J, V44, P383, DOI 10.1016/S0006-3495(83)84312-4; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY HE, 1957, J BIOPHYS BIOCHEM CY, V3, P631, DOI 10.1083/jcb.3.5.631; Jeneson JAL, 2009, AM J PHYSIOL-ENDOC M, V297, pE774, DOI 10.1152/ajpendo.00370.2009; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp GJ, 2001, J PHYSIOL-LONDON, V535, P901, DOI 10.1111/j.1469-7793.2001.00901.x; Kent-Braun JA, 1999, J APPL PHYSIOL, V87, P22, DOI 10.1152/jappl.1999.87.1.22; Kent-Braun JA, 2000, J APPL PHYSIOL, V88, P662, DOI 10.1152/jappl.2000.88.2.662; Kent-Braun JA, COMPREHENSIVE PHYSL, P997; KENTBRAUN JA, 1993, J APPL PHYSIOL, V75, P573, DOI 10.1152/jappl.1993.75.2.573; Lanza IR, 2007, J PHYSIOL-LONDON, V583, P1093, DOI 10.1113/jphysiol.2007.138362; Lanza IR, 2005, J APPL PHYSIOL, V99, P1736, DOI 10.1152/japplphysiol.00566.2005; Lanza IR, 2006, J PHYSL; Linari M, 2010, P ROY SOC B-BIOL SCI, V277, P19, DOI 10.1098/rspb.2009.1498; Maganaris CN, 1999, CLIN BIOMECH, V14, P661, DOI 10.1016/S0268-0033(99)00018-2; Maganaris CN, 2004, J THEOR BIOL, V230, P89, DOI 10.1016/j.jtbi.2004.04.025; Maganaris CN, 2004, EUR J APPL PHYSIOL, V91, P130, DOI 10.1007/s00421-003-1033-x; MARTONOSI AN, 1984, PHYSIOL REV, V64, P1240, DOI 10.1152/physrev.1984.64.4.1240; MELZER W, 1984, BIOPHYS J, V45, P637, DOI 10.1016/S0006-3495(84)84203-4; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P371, DOI 10.1113/jphysiol.1973.sp010193; MOON RB, 1973, J BIOL CHEM, V248, P7276; NARICI MV, 1989, EUR J APPL PHYSIOL O, V59, P310, DOI 10.1007/BF02388334; Oya T, 2009, J PHYSIOL-LONDON, V587, P4737, DOI 10.1113/jphysiol.2009.175695; Quinonez M, 2010, J MUSCLE RES CELL M, V31, P13, DOI 10.1007/s10974-009-9195-8; REN JM, 1988, ACTA PHYSIOL SCAND, V133, P101, DOI 10.1111/j.1748-1716.1988.tb08386.x; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; Shorten PR, 2007, J MUSCLE RES CELL M, V28, P293, DOI 10.1007/s10974-007-9125-6; Tevald MA, 2010, AM J PHYSIOL-REG I, V298, pR729, DOI 10.1152/ajpregu.00713.2009; TROUP JP, 1986, J APPL PHYSIOL, V60, P1743, DOI 10.1152/jappl.1986.60.5.1743; Umberger BR, 2011, P C INT SOC BIOM; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; VanCutsem M, 1997, CAN J APPL PHYSIOL, V22, P585, DOI 10.1139/h97-038; VANSOEST AJ, 1993, J BIOMECH, V26, P1, DOI 10.1016/0021-9290(93)90608-H; Walter G, 1999, J PHYSIOL-LONDON, V519, P901, DOI 10.1111/j.1469-7793.1999.0901n.x; Wexler AS, 1997, IEEE T BIO-MED ENG, V44, P337, DOI 10.1109/10.568909; Xia T, 2008, J BIOMECH, V41, P3046, DOI 10.1016/j.jbiomech.2008.07.013; Yoshitake Y, 2008, J NEUROSCI METH, V173, P271, DOI 10.1016/j.jneumeth.2008.06.022	56	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56013	10.1371/journal.pone.0056013	http://dx.doi.org/10.1371/journal.pone.0056013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405245	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400190
J	Guasch, L; Sala, E; Mulero, M; Valls, C; Salvado, MJ; Pujadas, G; Garcia-Vallve, S				Guasch, Laura; Sala, Esther; Mulero, Miquel; Valls, Cristina; Josepa Salvado, Maria; Pujadas, Gerard; Garcia-Vallve, Santiago			Identification of PPARgamma Partial Agonists of Natural Origin (II): In Silico Prediction in Natural Extracts with Known Antidiabetic Activity	PLOS ONE			English	Article							INDUCED-DIABETIC-RATS; HYPOGLYCEMIC ACTIVITY; CRYPTOLEPIS-SANGUINOLENTA; ANGELICA-KEISKEI; PPAR-GAMMA; SCUTELLARIA-BAICALENSIS; SALVIA-MILTIORRHIZA; MEDICINAL-PLANTS; DRUG DISCOVERY; GLUCOSE-UPTAKE	Background: Natural extracts have played an important role in the prevention and treatment of diseases and are important sources for drug discovery. However, to be effectively used in these processes, natural extracts must be characterized through the identification of their active compounds and their modes of action. Methodology/Principal Findings: From an initial set of 29,779 natural products that are annotated with their natural source and using a previously developed virtual screening procedure (carefully validated experimentally), we have predicted as potential peroxisome proliferators-activated receptor gamma (PPAR gamma) partial agonists 12 molecules from 11 extracts known to have antidiabetic activity. Six of these molecules are similar to molecules with described antidiabetic activity but whose mechanism of action is unknown. Therefore, it is plausible that these 12 molecules could be the bioactive molecules responsible, at least in part, for the antidiabetic activity of the extracts containing them. In addition, we have also identified as potential PPAR gamma partial agonists 10 molecules from 16 plants with undescribed antidiabetic activity but that are related (i.e., they are from the same genus) to plants with known antidiabetic properties. None of the 22 molecules that we predict as PPAR gamma partial agonists show chemical similarity with a group of 211 known PPAR gamma partial agonists obtained from the literature. Conclusions/Significance: Our results provide a new hypothesis about the active molecules of natural extracts with antidiabetic properties and their mode of action. We also suggest plants with undescribed antidiabetic activity that may contain PPAR gamma partial agonists. These plants represent a new source of potential antidiabetic extracts. Consequently, our work opens the door to the discovery of new antidiabetic extracts and molecules that can be of use, for instance, in the design of new antidiabetic drugs or functional foods focused towards the prevention/treatment of type 2 Diabetes Mellitus.	[Guasch, Laura; Sala, Esther; Mulero, Miquel; Valls, Cristina; Josepa Salvado, Maria; Pujadas, Gerard; Garcia-Vallve, Santiago] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigenom, Tarragona, Catalonia, Spain; [Pujadas, Gerard; Garcia-Vallve, Santiago] CEICS, TECNIO, CTNS, Reus, Catalonia, Spain	Universitat Rovira i Virgili	Garcia-Vallve, S (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigenom, Tarragona, Catalonia, Spain.	santi.garcia-vallve@urv.cat	PUJADAS, GERARD/W-9348-2019; Garcia-Vallve, Santi/A-4226-2008; Sala, Esther/AAB-4997-2022; Valls-Bautista, Cristina/K-8769-2014; Salvado, M. Josepa/B-6062-2015; Pujadas, Gerard/B-1457-2010; Mulero, Miquel/L-4672-2014	PUJADAS, GERARD/0000-0003-2598-8089; Garcia-Vallve, Santi/0000-0002-0348-7497; Valls-Bautista, Cristina/0000-0001-5583-5695; Salvado, M. Josepa/0000-0003-3883-3326; Pujadas, Gerard/0000-0003-2598-8089; Mulero, Miquel/0000-0003-2545-2065; Sala, Esther/0000-0002-5149-1992; Guasch, Laura/0000-0003-4990-7765	"Ministerio de Educacion y Ciencia'' of the Spanish Government [AGL2008-00387/ALI, AGL2011-25831/ALI]; Generalitat de Catalunya [ACC1O (TECCT11-1-0012)]; XRQTC grant from the "Generalitat de Catalunya''	"Ministerio de Educacion y Ciencia'' of the Spanish Government(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); XRQTC grant from the "Generalitat de Catalunya''	This study was supported by grants AGL2008-00387/ALI and AGL2011-25831/ALI from the "Ministerio de Educacion y Ciencia'' of the Spanish Government and the ACC1O (TECCT11-1-0012) program and XRQTC grant from the "Generalitat de Catalunya''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor Gabriel A, 2007, Pak J Biol Sci, V10, P537, DOI 10.3923/pjbs.2007.537.544; ARAI K, 1981, CHEM PHARM BULL, V29, P1005; Arredondo MF, 2004, J ETHNOPHARMACOL, V91, P13, DOI 10.1016/j.jep.2003.11.012; Aslan M, 2007, J ETHNOPHARMACOL, V109, P54, DOI 10.1016/j.jep.2006.07.001; BASNET P, 1995, PLANTA MED, V61, P402, DOI 10.1055/s-2006-958124; BASNET P, 1994, PLANTA MED, V60, P507, DOI 10.1055/s-2006-959560; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bierer DE, 1998, J MED CHEM, V41, P2754, DOI 10.1021/jm970735n; BLASKO G, 1988, J ORG CHEM, V53, P6113, DOI 10.1021/jo00261a026; Bnouham M, 2006, INT J DIABETES METAB, V14, P1; BRIGGS LH, 1950, J CHEM SOC, P2376, DOI 10.1039/jr9500002376; Budantsev, 1993, CHEM NAT COMPD, V29, P133, DOI [DOI 10.1007/BF00631041, 10.1007/BF00631041]; CHANDRASEKAR B, 1990, INDIAN J EXP BIOL, V28, P616; Chang FR, 1998, PHYTOCHEMISTRY, V49, P2015, DOI 10.1016/S0031-9422(98)00376-8; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Christensen KB, 2009, PHYTOTHER RES, V23, P1316, DOI 10.1002/ptr.2782; Cousins KR, 2011, J AM CHEM SOC, V133, P8388, DOI 10.1021/ja204075s; Dewi Rizna T, 2007, Pak J Biol Sci, V10, P3131, DOI 10.3923/pjbs.2007.3131.3135; Dey D, 2003, METABOLISM, V52, P1012, DOI 10.1016/S0026-0495(03)00152-5; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Eidi M, 2005, J ETHNOPHARMACOL, V100, P310, DOI 10.1016/j.jep.2005.03.008; El-Lakany AM, 2003, PHARMAZIE, V58, P75; Enoki T, 2007, J AGR FOOD CHEM, V55, P6013, DOI 10.1021/jf070720q; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; FERNANDO MR, 1990, GEN PHARMACOL, V21, P779, DOI 10.1016/0306-3623(90)91033-N; GHOSAL S, 1980, PHYTOCHEMISTRY, V19, P123, DOI 10.1016/0031-9422(80)85027-8; GLOMBITZA KW, 1981, TETRAHEDRON, V37, P3861, DOI 10.1016/S0040-4020(01)98884-2; GOMEZ F, 1985, PHYTOCHEMISTRY, V24, P1057, DOI 10.1016/S0031-9422(00)83182-9; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050816; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044971; Guasch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044972; Guasch L, 2012, J MOL GRAPH MODEL, V36, P1, DOI 10.1016/j.jmgm.2012.03.001; Guasch L, 2011, J COMPUT AID MOL DES, V25, P717, DOI 10.1007/s10822-011-9446-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANSEL R, 1980, PHYTOCHEMISTRY, V19, P639, DOI 10.1016/0031-9422(80)87030-0; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; IKESHIRO Y, 1991, PHYTOCHEMISTRY, V30, P2791, DOI 10.1016/0031-9422(91)85147-R; IKESHIRO Y, 1989, PHYTOCHEMISTRY, V28, P3139, DOI 10.1016/0031-9422(89)80294-8; Jahan N, 2001, HETEROCYCLES, V55, P1951; JAKUPOVIC J, 1986, PHYTOCHEMISTRY, V25, P1133, DOI 10.1016/S0031-9422(00)81569-1; JIMENEZ J, 1986, PLANTA MED, P260, DOI 10.1055/s-2007-969146; Jung SH, 2009, PHYTOMEDICINE, V16, P327, DOI 10.1016/j.phymed.2008.12.017; Kamperdick C, 1997, PHYTOCHEMISTRY, V45, P1049, DOI 10.1016/S0031-9422(97)00059-9; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; KIMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P2673, DOI 10.1080/00021369.1991.10870996; Kinoshita T, 1996, CHEM PHARM BULL, V44, P1208, DOI 10.1248/cpb.44.1208; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; LAMELA M, 1989, J ETHNOPHARMACOL, V27, P35, DOI 10.1016/0378-8741(89)90075-5; Lenta BN, 2007, CHEM PHARM BULL, V55, P464, DOI 10.1248/cpb.55.464; Li M, 2001, J NAT PROD, V64, P971, DOI 10.1021/np000350z; Likhitwitayawuid K, 2000, PLANTA MED, V66, P275, DOI 10.1055/s-2000-8656; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Luo J, 1998, DIABETIC MED, V15, P367, DOI 10.1002/(SICI)1096-9136(199805)15:5<367::AID-DIA576>3.0.CO;2-G; Matsuura M, 2001, PLANTA MED, V67, P230, DOI 10.1055/s-2001-12011; MESQUITA AAL, 1986, PHYTOCHEMISTRY, V25, P1255, DOI 10.1016/S0031-9422(00)81599-X; Michihiro F, 2006, FOODS FOOD INGRED J, V211, P141; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Negi JS, 2010, NAT PROD COMMUN, V5, P907; Nishimura R, 2007, BIOL PHARM BULL, V30, P1878, DOI 10.1248/bpb.30.1878; Nishioka T, 1998, J NAT PROD, V61, P1413, DOI 10.1021/np980163p; Pavana P, 2007, J ENVIRON BIOL, V28, P833; PERFUMI M, 1991, J ETHNOPHARMACOL, V34, P135, DOI 10.1016/0378-8741(91)90030-H; Petersen RK, 2011, J COMPUT AID MOL DES, V25, P107, DOI 10.1007/s10822-010-9398-5; Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379; Prabhakar PK, 2011, CHIN J INTEGR MED, V17, P563, DOI 10.1007/s11655-011-0810-3; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Rao YK, 2004, PHYTOCHEMISTRY, V65, P2317, DOI 10.1016/j.phytochem.2004.05.008; Sala E, 2011, EUR J MED CHEM, V46, P6098, DOI 10.1016/j.ejmech.2011.09.022; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016903; Schuster D, 2010, CURR PHARM DESIGN, V16, P1666, DOI 10.2174/138161210791164072; Sharaf MHM, 1996, J HETEROCYCLIC CHEM, V33, P789, DOI 10.1002/jhet.5570330343; SHARAF MHM, 1995, MAGN RESON CHEM, V33, P767, DOI 10.1002/mrc.1260331003; Shirwaikar A, 2004, J ETHNOPHARMACOL, V91, P171, DOI 10.1016/j.jep.2003.12.017; Simmonds MSJ, 2005, TRADITIONAL MED MODE, P19; Stewart M, 1997, AUST J CHEM, V50, P341, DOI 10.1071/C96120; Tan Y, 2011, CLIN SCI, V120, P297, DOI 10.1042/CS20100441; Tian LY, 2010, PHYTOMEDICINE, V17, P533, DOI 10.1016/j.phymed.2009.10.007; Ulubelen A, 2002, PLANTA MED, V68, P818, DOI 10.1055/s-2002-34408; Waisundara VY, 2008, AM J CHINESE MED, V36, P517, DOI 10.1142/S0192415X08005953; Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109; Wibudi Aris, 2008, Acta Med Indones, V40, P63; Yeo J, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-10; Zhang Y, 2009, ACTA PHARMACOL SIN, V30, P333, DOI 10.1038/aps.2009.5; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	88	22	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55889	10.1371/journal.pone.0055889	http://dx.doi.org/10.1371/journal.pone.0055889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405231	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400176
J	Segarra, G; Santpere, G; Elena, G; Trillas, I				Segarra, Guillem; Santpere, Gabriel; Elena, Georgina; Trillas, Isabel			Enhanced Botrytis cinerea Resistance of Arabidopsis Plants Grown in Compost May Be Explained by Increased Expression of Defense-Related Genes, as Revealed by Microarray Analysis	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; PATTERN-RECOGNITION RECEPTORS; ACQUIRED-RESISTANCE; DISEASE RESISTANCE; TRANSCRIPTION FACTORS; STRESS RESPONSES; SALICYLIC-ACID; ABSCISIC-ACID; HYPERSENSITIVE RESPONSE; CAMALEXIN BIOSYNTHESIS	Composts are the products obtained after the aerobic degradation of different types of organic matter waste and can be used as substrates or substrate/soil amendments for plant cultivation. There is a small but increasing number of reports that suggest that foliar diseases may be reduced when using compost, rather than standard substrates, as growing medium. The purpose of this study was to examine the gene expression alteration produced by the compost to gain knowledge of the mechanisms involved in compost-induced systemic resistance. A compost from olive marc and olive tree leaves was able to induce resistance against Botrytis cinerea in Arabidopsis, unlike the standard substrate, perlite. Microarray analyses revealed that 178 genes were differently expressed, with a fold change cut-off of 1, of which 155 were up-regulated and 23 were down-regulated in compost-grown, as against perlite-grown plants. A functional enrichment study of up-regulated genes revealed that 38 Gene Ontology terms were significantly enriched. Response to stress, biotic stimulus, other organism, bacterium, fungus, chemical and abiotic stimulus, SA and ABA stimulus, oxidative stress, water, temperature and cold were significantly enriched, as were immune and defense responses, systemic acquired resistance, secondary metabolic process and oxireductase activity. Interestingly, PR1 expression, which was equally enhanced by growing the plants in compost and by B. cinerea inoculation, was further boosted in compost-grown pathogen-inoculated plants. Compost triggered a plant response that shares similarities with both systemic acquired resistance and ABA-dependent/independent abiotic stress responses.	[Segarra, Guillem; Elena, Georgina; Trillas, Isabel] Univ Barcelona, Fac Biol, Dept Biol Vegetal, Unitat Fisiol Vegetal, Barcelona, Catalonia, Spain; [Santpere, Gabriel] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Catalonia, Spain; [Elena, Georgina] Inst Recerca & Tecnol Agroalimentaries Cabrils, Dept Patol Vegetal, Cabrils, Catalonia, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; IRTA	Segarra, G (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Vegetal, Unitat Fisiol Vegetal, Barcelona, Catalonia, Spain.	gsegarra@ub.edu	Trillas, M Isabel/L-8334-2014; Elena Jimenez, Georgina/M-3785-2014; Segarra, Guillem/R-1694-2018; Santpere, Gabriel/I-9437-2014	Elena Jimenez, Georgina/0000-0001-5053-4914; Segarra, Guillem/0000-0003-1634-9760; Santpere, Gabriel/0000-0001-5909-8637; Trillas Gay/0000-0001-9951-0972	Spanish Ministry of Science and Technology [AGL2010-21982-C02-02]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by the Spanish Ministry of Science and Technology (AGL2010-21982-C02-02). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Beck M, 2012, CURR OPIN PLANT BIOL, V15, P367, DOI 10.1016/j.pbi.2012.05.004; Bernoux M, 2011, CURR OPIN PLANT BIOL, V14, P512, DOI 10.1016/j.pbi.2011.05.005; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Borrero C, 2004, PHYTOPATHOLOGY, V94, P1094, DOI 10.1094/PHYTO.2004.94.10.1094; Chan ZL, 2012, GENOMICS, V100, P110, DOI 10.1016/j.ygeno.2012.06.004; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Doornbos RF, 2011, MOL PLANT MICROBE IN, V24, P395, DOI 10.1094/MPMI-05-10-0115; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Faulkner C, 2012, CURR OPIN PLANT BIOL, V15, P699, DOI 10.1016/j.pbi.2012.08.009; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hoitink HAJ, 1999, ANNU REV PHYTOPATHOL, V37, P427, DOI 10.1146/annurev.phyto.37.1.427; HOITINK HAJ, 1991, PLANT DIS, V75, P869, DOI 10.1094/PD-75-0869; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kavroulakis N, 2005, PHYSIOL MOL PLANT P, V66, P163, DOI 10.1016/j.pmpp.2005.06.003; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Litterick AM, 2004, CRIT REV PLANT SCI, V23, P453, DOI 10.1080/07352680490886815; MANTYLA E, 1995, PLANT PHYSIOL, V107, P141, DOI 10.1104/pp.107.1.141; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noble R, 2005, BIOCONTROL SCI TECHN, V15, P3, DOI 10.1080/09583150400015904; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Povero G, 2011, J PLANT RES, V124, P619, DOI 10.1007/s10265-010-0399-1; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Rogers EE, 1997, PLANT CELL, V9, P305, DOI 10.1105/tpc.9.3.305; Saga H, 2012, MOL PLANT MICROBE IN, V25, P684, DOI 10.1094/MPMI-09-11-0244; Sang MK, 2011, PHYTOPATHOLOGY, V101, P732, DOI 10.1094/PHYTO-10-10-0287; Segarra G, 2007, PROTEOMICS, V7, P3943, DOI 10.1002/pmic.200700173; Segarra G, 2007, EUR J PLANT PATHOL, V117, P393, DOI 10.1007/s10658-007-9108-x; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song JT, 2004, PLANT J, V40, P200, DOI 10.1111/j.1365-313X.2004.02200.x; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; Vallad GE, 2003, PHYSIOL MOL PLANT P, V63, P65, DOI 10.1016/j.pmpp.2003.10.003; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Wees SCM, 1999, PLANT MOL BIOL, V41, P537, DOI 10.1023/A:1006319216982; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Wan DL, 2012, PLANT CELL REP, V31, P1269, DOI 10.1007/s00299-012-1247-7; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Yogev A, 2010, BIOL CONTROL, V54, P46, DOI 10.1016/j.biocontrol.2010.03.004; Zhang W, 1998, PHYTOPATHOLOGY, V88, P450, DOI 10.1094/PHYTO.1998.88.5.450; Zheng MS, 2005, PLANT SCI, V168, P415, DOI 10.1016/j.plantsci.2004.09.016; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	70	26	27	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56075	10.1371/journal.pone.0056075	http://dx.doi.org/10.1371/journal.pone.0056075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405252	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400197
J	Bradley, EW; Carpio, LR; Westendorf, JJ				Bradley, Elizabeth W.; Carpio, Lomeli R.; Westendorf, Jennifer J.			Histone Deacetylase 3 Suppression Increases PH Domain and Leucine-rich Repeat Phosphatase (Phlpp)1 Expression in Chondrocytes to Suppress Akt Signaling and Matrix Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; ENDOCHONDRAL OSSIFICATION; MURINE CHONDROCYTES; GROWTH-PLATE; DIFFERENTIATION; RAPAMYCIN; PATHWAYS; CELLS; CHONDROGENESIS; MAINTENANCE	HDACs epigenetically regulate cellular processes by modifying chromatin and influencing gene expression. We previously reported that conditional deletion of Hdac3 in osteo-chondroprogenitor cells with Osx1-Cre caused severe osteopenia due to abnormal maturation of osteoblasts. The mice were also smaller. To address the abnormal longitudinal growth in these animals, the role of Hdac3 in chondrocyte differentiation was evaluated. We found that Hdac3 is highly expressed in resting and prehypertrophic growth plate chondrocytes, as well as in articular chondrocytes. Hdac3-deficient chondrocytes entered hypertrophy sooner and were smaller than normal chondrocytes. Extracellular matrix production was suppressed as glycosaminoglycan secretion and production of aggrecan, osteopontin, and matrix extracellular phosphoglycoprotein were reduced in Hdac3-deficient chondrocytes. These phenotypes led to the hypothesis that the Akt/mTOR pathway was repressed in these Hdac3-deficient chondrocytes because Akt promotes hypertrophy and matrix production in many tissues. The phosphorylation and activation of Akt, its substrate mTOR, and the mTOR substrate, p70 S6 kinase, were indeed reduced in Hdac3-deficient primary chondrocytes as well as in chondrocytes exposed to HDAC inhibitors. Expression of constitutively active Akt restored phosphorylation of mTOR and p70 S6K and matrix gene expression levels. Reduced phosphorylation of Akt and its substrates in Hdac3-deficient or HDAC inhibitors treated chondrocytes correlated with increased expression of the phosphatase Phlpp1. Hdac3 associated with a Phlpp1 promoter region containing Smad binding elements and was released after TGF beta was added to the culture. These data demonstrate that Hdac3 controls chondrocyte hypertrophy and matrix content by repressing Phlpp1 expression and facilitating Akt activity.	[Bradley, Elizabeth W.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Carpio, Lomeli R.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Westendorf, JJ (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		Shull, Lomeli/0000-0001-7537-8516; Bradley, Elizabeth/0000-0002-8814-5524	National Institutes of Health [AR48147, AR61873, AR56950, GM055252]; Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048147, T32AR056950, F32AR061873, R01AR068103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research and training grants from the National Institutes of Health (AR48147, AR61873, AR56950, and GM055252), Mayo Clinic, and the Mayo Graduate School.	Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Alvarez-Garcia O, 2007, PEDIATR NEPHROL, V22, P954, DOI 10.1007/s00467-007-0456-8; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bradley EW, 2011, CRIT REV EUKAR GENE, V21, P101; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chen WP, 2010, MOL BIOL REP, V37, P3967, DOI 10.1007/s11033-010-0055-9; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Jin EJ, 2007, J CELL BIOCHEM, V102, P252, DOI 10.1002/jcb.21430; Joosten LAB, 2011, MOL MED, V17, P391, DOI 10.2119/molmed.2011.00058; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Karp SJ, 2000, DEVELOPMENT, V127, P543; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Lambert Jr, 2001, METH MOL B, V176, P273; Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nasu Y, 2008, OSTEOARTHR CARTILAGE, V16, P723, DOI 10.1016/j.joca.2007.10.014; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Oh CD, 2001, EUR J PHARMACOL, V427, P175, DOI 10.1016/S0014-2999(01)01241-9; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Phornphutkul C, 2008, DEV DYNAM, V237, P702, DOI 10.1002/dvdy.21464; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Sun Z, 2011, J BIOL CHEM, V286, P33301, DOI 10.1074/jbc.M111.277707; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603	55	63	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9572	9582		10.1074/jbc.M112.423723	http://dx.doi.org/10.1074/jbc.M112.423723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23408427	Green Published, hybrid			2022-12-25	WOS:000317114000001
J	Zhang, N; Wang, XL; Huo, Q; Li, XY; Wang, HY; Schneider, P; Hu, GH; Yang, QF				Zhang, Ning; Wang, Xiaolong; Huo, Qiang; Li, Xiaoyan; Wang, Huiyun; Schneider, Pascal; Hu, Guohong; Yang, Qifeng			The Oncogene Metadherin Modulates the Apoptotic Pathway Based on the Tumor Necrosis Factor Superfamily Member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE-ELEVATED GENE-1; NATIVE TRAIL; CELLS; RESISTANCE; SURVIVIN; CHEMORESISTANCE; IDENTIFICATION; PROGRESSION; METASTASIS; EXPRESSION	Metadherin (MTDH), the newly discovered gene, is overexpressed in more than 40% of breast cancers. Recent studies have revealed that MTDH favors an oncogenic course and chemoresistance. With a number of breast cancer cell lines and breast tumor samples, we found that the relative expression of MTDH correlated with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity in breast cancer. In this study, we found that knockdown of endogenous MTDH cells sensitized the MDA-MB-231 cells to TRAIL-induced apoptosis both in vitro and in vivo. Conversely, stable overexpression of MTDH in MCF-7 cells enhanced cell survival with TRAIL treatment. Mechanically, MTDH down-regulated caspase-8, decreased caspase-8 recruitment into the TRAIL death-inducing signaling complex, decreased caspase-3 and poly(ADP-ribose) polymerase-2 processing, increased Bcl-2 expression, and stimulated TRAIL-induced Akt phosphorylation, without altering death receptor status. In MDA-MB-231 breast cancer cells, sensitization to TRAIL upon MTDH down-regulation was inhibited by the caspase inhibitor Z-VAD-fmk (benzyloxycarbonyl-VAD-fluoromethyl ketone), suggesting that MTDH depletion stimulates activation of caspases. In MCF-7 breast cancer cells, resistance to TRAIL upon MTDH overexpression was abrogated by depletion of Bcl-2, suggesting that MTDH-induced Bcl-2 expression contributes to TRAIL resistance. We further confirmed that MTDH may control Bcl-2 expression partly by suppressing miR-16. Collectively, our results point to a protective function of MTDH against TRAIL-induced death, whereby it inhibits the intrinsic apoptosis pathway through miR-16-mediated Bcl-2 up-regulation and the extrinsic apoptosis pathway through caspase-8 down-regulation.	[Zhang, Ning; Wang, Xiaolong; Huo, Qiang; Li, Xiaoyan; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250012, Shandong, Peoples R China; [Wang, Huiyun] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Hu, Guohong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Hu, Guohong] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China	Shandong University; State Key Lab Oncology South China; Sun Yat Sen University; University of Lausanne; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Hu, GH (corresponding author), Inst Hlth Sci, 225 South Chongqing Rd, Shanghai 200025, Peoples R China.	ghhu@sibs.ac.cn; qifengy@gmail.com	yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022; Zhang, Ning/GNP-1966-2022	Zhang, Ning/0000-0002-6430-4236; Hu, Guohong/0000-0002-2980-5166; Schneider, Pascal/0000-0003-0677-9409; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81072150, 81172529, 81272903]; Swiss National Science Foundation [31003A_138065]; Shandong Science and Technology Development Plan [2012GZC22115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Shandong Science and Technology Development Plan	This work was supported by National Natural Science Foundation of China (Grants 81072150, 81172529, and 81272903), the Swiss National Science Foundation (Grant 31003A_138065), and Shandong Science and Technology Development Plan (Grant 2012GZC22115).	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Keane MM, 1999, CANCER RES, V59, P734; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim EH, 2004, ONCOGENE, V23, P446, DOI 10.1038/sj.onc.1207025; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Li C, 2011, J SURG ONCOL, V103, P184, DOI 10.1002/jso.21788; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li XA, 2011, CANCER SCI, V102, P1151, DOI 10.1111/j.1349-7006.2011.01919.x; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Maksimovic-Ivanic D, 2012, IMMUNOL RES, V52, P157, DOI 10.1007/s12026-012-8284-8; Mehta K, 2002, J NATL CANCER I, V94, P1652; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Seol DW, 2001, CANCER RES, V61, P1138; Shankar S, 2009, MOL CANCER THER, V8, P1596, DOI 10.1158/1535-7163.MCT-08-1004; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak Henning, 2008, V414, P221; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205; Wei Y, 2009, CELL CYCLE, V8, P2132; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang QF, 2000, BREAST CANCER RES TR, V61, P211, DOI 10.1023/A:1006474307180; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yoon MJ, 2012, CARCINOGENESIS, V33, P492, DOI 10.1093/carcin/bgr298; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhou ZM, 2012, INT J CANCER, V130, P1504, DOI 10.1002/ijc.26122	44	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9396	9407		10.1074/jbc.M112.395913	http://dx.doi.org/10.1074/jbc.M112.395913			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23408429	Green Published, hybrid			2022-12-25	WOS:000316862200056
J	Bai, H; Wang, ZJ; Wang, YY; Zhuo, ML; Zhou, QH; Duan, JC; Yang, L; Wu, MN; An, TT; Zhao, J; Wang, J				Bai, Hua; Wang, Zhijie; Wang, Yuyan; Zhuo, Minglei; Zhou, Qinghua; Duan, Jianchun; Yang, Lu; Wu, Meina; An, Tongtong; Zhao, Jun; Wang, Jie			Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; ACQUIRED-RESISTANCE; GENETIC-HETEROGENEITY; KINASE INHIBITORS; GEFITINIB; TUMORS; ADENOCARCINOMAS; AMPLIFICATION; SENSITIVITY; EVOLUTION	Purpose: This study evaluated occurrence and potential clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with non-small cell lung cancer (NSCLC). Materials and Methods: Eighty-five stage IIIa-IV NSCLC patients who had undergone palliative surgical resection were included in this study. Of these, 45 patients carried EGFR mutations (group-M) and 40 patients were wild-type (group-W). Each tumor sample was microdissected to yield 28-34 tumor foci and Intratumoral EGFR mutation were determined using Denaturing High Performance Liquid Chromatography (DHPLC) and Amplification Refractory Mutation System (ARMS). EGFR copy numbers were measured using fluorescence in situ hybridization (FISH). Results: Microdissection yielded 1,431 tumor foci from EGFR mutant patients (group-M) and 1,238 foci from wild-type patients (group-W). The EGFR mutant frequencies in group-M were 80.6% (1,154/1,431) and 87.1% (1,247/1,431) using DHPLC and ARMS, respectively. A combination of EGFR-mutated and wild-type cells was detected in 32.9% (28/85) of samples by DHPLC and 28.2% (24/85) by ARMS, supporting the occurrence of intratumoral heterogeneity. Thirty-one patients (36.5%) were identified as EGFR FISH-positive. Patients harboring intratumoral mutational heterogeneity possessed lower EGFR copy numbers than those tumors contained mutant cells alone (16.7% vs. 71.0%, P<0.05). Among 26 patients who had received EGFR-TKIs, the mean EGFR mutation content was higher in patients showing partial response (86.1%) or stable disease (48.7%) compared with patients experiencing progressive disease (6.0%) (P = 0.001). There also showed relationship between progression-free survival (PFS) and different content of EGFR mutation groups (pure wild type EGFR, EGFR mutation with heterogeneity and pure mutated EGFR) (P = 0.001). Conclusion: Approximately 30% of patients presented intratumoral EGFR mutational heterogeneity, accompanying with relatively low EGFR copy number. EGFR mutant content was correlated with the response and prognosis of EGFR-TKIs.	[Bai, Hua; Wang, Zhijie; Wang, Yuyan; Zhuo, Minglei; Duan, Jianchun; Yang, Lu; Wu, Meina; An, Tongtong; Zhao, Jun; Wang, Jie] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Med Oncol, Beijing 100871, Peoples R China; [Zhou, Qinghua] Tianjin Med Univ, Dept Thorac Surg, Gen Hosp, Tianjin, Peoples R China	Peking University; Tianjin Medical University	Wang, J (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Med Oncol, Beijing 100871, Peoples R China.	wangjie_cc@yahoo.com	Duan, Jianchun/AAM-5765-2020	zhuo, minglei/0000-0003-2489-7791	National Natural Sciences Foundation Distinguished Young Scholars [81025012]; National Natural Sciences Foundation General Program [81172235]; Beijing Health Systems Academic Leader [2011-2-22]	National Natural Sciences Foundation Distinguished Young Scholars; National Natural Sciences Foundation General Program; Beijing Health Systems Academic Leader	This work was supported by the National Natural Sciences Foundation Distinguished Young Scholars [81025012]; and the National Natural Sciences Foundation General Program [81172235]; and the Beijing Health Systems Academic Leader [2011-2-22]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Chin TM, 2007, CLIN CHEM, V53, P62, DOI 10.1373/clinchem.2006.074831; Cohen V, 2006, CANCER, V107, P2858, DOI 10.1002/cncr.22331; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Diaz-Cano SJ, 2000, LAB INVEST, V80, P279, DOI 10.1038/labinvest.3780033; Ellison G, 2012, J CLIN PATHOL; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Janne PA, 2008, LUNG CANCER, V60, pS3, DOI 10.1016/S0169-5002(08)70099-0; Lichy JH, 2000, LAB INVEST, V80, P291, DOI 10.1038/labinvest.3780034; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Na II, 2012, J CANCER RES THER, V8, P373, DOI 10.4103/0973-1482.103515; NOWELL PC, 1986, CANCER RES, V46, P2203; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Puhringer-Oppermann FA, 2007, DIS ESOPHAGUS, V20, P9, DOI 10.1111/j.1442-2050.2007.00630.x; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Wu KH, 2012, INT J MOL SCI, V13, P11471, DOI 10.3390/ijms130911471; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906	31	77	86	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54170	10.1371/journal.pone.0054170	http://dx.doi.org/10.1371/journal.pone.0054170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418425	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300015
J	Carmona, R; Cano, E; Mattiotti, A; Gaztambide, J; Munoz-Chapuli, R				Carmona, Rita; Cano, Elena; Mattiotti, Andrea; Gaztambide, Joaquin; Munoz-Chapuli, Ramon			Cells Derived from the Coelomic Epithelium Contribute to Multiple Gastrointestinal Tissues in Mouse Embryos	PLOS ONE			English	Article							INTERSTITIAL-CELLS; SMOOTH-MUSCLE; SMALL-INTESTINE; HUMAN GUT; CAJAL; TRACT; DIFFERENTIATION; MORPHOGENESIS; MESOTHELIUM; ALPHA	Gut mesodermal tissues originate from the splanchnopleural mesenchyme. However, the embryonic gastrointestinal coelomic epithelium gives rise to mesenchymal cells, whose significance and fate are little known. Our aim was to investigate the contribution of coelomic epithelium-derived cells to the intestinal development. We have used the transgenic mouse model mWt1/IRES/GFP-Cre (Wt1(cre)) crossed with the Rosa26R-EYFP reporter mouse. In the gastrointestinal duct Wt1, the Wilms' tumor suppressor gene, is specific and dynamically expressed in the coelomic epithelium. In the embryos obtained from the crossbreeding, the Wt1-expressing cell lineage produces the yellow fluorescent protein (YFP) allowing for colocalization with differentiation markers through confocal microscopy and flow cytometry. Wt1(cre-YFP) cells were very abundant throughout the intestine during midgestation, declining in neonates. Wt1(cre-YFP) cells were also transiently observed within the mucosa, being apparently released into the intestinal lumen. YFP was detected in cells contributing to intestinal vascularization (endothelium, pericytes and smooth muscle), visceral musculature (circular, longitudinal and submucosal) as well as in Cajal and Cajal-like interstitial cells. Wt1(cre-YFP) mesenchymal cells expressed FGF9, a critical growth factor for intestinal development, as well as PDGFR alpha, mainly within developing villi. Thus, a cell population derived from the coelomic epithelium incorporates to the gut mesenchyme and contribute to a variety of intestinal tissues, probably playing also a signaling role. Our results support the origin of interstitial cells of Cajal and visceral circular muscle from a common progenitor expressing anoctamin-1 and SMC alpha-actin. Coelomic-derived cells contribute to the differentiation of at least a part of the interstitial cells of Cajal.	[Carmona, Rita; Cano, Elena; Mattiotti, Andrea; Munoz-Chapuli, Ramon] Univ Malaga, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain; [Gaztambide, Joaquin] Reg Hosp Carlos Haya, Pediat Surg Unit, Matern & Children Hosp, Malaga, Spain	Universidad de Malaga	Munoz-Chapuli, R (corresponding author), Univ Malaga, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain.	chapuli@uma.es	Munoz-Chapuli, Ramon/K-7306-2014; Carmona, Rita/K-4217-2014; Cano, Elena/AAU-9715-2020	Munoz-Chapuli, Ramon/0000-0001-6392-6802; Carmona, Rita/0000-0002-9686-473X; 	Ministerio de Ciencia e Innovacion [BFU2008-02384, BFU2011-25304]; TerCel network, ISCIII [RD06/0010/0015]; Junta de Andalucia [P08-CTS-03618, P11-CTS-7564]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); TerCel network, ISCIII(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia)	This study was supported by grants BFU2008-02384, BFU2011-25304 (Ministerio de Ciencia e Innovacion), RD06/0010/0015 (TerCel network, ISCIII), P08-CTS-03618 and P11-CTS-7564 (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guadix JA, 2011, DEVELOPMENT, V138, P1093, DOI 10.1242/dev.044594; BELL L, 1988, ANAT EMBRYOL, V177, P377, DOI 10.1007/BF00315847; Carmona IC, 2011, J CELL MOL MED, V15, P26, DOI 10.1111/j.1582-4934.2010.01207.x; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; Faussone-Pellegrini MS, 2007, J CELL MOL MED, V11, P482, DOI 10.1111/j.1582-4934.2007.00043.x; Fu M, 2004, ANAT EMBRYOL, V208, P33, DOI 10.1007/s00429-003-0371-0; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kluppel M, 1998, DEV DYNAM, V211, P60; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Lee JCF, 1999, AM J PHYSIOL-GASTR L, V277, pG409, DOI 10.1152/ajpgi.1999.277.2.G409; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Pieri L, 2008, J CELL MOL MED, V12, P1944, DOI 10.1111/j.1582-4934.2008.00461.x; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rolle U, 2007, PEDIATR SURG INT, V23, P1139, DOI 10.1007/s00383-007-2022-7; Sanders KM, 2012, EXP PHYSIOL, V97, P200, DOI 10.1113/expphysiol.2011.058248; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Streutker CJ, 2003, AM J SURG PATHOL, V27, P228, DOI 10.1097/00000478-200302000-00012; Su ZY, 2010, J ZHEJIANG UNIV-SC B, V11, P489, DOI 10.1631/jzus.B0900415; Torihashi S, 1997, GASTROENTEROLOGY, V112, P144, DOI 10.1016/S0016-5085(97)70229-4; Vanderwinden JM, 2000, CELL TISSUE RES, V302, P145, DOI 10.1007/s004410000264; Vanderwinden JM, 2002, CELL TISSUE RES, V309, P261, DOI 10.1007/s00441-002-0590-3; Wallace AS, 2005, CELL TISSUE RES, V319, P367, DOI 10.1007/s00441-004-1023-2; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Zhang XQ, 2006, DEVELOPMENT, V133, P173, DOI 10.1242/dev.02175	32	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55890	10.1371/journal.pone.0055890	http://dx.doi.org/10.1371/journal.pone.0055890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418471	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300062
J	Chhibber, S; Kaur, T; Kaur, S				Chhibber, Sanjay; Kaur, Tarsem; Kaur, Sandeep			Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; KLEBSIELLA-PNEUMONIAE; BACTERIAL-INFECTIONS; PHAGE THERAPY; COMPLICATED SKIN; VANCOMYCIN; MICE; PENETRATION; MELLITUS; PHARMACOKINETICS	Background: Staphylococcus aureus remains the predominant pathogen in diabetic foot infections and prevalence of methicillin resistant S. aureus (MRSA) strains further complicates the situation. The incidence of MRSA in infected foot ulcers is 15-30% and there is an alarming trend for its increase in many countries. Diabetes acts as an immunosuppressive state decreasing the overall immune functioning of body and to worsen the situation, wounds inflicted with drug resistant strains represent a morbid combination in diabetic patients. Foot infections caused by MRSA are associated with an increased risk of amputations, increased hospital stay, increased expenses and higher infection-related mortality. Hence, newer, safer and effective treatment strategies are required for treating MRSA mediated diabetic foot infections. The present study focuses on the use of lytic bacteriophage in combination with linezolid as an effective treatment strategy against foot infection in diabetic population. Methodology: Acute hindpaw infection with S. aureus ATCC 43300 was established in alloxan induced diabetic BALB/c mice. Therapeutic efficacy of a well characterized broad host range lytic bacteriophage, MR-10 was evaluated alone as well as in combination with linezolid in resolving the course of hindpaw foot infection in diabetic mice. The process of wound healing was also investigated. Results and Conclusions: A single administration of phage exhibited efficacy similar to linezolid in resolving the course of hindpaw infection in diabetic animals. However, combination therapy using both the agents was much more effective in arresting the entire infection process (bacterial load, lesion score, foot myeloperoxidase activity and histopathological analysis). The entire process of tissue healing was also hastened. Use of combined agents has been known to decrease the frequency of emergence of resistant mutants, hence this approach can serve as an effective strategy in treating MRSA mediated foot infections in diabetic individuals who do not respond to conventional antibiotic therapy.	[Chhibber, Sanjay; Kaur, Tarsem; Kaur, Sandeep] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Chhibber, S (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	sanjaychhibber8@gmail.com	Kaur, Sandeep/T-1863-2019	Kaur, Sandeep/0000-0003-3146-1611				Adam MH., 1959, BACTERIOPHAGES, P450, DOI 10.5962/bhl.title.6966; Bader MS, 2008, AM FAM PHYSICIAN, V78, P71; Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; BOGOVAZOVA GG, 1991, ZH MIKROB EPID IMMUN, P5; Bowling FL, 2007, DIABETES CARE, V30, P370, DOI 10.2337/dc06-2348; Brans TA, 1994, BURNS, V20, P548; Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002; Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005; Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0; CISLO M, 1987, ARCH IMMUNOL THER EX, V35, P175; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dang CN, 2003, DIABETIC MED, V20, P159, DOI 10.1046/j.1464-5491.2003.00860.x; Dryden MS, 2011, J ANTIMICROB CHEMOTH, V66, pIV7, DOI 10.1093/jac/dkr072; Duckworth DH, 2002, BIODRUGS, V16, P57, DOI 10.2165/00063030-200216010-00006; Falagas ME, 2008, LANCET INFECT DIS, V8, P53, DOI 10.1016/S1473-3099(07)70312-2; Goodridge L, 2003, APPL ENVIRON MICROB, V69, P5364, DOI 10.1128/AEM.69.9.5364-5371.2003; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Greenberger MJ, 1996, J INFECT DIS, V173, P159, DOI 10.1093/infdis/173.1.159; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Grimble SAJ, 2001, EUR J VASC ENDOVASC, V22, P215, DOI 10.1053/ejvs.2001.1436; Itani KMF, 2005, INT J ANTIMICROB AG, V26, P442, DOI 10.1016/j.ijantimicag.2005.09.003; Kochetkova VA, 1989, SOV MEDITISINA, V16, P23; Kumari S, 2009, J MICROBIOL BIOTECHN, V19, P622, DOI 10.4014/jmb.0808.493; Lazareva E. B., 2001, Antibiotiki i Khimioterapiya, V46, P10; Lipsky BA, 2004, CLIN INFECT DIS, V38, P17, DOI 10.1086/380449; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/383271; Lipsky BA, 2004, DIABETES-METAB RES, V20, pS68, DOI 10.1002/dmrr.453; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; Mathur M D, 2003, J Assoc Physicians India, V51, P593; MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187; Murugan S, 2008, J CLIN DIAGN RES, V2, P979; Oladeinde FO, 2007, CELL MOL BIOL, V53, P34, DOI 10.1170/T794; Pan DD, 2008, AFR J BIOTECHNOL, V7, P4369; Park S, 2009, INFECT IMMUN, V77, P1008, DOI 10.1128/IAI.00976-08; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Rogers LC, 2009, MRSA DIABETIC FOOT; RYBAK MJ, 1990, J ANTIMICROB CHEMOTH, V25, P679, DOI 10.1093/jac/25.4.679; SAKANDELIDZE VM, 1991, VRACHEBNOE DELO, P60; Sambrook J., 2002, MOL CLONING LAB MANU; Sharpe JN, 2005, AM J SURG, V189, P425, DOI 10.1016/j.amjsurg.2005.01.011; Stein GE, 2007, J ANTIMICROB CHEMOTH, V60, P819, DOI 10.1093/jac/dkm271; Stein GE, 2006, CLIN INFECT DIS, V43, P518, DOI 10.1086/505494; Stroj L, 1993, NEUROL NEUROCHIR POL, V3, P693; Sunagar R, 2010, RES MICROBIOL, V161, P854, DOI 10.1016/j.resmic.2010.09.011; Talon D, 2002, Eur J Intern Med, V13, P31, DOI 10.1016/S0953-6205(01)00189-3; TAN JS, 1975, J LAB CLIN MED, V85, P26; TATER D, 1987, HORM METAB RES, V19, P642, DOI 10.1055/s-2007-1011899; Turner JM, 2004, BRIT J DIABETES VASC, V4, P44; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; VinodKumar CS, 2011, INT J PHARM SCI DRUG, V3, P202; Wayne PA, 2006, M7A7 CLIN LAB STAND; WEBERDABROWSKA B, 1987, ARCH IMMUNOL THER EX, V35, P563; Weigelt J, 2004, AM J SURG, V188, P760, DOI 10.1016/j.amjsurg.2004.08.045; Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005; WILSON RM, 1986, CLIN EXP IMMUNOL, V63, P478; Wiskirchen DE, 2011, ANTIMICROB AGENTS CH, V55, P4170, DOI 10.1128/AAC.00445-11	60	118	120	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56022	10.1371/journal.pone.0056022	http://dx.doi.org/10.1371/journal.pone.0056022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418497	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300089
J	El-Shinawi, M; Mohamed, HT; El-Ghonaimy, EA; Tantawy, M; Younis, A; Schneider, RJ; Mohamed, MM				El-Shinawi, Mohamed; Mohamed, Hossam Taha; El-Ghonaimy, Eslam A.; Tantawy, Marwa; Younis, Amal; Schneider, Robert J.; Mohamed, Mona Mostafa			Human Cytomegalovirus Infection Enhances NF-kappa B/p65 Signaling in Inflammatory Breast Cancer Patients	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; PROGRAMMED CELL-DEATH; DRUG-RESISTANCE; EXPRESSION; CARCINOMA; EPIDEMIOLOGY; ANGIOGENESIS; SIGNATURE; PROMOTES	Human Cytomegalovirus (HCMV) is an endemic herpes virus that re-emerges in cancer patients enhancing oncogenic potential. Recent studies have shown that HCMV infection is associated with certain types of cancer morbidity such as glioblastoma. Although HCMV has been detected in breast cancer tissues, its role, if any, in the etiology of specific forms of breast cancer has not been investigated. In the present study we investigated the presence of HCMV infection in inflammatory breast cancer (IBC), a rapidly progressing form of breast cancer characterized by specific molecular signature. We screened for anti-CMV IgG antibodies in peripheral blood of 49 non-IBC invasive ductal carcinoma (IDC) and 28 IBC patients. In addition, we screened for HCMV-DNA in postsurgical cancer and non-cancer breast tissues of non-IBC and IBC patients. We also tested whether HCMV infection can modulate the expression and activation of transcriptional factor NF-kappa B/p65, a hallmark of IBC. Our results reveal that IBC patients are characterized by a statistically significant increase in HCMV IgG antibody titers compared to non-IBC patients. HCMV-DNA was significantly detected in cancer tissues than in the adjacent non-carcinoma tissues of IBC and IDC, and IBC cancer tissues were significantly more infected with HCMV-DNA compared to IDC. Further, HCMV sequence analysis detected different HCMV strains in IBC patients tissues, but not in the IDC specimens. Moreover, HCMV-infected IBC cancer tissues were found to be enhanced in NF-kappa B/p65 signaling compared to non-IBC patients. The present results demonstrated a correlation between HCMV infection and IBC. Etiology and causality of HCMV infection with IBC now needs to be rigorously examined.	[El-Shinawi, Mohamed] Ain Shams Univ, Dept Gen Surg, Fac Med, Cairo, Egypt; [Mohamed, Hossam Taha; El-Ghonaimy, Eslam A.; Tantawy, Marwa; Younis, Amal; Mohamed, Mona Mostafa] Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt; [Schneider, Robert J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Cairo University; New York University	Mohamed, MM (corresponding author), Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt.	mmostafa@sci.cu.edu.eg	Mohamed, Hossam Taha/GPX-1362-2022; Mohamed, Hossam Taha/N-8045-2018	Mohamed, Hossam Taha/0000-0003-1989-5783; Schneider, Robert/0000-0001-5807-5564; El-Shinawi, Mohamed/0000-0003-3645-2343; Tantawy, Marwa/0000-0001-6767-1093	Cairo University Research Sector; Avon Foundation USA [02-2011-062]	Cairo University Research Sector(Cairo University); Avon Foundation USA	Author MMM is supported by Cairo University Research Sector. Authors RJS and MMM are supported by Avon Foundation USA (Grant number 02-2011-062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Raawi D, 2011, INT J CLIN EXP MED, V4, P265; Allart S, 2002, J BIOL CHEM, V277, P29063, DOI 10.1074/jbc.M201974200; Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Blaheta RA, 2004, NEOPLASIA, V6, P323, DOI 10.1593/neo.03418; Blaheta RA, 2006, NEOPLASIA, V8, P807, DOI 10.1593/neo.06379; BONNIER P, 1995, INT J CANCER, V62, P382, DOI 10.1002/ijc.2910620404; Breathnach O, 1999, ANN ONCOL, V10, P461, DOI 10.1023/A:1008360927507; Chan G, 2009, VIRUS RES; Chan G, 2008, J VIROL, V82, P1040, DOI 10.1128/JVI.00864-07; Chang S, 1998, CANCER, V82, P2366; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Cinatl J, 1998, CANCER RES, V58, P367; Cobbs Charles S, 2011, Herpesviridae, V2, P10, DOI 10.1186/2042-4280-2-10; Cobbs CS, 2002, CANCER RES, V62, P3347; Duke TJ, 2010, ONCOL REP, V24, P1277, DOI 10.3892/or_00000983; Dumortier J, 2008, J VIROL, V82, P6524, DOI 10.1128/JVI.00502-08; Fagundes CP, 2011, BRAIN BEHAV IMMUN; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fiorentini S, 2011, J GEN VIROL, V92, P650, DOI 10.1099/vir.0.025395-0; Gong Y, 2008, SEMIN ONCOL, V35, P33, DOI 10.1053/j.seminoncol.2007.11.014; Hachana M, 2011, PATHOL RES PRACT, V207, P695, DOI 10.1016/j.prp.2011.09.007; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; Juckem LK, 2008, J IMMUNOL, V180, P4965, DOI 10.4049/jimmunol.180.7.4965; Labidi SI, 2008, ANN ONCOL, V19, P473, DOI 10.1093/annonc/mdm480; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lo AC, 2009, BREAST, V18, P55, DOI 10.1016/j.breast.2008.11.002; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Niedobitek G, 2001, INT J EXP PATHOL, V82, P149, DOI 10.1111/j.1365-2613.2001.iep190.x; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Retiere C, 1998, VIRUS RES, V57, P43, DOI 10.1016/S0168-1702(98)00083-5; Richardson AK, 2004, BRIT J CANCER, V90, P2149, DOI 10.1038/sj.bjc.6601822; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Shimamura M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001170; Smith MS, 2007, J VIROL, V81, P7683, DOI 10.1128/JVI.02839-06; Soderberg-Naucler C, 2008, J CLIN VIROL, V41, P218, DOI 10.1016/j.jcv.2007.11.009; Soderberg-Naucler C, 2012, ONCOIMMUNOLOGY, V1, P739, DOI 10.4161/onci.19441; Soliman AS, 2009, BREAST J, V15, P432, DOI 10.1111/j.1524-4741.2009.00755.x; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Sowmya P, 2009, J MED VIROL, V81, P861, DOI 10.1002/jmv.21459; Toi M, 2010, JPN J CLIN ONCOL, V40, pi13, DOI 10.1093/jjco/hyq122; Tsai JH, 2007, J CANCER RES CLIN, V133, P13, DOI 10.1007/s00432-006-0141-5; Van Laere S, 2005, BREAST CANCER RES TR, V93, P237, DOI 10.1007/s10549-005-5157-z; Van Laere SJ, 2006, BREAST CANCER RES TR, V95, P243, DOI 10.1007/s10549-005-9015-9; Van Laere SJ, 2006, CLIN CANCER RES, V12, P3249, DOI 10.1158/1078-0432.CCR-05-2800; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Zamora MR, 2011, SEMIN RESP CRIT CARE, V32, P454, DOI 10.1055/s-0031-1283285; Zhang S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-73; Zhang Y, 2009, TRANSPL P, V41, P1767, DOI 10.1016/j.transproceed.2009.03.064	55	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55755	10.1371/journal.pone.0055755	http://dx.doi.org/10.1371/journal.pone.0055755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418456	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300047
J	Fennell, JG; Baddeley, RJ				Fennell, John G.; Baddeley, Roland J.			Reward Is Assessed in Three Dimensions That Correspond to the Semantic Differential	PLOS ONE			English	Article							SEROTONIN; UNCERTAINTY; PREDICTION; CINGULATE; SIGNAL; RISK	If choices are to be made between alternatives like should I go for a walk or grab a coffee, a 'common currency' is needed to compare them. This quantity, often known as reward in psychology and utility in economics, is usually conceptualised as a single dimension. Here we propose that to make a comparison between different options it is important to know not only the average reward, but also both the risk and level of certainty (or control) associated with an option. Almost all objects can be the subject of choice, so if these dimensions are required in order to make a decision, they should be part of the meaning of those objects. We propose that this ubiquity is unique, so if we take an average over many concepts and domains these three dimensions (reward, risk, and uncertainty) should emerge as the three most important dimensions in the "meaning" of objects. We investigated this possibility by relating the three dimensions of reward to an old, robust and extensively studied factor analytic instrument known as the semantic differential. Across a very wide range of situations, concepts and cultures, factor analysis shows that 50% of the variance in rating scales is accounted for by just three dimensions, with these dimensions being Evaluation, Potency, and Activity [1]. Using a statistical analysis of internet blog entries and a betting experiment, we show that these three factors of the semantic differential are strongly correlated with the reward history associated with a given concept: Evaluation measures relative reward; Potency measures absolute risk; and Activity measures the uncertainty or lack of control associated with a concept. We argue that the 50% of meaning captured by the semantic differential is simply a summary of the reward history that allows decisions to be made between widely different options.	[Fennell, John G.; Baddeley, Roland J.] Univ Bristol, Bristol, Avon, England	University of Bristol	Fennell, JG (corresponding author), Univ Bristol, Bristol, Avon, England.	john.fennell@bristol.ac.uk	Fennell, John G/V-5947-2018	Fennell, John G/0000-0003-2991-3391				Bad, 2011, BAD RANDOLY CHOSEN B; Berry M, 2012, JOURNALISM; Boureau YL, 2010, NEUROPSYCHOPHARMACOL; COOLS R, 2010, NEUROPSYCHOPHARMACOL; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Dalton P, 2008, J SENS STUD, V23, P485, DOI 10.1111/j.1745-459X.2008.00167.x; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio Antonio, 1999, FEELING WHAT HAPPENS; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; ELLIOTT LL, 1963, AM J PSYCHOL, V76, P589, DOI 10.2307/1419708; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Francis C., 2006, MEAN AFFECTIVE RATIN; Good, 2011, GOOD RANDOMLY CHOSEN; Heise D, 2010, SURVEYING CULTURES D, DOI [10.1002/9780470575789, DOI 10.1002/9780470575789]; Heise David R, 2001, ELECT J SOCIOLOGY, V5; Houston AI, 2007, BIOLOGY LETT, V3, P365, DOI 10.1098/rsbl.2007.0111; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kim NH, 2009, KSCE J CIV ENG, V13, P65, DOI 10.1007/s12205-009-0065-0; Knight F. H., 1921, HART SCHAFFNER MARX, V31; Landis D, 1976, VARIATIONS BLACK WHI; MATLAB, 2008, MATLAB VERSION 7 6 0; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; McNeil A. J., 2005, QUANTITATIVE RISK MA; Miron M, 1969, WHAT IS IT IS BEING; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Osgood C.E., 1975, CROSS CULTURAL UNIVE; Osgood C.E., 1957, MEASUREMENT MEANING; OSGOOD CE, 1969, J PERS SOC PSYCHOL, V12, P194, DOI 10.1037/h0027715; OSGOOD CE, 1955, J EXP PSYCHOL, V50, P325, DOI 10.1037/h0043965; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; SCHNEIDER Danieli D., 2010, ROBOT LEARNING, V17, P65; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Technorati, 2011, STAT BLOG 2011; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Trimmer PC, 2011, ANIM COGN, V14, P465, DOI 10.1007/s10071-011-0387-4; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	46	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55588	10.1371/journal.pone.0055588	http://dx.doi.org/10.1371/journal.pone.0055588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418445	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300036
J	Geng, YS; Yang, J; Huang, WJ; Harrison, TJ; Zhou, Y; Wen, ZH; Wang, YC				Geng, Yansheng; Yang, Jun; Huang, Weijin; Harrison, Tim J.; Zhou, Yan; Wen, Zhiheng; Wang, Youchun			Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process	PLOS ONE			English	Article							HEPATITIS-E-VIRUS; PHYLOGENETIC ANALYSIS; BETA-CHAIN; AVIAN HEV; INFECTION; CELLS; GENOTYPE; TRANSLOCATION; VITRONECTIN; HEPATOCYTE	Hepatitis E virus (HEV) is endemic worldwide and a major cause of acute liver disease in developing countries. However, the molecular mechanisms of liver pathology and clinical disease are not well understood for HEV infection. Open reading frame 3 (ORF3) of HEV encodes a small phosphoprotein, which is assumed to be involved in liver pathology and clinical disease. In this study, the interactions between the HEV ORF3 protein and human proteins were investigated using a stringent, high-throughput yeast two-hybrid (Y2H) analysis. Thirty two proteins were shown to interact with genotype 1 ORF3, 28 of which have not been reported previously. These novel interactions were evaluated by coimmunoprecipitation of protein complexes from transfected cells. We found also that the ORF3 proteins of genotype 4 and rabbit HEV interacted with all of the human proteins identified by the genotype 1 ORF3 protein. However, the putative ORF3 protein derived from avian HEV did not interact with the majority of these human proteins. The identified proteins were used to infer an overall interaction map linking the ORF3 protein with components of the host cellular networks. Analysis of this interaction map, based on functional annotation with the Gene Ontology features and KEGG pathways, revealed an enrichment of host proteins involved in complement coagulation, cellular iron ion homeostasis and oxidative stress. Additional canonical pathway analysis highlighted the enriched biological pathways relevant to blood coagulation and hemostasis. Consideration of the clinical manifestations of hepatitis E reported previously and the results of biological analysis from this study suggests that the ORF3 protein is likely to lead to an imbalance of coagulation and fibrinolysis by interacting with host proteins and triggering the corresponding pathological processes. These results suggest critical approaches to further study of the pathogenesis of the HEV ORF3 protein.	[Geng, Yansheng; Huang, Weijin; Zhou, Yan; Wen, Zhiheng; Wang, Youchun] Natl Inst Food & Drug Control, Dept Cell Biol, Beijing, Peoples R China; [Geng, Yansheng] Hebei Univ, Hlth Sci Ctr, Baoding, Peoples R China; [Yang, Jun] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Harrison, Tim J.] UCL, Sch Med, Div Med, London W1N 8AA, England	National Institute of Food & Drug Control - China; Hebei University; St Jude Children's Research Hospital; University of London; University College London; UCL Medical School	Wang, YC (corresponding author), Natl Inst Food & Drug Control, Dept Cell Biol, 2 Tian Tan Xi Li, Beijing, Peoples R China.	wangyc@nifdc.org.cn	huang, weijin/AAY-5028-2020; Yang, Jun/N-2309-2018	huang, weijin/0000-0002-4246-8889; Yang, Jun/0000-0002-4233-3220; Meng, X.J./0000-0002-2739-1334	National Natural Science Foundation of China [81171549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant: 81171549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam Shahinul, 2009, Saudi J Gastroenterol, V15, P229, DOI 10.4103/1319-3767.56094; BARABASI AL, 1991, PHYS REV A, V44, P2730, DOI 10.1103/PhysRevA.44.2730; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chandra V, 2008, J VIROL, V82, P7100, DOI 10.1128/JVI.00403-08; Chandra V, 2010, J VIROL, V84, P3857, DOI 10.1128/JVI.01994-09; CRABTREE GR, 1982, J BIOL CHEM, V257, P7277; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Fields S, 2005, FEBS J, V272, P5391, DOI 10.1111/j.1742-4658.2005.04973.x; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Geng YS, 2011, INFECT GENET EVOL, V11, P476, DOI 10.1016/j.meegid.2010.12.012; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Huntoon KM, 2008, J LEUKOCYTE BIOL, V84, P170, DOI 10.1189/jlb.0208100; Ibrahim AS, 2009, J MED VIROL, V81, P1047, DOI 10.1002/jmv.21474; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Jia ZS, 2003, WORLD J GASTROENTERO, V9, P631, DOI 10.3748/wjg.v9.i3.631; Kamar N, 2008, AM J TRANSPLANT, V8, P1744, DOI 10.1111/j.1600-6143.2008.02286.x; Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08; Khadka S, 2011, MOL CELL PR IN PRESS; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Krawczynski K, 2007, NEW ENGL J MED, V356, P949, DOI 10.1056/NEJMe068311; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Ma HX, 2011, J MED VIROL, V83, P827, DOI 10.1002/jmv.22032; Marek A, 2010, VET MICROBIOL, V145, P54, DOI 10.1016/j.vetmic.2010.03.014; Meng X, 2011, VIRUS TAXONOMY CLASS, P991; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Moin SM, 2009, CELL MICROBIOL, V11, P1409, DOI 10.1111/j.1462-5822.2009.01340.x; Moin SM, 2007, J BIOL CHEM, V282, P21124, DOI 10.1074/jbc.M701696200; Morgenstern E, 2001, EUR J CELL BIOL, V80, P87, DOI 10.1078/0171-9335-00138; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; OTTO JM, 1987, J CELL BIOL, V105, P1067, DOI 10.1083/jcb.105.3.1067; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Peralta B, 2009, VET MICROBIOL, V137, P31, DOI 10.1016/j.vetmic.2008.12.010; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Ratra R, 2008, BIOCHEMISTRY-US, V47, P1957, DOI 10.1021/bi7016552; Ratra R, 2009, J GEN VIROL, V90, P1359, DOI 10.1099/vir.0.009274-0; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Sheikh A, 2002, AM J TROP MED HYG, V66, P721, DOI 10.4269/ajtmh.2002.66.721; Smith JL, 2001, J FOOD PROTECT, V64, P572, DOI 10.4315/0362-028X-64.4.572; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surjit M, 2006, J BIOL CHEM, V281, P8135, DOI 10.1074/jbc.M509568200; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tyagi S, 2005, J VIROL, V79, P12081, DOI 10.1128/JVI.79.18.12081-12087.2005; Tyagi S, 2004, J BIOL CHEM, V279, P29308, DOI 10.1074/jbc.M402017200; Tyagi S, 2002, J BIOL CHEM, V277, P22759, DOI 10.1074/jbc.M200185200; Wang YC, 2000, J GEN VIROL, V81, P1675, DOI 10.1099/0022-1317-81-7-1675; Wu YP, 2004, BLOOD, V104, P1034, DOI 10.1182/blood-2003-12-4293; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536; Zhao Q, 2010, EMERG INFECT DIS, V16, P1469, DOI 10.3201/eid1609.100626	55	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56320	10.1371/journal.pone.0056320	http://dx.doi.org/10.1371/journal.pone.0056320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418552	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300145
J	Jahchan, NS; Ouyang, GL; Luo, KX				Jahchan, Nadine S.; Ouyang, Gaoliang; Luo, Kunxin			Expression Profiles of SnoN in Normal and Cancerous Human Tissues Support Its Tumor Suppressor Role in Human Cancer	PLOS ONE			English	Article							TGF-BETA; CDNA-CLONES; SKI; OVEREXPRESSION; TUMORIGENESIS; GROWTH; MICROENVIRONMENT; ADENOCARCINOMA; AMPLIFICATION; CARCINOMAS	SnoN is a negative regulator of TGF-beta signaling and also an activator of the tumor suppressor p53 in response to cellular stress. Its role in human cancer is complex and controversial with both pro-oncogenic and anti-oncogenic activities reported. To clarify its role in human cancer and provide clinical relevance to its signaling activities, we examined SnoN expression in normal and cancerous human esophageal, ovarian, pancreatic and breast tissues. In normal tissues, SnoN is expressed in both the epithelium and the surrounding stroma at a moderate level and is predominantly cytoplasmic. SnoN levels in all tumor epithelia examined are lower than or similar to that in the matched normal samples, consistent with its anti-tumorigenic activity in epithelial cells. In contrast, SnoN expression in the stroma is highly upregulated in the infiltrating inflammatory cells in high-grade esophageal and ovarian tumor samples, suggesting that SnoN may potentially promote malignant progression through modulating the tumor microenvironment in these tumor types. The overall levels of SnoN expression in these cancer tissues do not correlate with the p53 status. However, in human cancer cell lines with amplification of the snoN gene, a strong correlation between increased SnoN copy number and inactivation of p53 was detected, suggesting that the tumor suppressor SnoN-p53 pathway must be inactivated, either through downregulation of SnoN or inactivation of p53, in order to allow cancer cell to proliferate and survive. These data strongly suggest that SnoN can function as a tumor suppressor at early stages of tumorigenesis in human cancer tissues.	[Jahchan, Nadine S.; Luo, Kunxin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ouyang, Gaoliang] Xiamen Univ, Coll Life Sci, Xiamen, Fujian, Peoples R China	University of California System; University of California Berkeley; Xiamen University	Luo, KX (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kluo@berkeley.edu			NIH [RO1 CA101891, RO1 DK090347]; DOD BCRP predoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA101891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP predoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by NIH RO1 CA101891 and RO1 DK090347 to K. Luo and DOD BCRP predoctoral fellowship to N. Jahchan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi I, 2008, ANN SURG ONCOL, V15, P2965, DOI 10.1245/s10434-008-9986-y; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bascom JL, 2005, CANCER RES, V65, P8617, DOI 10.1158/0008-5472.CAN-05-1985; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; BOYER PL, 1993, ONCOGENE, V8, P457; Chia JA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-252; Cianci R, 2010, J BIOL REG HOMEOS AG, V24, P239; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Goh AM, 2010, J PATHOL; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Jahchan NS, 2010, CANCER RES, V70, P4204, DOI 10.1158/0008-5472.CAN-10-0135; Jahchan NS, 2010, CURR OPIN PHARM; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nanjundan M, 2008, MOL ONCOL, V2, P164, DOI 10.1016/j.molonc.2008.05.001; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Pelzer T, 1996, DEV DYNAM, V205, P114; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Villanacci V, 2008, HUM PATHOL, V39, P403, DOI 10.1016/j.humpath.2007.07.009; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Zhang F, 2003, CANCER RES, V63, P5005; Zhang XY, 2009, INT J DERMATOL, V48, P579, DOI 10.1111/j.1365-4632.2009.03685.x; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55794	10.1371/journal.pone.0055794	http://dx.doi.org/10.1371/journal.pone.0055794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418461	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300052
J	Kok, J; Blyth, CC; Foo, H; Bailey, MJ; Pilcher, DV; Webb, SA; Seppelt, IM; Dwyer, DE; Iredell, JR				Kok, Jen; Blyth, Christopher C.; Foo, Hong; Bailey, Michael J.; Pilcher, David V.; Webb, Steven A.; Seppelt, Ian M.; Dwyer, Dominic E.; Iredell, Jonathan R.			Viral Pneumonitis Is Increased in Obese Patients during the First Wave of Pandemic A(H1N1) 2009 Virus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EXTRACORPOREAL MEMBRANE-OXYGENATION; IMMUNIZATION PRACTICES ACIP; H1N1 INFLUENZA; VACCINES RECOMMENDATIONS; ADVISORY-COMMITTEE; MORTALITY; INFECTION; HOSPITALIZATION; INFLAMMATION	Introduction: There is conflicting data as to whether obesity is an independent risk factor for mortality in severe pandemic (H1N1) 2009 influenza (A(H1N1)pdm09). It is postulated that excess inflammation and cytokine production in obese patients following severe influenza infection leads to viral pneumonitis and/or acute respiratory distress syndrome. Methods: Demographic, laboratory and clinical data prospectively collected from obese and non-obese patients admitted to nine adult Australian intensive care units (ICU) during the first A(H1N1)pdm09 wave, supplemented with retrospectively collected data, were compared. Results: Of 173 patients, 100 (57.8%), 73 (42.2%) and 23 (13.3%) had body mass index (BMI) <30 kg/m(2), >= 30 kg/m(2) (obese) and >= 40 kg/m(2) (morbidly obese) respectively. Compared to non-obese patients, obese patients were younger (mean age 43.4 vs. 48.4 years, p = 0.035) and more likely to develop pneumonitis (61% vs. 44%, p = 0.029). Extracorporeal membrane oxygenation use was greater in morbidly obese compared to non-obese patients (17.4% vs. 4.7%, p = 0.04). Higher mortality rates were observed in non-obese compared to obese patients, but not after adjusting for severity of disease. C-reactive protein (CRP) levels and hospital length of stay (LOS) were similar. Amongst ICU survivors, obese patients had longer ICU LOS (median 11.9 vs. 6.8 days, p = 0.017). Similar trends were observed when only patients infected with A(H1N1)pdm09 were examined. Conclusions: Among patients admitted to ICU during the first wave of A(H1N1)pdm09, obese and morbidly obese patients with severe infection were more likely to develop pneumonitis compared to non-obese patients, but mortality rates were not increased. CRP is not an accurate marker of pneumonitis.	[Kok, Jen; Dwyer, Dominic E.; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res,Sydney Inst Emerging I, Westmead, NSW 2145, Australia; [Kok, Jen; Dwyer, Dominic E.; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Res Excellence Crit Infect, Westmead, NSW 2145, Australia; [Blyth, Christopher C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Blyth, Christopher C.] Princess Margaret Hosp, Dept Paediat & Adolescent Med, Subiaco, WA, Australia; [Blyth, Christopher C.] Princess Margaret Hosp, PathWest Lab Med WA, Subiaco, WA, Australia; [Foo, Hong] Liverpool Hosp, Dept Microbiol & Infect Dis, Sydney South West Pathol Serv, Sydney, NSW, Australia; [Bailey, Michael J.; Pilcher, David V.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Pilcher, David V.] Australian & New Zealand Intens Care Soc Ctr Outc, Carlton, Vic, Australia; [Pilcher, David V.] Alfred Hosp, Dept Intens Care Med, Phahran, Vic, Australia; [Webb, Steven A.] Royal Perth Hosp, Intens Care Unit, Perth, WA, Australia; [Webb, Steven A.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Webb, Steven A.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Seppelt, Ian M.] Nepean Hosp, Dept Intens Care Med, Penrith, NSW, Australia; [Seppelt, Ian M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Western Australia; Liverpool Hospital; Monash University; Florey Institute of Neuroscience & Mental Health; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Nepean Hospital; University of Sydney; University of Sydney	Kok, J (corresponding author), Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res,Sydney Inst Emerging I, Westmead, NSW 2145, Australia.	jen.kok@swahs.health.nsw.gov.au	Blyth, Christopher/ABG-8231-2020; Bailey, Michael J/A-4499-2012	Blyth, Christopher/0000-0003-2017-0683; Bailey, Michael J/0000-0002-5551-1401; Pilcher, David/0000-0002-8939-7985				Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Australian Government Australian Institute of Health and Welfare, AUSTR HLTH 2010; Australian Government Department of Health and Ageing, 2010, 5 AUSTR GOV DEP HLTH; Australian Government Department of Health and Ageing, 2012, AUSTR PUBL ASS REP T; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Department of Health, 2006, GREEN BOOK INFL UPD; Diaz E, 2011, CHEST, V139, P382, DOI 10.1378/chest.10-1160; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fedson DS, 2009, EMERG INFECT DIS, V15, P365, DOI 10.3201/eid1503.080857; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Ho YC, 2009, J INFECTION, V58, P439, DOI 10.1016/j.jinf.2009.03.007; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Ingram PR, 2010, INTENS CARE MED, V36, P528, DOI 10.1007/s00134-009-1746-3; Iwasenko JM, 2010, CLIN INFECT DIS, V51, P70, DOI 10.1086/653610; Kim SH, 2011, AM J RESP CRIT CARE, V183, P1207, DOI 10.1164/rccm.201101-0110OC; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Lam YY, 2011, OBESITY, V19, P2113, DOI 10.1038/oby.2011.68; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Louie JK, 2012, PLOS ONE, V6; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Martino JL, 2011, CHEST, V140, P1198, DOI 10.1378/chest.10-3023; Memoli B, 2007, AM J PHYSIOL-ENDOC M, V293, pE1030, DOI 10.1152/ajpendo.00697.2006; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; New Zealand Ministry of Health, PORTR HLTH KEY RES 2; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; O'Dea JA, 2003, MED J AUSTRALIA, V179, P63, DOI 10.5694/j.1326-5377.2003.tb05430.x; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Riscili BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018166; Rodriguez A, 2011, MED INTENSIVA, V35, P208, DOI 10.1016/j.medin.2011.03.001; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tsatsanis C, 2010, J INFECT DIS, V202, P459, DOI 10.1086/653842; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	50	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55631	10.1371/journal.pone.0055631	http://dx.doi.org/10.1371/journal.pone.0055631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418448	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300039
J	Liu, CY; Li, YH; Yu, JZ; Feng, L; Hou, SW; Liu, YT; Guo, MF; Xie, Y; Meng, J; Zhang, HF; Xiao, BG; Ma, CG				Liu, Chunyun; Li, Yanhua; Yu, Jiezhong; Feng, Ling; Hou, Shaowei; Liu, Yueting; Guo, Mingfang; Xie, Yong; Meng, Jian; Zhang, Haifei; Xiao, Baoguo; Ma, Cungen			Targeting the Shift from M1 to M2 Macrophages in Experimental Autoimmune Encephalomyelitis Mice Treated with Fasudil	PLOS ONE			English	Article							RHO-KINASE; T-CELLS; MULTIPLE-SCLEROSIS; ALTERNATIVE ACTIVATION; IFN-GAMMA; POLARIZATION; INHIBITION; MONOCYTES; MIGRATION; CROSSTALK	We observed the therapeutic effect of Fasudil and explored its mechanisms in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Fasudil, a selective Rho kinase (ROCK) inhibitor, was injected intraperitoneally at 40 mg/kg/d in early and late stages of EAE induction. Fasudil ameliorated the clinical severity of EAE at different stages, and decreased the expression of ROCK-II in spleen, accompanied by an improvement in demyelination and inhibition of inflammatory cells. Fasudil mainly inhibited CD4(+)IL-17(+) T cells in early treatment, but also elevated CD4(+)IL-10(+) regulatory T cells and IL-10 production in late treatment. The treatment of Fasudil shifted inflammatory M1 to anti-inflammatory M2 macrophages in both early and late treatment, being shown by inhibiting CD16/32, iNOS, IL-12, TLR4 and CD40 and increasing CD206, Arg-1, IL-10 and CD14 in spleen. By using Western blot and immunohistochemistry, iNOS and Arg-1, as two most specific markers for M1 and M2, was inhibited or induced in splenic macrophages and spinal cords of EAE mice treated with Fasudil. In vitro experiments also indicate that Fasudil shifts M1 to M2 phenotype, which does not require the participation or auxiliary of other cells. The polarization of M2 macrophages was associated with the decrease of inflammatory cytokine IL-1 beta, TNF-alpha and MCP-1. These results demonstrate that Fasudil has therapeutic potential in EAE possibly through inducing the polarization of M2 macrophages and inhibiting inflammatory responses.	[Liu, Chunyun; Li, Yanhua; Yu, Jiezhong; Feng, Ling; Hou, Shaowei; Liu, Yueting; Guo, Mingfang; Xie, Yong; Meng, Jian; Zhang, Haifei; Ma, Cungen] Shanxi Datong Univ, Inst Brain Sci, Sch Med, Dept Neurol, Datong, Peoples R China; [Xiao, Baoguo] Fudan Univ, Inst Neurol, Huashan Hosp, Inst Brain Sci, Shanghai 200433, Peoples R China; [Xiao, Baoguo] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Ma, Cungen] Shanxi Univ Tradit Chinese Med, Dept Neurol, Taiyuan, Peoples R China	Shanxi Datong University; Fudan University; Fudan University	Xiao, BG (corresponding author), Fudan Univ, Inst Neurol, Huashan Hosp, Inst Brain Sci, Shanghai 200433, Peoples R China.	bgxiao@shmu.edu.cn; macungen2001@yahoo.com.cn			National Natural Science Foundation of China [81070957, 30972715, 81070956]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from National Natural Science Foundation of China (No. 81070957, No. 30972715 and No. 81070956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Bosurgi L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00062; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chan T, 2011, CELL IMMUNOL, V266, P180, DOI 10.1016/j.cellimm.2010.10.002; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Denkinger CM, 2003, J IMMUNOL, V170, P1274, DOI 10.4049/jimmunol.170.3.1274; Ding RY, 2011, J SURG RES, V171, pE209, DOI 10.1016/j.jss.2011.08.009; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Haas J, 2009, J NEUROIMMUNOL, V216, P113, DOI 10.1016/j.jneuroim.2009.06.011; Haegert DG, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/461304; Hara M, 2000, J NEUROSURG, V93, P94, DOI 10.3171/spi.2000.93.1.0094; Heasman Sarah J, 2010, Small GTPases, V1, P174, DOI 10.4161/sgtp.1.3.14724; Huang XN, 2011, J NEUROIMMUNOL, V239, P61, DOI 10.1016/j.jneuroim.2011.08.015; Jadidi-Niaragh F, 2011, IMMUNOPHARM IMMUNOT, V33, P545, DOI 10.3109/08923973.2010.513391; Pinto-Medel MJ, 2012, J NEUROIMMUNOL, V243, P1, DOI 10.1016/j.jneuroim.2011.11.008; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Li HM, 2009, J NEUROIMMUNOL, V208, P54, DOI 10.1016/j.jneuroim.2009.01.002; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lutterotti A, 2006, J NEUROIMMUNOL, V181, P145, DOI 10.1016/j.jneuroim.2006.09.002; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mensah-Brown EP, 2011, J NEUROIMMUNOL, V232, P68, DOI 10.1016/j.jneuroim.2010.10.010; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Pierot L, 2010, CURR OPIN CRIT CARE, V16, P110, DOI 10.1097/MCC.0b013e3283372ef2; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Segal BA, 2003, CURR ALLERGY ASTHM R, V3, P86, DOI 10.1007/s11882-003-0017-6; Sinha S, 2010, J NEUROIMMUNOL, V225, P52, DOI 10.1016/j.jneuroim.2010.04.013; Slotta JE, 2008, BRIT J SURG, V95, P976, DOI 10.1002/bjs.6082; Sosa RA, 2011, J INTERF CYTOK RES, V31, P753, DOI 10.1089/jir.2011.0052; Street CA, 2011, ANTICANCER RES, V31, P3645; Sun XJ, 2006, J NEUROIMMUNOL, V180, P126, DOI 10.1016/j.jneuroim.2006.06.027; Taylor BV, 2011, MULT SCLER J, V17, P1171, DOI 10.1177/1352458511421105; Tselis A, 2011, SEMIN NEUROL, V31, P307, DOI 10.1055/s-0031-1287656; Ukkonen M, 2007, MULT SCLER, V13, P701, DOI 10.1177/1352458506075378; Wang L, 2012, STEM CELLS DEV, V21, P1069, DOI 10.1089/scd.2011.0124; Wolf NA, 2007, J NEUROIMMUNOL, V185, P115, DOI 10.1016/j.jneuroim.2007.02.001; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076; Yu JZ, 2010, J NEUROSCI RES, V88, P1664, DOI 10.1002/jnr.22339	54	166	187	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54841	10.1371/journal.pone.0054841	http://dx.doi.org/10.1371/journal.pone.0054841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418431	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300021
J	Pope, RA; Parida, S; Bailey, D; Brownlie, J; Barrett, T; Banyard, AC				Pope, Robert A.; Parida, Satya; Bailey, Dalan; Brownlie, Joe; Barrett, Thomas; Banyard, Ashley C.			Early Events following Experimental Infection with Peste-Des-Petits Ruminants Virus Suggest Immune Cell Targeting	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; PATHOLOGICAL FINDINGS; RINDERPEST VIRUS; MEASLES-VIRUS; GOATS; CATTLE; OUTBREAK; MORBILLIVIRUS; SHEEP; PPR	Peste-des-petits ruminants virus (PPRV) is a viral pathogen that causes a devastating plague of small ruminants. PPRV is an economically significant disease that continues to be a major obstacle to the development of sustainable agriculture across the developing world. The current understanding of PPRV pathogenesis has been heavily assumed from the closely related rinderpest virus (RPV) and other morbillivirus infections alongside data derived from field outbreaks. There have been few studies reported that have focused on the pathogenesis of PPRV and very little is known about the processes underlying the early stages of infection. In the present study, 15 goats were challenged by the intranasal route with a virulent PPRV isolate, Cote d'Ivoire '89 (CI/89) and sacrificed at strategically defined time-points post infection to enable pre- and post-mortem sampling. This approach enabled precise monitoring of the progress and distribution of virus throughout the infection from the time of challenge, through peak viraemia and into a period of convalescence. Observations were then related to findings of previous field studies and experimental models of PPRV to develop a clinical scoring system for PPRV. Importantly, histopathological investigations demonstrated that the initial site for virus replication is not within the epithelial cells of the respiratory mucosa, as has been previously reported, but is within the tonsillar tissue and lymph nodes draining the site of inoculation. We propose that virus is taken up by immune cells within the respiratory mucosa which then transport virus to lymphoid tissues where primary virus replication occurs, and from where virus enters circulation. Based on these findings we propose a novel clinical scoring methodology for PPRV pathogenesis and suggest a fundamental shift away from the conventional model of PPRV pathogenesis.	[Pope, Robert A.; Parida, Satya; Bailey, Dalan; Barrett, Thomas; Banyard, Ashley C.] Pirbright Inst, Woking, Surrey, England; [Brownlie, Joe] Royal Vet Coll, Hatfield, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of London; University of London Royal Veterinary College	Parida, S (corresponding author), Pirbright Inst, Woking, Surrey, England.	satya.parida@pirbright.ac.uk; ashley.banyard@ahvla.gsi.gov.uk	Parida, Satya/E-5463-2015; Banyard, Ashley/C-7998-2011	Parida, Satya/0000-0001-8253-9461; Banyard, Ashley/0000-0002-1286-9825; Bailey, Dalan/0000-0002-5640-2266	BBSRC CIDLID Grant [BBH009485/1]; BBSRC [BB/H009485/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009485/1] Funding Source: researchfish	BBSRC CIDLID Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AB and SP are part funded by BBSRC CIDLID Grant BBH009485/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar M, 2012, VIRUS RES, V167, P43, DOI 10.1016/j.virusres.2012.03.018; Abubakar M, 2011, TROP ANIM HEALTH PRO, V43, P745, DOI 10.1007/s11250-010-9776-y; ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; Anderson J., 1991, USE MONOCLONAL ANTIB; Anderson J, 1996, FAO ANIMAL HLTH MANU, P81; APPEL MJG, 1969, AM J VET RES, V30, P1167; Banyard AC, 2010, J GEN VIROLOGY; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bao JY, 2011, RES VET SCI, V90, P238, DOI 10.1016/j.rvsc.2010.05.031; Barrett T., 2006, BIOL ANIMAL INFECT R, DOI [10.1016/B978-012088385-1/50033-2, DOI 10.1016/B978-012088385-1/50033-2]; Barrett T, 2008, ENCY VIROLOGY, P497; BORROW P, 1995, CURR TOP MICROBIOL, V191, P85; Brown CC, 1997, RES VET SCI, V63, P103, DOI 10.1016/S0034-5288(97)90000-X; BROWN CC, 1991, VET PATHOL, V28, P166, DOI 10.1177/030098589102800209; BROWN CC, 1994, VET PATHOL, V31, P194, DOI 10.1177/030098589403100206; BUNDZA A, 1988, CAN J VET RES, V52, P46; Chard LS, 2008, VIRUS RES, V136, P192, DOI 10.1016/j.virusres.2008.04.018; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Couacy-Hymann E, 2007, PREV VET MED, V78, P85, DOI 10.1016/j.prevetmed.2006.09.003; Das SC, 2000, J VIROL, V74, P9039, DOI 10.1128/JVI.74.19.9039-9047.2000; De Nardi M, 2012, TRANSBOUND EMERG DIS, V59, P214, DOI 10.1111/j.1865-1682.2011.01260.x; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; Diop M, 2005, EPIDEMIOL INFECT, V133, P711, DOI 10.1017/S0950268805003729; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; EMPRESS, 2008, PPRV MOR; ESOLEN LM, 1993, J INFECT DIS, V168, P47, DOI 10.1093/infdis/168.1.47; FAO, 2012, LIV EP CAUS HAV DEM; FAO, 2010, CAS DEF LIV DIS; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; FURLEY CW, 1987, VET REC, V121, P443, DOI 10.1136/vr.121.19.443; Govindarajan R, 1997, VET REC, V141, P573, DOI 10.1136/vr.141.22.573; Heaney J, 2005, J GEN VIROL, V86, P3349, DOI 10.1099/vir.0.81370-0; Kennedy S, 1998, J COMP PATHOL, V119, P201, DOI 10.1016/S0021-9975(98)80045-5; Khan HA, 2008, TROP ANIM HEALTH PRO, V40, P521, DOI 10.1007/s11250-008-9129-2; Kinne J, 2010, EPIDEMIOL INFECT, V138, P1211, DOI 10.1017/S0950268809991592; Kul O, 2007, VET PATHOL, V44, P479, DOI 10.1354/vp.44-4-479; Kulkarni DD, 1996, VET REC, V138, P187, DOI 10.1136/vr.138.8.187; Kumar P, 2004, J VET MED B, V51, P153, DOI 10.1111/j.1439-0450.2004.00747.x; Kwiatek O, 2007, J COMP PATHOL, V136, P111, DOI 10.1016/j.jcpa.2006.12.002; Lefevre P C, 1990, Rev Sci Tech, V9, P935; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; LIESS B, 1964, J HYG-CAMBRIDGE, V62, P81, DOI 10.1017/S0022172400039796; Mahapatra M, 2006, J GEN VIROL, V87, P2021, DOI 10.1099/vir.0.81721-0; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; Merck, 2005, REF TABL RECT TEMP H, P2581; MORNET P., 1956, Revue de l'Elevage. Productions animales - Productions fourrageres, V9, P313; Mrkic B, 2000, J VIROL, V74, P1364, DOI 10.1128/JVI.74.3.1364-1372.2000; Munir M, 2012, EMERG INFECT DIS, V18, P193, DOI 10.3201/eid1801.111304; Nawathe DR, 1983, REV SCI TECH OIE, V2, P77; OBI TU, 1983, ZBL VET MED B, V30, P751; OIE, 2011, RIND ER; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Osunkoya B O, 1990, West Afr J Med, V9, P35; PUGH DG, 2001, SHEEP GOAT MED; Radostits OM, 1994, VET MED A TXB DIS CA; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roeder P., 1999, FAO ANIM HLTH MAN, V5, P28; Russel A, 1984, In Pract, V6, P91; SHAILA MS, 1989, VET REC, V125, P602; Taylor W P, 1986, Rev Sci Tech, V5, P407, DOI 10.20506/rst.5.2.250; TAYLOR WP, 1984, PREV VET MED, V2, P157, DOI 10.1016/0167-5877(84)90059-X; Toplu N, 2004, J COMP PATHOL, V131, P135, DOI 10.1016/j.jcpa.2004.02.004; UGOCHUKWU EI, 1991, MICROBIOS, V65, P81; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; von Messling V, 2004, P NATL ACAD SCI USA, V101, P14216, DOI 10.1073/pnas.0403597101; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; WAFULA JS, 1987, TROP ANIM HEALTH PRO, V19, P173, DOI 10.1007/BF02239714; WAMWAYI HM, 1995, VET MICROBIOL, V44, P151, DOI 10.1016/0378-1135(95)00008-X; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817; WOHLSEIN P, 1993, VET PATHOL, V30, P544, DOI 10.1177/030098589303000608; WOHLSEIN P, 1995, VET MICROBIOL, V44, P141, DOI 10.1016/0378-1135(95)00007-W; Woo PCY, 2012, P NATL ACAD SCI USA, V109, P5435, DOI 10.1073/pnas.1119972109; Yanagi Y, 2006, J GEN VIROL, V87, P2767, DOI 10.1099/vir.0.82221-0	76	60	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55830	10.1371/journal.pone.0055830	http://dx.doi.org/10.1371/journal.pone.0055830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418464	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300055
J	Bengtsson, F; Brasselet, R; Johansson, RS; Arleo, A; Jorntell, H				Bengtsson, Fredrik; Brasselet, Romain; Johansson, Roland S.; Arleo, Angelo; Jorntell, Henrik			Integration of Sensory Quanta in Cuneate Nucleus Neurons In Vivo	PLOS ONE			English	Article							DORSAL COLUMN NUCLEI; HUMAN TACTILE AFFERENTS; THALAMOCORTICAL NEURONS; MECHANICAL STIMULATION; ROOT FIBERS; TRANSMISSION; SINGLE; ORGANIZATION; PLASTICITY; RESPONSES	Discriminative touch relies on afferent information carried to the central nervous system by action potentials (spikes) in ensembles of primary afferents bundled in peripheral nerves. These sensory quanta are first processed by the cuneate nucleus before the afferent information is transmitted to brain networks serving specific perceptual and sensorimotor functions. Here we report data on the integration of primary afferent synaptic inputs obtained with in vivo whole cell patch clamp recordings from the neurons of this nucleus. We find that the synaptic integration in individual cuneate neurons is dominated by 4-8 primary afferent inputs with large synaptic weights. In a simulation we show that the arrangement with a low number of primary afferent inputs can maximize transfer over the cuneate nucleus of information encoded in the spatiotemporal patterns of spikes generated when a human fingertip contact objects. Hence, the observed distributions of synaptic weights support high fidelity transfer of signals from ensembles of tactile afferents. Various anatomical estimates suggest that a cuneate neuron may receive hundreds of primary afferents rather than 4-8. Therefore, we discuss the possibility that adaptation of synaptic weight distribution, possibly involving silent synapses, may function to maximize information transfer in somatosensory pathways.	[Bengtsson, Fredrik; Jorntell, Henrik] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Brasselet, Romain; Arleo, Angelo] Univ Paris 06, CNRS, Unit Neurobiol Adapt Proc, Paris, France; [Johansson, Roland S.] Umea Univ, Dept Integrat Med Biol, Physiol Sect, Umea, Sweden	Lund University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Umea University	Jorntell, H (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	henrik.jorntell@med.lu.se	Johansson, Roland S/A-5890-2009; Arleo, Angelo/N-9255-2019	Johansson, Roland S/0000-0003-3288-8326; Arleo, Angelo/0000-0002-1990-1971	SENSOPAC; EU [IST-028056-SENSOPAC, 248587]; Hand Embodied (THE); French Medical Research Foundation [FDT20090916556]; Swedish Research Council [08291, 08667]; LinnA(C) grant from the Swedish Research Council [60012701]; Knut and Alice Wallenberg Foundation [KAW 2004.0119]; Medical Faculty at Lund University	SENSOPAC; EU(European Commission); Hand Embodied (THE); French Medical Research Foundation(Fondation pour la Recherche Medicale); Swedish Research Council(Swedish Research CouncilEuropean Commission); LinnA(C) grant from the Swedish Research Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Medical Faculty at Lund University	The work was supported by SENSOPAC (an Integrated Project funded by the EU under FP6, IST-028056-SENSOPAC), The Hand Embodied (THE) (an Integrated Project funded by the EU under FP7, project number 248587), the French Medical Research Foundation (project number FDT20090916556), the Swedish Research Council (project number 08291, 08667), a LinnA (c) grant (project number 60012701) from the Swedish Research Council, The Knut and Alice Wallenberg Foundation (project number KAW 2004.0119) and the Medical Faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1970, J PHYSIOL-LONDON, V210, P433, DOI 10.1113/jphysiol.1970.sp009219; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1096, DOI 10.1152/jn.1964.27.6.1096; Arleo A, 2010, NEURAL COMPUT, V22, P2031, DOI 10.1162/NECO_a_00006-Arleo; Bagnall MW, 2011, NEURON, V71, P180, DOI 10.1016/j.neuron.2011.05.032; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Canedo A, 1998, NEUROSCIENCE, V84, P603, DOI 10.1016/S0306-4522(97)00554-X; Canedo A, 2000, EUR J NEUROSCI, V12, P2515, DOI 10.1046/j.1460-9568.2000.00107.x; CULBERSON JL, 1989, SOMATOSENS MOT RES, V6, P319, DOI 10.3109/08990228909144680; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; DYKES RW, 1982, J NEUROPHYSIOL, V47, P389, DOI 10.1152/jn.1982.47.3.389; FERRINGTON DG, 1987, J PHYSIOL-LONDON, V386, P293, DOI 10.1113/jphysiol.1987.sp016535; FLORENCE SL, 1989, J COMP NEUROL, V286, P48, DOI 10.1002/cne.902860104; Gerstner W., 2002, SPIKING NEURON MODEL; GOLOVCHINSKY V, 1980, J NEUROPHYSIOL, V43, P1673, DOI 10.1152/jn.1980.43.6.1673; Granseth B, 2003, J NEUROPHYSIOL, V89, P2952, DOI 10.1152/jn.01160.2002; HEINO R, 1991, ANAT EMBRYOL, V184, P181, DOI 10.1007/BF01673255; Hsiao S, 2008, CURR OPIN NEUROBIOL, V18, P418, DOI 10.1016/j.conb.2008.09.001; ISOMURA G, 1988, NEUROSCI RES, V5, P395, DOI 10.1016/0168-0102(88)90025-9; Jenmalm P, 2003, EUR J NEUROSCI, V18, P164, DOI 10.1046/j.1460-9568.2003.02721.x; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINSKER R, 1988, COMPUTER, V21, P105, DOI 10.1109/2.36; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Macefield VG, 1996, EXP BRAIN RES, V108, P155; MILLAR J, 1976, EXP NEUROL, V50, P658, DOI 10.1016/0014-4886(76)90035-2; Nadal JP, 1998, NETWORK-COMP NEURAL, V9, P207, DOI 10.1088/0954-898X/9/2/004; NADAL JP, 1994, NETWORK-COMP NEURAL, V5, P565, DOI 10.1088/0954-898X/5/4/008; Niedermayer E, 1993, ELECTROENCEPHALOGRAP; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PETER G, 1986, J APPL PHYSIOL, V60, P1107, DOI 10.1152/jappl.1986.60.4.1107; PETTIT MJ, 1993, SCIENCE, V262, P2054, DOI 10.1126/science.8266104; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; PUBOLS BH, 1965, J NEUROPHYSIOL, V28, P312, DOI 10.1152/jn.1965.28.2.312; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; ROSEN I, 1969, J PHYSIOL-LONDON, V205, P209, DOI 10.1113/jphysiol.1969.sp008961; RUSTIONI A, 1968, J COMP NEUROL, V134, P113, DOI 10.1002/cne.901340107; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; TAKAHASHI T, 1992, J PHYSIOL-LONDON, V450, P593, DOI 10.1113/jphysiol.1992.sp019145; Toyoizumi T, 2005, P NATL ACAD SCI USA, V102, P5239, DOI 10.1073/pnas.0500495102; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; WEINBERG RJ, 1990, J COMP NEUROL, V300, P113, DOI 10.1002/cne.903000108; WEN CY, 1978, J ANAT, V127, P169; Zachariah MK, 2001, J NEUROPHYSIOL, V86, P900, DOI 10.1152/jn.2001.86.2.900	57	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56630	10.1371/journal.pone.0056630	http://dx.doi.org/10.1371/journal.pone.0056630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409195	Green Submitted, Green Published, gold			2022-12-25	WOS:000314660300078
J	Ishii, A; Saito, Y; Mitsui, J; Ishiura, H; Yoshimura, J; Arai, H; Yamashita, S; Kimura, S; Oguni, H; Morishita, S; Tsuji, S; Sasaki, M; Hirose, S				Ishii, Atsushi; Saito, Yoshiaki; Mitsui, Jun; Ishiura, Hiroyuki; Yoshimura, Jun; Arai, Hidee; Yamashita, Sumimasa; Kimura, Sadami; Oguni, Hirokazu; Morishita, Shinichi; Tsuji, Shoji; Sasaki, Masayuki; Hirose, Shinichi			Identification of ATP1A3 Mutations by Exome Sequencing as the Cause of Alternating Hemiplegia of Childhood in Japanese Patients	PLOS ONE			English	Article							ONSET DYSTONIA-PARKINSONISM; DE-NOVO MUTATIONS; GENE MUTATION; MIGRAINE; NA,K-ATPASE; ATAXIA	Background: Alternating hemiplegia of childhood (AHC) is a rare disorder characterized by transient repeated attacks of paresis and cognitive impairment. Recent studies from the U. S. and Europe have described ATP1A3 mutations in AHC. However, the genotype-phenotype relationship remains unclear. The purpose of this study was to identify the genetic abnormality in a Japanese cohort of AHC using exome analysis. Principal Findings: A total of 712,558 genetic single nucleotide variations in 8 patients with sporadic AHC were found. After a series of exclusions, mutations of three genes were regarded as candidate causes of AHC. Each patient harbored a heterozygous missense mutation of ATP1A3, which included G755C, E815K, C927Y and D801N. All mutations were at highly conserved amino acid residues and deduced to affect ATPase activity of the corresponding ATP pump, the product of ATP1A3. They were de novo mutations and not identified in 96 healthy volunteers. Using Sanger sequencing, E815K was found in two other sporadic cases of AHC. In this study, E815K was found in 5 of 10 patients (50%), a prevalence higher than that reported in two recent studies [19 of 82 (23%) and 7 of 24 (29%)]. Furthermore, the clinical data of the affected individuals indicated that E815K resulted in a severer phenotype compared with other ATP1A3 mutations. Interpretation: Heterozygous de novo mutations of ATP1A3 were identified in all Japanese patients with AHC examined in this study, confirming that ATP1A3 mutation is the cause of AHC.	[Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan; [Saito, Yoshiaki; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo, Japan; [Mitsui, Jun; Ishiura, Hiroyuki; Tsuji, Shoji] Univ Tokyo, Dept Neurol, Grad Sch Med, Tokyo, Japan; [Yoshimura, Jun; Morishita, Shinichi] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Arai, Hidee] Chiba Childrens Hosp, Dept Neurol, Chiba, Japan; [Yamashita, Sumimasa] Kanagawa Childrens Med Ctr, Div Child Neurol, Yokohama, Kanagawa, Japan; [Kimura, Sadami] Osaka Med Ctr, Div Child Neurol, Izumi, Japan; [Kimura, Sadami] Res Inst Maternal & Child Hlth, Izumi, Japan; [Oguni, Hirokazu] Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan	Fukuoka University; Fukuoka University; National Center for Neurology & Psychiatry - Japan; University of Tokyo; University of Tokyo; Chiba Children's Hospital; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University	Hirose, S (corresponding author), Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan.	hirose@fukuoka-u.ac.jp	Mitsui, Jun/B-5455-2012	Mitsui, Jun/0000-0001-7425-4765; Morishita, Shinichi/0000-0002-6201-8885; HIROSE, Shinichi/0000-0001-6796-3790; Yoshimura, Jun/0000-0003-2988-1123	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]; Japan Society for the Promotion of Science (JSPS) [21249062, 23659529, 23791201]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research, Japan Science and Technology Agency (JSP); Ministry of Health, Labor and Welfare of Japan [21B-5, 24-7]; "Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University", Recommended Projects of Fukuoka University [117016]; Japan Foundation for Pediatric Research; Japan Epilepsy Research Foundation; Kaibara Morikazu Medical Science Promotion Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research, Japan Science and Technology Agency (JSP); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); "Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University", Recommended Projects of Fukuoka University; Japan Foundation for Pediatric Research; Japan Epilepsy Research Foundation; Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation)	This work was supported in part by a grant-in-aid for Scientific Research on Innovative Areas "Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#221S0002), a grant-in-aid for Scientific Research (A) (#21249062, to SH), a grant-in-aid for Challenging Exploratory Research (#23659529, to SH), a grant-in-aid for Young Scientists (B) (#23791201, to AI) from the Japan Society for the Promotion of Science (JSPS), grants from Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research, Japan Science and Technology Agency (JSP), a research grant (#21B-5, #24-7, to MS, YS, and SH) for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare of Japan, "Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University", Recommended Projects of Fukuoka University (#117016), a research grant from the Japan Foundation for Pediatric Research (to AI), a research grant from the Japan Epilepsy Research Foundation (to AI), and a research grant from Kaibara Morikazu Medical Science Promotion Foundation (to AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; Brashear A, 1997, NEUROLOGY, V48, P1066, DOI 10.1212/WNL.48.4.1066; Brashear A, 2012, DEV MED CHILD NEUROL, V54, P1065, DOI 10.1111/j.1469-8749.2012.04421.x; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DOBYNS WB, 1993, NEUROLOGY, V43, P2596, DOI 10.1212/WNL.43.12.2596; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linazasoro G, 2002, MOVEMENT DISORD, V17, P608, DOI 10.1002/mds.10103; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Pittock SJ, 2000, NEUROLOGY, V55, P991, DOI 10.1212/WNL.55.7.991; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Saito TL, 2009, BIOINFORMATICS, V25, P1856, DOI 10.1093/bioinformatics/btp350; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674	23	65	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56120	10.1371/journal.pone.0056120	http://dx.doi.org/10.1371/journal.pone.0056120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409136	Green Published, Green Submitted, gold			2022-12-25	WOS:000314660300060
J	Marchetti, M; Capela, D; Poincloux, R; Benmeradi, N; Auriac, MC; Le Ru, A; Maridonneau-Parini, I; Batut, J; Masson-Boivin, C				Marchetti, Marta; Capela, Delphine; Poincloux, Renaud; Benmeradi, Nacer; Auriac, Marie-Christine; Le Ru, Aurelie; Maridonneau-Parini, Isabelle; Batut, Jacques; Masson-Boivin, Catherine			Queuosine Biosynthesis Is Required for Sinorhizobium meliloti-Induced Cytoskeletal Modifications on HeLa Cells and Symbiosis with Medicago truncatula	PLOS ONE			English	Article							RNA-GUANINE TRANSGLYCOSYLASE; GENETIC-CHARACTERIZATION; BACTERIAL TOXINS; RHO GTPASES; RHIZOBIUM; INFECTION; ALFALFA; GENOME; DIFFERENTIATION; IDENTIFICATION	Rhizobia are symbiotic soil bacteria able to intracellularly colonize legume nodule cells and form nitrogen-fixing symbiosomes therein. How the plant cell cytoskeleton reorganizes in response to rhizobium colonization has remained poorly understood especially because of the lack of an in vitro infection assay. Here, we report on the use of the heterologous HeLa cell model to experimentally tackle this question. We observed that the model rhizobium Sinorhizobium meliloti, and other rhizobia as well, were able to trigger a major reorganization of actin cytoskeleton of cultured HeLa cells in vitro. Cell deformation was associated with an inhibition of the three major small RhoGTPases Cdc42, RhoA and Rac1. Bacterial entry, cytoskeleton rearrangements and modulation of RhoGTPase activity required an intact S. meliloti biosynthetic pathway for queuosine, a hypermodifed nucleoside regulating protein translation through tRNA, and possibly mRNA, modification. We showed that an intact bacterial queuosine biosynthetic pathway was also required for effective nitrogen-fixing symbiosis of S. meliloti with its host plant Medicago truncatula, thus indicating that one or several key symbiotic functions of S. meliloti are under queuosine control. We discuss whether the symbiotic defect of que mutants may originate, at least in part, from an altered capacity to modify plant cell actin cytoskeleton.	[Marchetti, Marta; Capela, Delphine; Auriac, Marie-Christine; Batut, Jacques; Masson-Boivin, Catherine] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Marchetti, Marta; Capela, Delphine; Auriac, Marie-Christine; Batut, Jacques; Masson-Boivin, Catherine] CNRS, LIPM, UMR2594, Castanet Tolosan, France; [Poincloux, Renaud; Maridonneau-Parini, Isabelle] CNRS, IPBS, Toulouse, France; [Poincloux, Renaud; Maridonneau-Parini, Isabelle] Univ Toulouse 3, Univ Toulouse, IPBS, F-31062 Toulouse, France; [Benmeradi, Nacer] Inst Biol Cellulaire & Genet IBCG CNRS, Toulouse, France; [Le Ru, Aurelie] Ctr Dev Biol, Plateforme Microscopie FRBT, Toulouse, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Batut, J (corresponding author), INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France.	Jacques.Batut@toulouse.inra.fr	Maridonneau-Parini, Isabelle/F-1985-2011; Poincloux, Renaud/AAD-4746-2019	Poincloux, Renaud/0000-0003-2884-1744; Auriac, Marie-Christine/0000-0002-1202-032X; Maridonneau-Parini, Isabelle/0000-0003-0189-0976; AURELIE, LE RU/0000-0002-0236-791X	SPE INRA	SPE INRA	This work is part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR -10-LABX-41) and was supported by a grant from SPE INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Brembu T, 2006, CELL RES, V16, P435, DOI 10.1038/sj.cr.7310055; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; CHARLES TC, 1991, GENETICS, V127, P5; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Costa A, 2004, J CHROMATOGR B, V801, P237, DOI 10.1016/j.jchromb.2003.11.022; Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004; Darzynkiewicz Z., 1997, CURRENT PROTOCOLS CY; Davidson AL, 2001, CAN J BOT, V79, P767, DOI 10.1139/cjb-79-7-767; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; HIRSCH PR, 1979, J GEN MICROBIOL, V113, P219, DOI 10.1099/00221287-113-2-219; Hurt JK, 2007, NUCLEIC ACIDS RES, V35, P4905, DOI 10.1093/nar/gkm473; Ivanov S, 2010, CURR OPIN PLANT BIOL, V13, P372, DOI 10.1016/j.pbi.2010.04.005; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Soto MJ, 2011, CENT EUR J BIOL, V6, P911, DOI 10.2478/s11535-011-0069-x; Ke DX, 2012, PLANT PHYSIOL, V159, P131, DOI 10.1104/pp.112.197269; Lagares A, 2001, J BACTERIOL, V183, P1248, DOI 10.1128/JB.183.4.1248-1258.2001; LANGGUT W, 1990, FEBS LETT, V265, P33, DOI 10.1016/0014-5793(90)80877-L; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Liu W, 2010, J INTEGR PLANT BIOL, V52, P639, DOI 10.1111/j.1744-7909.2010.00944.x; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; MEIER F, 1985, EMBO J, V4, P823, DOI 10.1002/j.1460-2075.1985.tb03704.x; Murray JD, 2011, MOL PLANT MICROBE IN, V24, P631, DOI 10.1094/MPMI-08-10-0181; NOGUCHI S, 1982, J BIOL CHEM, V257, P6544; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shames SR, 2009, INT J BIOCHEM CELL B, V41, P380, DOI 10.1016/j.biocel.2008.08.013; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Szucs A, 2006, BBA-GENE STRUCT EXPR, V1759, P108, DOI 10.1016/j.bbaexp.2006.03.001; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Timmers ACJ, 1998, DEVELOPMENT, V125, P339; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Verma D P, 1998, Subcell Biochem, V29, P1; Vinayak M, 2010, BIOSCIENCE REP, V30, P135, DOI 10.1042/BSR20090057; Yokota K, 2009, PLANT CELL, V21, P267, DOI 10.1105/tpc.108.063693; Yuksel B, 2008, J EXP BOT, V59, P3831, DOI 10.1093/jxb/ern223	53	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56043	10.1371/journal.pone.0056043	http://dx.doi.org/10.1371/journal.pone.0056043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409119	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300052
J	Naushad, HS; Gupta, RS				Naushad, Hafiz Sohail; Gupta, Radhey S.			Phylogenomics and Molecular Signatures for Species from the Plant Pathogen-Containing Order Xanthomonadales	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; STENOTROPHOMONAS-MALTOPHILIA; PROTEIN SEQUENCES; EVOLUTIONARY RELATIONSHIPS; CONSERVED INDELS; GENE-TRANSFER; XYLELLA; BACTERIA; STRAINS; INSIGHTS	The species from the order Xanthomonadales, which harbors many important plant pathogens and some human pathogens, are currently distinguished primarily on the basis of their branching in the 16S rRNA tree. No molecular or biochemical characteristic is known that is specific for these bacteria. Phylogenetic and comparative analyses were conducted on 26 sequenced Xanthomonadales genomes to delineate their branching order and to identify molecular signatures consisting of conserved signature indels (CSIs) in protein sequences that are specific for these bacteria. In a phylogenetic tree based upon sequences for 28 proteins, Xanthomonadales species formed a strongly supported clade with Rhodanobacter sp. 2APBS1 as its deepest branch. Comparative analyses of protein sequences have identified 13 CSIs in widely distributed proteins such as GlnRS, TypA, MscL, LysRS, LipA, Tgt, LpxA, TolQ, ParE, PolA and TyrB that are unique to all species/strains from this order, but not found in any other bacteria. Fifteen additional CSIs in proteins (viz. CoxD, DnaE, PolA, SucA, AsnB, RecA, PyrG, LigA, MutS and TrmD) are uniquely shared by different Xanthomonadales except Rhodanobacter and in a few cases by Pseudoxanthomonas species, providing further support for the deep branching of these two genera. Five other CSIs are commonly shared by Xanthomonadales and 1-3 species from the orders Chromatiales, Methylococcales and Cardiobacteriales suggesting that these deep branching orders of Gammaproteobacteria might be specifically related. Lastly, 7 CSIs in ValRS, CarB, PyrE, GlyS, RnhB, MinD and X001065 are commonly shared by Xanthomonadales and a limited number of Beta-or Gamma-proteobacteria. Our analysis indicates that these CSIs have likely originated independently and they are not due to lateral gene transfers. The Xanthomonadales-specific CSIs reported here provide novel molecular markers for the identification of these important plant and human pathogens and also as potential targets for development of drugs/agents that specifically target these bacteria.	[Naushad, Hafiz Sohail; Gupta, Radhey S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Gupta, RS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	gupta@mcmaster.ca		Naushad, Sohail/0000-0001-8219-1717	NSERC (Natural Science and Engineering Research Council of Canada) [249924]	NSERC (Natural Science and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC (Natural Science and Engineering Research Council of Canada) 249924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chen J, 2010, J BACTERIOL, V192, P4534, DOI 10.1128/JB.00651-10; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Cutino-Jimenez AM, 2010, MOL PHYLOGENET EVOL, V54, P524, DOI 10.1016/j.ympev.2009.09.026; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Doddapaneni H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-225; Dutilh BE, 2004, J MOL EVOL, V58, P527, DOI 10.1007/s00239-003-2575-6; Gao BL, 2012, ANTON LEEUW INT J G, V101, P45, DOI 10.1007/s10482-011-9663-1; Gao B, 2009, INT J SYST EVOL MICR, V59, P234, DOI 10.1099/ijs.0.002741-0; Gao BL, 2005, INT J SYST EVOL MICR, V55, P2401, DOI 10.1099/ijs.0.63785-0; Griffiths E, 2006, INT J SYST EVOL MICR, V56, P99, DOI 10.1099/ijs.0.63927-0; Griffiths E, 2002, MICROBIOL-SGM, V148, P2541, DOI 10.1099/00221287-148-8-2541; Griffiths E, 2006, J MOL EVOL, V63, P283, DOI 10.1007/s00239-005-0286-x; Gupta Radhey S., 2001, International Microbiology, V4, P187, DOI 10.1007/s10123-001-0037-9; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Gupta RS, 2010, PHOTOSYNTH RES, V104, P357, DOI 10.1007/s11120-010-9553-9; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P2510, DOI 10.1099/ijs.0.005678-0; Gupta RS, 2007, J MOL EVOL, V64, P90, DOI 10.1007/s00239-006-0082-2; Gupta RS, 2002, THEOR POPUL BIOL, V61, P423, DOI 10.1006/tpbi.2002.1589; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Handy J, 1999, J MOL EVOL, V49, P709, DOI 10.1007/PL00006592; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Imhoff J.F., 2005, BERGEYS MANUAL SYSTE, VVolume 2 (The Proteobacteria), P587, DOI DOI 10.1007/0-387-29298-5; Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lee SH, 2012, J BACTERIOL, V194, P544, DOI 10.1128/JB.06436-11; Lima WC, 2008, J MOL EVOL, V66, P266, DOI 10.1007/s00239-008-9082-8; Lima WC, 2008, FEMS MICROBIOL LETT, V281, P87, DOI 10.1111/j.1574-6968.2008.01083.x; Lima WC, 2009, MOL BIOL EVOL, V26, P399, DOI 10.1093/molbev/msn261; Lima WC, 2005, OMICS, V9, P160, DOI 10.1089/omi.2005.9.160; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Martins-Pinheiro M, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-29; Monteiro-Vitorello CB, 2005, OMICS, V9, P146, DOI 10.1089/omi.2005.9.146; Naushad HS, 2012, ANTON LEEUW INT J G, V101, P105, DOI 10.1007/s10482-011-9628-4; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; SADDLER G, 2005, BERGEYS MANUAL SYSTE, V2; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Schreiber HL, 2010, SOUTHWEST ENTOMOL, V35, P479, DOI 10.3958/059.035.0336; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Waters V, 2011, AM J RESP CRIT CARE, V183, P635, DOI 10.1164/rccm.201009-1392OC; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004	67	36	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55216	10.1371/journal.pone.0055216	http://dx.doi.org/10.1371/journal.pone.0055216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23408961	gold, Green Published, Green Submitted			2022-12-25	WOS:000314660300008
J	Aisemberg, J; Vercelli, CA; Bariani, MV; Billi, SC; Wolfson, ML; Franchi, AM				Aisemberg, Julieta; Vercelli, Claudia A.; Bariani, Maria V.; Billi, Silvia C.; Wolfson, Manuel L.; Franchi, Ana M.			Progesterone Is Essential for Protecting against LPS-Induced Pregnancy Loss. LIF as a Potential Mediator of the Anti-inflammatory Effect of Progesterone	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; HUMAN MYOMETRIAL CELLS; HORMONAL-REGULATION; HUMAN ENDOMETRIUM; GENE-EXPRESSION; NITRIC-OXIDE; RAT UTERUS; EMBRYO IMPLANTATION; RECEPTOR EXPRESSION; MIFEPRISTONE RU486	Lipopolysaccharide (LPS) administration to mice on day 7 of gestation led to 100% embryonic resorption after 24 h. In this model, nitric oxide is fundamental for the resorption process. Progesterone may be responsible, at least in part, for a Th2 switch in the feto-maternal interface, inducing active immune tolerance against fetal antigens. Th2 cells promote the development of T cells, producing leukemia inhibitory factor (LIF), which seems to be important due to its immunomodulatory action during early pregnancy. Our aim was to evaluate the involvement of progesterone in the mechanism of LPS-induced embryonic resorption, and whether LIF can mediate hormonal action. Using in vivo and in vitro models, we provide evidence that circulating progesterone is an important component of the process by which infection causes embryonic resorption in mice. Also, LIF seems to be a mediator of the progesterone effect under inflammatory conditions. We found that serum progesterone fell to very low levels after 24 h of LPS exposure. Moreover, progesterone supplementation prevented embryonic resorption and LPS-induced increase of uterine nitric oxide levels in vivo. Results show that LPS diminished the expression of the nuclear progesterone receptor in the uterus after 6 and 12 h of treatment. We investigated the expression of LIF in uterine tissue from pregnant mice and found that progesterone up-regulates LIF mRNA expression in vitro. We observed that LIF was able to modulate the levels of nitric oxide induced by LPS in vitro, suggesting that it could be a potential mediator of the inflammatory action of progesterone. Our observations support the view that progesterone plays a critical role in a successful pregnancy as an anti-inflammatory agent, and that it could have possible therapeutic applications in the prevention of early reproductive failure associated with inflammatory disorders.	[Aisemberg, Julieta; Vercelli, Claudia A.; Bariani, Maria V.; Wolfson, Manuel L.; Franchi, Ana M.] Ctr Estudios Farmacol & Bot CONICET UBA, Buenos Aires, DF, Argentina; [Billi, Silvia C.] Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina		Aisemberg, J (corresponding author), Ctr Estudios Farmacol & Bot CONICET UBA, Buenos Aires, DF, Argentina.	jaisemberg@yahoo.com.ar		Bariani, Maria Victoria/0000-0003-2675-7936; Wolfson, Manuel Luis/0000-0003-3433-1521	"Alberto J. Roemmers" Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT) [10901]	"Alberto J. Roemmers" Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT)(ANPCyT)	This work was supported by research grants from the "Alberto J. Roemmers" Foundation (2004-2005) and by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT 2002/no10901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACE CI, 1995, MOL CELL ENDOCRINOL, V115, P95, DOI 10.1016/0303-7207(95)03674-V; ADASHI EY, 1990, AM J OBSTET GYNECOL, V162, P889, DOI 10.1016/0002-9378(90)91289-O; Agrawal V, 2012, ZYGOTE, P1; Agrawal V, 2011, FERTIL STERIL, V95, P1471, DOI 10.1016/j.fertnstert.2010.08.046; Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Auernhammer CJ, 2000, ENDOCR REV, V21, P313, DOI 10.1210/er.21.3.313; AVRECH OM, 1991, FERTIL STERIL, V56, P385; Bethea CL, 1998, ENDOCRINOLOGY, V139, P677, DOI 10.1210/en.139.2.677; Bowen JM, 2000, BIOL REPROD, V63, P1179, DOI 10.1095/biolreprod63.4.1179; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MA, 1994, CYTOKINE, V6, P300, DOI 10.1016/1043-4666(94)90027-2; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Cai LQ, 2000, CYTOKINE, V12, P1676, DOI 10.1006/cyto.2000.0758; Cervellati F, 2011, REPROD FERT DEVELOP, V23, P319, DOI 10.1071/RD10077; CHWALISZ K, 1995, ANN NY ACAD SCI, V761, P202, DOI 10.1111/j.1749-6632.1995.tb31380.x; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; DEANESLY R, 1973, J REPROD FERTIL, V35, P183; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diao HL, 2011, FERTIL STERIL, V95, P2087, DOI 10.1016/j.fertnstert.2011.01.160; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; ELGER W, 1987, AM J OBSTET GYNECOL, V157, P1065, DOI 10.1016/S0002-9378(87)80134-5; Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6; Fang X, 1997, ENDOCRINOLOGY, V138, P2763, DOI 10.1210/en.138.7.2763; Fidel P I Jr, 1998, J Matern Fetal Med, V7, P222; Friebe A, 2008, INT J BIOCHEM CELL B, V40, P2348, DOI 10.1016/j.biocel.2008.04.019; Goyeneche AA, 2003, BIOL REPROD, V68, P151, DOI 10.1095/biolreprod.102.007898; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Guo K, 1998, BIOL REPROD, V58, P739, DOI 10.1095/biolreprod58.3.739; Hambartsoumian E, 1998, AM J REPROD IMMUNOL, V39, P137; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Heikinheimo O, 1997, CLIN PHARMACOKINET, V33, P7, DOI 10.2165/00003088-199733010-00002; Hirsch E, 2002, BIOL REPROD, V67, P1337, DOI 10.1095/biolreprod67.4.1337; Kholkute SD, 2000, MOL HUM REPROD, V6, P337, DOI 10.1093/molehr/6.4.337; Laird SM, 1997, HUM REPROD, V12, P569; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Mahajan DK, 1997, FERTIL STERIL, V68, P967, DOI 10.1016/S0015-0282(97)00189-1; Marriott LK, 2007, ENDOCRINE, V32, P317, DOI 10.1007/s12020-008-9038-1; McCormack JT, 1998, BIOL REPROD, V58, P255, DOI 10.1095/biolreprod58.1.255; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; Murata T, 2003, J REPROD DEVELOP, V49, P425, DOI 10.1262/jrd.49.425; Nardo LG, 2006, REPROD BIOMED ONLINE, V13, P47, DOI 10.1016/S1472-6483(10)62015-9; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; OLSON NC, 1995, BRIT VET J, V151, P489, DOI 10.1016/S0007-1935(05)80023-5; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Reinhart KC, 1998, MOL HUM REPROD, V4, P301, DOI 10.1093/molehr/4.3.301; Ribeiro ML, 2005, P NATL ACAD SCI USA, V102, P8048, DOI 10.1073/pnas.0502899102; Rodriguez A, 2007, THERIOGENOLOGY, V67, P1092, DOI 10.1016/j.theriogenology.2006.11.015; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruan HC, 2006, HUM REPROD, V21, P2521, DOI 10.1093/humrep/del215; Salamonsen LA, 2000, SEMIN REPROD MED, V18, P299, DOI 10.1055/s-2000-12567; SANCHOTELLO M, 1992, J ENDOCRINOL, V135, P571, DOI 10.1677/joe.0.1350571; Seli E, 2005, HUM REPROD, V20, P3012, DOI 10.1093/humrep/dei188; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Slayden OD, 2004, ARCH HISTOL CYTOL, V67, P393, DOI 10.1679/aohc.67.393; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Szekeres-Bartho J, 2005, CHEM IMMUNOL ALLERGY, V89, P118, DOI 10.1159/000087953; Tan HQ, 2012, J CLIN ENDOCR METAB, V97, pE719, DOI 10.1210/jc.2011-3251; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Toth B, 2009, GYNECOL OBSTET INVES, V67, P269, DOI 10.1159/000210373; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; WARING PM, 1995, P NATL ACAD SCI USA, V92, P1337, DOI 10.1073/pnas.92.5.1337; Weber MA, 2005, LAB INVEST, V85, P276, DOI 10.1038/labinvest.3700216; Winer N, 2009, EUR J OBSTET GYN R B, V145, P53, DOI 10.1016/j.ejogrb.2009.04.028; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; YANG ZM, 1995, MOL REPROD DEV, V42, P407, DOI 10.1002/mrd.1080420406; Yang ZM, 1996, MOL REPROD DEV, V43, P470	69	69	72	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56161	10.1371/journal.pone.0056161	http://dx.doi.org/10.1371/journal.pone.0056161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409146	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200119
J	Vidal-Donet, JM; Carcel-Trullols, J; Casanova, B; Aguado, C; Knecht, E				Manuel Vidal-Donet, Jose; Carcel-Trullols, Jaime; Casanova, Bonaventura; Aguado, Carmen; Knecht, Erwin			Alterations in ROS Activity and Lysosomal pH Account for Distinct Patterns of Macroautophagy in LINCL and JNCL Fibroblasts	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSES; BATTEN-DISEASE; AUTOPHAGIC VACUOLES; MOUSE MODELS; CLN3; DEGRADATION; PROTEINS; BIOSYNTHESIS; TRAFFICKING; PROTEASOMES	Neuronal Ceroid Lipofuscinoses (NCL) are lysosomal storage disorders characterized by the accumulation of lipofuscin within lysosomes. Late infantile (LINCL) and juvenile (JNCL) are their most common forms and are caused by loss-of-function mutations in tripeptidyl peptidase 1 (TPP1), a lysosomal endopeptidase, and CLN3 protein (CLN3p), whose location and function is still controversial. LINCL patients suffer more severely from NCL consequences than JNCL patients, in spite of having in common an abnormal accumulation of material with a similar composition in the lysosomes. To identify distinctive characteristics that could explain the differences in the severity of LINCL and JNCL pathologies, we compared the protein degradation mechanisms in patients fibroblasts. Pulse-chase experiments show a significant decrease in protein degradation by macroautophagy in fibroblasts bearing TPP1 (CLN2) and CLN3p (CLN3) mutations. In CLN2 fibroblasts, LC3-II levels and other procedures indicate an impaired formation of autophagosomes, which confirms the pulse-chase experiments. This defect is linked to an accumulation of Reactive Oxygen Species (ROS), an upregulation of the Akt-mTOR signalling pathway and increased activities of the p38 alpha and ERK1/2 MAPKs. In CLN3 fibroblasts, LC3-II analysis indicates impairment in autophagosome maturation and there is also a defect in fluid phase endocytosis, two alterations that can be related to an observed increase of 0.5 units in lysosomal pH. CLN3 fibroblasts also accumulate ROS but to a lower extent than CLN2. TPP1 activity is completely abrogated in CLN2 and partially diminished in CLN3 fibroblasts. TPP1 cleaves small hydrophobic proteins like subunit c of mitochondrial ATP synthase and the lack or a lower activity of this enzyme can contribute to lipofuscin accumulation. These alterations in TPP1 activity lead to an increased ROS production, especially in CLN2 in which it is aggravated by a decrease in catalase activity. This could explain the earlier appearance of the symptoms in the LINCL form.	[Manuel Vidal-Donet, Jose; Carcel-Trullols, Jaime; Aguado, Carmen; Knecht, Erwin] Ctr Invest Principe Felipe, Lab Cellular Biol, Valencia, Spain; [Aguado, Carmen; Knecht, Erwin] CIBERER, Valencia, Spain; [Casanova, Bonaventura] Hosp La Fe, Dept Neurol, E-46009 Valencia, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe	Knecht, E (corresponding author), Ctr Invest Principe Felipe, Lab Cellular Biol, Valencia, Spain.	knecht@cipf.es	Casanova, Bonaventura/AAY-1027-2020; Aguado, Carmen/K-4354-2014; Knecht, Erwin/A-9366-2014; Knecht, Erwin/K-2432-2014	Aguado, Carmen/0000-0002-3113-4269; Knecht, Erwin/0000-0002-7208-3832	Spanish Ministry of Science and Innovation [BFU2011-22630]; Generalitat Valenciana [PROMETEO/2012/061]; Fundacio Marato TV3 [100130]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Spanish Ministry of Science and Innovation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacio Marato TV3; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (BFU2011-22630), Generalitat Valenciana (PROMETEO/2012/061), Fundacio Marato TV3 (Grant number 100130) and the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER). JMVD holds a fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118; Chattopadhyay S, 2000, J BACTERIOL, V182, P6418, DOI 10.1128/JB.182.22.6418-6423.2000; de Llano JJM, 2000, ANAL CHEM, V72, P2406, DOI 10.1021/ac991287p; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Esteban I, 2007, FEBS LETT, V581, P3415, DOI 10.1016/j.febslet.2007.06.043; Esteve JM, 2010, EXP CELL RES, V316, P2618, DOI 10.1016/j.yexcr.2010.06.019; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Golabek AA, 2000, MOL GENET METAB, V70, P203, DOI 10.1006/mgme.2000.3006; Hofmann SL, 1997, NEUROPEDIATRICS, V28, P27, DOI 10.1055/s-2007-973661; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jarvela I, 1999, HUM MOL GENET, V8, P1091, DOI 10.1093/hmg/8.6.1091; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; Jolly RD, 2002, NEUROCHEM INT, V40, P565, DOI 10.1016/S0197-0186(01)00128-0; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim Y, 2003, P NATL ACAD SCI USA, V100, P15458, DOI 10.1073/pnas.2136651100; KNECHT E, 1984, EXP CELL RES, V154, P224, DOI 10.1016/0014-4827(84)90682-7; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Luellmann-Rauch Renate, 2005, P1; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Pal A, 2009, J BIOL CHEM, V284, P3976, DOI 10.1074/jbc.M806947200; Pearce DA, 1999, NAT GENET, V22, P55, DOI 10.1038/8861; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Scherz-Shouval R, 2019, EMBO J, V38, DOI 10.15252/embj.2019101812; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Uusi-Rauva K, 2012, CELL MOL LIFE SCI, V69, P2075, DOI 10.1007/s00018-011-0913-1; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Weimer JM, 2002, NEUROMOL MED, V1, P111, DOI 10.1385/NMM:1:2:111; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010	49	63	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55526	10.1371/journal.pone.0055526	http://dx.doi.org/10.1371/journal.pone.0055526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408996	Green Published, gold, Green Submitted			2022-12-25	WOS:000315157200036
J	Schilling, B; Harasymczuk, M; Schuler, P; Egan, J; Ferrone, S; Whiteside, TL				Schilling, Bastian; Harasymczuk, Malgorzata; Schuler, Patrick; Egan, James; Ferrone, Soldano; Whiteside, Theresa L.			IRX-2, a Novel Immunotherapeutic, Enhances Functions of Human Dendritic Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MONOCLONAL-ANTIBODIES; T-CELLS; EFFECTOR-CELLS; FLOW-CYTOMETRY; TUMOR-CELLS; IN-VIVO; CANCER; ANTIGEN; MATURATION	Background: In a recent phase II clinical trial for HNSCC patients, IRX-2, a cell-derived biologic, promoted T-cell infiltration into the tumor and prolonged overall survival. Mechanisms responsible for these IRX-2-mediated effects are unknown. We hypothesized that IRX-2 enhanced tumor antigen-(TA)-specific immunity by up-regulating functions of dendritic cells (DC). Methodology/Principal Findings: Monocyte-derived DC obtained from 18 HNSCC patients and 12 healthy donors were matured using IRX-2 or a mix of TNF-alpha, IL-1 beta and IL-6 ("conv. mix''). Multicolor flow cytometry was used to study the DC phenotype and antigen processing machinery (APM) component expression. ELISPOT and cytotoxicity assays were used to evaluate tumor-reactive cytotoxic T lymphocytes (CTL). IL-12p70 and IL-10 production by DC was measured by Luminex (R) and DC migration toward CCL21 was tested in transwell migration assays. IRX-2-matured DC functions were compared with those of conv. mix-matured DC. IRX-2-matured DC expressed higher levels (p<0.05) of CD11c, CD40, CCR7 as well as LMP2, TAP1, TAP2 and tapasin than conv. mix-matured DC. IRX-2-matured DC migrated significantly better towards CCL21, produced more IL-12p70 and had a higher IL12p70/IL-10 ratio than conv. mix-matured DC (p<0.05 for all). IRX-2-matured DC carried a higher density of tumor antigen-derived peptides, and CTL primed with these DC mediated higher cytotoxicity against tumor targets (p<0.05) compared to the conv. mix-matured DC. Conclusion: Excellent ability of IRX-2 to induce ex vivo DC maturation in HNSCC patients explains, in part, its clinical benefits and emphasizes its utility in ex vivo maturation of DC generated for therapy.	[Schilling, Bastian; Harasymczuk, Malgorzata; Schuler, Patrick; Ferrone, Soldano; Whiteside, Theresa L.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Schilling, Bastian; Harasymczuk, Malgorzata; Schuler, Patrick; Ferrone, Soldano; Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Egan, James] IRX Therapeut Inc, Farmingdale, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whiteside, TL (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu	Schilling, Bastian/AAY-8646-2020	Schilling, Bastian/0000-0001-8859-4103	National Institutes of Health [PO-1 CA 109688]; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research described in this article was supported in part by National Institutes of Health grant PO-1 CA 109688 to TLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; Almand B, 2000, CLIN CANCER RES, V6, P1755; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandoh N, 2005, TISSUE ANTIGENS, V66, P185, DOI 10.1111/j.1399-0039.2005.00462.x; Berinstein NL, 2012, CANCER IMMUNOL IMMUN, V61, P771, DOI 10.1007/s00262-011-1134-z; Butterfield LH, 2008, J IMMUNOTHER, V31, P89, DOI 10.1097/CJI.0b013e318158fce0; Chaux P, 1996, LAB INVEST, V74, P975; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Egan JE, 2007, J IMMUNOTHER, V30, P624, DOI 10.1097/CJI.0b013e3180691593; Frasca L, 2008, J IMMUNOL, V180, P1471, DOI 10.4049/jimmunol.180.3.1471; Gabrilovich DI, 1997, CLIN CANCER RES, V3, P483; HEO DS, 1989, CANCER RES, V49, P5167; Hoffmann TK, 2000, J IMMUNOL, V165, P5938, DOI 10.4049/jimmunol.165.10.5938; Hoffmann TK, 2001, J IMMUNOTHER, V24, P162, DOI 10.1097/00002371-200103000-00011; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 2009, CURR OPIN INVEST DR, V10, P526; Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013; Kirkwood JM, 2009, CLIN CANCER RES, V15, P1443, DOI 10.1158/1078-0432.CCR-08-1231; LANGLADEDEMOYEN P, 1994, INT IMMUNOL, V6, P1759, DOI 10.1093/intimm/6.11.1759; Lopez-Abaitero A, 2009, J IMMUNOTHER, V32, P465, DOI 10.1097/CJI.0b013e3181a1c24e; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Muthuswamy R, 2010, BLOOD, V116, P1454, DOI 10.1182/blood-2009-12-258038; Ogino T, 2003, TISSUE ANTIGENS, V62, P385, DOI 10.1034/j.1399-0039.2003.00114.x; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Poon IKH, 2010, J LEUKOCYTE BIOL, V88, P559, DOI 10.1189/jlb.0210087; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; Rapidis AD, 2009, J ONCOL, V2009, DOI 10.1155/2009/346345; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; Schilling B, 2012, J MOL MED, V90, P139, DOI 10.1007/s00109-011-0813-8; TEMPONI M, 1989, HYBRIDOMA, V8, P85, DOI 10.1089/hyb.1989.8.85; Visus C, 2007, CANCER RES, V67, P10538, DOI 10.1158/0008-5472.CAN-07-1346; Wang XH, 2005, J IMMUNOL METHODS, V299, P139, DOI 10.1016/j.jim.2005.02.006; Whiteside TL, 2012, CANCER IMMUNOL IMMUN, V61, P783, DOI 10.1007/s00262-011-1136-x; Whiteside TL, 2004, J IMMUNOL, V173, P1526, DOI 10.4049/jimmunol.173.3.1526; Wolf GT, 2011, HEAD NECK-J SCI SPEC, V33, P1666, DOI 10.1002/hed.21660; Young MRI, 1997, INT J CANCER, V74, P69, DOI 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D	41	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e47234	10.1371/journal.pone.0047234	http://dx.doi.org/10.1371/journal.pone.0047234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23408925	gold, Green Accepted, Green Published			2022-12-25	WOS:000315157200002
J	Davis, AR; Coleman, D; Broad, A; Byrne, M; Dworjanyn, SA; Przeslawski, R				Davis, Andrew R.; Coleman, Daniel; Broad, Allison; Byrne, Maria; Dworjanyn, Symon A.; Przeslawski, Rachel			Complex Responses of Intertidal Molluscan Embryos to a Warming and Acidifying Ocean in the Presence of UV Radiation	PLOS ONE			English	Article							LIFE-HISTORY STAGES; CLIMATE-CHANGE; ULTRAVIOLET-RADIATION; ACIDIFICATION; TEMPERATURE; FERTILIZATION; LARVAE; STRESSORS; MORTALITY; EXPOSURE	Climate change and ocean acidification will expose marine organisms to synchronous multiple stressors, with early life stages being potentially most vulnerable to changing environmental conditions. We simultaneously exposed encapsulated molluscan embryos to three abiotic stressors-acidified conditions, elevated temperate, and solar UV radiation in large outdoor water tables in a multifactorial design. Solar UV radiation was modified with plastic filters, while levels of the other factors reflected IPCC predictions for near-future change. We quantified mortality and the rate of embryonic development for a mid-shore littorinid, Bembicium nanum, and low-shore opisthobranch, Dolabrifera brazieri. Outcomes were consistent for these model species with embryos faring significantly better at 26 degrees C than 22 degrees C. Mortality sharply increased at the lowest temperature (22 degrees C) and lowest pH (7.6) examined, producing a significant interaction. Under these conditions mortality approached 100% for each species, representing a 2- to 4-fold increase in mortality relative to warm (26 degrees C) non-acidified conditions. Predictably, development was more rapid at the highest temperature but this again interacted with acidified conditions. Development was slowed under acidified conditions at the lowest temperature. The presence of UV radiation had minimal impact on the outcomes, only slowing development for the littorinid and not interacting with the other factors. Our findings suggest that a warming ocean, at least to a threshold, may compensate for the effects of decreasing pH for some species. It also appears that stressors will interact in complex and unpredictable ways in a changing climate.	[Davis, Andrew R.; Coleman, Daniel; Broad, Allison; Przeslawski, Rachel] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	University of Wollongong; University of Sydney; University of Sydney; Southern Cross University	Davis, AR (corresponding author), Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	adavis@uow.edu.au	Broad, Allison/AAY-5852-2021; Davis, Andy/H-3607-2011; Byrne, Maria/K-6355-2016; Dworjanyn, Symon A/O-5633-2017	Broad, Allison/0000-0002-1402-6098; Davis, Andy/0000-0002-8146-7424; Byrne, Maria/0000-0002-8902-9808; Dworjanyn, Symon A/0000-0002-6690-8033; Przeslawski, Rachel/0000-0003-0269-3755; Coleman, Daniel/0000-0002-2472-9993	Australian Research Council	Australian Research Council(Australian Research Council)	The authors gratefully acknowledge the financial support of the Australian Research Council (to MB and ARD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D. T., 1961, PROC LINN SOC N S WALES, V86, P203; Australian Radiation Protection and Nuclear Safety Agency, 2012, AUSTR UV IND MOD SYD; Benkendorff K, 2004, AQUAT CONSERV, V14, P263, DOI 10.1002/aqc.604; Breitburg DL, 1999, LIMNOL OCEANOGR, V44, P837, DOI 10.4319/lo.1999.44.3_part_2.0837; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DCWDS, 2010, DCWDS; Deschaseaux ESM, 2010, J EXP MAR BIOL ECOL, V383, P130, DOI 10.1016/j.jembe.2009.12.013; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Edgar GJ, 2000, AUSTR MARINE LIFE; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Grant KP, 1995, CAN J ZOOL, V73, P2292, DOI 10.1139/z95-271; Gutowska MA, 2010, J COMP PHYSIOL B, V180, P323, DOI 10.1007/s00360-009-0412-y; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HEARST JE, 1995, SCIENCE, V268, P1858, DOI 10.1126/science.7604259; Hoffman JR, 2003, J PHYCOL, V39, P268, DOI 10.1046/j.1529-8817.2003.01111.x; Hofmann DJ, 1999, SCI ASSESSMENT OZONE; *INT PAN CLIM CHAN, 2007, 4 IPCC; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lough J. M., 2009, NCCARF PUBLICATION, V05/09; MORRIS S, 1983, ESTUAR COAST SHELF S, V17, P339, DOI 10.1016/0272-7714(83)90026-4; Moulin L, 2011, MAR POLLUT BULL, V62, P48, DOI 10.1016/j.marpolbul.2010.09.012; Nguyen HD, 2012, GLOBAL CHANGE BIOL, V18, P2466, DOI 10.1111/j.1365-2486.2012.02714.x; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pechenik J.A., 1987, P551; Pelletier E, 2006, PHOTOCHEM PHOTOBIOL, V82, P981, DOI 10.1562/2005-09-18-RA-688.1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Przeslawski R, 2007, MAR BIOL, V152, P991, DOI 10.1007/s00227-007-0748-3; Przeslawski R, 2005, MAR ECOL PROG SER, V298, P169, DOI 10.3354/meps298169; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Przeslawski R, 2004, MAR ECOL PROG SER, V268, P151, DOI 10.3354/meps268151; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Przeslawski R, 2011, MOLLUSCAN RES, V31, P152; Rudman WB, 2010, SEASLUG FORUM; Sheppard Brennand H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011372; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; SPIGHT TM, 1975, OECOLOGIA, V21, P1, DOI 10.1007/BF00345889; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Tevini M., 1993, EFFECTS HUMANS ANIMA; TRUCHOT JP, 1980, RESP PHYSIOL, V39, P241, DOI 10.1016/0034-5687(80)90056-0; van Uitregt VO, 2007, GLOBAL CHANGE BIOL, V13, P1114, DOI 10.1111/j.1365-2486.2007.01353.x; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wraith J, 2006, J CHEM ECOL, V32, P993, DOI 10.1007/s10886-006-9054-7; Zippay ML, 2010, MAR BIOL, V157, P707, DOI 10.1007/s00227-009-1354-3	55	70	70	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55939	10.1371/journal.pone.0055939	http://dx.doi.org/10.1371/journal.pone.0055939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23741396	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400183
J	Yamamoto, R; Noiri, Y; Yamaguchi, M; Asahi, Y; Maezono, H; Kuboniwa, M; Hayashi, M; Ebisu, S				Yamamoto, Reiko; Noiri, Yuichiro; Yamaguchi, Mikiyo; Asahi, Yoko; Maezono, Hazuki; Kuboniwa, Masae; Hayashi, Mikako; Ebisu, Shigeyuki			The sinR Ortholog PGN_0088 Encodes a Transcriptional Regulator That Inhibits Polysaccharide Synthesis in Porphyromonas gingivalis ATCC 33277 Biofilms	PLOS ONE			English	Article							HUMAN PERIODONTAL POCKETS; BACILLUS-SUBTILIS; BACTERIAL BIOFILMS; MASTER REGULATOR; GENE-EXPRESSION; AMYLOID FIBERS; ARG-GINGIPAIN; MATRIX; LOCALIZATION; FIMBRIAE	Biofilm-forming cells are distinct from well characterized planktonic cells and aggregate in the extracellular matrix, the so-called extracellular polymeric substances (EPS). The sinR gene of Bacillus subtilis encodes a transcriptional regulator that is known to be involved in the biosynthesis of EPS in biofilms. Porphyromonas gingivalis inhabits the subgingival and extraradicular biofilm of humans and is one of the primary pathogens that cause progressive marginal and refractory apical periodontitis. Furthermore, P. gingivalis possesses PGN_0088, which encodes a putative ortholog of B. subtilis sinR. Here, we investigated the role of PGN_0088 (sinR) on biofilm formation. P. gingivalis strains formed biofilms on saliva-coated glass surfaces in phosphate buffered saline. Quantitative analysis indicated that the biofilm of the sinR null mutant consisted of dense exopolysaccharide. Microscopic observations showed that the increased levels of exopolysaccharide produced by the sinR mutant changed the morphology of the EPS to a mesh-liked structure. Furthermore, physical analyses suggested that the enrichment of exopolysaccharide in the EPS enhanced the resistance of the biofilm to hydrodynamic shear force. The results presented here demonstrate sinR plays important roles in the ability of P. gingivalis strain ATCC 33277 to act as a negative mediator of exopolysaccharide accumulation and is indirectly associated with the structure of the EPS and the force of its adhesion to surfaces.	[Yamamoto, Reiko; Noiri, Yuichiro; Yamaguchi, Mikiyo; Asahi, Yoko; Maezono, Hazuki; Hayashi, Mikako; Ebisu, Shigeyuki] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka, Japan; [Kuboniwa, Masae] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka, Japan	Osaka University; Osaka University	Noiri, Y (corresponding author), Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka, Japan.	noiri@dent.osaka-u.ac.jp	Noiri, Yuichiro/AAA-4871-2021	MAEZONO, Hazuki/0000-0002-1929-2045; Kuboniwa, Masae/0000-0002-3332-2431; Asahi, Yoko/0000-0001-9443-5790	Japan Society for the Promotion of Science [20249076, 24390424, 24890118]; Grants-in-Aid for Scientific Research [24390425] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research (20249076, 24390424 and 24890118) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi Y, 2012, J APPL MICROBIOL, V112, P404, DOI 10.1111/j.1365-2672.2011.05194.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Dasanayake Ananda P, 2003, Dent Clin North Am, V47, P115, DOI 10.1016/S0011-8532(02)00056-3; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Hedge J.E., 1962, METHODS CARBOHYDRATE, P380; Inoue T, 2003, MICROBIOL IMMUNOL, V47, P877, DOI 10.1111/j.1348-0421.2003.tb03454.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Noguchi N, 2005, APPL ENVIRON MICROB, V71, P8738, DOI 10.1128/AEM.71.12.8738-8743.2005; Noiri Y, 2004, J DENT RES, V83, P941, DOI 10.1177/154405910408301210; Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001; Noiri Y, 1997, J PERIODONTAL RES, V32, P598, DOI 10.1111/j.1600-0765.1997.tb00937.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Winkelman JT, 2009, J BACTERIOL, V191, P3981, DOI 10.1128/JB.00278-09; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yamamoto R, 2011, APPL ENVIRON MICROB, V77, P6733, DOI 10.1128/AEM.00746-11	44	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56017	10.1371/journal.pone.0056017	http://dx.doi.org/10.1371/journal.pone.0056017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	24312461	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400192
J	Jiang, JQ; Zhou, ZW				Jiang, JiaQian; Zhou, Zhengwei			Removal of Pharmaceutical Residues by Ferrate(VI)	PLOS ONE			English	Article							WASTE-WATER TREATMENT; PERSONAL CARE PRODUCTS; DISRUPTING CHEMICALS EDCS; SEWAGE-TREATMENT PLANTS; POTASSIUM FERRATE(VI); ENDOCRINE DISRUPTORS; ACTIVE COMPOUNDS; RISK-ASSESSMENT; OXIDATION; CARBAMAZEPINE	Background: Pharmaceuticals and their metabolites are inevitably emitted into the waters. The adverse environmental and human health effects of pharmaceutical residues in water could take place under a very low concentration range; from several mu g/L to ng/L. These are challenges to the global water industries as there is no unit process specifically designed to remove these pollutants. An efficient technology is thus sought to treat these pollutants in water and waste water. Methodology/Major Results: A novel chemical, ferrate, was assessed using a standard jar test procedure for the removal of pharmaceuticals. The analytical protocols of pharmaceuticals were standard solid phase extraction together with various instrumentation methods including LC-MS, HPLC-UV and UV/Vis spectroscopy. Ferrate can remove more than 80% of ciprofloxacin (CIP) at ferrate dose of 1 mg Fe/L and 30% of ibuprofen (IBU) at ferrate dose of 2 mg Fe/L. Removal of pharmaceuticals by ferrate was pH dependant and this was in coordinate to the chemical/physical properties of pharmaceuticals. Ferrate has shown higher capability in the degradation of CIP than IBU; this is because CIP has electron-rich organic moieties (EOM) which can be readily degraded by ferrate oxidation and IBU has electron-withdrawing groups which has slow reaction rate with ferrate. Promising performance of ferrate in the treatment of real waste water effluent at both pH 6 and 8 and dose range of 1-5 mg Fe/L was observed. Removal efficiency of ciprofloxacin was the highest among the target compounds (63%), followed by naproxen (43%). On the other hand, n-acetyl sulphamethoxazole was the hardest to be removed by ferrate (8% only). Conclusions: Ferrate is a promising chemical to be used to treat pharmaceuticals in waste water. Adjusting operating conditions in terms of the properties of target pharmaceuticals can maximise the pharmaceutical removal efficiency.	[Jiang, JiaQian; Zhou, Zhengwei] Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Jiang, JQ (corresponding author), Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland.	jiaqian.jiang@gcu.ac.uk	Jiang, Jia-Qian/O-9493-2014; Zhou, Zhengwei/M-9957-2015	Jiang, Jia-Qian/0000-0003-3607-8910; Zhou, Zhengwei/0000-0001-9014-5139; Bines, Julie/0000-0002-5452-6601	Glasgow Caledonian University Research Committee	Glasgow Caledonian University Research Committee	The authors thank the Glasgow Caledonian University Research Committee for offering a research studentship to ZZ for his PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anquandah GAK, 2011, ENVIRON SCI TECHNOL, V45, P10575, DOI 10.1021/es202237g; Castiglioni S, 2006, ENVIRON SCI TECHNOL, V40, P357, DOI 10.1021/es050991m; Comeau F, 2008, SCI TOTAL ENVIRON, V396, P132, DOI 10.1016/j.scitotenv.2008.02.031; Comerton AM, 2008, J MEMBRANE SCI, V313, P323, DOI 10.1016/j.memsci.2008.01.021; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Ferrari B, 2003, ECOTOX ENVIRON SAFE, V55, P359, DOI 10.1016/S0147-6513(02)00082-9; Filip J, 2011, CHEM-EUR J, V17, P10097, DOI 10.1002/chem.201100711; Grung M, 2008, ECOTOX ENVIRON SAFE, V71, P328, DOI 10.1016/j.ecoenv.2007.10.015; Hu L, 2009, ENVIRON SCI TECHNOL, V43, P509, DOI 10.1021/es8023513; Jiang JQ, 2007, J HAZARD MATER, V146, P617, DOI 10.1016/j.jhazmat.2007.04.075; Jiang JQ, 2012, GLOBAL NEST J, V14, P93; Jiang JQ, 2007, DESALINATION, V210, P266, DOI 10.1016/j.desal.2006.05.051; Jiang JQ, 2012, SEP PURIF TECHNOL, V88, P95, DOI 10.1016/j.seppur.2011.12.021; Jiang JQ, 2009, SEP PURIF TECHNOL, V68, P227, DOI 10.1016/j.seppur.2009.05.007; Jiang JQ, 2002, WATER RES, V36, P1397, DOI 10.1016/S0043-1354(01)00358-X; Jiang JQ, 2006, J ENVIRON MANAGE, V79, P215, DOI 10.1016/j.jenvman.2005.06.009; Jiang JQ, 2005, CHEMOSPHERE, V61, P544, DOI 10.1016/j.chemosphere.2005.02.029; Jiang JQ, 2001, ENVIRON ENG SCI, V18, P323, DOI 10.1089/10928750152726041; Jiang JQ, 2001, SEPAR PURIF METHOD, V30, P127, DOI 10.1081/SPM-100102986; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Lee HB, 2007, J CHROMATOGR A, V1139, P45, DOI 10.1016/j.chroma.2006.11.068; Lee Y, 2009, ENVIRON SCI TECHNOL, V43, P3831, DOI 10.1021/es803588k; Lishman L, 2006, SCI TOTAL ENVIRON, V367, P544, DOI 10.1016/j.scitotenv.2006.03.021; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; Okuda T, 2008, WATER SCI TECHNOL, V57, P65, DOI 10.2166/wst.2008.822; Paxeus N, 2004, WATER SCI TECHNOL, V50, P253, DOI 10.2166/wst.2004.0335; Santos JL, 2007, ENVIRON INT, V33, P596, DOI 10.1016/j.envint.2006.09.014; Seitz W, 2008, CHEMOSPHERE, V70, P1238, DOI 10.1016/j.chemosphere.2007.07.081; Sharma VK, 2008, J WATER SUPPLY RES T, V57, P419, DOI 10.2166/aqua.2008.077; Sharma VK, 2006, ENVIRON CHEM LETT, V3, P182, DOI 10.1007/s10311-005-0002-5; Sharma VK, 2012, CHEMOSPHERE, V87, P644, DOI 10.1016/j.chemosphere.2012.01.019; Sharma VK, 2011, CHEMOSPHERE, V82, P1083, DOI 10.1016/j.chemosphere.2010.12.053; Sharma VK, 2010, J ENVIRON SCI HEAL A, V45, P645, DOI 10.1080/10934521003648784; Sharma VK, 2002, ADV ENVIRON RES, V6, P143, DOI 10.1016/S1093-0191(01)00119-8; Sharma VK, 2001, PHYS CHEM CHEM PHYS, V3, P2059, DOI 10.1039/b101432n; Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desal.2005.12.052; Stanford C, 2010, WATER AIR SOIL POLL, V209, P483, DOI 10.1007/s11270-009-0216-4; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Wang L, 2010, SCI TOTAL ENVIRON, V408, P3139, DOI 10.1016/j.scitotenv.2010.04.047; Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799; Yang B, 2012, WATER RES, V46, P2194, DOI 10.1016/j.watres.2012.01.047; Zhou ZW, 2012, J APPL SPECTROSC+, V79, P459, DOI 10.1007/s10812-012-9623-1	42	182	186	14	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55729	10.1371/journal.pone.0055729	http://dx.doi.org/10.1371/journal.pone.0055729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409029	Green Published, Green Submitted, gold			2022-12-25	WOS:000315157200054
J	Kumar, S; Kaur, G				Kumar, Sushil; Kaur, Gurcharan			Intermittent Fasting Dietary Restriction Regimen Negatively Influences Reproduction in Young Rats: A Study of Hypothalamo-Hypophysial-Gonadal Axis	PLOS ONE			English	Article							LUTEINIZING-HORMONE SECRETION; CHRONIC FOOD RESTRICTION; NEURON-GLIAL PLASTICITY; NEUROPEPTIDE-Y; METABOLIC HORMONES; BODY-WEIGHT; SEXUAL DEVELOPMENT; ANOREXIA-NERVOSA; FEED RESTRICTION; ENERGY-BALANCE	Nutritional infertility is very common in societies where women fail to eat enough to match their energy expenditure and such females often present as clinical cases of anorexia nervosa. The cellular and molecular mechanisms that link energy balance and central regulation of reproduction are still not well understood. Peripheral hormones such as estradiol, testosterone and leptin, as well as neuropeptides like kisspeptin and neuropeptides Y (NPY) play a potential role in regulation of reproduction and energy balance with their primary target converging on the hypothalamic median eminence-arcuate region. The present study was aimed to explore the effects of negative energy state resulting from intermittent fasting dietary restriction (IF-DR) regimen on complete hypothalamo-hypophysial-gonadal axis in Wistar strain young female and male rats. Significant changes in body weight, blood glucose, estrous cyclicity and serum estradiol, testosterone and LH level indicated the negative role of IF-DR regimen on reproduction in these young animals. Further, it was elucidated whether serum level of metabolic hormone, leptin plays a mechanistic role in suppressing hypothalamo-hypophysial-gonadal (HPG) axis via energy regulators, kisspeptin and NPY in rats on IF-DR regimen. We also studied the effect of IF-DR regimen on structural remodeling of GnRH axon terminals in median eminence region of hypothalamus along with the glial cell marker, GFAP and neuronal plasticity marker, PSA-NCAM using immunostaining, Western blotting and RT-PCR. Together these data suggest that IF-DR regimen negatively influences reproduction in young animals due to its adverse effects on complete hypothalamus-hypophysial-gonadal axis and may explain underlying mechanism(s) to understand the clinical basis of nutritional infertility.	[Kumar, Sushil; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Kaur, Gurcharan/V-6033-2019	Kaushik, Nutan/0000-0002-3870-8093	Indo-French Centre for Promotion of Advanced Research (IFCPAR); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	Indo-French Centre for Promotion of Advanced Research (IFCPAR)(French National Research Agency (ANR)); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	The study was supported by a Grant from the Indo-French Centre for Promotion of Advanced Research (IFCPAR) and Indian Council of Medical Research (ICMR) under the National Task Force Program. Mr. Sushil Kumar is thankful to the IFCPAR, New Delhi for the research fellowship provided during this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; ALMOND GW, 1990, J ANIM SCI, V68, P1077, DOI 10.2527/1990.6841077x; Archer ZA, 2004, J ENDOCRINOL, V182, P409, DOI 10.1677/joe.0.1820409; Backholer K, 2010, ENDOCRINOLOGY, V151, P2233, DOI 10.1210/en.2009-1190; Bojkowska K, 2008, HORM BEHAV, V53, P342, DOI 10.1016/j.yhbeh.2007.10.013; Bonfanti L, 2009, CELL ADHES MIGR, V3, P43, DOI 10.4161/cam.3.1.7258; Booth PJ, 1996, J ANIM SCI, V74, P840; Brito LFC, 2007, REPRODUCTION, V134, P171, DOI 10.1530/REP-06-0353; Brito LFC, 2007, DOMEST ANIM ENDOCRIN, V33, P1, DOI 10.1016/j.domaniend.2006.04.001; CAMERON JL, 1991, J CLIN ENDOCR METAB, V73, P35, DOI 10.1210/jcem-73-1-35; Casanueva FF, 1999, FRONT NEUROENDOCRIN, V20, P317, DOI 10.1006/frne.1999.0187; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254-255, P127; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Glidewell-Kenney C, 2007, P NATL ACAD SCI USA, V104, P8173, DOI 10.1073/pnas.0611514104; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; GUY J, 1988, REGUL PEPTIDES, V23, P209, DOI 10.1016/0167-0115(88)90028-6; Haas VK, 2009, AM J CLIN NUTR, V89, P1005, DOI 10.3945/ajcn.2008.26958; Henry BA, 2004, J NEUROENDOCRINOL, V16, P244, DOI 10.1111/j.0953-8194.2004.01157.x; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Ichimaru T, 2001, ENDOCRINOLOGY, V142, P2489, DOI 10.1210/en.142.6.2489; Kaiser UB, 2005, ENDOCRINE, V26, P277, DOI 10.1385/ENDO:26:3:277; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kaur G, 2002, BRAIN RES, V954, P21, DOI 10.1016/S0006-8993(02)03301-2; Kinzig KP, 2009, AM J PHYSIOL-ENDOC M, V296, pE282, DOI 10.1152/ajpendo.90523.2008; Kumar S, 2011, MOL CELL ENDO, DOI 10.1016; Langle SL, 2002, J PHYSIOL-PARIS, V96, P169, DOI 10.1016/S0928-4257(02)00003-7; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Martin B, 2008, AGEING RES REV, V7, P209, DOI 10.1016/j.arr.2008.01.002; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Miller KK, 2007, J CLIN ENDOCR METAB, V92, P1334, DOI 10.1210/jc.2006-2501; Nagatani S, 2001, J NEUROENDOCRINOL, V13, P371, DOI 10.1046/j.1365-2826.2001.00638.x; Narita K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028136; Parkash J, 2005, J ENDOCRINOL, V186, P397, DOI 10.1677/joe.1.06156; Parkash J, 2007, NEURON GLIA BIOL, V3, P299, DOI 10.1017/S1740925X07000701; Parkash J, 2007, BRAIN RES BULL, V74, P317, DOI 10.1016/j.brainresbull.2007.07.005; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Prevot V, 1998, NEUROSCIENCE, V84, P177, DOI 10.1016/S0306-4522(97)00537-X; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Prevot V, 2010, FRONT NEUROENDOCRIN, V31, P241, DOI 10.1016/j.yfrne.2010.05.003; Quesnel H, 1998, J ANIM SCI, V76, P856; Santos ZA, 2011, J NUTR SCI VITAMINOL, V55, P1; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Singh R, 2012, AGE, V34, P917, DOI 10.1007/s11357-011-9289-2; Smith JT, 2008, ENDOCRINOLOGY, V149, P1951, DOI 10.1210/en.2007-1425; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022333; Sucajtys-Szulc E, 2008, NEUROSCI LETT, V433, P174, DOI 10.1016/j.neulet.2008.01.004; Tropp J, 2001, PHYSIOL BEHAV, V73, P553, DOI 10.1016/S0031-9384(01)00487-5; True C, 2011, J NEUROENDOCRINOL, V23, P1099, DOI 10.1111/j.1365-2826.2011.02144.x; VELDHUIS JD, 1993, J CLIN ENDOCR METAB, V76, P587, DOI 10.1210/jcem.76.3.8445014; VERMEULEN A, 1993, ENVIRON HEALTH PERSP, V101, P91, DOI 10.2307/3431381; Wade GN, 2004, AM J PHYSIOL-REG I, V287, pR1277, DOI 10.1152/ajpregu.00475.2004; Wagenmaker ER, 2010, BIOL REPROD, V82, P1206, DOI 10.1095/biolreprod.109.078774; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	60	59	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e52416	10.1371/journal.pone.0052416	http://dx.doi.org/10.1371/journal.pone.0052416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23409154	Green Published, Green Submitted, gold			2022-12-25	WOS:000315483200038
J	Liu, Y; Luo, HS; Liang, CB; Xia, H; Xu, WJ; Chen, JH; Chen, MK				Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai			Actions of Hydrogen Sulfide and ATP-Sensitive Potassium Channels on Colonic Hypermotility in a Rat Model of Chronic Stress	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; K+ CHANNELS; GASTROINTESTINAL-TRACT; VISCERAL HYPERSENSITIVITY; CALCIUM-CHANNELS; IN-VITRO; MOTILITY; COLITIS	Objective: To investigate the potential role of hydrogen sulphide (H2S) and ATP-sensitive potassium (K-ATP) channels in chronic stress-induced colonic hypermotility. Methods: Male Wistar rats were submitted daily to 1 h of water avoidance stress (WAS) or sham WAS (SWAS) for 10 consecutive days. Organ bath recordings, H2S production, immunohistochemistry and western blotting were performed on rat colonic samples to investigate the role of endogenous H2S in repeated WAS-induced hypermotility. Organ bath recordings and western blotting were used to detect the role of K-ATP channels in repeated WAS. Results: Repeated WAS increased the number of fecal pellets per hour and the area under the curve of the spontaneous contractions of colonic strips, and decreased the endogenous production of H2S and the expression of H2S-producing enzymes in the colon devoid of mucosa and submucosa. Inhibitors of H2S-producing enzymes increased the contractile activity of colonic strips in the SWAS rats. NaHS concentration-dependently inhibited the spontaneous contractions of the strips and the NaHS IC50 for the WAS rats was significantly lower than that for the SWAS rats. The inhibitory effect of NaHS was significantly reduced by glybenclamide. Repeated WAS treatment resulted in up-regulation of Kir6.1 and SUR2B of K-ATP channels in the colon devoid of mucosa and submucosa. Conclusion: The colonic hypermotility induced by repeated WAS may be associated with the decreased production of endogenous H2S. The increased expression of the subunits of K-ATP channels in colonic smooth muscle cells may be a defensive response to repeated WAS. H2S donor may have potential clinical utility in treating chronic stress-induced colonic hypermotility.	[Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Liu, Ying] Guilin Med Coll, Affiliated Hosp, Dept Gastroenterol, Guilin, Peoples R China	Wuhan University; Guilin Medical University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	xhkhsluo@126.com		Chen, Mingkai/0000-0001-6771-0523; Chen, Mingkai/0000-0003-2652-6863	National Natural Science Foundation of China [81070297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070297). The URL of the funder's website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataka K, 2012, AM J PHYSIOL-GASTR L, V303, pG519, DOI 10.1152/ajpgi.00390.2011; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Choudhury BK, 2009, AM J PHYSIOL-GASTR L, V296, pG1238, DOI 10.1152/ajpgi.90712.2008; Dhaese I, 2010, EUR J PHARMACOL, V628, P179, DOI 10.1016/j.ejphar.2009.11.024; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P1306, DOI 10.1111/j.1365-2982.2008.01201.x; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Hansen MB, 2003, PHARMACOL TOXICOL, V92, P249, DOI 10.1034/j.1600-0773.2003.920601.x; Hennig B, 2009, BRIT J PHARMACOL, V158, P1263, DOI 10.1111/j.1476-5381.2009.00385.x; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jimenez M, 2010, NEUROGASTROENT MOTIL, V22, P1149, DOI 10.1111/j.1365-2982.2010.01600.x; Jin XC, 2004, AM J PHYSIOL-GASTR L, V287, pG274, DOI 10.1152/ajpgi.00472.2003; Jun JY, 2001, AM J PHYSIOL-CELL PH, V281, pC857, DOI 10.1152/ajpcell.2001.281.3.C857; Kasparek MS, 2012, J SURG RES, V175, P234, DOI 10.1016/j.jss.2011.03.069; Koh SD, 1998, BIOPHYS J, V75, P1793, DOI 10.1016/S0006-3495(98)77621-0; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Li QJ, 2011, AM J PHYSIOL-GASTR L, V300, pG154, DOI 10.1152/ajpgi.00393.2010; Liang CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031774; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Linden DR, 2010, ANTIOXID REDOX SIGN, V12, P1135, DOI 10.1089/ars.2009.2885; Martin GR, 2010, DIGEST LIVER DIS, V42, P103, DOI 10.1016/j.dld.2009.05.016; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Pluja L, 1998, CAN J PHYSIOL PHARM, V76, P1166, DOI 10.1139/cjpp-76-12-1166; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tian XY, 2006, BRAIN RES, V1088, P101, DOI 10.1016/j.brainres.2006.03.014; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Xu GY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-44; Zhang M, 2010, NEUROGASTROENT MOTIL, V22, pe162, DOI 10.1111/j.1365-2982.2009.01467.x; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014	38	130	141	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55853	10.1371/journal.pone.0055853	http://dx.doi.org/10.1371/journal.pone.0055853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23437170	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400167
J	Siegmund, U; Heller, J; van Kan, JAL; Tudzynski, P				Siegmund, Ulrike; Heller, Jens; van Kan, Jan A. L.; Tudzynski, Paul			The NADPH Oxidase Complexes in Botrytis cinerea: Evidence for a Close Association with the ER and the Tetraspanin Pls1	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; APPRESSORIUM-MEDIATED PENETRATION; GRAY MOLD FUNGUS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; ASCOSPORE GERMINATION; CELL-DIFFERENTIATION; FUNCTIONAL-ANALYSIS; LOCALIZATION; ACTIVATION	NADPH oxidases (Nox) are major enzymatic systems that generate reactive-oxygen species (ROS) in multicellular eukaryotes. In several fungi they have been shown to be involved in sexual differentiation and pathogenicity. However, in contrast to the well characterized mammalian systems, basic information on the composition, recruitment, and localization of fungal Nox complexes and on the molecular mechanisms of their cellular effects are still lacking. Here we give a detailed analysis of components of the Nox complexes in the gray mold fungus Botrytis cinerea. It had previously been shown that the two catalytic transmembrane subunits BcNoxA and B are important for development of sclerotia and for full virulence, with BcNoxA being involved in spreading of lesions and BcNoxB in penetration; BcNoxR functions as a regulator of both subunits. Here we present evidence (using for the first time a functional GFP fusion able to complement the Delta bcnoxA mutant) that BcNoxA localizes mainly to the ER and at the plasma membrane; BcNoxB shows a similar localization pattern, while the regulator BcNoxR is found in vesicles throughout the hyphae and at the hyphal tip. To identify possible interaction partners, which could be involved in the localization or recruitment of the Nox complexes, we functionally characterized the tetraspanin Pls1, a transmembrane protein, which had been suggested to be a NoxB-interacting partner in the saprophyte Podospora anserina. Knock-out experiments and GFP fusions substantiate a link between BcNoxB and BcPls1 because both deletion mutants have overlapping phenotypes (especially a defect in penetration), and the proteins show a similar localization pattern (ER). However, in contrast to the corresponding protein in P. anserina BcPls1 is important for female fertility, but not for ascospore germination.	[Siegmund, Ulrike; Heller, Jens; Tudzynski, Paul] Westfael Wilhelms Univ Muenster, Inst Biol & Biotechnol Pflanzen, Munster, Germany; [van Kan, Jan A. L.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Tudzynski, P (corresponding author), Westfael Wilhelms Univ Muenster, Inst Biol & Biotechnol Pflanzen, Munster, Germany.	tudzyns@uni-muenster.de		van Kan, Jan/0000-0003-3563-1550	Deutsche Forschungsgemeinschaft (DFG) [Tu50/17]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding agency: Deutsche Forschungsgemeinschaft (DFG; www.dfg.de), project Tu50/17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chin CF, 2012, MOL BIOL CELL, V23, P45, DOI 10.1091/mbc.E11-05-0434; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fernandes DC, 2009, ARCH BIOCHEM BIOPHYS, V484, P197, DOI 10.1016/j.abb.2009.01.022; Giesbert S, 2008, MOL PLANT PATHOL, V9, P317, DOI [10.1111/j.1364-3703.2008.00466.x, 10.1111/J.1364-3703.2008.00466.X]; Gourgues M, 2004, MOL MICROBIOL, V51, P619, DOI 10.1046/j.1365-2958.2003.03866.x; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jonkers W, 2011, MOL PLANT PATHOL, V12, P548, DOI 10.1111/J.1364-3703.2010.00689.X; KANGATHARALINGAM N, 1984, CURR MICROBIOL, V10, P99, DOI 10.1007/BF01575767; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Lalucque H, 2003, TRENDS MICROBIOL, V11, P9, DOI 10.1016/S0966-842X(02)00007-0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lambou K, 2008, EUKARYOT CELL, V7, P1809, DOI 10.1128/EC.00149-08; Lambou K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-63; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Lardy B, 2005, BBA-MOL CELL RES, V1744, P199, DOI 10.1016/j.bbamcr.2005.02.004; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Letourneur F, 1998, J BIOL CHEM, V273, P33273, DOI 10.1074/jbc.273.50.33273; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Masaki R, 1996, J BIOL CHEM, V271, P16939, DOI 10.1074/jbc.271.28.16939; Meitinger F, 2010, J CELL SCI, V123, P1851, DOI 10.1242/jcs.063891; Miller, 1972, EXPT MOL GENETICS; Pagani M, 2001, FEBS LETT, V508, P117, DOI 10.1016/S0014-5793(01)03034-4; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Sambrook J., 1989, MOL CLONING LAB MANU; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tenberge KB, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P67; Tudzynski P., 2009, MYCOTA, P29; VANDERVLUGTBERGMANS CJB, 1993, MYCOL RES, V97, P1193, DOI 10.1016/S0953-7562(09)81284-7; Veneault-Fourrey C, 2005, FUNGAL GENET BIOL, V42, P306, DOI 10.1016/j.fgb.2005.01.009; Vogel H.J., 1956, MICROB GENET B, V13, P42; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhang G, 2006, J CELL BIOL, V174, P207, DOI 10.1083/jcb.200604094	72	53	56	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55879	10.1371/journal.pone.0055879	http://dx.doi.org/10.1371/journal.pone.0055879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418468	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300059
J	Wang, CH; Chang, CC; Liang, YM; Shih, CM; Chiu, WS; Tseng, P; Hung, DL; Tzeng, OJL; Muggleton, NG; Juan, CH				Wang, Chun-Hao; Chang, Che-Chien; Liang, Yen-Ming; Shih, Chun-Ming; Chiu, Wen-Sheng; Tseng, Philip; Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung			Open vs. Closed Skill Sports and the Modulation of Inhibitory Control	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; BASKETBALL PLAYERS; PHYSICAL-ACTIVITY; REACTION-TIME; BALL GAMES; EXPERTISE; COGNITION; BASEBALL; FITNESS; BRAIN	Background: Inhibitory control, or the ability to suppress planned but inappropriate prepotent actions in the current environment, plays an important role in the control of human performance. Evidence from empirical studies utilizing a sport-specific design has shown that athletes have superior inhibitory control. However, less is known about whether this superiority might (1) still be seen in a general cognitive task without a sport-related context; (2) be modulated differentially by different sporting expertise (e.g., tennis versus swimming). Methodology/Principal Findings: Here we compared inhibitory control across tennis players, swimmers and sedentary non-athletic controls using a stop-signal task without a sport-specific design. Our primary finding showed that tennis players had shorter stop-signal reaction times (SSRTs) when compared to swimmers and sedentary controls, whereas no difference was found between swimmers and sedentary controls. Importantly, this effect was further confirmed after considering potential confounding factors (e.g., BMI, training experience, estimated levels of physical activity and VO2max), indicative of better ability to inhibit unrequired responses in tennis players. Conclusions/Significance: This suggests that fundamental inhibitory control in athletes can benefit from open skill training. Sport with both physical and cognitive demands may provide a potential clinical intervention for those who have difficulties in inhibitory control.	[Wang, Chun-Hao; Hung, Daisy L.; Tzeng, Ovid J. L.] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Wang, Chun-Hao; Shih, Chun-Ming; Tseng, Philip; Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung] Natl Cent Univ, Inst Cognit Neurosci, Jhongli, Taiwan; [Chang, Che-Chien; Liang, Yen-Ming; Chiu, Wen-Sheng] Natl Cent Univ, Off Phys Educ, Jhongli, Taiwan; [Shih, Chun-Ming] Shu Te Univ, Grad Sch Human Sexual, Kaohsiung, Taiwan; [Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung] Natl Yang Ming Univ, Labs Cognit Neurosci, Taipei 112, Taiwan; [Tzeng, Ovid J. L.] Acad Sinica, Inst Linguist, Taipei 115, Taiwan; [Muggleton, Neil G.] UCL, Inst Cognit Neurosci, London, England	National Yang Ming Chiao Tung University; National Central University; National Central University; Shu-Te University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; University of London; University College London	Juan, CH (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Jhongli, Taiwan.	chijuan@cc.ncu.edu.tw	Muggleton, Neil/AAV-8929-2020; Tseng, Philip/AAG-4849-2021	Tseng, Philip/0000-0001-5120-5979; Tzeng, Ovid J. L./0000-0002-0844-7865; Wang, Chun-Hao/0000-0002-0180-7207	National Science Council, Taiwan [NSC-101-2628-H-008-001-MY4, NSC-101-2410-H-008-033-MY3, NSC-99-2410-H-008-022-MY3, NSC-100-2511-S-008-019, NSC-98-2410-H-008-010-MY3, NSC-98-2517-S-004-001-MY3, NSC-099-2811-H-008-005, NSC-100-2410-H-008-074-MY3]; UK Medical Research Council	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CHW, CMS, PT, DLH, OJT and CHJ were supported by the National Science Council, Taiwan (Grant numbers: NSC-101-2628-H-008-001-MY4, NSC-101-2410-H-008-033-MY3, NSC-99-2410-H-008-022-MY3, NSC-100-2511-S-008-019, NSC-98-2410-H-008-010-MY3, NSC-98-2517-S-004-001-MY3, NSC-099-2811-H-008-005). NGM was supported by the UK Medical Research Council and the National Science Council, Taiwan (Grant number: NSC-100-2410-H-008-074-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Boehler CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026386; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Chan JSY, 2011, PSYCHOL SPORT EXERC, V12, P509, DOI 10.1016/j.psychsport.2011.04.006; Chen CY, 2008, BEHAV BRAIN RES, V187, P483, DOI 10.1016/j.bbr.2007.10.011; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Crevits L, 2000, NEURO-OPHTHALMOLOGY, V24, P331, DOI 10.1076/noph.24.2.331.7155; Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966; Di Russo F, 2003, VISION RES, V43, P1837, DOI 10.1016/S0042-6989(03)00299-2; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Di Russo F, 2010, J NEUROTRAUM, V27, P2309, DOI 10.1089/neu.2010.1501; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Fujiwara K, 2009, INT J SPORTS MED, V30, P647, DOI 10.1055/s-0029-1220732; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; George JD, 1997, MED SCI SPORT EXER, V29, P415, DOI 10.1097/00005768-199703000-00019; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; Lenoir M, 2000, PERCEPT MOTOR SKILL, V91, P546, DOI 10.2466/pms.2000.91.2.546; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Li CSR, 2005, EXP BRAIN RES, V167, P305, DOI 10.1007/s00221-005-0110-2; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Marinovic W, 2009, EXP BRAIN RES, V197, P311, DOI 10.1007/s00221-009-1916-0; Maximova K, 2009, AM J EPIDEMIOL, V170, P1084, DOI 10.1093/aje/kwp255; Muggleton NG, 2010, J COGNITIVE NEUROSCI, V22, P2804, DOI 10.1162/jocn.2010.21416; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; Nakamoto H, 2008, BRAIN RES, V1189, P179, DOI 10.1016/j.brainres.2007.10.096; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Overney LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002380; Ozel S, 2004, J PSYCHOL, V138, P49, DOI 10.3200/JRLP.138.1.49-64; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Scisco JL, 2008, INT J PSYCHOPHYSIOL, V69, P52, DOI 10.1016/j.ijpsycho.2008.02.009; Senderecka M, 2012, INT J PSYCHOPHYSIOL, V85, P93, DOI 10.1016/j.ijpsycho.2011.05.007; Taddei F, 2012, MED SCI SPORT EXER, V44, P1057, DOI 10.1249/MSS.0b013e31824529c2; Tsai CL, 2009, RES DEV DISABIL, V30, P1268, DOI 10.1016/j.ridd.2009.05.001; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	46	194	198	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55773	10.1371/journal.pone.0055773	http://dx.doi.org/10.1371/journal.pone.0055773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418458	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300049
J	Miller, CT; Fraser, SF; Levinger, I; Straznicky, NE; Dixon, JB; Reynolds, J; Selig, SE				Miller, Clint T.; Fraser, Steve F.; Levinger, Itamar; Straznicky, Nora E.; Dixon, John B.; Reynolds, John; Selig, Steve E.			The Effects of Exercise Training in Addition to Energy Restriction on Functional Capacities and Body Composition in Obese Adults during Weight Loss: A Systematic Review	PLOS ONE			English	Review							FAT-FREE MASS; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; POSTMENOPAUSAL WOMEN; CALORIC RESTRICTION; SKELETAL-MUSCLE; OLDER PERSONS; ABDOMINAL FAT; RISK-FACTORS; HIGH-PROTEIN	Background: Obesity is associated with impairments of physical function, cardiovascular fitness, muscle strength and the capacity to perform activities of daily living. This review examines the specific effects of exercise training in relation to body composition and physical function demonstrated by changes in cardiovascular fitness, and muscle strength when obese adults undergo energy restriction. Methods: Electronic databases were searched for randomised controlled trials comparing energy restriction plus exercise training to energy restriction alone. Studies published to May 2013 were included if they used multi-component methods for analysing body composition and assessed measures of fitness in obese adults. Results: Fourteen RCTs met the inclusion criteria. Heterogeneity of study characteristics prevented meta-analysis. Energy restriction plus exercise training was more effective than energy restriction alone for improving cardiovascular fitness, muscle strength, and increasing fat mass loss and preserving lean body mass, depending on the type of exercise training. Conclusion: Adding exercise training to energy restriction for obese middle-aged and older individuals results in favourable changes to fitness and body composition. Whilst weight loss should be encouraged for obese individuals, exercise training should be included in lifestyle interventions as it offers additional benefits.	[Miller, Clint T.; Fraser, Steve F.; Selig, Steve E.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia; [Levinger, Itamar] Victoria Univ, Sch Sport & Exercise Sci, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Straznicky, Nora E.] Baker IDI Heart & Diabet Inst, Human Neurotransmitters Lab, Melbourne, Vic, Australia; [Dixon, John B.] Baker IDI Heart & Diabet Inst, Clin Obes Res Lab, Melbourne, Vic, Australia; [Reynolds, John] Deakin Univ, Fac Hlth, Biostat Unit, Melbourne, Vic, Australia	Deakin University; Victoria University; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Deakin University	Selig, SE (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Exercise & Sports Sci, Melbourne, Vic, Australia.	steve.selig@deakin.edu.au	Dixon, John B/A-5318-2011; Wrighton, Kelly C/ABD-6621-2021; Reynolds, John/D-2591-2013	Dixon, John B/0000-0001-5391-4082; Wrighton, Kelly C/0000-0003-0434-4217; Reynolds, John/0000-0002-8825-8625; Fraser, Steve F/0000-0003-0202-9619; Miller, Clint/0000-0001-7743-6986; Banfield, Jill/0000-0001-8203-8771; Miller, Christopher/0000-0002-9448-8144; Handley, Kim/0000-0003-0531-3009; Levinger, Itamar/0000-0001-9194-2033	Heart Foundation [G11M5892]; Diabetes Australia Millennium Grant	Heart Foundation; Diabetes Australia Millennium Grant	Dr. Itamar Levinger is a Heart Foundation Research Fellow (PR 11M 6086 and Prof John Dixon is an NHMRC Senior Research Fellow. Dr. Nora Straznicky is funded by a Heart Foundation Grant-in-Aid (G11M5892) and a Diabetes Australia Millennium Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Alvarez VP, 2007, OBES SURG, V17, P211, DOI 10.1007/s11695-007-9032-3; Amati F, 2008, J APPL PHYSIOL, V105, P825, DOI 10.1152/japplphysiol.90384.2008; Anandacoomarasamy A, 2009, CURR OPIN RHEUMATOL, V21, P71, DOI 10.1097/BOR.0b013e32831bc0d7; Beavers KM, 2011, AM J CLIN NUTR, V94, P767, DOI 10.3945/ajcn.110.004895; Beckman LM, 2010, J AM DIET ASSOC, V110, P571, DOI 10.1016/j.jada.2009.12.023; Blazer DG, 2006, J AM GERIATR SOC, V54, P502, DOI 10.1111/j.1532-5415.2005.00607.x; Bouchard DR, 2011, METAB SYNDR RELAT D, V9, P225, DOI 10.1089/met.2010.0101; Bouchard DR, 2009, MENOPAUSE, V16, P66, DOI 10.1097/gme.0b013e31817dacf7; BRAY GA, 1988, WESTERN J MED, V149, P429; Byrne NM, 2003, AM J CLIN NUTR, V77, P1368, DOI 10.1093/ajcn/77.6.1368; Campbell KL, 2012, J CLIN ONCOL, V30, P2314, DOI 10.1200/JCO.2011.37.9792; Capodaglio P, 2010, INT J OCCUP SAF ERGO, V16, P507, DOI 10.1080/10803548.2010.11076863; Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483; Chmelo E, 2012, J PHYS ACT HEALTH; Clemes SA, 2010, OCCUP MED-OXFORD, V60, P101, DOI 10.1093/occmed/kqp127; Coulson JC, 2008, INT J WORKPLACE HEAL, V1, P176, DOI 10.1108/17538350810926534; Craig BN, 2006, AM J IND MED, V49, P249, DOI 10.1002/ajim.20290; Daly RM, 2005, OSTEOPOROSIS INT, V16, P1703, DOI 10.1007/s00198-005-1906-4; Das SK, 2005, CURR OPIN CLIN NUTR, V8, P602, DOI 10.1097/01.mco.0000171122.60665.5f; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Duvigneaud N, 2008, J SPORT MED PHYS FIT, V48, P201; Fields DA, 2005, CURR OPIN CLIN NUTR, V8, P624, DOI 10.1097/01.mco.0000171127.44525.07; Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI [10.1016/S1521-6918(04)00091-5, 10.1016/j.bpg.2004.06.030]; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Frimel TN, 2008, MED SCI SPORT EXER, V40, P1213, DOI 10.1249/MSS.0b013e31816a85ce; Fruhbeck G, 2004, NEW ENGL J MED, V350, P308, DOI 10.1056/NEJM200401153500323; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GARROW JS, 1995, EUR J CLIN NUTR, V49, P1; GENAIDY AM, 1992, ERGONOMICS, V35, P1081, DOI 10.1080/00140139208967384; Glasziou P.P., 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1017/CBO9780511543500; GOING SB, 1993, AM J CLIN NUTR, V57, P845, DOI 10.1093/ajcn/57.6.845; Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; Hills A P, 2002, Obes Rev, V3, P35, DOI 10.1046/j.1467-789X.2002.00054.x; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; Hulens M, 2003, SCAND J MED SCI SPOR, V13, P98, DOI 10.1034/j.1600-0838.2003.10273.x; Hulens M, 2001, INT J OBESITY, V25, P676, DOI 10.1038/sj.ijo.0801560; Ismail I, 2012, OBES REV, V13, P68, DOI 10.1111/j.1467-789X.2011.00931.x; Janssen I, 1999, INT J OBESITY, V23, P1035, DOI 10.1038/sj.ijo.0801038; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Janssen I, 2011, J OBES, V2011, DOI 10.1155/2011/531403; Jebb SA, 1999, MED SCI SPORT EXER, V31, pS534, DOI 10.1097/00005768-199911001-00008; Kaila B, 2008, CAN J GASTROENTEROL, V22, P61, DOI 10.1155/2008/609039; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1011, DOI 10.1097/00005768-200106000-00022; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; Leone N, 2011, OBESITY; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; Manini TM, 2010, OBESITY, V18, P1168, DOI 10.1038/oby.2009.317; Marks BL, 1996, SPORTS MED, V22, P273, DOI 10.2165/00007256-199622050-00001; Messier V, 2010, J SPORT SCI, V28, P83, DOI 10.1080/02640410903390105; Miller GD, 2006, OBESITY, V14, P1219, DOI 10.1038/oby.2006.139; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Monteiro Maria Silvia, 2011, Rev. esc. enferm. USP, V45, P1177; Nicklas BJ, 2009, AM J CLIN NUTR, V89, P1043, DOI 10.3945/ajcn.2008.26938; Payne RW, 2011, GUIDE GENSTAT RELEAS; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684; Ruiz JR, 2010, J PEDIATR-US, V157, P917, DOI 10.1016/j.jpeds.2010.06.026; Stenholm S, 2009, INT J OBESITY, V33, P635, DOI 10.1038/ijo.2009.62; Stenholm S, 2013, J GERONTOL A, P1079; Straznicky NE, 2010, DIABETES, V59, P71, DOI 10.2337/db09-0934; Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429; Vargas CB, 2013, OBES SURG, V23, P1590, DOI 10.1007/s11695-013-0924-0; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Vieira ER, 2008, INT J IND ERGONOM, V38, P143, DOI 10.1016/j.ergon.2006.02.001; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Vingard E, 2009, WORK, V34, P339, DOI 10.3233/WOR-2009-0932; WEBSTER JD, 1984, HUM NUTR-CLIN NUTR, V38C, P299; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Weiss EP, 2007, J APPL PHYSIOL, V102, P634, DOI 10.1152/japplphysiol.00853.2006; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; Woodrow G, 2007, PERITON DIALYSIS INT, V27, pS245; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321; Wycherley TP, 2010, DIABETES CARE, V33, P969, DOI 10.2337/dc09-1974	82	194	199	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81692	10.1371/journal.pone.0081692	http://dx.doi.org/10.1371/journal.pone.0081692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	23405248	gold, Green Published, Green Accepted			2022-12-25	WOS:000327543500119
J	Miller, CS; Handley, KM; Wrighton, KC; Frischkorn, KR; Thomas, BC; Banfield, JF				Miller, Christopher S.; Handley, Kim M.; Wrighton, Kelly C.; Frischkorn, Kyle R.; Thomas, Brian C.; Banfield, Jillian F.			Short-Read Assembly of Full-Length 16S Amplicons Reveals Bacterial Diversity in Subsurface Sediments	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; MICROBIAL DIVERSITY; RARE BIOSPHERE; ENVIRONMENTAL SURVEYS; SPECIES RICHNESS; BODY HABITATS; DEEP-SEA; SEQUENCE; COMMUNITIES; URANIUM	In microbial ecology, a fundamental question relates to how community diversity and composition change in response to perturbation. Most studies have had limited ability to deeply sample community structure (e.g. Sanger-sequenced 16S rRNA libraries), or have had limited taxonomic resolution (e. g. studies based on 16S rRNA hypervariable region sequencing). Here, we combine the higher taxonomic resolution of near-full-length 16S rRNA gene amplicons with the economics and sensitivity of short-read sequencing to assay the abundance and identity of organisms that represent as little as 0.01% of sediment bacterial communities. We used a new version of EMIRGE optimized for large data size to reconstruct near-full-length 16S rRNA genes from amplicons sheared and sequenced with Illumina technology. The approach allowed us to differentiate the community composition among samples acquired before perturbation, after acetate amendment shifted the predominant metabolism to iron reduction, and once sulfate reduction began. Results were highly reproducible across technical replicates, and identified specific taxa that responded to the perturbation. All samples contain very high alpha diversity and abundant organisms from phyla without cultivated representatives. Surprisingly, at the time points measured, there was no strong loss of evenness, despite the selective pressure of acetate amendment and change in the terminal electron accepting process. However, community membership was altered significantly. The method allows for sensitive, accurate profiling of the "long tail'' of low abundance organisms that exist in many microbial communities, and can resolve population dynamics in response to environmental change.	[Miller, Christopher S.; Handley, Kim M.; Wrighton, Kelly C.; Frischkorn, Kyle R.; Thomas, Brian C.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Miller, CS (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	christopher.s.miller@ucdenver.edu	Dixon, John B/A-5318-2011; Wrighton, Kelly C/ABD-6621-2021; Reynolds, John/D-2591-2013	Dixon, John B/0000-0001-5391-4082; Wrighton, Kelly C/0000-0003-0434-4217; Reynolds, John/0000-0002-8825-8625; Fraser, Steve F/0000-0003-0202-9619; Miller, Clint/0000-0001-7743-6986; Banfield, Jill/0000-0001-8203-8771; Miller, Christopher/0000-0002-9448-8144; Handley, Kim/0000-0003-0531-3009; Levinger, Itamar/0000-0001-9194-2033	IFRC, Subsurface Biogeochemical Research Program; Office of Science, Biological and Environmental Research, US Department of Energy (DOE) [DE-AC02-05CH11231]	IFRC, Subsurface Biogeochemical Research Program; Office of Science, Biological and Environmental Research, US Department of Energy (DOE)	Funding was provided by the IFRC, Subsurface Biogeochemical Research Program and the Knowledgebase Program (DE-AC02-05CH11231), Office of Science, Biological and Environmental Research, US Department of Energy ( DOE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-490; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beman JM, 2012, LIMNOL OCEANOGR, V57, P711, DOI 10.4319/lo.2012.57.3.0711; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Handley KM, 2012, FEMS MICROBIOL ECOL, V81, P188, DOI 10.1111/j.1574-6941.2012.01363.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harismendy O, 2009, BIOTECHNIQUES, V46, P229, DOI 10.2144/000113082; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Holmes DE, 2007, ISME J, V1, P663, DOI 10.1038/ismej.2007.85; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Li L, 2010, J CONTAM HYDROL, V112, P45, DOI 10.1016/j.jconhyd.2009.10.006; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Mueller RS, 2011, ENVIRON MICROBIOL, V13, P2279, DOI 10.1111/j.1462-2920.2011.02486.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spring S, 2009, STAND GENOMIC SCI, V1, P242, DOI 10.4056/sigs.39508; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrionis HA, 2005, APPL ENVIRON MICROB, V71, P6308, DOI 10.1128/AEM.71.10.6308-6318.2005; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	67	194	199	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e56018	10.1371/journal.pone.0056018	http://dx.doi.org/10.1371/journal.pone.0056018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405248	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400193
J	Yang, DY; Baumgartner, RN; Slattery, ML; Wang, CX; Giuliano, AR; Murtaugh, MA; Risendal, BC; Byers, T; Baumgartner, KB				Yang, Dongyan; Baumgartner, Richard N.; Slattery, Martha L.; Wang, Chenxi; Giuliano, Anna R.; Murtaugh, Maureen A.; Risendal, Betsy C.; Byers, Tim; Baumgartner, Kathy B.			Dietary Intake of Folate, B-Vitamins and Methionine and Breast Cancer Risk among Hispanic and Non-Hispanic White Women	PLOS ONE			English	Article							ONE-CARBON METABOLISM; SOUTHWESTERN UNITED-STATES; ESTROGEN-RECEPTOR STATUS; MTHFR POLYMORPHISMS; BODY-SIZE; POSTMENOPAUSAL WOMEN; GENE POLYMORPHISMS; COLON-CANCER; ALCOHOL; NUTRIENTS	Background: Low dietary folate intake is associated with several neoplasias, but reports are inconsistent for breast cancer. Additionally, the association of folate with breast cancer estrogen receptor (ER) status is not well established. Objective: To determine if dietary intakes of folate, B-vitamins (B-2, B-6, B-12) and methionine are associated with breast cancer risk and ER status in Hispanic, and non-Hispanic White women in the southwestern US. Materials and Methods: Primary breast cancer cases (n = 2,325) in the 4-Corners region (Arizona, Colorado, New Mexico and Utah), diagnosed between October 1999 and May 2004, were identified through state cancer registries. Controls (n = 2,525) were frequency-matched by ethnicity and age (+/- 5 years). Dietary intake, physical activity and other exposures were assessed using in-person interviews. Risk was assessed through multivariable and multinomial logistic regression with adjustment for relevant covariates. Result: While there was no overall association with breast cancer, the highest quartile of folate intake was marginally inversely associated with ER- breast cancer (Odds Ratio (OR) = 0.50, 95% CI 0.25-1.00, p for trend = 0.07). Vitamin B-12 intake was inversely associated with breast cancer also (OR = 0.73, 95% CI 0.53-1.00, p for trend = 0.06), particularly for the highest quartile of ER+ breast cancer (OR = 0.67, 95% CI 0.46-0.99, p for trend = 0.06), among NHW women (OR = 0.49, 95% CI 0.29-0.81, p for trend = 0.01) and invasive breast cancer (OR = 0.63; 95% CI: 0.42, 0.93, P-trend = 0.01). Methionine intake was also inversely associated with ER+ breast cancer (OR for 4th quartile = 0.83, 95% CI 0.66-1.03, p for trend = 0.04), primarily among Hispanic women (OR = 0.71, 95% CI 0.47-1.06, and P for trend = 0.02). Conclusion: Higher intake of folate is marginally associated with a lower risk for ER- breast cancer, and higher intakes of vitamin B-12 and methionine are marginally associated with a lower risk of ER+ breast cancer.	[Yang, Dongyan; Baumgartner, Richard N.; Wang, Chenxi; Baumgartner, Kathy B.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA; [Slattery, Martha L.; Murtaugh, Maureen A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Risendal, Betsy C.; Byers, Tim] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA	University of Louisville; Utah System of Higher Education; University of Utah; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Yang, DY (corresponding author), Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA.	d0yang01@louisville.edu	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Cancer Institute [CA 078682, CA 078762, CA078552, CA078802, N01-PC-67000]; Utah Cancer Registry; State of Utah Department of Health	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Utah Cancer Registry; State of Utah Department of Health	This research was supported by the grants from the National Cancer Institute (CA 078682, CA 078762, CA078552, and CA078802). This research also was supported by the Utah Cancer Registry, which is funded by Contract #N01-PC-67000 from the National Cancer Institute, and with additional support from the State of Utah Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Baumgartner Kathy B., 2002, Ethnicity & Disease, V12, P460; Buechley RW, 1976, GEN USEFUL ETHNIC SE; Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; DuBose Katrina D, 2007, J Phys Act Health, V4, P343; Durnitrescu RG, 2005, ALCOHOL, V35, P213, DOI 10.1016/j.alcohol.2005.04.005; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; HOWARD CA, 1983, AM J EPIDEMIOL, V117, P27, DOI 10.1093/oxfordjournals.aje.a113512; Institute of Medicine, 1998, DIET REF INT THIAM R, P1; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Koutros S, 2008, AM J EPIDEMIOL, V167, P287, DOI 10.1093/aje/kwm307; Lajous M, 2006, CANCER EPIDEM BIOMAR, V15, P443, DOI 10.1158/1055-9965.EPI-05-0532; Lajous M, 2006, CANCER CAUSE CONTROL, V17, P1209, DOI 10.1007/s10552-006-0053-3; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Levi F, 2001, INT J CANCER, V91, P260, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1041&gt;3.3.CO;2-R; Lewis SJ, 2006, JNCI-J NATL CANCER I, V98, P1607, DOI 10.1093/jnci/djj440; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Murtaugh MA, 2008, AM J CLIN NUTR, V87, P978, DOI 10.1093/ajcn/87.4.978; Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008; Murtaugh MA, 2007, CANCER CAUSE CONTROL, V18, P153, DOI 10.1007/s10552-006-0099-2; Negri E, 2000, J NATL CANCER I, V92, P1270, DOI 10.1093/jnci/92.15.1270-a; Osborne CK, 1991, BREAST DIS, P301; Prinz-Langenohl R, 2001, EUR J NUTR, V40, P98, DOI 10.1007/PL00007387; Risendal B, 2008, CANC CAUSES CONTROL; Rogers A, 2004, AM J EPIDEMIOL, V160, P85, DOI 10.1093/aje/kwh176; Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266; Rollison DE, 2008, AM J EPIDEMIOL, V167, P447, DOI 10.1093/aje/kwm322; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sellers TA, 2002, CANCER EPIDEM BIOMAR, V11, P1104; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Shrubsole MJ, 2004, CANCER EPIDEM BIOMAR, V13, P190, DOI 10.1158/1055-9965.EPI-03-0273; Shrubsole MJ, 2001, CANCER RES, V61, P7136; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Slattery ML, 2008, OBESITY, V16, P339, DOI 10.1038/oby.2007.44; Slattery ML, 2007, BREAST CANCER RES TR, V105, P327, DOI 10.1007/s10549-006-9453-z; Slattery ML, 2007, ANN EPIDEMIOL, V17, P342, DOI 10.1016/j.annepidem.2006.10.017; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPI-06-0667; Slattery ML, 2007, BREAST CANCER RES TR, V102, P85, DOI 10.1007/s10549-006-9292-y; SLATTERY ML, 1994, J AM DIET ASSOC, V94, P761, DOI 10.1016/0002-8223(94)91944-5; Slattery ML, 2005, CANCER CAUSE CONTROL, V16, P1147, DOI 10.1007/s10552-005-0318-2; STANFORD JL, 1989, AM J PUBLIC HEALTH, V79, P71, DOI 10.2105/AJPH.79.1.71; Steffen AD, 2008, CANCER EPIDEM BIOMAR, V17, P447, DOI 10.1158/1055-9965.EPI-07-2576; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Suzuki T, 2008, CARCINOGENESIS, V29, P356, DOI 10.1093/carcin/bgm295; Sweeney C, 2008, CANCER CAUSE CONTROL, V19, P391, DOI 10.1007/s10552-007-9098-1; Sweeney C, 2007, AM J EPIDEMIOL, V166, P1210, DOI 10.1093/aje/kwm192; Sweeney C, 2007, CANCER EPIDEM BIOMAR, V16, P142, DOI 10.1158/1055-9965.EPI-06-0706; Ulrich CM, 2006, NUTRIENT-GENE INTERACTIONS IN CANCER, P75, DOI 10.1201/9781420004847.ch5; Ulrich CM, 2007, AM J CLIN NUTR, V86, P271, DOI 10.1093/ajcn/86.2.271; Wang C, 2008, BREAST CANC RES TREA; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2012, NUTR EPIDEMIOLOGY; Word DL, 1996, 13 US BUR CENS POP D, P1; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; Zhu KM, 1998, CANCER CAUSE CONTROL, V9, P615, DOI 10.1023/A:1008819210777	78	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54495	10.1371/journal.pone.0054495	http://dx.doi.org/10.1371/journal.pone.0054495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23667467	gold, Green Published, Green Submitted			2022-12-25	WOS:000315100000006
J	Yang, DZ; Wang, W; Li, LP; Peng, YL; Chen, P; Huang, HY; Guo, YL; Xia, XW; Wang, YY; Wang, HY; Wang, WE; Zeng, CY				Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Huang, Haiyun; Guo, Yanli; Xia, Xuewei; Wang, Yuanyuan; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu			The Relative Contribution of Paracine Effect versus Direct Differentiation on Adipose-Derived Stem Cell Transplantation Mediated Cardiac Repair	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FUNCTIONAL IMPROVEMENT; REGENERATIVE MEDICINE; PARACRINE MECHANISMS; CONDITIONED MEDIUM; STROMAL CELLS; IN-VITRO; HEART; THERAPY; DISEASE	Background: Recent studies have demonstrated that transplantation of adipose-derived stem cell (ADSC) can improve cardiac function in animal models of myocardial infarction (MI). However, the mechanisms underlying the beneficial effect are not fully understood. In this study, we characterized the paracrine effect of transplanted ADSC and investigated its relative importance versus direct differentiation in ADSC transplantation mediated cardiac repair. Methodology/Principal Findings: MI was experimentally induced in mice by ligation of the left anterior descending coronary artery. Either human ADSC, conditioned medium (CM) collected from the same amount of ADSC or control medium was injected into the peri-infarct region immediately after MI. Compared with the control group, both ADSC and ADSC-CM significantly reduced myocardial infarct size and improved cardiac function. The therapeutic efficacy of ADSC was moderately superior to ADSC-CM. ADSC-CM significantly reduced cardiomyocyte apoptosis in the infarct border zone, to a similar degree with ADSC treatment. ADSC enhanced angiogenesis in the infarct border zone, but to a stronger degree than that seen in the ADSC-CM treatment. ADSC was able to differentiate to endothelial cell and smooth muscle cell in post-MI heart; these ADSC-derived vascular cells amount to about 9% of the enhanced angiogenesis. No cardiomyocyte differentiated from ADSC was found. Conclusions: ADSC-CM is sufficient to improve cardiac function of infarcted hearts. The therapeutic function of ADSC transplantation is mainly induced by paracrine-mediated cardioprotection and angiogenesis, while ADSC differentiation contributes a minor benefit by being involved in angiogenesis. Highlights 1 ADSC-CM is sufficient to exert a therapeutic potential. 2. ADSC was able to differentiate to vascular cells but not cardiomyocyte. 3. ADSC derived vascular cells amount to about 9% of the enhanced angiogenesis. 4. Paracrine effect is the major mechanism of ADSC therapeutic function for MI.	[Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Xia, Xuewei; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Huang, Haiyun; Guo, Yanli] Third Mil Med Univ, Southwest Hosp, Dept Ultrasonog, Chongqing, Peoples R China; [Wang, Yuanyuan] Third Mil Med Univ, Daping Hosp, Dept Plast Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Wang, WE (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	wangw28@gmail.com; cyzeng1@hotmail.com	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Natural Science Foundation of China [31130029, 81100111, 30925018]; Natural Science Foundation Project of CQ CSTC (CSTC) [2009BA5044]; National Basic Research Program of China (973 Program) [2008CB517308, 2012CB517801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC (CSTC)(Natural Science Foundation Project of CQ CSTC); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the grants from the National Natural Science Foundation of China (31130029, 81100111, 30925018), Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA5044), and National Basic Research Program of China (973 Program, 2008CB517308, 2012CB517801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Christoffels V, 2011, NATURE, V474, P585, DOI 10.1038/474585a; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Deveza L, 2013, STEM CELLS DEV, V22, P483, DOI 10.1089/scd.2012.0201; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li XH, 2007, J MOL CELL CARDIOL, V42, P295, DOI 10.1016/j.yjmcc.2006.07.002; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Ramkisoensing AA, 2012, STEM CELLS, V30, P1236, DOI 10.1002/stem.1086; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sanchez PL, 2010, EUR HEART J, V31, P394, DOI 10.1093/eurheartj/ehp403; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xiong DZ, 2010, J MOL CELL CARDIOL, V48, P211, DOI 10.1016/j.yjmcc.2009.07.003; Yang JJ, 2012, TOHOKU J EXP MED, V226, P231, DOI 10.1620/tjem.226.231; Zhang HY, 2010, CIRC RES, V107, P800, DOI 10.1161/CIRCRESAHA.110.219220	40	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59020	10.1371/journal.pone.0059020	http://dx.doi.org/10.1371/journal.pone.0059020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23667467	gold, Green Published, Green Submitted			2022-12-25	WOS:000317562100066
J	Li, FZ; Li, LB; Zhong, Y; Xie, QD; Huang, JH; Kang, XJ; Wang, D; Xu, L; Huang, TH				Li, FangZheng; Li, LianBing; Zhong, Ying; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua			Relationship between LTR Methylation and gag Expression of HIV-1 in Human Spermatozoa and SpermDerived Embryos	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GERM-CELL DEVELOPMENT; PATERNAL GENOME; ACTIVE DEMETHYLATION; DNA METHYLATION; HUMAN-SPERM; VERTICAL TRANSMISSION; PARENTAL ALLELES; MOUSE EMBRYO; GENE	Objective: Studying the methylation status of long terminal repeats (LTR) and its relationship to gag expression of HIV-1 in order to explore regulation mechanism of HIV-1 gene expression in vertical transmission from sperm to embryo. Methods/Principal Findings: Sperm samples were collected from a healthy donor and seven patients with HIV/AIDS. Zona-free hamster ova were fertilized by donor's spermatozoa transfected with pIRES2-EGFP-LTR-gag and patient's spermatozoa to obtain zygotes and 2-cell embryos, respectively. Interspecific in vitro fertilization, bisulfite sequencing PCR (BSP), RT-PCR, nested RT-PCR, nested real-time qRT-PCR and 2(-Delta Delta Ct) method, indirect immunofluoresence (IF) assay were performed. For donor's samples, the methylation rates of HIV-1 LTR were 0.56%, 1.67%, 0.56%, 0.56% in plasmid, spermatozoa, zygotes and 2-cell embryos, respectively while spermatozoa were transfected with unmethylated plasmid, and were 95.0%, 84.44%, 3.3%, 1.67% while transfected with methylated plasmid. The positive bands for HIV-1 gag cDNA were detected in spermatozoa and 2-cell embryos. The positive signals for HIV-1 p24 Gag protein were detected in 2-cell embryos but not in spermatozoa. For patient's samples, methylation rates of HIV-1 LTR were different in spermatozoa among patients. After fertilization, CpG sites in HIV-1 LTR were highly demethylated in zygotes and 2-cell embryos. The gag transcription levels increased with decreasing of methylation rates of HIV-1 LTR, which showed a strong negative correlations between gag transcription levels and methylation rates of HIV-LTR ether in the spermatozoa (r = -0.9877, P < 0.0001) or in the sperm-derived 2-cell embryos (r = 20.9092, P = 0.0045). Conclusion: LTR methylation regulates expression of HIV-1 gag in vertical transmission from sperm to embryo.	[Li, FangZheng; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua] Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Li, LianBing] Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China; [Zhong, Ying] Chengdu Jinjiang Hosp Maternal & Child Hlth Care, Ctr Reprod Med, Chengdu, Sichuan, Peoples R China	Shantou University	Huang, TH (corresponding author), Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	thhuang@stu.edu.cn	; Scott, Maxwell/J-1935-2015	li, feng/0000-0003-2227-9893; Scott, Maxwell/0000-0001-6536-4735	National Natural Science Foundation of China; Li Ka Shing Shantou University Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Shantou University Foundation	This work was financially supported by the National Natural Science Foundation of China and the Li Ka Shing Shantou University Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Ali BA, 2006, ASIAN J ANDROL, V8, P273, DOI 10.1111/j.1745-7262.2006.00141.x; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; BACHILLER D, 1991, MOL REPROD DEV, V30, P194, DOI 10.1002/mrd.1080300305; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; BAGASRA O, 1988, J ACQ IMMUN DEF SYND, V1, P431; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gao YS, 2009, CURR HIV RES, V7, P562, DOI 10.2174/157016209789346237; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KOHLER M, 1995, INFUSIONSTHERAPIE, V22, P46; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; McGowan JP, 2000, J ANTIMICROB CHEMOTH, V46, P657, DOI 10.1093/jac/46.5.657; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; RAHE B, 1983, NUCLEIC ACIDS RES, V11, P7947, DOI 10.1093/nar/11.22.7947; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028586; Wang DA, 2011, J MED VIROL, V83, P16, DOI 10.1002/jmv.21767; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	37	122	130	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54801	10.1371/journal.pone.0054801	http://dx.doi.org/10.1371/journal.pone.0054801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23409170	Green Submitted, Green Published, gold			2022-12-25	WOS:000315211500028
J	Ai, HS; Huang, LS; Ren, J				Ai, Huashui; Huang, Lusheng; Ren, Jun			Genetic Diversity, Linkage Disequilibrium and Selection Signatures in Chinese and Western Pigs Revealed by Genome-Wide SNP Markers	PLOS ONE			English	Article							B RECEPTOR GENE; DOMESTIC PIG; ADAPTATION; DELETION; TRAITS; ORIGIN; BREEDS; EXTENT	To investigate population structure, linkage disequilibrium (LD) pattern and selection signature at the genome level in Chinese and Western pigs, we genotyped 304 unrelated animals from 18 diverse populations using porcine 60 K SNP chips. We confirmed the divergent evolution between Chinese and Western pigs and showed distinct topological structures of the tested populations. We acquired the evidence for the introgression of Western pigs into two Chinese pig breeds. Analysis of runs of homozygosity revealed that historical inbreeding reduced genetic variability in several Chinese breeds. We found that intrapopulation LD extents are roughly comparable between Chinese and Western pigs. However, interpopulation LD is much longer in Western pigs compared with Chinese pigs with average r(0.3)(2) values of 125 kb for Western pigs and only 10.5 kb for Chinese pigs. The finding indicates that higher-density markers are required to capture LD with causal variants in genome-wide association studies and genomic selection on Chinese pigs. Further, we looked across the genome to identify candidate loci under selection using F-ST outlier tests on two contrast samples: Tibetan pigs versus lowland pigs and belted pigs against non-belted pigs. Interestingly, we highlighted several genes including ADAMTS12, SIM1 and NOS1 that show signatures of natural selection in Tibetan pigs and are likely important for genetic adaptation to high altitude. Comparison of our findings with previous reports indicates that the underlying genetic basis for high-altitude adaptation in Tibetan pigs, Tibetan peoples and yaks is likely distinct from one another. Moreover, we identified the strongest signal of directional selection at the EDNRB loci in Chinese belted pigs, supporting EDNRB as a promising candidate gene for the white belt coat color in Chinese pigs. Altogether, our findings advance the understanding of the genome biology of Chinese and Western pigs.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Ren, Jun/H-9793-2019; Cheng, Alfred/C-3327-2014; Wu, William K.K./A-3277-2009; Chan, Franky/M-1043-2018; Chan, Francis K.L./F-4851-2010; SUNG, Joseph J Y/R-3203-2018	Yu, Fei-Hai/0000-0001-5007-1745; Cheng, Alfred/0000-0003-2345-6951; Dong, Bi-Cheng/0000-0002-9658-9969; Wu, William K.K./0000-0002-5662-5240; Chan, Franky/0000-0003-0567-2052; Zhang, Lin/0000-0003-1634-3780; Chan, Francis K.L./0000-0001-7388-2436; SUNG, Joseph J Y/0000-0003-3125-5199	Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31160450]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1136) and National Natural Science Foundation of China (31160450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Fan B, 2002, ANIM GENET, V33, P422, DOI 10.1046/j.1365-2052.2002.00898.x; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Giuffra E, 2000, GENETICS, V154, P1785; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kline DD, 1998, J PHYSIOL-LONDON, V511, P273, DOI 10.1111/j.1469-7793.1998.273bi.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; McLaren D. G., 1990, Animal Breeding Abstracts, V58, P347; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren Jun, 2002, Acta Genetica Sinica, V29, P774; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; SVED J A, 1971, Theoretical Population Biology, V2, P125; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang SL, 2003, GENET SEL EVOL, V35, P657, DOI 10.1051/gse:2003045	42	212	229	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56001	10.1371/journal.pone.0056001	http://dx.doi.org/10.1371/journal.pone.0056001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409110	Green Submitted, gold, Green Published			2022-12-25	WOS:000315157200102
